Citrus Sinensis ID: 043148

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------
Protein Sequence
EKNKTGLIVGLLVGIGALACGLGVIWFMYWRKRVGGHKEAIDIALEDEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPMYYAPPINILKFTYTSSGVTESDKFYGTQNSGSSGSTYSSLSSAASTKALLNSQKADV
Secondary Structure (PSIPRED)
cccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccccEEcHHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEccccccHHHHHHHHHHHHHcccccccccccccEEccccEEEEEEEEHHHHHHHHHHcccccccEEEccccccccccccccccccccccccccccccccccccEEccccccccHHHHcccccccccccHHHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHccHHccccccccEEcHHHHHHHHccccHHccccccccccEEEEEccccccEEEEEEEEccccccHHHHHHHHHHHHHHHHHHHHHHHHHcccccccEEHHEHHHHHHHHHHHHHccccEEEEEcccHcHEEEcccccccHccccHHEEccccccccEEEEEEccccccHHHHHccccccHHHHHHHHHEEEHHHccccccccccccccHHHHHHHHHHHHccccHHHccccccccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
EKNKTGLIVGLLVGIGALACGLGVIWFMYWRKRVGGHKEAIDIALEdefekgtgpkrftYRELSRATNnfaeagklgeggfggvyrgllsdqnTEIAVKRVsrgskqgkkeYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQcivhrdikssnvvldsnfnaklgdfglarlvdhelgsqttVLAGTmgylapecvttgkaskesdvYSFGVVALEVAcgrkpveprqepskvRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGlwcchpdftnrpsIRQVINVLnfeaplpslpsklpvpmyyappinilkftytssgvtesdkfygtqnsgssgstysslsSAASTKALLNSQKADV
Flexible Loop (DISEMBL)
EKNKTGLIVGLLVGIGALACGLGVIWFMYWRKRVGGHKEAIDIAledefekgtgpkrfTYRELSRATNNfaeagklgegGFGGVYRGLLSDQNTEIavkrvsrgskqgkkeyisevriisrLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAcgrkpveprqepskvrlvEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPMYYAPPINILKFTYTSSGVTESDKFYGTQNSGSSGstysslssaastkallnsqkadv
Low Complexity Region (SEG)
EKNKTglivgllvgigalacglgviWFMYWRKRVGGHKEAIDIALEDEFEKGTGPKRFTYRELSRATNNfaeagklgeggfggVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAplpslpsklpvpMYYAPPINILKFTYTSSGVTESDKFYgtqnsgssgstysslssaastkallnsQKADV
Disordered region (IsUnstruct)
*****GLIVGLLVGIGALACGLGVIWFMYWRKRVGGHKEAIDIALEDEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVK***********EYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRK*********KVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPMYYAPPINILKFTYTSSGV***************************************
Disordered Region (DISOPRED)
***KTGL*VGLLVGIGALACGLGVIWFMYWRKRVG***********DEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVS******KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPV*****PSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLP************************************************************
Disordered Region (DISEMBL)
EKNKTGLIVGLLVGIGALACGLGVIWFMYWRKRVGGHKEAIDIALEDEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPMYYAPPINILKFTYTSSGVTESDKFYG*******************************
Disordered Region (DISPRO)
***KTGLIVGLLVGIGALACGLGVIWFMYWRKRVGG*******ALE***EKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPV***********************************************************
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
EKNKTGLIVGLLVGIGALACGLGVIWFMYWRKRVGGHKEAIDIALEDEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPMYYAPPINILKFTYTSSGVTESDKFYGTQNSGSSGSTYSSLSSAASTKALLNSQKADV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	387	2.2.26 [Sep-21-2011]
Q9LXA5	651	L-type lectin-domain cont	yes	no	0.852	0.506	0.546	1e-110
Q9LSL5	675	L-type lectin-domain cont	no	no	0.834	0.478	0.501	1e-101
Q9FHG4	681	Probable L-type lectin-do	no	no	0.819	0.465	0.435	5e-77
Q9LFH9	715	L-type lectin-domain cont	no	no	0.824	0.446	0.429	2e-75
O80939	675	L-type lectin-domain cont	no	no	0.695	0.398	0.461	6e-73
Q9LYX1	711	L-type lectin-domain cont	no	no	0.819	0.445	0.430	1e-71
Q9M2S4	684	L-type lectin-domain cont	no	no	0.824	0.466	0.411	2e-71
Q9FG33	652	Probable L-type lectin-do	no	no	0.844	0.501	0.404	4e-71
O81292	674	L-type lectin-domain cont	no	no	0.811	0.465	0.406	3e-70
Q9M345	677	L-type lectin-domain cont	no	no	0.713	0.407	0.449	7e-70

>sp|Q9LXA5|LRK91_ARATH L-type lectin-domain containing receptor kinase IX.1 OS=Arabidopsis thaliana GN=LECRK91 PE=2 SV=1

 Score =  399 bits (1025), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 200/366 (54%), Positives = 259/366 (70%), Gaps = 36/366 (9%)

Query: 1   EKNKTGLIVGLLVGIGALACGLGVIWFMYWRKRVGGHKEAIDI----ALEDEFEKGTGPK 56
           + +K G+I+G+ V  G +     +   + + KR    K+A +     ++ ++ E+G GP+
Sbjct: 263 QNDKKGMIIGISVS-GFVLLTFFITSLIVFLKRKQQKKKAEETENLTSINEDLERGAGPR 321

Query: 57  RFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEV 116
           +FTY++L+ A NNFA+  KLGEGGFG VYRG L+  +  +A+K+ + GSKQGK+E+++EV
Sbjct: 322 KFTYKDLASAANNFADDRKLGEGGFGAVYRGYLNSLDMMVAIKKFAGGSKQGKREFVTEV 381

Query: 117 RIISRLRHRNLVHLIGWCHEQRQLIL-----------------------H---KIALGLA 150
           +IIS LRHRNLV LIGWCHE+ + ++                       H   KI LGLA
Sbjct: 382 KIISSLRHRNLVQLIGWCHEKDEFLMIYEFMPNGSLDAHLFGKKPHLAWHVRCKITLGLA 441

Query: 151 SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGY 210
           SA+LYLHEEWEQC+VHRDIK+SNV+LDSNFNAKLGDFGLARL+DHELG QTT LAGT GY
Sbjct: 442 SALLYLHEEWEQCVVHRDIKASNVMLDSNFNAKLGDFGLARLMDHELGPQTTGLAGTFGY 501

Query: 211 LAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQ---EPSKVRLVEWVWDLYGKGQ 267
           +APE ++TG+ASKESDVYSFGVV LE+  GRK V+ RQ   EP    LVE +WDLYGKG+
Sbjct: 502 MAPEYISTGRASKESDVYSFGVVTLEIVTGRKSVDRRQGRVEPV-TNLVEKMWDLYGKGE 560

Query: 268 LLEAADGRLS-KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKL 326
           ++ A D +L    FDE+Q ECLMIVGLWC HPD   RPSI+Q I VLN EAP+P LP+K+
Sbjct: 561 VITAIDEKLRIGGFDEKQAECLMIVGLWCAHPDVNTRPSIKQAIQVLNLEAPVPHLPTKM 620

Query: 327 PVPMYY 332
           PV  Y+
Sbjct: 621 PVATYH 626

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LSL5|LRK92_ARATH L-type lectin-domain containing receptor kinase IX.2 OS=Arabidopsis thaliana GN=LECRK92 PE=2 SV=1

 Score =  369 bits (948), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 184/367 (50%), Positives = 249/367 (67%), Gaps = 44/367 (11%)

Query: 9   VGLLVGIGA--------LACGLGVIWFMYWRKRVGGHKEAIDIALEDEFEKGTGPKRFTY 60
           +GL++GI A        +     V+W    RK+     E + I++  + E+  GP++F+Y
Sbjct: 282 IGLVIGISASGFVFLTFMVITTVVVWSRKQRKKKERDIENM-ISINKDLEREAGPRKFSY 340

Query: 61  RELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIIS 120
           ++L  ATN F+   KLGEGGFG VY G L + NT +AVK++S  S+QGK E+++EV+IIS
Sbjct: 341 KDLVSATNRFSSHRKLGEGGFGAVYEGNLKEINTMVAVKKLSGDSRQGKNEFLNEVKIIS 400

Query: 121 RLRHRNLVHLIGWCHEQRQLIL---------------------------HKIALGLASAV 153
           +LRHRNLV LIGWC+E+ + +L                           +KI LGLASA+
Sbjct: 401 KLRHRNLVQLIGWCNEKNEFLLIYELVPNGSLNSHLFGKRPNLLSWDIRYKIGLGLASAL 460

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAP 213
           LYLHEEW+QC++HRDIK+SN++LDS FN KLGDFGLARL++HELGS TT LAGT GY+AP
Sbjct: 461 LYLHEEWDQCVLHRDIKASNIMLDSEFNVKLGDFGLARLMNHELGSHTTGLAGTFGYMAP 520

Query: 214 ECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPS-------KVRLVEWVWDLYGKG 266
           E V  G ASKESD+YSFG+V LE+  GRK +E  QE +       +  LVE VW+LYGK 
Sbjct: 521 EYVMKGSASKESDIYSFGIVLLEIVTGRKSLERTQEDNSDTESDDEKSLVEKVWELYGKQ 580

Query: 267 QLLEA-ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSK 325
           +L+ +  D +L ++FD+++ ECL+++GLWC HPD  +RPSI+Q I V+NFE+PLP LP K
Sbjct: 581 ELITSCVDDKLGEDFDKKEAECLLVLGLWCAHPDKNSRPSIKQGIQVMNFESPLPDLPLK 640

Query: 326 LPVPMYY 332
            PV MYY
Sbjct: 641 RPVAMYY 647

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FHG4|LRKS7_ARATH Probable L-type lectin-domain containing receptor kinase S.7 OS=Arabidopsis thaliana GN=LECRKS7 PE=2 SV=1

 Score =  288 bits (737), Expect = 5e-77,   Method: Compositional matrix adjust.
 Identities = 158/363 (43%), Positives = 220/363 (60%), Gaps = 46/363 (12%)

Query: 2   KNKTGLIVGLLVGIGALACGLGVIWFMYWR----KRVGGHKEAIDIALEDEFEKGTGPKR 57
           +++  L +GL +    L C L +  F Y+     K V   KE        + E  TG + 
Sbjct: 301 RHRHNLAIGLGISCPVLIC-LALFVFGYFTLKKWKSVKAEKEL-------KTELITGLRE 352

Query: 58  FTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVR 117
           F+Y+EL  AT  F  +  +G G FG VYR +     T  AVKR    S +GK E+++E+ 
Sbjct: 353 FSYKELYTATKGFHSSRVIGRGAFGNVYRAMFVSSGTISAVKRSRHNSTEGKTEFLAELS 412

Query: 118 IISRLRHRNLVHLIGWCHEQRQLIL----------------------------HK--IAL 147
           II+ LRH+NLV L GWC+E+ +L+L                            H+  IA+
Sbjct: 413 IIACLRHKNLVQLQGWCNEKGELLLVYEFMPNGSLDKILYQESQTGAVALDWSHRLNIAI 472

Query: 148 GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT 207
           GLASA+ YLH E EQ +VHRDIK+SN++LD NFNA+LGDFGLARL +H+    +T+ AGT
Sbjct: 473 GLASALSYLHHECEQQVVHRDIKTSNIMLDINFNARLGDFGLARLTEHDKSPVSTLTAGT 532

Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSK-VRLVEWVWDLYGKG 266
           MGYLAPE +  G A++++D +S+GVV LEVACGR+P++   E  K V LV+WVW L+ +G
Sbjct: 533 MGYLAPEYLQYGTATEKTDAFSYGVVILEVACGRRPIDKEPESQKTVNLVDWVWRLHSEG 592

Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE---APLPSLP 323
           ++LEA D RL  EFDE  M+ L++VGL C HPD   RPS+R+V+ +LN E   +P+P + 
Sbjct: 593 RVLEAVDERLKGEFDEEMMKKLLLVGLKCAHPDSNERPSMRRVLQILNNEIEPSPVPKMK 652

Query: 324 SKL 326
             L
Sbjct: 653 PTL 655

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFH9|LRK81_ARATH L-type lectin-domain containing receptor kinase VIII.1 OS=Arabidopsis thaliana GN=LECRK81 PE=1 SV=1

 Score =  282 bits (722), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 155/361 (42%), Positives = 214/361 (59%), Gaps = 42/361 (11%)

Query: 2   KNKTGLIVGLLV-GIGALACGLGVIWFMYWRKRVGGHKEAIDIALEDEF--EKGTGPKRF 58
           K   G I G++  G   LA   G ++++Y        K+   +   D F  E    PK F
Sbjct: 312 KENPGTIAGVVTAGAFFLALFAGALFWVY-------SKKFKRVERSDSFASEIIKAPKEF 364

Query: 59  TYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRI 118
           +Y+EL   T NF E+  +G G FG VYRG+L +    +AVKR S  S+  K E++SE+ I
Sbjct: 365 SYKELKAGTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQDKKNEFLSELSI 424

Query: 119 ISRLRHRNLVHLIGWCHEQRQLIL--------------------------HKIALGLASA 152
           I  LRHRNLV L GWCHE+ +++L                           KI LG+ASA
Sbjct: 425 IGSLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFESRFTLPWDHRKKILLGVASA 484

Query: 153 VLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLA 212
           + YLH E E  ++HRD+KSSN++LD +FNAKLGDFGLAR ++H+   + TV AGTMGYLA
Sbjct: 485 LAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKSPEATVAAGTMGYLA 544

Query: 213 PECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSK------VRLVEWVWDLYGKG 266
           PE + TG+AS+++DV+S+G V LEV  GR+P+E      +        LVEWVW LY +G
Sbjct: 545 PEYLLTGRASEKTDVFSYGAVVLEVVSGRRPIEKDLNVQRHNVGVNPNLVEWVWGLYKEG 604

Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKL 326
           ++  AAD RL  +FDE +M  +++VGL C HPD   RP++R V+ +L  EA +P +P   
Sbjct: 605 KVSAAADSRLEGKFDEGEMWRVLVVGLACSHPDPAFRPTMRSVVQMLIGEADVPVVPKSR 664

Query: 327 P 327
           P
Sbjct: 665 P 665

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1

 Score =  275 bits (702), Expect = 6e-73,   Method: Compositional matrix adjust.
 Identities = 137/297 (46%), Positives = 189/297 (63%), Gaps = 28/297 (9%)

Query: 54  GPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI 113
           G  RF +++L  AT  F E G LG GGFG VY+G++     EIAVKRVS  S+QG KE++
Sbjct: 331 GKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFV 390

Query: 114 SEVRIISRLRHRNLVHLIGWCHEQRQLILH---------------------------KIA 146
           +E+  I R+ HRNLV L+G+C  + +L+L                            K+ 
Sbjct: 391 AEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPEVTLNWKQRIKVI 450

Query: 147 LGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG 206
           LG+AS + YLHEEWEQ ++HRD+K+SNV+LD   N +LGDFGLARL DH    QTT + G
Sbjct: 451 LGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVG 510

Query: 207 TMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKV-RLVEWVWDLYGK 265
           T+GYLAPE   TG+A+  +DV++FG   LEVACGR+P+E +QE  +   LV+WV+ L+ K
Sbjct: 511 TLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNK 570

Query: 266 GQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSL 322
           G +L A D  +  E DE+++E ++ +GL C H D   RPS+RQV++ L  +A LP L
Sbjct: 571 GDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLRGDAKLPEL 627

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYX1|LRK82_ARATH L-type lectin-domain containing receptor kinase VIII.2 OS=Arabidopsis thaliana GN=LECRK82 PE=2 SV=1

 Score =  270 bits (691), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 154/358 (43%), Positives = 214/358 (59%), Gaps = 41/358 (11%)

Query: 4   KTGLIVGLLVGIGA--LACGLGVIWFMYWRKRVGGHKEAIDIALEDEFEKGTGPKRFTYR 61
           K+   V  +V  GA  LA   GVI ++Y +K     K     +L  E  K   P+ FTY+
Sbjct: 311 KSPAAVAGVVTAGAFFLALFAGVIIWVYSKKIKYTRKSE---SLASEIMKS--PREFTYK 365

Query: 62  ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISR 121
           EL  AT+ F+ +  +G G FG VY+G+L D    IA+KR S  S QG  E++SE+ +I  
Sbjct: 366 ELKLATDCFSSSRVIGNGAFGTVYKGILQDSGEIIAIKRCSHIS-QGNTEFLSELSLIGT 424

Query: 122 LRHRNLVHLIGWCHEQRQLIL--------------------------HKIALGLASAVLY 155
           LRHRNL+ L G+C E+ +++L                           KI LG+ASA+ Y
Sbjct: 425 LRHRNLLRLQGYCREKGEILLIYDLMPNGSLDKALYESPTTLPWPHRRKILLGVASALAY 484

Query: 156 LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPEC 215
           LH+E E  I+HRD+K+SN++LD+NFN KLGDFGLAR  +H+     T  AGTMGYLAPE 
Sbjct: 485 LHQECENQIIHRDVKTSNIMLDANFNPKLGDFGLARQTEHDKSPDATAAAGTMGYLAPEY 544

Query: 216 VTTGKASKESDVYSFGVVALEVACGRKPV-EPRQEPS-----KVRLVEWVWDLYGKGQLL 269
           + TG+A++++DV+S+G V LEV  GR+P+  P  EP      +  LV+WVW LY +G+LL
Sbjct: 545 LLTGRATEKTDVFSYGAVVLEVCTGRRPITRPEPEPGLRPGLRSSLVDWVWGLYREGKLL 604

Query: 270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLP 327
            A D RLS EF+  +M  +M+VGL C  PD   RP++R V+ +L  EA +P +P   P
Sbjct: 605 TAVDERLS-EFNPEEMSRVMMVGLACSQPDPVTRPTMRSVVQILVGEADVPEVPIAKP 661

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1

 Score =  269 bits (688), Expect = 2e-71,   Method: Compositional matrix adjust.
 Identities = 146/355 (41%), Positives = 205/355 (57%), Gaps = 36/355 (10%)

Query: 47  DEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK 106
           +E+E   GP RF+YREL +ATN F +   LG GGFG VY+G L   +  +AVKR+S  S+
Sbjct: 323 EEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESR 382

Query: 107 QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL------------------------ 142
           QG +E++SEV  I  LRHRNLV L+GWC  +  L+L                        
Sbjct: 383 QGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPEVILT 442

Query: 143 ----HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG 198
                KI  G+AS +LYLHE WEQ ++HRDIK++NV+LDS  N ++GDFGLA+L +H   
Sbjct: 443 WKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSD 502

Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW 258
              T + GT GYLAPE   +GK +  +DVY+FG V LEVACGR+P+E    P ++ +V+W
Sbjct: 503 PGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEELVMVDW 562

Query: 259 VWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP 318
           VW  +  G + +  D RL+ EFDE ++  ++ +GL C +     RP++RQV  V+  E  
Sbjct: 563 VWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQV--VMYLEKQ 620

Query: 319 LPSLPSKLPVPMYY-APPINILKFTYTSSG----VTESDKFYGTQNSGSSGSTYS 368
            PS P  +P P +  A     L     S+G      +S +FY   N  ++ S +S
Sbjct: 621 FPS-PEVVPAPDFLDANDSMCLDERSGSAGEFEDFVDSARFYSGPNETTTSSIFS 674

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FG33|LRKS5_ARATH Probable L-type lectin-domain containing receptor kinase S.5 OS=Arabidopsis thaliana GN=LECRKS5 PE=2 SV=1

 Score =  268 bits (686), Expect = 4e-71,   Method: Compositional matrix adjust.
 Identities = 151/373 (40%), Positives = 215/373 (57%), Gaps = 46/373 (12%)

Query: 11  LLVGIGALACGLGVIWFMYWRKRVGGHKEAIDIALEDEFEK-GTGPKRFTYRELSRATNN 69
            +VGIGA    L      Y R R    +   DI  E E +     P++F  REL RAT N
Sbjct: 278 FIVGIGAFLGAL------YLRSRSKAGETNPDI--EAELDNCAANPQKFKLRELKRATGN 329

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVH 129
           F    KLG+GGFG V++G    Q  +IAVKRVS  S QGK+E+I+E+  I  L HRNLV 
Sbjct: 330 FGAENKLGQGGFGMVFKGKW--QGRDIAVKRVSEKSHQGKQEFIAEITTIGNLNHRNLVK 387

Query: 130 LIGWCHEQRQLIL-----------------------------HKIALGLASAVLYLHEEW 160
           L+GWC+E+++ +L                               I  GL+ A+ YLH   
Sbjct: 388 LLGWCYERKEYLLVYEYMPNGSLDKYLFLEDKSRSNLTWETRKNIITGLSQALEYLHNGC 447

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTV-LAGTMGYLAPECVTT 218
           E+ I+HRDIK+SNV+LDS+FNAKLGDFGLAR++   E+   +T  +AGT GY+APE    
Sbjct: 448 EKRILHRDIKASNVMLDSDFNAKLGDFGLARMIQQSEMTHHSTKEIAGTPGYMAPETFLN 507

Query: 219 GKASKESDVYSFGVVALEVACGRKP----VEPRQEPSKVRLVEWVWDLYGKGQLLEAADG 274
           G+A+ E+DVY+FGV+ LEV  G+KP    V+  Q      +V W+W+LY  G + +AAD 
Sbjct: 508 GRATVETDVYAFGVLMLEVVSGKKPSYVLVKDNQNNYNNSIVNWLWELYRNGTITDAADP 567

Query: 275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPMYYAP 334
            +   FD+ +M+ ++++GL CCHP+   RPS++ V+ VL  E   P +P++ P  ++ A 
Sbjct: 568 GMGNLFDKEEMKSVLLLGLACCHPNPNQRPSMKTVLKVLTGETSPPDVPTERPAFVWPAM 627

Query: 335 PINILKFTYTSSG 347
           P +     Y+ +G
Sbjct: 628 PPSFSDIDYSLTG 640

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1

 Score =  266 bits (679), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 142/349 (40%), Positives = 209/349 (59%), Gaps = 35/349 (10%)

Query: 2   KNKTGLIVGLLVGIGALACGLGVIWFMYWRKRVGGHKEAIDIALEDEFEKGTGPKRFTYR 61
           KN+  L   LL+ +  +   + ++ F+  R+R    +       ED +E   G  R  ++
Sbjct: 294 KNRMPLFSLLLIPVLFVVSLIFLVRFIVRRRRKFAEE------FED-WETEFGKNRLRFK 346

Query: 62  ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISR 121
           +L  AT  F +   LG GGFG VYRG++     EIAVKRVS  S+QG KE+++E+  I R
Sbjct: 347 DLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGR 406

Query: 122 LRHRNLVHLIGWCHEQRQLIL---------------------------HKIALGLASAVL 154
           + HRNLV L+G+C  + +L+L                             + +G+AS + 
Sbjct: 407 MSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCPEVTLDWKQRFNVIIGVASGLF 466

Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLHEEWEQ ++HRDIK+SNV+LD+ +N +LGDFGLARL DH    QTT + GT GYLAP+
Sbjct: 467 YLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPD 526

Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSK-VRLVEWVWDLYGKGQLLEAAD 273
            V TG+A+  +DV++FGV+ LEVACGR+P+E   E  + V LV+ V+  + +G +L+A D
Sbjct: 527 HVRTGRATTATDVFAFGVLLLEVACGRRPIEIEIESDESVLLVDSVFGFWIEGNILDATD 586

Query: 274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSL 322
             L   +D+R++E ++ +GL C H D   RP++RQV+  L  +A LP L
Sbjct: 587 PNLGSVYDQREVETVLKLGLLCSHSDPQVRPTMRQVLQYLRGDATLPDL 635

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1

 Score =  265 bits (676), Expect = 7e-70,   Method: Compositional matrix adjust.
 Identities = 137/305 (44%), Positives = 186/305 (60%), Gaps = 29/305 (9%)

Query: 47  DEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK 106
           D++E   G  RF ++EL  AT  F E   LG GGFG VYRG+L     E+AVKRVS  SK
Sbjct: 324 DDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLEVAVKRVSHDSK 383

Query: 107 QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL------------------------ 142
           QG KE+++E+  I R+ HRNLV L+G+C  + +L+L                        
Sbjct: 384 QGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNPETTLDW 443

Query: 143 ---HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS 199
                I  G+AS + YLHEEWEQ ++HRD+K+SNV+LD++FN +LGDFGLARL DH    
Sbjct: 444 KQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLYDHGSDP 503

Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKV-RLVEW 258
           QTT + GT+GYLAPE   TG+A+  +DVY+FG   LEV  GR+P+E          LVEW
Sbjct: 504 QTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDTFLLVEW 563

Query: 259 VWDLYGKGQLLEAADGRL-SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA 317
           V+ L+ +G ++EA D +L S  +D  ++E ++ +GL C H D   RPS+RQV+  L  + 
Sbjct: 564 VFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPSMRQVLQYLRGDM 623

Query: 318 PLPSL 322
            LP L
Sbjct: 624 ALPEL 628

Required during pollen development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	387
255572617	637	kinase, putative [Ricinus communis] gi|2	0.974	0.591	0.727	1e-167
224095075	692	predicted protein [Populus trichocarpa]	1.0	0.559	0.732	1e-164
356523924	700	PREDICTED: L-type lectin-domain containi	0.956	0.528	0.709	1e-159
356566145	679	PREDICTED: L-type lectin-domain containi	0.956	0.544	0.713	1e-158
359496509	957	PREDICTED: L-type lectin-domain containi	0.989	0.400	0.694	1e-157
357517167	682	Lectin receptor-like kinase Tg-20 [Medic	0.948	0.538	0.666	1e-149
449432968	685	PREDICTED: L-type lectin-domain containi	0.981	0.554	0.669	1e-141
449478284	684	PREDICTED: LOW QUALITY PROTEIN: L-type l	0.981	0.555	0.667	1e-141
147789906	620	hypothetical protein VITISV_035640 [Viti	0.914	0.570	0.608	1e-136
359475597	696	PREDICTED: L-type lectin-domain containi	0.930	0.517	0.598	1e-132

>gi|255572617|ref|XP_002527242.1| kinase, putative [Ricinus communis] gi|223533418|gb|EEF35168.1| kinase, putative [Ricinus communis]

 Score =  593 bits (1528), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 301/414 (72%), Positives = 343/414 (82%), Gaps = 37/414 (8%)

Query: 2   KNKTGLIVGLLVGIGALACGLGVIWFMYWRKRVGG--HKEAIDIALEDEFEKGTGPKRFT 59
           K+KT L+VGL  G   LA G+GV+ F+YWRKR GG   +E +D +++DEFEKGTGPKRFT
Sbjct: 233 KSKTSLVVGLASGSVLLASGIGVLCFVYWRKRSGGGNEEEIVDGSMDDEFEKGTGPKRFT 292

Query: 60  YRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRII 119
           YREL+ AT+NF+EAGKLGEGGFGGVY+GLLS   TE+AVK+VSRGSKQG+KEY+SEV+II
Sbjct: 293 YRELTHATSNFSEAGKLGEGGFGGVYKGLLSGSKTEVAVKKVSRGSKQGRKEYVSEVKII 352

Query: 120 SRLRHRNLVHLIGWCHEQRQLIL--------------------------HKIALGLASAV 153
           SRLRHRNLV LIGWCHE+ + +L                          +KIALGLASA+
Sbjct: 353 SRLRHRNLVQLIGWCHERNEFLLVYEFMPNGSLDTRLFGGVTMLIWSVRYKIALGLASAL 412

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAP 213
           LYLHEEWEQC+VHRDIKSSNV+LDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAP
Sbjct: 413 LYLHEEWEQCVVHRDIKSSNVMLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAP 472

Query: 214 ECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD 273
           ECVTTGKASKESDVYSFGVVALE+ CGR+PV+ RQEP KVRLVEWVWDLYGKGQL+EA D
Sbjct: 473 ECVTTGKASKESDVYSFGVVALEITCGRRPVDVRQEPDKVRLVEWVWDLYGKGQLVEAVD 532

Query: 274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPMYYA 333
            RLS+EFDERQ+ECLMIVGLWCCHPDF +RPSIRQVINVLNFEAPLPSLP+KLPVPMYYA
Sbjct: 533 KRLSREFDERQLECLMIVGLWCCHPDFNHRPSIRQVINVLNFEAPLPSLPAKLPVPMYYA 592

Query: 334 PPINILKFTYTSSGVTESDKFYGTQNSGSSGSTYSSLSSAASTKALLNSQKADV 387
           PP+N+ KF+YTSSG+T         N+G+S ST SSL SA S K+LL  +K DV
Sbjct: 593 PPMNMCKFSYTSSGLT---------NTGTSCSTNSSLLSAESAKSLLKPEKIDV 637

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224095075|ref|XP_002310341.1| predicted protein [Populus trichocarpa] gi|222853244|gb|EEE90791.1| predicted protein [Populus trichocarpa]

 Score =  584 bits (1506), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 307/419 (73%), Positives = 348/419 (83%), Gaps = 32/419 (7%)

Query: 1   EKNKTGLIVGLLVGIGALAC-GLGVIWF-MYWRK---RVGGHKEAIDIALEDEFEKGTGP 55
           +K KTGL+VGL VGIG L   G+GV+ F + WRK   R     EAID++++DEFEKGTGP
Sbjct: 274 DKKKTGLVVGLAVGIGVLTTFGIGVLCFVLCWRKNRTRCEKDNEAIDVSMDDEFEKGTGP 333

Query: 56  KRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSD-QNTEIAVKRVSRGSKQGKKEYIS 114
           KRFTYREL RATNNFAE GKLGEGGFGGVY+GLL++  NTE+AVKRVSRGSKQGKKEY+S
Sbjct: 334 KRFTYRELIRATNNFAEGGKLGEGGFGGVYKGLLNEGTNTEVAVKRVSRGSKQGKKEYVS 393

Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQLIL--------------------------HKIALG 148
           EV+IISRLRHRNLV LIGWCHE+ +L+L                          +KIALG
Sbjct: 394 EVKIISRLRHRNLVQLIGWCHERGELLLVYEFMLNGSLDSHLFGGQVMLVWNLRYKIALG 453

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           LASA+LYLHEEWEQC+VHRDIKSSNV+LDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM
Sbjct: 454 LASALLYLHEEWEQCVVHRDIKSSNVMLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 513

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL 268
           GYLAPECVTTGKASKESDVYSFGVVALE+ CGR+PVE RQEP KVRLVEWVW+LYG+GQL
Sbjct: 514 GYLAPECVTTGKASKESDVYSFGVVALEITCGRRPVETRQEPCKVRLVEWVWNLYGEGQL 573

Query: 269 LEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPV 328
           L+A D  L  +FDERQMECLMIVGLWCCHPD+T RPSIRQVINVLNFEAPLP+LPSKLPV
Sbjct: 574 LDAVDKMLCTDFDERQMECLMIVGLWCCHPDYTLRPSIRQVINVLNFEAPLPTLPSKLPV 633

Query: 329 PMYYAPPINILKFTYTSSGVTESDKFYGTQNSGSSGSTYSSLSSAASTKALLNSQKADV 387
           PMYYAPP+++ KF+YTSSG+T   + Y TQ S SS ST SS+ SA  TKALLN++K+D+
Sbjct: 634 PMYYAPPMSMCKFSYTSSGITADSERYQTQCSCSSCSTNSSMLSAGPTKALLNTRKSDI 692

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356523924|ref|XP_003530584.1| PREDICTED: L-type lectin-domain containing receptor kinase IX.1-like [Glycine max]

 Score =  566 bits (1458), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 290/409 (70%), Positives = 335/409 (81%), Gaps = 39/409 (9%)

Query: 1   EKNKTGLIVGLLVGIGA-LACGLGVIWFMYWRKRVGGHKE--AIDIALEDEFEKGTGPKR 57
           +K K GL+VGL VG+G  L C +G++WF +WR++  G +E   +D +++DEFE+GTGPKR
Sbjct: 302 KKVKVGLVVGLSVGLGCCLVCVVGLLWFTFWRRKNKGKEENLGVDASIDDEFERGTGPKR 361

Query: 58  FTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVR 117
           FTYRELS ATNNFAE GKLGEGGFGGVY+GL+ + N E+AVKRVS+GSKQGKKEY+SEVR
Sbjct: 362 FTYRELSNATNNFAEEGKLGEGGFGGVYKGLVVNSNLEVAVKRVSKGSKQGKKEYVSEVR 421

Query: 118 IISRLRHRNLVHLIGWCHEQRQLIL--------------------------HKIALGLAS 151
           +ISRLRHRNLV LIGWCHEQ +L+L                          HK+ALGLAS
Sbjct: 422 VISRLRHRNLVQLIGWCHEQGELLLVYEYMPNGSLDSHIFGNRVMLSWVVRHKVALGLAS 481

Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL 211
           A+LYLHEEWEQC+VHRDIKSSNV+LD+NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL
Sbjct: 482 ALLYLHEEWEQCVVHRDIKSSNVMLDANFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL 541

Query: 212 APECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA 271
           APECVTTGK+SKESDVYSFGVVALE+ CGRKPVE R+EPSKVRLVEWVW LYGKG+LLEA
Sbjct: 542 APECVTTGKSSKESDVYSFGVVALEITCGRKPVEVREEPSKVRLVEWVWSLYGKGKLLEA 601

Query: 272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPMY 331
           AD +L+ EF+E+QMECLMIVGLWCCHPD T RPSIRQVI+VLN EAPLPSLPSKLPVPMY
Sbjct: 602 ADKKLNWEFEEQQMECLMIVGLWCCHPDHTMRPSIRQVISVLNLEAPLPSLPSKLPVPMY 661

Query: 332 YAPPINILKFTYTSSGVTESDKFYGTQNSGSSGSTYSSLSSAASTKALL 380
           YAPP+++ KF+YTSSGVT + K           S YSS+ SA S K+LL
Sbjct: 662 YAPPMDMCKFSYTSSGVTSTTK---------ESSPYSSM-SAGSGKSLL 700

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356566145|ref|XP_003551295.1| PREDICTED: L-type lectin-domain containing receptor kinase IX.1-like [Glycine max]

 Score =  565 bits (1456), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 284/398 (71%), Positives = 329/398 (82%), Gaps = 28/398 (7%)

Query: 1   EKNKTGLIVGLLVGIGALACGLGVIWFMYWRKRVGGHKE--AIDIALEDEFEKGTGPKRF 58
           +K K GL+VGL VG+G L C +G++WF +WR++  G ++   +D +++DEFE+GTGPKRF
Sbjct: 280 KKVKVGLVVGLSVGLGCLVCVVGLLWFTFWRRKNKGKEDNLGVDASIDDEFERGTGPKRF 339

Query: 59  TYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRI 118
           TY ELS ATNNFAE GKLGEGGFGGVY+G++   N E+AVKRVS+GSKQGKKEY+SEVR+
Sbjct: 340 TYPELSNATNNFAEEGKLGEGGFGGVYKGIVVHSNLEVAVKRVSKGSKQGKKEYVSEVRV 399

Query: 119 ISRLRHRNLVHLIGWCHEQRQLIL--------------------------HKIALGLASA 152
           ISRLRHRNLV LIGWCHEQ +L+L                          HK+ALGLASA
Sbjct: 400 ISRLRHRNLVQLIGWCHEQGELLLVYEYMPNGSLDSHLFGNRVMLSWVVRHKVALGLASA 459

Query: 153 VLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLA 212
           +LYLHEEWEQC+VHRDIKSSNV+LD+NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLA
Sbjct: 460 LLYLHEEWEQCVVHRDIKSSNVMLDANFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLA 519

Query: 213 PECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA 272
           PECVTTGK+SKESDVYSFGVVALE+ CGRKPVE R+EPSKVRLVEWVW LYGKG+LLEAA
Sbjct: 520 PECVTTGKSSKESDVYSFGVVALEITCGRKPVEVREEPSKVRLVEWVWSLYGKGKLLEAA 579

Query: 273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPMYY 332
           D +L+ EF+E+QMECLMIVGLWCCHPD T RPSIRQVI+VLNFEAPLPSLPSKLPVPMYY
Sbjct: 580 DQKLNWEFEEQQMECLMIVGLWCCHPDHTMRPSIRQVISVLNFEAPLPSLPSKLPVPMYY 639

Query: 333 APPINILKFTYTSSGVTESDKFYGTQNSGSSGSTYSSL 370
           APP+++ KF+YTSSGVT + K     +S S GS  S L
Sbjct: 640 APPMDMCKFSYTSSGVTSTTKASSPYSSISEGSGKSLL 677

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496509|ref|XP_003635251.1| PREDICTED: L-type lectin-domain containing receptor kinase IX.1-like [Vitis vinifera]

 Score =  560 bits (1442), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 289/416 (69%), Positives = 327/416 (78%), Gaps = 33/416 (7%)

Query: 2   KNKTGLIVGLLVGIGALACGLGVIWFMYWRKRVGGHKE--AIDIALEDEFEKGTGPKRFT 59
           K   GL+V L+V IG L CG G  WF++WRKRVG  KE  A+++A++DEFEKGTGPKRFT
Sbjct: 545 KKSFGLVVALVVTIGVLTCGSGGYWFIWWRKRVGPRKEDMALELAIDDEFEKGTGPKRFT 604

Query: 60  YRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRII 119
           YRELS AT NF+E GKLGEGGFGGVY+GLLSD  TE+AVKRVSRGSKQGKKEY+SEV+II
Sbjct: 605 YRELSHATKNFSEEGKLGEGGFGGVYKGLLSDSKTEVAVKRVSRGSKQGKKEYVSEVKII 664

Query: 120 SRLRHRNLVHLIGWCHEQRQLIL--------------------------HKIALGLASAV 153
           SRLRHRNLV LIGWCHE  +L+L                          +KIALGLAS++
Sbjct: 665 SRLRHRNLVQLIGWCHEHGELLLVYEFMPNGSLDTHLFGGNSTLTWTVRYKIALGLASSL 724

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAP 213
           LYLHEEWEQC+VHRDIKSSN++LDSNFNAKLGDFGLAR VDHELGSQTTVLAGTMGYLAP
Sbjct: 725 LYLHEEWEQCVVHRDIKSSNIMLDSNFNAKLGDFGLARFVDHELGSQTTVLAGTMGYLAP 784

Query: 214 ECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD 273
           ECVTTGKASKESDVYSFGVVALE+ CGR+PVEPR EPSK RLVEWVW LYGKGQL EA D
Sbjct: 785 ECVTTGKASKESDVYSFGVVALEITCGRRPVEPRAEPSKTRLVEWVWSLYGKGQLFEAVD 844

Query: 274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPMYYA 333
             LS EFD+RQMECLM VGLWCCHPD T+RPSIRQVINVL+FEAPLP+LP  +PVPMY+A
Sbjct: 845 KGLSMEFDQRQMECLMTVGLWCCHPDSTHRPSIRQVINVLSFEAPLPNLPMTMPVPMYFA 904

Query: 334 PPINILKFTYTSSGVTESDKFYGTQNSGSSGS--TYSSLSSAASTKALLNSQKADV 387
           PP+++  F+YTSS      +   +  SG S +  T  S  S  S+KALL   K DV
Sbjct: 905 PPMHMCTFSYTSSATPTDSQ---SHQSGCSCNICTSDSSMSLGSSKALLKLPKPDV 957

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357517167|ref|XP_003628872.1| Lectin receptor-like kinase Tg-20 [Medicago truncatula] gi|355522894|gb|AET03348.1| Lectin receptor-like kinase Tg-20 [Medicago truncatula]

 Score =  533 bits (1373), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 274/411 (66%), Positives = 321/411 (78%), Gaps = 44/411 (10%)

Query: 4   KTGLIVGLLVGIGALACGLGVIWFMYWRKRVGGHK------EAIDIAL-EDEFEKGTGPK 56
           K GL VGL VG G+L C +G++WF +WRKR   +K         D ++ EDEFE+GTGPK
Sbjct: 282 KVGLGVGLSVGFGSLTCLVGLLWFTFWRKRKVINKGERDNNRDFDASIDEDEFERGTGPK 341

Query: 57  RFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNT-EIAVKRVSRGSKQGKKEYISE 115
           RFTY+ELS +TN F E GKLGEGGFGGVY+GLL   N  E+AVKRVS+GS+QGKKEYISE
Sbjct: 342 RFTYKELSNSTNGFDEKGKLGEGGFGGVYKGLLEKNNKLEVAVKRVSKGSRQGKKEYISE 401

Query: 116 VRIISRLRHRNLVHLIGWCHEQRQLIL--------------------------HKIALGL 149
           VRIIS+LRHRNLV L+GWCHE+ +L+L                          +KIALG+
Sbjct: 402 VRIISKLRHRNLVQLLGWCHEKSELLLVYEYMPNGSLDYHLFGKGVMLTWSVRYKIALGI 461

Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           AS++LYLHEEWEQC+VHRDIKSSNV+LD+NFNAKLGDFGLARLVDHELGSQTTVLAGTMG
Sbjct: 462 ASSLLYLHEEWEQCVVHRDIKSSNVMLDANFNAKLGDFGLARLVDHELGSQTTVLAGTMG 521

Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL 269
           YLAPECVTTGK+SKESDVYSFGVVALE+ CGR+ +E  +E  K+RLVEWVW+LYGKG+L 
Sbjct: 522 YLAPECVTTGKSSKESDVYSFGVVALEITCGRRSIESNEEAKKIRLVEWVWELYGKGELF 581

Query: 270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVP 329
           E  D  L+ EFDER+MECLM+VGLWCCHPDFT RPSIRQVINVLNFEAPLPSLPSKLPVP
Sbjct: 582 EGVDRGLNLEFDERKMECLMVVGLWCCHPDFTMRPSIRQVINVLNFEAPLPSLPSKLPVP 641

Query: 330 MYYAPPINILKFTYTSSGVTESDKFYGTQNSGSSGSTYSSLSSAASTKALL 380
           MY+APP+ + +F+YTS G+T         N+    STYSS+ SA S K+LL
Sbjct: 642 MYFAPPMEMCRFSYTSDGLT---------NTTKGSSTYSSI-SAGSRKSLL 682

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449432968|ref|XP_004134270.1| PREDICTED: L-type lectin-domain containing receptor kinase IX.1-like [Cucumis sativus]

 Score =  508 bits (1309), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 276/412 (66%), Positives = 330/412 (80%), Gaps = 32/412 (7%)

Query: 1   EKNK-TGLIVGLLVGIGALACGLGVIWFMYWRKRVGGHKEAIDIALEDEFEKGTGPKRFT 59
           +KNK TGL +GL VG+G   CGL ++   +W K++   ++ +D +++DEFEKGTGPKRFT
Sbjct: 276 DKNKNTGLAIGLGVGLGVGICGLILLGLFWWGKKLRRMEDDVDDSIDDEFEKGTGPKRFT 335

Query: 60  YRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRII 119
           YREL+RAT NF EAGKLGEGGFGGVY+GLL++ NTEIAVKRVSRGS+QGKKEYISEV+II
Sbjct: 336 YRELTRATKNFDEAGKLGEGGFGGVYKGLLTESNTEIAVKRVSRGSRQGKKEYISEVKII 395

Query: 120 SRLRHRNLVHLIGWCHEQRQLIL--------------------------HKIALGLASAV 153
           SRLRHRNLV L GWCHE+ + +L                          +KIA+GLAS++
Sbjct: 396 SRLRHRNLVQLFGWCHEKGEFLLVYEFMPNGSLDTHLFRGQTMLSWPVRYKIAIGLASSL 455

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAP 213
           LYLHEEWEQC+VHRDIKSSNV+LDSNFNAKLGDFGLAR VDHELGSQTTVLAGTMGYLAP
Sbjct: 456 LYLHEEWEQCVVHRDIKSSNVMLDSNFNAKLGDFGLARFVDHELGSQTTVLAGTMGYLAP 515

Query: 214 ECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD 273
           ECVT GKASKESDVYSFGVVALE+ACGR+PVE R EP +VRLVEWVW+ YG+G++L+ AD
Sbjct: 516 ECVTDGKASKESDVYSFGVVALEIACGRRPVESRAEPDQVRLVEWVWESYGRGEVLKTAD 575

Query: 274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPMYYA 333
            RL  EFDE+QME LM+VGLWCCHPDF  RPSIRQVIN LNFEA LP+LP+KLPVPMY+A
Sbjct: 576 KRLEMEFDEQQMEALMVVGLWCCHPDFKLRPSIRQVINALNFEASLPTLPAKLPVPMYFA 635

Query: 334 PPINILKFTYTSSGVTESDKFYGTQNSGSSGSTYSS-LSSAASTKALLNSQK 384
           P +N+  F+YTSSG T  D+   +Q S S+ STY++  S + S+ +LL SQ+
Sbjct: 636 PSMNLCNFSYTSSG-TPVDR---SQCSCSNCSTYTTQSSGSGSSVSLLKSQR 683

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449478284|ref|XP_004155273.1| PREDICTED: LOW QUALITY PROTEIN: L-type lectin-domain containing receptor kinase IX.1-like [Cucumis sativus]

 Score =  506 bits (1302), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 275/412 (66%), Positives = 329/412 (79%), Gaps = 32/412 (7%)

Query: 1   EKNK-TGLIVGLLVGIGALACGLGVIWFMYWRKRVGGHKEAIDIALEDEFEKGTGPKRFT 59
           +KNK TGL +GL VG+G   CGL ++   +W K++   ++ +D +++DEFEKGTGPKRFT
Sbjct: 275 DKNKNTGLAIGLGVGLGVGICGLILLGLFWWGKKLRRMEDDVDDSIDDEFEKGTGPKRFT 334

Query: 60  YRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRII 119
           YREL+RAT NF EAGKLGEGGFGGVY+GLL++ NTEIAVKRVSRGS+QG KEYISEV+II
Sbjct: 335 YRELTRATKNFDEAGKLGEGGFGGVYKGLLTESNTEIAVKRVSRGSRQGXKEYISEVKII 394

Query: 120 SRLRHRNLVHLIGWCHEQRQLIL--------------------------HKIALGLASAV 153
           SRLRHRNLV L GWCHE+ + +L                          +KIA+GLAS++
Sbjct: 395 SRLRHRNLVQLFGWCHEKGEFLLVYEFMPNGSLDTHLFRGQTMLSWPVRYKIAIGLASSL 454

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAP 213
           LYLHEEWEQC+VHRDIKSSNV+LDSNFNAKLGDFGLAR VDHELGSQTTVLAGTMGYLAP
Sbjct: 455 LYLHEEWEQCVVHRDIKSSNVMLDSNFNAKLGDFGLARFVDHELGSQTTVLAGTMGYLAP 514

Query: 214 ECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD 273
           ECVT GKASKESDVYSFGVVALE+ACGR+PVE R EP +VRLVEWVW+ YG+G++L+ AD
Sbjct: 515 ECVTDGKASKESDVYSFGVVALEIACGRRPVESRAEPDQVRLVEWVWESYGRGEVLKTAD 574

Query: 274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPMYYA 333
            RL  EFDE+QME LM+VGLWCCHPDF  RPSIRQVIN LNFEA LP+LP+KLPVPMY+A
Sbjct: 575 KRLEMEFDEQQMEALMVVGLWCCHPDFKLRPSIRQVINALNFEASLPTLPAKLPVPMYFA 634

Query: 334 PPINILKFTYTSSGVTESDKFYGTQNSGSSGSTYSS-LSSAASTKALLNSQK 384
           P +N+  F+YTSSG T  D+   +Q S S+ STY++  S + S+ +LL SQ+
Sbjct: 635 PSMNLCNFSYTSSG-TPVDR---SQCSCSNCSTYTTQSSGSGSSVSLLKSQR 682

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147789906|emb|CAN64986.1| hypothetical protein VITISV_035640 [Vitis vinifera]

 Score =  490 bits (1261), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 241/396 (60%), Positives = 296/396 (74%), Gaps = 42/396 (10%)

Query: 1   EKNKTGLIVGLLVGIGALACGLGVIWFMYWRKR-VGGHKEA---IDIALEDEFEKGTGPK 56
           E  KTGL+VGL VG   +  GLG++W+  W+KR  GG +E     D+A++++FEKGTGP+
Sbjct: 208 EGKKTGLMVGLSVGAFVVVAGLGLVWYYMWKKRNTGGDQEDGADSDLAMDEDFEKGTGPR 267

Query: 57  RFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEV 116
           +F++ EL+ AT+NFAE  KLGEGGFGGVYRG L + N+ +AVKRVSR S+QG KEY SEV
Sbjct: 268 KFSFYELALATSNFAEEQKLGEGGFGGVYRGFLRELNSYVAVKRVSRNSQQGMKEYASEV 327

Query: 117 RIISRLRHRNLVHLIGWCH----------------------EQRQLIL----HKIALGLA 150
           +I  RLRHRNLV L+GWCH                      E++ L+     ++IALGLA
Sbjct: 328 KIFCRLRHRNLVQLMGWCHKKEELLLVYELLPNGSLSTCLFEEKTLLTWSMRYRIALGLA 387

Query: 151 SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGY 210
           S++LYLHEEWEQC+VHRDIKSSNV+LDS+FNAKLGDFGLARLVDH  GSQTTVL+GTMGY
Sbjct: 388 SSLLYLHEEWEQCVVHRDIKSSNVMLDSDFNAKLGDFGLARLVDHGKGSQTTVLSGTMGY 447

Query: 211 LAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE 270
           +APEC  TGKASKESDVYSFG+VALE+ CGR+ VE + E +++RLVEWVWDLYG G+LLE
Sbjct: 448 MAPECFVTGKASKESDVYSFGIVALEICCGRRAVEAKVEENQIRLVEWVWDLYGVGKLLE 507

Query: 271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPM 330
           AAD RLS ++DE+QME LMIVGLWC HPD   RPS+RQ I+VLN EA LP LP K+PVPM
Sbjct: 508 AADPRLSADYDEQQMERLMIVGLWCAHPDCNARPSMRQAISVLNSEALLPLLPIKMPVPM 567

Query: 331 YYAPPI------------NILKFTYTSSGVTESDKF 354
           YYAPP             N  +F+ +S+G T+S KF
Sbjct: 568 YYAPPALQTSYSTSVSERNHTQFSNSSNGTTDSSKF 603

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359475597|ref|XP_002264871.2| PREDICTED: L-type lectin-domain containing receptor kinase IX.1-like [Vitis vinifera]

 Score =  478 bits (1229), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 237/396 (59%), Positives = 298/396 (75%), Gaps = 36/396 (9%)

Query: 1   EKNKTGLIVGLLVGIGALACGLGVIWFMYWRKR-VGGHKEA---IDIALEDEFEKGTGPK 56
           E  KTGL+VGL VG   +  GLG++W+  W+KR  GG +E     D+A++++FEKGTGP+
Sbjct: 284 EGKKTGLMVGLSVGAFVVVGGLGLVWYYMWKKRNTGGDQEDGADSDLAMDEDFEKGTGPR 343

Query: 57  RFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEV 116
           +F++ EL+ AT+NF++  KLGEGGFGGVYRG L + N+ +AVKRV+R S+QG KEY SEV
Sbjct: 344 KFSFNELALATSNFSDGEKLGEGGFGGVYRGFLGELNSYVAVKRVTRNSQQGMKEYASEV 403

Query: 117 RIISRLRHRNLVHLIGWCHEQRQLIL--------------------------HKIALGLA 150
           +I  RLRHRNLV L+GWCH++ +L+L                          ++IALGLA
Sbjct: 404 KIFCRLRHRNLVRLMGWCHQKGELLLVYELLPNGSLSTCLFEEKTLLTWAMRYRIALGLA 463

Query: 151 SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGY 210
           S++LYLHEEWEQC+VHRDIKSSNV+LDS+FNAKLG FGLARLVDH  GSQTTVLAGTMGY
Sbjct: 464 SSLLYLHEEWEQCVVHRDIKSSNVMLDSDFNAKLGYFGLARLVDHGKGSQTTVLAGTMGY 523

Query: 211 LAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE 270
           +APEC  TGKASKESDVYSFG+V LE+ CGR+ VE + E +++RLVEWVWDLYG G+LLE
Sbjct: 524 IAPECFMTGKASKESDVYSFGIVVLEICCGRRAVETKAEENQIRLVEWVWDLYGVGKLLE 583

Query: 271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPM 330
           AAD RLS ++D++QME LMIVGLWC HPD   RPS+RQ I+VLN EA LP LP K+PV M
Sbjct: 584 AADPRLSADYDDQQMERLMIVGLWCAHPDCNARPSMRQAISVLNSEALLPLLPIKMPVAM 643

Query: 331 YYAPPINILKFTYTSSGVTESDKFYGTQNSGSSGST 366
           YYAPP   L+ +Y++S ++E +    TQ S SS  T
Sbjct: 644 YYAPP--ALQTSYSTS-LSERNH---TQFSNSSNGT 673

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	387
TAIR|locus:2142499	651	AT5G10530 [Arabidopsis thalian	0.478	0.284	0.673	3e-89
TAIR|locus:2155685	675	AT5G65600 [Arabidopsis thalian	0.537	0.308	0.531	5.8e-82
TAIR|locus:2162212	681	AT5G55830 [Arabidopsis thalian	0.444	0.252	0.578	6e-68
TAIR|locus:2083986	715	AT3G53380 [Arabidopsis thalian	0.449	0.243	0.522	6.8e-65
TAIR|locus:2040681	675	RLK "receptor lectin kinase" [	0.449	0.257	0.514	3.7e-64
TAIR|locus:2099941	684	AT3G55550 [Arabidopsis thalian	0.439	0.248	0.470	1.1e-61
TAIR|locus:2143528	711	AT5G03140 [Arabidopsis thalian	0.447	0.243	0.522	1.8e-61
TAIR|locus:2196608	656	AT1G15530 [Arabidopsis thalian	0.444	0.262	0.471	3.6e-60
TAIR|locus:2133239	669	AT4G02420 [Arabidopsis thalian	0.449	0.260	0.485	4.2e-60
TAIR|locus:2084375	677	AT3G53810 [Arabidopsis thalian	0.488	0.279	0.456	1e-59

TAIR|locus:2142499 AT5G10530 [Arabidopsis thaliana (taxid:3702)]

 Score = 651 (234.2 bits), Expect = 3.0e-89, Sum P(2) = 3.0e-89
 Identities = 132/196 (67%), Positives = 152/196 (77%)

Query:   129 HLIGWCHEQRQLILH---KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLG 185
             HL G   ++  L  H   KI LGLASA+LYLHEEWEQC+VHRDIK+SNV+LDSNFNAKLG
Sbjct:   420 HLFG---KKPHLAWHVRCKITLGLASALLYLHEEWEQCVVHRDIKASNVMLDSNFNAKLG 476

Query:   186 DFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
             DFGLARL+DHELG QTT LAGT GY+APE ++TG+ASKESDVYSFGVV LE+  GRK V+
Sbjct:   477 DFGLARLMDHELGPQTTGLAGTFGYMAPEYISTGRASKESDVYSFGVVTLEIVTGRKSVD 536

Query:   246 PRQ---EPSKVRLVEWVWDLYGKGQLLEAADGRLS-KEFDERQMECLMIVGLWCCHPDFT 301
              RQ   EP    LVE +WDLYGKG+++ A D +L    FDE+Q ECLMIVGLWC HPD  
Sbjct:   537 RRQGRVEPV-TNLVEKMWDLYGKGEVITAIDEKLRIGGFDEKQAECLMIVGLWCAHPDVN 595

Query:   302 NRPSIRQVINVLNFEA 317
              RPSI+Q I VLN EA
Sbjct:   596 TRPSIKQAIQVLNLEA 611

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2155685 AT5G65600 [Arabidopsis thaliana (taxid:3702)]

 Score = 597 (215.2 bits), Expect = 5.8e-82, Sum P(2) = 5.8e-82
 Identities = 119/224 (53%), Positives = 157/224 (70%)

Query:   141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ 200
             I +KI LGLASA+LYLHEEW+QC++HRDIK+SN++LDS FN KLGDFGLARL++HELGS 
Sbjct:   448 IRYKIGLGLASALLYLHEEWDQCVLHRDIKASNIMLDSEFNVKLGDFGLARLMNHELGSH 507

Query:   201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPS-------KV 253
             TT LAGT GY+APE V  G ASKESD+YSFG+V LE+  GRK +E  QE +       + 
Sbjct:   508 TTGLAGTFGYMAPEYVMKGSASKESDIYSFGIVLLEIVTGRKSLERTQEDNSDTESDDEK 567

Query:   254 RLVEWVWDLYGKGQLLEAA-DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINV 312
              LVE VW+LYGK +L+ +  D +L ++FD+++ ECL+++GLWC HPD  +RPSI+Q I V
Sbjct:   568 SLVEKVWELYGKQELITSCVDDKLGEDFDKKEAECLLVLGLWCAHPDKNSRPSIKQGIQV 627

Query:   313 LNFEAXXXXXXXXXXXXMYY--------APPINILKFTYTSSGV 348
             +NFE+            MYY        +P +N    + T SG+
Sbjct:   628 MNFESPLPDLPLKRPVAMYYISTTTSSSSPSVNSNGVSVTFSGI 671

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009723 "response to ethylene stimulus" evidence=RCA

TAIR|locus:2162212 AT5G55830 [Arabidopsis thaliana (taxid:3702)]

 Score = 533 (192.7 bits), Expect = 6.0e-68, Sum P(2) = 6.0e-68
 Identities = 100/173 (57%), Positives = 133/173 (76%)

Query:   145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL 204
             IA+GLASA+ YLH E EQ +VHRDIK+SN++LD NFNA+LGDFGLARL +H+    +T+ 
Sbjct:   470 IAIGLASALSYLHHECEQQVVHRDIKTSNIMLDINFNARLGDFGLARLTEHDKSPVSTLT 529

Query:   205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSK-VRLVEWVWDLY 263
             AGTMGYLAPE +  G A++++D +S+GVV LEVACGR+P++   E  K V LV+WVW L+
Sbjct:   530 AGTMGYLAPEYLQYGTATEKTDAFSYGVVILEVACGRRPIDKEPESQKTVNLVDWVWRLH 589

Query:   264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE 316
              +G++LEA D RL  EFDE  M+ L++VGL C HPD   RPS+R+V+ +LN E
Sbjct:   590 SEGRVLEAVDERLKGEFDEEMMKKLLLVGLKCAHPDSNERPSMRRVLQILNNE 642

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

TAIR|locus:2083986 AT3G53380 [Arabidopsis thaliana (taxid:3702)]

 Score = 482 (174.7 bits), Expect = 6.8e-65, Sum P(2) = 6.8e-65
 Identities = 94/180 (52%), Positives = 128/180 (71%)

Query:   144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
             KI LG+ASA+ YLH E E  ++HRD+KSSN++LD +FNAKLGDFGLAR ++H+   + TV
Sbjct:   476 KILLGVASALAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKSPEATV 535

Query:   204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSK------VRLVE 257
              AGTMGYLAPE + TG+AS+++DV+S+G V LEV  GR+P+E      +        LVE
Sbjct:   536 AAGTMGYLAPEYLLTGRASEKTDVFSYGAVVLEVVSGRRPIEKDLNVQRHNVGVNPNLVE 595

Query:   258 WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA 317
             WVW LY +G++  AAD RL  +FDE +M  +++VGL C HPD   RP++R V+ +L  EA
Sbjct:   596 WVWGLYKEGKVSAAADSRLEGKFDEGEMWRVLVVGLACSHPDPAFRPTMRSVVQMLIGEA 655

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 483 (175.1 bits), Expect = 3.7e-64, Sum P(2) = 3.7e-64
 Identities = 90/175 (51%), Positives = 125/175 (71%)

Query:   144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
             K+ LG+AS + YLHEEWEQ ++HRD+K+SNV+LD   N +LGDFGLARL DH    QTT 
Sbjct:   448 KVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTH 507

Query:   204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKV-RLVEWVWDL 262
             + GT+GYLAPE   TG+A+  +DV++FG   LEVACGR+P+E +QE  +   LV+WV+ L
Sbjct:   508 VVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGL 567

Query:   263 YGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA 317
             + KG +L A D  +  E DE+++E ++ +GL C H D   RPS+RQV++ L  +A
Sbjct:   568 WNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLRGDA 622

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)]

 Score = 434 (157.8 bits), Expect = 1.1e-61, Sum P(2) = 1.1e-61
 Identities = 80/170 (47%), Positives = 115/170 (67%)

Query:   144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
             KI  G+AS +LYLHE WEQ ++HRDIK++NV+LDS  N ++GDFGLA+L +H      T 
Sbjct:   448 KIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSDPGATR 507

Query:   204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLY 263
             + GT GYLAPE   +GK +  +DVY+FG V LEVACGR+P+E    P ++ +V+WVW  +
Sbjct:   508 VVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEELVMVDWVWSRW 567

Query:   264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
               G + +  D RL+ EFDE ++  ++ +GL C +     RP++RQV+  L
Sbjct:   568 QSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYL 617

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2143528 AT5G03140 [Arabidopsis thaliana (taxid:3702)]

 Score = 476 (172.6 bits), Expect = 1.8e-61, Sum P(2) = 1.8e-61
 Identities = 94/180 (52%), Positives = 127/180 (70%)

Query:   144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
             KI LG+ASA+ YLH+E E  I+HRD+K+SN++LD+NFN KLGDFGLAR  +H+     T 
Sbjct:   473 KILLGVASALAYLHQECENQIIHRDVKTSNIMLDANFNPKLGDFGLARQTEHDKSPDATA 532

Query:   204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPV-EPRQEPS-----KVRLVE 257
              AGTMGYLAPE + TG+A++++DV+S+G V LEV  GR+P+  P  EP      +  LV+
Sbjct:   533 AAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVCTGRRPITRPEPEPGLRPGLRSSLVD 592

Query:   258 WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA 317
             WVW LY +G+LL A D RLS EF+  +M  +M+VGL C  PD   RP++R V+ +L  EA
Sbjct:   593 WVWGLYREGKLLTAVDERLS-EFNPEEMSRVMMVGLACSQPDPVTRPTMRSVVQILVGEA 651

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2196608 AT1G15530 [Arabidopsis thaliana (taxid:3702)]

 Score = 439 (159.6 bits), Expect = 3.6e-60, Sum P(2) = 3.6e-60
 Identities = 84/178 (47%), Positives = 124/178 (69%)

Query:   137 QRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE 196
             +R+ +++ +A GL     YLH  W+Q ++HRDIKSSN++LDS    +LGDFGLA+L +H 
Sbjct:   458 RRRQVINDVAEGLN----YLHHGWDQVVIHRDIKSSNILLDSEMRGRLGDFGLAKLYEHG 513

Query:   197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
                 TT + GT+GYLAPE  +    ++ SDVYSFGVV LEV  GR+P+E  +E   V LV
Sbjct:   514 GAPNTTRVVGTLGYLAPELASASAPTEASDVYSFGVVVLEVVSGRRPIEYAEEEDMV-LV 572

Query:   257 EWVWDLYGKGQLLEAADGRLSKEFDE-RQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
             +WV DLYG G++++AAD R+  E +   ++E L+ +GL CCHPD   RP++R+++++L
Sbjct:   573 DWVRDLYGGGRVVDAADERVRSECETMEEVELLLKLGLACCHPDPAKRPNMREIVSLL 630

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)]

 Score = 464 (168.4 bits), Expect = 4.2e-60, Sum P(2) = 4.2e-60
 Identities = 85/175 (48%), Positives = 126/175 (72%)

Query:   144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
             K+  G+ASA+ YLHEEWEQ ++HRD+K+SNV+LD+  N +LGDFGLA+L DH    QTT 
Sbjct:   451 KVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQLCDHGSDPQTTR 510

Query:   204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE-PRQEPSKVRLVEWVWDL 262
             + GT GYLAP+ + TG+A+  +DV++FGV+ LEVACGR+P+E   Q   +V LV+WV+  
Sbjct:   511 VVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQSGERVVLVDWVFRF 570

Query:   263 YGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA 317
             + +  +L+A D  L  E+D++++E ++ +GL C H D   RP++RQV+  L  +A
Sbjct:   571 WMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQVLQYLRGDA 625

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)]

 Score = 440 (159.9 bits), Expect = 1.0e-59, Sum P(2) = 1.0e-59
 Identities = 90/197 (45%), Positives = 128/197 (64%)

Query:   119 ISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS 178
             + +  + N    + W  +QR  I+     G+AS + YLHEEWEQ ++HRD+K+SNV+LD+
Sbjct:   429 LDKYLYNNPETTLDW--KQRSTIIK----GVASGLFYLHEEWEQVVIHRDVKASNVLLDA 482

Query:   179 NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVA 238
             +FN +LGDFGLARL DH    QTT + GT+GYLAPE   TG+A+  +DVY+FG   LEV 
Sbjct:   483 DFNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVV 542

Query:   239 CGRKPVEPRQEPSKV-RLVEWVWDLYGKGQLLEAADGRL-SKEFDERQMECLMIVGLWCC 296
              GR+P+E          LVEWV+ L+ +G ++EA D +L S  +D  ++E ++ +GL C 
Sbjct:   543 SGRRPIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCS 602

Query:   297 HPDFTNRPSIRQVINVL 313
             H D   RPS+RQV+  L
Sbjct:   603 HSDPRARPSMRQVLQYL 619

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009555 "pollen development" evidence=IMP

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	387
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-44
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-43
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-42
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-39
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-38
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-36
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-29
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-22
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-20
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-20
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-19
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-19
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-14
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-14
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.001

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  152 bits (387), Expect = 5e-44
 Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 42/266 (15%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY--ISEVRIISRLRHRNLVHLI 131
            KLG G FG VY+         +AVK + + S++ KK+     E+RI+ RL H N+V LI
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 132 GWCHEQRQ--LILH-----------------------KIALGLASAVLYLHEEWEQCIVH 166
               ++    L++                        KIAL +   + YLH      I+H
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG---IIH 121

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-ASKES 225
           RD+K  N++LD N   K+ DFGLA+ +  +  S  T   GT  Y+APE +  G     + 
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180

Query: 226 DVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM 285
           DV+S GV+  E+  G+ P        +++L+          ++L         ++     
Sbjct: 181 DVWSLGVILYELLTGKPPFSGENILDQLQLIR---------RILGPPLEFDEPKWSSGSE 231

Query: 286 ECLMIVGLWCCHPDFTNRPSIRQVIN 311
           E   ++   C + D + RP+  +++ 
Sbjct: 232 EAKDLIK-KCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  151 bits (385), Expect = 1e-43
 Identities = 61/195 (31%), Positives = 93/195 (47%), Gaps = 31/195 (15%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI-SEVRIISRLRHRNLVHLIGW 133
           KLGEG FG VY          +A+K + +   +  +E I  E++I+ +L+H N+V L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 134 CHEQRQLIL-------------------------HKIALGLASAVLYLHEEWEQCIVHRD 168
             ++ +L L                               + SA+ YLH    + IVHRD
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHS---KGIVHRD 122

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           +K  N++LD + + KL DFGLAR +D   G + T   GT  Y+APE +      K  D++
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEYMAPEVLLGKGYGKAVDIW 180

Query: 229 SFGVVALEVACGRKP 243
           S GV+  E+  G+ P
Sbjct: 181 SLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  147 bits (374), Expect = 2e-42
 Identities = 59/190 (31%), Positives = 90/190 (47%), Gaps = 33/190 (17%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI-SEVRIISRLRHRNLVHLIGWC 134
           LGEGGFG VY         ++A+K + +       E +  E+ I+ +L H N+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 135 HEQRQLIL--------------------------HKIALGLASAVLYLHEEWEQCIVHRD 168
            ++  L L                           +I L +   + YLH      I+HRD
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 169 IKSSNVVLDS-NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT-TGKASKESD 226
           +K  N++LDS N   KL DFGL++L+  +  S    + GT  Y+APE +   G  S++SD
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 227 VYSFGVVALE 236
           ++S GV+  E
Sbjct: 177 IWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  140 bits (355), Expect = 3e-39
 Identities = 77/277 (27%), Positives = 122/277 (44%), Gaps = 63/277 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNT----EIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVH 129
           KLGEG FG VY+G L  +      E+AVK +    S+Q  +E++ E RI+ +L H N+V 
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 130 LIGWCHEQRQLI--------------------------LHKIALGLASAVLYLHEEWEQC 163
           L+G C E+  L                           L   AL +A  + YL     + 
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES---KN 122

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG---YLAPECVTTGK 220
            +HRD+ + N ++  N   K+ DFGL+R +  +         G      ++APE +  GK
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD---DYYRKRGGKLPIRWMAPESLKEGK 179

Query: 221 ASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE 279
            + +SDV+SFGV+  E+   G +P  P     +V  +E++               RL + 
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP-YPGMSNEEV--LEYL-----------KNGYRLPQP 225

Query: 280 F---DERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
                E     LM   L C   D  +RP+  +++ +L
Sbjct: 226 PNCPPELYD--LM---LQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  139 bits (352), Expect = 7e-39
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 64/278 (23%)

Query: 75  KLGEGGFGGVYRGLLSDQN----TEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVH 129
           KLGEG FG VY+G L  +      E+AVK +    S+Q  +E++ E RI+ +L H N+V 
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 130 LIGWCHEQRQLI---------------------------LHKIALGLASAVLYLHEEWEQ 162
           L+G C E+  L+                           L   AL +A  + YL     +
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---K 122

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG---YLAPECVTTG 219
             +HRD+ + N ++  N   K+ DFGL+R +  +       + G      ++APE +  G
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD---DYYKVKGGKLPIRWMAPESLKEG 179

Query: 220 KASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK 278
           K + +SDV+SFGV+  E+   G    EP    S   ++E++               RL K
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGE---EPYPGMSNAEVLEYL-----------KKGYRLPK 225

Query: 279 EF---DERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
                 E  +  LM   L C   D  +RP+  +++ +L
Sbjct: 226 PPNCPPE--LYKLM---LQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  138 bits (350), Expect = 2e-38
 Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 58/275 (21%)

Query: 75  KLGEGGFGGVYRGLL----SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVH 129
           KLGEG FG VY+G L        T++AVK +  G S++ ++E++ E  I+ +L H N+V 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 130 LIGWCHEQRQLI--------------------------LHKIALGLASAVLYLHEEWEQC 163
           L+G C +   L                           L ++AL +A  + YL     + 
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES---KN 122

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG---YLAPECVTTGK 220
            VHRD+ + N ++  N   K+ DFGL+R +  +         G      ++APE +  GK
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYED--DYYRKRGGGKLPIKWMAPESLKDGK 180

Query: 221 ASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK- 278
            + +SDV+SFGV+  E+   G +P  P     +V             +LLE    RL + 
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPY-PGMSNEEVL------------ELLE-DGYRLPRP 226

Query: 279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           E    ++  LM   L C   D  +RP+  +++  L
Sbjct: 227 ENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  138 bits (349), Expect = 2e-38
 Identities = 61/200 (30%), Positives = 91/200 (45%), Gaps = 35/200 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG 132
            LG G FG VY  L  D    +AVK   +S  S++  +    E+RI+S L+H N+V   G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 133 WCHEQRQLILHKIALGLAS----------------------------AVLYLHEEWEQCI 164
                 +     I L   S                             + YLH      I
Sbjct: 67  -SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS---NGI 122

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLV-DHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           VHRDIK +N+++DS+   KL DFG A+ + D E G  T  + GT  ++APE +   +  +
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR 182

Query: 224 ESDVYSFGVVALEVACGRKP 243
            +D++S G   +E+A G+ P
Sbjct: 183 AADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  132 bits (335), Expect = 3e-36
 Identities = 77/283 (27%), Positives = 124/283 (43%), Gaps = 67/283 (23%)

Query: 75  KLGEGGFGGVYRGLLSD---QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHL 130
           KLGEG FG VY+G L     + TE+AVK +    S++ +K+++ E R++ +L H N+V L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 131 IGWCHEQRQLI----------------------------------LHKIALGLASAVLYL 156
           +G C E+  L                                   L   A+ +A  + YL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG-----YL 211
                +  VHRD+ + N ++  +   K+ DFGL+R V  +   +      T G     ++
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRWM 174

Query: 212 APECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE 270
           APE +  G  + +SDV+SFGV+  E+   G  P       S   ++E++     KG  L 
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL---SNEEVLEYL----RKGYRLP 227

Query: 271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
             +     E  E     LM   L C   D  +RP+  +++  L
Sbjct: 228 KPEY-CPDELYE-----LM---LSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  118 bits (298), Expect = 5e-31
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 37/201 (18%)

Query: 75  KLGEGGFGGVYRGL-LSDQNTEIAVKRV--SRGSKQGKKEYISEVRIISRLRHRNLVHLI 131
           ++G+G FG VY     SD      +K +  S  S++ +++ ++EV+I+ +L H N++   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKL-YVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 132 G-WCHEQR--------------QLILHKIALG--------------LASAVLYLHEEWEQ 162
             +  + +              Q I  +   G              L  A+ YLH    +
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---R 122

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRDIK  N+ L SN   KLGDFG+++++   +    TV+ GT  YL+PE       +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181

Query: 223 KESDVYSFGVVALEVACGRKP 243
            +SD++S G V  E+   + P
Sbjct: 182 YKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  114 bits (288), Expect = 1e-29
 Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 33/196 (16%)

Query: 75  KLGEGGFGGVYRGL-LSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG- 132
           K+G+GGFG VY+         E+A+K +   SK+ K++ I+E++I+ + +H N+V   G 
Sbjct: 7   KIGKGGFGEVYKARHKRTGK-EVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 133 -------W-CHEQ------RQLILHK-----------IALGLASAVLYLHEEWEQCIVHR 167
                  W   E       + L+              +   L   + YLH      I+HR
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHR 122

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           DIK++N++L S+   KL DFGL+             + GT  ++APE +       ++D+
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLS--AQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADI 180

Query: 228 YSFGVVALEVACGRKP 243
           +S G+ A+E+A G+ P
Sbjct: 181 WSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  106 bits (266), Expect = 2e-26
 Identities = 71/203 (34%), Positives = 98/203 (48%), Gaps = 36/203 (17%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLV--- 128
            K+G G FG VY  +  D    +AVK  R+     +  KE   E++++  L+H NLV   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 129 ----H---------------LIGWCHEQRQLILHKI---ALGLASAVLYLHEEWEQCIVH 166
               H               L       R L  H I    L L   + YLH      IVH
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS---HGIVH 122

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLA-RLVDHE--LGSQTTVLAGTMGYLAPECVTTGKAS- 222
           RDIK +N+ LD N   KLGDFG A +L ++   +G +   LAGT  Y+APE +T GK   
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 223 --KESDVYSFGVVALEVACGRKP 243
             + +D++S G V LE+A G++P
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 8e-25
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 39/200 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVS--RGSKQGKKEYISEVRIISRLRHRNLVHLIG 132
            +G G FG VY+GL  +    +A+K++S  +  ++  K  + E+ ++  L+H N+V  IG
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 133 WCHEQRQL--------------ILHK---------------IALGLASAVLYLHEEWEQC 163
                  L              I+ K               +  GLA    YLH   EQ 
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLA----YLH---EQG 119

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           ++HRDIK++N++   +   KL DFG+A  ++ ++      + GT  ++APE +    AS 
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMSGAST 178

Query: 224 ESDVYSFGVVALEVACGRKP 243
            SD++S G   +E+  G  P
Sbjct: 179 ASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 99.7 bits (249), Expect = 3e-24
 Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 37/197 (18%)

Query: 77  GEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGW 133
           G+G FG V      D     A+K +++     K   +  ++E RI+  L H  LV+L  W
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL--W 66

Query: 134 ---CHEQ--------------RQLILHK----------IALGLASAVLYLHEEWEQCIVH 166
                E+              R  +  K              +  A+ YLH    + I+H
Sbjct: 67  YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS---KGIIH 123

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
           RDIK  N++LD   +  + DF +A  V     + TT  +GT GY+APE +     S   D
Sbjct: 124 RDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVD 181

Query: 227 VYSFGVVALEVACGRKP 243
            +S GV A E   G++P
Sbjct: 182 WWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  100 bits (250), Expect = 1e-23
 Identities = 71/297 (23%), Positives = 116/297 (39%), Gaps = 53/297 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKE---YISEVRIISRLRH-RNLVHL 130
           KLGEG FG VY          +A+K +++  +   KE   ++ E++I++ L H  N+V L
Sbjct: 7   KLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 131 IGWCHEQRQLIL----------------------------HKIALGLASAVLYLHEEWEQ 162
             +  ++  L L                              I   + SA+ YLH    +
Sbjct: 64  YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---K 120

Query: 163 CIVHRDIKSSNVVLDSN-FNAKLGDFGLARLVDHELGSQ-----TTVLAGTMGYLAPECV 216
            I+HRDIK  N++LD +    KL DFGLA+L+     +       +   GT GY+APE +
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180

Query: 217 T---TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKV-RLVEWVWDLYGKGQLLEAA 272
                  AS  SD++S G+   E+  G  P E  +  S   + ++ + +L        + 
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP-----TPSL 235

Query: 273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVP 329
              LS    E   +    +       D  NR S    ++                + 
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292

Length = 384

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 79/284 (27%)

Query: 76  LGEGGFGGVYRGLL---SDQNTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLI 131
           +G G FG V RG L     +  ++A+K +  GS   ++ ++++E  I+ +  H N++ L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 132 GWC------------------------HEQR----QLILHKIALGLASAVLYLHEEWEQC 163
           G                          ++ +    QL+   +  G+AS + YL E     
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV--GMLRGIASGMKYLSE---MN 126

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG------YLAPECVT 217
            VHRD+ + N++++SN   K+ DFGL+R ++    + T     T G      + APE + 
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT-----TKGGKIPIRWTAPEAIA 181

Query: 218 TGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-R 275
             K +  SDV+SFG+V  EV + G +P                WD+  +  +    DG R
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP---------------YWDMSNQDVIKAVEDGYR 226

Query: 276 LSKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVL 313
           L        M+C      LM   L C   D   RP+  Q+++ L
Sbjct: 227 LPPP-----MDCPSALYQLM---LDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.3 bits (243), Expect = 3e-23
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 40/200 (20%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG- 132
            KLGEG +G VY+ +  +    +A+K V    ++  +E I E+ I+ +     +V   G 
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGS 66

Query: 133 -------W-----C-----------------HEQRQLILHKIALGLASAVLYLHEEWEQC 163
                  W     C                  E+   IL++   GL     YLH      
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE----YLHS---NK 119

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
            +HRDIK+ N++L+    AKL DFG++  +   +  + TV+ GT  ++APE +     + 
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNN 178

Query: 224 ESDVYSFGVVALEVACGRKP 243
           ++D++S G+ A+E+A G+ P
Sbjct: 179 KADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 96.7 bits (241), Expect = 5e-23
 Identities = 76/269 (28%), Positives = 117/269 (43%), Gaps = 58/269 (21%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCH 135
           +G+G FG V  G    +  ++AVK +   S    + +++E  +++ LRH NLV L+G   
Sbjct: 14  IGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 136 EQ-----------------------RQLI----LHKIALGLASAVLYLHEEWEQCIVHRD 168
           +                        R +I        AL +   + YL    E+  VHRD
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           + + NV++  +  AK+ DFGLA+       S    +  T    APE +   K S +SDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVW 183

Query: 229 SFGVVALEV-ACGRKPVEPRQEPSK--VRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM 285
           SFG++  E+ + GR P  PR  P K  V  VE       KG  +EA +G    E  +   
Sbjct: 184 SFGILLWEIYSFGRVPY-PR-IPLKDVVPHVE-------KGYRMEAPEG-CPPEVYKVMK 233

Query: 286 ECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
           +C      W    D   RP+ +Q+   L 
Sbjct: 234 DC------W--ELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 96.5 bits (241), Expect = 9e-23
 Identities = 51/224 (22%), Positives = 94/224 (41%), Gaps = 51/224 (22%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYIS-EVRIISRL-R 123
           ++F     +GEG F  V      + N E A+K + +    K+ K +Y+  E  +++RL  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 124 HRNLVHLIGWCHEQRQL--------------ILHK-----------IALGLASAVLYLHE 158
           H  ++ L     ++  L               + K            A  +  A+ YLH 
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH- 119

Query: 159 EWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA------------- 205
              + I+HRD+K  N++LD + + K+ DFG A+++D     ++                 
Sbjct: 120 --SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 206 ------GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
                 GT  Y++PE +    A K SD+++ G +  ++  G+ P
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 36/197 (18%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVH 129
           F    KLG G FG V+ GL  +    +A+K +       ++++  EV+ + RLRH++L+ 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 130 LIGWCHEQR------QLI---------------------LHKIALGLASAVLYLHEEWEQ 162
           L   C          +L+                     L  +A  +A  + YL E   Q
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---Q 123

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGK 220
             +HRD+ + N+++  +   K+ DFGLARL+  D  L S   +      + APE  + G 
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAASHGT 180

Query: 221 ASKESDVYSFGVVALEV 237
            S +SDV+SFG++  E+
Sbjct: 181 FSTKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 94.7 bits (236), Expect = 3e-22
 Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 62/272 (22%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIG 132
           G+LG G  G V + L       +AVK +     +   K+ + E+ I+ +     +V   G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 133 WCHEQRQL--------------------------ILHKIALGLASAVLYLHEEWEQCIVH 166
             +    +                          IL KIA+ +   + YLHE+ +  I+H
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIH 124

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES 225
           RD+K SN++++S    KL DFG++ +LV+    S      GT  Y+APE +     S +S
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVN----SLAKTFVGTSSYMAPERIQGNDYSVKS 180

Query: 226 DVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA---------ADGRL 276
           D++S G+  +E+A GR P  P  +P                +LL+            G+ 
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDPPDGIF-----------ELLQYIVNEPPPRLPSGKF 229

Query: 277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQ 308
           S +F  +    L      C   D   RPS ++
Sbjct: 230 SPDF--QDFVNL------CLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 94.2 bits (235), Expect = 3e-22
 Identities = 71/276 (25%), Positives = 117/276 (42%), Gaps = 60/276 (21%)

Query: 75  KLGEGGFGGVYRGL-LSDQNTEIAVKRVSRGS-KQGKKEY-ISEVRIISRLRHRNLVHLI 131
            +G+G FG V +    SD    +  K +  G+  + +K+  +SEV I+  L+H N+V   
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKI-LVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 132 GW---------------------------CHEQRQLI----LHKIALGLASAVLYLH--E 158
                                        C ++R+ I    + +I   L  A+   H   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 159 EWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT 218
           +    ++HRD+K +N+ LD+N N KLGDFGLA+++ H+  S      GT  Y++PE +  
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKTYVGTPYYMSPEQLNH 184

Query: 219 GKASKESDVYSFGVVALEVACGRKPVEPR---QEPSKVRLVEWVWDLYGKGQLLEAADGR 275
               ++SD++S G +  E+     P   R   Q  SK++         GK         R
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK--------EGK---FRRIPYR 233

Query: 276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
            S E +E     L +       PD   RPS  +++ 
Sbjct: 234 YSSELNEVIKSMLNV------DPD--KRPSTEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 94.4 bits (235), Expect = 5e-22
 Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 39/214 (18%)

Query: 75  KLGEGGFGGVYRG---LLSDQNTE-IAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVH 129
           +LGEG FG V       L D   E +AVK ++  G +Q + ++  E+ I+  L H N+V 
Sbjct: 11  QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 130 LIGWCHEQRQLILHKI----------------------------ALGLASAVLYLHEEWE 161
             G C +     L  I                            +  +   + YL     
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS--- 127

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTG 219
           Q  +HRD+ + N++++S    K+ DFGLA+++  D +           + + APEC+ T 
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187

Query: 220 KASKESDVYSFGVVALEV-ACGRKPVEPRQEPSK 252
           K S  SDV+SFGV   E+   G     P  E  +
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR 221

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 93.8 bits (234), Expect = 8e-22
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 39/199 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG-- 132
           K+GEG  G VY+        E+A+K++ R  KQ K+  I+E+ I+   +H N+V      
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84

Query: 133 ------W----------------CHEQR----QL--ILHKIALGLASAVLYLHEEWEQCI 164
                 W                 +  R    Q+  +  ++  GL     YLH    Q +
Sbjct: 85  LVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLE----YLHS---QNV 137

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
           +HRDIKS N++L  + + KL DFG A  +  E   + +V+ GT  ++APE +       +
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGPK 196

Query: 225 SDVYSFGVVALEVACGRKP 243
            D++S G++ +E+A G  P
Sbjct: 197 VDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 72/275 (26%), Positives = 125/275 (45%), Gaps = 59/275 (21%)

Query: 76  LGEGGFGGVYRGLLSDQN----TEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHL 130
           LG G FG VY+G+   +       +A+K +   +  +  KE + E  +++ + H ++V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 131 IGWC-HEQRQLIL--------------HKIALG----------LASAVLYLHEEWEQCIV 165
           +G C   Q QLI               HK  +G          +A  + YL E   + +V
Sbjct: 75  LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLV 131

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM--GYLAPECVTTGKASK 223
           HRD+ + NV++ +  + K+ DFGLA+L+D +   +     G +   ++A E +     + 
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLDVD-EKEYHAEGGKVPIKWMALESILHRIYTH 190

Query: 224 ESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE 282
           +SDV+S+GV   E+   G KP E       +  VE + DL  KG+ L             
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYE------GIPAVE-IPDLLEKGERLPQPP--------- 234

Query: 283 RQMEC---LMIVGLWCCHPDFTNRPSIRQVINVLN 314
               C   + +V + C   D  +RP+ +++IN  +
Sbjct: 235 ---ICTIDVYMVLVKCWMIDAESRPTFKELINEFS 266

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 91.6 bits (228), Expect = 3e-21
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 50/209 (23%)

Query: 74  GKLGEGGFGGVYRGLL---SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVH 129
            +LG G FG V +G+    S +  E+AVK + +     GKKE++ E  ++++L H  +V 
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 130 LIGWCHE--------------------QRQLI--------LHKIALGLASAVLYLHEEWE 161
           LIG C                      +R+ I         H++A+G+A    YL     
Sbjct: 61  LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMA----YLE---S 113

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG------YLAPEC 215
           +  VHRD+ + NV+L +   AK+ DFG++R     LG+ +     T        + APEC
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSR----ALGAGSDYYRATTAGRWPLKWYAPEC 169

Query: 216 VTTGKASKESDVYSFGVVALEV-ACGRKP 243
           +  GK S +SDV+S+GV   E  + G KP
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 91.3 bits (227), Expect = 6e-21
 Identities = 61/217 (28%), Positives = 86/217 (39%), Gaps = 40/217 (18%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQG-KKEYISEVRIISRLRHRN 126
               E  +LGEG  G V +  L +     A+K ++       +K+ + E+ I    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 127 LVHLIGWCHEQRQ-------------------------------LILHKIALGLASAVLY 155
           +V   G   ++                                  +L KIA  +   + Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 156 LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPE 214
           LH    + I+HRDIK SN++L      KL DFG    V  EL  S      GT  Y+APE
Sbjct: 121 LHS---RKIIHRDIKPSNILLTRKGQVKLCDFG----VSGELVNSLAGTFTGTSFYMAPE 173

Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPS 251
            +     S  SDV+S G+  LEVA  R P  P  EP 
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP 210

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 90.6 bits (225), Expect = 8e-21
 Identities = 64/203 (31%), Positives = 91/203 (44%), Gaps = 44/203 (21%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGK-KEYIS----EVRIISRLRHRNLVHL 130
           LG G FG VY GL  D     AVK VS        +E +     E+ ++S+L+H N+V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 131 IGWCHEQRQLI----------LHK-------------------IALGLASAVLYLHEEWE 161
           +G   E+  L           L K                   I LGL     YLH+   
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLE----YLHD--- 120

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE-CVTTGK 220
           +  VHRDIK +N+++D+N   KL DFG+A+ V     S      G+  ++APE     G 
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGSPYWMAPEVIAQQGG 178

Query: 221 ASKESDVYSFGVVALEVACGRKP 243
               +D++S G   LE+A G+ P
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 89.7 bits (222), Expect = 1e-20
 Identities = 64/189 (33%), Positives = 96/189 (50%), Gaps = 33/189 (17%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWC 134
           LG+G FG V++G L D+ T +AVK       Q  K +++SE RI+ +  H N+V LIG C
Sbjct: 3   LGKGNFGEVFKGTLKDK-TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 135 HEQRQLI---------------------------LHKIALGLASAVLYLHEEWEQCIVHR 167
             QRQ I                           L K AL  A+ + YL  E + CI HR
Sbjct: 62  -TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL--ESKNCI-HR 117

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           D+ + N ++  N   K+ DFG++R  D  + S + +    + + APE +  G+ S ESDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177

Query: 228 YSFGVVALE 236
           +S+G++  E
Sbjct: 178 WSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 29/197 (14%)

Query: 75  KLGEGGFGGVYRGLLSDQNTE---IAVKRVSRGSKQGKKE-YISEVRIISRLRHRNLVHL 130
            +GEG FG VY+G+      E   +AVK     +    +E ++ E  I+ +  H ++V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 131 IGWCHEQRQLIL---------------HKIALGLASAVLYLHE--------EWEQCIVHR 167
           IG   E    I+               +K +L LAS +LY ++        E ++  VHR
Sbjct: 73  IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRF-VHR 131

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           DI + NV++ S    KLGDFGL+R ++ E   + +     + ++APE +   + +  SDV
Sbjct: 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDV 191

Query: 228 YSFGVVALEV-ACGRKP 243
           + FGV   E+   G KP
Sbjct: 192 WMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 47/172 (27%), Positives = 75/172 (43%), Gaps = 39/172 (22%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKE------YISEVRIISRLRHRNL 127
            KLGEG +G VY+         +A+K++    +   +E       + E+ ++  L+H N+
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKI----RLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 128 VHLIGWCHEQRQLI---------LHK----------------IALGLASAVLYLHEEWEQ 162
           V L+   H +R+L          L K                I   L   + Y H     
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---H 117

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
            I+HRD+K  N++++ +   KL DFGLAR     L + T  +  T+ Y APE
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPE 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 42/212 (19%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGK--KEYISEVRIISRLRH- 124
            +  + G++G G FG V + L     T +AVKR+ R +   K  K  + ++ ++ R    
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDC 62

Query: 125 RNLVHLIG--------W------------------CHEQRQL---ILHKIALGLASAVLY 155
             +V   G        W                     +  +   IL KIA+    A+ Y
Sbjct: 63  PYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122

Query: 156 LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPE 214
           L EE +  I+HRD+K SN++LD N N KL DFG++ +LVD       T  AG   Y+APE
Sbjct: 123 LKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPE 177

Query: 215 CVTTGKASK---ESDVYSFGVVALEVACGRKP 243
            +           SDV+S G+   EVA G+ P
Sbjct: 178 RIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 33/197 (16%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLG G FG V+ GL ++  T +AVK +  G+    K++++E +I+ +LRH  L+ L   C
Sbjct: 13  KLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 135 ------------------------HEQRQLILHK---IALGLASAVLYLHEEWEQCIVHR 167
                                      R L L +   +A  +AS + YL     Q  +HR
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHR 127

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           D+ + NV++  N   K+ DFGLAR++  ++          + + APE     + S +SDV
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 228 YSFGVVALE-VACGRKP 243
           +SFG++  E V  GR P
Sbjct: 188 WSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 88.3 bits (219), Expect = 5e-20
 Identities = 71/282 (25%), Positives = 123/282 (43%), Gaps = 57/282 (20%)

Query: 67  TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVS---RGSKQGKKEYISEVRIISRLR 123
             NF    K+G+G F  VY+ +       +A+K+V        + +++ + E+ ++ +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 124 HRNLV-------------------------HLIGWCHEQRQLI----LHKIALGLASAVL 154
           H N++                          +I    +Q++LI    + K  + L SA+ 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV---LAGTMGYL 211
           ++H    + I+HRDIK +NV + +    KLGD GL R       S+TT    L GT  Y+
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYM 173

Query: 212 APECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA 271
           +PE +     + +SD++S G +  E+A  + P        K+ L    + L  K   +E 
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL----YSLCKK---IEK 222

Query: 272 AD-GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINV 312
            D   L  +    ++  L+     C +PD   RP I  V+ V
Sbjct: 223 CDYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 9e-20
 Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 38/200 (19%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCH 135
           LG G FG V+ G    +  ++A+K +  G+   + ++I E +++ +L H NLV L G C 
Sbjct: 12  LGSGQFGVVHLGKWRGK-IDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 136 EQRQL--------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDI 169
           +QR +                           L  +   +  A+ YL        +HRD+
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDL 126

Query: 170 KSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESD 226
            + N ++  +   K+ DFGLAR V   L  Q T   GT   + +  PE     + S +SD
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 227 VYSFGVVALEV-ACGRKPVE 245
           V+SFGV+  EV + G+ P E
Sbjct: 184 VWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 54/219 (24%)

Query: 74  GKLGEGGFGGVYRG----LLSDQNTEI-AVKRVSRG-SKQGKKEYISEVRIISRLRHRNL 127
            +LGEG FG V+ G    L  + + E+ AVK +    S   +K++  E  +++  +H N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 128 VHLIGWCHEQRQLI---------------------------------------LHKIALG 148
           V   G C E    I                                       L +IA+ 
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV---DHELGSQTTVLA 205
           +AS ++YL     Q  VHRD+ + N ++  +   K+GDFG++R V   D+      T+L 
Sbjct: 131 IASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 206 GTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKP 243
             + ++ PE +   K + ESDV+SFGVV  E+   G++P
Sbjct: 188 --IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 55/202 (27%), Positives = 84/202 (41%), Gaps = 36/202 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTE---IAVKRVSRGSKQG-KKEYISEVRIISRLRHRNLVHL 130
           KLG+G FG V RG  S    +   +AVK +          +++ E  I+  L H NL+ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 131 IGW--------------------CHEQRQL------ILHKIALGLASAVLYLHEEWEQCI 164
            G                        +  L       L   A+ +A+ + YL     +  
Sbjct: 62  YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRF 118

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
           +HRD+ + N++L S+   K+GDFGL R    + +       L     + APE + T   S
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178

Query: 223 KESDVYSFGVVALEV-ACGRKP 243
             SDV+ FGV   E+   G +P
Sbjct: 179 HASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 86.0 bits (214), Expect = 2e-19
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 36/198 (18%)

Query: 76  LGEGGFGGVYRGLLSDQNTE--IAVKRVSRGS--KQGKKEY-ISEVRIISRLRHRNLVHL 130
           LG+G FG V   L+  ++T    A+K + +    K+ + E+ ++E  I+SR+ H  +V L
Sbjct: 1   LGKGSFGKVL--LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 131 I------------------G--WCHEQRQLIL-----HKIALGLASAVLYLHEEWEQCIV 165
                              G  + H  ++           A  +  A+ YLH      I+
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHS---LGII 115

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES 225
           +RD+K  N++LD++ + KL DFGLA+ +  E GS+T    GT  YLAPE +      K  
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSE-GSRTNTFCGTPEYLAPEVLLGKGYGKAV 174

Query: 226 DVYSFGVVALEVACGRKP 243
           D +S GV+  E+  G+ P
Sbjct: 175 DWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 62/268 (23%), Positives = 113/268 (42%), Gaps = 49/268 (18%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-EVRIISRLRHRNLVHLIG 132
             LG+G  G VY+          A+K++     +  ++ +  E++ +       +V   G
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 133 WCHEQRQL-----------------------------ILHKIALGLASAVLYLHEEWEQC 163
             +++ ++                             I  +I  GL     YLH +    
Sbjct: 67  AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLD----YLHTKRH-- 120

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           I+HRDIK SN++++S    K+ DFG+++++++ L    T + GT+ Y++PE +     S 
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSY 179

Query: 224 ESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER 283
            +D++S G+  LE A G+ P  P  +PS   L++ + D    G          S EF + 
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----GPPPSLPAEEFSPEFRDF 235

Query: 284 QMECLMIVGLWCCHPDFTNRPSIRQVIN 311
              CL          D   RPS  +++ 
Sbjct: 236 ISACL--------QKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 4e-19
 Identities = 63/196 (32%), Positives = 99/196 (50%), Gaps = 42/196 (21%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG 132
           K+G+G FG VY+G+L   NTE+AVK  R +      K++++ E  I+ +  H N+V LIG
Sbjct: 2   KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDL-KRKFLQEAEILKQYDHPNIVKLIG 59

Query: 133 WCHEQRQLI---------------------------LHKIALGLASAVLYLHEEWEQCIV 165
            C  Q+Q I                           L +++L  A+ + YL  E + CI 
Sbjct: 60  VC-VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESKNCI- 115

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECVTTGKA 221
           HRD+ + N ++  N   K+ DFG++R    E G   TV  G     + + APE +  G+ 
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 222 SKESDVYSFGVVALEV 237
           + ESDV+S+G++  E 
Sbjct: 173 TSESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 86.4 bits (215), Expect = 4e-19
 Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 39/200 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKE-----YISEVRIISRLRHRNLVH 129
           ++GEG +G VY+         +A+K++     + +KE      I E++++ +LRH N+V 
Sbjct: 6   QIGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 130 LIGWCHEQRQ----------------LILHK-----------IALGLASAVLYLHEEWEQ 162
           L      + +                L+                  L   + YLH     
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SN 119

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT-TGKA 221
            I+HRDIK SN++++++   KL DFGLAR       +  T    T+ Y  PE +    + 
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRY 179

Query: 222 SKESDVYSFGVVALEVACGR 241
             E D++S G +  E+  G+
Sbjct: 180 GPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 84.6 bits (209), Expect = 1e-18
 Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 40/204 (19%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ---GKKEY---ISEVRIISRLRHRNLVH 129
           LG+G +G VY GL + Q   IAVK+V   +      +KEY     EV ++  L+H N+V 
Sbjct: 8   LGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 130 LIGWCHEQR-------------------------QLILHKIALGLASAVLYLHEEWEQCI 164
            +G C +                           + +  K    +   V YLH     C+
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN---NCV 123

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVD--HELGSQTTVLA---GTMGYLAPECVTTG 219
           VHRDIK +NV+L  N   KL DFG AR +      G+ + +L    GT  ++APE +   
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 220 KASKESDVYSFGVVALEVACGRKP 243
              ++SD++S G    E+A G+ P
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 83.1 bits (205), Expect = 3e-18
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 38/203 (18%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           ++G G FG V+ G   ++  ++A+K +  G+   ++++I E +++ +L H  LV L G C
Sbjct: 11  EIGSGQFGLVWLGYWLEK-RKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 135 HE----------------------QRQLILHKIALGL----ASAVLYLHEEWEQCIVHRD 168
            E                      QR     +  LG+       + YL       ++HRD
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRD 125

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKES 225
           + + N ++  N   K+ DFG+ R V   L  Q T   GT   + + +PE  +  K S +S
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFV---LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182

Query: 226 DVYSFGVVALEV-ACGRKPVEPR 247
           DV+SFGV+  EV + G+ P E R
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENR 205

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 82.9 bits (205), Expect = 3e-18
 Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 43/214 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRV--SRGSKQGKKEYISEVRIISRLRHRNLV-HLI 131
           K+G+G FG V++ +        A+K++  S+ +++ ++E I E R++++L    ++ +  
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 132 GWCHEQRQLI---------LHK---------------------IALGLASAVLYLHEEWE 161
            +  + +  I         LHK                     I LGLA    +LH    
Sbjct: 67  SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----HLHS--- 119

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV-DHELGSQTTVLAGTMGYLAPECVTTGK 220
           + I+HRDIKS N+ LD+  N K+GD G+A+L+ D+   + T V  GT  YL+PE      
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV--GTPYYLSPELCEDKP 177

Query: 221 ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR 254
            +++SDV++ GVV  E   G+ P +   + + + 
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALIL 211

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 82.9 bits (205), Expect = 3e-18
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 37/210 (17%)

Query: 69  NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRN 126
           +F    KLG+G +G VY+      N   A+K V  G  S++ +++ ++E+RI++ + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 127 -------------------------LVHLIGWCHEQRQLI----LHKIALGLASAVLYLH 157
                                    L   I    ++R+LI    + +I + L   +  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 158 EEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT 217
           E   Q I+HRD+KS+N++L +N   K+GD G+++++   +        GT  Y+APE   
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWK 174

Query: 218 TGKASKESDVYSFGVVALEVACGRKPVEPR 247
               S +SD++S G +  E+A    P E R
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 36/203 (17%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY---ISEVRIISRLRHRN 126
           F +  ++G G FG VY       N  +A+K++S   KQ  +++   I EVR + +LRH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 127 LVHLIGWCH--EQRQLILHKIALGLASAVLYLHEEWEQ---------------------C 163
            +   G C+  E    ++ +  LG AS +L +H++  Q                      
Sbjct: 77  TIEYKG-CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE 135

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT---GK 220
            +HRDIK+ N++L      KL DFG A LV     + + V  GT  ++APE +     G+
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVS---PANSFV--GTPYWMAPEVILAMDEGQ 190

Query: 221 ASKESDVYSFGVVALEVACGRKP 243
              + DV+S G+  +E+A  RKP
Sbjct: 191 YDGKVDVWSLGITCIELA-ERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 83.0 bits (205), Expect = 4e-18
 Identities = 75/266 (28%), Positives = 125/266 (46%), Gaps = 54/266 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLG G +G VY G+    +  +AVK + +      +E++ E  ++  ++H NLV L+G C
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 135 -HE----------------------QRQL----ILHKIALGLASAVLYLHEEWEQCIVHR 167
             E                       RQ     +L  +A  ++SA+ YL +   +  +HR
Sbjct: 72  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHR 128

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKE 224
           D+ + N ++  N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185

Query: 225 SDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER 283
           SDV++FGV+  E+A  G  P  P  + S+      V++L  KG  +E  +G   K ++  
Sbjct: 186 SDVWAFGVLLWEIATYGMSPY-PGIDLSQ------VYELLEKGYRMERPEGCPPKVYE-- 236

Query: 284 QMECLMIVGLWCCHPDFTNRPSIRQV 309
               LM     C   + ++RPS  ++
Sbjct: 237 ----LM---RACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 83.2 bits (206), Expect = 7e-18
 Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 39/231 (16%)

Query: 65  RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS---EVRIISR 121
           R+   F +  ++GEG +G VYR   +     +A+K+V R   +     IS   E+ ++  
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLREITLLLN 62

Query: 122 LRHRNLVHL---------------IGWC-HEQRQLI-----------LHKIALGLASAVL 154
           LRH N+V L               + +C  +   L+           +  + L L   + 
Sbjct: 63  LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122

Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLHE +   I+HRD+K SN++L      K+ DFGLAR         T  +  T+ Y APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178

Query: 215 CVTTGKASKES-DVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYG 264
            +        + D+++ G +  E+    KP+ P +  S++  ++ +  L G
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGK--SEIEQLDLIIQLLG 226

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 82.4 bits (204), Expect = 8e-18
 Identities = 47/196 (23%), Positives = 80/196 (40%), Gaps = 32/196 (16%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLI 131
           GK+GEG +G VY+         +A+K++    +     K  + E++++  L H N++ L+
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 132 GWCHEQRQLIL----------------------HKIA---LGLASAVLYLHEEWEQCIVH 166
                +  L L                        I      L   + + H      I+H
Sbjct: 65  DVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILH 121

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES- 225
           RD+K  N+++++    KL DFGLAR     +   T  +  T  Y APE +   K      
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYSTPV 180

Query: 226 DVYSFGVVALEVACGR 241
           D++S G +  E+   R
Sbjct: 181 DIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.8 bits (204), Expect = 8e-18
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 34/202 (16%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY---ISEVRIISRLRHRN 126
           F++  ++G G FG VY       +  +A+K++S   KQ  +++   I EVR + +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 127 LVHLIG-WCHEQRQLILHKIALGLASAVLYLHEEWEQCI--------------------- 164
            +   G +  E    ++ +  LG AS +L +H++  Q +                     
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT---GKA 221
           +HRD+K+ N++L      KLGDFG A ++     +      GT  ++APE +     G+ 
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILAMDEGQY 191

Query: 222 SKESDVYSFGVVALEVACGRKP 243
             + DV+S G+  +E+A  RKP
Sbjct: 192 DGKVDVWSLGITCIELA-ERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 82.2 bits (203), Expect = 9e-18
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 37/207 (17%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCH 135
           LG+G +G VY          IA+K +     +  +    E+ + S L+HRN+V  +G   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 136 EQR--QLILHKIALGLASAVL--------------------------YLHEEWEQCIVHR 167
           E    ++ + ++  G  SA+L                          YLH+     IVHR
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHR 132

Query: 168 DIKSSNVVLDSNFNA-KLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPECVTTGKA--SK 223
           DIK  NV++++     K+ DFG + RL    +   T    GT+ Y+APE +  G      
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGYGA 190

Query: 224 ESDVYSFGVVALEVACGRKPVEPRQEP 250
            +D++S G   +E+A G+ P     EP
Sbjct: 191 PADIWSLGCTIVEMATGKPPFIELGEP 217

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 37/199 (18%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLG G FG V+ G   +  T++AVK +  G+    + ++ E +I+ +LRH  LV L   C
Sbjct: 13  KLGAGQFGEVWMGTW-NGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 135 HEQ------------------------RQLILHK---IALGLASAVLYLHEEWEQCIVHR 167
            E+                        ++L L +   +A  +A  + YL     +  +HR
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKES 225
           D+ + N+++  N   K+ DFGLARL+  D     +       + + APE    G+ + +S
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFTIKS 185

Query: 226 DVYSFGVVALE-VACGRKP 243
           DV+SFG++  E V  GR P
Sbjct: 186 DVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 81.3 bits (201), Expect = 1e-17
 Identities = 62/267 (23%), Positives = 118/267 (44%), Gaps = 55/267 (20%)

Query: 76  LGEGGFGG--VYRGLLSDQNTEIAVKRV--SRGSKQGKKEYISEVRIISRLRHRNLVHLI 131
           LG+G FG   +YR   ++ ++ +  K V  +R S++ +++ ++E+ I+S L+H N++   
Sbjct: 8   LGKGAFGEATLYRR--TEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 132 G-------------WC----------HEQRQLILHKIALG----LASAVLYLHEEWEQCI 164
                         +            ++ QL   ++ L     + SAV Y+H+     I
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GI 122

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
           +HRDIK+ N+ L      KLGDFG+++++  E     TV+ GT  Y++PE     K + +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNFK 181

Query: 225 SDVYSFGVVALEVACGRKPVEPRQEPSKV-RLVEWVWDLYGKGQLLEAADGRLSKEFDER 283
           SD+++ G V  E+   ++  +     + V ++V+  +                S E    
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY---------TPVVSVYSSELISL 232

Query: 284 QMECLMIVGLWCCHPDFTNRPSIRQVI 310
               L          D   RP+  +V+
Sbjct: 233 VHSLL--------QQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 84/286 (29%), Positives = 115/286 (40%), Gaps = 67/286 (23%)

Query: 76  LGEGGFGGV----YRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHL 130
           LGEG FG V    Y          +AVK + R   +Q    +  E+ I+  L H N+V  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 131 IGWCHEQ----RQLILHKIALG------------LASAVL----------YLHEEWEQCI 164
            G C EQ     QLI+  + LG            LA  +L          YLH    Q  
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS---QHY 128

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKAS 222
           +HRD+ + NV+LD++   K+GDFGLA+ V   HE           + + A EC+   K S
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFS 188

Query: 223 KESDVYSFGVVALEVACGRKPVEPRQEPSK---------------VRLVEWVWDLYGKGQ 267
             SDV+SFGV   E+       + +Q P K               VRL+E    L  +G 
Sbjct: 189 YASDVWSFGVTLYELL---THCDSKQSPPKKFEEMIGPKQGQMTVVRLIE----LLERGM 241

Query: 268 LLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
            L        +E       C      W     F  RP+ R +I +L
Sbjct: 242 RLPCPK-NCPQEVYILMKNC------WETEAKF--RPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 35/201 (17%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLI-G 132
           G+LG+G FG VY+    +     A K +   S++  ++++ E+ I+S  +H N+V L   
Sbjct: 11  GELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 133 WCHEQRQLILHKIALGLA-------------------------SAVLYLHEEWEQCIVHR 167
           + +E +  IL +   G A                          A+ +LH      ++HR
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHR 127

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE--- 224
           D+K+ N++L  + + KL DFG++      L  + T + GT  ++APE V           
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYD 186

Query: 225 --SDVYSFGVVALEVACGRKP 243
             +D++S G+  +E+A    P
Sbjct: 187 YKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 39/209 (18%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSR-GSKQGKKEYISEVRIISRLRHR- 125
           N+    G++G G  G VY+         +AVK++ R G+K+  K  + ++ ++    H  
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVL-KSHDC 73

Query: 126 -NLV----------------HLIGWCHEQ---------RQLILHKIALGLASAVLYLHEE 159
             +V                 L+  C ++          + IL K+ + +  A+ YL E+
Sbjct: 74  PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK 133

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPECVT- 217
               ++HRD+K SN++LD++ N KL DFG++ RLVD +  +++   AG   Y+APE +  
Sbjct: 134 --HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS---AGCAAYMAPERIDP 188

Query: 218 ---TGKASKESDVYSFGVVALEVACGRKP 243
                K    +DV+S G+  +E+A G+ P
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 34/202 (16%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY---ISEVRIISRLRHRN 126
           F    ++G G FG VY    S  N  +AVK++S   KQ  +++   I EV+ + +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 127 LVHLIG-WCHEQRQLILHKIALGLASAVLYLHEEWEQ---------------------CI 164
            +   G +  E    ++ +  LG AS +L +H++  Q                      +
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT---GKA 221
           +HRDIK+ N++L      KL DFG A        S      GT  ++APE +     G+ 
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKS-----SPANSFVGTPYWMAPEVILAMDEGQY 197

Query: 222 SKESDVYSFGVVALEVACGRKP 243
             + DV+S G+  +E+A  RKP
Sbjct: 198 DGKVDVWSLGITCIELA-ERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 79.5 bits (196), Expect = 7e-17
 Identities = 72/277 (25%), Positives = 127/277 (45%), Gaps = 60/277 (21%)

Query: 76  LGEGGFGGVYRGLLS---DQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLI 131
           +G G FG V RG L     +   +A+K +  G +++ +++++SE  I+ +  H N++HL 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 132 GWCHEQRQLI--------------------------LHKIALGLASAVLYLHEEWEQCIV 165
           G   + R ++                          L  +  G+A+ + YL E      V
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYV 128

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG--SQTTVLAGTMG--YLAPECVTTGKA 221
           HRD+ + N++++SN   K+ DFGL+R ++ +    + T+ L G +   + APE +   K 
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188

Query: 222 SKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA--ADGRLSK 278
           +  SDV+S+G+V  EV + G +P                WD+  +  ++ A   D RL  
Sbjct: 189 TSASDVWSYGIVMWEVMSYGERP---------------YWDMSNQ-DVINAIEQDYRLPP 232

Query: 279 EFD-ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
             D    +  LM   L C   D   RP   Q+++ L+
Sbjct: 233 PMDCPTALHQLM---LDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 60/281 (21%), Positives = 113/281 (40%), Gaps = 62/281 (22%)

Query: 76  LGEGGFGGVYRGLL-----SDQNTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVH 129
           LG+G FG VY GL       +  T +A+K V+  +   ++ E+++E  ++      ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 130 LIGWC-HEQRQLI----------------------------------LHKIALGLASAVL 154
           L+G     Q  L+                                    ++A  +A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV-DHELGSQTTVLAGTMGYLAP 213
           YL     +  VHRD+ + N ++  +   K+GDFG+ R + + +   +       + ++AP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 214 ECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA 272
           E +  G  + +SDV+SFGVV  E+A    +P +           E V      G  L+  
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-------EEVLKFVIDGGHLDLP 243

Query: 273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           +    K  +  +M         C   +   RP+  ++++ L
Sbjct: 244 ENCPDKLLELMRM---------CWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 69/268 (25%), Positives = 107/268 (39%), Gaps = 55/268 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGW 133
            +G G    VY  +    N ++A+KR+     Q    E   EV+ +S+  H N+V     
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 134 CHEQRQL---------------ILHKIALG-----LASAVL--------YLHEEWEQCIV 165
                +L               +      G     + + VL        YLH       +
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQI 124

Query: 166 HRDIKSSNVVLDSNFNAKLGDFG----LARLVDHELGSQTTVLAGTMGYLAPECVT--TG 219
           HRDIK+ N++L  + + K+ DFG    LA   D     + T   GT  ++APE +    G
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF-VGTPCWMAPEVMEQVHG 183

Query: 220 KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE--AADGRLS 277
              K +D++SFG+ A+E+A G  P   +  P KV ++     L      LE  A   + S
Sbjct: 184 YDFK-ADIWSFGITAIELATGAAPYS-KYPPMKVLMLT----LQNDPPSLETGADYKKYS 237

Query: 278 KEFDERQMECLMIVGLWCCHPDFTNRPS 305
           K F +    CL          D + RP+
Sbjct: 238 KSFRKMISLCLQ--------KDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 37/209 (17%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVS--RGSKQGKKEYIS---EVRIISRL 122
            N+     LG+G FG VY     D   E+AVK+V     S + KKE  +   E++++  L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 123 RHRNLVHLIGWCHEQRQLI--------------------------LHKIALGLASAVLYL 156
           +H  +V   G C    + +                            K    +   V YL
Sbjct: 62  QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYL 120

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV--LAGTMGYLAPE 214
           H      IVHRDIK +N++ DS  N KLGDFG ++ +     S T +  + GT  +++PE
Sbjct: 121 HS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177

Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            ++     +++DV+S G   +E+   + P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 79.0 bits (194), Expect = 2e-16
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 34/202 (16%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY---ISEVRIISRLRHRN 126
           F +  ++G G FG VY       N  +A+K++S   KQ  +++   I EV+ + R++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 127 LVHLIG-WCHEQRQLILHKIALGLASAVLYLHEEWEQCI--------------------- 164
            +   G +  E    ++ +  LG AS +L +H++  Q +                     
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT---GKA 221
           +HRDIK+ N++L      KL DFG A +      S      GT  ++APE +     G+ 
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIA-----SPANSFVGTPYWMAPEVILAMDEGQY 201

Query: 222 SKESDVYSFGVVALEVACGRKP 243
             + DV+S G+  +E+A  RKP
Sbjct: 202 DGKVDVWSLGITCIELA-ERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 32/196 (16%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLG G FG V+ G   + NT++AVK +  G+    + ++ E +I+ +LRH  LV L    
Sbjct: 13  KLGNGQFGEVWMGTW-NGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 135 HEQ-----------------------RQLILHKI---ALGLASAVLYLHEEWEQCIVHRD 168
            E+                       R L L  +   A  +A+ + Y+        +HRD
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           ++S+N+++      K+ DFGLARL++    +        + + APE    G+ + +SDV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 229 SFGVVALE-VACGRKP 243
           SFG++  E V  GR P
Sbjct: 188 SFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 40/205 (19%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRV-SRGSKQGKKEYISEVRIISRLRH-RNLVHLIG- 132
           LG G +G V +       T +AVKR+ +  + Q +K  + ++ I  R       V   G 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 133 -------W-CHE--------------QRQL-----ILHKIALGLASAVLYLHEEWEQCIV 165
                  W C E               + L     IL KIA+ +  A+ YLH +    ++
Sbjct: 69  LFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VI 126

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPECVTTGKASK- 223
           HRD+K SNV+++ N   KL DFG++  LVD       T+ AG   Y+APE +      K 
Sbjct: 127 HRDVKPSNVLINRNGQVKLCDFGISGYLVD---SVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 224 ---ESDVYSFGVVALEVACGRKPVE 245
              +SDV+S G+  +E+A GR P +
Sbjct: 184 YDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 77.1 bits (190), Expect = 5e-16
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 57/226 (25%)

Query: 62  ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQN-----TEIAVKRV-SRGSKQGKKEYISE 115
           E+  +   F E   LGEG FG VY+G L+  N     T +A+K +      + ++E+  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 116 VRIISRLRHRNLVHLIGWCHEQRQLI----------LHK--------------------- 144
             ++S L+H N+V L+G C +++             LH+                     
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 145 ----------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV- 193
                     IA+ +A+ + YL        VHRD+ + N ++      K+ DFGL+R + 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 194 --DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
             D+      ++L   + ++ PE +  GK + ESD++SFGVV  E+
Sbjct: 176 SADYYRVQSKSLLP--VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 76.9 bits (189), Expect = 5e-16
 Identities = 67/276 (24%), Positives = 127/276 (46%), Gaps = 60/276 (21%)

Query: 76  LGEGGFGGVYRGLL---SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLI 131
           +G G FG V  G L     +   +A+K +  G +++ +++++SE  I+ +  H N++HL 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 132 GWC------------------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIV 165
           G                          H+ +  ++  + +  G+AS + YL +      V
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYV 128

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASK 223
           HRD+ + N++++SN   K+ DFGL+R+++ +  +  T   G +   + APE +   K + 
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTS 188

Query: 224 ESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFD 281
            SDV+S+G+V  EV + G +P                W++  +  +    +G RL     
Sbjct: 189 ASDVWSYGIVMWEVMSYGERP---------------YWEMSNQDVIKAIEEGYRLPAP-- 231

Query: 282 ERQMEC---LMIVGLWCCHPDFTNRPSIRQVINVLN 314
              M+C   L  + L C   D   RP   Q++++L+
Sbjct: 232 ---MDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 73/296 (24%), Positives = 116/296 (39%), Gaps = 100/296 (33%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIG-- 132
           +GEG +G VY+         +A+K +    +  ++E   E  I+ +   H N+    G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 133 ------------W-----C--------------------HEQRQLILHKIALGLASAVLY 155
                       W     C                     E    IL +   GLA    Y
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA----Y 128

Query: 156 LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPEC 215
           LHE     ++HRDIK  N++L  N   KL DFG++  +D  LG + T + GT  ++APE 
Sbjct: 129 LHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEV 184

Query: 216 VTTGKASKE---------SDVYSFGVVALEVACGRKPVE-----------PRQEPSKVRL 255
           +    A  E         SDV+S G+ A+E+A G+ P+            PR  P  ++ 
Sbjct: 185 I----ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240

Query: 256 VE-WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVI 310
            E W                  SK+F++   ECL+         ++  RP + +++
Sbjct: 241 PENW------------------SKKFNDFISECLI--------KNYEQRPFMEELL 270

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 77.0 bits (189), Expect = 5e-16
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 32/196 (16%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLG+G FG V+ G   +  T +A+K +  G+    + ++ E +++ +LRH  LV L    
Sbjct: 13  KLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 135 HEQRQLI--------------------------LHKIALGLASAVLYLHEEWEQCIVHRD 168
            E+   I                          L  +A  +AS + Y+        VHRD
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           ++++N+++  N   K+ DFGLARL++    +        + + APE    G+ + +SDV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 229 SFGVVALEVAC-GRKP 243
           SFG++  E+   GR P
Sbjct: 188 SFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 69/274 (25%), Positives = 123/274 (44%), Gaps = 56/274 (20%)

Query: 76  LGEGGFGGVYRGLLS---DQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLI 131
           +G G FG V+RG+L     +   +A+K +  G +++ +++++SE  I+ +  H N++ L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 132 GWCHEQRQLI--------------------------LHKIALGLASAVLYLHEEWEQCIV 165
           G   + +  +                          L  +  G+A+ + YL +      V
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYV 129

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASK 223
           HRD+ + N++++SN   K+ DFGL+R+++ +     T   G +   + APE +   K + 
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189

Query: 224 ESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFD 281
            SDV+SFG+V  EV + G +P                WD+     +    DG RL    D
Sbjct: 190 ASDVWSFGIVMWEVMSFGERP---------------YWDMSNHEVMKAINDGFRLPAPMD 234

Query: 282 -ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
               +  LM   L C   D   RP    ++N+L+
Sbjct: 235 CPSAVYQLM---LQCWQQDRARRPRFVDIVNLLD 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 32/198 (16%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           +LG G FG V  G    Q  ++A+K +  GS   + E+I E +++ +L H  LV L G C
Sbjct: 11  ELGTGQFGVVKYGKWRGQY-DVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 135 HEQRQLILHKIALGLASAVLYLHEE---------WEQC--------------IVHRDIKS 171
            +QR + +    +     + YL E           E C               +HRD+ +
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAA 128

Query: 172 SNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVY 228
            N ++D     K+ DFGL+R V   L  + T   G+   + +  PE +   K S +SDV+
Sbjct: 129 RNCLVDDQGCVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185

Query: 229 SFGVVALEV-ACGRKPVE 245
           +FGV+  EV + G+ P E
Sbjct: 186 AFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 33/196 (16%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYI-SEVRIISRLRHRNLVHLIG 132
           LG GGFG V    +  +N   A+K V +    + G++E+I SE  I+    H  +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 133 WCHEQRQL--------------ILHKIAL--------GLASAVL---YLHEEWEQCIVHR 167
              +++ +              IL    L         +A  VL   YLH    + I++R
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN---RGIIYR 117

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           D+K  N++LDSN   KL DFG A+ +  + G +T    GT  Y+APE +         D 
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAKKL--KSGQKTWTFCGTPEYVAPEIILNKGYDFSVDY 175

Query: 228 YSFGVVALEVACGRKP 243
           +S G++  E+  GR P
Sbjct: 176 WSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 36/197 (18%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI-SEVRIISRLRHRNLV----- 128
           K+G+G  G VY  +      E+A+K+++   +Q KKE I +E+ ++   +H N+V     
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 129 HLIGWCHEQRQLILHKIALGLASAVL----------------------YLHEEWEQCIVH 166
           +L+G   ++  +++  +A G  + V+                      +LH      ++H
Sbjct: 85  YLVG---DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIH 138

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
           RDIKS N++L  + + KL DFG    +  E   ++T + GT  ++APE VT      + D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 197

Query: 227 VYSFGVVALEVACGRKP 243
           ++S G++A+E+  G  P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 39/199 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-EVRIISRLRHRNLVHLIG- 132
            +G+G FG VY+ +    N  +A+K +     + + E I  E++ +S+ R   +    G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 133 -------W-----C--------------HEQR-QLILHKIALGLASAVLYLHEEWEQCIV 165
                  W     C               E     IL ++ LGL     YLHEE +   +
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLE----YLHEEGK---I 120

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
           HRDIK++N++L    + KL DFG++ +L        T V  GT  ++APE +      ++
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV--GTPFWMAPEVIKQSGYDEK 178

Query: 225 SDVYSFGVVALEVACGRKP 243
           +D++S G+ A+E+A G  P
Sbjct: 179 ADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 52/208 (25%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-----EVRIISRLRHRNLVH 129
           KLGEG +  VY+    +    +A+K++  G ++  K+ I+     E++++  L+H N++ 
Sbjct: 7   KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66

Query: 130 LIG-WCHEQ-------------RQLILHK-IALGLA----------SAVLYLHEEWEQCI 164
           L+  + H+               ++I  K I L  A            + YLH  W   I
Sbjct: 67  LLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---I 123

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL---AGTMGYLAPE------C 215
           +HRD+K +N+++ S+   KL DFGLAR      GS    +     T  Y APE       
Sbjct: 124 LHRDLKPNNLLIASDGVLKLADFGLAR----SFGSPNRKMTHQVVTRWYRAPELLFGARH 179

Query: 216 VTTGKASKESDVYSFGVVALEVACGRKP 243
              G      D++S G +  E+   R P
Sbjct: 180 YGVG-----VDMWSVGCIFAEL-LLRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 39/210 (18%)

Query: 69  NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRV--SRGSKQGKKEYIS---EVRIISRLR 123
           N+     LG G FG VY    +D   E+AVK+V     S++  KE  +   E++++  LR
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 124 HRNLVHLIGWC---HEQRQL-------------------------ILHKIALGLASAVLY 155
           H  +V   G C    E+++L                         +  +    +   V Y
Sbjct: 63  HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121

Query: 156 LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV--LAGTMGYLAP 213
           LH      IVHRDIK +N++ DS  N KLGDFG ++ +     S T +  + GT  +++P
Sbjct: 122 LHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 214 ECVTTGKASKESDVYSFGVVALEVACGRKP 243
           E ++     +++DV+S     +E+   + P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 58/193 (30%), Positives = 90/193 (46%), Gaps = 31/193 (16%)

Query: 76  LGEGGFGGV----YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLI 131
           LG+G FG V    Y  L  +    +AVK++   + +  +++  E+ I+  L+H N+V   
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 132 GWCHE--QRQLILHKIALGLASAVLYL--HEE-----------WEQC----------IVH 166
           G C+   +R L L    L   S   YL  H E            + C           VH
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
           RD+ + N++++S    K+GDFGL +++  D E           + + APE +T  K S  
Sbjct: 132 RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVA 191

Query: 225 SDVYSFGVVALEV 237
           SDV+SFGVV  E+
Sbjct: 192 SDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 54/202 (26%), Positives = 83/202 (41%), Gaps = 31/202 (15%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHR 125
           N +   G +GEG +G V +         +A+K  + S   +  KK  + EV+++ +LRH 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 126 NLVHLIGWCHEQRQL----------ILH---------------KIALGLASAVLYLHEEW 160
           N+V+L      + +L          +L                     L  A+ Y H   
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS-- 118

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPEC-VTTG 219
              I+HRDIK  N+++  +   KL DFG AR +     S  T    T  Y APE  V   
Sbjct: 119 -HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Query: 220 KASKESDVYSFGVVALEVACGR 241
              K  DV++ G +  E+  G 
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 41/173 (23%), Positives = 73/173 (42%), Gaps = 30/173 (17%)

Query: 69  NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGK--KEYISEVRIISRLRHRN 126
            +   G++GEG  G V++    +    +A+K+V+    +G    + + E++ +   +H  
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 127 LVHLIG----------------------WCHEQRQL---ILHKIALGLASAVLYLHEEWE 161
           +V L+                          E+R L    +      L   V Y+H    
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN-- 118

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
             I+HRD+K +N+++ ++   K+ DFGLARL   E     +    T  Y APE
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 42/210 (20%)

Query: 69  NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVS---RGSKQGKKEYISEVRIISRLRHR 125
           NF    K+G G F  VYR         +A+K+V        + +++ + E+ ++ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 126 NLV-------------------------HLIGWCHEQRQLI----LHKIALGLASAVLYL 156
           N++                          +I +  +Q++LI    + K  + L SAV ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV---LAGTMGYLAP 213
           H    + ++HRDIK +NV + +    KLGD GL R       S+TT    L GT  Y++P
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMSP 175

Query: 214 ECVTTGKASKESDVYSFGVVALEVACGRKP 243
           E +     + +SD++S G +  E+A  + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 38/107 (35%), Positives = 65/107 (60%), Gaps = 7/107 (6%)

Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL KI++ +   + YL E+ +  I+HRD+K SN++++S    KL DFG++ +L+D    S
Sbjct: 100 ILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 153

Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
                 GT  Y++PE +     + +SD++S G+  +E+A GR P+ P
Sbjct: 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 60/195 (30%), Positives = 89/195 (45%), Gaps = 33/195 (16%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQG-KKEYISEVRIISRLRHRNLVHLIG-- 132
           LG G  G V +       T +A K V  G+K   +K+ + E++I+   R   +V   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 133 -------WCHEQRQL----------------ILHKIALGLASAVLYLHEEWEQCIVHRDI 169
                   C E                    IL KIA+ +   + YL+      I+HRDI
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDI 130

Query: 170 KSSNVVLDSNFNAKLGDFGLARLVDHEL-GSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           K SN++++S    KL DFG    V  EL  S      GT  Y++PE +  GK + +SDV+
Sbjct: 131 KPSNILVNSRGQIKLCDFG----VSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVW 186

Query: 229 SFGVVALEVACGRKP 243
           S G+  +E+A G+ P
Sbjct: 187 SLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 74.9 bits (185), Expect = 5e-15
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 50/208 (24%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLVHLIG 132
           +G G +G V   +      ++A+K++S         K+    E++++  LRH N++ L+ 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENIIGLLD 66

Query: 133 ---------------------------------WCHEQRQLILHKIALGLASAVLYLHEE 159
                                               +  Q  L++I  GL     YLH  
Sbjct: 67  ILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLK----YLHS- 121

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG---TMGYLAPECV 216
               ++HRD+K SN++++SN + K+ DFGLAR VD +   +   L     T  Y APE +
Sbjct: 122 --ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD-EDEKGFLTEYVVTRWYRAPELL 178

Query: 217 TTGKA-SKESDVYSFGVVALEVACGRKP 243
            +    +K  D++S G +  E+   RKP
Sbjct: 179 LSSSRYTKAIDIWSVGCIFAELL-TRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 73.9 bits (181), Expect = 6e-15
 Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 33/191 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGW 133
           ++G G FG V+ G L   NT +AVK          K +++ E RI+ +  H N+V LIG 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 134 CHEQRQLI---------------------------LHKIALGLASAVLYLHEEWEQCIVH 166
           C  Q+Q I                           L ++    A+ + YL     +  +H
Sbjct: 62  C-TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIH 117

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT-MGYLAPECVTTGKASKES 225
           RD+ + N ++      K+ DFG++R  +  + + T  +    + + APE +  G+ S ES
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177

Query: 226 DVYSFGVVALE 236
           DV+SFG++  E
Sbjct: 178 DVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 73.8 bits (181), Expect = 6e-15
 Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 28/211 (13%)

Query: 75  KLGEGGFGGVYRGL--LSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLI 131
           +LG G FG V +G+  +  +  ++A+K +   + K  + E + E  I+ +L +  +V +I
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 132 GWCHEQRQLILHKIALG---------------LASAVLYLHEEW-------EQCIVHRDI 169
           G C  +  +++ ++A G               +++ V  +H+          +  VHRD+
Sbjct: 62  GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDL 121

Query: 170 KSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT--MGYLAPECVTTGKASKESDV 227
            + NV+L +   AK+ DFGL++ +  +        AG   + + APEC+   K S  SDV
Sbjct: 122 AARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDV 181

Query: 228 YSFGVVALEV-ACGRKPVEPRQEPSKVRLVE 257
           +S+G+   E  + G+KP +  + P  +  +E
Sbjct: 182 WSYGITMWEAFSYGQKPYKKMKGPEVMSFIE 212

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 42/205 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVS--RGSKQGKKEYISEVRIISRLRHRNLVHLIG 132
           K+GEG FG +Y       +    +K +   +   + K+    EV ++++++H N+V    
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 133 WCHEQRQLILH-------------------------------KIALGLASAVLYLHEEWE 161
              E  +L +                                +I+LGL     ++H+   
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK----HIHD--- 119

Query: 162 QCIVHRDIKSSNVVLDSN-FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK 220
           + I+HRDIKS N+ L  N   AKLGDFG+AR ++  +    T   GT  YL+PE      
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEICQNRP 178

Query: 221 ASKESDVYSFGVVALEVACGRKPVE 245
            + ++D++S G V  E+   + P E
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 65/229 (28%), Positives = 111/229 (48%), Gaps = 48/229 (20%)

Query: 76  LGEGGFGGVYRGLLSDQ----NTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHL 130
           LG G FG VY+G+   +       +A+K ++  +  +   E++ E  I++ + H +LV L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 131 IGWC---------------------HEQRQLILHKIALG----LASAVLYLHEEWEQCIV 165
           +G C                     HE +  I  ++ L     +A  ++YL E   + +V
Sbjct: 75  LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLV 131

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM--GYLAPECVTTGKASK 223
           HRD+ + NV++ S  + K+ DFGLARL++ +   +     G M   ++A EC+   K + 
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGD-EKEYNADGGKMPIKWMALECIHYRKFTH 190

Query: 224 ESDVYSFGVVALEVAC-GRKPVE--PRQEPSKVRLVEWVWDLYGKGQLL 269
           +SDV+S+GV   E+   G KP +  P +E         + DL  KG+ L
Sbjct: 191 QSDVWSYGVTIWELMTFGGKPYDGIPTRE---------IPDLLEKGERL 230

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 65/270 (24%), Positives = 123/270 (45%), Gaps = 54/270 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLG G FG V+ G  +  +T++A+K + +GS    + +++E  ++ +L+H  LV L    
Sbjct: 13  KLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 135 HEQ-----------------------RQLILHKI---ALGLASAVLYLHEEWEQCIVHRD 168
            ++                        +L ++K+   A  +A  + ++     +  +HRD
Sbjct: 71  TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRD 127

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKES 225
           ++++N+++      K+ DFGLARL++    ++ T   G    + + APE +  G  + +S
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFTIKS 184

Query: 226 DVYSFGVVALE-VACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ 284
           DV+SFG++  E V  GR P      P  ++ +E       +G  +   D    +E  E  
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-------RGYRMPRPDN-CPEELYELM 236

Query: 285 MECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
             C      W   P+   RP+   + +VL 
Sbjct: 237 RLC------WKEKPE--ERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 49/210 (23%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRV------SRGSKQGKKEYI----SEVRIISRLRHR 125
           +G+G +G VY  L       +AVK+V      +      +K+ +    SE+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 126 NLVHL---------------------IGWCHE-----QRQLILH---KIALGLASAVLYL 156
           N+V                       IG C       + QL+     ++  GLA    YL
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA----YL 124

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPEC 215
           H    + I+HRD+K+ N+++D++   K+ DFG+++  D    + Q   + G++ ++APE 
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 216 VTTGKA--SKESDVYSFGVVALEVACGRKP 243
           + +     S + D++S G V LE+  GR+P
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 71/279 (25%), Positives = 117/279 (41%), Gaps = 55/279 (19%)

Query: 69  NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVS---RGSKQGKKEYISEVRIISRLRHR 125
           NF    K+G G F  VYR         +A+K+V        + + + I E+ ++ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 126 NLV-------------------------HLIGWCHEQRQLILHKIA----LGLASAVLYL 156
           N++                          +I    +Q++LI  K      + L SA+ ++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV---LAGTMGYLAP 213
           H    + ++HRDIK +NV + +    KLGD GL R       S+TT    L GT  Y++P
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMSP 175

Query: 214 ECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD 273
           E +     + +SD++S G +  E+A  + P    +            +LY   + +E  D
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLYSLCKKIEQCD 224

Query: 274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINV 312
                  D    E   +V + C +PD   RP I  V +V
Sbjct: 225 -YPPLPSDHYSEELRQLVNM-CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 54/211 (25%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVS----RGSKQGK--KEYISEVRIISRLRHRNLVH 129
           LG G F   Y+       T +AVK+V+      S+Q +  +    E+R+++RL H +++ 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 130 LIG-WCHEQRQLI----------------------------LHKIALGLASAVLYLHEEW 160
           ++G  C +    +                              ++  GL+    YLHE  
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLS----YLHENQ 123

Query: 161 EQCIVHRDIKSSNVVLDSN-FNAKLGDFGLARLVDHELGSQTT-------VLAGTMGYLA 212
              I+HRD+K +N+++DS     ++ DFG A      L ++ T        L GT+ ++A
Sbjct: 124 ---IIHRDVKGANLLIDSTGQRLRIADFGAAA----RLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 213 PECVTTGKASKESDVYSFGVVALEVACGRKP 243
           PE +   +  +  DV+S G V +E+A  + P
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 43/208 (20%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIG 132
           LG+GGFG V    +       A K++ +     ++G++  ++E +I+ ++  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 133 WCHEQRQLIL------------H-------------------KIALGLASAVLYLHEEWE 161
               +  L L            H                   +I  GL     +LH+   
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGL----EHLHQRR- 115

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA 221
             IV+RD+K  NV+LD + N ++ D GLA  V+ + G +    AGT GY+APE +     
Sbjct: 116 --IVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVY 171

Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
               D ++ G    E+  GR P   R+E
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKE 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 38/196 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
            +GEG FG V +G  + Q  ++AVK +        + ++ E  ++++L H+NLV L+G  
Sbjct: 13  IIGEGEFGAVLQGEYTGQ--KVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 135 HEQ----------------------RQLI----LHKIALGLASAVLYLHEEWEQCIVHRD 168
                                    R L+    L + +L +A  + YL     + +VHRD
Sbjct: 69  LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRD 125

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           + + N+++  +  AK+ DFGLAR+    +G   + L   + + APE +   K S +SDV+
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLP--VKWTAPEALKHKKFSSKSDVW 181

Query: 229 SFGVVALEV-ACGRKP 243
           S+GV+  EV + GR P
Sbjct: 182 SYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 53/187 (28%), Positives = 80/187 (42%), Gaps = 37/187 (19%)

Query: 92  QNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHR---NLVHLIGW----CHEQR------ 138
           Q  ++ VK V+ G   G      E+ I+  + HR   NL+H   W    C          
Sbjct: 118 QRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDL 172

Query: 139 -------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLG 185
                        Q I   I   L  A+ YLH    + I+HRD+K+ N+ LD   NA LG
Sbjct: 173 FTYVDRSGPLPLEQAIT--IQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLG 227

Query: 186 DFGLA-RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPV 244
           DFG A +L  H    Q    +GT+   +PE +       ++D++S G+V  E++     +
Sbjct: 228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Query: 245 EPRQEPS 251
             +Q  S
Sbjct: 288 FGKQVKS 294

Length = 392

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 37/196 (18%)

Query: 76  LGEGGFGGVYRGLLSD---QNTEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLI 131
           +G+G FG VY G L D   Q    AVK ++R +   + ++++ E  I+    H N++ L+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 132 GWCHEQ----------------RQLILHK---------IALGL--ASAVLYLHEEWEQCI 164
           G C                   R  I  +         I  GL  A  + YL     +  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKF 119

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLV-DHELGSQTTVLAGTM--GYLAPECVTTGKA 221
           VHRD+ + N +LD +F  K+ DFGLAR + D E  S        +   ++A E + T K 
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179

Query: 222 SKESDVYSFGVVALEV 237
           + +SDV+SFGV+  E+
Sbjct: 180 TTKSDVWSFGVLLWEL 195

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 55/194 (28%), Positives = 97/194 (50%), Gaps = 28/194 (14%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLG+G FG V+ G   +  T++A+K +  G+    + ++ E +I+ +LRH  LV L    
Sbjct: 13  KLGQGCFGEVWMGTW-NGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 135 HEQRQLILHKIALGLASAVLYLHE------EWEQCI------------------VHRDIK 170
            E+   I+ +  +G  S + +L E      +  Q +                  +HRD++
Sbjct: 71  SEEPIYIVTEF-MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLR 129

Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSF 230
           ++N+++  N   K+ DFGLARL++    +        + + APE    G+ + +SDV+SF
Sbjct: 130 AANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189

Query: 231 GVVALE-VACGRKP 243
           G++  E V  GR P
Sbjct: 190 GILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 54/226 (23%), Positives = 95/226 (42%), Gaps = 61/226 (26%)

Query: 68  NNFAEAGKLGEGGFGGVYR----GLLSDQN-TEIAVKRVSRG-SKQGKKEYISEVRIISR 121
           NN      +G+G FG V++    GLL  +  T +AVK +    S   + ++  E  +++ 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 122 LRHRNLVHLIGWCHEQRQLIL---------------HK---------------------- 144
             H N+V L+G C   + + L               H+                      
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 145 ----------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--- 191
                     IA  +A+ + YL E   +  VHRD+ + N ++  N   K+ DFGL+R   
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
             D+   S+   +   + ++ PE +   + + ESDV+++GVV  E+
Sbjct: 182 SADYYKASENDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 42/205 (20%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTE--IAVKRVSRGSKQG--KKEYISEVRIISRLRHRNLVH 129
           G+LG G FG V +G+   + +E  +AVK +   +     K E + E  ++ +L +  +V 
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 130 LIGWCHEQRQL----------------------------ILHKIALGLASAVLYLHEEWE 161
           +IG C  +  +                            ++H++++G+     YL    E
Sbjct: 61  MIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMK----YLE---E 113

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTG 219
              VHRD+ + NV+L +   AK+ DFGL++ +  D       T     + + APEC+   
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 220 KASKESDVYSFGVVALEV-ACGRKP 243
           K S +SDV+SFGV+  E  + G+KP
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 31/207 (14%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----H 129
           K+GEG  G V          ++AVK++    +Q ++   +EV I+    H N+V     +
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 130 LIG---WCHEQ-------RQLILHK---------IALGLASAVLYLHEEWEQCIVHRDIK 170
           L+G   W   +         ++ H          + L +  A+ YLH    Q ++HRDIK
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIK 145

Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSF 230
           S +++L S+   KL DFG    V  E+  + + L GT  ++APE ++      E D++S 
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS-LVGTPYWMAPEVISRLPYGTEVDIWSL 204

Query: 231 GVVALEVACGRKPV---EPRQEPSKVR 254
           G++ +E+  G  P     P Q   ++R
Sbjct: 205 GIMVIEMIDGEPPYFNEPPLQAMRRIR 231

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 49/218 (22%)

Query: 67  TNNFAEAGKLGEGGFGGV--YRGLLSDQNTEIAVKRVSRGSKQ---GKKEYISEVRIISR 121
           TN + +   +G G FG V   R  L+ QN  +A+K++ +        K+ Y  E++++  
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQN--VAIKKIMKPFSTPVLAKRTY-RELKLLKH 65

Query: 122 LRHRNLVHL----------IGWCHE---------------QRQLI---LHKIALGLASAV 153
           LRH N++ L          I +  E               ++Q I   L++I  GL    
Sbjct: 66  LRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLK--- 122

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAP 213
            Y+H      +VHRD+K SN++++ N + K+ DFGLAR+ D     Q T    T  Y AP
Sbjct: 123 -YVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDP----QMTGYVSTRYYRAP 174

Query: 214 ECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEP 250
           E + T  K   E D++S G +  E+  G KP+ P ++ 
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDH 211

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 41/207 (19%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVH 129
           +    ++G G +G VY+         +A+K +        +    E+ ++   RH N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 130 LIG--------W-CHE-----QRQLILHK---------IA-------LGLASAVLYLHEE 159
             G        W   E       Q I            IA        GLA    YLHE 
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA----YLHE- 119

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV--- 216
                +HRDIK +N++L  + + KL DFG++  +   +  + + + GT  ++APE     
Sbjct: 120 --TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVE 176

Query: 217 TTGKASKESDVYSFGVVALEVACGRKP 243
             G    + D+++ G+ A+E+A  + P
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 38/164 (23%)

Query: 66  ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVS-RGSKQGKK-EYISEVRIISRLR 123
              ++   GKLGEG FG VY+         +A+K++     K G     + E++I+ +L+
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 124 HRNLVHLIGWCHEQRQLILHK---------------------------------IALGLA 150
           H N+V LI    E+      K                                   L L 
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125

Query: 151 SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD 194
             + YLHE     I+HRDIK++N+++D+    K+ DFGLAR  D
Sbjct: 126 EGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYD 166

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 33/197 (16%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-EVRIISRLRH---RNLVHLI 131
           +G G +G VYRG        +A+K ++  +       I  EV ++S+LR     N+    
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 132 G-WCHEQRQLILHKIALG-----------------------LASAVLYLHEEWEQCIVHR 167
           G +    R  I+ + A G                       +  A+ Y+H+     ++HR
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV---GVIHR 125

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKESD 226
           DIK++N+++ +  N KL DFG+A L++     ++T   GT  ++APE +T GK    ++D
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGKYYDTKAD 184

Query: 227 VYSFGVVALEVACGRKP 243
           ++S G+   E+A G  P
Sbjct: 185 IWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 31/200 (15%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-EVRIISRLRHRNLV 128
           F +  ++G+G FG V++G+ +     +A+K +     + + E I  E+ ++S+     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 129 HLIGWCHEQRQLILHKIALGLASAVL------------------------YLHEEWEQCI 164
              G   +  +L +    LG  SA+                         YLH E +   
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK--- 122

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +HRDIK++NV+L    + KL DFG+A +L D ++   T V  GT  ++APE +       
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIQQSAYDS 180

Query: 224 ESDVYSFGVVALEVACGRKP 243
           ++D++S G+ A+E+A G  P
Sbjct: 181 KADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 71.0 bits (174), Expect = 7e-14
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 47/213 (22%)

Query: 76  LGEGGFGGVYRGLLSD------QNTEIAVKRVSRGSK-QGKKEYISEVRIISRLRHRNLV 128
           LG G FG VY G  +D          +AVK + +G+  Q KKE++ E  ++S   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 129 HLIGWC--HEQRQLILHKIALG-------------LASAVLYLHEEWEQCI--------- 164
            L+G C  +E + +I+  +  G                 +L L E  + C+         
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 165 -----VHRDIKSSNVVL-----DSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMGYL 211
                +HRD+ + N ++     D++   K+GDFGLAR +   D+       +L   + ++
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL--PVRWM 180

Query: 212 APECVTTGKASKESDVYSFGVVALEV-ACGRKP 243
           APE +  GK + +SDV+SFGV+  E+   G++P
Sbjct: 181 APESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 71.3 bits (174), Expect = 8e-14
 Identities = 51/195 (26%), Positives = 95/195 (48%), Gaps = 32/195 (16%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----H 129
           K+G+G  G VY  +      E+A+K+++   +  K+  I+E+ ++   ++ N+V     +
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 130 LIG---W------------------CHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRD 168
           L+G   W                  C ++ Q+    +      A+ +LH      ++HRD
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--AVCRECLQALDFLHSNQ---VIHRD 140

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           IKS N++L  + + KL DFG    +  E   ++T + GT  ++APE VT      + D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 229 SFGVVALEVACGRKP 243
           S G++A+E+  G  P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 31/200 (15%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-EVRIISRLRHRNLV 128
           F +  ++G+G FG VY+G+ +     +A+K +     + + E I  E+ ++S+     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 129 HLIGWCHEQRQLILHKIALGLASAVL------------------------YLHEEWEQCI 164
              G   +  +L +    LG  SA+                         YLH E +   
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERK--- 122

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +HRDIK++NV+L    + KL DFG+A +L D ++   T V  GT  ++APE +       
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQSAYDF 180

Query: 224 ESDVYSFGVVALEVACGRKP 243
           ++D++S G+ A+E+A G  P
Sbjct: 181 KADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 70.6 bits (173), Expect = 8e-14
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 42/207 (20%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRV--SRGSKQGKKEYIS-------EVRIISRLRHRN 126
           +G G FG VY G+ +     +AVK+V     S   K    S       E+ ++  L+H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 127 LVHLIGWCHEQRQL--ILHKIALGLASAVL-----------------------YLHEEWE 161
           +V  +G   +   L   L  +  G  +A+L                       YLH    
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH---N 124

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT-----VLAGTMGYLAPECV 216
           + I+HRDIK +N+++D+    K+ DFG+++ ++    S  T      L G++ ++APE V
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184

Query: 217 TTGKASKESDVYSFGVVALEVACGRKP 243
                ++++D++S G + +E+  G+ P
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 70.7 bits (174), Expect = 9e-14
 Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 35/196 (17%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYI-SEVRIISRLRHRNLVHLIG 132
           LG G FG V            A+K +S+    K  + E++ +E RI+  +RH  LV+L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 133 WCHEQRQLIL---------------------HKIALGLASAVL----YLHEEWEQCIVHR 167
              +   L L                       +A   A+ V+    YLH      IV+R
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYR 125

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           D+K  N++LDS+   K+ DFG A+ V      +T  L GT  YLAPE + +    K  D 
Sbjct: 126 DLKPENLLLDSDGYIKITDFGFAKRVK----GRTYTLCGTPEYLAPEIILSKGYGKAVDW 181

Query: 228 YSFGVVALEVACGRKP 243
           ++ G++  E+  G  P
Sbjct: 182 WALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 55/196 (28%), Positives = 96/196 (48%), Gaps = 34/196 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI-SEVRIISRLRHRNLV----- 128
           K+G+G  G V+  +      E+A+K+++   KQ KKE I +E+ ++  L++ N+V     
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 129 HLIG---------------------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHR 167
            L+G                      C ++ Q+    +      A+ +LH      ++HR
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA--AVCRECLQALEFLHANQ---VIHR 139

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           DIKS NV+L  + + KL DFG    +  E   ++T + GT  ++APE VT      + D+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDI 198

Query: 228 YSFGVVALEVACGRKP 243
           +S G++A+E+  G  P
Sbjct: 199 WSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 38/107 (35%), Positives = 65/107 (60%), Gaps = 7/107 (6%)

Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL K+++ +   + YL E+ +  I+HRD+K SN++++S    KL DFG++ +L+D    S
Sbjct: 104 ILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 157

Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
                 GT  Y++PE +     S +SD++S G+  +E+A GR P+ P
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 32/195 (16%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRV--SRGSKQGKKEYISEVRIISRLRHRNLVHLI 131
           G +GEG +G V +    +    +A+K+   S   K  KK  + E+R++ +LRH NLV+LI
Sbjct: 7   GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 132 GWCHEQRQLIL-------------------------HKIALGLASAVLYLHEEWEQCIVH 166
                +++L L                          K    +   + + H      I+H
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIH 123

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE-CVTTGKASKES 225
           RDIK  N+++  +   KL DFG AR +       T  +A T  Y APE  V   K  +  
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRAPELLVGDTKYGRAV 182

Query: 226 DVYSFGVVALEVACG 240
           D+++ G +  E+  G
Sbjct: 183 DIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 60/234 (25%), Positives = 92/234 (39%), Gaps = 73/234 (31%)

Query: 75  KLGEGGFGGVY----------------RGLLSDQNTEIAVK--RVSRGSKQGKKEYISEV 116
           KLGEG FG V+                    +D    +AVK  R    S   +++++ EV
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-ASDNAREDFLKEV 70

Query: 117 RIISRLRHRNLVHLIGWCHEQRQLI----------------------------------- 141
           +I+SRL   N+  L+G C     L                                    
Sbjct: 71  KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130

Query: 142 -LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ 200
            L  +A  +AS + YL        VHRD+ + N ++  N+  K+ DFG++R     L S 
Sbjct: 131 TLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSS 183

Query: 201 -------TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVA--CGRKPVE 245
                     L   + ++A E V  GK + +SDV++FGV   E+   C  +P E
Sbjct: 184 DYYRVQGRAPLP--IRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 37/202 (18%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYIS---EVRIISRLRHRNLVHL 130
           LG+G FG VY    +D   E+AVK+V     S +  KE  +   E++++  L H  +V  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 131 IGWCHEQRQLIL---------------------------HKIALGLASAVLYLHEEWEQC 163
            G   +  +  L                            K    +   V YLH      
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS---NM 126

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA--GTMGYLAPECVTTGKA 221
           IVHRDIK +N++ DS  N KLGDFG ++ +     S T + +  GT  +++PE ++    
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186

Query: 222 SKESDVYSFGVVALEVACGRKP 243
            +++D++S G   +E+   + P
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 60/201 (29%), Positives = 89/201 (44%), Gaps = 32/201 (15%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           LA  VL +H   +   VHRDIK  NV++D   + KL DFG A  +       + +  GT 
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167

Query: 209 GYLAPECVTT----GKASK--ESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDL 262
            Y+APE +TT    GK +   E D +S GV+A E+  GR P     E +  +    +  +
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH---EGTSAKTYNNI--M 222

Query: 263 YGKGQLLEAADGRLSKEFDE-------RQMECLMIVGLWCCHPDFTNRP--SIRQVI--- 310
             +  L    D ++S +F +        Q E L   GL CCHP F+     +IR  +   
Sbjct: 223 NFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEGL-CCHPFFSKIDWNNIRNSLPPF 281

Query: 311 --------NVLNFEAPLPSLP 323
                   +  NF+ P  +  
Sbjct: 282 VPTLKSDDDTSNFDEPEKNST 302

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 56/225 (24%)

Query: 68  NNFAEAGKLGEGGFGGVYRG----LLSDQNT-EIAVKRVSRGSKQGKKEYISEVRIISRL 122
           +N     +LGEG FG V+      L  +Q+   +AVK +   S   +K++  E  +++ L
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64

Query: 123 RHRNLVHLIGWCHEQRQLI---------------------------------------LH 143
           +H ++V   G C E   LI                                       LH
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV----DHELGS 199
            IA  +A+ ++YL     Q  VHRD+ + N ++  N   K+GDFG++R V     + +G 
Sbjct: 125 -IAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180

Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKP 243
            T +    + ++ PE +   K + ESDV+S GVV  E+   G++P
Sbjct: 181 HTML---PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 40/200 (20%)

Query: 65  RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKE-----YISEVRII 119
           R+ + + +  ++ EG +G VYR         +A+K++    +   KE      + E+ I+
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE---KEGFPITSLREINIL 58

Query: 120 SRLRHRNLVHL----IGWC------------HEQRQLILHK-----------IALGLASA 152
            +L+H N+V +    +G              H+ + L+              + L L S 
Sbjct: 59  LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSG 118

Query: 153 VLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLA 212
           V +LH+ W   I+HRD+K+SN++L++    K+ DFGLAR     L   T ++  T+ Y A
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRA 174

Query: 213 PECVT-TGKASKESDVYSFG 231
           PE +    + S   D++S G
Sbjct: 175 PELLLGAKEYSTAIDMWSVG 194

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 32/195 (16%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRV--SRGSKQGKKEYISEVRIISRLRHRNLVHLI 131
            K+GEG +G V++    +    +A+K+   S      KK  + E+R++ +L+H NLV+LI
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 132 GWCHEQRQL----------ILH---------------KIALGLASAVLYLHEEWEQCIVH 166
                +R+L          +L+               KI      AV + H+    CI H
Sbjct: 67  EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH--NCI-H 123

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE-CVTTGKASKES 225
           RD+K  N+++      KL DFG AR++       T  +A T  Y APE  V   +     
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPELLVGDTQYGPPV 182

Query: 226 DVYSFGVVALEVACG 240
           DV++ G V  E+  G
Sbjct: 183 DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 62/222 (27%)

Query: 75  KLGEGGFGGVY----RGLLSDQN-TEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVH 129
           +LGEG FG V+      LL +Q+   +AVK +   S+  ++++  E  +++ L+H+++V 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 130 LIGWCHEQRQLI----------------------------------------LHKIALGL 149
             G C E R L+                                        +  IA  +
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 150 ASAVLYL---HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV----DHELGSQTT 202
           AS ++YL   H       VHRD+ + N ++      K+GDFG++R +     + +G +T 
Sbjct: 132 ASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 203 VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKP 243
           +    + ++ PE +   K + ESD++SFGVV  E+   G++P
Sbjct: 186 L---PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 68.8 bits (168), Expect = 2e-13
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 54/209 (25%)

Query: 76  LGEGGFGGVYRGLL-----SDQN---TEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNL 127
           +GEG FG   R LL     SDQ     EI + + S   +  +KE +    ++++++H N+
Sbjct: 8   VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAV----LLAKMKHPNI 60

Query: 128 V----------HL---IGWCH---------EQR------QLILH---KIALGLASAVLYL 156
           V          HL   + +C           QR        IL    ++ LG    V ++
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG----VQHI 116

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV 216
           HE+    ++HRDIKS N+ L  N   KLGDFG ARL+        T + GT  Y+ PE  
Sbjct: 117 HEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172

Query: 217 TTGKASKESDVYSFGVVALEVACGRKPVE 245
                + +SD++S G +  E+   + P +
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPFQ 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 32/216 (14%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           +LG G FG V+ G    Q  ++A+K ++ G+   ++++I E +++ +L H  LV L G C
Sbjct: 11  ELGSGQFGVVHLGKWRAQ-IKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 135 HEQRQL-----------ILH-----------KIALGLASAVLYLHEEWEQ-CIVHRDIKS 171
            +Q+ L           +L+            + L +   V    E  E+   +HRD+ +
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAA 128

Query: 172 SNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVY 228
            N ++ S    K+ DFG+ R V   L  + T  +G    + +  PE     K S +SDV+
Sbjct: 129 RNCLVSSTGVVKVSDFGMTRYV---LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185

Query: 229 SFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLY 263
           SFGV+  EV   G+ P E +     V ++   + LY
Sbjct: 186 SFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY 221

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 52/193 (26%), Positives = 91/193 (47%), Gaps = 28/193 (14%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----H 129
           K+GEG  G V    +      +AVK++    +Q ++   +EV I+   +H N+V     +
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 130 LIG---WCHEQ-------RQLILHK---------IALGLASAVLYLHEEWEQCIVHRDIK 170
           L+G   W   +         ++ H          + L +  A+  LH    Q ++HRDIK
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIK 143

Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSF 230
           S +++L  +   KL DFG    V  E+  + + L GT  ++APE ++      E D++S 
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS-LVGTPYWMAPELISRLPYGPEVDIWSL 202

Query: 231 GVVALEVACGRKP 243
           G++ +E+  G  P
Sbjct: 203 GIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 38/107 (35%), Positives = 65/107 (60%), Gaps = 7/107 (6%)

Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL K+++ +   + YL E+ +  I+HRD+K SN++++S    KL DFG++ +L+D    S
Sbjct: 104 ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 157

Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
                 GT  Y++PE +     S +SD++S G+  +E+A GR P+ P
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 31/201 (15%)

Query: 69  NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY-ISEVRIISRLRHRNL 127
           NF +  KLGEG +  VY+G        +A+K +   +++G     I E+ ++  L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 128 VHLIGWCHEQRQLIL-----------------HKIALGLASAVLYLHEEW-------EQC 163
           V L    H + +L+L                  + AL   +   + ++         E  
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG--SQTTVLAGTMGYLAPECVTTGKA 221
           ++HRD+K  N++++     KL DFGLAR     +   S   V   T+ Y AP+ +   + 
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRAPDVLLGSRT 177

Query: 222 SKES-DVYSFGVVALEVACGR 241
              S D++S G +  E+  GR
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 75/265 (28%), Positives = 118/265 (44%), Gaps = 60/265 (22%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCH 135
           +G+G FG V  G    +  ++AVK +   +    + +++E  ++++LRH NLV L+G   
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 136 EQ------------------------RQLI----LHKIALGLASAVLYLHEEWEQCIVHR 167
           E+                        R ++    L K +L +  A+ YL        VHR
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHR 126

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           D+ + NV++  +  AK+ DFGL +    E  S        + + APE +   K S +SDV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182

Query: 228 YSFGVVALEV-ACGRKPVEPRQEPSK--VRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ 284
           +SFG++  E+ + GR P  PR  P K  V  VE       KG  ++A DG     +D  +
Sbjct: 183 WSFGILLWEIYSFGRVPY-PRI-PLKDVVPRVE-------KGYKMDAPDGCPPVVYDVMK 233

Query: 285 MECLMIVGLWCCHPDFTNRPSIRQV 309
                     C H D   RPS  Q+
Sbjct: 234 Q---------CWHLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 55/213 (25%), Positives = 86/213 (40%), Gaps = 50/213 (23%)

Query: 76  LGEGGFGGVYRGLLS---DQNTEIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLVH 129
           LG G FG VY GL         E+ V   +     S+Q + +++ E  I+S+  H+N+V 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 130 LIGWCHEQ--------------------------------RQLILHKIALGLASAVLYLH 157
           LIG   E+                                    L   A  +A    YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 158 EEWEQCIVHRDIKSSNVVLDSNFN---AKLGDFGLARLV---DHELGSQTTVLAGTMGYL 211
           E      +HRDI + N +L        AK+ DFG+AR +    +       +L   + ++
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP--IKWM 188

Query: 212 APECVTTGKASKESDVYSFGVVALEV-ACGRKP 243
            PE    G  + ++DV+SFGV+  E+ + G  P
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 59/221 (26%)

Query: 75  KLGEGGFGGVYRGL---LSDQNTE--IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVH 129
           +LGEG FG V+      LS    +  +AVK +   +   +K++  E  +++ L+H ++V 
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 130 LIGWCHEQRQLI------------------------------------------LHKIAL 147
             G C +   LI                                          LH IA 
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH-IAS 130

Query: 148 GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV----DHELGSQTTV 203
            +AS ++YL     Q  VHRD+ + N ++ +N   K+GDFG++R V     + +G  T +
Sbjct: 131 QIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKP 243
               + ++ PE +   K + ESDV+SFGV+  E+   G++P
Sbjct: 188 ---PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 64/227 (28%)

Query: 75  KLGEGGFGGVY----RGLL----------SDQNTEIAVKRV-SRGSKQGKKEYISEVRII 119
           KLGEG FG V+     GL             Q   +AVK + +  +K  + +++ E++I+
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 120 SRLRHRNLVHLIGWCHE---------------------QRQL-----------------I 141
           SRL++ N++ L+G C                       QR++                 +
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 142 LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV---DHELG 198
           L+ +A+ +AS + YL        VHRD+ + N ++ +++  K+ DFG++R +   D+   
Sbjct: 132 LY-MAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV--ACGRKP 243
               VL   + ++A E +  GK +  SDV++FGV   E+   C  +P
Sbjct: 188 QGRAVLP--IRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 68.2 bits (166), Expect = 7e-13
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 39/204 (19%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-EVRIISRLRHRNLV 128
           F +  K+G+G FG V++G+ +     +A+K +     + + E I  E+ ++S+     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 129 HLIG--------WC--------------------HEQRQLILHKIALGLASAVLYLHEEW 160
              G        W                       Q   IL +I  GL     YLH E 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLD----YLHSEK 121

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPECVTTG 219
           +   +HRDIK++NV+L  +   KL DFG+A +L D ++  +     GT  ++APE +   
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQS 176

Query: 220 KASKESDVYSFGVVALEVACGRKP 243
               ++D++S G+ A+E+A G  P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.0 bits (166), Expect = 7e-13
 Identities = 37/104 (35%), Positives = 60/104 (57%), Gaps = 8/104 (7%)

Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR-LVDHELGS 199
           +L +IA+ +   + YL   W   I+HRD+K SN+++++    KL DFG++  LV+    S
Sbjct: 96  VLGRIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----S 148

Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
                 GT  Y+APE ++  +    SDV+S G+  +E+A GR P
Sbjct: 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 68.2 bits (166), Expect = 8e-13
 Identities = 50/195 (25%), Positives = 95/195 (48%), Gaps = 32/195 (16%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----H 129
           K+G+G  G VY  +      E+A+++++   +  K+  I+E+ ++   ++ N+V     +
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 130 LIG---W------------------CHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRD 168
           L+G   W                  C ++ Q+    +      A+ +LH      ++HRD
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--AVCRECLQALEFLHSNQ---VIHRD 141

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           IKS N++L  + + KL DFG    +  E  S+ + + GT  ++APE VT      + D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 229 SFGVVALEVACGRKP 243
           S G++A+E+  G  P
Sbjct: 201 SLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 64/266 (24%), Positives = 125/266 (46%), Gaps = 52/266 (19%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVS--RGSKQGKKEYISEVRIISRLRHRNLVH---- 129
           +G+G +G V          +  +K+++    S++ +K    E +++S+L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 130 ----------LIGWCH---------EQR-QLILHKIAL----GLASAVLYLHEEWEQCIV 165
                     ++G+C          EQ+ +L+     +     +A A+ YLHE+    I+
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---IL 124

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES 225
           HRD+K+ NV L      K+GD G+AR+++++    +T L GT  Y++PE  +    + +S
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNKPYNYKS 183

Query: 226 DVYSFGVVALEVACGRKPVEPRQEPSKV-RLVEWVWDLYGKGQLLEAADGRLSKEFDERQ 284
           DV++ G    E+A  +     +   S V R++E        G+L       + K++    
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--------GKLPP-----MPKDYSPEL 230

Query: 285 MECLMIVGLWCCHPDFTNRPSIRQVI 310
            E  +I  +    P+   RPS++ ++
Sbjct: 231 GE--LIATMLSKRPE--KRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 37/210 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----H 129
           K+GEG  G V          ++AVK++    +Q ++   +EV I+   +H N+V     +
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 130 LIG---WC-------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHR 167
           L+G   W                    +E++   +    L    A+ +LH    Q ++HR
Sbjct: 86  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLK---ALSFLHA---QGVIHR 139

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           DIKS +++L S+   KL DFG    V  E+  +   L GT  ++APE ++      E D+
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPEVISRLPYGTEVDI 198

Query: 228 YSFGVVALEVACGRKP---VEPRQEPSKVR 254
           +S G++ +E+  G  P     P Q   ++R
Sbjct: 199 WSLGIMVIEMVDGEPPYFNEPPLQAMKRIR 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 53/193 (27%), Positives = 92/193 (47%), Gaps = 28/193 (14%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----H 129
           K+GEG  G V          ++AVK +    +Q ++   +EV I+   +H+N+V     +
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 130 LIG---WCH-------------EQRQLILHKIAL---GLASAVLYLHEEWEQCIVHRDIK 170
           L+G   W                Q +L   +IA     +  A+ YLH    Q ++HRDIK
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIK 144

Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSF 230
           S +++L  +   KL DFG    +  ++  + + L GT  ++APE ++      E D++S 
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRTPYGTEVDIWSL 203

Query: 231 GVVALEVACGRKP 243
           G++ +E+  G  P
Sbjct: 204 GIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 37/197 (18%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLI-G 132
           G+LG+G FG VY+    +     A K +   S++  ++Y+ E+ I++   H N+V L+  
Sbjct: 11  GELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 133 WCHEQRQLILHKIALGLA-------------------------SAVLYLHEEWEQCIVHR 167
           + +E    IL +   G A                          A+ YLH   E  I+HR
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHR 127

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE--- 224
           D+K+ N++   + + KL DFG++      +  + + + GT  ++APE V   + SK+   
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMC-ETSKDRPY 185

Query: 225 ---SDVYSFGVVALEVA 238
              +DV+S G+  +E+A
Sbjct: 186 DYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 27/194 (13%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRV--SRGSKQGKKEYISEVRIISRLRHRNL 127
           + +  K+GEG FG        +   +  +K +  S+ S + ++E   EV ++S ++H N+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 128 VH-------------LIGWC---------HEQRQLIL--HKIALGLASAVLYLHEEWEQC 163
           V              ++ +C         + QR ++    +I        L L    ++ 
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           I+HRDIKS N+ L  +   KLGDFG+AR+++  +    T + GT  YL+PE       + 
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNN 180

Query: 224 ESDVYSFGVVALEV 237
           +SD+++ G V  E+
Sbjct: 181 KSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 39/203 (19%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVS--RGSKQGKKEYIS---EVRIISRLRHRNLVHL 130
           LG+G FG VY     D   E+A K+V     S +  KE  +   E++++  L+H  +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 131 IGWC---HEQRQL-------------------------ILHKIALGLASAVLYLHEEWEQ 162
            G C     ++ L                         +  K    +   + YLH     
Sbjct: 70  YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS---N 125

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV--LAGTMGYLAPECVTTGK 220
            IVHRDIK +N++ DS  N KLGDFG ++ +     S T +  + GT  +++PE ++   
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185

Query: 221 ASKESDVYSFGVVALEVACGRKP 243
             +++DV+S G   +E+   + P
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 6/98 (6%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT-VLAGT 207
           +   + +LHE   + I++RD+K  NV+LDS  + K+ DFG+ +  +  LG  TT    GT
Sbjct: 105 IVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGT 159

Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
             Y+APE ++        D ++ GV+  E+  G+ P E
Sbjct: 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 37/101 (36%), Positives = 53/101 (52%), Gaps = 5/101 (4%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +   +L+LH      IV+RD+K  NV+LD   N +L D GLA  V+ + G   T  AGT 
Sbjct: 104 ITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTN 158

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
           GY+APE +     S   D ++ G    E+  GR P +  +E
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 49/203 (24%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLV---- 128
           +G G +G V     +    ++A+K++SR    +   K+ Y  E+R++  + H N++    
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGLLD 81

Query: 129 ------------------HLIG-----------WCHEQRQLILHKIALGLASAVLYLHEE 159
                             HL+G              +  Q ++++I  GL     Y+H  
Sbjct: 82  VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLK----YIHS- 136

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT- 218
               I+HRD+K SN+ ++ +   K+ DFGLAR  D E+    T    T  Y APE +   
Sbjct: 137 --AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNW 190

Query: 219 GKASKESDVYSFGVVALEVACGR 241
              ++  D++S G +  E+  G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.7 bits (160), Expect = 6e-12
 Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 36/213 (16%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY---ISEVRIISRLRHRNLVHLIG 132
           +G+G FG VY+    D     A+K +S+     KKE    I E  I+ R        ++G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 133 ------------------------WCHEQRQ--LILHKIALGLASAVLYLHEEWEQCIVH 166
                                   W H Q++      +    +A  VL L    +  IV+
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFW-HLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVY 119

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQTTVLAGTMGYLAPECVTTGKA-SK 223
           RD+K  N++LD+  +  L DFGL++  L D++    T    GT  YLAPE +   K  +K
Sbjct: 120 RDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAPEVLLDEKGYTK 176

Query: 224 ESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
             D +S GV+  E+ CG  P          R +
Sbjct: 177 HVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 65.6 bits (160), Expect = 8e-12
 Identities = 40/117 (34%), Positives = 63/117 (53%), Gaps = 15/117 (12%)

Query: 135 HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD 194
           H   +  L  +A  + S + YLH    + IVHRDIK SN++++S  N K+ DFG++R++ 
Sbjct: 163 HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219

Query: 195 HELGSQTTVLAGTMGYLAPECVTT--------GKASKESDVYSFGVVALEVACGRKP 243
             +    + + GT+ Y++PE + T        G A    D++S GV  LE   GR P
Sbjct: 220 QTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYA---GDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 64.7 bits (157), Expect = 8e-12
 Identities = 52/210 (24%), Positives = 101/210 (48%), Gaps = 32/210 (15%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHL---- 130
           KLG G FG V+     +++T++AVK +  GS    + +++E  ++  L+H  LV L    
Sbjct: 13  KLGAGQFGEVWMATY-NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV 70

Query: 131 -------IGWCHEQRQLI---------------LHKIALGLASAVLYLHEEWEQCIVHRD 168
                  I     +  L+               L   +  +A  + ++ +   +  +HRD
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 127

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           ++++N+++ ++   K+ DFGLAR+++    +        + + APE +  G  + +SDV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187

Query: 229 SFGVVALE-VACGRKPVEPRQEPSKVRLVE 257
           SFG++ +E V  GR P      P  +R +E
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPEVIRALE 217

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 40/206 (19%)

Query: 76  LGEGGFGGVYRG--LLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG- 132
           +G G +G VY+G  + + Q   I V  V+   ++  K+ I+ ++  S   HRN+    G 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNIATYYGA 71

Query: 133 -------WCHEQRQLILHKIALGLASAVL------YLHEEW----------------EQC 163
                     +Q  L++     G  + ++       L EEW                +  
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 131

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           ++HRDIK  NV+L  N   KL DFG++  +D  +G + T + GT  ++APE +   +   
Sbjct: 132 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPD 190

Query: 224 -----ESDVYSFGVVALEVACGRKPV 244
                +SD++S G+ A+E+A G  P+
Sbjct: 191 ATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 33/223 (14%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SA+++LH+   + I++RD+K  NV+LD   + KL DFG+ +      G  T+   GT 
Sbjct: 105 ITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFCGTP 160

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV---EWVWDLYGK 265
            Y+APE +         D ++ GV+  E+ CG  P E   E      +   E V+  +  
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS 220

Query: 266 GQLLEAADGRLSKEFDERQMECLMIVG----LWCCHPDFTN---------------RPSI 306
              ++     ++K    R +  L + G    L   HP F                 RP I
Sbjct: 221 QDAVDILKAFMTKNPTMR-LGSLTLGGEEAILR--HPFFKELDWEKLNRRQIEPPFRPRI 277

Query: 307 RQVINVLNFEAP-LPSLPSKLPVPMYYAPPIN---ILKFTYTS 345
           +   +V NF+   +   P   P+     P IN      F+YT+
Sbjct: 278 KSREDVSNFDPDFIKEDPVLTPIEESLLPMINQDEFRNFSYTA 320

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 60/212 (28%)

Query: 76  LGEGGFGGVYRGLLSDQNTEI--AVKRVSR-GSKQGKKEYISEVRIISRL-RHRNLVHLI 131
           +GEG FG V +  +      +  A+KR+    SK   +++  E+ ++ +L  H N+++L+
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 132 GWCHEQRQL-----------------------------ILHKIALGLASAVL-------- 154
           G C  +  L                             I +  A  L+S  L        
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 155 ----YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG- 209
               YL ++     +HRD+ + N+++  N+ AK+ DFGL+R        Q   +  TMG 
Sbjct: 135 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 184

Query: 210 ----YLAPECVTTGKASKESDVYSFGVVALEV 237
               ++A E +     +  SDV+S+GV+  E+
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 49/205 (23%), Positives = 94/205 (45%), Gaps = 29/205 (14%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKR--VSRGSKQGKKEYISEVRIISRLRHRNLVHLIGW 133
           +G G FG V+          + +K+  V + +K  +    +E +++  L H N++     
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 134 CHEQRQL-ILHKIALG-----------------------LASAVLYLHEEWEQCIVHRDI 169
             E + L I+ + A G                           +L LH    + I+HRD+
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127

Query: 170 KSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           K+ N++LD +    K+GDFG+++++  +  + T V  GT  Y++PE       +++SD++
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPELCEGKPYNQKSDIW 185

Query: 229 SFGVVALEVACGRKPVEPRQEPSKV 253
           + G V  E+A  ++  E    P+ V
Sbjct: 186 ALGCVLYELASLKRAFEAANLPALV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 49/193 (25%), Positives = 95/193 (49%), Gaps = 38/193 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLG G FG V+ G  ++ +T++AVK +  G+    + ++ E  ++  L+H  LV L    
Sbjct: 13  KLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 135 ------------------------HEQRQLILHKI---ALGLASAVLYLHEEWEQCIVHR 167
                                    E  +++L K+   +  +A  + Y+     +  +HR
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 127

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKE 224
           D++++NV++  +   K+ DFGLAR+++    ++ T   G    + + APE +  G  + +
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSFTIK 184

Query: 225 SDVYSFGVVALEV 237
           SDV+SFG++  E+
Sbjct: 185 SDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 4/95 (4%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SA+ YLH      +V+RD+K  N++LD + + K+ DFGL +      G+      GT 
Sbjct: 104 IVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTP 159

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 74/284 (26%), Positives = 120/284 (42%), Gaps = 64/284 (22%)

Query: 69  NFAEAGKLGEGGFGGVY--RGLLSDQNTEIAVKRVS-------RGSKQGKKEY---ISEV 116
            +A    LG G FG VY  R   + QN  +A+K ++       +  ++  K     +SEV
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNL-LALKEINVHNPAFGKDKRERDKSIGDIVSEV 59

Query: 117 RII-SRLRHRNLVH----------------LIGWC---------HEQRQLI----LHKIA 146
            II  +LRH N+V                 LI             E++Q      +  I 
Sbjct: 60  TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 147 LGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG 206
           + +  A+ YLH+E  + IVHRD+  +N++L  +    + DFGLA+    E  S+ T + G
Sbjct: 120 VQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE--SKLTSVVG 175

Query: 207 TMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPS-KVRLVEWVWDLYGK 265
           T+ Y  PE V      +++DV++FG +  ++   + P       S   ++VE V++   +
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE 235

Query: 266 GQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQV 309
           G   E     ++                 C  PD   RP I QV
Sbjct: 236 GMYSEDVTDVIT----------------SCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 35/196 (17%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG- 132
           G+LG+G FG VY+    +     A K +   S++  ++Y+ E+ I++   H  +V L+G 
Sbjct: 18  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 133 WCHEQRQLILHKIALGLA-------------------------SAVLYLHEEWEQCIVHR 167
           +  + +  I+ +   G A                          A+ YLH      I+HR
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHR 134

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT--TGKASK-- 223
           D+K+ NV+L  + + KL DFG++      L  + + + GT  ++APE V   T K +   
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPYD 193

Query: 224 -ESDVYSFGVVALEVA 238
            ++D++S G+  +E+A
Sbjct: 194 YKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 45/183 (24%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVS-RGSKQGKKEYISEVRIISRLR----- 123
           + E  ++GEG +G VY+    +    +A+K+V    S++G    +S +R I+ L+     
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLKQLESF 58

Query: 124 -HRNLVHLIGWCHEQ---RQLILHKI----------------ALGLA------------S 151
            H N+V L+  CH     R+L L  +                  GL              
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL 211
            V +LH      IVHRD+K  N+++ S+   K+ DFGLAR+   E+ + T+V+  T+ Y 
Sbjct: 119 GVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM-ALTSVVV-TLWYR 173

Query: 212 APE 214
           APE
Sbjct: 174 APE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 54/213 (25%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY----ISEVRIISRLRHRNL--- 127
            +GEG +G V          ++A+K++S    Q    +    + E++I+ R +H N+   
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKHENIIGI 68

Query: 128 --------------VHLIGWCHEQRQLILHKIALGLASAVL-----------------YL 156
                         V+++    E  +  L+K+   + +  L                 Y+
Sbjct: 69  LDIIRPPSFESFNDVYIV---QELMETDLYKL---IKTQHLSNDHIQYFLYQILRGLKYI 122

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD--HELGSQTTVLAGTMGYLAPE 214
           H      ++HRD+K SN++L++N + K+ DFGLAR+ D  H+     T    T  Y APE
Sbjct: 123 HS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179

Query: 215 CVTTGKA-SKESDVYSFGVVALEVACGRKPVEP 246
            +   K  +K  D++S G +  E+   R P+ P
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFP 211

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 48/195 (24%), Positives = 74/195 (37%), Gaps = 61/195 (31%)

Query: 70  FAEAGKLGEGGFGGVY--RGLLSDQNTEIAVKRVSRGSKQGKKEY-------ISEVRIIS 120
           +   G +G G +G VY  +        E A+K+     K  K++Y         E+ ++ 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF----KGDKEQYTGISQSACREIALLR 57

Query: 121 RLRHRNLVHLIG---------------------W--CHEQRQLILHKIALG--------L 149
            L+H N+V L+                      W      RQ     I           +
Sbjct: 58  ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117

Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA----KLGDFGLARLVDHELGSQTTVLA 205
            + V YLH  W   ++HRD+K +N+++          K+GD GLARL +  L      LA
Sbjct: 118 LNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP----LA 170

Query: 206 G------TMGYLAPE 214
                  T+ Y APE
Sbjct: 171 DLDPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 42/127 (33%), Positives = 68/127 (53%), Gaps = 12/127 (9%)

Query: 143 HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL----VDHELG 198
           +++ L     VL L E   + ++HRD+KS+N+ L      KLGDFG ++     V  ++ 
Sbjct: 169 YEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228

Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW 258
           S      GT  YLAPE     + SK++D++S GV+  E+    +P    + PS+  +++ 
Sbjct: 229 SS---FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQ 282

Query: 259 VWDLYGK 265
           V  LYGK
Sbjct: 283 V--LYGK 287

Length = 478

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 12/100 (12%)

Query: 152 AVLYLHEEWEQC-IVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELG-----SQTTV 203
           A+ YLH       I+HRD+K  N+++DSN + KL DFGL++  LV  ++       +   
Sbjct: 105 ALEYLH----SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160

Query: 204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           + GT  Y+APE +     SK  D +S G +  E   G  P
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 50/211 (23%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRGSKQGKKE-YISEVRIISR 121
           NN +    LG G FG V          SD   ++AVK +   +   ++E  +SE++I+S 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 122 L-RHRNLVHLIGWC----------------------HEQRQLIL---------HKIALGL 149
           L  H N+V+L+G C                        +R+  L         +++A G+
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154

Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT-- 207
           A    +L    + CI HRD+ + NV+L      K+ DFGLAR + ++  S   V      
Sbjct: 155 A----FL--ASKNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMND--SNYVVKGNARL 205

Query: 208 -MGYLAPECVTTGKASKESDVYSFGVVALEV 237
            + ++APE +     + ESDV+S+G++  E+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 43/134 (32%), Positives = 68/134 (50%), Gaps = 24/134 (17%)

Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ 200
           I  +I  GLA   L+ H+     ++HRDIK  NV+L  N   KL DFG++  +D  +G +
Sbjct: 126 ICREILRGLAH--LHAHK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 178

Query: 201 TTVLAGTMGYLAPECVTTGKASK-----ESDVYSFGVVALEVACGRKP-----------V 244
            T + GT  ++APE +   +         SD++S G+ A+E+A G  P           +
Sbjct: 179 NTFI-GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 237

Query: 245 EPRQEPSKVRLVEW 258
            PR  P K++  +W
Sbjct: 238 IPRNPPPKLKSKKW 251

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 65/285 (22%)

Query: 76  LGEGGFGGVYRGLL--SDQNTEIAVK-RVSR--GSKQGKKEYISEVRIISRLRHRNLVHL 130
           LG G FG VY+G+     +N +I V  +V R   S +  KE + E  +++ +    +  L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 131 IGWCHEQR-QLILHKIALG------------------------LASAVLYLHEEWEQCIV 165
           +G C     QL+   +  G                        +A  + YL E     +V
Sbjct: 75  LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LV 131

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTG 219
           HRD+ + NV++ S  + K+ DFGLARL+D      H  G +  +      ++A E +   
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI-----KWMALESILHR 186

Query: 220 KASKESDVYSFGVVALEVAC-GRKPVE--PRQEPSKVRLVEWVWDLYGKGQLLEAADGRL 276
           + + +SDV+S+GV   E+   G KP +  P +E         + DL  KG+       RL
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---------IPDLLEKGE-------RL 230

Query: 277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPS 321
            +         +++V  W    +   RP  R++++  +  A  PS
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDSE--CRPRFRELVDEFSRMARDPS 273

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 45/201 (22%)

Query: 76  LGEGGFGGVYRGLLSDQNTE-------IAVKRVSRGSKQGKKEYI-SEVRIISRLRHRNL 127
           +G G FG V+  L+ D+ +E       +A+  V R  KQ  ++++ +E R++  + H  +
Sbjct: 9   VGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIR-LKQ--EQHVHNEKRVLKEVSHPFI 63

Query: 128 VHLIGWCHEQRQL--ILHKIALG-----------------------LASAVLYLHEEWEQ 162
           + L    H+QR L  ++  +  G                       +  A+ YLH    +
Sbjct: 64  IRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS---K 120

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            IV+RD+K  N++LD   + KL DFG A+    +L  +T  L GT  YLAPE + +   +
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTPEYLAPEVIQSKGHN 176

Query: 223 KESDVYSFGVVALEVACGRKP 243
           K  D ++ G++  E+  G  P
Sbjct: 177 KAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 36/107 (33%), Positives = 60/107 (56%), Gaps = 10/107 (9%)

Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT- 202
           +IA+GL     +LH    + I++RD+K  NV+LD+  + K+ DFG+ +  ++  G +TT 
Sbjct: 109 EIAIGL----FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTR 159

Query: 203 VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
              GT  Y+APE +      K  D ++FGV+  E+  G+ P +   E
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 57/226 (25%)

Query: 62  ELSRATNNFAEAGKLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRGSKQG-KKEYISE 115
           E++ +T  F E  +LGE  FG VY+G L      +Q   +A+K +   ++   ++E+  E
Sbjct: 1   EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 116 VRIISRLRHRNLVHLIGWCHEQRQLI----------LHK--------------------- 144
             + SRL+H N+V L+G   +++ L           LH+                     
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 145 ----------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV- 193
                     I   +A+ + +L       +VH+D+ + NV++    N K+ D GL R V 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 194 --DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
             D+      ++L   + +++PE +  GK S +SD++S+GVV  EV
Sbjct: 176 AADYYKLMGNSLLP--IRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 49/203 (24%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV---- 128
           +G G +G V     +     +AVK++SR  +     K+ Y  E+R++  ++H N++    
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83

Query: 129 ------------------HLIGW-------CH----EQRQLILHKIALGLASAVLYLHEE 159
                             HL+G        C     +  Q ++++I  GL     Y+H  
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS- 138

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
               I+HRD+K SN+ ++ +   K+ DFGLAR  D E+    T    T  Y APE +   
Sbjct: 139 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNW 192

Query: 220 KASKES-DVYSFGVVALEVACGR 241
               ++ D++S G +  E+  GR
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 62.0 bits (150), Expect = 7e-11
 Identities = 68/281 (24%), Positives = 127/281 (45%), Gaps = 64/281 (22%)

Query: 75  KLGEGGFGGVY----RGLLSDQ-NTEIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLV 128
           +LG+G FG VY    +G++ D+  T +A+K V+   S + + E+++E  ++      ++V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 129 HLIGWCHE-QRQLILH----------------------------------KIALGLASAV 153
            L+G   + Q  L++                                   ++A  +A  +
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMGY 210
            YL+       VHRD+ + N ++  +F  K+GDFG+ R +   D+       +L   + +
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--VRW 187

Query: 211 LAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE 270
           ++PE +  G  +  SDV+SFGVV  E+A   +  +P Q  S  +++ +V +    G LL+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--QPYQGMSNEQVLRFVME----GGLLD 241

Query: 271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
             D      F+  +M        W  +P    RPS  ++I+
Sbjct: 242 KPDNCPDMLFELMRM-------CWQYNPKM--RPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.3 bits (154), Expect = 7e-11
 Identities = 37/110 (33%), Positives = 60/110 (54%), Gaps = 7/110 (6%)

Query: 138 RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL----V 193
           R    H+  L     +L +H    + ++HRDIKS+N++L SN   KLGDFG +++    V
Sbjct: 138 RTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATV 197

Query: 194 DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             ++G       GT  Y+APE       SK++D++S GV+  E+   ++P
Sbjct: 198 SDDVGR---TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 36/100 (36%), Positives = 52/100 (52%), Gaps = 5/100 (5%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +A  VL +H   +   VHRDIK  NV+LD N + +L DFG    ++ +   Q++V  GT 
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167

Query: 209 GYLAPECVTT-----GKASKESDVYSFGVVALEVACGRKP 243
            Y++PE +       GK   E D +S GV   E+  G  P
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 6/96 (6%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR-LVDHELGSQTTVLAGT 207
           LA A+ +LH      I++RD+K  N++LD   + KL DFGL++  +DHE   +     GT
Sbjct: 107 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGT 161

Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           + Y+APE V     ++ +D +SFGV+  E+  G  P
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 59/218 (27%)

Query: 69  NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQG--KKEYISEVRIISRLRHRN 126
           ++ +  K+GEG +G VY+G        +A+K++   S++       I E+ ++  L+H N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 127 LVHLIGWCHEQRQLIL-------------------------------HKIALGLASAVLY 155
           +V L     ++ +L L                               ++I  G    +L+
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQG----ILF 116

Query: 156 LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-------RLVDHELGSQTTVLAGTM 208
            H    + ++HRD+K  N+++D+    KL DFGLA       R+  HE          T+
Sbjct: 117 CHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHE--------VVTL 165

Query: 209 GYLAPECVTTGKA--SKESDVYSFGVVALEVACGRKPV 244
            Y APE V  G    S   D++S G +  E+A  +KP+
Sbjct: 166 WYRAPE-VLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 62.2 bits (151), Expect = 8e-11
 Identities = 61/240 (25%), Positives = 101/240 (42%), Gaps = 65/240 (27%)

Query: 62  ELSRATNNFAEAGKLGEGGFGGVY----RGLL------------SDQNTEIAVKRV-SRG 104
           E  R    F E  KLGEG FG V+     G+              +Q   +AVK +    
Sbjct: 1   EFPRKRLTFKE--KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA 58

Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------------------HE-QRQ 139
           +K  + +++ E++I+SRL+  N++ L+  C                        HE Q  
Sbjct: 59  NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA 118

Query: 140 LI-----------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
                        L  +A  +AS + YL        VHRD+ + N ++  N+  K+ DFG
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFG 175

Query: 189 LARLV---DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVA--CGRKP 243
           ++R +   D+       VL   + +++ E +  GK +  SDV++FGV   E+   C  +P
Sbjct: 176 MSRNLYSGDYYRIQGRAVLP--IRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 30/220 (13%)

Query: 50  EKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQN-TEIAVKRVSRGS--K 106
           +K +   +   R+      +F     LG G FG V      +++   +A+KR  +    K
Sbjct: 12  KKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK 71

Query: 107 QGKKEYI-SEVRIISRLRHRNLVHLIGWCHEQRQLIL---------------------HK 144
           Q + +++ SE +I++ + H   V+L G   ++  L L                     + 
Sbjct: 72  QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND 131

Query: 145 IALGLASAVLYLHEEWEQC-IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
           +    A+ ++ + E  +   IV+RD+K  N++LD +   K+ DFG A++VD    ++T  
Sbjct: 132 VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYT 187

Query: 204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           L GT  Y+APE +      K +D ++ G+   E+  G  P
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 3/95 (3%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SA+ YLH E    +V+RD+K  N++LD + + K+ DFGL +    + G+      GT 
Sbjct: 104 IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFCGTP 160

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.4 bits (152), Expect = 8e-11
 Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 51/210 (24%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLV----- 128
           +G G +G V     S+ N ++A+K+++    ++   K  + E++++  L H N++     
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 129 -----------------------HLI-----GWCHEQRQLILHKIALGLASAVLYLHEEW 160
                                  H I         +  Q  L+++  GL     Y+H   
Sbjct: 73  MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLK----YIHS-- 126

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE----CV 216
              ++HRD+K SN++L++N + K+ DFGLAR    E G   T    T  Y APE    C 
Sbjct: 127 -ANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLLNCS 184

Query: 217 TTGKASKESDVYSFGVVALEVACGRKPVEP 246
               A    DV+S G +  E+  GRKP+ P
Sbjct: 185 EYTTA---IDVWSVGCIFAELL-GRKPLFP 210

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 61.8 bits (150), Expect = 9e-11
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 40/208 (19%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIG 132
            +LG+G +G VY+ L       +A+K +     + K  + I E+ I+ +     +V   G
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 133 ---------WCHEQR-------------------QLILHKIALGLASAVLYLHEEWEQCI 164
                     C E                     + +L +I   +   + +L EE    I
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK- 223
           +HRD+K +NV+++ N   KL DFG++  +   L ++T +  G   Y+APE + +G  ++ 
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-AKTNI--GCQSYMAPERIKSGGPNQN 181

Query: 224 -----ESDVYSFGVVALEVACGRKPVEP 246
                +SDV+S G+  LE+A GR P  P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPP 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 61.6 bits (150), Expect = 9e-11
 Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 34/201 (16%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVS-RGSKQG-KKEYISEVRIISRLRHRNLVHLIG 132
           K+GEG +G VY+         +A+K++      +G     I E+ ++  L H N+V L+ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 133 WCHEQRQLIL----------------HKIALG----------LASAVLYLHEEWEQCIVH 166
             H + +L L                    L           L   + Y H      ++H
Sbjct: 66  VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLH 122

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKES 225
           RD+K  N+++D     KL DFGLAR     + + T  +  T+ Y APE +   +  S   
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTPV 181

Query: 226 DVYSFGVVALEVACGRKPVEP 246
           D++S G +  E+   R+P+ P
Sbjct: 182 DIWSIGCIFAEM-VNRRPLFP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 42/206 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLR---HRNLVH 129
           ++G G +G VY+         +A+K  RV           + EV ++ RL    H N+V 
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 130 LIGWCHEQRQLILHKIAL-------------------GLA------------SAVLYLHE 158
           L+  C   R     K+ L                   GL               + +LH 
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 159 EWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT 218
               CIVHRD+K  N+++ S    KL DFGLAR+   ++     V+  T+ Y APE +  
Sbjct: 127 ---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVLLQ 181

Query: 219 GKASKESDVYSFGVVALEVACGRKPV 244
              +   D++S G +  E+   RKP+
Sbjct: 182 STYATPVDMWSVGCIFAEMF-RRKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 51/192 (26%), Positives = 82/192 (42%), Gaps = 48/192 (25%)

Query: 64  SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVS-RGSKQG-KKEYISEVRIISR 121
            R  + F   G++GEG +G VY+    D    +A+K+V     K+G     I E++I+ +
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 122 LRHRNLVHL---------------------------------------IGWCHEQRQLIL 142
           L HRN+V+L                                       + +  +  +  +
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122

Query: 143 HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT 202
            ++  GL     Y H+   +  +HRDIK SN++L++    KL DFGLARL + E     T
Sbjct: 123 KQLLEGLN----YCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175

Query: 203 VLAGTMGYLAPE 214
               T+ Y  PE
Sbjct: 176 NKVITLWYRPPE 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 27/195 (13%)

Query: 69  NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRN 126
           NF +  K+GEG +G VY+         +A+K  R+   ++      I E+ ++  L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 127 LVHLIGWCHEQRQLIL------------------HKIALGLASAVLY-LHEEWEQC---- 163
           +V L+   H + +L L                    I L L  + L+ L +    C    
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-AS 222
           ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ Y APE +   K  S
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYS 179

Query: 223 KESDVYSFGVVALEV 237
              D++S G +  E+
Sbjct: 180 TAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 57/202 (28%), Positives = 86/202 (42%), Gaps = 42/202 (20%)

Query: 76  LGEGGFGGVYRGLLSDQNTE---IAVKRVSRGSKQGKKE---YISEVRI---ISRLRHRN 126
           LG G FG V   LL++        A+K + +G    + E    + E RI    +  RH  
Sbjct: 7   LGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 127 LVHLIGWC---------------------HEQRQLILHKIALGLASAVL----YLHEEWE 161
           LV+L   C                     H    +     A+  A+ V+    YLHE   
Sbjct: 64  LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHE--- 119

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA 221
             IV+RD+K  N++LD+    K+ DFGL +      G +T+   GT  +LAPE +T    
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVLTETSY 178

Query: 222 SKESDVYSFGVVALEVACGRKP 243
           ++  D +  GV+  E+  G  P
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 64/255 (25%), Positives = 103/255 (40%), Gaps = 87/255 (34%)

Query: 62  ELSRATNNFAEAGKLGEGGFGGVY----------------------RGLLSDQNTEIAVK 99
           +  R    F E  KLGEG FG V+                      R LL      +AVK
Sbjct: 1   KFPRGHLLFKE--KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLL------VAVK 52

Query: 100 RV-SRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-------------------- 138
            +    +K  + +++ EV+I+SRL+  N++ L+G C ++                     
Sbjct: 53  ILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSS 112

Query: 139 -------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSN 173
                                      +LH +AL +AS + YL        VHRD+ + N
Sbjct: 113 HHLDDKEENGNDAVPPAHCLPAISYSSLLH-VALQIASGMKYLSS---LNFVHRDLATRN 168

Query: 174 VVLDSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSF 230
            ++  N   K+ DFG++R +   D+       VL   + ++A EC+  GK +  SDV++F
Sbjct: 169 CLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP--IRWMAWECILMGKFTTASDVWAF 226

Query: 231 GVVALEV--ACGRKP 243
           GV   E+   C  +P
Sbjct: 227 GVTLWEILMLCKEQP 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 55/197 (27%), Positives = 83/197 (42%), Gaps = 38/197 (19%)

Query: 76  LGEGGFGGV----YRGLLSDQNTEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHL 130
           LGEG FG V    Y     +   ++AVK +   S      +   E+ I+  L H N+V  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 131 IGWCHEQR----QLI------------------------LHKIALGLASAVLYLHEEWEQ 162
            G C E      +LI                          K A+ +   + YL     +
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---R 128

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV--LAGTMGYLAPECVTTGK 220
             VHRD+ + NV+++S    K+GDFGL + ++ +    T    L   + + APEC+   K
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 221 ASKESDVYSFGVVALEV 237
               SDV+SFGV   E+
Sbjct: 189 FYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 72/293 (24%), Positives = 131/293 (44%), Gaps = 65/293 (22%)

Query: 75  KLGEGGFGGVYRGLLSD-----QNTEIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLV 128
           +LG+G FG VY G   D       T +AVK V+   S + + E+++E  ++      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 129 HLIGWCHEQR------QLILH-----------------------------KIALGLASAV 153
            L+G   + +      +L+ H                             ++A  +A  +
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMGY 210
            YL+    +  VHRD+ + N ++  +F  K+GDFG+ R +   D+       +L   + +
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--VRW 187

Query: 211 LAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE 270
           +APE +  G  +  SD++SFGVV  E+    +  +P Q  S  +++++V D    G  L+
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVMD----GGYLD 241

Query: 271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLP 323
             D    +  D  +M C      W  +P    RP+  +++N+L  +   PS P
Sbjct: 242 QPDNCPERVTDLMRM-C------WQFNPKM--RPTFLEIVNLLK-DDLHPSFP 284

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 68/274 (24%), Positives = 115/274 (41%), Gaps = 58/274 (21%)

Query: 76  LGEGGFGGVYRGLL---SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLI 131
           LG G FG + RG L   S +   +A+  +  G S + ++ +++E   + +  H N+V L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 132 GWC------------------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIV 165
           G                          HE + +    + +  GLAS + YL E      V
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYV 129

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL--APECVTTGKASK 223
           H+ + +  V+++S+   K+  F   RL + +  +  T ++G    L  APE +     S 
Sbjct: 130 HKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSS 187

Query: 224 ESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFD 281
            SDV+SFG+V  EV + G +P                WD+ G+  +    DG RL    +
Sbjct: 188 ASDVWSFGIVMWEVMSYGERP---------------YWDMSGQDVIKAVEDGFRLPAPRN 232

Query: 282 ERQ-MECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
               +  LM   L C   +   RP   Q+ ++L+
Sbjct: 233 CPNLLHQLM---LDCWQKERGERPRFSQIHSILS 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 47/181 (25%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKE-----YISEVRIISRLRHRNLVH 129
           K+G+G FG V++         +A+K+V   ++   KE      + E++I+  L+H N+V+
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENVVN 75

Query: 130 LIGWCHEQRQ----------LIL----HKIA-----------LG--------LASAVLYL 156
           LI  C  +            L+     H +A           L         L + + Y+
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI 135

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG---TMGYLAP 213
           H      I+HRD+K++N+++  +   KL DFGLAR       S+         T+ Y  P
Sbjct: 136 HR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 214 E 214
           E
Sbjct: 193 E 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 42/226 (18%)

Query: 76  LGEGGFGGVYRGLLSDQNTEI----AVKRV-SRGSKQGKKEYISEVRIISRLRHRNLVHL 130
           LG G FG V++G+   +   I    A+K +  R  +Q  +E    +  +  L H  +V L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 131 IGWC-HEQRQLILHKIALG------------------------LASAVLYLHEEWEQCIV 165
           +G C     QL+     LG                        +A  + YL E     +V
Sbjct: 75  LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMV 131

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT-MGYLAPECVTTGKASKE 224
           HR++ + N++L S+   ++ DFG+A L+  +          T + ++A E +  G+ + +
Sbjct: 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ 191

Query: 225 SDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL 269
           SDV+S+GV   E+ + G +P       + +R  E V DL  KG+ L
Sbjct: 192 SDVWSYGVTVWEMMSYGAEPY------AGMRPHE-VPDLLEKGERL 230

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 8/97 (8%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQTTVLAG 206
           + SA+ YLH    + +V+RDIK  N++LD + + K+ DFGL +  + D   G+      G
Sbjct: 104 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKTFCG 157

Query: 207 TMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           T  YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 50/210 (23%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV---HLIG 132
           LG G  G V+  + SD +  +AVK++     Q  K  + E++II RL H N+V    ++G
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 133 WCH-------------------------------EQRQLILHKIAL---GLASAVLYLHE 158
                                             EQ  L      L    L   + Y+H 
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS 132

Query: 159 EWEQCIVHRDIKSSNVVLDS-NFNAKLGDFGLARLVDHELG-----SQTTVLAGTMGYLA 212
                ++HRD+K +NV +++ +   K+GDFGLAR+VD         S+  V   T  Y +
Sbjct: 133 ---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV---TKWYRS 186

Query: 213 PECV-TTGKASKESDVYSFGVVALEVACGR 241
           P  + +    +K  D+++ G +  E+  G+
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 43/206 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG 132
           K+GEG +G VY+      N  IA+K  R+ +  +      I E+ ++  ++H N+V L  
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 133 WCHEQRQLIL------------------------------HKIALGLASAVLYLHEEWEQ 162
             H +++L L                              ++I  G+A    Y H     
Sbjct: 69  VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCHS---H 121

Query: 163 CIVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA 221
            ++HRD+K  N+++D   NA KL DFGLAR     + + T  +  T+ Y APE +   + 
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRH 180

Query: 222 -SKESDVYSFGVVALEVACGRKPVEP 246
            S   D++S G +  E+   +KP+ P
Sbjct: 181 YSTPVDIWSVGCIFAEMV-NQKPLFP 205

Length = 294

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 57/226 (25%)

Query: 62  ELSRATNNFAEAGKLGEGGFGGVYRGLL----SDQNTEIAVKRVSR-GSKQGKKEYISEV 116
           EL  +   F E  +LGE  FG +Y+G L     D    +A+K +    + Q   E+  E 
Sbjct: 1   ELPLSAVRFME--ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 117 RIISRLRHRNLVHLIGWCHEQR----------QLILHK---------------------- 144
            +++ L H N+V L+G   +++          Q  LH+                      
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 145 ----------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV- 193
                     IA+ +A+ + YL   +    VH+D+ + N+++    + K+ D GL+R + 
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 194 --DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
             D+      ++L   + ++ PE +  GK S +SD++SFGVV  E+
Sbjct: 176 SADYYRVQPKSLLP--IRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 35/94 (37%), Positives = 46/94 (48%), Gaps = 8/94 (8%)

Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL 211
            V  LH+   + I+HRDIK  N+++D   + KL DFGL+R      G +     GT  YL
Sbjct: 109 GVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYL 160

Query: 212 APECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           APE +      K SD +S G V  E   G  P  
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 38/108 (35%), Positives = 58/108 (53%), Gaps = 12/108 (11%)

Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQT 201
           +IA+GL     +LH    + I++RD+K  NV+LDS  + K+ DFG+ +  + D   G  T
Sbjct: 109 EIAIGL----FFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---GVTT 158

Query: 202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
               GT  Y+APE +      K  D ++FGV+  E+  G+ P E   E
Sbjct: 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 52/220 (23%), Positives = 98/220 (44%), Gaps = 45/220 (20%)

Query: 76  LGEGGFGGVYRGLLSDQNT--EIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLI 131
           LGEG FG V  G L+  ++  ++AVK  +++  ++   ++++SE   +    H N++ LI
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 132 GWCHEQRQ-------------------------------------LILHKIALGLASAVL 154
           G C +  +                                      +L K    +AS + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAP 213
           YL     +  +HRD+ + N +L+ N N  + DFGL+ ++ + +   Q  +    + ++A 
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 214 ECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKV 253
           E +     + +SDV+SFGV   E+A   +   P  E S++
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 30/198 (15%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGW 133
           KLGEG +  VY+G     +  +A+K +    ++G     I EV ++  L+H N+V L   
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 134 CHEQRQLIL----------------------HKIALGLASAVLYLHEEWEQCIVHRDIKS 171
            H ++ L L                      H + L L   +  L+    + ++HRD+K 
Sbjct: 73  IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132

Query: 172 SNVVLDSNFNAKLGDFGLARL--VDHELGSQTTVLAGTMGYLAPECVT-TGKASKESDVY 228
            N++++     KL DFGLAR   +  +  S   V   T+ Y  P+ +  +   S + D++
Sbjct: 133 QNLLINERGELKLADFGLARAKSIPTKTYSNEVV---TLWYRPPDILLGSTDYSTQIDMW 189

Query: 229 SFGVVALEVACGRKPVEP 246
             G +  E++ GR P+ P
Sbjct: 190 GVGCIFYEMSTGR-PLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 2/104 (1%)

Query: 142 LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT 201
             ++ + +A  VL L    +  I++RDIK  N++LDS  +  L DFGL++    E   + 
Sbjct: 104 ESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163

Query: 202 TVLAGTMGYLAPECVTTGKA--SKESDVYSFGVVALEVACGRKP 243
               GT+ Y+APE +  G     K  D +S GV+  E+  G  P
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 11/112 (9%)

Query: 142 LHK--IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS 199
           +HK  I   L  A+ Y+H      ++HRD+K SN++L+S+   KL DFGLAR +     +
Sbjct: 107 VHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163

Query: 200 QT----TVLAGTMGYLAPEC-VTTGKASKESDVYSFGVVALEVACGRKPVEP 246
                 T    T  Y APE  + + + +K  D++S G +  E+  G KP+ P
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFP 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 37/213 (17%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIG 132
           LG+GGFG V    +       A K++ +     ++G+   ++E +I+ ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66

Query: 133 WCHEQRQ-------------LILHKIALGLAS-----AVLY----------LHEEWEQCI 164
           + +E +              L  H   +G A      AV Y          LH+E    I
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---I 123

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
           V+RD+K  N++LD + + ++ D GLA  V    G       GT+GY+APE V   + +  
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRVGTVGYMAPEVVKNERYTFS 181

Query: 225 SDVYSFGVVALEVACGRKPVEPRQEPSKVRLVE 257
            D ++ G +  E+  G+ P + R++  K   VE
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 25/203 (12%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRV--SRGSKQGKKEYISEVRIISRLRHR 125
           N F   G +GEG +G V +    +    +A+K+   S  +++ K+  + E++++  L+  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 126 NLVHLIGWCHEQRQL-------------ILHKIALG-----LASAVLYLHEEWEQC---- 163
           N+V L      + +L             +L ++  G     + S +  L +    C    
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND 120

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           IVHRDIK  N+++  N   KL DFG AR +     +  T    T  Y +PE +      K
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180

Query: 224 ESDVYSFGVVALEVACGRKPVEP 246
             D++S G +  E++ G +P+ P
Sbjct: 181 AVDMWSVGCILGELSDG-QPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 32/204 (15%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY---ISEVRIISRLRHRNLVHLIG 132
           LG+GGFG V    +       A K++++   + +K Y   + E RI++++  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 133 WCHEQRQLIL--------------------------HKIALGLASAVLYLHEEWEQCIVH 166
               +  L L                           +     A  +  L    ++ I++
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES 225
           RD+K  NV+LD++ N ++ D GLA  L D +  S+T   AGT G++APE +   +     
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPELLQGEEYDFSV 178

Query: 226 DVYSFGVVALEVACGRKPVEPRQE 249
           D ++ GV   E+   R P   R E
Sbjct: 179 DYFALGVTLYEMIAARGPFRARGE 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 1/95 (1%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           L+   L L    +Q I++RD+K  N++LD+  + KL DFGL +   HE G+ T    GT+
Sbjct: 106 LSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVTHTFCGTI 164

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            Y+APE +      K  D +S G +  ++  G  P
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 51/216 (23%), Positives = 82/216 (37%), Gaps = 57/216 (26%)

Query: 69  NFAEAGKLGEGGFGGVYRG-----LLSDQNTEIAVKRV-SRGSKQGKKEYISEVRIISRL 122
           N  E   LG G FG V+             T + VK +     +  + E+  E+ +  +L
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 123 RHRNLVHLIGWCHE--------------------------------------QRQLILHK 144
            H+N+V L+G C E                                      Q+  +  +
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV---DHELGSQT 201
           IALG+    L          VHRD+ + N ++ S    K+    L++ V   ++      
Sbjct: 126 IALGMDH--LSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178

Query: 202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            +    + +LAPE V     S +SDV+SFGV+  EV
Sbjct: 179 LI---PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 59.5 bits (145), Expect = 5e-10
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 60/209 (28%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS--------EVRIISRL-RHR 125
           +LG+G FG VY     +    +A+K++       KK++ S        EV+ + +L  H 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHP 58

Query: 126 NLVHLIGWCHEQRQL------------------------------ILHKIALGLASAVLY 155
           N+V L     E  +L                              I+++I  GLA    +
Sbjct: 59  NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA----H 114

Query: 156 LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT--TVLAGTMGYLAP 213
           +H+       HRD+K  N+++      K+ DFGLAR    E+ S+   T    T  Y AP
Sbjct: 115 IHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTRWYRAP 167

Query: 214 ECV-TTGKASKESDVYSFGVVALEVACGR 241
           E +  +   S   D+++ G +  E+   R
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 32/89 (35%), Positives = 53/89 (59%), Gaps = 9/89 (10%)

Query: 153 VLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS--QTTVLAGTMGY 210
           V Y+H+   + I+HRD+K+ N+ L +N   K+GDFG++RL+   +GS    T   GT  Y
Sbjct: 119 VHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL---MGSCDLATTFTGTPYY 171

Query: 211 LAPECVTTGKASKESDVYSFGVVALEVAC 239
           ++PE +       +SD++S G +  E+ C
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 47/217 (21%)

Query: 76  LGEGGFGGVYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHL 130
           LG G FG VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 131 IGWCHEQR-QLILHKIALG------------------------LASAVLYLHEEWEQCIV 165
           +G C     QLI   +  G                        +A  + YL    E+ +V
Sbjct: 75  LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLV 131

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTG 219
           HRD+ + NV++ +  + K+ DFGLA+L+       H  G +  +      ++A E +   
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI-----KWMALESILHR 186

Query: 220 KASKESDVYSFGVVALEVAC-GRKPVE--PRQEPSKV 253
             + +SDV+S+GV   E+   G KP +  P  E S +
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 223

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 36/108 (33%), Positives = 59/108 (54%), Gaps = 12/108 (11%)

Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQT 201
           +I++GL     +LH    + I++RD+K  NV+LDS  + K+ DFG+ +  +VD   G  T
Sbjct: 109 EISVGL----FFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---GVTT 158

Query: 202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
               GT  Y+APE +      K  D +++GV+  E+  G+ P +   E
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 36/206 (17%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLV 128
           + +  KLGEG +  V++G        +A+K +    ++G     I EV ++  L+H N+V
Sbjct: 7   YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66

Query: 129 HLIGWCHEQRQLIL----------------------HKIAL---GLASAVLYLHEEWEQC 163
            L    H +R L L                      H + +    L   + Y H+   + 
Sbjct: 67  TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RK 123

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARL--VDHELGSQTTVLAGTMGYLAPECVT-TGK 220
           I+HRD+K  N++++     KL DFGLAR   V  +  S   V   T+ Y  P+ +  + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV---TLWYRPPDVLLGSTE 180

Query: 221 ASKESDVYSFGVVALEVACGRKPVEP 246
            S   D++  G +  E+A GR P+ P
Sbjct: 181 YSTPIDMWGVGCILYEMATGR-PMFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 29/93 (31%), Positives = 53/93 (56%), Gaps = 4/93 (4%)

Query: 151 SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGY 210
             + +LH++    I++RD+K  NV+LD + + K+ DFG+ +  +     + +   GT  Y
Sbjct: 107 CGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDY 162

Query: 211 LAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           +APE +   K ++  D +SFGV+  E+  G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 36/208 (17%)

Query: 69  NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-QG-KKEYISEVRIISRLRHRN 126
            + +  K+GEG +G V++    + +  +A+KRV      +G     + E+ ++  L+H+N
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 127 LVHLIGWCHEQRQLIL---------------------HKIA----LGLASAVLYLHEEWE 161
           +V L    H  ++L L                      +I       L   + + H    
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS--- 117

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARL--VDHELGSQTTVLAGTMGYLAPECVTTG 219
             ++HRD+K  N++++ N   KL DFGLAR   +     S   V   T+ Y  P+ +   
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV---TLWYRPPDVLFGA 174

Query: 220 KASKES-DVYSFGVVALEVACGRKPVEP 246
           K    S D++S G +  E+A   +P+ P
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 7/89 (7%)

Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH    + I++RD+K  N++LD+  + K+ DFG A+ V      +T  L GT  YLAPE
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP----DRTFTLCGTPEYLAPE 185

Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +    K  D ++ GV+  E   G  P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 60/266 (22%), Positives = 105/266 (39%), Gaps = 35/266 (13%)

Query: 72  EAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLI 131
           E   +  G  G  Y+G       +  VK ++          I+++    +L+H N+V LI
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEIND-VNSIPSSEIADMG---KLQHPNIVKLI 749

Query: 132 GWCHEQRQLIL----------------------HKIALGLASAVLYLHEEWEQCIVHRDI 169
           G C  ++   L                       KIA+G+A A+ +LH      +V  ++
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL 809

Query: 170 KSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYS 229
               +++D      L      RL    L    T    +  Y+APE   T   +++SD+Y 
Sbjct: 810 SPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYG 863

Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE--FDERQMEC 287
           FG++ +E+  G+ P +         +VEW    Y    L    D  +  +   ++ ++  
Sbjct: 864 FGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVE 922

Query: 288 LMIVGLWCCHPDFTNRPSIRQVINVL 313
           +M + L C   D T RP    V+  L
Sbjct: 923 VMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 7/147 (4%)

Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAP 213
           +LH +    I++RD+K  NV+LD + + K+ DFG+ +  ++  G ++ +   GT  Y+AP
Sbjct: 111 FLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAP 165

Query: 214 ECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD 273
           E +   K +   D +SFGV+  E+  G+ P     E      +      Y +    E+ D
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKD 225

Query: 274 GRLSKEFDERQMECLMIVGLWCCHPDF 300
             L K F+      L +VG    HP F
Sbjct: 226 -ILEKLFERDPTRRLGVVGNIRGHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 55/216 (25%)

Query: 76  LGEGGFGGVYRGLLSDQNTEI--AVKRVSR-GSKQGKKEYISEVRIISRL-RHRNLVHLI 131
           +GEG FG V R ++     ++  A+K +    S+   +++  E+ ++ +L  H N+++L+
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 132 GWCHEQRQLIL-----------------------------HKIALGLASAVLY------- 155
           G C  +  L +                             H  A  L S  L        
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 156 --LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG---- 209
             +    E+  +HRD+ + NV++  N  +K+ DFGL+R        +   +  TMG    
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKKTMGRLPV 182

Query: 210 -YLAPECVTTGKASKESDVYSFGVVALE-VACGRKP 243
            ++A E +     + +SDV+SFGV+  E V+ G  P
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 47/209 (22%)

Query: 74  GK-LGEGGFGGVYRGLLSDQNT---EIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNL 127
           GK LGEG FG V  G LS  +    ++AVK  ++   +    +E++SE   +    H N+
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 128 VHLIGWCHEQRQL-------------------------------------ILHKIALGLA 150
           + LIG C E   L                                      L K  + +A
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 151 SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV-DHELGSQTTVLAGTMG 209
             + YL     +  +HRD+ + N +L  +    + DFGL++ +   +   Q  +    + 
Sbjct: 124 LGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVA 238
           ++A E +     + +SDV++FGV   E+A
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIA 209

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 30/198 (15%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGW 133
           KLGEG +  V++G        +A+K +    ++G     I EV ++  L+H N+V L   
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 134 CHEQRQLIL----------------------HKIALGLASAVLYLHEEWEQCIVHRDIKS 171
            H  + L L                      H + + L   +  L     + ++HRD+K 
Sbjct: 73  VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKP 132

Query: 172 SNVVLDSNFNAKLGDFGLARL--VDHELGSQTTVLAGTMGYLAPECVT-TGKASKESDVY 228
            N++++     KL DFGLAR   V  +  S   V   T+ Y  P+ +  + + S + D++
Sbjct: 133 QNLLINERGELKLADFGLARAKSVPTKTYSNEVV---TLWYRPPDVLLGSSEYSTQIDMW 189

Query: 229 SFGVVALEVACGRKPVEP 246
             G +  E+A GR P+ P
Sbjct: 190 GVGCIFFEMASGR-PLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 14/137 (10%)

Query: 118 IISRLRHRNLVHLIGWCHE----QRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSN 173
           ++  L   +L+  I  CH+    +      +I  GL     +LH    + IV+RD+K  N
Sbjct: 74  VMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQ----FLHS---KGIVYRDLKLDN 126

Query: 174 VVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGV 232
           ++LD++ + K+ DFG+ +  ++ LG ++T    GT  Y+APE +   K +   D +SFGV
Sbjct: 127 ILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGV 184

Query: 233 VALEVACGRKPVEPRQE 249
           +  E+  G+ P     E
Sbjct: 185 LLYEMLIGQSPFHGHDE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 2/103 (1%)

Query: 143 HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT 202
            ++ +     VL L    +  I++RDIK  N++LDSN +  L DFGL++    +   +  
Sbjct: 105 QEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY 164

Query: 203 VLAGTMGYLAPECVTTGKA--SKESDVYSFGVVALEVACGRKP 243
              GT+ Y+AP+ V  G     K  D +S GV+  E+  G  P
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 31/205 (15%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIG 132
           LG+GGFG V    +       A K++ +     ++G+   ++E RI+ ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66

Query: 133 WCHEQRQ-------------LILHKIALGLAS-----AVLY-------LHEEWEQCIVHR 167
           + +E +              L  H   +G        A+ Y       L +   + IV+R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           D+K  N++LD   + ++ D GLA  V    G       GT+GY+APE +   K +   D 
Sbjct: 127 DLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDW 184

Query: 228 YSFGVVALEVACGRKPVEPRQEPSK 252
           +  G +  E+  G+ P   R+E  K
Sbjct: 185 WGLGCLIYEMIQGQSPFRKRKERVK 209

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 46/213 (21%), Positives = 90/213 (42%), Gaps = 52/213 (24%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--QGKKEYISEVRIISRLRHRNLV---- 128
            +G G +G V   + +    ++A+K++          K  + E++I+   +H N++    
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71

Query: 129 ------------------------HLIGWCHEQRQL-------ILHKIALGLASAVLYLH 157
                                   H+I   H  + L        L+++  GL     Y+H
Sbjct: 72  ILRPPGADFKDVYVVMDLMESDLHHII---HSDQPLTEEHIRYFLYQLLRGLK----YIH 124

Query: 158 EEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH---ELGSQTTVLAGTMGYLAPE 214
                 ++HRD+K SN++++ +   ++GDFG+AR +     E     T    T  Y APE
Sbjct: 125 S---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Query: 215 CV-TTGKASKESDVYSFGVVALEVACGRKPVEP 246
            + +  + +   D++S G +  E+  GR+ + P
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEM-LGRRQLFP 213

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 4/95 (4%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SA+ YLH      IV+RD+K  N++LD + + K+ DFGL +    +  +  T   GT 
Sbjct: 104 IVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTP 159

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 43/208 (20%)

Query: 74  GKLGEGGFGGVYRGL-LSDQNTEIAVKRVS-RGSKQGKK-EYISEVRIISRLR---HRNL 127
            ++GEG +G V++   L +    +A+KRV  +  ++G     I EV ++  L    H N+
Sbjct: 7   AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66

Query: 128 VHLIGWC----------------HEQRQLI---------------LHKIALGLASAVLYL 156
           V L   C                H  + L                +  +   L   + +L
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV 216
           H      +VHRD+K  N+++ S+   KL DFGLAR+  +      T +  T+ Y APE +
Sbjct: 127 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLWYRAPEVL 181

Query: 217 TTGKASKESDVYSFGVVALEVACGRKPV 244
                +   D++S G +  E+   RKP+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMF-RRKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 35/100 (35%), Positives = 49/100 (49%), Gaps = 5/100 (5%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           LA  VL +    +   VHRDIK  NV+LD N + +L DFG    +  +   Q+ V  GT 
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167

Query: 209 GYLAPECVT-----TGKASKESDVYSFGVVALEVACGRKP 243
            Y++PE +       G+   E D +S GV   E+  G  P
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 9/116 (7%)

Query: 135 HEQRQLILHK-----IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL 189
           H QRQ  L +      +  ++ A+ YLHE   + I++RD+K  NV+LDS  + KL D+G+
Sbjct: 86  HMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM 142

Query: 190 ARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
            +      G  T+   GT  Y+APE +         D ++ GV+  E+  GR P +
Sbjct: 143 CK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 51/187 (27%)

Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL-ARLVDHELGS 199
           ILH+  +GL     +LH       +HRD+K +N++L +    KL DFG+ A+L    L  
Sbjct: 129 ILHEALMGLQ----HLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181

Query: 200 QTTVLAGTMGYLAPECVTTGKASKES-----DVYSFGVVALEVACGRKPVE--------- 245
            T+V  GT  ++APE +   +    +     DV+S G+ A+E+  G  P+          
Sbjct: 182 NTSV--GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF 239

Query: 246 --PRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNR 303
             PR  P  +   E +W                S EF++   +CL          D+  R
Sbjct: 240 KIPRNPPPTLHQPE-LW----------------SNEFNDFIRKCLT--------KDYEKR 274

Query: 304 PSIRQVI 310
           P++  ++
Sbjct: 275 PTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 54/209 (25%)

Query: 76  LGEGGFGGVYRGLLSDQNTEI--AVKRVSR-GSKQGKKEYISEVRIISRL-RHRNLVHLI 131
           +GEG FG V +  +      +  A+KR+    SK   +++  E+ ++ +L  H N+++L+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 132 GWCHEQ-------------------------------------------RQLILHKIALG 148
           G C  +                                           +QL+    A  
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL--HFAAD 120

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +A  + YL ++     +HRD+ + N+++  N+ AK+ DFGL+R    E+  + T+    +
Sbjct: 121 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 175

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEV 237
            ++A E +     +  SDV+S+GV+  E+
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 56.3 bits (136), Expect = 6e-09
 Identities = 50/211 (23%), Positives = 97/211 (45%), Gaps = 52/211 (24%)

Query: 76  LGEGGFGGVYRGLL-----SDQNTEIAVKRV-SRGSKQGKKEYISEVRIISRL-RHRNLV 128
           LGEG FG V +         ++ + +AVK +    +++   + +SE+ ++  + +H+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 129 HLIGWCHEQ---------------RQLI--------------------------LHKIAL 147
           +L+G C ++               R  +                          L   A 
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 148 GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAG 206
            +A  + +L    ++CI HRD+ + NV++  +   K+ DFGLAR + H +   +TT    
Sbjct: 140 QVARGMEFL--ASKKCI-HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196

Query: 207 TMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            + ++APE +     + +SDV+SFGV+  E+
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 56.3 bits (136), Expect = 7e-09
 Identities = 35/98 (35%), Positives = 49/98 (50%), Gaps = 4/98 (4%)

Query: 146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA 205
           A  +ASA+ YLH      I++RD+K  N++LDS  +  L DFGL +    E    T+   
Sbjct: 102 AAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFC 157

Query: 206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           GT  YLAPE +      +  D +  G V  E+  G  P
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.9 bits (135), Expect = 7e-09
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 53/206 (25%)

Query: 78  EGGFGGVYRGLLSDQNT----EIAVKRVSRGSKQGKKEY-ISEVRIISRLRHRNLVHLIG 132
           EG FG ++ G+L D+      E+ VK V   + + +    + E  ++  L H+N++ ++ 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 133 WCHE------------------------------------QRQLILHKIALGLASAVLYL 156
            C E                                     +QL+   +A+ +A  + YL
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH--MAIQIACGMSYL 133

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV---D-HELGSQTTVLAGTMGYLA 212
           H+   + ++H+DI + N V+D     K+ D  L+R +   D H LG         + ++A
Sbjct: 134 HK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN---RPVKWMA 187

Query: 213 PECVTTGKASKESDVYSFGVVALEVA 238
            E +   + S  SDV+SFGV+  E+ 
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 55.7 bits (134), Expect = 8e-09
 Identities = 66/276 (23%), Positives = 110/276 (39%), Gaps = 55/276 (19%)

Query: 75  KLGEGGFGGVYRG-LLSDQNT-EIAVKRV-SRGSKQGKKEYISEVRIISRLRHRNLVHLI 131
           ++G G FG V  G + S     ++ VK +    S Q + +++ E +    L+H NL+  +
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 132 GWCHE----------------------QRQ--------LILHKIALGLASAVLYLHEEWE 161
           G C E                       R+          L ++A  +A  +L+LH+   
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--- 118

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT-VLAGTMGYLAPECV---- 216
              +H D+   N +L ++   K+GD+GL+     E    T   L   + ++APE V    
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 217 ---TTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD 273
                   +KES+V+S GV   E+       E   +P +    E V     + Q L+   
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL------FELGSQPYRHLSDEQVLTYTVREQQLKLPK 232

Query: 274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQV 309
            RL     +R  E +    L    P+   RPS  +V
Sbjct: 233 PRLKLPLSDRWYEVMQFCWL---QPE--QRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 56.1 bits (135), Expect = 8e-09
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 56/214 (26%)

Query: 76  LGEGGFGGVYRGLL-------SDQNTEIAVKRVS-RGSKQGKKEYISEVRIISRL-RHRN 126
           LGEG FG V R           DQ   +AVK +    + +   + ISE+ ++  + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 127 LVHLIGWCHEQRQLI-----------------------------------------LHKI 145
           +++L+G C ++  L                                          L   
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA 205
           A  +A  + YL  E  +CI HRD+ + NV++  +   K+ DFGLAR V H++        
Sbjct: 140 AYQVARGMEYL--ESRRCI-HRDLAARNVLVTEDNVMKIADFGLARGV-HDIDYYKKTSN 195

Query: 206 GTM--GYLAPECVTTGKASKESDVYSFGVVALEV 237
           G +   ++APE +     + +SDV+SFG++  E+
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 56.0 bits (135), Expect = 9e-09
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 4/104 (3%)

Query: 146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA 205
           A  +  A+++LH      +++RD+K  N++LD+  + KL DFG+ +      G  TT   
Sbjct: 102 AAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFC 157

Query: 206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
           GT  Y+APE +   +     D ++ GV+  E+  G+ P E   E
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 9/116 (7%)

Query: 135 HEQRQLILHK-----IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL 189
           H QRQ  L +      A  +  A+ +LHE   + I++RD+K  NV+LD++ + KL D+G+
Sbjct: 86  HMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGM 142

Query: 190 ARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
            +      G  T+   GT  Y+APE +   +     D ++ GV+  E+  GR P +
Sbjct: 143 CK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 44/184 (23%)

Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL-ARLVDHELGSQTTV 203
           I+  L  A+L L       I+HRD+K +N++L +    KL DFG+ A+L    L   T+V
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189

Query: 204 LAGTMGYLAPECVTTGKASKES-----DVYSFGVVALEVACGRKPVE-----------PR 247
             GT  ++APE +   +    S     DV+S G+ A+E+  G  P+            PR
Sbjct: 190 --GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR 247

Query: 248 QEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIR 307
             P  +   E                 +  + F+    +CL+         DF  RPS+ 
Sbjct: 248 NPPPTLLHPE-----------------KWCRSFNHFISQCLI--------KDFEARPSVT 282

Query: 308 QVIN 311
            ++ 
Sbjct: 283 HLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 54/213 (25%)

Query: 76  LGEGGFGGVYR----GLLSDQN---TEIAVKRV-SRGSKQGKKEYISEVRIISRL-RHRN 126
           LGEG FG V      GL  ++    T++AVK + S  +++   + ISE+ ++  + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 127 LVHLIGWCHEQRQLI-----------------------------------------LHKI 145
           +++L+G C +   L                                          L   
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVL 204
           A  +A  + YL  +  +CI HRD+ + NV++  +   K+ DFGLAR + H +   +TT  
Sbjct: 146 AYQVARGMEYLASK--KCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              + ++APE +     + +SDV+SFGV+  E+
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 13/140 (9%)

Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHS---A 145

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE V  G   
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPE-VILGMGY 202

Query: 223 KES-DVYSFGVVALEVACGR 241
           KE+ D++S G +  E+  G 
Sbjct: 203 KENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 46/194 (23%), Positives = 83/194 (42%), Gaps = 29/194 (14%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKE---YISEVRIISRLRHRNLVHLI 131
           ++G+GG+G V+     D    +A+KR+ +       E    ++E  I++  +   LV L+
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 132 GWCHEQ---------------RQLILHKIALGLASAVLYLHEEWEQC-------IVHRDI 169
               +                R L+ +   L    A  Y+ E +E          +HRD+
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDL 127

Query: 170 KSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           K  N ++D++ + KL DFGL++     + +    + G+  Y+APE +         D +S
Sbjct: 128 KPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWS 183

Query: 230 FGVVALEVACGRKP 243
            G +  E  CG  P
Sbjct: 184 LGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 37/102 (36%), Positives = 51/102 (50%), Gaps = 4/102 (3%)

Query: 146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA 205
           A  +ASA+ YLH      IV+RD+K  N++LDS  +  L DFGL +  + E    T+   
Sbjct: 102 AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFC 157

Query: 206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPR 247
           GT  YLAPE +      +  D +  G V  E+  G  P   R
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 37/213 (17%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIG 132
           LG+GGFG V    +       A KR+ +     ++G+   ++E +I+ ++  + +V+L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66

Query: 133 WCHEQRQ-------------LILHKIALG-----------LASAVL----YLHEEWEQCI 164
           + +E +              L  H   +G            A+ +L     LH E     
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NT 123

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
           V+RD+K  N++LD   + ++ D GLA  +    G       GT+GY+APE +   + +  
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRVGTVGYMAPEVLNNQRYTLS 181

Query: 225 SDVYSFGVVALEVACGRKPVEPRQEPSKVRLVE 257
            D +  G +  E+  G+ P   R+E  K   V+
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 50/207 (24%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRV------SRGSKQGKKEYISEVRIISRLRHRNLV 128
           ++G G FG V   LL + +  ++  RV      +  +   +  ++ EV+    L H N++
Sbjct: 2   EIGNGWFGKV---LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 129 HLIGWCHE------------------------------QRQLILHKIALGLASAVLYLHE 158
             +G C E                               ++ +L ++A  +AS +L+LH+
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 159 EWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT-VLAGTMGYLAPECVT 217
                 +H D+   N  L ++ + K+GD+GLA     E    T    A  + +LAPE V 
Sbjct: 119 ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 218 -------TGKASKESDVYSFGVVALEV 237
                      +K+S+++S GV   E+
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 56/201 (27%), Positives = 84/201 (41%), Gaps = 33/201 (16%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKE--YISEVR--IISRLRHRNLVHLI 131
           +G+G FG V         +  AVK + + +   KKE  +I   R  ++  L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 132 G--------------------WCHEQRQLILHK-----IALGLASAVLYLHEEWEQCIVH 166
                                + H QR+    +      A  +ASA+ YLH      I++
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIY 119

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
           RD+K  N++LDS  +  L DFGL +       + T+   GT  YLAPE +      +  D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-TSTFCGTPEYLAPEVLRKEPYDRTVD 178

Query: 227 VYSFGVVALEVACGRKPVEPR 247
            +  G V  E+  G  P   R
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 37/213 (17%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIG 132
           LG+GGFG V    +       A K++ +     ++G+   ++E +I+ ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 133 WCHEQRQ-------------LILHKIALGLAS-----AVLY----------LHEEWEQCI 164
           + +E +              L  H   +G        AV Y          LH E    I
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---I 123

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
           V+RD+K  N++LD   + ++ D GLA  V+   G       GT+GY+APE V   + +  
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181

Query: 225 SDVYSFGVVALEVACGRKPVEPRQEPSKVRLVE 257
            D +  G +  E+  G+ P   R+E  K   VE
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 49/203 (24%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLVHL-- 130
           +G G +G V     +    ++AVK++SR  +     ++ Y  E+R++  ++H N++ L  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGLLD 81

Query: 131 ---------------------------IGWCH----EQRQLILHKIALGLASAVLYLHEE 159
                                      I  C     E  Q +++++  GL     Y+H  
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLK----YIHS- 136

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
               I+HRD+K SNV ++ +   ++ DFGLAR  D E+    T    T  Y APE +   
Sbjct: 137 --AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----TGYVATRWYRAPEIMLNW 190

Query: 220 KASKES-DVYSFGVVALEVACGR 241
               ++ D++S G +  E+  G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 31/81 (38%), Positives = 45/81 (55%), Gaps = 1/81 (1%)

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV-TTGKAS 222
           IV+RDIK  N++LDS  +  L DFGL++    E   +T    GT+ Y+APE +   G   
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185

Query: 223 KESDVYSFGVVALEVACGRKP 243
           K  D +S G++  E+  G  P
Sbjct: 186 KAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 5/100 (5%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           LA  V+ +    +   VHRDIK  N+++D N + +L DFG    +  +   Q++V  GT 
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 167

Query: 209 GYLAPECVTT-----GKASKESDVYSFGVVALEVACGRKP 243
            Y++PE +       GK   E D +S GV   E+  G  P
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 37/113 (32%), Positives = 57/113 (50%), Gaps = 7/113 (6%)

Query: 135 HEQRQLILHKIALGLASA--VLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR- 191
           H QRQ  L +      SA   L L+   E+ I++RD+K  NV+LD+  + KL D+G+ + 
Sbjct: 86  HMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145

Query: 192 -LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            +     G  T+   GT  Y+APE +         D ++ GV+  E+  GR P
Sbjct: 146 GIRP---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 54/213 (25%)

Query: 76  LGEGGFGGVYR----GLLSDQNTE---IAVKRVS-RGSKQGKKEYISEVRIISRL-RHRN 126
           LGEG FG V      G+  D+  E   +AVK +    +++   + +SE+ ++  + +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 127 LVHLIGWCHEQ---------------RQLILHKIALG----------------------- 148
           +++L+G C +                R+ +  +   G                       
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 149 ---LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVL 204
              +A  + YL  +  +CI HRD+ + NV++  N   K+ DFGLAR V++ +   +TT  
Sbjct: 143 TYQVARGMEYLASQ--KCI-HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              + ++APE +     + +SDV+SFGV+  E+
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 35/227 (15%)

Query: 66  ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKK-EYISEVRIISRLRH 124
           A  ++    KLGEG +  VY+G+       +A+K +S  +++G     I E  ++  L+H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 125 RNLVHLIGWCHEQRQLIL----------------------HKIAL---GLASAVLYLHEE 159
            N+V L    H +  L                        + + L    L   + Y+H  
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG- 121

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT-TVLAGTMGYLAPECVT- 217
             Q I+HRD+K  N+++      KL DFGLAR     + SQT +    T+ Y  P+ +  
Sbjct: 122 --QHILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLG 177

Query: 218 TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYG 264
               S   D++  G + +E+  G +P  P       +L E +W + G
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFEQL-EKIWTVLG 222

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 36/98 (36%), Positives = 53/98 (54%), Gaps = 10/98 (10%)

Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV- 203
           +A  L SA+ Y+H E    I+HRDIK+ NV+++   +  LGDFG A       GS +T  
Sbjct: 265 VARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFAR---GSWSTPF 318

Query: 204 ---LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVA 238
              +AGT+   APE +     +   D++S G+V  E A
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 53.8 bits (129), Expect = 6e-08
 Identities = 45/208 (21%), Positives = 88/208 (42%), Gaps = 47/208 (22%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSR--GSKQGKKEYISEVRIISRLRHRNL 127
           + +  ++G G +G V   L      ++A+K++ R   S+   K    E+R++  ++H N+
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76

Query: 128 VHLIG---------------------------------WCHEQRQLILHKIALGLASAVL 154
           + L+                                     ++ Q +++++  GL     
Sbjct: 77  IGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLK---- 132

Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           Y+H      I+HRD+K  N+ ++ +   K+ DFGLAR  D E+         T  Y APE
Sbjct: 133 YIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----TRWYRAPE 185

Query: 215 CVTTG-KASKESDVYSFGVVALEVACGR 241
            +      ++  D++S G +  E+  G+
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 49/212 (23%)

Query: 74  GKLGEGGFGGV--YRGLLSDQNTEIAVKRVSR--GSKQGKKEYISEVRIISRLR-HRNLV 128
            +LG+G +G V   R   + +   +A+K+++     K   K  + E++++   R H+N+ 
Sbjct: 6   KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65

Query: 129 HLIG------------WCHE--------------QR------QLILHKIALGLASAVLYL 156
            L              + +E              Q       Q  +++I  GL     Y+
Sbjct: 66  CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLK----YI 121

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQ-TTVLAGTMGYLAP 213
           H      ++HRD+K  N++++++   K+ DFGLAR    +    +   T    T  Y AP
Sbjct: 122 HS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178

Query: 214 ECVTTGKA-SKESDVYSFGVVALEVACGRKPV 244
           E + + ++ +K  DV+S G +  E+  GRKPV
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAEL-LGRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 36/99 (36%), Positives = 47/99 (47%), Gaps = 4/99 (4%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +ASA+ YLH      IV+RD+K  N++LDS  +  L DFGL +         TT   GT 
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTP 160

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPR 247
            YLAPE +         D +  G V  E+  G  P   R
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 28/210 (13%)

Query: 62  ELSRAT--NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRII 119
           +LSR     +F    ++G G +G VY+    +     A+K +     +       E+ ++
Sbjct: 1   DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMM 60

Query: 120 SRLRHRNLVHLIG--------W-CHE-----QRQLILHKIALGLASAVLYLHEEWEQCI- 164
              +H N+V   G        W C E       Q I H       S + Y+  E  Q + 
Sbjct: 61  KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLY 120

Query: 165 -------VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT 217
                  +HRDIK +N++L  N + KL DFG++  +   +  + + + GT  ++APE   
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAA 179

Query: 218 T---GKASKESDVYSFGVVALEVACGRKPV 244
               G  ++  D+++ G+ A+E+A  + P+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 49/200 (24%), Positives = 83/200 (41%), Gaps = 45/200 (22%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLVHLIG 132
           +G G  G V     +     +AVK++SR        K+ Y  E+ ++  + H+N++ L+ 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLN 87

Query: 133 ------------------------WC--------HEQRQLILHKIALGLASAVLYLHEEW 160
                                    C        HE+   +L+++  G+     +LH   
Sbjct: 88  VFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK----HLHS-- 141

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK 220
              I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +    
Sbjct: 142 -AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGMG 198

Query: 221 ASKESDVYSFGVVALEVACG 240
             +  D++S G +  E+  G
Sbjct: 199 YKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 29/85 (34%), Positives = 44/85 (51%), Gaps = 8/85 (9%)

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE--LGSQTTVLAGTMGYLAPECVTT---- 218
           +HRD+K  N++LD + + KL DFG    +D    +   T V  GT  Y++PE + +    
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV--GTPDYISPEVLKSQGGD 221

Query: 219 GKASKESDVYSFGVVALEVACGRKP 243
           G   +E D +S GV   E+  G  P
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 41/148 (27%), Positives = 63/148 (42%), Gaps = 37/148 (25%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIG 132
            KLGEG +  VY+G        +A+K +    ++G     I E  ++  L+H N+V L  
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70

Query: 133 WCHEQRQLIL----------------------HKIAL-------GLASAVLYLHEEWEQC 163
             H ++ L L                      H + L       GLA    Y H+   + 
Sbjct: 71  IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA----YCHQ---RR 123

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           ++HRD+K  N+++      KL DFGLAR
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 15/100 (15%)

Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL---VDHEL 197
           I  +I  GL     YLH    Q I+HRD+K+ N+ ++      +GD G A+        L
Sbjct: 162 IEKQILEGLR----YLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214

Query: 198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           G     LAGT+   APE +   K + ++D++S G+V  E+
Sbjct: 215 G-----LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 38/124 (30%), Positives = 51/124 (41%), Gaps = 30/124 (24%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA------------------ 190
           +A  VL L    +   +HRDIK  N+++D++ + KL DFGL                   
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166

Query: 191 ------RLVDHELGSQTTVLA----GTMGYLAPECVTTGKA-SKESDVYSFGVVALEVAC 239
                  LV      Q  V A    GT  Y+APE V  G     E D +S GV+  E+  
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLY 225

Query: 240 GRKP 243
           G  P
Sbjct: 226 GFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 65/291 (22%), Positives = 110/291 (37%), Gaps = 76/291 (26%)

Query: 76  LGEGGFGGVYRGLLSDQN-----TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVH 129
           LGEG FG V +            T +AVK +   +   + ++ +SE  ++ ++ H +++ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 130 LIGWCHEQRQLILHKIALGLASAVLYLHEE------------------------------ 159
           L G C +   L+L        S   +L E                               
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 160 ------WEQC----------IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG----S 199
                 W+            +VHRD+ + NV++      K+ DFGL+R V  E      S
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187

Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE-VACGRKPVEPRQEPSKVRLVEW 258
           +  +    + ++A E +     + +SDV+SFGV+  E V  G  P  P   P      E 
Sbjct: 188 KGRI---PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIAP------ER 237

Query: 259 VWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQV 309
           +++L   G  +E  +   S+E     + C      W   PD   RP+   +
Sbjct: 238 LFNLLKTGYRMERPEN-CSEEMYNLMLTC------WKQEPD--KRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 70/308 (22%), Positives = 126/308 (40%), Gaps = 79/308 (25%)

Query: 62  ELSRATNNFAEAGKLGEGGFGGVYR----GLLSDQN---TEIAVKRVSR-GSKQGKKEYI 113
           ELSR      +   LGEG FG V      G+  D+      +AVK +    + +   + +
Sbjct: 8   ELSRTRLTLGKP--LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65

Query: 114 SEVRIISRL-RHRNLVHLIGWCHE------------------------------------ 136
           SE+ ++  + +H+N+++L+G C +                                    
Sbjct: 66  SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125

Query: 137 --QRQLILHKI---ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
             + QL    +   A  +A  + YL  +  +CI HRD+ + NV++  +   K+ DFGLAR
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQ--KCI-HRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 192 LVDHELGSQTTVLAGTM--GYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
            V H +        G +   ++APE +     + +SDV+SFGV+  E+            
Sbjct: 183 DV-HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI------FTLGGS 235

Query: 250 PSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMEC---LMIVGLWCCHPDFTNRPSI 306
           P     VE ++ L  +G  +            ++   C   L ++   C H   + RP+ 
Sbjct: 236 PYPGIPVEELFKLLKEGHRM------------DKPANCTHELYMIMRECWHAVPSQRPTF 283

Query: 307 RQVINVLN 314
           +Q++  L+
Sbjct: 284 KQLVEDLD 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 51.1 bits (123), Expect = 3e-07
 Identities = 48/201 (23%), Positives = 78/201 (38%), Gaps = 50/201 (24%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS--------EVRIISRLR-H 124
           GK+GEG F  V +          A+K +       KK + S        E++ + RL  H
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRRLSPH 57

Query: 125 RNLVHLIGWCHEQRQ----LILH-----------------------KIALGLASAVLYLH 157
            N++ LI    +++     L+                              L  ++ ++H
Sbjct: 58  PNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 158 EEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV- 216
                 I HRDIK  N+++  +   KL DFG  R +  +     T    T  Y APEC+ 
Sbjct: 118 R---NGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP--PYTEYISTRWYRAPECLL 171

Query: 217 TTGKASKESDVYSFGVVALEV 237
           T G    + D+++ G V  E+
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEI 192

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 4/98 (4%)

Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A  VL L       ++HRD+K  N++LD + + KL DFG    +D     +     GT  
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD 208

Query: 210 YLAPECVTT----GKASKESDVYSFGVVALEVACGRKP 243
           Y++PE + +    G   +E D +S GV   E+  G  P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 51/227 (22%), Positives = 89/227 (39%), Gaps = 64/227 (28%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVS----RGSKQGKKEYIS----------EVRIISR 121
           LGEG +G V +   +     +A+K+V            ++ +           E++I++ 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 122 LRHRNLVHLIG-WCHE---------------------------QRQLILHKIALGLASAV 153
           ++H N++ L+  +                              Q + IL +I  GL    
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNV-- 134

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR----------LVDHELGSQT-- 201
             LH+ +    +HRD+  +N+ ++S    K+ DFGLAR          L   E   +   
Sbjct: 135 --LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 202 -TVLAGTMGYLAPECVT-TGKASKESDVYSFGVVALEVACGRKPVEP 246
            T    T+ Y APE +    K     D++S G +  E+  G KP+ P
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFP 235

Length = 335

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 40/127 (31%), Positives = 67/127 (52%), Gaps = 11/127 (8%)

Query: 139 QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG 198
           ++ L++I  GL     YLH      I+HRDIK  N++++SN   K+ DFGLAR+ + +  
Sbjct: 106 KVFLYQILRGLK----YLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158

Query: 199 SQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKPVEPRQEPSKVRLVE 257
              T    T  Y APE +   +    + D++S G +  E+  GR+ +   Q P  ++ ++
Sbjct: 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAEL-LGRRILFQAQSP--IQQLD 215

Query: 258 WVWDLYG 264
            + DL G
Sbjct: 216 LITDLLG 222

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.9 bits (121), Expect = 5e-07
 Identities = 43/136 (31%), Positives = 67/136 (49%), Gaps = 13/136 (9%)

Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 86  TPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHS---A 138

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE V  G   
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPE-VILGMGY 195

Query: 223 KES-DVYSFGVVALEV 237
           KE+ D++S G +  E+
Sbjct: 196 KENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 47/220 (21%), Positives = 83/220 (37%), Gaps = 67/220 (30%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLVHL 130
             +G+GG G VY       +  +A+K++      +   KK ++ E +I + L H  +V +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 131 IGWC-----------------------------------HEQRQL-----ILHKIALGLA 150
              C                                    E+  +     I HKI     
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC---- 123

Query: 151 SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE-------------- 196
           + + Y+H    + ++HRD+K  N++L       + D+G A     E              
Sbjct: 124 ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 197 LGSQTTV---LAGTMGYLAPECVTTGKASKESDVYSFGVV 233
             S  T+   + GT  Y+APE +    AS+ +D+Y+ GV+
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220

Length = 932

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 40/202 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG-- 132
           ++G G +G VY+          AVK +             E+ ++   +H N+V   G  
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 133 ------W-CHE-----QRQLILH--------KIAL-------GLASAVLYLHEEWEQCIV 165
                 W C E       Q I H        +IA        GLA    YLH + +   +
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLA----YLHSKGK---M 128

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT---TGKAS 222
           HRDIK +N++L  N + KL DFG+A  +   +  + + + GT  ++APE       G  +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187

Query: 223 KESDVYSFGVVALEVACGRKPV 244
           +  D+++ G+ A+E+A  + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.9 bits (119), Expect = 6e-07
 Identities = 36/141 (25%), Positives = 63/141 (44%), Gaps = 10/141 (7%)

Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A  +L L     + +V+RD+K +N++LD + + ++ D GLA   D     +     GT G
Sbjct: 104 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFS-KKKPHASVGTHG 160

Query: 210 YLAPECVTTGKASKES-DVYSFGVVALEVACGRKPVEPRQEPSKV---RLVEWV---WDL 262
           Y+APE +  G A   S D +S G +  ++  G  P    +   K    R+   +      
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 220

Query: 263 YGKGQLLEAADGRLSKEFDER 283
               +L    +G L ++ + R
Sbjct: 221 SFSPELRSLLEGLLQRDVNRR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 44/138 (31%), Positives = 67/138 (48%), Gaps = 13/138 (9%)

Query: 107 QGKKEYISEVRIISRLRHRNLVHLIGWC--HEQRQLILHKIALGLASAVLYLHEEWEQCI 164
           Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH      I
Sbjct: 87  QKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIK----HLHS---AGI 139

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
           +HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE V  G   KE
Sbjct: 140 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPE-VILGMGYKE 196

Query: 225 S-DVYSFGVVALEVACGR 241
           + D++S G +  E+  G 
Sbjct: 197 NVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 49.7 bits (118), Expect = 9e-07
 Identities = 40/150 (26%), Positives = 65/150 (43%), Gaps = 29/150 (19%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRN 126
           +++ +  KLGEG +  VY+G        +A+K +    ++G     I E  ++  L+H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 127 LVHLIGWCHEQRQLIL---------------HKIAL----------GLASAVLYLHEEWE 161
           +V L    H +  L L               H   L           L   + Y+H+ + 
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY- 123

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
             I+HRD+K  N+++      KL DFGLAR
Sbjct: 124 --ILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 1/80 (1%)

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N++LD   +  L DFGL +L + +   +T    GT  YLAPE +     +K
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172

Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+  G  P
Sbjct: 173 AVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 9/93 (9%)

Query: 162 QCIVHRDIKSSNVVL---DSNFNAKLGDFGLARL------VDHELGSQTTVLAGTMGYLA 212
           Q IVHRD+K  N+++       +AK+ DFG+  L       D    ++TT + GT  Y A
Sbjct: 98  QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCA 157

Query: 213 PECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           PE +     +  SD+Y++G++ LE   G++ V+
Sbjct: 158 PEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 4/98 (4%)

Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A  VL L        +HRD+K  N++LD + + KL DFG    ++ E   +     GT  
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208

Query: 210 YLAPECVTT----GKASKESDVYSFGVVALEVACGRKP 243
           Y++PE + +    G   +E D +S GV   E+  G  P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 52/225 (23%), Positives = 98/225 (43%), Gaps = 50/225 (22%)

Query: 56  KRFTYRELSRATNNFAEAGKL-GEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS 114
           ++    +++R+ N   + G + G G FG VY  +  D + ++A+K+V +  +   +E + 
Sbjct: 53  EKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL- 111

Query: 115 EVRIISRLRHRNLVHLIGWCH------EQRQLIL-----------HKI------------ 145
              I+  L H N++ L  + +       ++ + L           HK             
Sbjct: 112 ---IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALP 168

Query: 146 -------ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHEL 197
                  +  L  A+ Y+H ++   I HRD+K  N+++D N +  KL DFG A+   + L
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLL 222

Query: 198 GSQTTV-LAGTMGYLAPECVT-TGKASKESDVYSFGVVALEVACG 240
             Q +V    +  Y APE +      +   D++S G +  E+  G
Sbjct: 223 AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 6/104 (5%)

Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
              +L L     + +V+RD+K +N++LD + + ++ D GLA     +   +     GT G
Sbjct: 104 TEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHG 160

Query: 210 YLAPECVTTGKASKES-DVYSFGVVALEVACGRKPVEPRQEPSK 252
           Y+APE +  G A   S D +S G +  ++  G  P   RQ  +K
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTK 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 32/166 (19%)

Query: 101 VSRGSKQGKKEYISEVRIISRLRHRNLVHLIG-------------------WCH--EQRQ 139
           +  G + G     +E  I+  + H +++ L G                   +C+   +R 
Sbjct: 122 IKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRN 178

Query: 140 LILHKIALGLASAVL----YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH 195
           + +  I L +  +VL    YLHE     I+HRDIK+ N+ ++   +  LGDFG A     
Sbjct: 179 IAICDI-LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234

Query: 196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGR 241
              ++    AGT+   APE +         D++S G+V  E+A   
Sbjct: 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 38/134 (28%), Positives = 65/134 (48%), Gaps = 14/134 (10%)

Query: 136 EQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH 195
           E  Q  L+++   L     Y+H      + HRD+K  N++ +++   K+ DFGLAR+  +
Sbjct: 103 EHHQFFLYQLLRALK----YIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155

Query: 196 ELGSQT--TVLAGTMGYLAPECVTT--GKASKESDVYSFGVVALEVACGRKPVEPRQEPS 251
           +  +    T    T  Y APE   +   K +   D++S G +  EV  G KP+ P +  +
Sbjct: 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGK--N 212

Query: 252 KVRLVEWVWDLYGK 265
            V  ++ + DL G 
Sbjct: 213 VVHQLDLITDLLGT 226

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 70/283 (24%), Positives = 107/283 (37%), Gaps = 70/283 (24%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ----GKKEYISE-----VRIISRLRHRN 126
           LG+G F  +Y+G+L  Q+    V      S      G     S        ++S+L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 127 LVHLIGWCHEQRQLI-------------LHK------------IALGLASAVLYLHEEWE 161
           LV L G C     ++             LH+            +A  LASA+ YL +   
Sbjct: 63  LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED--- 119

Query: 162 QCIVHRDIKSSNVVL---DSNFN----AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           + +VH ++   N+++     N       KL D G+   V   L  +  V    + ++APE
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV---LSREERVE--RIPWIAPE 174

Query: 215 CVTTGKASKES--DVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA 271
           C+  G+AS     D +SFG   LE+   G +P+       K R        Y     L  
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-------YQDQHRLPM 227

Query: 272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
            D     E      +C           D T RPS R ++  LN
Sbjct: 228 PD---CAELANLINQCW--------TYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 45/201 (22%), Positives = 86/201 (42%), Gaps = 46/201 (22%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSR--GSKQGKKEYISEVRIISRLRHRNLVHLIG- 132
           +G G +G V   +      ++A+K++SR   S+   K    E+ ++  ++H N++ L+  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 133 -------------------------------WCHEQRQLILHKIALGLASAVLYLHEEWE 161
                                             ++ Q +++++  GL     Y+H    
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLK----YIHS--- 135

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG-K 220
             I+HRD+K  N+ ++ +   K+ DFGLAR  D E+    T    T  Y APE +     
Sbjct: 136 AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILNWMH 191

Query: 221 ASKESDVYSFGVVALEVACGR 241
            ++  D++S G +  E+  G+
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 35/109 (32%), Positives = 50/109 (45%), Gaps = 23/109 (21%)

Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA------ 205
           A+ YLH      IVHRD+K  N+++ S  + KL DFGL+++    L S TT L       
Sbjct: 113 ALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEK 166

Query: 206 -----------GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
                      GT  Y+APE +      K  D ++ G++  E   G  P
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 46/209 (22%), Positives = 88/209 (42%), Gaps = 45/209 (21%)

Query: 76  LGEGGFGGVYRGLLSDQ-------NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV 128
           LG+G F  +++G+  +         TE+ +K + +  +   + +     ++S+L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 129 HLIGWCHEQRQLIL------------------HKI--------ALGLASAVLYLHEEWEQ 162
              G C    + I+                  + I        A  LA A+ +L    ++
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM-----GYLAPECVT 217
            + H ++ + NV+L    + K G+    +L D   G   TVL   +      ++ PEC+ 
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP--GISITVLPKEILLERIPWVPPECIE 177

Query: 218 TGKA-SKESDVYSFGVVALEVACG-RKPV 244
             +  S  +D +SFG    E+  G  KP+
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFSGGDKPL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 17/90 (18%)

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPE---- 214
           CI HRD+ + NV+L     AK+ DFGLAR +   +     V+ G     + ++APE    
Sbjct: 233 CI-HRDVAARNVLLTDGRVAKICDFGLARDI---MNDSNYVVKGNARLPVKWMAPESIFD 288

Query: 215 CVTTGKASKESDVYSFGVVALEV-ACGRKP 243
           CV T     +SDV+S+G++  E+ + G+ P
Sbjct: 289 CVYT----VQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 42/146 (28%), Positives = 59/146 (40%), Gaps = 37/146 (25%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA------------RLVDHE 196
           +A  VL +    +   +HRDIK  N++LDS  + KL DFGL             R ++H 
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166

Query: 197 LGSQTTV----------------------LAGTMGYLAPECVTTGKASKESDVYSFGVVA 234
           L S  T                         GT  Y+APE       +K  D +S GV+ 
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 235 LEVACGRKPV--EPRQEPSKVRLVEW 258
            E+  G  P   E  QE  K +++ W
Sbjct: 227 YEMLIGYPPFCSETPQETYK-KVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 35/116 (30%), Positives = 47/116 (40%), Gaps = 37/116 (31%)

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGL------------ARLVDHELGSQTT---------- 202
           +HRDIK  N++LD+  + KL DFGL             R++ H L S             
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 203 -----------VLA----GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
                       LA    GT  Y+APE       +KE D +S GV+  E+  G  P
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 47/212 (22%)

Query: 76  LGEGGFGGVYRGLLSDQN---TEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHL 130
           LG+G FG V    L  ++    ++AVK  +    S    +E++ E   +    H N++ L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 131 IGWCHEQR-------------------------------------QLILHKIALGLASAV 153
           IG     R                                        L +  + +AS +
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR-LVDHELGSQTTVLAGTMGYLA 212
            YL     +  +HRD+ + N +L+ N    + DFGL++ +   +   Q       + +LA
Sbjct: 127 EYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 213 PECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
            E +     +  SDV++FGV   E+   G+ P
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.8 bits (113), Expect = 7e-06
 Identities = 27/89 (30%), Positives = 48/89 (53%), Gaps = 3/89 (3%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           L  AV Y+H+   + ++HRDIK  N+ L+ +    LGDFG A   + E  +      GT+
Sbjct: 276 LLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEV 237
              +PE +      + +D++S G++ L++
Sbjct: 333 ATNSPEILAGDGYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.8 bits (112), Expect = 7e-06
 Identities = 31/108 (28%), Positives = 48/108 (44%), Gaps = 19/108 (17%)

Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD-SNFNAKLGDFGLARLVDHELGSQTT 202
           KI   L  A+  LH+     I+H DIK  NV+ D +     L D+GL +++        +
Sbjct: 113 KIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----S 164

Query: 203 VLAGTMGYLAPECVTTGKASKESDVYSF-----GVVALEVACGRKPVE 245
              GT+ Y +PE     K    +   SF     GV+  E+  G+ P +
Sbjct: 165 CYDGTLDYFSPE-----KIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207

Length = 267

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 43/194 (22%), Positives = 73/194 (37%), Gaps = 59/194 (30%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA---RLV---------DH- 195
           L  A+  +H+      +HRDIK  N+++D + + KL DFGL    R           DH 
Sbjct: 110 LTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166

Query: 196 ---------ELGS----------------QTTVLA----GTMGYLAPECVTTGKASKESD 226
                    E                       LA    GT  Y+APE +     ++  D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226

Query: 227 VYSFGVVALEVACGRKP-VEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM 285
            +S GV+  E+  G+ P +      ++++++ W   L+   Q       +LS+       
Sbjct: 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQ------AKLSR------- 273

Query: 286 ECLMIVGLWCCHPD 299
           E   ++   CC  +
Sbjct: 274 EASDLILRLCCGAE 287

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 55/228 (24%)

Query: 72  EAGKLGEGGFGGVYRGLLSD--QNTEIAVKRVSRGSKQGKKEYIS---EVRIISRLRHRN 126
           E  K+G G +G VY+    D     E A+K++     +G    +S   E+ ++  L+H N
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI-----EGTGISMSACREIALLRELKHPN 59

Query: 127 LVHL--IGWCHEQRQLIL----------HKIALGLAS----------------------- 151
           ++ L  +   H  R++ L          H I    AS                       
Sbjct: 60  VIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119

Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVL----DSNFNAKLGDFGLARLVDHELGSQTTV--LA 205
            + YLH  W   ++HRD+K +N+++          K+ D G ARL +  L     +  + 
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 206 GTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSK 252
            T  Y APE +   +  +K  D+++ G +  E+         RQE  K
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 224

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 26/76 (34%), Positives = 44/76 (57%), Gaps = 5/76 (6%)

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE---LGSQTTVLAGTMGYLAPECVTTGKA 221
           VHRD+ + NV+L      K+ DFGLAR + H+   +   +T L   + ++APE +     
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP--VKWMAPESIFDNLY 316

Query: 222 SKESDVYSFGVVALEV 237
           +  SDV+S+G++  E+
Sbjct: 317 TTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 28/80 (35%), Positives = 46/80 (57%), Gaps = 8/80 (10%)

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECVT 217
           +CI HRD+ + N++L  N   K+ DFGLAR +  +      V  G+    + ++APE + 
Sbjct: 194 KCI-HRDLAARNILLSENNVVKICDFGLARDIYKD---PDYVRKGSARLPLKWMAPESIF 249

Query: 218 TGKASKESDVYSFGVVALEV 237
               + +SDV+SFGV+  E+
Sbjct: 250 DKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 45.9 bits (108), Expect = 3e-05
 Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 62/234 (26%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTE--IAVKRVS-RGSKQGKK-EYISEVRIISRLR 123
           N +    K+G G FG V+  L+  + T+     K +S RG K+ +K + + EV ++  L+
Sbjct: 13  NEYEVIKKIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70

Query: 124 HRNLVHLIGWC---HEQRQLILHK----------------------------IALGLASA 152
           H+N+V  I        Q+  IL +                            I   L  A
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 153 VLYLHEEWE----QCIVHRDIKSSNVVLDS-------------NFN----AKLGDFGLAR 191
           + Y H   +    + ++HRD+K  N+ L +             N N    AK+GDFGL++
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 192 LVDHELGSQTTVLAGTMGYLAPECV--TTGKASKESDVYSFGVVALEVACGRKP 243
            +  E  + + V  GT  Y +PE +   T     +SD+++ G +  E+  G+ P
Sbjct: 191 NIGIESMAHSCV--GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 53/228 (23%), Positives = 92/228 (40%), Gaps = 55/228 (24%)

Query: 72  EAGKLGEGGFGGVYRGLLSD--QNTEIAVKRVSRGSKQGKKEYIS---EVRIISRLRHRN 126
           E  K+G G +G VY+    D   + + A+K++     +G    +S   E+ ++  L+H N
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI-----EGTGISMSACREIALLRELKHPN 59

Query: 127 LVHL--IGWCHEQRQLIL----------HKIALGLAS----------------------- 151
           ++ L  +   H  R++ L          H I    AS                       
Sbjct: 60  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119

Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVL----DSNFNAKLGDFGLARLVDHELGSQTTV--LA 205
            + YLH  W   ++HRD+K +N+++          K+ D G ARL +  L     +  + 
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 206 GTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSK 252
            T  Y APE +   +  +K  D+++ G +  E+         RQE  K
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 24/158 (15%)

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECV 216
           + CI HRD+ + N++L      K+ DFGLAR + ++      V+ G     + ++APE +
Sbjct: 233 KNCI-HRDLAARNILLTHGRITKICDFGLARDIRND---SNYVVKGNARLPVKWMAPESI 288

Query: 217 TTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR 275
                + ESDV+S+G++  E+ + G  P       SK          Y   ++++     
Sbjct: 289 FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK---------FY---KMIKEGYRM 336

Query: 276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           LS E    +M  +M     C   D   RP+ +Q++ ++
Sbjct: 337 LSPECAPSEMYDIMKS---CWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 54/215 (25%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRV-------SRGSKQGKKEYISEVRIISRLRHRNL 127
           ++G G FG V   LLS+  T+  V RV       +  SK+ + E++ +      L+H N+
Sbjct: 2   EIGNGWFGKV---LLSEIYTDTGVARVVVKELKANASSKE-QNEFLQQGDPYRILQHPNI 57

Query: 128 VHLIGWCHE---------------------QRQ--------LILHKIALGLASAVLYLHE 158
           +  +G C E                     Q Q        L+L ++A  +A+ V ++H+
Sbjct: 58  LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117

Query: 159 EWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL--ARLVDHELGSQTTVLAGTMGYLAPECV 216
                 +H D+   N  L S+   K+GD+G+  +R  +  + ++       + +LAPE V
Sbjct: 118 ---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELV 173

Query: 217 T-------TGKASKESDVYSFGVVALEV-ACGRKP 243
                   T + +K S+V++ GV   E+     +P
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 8/80 (10%)

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECVT 217
           +CI HRD+ + N++L  N   K+ DFGLAR +  +      V  G     + ++APE + 
Sbjct: 199 KCI-HRDLAARNILLSENNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWMAPETIF 254

Query: 218 TGKASKESDVYSFGVVALEV 237
               + +SDV+SFGV+  E+
Sbjct: 255 DRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.1 bits (104), Expect = 8e-05
 Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 8/80 (10%)

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECVT 217
           +CI HRD+ + N++L  N   K+ DFGLAR +  +      V  G     + ++APE + 
Sbjct: 193 KCI-HRDLAARNILLSENNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWMAPESIF 248

Query: 218 TGKASKESDVYSFGVVALEV 237
               + +SDV+SFGV+  E+
Sbjct: 249 DKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 25/76 (32%), Positives = 43/76 (56%), Gaps = 5/76 (6%)

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE---LGSQTTVLAGTMGYLAPECVTTGKA 221
           VHRD+ + NV++      K+ DFGLAR +  +   +   +T L   + ++APE +     
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP--LKWMAPESIFNNLY 318

Query: 222 SKESDVYSFGVVALEV 237
           +  SDV+SFG++  E+
Sbjct: 319 TTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 47/227 (20%), Positives = 81/227 (35%), Gaps = 61/227 (26%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY---ISEVRIISRLRHRNLVHL- 130
            LG+G  G V+   L       A+K + +     + +    ++E  I++ L H  L  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 131 --------IGWCHE-----------QRQ---LILHKIALGLASAVL----YLHEEWEQCI 164
                   +    +           QRQ    +  ++A   A+ VL    YLH      I
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGI 124

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLA----------------------------RLVDHE 196
           V+RD+K  N++L  + +  L DF L+                                 E
Sbjct: 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184

Query: 197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
              ++    GT  Y+APE ++        D ++ G++  E+  G  P
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 43/209 (20%), Positives = 79/209 (37%), Gaps = 44/209 (21%)

Query: 75  KLGEGGFGG--VYRGLLSDQNTEIAVKRVSRGSKQGK--KEYISEVRIISRLRHRN-LVH 129
            +G+       V+       NT +AVK+++  S   +  K    E+    +L+H N L +
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 130 LIGWCHEQRQLILHK-----------------------IAL---GLASAVLYLHEEWEQC 163
           +  +  +    ++                         IA     + +A+ Y+H +    
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK--GF 122

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG------YLAPECVT 217
           I HR +K+S+++L  +    L     +  +      Q  V            +L+PE + 
Sbjct: 123 I-HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181

Query: 218 T---GKASKESDVYSFGVVALEVACGRKP 243
               G   K SD+YS G+ A E+A G  P
Sbjct: 182 QNLQGYNEK-SDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 22/68 (32%), Positives = 41/68 (60%), Gaps = 6/68 (8%)

Query: 125 RNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKL 184
           ++L+H+ G+  E+  +   K    +A A+ YLH      I+HRD+K  N+++ +  + KL
Sbjct: 92  KSLLHIYGYFDEEMAV---KYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKL 145

Query: 185 GDFGLARL 192
            DFGL+++
Sbjct: 146 TDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 38/146 (26%), Positives = 57/146 (39%), Gaps = 37/146 (25%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA------------RLVDHE 196
           +A  VL +    +   +HRDIK  N++LD+  + KL DFGL             R + H 
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 197 LGSQTTV----------------------LAGTMGYLAPECVTTGKASKESDVYSFGVVA 234
             S  +                         GT  Y+APE       +K  D +S GV+ 
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 235 LEVACGRKPV--EPRQEPSKVRLVEW 258
            E+  G  P   E  QE  + +++ W
Sbjct: 227 YEMLIGYPPFCSETPQETYR-KVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	387
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.83
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.78
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.77
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.77
PRK12274	218	serine/threonine protein kinase; Provisional	99.73
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.73
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.73
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.7
PRK10345	210	hypothetical protein; Provisional	99.68
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.62
smart00090	237	RIO RIO-like kinase.	99.61
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.6
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.55
PRK14879	211	serine/threonine protein kinase; Provisional	99.54
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.53
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.52
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.47
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.43
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.41
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.27
KOG1243	690	consensus Protein kinase [General function predict	99.19
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.09
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.04
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.01
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.01
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.9
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.81
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.75
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.74
COG4248	637	Uncharacterized protein with protein kinase and he	98.49
KOG3087	229	consensus Serine/threonine protein kinase [General	98.47
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.47
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.44
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.22
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.18
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	97.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.9
PRK09902	216	hypothetical protein; Provisional	97.83
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.76
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.73
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.55
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.44
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.43
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.32
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.26
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.19
PF01636	239	APH: Phosphotransferase enzyme family This family	96.98
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	96.97
KOG1235	538	consensus Predicted unusual protein kinase [Genera	96.94
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.9
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	96.79
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.53
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	96.48
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.33
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.22
PLN02876	822	acyl-CoA dehydrogenase	96.21
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.2
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.12
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.0
PRK05231	319	homoserine kinase; Provisional	95.92
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.83
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	95.39
PRK12396	409	5-methylribose kinase; Reviewed	95.08
PLN02236	344	choline kinase	94.97
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	94.76
PRK10593	297	hypothetical protein; Provisional	93.97
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	93.93
PHA03111	444	Ser/Thr kinase; Provisional	93.74
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	93.45
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	93.37
PF02439	38	Adeno_E3_CR2: Adenovirus E3 region protein CR2; In	93.14
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	93.05
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	92.86
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	92.72
KOG1093	725	consensus Predicted protein kinase (contains TBC a	92.6
PF04478	154	Mid2: Mid2 like cell wall stress sensor; InterPro:	92.12
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	91.68
PRK10271	188	thiK thiamine kinase; Provisional	91.64
PLN02756	418	S-methyl-5-thioribose kinase	91.59
KOG4258	1025	consensus Insulin/growth factor receptor (contains	91.47
PF12877	684	DUF3827: Domain of unknown function (DUF3827); Int	91.28
PRK06148	1013	hypothetical protein; Provisional	90.91
COG2334	331	Putative homoserine kinase type II (protein kinase	90.71
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	90.71

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-51  Score=387.73  Aligned_cols=260  Identities=49%  Similarity=0.812  Sum_probs=225.8

Q ss_pred             CCCccCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehh
Q 043148           54 GPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGW  133 (387)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  133 (387)
                      ..+.|++.|+..+|++|...+.||+|+||.||+|.+.+ +..||||++.........+|.+|++++.+++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            46679999999999999999999999999999999976 58999998876544314569999999999999999999999


Q ss_pred             hcchhh-HHH---------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEc
Q 043148          134 CHEQRQ-LIL---------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLG  185 (387)
Q Consensus       134 ~~~~~~-~~l---------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~  185 (387)
                      |.+... .++                           .+|+.++|+||+|||+.+.+.||||||||+|||||+++++||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            987663 322                           4899999999999999888899999999999999999999999


Q ss_pred             cccccccccCCCCceeeee-ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc
Q 043148          186 DFGLARLVDHELGSQTTVL-AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYG  264 (387)
Q Consensus       186 Dfg~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  264 (387)
                      |||+++..... ....... .||.+|+|||++..+..+.++|||||||+|+||++|+.+.+.........+++|++..+.
T Consensus       220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            99999755431 1122222 799999999999999999999999999999999999998876554455568999999999


Q ss_pred             cCchhhhhcccCC-ccccH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          265 KGQLLEAADGRLS-KEFDE-RQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       265 ~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ++.+.+++|+++. ...+. .....+..++.+|++.+|..||+|.||+++|..
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence            9999999999987 56554 678889999999999999999999999999953

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-47  Score=356.48  Aligned_cols=228  Identities=26%  Similarity=0.441  Sum_probs=195.1

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHHH--
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL--  142 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l--  142 (387)
                      .+|...+.||+|||+.||.+++.++|..||+|++.+.   ....++...+|+++.+.|+|||||+++++|++....++  
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999999889999999999764   34557788999999999999999999999999876553  


Q ss_pred             -----------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          143 -----------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       143 -----------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                             +.+..||+.||.|||+   .+|+|||||..|+||+++.++||+|||+|..+..+. .
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-E  173 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc-c
Confidence                                   6899999999999999   999999999999999999999999999999876542 3


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ...+.+|||.|.|||++....++..+||||+||+||-|+.|++||+.....+....+.       .      .    .-.
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik-------~------~----~Y~  236 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK-------L------N----EYS  236 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH-------h------c----Ccc
Confidence            4567789999999999999999999999999999999999999998655333322221       0      0    112


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ++...+....+|+..+|+.||.+|||+++|+.+.++.
T Consensus       237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence            2334556678899999999999999999999999983

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-46  Score=333.16  Aligned_cols=230  Identities=27%  Similarity=0.385  Sum_probs=190.8

Q ss_pred             cccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-H--------
Q 043148           71 AEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-L--------  140 (387)
Q Consensus        71 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~--------  140 (387)
                      +..+.||+|..|+||+++++.+++.+|+|.+... .....+++.+|++++.+.+|||||.++|.|..... .        
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            3477899999999999999999999999999544 45567899999999999999999999999877663 2        


Q ss_pred             -----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          141 -----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       141 -----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                       ++-.++.++++||.|||+.  ++||||||||+|||++..|++||||||.++.+...   ....
T Consensus       162 gGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~t  236 (364)
T KOG0581|consen  162 GGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANT  236 (364)
T ss_pred             CCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hccc
Confidence                             2357999999999999963  89999999999999999999999999999876543   4567


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC--cchhhHHHHHHHHhccCchhhhhcccCCcccc
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE--PSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD  281 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (387)
                      .+||..|||||.+.+..|+.++||||||+.++|+.+|+.||.....  .+...+..+            +.+. ..+..+
T Consensus       237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~------------Iv~~-ppP~lP  303 (364)
T KOG0581|consen  237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA------------IVDE-PPPRLP  303 (364)
T ss_pred             ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH------------HhcC-CCCCCC
Confidence            7899999999999999999999999999999999999999987522  121222221            1221 122333


Q ss_pred             H-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          282 E-RQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       282 ~-~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      . ..+.++..++..||+.||.+||++.|+++|.|....
T Consensus       304 ~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  304 EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             cccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence            3 367779999999999999999999999999986543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.2e-46  Score=323.71  Aligned_cols=244  Identities=27%  Similarity=0.390  Sum_probs=194.8

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      +.|+.+.++|+|+||+||+++.+++|+.||||++....  ..-.+-.++|+++|++|+|+|+|.++++|...+.+     
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45777889999999999999999999999999996543  34466789999999999999999999988665432     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          .+.+++.|++.|+.|+|+   +++|||||||+||||+.++.+||||||+|+.+.. .+..
T Consensus        82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~  157 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDN  157 (396)
T ss_pred             ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccch
Confidence                                237899999999999999   9999999999999999999999999999998764 2445


Q ss_pred             eeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------HHhccCc----
Q 043148          201 TTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW--------DLYGKGQ----  267 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~----  267 (387)
                      .+..+.|.+|.|||.+.+ .+|+..+||||+||++.||++|...|.+..+.++...+....        ..+....    
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence            566788999999999887 679999999999999999999999999888777665443221        1111111    


Q ss_pred             --hhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          268 --LLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       268 --~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                        +.+.-++...+..-+....-+++++..|++.||.+|++-+|++.|..|
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF  287 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF  287 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence              111111111111122345568899999999999999999999998765

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=344.09  Aligned_cols=225  Identities=33%  Similarity=0.500  Sum_probs=182.5

Q ss_pred             cccCcccccCceEEEEEEECCCCeE-EEEEEecCCCh--hhHHHHHHHHHHHhcCCCCCccceehhhcchh-hHH-----
Q 043148           71 AEAGKLGEGGFGGVYRGLLSDQNTE-IAVKRVSRGSK--QGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-QLI-----  141 (387)
Q Consensus        71 ~~~~~lg~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~-----  141 (387)
                      ...+.||+|+||+||+|.+++  .. ||||++.....  ...+.|.+|+.+|.+++|||||+|+|+|.+.. ...     
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            345569999999999999964  45 99999976532  22569999999999999999999999998765 111     


Q ss_pred             ----------------------HHHHHHHHHHHHHHhhhhcccc-eeeccCCcceeEeCCCC-cEEEccccccccccCCC
Q 043148          142 ----------------------LHKIALGLASAVLYLHEEWEQC-IVHRDIKSSNVVLDSNF-NAKLGDFGLARLVDHEL  197 (387)
Q Consensus       142 ----------------------l~~i~~~i~~~l~~LH~~~~~~-iiH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~  197 (387)
                                            ...++.+||+||.|||+   ++ ||||||||+|||++.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence                                  16799999999999999   77 99999999999999997 99999999998765432


Q ss_pred             CceeeeeecCCcccCchhhc--cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          198 GSQTTVLAGTMGYLAPECVT--TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                       ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.......   ..            ..+....
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~------------~~v~~~~  262 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VA------------SAVVVGG  262 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HH------------HHHHhcC
Confidence             2233367999999999999  5689999999999999999999999998766421   11            1112222


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .....+..+...+..++.+||+.||..||++.+++..|...
T Consensus       263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence            33444444777789999999999999999999999998743

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-46  Score=335.88  Aligned_cols=235  Identities=26%  Similarity=0.401  Sum_probs=191.5

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh-------hhHHHHHHHHHHHhcCCCCCccceehhhcchh
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-------QGKKEYISEVRIISRLRHRNLVHLIGWCHEQR  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  138 (387)
                      ..+.|.+.+.||+|+||.|-+|..+.+|+.||||++++...       .......+|+++|++|+|||||++.+++....
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            45668888999999999999999999999999999976411       12234579999999999999999999998876


Q ss_pred             hHHH-------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC---CcEEEcccccc
Q 043148          139 QLIL-------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN---FNAKLGDFGLA  190 (387)
Q Consensus       139 ~~~l-------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kl~Dfg~~  190 (387)
                      ..|+                         ..++.|++.|+.|||+   +||+||||||+|||+..+   ..+||+|||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchh
Confidence            5443                         5799999999999999   999999999999999766   67999999999


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhccCC---CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVTTGK---ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ  267 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (387)
                      +..+.  .....+.+||+.|.|||++.+..   +..++|+||+||+||-+++|..||.+.......      .+.+..+.
T Consensus       327 K~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl------~eQI~~G~  398 (475)
T KOG0615|consen  327 KVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL------KEQILKGR  398 (475)
T ss_pred             hcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH------HHHHhcCc
Confidence            98763  45677889999999999998654   345889999999999999999999875543211      11111221


Q ss_pred             hhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          268 LLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ..      ..+....+..++..+++.++|..||++|||+.|+++|+|+..
T Consensus       399 y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~  442 (475)
T KOG0615|consen  399 YA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD  442 (475)
T ss_pred             cc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence            11      123345677888999999999999999999999999999863

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-46  Score=346.94  Aligned_cols=222  Identities=30%  Similarity=0.491  Sum_probs=188.6

Q ss_pred             ccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH----------
Q 043148           72 EAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------  141 (387)
Q Consensus        72 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----------  141 (387)
                      ..+.||+|.||.||.|.+.. ...||+|.++.. .-..++|.+|+++|++|+|+|||+++|+|..+..++          
T Consensus       210 l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  210 LIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            46789999999999999976 458999999765 344678999999999999999999999998865322          


Q ss_pred             -----------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          142 -----------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       142 -----------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                       +..++.|||+|++||.+   +++|||||.++||||+++..+||+|||+++....+........
T Consensus       288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~  364 (468)
T KOG0197|consen  288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG  364 (468)
T ss_pred             HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence                             26899999999999999   9999999999999999999999999999996665544444444


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      .-+..|.|||.+..+.++.+||||||||+||||+| |+.||..+...+...                .++....-..+..
T Consensus       365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~----------------~le~GyRlp~P~~  428 (468)
T KOG0197|consen  365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE----------------LLERGYRLPRPEG  428 (468)
T ss_pred             CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH----------------HHhccCcCCCCCC
Confidence            55779999999999999999999999999999999 999998877654333                2233344455677


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ++..+.+++..||+.+|++|||++.+...+.
T Consensus       429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~  459 (468)
T KOG0197|consen  429 CPDEVYELMKSCWHEDPEDRPTFETLREVLE  459 (468)
T ss_pred             CCHHHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence            8888999999999999999999998888775

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=324.78  Aligned_cols=229  Identities=24%  Similarity=0.424  Sum_probs=181.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ..+|...++||.|+||+||+|+++.++..||||.+.+.  .....+.+..|+.+|+.++|||||+++++++..+..    
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            46788888999999999999999999999999999776  566677889999999999999999999877655432    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC------CcEEEccccccccc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN------FNAKLGDFGLARLV  193 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~------~~~kl~Dfg~~~~~  193 (387)
                                           ..+.++.|+|.||++||+   ++||||||||.||||+.+      -.+||+|||+++.+
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence                                 236899999999999999   999999999999999865      45899999999988


Q ss_pred             cCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          194 DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       194 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ...  .-....+|++.|||||++..++|+.|+|+||+|+++|++++|+.||......+....+       ..       +
T Consensus       166 ~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~-------~k-------~  229 (429)
T KOG0595|consen  166 QPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI-------KK-------G  229 (429)
T ss_pred             Cch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-------hc-------c
Confidence            753  3445678999999999999999999999999999999999999999866544322211       11       1


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .......+......+.++....++.+|.+|-++.+-..+..
T Consensus       230 ~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~  270 (429)
T KOG0595|consen  230 NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPF  270 (429)
T ss_pred             ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhh
Confidence            11222233333334456666677777778877776665543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.4e-44  Score=305.98  Aligned_cols=258  Identities=22%  Similarity=0.328  Sum_probs=198.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ--GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      .+|...++||+|.||.||+|++..+|+.||||+++.....  -....++|++.|+.++|+||+.++++|.....+     
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677788999999999999999999999999999765332  245678999999999999999999988654321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          -+..++.++++||+|||+   +.|+||||||.|+|++.+|.+||+|||+++.+.......
T Consensus        82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence                                136899999999999999   999999999999999999999999999999887654333


Q ss_pred             eeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC---------chhh
Q 043148          201 TTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG---------QLLE  270 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~  270 (387)
                      . ..+-|..|.|||.+.+. .|+..+||||.||++.||+.|.+-|.+..+.++...+-.+.......         ...+
T Consensus       159 ~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  159 T-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             c-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence            2 23678999999998875 59999999999999999999998888877666554443221111110         0001


Q ss_pred             --hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC-CCCCCCCCCCCc
Q 043148          271 --AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA-PLPSLPSKLPVP  329 (387)
Q Consensus       271 --~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~-~~~~~~~~~~~~  329 (387)
                        .............+...+++++..++..||.+|+++.|+++|.++.. +.|..|...|.|
T Consensus       238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p  299 (318)
T KOG0659|consen  238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIP  299 (318)
T ss_pred             HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCC
Confidence              11111112233445566789999999999999999999999988764 455555555544

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-44  Score=308.67  Aligned_cols=231  Identities=25%  Similarity=0.389  Sum_probs=185.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehh-hcchhh-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGW-CHEQRQ-----  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~-----  139 (387)
                      .+|.+.++||+|.||+||++....+|..+|.|.+...  +...++++..|+.+|++|+|||||+++++ +.++.+     
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4566788999999999999999999999999998643  55667889999999999999999999984 333322     


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhhhhccc-ceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          140 -------------------------LILHKIALGLASAVLYLHEEWEQ-CIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       140 -------------------------~~l~~i~~~i~~~l~~LH~~~~~-~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                                               ..+++++.|++.||.++|+...+ -++||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence                                     12378999999999999985433 3889999999999999999999999999987


Q ss_pred             cCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          194 DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       194 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      .... ......+|||.||+||.+.+..|+.++||||+||++|||+.-+.||.+..-.+   +    ...+..+       
T Consensus       179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~---L----~~KI~qg-------  243 (375)
T KOG0591|consen  179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS---L----CKKIEQG-------  243 (375)
T ss_pred             cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH---H----HHHHHcC-------
Confidence            6542 23445789999999999999999999999999999999999999998763211   1    1111121       


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                       ..++-.....+..+..++..|+..||..||+.-.+++.+.
T Consensus       244 -d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  244 -DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             -CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence             2222233677888999999999999999998555555443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-44  Score=327.32  Aligned_cols=252  Identities=23%  Similarity=0.292  Sum_probs=201.1

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChh-hHHHHHHHHHHHhcCC-CCCccceehhhcchh-hHH
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ-GKKEYISEVRIISRLR-HRNLVHLIGWCHEQR-QLI  141 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~  141 (387)
                      ...++|...++||.|.||.||+|+...+|..||||++++.-.. +.--=++|++.|.+|+ |||||++.+++.+.. .++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            3467899999999999999999999999999999999765322 2223468999999998 999999999988766 222


Q ss_pred             -------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          142 -------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       142 -------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                               +..|+.||++||+|+|.   +|+.||||||+|||+..+..+||+|||+||.+...
T Consensus        87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccC
Confidence                                     26899999999999999   99999999999999999999999999999977653


Q ss_pred             CCceeeeeecCCcccCchhhc-cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC------chh
Q 043148          197 LGSQTTVLAGTMGYLAPECVT-TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG------QLL  269 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~  269 (387)
                        ...+.++.|.+|.|||++. .+.|+.+.||||+|||++|+.+-+..|.+..+.+++..+..+.....+.      .+.
T Consensus       164 --pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  164 --PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             --CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence              3456678899999999876 5669999999999999999999999999988777766555443221111      111


Q ss_pred             hhhcccCC-------ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 043148          270 EAADGRLS-------KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPS  321 (387)
Q Consensus       270 ~~~~~~~~-------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  321 (387)
                      ..+.-++.       ...-...+..+.+++..|+++||.+|||+.|.+++..+....+.
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence            11211111       11223367778899999999999999999999999998766554

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-44  Score=353.00  Aligned_cols=230  Identities=27%  Similarity=0.444  Sum_probs=190.7

Q ss_pred             hCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCCccceehhhcchhhHH
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGSKQ-GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  141 (387)
                      .+....+.||+|.||+||+|+..+     +...||||.++..... ..++|++|+++|..|+|||||+|+|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            444556789999999999998643     3467999999877554 7899999999999999999999999997765432


Q ss_pred             ---------------------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcE
Q 043148          142 ---------------------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA  182 (387)
Q Consensus       142 ---------------------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  182 (387)
                                                             ++.||.|||.|+.||-+   +.+|||||..+|+||.++..+
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEE
Confidence                                                   26899999999999999   999999999999999999999


Q ss_pred             EEccccccccccCCCCceee-eeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 043148          183 KLGDFGLARLVDHELGSQTT-VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVW  260 (387)
Q Consensus       183 kl~Dfg~~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~  260 (387)
                      ||+|||+++..-........ ...-+++|||||.+..++++.++|||||||+|||+++ |+.||.+..+.+.+..+    
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i----  718 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI----  718 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH----
Confidence            99999999865443222222 3345679999999999999999999999999999999 99999987765533222    


Q ss_pred             HHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                         ..+        ++ -..++.++..+..|+..||+.+|++||++.||-..|...
T Consensus       719 ---~~g--------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  719 ---RAG--------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             ---HcC--------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence               222        22 456677888899999999999999999999999998643

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-44  Score=318.04  Aligned_cols=231  Identities=25%  Similarity=0.314  Sum_probs=189.0

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHHH
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL  142 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  142 (387)
                      ..++|+..+.||+|+||+||.++.+++++.+|+|++++..   ....+....|..+|.+++||.||++.-.|++...+++
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3577889999999999999999999999999999997752   3446778899999999999999999988877655443


Q ss_pred             -------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          143 -------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       143 -------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                               +-++..|+.||.|||+   ++||||||||+|||||..|+++|+|||+++..... 
T Consensus       103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-  178 (357)
T ss_pred             EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC-
Confidence                                     4578899999999999   99999999999999999999999999999854332 


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      +......+||+.|||||++.+..|+..+|.||+|+++|||++|..||...+.....+.+       ..++         .
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I-------~~~k---------~  242 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI-------LKGK---------L  242 (357)
T ss_pred             CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH-------hcCc---------C
Confidence            34455689999999999999999999999999999999999999999876643322211       1111         1


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHHhccC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRP----SIRQVINVLNFE  316 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RP----s~~evl~~l~~~  316 (387)
                      ...+........+++.+.+..||++|.    .+.+|-+|..+.
T Consensus       243 ~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~  285 (357)
T KOG0598|consen  243 PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFK  285 (357)
T ss_pred             CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccc
Confidence            122222445577889999999999995    688888888654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-43  Score=323.42  Aligned_cols=257  Identities=25%  Similarity=0.336  Sum_probs=200.8

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchh--hH--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--QL--  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~--  140 (387)
                      .+.|+.+++||+|.||.||+|++..+|+.||+|+++...  .....-..+||.+|++|+||||++|.+...+..  .+  
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            456777889999999999999999999999999997654  444566789999999999999999988665441  11  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                             -+..++.|++.||.|||+   ++|+|||||.+|||||.+|.+||+|||||+++....
T Consensus       196 VFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  196 VFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence                                   136799999999999999   999999999999999999999999999999888776


Q ss_pred             CceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH-----HhccCchh--
Q 043148          198 GSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWD-----LYGKGQLL--  269 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~--  269 (387)
                      ....+..+-|++|.|||++.+. .|+.++|+||.||||.||++|+..|.+..+.++...+..+..     .|....+.  
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence            6667777889999999999875 599999999999999999999999998887766655533211     01111111  


Q ss_pred             hhhcc------cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc-CCCCCCCCCCCC
Q 043148          270 EAADG------RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF-EAPLPSLPSKLP  327 (387)
Q Consensus       270 ~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~-~~~~~~~~~~~~  327 (387)
                      ..+.+      ++. +.....+...++|+..+|..||.+|.|+.++++.-+| ..+.+..|+.+|
T Consensus       353 ~~~kp~~~y~r~l~-E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp  416 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLR-ETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLP  416 (560)
T ss_pred             cccCCCCcccchHH-HHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCC
Confidence            11111      111 1122234456789999999999999999999999888 444444444443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=327.39  Aligned_cols=234  Identities=25%  Similarity=0.352  Sum_probs=191.8

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  139 (387)
                      .....+|...+.||.|+|++||+|+.+.+++.+|||++.+.-   ....+....|-+.|..| .||.|++|+-.|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            445678999999999999999999999999999999996641   22234566899999999 89999999998888655


Q ss_pred             HHH-------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          140 LIL-------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       140 ~~l-------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                      +|+                         +.++.+|+.||+|||+   +|||||||||+|||||+|+++||+|||.++.+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            442                         6789999999999999   999999999999999999999999999998775


Q ss_pred             CCCCc----------e--eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 043148          195 HELGS----------Q--TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDL  262 (387)
Q Consensus       195 ~~~~~----------~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  262 (387)
                      .....          .  ...++||-.|.+||++.....+..+|+|+|||+||.|+.|++||.+..+--   ..+     
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---iFq-----  297 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---IFQ-----  297 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---HHH-----
Confidence            43211          1  145889999999999999999999999999999999999999998765321   111     


Q ss_pred             hccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          263 YGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                             ++++  +.-++++..++.+.+|+.+.|..||.+|+|.++|-+|++|..
T Consensus       298 -------kI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  298 -------KIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             -------HHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence                   1111  122334444466788999999999999999999999998753

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-43  Score=327.44  Aligned_cols=244  Identities=29%  Similarity=0.479  Sum_probs=186.5

Q ss_pred             HHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh
Q 043148           61 RELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR  138 (387)
Q Consensus        61 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  138 (387)
                      ++.....+.+.+...||+|.||+||+|+|.+   .||||++...  .....+.|.+|+..+++-+|.||+=|+|||.+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            4444455556678899999999999999976   4999999765  3456788999999999999999999999997755


Q ss_pred             hHH-------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          139 QLI-------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       139 ~~~-------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                      ..+                         ++.|+.||++|+.|||.   ++|||||||..|||+.+++.+||+|||++..-
T Consensus       462 ~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  462 LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence            432                         27899999999999999   99999999999999999999999999998643


Q ss_pred             cCC-CCceeeeeecCCcccCchhhcc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh
Q 043148          194 DHE-LGSQTTVLAGTMGYLAPECVTT---GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL  269 (387)
Q Consensus       194 ~~~-~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (387)
                      ..- .........|...|||||++..   .+|++.+||||||+++|||++|..||. ....+++-      -+++.+-+.
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIi------fmVGrG~l~  611 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQII------FMVGRGYLM  611 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheE------EEecccccC
Confidence            221 1122334457788999999874   468999999999999999999999998 33332210      001111100


Q ss_pred             hhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC-CCCC
Q 043148          270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP-LPSL  322 (387)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~-~~~~  322 (387)
                          +++ ......+...+.+|+..||..++++||.+.+|+..|....+ .|.+
T Consensus       612 ----pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki  660 (678)
T KOG0193|consen  612 ----PDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKI  660 (678)
T ss_pred             ----ccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccc
Confidence                001 11223456778999999999999999999999997764433 3443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=339.48  Aligned_cols=244  Identities=26%  Similarity=0.458  Sum_probs=197.1

Q ss_pred             cCHHHHHHHhhC---------ccccCcccccCceEEEEEEECCCC---eEEEEEEecCC-ChhhHHHHHHHHHHHhcCCC
Q 043148           58 FTYRELSRATNN---------FAEAGKLGEGGFGGVYRGLLSDQN---TEIAVKRVSRG-SKQGKKEYISEVRIISRLRH  124 (387)
Q Consensus        58 ~~~~~~~~~~~~---------~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h  124 (387)
                      +||+|-..+...         ..+.+.||.|.||.||+|+++..|   ..||||.++.. ....+.+|+.|+.||.+++|
T Consensus       610 ~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH  689 (996)
T KOG0196|consen  610 HTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH  689 (996)
T ss_pred             ccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC
Confidence            566654444333         345688999999999999997665   46999999876 45567899999999999999


Q ss_pred             CCccceehhhcchhhH--------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC
Q 043148          125 RNLVHLIGWCHEQRQL--------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS  178 (387)
Q Consensus       125 ~niv~l~~~~~~~~~~--------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~  178 (387)
                      |||++|.|+....+..                          .|..++++||.|+.||-+   .++|||||.++|||++.
T Consensus       690 PNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNs  766 (996)
T KOG0196|consen  690 PNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNS  766 (996)
T ss_pred             CcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeecc
Confidence            9999999986554322                          135789999999999999   99999999999999999


Q ss_pred             CCcEEEccccccccccCCCCceeeee--ecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 043148          179 NFNAKLGDFGLARLVDHELGSQTTVL--AGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRL  255 (387)
Q Consensus       179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~--~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~  255 (387)
                      +..+|++|||+++.+.++.....+..  .-+.+|.|||.+..++++.++||||||++|||.++ |..||-++.+.+.+..
T Consensus       767 nLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka  846 (996)
T KOG0196|consen  767 NLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA  846 (996)
T ss_pred             ceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH
Confidence            99999999999998766543333222  23579999999999999999999999999999877 9999987776554332


Q ss_pred             HHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 043148          256 VEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLP  320 (387)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  320 (387)
                      +                +..+.-..+.+++..|.+|++.|||.|-.+||.+.||+.+|......|
T Consensus       847 I----------------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  847 I----------------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             H----------------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            2                223334455678888999999999999999999999999998554433

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.9e-42  Score=318.27  Aligned_cols=227  Identities=29%  Similarity=0.420  Sum_probs=190.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----  141 (387)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..  ..+.+.+.+|+++++.++|||||.++++|+...+++    
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888889999999999999999999999999997653  445677999999999999999999999998765432    


Q ss_pred             --------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          142 --------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       142 --------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                          +..++.++..||.|||+   .+|+|||+||.|||++.++.+|++|||+++.+..+. ...
T Consensus        82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~vl  157 (808)
T KOG0597|consen   82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-SVL  157 (808)
T ss_pred             hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCc-eee
Confidence                                26899999999999999   999999999999999999999999999999876643 334


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD  281 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (387)
                      +...|||.|||||++.+++|+..+|+||+||++||++.|++||......   .++.   ....        |   ....+
T Consensus       158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~---~Lv~---~I~~--------d---~v~~p  220 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT---QLVK---SILK--------D---PVKPP  220 (808)
T ss_pred             eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH---HHHH---HHhc--------C---CCCCc
Confidence            5568999999999999999999999999999999999999999643211   1111   1111        1   11233


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          282 ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       282 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .....++.+++...+..||..|.+..+++.|.+.
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~  254 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFW  254 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHHHhcChHH
Confidence            4677788999999999999999999999999864

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=311.34  Aligned_cols=236  Identities=27%  Similarity=0.418  Sum_probs=186.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcch----------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ----------  137 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----------  137 (387)
                      .++...+.||+|+||.||++...++|...|||.+...+....+.+.+|+.+|.+++|||||+++|.....          
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            4456688999999999999999988999999998766444467789999999999999999999952111          


Q ss_pred             ------------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC-CCcEEEccccccccccC--C
Q 043148          138 ------------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS-NFNAKLGDFGLARLVDH--E  196 (387)
Q Consensus       138 ------------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~--~  196 (387)
                                        .+..++.+..||++||+|||+   ++++||||||+|||++. ++.+||+|||++.....  .
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence                              223457899999999999999   99999999999999999 79999999999986653  2


Q ss_pred             CCceeeeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .........||+.|||||++..+. ...++|||||||++.||+||+.||....     ....+....         ....
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~i---------g~~~  239 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLI---------GRED  239 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHH---------hccC
Confidence            223344568999999999998643 3459999999999999999999998641     111111111         1111


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLP  320 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  320 (387)
                      ..+..+...+....+++..|++.||.+|||++++++|++.....+
T Consensus       240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            123455556777899999999999999999999999998766544

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=318.38  Aligned_cols=231  Identities=25%  Similarity=0.410  Sum_probs=193.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-------  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-------  140 (387)
                      ..|....+||+|+-|.||.+....++..||||++.......++-+++|+.+|+..+|+|||++++.+...+++       
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4577778899999999999999999999999999887777778889999999999999999999876554332       


Q ss_pred             -----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          141 -----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       141 -----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                       .+..|+.++++||+|||.   ++|+|||||.+|||++.+|.+||+|||++..+..... ....
T Consensus       353 ~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~T  428 (550)
T KOG0578|consen  353 EGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRST  428 (550)
T ss_pred             CCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccc
Confidence                             236799999999999999   9999999999999999999999999999987766543 3345


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      .+||+.|||||++....|++++||||||++++||+-|+.||-......-..++      .        .........++.
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI------a--------~ng~P~lk~~~k  494 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------A--------TNGTPKLKNPEK  494 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH------h--------hcCCCCcCCccc
Confidence            67999999999999999999999999999999999999999754332111111      0        112223344566


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .+..+.+++.+||+.|+.+||++.|+|+|.++.
T Consensus       495 lS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  495 LSPELKDFLDRCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             cCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence            778899999999999999999999999998873

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=316.61  Aligned_cols=232  Identities=28%  Similarity=0.393  Sum_probs=188.2

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC----Ch-hhHHHHHHHHHHHhcCC-CCCccceehhhcchh
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG----SK-QGKKEYISEVRIISRLR-HRNLVHLIGWCHEQR  138 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  138 (387)
                      ...++|...+.||+|+||.|++|....++..||+|++.+.    .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3457889999999999999999999999999999977653    11 23456668999999998 999999998765533


Q ss_pred             hH-------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC-CcEEEcccccccc
Q 043148          139 QL-------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN-FNAKLGDFGLARL  192 (387)
Q Consensus       139 ~~-------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfg~~~~  192 (387)
                      ..                         ....++.|++.|++|||+   ++|+||||||+|||+|.+ +++||+|||++..
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            22                         126799999999999999   999999999999999999 9999999999987


Q ss_pred             ccCCCCceeeeeecCCcccCchhhccCC-CC-CccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          193 VDHELGSQTTVLAGTMGYLAPECVTTGK-AS-KESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       193 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      .. .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||...........       +..+    
T Consensus       171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-------i~~~----  238 (370)
T KOG0583|consen  171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-------IRKG----  238 (370)
T ss_pred             cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-------HhcC----
Confidence            74 2234556778999999999999877 75 899999999999999999999987443221111       1111    


Q ss_pred             hhcccCCccccHHH-HHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          271 AADGRLSKEFDERQ-MECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       271 ~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                            ...++... +..+..++.+|+..||.+|+|+.+++++.|+..
T Consensus       239 ------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 ------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                  11222222 667889999999999999999999999999987

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-41  Score=311.69  Aligned_cols=235  Identities=27%  Similarity=0.421  Sum_probs=189.1

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCCccceehhhcchhhHHH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ-GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL----  142 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l----  142 (387)
                      +...+.++||+|-||.|.++.... +..||||+++..... .+++|.+|+++|.+++|||||+++|+|..++.+.+    
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            445667899999999999999865 799999999887544 45899999999999999999999999976654433    


Q ss_pred             -----------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC-CC
Q 043148          143 -----------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE-LG  198 (387)
Q Consensus       143 -----------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-~~  198 (387)
                                             ..|+.||+.|++||.+   ..++||||.++|+|+|.++++||+|||+++.+-.. ..
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCce
Confidence                                   5799999999999999   99999999999999999999999999999854433 23


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHH--hCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVA--CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                      ......+-+++|||||.+.-++++.++|||+||+++||++  +...||+...+.+..   +........+...      .
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~~~~------~  764 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQGRQ------V  764 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCCCcc------e
Confidence            3344556788999999999999999999999999999984  588999876654332   2222222222111      1


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ....+.-++..+.+++..||..|-.+||+++++..+|..
T Consensus       765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            122345567778899999999999999999999988864

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-40  Score=315.44  Aligned_cols=237  Identities=24%  Similarity=0.359  Sum_probs=182.8

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .+|...+.||+|+||.||+|++..+++.||||.+.... ......+.+|+++++.++|+||+++++++.+...       
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            44556789999999999999999889999999986543 3345678999999999999999999987755322       


Q ss_pred             --------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeee
Q 043148          140 --------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA  205 (387)
Q Consensus       140 --------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  205 (387)
                                    ..+..++.||+.||.|||+   ++++||||||+|||+++++.+||+|||+++....... ......
T Consensus       154 ~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~  229 (353)
T PLN00034        154 MDGGSLEGTHIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSV  229 (353)
T ss_pred             CCCCcccccccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cccccc
Confidence                          2346799999999999999   9999999999999999999999999999986543221 223346


Q ss_pred             cCCcccCchhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          206 GTMGYLAPECVTT-----GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       206 g~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      |+..|+|||.+..     ...+.++|||||||++|||++|+.||......+........   .          .......
T Consensus       230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~----------~~~~~~~  296 (353)
T PLN00034        230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---C----------MSQPPEA  296 (353)
T ss_pred             cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---h----------ccCCCCC
Confidence            8999999998743     23456899999999999999999999743322211111100   0          0011122


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPS  321 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  321 (387)
                      .......+.+++.+||+.||.+||++.|+++|.|+....+.
T Consensus       297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        297 PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            23345568899999999999999999999999998876544

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.8e-41  Score=308.95  Aligned_cols=245  Identities=23%  Similarity=0.307  Sum_probs=185.3

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      ++|.+.+.||+|+||.||++++..++..||+|++....  ....+.+.+|++++..++||||+++++++.+....     
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999999999999999986542  33456788999999999999999999877543221     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          .+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++..........
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence                                236789999999999999   999999999999999999999999999998664432223


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------H-HhccCchhhh
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW--------D-LYGKGQLLEA  271 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~--------~-~~~~~~~~~~  271 (387)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+....        . ..........
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            334568999999999998889999999999999999999999998654332221111110        0 0000000000


Q ss_pred             hcccC------CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          272 ADGRL------SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       272 ~~~~~------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ..+..      ........+..+.+++.+||+.||.+|||++|+++|.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00000      001112245568999999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-41  Score=303.45  Aligned_cols=242  Identities=22%  Similarity=0.304  Sum_probs=189.0

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      ..++|+..+.||.|.-++||+|+....+..||||++... +..+.+.+.+|+..|+.++||||++++..|.....     
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            357788899999999999999999999999999999765 34446889999999999999999999887755443     


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            ..+..|++++++||.|||.   +|.||||||+.||||+.+|.+||+|||.+..+....
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence                                  2346799999999999999   999999999999999999999999999887554432


Q ss_pred             Cce---eeeeecCCcccCchhhcc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          198 GSQ---TTVLAGTMGYLAPECVTT--GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       198 ~~~---~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                      .+.   ....+||+.|||||++..  ..|+.|+||||||++..||.+|..||..........     .. +.. ......
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl-----~t-Lqn-~pp~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL-----LT-LQN-DPPTLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH-----HH-hcC-CCCCcc
Confidence            111   144589999999999543  459999999999999999999999998765432211     11 111 111000


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      -..+..+........+..++..||+.||.+|||+++++++.+|..
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~  298 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKK  298 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhh
Confidence            112222333344557888999999999999999999999988754

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-42  Score=319.13  Aligned_cols=224  Identities=28%  Similarity=0.496  Sum_probs=183.5

Q ss_pred             ccCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcc
Q 043148           57 RFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE  136 (387)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  136 (387)
                      .+.++++..       ++-||.|+.|.||+|+++  ++.||||+++.       .-..+|+.|++|+||||+.|.|+|..
T Consensus       120 eiPFe~IsE-------LeWlGSGaQGAVF~Grl~--netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  120 EIPFEEISE-------LEWLGSGAQGAVFLGRLH--NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             cCCHHHhhh-------hhhhccCcccceeeeecc--CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecC
Confidence            345555544       557999999999999995  57899998843       33468999999999999999998866


Q ss_pred             hhh-------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          137 QRQ-------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       137 ~~~-------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      ..-                         ..+..+..+||.|+.|||.   +.|||||||.-||||..+..+||+|||-++
T Consensus       184 sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchH
Confidence            432                         1246889999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       192 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                      .....  .....++||..|||||++...+.++|+|||||||+||||+||..||.+.+....+.         +-      
T Consensus       261 e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw---------GV------  323 (904)
T KOG4721|consen  261 ELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW---------GV------  323 (904)
T ss_pred             hhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE---------ec------
Confidence            66543  45567889999999999999999999999999999999999999998655432211         00      


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      -...+.-..+..+++.+.-|++.||+..|.+||++++++.||+..
T Consensus       324 GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  324 GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            111233455667788899999999999999999999999999643

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-40  Score=291.18  Aligned_cols=247  Identities=24%  Similarity=0.295  Sum_probs=190.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCCccceehh-----------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ--GKKEYISEVRIISRLRHRNLVHLIGW-----------  133 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~-----------  133 (387)
                      .++|+.+++|++|.||.||+|+++.++..||+|+++.....  -.-..++|+.+|.+.+|||||.+-++           
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            35577789999999999999999999999999999754322  23356799999999999999997653           


Q ss_pred             ----hcchhhHHH------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          134 ----CHEQRQLIL------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       134 ----~~~~~~~~l------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                          |+.+-..++            .-+..|+++|++|||.   +.|+|||||++|+|+...|.+||+|||+|+.++...
T Consensus       155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence                333222222            5688999999999999   999999999999999999999999999999887653


Q ss_pred             CceeeeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH--------hccCch
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDL--------YGKGQL  268 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~  268 (387)
                       ...+..+-|.+|.|||.+.+.. |+.+.|+||+|||+.||+++++.|.+....++.+.+-.....        +..-..
T Consensus       232 -k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~  310 (419)
T KOG0663|consen  232 -KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA  310 (419)
T ss_pred             -ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence             3345566799999999988765 999999999999999999999999988877766555332211        111000


Q ss_pred             h------hhhcccCCccccHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          269 L------EAADGRLSKEFDER-QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       269 ~------~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .      +..-..+...+... ..+.-.+|+...+..||.+|.|++|.++|-||..
T Consensus       311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e  366 (419)
T KOG0663|consen  311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE  366 (419)
T ss_pred             hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence            0      00001112222222 3466788999999999999999999999998765

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-40  Score=317.12  Aligned_cols=241  Identities=21%  Similarity=0.234  Sum_probs=180.3

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      .+|.+.+.||+|+||.||++.+..+++.||+|...      ...+.+|++++++++||||+++++++.....        
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            57999999999999999999999999999999753      2457789999999999999999987654321        


Q ss_pred             ----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          140 ----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       140 ----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                      ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.............
T Consensus       166 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~  242 (391)
T PHA03212        166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG  242 (391)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence                            1136788999999999999   999999999999999999999999999997543322223334


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcc----hhhHHHHHHHHhccC----------chh
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPS----KVRLVEWVWDLYGKG----------QLL  269 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~----------~~~  269 (387)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .......+.......          .+.
T Consensus       243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~  322 (391)
T PHA03212        243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD  322 (391)
T ss_pred             ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence            578999999999998899999999999999999999998875432211    011111111110000          000


Q ss_pred             hhh---------cccCCc--cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          270 EAA---------DGRLSK--EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       270 ~~~---------~~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ...         .+....  ......+..+.+++.+||+.||.+|||++|++++.|+..
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~  381 (391)
T PHA03212        323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD  381 (391)
T ss_pred             HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence            000         000000  001124556889999999999999999999999999865

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-40  Score=296.98  Aligned_cols=241  Identities=22%  Similarity=0.280  Sum_probs=184.9

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh---hHHH---
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR---QLIL---  142 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~l---  142 (387)
                      .|...+.+|.|+||.||+|...+++..||||++-...    +.--+|+++|+.++|||||++.-+|....   ..++   
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4566789999999999999999999999999984432    23347999999999999999988775432   1221   


Q ss_pred             ---------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC-CcEEEcccccccccc
Q 043148          143 ---------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN-FNAKLGDFGLARLVD  194 (387)
Q Consensus       143 ---------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~  194 (387)
                                                 +-+..||.+||.|||+   .+|+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus       101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen  101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence                                       4578999999999999   999999999999999976 899999999999876


Q ss_pred             CCCCceeeeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC-------
Q 043148          195 HELGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG-------  266 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  266 (387)
                      .+..  ......|..|.|||.+.+.. |+.+.||||.||++.||+-|+.-|.+....++...+-.+.....+.       
T Consensus       178 ~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  178 KGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             cCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence            6433  34456788999999998765 9999999999999999999999999866555443332221111111       


Q ss_pred             -----chhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          267 -----QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       267 -----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                           ...++....+..-+.......+++++.++++.+|.+|.++.|++.|..|..-
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL  312 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence                 1111111111122334456678899999999999999999999999887543

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-41  Score=283.85  Aligned_cols=228  Identities=27%  Similarity=0.396  Sum_probs=191.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHHH-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-  142 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l-  142 (387)
                      .++|+..+.||+|.||.||+|+.+.++..||+|++.+..   ..-.+++.+|+++-+.|+||||+++++||.+....++ 
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            466788999999999999999999999999999997652   3346789999999999999999999999988765443 


Q ss_pred             --------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          143 --------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       143 --------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                                ..+..|+|.||.|+|.   +++|||||||+|+|++..+.+||+|||.+..... 
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-  176 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence                                      4688999999999999   9999999999999999999999999999865432 


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                        ....+.+||..|.+||...+..++..+|+|++|++.||++.|..||+.....+....+.          -       .
T Consensus       177 --~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~----------k-------~  237 (281)
T KOG0580|consen  177 --NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR----------K-------V  237 (281)
T ss_pred             --CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH----------H-------c
Confidence              34456789999999999999999999999999999999999999998766433222111          0       1


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ...++........+++..|+..+|.+|.+..|++.|+|..+
T Consensus       238 ~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  238 DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            12233455666889999999999999999999999999654

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1e-40  Score=313.40  Aligned_cols=227  Identities=25%  Similarity=0.338  Sum_probs=181.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      .++|...+.||+|+||.||+|++..+++.||+|.+....   ....+.+.+|+.++..++||||+++++++.+....   
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            367888999999999999999999999999999986532   23356788999999999999999999876543321   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....  
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--  171 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence                                  125678999999999999   99999999999999999999999999999765432  


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                        .....|++.|+|||++.+..++.++|||||||++|||++|+.||.......   .    ......+.        +  
T Consensus       172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~----~~~i~~~~--------~--  232 (329)
T PTZ00263        172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---I----YEKILAGR--------L--  232 (329)
T ss_pred             --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---H----HHHHhcCC--------c--
Confidence              223468999999999999889999999999999999999999997543211   1    11111111        0  


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFEA  317 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  317 (387)
                      .++......+.+++.+||+.||.+||+     +++++.|.|+..
T Consensus       233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        233 KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            112223445788999999999999996     799999998764

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=334.94  Aligned_cols=227  Identities=31%  Similarity=0.468  Sum_probs=183.8

Q ss_pred             CccccCcccccCceEEEEEEECCCCe-----EEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH-
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNT-----EIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI-  141 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-  141 (387)
                      +......||+|.||.||.|...+...     .||||.+.+. +.+...+|++|..+|++++|||||+++|+|.+....+ 
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            34456789999999999999865433     4999999776 4667889999999999999999999999997643221 


Q ss_pred             -------------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccc
Q 043148          142 -------------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA  190 (387)
Q Consensus       142 -------------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~  190 (387)
                                                     |..++.+||+|+.||++   +++|||||.++|+||++...+||+|||+|
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchh
Confidence                                           36899999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCcee-eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCch
Q 043148          191 RLVDHELGSQT-TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQL  268 (387)
Q Consensus       191 ~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (387)
                      +.+........ ....-+..|||||.+..+.++.|+|||||||+|||++| |..||....+.+...              
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~--------------  915 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL--------------  915 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH--------------
Confidence            94433322222 22244578999999999999999999999999999999 999998766543221              


Q ss_pred             hhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          269 LEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                       .+.... .-+.+..+++.+.+++..||+.+|++||++..|++.+.
T Consensus       916 -~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~  959 (1025)
T KOG1095|consen  916 -DVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDP  959 (1025)
T ss_pred             -HHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence             111111 23445677888999999999999999999999999775

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=301.87  Aligned_cols=228  Identities=21%  Similarity=0.340  Sum_probs=190.4

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHHH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL----  142 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l----  142 (387)
                      ..|...+.||+|.||.||+|.+..+++.||+|++.... .....+.++|+.+|.+++++||.+++|.+..+..+.+    
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            34556678999999999999999999999999997653 4456788999999999999999999998766554433    


Q ss_pred             ---------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          143 ---------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       143 ---------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                           .-++.+++.||.|||+   .+.+|||||+.|||+..+|.+||+|||++.......... 
T Consensus        93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-  168 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-  168 (467)
T ss_pred             hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence                                 3578899999999999   999999999999999999999999999998776554433 


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD  281 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (387)
                      ...+||+.|||||++....|+.++||||||++.+||.+|.+|+....+....                -++.+..++...
T Consensus       169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----------------flIpk~~PP~L~  232 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----------------FLIPKSAPPRLD  232 (467)
T ss_pred             ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----------------EeccCCCCCccc
Confidence            6788999999999999889999999999999999999999999876653221                122223333444


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          282 ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       282 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ......+.+++..||..||+.||++.++++|-+.
T Consensus       233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FI  266 (467)
T KOG0201|consen  233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFI  266 (467)
T ss_pred             cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHH
Confidence            4566678999999999999999999999998653

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.1e-40  Score=309.43  Aligned_cols=223  Identities=25%  Similarity=0.315  Sum_probs=176.7

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----------  140 (387)
                      +.||+|+||.||+++...+|+.||+|++....   ......+.+|++++..++||||+++++++.+....          
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999999999999999987532   23345678999999999999999998876543321          


Q ss_pred             ---------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeee
Q 043148          141 ---------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA  205 (387)
Q Consensus       141 ---------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  205 (387)
                                     .+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... ........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~  156 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFC  156 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCccccee
Confidence                           225688999999999999   99999999999999999999999999998753221 12233456


Q ss_pred             cCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHH
Q 043148          206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM  285 (387)
Q Consensus       206 g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (387)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..    .....      +    ..++....
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~----~~~~~------~----~~~p~~~~  219 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FE----LILME------E----IRFPRTLS  219 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH---HH----HHHcC------C----CCCCCCCC
Confidence            89999999999999999999999999999999999999975432211   11    11000      0    11223345


Q ss_pred             HHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          286 ECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       286 ~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      ..+.+++.+||+.||.+||     ++.++++|.|+..
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            5678899999999999999     8999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-40  Score=304.42  Aligned_cols=225  Identities=26%  Similarity=0.281  Sum_probs=180.4

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ++|...+.||+|+||.||+|....+++.||+|.+....   ....+.+.+|+++++.++||||+++++++.+....    
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888899999999999999999889999999986432   23356688999999999999999998876553321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           ....++.|++.||+|||+   ++++||||||+|||++.++.+||+|||++......   
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---  154 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---  154 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence                                 125688999999999999   99999999999999999999999999998765432   


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                       .....|++.|+|||++.+..++.++|||||||++|||++|+.||.........   .    ....+.          ..
T Consensus       155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~---~----~i~~~~----------~~  216 (291)
T cd05612         155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY---E----KILAGK----------LE  216 (291)
T ss_pred             -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----HHHhCC----------cC
Confidence             22346899999999999888999999999999999999999999765422111   1    111110          11


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFE  316 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~  316 (387)
                      ++......+.+++.+||+.||.+||+     ++++++|.|+.
T Consensus       217 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  258 (291)
T cd05612         217 FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK  258 (291)
T ss_pred             CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence            22223456789999999999999995     99999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.6e-40  Score=304.98  Aligned_cols=244  Identities=21%  Similarity=0.257  Sum_probs=180.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      ++|...+.||+|+||.||+|+...++..||+|.+.... ......+.+|+++++.++||||+++++++.+...       
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888999999999999999999999999999986543 2234567899999999999999999987654321       


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~  160 (288)
T cd07871          85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTY  160 (288)
T ss_pred             CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-ccc
Confidence                              1235688999999999999   999999999999999999999999999987543321 122


Q ss_pred             eeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------HHhcc-Cchhhh
Q 043148          202 TVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW--------DLYGK-GQLLEA  271 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~-~~~~~~  271 (387)
                      ....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....        ..... ......
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            33467899999998875 558999999999999999999999997655433222211110        00000 000000


Q ss_pred             hcccCCc----cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          272 ADGRLSK----EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       272 ~~~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ..+....    .........+.+++.+|++.||.+|||++|+++|.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            1110000    0011234457899999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-40  Score=315.14  Aligned_cols=228  Identities=23%  Similarity=0.295  Sum_probs=190.9

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHHH--
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL--  142 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l--  142 (387)
                      .-|+..+.||.|+-|.|-+|++..+|+..|||++.+.   .........+|+-+|+.+.|||++++++++++..++++  
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4466788999999999999999999999999999765   23345667899999999999999999999988766543  


Q ss_pred             -----------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          143 -----------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       143 -----------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                             .+++.||+.|+.|+|.   .+|+||||||+|+|||..+++||+|||+|.....  +.
T Consensus        92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--gk  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP--GK  166 (786)
T ss_pred             EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC--Cc
Confidence                                   5899999999999999   8999999999999999999999999999975433  34


Q ss_pred             eeeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ...+.+|.+.|+|||++.+.+| +.++||||+|||||.|++|+.||++.+...       ....+..|          ..
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~-------LLlKV~~G----------~f  229 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV-------LLLKVQRG----------VF  229 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH-------HHHHHHcC----------cc
Confidence            5567789999999999999997 689999999999999999999998443221       11112222          22


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      +.+...+..+.+|+.+++..||.+|.|++||++|+|...
T Consensus       230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g  268 (786)
T KOG0588|consen  230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG  268 (786)
T ss_pred             cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence            445566777889999999999999999999999998654

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=288.13  Aligned_cols=226  Identities=26%  Similarity=0.338  Sum_probs=187.5

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHHH--
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL--  142 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l--  142 (387)
                      ++|+..+.||.|+||.|.+++.+.+|..+|+|++.+..   ....+...+|..+|+.+.||+++++++.|.+...+++  
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            45666889999999999999999999999999997653   2334567789999999999999999998887665432  


Q ss_pred             -----------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          143 -----------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       143 -----------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                             +-++.+|+.||+|||+   ++|++|||||+|||||.+|.+||+|||+++....    
T Consensus       124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~----  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG----  196 (355)
T ss_pred             eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC----
Confidence                                   5689999999999999   9999999999999999999999999999987654    


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ...+.+|||.|+|||++....|+.++|.|||||++|||+.|..||.........       +.+        +..  .-.
T Consensus       197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY-------~KI--------~~~--~v~  259 (355)
T KOG0616|consen  197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY-------EKI--------LEG--KVK  259 (355)
T ss_pred             cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH-------HHH--------HhC--ccc
Confidence            467789999999999999999999999999999999999999999876653221       111        111  123


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCC-----CCHHHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNR-----PSIRQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~R-----Ps~~evl~~l~~~~  317 (387)
                      ++......+.+|+...++.|-.+|     ...++|-.|.||..
T Consensus       260 fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  260 FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence            444455567888899999999999     45678888988753

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=301.74  Aligned_cols=237  Identities=22%  Similarity=0.252  Sum_probs=189.1

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--------------hhHHHHHHHHHHHhcCCCCCccc
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--------------QGKKEYISEVRIISRLRHRNLVH  129 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~  129 (387)
                      ....++|.....||+|.||.|-+|+...+++.||||++.+...              ...+...+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            3446889999999999999999999999999999999975421              12357889999999999999999


Q ss_pred             eehhhcchhh---------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcE
Q 043148          130 LIGWCHEQRQ---------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA  182 (387)
Q Consensus       130 l~~~~~~~~~---------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  182 (387)
                      |+++..+...                           ...++++.++..||+|||.   ++||||||||+|+||+++|.+
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcE
Confidence            9987654321                           1237899999999999999   999999999999999999999


Q ss_pred             EEccccccccccCC----CCceeeeeecCCcccCchhhccCC----CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 043148          183 KLGDFGLARLVDHE----LGSQTTVLAGTMGYLAPECVTTGK----ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR  254 (387)
Q Consensus       183 kl~Dfg~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~  254 (387)
                      ||+|||.+......    ........+|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||.+....+.. 
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~-  328 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF-  328 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH-
Confidence            99999999766322    112233468999999999887632    367899999999999999999999765432211 


Q ss_pred             HHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          255 LVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                                    .++....+.....++..+.+.+|+.++|..||+.|.+..+|..|+|....
T Consensus       329 --------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  329 --------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             --------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                          12233333333334567789999999999999999999999999996554

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.9e-40  Score=302.09  Aligned_cols=230  Identities=24%  Similarity=0.308  Sum_probs=180.2

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      |...+.||+|+||.||++.+..+++.||+|.+....   ......+.+|++++..++|+||+++++++.+...       
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            667789999999999999999899999999986542   2234567899999999999999999886644321       


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          .....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++......  .
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--E  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--C
Confidence                                1225688999999999999   99999999999999999999999999999765332  1


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||............   ......          ....
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~----------~~~~  223 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVKE----------DQEE  223 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhhc----------cccc
Confidence            223346899999999999999999999999999999999999999865433211111   111100          0112


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  317 (387)
                      ++...+..+.+++.+||+.||.+||+     ++++++|.|+..
T Consensus       224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~  266 (285)
T cd05631         224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN  266 (285)
T ss_pred             CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence            23334556889999999999999997     899999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=294.47  Aligned_cols=249  Identities=18%  Similarity=0.251  Sum_probs=192.0

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecC--CChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSR--GSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-----  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  138 (387)
                      ....|...+.||+|+||.|..+.++.+|..||||++..  ......++..+|+++|+.++|+||+.+.+.+....     
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            34566667899999999999999999999999999973  35666788999999999999999999998765411     


Q ss_pred             ------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          139 ------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       139 ------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                                              ......++.|+++||.|+|+   .+++||||||.|+|++.+..+||+|||+|+...
T Consensus       100 DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  100 DVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLD  176 (359)
T ss_pred             eeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeecc
Confidence                                    01125788999999999999   999999999999999999999999999999775


Q ss_pred             CC-CCceeeeeecCCcccCchhhc-cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH--------Hhc
Q 043148          195 HE-LGSQTTVLAGTMGYLAPECVT-TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWD--------LYG  264 (387)
Q Consensus       195 ~~-~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~--------~~~  264 (387)
                      .. .....+..+-|.+|.|||++. ...|+.+.||||.|||+.||++|+..|.+.+..++..++.....        .+.
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            42 122345677899999999876 45699999999999999999999999998876665554432211        111


Q ss_pred             cCchhhhh---cccCC---ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          265 KGQLLEAA---DGRLS---KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       265 ~~~~~~~~---~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .......+   .....   ...-+......++|+.++|..||.+|+|++|.++|+.+..
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~  315 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP  315 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence            11111111   00000   1111234455789999999999999999999999987654

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-39  Score=306.52  Aligned_cols=231  Identities=25%  Similarity=0.386  Sum_probs=176.0

Q ss_pred             hhCccccCcccccCceEEEEEEEC-----CCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLS-----DQNTEIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  139 (387)
                      .++|.+.+.||+|+||.||+|.+.     .++..||||++.... ......+.+|++++..+ +||||++++++|.....
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            467888999999999999999752     335679999987543 33456789999999999 89999999987653211


Q ss_pred             --------------------------------------------------------------------------------
Q 043148          140 --------------------------------------------------------------------------------  139 (387)
Q Consensus       140 --------------------------------------------------------------------------------  139 (387)
                                                                                                      
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence                                                                                            


Q ss_pred             --------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-ceeeeeecCCcc
Q 043148          140 --------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGY  210 (387)
Q Consensus       140 --------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y  210 (387)
                              ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....... .......+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence                    0113477899999999999   9999999999999999999999999999976533211 112223456789


Q ss_pred             cCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHH
Q 043148          211 LAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM  289 (387)
Q Consensus       211 ~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  289 (387)
                      +|||++.+..++.++||||||+++|||++ |..||.........      ......+..         ...+...+..+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF------CQRLKDGTR---------MRAPENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH------HHHHhcCCC---------CCCCCCCCHHHH
Confidence            99999998899999999999999999997 99999764432111      111111110         111223445688


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          290 IVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       290 ~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      +++.+||+.||.+|||+.|+++.|+.
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~  333 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGD  333 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHH
Confidence            99999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.1e-39  Score=298.94  Aligned_cols=240  Identities=23%  Similarity=0.335  Sum_probs=176.6

Q ss_pred             hCccccCcccccCceEEEEEEECC-CCeEEEEEEecCCC--hhhHHHHHHHHHHHhcC---CCCCccceehhhcch----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSD-QNTEIAVKRVSRGS--KQGKKEYISEVRIISRL---RHRNLVHLIGWCHEQ----  137 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~----  137 (387)
                      ++|...+.||+|+||.||+|++.. ++..||+|.+....  ......+.+|+.+++.+   +||||++++++|...    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            468888999999999999999854 46889999986542  22234566777777665   699999999876311    


Q ss_pred             ---------------------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccc
Q 043148          138 ---------------------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA  190 (387)
Q Consensus       138 ---------------------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~  190 (387)
                                                 ....+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence                                       011236789999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC---c
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG---Q  267 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~  267 (387)
                      +.....  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....   +.......   .
T Consensus       158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~---i~~~~~~~~~~~  232 (290)
T cd07862         158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIGLPGEED  232 (290)
T ss_pred             EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHHhCCCChhh
Confidence            765432  223345689999999999888899999999999999999999999987654332221   11111000   0


Q ss_pred             h-------hhhhcccCC---ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          268 L-------LEAADGRLS---KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       268 ~-------~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .       .........   ..........+.+++.+||+.||++|||+.|+++|.|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            0       000000000   01112234567899999999999999999999998874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.8e-40  Score=307.78  Aligned_cols=243  Identities=21%  Similarity=0.316  Sum_probs=180.0

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      +|.+.+.||+|+||.||+|+...++..||||.+...  .......+.+|+++++.++||||+++++++....        
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477888999999999999999999999999998643  2334567889999999999999999987653211        


Q ss_pred             ---------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          139 ---------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       139 ---------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                           ......++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence                                 11125789999999999999   999999999999999999999999999997543221


Q ss_pred             Cc--eeeeeecCCcccCchhhcc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc--------
Q 043148          198 GS--QTTVLAGTMGYLAPECVTT--GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGK--------  265 (387)
Q Consensus       198 ~~--~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------  265 (387)
                      ..  ......|++.|+|||++.+  ..++.++|||||||++|||++|+.||...........   +......        
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~  234 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL---ITDLLGTPSPETISR  234 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH---HHHHhCCCCHHHHHH
Confidence            11  1223468999999999875  5789999999999999999999999976543222111   1111100        


Q ss_pred             ---Cc---hhhhhcccCCcccc---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          266 ---GQ---LLEAADGRLSKEFD---ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       266 ---~~---~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                         ..   ....+.........   ......+.+++.+||+.||.+|||++|++++.|+..
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~  295 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG  295 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence               00   00001110000000   112345789999999999999999999999999754

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.3e-39  Score=300.77  Aligned_cols=246  Identities=21%  Similarity=0.288  Sum_probs=181.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      .++|...+.||+|+||.||+|+...+++.||||.+..... .....+.+|+.+++.++||||+++++++.+....     
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            4678999999999999999999998899999999865432 2345678899999999999999999876543221     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++....... ..
T Consensus        84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  159 (303)
T cd07869          84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HT  159 (303)
T ss_pred             CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-cc
Confidence                                236789999999999999   999999999999999999999999999987543221 12


Q ss_pred             eeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCch------hh--h
Q 043148          201 TTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL------LE--A  271 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~--~  271 (387)
                      .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.......  .....+.........      ..  .
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhhccc
Confidence            233457899999999875 458899999999999999999999998654321  111111111110000      00  0


Q ss_pred             hcc-cCC----ccccH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          272 ADG-RLS----KEFDE-----RQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       272 ~~~-~~~----~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ..+ ...    .....     .....+.+++.+|++.||.+|||+.|+++|.|+..-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence            000 000    00000     112457789999999999999999999999998653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-40  Score=307.75  Aligned_cols=234  Identities=21%  Similarity=0.264  Sum_probs=182.8

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ++|...+.||+|+||.||+|++..+++.||||++....   ......+.+|++++..++||||+++++++.+....    
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999999889999999986532   23356788999999999999999998876554321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           ....++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++.....    
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----  153 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence                                 125688999999999999   9999999999999999999999999999975433    


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+   ...   .   ..........
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~---~---~~~~~~~~~~  224 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL---KYW---K---ETLQRPVYDD  224 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH---Hhc---c---ccccCCCCCc
Confidence            223456899999999999989999999999999999999999999765432221111   000   0   0000000010


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .....+..+.+++.+||+.+|.+||++++++++.|+..
T Consensus       225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence            01234556788999999999999999999999998764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.2e-38  Score=337.39  Aligned_cols=239  Identities=25%  Similarity=0.434  Sum_probs=186.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI-----  141 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-----  141 (387)
                      ...|...+.||+|+||.||+|++..++..||||.+......    ...|++.+++++|||||+++|+|.+....+     
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            34577788999999999999999888999999998654322    234688999999999999999986644321     


Q ss_pred             -----------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          142 -----------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       142 -----------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                       ...++.|+++||+|||+.+.++++||||||+||+++.++..++. ||........     ...
T Consensus       765 ~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~  838 (968)
T PLN00113        765 IEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKC  838 (968)
T ss_pred             CCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCc
Confidence                             25789999999999996555899999999999999999988875 6655432211     123


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc--cccH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK--EFDE  282 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  282 (387)
                      .+++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+|..............++.+..  ..+.
T Consensus       839 ~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  917 (968)
T PLN00113        839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ  917 (968)
T ss_pred             cccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence            578899999999999999999999999999999999999954322 2234556665554444455555655533  2345


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          283 RQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .....+.+++.+||+.||++||||+||++.|+..
T Consensus       918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            5667788999999999999999999999999754

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.1e-39  Score=309.69  Aligned_cols=244  Identities=20%  Similarity=0.274  Sum_probs=184.0

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-----h--
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-----Q--  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~--  139 (387)
                      +|+..+.||+|+||.||++.+..+++.||||.+...  .....+.+.+|++++..++||||+++++++....     .  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            467788999999999999999888999999998653  2334567889999999999999999998775443     1  


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            ..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++......
T Consensus        81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence                                  1135788999999999999   999999999999999999999999999998654432


Q ss_pred             CceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh------
Q 043148          198 GSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE------  270 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------  270 (387)
                      ........+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+   ....+......      
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI---TDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHHcCCCCHHHHHHhhH
Confidence            2233344578899999998874 4799999999999999999999999866543322221   11111110000      


Q ss_pred             -----hhcccC-Cc------cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          271 -----AADGRL-SK------EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       271 -----~~~~~~-~~------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                           +..... ..      .........+.+++.+||+.||.+|||+.|+++|.|+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                 000000 00      1112234567899999999999999999999999987653

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.4e-39  Score=305.40  Aligned_cols=244  Identities=21%  Similarity=0.246  Sum_probs=184.7

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-----  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  138 (387)
                      ..++|...+.||+|+||.||++.+..+|..||||.+...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            458899999999999999999999989999999998653  3344567889999999999999999998764321     


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876          99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence                                   11235688999999999999   9999999999999999999999999999975433


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc--------
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ--------  267 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  267 (387)
                      .  .......+|+.|+|||++.+..++.++||||||+++|||++|+.||...+..+...   ..........        
T Consensus       176 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         176 N--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN---KVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             C--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCcHHHHHHHH
Confidence            2  12233467899999999999999999999999999999999999998654322111   1111000000        


Q ss_pred             --hhhhhc--ccCC----------------ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          268 --LLEAAD--GRLS----------------KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       268 --~~~~~~--~~~~----------------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                        ......  +...                ..........+.+++.+||+.||.+|||+.|+++|+|+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence              000000  0000                0011122456789999999999999999999999998754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.8e-39  Score=303.05  Aligned_cols=243  Identities=22%  Similarity=0.312  Sum_probs=183.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      .++|+..+.||+|+||.||++++..++..+|+|.+... .....+.+.+|++++.+++||||+++++++.+...      
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            36788999999999999999999999999999998754 23445679999999999999999999987654321      


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.+++.||.|||+.  .+|+||||||+|||++.++.+||+|||++......   .
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~  158 (331)
T cd06649          84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M  158 (331)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc---c
Confidence                               12357889999999999981  36999999999999999999999999998755332   2


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC--------------
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG--------------  266 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------------  266 (387)
                      .....|++.|+|||++.+..++.++||||||+++|||++|+.||......+.....   ......+              
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  235 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF---GRPVVDGEEGEPHSISPRPRP  235 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh---cccccccccCCccccCccccc
Confidence            22346899999999999889999999999999999999999999754322111100   0000000              


Q ss_pred             ----------------chhhhh----cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          267 ----------------QLLEAA----DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       267 ----------------~~~~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                                      ...+..    ...............+.+++.+||+.||++|||++++++|+|+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~  306 (331)
T cd06649         236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR  306 (331)
T ss_pred             ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence                            000000    000000011124556889999999999999999999999998764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-39  Score=290.92  Aligned_cols=248  Identities=22%  Similarity=0.264  Sum_probs=189.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCC-ccceehhhcchhh----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--QGKKEYISEVRIISRLRHRN-LVHLIGWCHEQRQ----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~----  139 (387)
                      ...|...++||+|.||+||+|+.+.+|+.||+|.++....  .......+|+.+|++|+|+| ||++++++...+.    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            3445667789999999999999999999999999976543  24566789999999999999 9999998766441    


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccc
Q 043148          140 ------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL  189 (387)
Q Consensus       140 ------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~  189 (387)
                                                    ..++.++.||+.||+|||+   ++|+||||||.||||+++|.+||+|||+
T Consensus        90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence                                          1347899999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCch
Q 043148          190 ARLVDHELGSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL  268 (387)
Q Consensus       190 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (387)
                      ++....+. ......+.|..|.|||++.+. .|+...||||+||++.||++++..|.+..+.++...+-.......+...
T Consensus       167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            99665432 234556789999999999887 5999999999999999999999999887764444333222111111100


Q ss_pred             ---hhh-----hcccCC--ccccHH---HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          269 ---LEA-----ADGRLS--KEFDER---QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       269 ---~~~-----~~~~~~--~~~~~~---~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                         ...     .-+...  ......   ......+++.+|++.+|.+|.|++.++.|..+...
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence               000     000010  011111   11357889999999999999999999999876543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.3e-39  Score=299.04  Aligned_cols=234  Identities=23%  Similarity=0.286  Sum_probs=187.8

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHHH
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL  142 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  142 (387)
                      ..++|+.++.||+|+||.||+++-+++|..+|+|++++..   ....+....|-.+|...++|+||+|+-.|.+...++|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999999999999999998764   3345677889999999999999999999988776554


Q ss_pred             -------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC--
Q 043148          143 -------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH--  195 (387)
Q Consensus       143 -------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~--  195 (387)
                                               +.++.+++.|+..||.   .|+|||||||+|+|||..|++||+||||+.-+..  
T Consensus       219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence                                     4567778889999998   9999999999999999999999999999853211  


Q ss_pred             ---------------------CCCc-----e------------------eeeeecCCcccCchhhccCCCCCccchHHHH
Q 043148          196 ---------------------ELGS-----Q------------------TTVLAGTMGYLAPECVTTGKASKESDVYSFG  231 (387)
Q Consensus       196 ---------------------~~~~-----~------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G  231 (387)
                                           +...     .                  ....+|||.|||||++.+..|+..+|.||+|
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                                 0000     0                  0134799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCcchhhHH-HHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCC---CHH
Q 043148          232 VVALEVACGRKPVEPRQEPSKVRLV-EWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRP---SIR  307 (387)
Q Consensus       232 vil~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP---s~~  307 (387)
                      ||+|||+.|.+||......+....+ .|...              +..........+..+||.+|+. ||.+|.   .++
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~  440 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAE  440 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence            9999999999999988766554333 22211              1111112223567889999998 999996   599


Q ss_pred             HHHHHhccCC
Q 043148          308 QVINVLNFEA  317 (387)
Q Consensus       308 evl~~l~~~~  317 (387)
                      ||-+|++|..
T Consensus       441 EIK~HPfF~~  450 (550)
T KOG0605|consen  441 EIKKHPFFKG  450 (550)
T ss_pred             HHhcCCcccc
Confidence            9999999764

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.5e-39  Score=303.62  Aligned_cols=249  Identities=20%  Similarity=0.220  Sum_probs=185.6

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh----
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----  138 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  138 (387)
                      ...++|...+.||+|+||.||++.+..+++.||||.+...  .......+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3457899999999999999999999888999999998754  2334567889999999999999999998764321    


Q ss_pred             ------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          139 ------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       139 ------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                                              ...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence                                    11125688999999999999   999999999999999999999999999997654


Q ss_pred             CCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH----------------
Q 043148          195 HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW----------------  258 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~----------------  258 (387)
                      ..  .......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+.......                
T Consensus       171 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (355)
T cd07874         171 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_pred             Cc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence            32  122334689999999999988999999999999999999999999976543221111000                


Q ss_pred             HHHHhccC-ch-----hhhhcccC---CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          259 VWDLYGKG-QL-----LEAADGRL---SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       259 ~~~~~~~~-~~-----~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ........ ..     ........   ...........+.+++.+|++.||.+|||+.|+++|+|+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence            00000000 00     00000000   011112234567899999999999999999999999987643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=308.47  Aligned_cols=232  Identities=24%  Similarity=0.360  Sum_probs=193.5

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  139 (387)
                      ....++|...+.||+|.||+|+++.++.+++.+|||.+++.   ...+.+..+.|.+++... +||.+++++..|....+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            34457899999999999999999999999999999999886   345677888999998877 59999999998877655


Q ss_pred             HHH------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 LIL------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ~~l------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                      +++                        +-++..|+.||.|||+   ++||+||||.+|||||.+|.+||+|||+++..- 
T Consensus       444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-  519 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-  519 (694)
T ss_pred             EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccC-
Confidence            432                        5688899999999999   999999999999999999999999999998533 


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      ..+..+.+.+|||.|||||++.+..|+.++|.|||||+||||+.|+.||.+.++.+.-+.+               +.. 
T Consensus       520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI---------------~~d-  583 (694)
T KOG0694|consen  520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI---------------VND-  583 (694)
T ss_pred             CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---------------hcC-
Confidence            2345778899999999999999999999999999999999999999999987755432211               100 


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFE  316 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~  316 (387)
                       ...++...+.+...++.+.+..+|++|.-     +++|.+|+.|.
T Consensus       584 -~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr  628 (694)
T KOG0694|consen  584 -EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFR  628 (694)
T ss_pred             -CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccc
Confidence             12344556667888999999999999985     57888888764

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.5e-39  Score=299.97  Aligned_cols=223  Identities=26%  Similarity=0.319  Sum_probs=175.8

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----------  140 (387)
                      +.||+|+||.||++....+|..||+|.+...   .......+.+|+++++.++||||+++++++......          
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3699999999999999989999999998653   233455678899999999999999998876543221          


Q ss_pred             ---------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeee
Q 043148          141 ---------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA  205 (387)
Q Consensus       141 ---------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  205 (387)
                                     .+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++...... ........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~  156 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFC  156 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcccccc
Confidence                           236788999999999999   99999999999999999999999999998743221 11223456


Q ss_pred             cCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHH
Q 043148          206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM  285 (387)
Q Consensus       206 g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (387)
                      |++.|+|||++.+..++.++|||||||++|||++|+.||...........       ....      .    ..++....
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~-------~~~~------~----~~~p~~~~  219 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-------ILME------E----IRFPRTLS  219 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-------HhcC------C----CCCCCCCC
Confidence            89999999999988999999999999999999999999975443211110       0000      0    01222344


Q ss_pred             HHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          286 ECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       286 ~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      ..+.+++.+||+.||.+||     ++.++++|.|+..
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence            5678899999999999998     8999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.3e-38  Score=303.41  Aligned_cols=244  Identities=20%  Similarity=0.245  Sum_probs=185.2

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-----  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  138 (387)
                      ..++|...+.||+|+||.||++.+..+++.||||++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            457899999999999999999999988999999998754  2344567889999999999999999988654321     


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             CeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence                                   11235789999999999999   9999999999999999999999999999976543


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc----------
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGK----------  265 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------  265 (387)
                      ..  ......++..|+|||++.+..++.++|||||||++|||++|+.||......+....+   ......          
T Consensus       179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  253 (364)
T cd07875         179 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV---IEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             CC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCCHHHHHhhh
Confidence            21  223346889999999999999999999999999999999999999765433221111   110000          


Q ss_pred             ---------C-c-----hhhhhccc---CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          266 ---------G-Q-----LLEAADGR---LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       266 ---------~-~-----~~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                               . .     ..+.....   ............+.+++.+|++.||.+|||+.|+++|.|+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                     0 0     00000000   001111122346789999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.5e-39  Score=299.56  Aligned_cols=230  Identities=24%  Similarity=0.411  Sum_probs=177.3

Q ss_pred             hCccccCcccccCceEEEEEEECCCCe----EEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNT----EIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      .+|+..+.||+|+||.||+|++..++.    .||+|.+.... ....+++.+|+.+++.++||||++++|+|.....   
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v   86 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   86 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence            568889999999999999999865554    38999986543 3456788999999999999999999998754321   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            ..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++......
T Consensus        87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence                                  1235788999999999999   999999999999999999999999999998665432


Q ss_pred             Cce-eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          198 GSQ-TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       198 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      ... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+.       ......+.        
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~--------  228 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGE--------  228 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHhCCC--------
Confidence            211 112234568999999999999999999999999999998 9999975432211       11111110        


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                       ....+..+...+.+++.+||+.||.+||++.+++..+...
T Consensus       229 -~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         229 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             0011122334578899999999999999999999988644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.8e-39  Score=313.59  Aligned_cols=239  Identities=21%  Similarity=0.302  Sum_probs=177.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcch---------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ---------  137 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  137 (387)
                      .++|...+.||+|+||.||+|....+++.||||.+....    ....+|+.+|+.++||||+++++++...         
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999999889999999885432    2345799999999999999987654211         


Q ss_pred             ------------h---------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC-cEEEccccc
Q 043148          138 ------------R---------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF-NAKLGDFGL  189 (387)
Q Consensus       138 ------------~---------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfg~  189 (387)
                                  -               ...+..++.|++.||.|||+   ++|+||||||+|||++.++ .+||+|||+
T Consensus       141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecccc
Confidence                        0               01225678899999999999   9999999999999999665 699999999


Q ss_pred             cccccCCCCceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCch
Q 043148          190 ARLVDHELGSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL  268 (387)
Q Consensus       190 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (387)
                      ++......  ......|++.|+|||++.+. .++.++|||||||++|||++|..||.+....+....+   .........
T Consensus       218 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i---~~~~~~p~~  292 (440)
T PTZ00036        218 AKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI---IQVLGTPTE  292 (440)
T ss_pred             chhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCCH
Confidence            98654321  22334679999999998764 6899999999999999999999999875543322211   111111000


Q ss_pred             ----------hh-----hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          269 ----------LE-----AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       269 ----------~~-----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                                .+     .....+...++...+..+.+|+.+||+.||.+|||+.|+++|.|+..
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD  356 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence                      00     00001111122234456889999999999999999999999999754

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.2e-40  Score=294.98  Aligned_cols=226  Identities=24%  Similarity=0.399  Sum_probs=187.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHHH-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-  142 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l-  142 (387)
                      ..+|++.+.||+|.||.|-+|+....|+.||||.+++.   +.++.-.+.+|+++|+.|+||||+.++++|++.+..++ 
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            35688888999999999999999888999999999876   34555567899999999999999999999987654322 


Q ss_pred             ------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          143 ------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       143 ------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                              +.++.||.+|+.|+|.   ++++|||||.+|||+|.|+++||+|||++..+...  
T Consensus       132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--  206 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--  206 (668)
T ss_pred             EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc--
Confidence                                    6899999999999999   99999999999999999999999999999877653  


Q ss_pred             ceeeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      .....++|++-|.+||++.+.+| ++.+|-|||||+||-|+.|..||++.+....+..+       ..+...        
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI-------s~GaYr--------  271 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI-------SRGAYR--------  271 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh-------hccccc--------
Confidence            34567899999999999999987 68999999999999999999999887643222211       111111        


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                         .+..+....-|+.|+|..||.+|-|+.+|..|.|.
T Consensus       272 ---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  272 ---EPETPSDASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             ---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence               11122335668999999999999999999999874

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-39  Score=299.67  Aligned_cols=221  Identities=23%  Similarity=0.273  Sum_probs=174.9

Q ss_pred             ccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------------
Q 043148           76 LGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------------  140 (387)
Q Consensus        76 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------------  140 (387)
                      ||+|+||.||++++..+++.||+|.+...   .......+.+|+.++..++||||+++++++.+....            
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999999999999998653   233456788999999999999999998877553221            


Q ss_pred             -------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecC
Q 043148          141 -------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT  207 (387)
Q Consensus       141 -------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~  207 (387)
                                   ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... .......||
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt  156 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT  156 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence                         125688999999999999   999999999999999999999999999987533221 223345689


Q ss_pred             CcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHH
Q 043148          208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMEC  287 (387)
Q Consensus       208 ~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (387)
                      +.|+|||++.+..++.++|||||||++|||++|+.||........      ..... ..          ...++......
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~~~~~-~~----------~~~~~~~~~~~  219 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------YRKIL-QE----------PLRFPDGFDRD  219 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------HHHHH-cC----------CCCCCCcCCHH
Confidence            999999999999999999999999999999999999975432211      11111 10          11222334456


Q ss_pred             HHHHHHHhcCCCCCCCC---CHHHHHHHhccCC
Q 043148          288 LMIVGLWCCHPDFTNRP---SIRQVINVLNFEA  317 (387)
Q Consensus       288 l~~l~~~cl~~dp~~RP---s~~evl~~l~~~~  317 (387)
                      +.+++.+||+.||.+||   ++.|++.|+|+..
T Consensus       220 ~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~  252 (312)
T cd05585         220 AKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ  252 (312)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence            78899999999999997   5799999998764

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.6e-39  Score=299.85  Aligned_cols=223  Identities=25%  Similarity=0.312  Sum_probs=175.8

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----------  140 (387)
                      +.||+|+||.||+++...++..||+|++...   .......+.+|+++++.++||||+++++++.+....          
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999999999999999999754   233456788999999999999999998776543221          


Q ss_pred             ---------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeee
Q 043148          141 ---------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA  205 (387)
Q Consensus       141 ---------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  205 (387)
                                     .+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... ........
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~  156 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFC  156 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccccccc
Confidence                           225789999999999999   99999999999999999999999999998753222 11223456


Q ss_pred             cCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHH
Q 043148          206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM  285 (387)
Q Consensus       206 g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (387)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||.........       ......      +    ..++....
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-------~~~~~~------~----~~~p~~~~  219 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILME------D----IKFPRTLS  219 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-------HHhccC------C----ccCCCCCC
Confidence            899999999999889999999999999999999999999754322111       111000      0    11222334


Q ss_pred             HHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          286 ECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       286 ~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      ..+.+++.+||+.||.+||     ++.++++|.|+..
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            5678899999999999997     8999999988754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.5e-38  Score=302.72  Aligned_cols=241  Identities=22%  Similarity=0.275  Sum_probs=188.0

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-C-----CCccceehhhcchhhHH-
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-H-----RNLVHLIGWCHEQRQLI-  141 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~-  141 (387)
                      +|.+.+.||+|.||.|.++.+..+++.||||+++.. ..-..+-+.|+.+|..|+ |     -|+|+++++|...++.+ 
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            788999999999999999999999999999999764 333566678999999996 4     39999999987655443 


Q ss_pred             -------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC--cEEEcccccccccc
Q 043148          142 -------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF--NAKLGDFGLARLVD  194 (387)
Q Consensus       142 -------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~--~~kl~Dfg~~~~~~  194 (387)
                                               ++.++.||+.||.+||+   .+|||+||||+||||..-.  .+||+|||.+....
T Consensus       266 VfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~  342 (586)
T KOG0667|consen  266 VFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES  342 (586)
T ss_pred             eehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence                                     37899999999999998   9999999999999997543  69999999998665


Q ss_pred             CCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH--------H----
Q 043148          195 HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWD--------L----  262 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~--------~----  262 (387)
                      ..    ......+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+..+-++...+..+..        .    
T Consensus       343 q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~  418 (586)
T KOG0667|consen  343 QR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA  418 (586)
T ss_pred             Cc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence            43    2256678899999999999999999999999999999999988988777666554433211        0    


Q ss_pred             ---hcc-Cch------hh----------------hhcc-cCC-------ccccHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 043148          263 ---YGK-GQL------LE----------------AADG-RLS-------KEFDERQMECLMIVGLWCCHPDFTNRPSIRQ  308 (387)
Q Consensus       263 ---~~~-~~~------~~----------------~~~~-~~~-------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~e  308 (387)
                         +.. ...      .+                ..+. +..       .......-..+.+++.+|+.+||.+|+|..+
T Consensus       419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q  498 (586)
T KOG0667|consen  419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ  498 (586)
T ss_pred             ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence               000 000      00                0000 000       0111133456799999999999999999999


Q ss_pred             HHHHhccCC
Q 043148          309 VINVLNFEA  317 (387)
Q Consensus       309 vl~~l~~~~  317 (387)
                      +++|.|+..
T Consensus       499 al~Hpfl~~  507 (586)
T KOG0667|consen  499 ALNHPFLTG  507 (586)
T ss_pred             HhcCccccc
Confidence            999999763

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.3e-39  Score=304.38  Aligned_cols=233  Identities=22%  Similarity=0.243  Sum_probs=180.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      ++|...+.||+|+||.||+++...++..||+|.+....   ....+.+.+|+.++..++||||+++++++.+...     
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999999999999999997542   2345678899999999999999999887654321     


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence                                 1235688999999999999   9999999999999999999999999999986654333


Q ss_pred             ceeeeeecCCcccCchhhc------cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          199 SQTTVLAGTMGYLAPECVT------TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                      .......||+.|+|||++.      ...++.++|||||||++|||++|+.||.........      ...........  
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~~--  229 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY------NNIMNFQRFLK--  229 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH------HHHHcCCCccC--
Confidence            2333456899999999986      456789999999999999999999999765432111      11111110000  


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                           .......+..+.+++..|++ +|.+||+++++++|.|+..
T Consensus       230 -----~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         230 -----FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence                 00111234557788999998 9999999999999998764

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.6e-38  Score=292.25  Aligned_cols=232  Identities=17%  Similarity=0.283  Sum_probs=176.9

Q ss_pred             CccCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhh---HHHHHHHHHHHhcCCCCCccceeh
Q 043148           56 KRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQG---KKEYISEVRIISRLRHRNLVHLIG  132 (387)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~  132 (387)
                      +.++.+++..     .....||+|++|.||+|.+  +|+.||||.++......   .+.+.+|+++|.+++||||++++|
T Consensus        13 ~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g   85 (283)
T PHA02988         13 KCIESDDIDK-----YTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG   85 (283)
T ss_pred             eecCHHHcCC-----CCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence            4455555522     2235799999999999998  58899999997653322   467889999999999999999999


Q ss_pred             hhcc--hh--hH-------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEE
Q 043148          133 WCHE--QR--QL-------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAK  183 (387)
Q Consensus       133 ~~~~--~~--~~-------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  183 (387)
                      ++.+  ..  ..                         ....++.+++.||.|||+.  .+++||||||+|||+++++.+|
T Consensus        86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~k  163 (283)
T PHA02988         86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLK  163 (283)
T ss_pred             eEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEE
Confidence            8765  11  11                         1157889999999999972  4788999999999999999999


Q ss_pred             EccccccccccCCCCceeeeeecCCcccCchhhcc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 043148          184 LGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT--GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWD  261 (387)
Q Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~  261 (387)
                      |+|||+++.....    .....++..|+|||++.+  ..++.++|||||||++|||++|+.||......+..   ..+  
T Consensus       164 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~---~~i--  234 (283)
T PHA02988        164 IICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY---DLI--  234 (283)
T ss_pred             EcccchHhhhccc----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH---HHH--
Confidence            9999998765432    123457889999999976  67999999999999999999999999865422111   110  


Q ss_pred             HhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          262 LYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                       ...         ......+...+..+.+++.+||+.||.+|||++|+++.|..
T Consensus       235 -~~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        235 -INK---------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             -Hhc---------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence             000         01111222345668899999999999999999999998863

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.1e-38  Score=305.67  Aligned_cols=233  Identities=21%  Similarity=0.259  Sum_probs=175.5

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      .|...+.||+|+||.||+|++..+++.||||++....   ......+.+|++++..++||||+++++++.+....     
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999999999999999996532   23456788999999999999999999877654322     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC--
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG--  198 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~--  198 (387)
                                          ....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++........  
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence                                125678899999999999   9999999999999999999999999999754311000  


Q ss_pred             --------------------------------------------ceeeeeecCCcccCchhhccCCCCCccchHHHHHHH
Q 043148          199 --------------------------------------------SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVA  234 (387)
Q Consensus       199 --------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil  234 (387)
                                                                  .......||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                        001134689999999999988899999999999999


Q ss_pred             HHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHH--hcCCCCCCCCCHHHHHHH
Q 043148          235 LEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLW--CCHPDFTNRPSIRQVINV  312 (387)
Q Consensus       235 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dp~~RPs~~evl~~  312 (387)
                      |||++|+.||..........      ......       ..+...........+.+++.+  |+..+|..||+++++++|
T Consensus       239 ~elltG~~Pf~~~~~~~~~~------~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQL------KVINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHH------HHHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            99999999997654322111      000000       000000111123445666666  666777779999999999


Q ss_pred             hccCC
Q 043148          313 LNFEA  317 (387)
Q Consensus       313 l~~~~  317 (387)
                      .|+..
T Consensus       306 p~f~~  310 (381)
T cd05626         306 PFFSE  310 (381)
T ss_pred             cccCC
Confidence            98754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.4e-39  Score=299.82  Aligned_cols=227  Identities=24%  Similarity=0.321  Sum_probs=175.8

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHH---hcCCCCCccceehhhcchhhH---
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRII---SRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      |.+.+.||+|+||.||+|.+..+++.||||.+....   ....+.+..|++++   ..++||||+++++++.+....   
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            566789999999999999999999999999996532   22345566676655   567899999999877553321   


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           ....++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++..... ..
T Consensus        81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~  156 (324)
T cd05589          81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GD  156 (324)
T ss_pred             EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CC
Confidence                                 225789999999999999   99999999999999999999999999998643222 12


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+...      . +....          ..
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~------~-i~~~~----------~~  219 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------S-IVNDE----------VR  219 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH------H-HHhCC----------CC
Confidence            2334568999999999999899999999999999999999999997654321111      0 10100          11


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      .+...+..+.+++.+||+.||.+||     ++.+++++.|+..
T Consensus       220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         220 YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence            2223345578899999999999999     6999999988754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-39  Score=305.72  Aligned_cols=233  Identities=21%  Similarity=0.259  Sum_probs=182.3

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ++|...+.||+|+||.||+|+...+++.||||++....   ......+..|++++..++||||+++++++.+....    
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999999889999999986532   23456788999999999999999998877553321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC--
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL--  197 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--  197 (387)
                                           .+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++.......  
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence                                 225688999999999999   999999999999999999999999999997654432  


Q ss_pred             --------------------------CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 043148          198 --------------------------GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPS  251 (387)
Q Consensus       198 --------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~  251 (387)
                                                ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                      112234568999999999999999999999999999999999999998655221


Q ss_pred             hhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHhccCC
Q 043148          252 KVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPS-IRQVINVLNFEA  317 (387)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~evl~~l~~~~  317 (387)
                      ...      ......       ..+........+..+.+++..|++ ||.+||+ ++++++|+|+..
T Consensus       238 ~~~------~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         238 TYN------KIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             HHH------HHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            111      110000       000000011135567889999998 9999999 999999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=305.57  Aligned_cols=227  Identities=25%  Similarity=0.421  Sum_probs=192.0

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-------  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-------  140 (387)
                      .+....++||-|.||.||.|.|+.-...||||.++.. .-..++|+.|+.+|+.++|||+|+|+|+|..+..+       
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            4566778999999999999999999999999999654 44578999999999999999999999999765432       


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          +|++++.||..|++||..   +.+|||||.++|+|+.++..+|++|||+++++..+....
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence                                347899999999999998   999999999999999999999999999999987654433


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      .....-++.|.|||.+....++-|+|||+|||+|||+.| |..||.+.+...                ...++.....-+
T Consensus       423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq----------------VY~LLEkgyRM~  486 (1157)
T KOG4278|consen  423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYGLLEKGYRMD  486 (1157)
T ss_pred             ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH----------------HHHHHhcccccc
Confidence            333344678999999999999999999999999999988 999998755322                222333444555


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      -++.++..+.+|++.||+++|.+||++.|+.+.++
T Consensus       487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            67778888999999999999999999999988764

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-38  Score=300.18  Aligned_cols=243  Identities=20%  Similarity=0.298  Sum_probs=182.2

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchh----
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----  138 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  138 (387)
                      ...++|...+.||+|+||.||+|.+..++..||||.+....  ......+.+|+++++.++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            45678999999999999999999998889999999986542  233456789999999999999999998764321    


Q ss_pred             -------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          139 -------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       139 -------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                                               ...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          92 FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             cCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceec
Confidence                                     11236789999999999999   99999999999999999999999999999865


Q ss_pred             cCCCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc-----
Q 043148          194 DHELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ-----  267 (387)
Q Consensus       194 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  267 (387)
                      ...    .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+...   ..........     
T Consensus       169 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~  241 (343)
T cd07878         169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK---RIMEVVGTPSPEVLK  241 (343)
T ss_pred             CCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHHhCCCCHHHHH
Confidence            432    233468999999999876 568999999999999999999999997654322111   1111110000     


Q ss_pred             ------hhhhhc--ccCCc----cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          268 ------LLEAAD--GRLSK----EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       268 ------~~~~~~--~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                            ......  +....    .........+.+++.+|++.||.+|||+.|+++|.|+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~  303 (343)
T cd07878         242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ  303 (343)
T ss_pred             hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence                  000000  00000    000012234678999999999999999999999999865

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=281.38  Aligned_cols=234  Identities=26%  Similarity=0.298  Sum_probs=187.8

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH--
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI--  141 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~--  141 (387)
                      ..+.|++.+.||+|.|+.||+.....+|+.+|+|++...  +..+.+++.+|+++-+.|+|||||++.+.+.+....+  
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            456677788999999999999999999999999988543  4456788999999999999999999988665543221  


Q ss_pred             -----------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC---CcEEEccccccccccC
Q 043148          142 -----------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN---FNAKLGDFGLARLVDH  195 (387)
Q Consensus       142 -----------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kl~Dfg~~~~~~~  195 (387)
                                             ......||+.+|.|+|.   ++|+|||+||+|+++...   --+||+|||++.... 
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-  164 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence                                   14678999999999999   999999999999999643   358999999998776 


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                       .+......+|||+|||||++...+|+..+|||+.||+||-|+.|+.||.+.+...   +.+    .+..+.      -.
T Consensus       165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---lye----~I~~g~------yd  230 (355)
T KOG0033|consen  165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYE----QIKAGA------YD  230 (355)
T ss_pred             -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---HHH----HHhccc------cC
Confidence             2344556789999999999999999999999999999999999999998644321   211    111111      11


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ......+...+...+|+.+||..||.+|.|+.|.++|+|...
T Consensus       231 ~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  231 YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            223334456667889999999999999999999999999643

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-38  Score=299.42  Aligned_cols=233  Identities=24%  Similarity=0.234  Sum_probs=177.9

Q ss_pred             CccccCcccccCceEEEEEEEC---CCCeEEEEEEecCC----ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh-
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLS---DQNTEIAVKRVSRG----SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ-  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-  139 (387)
                      +|...+.||+|+||.||+++..   .++..||+|++.+.    .....+.+..|++++..+ +||||+++++++.+... 
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4778899999999999998864   46789999998643    123345678899999999 59999999876644321 


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                              ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence                                    1235688899999999999   9999999999999999999999999999976544


Q ss_pred             CCCceeeeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      ..........||+.|+|||++.+.. ++.++|||||||++|||++|+.||............   ......      .++
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~---~~~~~~------~~~  228 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV---SRRILK------CDP  228 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH---HHHHhc------CCC
Confidence            3333333457899999999998654 789999999999999999999999754332221111   111100      111


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                          ..+......+.+++.+||+.||++||     +++++++|.|+..
T Consensus       229 ----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         229 ----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence                12223445578899999999999999     8899999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.2e-39  Score=300.34  Aligned_cols=222  Identities=25%  Similarity=0.332  Sum_probs=168.8

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHH-HHhcCCCCCccceehhhcchhhH---------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVR-IISRLRHRNLVHLIGWCHEQRQL---------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~---------  140 (387)
                      +.||+|+||.||+|++..++..||+|++.+..   ......+..|.. +++.++||||+++++++.+....         
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999999999999999986532   222344555554 57889999999998876543211         


Q ss_pred             ----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          141 ----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 ----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                      .+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  156 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTF  156 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccccc
Confidence                            125688999999999999   999999999999999999999999999987532221 122345


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .|++.|+|||.+.+..++.++|||||||++|||++|+.||...+...   ...   ... ..          ....+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~---~i~-~~----------~~~~~~~~  219 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYD---NIL-HK----------PLQLPGGK  219 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHH---HHh-cC----------CCCCCCCC
Confidence            68999999999998889999999999999999999999997643211   111   111 10          01122233


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCH----HHHHHHhccC
Q 043148          285 MECLMIVGLWCCHPDFTNRPSI----RQVINVLNFE  316 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs~----~evl~~l~~~  316 (387)
                      ...+.+++.+||+.||.+||+.    .++++++++.
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~  255 (321)
T cd05603         220 TVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFS  255 (321)
T ss_pred             CHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcC
Confidence            4567889999999999999864    5888888764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.6e-38  Score=295.20  Aligned_cols=235  Identities=27%  Similarity=0.419  Sum_probs=175.5

Q ss_pred             hCccccCcccccCceEEEEEEECC----------------CCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccce
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSD----------------QNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHL  130 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  130 (387)
                      ++|...+.||+|+||.||++.+..                ++..||+|.+.... .....++.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578888999999999999998643                34579999987643 3445689999999999999999999


Q ss_pred             ehhhcchhhH--------------------------------------------HHHHHHHHHHHHHHHhhhhcccceee
Q 043148          131 IGWCHEQRQL--------------------------------------------ILHKIALGLASAVLYLHEEWEQCIVH  166 (387)
Q Consensus       131 ~~~~~~~~~~--------------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH  166 (387)
                      ++++.+....                                            .+..++.|++.||.|||+   .+++|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence            9876542211                                            134689999999999999   99999


Q ss_pred             ccCCcceeEeCCCCcEEEccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh--CCCC
Q 043148          167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC--GRKP  243 (387)
Q Consensus       167 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t--g~~p  243 (387)
                      |||||+|||++.++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999765432211 1122345778999999988889999999999999999986  5677


Q ss_pred             CCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          244 VEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      |.......   ....+.........      ......+..++..+.+++.+||+.||.+|||+.+|.+.|.
T Consensus       242 ~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQ---VIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHH---HHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            76544322   12222111111100      0001112234456889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=307.59  Aligned_cols=231  Identities=28%  Similarity=0.414  Sum_probs=181.4

Q ss_pred             hCccccCcccccCceEEEEEEECCCCe---E-EEEEEecC---CChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNT---E-IAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  140 (387)
                      ++-...++||+|+||.||+|.++..+.   . ||||..+.   .......+|++|+++|++++|||||+++|++......
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            444456899999999999999865422   3 89999875   3466788999999999999999999999988765543


Q ss_pred             HH--------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          141 IL--------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       141 ~l--------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                      ++                          ..++.+.|.||+|||+   ++++||||.++|+|++.++.+||+|||+++...
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            32                          5789999999999999   999999999999999999999999999987543


Q ss_pred             CCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          195 HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ... .......-+..|+|||.+....|+.++|||||||++||+++ |..||.+....+...   ++            ..
T Consensus       314 ~~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~---kI------------~~  377 (474)
T KOG0194|consen  314 QYV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA---KI------------VK  377 (474)
T ss_pred             cee-eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH---HH------------Hh
Confidence            111 11111235679999999999999999999999999999998 889998776442211   11            11


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .......+...+..+..++..||..+|++||+|.++.+.+....
T Consensus       378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~  421 (474)
T KOG0194|consen  378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE  421 (474)
T ss_pred             cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence            11222233355666778888999999999999999999887443

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.4e-39  Score=303.33  Aligned_cols=227  Identities=25%  Similarity=0.319  Sum_probs=180.0

Q ss_pred             hhCccccCcccccCceEEEEEEECCCC-eEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQN-TEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      .++|...+.||+|+||.||+|.+..++ ..||+|.+...   .....+.+.+|++++..++||||+++++++.+....  
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            456888999999999999999876554 68999998643   223356788999999999999999999887654322  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                             ....++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++...... 
T Consensus       109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence                                   125788999999999999   99999999999999999999999999999765432 


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||........   .    .....+.          
T Consensus       185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~----~~i~~~~----------  244 (340)
T PTZ00426        185 ---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---Y----QKILEGI----------  244 (340)
T ss_pred             ---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---H----HHHhcCC----------
Confidence               2345689999999999988899999999999999999999999976442211   1    1111111          


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      ..++......+.+++.+|++.||.+|+     +++++++|+|+..
T Consensus       245 ~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        245 IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            011222344577899999999999995     8999999999764

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-39  Score=304.83  Aligned_cols=226  Identities=28%  Similarity=0.455  Sum_probs=188.0

Q ss_pred             cccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--------------
Q 043148           75 KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--------------  140 (387)
Q Consensus        75 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--------------  140 (387)
                      .||+|.||+||-|++..+...+|||-+...+....+-+..|+.+.+.|+|.|||+++|.|.++...              
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            699999999999999999999999999877777778899999999999999999999998765432              


Q ss_pred             --------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC-CCCcEEEccccccccccCCCCceeeeee
Q 043148          141 --------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD-SNFNAKLGDFGLARLVDHELGSQTTVLA  205 (387)
Q Consensus       141 --------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  205 (387)
                                    .+-.+..||++||.|||+   +.|+|||||-+||||+ -.|.+||+|||-++.+..- ...+..+.
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFT  737 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFT  737 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC-Cccccccc
Confidence                          224578999999999999   9999999999999997 5788999999998765432 23455678


Q ss_pred             cCCcccCchhhccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          206 GTMGYLAPECVTTGK--ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       206 g~~~y~aPE~~~~~~--~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      ||+-|||||++..++  |+.++|||||||++.||.||++||.....+.-.              +.++---...+..+.+
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------------MFkVGmyKvHP~iPee  803 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------------MFKVGMYKVHPPIPEE  803 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------------hhhhcceecCCCCcHH
Confidence            999999999998654  899999999999999999999999876544210              1111111234567788


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .......++++|+.+||.+||++.++++.++....
T Consensus       804 lsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  804 LSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            88999999999999999999999999998775543

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=296.31  Aligned_cols=229  Identities=25%  Similarity=0.387  Sum_probs=186.0

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCChh---hHHHHHHHHHHHhcCCCCCccceehhhcchhhHH----
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ---GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----  141 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----  141 (387)
                      .|..++.||.|+||.||-|++..+...||||.++....+   ..++++.|++.|.+++|||++.+-|++..+...+    
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            356677899999999999999999999999999876443   4578889999999999999999988775543322    


Q ss_pred             ---------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          142 ---------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       142 ---------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                           +..|+.+.+.||+|||+   .+.||||||+.|||+.+.|.+||+|||.+....+     
T Consensus       107 YClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----  178 (948)
T KOG0577|consen  107 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----  178 (948)
T ss_pred             HHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence                                 24688999999999999   9999999999999999999999999999876543     


Q ss_pred             eeeeecCCcccCchhhc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          201 TTVLAGTMGYLAPECVT---TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      ...++|||.|||||++.   .+.|+-++||||||++..||.-+++|+..++..+-..      .      +...-.|.+ 
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY------H------IAQNesPtL-  245 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------H------IAQNESPTL-  245 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH------H------HHhcCCCCC-
Confidence            44678999999999975   5789999999999999999999999987655322111      1      111111222 


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLP  320 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  320 (387)
                        -..+.+..+.+++..||+.-|.+|||.++++.|.+.....|
T Consensus       246 --qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  246 --QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             --CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence              24566778999999999999999999999999987655443

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-38  Score=289.04  Aligned_cols=229  Identities=24%  Similarity=0.371  Sum_probs=176.7

Q ss_pred             hhCccccCcccccCceEEEEEEEC---CCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLS---DQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      .++|...+.||+|+||.||+|.+.   ..+..||+|.++... ......+.+|+.++..++||||+++++++......  
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356788899999999999999875   346789999987653 33456789999999999999999999986553222  


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          141 ------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       141 ------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                              .+..++.|++.||+|||+   ++++||||||+|||++.++.+|++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence                                    236789999999999999   99999999999999999999999999987643322


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .........++..|+|||.+.+..++.++||||||+++||+++ |+.||......+.   ..    ...++         
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~----~~~~~---------  224 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IK----AVEDG---------  224 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH----HHHCC---------
Confidence            1111122334678999999999999999999999999999875 9999976543221   11    11111         


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .....+..++..+.+++..||+.+|.+||++++|++.|.
T Consensus       225 ~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~  263 (266)
T cd05064         225 FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILS  263 (266)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence            111123335566889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-38  Score=297.56  Aligned_cols=223  Identities=24%  Similarity=0.329  Sum_probs=173.4

Q ss_pred             CcccccCceEEEEEEEC---CCCeEEEEEEecCC----ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------
Q 043148           74 GKLGEGGFGGVYRGLLS---DQNTEIAVKRVSRG----SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------  140 (387)
                      +.||+|+||.||+++..   .+++.||||++...    .......+..|+++++.++||||+++++++.+....      
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999863   46789999998653    223345678899999999999999999877554321      


Q ss_pred             -------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          141 -------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       141 -------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                         ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  157 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT  157 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence                               124578899999999999   999999999999999999999999999987433221 122


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD  281 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (387)
                      ....|++.|+|||++.+..++.++||||||+++|||++|+.||........   ..   ... .+        .  ...+
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~---~~---~~~-~~--------~--~~~~  220 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT---ID---KIL-KG--------K--LNLP  220 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH---HH---HHH-cC--------C--CCCC
Confidence            335689999999999988899999999999999999999999976442211   11   111 11        0  1122


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          282 ERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       282 ~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      ......+.+++.+||+.||.+||     ++++++++.|+..
T Consensus       221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence            23345678999999999999999     8999999998754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-38  Score=296.91  Aligned_cols=247  Identities=20%  Similarity=0.297  Sum_probs=183.0

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------  140 (387)
                      ++|...+.||+|+||.||+|++..++..||+|.+.... ......+.+|+++++.++||||+++++++......      
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999999889999999986543 22345678899999999999999999987543221      


Q ss_pred             -------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          141 -------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       141 -------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                         .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++........ ..
T Consensus        86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  161 (309)
T cd07872          86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TY  161 (309)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-cc
Confidence                               125688899999999999   9999999999999999999999999999875433211 12


Q ss_pred             eeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhccC-chhhh
Q 043148          202 TVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV--------WDLYGKG-QLLEA  271 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~  271 (387)
                      ....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+........        |...... .....
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            23457889999998865 45899999999999999999999999866543332222111        1100000 00000


Q ss_pred             hcccCCc----cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          272 ADGRLSK----EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       272 ~~~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ..+....    .........+.+++.+|++.||.+|||+.|+++|.|+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            0000000    0111234567899999999999999999999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-39  Score=304.54  Aligned_cols=233  Identities=21%  Similarity=0.248  Sum_probs=177.9

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ++|...+.||+|+||.||+++...+++.||||++....   ......+.+|++++..++||||+++++++.+....    
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999999999999999996532   23345678899999999999999998876554321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+......
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence                                 225788999999999999   99999999999999999999999999998754321100


Q ss_pred             -------------------------------------eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCC
Q 043148          200 -------------------------------------QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRK  242 (387)
Q Consensus       200 -------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~  242 (387)
                                                           ......||+.|+|||++....++.++|||||||++|||++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence                                                 0112358999999999999899999999999999999999999


Q ss_pred             CCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHhccCC
Q 043148          243 PVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPS---IRQVINVLNFEA  317 (387)
Q Consensus       243 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs---~~evl~~l~~~~  317 (387)
                      ||........   ...+   ....       ..+...........+.+++..|+. +|.+|++   ++++++|.|+..
T Consensus       238 Pf~~~~~~~~---~~~i---~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~  301 (364)
T cd05599         238 PFCSDNPQET---YRKI---INWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG  301 (364)
T ss_pred             CCCCCCHHHH---HHHH---HcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            9976543211   1111   1000       000000011224456778888886 8999997   999999998754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=291.63  Aligned_cols=231  Identities=24%  Similarity=0.312  Sum_probs=181.4

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      +|+..+.||+|+||.||++....+++.||+|.+....   ......+.+|+.+++.++||||+++++++.+....     
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4677889999999999999998889999999986532   22235677899999999999999998876543211     


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence                                  125688999999999999   999999999999999999999999999997654321 


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                       ......|++.|+|||++.+..++.++||||||+++|||++|+.||...........   +......          ...
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~---~~~~~~~----------~~~  222 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE---VERRVKE----------DQE  222 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH---HHHHhhh----------ccc
Confidence             22234688999999999988899999999999999999999999986443221111   1111100          112


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      ..+...+..+.+++..||+.||.+||     ++++++++.|+..
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            23334556688999999999999999     8999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3e-38  Score=287.25  Aligned_cols=227  Identities=27%  Similarity=0.449  Sum_probs=178.4

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      .+|...+.||+|+||.||+|.+..++..||+|.+... .....++.+|++++..++||||+++++++.....        
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            4577788999999999999999988999999998654 3446788999999999999999999987654321        


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.|++.||+|||+   ++++||||||+||++++++.+||+|||++..........
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence                               1225688999999999999   999999999999999999999999999997654432111


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......+..|+|||.+.+..++.++||||||+++|||++ |..||......+.       +.....         .....
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~---------~~~~~  225 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEK---------GYRME  225 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHC---------CCCCC
Confidence            112223567999999998899999999999999999998 9999875432211       111111         11112


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus       226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~  260 (263)
T cd05052         226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE  260 (263)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            23334566889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-39  Score=301.77  Aligned_cols=225  Identities=25%  Similarity=0.452  Sum_probs=189.0

Q ss_pred             ccccCcccccCceEEEEEEECC----CCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSD----QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ....+.||.|-||.||+|.+..    ....||||..+.. ...+.+.|+.|..+|++++|||||+++|+|.+....    
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmE  470 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVME  470 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEe
Confidence            3346789999999999998743    2346999999874 455678899999999999999999999999875321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           .+..++.||..+|+|||+   ..++||||..+|||+.....+||+|||+++.+......
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence                                 236789999999999999   99999999999999999999999999999998877666


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ..+...-++.|||||.+.-..++.++|||.|||.+||++. |..||.+..+.+.+-.+                ...-..
T Consensus       548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i----------------EnGeRl  611 (974)
T KOG4257|consen  548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI----------------ENGERL  611 (974)
T ss_pred             hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe----------------cCCCCC
Confidence            6666667889999999999999999999999999999977 99999887665433211                112233


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL  313 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  313 (387)
                      ..++.++..|..++.+||++||.+||.+.|+...|
T Consensus       612 P~P~nCPp~LYslmskcWayeP~kRPrftei~~~l  646 (974)
T KOG4257|consen  612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAIL  646 (974)
T ss_pred             CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHH
Confidence            45677888899999999999999999999988766

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.6e-38  Score=297.90  Aligned_cols=223  Identities=25%  Similarity=0.302  Sum_probs=170.0

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHH-HHhcCCCCCccceehhhcchhhH---------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVR-IISRLRHRNLVHLIGWCHEQRQL---------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~---------  140 (387)
                      +.||+|+||.||+|++..+|+.||+|++....   .....++..|.. +++.++||||+++++++.+....         
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999999999999999986532   222345555555 46789999999998876543211         


Q ss_pred             ----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          141 ----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 ----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                      ....++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++...... .......
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~  156 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTF  156 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccccc
Confidence                            125688999999999999   99999999999999999999999999998743221 1223345


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||......+..      .... ...          .......
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~-~~~----------~~~~~~~  219 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY------DNIL-NKP----------LRLKPNI  219 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH------HHHH-cCC----------CCCCCCC
Confidence            6899999999999989999999999999999999999999764322111      1111 110          0111223


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCH----HHHHHHhccCC
Q 043148          285 MECLMIVGLWCCHPDFTNRPSI----RQVINVLNFEA  317 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs~----~evl~~l~~~~  317 (387)
                      ...+.+++.+||+.||.+||++    .+++++.|+..
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         220 SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence            4567889999999999999987    68998888643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.8e-38  Score=300.94  Aligned_cols=231  Identities=25%  Similarity=0.386  Sum_probs=175.6

Q ss_pred             hhCccccCcccccCceEEEEEEE-----CCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  139 (387)
                      .++|...+.||+|+||.||+|.+     .+++..||||+++... ....+.+.+|++++..+ +||||++++++|.+...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45688899999999999999974     3456789999986542 33456788999999999 89999999987654321


Q ss_pred             H-------------------------------------------------------------------------------
Q 043148          140 L-------------------------------------------------------------------------------  140 (387)
Q Consensus       140 ~-------------------------------------------------------------------------------  140 (387)
                      .                                                                               
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            1                                                                               


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           .+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                                 124578899999999999   99999999999999999999999999999765432211


Q ss_pred             e-eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          200 Q-TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       200 ~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      . .....++..|+|||.+.+..++.++||||||+++|||++ |..||........  ...    ....+.         .
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~----~~~~~~---------~  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYK----MIKEGY---------R  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHH----HHHhCc---------c
Confidence            1 112234567999999999999999999999999999998 8889875432211  111    111110         1


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ...+...+..+.+++.+||+.||++||++.||++.|+.
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            11111224568899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.6e-39  Score=306.70  Aligned_cols=233  Identities=21%  Similarity=0.268  Sum_probs=175.1

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      .+|.+.+.||+|+||.||+++...+++.||||.+....   ......+.+|++++..++||||+++++.+.+....    
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36888999999999999999999999999999986432   22345688999999999999999998876543321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC--
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL--  197 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--  197 (387)
                                           .+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++..+....  
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence                                 225678899999999999   999999999999999999999999999975321100  


Q ss_pred             ----------------------------------------CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHH
Q 043148          198 ----------------------------------------GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV  237 (387)
Q Consensus       198 ----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el  237 (387)
                                                              ........||+.|+|||++.+..++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                    0001134689999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHhc
Q 043148          238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRP---SIRQVINVLN  314 (387)
Q Consensus       238 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP---s~~evl~~l~  314 (387)
                      ++|+.||......+....      ......       .+...........+.+++.+|+ .+|.+|+   ++.++++|.|
T Consensus       238 l~G~~Pf~~~~~~~~~~~------i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~  303 (376)
T cd05598         238 LVGQPPFLADTPAETQLK------VINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF  303 (376)
T ss_pred             hhCCCCCCCCCHHHHHHH------HhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence            999999986543221110      000000       0000011122334556666665 4999999   9999999999


Q ss_pred             cCC
Q 043148          315 FEA  317 (387)
Q Consensus       315 ~~~  317 (387)
                      +..
T Consensus       304 ~~~  306 (376)
T cd05598         304 FKG  306 (376)
T ss_pred             cCC
Confidence            764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.6e-38  Score=288.56  Aligned_cols=236  Identities=22%  Similarity=0.304  Sum_probs=182.3

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      ++|...+.||+|+||.||+|.+..++..||+|.+... ......++.+|++++.+++||||+++++++.....       
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3567788999999999999999888999999998654 33445678999999999999999999997654322       


Q ss_pred             --------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeee
Q 043148          140 --------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA  205 (387)
Q Consensus       140 --------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  205 (387)
                                    ..+..++.|++.||.|||+   .+++|+||||+|||++.++.++|+|||++......   ......
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~~  154 (279)
T cd06619          81 MDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYV  154 (279)
T ss_pred             CCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccCCC
Confidence                          2336799999999999999   99999999999999999999999999999755432   223346


Q ss_pred             cCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHH
Q 043148          206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM  285 (387)
Q Consensus       206 g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (387)
                      ++..|+|||.+.+..++.++||||||+++|+|++|+.||.......................     .+.+   ......
T Consensus       155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~---~~~~~~  226 (279)
T cd06619         155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL---PVGQFS  226 (279)
T ss_pred             CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC---CCCcCC
Confidence            88999999999988899999999999999999999999975432221110000011110000     0111   112234


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          286 ECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       286 ~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ..+.+++.+||+.||.+||+++|++++.|+..
T Consensus       227 ~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~  258 (279)
T cd06619         227 EKFVHFITQCMRKQPKERPAPENLMDHPFIVQ  258 (279)
T ss_pred             HHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence            45789999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.7e-38  Score=302.57  Aligned_cols=239  Identities=19%  Similarity=0.228  Sum_probs=181.7

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  139 (387)
                      +....++|+..+.||+|+||.||+++...+++.+|+|.+.+.   .......+.+|+.+++.++||||+++++++.+...
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            334457899999999999999999999999999999998642   22334568899999999999999999987655432


Q ss_pred             H------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 L------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ~------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                      .                        ....++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++.....
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            1                        235688999999999999   9999999999999999999999999999986644


Q ss_pred             CCCceeeeeecCCcccCchhhccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTG----KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                      ..........||+.|+|||++.+.    .++.++|||||||++|||++|+.||.........   .   .......    
T Consensus       195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~---~---~i~~~~~----  264 (370)
T cd05621         195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY---S---KIMDHKN----  264 (370)
T ss_pred             CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH---H---HHHhCCc----
Confidence            322223355799999999998754    3788999999999999999999999765422111   1   1110000    


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhccCC
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTN--RPSIRQVINVLNFEA  317 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~l~~~~  317 (387)
                         .+........+..+.+++..|++.++.+  ||++.|+++|.|+..
T Consensus       265 ---~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         265 ---SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             ---ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence               0111111223555778888899866544  899999999999865

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-38  Score=304.15  Aligned_cols=236  Identities=19%  Similarity=0.219  Sum_probs=182.1

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      ..++|...+.||+|+||.||+++...++..||+|.+...   .......+.+|+.+++.++||||+++++++.+....  
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            457889999999999999999999999999999998643   223345678899999999999999999876553321  


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++........
T Consensus       121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence                                  225678899999999999   9999999999999999999999999999976543322


Q ss_pred             ceeeeeecCCcccCchhhccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          199 SQTTVLAGTMGYLAPECVTTG----KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.........   .   .......       
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~---~i~~~~~-------  264 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY---S---KIMDHKN-------  264 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH---H---HHHcCCC-------
Confidence            223345689999999998653    3789999999999999999999999765432111   1   1110000       


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhccCC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTN--RPSIRQVINVLNFEA  317 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~l~~~~  317 (387)
                      .+........+..+.+++..|++.+|.+  ||+++++++|.|+..
T Consensus       265 ~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         265 SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            0100111124566888999999999988  999999999998764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.5e-38  Score=289.73  Aligned_cols=239  Identities=24%  Similarity=0.332  Sum_probs=176.8

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcC---CCCCccceehhhcchh-----
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRL---RHRNLVHLIGWCHEQR-----  138 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~-----  138 (387)
                      +|...+.||+|+||.||+|++..+++.||+|.+....  ......+.+|+.+++.+   +||||+++++++....     
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778889999999999999999999999999986532  22234566777777665   7999999998764311     


Q ss_pred             --------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccc
Q 043148          139 --------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL  192 (387)
Q Consensus       139 --------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~  192 (387)
                                                ...+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence                                      11236789999999999999   9999999999999999999999999999976


Q ss_pred             ccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh---
Q 043148          193 VDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL---  269 (387)
Q Consensus       193 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  269 (387)
                      .....  ......++..|+|||++.+..++.++|||||||++|||++|+.||......+....   +..........   
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~  232 (288)
T cd07863         158 YSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK---IFDLIGLPPEDDWP  232 (288)
T ss_pred             ccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH---HHHHhCCCChhhCc
Confidence            54321  22234578899999999988899999999999999999999999976543322211   11111100000   


Q ss_pred             -------hhhcc---cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          270 -------EAADG---RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       270 -------~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                             ....+   .............+.+++.+|++.||.+|||+.|++.|.||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                   00000   00011112345567899999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.8e-39  Score=299.53  Aligned_cols=224  Identities=25%  Similarity=0.322  Sum_probs=174.8

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----------  140 (387)
                      +.||+|+||.||++....++..||+|.+...   .......+..|++++..++||||+++++++.+....          
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999999989999999999653   223346678899999999999999998776543321          


Q ss_pred             ---------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeee
Q 043148          141 ---------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA  205 (387)
Q Consensus       141 ---------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  205 (387)
                                     .+..++.|++.||.|||+.  ++|+||||||+|||++.++.+||+|||+++..... ........
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~  157 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFC  157 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccccc
Confidence                           1256889999999999962  69999999999999999999999999998753222 11223456


Q ss_pred             cCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHH
Q 043148          206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM  285 (387)
Q Consensus       206 g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (387)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||..........       .....      .    ..++....
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~-------~i~~~------~----~~~p~~~~  220 (325)
T cd05594         158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE-------LILME------E----IRFPRTLS  220 (325)
T ss_pred             CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH-------HHhcC------C----CCCCCCCC
Confidence            8999999999999899999999999999999999999997544221111       11000      0    11122234


Q ss_pred             HHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          286 ECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       286 ~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      ..+.+++.+||+.||.+|+     ++.++++|.|+..
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence            5578899999999999996     9999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.4e-37  Score=289.02  Aligned_cols=238  Identities=20%  Similarity=0.311  Sum_probs=169.1

Q ss_pred             cCcccccCceEEEEEEECC--CCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh------------
Q 043148           73 AGKLGEGGFGGVYRGLLSD--QNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------------  138 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------------  138 (387)
                      .++||+|+||.||+|+...  +++.+|+|.+....  ....+.+|++++++++||||+++++++....            
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            4589999999999999753  56889999986532  2345778999999999999999988653211            


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe----CCCCcEEEccccccc
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL----DSNFNAKLGDFGLAR  191 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~~kl~Dfg~~~  191 (387)
                                             ...+..++.|++.||.|||+   ++|+||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence                                   11236789999999999999   999999999999999    466789999999998


Q ss_pred             cccCCCC--ceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcch------hhHHHHHHHH
Q 043148          192 LVDHELG--SQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSK------VRLVEWVWDL  262 (387)
Q Consensus       192 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~------~~~~~~~~~~  262 (387)
                      .......  .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||........      ......+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            6654321  122345689999999998764 589999999999999999999999975432211      1111111111


Q ss_pred             hccCc---------------hhhhhcccCCc---------cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          263 YGKGQ---------------LLEAADGRLSK---------EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       263 ~~~~~---------------~~~~~~~~~~~---------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .+...               ...........         .........+.+++.+||+.||.+|||++|+++|.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            10000               00000000000         0000012347789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.2e-39  Score=313.90  Aligned_cols=250  Identities=20%  Similarity=0.239  Sum_probs=178.2

Q ss_pred             HHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCC------CCccceehhhc
Q 043148           62 ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRH------RNLVHLIGWCH  135 (387)
Q Consensus        62 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~  135 (387)
                      ++....++|.+.+.||+|+||.||+|.+..++..||||+++... ....++..|+++++.++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445688999999999999999999998889999999996532 223445667777776654      45777777664


Q ss_pred             chh-------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC----------
Q 043148          136 EQR-------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF----------  180 (387)
Q Consensus       136 ~~~-------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----------  180 (387)
                      ...                         ...+..++.||+.||.|||+.  .+|+||||||+|||++.++          
T Consensus       202 ~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        202 NETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             cCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccc
Confidence            321                         112357899999999999971  4999999999999998765          


Q ss_pred             ------cEEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 043148          181 ------NAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR  254 (387)
Q Consensus       181 ------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~  254 (387)
                            .+||+|||.+.....    ......||+.|+|||++.+..|+.++|||||||++|||++|+.||......+...
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  355 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH  355 (467)
T ss_pred             cCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                  499999998754322    2234578999999999999999999999999999999999999998765433332


Q ss_pred             HHHHHHHH----h----ccCchhhhhc------ccCC-----------ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 043148          255 LVEWVWDL----Y----GKGQLLEAAD------GRLS-----------KEFDERQMECLMIVGLWCCHPDFTNRPSIRQV  309 (387)
Q Consensus       255 ~~~~~~~~----~----~~~~~~~~~~------~~~~-----------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ev  309 (387)
                      .+......    +    ......++.+      +...           ..........+.+|+.+||+.||.+|||++|+
T Consensus       356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~  435 (467)
T PTZ00284        356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM  435 (467)
T ss_pred             HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence            22111000    0    0000000000      0000           00001123457799999999999999999999


Q ss_pred             HHHhccCCC
Q 043148          310 INVLNFEAP  318 (387)
Q Consensus       310 l~~l~~~~~  318 (387)
                      ++|.|+...
T Consensus       436 L~Hp~~~~~  444 (467)
T PTZ00284        436 TTHPYVLKY  444 (467)
T ss_pred             hcCcccccc
Confidence            999998754

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.5e-38  Score=301.06  Aligned_cols=231  Identities=24%  Similarity=0.388  Sum_probs=175.3

Q ss_pred             hhCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  139 (387)
                      .++|...+.||+|+||.||+|++..     ++..||||++.... ......+.+|+++++.+ +|+||++++++|.+...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            4578889999999999999998643     33579999997543 33456788999999999 89999999997654321


Q ss_pred             H-------------------------------------------------------------------------------
Q 043148          140 L-------------------------------------------------------------------------------  140 (387)
Q Consensus       140 ~-------------------------------------------------------------------------------  140 (387)
                      .                                                                               
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            1                                                                               


Q ss_pred             ----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce-eee
Q 043148          141 ----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ-TTV  203 (387)
Q Consensus       141 ----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~  203 (387)
                                      .+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++......... ...
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                            125688999999999999   999999999999999999999999999997654322111 112


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      ..+++.|+|||++.+..++.++||||||+++|||++ |+.||.........      ......         ......+.
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~------~~~~~~---------~~~~~~~~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF------YKMVKR---------GYQMSRPD  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH------HHHHHc---------ccCccCCC
Confidence            234567999999998899999999999999999997 99999764332111      111101         11111112


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          283 RQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ..+..+.+++.+||+.||.+|||+.+|++.|..
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            234568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.6e-38  Score=294.45  Aligned_cols=223  Identities=24%  Similarity=0.333  Sum_probs=170.5

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH---------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL---------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~---------  140 (387)
                      +.||+|+||.||+|.+..++..||+|.+....   ....+.+..|..++..+ +||||+++++++......         
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999999999999999986532   23344566777777654 899999998876543221         


Q ss_pred             ----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          141 ----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 ----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                      .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~  156 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF  156 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence                            125688999999999999   999999999999999999999999999997543221 223345


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||.........   .   ... ..          ....+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~---~---~i~-~~----------~~~~~~~~  219 (316)
T cd05592         157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF---D---SIL-ND----------RPHFPRWI  219 (316)
T ss_pred             cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH---H---HHH-cC----------CCCCCCCC
Confidence            6899999999999888999999999999999999999999765432111   1   110 00          11122233


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHH-HHHHHhccCC
Q 043148          285 MECLMIVGLWCCHPDFTNRPSIR-QVINVLNFEA  317 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs~~-evl~~l~~~~  317 (387)
                      ...+.+++.+||+.||.+||++. +++++.++..
T Consensus       220 ~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05592         220 SKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG  253 (316)
T ss_pred             CHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence            45577899999999999999865 7778877643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.6e-38  Score=296.55  Aligned_cols=247  Identities=22%  Similarity=0.342  Sum_probs=182.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      .++|+..+.||+|+||.||++.+..++..+|+|.+... .......+.+|+++++.++||||++++++|.+....     
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            46788999999999999999999988999999998754 334456789999999999999999999987654321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          .+..++.+++.||.|||+.  .+++||||||+|||++.++.+||+|||++......   .
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~  158 (333)
T cd06650          84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M  158 (333)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---c
Confidence                                2257889999999999971  47999999999999999999999999998755332   1


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH-------------------
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWD-------------------  261 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~-------------------  261 (387)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||.............-...                   
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            2234688999999999988899999999999999999999999975432211100000000                   


Q ss_pred             -HhccC-----chhhhhc---ccCCcccc-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          262 -LYGKG-----QLLEAAD---GRLSKEFD-ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       262 -~~~~~-----~~~~~~~---~~~~~~~~-~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                       .....     ......+   .......+ ......+.+++.+||+.||.+|||+.|++++.++...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence             00000     0000000   00000000 1123557899999999999999999999999987643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5e-38  Score=288.71  Aligned_cols=228  Identities=27%  Similarity=0.438  Sum_probs=178.4

Q ss_pred             hCccccCcccccCceEEEEEEECCCC-----eEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQN-----TEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  139 (387)
                      ++|+..+.||+|+||.||+|.....+     ..||+|.+.... ......+.+|++++..++||||+++++++.+...  
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            46777889999999999999876554     679999986543 3345678999999999999999999987653211  


Q ss_pred             ---------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC
Q 043148          140 ---------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF  180 (387)
Q Consensus       140 ---------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~  180 (387)
                                                             ..+..++.|++.||.|||+   ++++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence                                                   1124689999999999999   9999999999999999999


Q ss_pred             cEEEccccccccccCCC-CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 043148          181 NAKLGDFGLARLVDHEL-GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEW  258 (387)
Q Consensus       181 ~~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~  258 (387)
                      .+||+|||+++...... ........+++.|+|||.+....++.++||||||+++|||++ |..||.+....+.   .. 
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~---~~-  237 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV---IE-  237 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH-
Confidence            99999999987543321 112223346788999999988889999999999999999998 9999976543221   11 


Q ss_pred             HHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          259 VWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                         .+..+         .....+...+..+.+++.+||+.||.+||++.||+++|.
T Consensus       238 ---~i~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05048         238 ---MIRSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR  281 (283)
T ss_pred             ---HHHcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence               11111         111223455677899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=285.43  Aligned_cols=230  Identities=25%  Similarity=0.391  Sum_probs=180.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-----hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-----KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      ++|...+.||+|+||.||++....++..+|+|.+....     ....+.+.+|++++++++||||+++++++.+...   
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            56888999999999999999998889999999986432     1224568899999999999999999997654321   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            .....++.+++.||.|||+   .+++||||+|+||++++++.++|+|||+++......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence                                  1225788999999999999   999999999999999999999999999987554321


Q ss_pred             Ccee--eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          198 GSQT--TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       198 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      ....  ....++..|+|||.+.+..++.++||||||+++|||++|+.||.........      ...         ....
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~---------~~~~  223 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKI---------ATQP  223 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHH---------hccC
Confidence            1111  2345678899999999888999999999999999999999999754322111      110         0111


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .....+......+.+++..||+.+|.+|||+.+++++.|+
T Consensus       224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            1122333455568889999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.3e-38  Score=298.96  Aligned_cols=234  Identities=23%  Similarity=0.273  Sum_probs=173.1

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ++|+..+.||+|+||+||++....+++.||||++....   ......+..|+.++..++||||+++++.+.+....    
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999999999999999996532   23345678899999999999999998876554321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-  198 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-  198 (387)
                                           ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence                                 126788999999999999   9999999999999999999999999999875432100 


Q ss_pred             ---------------------------------ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 043148          199 ---------------------------------SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE  245 (387)
Q Consensus       199 ---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~  245 (387)
                                                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                             00123469999999999999999999999999999999999999997


Q ss_pred             CCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHH--hcCCCCCCCCCHHHHHHHhccCC
Q 043148          246 PRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLW--CCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .....+....   +...  ...   ..   .....  .....+.+++.+  |...++..||+++||++|.|+..
T Consensus       238 ~~~~~~~~~~---i~~~--~~~---~~---~p~~~--~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~  298 (363)
T cd05628         238 SETPQETYKK---VMNW--KET---LI---FPPEV--PISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEG  298 (363)
T ss_pred             CCCHHHHHHH---HHcC--cCc---cc---CCCcC--CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCC
Confidence            6543221111   1100  000   00   01110  112334445554  33334556799999999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=301.97  Aligned_cols=233  Identities=21%  Similarity=0.246  Sum_probs=175.3

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ++|...+.||+|+||.||++....+++.||||.+....   ....+.+.+|++++..++||||+++++++.+....    
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999999999999999986532   23346788899999999999999998876554321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+......
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence                                 125678999999999999   99999999999999999999999999998633210000


Q ss_pred             ----------------------------------------------eeeeeecCCcccCchhhccCCCCCccchHHHHHH
Q 043148          200 ----------------------------------------------QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVV  233 (387)
Q Consensus       200 ----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvi  233 (387)
                                                                    ......||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                          0012458999999999999899999999999999


Q ss_pred             HHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCC---CCHHHHH
Q 043148          234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNR---PSIRQVI  310 (387)
Q Consensus       234 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Ps~~evl  310 (387)
                      +|||++|+.||......+...      ..........     +..  .......+.+++.+|+. +|.+|   +++.|++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~------~i~~~~~~~~-----~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYR------KIINWRETLY-----FPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHH------HHHccCCccC-----CCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            999999999997644322111      0000000000     000  01223457788889997 66654   6999999


Q ss_pred             HHhccCC
Q 043148          311 NVLNFEA  317 (387)
Q Consensus       311 ~~l~~~~  317 (387)
                      +|.|+..
T Consensus       304 ~hp~~~~  310 (377)
T cd05629         304 SHPFFRG  310 (377)
T ss_pred             cCCCcCC
Confidence            9998763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=286.65  Aligned_cols=242  Identities=27%  Similarity=0.342  Sum_probs=173.3

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhc--CCCCCccceehhhcchh----hH--
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISR--LRHRNLVHLIGWCHEQR----QL--  140 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~--  140 (387)
                      .....+.||+|+||.||+|.+.  ++.||||++.   ..+.+.|++|-+|.+.  ++|+||++|++.-....    +.  
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc--CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            3444668999999999999994  5899999994   4567889999998875  58999999998754432    11  


Q ss_pred             ------------H----------HHHHHHHHHHHHHHhhhhc------ccceeeccCCcceeEeCCCCcEEEcccccccc
Q 043148          141 ------------I----------LHKIALGLASAVLYLHEEW------EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL  192 (387)
Q Consensus       141 ------------~----------l~~i~~~i~~~l~~LH~~~------~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~  192 (387)
                                  +          +.+++..+++||+|||++.      +++|+|||||++||||.+|+++.|+|||++..
T Consensus       286 Vt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             EeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence                        1          2689999999999999864      67899999999999999999999999999987


Q ss_pred             ccCCCC-ceeeeeecCCcccCchhhccCC-C-----CCccchHHHHHHHHHHHhCCCCCCC-CCCcchhh---------H
Q 043148          193 VDHELG-SQTTVLAGTMGYLAPECVTTGK-A-----SKESDVYSFGVVALEVACGRKPVEP-RQEPSKVR---------L  255 (387)
Q Consensus       193 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~-~-----~~~~Dvws~Gvil~el~tg~~p~~~-~~~~~~~~---------~  255 (387)
                      +..... ......+||.+|||||++.+.. +     -.+.||||+|.+||||+++..-+.. ..+.-+..         .
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            765432 2233478999999999997643 2     2468999999999999998765532 11111110         1


Q ss_pred             HHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          256 VEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .+.++..+-..+....+...+..   ...+..+.+.+..||..|++.|.|+.=+-+.++....
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            12222222111111111111111   1345668899999999999999999887777664433

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.8e-38  Score=296.35  Aligned_cols=240  Identities=19%  Similarity=0.209  Sum_probs=173.0

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      ...+|.+.+.||+|+||.||+|....++..||+|.....      ....|+.++++++||||+++++++.+....     
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            346799999999999999999999988999999975432      235699999999999999999977553321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....  ..
T Consensus       138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~  212 (357)
T PHA03209        138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PA  212 (357)
T ss_pred             ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC--cc
Confidence                                126789999999999999   99999999999999999999999999998753322  12


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhH----HHHHHH---Hhcc--Cch---
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRL----VEWVWD---LYGK--GQL---  268 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~----~~~~~~---~~~~--~~~---  268 (387)
                      .....||+.|+|||++.+..++.++|||||||++|||+++..|+...........    ......   ....  ..+   
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            2335689999999999998999999999999999999986555432221110000    000111   0000  000   


Q ss_pred             ------hhhhcc-cCC-c---c----ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          269 ------LEAADG-RLS-K---E----FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       269 ------~~~~~~-~~~-~---~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                            ....+. ... .   .    ........+..++.+||+.||.+|||+.|+++|.|+.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~  355 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA  355 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence                  000000 000 0   0    0001223455689999999999999999999999875

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.9e-38  Score=308.95  Aligned_cols=234  Identities=23%  Similarity=0.258  Sum_probs=182.4

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--  138 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  138 (387)
                      .....++|.+.+.||+|+||.||++++..+++.||||.+...  .......+.+|+.++..++|+||+++.+.+....  
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            344567999999999999999999999989999999998654  3445667889999999999999998765432110  


Q ss_pred             -----------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEE
Q 043148          139 -----------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAK  183 (387)
Q Consensus       139 -----------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  183 (387)
                                                         ...+..++.|++.||.|||+   ++|+||||||+|||++.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEE
Confidence                                               11125688999999999999   9999999999999999999999


Q ss_pred             EccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 043148          184 LGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDL  262 (387)
Q Consensus       184 l~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  262 (387)
                      |+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.      ... 
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~~~-  256 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MHK-  256 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHH-
Confidence            999999986543221 122345689999999999999999999999999999999999999975432111      111 


Q ss_pred             hccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          263 YGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ...+.         ....+...+..+.+++.+||+.||.+||++.+++++.+.
T Consensus       257 ~~~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~  300 (496)
T PTZ00283        257 TLAGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPIC  300 (496)
T ss_pred             HhcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHH
Confidence            11111         111223345568899999999999999999999998653

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=268.92  Aligned_cols=235  Identities=23%  Similarity=0.288  Sum_probs=185.4

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      ..++|.+.+.||+|||..||+++...++..+|+|++...+.++.+..++|++..++++|||++++++++..+..      
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            45789999999999999999999888999999999988888888999999999999999999999988644321      


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          140 ----------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       140 ----------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                                                  .-+..++.++++||++||+. ..++.||||||.|||+.+.+.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence                                        11368999999999999982 2349999999999999999999999999987


Q ss_pred             cccCCCCce--------eeeeecCCcccCchhhc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 043148          192 LVDHELGSQ--------TTVLAGTMGYLAPECVT---TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW  260 (387)
Q Consensus       192 ~~~~~~~~~--------~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~  260 (387)
                      ...-.....        ......|..|.|||.+.   +...++++|||||||+||+|+.|..||+.....          
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~----------  247 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ----------  247 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc----------
Confidence            543211110        11235788999999886   445789999999999999999999999743221          


Q ss_pred             HHhccCch-hhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          261 DLYGKGQL-LEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       261 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                          .+.+ ..+..+.+........++.+.+++.+|++.||.+||+..+++.++..
T Consensus       248 ----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  248 ----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             ----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                0111 11122222222223377889999999999999999999999998763

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.4e-38  Score=299.38  Aligned_cols=242  Identities=20%  Similarity=0.231  Sum_probs=183.4

Q ss_pred             HHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcc
Q 043148           60 YRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHE  136 (387)
Q Consensus        60 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  136 (387)
                      +.++....++|...+.||+|+||.||++++..+++.+|+|.+...   .......+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            344555678999999999999999999999999999999998642   22334567899999999999999999987654


Q ss_pred             hhhH------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccc
Q 043148          137 QRQL------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL  192 (387)
Q Consensus       137 ~~~~------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~  192 (387)
                      ....                        ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            3221                        125678999999999999   9999999999999999999999999999986


Q ss_pred             ccCCCCceeeeeecCCcccCchhhccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCch
Q 043148          193 VDHELGSQTTVLAGTMGYLAPECVTTG----KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL  268 (387)
Q Consensus       193 ~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (387)
                      .............||+.|+|||++...    .++.++|||||||++|||++|+.||........   .   .........
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~---~~i~~~~~~  265 (371)
T cd05622         192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---Y---SKIMNHKNS  265 (371)
T ss_pred             cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH---H---HHHHcCCCc
Confidence            644322233345799999999998753    378999999999999999999999976442211   1   111111000


Q ss_pred             hhhhcccCCccccHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhccCC
Q 043148          269 LEAADGRLSKEFDERQMECLMIVGLWCCHPDFTN--RPSIRQVINVLNFEA  317 (387)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~l~~~~  317 (387)
                             +........+..+.+++..|+..++.+  ||+++++++|+|+..
T Consensus       266 -------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         266 -------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             -------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence                   011111234556788899999854443  789999999998765

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.4e-38  Score=291.87  Aligned_cols=244  Identities=20%  Similarity=0.280  Sum_probs=181.5

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      ++|...+.||+|+||.||+|++..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+...       
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57888999999999999999999889999999986543 2334567889999999999999999998754321       


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||++........ ..
T Consensus        86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~  161 (301)
T cd07873          86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY  161 (301)
T ss_pred             cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cc
Confidence                              1235688999999999999   9999999999999999999999999999875433211 12


Q ss_pred             eeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc---Cchhhhh-----
Q 043148          202 TVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGK---GQLLEAA-----  272 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-----  272 (387)
                      ....+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+....   +......   .......     
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCChhhchhhhccccc
Confidence            233568899999988754 478899999999999999999999976543322211   1111100   0000000     


Q ss_pred             ----cccCCc----cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          273 ----DGRLSK----EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       273 ----~~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                          .+....    .........+.+++.+|++.||.+|||++|+++|.|+..-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                000000    0111234457889999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.4e-38  Score=293.97  Aligned_cols=223  Identities=22%  Similarity=0.296  Sum_probs=174.4

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH---------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL---------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~---------  140 (387)
                      +.||+|+||.||+|++..+++.||||++...   .......+..|.+++..+ +||||+++++++.+....         
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            3699999999999999998999999998653   233445677899998866 799999999877553321         


Q ss_pred             ----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          141 ----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 ----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                      ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++....... ......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~  156 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTF  156 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccccc
Confidence                            125688999999999999   999999999999999999999999999987533221 222345


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .|++.|+|||++.+..++.++||||||+++|||++|+.||........   ...   .. .+.          ...+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~~~---i~-~~~----------~~~p~~~  219 (321)
T cd05591         157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---FES---IL-HDD----------VLYPVWL  219 (321)
T ss_pred             ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---HHH---HH-cCC----------CCCCCCC
Confidence            689999999999988999999999999999999999999976543221   111   11 110          0111223


Q ss_pred             HHHHHHHHHHhcCCCCCCCC-------CHHHHHHHhccCC
Q 043148          285 MECLMIVGLWCCHPDFTNRP-------SIRQVINVLNFEA  317 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RP-------s~~evl~~l~~~~  317 (387)
                      ...+.+++..||+.||.+||       +++++++|.|+..
T Consensus       220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            45578899999999999999       9999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.7e-38  Score=283.31  Aligned_cols=225  Identities=26%  Similarity=0.431  Sum_probs=173.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      ++|...+.||+|+||.||++.+.. +..+|+|.+... .....++.+|+++++.++||||+++++++.+...        
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            457778899999999999999865 568999988643 3335678899999999999999999987654321        


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.+++.||.|||+   ++++||||||+||+++.++.+||+|||+++..........
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05114          82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS  158 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence                              1236788999999999999   9999999999999999999999999999876543222112


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.   ...+.    .+..         ...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i~----~~~~---------~~~  222 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMIS----RGFR---------LYR  222 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHH----CCCC---------CCC
Confidence            22234568999999988889999999999999999999 8999975543221   11111    1100         011


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINVL  313 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  313 (387)
                      +...+..+.+++.+||+.+|.+||++.++++.|
T Consensus       223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            112234678999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=290.20  Aligned_cols=232  Identities=23%  Similarity=0.306  Sum_probs=194.5

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----  141 (387)
                      .-|...+.||+|.|.+|-+|++--+|..||||++.+.  +.-....+.+|+++|+.++|||||++|++...+..++    
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4466678899999999999999889999999999765  3445678899999999999999999999875543222    


Q ss_pred             ----------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC-CCCcEEEccccccccccCCCC
Q 043148          142 ----------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD-SNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       142 ----------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            -.+++.||..|+.|+|.   ..++||||||+||.+- +-|-+||.|||++..+.+  +
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P--G  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP--G  172 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC--c
Confidence                                  26899999999999999   8999999999998764 567899999999987655  4


Q ss_pred             ceeeeeecCCcccCchhhccCCCC-CccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKAS-KESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      ......+|++.|.|||++.+..|+ +++||||||||||.|++|+.||+..++.+..               ..++|-.  
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDCK--  235 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDCK--  235 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhccc--
Confidence            566678899999999999999885 6899999999999999999999987765543               3344433  


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPS  321 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  321 (387)
                      -..+...+..+.+||..||..||++|.+.+||+.+.|...--+.
T Consensus       236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG  279 (864)
T ss_pred             ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence            24567788889999999999999999999999999997654333

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.7e-38  Score=287.28  Aligned_cols=225  Identities=23%  Similarity=0.297  Sum_probs=174.6

Q ss_pred             ccccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------------
Q 043148           76 LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------------  139 (387)
Q Consensus        76 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------------  139 (387)
                      ||+|+||+||++.+..+++.+|+|.+.....   ...+.+..|+++++.++||||+++.+++.....             
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            7999999999999998999999999865422   233567889999999999999998876543221             


Q ss_pred             ----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          140 ----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       140 ----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                      ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence                            1225688999999999999   9999999999999999999999999999976543221 2233


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      ..|++.|+|||.+.+..++.++||||||+++|||++|+.||...........   ....        ....  ....+..
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~--------~~~~--~~~~~~~  223 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE---LKQR--------ILND--SVTYPDK  223 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH---HHHh--------hccc--CCCCccc
Confidence            4688999999999999999999999999999999999999976443211110   0000        0011  1122334


Q ss_pred             HHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          284 QMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      .+..+.+++..||+.||.+||     +++++++|.|+..
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            556688999999999999999     8899999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-38  Score=293.83  Aligned_cols=227  Identities=23%  Similarity=0.350  Sum_probs=191.1

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      ++|...+.+|+|+||.+++.+++.++..+++|.+...  ....+....+|+.++++++|||||.+.+.|.++..      
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            5688889999999999999999999999999998654  34445578899999999999999999887765443      


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            ..+..++.|++.|+.|||+   +.|+|||||+.|||++.+..+||+|||+++.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence                                  1237899999999999998   999999999999999999999999999999887754


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                       ......+||+.||+||.+.+.+|+.|+|||||||++|||++-+.+|...+.......+               . +...
T Consensus       161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki---------------~-~~~~  223 (426)
T KOG0589|consen  161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI---------------N-RGLY  223 (426)
T ss_pred             -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH---------------h-hccC
Confidence             2445678999999999999999999999999999999999999999876644322111               1 1123


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ...+..+...+..++..|++.+|..||++.+++.++-
T Consensus       224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~  260 (426)
T KOG0589|consen  224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPH  260 (426)
T ss_pred             CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChh
Confidence            4455667778999999999999999999999998754

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.8e-38  Score=296.43  Aligned_cols=223  Identities=26%  Similarity=0.282  Sum_probs=169.8

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHH-HHhcCCCCCccceehhhcchhhH---------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVR-IISRLRHRNLVHLIGWCHEQRQL---------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~---------  140 (387)
                      +.||+|+||.||+++...+|+.+|+|++...   .......+..|.. +++.++||||+++++++......         
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3699999999999999999999999998653   2233445556655 46779999999998876543221         


Q ss_pred             ----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          141 ----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 ----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                      ....++.||+.||.|||+   ++++||||||+|||++.++.+||+|||+++..... .......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~  156 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTF  156 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcccc
Confidence                            125789999999999999   99999999999999999999999999998743221 1223345


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .|++.|+|||++.+..++.++|||||||++|||++|+.||......+..       .......        +  ......
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-------~~~~~~~--------~--~~~~~~  219 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY-------DNILHKP--------L--VLRPGA  219 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH-------HHHHcCC--------c--cCCCCC
Confidence            6899999999999999999999999999999999999999764422111       1111110        0  111123


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCH----HHHHHHhccCC
Q 043148          285 MECLMIVGLWCCHPDFTNRPSI----RQVINVLNFEA  317 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs~----~evl~~l~~~~  317 (387)
                      ...+.+++.+|++.||.+||++    .++++|.|+..
T Consensus       220 ~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         220 SLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             CHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence            4457789999999999999976    58888888754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.1e-38  Score=292.48  Aligned_cols=223  Identities=24%  Similarity=0.306  Sum_probs=172.0

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH---------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL---------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~---------  140 (387)
                      +.||+|+||.||+|++..+|..||+|.+....   ......+..|..++..+ +||||+++++++.+....         
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999999999999999986532   23345667788888754 899999998876553322         


Q ss_pred             ----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          141 ----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 ----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                      ....++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... .......
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~  156 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTF  156 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceecc
Confidence                            125678999999999999   99999999999999999999999999998743221 1223345


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .|++.|+|||++.+..++.++|||||||++|||++|+.||.......   ..+    .....      .+    ..+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~----~~~~~------~~----~~~~~~  219 (316)
T cd05620         157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFE----SIRVD------TP----HYPRWI  219 (316)
T ss_pred             CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhC------CC----CCCCCC
Confidence            68999999999999999999999999999999999999997544221   111    11000      11    112223


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCH-HHHHHHhccCC
Q 043148          285 MECLMIVGLWCCHPDFTNRPSI-RQVINVLNFEA  317 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs~-~evl~~l~~~~  317 (387)
                      ...+.+++.+||+.||.+||++ +++++|.|+..
T Consensus       220 ~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~  253 (316)
T cd05620         220 TKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT  253 (316)
T ss_pred             CHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence            4557889999999999999997 57888888754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7e-38  Score=294.12  Aligned_cols=230  Identities=22%  Similarity=0.282  Sum_probs=175.8

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH---------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL---------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~---------  140 (387)
                      +.||+|+||.||++++..+++.+|+|.+.+.   .....+.+..|+.++.++ +||||+++++++.+....         
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            3699999999999999999999999999754   233445677899988776 899999999876543221         


Q ss_pred             ----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          141 ----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 ----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                      ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... .......
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~~  156 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTF  156 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccccc
Confidence                            125688999999999999   99999999999999999999999999998753221 1122345


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPS--KVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      .||+.|+|||++.+..++.++||||||+++|||++|+.||.......  ......+.........          ..++.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~p~  226 (329)
T cd05618         157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRIPR  226 (329)
T ss_pred             cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CCCCC
Confidence            68999999999999999999999999999999999999996422111  1111122222211111          11223


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHhccCC
Q 043148          283 RQMECLMIVGLWCCHPDFTNRPS------IRQVINVLNFEA  317 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RPs------~~evl~~l~~~~  317 (387)
                      .....+.+++.+||+.||.+||+      +.++++|.|+..
T Consensus       227 ~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         227 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            34456788999999999999998      689999988753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=301.93  Aligned_cols=229  Identities=25%  Similarity=0.282  Sum_probs=184.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCCccceehh------------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRNLVHLIGW------------  133 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~------------  133 (387)
                      ..++.+.+.|.+|||+.||+|.+...|..+|+|++-..+....+...+|+++|+.|+ |+|||.+++.            
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            345667889999999999999999877999999998878888999999999999996 9999999882            


Q ss_pred             --------hcchh--------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          134 --------CHEQR--------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       134 --------~~~~~--------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                              |....              +..+++|+.++++|+++||. ++.+|||||||-+||||+.++..||||||.+.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence                    22110              12247999999999999997 45779999999999999999999999999986


Q ss_pred             cccCCCCce--------eeeeecCCcccCchhhc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 043148          192 LVDHELGSQ--------TTVLAGTMGYLAPECVT---TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW  260 (387)
Q Consensus       192 ~~~~~~~~~--------~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~  260 (387)
                      ..-......        .....-|+-|.|||.+.   +...++|+|||+|||+||-||....||+.....          
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----------  264 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----------  264 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence            432221110        01123478999999764   667899999999999999999999999865432          


Q ss_pred             HHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                               .++.........+.+..++.+||..||+.||.+||++-+|+..+..
T Consensus       265 ---------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  265 ---------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             ---------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence                     2333334334446789999999999999999999999999988753

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.4e-37  Score=287.84  Aligned_cols=234  Identities=21%  Similarity=0.341  Sum_probs=185.0

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      ..+|...+.||+|+||.||+|....++..|++|.+..........+.+|+.+++.++||||+++++++.....       
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            3578888899999999999999988899999999977655566788999999999999999999987654321       


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          140 -----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       140 -----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                       ..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........ ...
T Consensus        99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~  174 (296)
T cd06654          99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS  174 (296)
T ss_pred             cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccC
Confidence                             1235788999999999999   9999999999999999999999999999875443211 122


Q ss_pred             eeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          203 VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       203 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      ...+++.|+|||.+.+..++.++|||||||++|+|++|+.||.........  .    .....        .......+.
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~----~~~~~--------~~~~~~~~~  240 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--Y----LIATN--------GTPELQNPE  240 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--H----HHhcC--------CCCCCCCcc
Confidence            345788999999998888999999999999999999999999754432111  0    00000        000111223


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          283 RQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .....+.+++.+||..||.+||++.+++++.|+...
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             ccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            345668889999999999999999999999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-38  Score=272.65  Aligned_cols=236  Identities=25%  Similarity=0.340  Sum_probs=190.1

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC----h----hhHHHHHHHHHHHhcC-CCCCccceehh
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS----K----QGKKEYISEVRIISRL-RHRNLVHLIGW  133 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~----~~~~~~~~E~~~l~~l-~h~niv~l~~~  133 (387)
                      -....+.|...+.||.|..++|-+...+.+|..+|+|++....    .    .-.+.-.+|+.+|+++ .||||+.+.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            3455677888899999999999999999999999999985431    1    1234556899999998 69999999999


Q ss_pred             hcchhhHHH-------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccc
Q 043148          134 CHEQRQLIL-------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG  188 (387)
Q Consensus       134 ~~~~~~~~l-------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  188 (387)
                      ++.....++                         +.|+.|+..|++|||.   +.|+||||||+|||+|+|.++||+|||
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccc
Confidence            987765543                         6899999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCceeeeeecCCcccCchhhcc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 043148          189 LARLVDHELGSQTTVLAGTMGYLAPECVTT------GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDL  262 (387)
Q Consensus       189 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  262 (387)
                      ++..+..  +......+|||+|+|||.+..      ..|+..+|+|++||++|.|+.|..||-.....-       +..+
T Consensus       169 Fa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-------MLR~  239 (411)
T KOG0599|consen  169 FACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-------MLRM  239 (411)
T ss_pred             eeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-------HHHH
Confidence            9987654  445667789999999998863      358899999999999999999999995432111       1122


Q ss_pred             hccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          263 YGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      +.+++.      ........+.+....+|+.+||+.||.+|.|++|+++|+++.
T Consensus       240 ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  240 IMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             HHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence            222221      112233456677789999999999999999999999999973

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.1e-38  Score=294.13  Aligned_cols=230  Identities=21%  Similarity=0.275  Sum_probs=176.4

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH---------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL---------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~---------  140 (387)
                      +.||+|+||.||++.+..+++.||+|+++..   .....+.+..|..++..+ +||||+++++++.+....         
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3699999999999999999999999999753   223345688899999988 799999999876553321         


Q ss_pred             ----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          141 ----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 ----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                      ....++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++..... .......
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~  156 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTF  156 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccccc
Confidence                            125788999999999999   99999999999999999999999999998642211 1223345


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPS--KVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ......+.........          ...+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~p~  226 (329)
T cd05588         157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ----------IRIPR  226 (329)
T ss_pred             cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC----------CCCCC
Confidence            68999999999999999999999999999999999999997432211  1111122222211111          11222


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHhccCC
Q 043148          283 RQMECLMIVGLWCCHPDFTNRPS------IRQVINVLNFEA  317 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RPs------~~evl~~l~~~~  317 (387)
                      ..+..+.+++.+||+.||.+||+      ++++++|.|+..
T Consensus       227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            33455788999999999999987      799999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.6e-38  Score=294.28  Aligned_cols=228  Identities=21%  Similarity=0.292  Sum_probs=176.6

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCC-Cccceehhhcchhh-----
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHR-NLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~-----  139 (387)
                      +|...+.||+|+||.||+|+...+++.||||++...   .....+.+..|.+++..++|+ +|+++++++.+.+.     
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            477888999999999999999998999999998653   233456788899999999765 57777766543221     


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          .....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++...... ..
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GK  156 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CC
Confidence                                1125688999999999999   99999999999999999999999999998643221 12


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   ...+.    ..          ...
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~i~----~~----------~~~  219 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQSIM----EH----------NVS  219 (324)
T ss_pred             ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHH----cC----------CCC
Confidence            23345689999999999999999999999999999999999999976542211   11110    10          111


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSI-----RQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~-----~evl~~l~~~~  317 (387)
                      ++......+.+++.+||+.||.+|++.     +++++|+++..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         220 YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            222344567889999999999999976     89999988754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.7e-37  Score=292.28  Aligned_cols=231  Identities=25%  Similarity=0.388  Sum_probs=176.0

Q ss_pred             hhCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccceehhhcchh-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQR-  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-  138 (387)
                      .++|.+.+.||+|+||.||+|...+     +++.||+|++.... ....+.+..|++++.++ +|+||++++++|.... 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            3578889999999999999997543     34789999986543 33346788999999999 8999999998764321 


Q ss_pred             --------------------------------------------------------------------------------
Q 043148          139 --------------------------------------------------------------------------------  138 (387)
Q Consensus       139 --------------------------------------------------------------------------------  138 (387)
                                                                                                      
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence                                                                                            


Q ss_pred             ------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-ceeeeeecCCccc
Q 043148          139 ------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYL  211 (387)
Q Consensus       139 ------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~  211 (387)
                            ...+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+..... .......++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence                  01134678999999999999   9999999999999999999999999999986533211 1122334567899


Q ss_pred             CchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHH
Q 043148          212 APECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMI  290 (387)
Q Consensus       212 aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  290 (387)
                      |||++.+..++.++|||||||++|||++ |..||......+..      ......+         .....+......+.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~------~~~~~~~---------~~~~~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF------CRRLKEG---------TRMRAPEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH------HHHHhcc---------CCCCCCccCCHHHHH
Confidence            9999999999999999999999999998 99999754322111      1111111         111112234456889


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          291 VGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       291 l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ++.+||+.+|.+||++.|++++|..
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHH
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.1e-38  Score=293.96  Aligned_cols=223  Identities=26%  Similarity=0.344  Sum_probs=174.1

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH---------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL---------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~---------  140 (387)
                      +.||+|+||.||+|++..+++.||||++.+.   .....+.+..|..++..+ +||||+++++++.+....         
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999999999999999998653   223455677888888876 699999998876543221         


Q ss_pred             ----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          141 ----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 ----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                      ....++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++..... .......
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~  156 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTF  156 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCccccc
Confidence                            125688999999999999   99999999999999999999999999998753222 1223345


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .||+.|+|||++.+..++.++||||||+++|||++|+.||........   ..    .+....          ...+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~----~i~~~~----------~~~~~~~  219 (320)
T cd05590         157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FE----AILNDE----------VVYPTWL  219 (320)
T ss_pred             ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HH----HHhcCC----------CCCCCCC
Confidence            689999999999988999999999999999999999999976543211   11    111110          0112223


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCH------HHHHHHhccCC
Q 043148          285 MECLMIVGLWCCHPDFTNRPSI------RQVINVLNFEA  317 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs~------~evl~~l~~~~  317 (387)
                      ...+.+++.+||+.||.+||++      +++++|.|+..
T Consensus       220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         220 SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence            4567889999999999999998      89999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-37  Score=282.74  Aligned_cols=227  Identities=24%  Similarity=0.442  Sum_probs=175.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------  140 (387)
                      .++|+..++||+|+||.||+|.... +..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+....      
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            3578889999999999999999764 6789999886543 3467889999999999999999998876543221      


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           .+..++.+++.||+|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence                                 124678899999999999   99999999999999999999999999999865443221


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ......++..|+|||.+....++.++||||||+++|+|++ |+.||.......   ....+.    ...         ..
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~~---------~~  223 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQ----RGY---------RM  223 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHH----cCC---------CC
Confidence            2222335678999999988889999999999999999998 999997543221   111111    110         01


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ......+..+.+++.+||+.+|++||+++++++.|+
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  259 (261)
T cd05072         224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD  259 (261)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence            111223455788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-37  Score=283.77  Aligned_cols=234  Identities=26%  Similarity=0.377  Sum_probs=180.6

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      +.+++++.....||+|+||.||+|.+..++..|++|.+........+.+.+|+++++.++|+||+++++++.....    
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            3445666666789999999999999988899999999887766667889999999999999999999987654321    


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC-CCcEEEcccccccccc
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS-NFNAKLGDFGLARLVD  194 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~  194 (387)
                                              ..+..++.|++.||.|||+   ++++||||||+||+++. ++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence                                    1124577899999999999   99999999999999986 6799999999987553


Q ss_pred             CCCCceeeeeecCCcccCchhhccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          195 HELGSQTTVLAGTMGYLAPECVTTGK--ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                      ... .......+++.|+|||.+....  ++.++||||||+++|+|++|+.||.........   .+....          
T Consensus       161 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~----------  226 (268)
T cd06624         161 GIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGM----------  226 (268)
T ss_pred             cCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhh----------
Confidence            321 1122335788999999986543  789999999999999999999999754322110   000000          


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                       .......+......+.+++.+||+.+|.+|||+.|++++.|+
T Consensus       227 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         227 -FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence             001122333455668899999999999999999999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-37  Score=298.30  Aligned_cols=244  Identities=24%  Similarity=0.262  Sum_probs=180.0

Q ss_pred             hhCccccCcccccCceEEEEEEECC--CCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD--QNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      ..+|.+.+.||+|+||.||++...+  .+..||+|.+...     ..+.+|+++++.++||||+++++++.....     
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            4579999999999999999997643  4578999988543     345689999999999999999876543221     


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-c
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-S  199 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  199 (387)
                                         ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++........ .
T Consensus       166 e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~  242 (392)
T PHA03207        166 PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP  242 (392)
T ss_pred             hhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence                               1236789999999999999   9999999999999999999999999999976543322 1


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCch----------h
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL----------L  269 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~  269 (387)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............+.........          .
T Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  322 (392)
T PHA03207        243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC  322 (392)
T ss_pred             cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence            223456899999999999999999999999999999999999999765543322222222111111000          0


Q ss_pred             hh---hcccCCccc--c-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          270 EA---ADGRLSKEF--D-----ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       270 ~~---~~~~~~~~~--~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ..   ........+  +     ......+.+++.+||+.||++|||+.|++.+.|+...
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            00   000000000  0     1123457789999999999999999999999998653

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.9e-38  Score=307.62  Aligned_cols=227  Identities=19%  Similarity=0.253  Sum_probs=178.8

Q ss_pred             CccccCcccccCceEEEEEEECCC-CeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQ-NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-------  140 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-------  140 (387)
                      .|...+.||+|+||.||+|....+ +..||+|.+..........+.+|+.+++.++||||++++++|......       
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            388899999999999999998777 788999987665555566788899999999999999999987553221       


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence                                  124588899999999999   9999999999999999999999999999986543221


Q ss_pred             -ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 -SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 -~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ...   ... .+.        . 
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~---~~~-~~~--------~-  288 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQ---QVL-YGK--------Y-  288 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHH-hCC--------C-
Confidence             12334568999999999999899999999999999999999999997543221   111   100 010        0 


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ...+...+..+.+++.+||+.||.+||++.+++.+.+
T Consensus       289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~  325 (478)
T PTZ00267        289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEF  325 (478)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHH
Confidence            1112234456889999999999999999999987643

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-37  Score=301.27  Aligned_cols=240  Identities=22%  Similarity=0.253  Sum_probs=174.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      .+|.+.+.||+|+||.||++.+..+++.||||...      ...+.+|+++|++++|+|||++++++.....        
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            35888899999999999999999999999999642      2345689999999999999999987654321        


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc-ee
Q 043148          140 -----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS-QT  201 (387)
Q Consensus       140 -----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~  201 (387)
                                       ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++........ ..
T Consensus       243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence                             1236799999999999999   99999999999999999999999999999765432211 12


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCC-Ccc----hhhHHHHHHHHhc-cCc--------
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQ-EPS----KVRLVEWVWDLYG-KGQ--------  267 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~-~~~----~~~~~~~~~~~~~-~~~--------  267 (387)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..|+.... ...    ...+...+..... ...        
T Consensus       320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~  399 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR  399 (461)
T ss_pred             cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence            23468999999999999999999999999999999999887653322 111    0111111110000 000        


Q ss_pred             hhhhh--------cccCCcccc---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          268 LLEAA--------DGRLSKEFD---ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       268 ~~~~~--------~~~~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      +....        .+.......   ......+.+|+.+||+.||.+|||+.|+++|.|+.
T Consensus       400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~  459 (461)
T PHA03211        400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ  459 (461)
T ss_pred             HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence            00000        000000000   01223577899999999999999999999999975

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-38  Score=297.04  Aligned_cols=223  Identities=26%  Similarity=0.375  Sum_probs=183.4

Q ss_pred             ccCcccccCceEEEEEEECCC---CeEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCCccceehhhcchhhHH------
Q 043148           72 EAGKLGEGGFGGVYRGLLSDQ---NTEIAVKRVSRGSKQ-GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------  141 (387)
Q Consensus        72 ~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~------  141 (387)
                      ..++||+|.||+|++|.|...   ...||||+++..... ...+|++|+.+|.+|+|||+++|+|+..+....+      
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELap  193 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAP  193 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhcc
Confidence            356899999999999999653   356999999766433 6789999999999999999999999887643222      


Q ss_pred             --------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          142 --------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       142 --------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                          |..++.|||.||.||.+   +++|||||..+|+||-....+||+|||+.+.++.+...-.
T Consensus       194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv  270 (1039)
T KOG0199|consen  194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV  270 (1039)
T ss_pred             cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence                                36899999999999999   9999999999999999999999999999998766533221


Q ss_pred             e--eeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          202 T--VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       202 ~--~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .  ...-...|.|||.+....++.++|||+|||++|||++ |+.||.+.....                +.+.+|.+-.-
T Consensus       271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~~erL  334 (1039)
T KOG0199|consen  271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDAGERL  334 (1039)
T ss_pred             ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhccccccC
Confidence            1  1223568999999999999999999999999999999 999998766433                22233333334


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL  313 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  313 (387)
                      ..++.+++.+.+++..||..+|.+|||+..|.+.+
T Consensus       335 pRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            55677899999999999999999999999998554

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.9e-37  Score=284.49  Aligned_cols=229  Identities=25%  Similarity=0.388  Sum_probs=173.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCe----EEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNT----EIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      ++|...+.||+|+||.||+|.+..++.    .+++|.+.... .....++..|+..+..++||||+++++++.....   
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i   86 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV   86 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence            456778899999999999999876665    47788775432 2334677888889999999999999998643221   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            ..+..++.|++.||.|||+   ++++||||||+|||+++++.+||+|||+++......
T Consensus        87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence                                  1236789999999999999   999999999999999999999999999997654321


Q ss_pred             C-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          198 G-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       198 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      . .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+......       .+....+...      
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~------  230 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGERL------  230 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcC------
Confidence            1 11223446778999999998889999999999999999998 9999976542211       1111111110      


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                         ..+..+...+.+++..||+.||.+|||+.|+++.+..
T Consensus       231 ---~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~  267 (279)
T cd05111         231 ---AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR  267 (279)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence               0111123446778999999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.5e-38  Score=284.04  Aligned_cols=228  Identities=26%  Similarity=0.456  Sum_probs=181.6

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      ...+|...+.||.|+||.||+|.+.. +..+++|.+.........++..|+.+++.++||||+++++++.+....     
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            45678889999999999999999987 889999999876665677899999999999999999999876543221     


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.+++.||.|||+   ++++|+||+|+||+++.++.+||+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence                                  235788999999999999   9999999999999999999999999999976543221


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      . .....++..|+|||.+....++.++||||||+++|+|++ |+.||......+.   .....    .         ...
T Consensus       160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~~----~---------~~~  222 (261)
T cd05148         160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQIT----A---------GYR  222 (261)
T ss_pred             c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHHH----h---------CCc
Confidence            1 112335678999999988889999999999999999998 8999976442211   11111    0         111


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ...+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~  259 (261)
T cd05148         223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELD  259 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1222344566889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-38  Score=288.59  Aligned_cols=223  Identities=33%  Similarity=0.570  Sum_probs=168.7

Q ss_pred             ccCcccccCceEEEEEEEC----CCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           72 EAGKLGEGGFGGVYRGLLS----DQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        72 ~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      ..+.||.|.||.||+|.+.    ..+..|+||.+... .....+.+.+|++.+.+++||||++++|+|.+...       
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3568999999999999997    34678999999654 33457899999999999999999999998874321       


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-  198 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-  198 (387)
                                          ..+..++.|++.||.|||+   ++++|+||+++||+++.++.+||+|||++........ 
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence                                1236799999999999999   8999999999999999999999999999986632211 


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      ...........|+|||.+....++.++||||||+++|||++ |+.||......+   ...    ...++..         
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~----~~~~~~~---------  223 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIE----KLKQGQR---------  223 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHH----HHHTTEE---------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc----ccccccc---------
Confidence            12223346778999999998889999999999999999999 788986653221   111    1111111         


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL  313 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  313 (387)
                      ...+..++..+.+++..||+.||.+|||+.++++.|
T Consensus       224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            112233455688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-37  Score=281.79  Aligned_cols=230  Identities=28%  Similarity=0.447  Sum_probs=177.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCC---CeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQ---NTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      .++|+..+.||+|+||.||+|.+...   ...||||.+... ......+|.+|+.++..++||||+++++++.+...   
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            35788899999999999999998643   457999998654 33446688999999999999999999887644321   


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                             ..+..++.+++.||.|||+   ++++||||||+|||+++++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence                                   1236788999999999999   99999999999999999999999999999876522


Q ss_pred             CCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          197 LGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       197 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      ... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......   ...    ......       
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~----~~~~~~-------  225 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIK----AVEDGY-------  225 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHH----HHHcCC-------
Confidence            111 1112234678999999998889999999999999999998 999986543221   111    111110       


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                        ....+...+..+.+++.+||+.+|.+||++++|+++|..
T Consensus       226 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         226 --RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence              011122345568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-37  Score=282.23  Aligned_cols=232  Identities=30%  Similarity=0.489  Sum_probs=178.9

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHH--HHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKK--EYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      |+..+.||+|+||+||++....++..+|+|.+.........  ...+|+.++.+++||||+++++++.+...        
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            56778999999999999999999999999999876543322  34569999999999999999987754321        


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          140 -----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       140 -----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                       ..+..++.|++.||.+||+   .+++|+||||+||++++++.++|+|||.+.... .......
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~  156 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFN  156 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBS
T ss_pred             cccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccccc
Confidence                             1237899999999999999   999999999999999999999999999997542 1223344


Q ss_pred             eeecCCcccCchhhc-cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcccc
Q 043148          203 VLAGTMGYLAPECVT-TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD  281 (387)
Q Consensus       203 ~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (387)
                      ...++..|+|||++. +..++.++||||+|+++|+|++|..||......+..........   . ..   ... ...  .
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---~-~~---~~~-~~~--~  226 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---R-PL---PSS-SQQ--S  226 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---T-HH---HHH-TTS--H
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc---c-cc---ccc-ccc--c
Confidence            556888999999998 78899999999999999999999999986622221111111110   0 00   000 000  0


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          282 ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       282 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ......+.+++..||+.||++||++.+++++.|+
T Consensus       227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  227 REKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             chhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            0012678999999999999999999999999885

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-37  Score=280.46  Aligned_cols=227  Identities=29%  Similarity=0.467  Sum_probs=176.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------  140 (387)
                      .++|...+.||+|+||.||+|.+.. +..||+|.++... ...+++.+|++++++++||||+++++++...+..      
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            4568888999999999999999765 5789999986543 3457789999999999999999999876543221      


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           .+..++.+++.||.|||+   ++++||||||+||+++.++.+||+|||+++........
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence                                 125788999999999999   99999999999999999999999999999866532211


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......+..|+|||.+.+..++.++||||||+++|||++ |+.||.........   .    .....         ...
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~----~~~~~---------~~~  223 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL---Q----QVDQG---------YRM  223 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---H----HHHcC---------CCC
Confidence            1111223457999999998889999999999999999999 99999754322111   1    11110         011


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ..+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~  259 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE  259 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence            122234566889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=291.35  Aligned_cols=235  Identities=21%  Similarity=0.248  Sum_probs=174.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ++|.+.+.||+|+||.||+++...+++.||+|.+.+.   .....+.+.+|+.++..++|+||+++++++.+....    
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4688899999999999999999999999999998642   223345688999999999999999998876543221    


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence                                  235688999999999999   9999999999999999999999999999876544332


Q ss_pred             ceeeeeecCCcccCchhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          199 SQTTVLAGTMGYLAPECVTT-----GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      .......||+.|+|||++..     ..++.++|||||||++|||++|+.||......+..      ...........   
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~~---  228 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKEHFQ---  228 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCccc---
Confidence            23334568999999999863     45788999999999999999999999754322111      11111110000   


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHHhccCC
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHP--DFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~--dp~~RPs~~evl~~l~~~~  317 (387)
                        +.. .....+..+.+++.+|+..  ++..||+++++++|.|+..
T Consensus       229 --~~~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         229 --FPP-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             --CCC-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence              000 0111344566677776544  4445899999999999754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.4e-37  Score=285.88  Aligned_cols=227  Identities=26%  Similarity=0.387  Sum_probs=173.8

Q ss_pred             CccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGSK-QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      +|...+.||+|+||.||+|.+..     .+..||+|.+..... .....+.+|+.++..++||||+++++++.+...   
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            45667889999999999998754     257899999975432 335678899999999999999999886643211   


Q ss_pred             --------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc
Q 043148          140 --------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN  181 (387)
Q Consensus       140 --------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~  181 (387)
                                                            ..+..++.|++.||.|||+   ++++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence                                                  1124688899999999999   99999999999999999999


Q ss_pred             EEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 043148          182 AKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWV  259 (387)
Q Consensus       182 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~  259 (387)
                      +||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.   .   
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~---  236 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---I---  236 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H---
Confidence            99999999876543221 11223345678999999988889999999999999999998 8888875432211   1   


Q ss_pred             HHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          260 WDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                       ..+.....         ...+...+..+.+++..||+.+|.+||++++|+..|.
T Consensus       237 -~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         237 -EMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             -HHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence             11111111         1122344566889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-37  Score=291.50  Aligned_cols=223  Identities=23%  Similarity=0.305  Sum_probs=174.9

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH---------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL---------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~---------  140 (387)
                      +.||+|+||.||++++..++..||||.+.+.   .......+..|.+++..+ +||||+++++++.+....         
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999999998999999998753   223455677899999888 799999999876543321         


Q ss_pred             ----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          141 ----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 ----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                      ....++.|++.||.|||+   ++++||||||+|||+++++.+||+|||+++..... .......
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~  156 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTSTF  156 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCcccce
Confidence                            125688999999999999   99999999999999999999999999998643221 1122344


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .|++.|+|||++.+..++.++|||||||++|||++|+.||........   .    .......          ...+...
T Consensus       157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~----~~i~~~~----------~~~~~~~  219 (318)
T cd05570         157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---F----QSILEDE----------VRYPRWL  219 (318)
T ss_pred             ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---H----HHHHcCC----------CCCCCcC
Confidence            689999999999999999999999999999999999999975442211   1    1111110          1122234


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCH-----HHHHHHhccCC
Q 043148          285 MECLMIVGLWCCHPDFTNRPSI-----RQVINVLNFEA  317 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs~-----~evl~~l~~~~  317 (387)
                      +..+.+++.+||+.||.+||++     .+++++.|+..
T Consensus       220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            4568899999999999999999     99999988754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.7e-37  Score=280.41  Aligned_cols=231  Identities=26%  Similarity=0.380  Sum_probs=180.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      ++|...+.||+|+||.||+|+...++..||||.+...   .......+.+|+++++.++||||+++++++.+...     
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5788899999999999999999888999999987542   23445678899999999999999999987654211     


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                              ..+..++.+++.||.|||+   ++++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence                                    1225788999999999999   9999999999999999999999999999876543


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      ... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||....... .....    ....        ..
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~----~~~~--------~~  224 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQ----KIEQ--------CD  224 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHH----HHhc--------CC
Confidence            221 1223457889999999988889999999999999999999999986543211 11111    1111        01


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ............+.+++.+||+.+|.+||++.+|++.+..
T Consensus       225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~  264 (267)
T cd08228         225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ  264 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence            1111223445668899999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.9e-37  Score=280.84  Aligned_cols=226  Identities=27%  Similarity=0.456  Sum_probs=174.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-------  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-------  140 (387)
                      ++|...+.||+|+||.||+|.+.+ +..+|+|.+.... ....++.+|+.++.+++||||+++++++.+....       
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            457788899999999999998865 4569999886543 3356789999999999999999999987543211       


Q ss_pred             -------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          141 -------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       141 -------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                         .+..++.+++.||.|||+   .+++|+||||+||+++.++.+||+|||.++..........
T Consensus        82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence                               236799999999999999   9999999999999999999999999999876543321111


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      ....++..|++||.+.+..++.++||||||+++|||++ |+.||........   ..    ....+.         ....
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~----~~~~~~---------~~~~  222 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VE----KVSQGL---------RLYR  222 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH----HHhcCC---------CCCC
Confidence            22235568999999988889999999999999999998 9999975443211   11    111110         0011


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      +...+..+.+++.+||+.||.+||++.++++.++
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            1123466889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-37  Score=290.37  Aligned_cols=223  Identities=23%  Similarity=0.312  Sum_probs=172.0

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhc-CCCCCccceehhhcchhhH---------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISR-LRHRNLVHLIGWCHEQRQL---------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~---------  140 (387)
                      +.||+|+||.||+|++..++..||||.+....   ......+..|..++.. ++||||+++++++.+....         
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999999989999999986542   2334556778888876 4899999999876543321         


Q ss_pred             ----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          141 ----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 ----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                      ....++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++....... ......
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  156 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTF  156 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeee
Confidence                            125688999999999999   999999999999999999999999999987432211 123345


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   ...    ....      .+    ..+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~~----i~~~------~~----~~~~~~  219 (316)
T cd05619         157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---FQS----IRMD------NP----CYPRWL  219 (316)
T ss_pred             cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---HHH----HHhC------CC----CCCccC
Confidence            689999999999988999999999999999999999999976542211   111    1000      01    111223


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHH-HHHHHhccCC
Q 043148          285 MECLMIVGLWCCHPDFTNRPSIR-QVINVLNFEA  317 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs~~-evl~~l~~~~  317 (387)
                      ...+.+++.+||+.||.+||++. ++.++.++..
T Consensus       220 ~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05619         220 TREAKDILVKLFVREPERRLGVKGDIRQHPFFRE  253 (316)
T ss_pred             CHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence            44578899999999999999996 8888887644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=264.49  Aligned_cols=230  Identities=25%  Similarity=0.412  Sum_probs=180.4

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhHHH-----
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQLIL-----  142 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l-----  142 (387)
                      ...+..||.|..|.|++++++.+|..+|||.+.+. +.++.++++..++++..- +.|.||+.+|||-.+....+     
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            33466799999999999999999999999999775 456678888888887655 48999999999876544332     


Q ss_pred             --------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          143 --------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       143 --------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                          -++...+.+||.||.+  +.+|+|||+||+|||+|+.|++|++|||++..+-..  ...+
T Consensus       174 s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAht  249 (391)
T KOG0983|consen  174 STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAHT  249 (391)
T ss_pred             HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc--cccc
Confidence                                3567778999999998  488999999999999999999999999999765442  2334


Q ss_pred             eeecCCcccCchhhcc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          203 VLAGTMGYLAPECVTT---GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       203 ~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ...|-+.|||||.+..   ..|+-.+||||||++++||.||+.||.+....-..  ...+         .+...+.+...
T Consensus       250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~--ltkv---------ln~ePP~L~~~  318 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV--LTKV---------LNEEPPLLPGH  318 (391)
T ss_pred             cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH--HHHH---------HhcCCCCCCcc
Confidence            5568899999999864   45899999999999999999999999876543211  1111         11111233222


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .  ..+..+.+++..||+.|+.+||...++++|.+..
T Consensus       319 ~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~  353 (391)
T KOG0983|consen  319 M--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK  353 (391)
T ss_pred             c--CcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence            1  1566688999999999999999999999998643

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7e-38  Score=300.22  Aligned_cols=232  Identities=22%  Similarity=0.265  Sum_probs=173.7

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      +|...+.||+|+||.||+|+...+++.||+|.+....   ......+.+|+++++.++||||+++++.+.+....     
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999999999999999986532   23345788999999999999999999877543221     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC---
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL---  197 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~---  197 (387)
                                          .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+....   
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence                                225678899999999999   999999999999999999999999999975321100   


Q ss_pred             -------------------------------------------CceeeeeecCCcccCchhhccCCCCCccchHHHHHHH
Q 043148          198 -------------------------------------------GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVA  234 (387)
Q Consensus       198 -------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil  234 (387)
                                                                 ........||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                       0001124689999999999998999999999999999


Q ss_pred             HHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q 043148          235 LEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPS---IRQVIN  311 (387)
Q Consensus       235 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs---~~evl~  311 (387)
                      |||++|+.||......+...      .....       ...+...........+.+++.+++ .+|.+|++   ++++++
T Consensus       239 ~elltG~~Pf~~~~~~~~~~------~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQM------KVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHH------HHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            99999999997654322111      10000       000111111122334556666655 49999987   999999


Q ss_pred             HhccCC
Q 043148          312 VLNFEA  317 (387)
Q Consensus       312 ~l~~~~  317 (387)
                      |.|+..
T Consensus       305 hp~f~~  310 (382)
T cd05625         305 HPFFKT  310 (382)
T ss_pred             CCCcCC
Confidence            998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=297.28  Aligned_cols=224  Identities=26%  Similarity=0.395  Sum_probs=181.0

Q ss_pred             ccCcccccCceEEEEEEECCCC----eEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH-----
Q 043148           72 EAGKLGEGGFGGVYRGLLSDQN----TEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI-----  141 (387)
Q Consensus        72 ~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-----  141 (387)
                      ..++||+|+||+||+|.+.-.|    .+||+|++... ..+...++++|+-.|.+|+|||+++++|+|......+     
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~m  779 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLM  779 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhc
Confidence            3678999999999999985544    46899988654 4555788999999999999999999999997654222     


Q ss_pred             --------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc-e
Q 043148          142 --------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS-Q  200 (387)
Q Consensus       142 --------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~  200 (387)
                                          ++.++.|||+||.|||.   +.++||||..+||||.+-..+||.|||+++........ .
T Consensus       780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~  856 (1177)
T KOG1025|consen  780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS  856 (1177)
T ss_pred             ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence                                36899999999999998   99999999999999999999999999999977654322 1


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      .....-.+.|||=|.+....|+.++|||||||++||++| |..|+.+....+.                .+++.....-.
T Consensus       857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------------~dlle~geRLs  920 (1177)
T KOG1025|consen  857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------------PDLLEKGERLS  920 (1177)
T ss_pred             ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----------------hHHHhccccCC
Confidence            222233568999999999999999999999999999998 9999987654332                22222222234


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .++.+...+..++.+||..|+..||+++++.....
T Consensus       921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs  955 (1177)
T KOG1025|consen  921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS  955 (1177)
T ss_pred             CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence            45667777889999999999999999999987653

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.1e-37  Score=292.26  Aligned_cols=227  Identities=23%  Similarity=0.311  Sum_probs=176.0

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH----
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~----  140 (387)
                      +|...+.||+|+||.||+|+...++..||||.+.+..   ......+..|..++..+ +|++|+++++++.+.+..    
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778889999999999999999989999999987542   22344567788888877 588999888766443211    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... ..
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GV  156 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-CC
Confidence                                 225789999999999999   99999999999999999999999999998753321 11


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ...+.    ..          ...
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~~~i~----~~----------~~~  219 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQSIM----EH----------NVA  219 (323)
T ss_pred             ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---HHHHH----hC----------CCC
Confidence            22345689999999999999999999999999999999999999976543221   11111    11          011


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFE  316 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~  316 (387)
                      ++......+.+++.+|++.||.+|++     ..++.+|.++.
T Consensus       220 ~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~  261 (323)
T cd05616         220 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  261 (323)
T ss_pred             CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcC
Confidence            22334556788999999999999997     48888887764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=290.57  Aligned_cols=234  Identities=26%  Similarity=0.331  Sum_probs=194.4

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHHhcCC-CCCccceehhhcchhhHH
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK---QGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQLI  141 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  141 (387)
                      ....|...+.||+|.||.||+++.+.+|..+|+|.+.+...   .....+.+|+.+|+++. |||||.+.+++++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34668888999999999999999999999999999976533   24568999999999998 999999999887654222


Q ss_pred             ------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC----CcEEEccccccccc
Q 043148          142 ------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN----FNAKLGDFGLARLV  193 (387)
Q Consensus       142 ------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~----~~~kl~Dfg~~~~~  193 (387)
                                              ...++.|++.++.|||+   .+++||||||+|+|+...    +.+|++|||++...
T Consensus       113 lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence                                    14688999999999999   999999999999999643    47999999999877


Q ss_pred             cCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          194 DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       194 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ..  .......+||+.|+|||++....|+..+||||+||++|.|++|..||...........       +..+..     
T Consensus       190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-------i~~~~~-----  255 (382)
T KOG0032|consen  190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-------ILRGDF-----  255 (382)
T ss_pred             cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-------HHcCCC-----
Confidence            66  4566778999999999999999999999999999999999999999987664432211       111111     


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                       .......+.....+.+++..|+..||.+|+|+.++++|+|...
T Consensus       256 -~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~  298 (382)
T KOG0032|consen  256 -DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKS  298 (382)
T ss_pred             -CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence             2334455667888999999999999999999999999999654

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.3e-37  Score=278.04  Aligned_cols=226  Identities=25%  Similarity=0.421  Sum_probs=180.2

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      +|...+.||+|+||.||++....++..|++|.+...  .......+.+|+++++.++||||+++++++.+...       
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            467788999999999999999989999999998643  34557789999999999999999999987654321       


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          ..+..++.+++.||.|||+   ++++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence                                1225688999999999998   9999999999999999999999999999876544321 


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......+++.|+|||++.+..++.++|+||||+++|||++|+.||.......   ....    ...+         ....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~---------~~~~  220 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILK----IIRG---------VFPP  220 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHcC---------CCCC
Confidence            2233457889999999998889999999999999999999999997554211   1111    1011         1112


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .+......+.+++.+||+.+|++||++.+++++.+
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  255 (256)
T cd08529         221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS  255 (256)
T ss_pred             CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence            22244566889999999999999999999999865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.8e-37  Score=285.08  Aligned_cols=235  Identities=23%  Similarity=0.359  Sum_probs=186.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      ..+|...+.||+|+||.||++....++..||+|.+........+.+.+|+.+++.++||||+++++++.....       
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            4678889999999999999999988899999999976655556778899999999999999999987754321       


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          140 -----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       140 -----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                       ..+..++.+++.||.|||+   .+++||||||+|||++.++.++|+|||++........ ...
T Consensus        98 ~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~  173 (297)
T cd06656          98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS  173 (297)
T ss_pred             cCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcC
Confidence                             1235788999999999999   9999999999999999999999999999876543321 122


Q ss_pred             eeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          203 VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       203 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|+.||............              ..........+.
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--------------~~~~~~~~~~~~  239 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------ATNGTPELQNPE  239 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee--------------ccCCCCCCCCcc
Confidence            345788999999999888999999999999999999999999754432111000              000000111223


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 043148          283 RQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPL  319 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  319 (387)
                      .....+.+++.+||+.+|.+||++++++++.|+....
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            3455678899999999999999999999999987554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.8e-37  Score=281.31  Aligned_cols=232  Identities=21%  Similarity=0.323  Sum_probs=177.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .++|.+.+.||+|+||.||+|+...++..||+|++..........+.+|+.++..++||||+++++++.....       
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            3568889999999999999999988899999999976554555678899999999999999999887644321       


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++........ ..
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~  163 (267)
T cd06646          88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KR  163 (267)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-cc
Confidence                              1225688999999999999   9999999999999999999999999999986543211 12


Q ss_pred             eeeecCCcccCchhhc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          202 TVLAGTMGYLAPECVT---TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ....+++.|+|||.+.   ...++.++||||||+++|||++|+.||...........       .....   ...+..  
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~~~---~~~~~~--  231 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSKSN---FQPPKL--  231 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eecCC---CCCCCC--
Confidence            2345788999999874   34478899999999999999999999864432111000       00000   000111  


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ......+..+.+++.+||+.+|.+||++++++++|+
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            011223456889999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.1e-37  Score=285.36  Aligned_cols=238  Identities=21%  Similarity=0.325  Sum_probs=168.7

Q ss_pred             cCcccccCceEEEEEEECC--CCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh------------
Q 043148           73 AGKLGEGGFGGVYRGLLSD--QNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------------  138 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------------  138 (387)
                      ..+||+|+||.||+|+..+  ++..||+|.+....  ....+.+|+++++.++||||+++++++....            
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3579999999999999754  45789999986543  2346788999999999999999988763211            


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe----CCCCcEEEccccccc
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL----DSNFNAKLGDFGLAR  191 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~~kl~Dfg~~~  191 (387)
                                             ...+..++.|++.||.|||+   ++++||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence                                   11235789999999999999   999999999999999    567799999999998


Q ss_pred             cccCCCC--ceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcch------hhHHHHHHHH
Q 043148          192 LVDHELG--SQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSK------VRLVEWVWDL  262 (387)
Q Consensus       192 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~------~~~~~~~~~~  262 (387)
                      .......  .......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||........      ..........
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            6654321  122345688999999998764 589999999999999999999999975432111      0001111110


Q ss_pred             hccC---------------chhhhhc-ccC--------CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          263 YGKG---------------QLLEAAD-GRL--------SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       263 ~~~~---------------~~~~~~~-~~~--------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ....               ....... ...        ...........+.+++.+|++.||.+|||+.|+++|+|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0000               0000000 000        000001123347789999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.7e-37  Score=278.09  Aligned_cols=222  Identities=27%  Similarity=0.436  Sum_probs=171.5

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------------  140 (387)
                      +.||+|+||.||+|.+..+++.+|+|.+... .......+.+|+++++.++||||++++++|......            
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            3699999999999999888999999987643 334457799999999999999999999887543221            


Q ss_pred             --------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce-eeeee
Q 043148          141 --------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ-TTVLA  205 (387)
Q Consensus       141 --------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~  205 (387)
                                    .+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++.......... .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence                          125688999999999999   999999999999999999999999999987543221111 01112


Q ss_pred             cCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       206 g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .+..|+|||.+.+..++.++||||||+++|||++ |..||........       ....         ........+...
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~---------~~~~~~~~~~~~  221 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAI---------EQGVRLPCPELC  221 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHH---------HcCCCCCCcccC
Confidence            3457999999998889999999999999999998 8888865432211       1111         011111223344


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          285 MECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      +..+.+++.+||+.+|.+|||+.++++.|.
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.4e-37  Score=278.58  Aligned_cols=221  Identities=27%  Similarity=0.421  Sum_probs=171.3

Q ss_pred             cccccCceEEEEEEE--CCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----------
Q 043148           75 KLGEGGFGGVYRGLL--SDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----------  139 (387)
Q Consensus        75 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----------  139 (387)
                      .||+|+||.||+|.+  ..++..+|+|++....  ....+++.+|+.++..++||||+++++++.+...           
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~   81 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP   81 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence            699999999999965  4557889999986543  3346788999999999999999999987643211           


Q ss_pred             -------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce--eeee
Q 043148          140 -------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ--TTVL  204 (387)
Q Consensus       140 -------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~  204 (387)
                                   .....++.|++.||.|||+   ++++||||||.||+++.++.+||+|||+++.........  ....
T Consensus        82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence                         1236789999999999999   999999999999999999999999999998664432211  1122


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      .++..|+|||.+....++.++||||||+++|||++ |+.||......+.   ..    ....+         .....+..
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~----~i~~~---------~~~~~~~~  222 (257)
T cd05116         159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQ----MIESG---------ERMECPQR  222 (257)
T ss_pred             CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHCC---------CCCCCCCC
Confidence            33578999999988889999999999999999998 9999976443221   11    11111         11122233


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .+..+.+++.+||+.||.+||++++|++.|.
T Consensus       223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~  253 (257)
T cd05116         223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLR  253 (257)
T ss_pred             CCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence            4556889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.5e-38  Score=293.08  Aligned_cols=223  Identities=23%  Similarity=0.300  Sum_probs=172.8

Q ss_pred             CcccccCceEEEEEEE---CCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--------
Q 043148           74 GKLGEGGFGGVYRGLL---SDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--------  140 (387)
                      +.||+|+||.||+++.   ..+|..+|+|++....  ......+..|++++.+++||||+++++++.+....        
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999876   3568899999996532  22345677899999999999999998876543221        


Q ss_pred             -----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          141 -----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       141 -----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                       .+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++....... .....
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~  157 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS  157 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence                             236789999999999999   999999999999999999999999999987543321 22334


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      ..|++.|+|||.+.+..++.++||||||+++|||++|+.||........   ..   ... ..        .  ...+..
T Consensus       158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~---~i~-~~--------~--~~~p~~  220 (318)
T cd05582         158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MT---MIL-KA--------K--LGMPQF  220 (318)
T ss_pred             ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HH---HHH-cC--------C--CCCCCC
Confidence            5689999999999988899999999999999999999999976442211   11   110 10        0  112223


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccCC
Q 043148          284 QMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFEA  317 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  317 (387)
                      ....+.+++.+||+.||.+||+     +++++.+.|+..
T Consensus       221 ~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         221 LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence            3455788999999999999999     677888887653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.6e-37  Score=290.05  Aligned_cols=230  Identities=21%  Similarity=0.269  Sum_probs=176.7

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH---------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL---------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~---------  140 (387)
                      +.||+|+||.||++....+++.||+|++....   ....+.+..|+.++.++ +||||+++++++.+....         
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999999999999999997542   23456688999999888 699999998876543221         


Q ss_pred             ----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          141 ----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 ----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                      .+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++..... .......
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~  156 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTF  156 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceecc
Confidence                            125689999999999999   99999999999999999999999999998743221 1223345


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .||+.|+|||++.+..++.++||||||+++|||++|+.||.............+........          ....+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~p~~~  226 (327)
T cd05617         157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK----------PIRIPRFL  226 (327)
T ss_pred             cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC----------CCCCCCCC
Confidence            68999999999999999999999999999999999999997543322222222222221111          11122233


Q ss_pred             HHHHHHHHHHhcCCCCCCCCC------HHHHHHHhccCC
Q 043148          285 MECLMIVGLWCCHPDFTNRPS------IRQVINVLNFEA  317 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs------~~evl~~l~~~~  317 (387)
                      +..+.+++.+||+.||.+|++      ++++++|.++..
T Consensus       227 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         227 SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            455788999999999999997      579999988754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.2e-37  Score=282.04  Aligned_cols=229  Identities=27%  Similarity=0.431  Sum_probs=177.9

Q ss_pred             hhCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCCccceehhhcchhh-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGSKQ-GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  139 (387)
                      .++|.+.+.||+|+||.||+|.+.+     ++..||||.+...... ..+.+.+|+++++.++||||+++++++..... 
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3567788899999999999998743     3578999998765443 46789999999999999999999987654321 


Q ss_pred             --------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc
Q 043148          140 --------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN  181 (387)
Q Consensus       140 --------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~  181 (387)
                                                            ..+..++.+++.||.|||+   ++++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence                                                  1235678999999999999   99999999999999999999


Q ss_pred             EEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 043148          182 AKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWV  259 (387)
Q Consensus       182 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~  259 (387)
                      +||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.   ...+
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~~  237 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IECI  237 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH
Confidence            99999999875432211 11122345678999999999999999999999999999998 9999975543221   1111


Q ss_pred             HHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          260 WDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                          ..+.         ....+...+..+.+++..||+.||.+||++.||++.|.
T Consensus       238 ----~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 ----TQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ----HcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                1111         11122234566889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.2e-37  Score=286.28  Aligned_cols=245  Identities=22%  Similarity=0.317  Sum_probs=180.8

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      ++|...+.||+|+||.||++.+..++..+|+|.+... ......++.+|++++.+++||||++++++|.+...       
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            3688899999999999999999989999999998654 23345678899999999999999999987654321       


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.|++.||.|||+.  .+++|+||||+|||++.++.+||+|||++......   ..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~  155 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MA  155 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc---cc
Confidence                              12367899999999999972  58999999999999999999999999998754332   12


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC---------------
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG---------------  266 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------------  266 (387)
                      ....++..|+|||.+.+..++.++|+||||+++|||++|+.||......................               
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            23467889999999988889999999999999999999999996543221111000000000000               


Q ss_pred             --chhhhhcc---cCCccc-cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          267 --QLLEAADG---RLSKEF-DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       267 --~~~~~~~~---~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                        ...+..+.   ...... .......+.+++.+||+.||++||++.+|++++|+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence              00000000   000000 1123456889999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.6e-37  Score=281.86  Aligned_cols=232  Identities=25%  Similarity=0.407  Sum_probs=177.0

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCe----EEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNT----EIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR---  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  138 (387)
                      .++|...+.||+|+||.||+|.+..++.    .||+|.+... .......+.+|+.++..++||||++++++|....   
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l   85 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL   85 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEE
Confidence            3567888999999999999999866665    4899998654 3344677889999999999999999988764321   


Q ss_pred             ----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          139 ----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       139 ----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                            ...+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence                                  11236789999999999999   99999999999999999999999999999866432


Q ss_pred             CCce-eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          197 LGSQ-TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       197 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      .... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.......   ...+    ...+.       
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~-------  228 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDL----LEKGE-------  228 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCC-------
Confidence            2111 112234678999999988889999999999999999998 899987543221   1111    11110       


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                        ....+...+..+.+++.+||+.||.+||++.++++.+....
T Consensus       229 --~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         229 --RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             --cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence              11112234456788999999999999999999998886443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.3e-37  Score=284.62  Aligned_cols=234  Identities=22%  Similarity=0.345  Sum_probs=185.3

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      .+|...+.||.|+||.||+|....+++.|++|.+........+.+.+|+.+++.++||||+++++++.+...        
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            468889999999999999999988899999999976655556788999999999999999999998754322        


Q ss_pred             ----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          140 ----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       140 ----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                      ..+..++.+++.||.|||+   .+++||||+|+||+++.++.+||+|||++........ ....
T Consensus        99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~  174 (296)
T cd06655          99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRST  174 (296)
T ss_pred             CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCC
Confidence                            1236788999999999999   9999999999999999999999999999876543321 1223


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      ..++..|+|||.+.+..++.++|||||||++|+|++|+.||..........   ...    ...       ......+..
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~---~~~----~~~-------~~~~~~~~~  240 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIA----TNG-------TPELQNPEK  240 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH----hcC-------CcccCCccc
Confidence            457889999999998889999999999999999999999997654322111   000    000       000111223


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPL  319 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  319 (387)
                      ....+.+++.+||+.||.+||++.+++++.|+....
T Consensus       241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             CCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            445678899999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.2e-37  Score=283.52  Aligned_cols=243  Identities=23%  Similarity=0.297  Sum_probs=177.0

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      +|...+.||+|+||.||+|+...++..||+|.+....  ....+.+.+|+.++..++||||+++++++.+...       
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4777889999999999999999889999999986542  2234678899999999999999999987754321       


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          ..+..++.|++.||.|||+   ++++||||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (285)
T cd07861          81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-  156 (285)
T ss_pred             CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence                                1125689999999999999   9999999999999999999999999999875543221 


Q ss_pred             eeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHH-HH-------HHHHhcc-Cchh
Q 043148          200 QTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV-EW-------VWDLYGK-GQLL  269 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~-~~-------~~~~~~~-~~~~  269 (387)
                      ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+..... ..       .|..... ....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            12233567889999988754 4788999999999999999999999765432211100 00       0000000 0000


Q ss_pred             hhhcc---cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          270 EAADG---RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       270 ~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .....   .............+.+++.+||+.||.+|||+.+|+++.|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            00000   00000111234567899999999999999999999998774

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.3e-37  Score=276.95  Aligned_cols=228  Identities=24%  Similarity=0.361  Sum_probs=181.3

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      ++|+..+.||+|+||.||+|....++..+++|.+.....  .+++.+|+++++.++||||+++++++.+...        
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578888999999999999999988889999999865432  6789999999999999999999987755422        


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~  156 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR  156 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence                              1236789999999999999   9999999999999999999999999999876544321 22


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD  281 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (387)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........       ...     ...+  ....+
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~-----~~~~--~~~~~  222 (256)
T cd06612         157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPN-----KPPP--TLSDP  222 (256)
T ss_pred             ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hcc-----CCCC--CCCch
Confidence            334578899999999988899999999999999999999999975433221100       000     0000  11122


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          282 ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       282 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ......+.+++.+||+.||.+|||+.|++++.|+
T Consensus       223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             hhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            3345568899999999999999999999998764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.8e-37  Score=278.22  Aligned_cols=227  Identities=28%  Similarity=0.451  Sum_probs=176.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      .++|.+.+.||+|+||.||+|.... +..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.+..        
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEec
Confidence            3567888999999999999998764 66799999875433 3567999999999999999999988764321        


Q ss_pred             ------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          139 ------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       139 ------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                        ...+..++.+++.||.|||+   ++++||||||+||++++++.++|+|||++..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence                              11236789999999999999   999999999999999999999999999997654332111


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+   .....    .         ......
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~---------~~~~~~  223 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQV----E---------RGYRMP  223 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----H---------cCCCCC
Confidence            122234568999999988889999999999999999999 899997543221   11111    0         111112


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .+...+..+.+++.+||+.+|.+|||++++++.|+
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  258 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE  258 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence            23344566899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.6e-37  Score=282.84  Aligned_cols=230  Identities=25%  Similarity=0.347  Sum_probs=177.9

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------  140 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------  140 (387)
                      |+..+.||+|+||.||++.+..+++.||+|.+....   ......+.+|+.++..++|+||+.+++.+.+....      
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            666788999999999999999999999999986542   22235577899999999999999998765442211      


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           .+..++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence                                 125678999999999999   999999999999999999999999999987543321  


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..................             ....
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-------------~~~~  223 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-------------VQEE  223 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-------------hhhh
Confidence            112346889999999999888999999999999999999999999764432211111111000             0011


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  317 (387)
                      ........+.+++..||+.||.+|||     ++|+++|.|+..
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            12223445788999999999999999     999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.3e-37  Score=281.72  Aligned_cols=230  Identities=24%  Similarity=0.429  Sum_probs=175.8

Q ss_pred             HhhCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  139 (387)
                      ..++|+..+.||+|+||.||+|.+.+     .+..||+|.+.... .....++.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            46779999999999999999998642     35679999986432 3345678999999999999999999987654211


Q ss_pred             -----------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEE
Q 043148          140 -----------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKL  184 (387)
Q Consensus       140 -----------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl  184 (387)
                                                         ..+..++.+++.||.|||+   ++++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence                                               1234578899999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCce-eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 043148          185 GDFGLARLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDL  262 (387)
Q Consensus       185 ~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~  262 (387)
                      +|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.........       ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~-------~~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL-------RF  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HH
Confidence            9999987543321111 112234678999999998889999999999999999999 78898754432111       11


Q ss_pred             hccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          263 YGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ......         ...+...+..+.+++.+||+.||.+|||+.|+++++.
T Consensus       234 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 VMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            111111         1112233456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.7e-37  Score=281.23  Aligned_cols=231  Identities=22%  Similarity=0.325  Sum_probs=179.8

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----------  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----------  139 (387)
                      |++.+.||+|+||.||+|.+..++..+++|.+........+.+.+|+++++.++||||+++++++.....          
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            4567789999999999999999899999999977666667789999999999999999999987654321          


Q ss_pred             ----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          140 ----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       140 ----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                      ..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....... .....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~  162 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS  162 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-ccccc
Confidence                            1235688999999999999   999999999999999999999999999987543321 12233


Q ss_pred             eecCCcccCchhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          204 LAGTMGYLAPECVT-----TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       204 ~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ..++..|+|||.+.     +..++.++|||||||++|||++|+.||.........      ...... .     .+.  .
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~-~-----~~~--~  228 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKS-E-----PPT--L  228 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH------HHHhhc-C-----CCC--C
Confidence            46788999999874     345778999999999999999999999754322111      010000 0     000  0


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ..+...+..+.+++.+||+.||.+||++.+++++.++...
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            1122334568899999999999999999999999987653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.1e-37  Score=282.02  Aligned_cols=225  Identities=25%  Similarity=0.309  Sum_probs=170.4

Q ss_pred             ccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------------
Q 043148           76 LGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------------  140 (387)
Q Consensus        76 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------------  140 (387)
                      ||+|+||.||++....+|+.+|+|.+....   ......+..|++++++++||||+++++++.+....            
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999999999999999986432   12234556799999999999999998876543221            


Q ss_pred             ---------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeee
Q 043148          141 ---------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA  205 (387)
Q Consensus       141 ---------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  205 (387)
                                     .+..++.|++.||+|||+   ++++||||||+||+++.++.++|+|||++......  .......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence                           124678899999999999   99999999999999999999999999998765432  1223346


Q ss_pred             cCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHH
Q 043148          206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM  285 (387)
Q Consensus       206 g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (387)
                      |+..|+|||++.+..++.++|||||||++|||++|+.||........  .........         ...... ......
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~---------~~~~~~-~~~~~~  223 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL---------EDEVKF-EHQNFT  223 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh---------cccccc-ccccCC
Confidence            88999999999988899999999999999999999999975432211  111111111         000100 011234


Q ss_pred             HHHHHHHHHhcCCCCCCCCCH----HHHHHHhccCC
Q 043148          286 ECLMIVGLWCCHPDFTNRPSI----RQVINVLNFEA  317 (387)
Q Consensus       286 ~~l~~l~~~cl~~dp~~RPs~----~evl~~l~~~~  317 (387)
                      ..+.+++.+||+.||.+||++    ++++.|.|+..
T Consensus       224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         224 EESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             HHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence            557899999999999999999    55667777643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.7e-37  Score=282.15  Aligned_cols=229  Identities=26%  Similarity=0.418  Sum_probs=177.3

Q ss_pred             hCccccCcccccCceEEEEEEEC-----CCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLS-----DQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      ++|.+.+.||+|+||.||++...     .++..+|+|.+........+.+.+|++++.+++||||+++++++.....   
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56788899999999999999852     3456799999977666667789999999999999999999987654221   


Q ss_pred             -----------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEE
Q 043148          140 -----------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKL  184 (387)
Q Consensus       140 -----------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl  184 (387)
                                                         ..+..++.|++.||+|||+   ++++||||||+||+++.++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence                                               1235688999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 043148          185 GDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDL  262 (387)
Q Consensus       185 ~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~  262 (387)
                      +|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.   .    ..
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~----~~  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---I----EC  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HH
Confidence            99999975533211 11122334678999999998889999999999999999998 8999865443211   1    11


Q ss_pred             hccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          263 YGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ...+...         ..+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus       235 i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~  278 (288)
T cd05093         235 ITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN  278 (288)
T ss_pred             HHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            1111110         1111234458899999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=278.12  Aligned_cols=226  Identities=26%  Similarity=0.441  Sum_probs=173.5

Q ss_pred             ccccCcccccCceEEEEEEECCC---CeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQ---NTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      |...+.||+|+||.||+|.+..+   +..||+|.+...  .......+.+|++.++.++||||+++++++.+...     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            45678899999999999997653   378999998754  23445688999999999999999999986533221     


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccc
Q 043148          140 --------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF  187 (387)
Q Consensus       140 --------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  187 (387)
                                                      ..+..++.|++.||.|||+   ++++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence                                            1125688999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcc
Q 043148          188 GLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGK  265 (387)
Q Consensus       188 g~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  265 (387)
                      |+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+   ..++..    .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~----~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLR----H  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----c
Confidence            999865432211 1122234678999999988889999999999999999999 889986543221   111111    1


Q ss_pred             CchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          266 GQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      +.         ....+...+..+.+++.+||+.||++||++.|+++.|.
T Consensus       231 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~  270 (273)
T cd05035         231 GN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE  270 (273)
T ss_pred             CC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11         11122334566889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.8e-37  Score=280.92  Aligned_cols=229  Identities=26%  Similarity=0.394  Sum_probs=175.4

Q ss_pred             hhCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  140 (387)
                      .++|...+.||+|+||.||+|.+..     .+..||+|.+.... ......+..|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678889999999999999999976     67889999886543 33456799999999999999999999875433211


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC---cEEEc
Q 043148          141 --------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF---NAKLG  185 (387)
Q Consensus       141 --------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kl~  185 (387)
                                                      .+..++.+|+.||.|||+   ++++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence                                            124688999999999999   8999999999999998765   58999


Q ss_pred             cccccccccCCCCce-eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHh
Q 043148          186 DFGLARLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLY  263 (387)
Q Consensus       186 Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  263 (387)
                      |||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||..........       ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~-------~~  234 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME-------FV  234 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HH
Confidence            999998653221111 112223567999999998889999999999999999997 999997644322111       11


Q ss_pred             ccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ...         .....+...+..+.+++.+||+.+|.+||++.+|+++|.
T Consensus       235 ~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            110         111122333456889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.4e-36  Score=277.44  Aligned_cols=225  Identities=27%  Similarity=0.447  Sum_probs=172.7

Q ss_pred             cccCcccccCceEEEEEEECCCCe--EEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           71 AEAGKLGEGGFGGVYRGLLSDQNT--EIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        71 ~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      .+.+.||+|+||.||+|.+..++.  .+|+|.++..  .....+.+..|++++..++||||++++++|....        
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456789999999999999877664  6999988654  3445678899999999999999999988652110        


Q ss_pred             -----------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccc
Q 043148          139 -----------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL  189 (387)
Q Consensus       139 -----------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~  189 (387)
                                                   ...+..++.|++.||.|||+   ++|+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence                                         11135788999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCc
Q 043148          190 ARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQ  267 (387)
Q Consensus       190 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (387)
                      ++........ ......+++.|++||.+.+..++.++||||||+++|||++ |+.||.......   .    ......+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---I----YDYLRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHcCC
Confidence            9866432211 1122345678999999998889999999999999999999 888987543221   1    11111111


Q ss_pred             hhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          268 LLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .         ...+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       232 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  269 (272)
T cd05075         232 R---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE  269 (272)
T ss_pred             C---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            1         0111233455889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4e-37  Score=289.26  Aligned_cols=235  Identities=21%  Similarity=0.252  Sum_probs=176.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ++|...+.||+|+||.||+++...+++.||+|.+.+.   .......+.+|..++..++|+||+++++++.+.+..    
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4788899999999999999999999999999998652   223345678899999999999999998876543221    


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence                                  225678899999999999   9999999999999999999999999999976654333


Q ss_pred             ceeeeeecCCcccCchhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          199 SQTTVLAGTMGYLAPECVTT-----GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      .......|++.|+|||++.+     ..++.++||||||+++|||++|+.||......+..      ..........    
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~~~----  227 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHEERF----  227 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH------HHHHcCCCcc----
Confidence            23334568999999999875     46789999999999999999999999754422111      1111110000    


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhccCC
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTN--RPSIRQVINVLNFEA  317 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~l~~~~  317 (387)
                       .+. ......+..+.+++.+|+..++++  |++++++++|.|+..
T Consensus       228 -~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         228 -QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             -cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence             011 111123456778888888766544  579999999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.2e-37  Score=282.72  Aligned_cols=241  Identities=22%  Similarity=0.329  Sum_probs=177.2

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      +|...+.||+|+||.||+|++..+|..+|+|.+....  ......+.+|+++++.++||||+++++++.+...       
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777889999999999999999999999999986532  2234567889999999999999999887654322       


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.||++||.|||+   ++++||||||+||+++.++.+||+|||+++....... ..
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~  156 (284)
T cd07839          81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CY  156 (284)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-Cc
Confidence                              1236789999999999999   9999999999999999999999999999976543221 12


Q ss_pred             eeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc------hhhhhcc
Q 043148          202 TVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ------LLEAADG  274 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~  274 (387)
                      ....+++.|+|||.+.+.. ++.++||||||+++|||++|..|+.......  ..............      .....+.
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            2345688999999987654 7899999999999999999999865433221  11111111110000      0000000


Q ss_pred             ----cCC-----ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          275 ----RLS-----KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       275 ----~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                          ...     .......+..+.+++.+||+.||.+|||+++++++.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                000     01112245667899999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=291.04  Aligned_cols=222  Identities=25%  Similarity=0.287  Sum_probs=166.9

Q ss_pred             ccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcC---CCCCccceehhhcchhh----------
Q 043148           76 LGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRL---RHRNLVHLIGWCHEQRQ----------  139 (387)
Q Consensus        76 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----------  139 (387)
                      ||+|+||.||+|++..++..||||++....   ......+..|..++...   +||||+++++++.+...          
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999986432   12234455677777655   69999998876544321          


Q ss_pred             ---------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          140 ---------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       140 ---------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                     ..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++....... ......
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~  156 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTF  156 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCc
Confidence                           1225688999999999999   999999999999999999999999999987532221 222345


Q ss_pred             ecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          205 AGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      .||+.|+|||.+.+. .++.++|||||||++|||++|+.||........       ......+.      ..+..   ..
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~------~~~~~---~~  220 (330)
T cd05586         157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-------YRNIAFGK------VRFPK---NV  220 (330)
T ss_pred             cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-------HHHHHcCC------CCCCC---cc
Confidence            689999999998764 489999999999999999999999976432211       11111111      01111   12


Q ss_pred             HHHHHHHHHHHhcCCCCCCCC----CHHHHHHHhccCC
Q 043148          284 QMECLMIVGLWCCHPDFTNRP----SIRQVINVLNFEA  317 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RP----s~~evl~~l~~~~  317 (387)
                      ....+.+++.+||+.||.+||    ++.++++|.|+..
T Consensus       221 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         221 LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence            345577899999999999998    7999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-37  Score=277.82  Aligned_cols=225  Identities=27%  Similarity=0.439  Sum_probs=172.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      .+|...+.||+|+||.||++.+.. +..+|+|.+.... .....+.+|+++++.++||||+++++++.+...        
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            346778899999999999998864 6689999986432 234678899999999999999999887644321        


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        .....++.|++.||+|||+   ++++||||||+||+++.++.+||+|||+++..........
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence                              1236789999999999999   9999999999999999999999999999876543221111


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..   ..    ....         .....
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~----~~~~---------~~~~~  222 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---ES----VSAG---------YRLYR  222 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---HH----HHcC---------CcCCC
Confidence            12223457999999998889999999999999999999 89999754432211   11    1110         11111


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINVL  313 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  313 (387)
                      +...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            223455688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-37  Score=279.73  Aligned_cols=231  Identities=22%  Similarity=0.361  Sum_probs=183.3

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      ++|...+.||.|+||.||+|.+..++..+|+|.+.... ......+.+|+++++.++|+||+++++++.+...       
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36778889999999999999999899999999986543 3445678899999999999999999987654321       


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          140 -----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       140 -----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                       ..+..++.|++.||.|||+   ++++|+||+|+||++++++.++|+|||+++...... ....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  156 (274)
T cd06609          81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRN  156 (274)
T ss_pred             eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cccc
Confidence                             2236789999999999999   999999999999999999999999999998765432 1223


Q ss_pred             eeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          203 VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       203 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|+.||........   ..   . ....         .......
T Consensus       157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~---~-~~~~---------~~~~~~~  220 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LF---L-IPKN---------NPPSLEG  220 (274)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HH---H-hhhc---------CCCCCcc
Confidence            34578889999999988899999999999999999999999975442211   10   0 0000         1111111


Q ss_pred             H-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          283 R-QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       283 ~-~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      . .+..+.+++.+||..||.+|||+++++++.|+...
T Consensus       221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         221 NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence            1 45568889999999999999999999999987653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9e-37  Score=277.43  Aligned_cols=227  Identities=27%  Similarity=0.444  Sum_probs=176.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      .++|.+.++||+|+||.||+|.+.++ ..||+|.+.... ...+++.+|+++++.++||||+++++++.+..        
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcC
Confidence            35688899999999999999998764 569999987533 23567899999999999999999988653321        


Q ss_pred             ------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          139 ------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       139 ------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                        ...+..++.+++.||+|||+   ++++||||||+||+++.++.+||+|||.++.........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence                              01235788999999999999   999999999999999999999999999997664432222


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      .....++..|+|||...+..++.++||||||+++|||++ |..||.........       ......         ....
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-------~~~~~~---------~~~~  223 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERG---------YRMP  223 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-------HHHhcC---------CCCC
Confidence            223345678999999988889999999999999999999 88888755432111       111010         0111


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .....+..+.+++.+|++.||.+||++.++++.|+
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~  258 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE  258 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            22345566889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.3e-37  Score=281.53  Aligned_cols=231  Identities=22%  Similarity=0.351  Sum_probs=178.1

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcchh-----
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQR-----  138 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  138 (387)
                      .+.+.|...+.||+|+||.||+|....+++.||+|.+.... .....+..|+.++..+ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677888899999999999999999999999999986543 3456788999999998 7999999998764321     


Q ss_pred             ----------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccc
Q 043148          139 ----------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA  190 (387)
Q Consensus       139 ----------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~  190 (387)
                                                  ...+..++.|++.||.|||+   ++++|+||+|+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence                                        11125688999999999999   99999999999999999999999999998


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVT-----TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGK  265 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  265 (387)
                      ....... .......|++.|+|||++.     +..++.++|||||||++|||++|+.||..........      . ...
T Consensus       159 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~-~~~  230 (272)
T cd06637         159 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------L-IPR  230 (272)
T ss_pred             eeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------H-Hhc
Confidence            7654322 1223456888999999986     3457889999999999999999999996543221110      0 000


Q ss_pred             CchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          266 GQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ..     ..   .......+..+.+++.+||+.||.+|||+.+++++.|+
T Consensus       231 ~~-----~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         231 NP-----AP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CC-----CC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            00     00   01111234457899999999999999999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.4e-37  Score=277.52  Aligned_cols=227  Identities=25%  Similarity=0.455  Sum_probs=176.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .++|...++||+|+||.||+|...+ +..||+|.+.... ....++.+|+.+++.++|+||+++++++.+...       
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcC
Confidence            4668888999999999999999765 7889999986543 335688999999999999999999887543210       


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         .....++.+++.||+|||+   .+++||||||+||+++.++.++|+|||++..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence                               1125688999999999998   999999999999999999999999999997655322222


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||..........   .    ....         ....
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~----~~~~---------~~~~  223 (260)
T cd05067         160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ---N----LERG---------YRMP  223 (260)
T ss_pred             ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH---H----HHcC---------CCCC
Confidence            222345678999999988889999999999999999999 999997654322111   1    1111         1111


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .+...+..+.+++.+||+.+|++||+++++++.|.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence            22233456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.1e-37  Score=281.73  Aligned_cols=244  Identities=23%  Similarity=0.308  Sum_probs=175.9

Q ss_pred             hCccccCcccccCceEEEEEEE----CCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLL----SDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-----  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  138 (387)
                      ++|...+.||+|+||.||++..    ..++..||+|.+........+.+.+|++++..++||||+++++++....     
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4677888999999999999984    3467899999998776666778999999999999999999988653211     


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ...+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence                                   01125688999999999999   9999999999999999999999999999986543


Q ss_pred             CCCce--eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH-HHHHhccCchhhhh
Q 043148          196 ELGSQ--TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW-VWDLYGKGQLLEAA  272 (387)
Q Consensus       196 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  272 (387)
                      .....  .....++..|+|||.+.+..++.++||||||+++|||++|..|+....... ...... .........+.+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-MRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-hhhcccccccccchHHHHHHH
Confidence            22111  111223446999999988889999999999999999999887754322110 000000 00000000011111


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ........+...+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            1111111223345568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=283.85  Aligned_cols=245  Identities=24%  Similarity=0.364  Sum_probs=184.0

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      ++|+..+.||+|+||.||+|.+.+++..||+|.+...  .....+.+.+|+++++.++|+||+++++++.+....     
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3688889999999999999999988999999998653  233457889999999999999999999987653321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          .+..++.+++.||.|||+   ++++|+||+|+||++++++.+||+|||++..........
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence                                235788999999999999   999999999999999999999999999988665443223


Q ss_pred             eeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH--------Hhc-cCchh-
Q 043148          201 TTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWD--------LYG-KGQLL-  269 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~--------~~~-~~~~~-  269 (387)
                      .....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+..........        ... ..... 
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            3345678899999999887 789999999999999999999999976543322111111100        000 00000 


Q ss_pred             ----hhhccc-CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          270 ----EAADGR-LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       270 ----~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                          +..+.. ....++...+..+.+++.+||+.+|++||++++++++.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                000000 0001122236778999999999999999999999998774

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=9.2e-37  Score=286.99  Aligned_cols=235  Identities=20%  Similarity=0.238  Sum_probs=174.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ++|...+.||+|+||.||++++..+++.+|+|.+.+.   .......+.+|+.++..++|+||+++++++.+....    
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4688899999999999999999999999999998642   122344578899999999999999998766443211    


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence                                  235688899999999999   9999999999999999999999999999875433322


Q ss_pred             ceeeeeecCCcccCchhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          199 SQTTVLAGTMGYLAPECVT-----TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.........      ..........    
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~~~----  227 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKERF----  227 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH------HHHhCCCccc----
Confidence            2233456899999999986     345889999999999999999999999754422211      1111110000    


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCC--CCCCHHHHHHHhccCC
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFT--NRPSIRQVINVLNFEA  317 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~--~RPs~~evl~~l~~~~  317 (387)
                       .. .......+..+.+++.+|+..++.  .|++++++++|.|+..
T Consensus       228 -~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         228 -QF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             -cC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence             00 011122345567778887755444  4789999999998753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-36  Score=276.96  Aligned_cols=230  Identities=27%  Similarity=0.380  Sum_probs=178.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      ++|...+.||+|+||.||++....++..+|||.+...   ......++.+|+++++.++||||+++++++.+...     
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677788999999999999999888999999987653   23345688899999999999999999987654221     


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                              ..+..++.+++.||.|||+   ++++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence                                    1225678999999999999   9999999999999999999999999999876543


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      ... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .....    ..     .   ...
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~----~~-----~---~~~  224 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK----KI-----E---QCD  224 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhh----hh-----h---cCC
Confidence            221 1223457889999999988889999999999999999999999996543211 11110    00     0   001


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ............+.+++.+||+.||.+|||+.+|++.+.
T Consensus       225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~  263 (267)
T cd08229         225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAK  263 (267)
T ss_pred             CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence            111112335567889999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.4e-36  Score=286.58  Aligned_cols=246  Identities=20%  Similarity=0.236  Sum_probs=185.4

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-----  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  138 (387)
                      ..++|...+.||+|+||.||+|....+++.||+|.+...  .......+.+|+.+++.++||||+++++++....     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999999989999999998643  3334567788999999999999999988764221     


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ...+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+++....
T Consensus        94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence                                   11235689999999999999   9999999999999999999999999999986543


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC---------
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG---------  266 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  266 (387)
                      ..  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+......   .+.......         
T Consensus       171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         171 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN---KIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             CC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHhcCCCCHHHHHHhh
Confidence            22  1223457889999999999999999999999999999999999997654322111   111100000         


Q ss_pred             ----------------chhhhhcccC----CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 043148          267 ----------------QLLEAADGRL----SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPL  319 (387)
Q Consensus       267 ----------------~~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  319 (387)
                                      .+.+......    ...........+.+++.+||+.||.+|||+.|++++.|+..-.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~  318 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY  318 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence                            0001110000    0111223455678999999999999999999999999876433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-37  Score=288.49  Aligned_cols=247  Identities=19%  Similarity=0.266  Sum_probs=182.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  138 (387)
                      .++|.+.+.||+|+||.||+|.+..+|..||+|.+.... ......+.+|+.++++++||||+++++++....       
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            478999999999999999999999899999999986432 234566888999999999999999988653321       


Q ss_pred             ---------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          139 ---------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       139 ---------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                           ...+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          84 YIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence                                 11235688999999999999   999999999999999999999999999987654321


Q ss_pred             Cc--eeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCch---hhh
Q 043148          198 GS--QTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL---LEA  271 (387)
Q Consensus       198 ~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  271 (387)
                      ..  ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........   ...+.........   ..+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHHHh
Confidence            11  1123457889999998754 4688999999999999999999999975432211   1111111111100   000


Q ss_pred             hc-----------ccCCc---cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 043148          272 AD-----------GRLSK---EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPL  319 (387)
Q Consensus       272 ~~-----------~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  319 (387)
                      .+           .....   .........+.+++.+||+.||.+|||+.|++++.|+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            00           00000   00112345688999999999999999999999999877544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.7e-37  Score=289.79  Aligned_cols=222  Identities=26%  Similarity=0.322  Sum_probs=167.9

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHH-HHhcCCCCCccceehhhcchhhH---------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVR-IISRLRHRNLVHLIGWCHEQRQL---------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~---------  140 (387)
                      +.||+|+||.||++++..++..||+|++....   ......+..|.. +++.++||||+++++++.+....         
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999999989999999986532   122334444544 56788999999998876543321         


Q ss_pred             ----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          141 ----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 ----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                      .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... .......
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~  156 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTF  156 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCcccc
Confidence                            125688999999999999   99999999999999999999999999998753222 1223345


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .|++.|+|||++.+..++.++|||||||++|||++|+.||......+.   ...+.    ..        .  .......
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~----~~--------~--~~~~~~~  219 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNIL----NK--------P--LQLKPNI  219 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHHHH----hC--------C--cCCCCCC
Confidence            689999999999999999999999999999999999999975443211   11111    00        0  1112233


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHH----HHHHHhccC
Q 043148          285 MECLMIVGLWCCHPDFTNRPSIR----QVINVLNFE  316 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs~~----evl~~l~~~  316 (387)
                      ...+.+++.+|++.||.+||++.    ++.+++++.
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~  255 (325)
T cd05602         220 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFS  255 (325)
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccC
Confidence            45578899999999999999865    777777653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.3e-36  Score=276.99  Aligned_cols=230  Identities=24%  Similarity=0.391  Sum_probs=175.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-----hhhHHHHHHHHHHHhcCCCCCccceehhhcchh--h-
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-----KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--Q-  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~-  139 (387)
                      .+|...+.||+|+||.||+|....++..|++|.+....     ......+.+|+.+++.++||||+++++++.+..  . 
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888899999999999999998889999999886432     223456889999999999999999998764321  0 


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                              .....++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||+++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence                                    1125689999999999998   9999999999999999999999999999875533


Q ss_pred             CC--CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          196 EL--GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       196 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ..  ........++..|+|||.+.+..++.++||||||+++|||++|+.||.........      ....         .
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~---------~  223 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIA---------T  223 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHh---------c
Confidence            11  11112345788999999999888999999999999999999999999754322111      1110         0


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .......+......+..++ .||..+|.+||+++||++|.++.
T Consensus       224 ~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         224 QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            0111222333344455565 68889999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-36  Score=276.70  Aligned_cols=228  Identities=23%  Similarity=0.420  Sum_probs=177.5

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCChh---------hHHHHHHHHHHHhcCCCCCccceehhhcchhh
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ---------GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  139 (387)
                      +|.....||+|+||.||+|....++..+|+|.+......         ..+.+.+|+.+++.++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            366778999999999999999888899999988654221         12568899999999999999999987654322


Q ss_pred             H-------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          140 L-------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       140 ~-------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                      .                         .+..++.+++.||.|||+   .+++||||+|+||+++.++.++|+|||+++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            1                         225789999999999999   999999999999999999999999999988665


Q ss_pred             CCCC-----ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh
Q 043148          195 HELG-----SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL  269 (387)
Q Consensus       195 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (387)
                      ....     .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.........      ....      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~------  225 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI------FKIG------  225 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH------HHHh------
Confidence            3211     1111234788999999999888999999999999999999999999764322111      1100      


Q ss_pred             hhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .    ......+...+..+.+++.+||+.||.+||++.+++++.++
T Consensus       226 ~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         226 E----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             c----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            0    11122233345668889999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.2e-37  Score=281.13  Aligned_cols=242  Identities=27%  Similarity=0.360  Sum_probs=176.6

Q ss_pred             ccccCcccccCceEEEEEEE----CCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           70 FAEAGKLGEGGFGGVYRGLL----SDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      |...+.||+|+||.||++..    ..++..||+|.+.... ......+.+|+++++.++||||+++++++.....     
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37788999999999988653    3457889999987543 3346778899999999999999999997643211     


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           ..+..++.|++.||.|||+   ++++||||||+|||+++++.+||+|||+++.......
T Consensus        86 v~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          86 IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             EecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence                                 1126789999999999999   9999999999999999999999999999976543211


Q ss_pred             c--eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          199 S--QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       199 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                      .  ......++..|+|||.+....++.++||||||+++|||++|+.|+....... .................+..+...
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLERGM  241 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhcCC
Confidence            1  1112234567999999988889999999999999999999999986543211 000100000000011112222222


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ....+...+..+.+++..||+.+|.+|||++++++.|+.
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~  280 (283)
T cd05080         242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE  280 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            222233445678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8e-37  Score=282.18  Aligned_cols=232  Identities=23%  Similarity=0.323  Sum_probs=181.0

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      +.|.+.+.||+|+||.||+|.+..++..+++|.+........+.+.+|+++++.++||||+++++++.....        
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            567888999999999999999999899999999987766677889999999999999999999987643221        


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.|++.+|.|||+   .+++||||||+||+++.++.+||+|||++....... ...
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~  167 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRR  167 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccc
Confidence                              1236789999999999999   999999999999999999999999999986543221 122


Q ss_pred             eeeecCCcccCchhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          202 TVLAGTMGYLAPECVT-----TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                      ....+++.|+|||.+.     ...++.++|||||||++|||++|..||........      ..... ...     .+. 
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~-~~~-----~~~-  234 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIA-KSE-----PPT-  234 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHh-cCC-----Ccc-
Confidence            3445788999999884     34568899999999999999999999875432111      11110 000     000 


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                       ...+......+.+++.+||+.||.+||++++++++.++..
T Consensus       235 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  274 (292)
T cd06644         235 -LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS  274 (292)
T ss_pred             -CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence             0112233456788999999999999999999999988643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.2e-37  Score=281.19  Aligned_cols=229  Identities=22%  Similarity=0.290  Sum_probs=176.7

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      |...+.||+|+||.||+|.+..+++.+|+|.+....   ......+.+|++++..++|+||+.+.+++.+...       
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566778999999999999999999999999986542   2233457889999999999999998876543221       


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          ..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++......  .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence                                1236788999999999999   99999999999999999999999999998754332  1


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||............   .......          ...
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~---~~~~~~~----------~~~  223 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV---DRRVLET----------EEV  223 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhhhcc----------ccc
Confidence            222346899999999999888999999999999999999999999764432211111   1111000          011


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFE  316 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~  316 (387)
                      ........+.+++..||+.||.+||+     +.+++++.++.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~  265 (285)
T cd05632         224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR  265 (285)
T ss_pred             cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhh
Confidence            22233445788999999999999999     88999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.5e-37  Score=280.45  Aligned_cols=244  Identities=24%  Similarity=0.341  Sum_probs=180.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      ++|+..+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|+++++.++|||++++++++......     
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999999889999999986432  22345688999999999999999999977554321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          .+..++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++........ .
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~  156 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D  156 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence                                236799999999999999   9999999999999999999999999999986644321 2


Q ss_pred             eeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------HHhccCch-hh
Q 043148          201 TTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW--------DLYGKGQL-LE  270 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~-~~  270 (387)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+.........        ..+..... ..
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            223456788999999876 457899999999999999999999998655432211111000        00000000 00


Q ss_pred             hhcccCCc-----cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          271 AADGRLSK-----EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       271 ~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ...+....     ......+..+.+++.+||+.||.+||++.|++.+.|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            00000000     0011235668899999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-36  Score=279.13  Aligned_cols=228  Identities=22%  Similarity=0.365  Sum_probs=180.0

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-------  140 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-------  140 (387)
                      .|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+++++.++||||+++++++......       
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3556678999999999999998889999999986543 34456788999999999999999999987554321       


Q ss_pred             -----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          141 -----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       141 -----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                       .+..++.+++.||.|||+   ++++|+||+|+||++++++.++|+|||++....... .....
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~  160 (277)
T cd06642          85 GGGSALDLLKPGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNT  160 (277)
T ss_pred             CCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhhhc
Confidence                             235788999999999999   999999999999999999999999999987654321 11223


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.|+..........       ..         ...........
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~---------~~~~~~~~~~~  224 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LI---------PKNSPPTLEGQ  224 (277)
T ss_pred             ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hh---------hcCCCCCCCcc
Confidence            457889999999998889999999999999999999999987543221110       00         01111122233


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .+..+.+++.+||+.+|.+||++.+++++.|+.
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06642         225 YSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT  257 (277)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence            456688999999999999999999999998864

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=9.2e-37  Score=280.45  Aligned_cols=228  Identities=25%  Similarity=0.407  Sum_probs=174.0

Q ss_pred             hCccccCcccccCceEEEEEEEC----CCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLS----DQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      .+|+..+.||+|+||.||+|.+.    .++..+++|.+.... ......+.+|+++++.++||||+++++++......  
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            45677889999999999999852    346789999987543 34456788999999999999999999875442211  


Q ss_pred             ----------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC
Q 043148          141 ----------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF  180 (387)
Q Consensus       141 ----------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~  180 (387)
                                                              .+..++.+++.||.|||+   ++++||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence                                                    124588999999999999   9999999999999999999


Q ss_pred             cEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 043148          181 NAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEW  258 (387)
Q Consensus       181 ~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~  258 (387)
                      .+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......   ..+ 
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~-  237 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIE-  237 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH-
Confidence            999999999976543211 11222335678999999988889999999999999999998 999986543211   111 


Q ss_pred             HHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          259 VWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                         ......         ....+...+..+.+++.+||+.||.+||++.+|+++|.
T Consensus       238 ---~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         238 ---MVRKRQ---------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             ---HHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence               111111         11122233456888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.6e-38  Score=295.65  Aligned_cols=226  Identities=23%  Similarity=0.383  Sum_probs=182.0

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCC----ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---------
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG----SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---------  139 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---------  139 (387)
                      ..+||+|+|-+||+|.+..+|..||.-.++..    +....++|..|+++|+.|+||||++++.++.+...         
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            45899999999999999999999987655332    34456889999999999999999999998866432         


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC-CCcEEEccccccccccCCCCce
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS-NFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                        ..+..|+.||++||.|||+. .++|||||||.+||||+. -|.+||+|+|+|.......   
T Consensus       125 ~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~---  200 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH---  200 (632)
T ss_pred             ccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc---
Confidence                              23478999999999999984 589999999999999985 5799999999999876543   


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      .....|||.|||||.+. ..|++.+||||||+.++||+|+..||.......++      +..+..|.....+.       
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI------YKKV~SGiKP~sl~-------  266 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI------YKKVTSGIKPAALS-------  266 (632)
T ss_pred             cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH------HHHHHcCCCHHHhh-------
Confidence            23368999999999887 78999999999999999999999999987765432      23333332222221       


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                       .-...++.++|.+|+.. ..+|||+.|+|++.++...
T Consensus       267 -kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  267 -KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             -ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence             11123478899999999 8999999999999887664

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.3e-37  Score=282.83  Aligned_cols=244  Identities=23%  Similarity=0.347  Sum_probs=179.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.+.....  ...+.+.+|+++++.++||||+++++++.+...      
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            467888999999999999999988899999999865422  235678899999999999999999998765332      


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++....... ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~  156 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV  156 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence                               1236789999999999999   999999999999999999999999999987654332 22


Q ss_pred             eeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------HHhccCchh-h
Q 043148          201 TTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW--------DLYGKGQLL-E  270 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~-~  270 (387)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.........        ......... .
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            223457889999998875 447889999999999999999999997544322111111000        000000000 0


Q ss_pred             hhcccCC-----ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          271 AADGRLS-----KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       271 ~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ...+...     .......+..+.+++.+||+.+|.+||++.+++++.|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0000000     00112345668899999999999999999999998774

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.3e-37  Score=302.97  Aligned_cols=250  Identities=20%  Similarity=0.273  Sum_probs=172.8

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCe-EEEEEE--------------ec---CCChhhHHHHHHHHHHHhcCCCCC
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNT-EIAVKR--------------VS---RGSKQGKKEYISEVRIISRLRHRN  126 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~n  126 (387)
                      ...++|.+.+.||+|+||.||++.++.... ..+.|.              +.   .........+.+|+++|..++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            346789999999999999999987643221 112111              10   112223456889999999999999


Q ss_pred             ccceehhhcchhhH-----------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC
Q 043148          127 LVHLIGWCHEQRQL-----------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD  177 (387)
Q Consensus       127 iv~l~~~~~~~~~~-----------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~  177 (387)
                      |+++++++.+....                             .+..++.|++.||.|||+   ++|+||||||+|||++
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~  301 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN  301 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence            99999876543321                             124689999999999999   9999999999999999


Q ss_pred             CCCcEEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCC-CCCCCCcchhhHH
Q 043148          178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP-VEPRQEPSKVRLV  256 (387)
Q Consensus       178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p-~~~~~~~~~~~~~  256 (387)
                      .++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|..+ +..........+.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999999987654333233345789999999999999999999999999999999998754 4433222111111


Q ss_pred             HHHHHHhcc--C-------chhhhhcc----cCCcccc-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          257 EWVWDLYGK--G-------QLLEAADG----RLSKEFD-----ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       257 ~~~~~~~~~--~-------~~~~~~~~----~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      . +...+..  .       .+.+.++.    ......+     ......+.+++.+||+.||++|||+.|+++|.|+...
T Consensus       382 ~-~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        382 K-IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             H-HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            1 1110000  0       00000000    0000000     0122346678899999999999999999999997653

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.3e-36  Score=281.44  Aligned_cols=227  Identities=24%  Similarity=0.384  Sum_probs=173.4

Q ss_pred             hCccccCcccccCceEEEEEEECCCCe--EEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNT--EIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~----  139 (387)
                      ++|.+.+.||+|+||.||+|.+..++.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++.+...    
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            568888999999999999999877664  4788888643 334456789999999999 79999999887643211    


Q ss_pred             -------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcE
Q 043148          140 -------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA  182 (387)
Q Consensus       140 -------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  182 (387)
                                                           ..+..++.|++.||+|||+   ++++||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence                                                 1236788999999999999   999999999999999999999


Q ss_pred             EEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 043148          183 KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWD  261 (387)
Q Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~  261 (387)
                      ||+|||++......  ........+..|+|||.+....++.++||||||+++|||++ |..||......+.   ..    
T Consensus       159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~~----  229 (297)
T cd05089         159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---YE----  229 (297)
T ss_pred             EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----
Confidence            99999998643221  11111223557999999988889999999999999999997 9999975443211   11    


Q ss_pred             HhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          262 LYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ..         ........+...+..+.+++..||+.+|.+||+++++++.|..
T Consensus       230 ~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  274 (297)
T cd05089         230 KL---------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR  274 (297)
T ss_pred             HH---------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            11         1111111222344568899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.8e-36  Score=280.21  Aligned_cols=236  Identities=25%  Similarity=0.375  Sum_probs=177.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCC----------------eEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccc
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQN----------------TEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVH  129 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  129 (387)
                      .++|.+.+.||+|+||.||++.+...+                ..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            467888999999999999999876533                568999987653 345678899999999999999999


Q ss_pred             eehhhcchh------------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcce
Q 043148          130 LIGWCHEQR------------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSN  173 (387)
Q Consensus       130 l~~~~~~~~------------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~N  173 (387)
                      ++++|....                                    ...+..++.|++.||.|||+   .+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence            998764421                                    11235788999999999999   999999999999


Q ss_pred             eEeCCCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh--CCCCCCCCCCc
Q 043148          174 VVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC--GRKPVEPRQEP  250 (387)
Q Consensus       174 ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t--g~~p~~~~~~~  250 (387)
                      |+++.++.++|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999875433211 11223345678999999988889999999999999999998  67788654322


Q ss_pred             chhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          251 SKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .   ........+.....      ......+...+..+.+++.+||+.||.+|||+.||++.|.
T Consensus       241 ~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q---VIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H---HHHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            2   12222211111110      1111112233456899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=283.43  Aligned_cols=232  Identities=21%  Similarity=0.256  Sum_probs=181.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      ++|...+.||+|+||.||++....++..+|+|.+.....   ...+.+..|++++..++||||+++++.+.+...     
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            468888999999999999999998899999999976432   245678899999999999999999887644221     


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            .....++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence                                  1235688999999999999   999999999999999999999999999986543211


Q ss_pred             Cc----------------------------eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 043148          198 GS----------------------------QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE  249 (387)
Q Consensus       198 ~~----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~  249 (387)
                      ..                            ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                            01123578899999999988899999999999999999999999976543


Q ss_pred             cchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHHhccCC
Q 043148          250 PSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPS----IRQVINVLNFEA  317 (387)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs----~~evl~~l~~~~  317 (387)
                      .....               .+.............+..+.+++.+||+.||.+||+    ++|++++.|+..
T Consensus       238 ~~~~~---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         238 DETFS---------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             HHHHH---------------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence            22110               111111111111225667899999999999999999    999999988754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=278.98  Aligned_cols=234  Identities=21%  Similarity=0.350  Sum_probs=183.4

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .++|.+.+.||.|+||.||++.+..++..+|+|.+........+.+..|++++++++||||+++++++.+...       
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            4568888999999999999999988899999999987666667789999999999999999999987654322       


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~  159 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QK  159 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc-cc
Confidence                               1236789999999999999   999999999999999999999999999987544322 12


Q ss_pred             eeeeecCCcccCchhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          201 TTVLAGTMGYLAPECVT-----TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .....+++.|++||.+.     ...++.++||||||+++|||++|+.||.........      .... ....     + 
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~~~~-----~-  226 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL------LKIL-KSEP-----P-  226 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH------HHHh-cCCC-----C-
Confidence            23446888999999875     344678999999999999999999999765322111      1110 0000     0 


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                       ....+......+.+++..||+.+|.+||++.+++++.|+...
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         227 -TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             -CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence             011122344567889999999999999999999999987543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-36  Score=278.79  Aligned_cols=228  Identities=25%  Similarity=0.394  Sum_probs=176.3

Q ss_pred             hCccccCcccccCceEEEEEEEC-----CCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLS-----DQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      ++|...++||+|+||.||++...     .++..+|+|.+..........+.+|++++..++|+||+++++++.+...   
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            56777889999999999999742     3467899999887776777889999999999999999999987653211   


Q ss_pred             -------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcE
Q 043148          140 -------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA  182 (387)
Q Consensus       140 -------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  182 (387)
                                                           ..+..++.|++.||+|||+   ++++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence                                                 2235688999999999999   999999999999999999999


Q ss_pred             EEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 043148          183 KLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVW  260 (387)
Q Consensus       183 kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~  260 (387)
                      ||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....     
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-----  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC-----  236 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH-----
Confidence            9999999875533211 11122234678999999998889999999999999999998 8999865443221110     


Q ss_pred             HHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                        ...+         .....+...+..+.+++.+||+.||.+||++++|++.|.
T Consensus       237 --~~~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 --ITQG---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             --HHcC---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence              0011         011112233455789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.2e-37  Score=286.20  Aligned_cols=228  Identities=21%  Similarity=0.292  Sum_probs=174.5

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCC-CCCccceehhhcchhhH----
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~----  140 (387)
                      +|+..+.||+|+||.||++....+++.||+|++....   ....+.+..|..++..+. |++|+++.+++.+....    
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667789999999999999999999999999987532   233456788999998885 56777777765443211    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           ....++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++...... .
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-V  156 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-c
Confidence                                 225789999999999999   999999999999999999999999999987543221 1


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ....+.    ..        .  ..
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~----~~--------~--~~  219 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIM----EH--------N--VS  219 (323)
T ss_pred             cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hC--------C--CC
Confidence            2233468999999999998889999999999999999999999997654221   111111    10        0  11


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  317 (387)
                      .+...+..+.+++.+||+.+|.+|++     .+++.+|.++..
T Consensus       220 ~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         220 YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence            22233456788999999999999997     578888877653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.5e-36  Score=280.26  Aligned_cols=230  Identities=26%  Similarity=0.420  Sum_probs=179.1

Q ss_pred             hCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      ++|...+.||+|+||.||+|....     ++..+++|.+........+.+.+|++++++++||||+++++++.+...   
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            457788899999999999998532     356799999877666667789999999999999999999987654221   


Q ss_pred             --------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc
Q 043148          140 --------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN  181 (387)
Q Consensus       140 --------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~  181 (387)
                                                            .....++.+++.||+|||+   ++++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence                                                  1236789999999999999   99999999999999999999


Q ss_pred             EEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 043148          182 AKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWV  259 (387)
Q Consensus       182 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~  259 (387)
                      ++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   ..+  
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~--  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIE--  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--
Confidence            99999999975543211 11122345778999999998889999999999999999998 999987544322   111  


Q ss_pred             HHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          260 WDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                        ....+..         ...+...+..+.+++.+||+.||++||++++|++.|...
T Consensus       237 --~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         237 --CITQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             --HHhCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence              1111111         111222345688999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-36  Score=280.73  Aligned_cols=230  Identities=23%  Similarity=0.324  Sum_probs=179.9

Q ss_pred             cccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----------
Q 043148           71 AEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----------  139 (387)
Q Consensus        71 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----------  139 (387)
                      .....||+|+||.||++....++..||||.+........+.+.+|+.+++.++||||+++++.+.....           
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~  104 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG  104 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence            334579999999999999988899999999876655666788999999999999999999887544321           


Q ss_pred             -------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeec
Q 043148          140 -------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG  206 (387)
Q Consensus       140 -------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g  206 (387)
                                   ..+..++.+++.||.|||+   ++++||||||+||+++.++.++|+|||++........ ......+
T Consensus       105 ~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~  180 (292)
T cd06658         105 ALTDIVTHTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVG  180 (292)
T ss_pred             cHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeec
Confidence                         1236789999999999999   8999999999999999999999999999875543221 2233568


Q ss_pred             CCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHH
Q 043148          207 TMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME  286 (387)
Q Consensus       207 ~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (387)
                      +..|+|||.+.+..++.++||||||+++|||++|+.||.........   ..+.         ....+...  .......
T Consensus       181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~~---------~~~~~~~~--~~~~~~~  246 (292)
T cd06658         181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM---RRIR---------DNLPPRVK--DSHKVSS  246 (292)
T ss_pred             CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH---------hcCCCccc--cccccCH
Confidence            89999999998888999999999999999999999999754322111   1000         01111111  1112344


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          287 CLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       287 ~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .+.+++.+||+.||.+|||+++++++.|+...
T Consensus       247 ~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         247 VLRGFLDLMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence            57789999999999999999999999887754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-36  Score=310.39  Aligned_cols=236  Identities=24%  Similarity=0.359  Sum_probs=178.8

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh---
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR---  138 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  138 (387)
                      ....++|.+.+.||+|+||.||++.+..++..+|+|.+...  .......+..|+.++..|+|||||+++++|.+..   
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            34567899999999999999999999999999999998653  3344677899999999999999999998763311   


Q ss_pred             ----------------------------hHHHHHHHHHHHHHHHHhhhhc----ccceeeccCCcceeEeCC--------
Q 043148          139 ----------------------------QLILHKIALGLASAVLYLHEEW----EQCIVHRDIKSSNVVLDS--------  178 (387)
Q Consensus       139 ----------------------------~~~l~~i~~~i~~~l~~LH~~~----~~~iiH~dlk~~Nill~~--------  178 (387)
                                                  ...+..++.||+.||.|||+..    .++|+||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence                                        1123678999999999999832    145999999999999964        


Q ss_pred             ---------CCcEEEccccccccccCCCCceeeeeecCCcccCchhhcc--CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 043148          179 ---------NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT--GKASKESDVYSFGVVALEVACGRKPVEPR  247 (387)
Q Consensus       179 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~el~tg~~p~~~~  247 (387)
                               ...+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||||+||||++|+.||...
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     2348999999997654321  2233468999999999864  45889999999999999999999999754


Q ss_pred             CCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          248 QEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .....  +.    ..+...       +.+.   ....+..+.+|+..||+.+|.+||++.|++.+.++..
T Consensus       247 ~~~~q--li----~~lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~  300 (1021)
T PTZ00266        247 NNFSQ--LI----SELKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN  300 (1021)
T ss_pred             CcHHH--HH----HHHhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence            32211  11    111111       0010   0122455888999999999999999999998877653

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-36  Score=285.74  Aligned_cols=247  Identities=19%  Similarity=0.279  Sum_probs=181.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      .++|...+.||+|+||.||+|.+..+|..||||.+....  ......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999998889999999986532  223456889999999999999999998765321      


Q ss_pred             ----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          139 ----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       139 ----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                            ...+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879          94 DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             eEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence                                  11235688999999999999   99999999999999999999999999998754332


Q ss_pred             CCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhccCc
Q 043148          197 LGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV--------WDLYGKGQ  267 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  267 (387)
                          .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...............        .+......
T Consensus       171 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (342)
T cd07879         171 ----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA  246 (342)
T ss_pred             ----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence                123456788999999876 45889999999999999999999999865432211111000        00000000


Q ss_pred             hhhhhc--cc-CCccc---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 043148          268 LLEAAD--GR-LSKEF---DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLP  320 (387)
Q Consensus       268 ~~~~~~--~~-~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  320 (387)
                      ......  +. .....   .......+.+++..||+.||.+||++++++.|.|+....+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            000000  00 00000   0123445789999999999999999999999998876543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.3e-36  Score=279.36  Aligned_cols=240  Identities=23%  Similarity=0.321  Sum_probs=176.7

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      +|+..+.||.|+||.||+|++..++..||||.+....  ......+.+|++++++++||||+++++++.+...       
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778889999999999999999889999999886542  2234678899999999999999999998654321       


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.+++.||+|||+   ++++|+||+|+||+++.++.+||+|||++....... ..
T Consensus        81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~  156 (284)
T cd07860          81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RT  156 (284)
T ss_pred             cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-cc
Confidence                               1236788999999999999   999999999999999999999999999987654321 11


Q ss_pred             eeeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc---------hhh
Q 043148          201 TTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ---------LLE  270 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~  270 (387)
                      .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||......+...  . .........         ...
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF--R-IFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--H-HHHHhCCCChhhhhhhhHHHH
Confidence            22334678899999887644 6889999999999999999999997654322111  1 000000000         000


Q ss_pred             --hhcccCC----ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          271 --AADGRLS----KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       271 --~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                        ...+...    ..........+.+++.+||+.||.+|||+++++++.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence              0000000    00111233457789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.3e-36  Score=274.01  Aligned_cols=221  Identities=24%  Similarity=0.436  Sum_probs=170.3

Q ss_pred             cccccCceEEEEEEEC--CCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchh-------------
Q 043148           75 KLGEGGFGGVYRGLLS--DQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-------------  138 (387)
Q Consensus        75 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------------  138 (387)
                      .||+|+||.||+|.+.  +++..||+|.+.... ....+.+.+|+.++++++||||++++++|....             
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L   81 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL   81 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence            4899999999999775  445679999986653 334567899999999999999999998764321             


Q ss_pred             ------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce--eeee
Q 043148          139 ------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ--TTVL  204 (387)
Q Consensus       139 ------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~  204 (387)
                                  ...+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++..........  ....
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence                        11236789999999999999   999999999999999999999999999997554322111  1112


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      .++..|+|||.+....++.++||||||+++||+++ |..||......+..       .....+         .....+..
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~---------~~~~~~~~  222 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-------SFIEQG---------KRLDCPAE  222 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCC---------CCCCCCCC
Confidence            23568999999988889999999999999999996 99999765432211       111111         11122334


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .+..+.+++..||+.||++||++.+|.+.|.
T Consensus       223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~  253 (257)
T cd05115         223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMR  253 (257)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            4567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.8e-36  Score=271.97  Aligned_cols=221  Identities=30%  Similarity=0.469  Sum_probs=170.3

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------------  139 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------------  139 (387)
                      +.||+|+||.||+|... ++..+|+|.+.... ......+.+|+++++.++||||+++++++.....             
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36999999999999875 47899999987653 3334578899999999999999999987654322             


Q ss_pred             -------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeec
Q 043148          140 -------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG  206 (387)
Q Consensus       140 -------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g  206 (387)
                                   ..+..++.+++.+|.|||+   ++++||||+|+||+++.++.+||+|||++...............+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence                         1236788999999999999   999999999999999999999999999987543322111122234


Q ss_pred             CCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHH
Q 043148          207 TMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM  285 (387)
Q Consensus       207 ~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (387)
                      ++.|+|||++....++.++||||||+++||+++ |..||........   ..    ....+         .....+...+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~----~~~~~---------~~~~~~~~~~  220 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---RE----QVEKG---------YRMSCPQKCP  220 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HH----HHHcC---------CCCCCCCCCC
Confidence            567999999998889999999999999999998 9999975532211   11    11111         0111222345


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          286 ECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       286 ~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ..+.+++.+||+.+|++||++.++++.|.
T Consensus       221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         221 DDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            66889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-36  Score=271.93  Aligned_cols=233  Identities=23%  Similarity=0.253  Sum_probs=188.0

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI--  141 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~--  141 (387)
                      .++|+..+.||.|.-|+||++++.+++..+|+|++.+..-   ....+.+.|.+||+.++||.++.|++.++.....+  
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3556778899999999999999999999999999977643   33456778999999999999999988766543322  


Q ss_pred             -------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC-
Q 043148          142 -------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-  195 (387)
Q Consensus       142 -------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-  195 (387)
                                               .+-++..++-||+|||.   .|||.|||||+||||.++|++.|+||.++..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence                                     25688899999999999   9999999999999999999999999998643211 


Q ss_pred             --------------------------------C-C---------------------CceeeeeecCCcccCchhhccCCC
Q 043148          196 --------------------------------E-L---------------------GSQTTVLAGTMGYLAPECVTTGKA  221 (387)
Q Consensus       196 --------------------------------~-~---------------------~~~~~~~~g~~~y~aPE~~~~~~~  221 (387)
                                                      . .                     +......+||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                     011234579999999999999999


Q ss_pred             CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCC
Q 043148          222 SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFT  301 (387)
Q Consensus       222 ~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~  301 (387)
                      +.++|+|+|||++|||+.|..||.+....+..               ..++...+........+..+.+||.+.|..||+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence            99999999999999999999999988765433               233333333333336677789999999999999


Q ss_pred             CCCC----HHHHHHHhccCC
Q 043148          302 NRPS----IRQVINVLNFEA  317 (387)
Q Consensus       302 ~RPs----~~evl~~l~~~~  317 (387)
                      +|..    +.||-+|.+|+.
T Consensus       378 kRlg~~rGA~eIK~HpFF~g  397 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRHPFFEG  397 (459)
T ss_pred             hhhccccchHHhhcCccccC
Confidence            9998    999999998764

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.1e-36  Score=279.14  Aligned_cols=228  Identities=26%  Similarity=0.387  Sum_probs=174.1

Q ss_pred             CccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      +|.+.+.||+|+||.||+|....     ....+++|.+.... .....++.+|+.+++.++||||+++++.|.....   
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46778899999999999998743     23579999886543 3445678999999999999999999886543211   


Q ss_pred             ----------------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcce
Q 043148          140 ----------------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSN  173 (387)
Q Consensus       140 ----------------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~N  173 (387)
                                                                    ..+..++.|++.||.|||+   .+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence                                                          1125788999999999998   999999999999


Q ss_pred             eEeCCCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcc
Q 043148          174 VVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPS  251 (387)
Q Consensus       174 ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~  251 (387)
                      ||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999975533211 11222345678999999988889999999999999999998 999997543221


Q ss_pred             hhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          252 KVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                             .+......         .....+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       238 -------~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~  285 (290)
T cd05045         238 -------LFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK  285 (290)
T ss_pred             -------HHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence                   11111111         1111223344568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-36  Score=277.24  Aligned_cols=229  Identities=24%  Similarity=0.424  Sum_probs=176.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCC-----CeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQ-----NTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  139 (387)
                      .++|.+.+.||+|+||.||+|.+...     +..||+|.+.... ......+.+|+.++..++||||+++++++.+... 
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            46788889999999999999988643     3789999986543 3445678899999999999999999987543211 


Q ss_pred             ----------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEc
Q 043148          140 ----------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLG  185 (387)
Q Consensus       140 ----------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~  185 (387)
                                                        ..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence                                              1235688999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHh
Q 043148          186 DFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLY  263 (387)
Q Consensus       186 Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  263 (387)
                      |||+++....... .......++..|+|||.+....++.++||||||+++||+++ |..||......+.   ..    ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~----~~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LK----FV  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HH----HH
Confidence            9999875543221 12223346788999999988889999999999999999998 9999875443221   11    11


Q ss_pred             ccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ..+.         ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       235 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 IDGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             hcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1111         11122223566889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.3e-37  Score=293.21  Aligned_cols=233  Identities=24%  Similarity=0.286  Sum_probs=175.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ++|+..+.||+|+||.||++....+++.||+|++....   ......+..|++++..++||||+++++++.+....    
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888899999999999999999999999999986432   23356788899999999999999998876553321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-  198 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-  198 (387)
                                           ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++........ 
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence                                 225688999999999999   9999999999999999999999999999864422100 


Q ss_pred             ---------------------------------ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 043148          199 ---------------------------------SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE  245 (387)
Q Consensus       199 ---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~  245 (387)
                                                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                             00113468999999999999999999999999999999999999997


Q ss_pred             CCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHhccCC
Q 043148          246 PRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRP---SIRQVINVLNFEA  317 (387)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP---s~~evl~~l~~~~  317 (387)
                      ..........+      ......  .   .....  ......+.+++.+|+. ||.+|+   +++++++|.|+..
T Consensus       238 ~~~~~~~~~~i------~~~~~~--~---~~p~~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~  298 (360)
T cd05627         238 SETPQETYRKV------MNWKET--L---VFPPE--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG  298 (360)
T ss_pred             CCCHHHHHHHH------HcCCCc--e---ecCCC--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence            65432211110      000000  0   00011  0123446667777664 999998   5899999999764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=281.85  Aligned_cols=244  Identities=21%  Similarity=0.332  Sum_probs=178.9

Q ss_pred             CccccCcccccCceEEEEEEECC--CCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcch--hh--
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSD--QNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ--RQ--  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~--  139 (387)
                      +|...+.||+|+||.||+|....  ++..||+|.+....   ......+.+|+.++..++||||+++++++.+.  ..  
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            46778899999999999999988  78999999997632   33346778899999999999999999987655  11  


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC----CCcEEEcccc
Q 043148          140 ---------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS----NFNAKLGDFG  188 (387)
Q Consensus       140 ---------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~----~~~~kl~Dfg  188 (387)
                                                 ..+..++.|++.||.|||+   ++++||||||+||+++.    ++.+||+|||
T Consensus        81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence                                       1125688999999999999   99999999999999999    9999999999


Q ss_pred             ccccccCCCC--ceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh------hHHHHH
Q 043148          189 LARLVDHELG--SQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKV------RLVEWV  259 (387)
Q Consensus       189 ~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~------~~~~~~  259 (387)
                      ++........  .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.........      .....+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9986544322  112234578889999988764 5789999999999999999999999865543210      011111


Q ss_pred             HHHhccC------------chhh---hhc-ccCC-----ccccH--HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          260 WDLYGKG------------QLLE---AAD-GRLS-----KEFDE--RQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       260 ~~~~~~~------------~~~~---~~~-~~~~-----~~~~~--~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .......            ....   ... ....     .....  .....+.+++.+||+.||++|||+.|++++.||
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            1111000            0000   000 0000     00001  234468899999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-36  Score=279.67  Aligned_cols=235  Identities=23%  Similarity=0.378  Sum_probs=174.2

Q ss_pred             hCccccCcccccCceEEEEEEECCC--------------CeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceeh
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQ--------------NTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIG  132 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~  132 (387)
                      ++|.+.+.||+|+||.||++...+.              ...||+|.+... .......+.+|++++.+++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5788899999999999999987542              235899998754 3344567999999999999999999998


Q ss_pred             hhcchhh-------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeE
Q 043148          133 WCHEQRQ-------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVV  175 (387)
Q Consensus       133 ~~~~~~~-------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nil  175 (387)
                      ++.....                                     ..+..++.+++.||.|||+   .+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence            7643221                                     1235688999999999999   99999999999999


Q ss_pred             eCCCCcEEEccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh--CCCCCCCCCCcch
Q 043148          176 LDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC--GRKPVEPRQEPSK  252 (387)
Q Consensus       176 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t--g~~p~~~~~~~~~  252 (387)
                      ++.++.+||+|||++......... ......++..|+|||.+....++.++||||||+++|||++  |..||........
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            999999999999998755332111 1122234678999999988889999999999999999988  6677765443221


Q ss_pred             hhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          253 VRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ....   ........      .......+...+..+.+++.+||+.||.+||++++|++.|.
T Consensus       242 ~~~~---~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 IENT---GEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHH---HHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1111   11111000      00001111223457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.1e-36  Score=281.35  Aligned_cols=232  Identities=26%  Similarity=0.406  Sum_probs=177.6

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCC-----CeEEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcch
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQ-----NTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ  137 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  137 (387)
                      ...++|...+.||+|+||.||++.....     ...+|+|.+... ......++.+|++++.++ +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            3456788889999999999999987643     378999998754 334456788999999999 899999999876543


Q ss_pred             hhH-----------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe
Q 043148          138 RQL-----------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL  176 (387)
Q Consensus       138 ~~~-----------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill  176 (387)
                      ...                                         .+..++.|++.||.|||+   ++++||||||+|||+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence            221                                         124589999999999998   999999999999999


Q ss_pred             CCCCcEEEccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 043148          177 DSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVR  254 (387)
Q Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~  254 (387)
                      +.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.. 
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-  244 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-  244 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH-
Confidence            99999999999999865432211 1122234678999999988889999999999999999997 99998754322111 


Q ss_pred             HHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          255 LVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                            .....+         .....+......+.+++.+||+.||++|||+.++++.|..
T Consensus       245 ------~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         245 ------KLLKEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             ------HHHHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence                  111111         1111223345568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.7e-36  Score=274.99  Aligned_cols=229  Identities=26%  Similarity=0.495  Sum_probs=176.0

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCe---EEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNT---EIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      .++|+..+.||+|+||.||+|.+..++.   .+|+|.+... .....+++..|++++..++||||+++++++.+....  
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3567788999999999999999875443   7999998654 344467789999999999999999999887543321  


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          141 ------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       141 ------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                              .+..++.+++.||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence                                    235788999999999999   99999999999999999999999999998765432


Q ss_pred             CCceee--eeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          197 LGSQTT--VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       197 ~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ......  ....++.|+|||.+....++.++||||||+++|||++ |+.||......+   ...    .....       
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~----~i~~~-------  226 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMK----AINDG-------  226 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHH----HHhcC-------
Confidence            221111  1123457999999988889999999999999999997 999996543221   111    11111       


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                        .........+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus       227 --~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~  265 (268)
T cd05063         227 --FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD  265 (268)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence              011112234456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.7e-36  Score=288.60  Aligned_cols=231  Identities=24%  Similarity=0.383  Sum_probs=176.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCC-----CeEEEEEEecCCC-hhhHHHHHHHHHHHhcCC-CCCccceehhhcchhh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQ-----NTEIAVKRVSRGS-KQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  139 (387)
                      .++|.+.+.||+|+||.||+|.+...     +..||||++.... ....+.+.+|++++..+. ||||++++++|.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            46788889999999999999986432     3479999996543 334567999999999996 9999999988754311


Q ss_pred             H-------------------------------------------------------------------------------
Q 043148          140 L-------------------------------------------------------------------------------  140 (387)
Q Consensus       140 ~-------------------------------------------------------------------------------  140 (387)
                      .                                                                               
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            0                                                                               


Q ss_pred             ------------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC
Q 043148          141 ------------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS  178 (387)
Q Consensus       141 ------------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~  178 (387)
                                                                .+..++.|++.||.|||+   ++++||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence                                                      113578899999999999   99999999999999999


Q ss_pred             CCcEEEccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHH
Q 043148          179 NFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLV  256 (387)
Q Consensus       179 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~  256 (387)
                      ++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.........   
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~---  349 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF---  349 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH---
Confidence            999999999999765432211 1222346678999999998889999999999999999997 99998754322111   


Q ss_pred             HHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          257 EWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                         ......+         .....+...+..+.+++.+||+.||++||++.+|.++|..
T Consensus       350 ---~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         350 ---YNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             ---HHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence               1111111         1111223445668899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.2e-36  Score=279.41  Aligned_cols=228  Identities=25%  Similarity=0.391  Sum_probs=178.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      +.|...+.||+|+||.||+|....++..||+|.+....   ....+++.+|+++++.++||||++++++|.+...     
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            55778889999999999999998889999999986432   2334678899999999999999999987754321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          ..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......   
T Consensus        95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---  168 (307)
T cd06607          95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---  168 (307)
T ss_pred             HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence                                1225688999999999999   99999999999999999999999999998754332   


Q ss_pred             eeeeeecCCcccCchhhc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          200 QTTVLAGTMGYLAPECVT---TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                        ....++..|+|||++.   ...++.++||||||+++|||++|+.||.........      .... ..        ..
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------~~~~-~~--------~~  231 (307)
T cd06607         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIA-QN--------DS  231 (307)
T ss_pred             --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------HHHh-cC--------CC
Confidence              2335788899999874   456889999999999999999999999754322111      1100 00        00


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ...........+.+++.+||+.||.+||++.+++.++|+...
T Consensus       232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         232 PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            111122345668999999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.8e-36  Score=276.01  Aligned_cols=231  Identities=19%  Similarity=0.321  Sum_probs=177.0

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      ++|...+.||+|+||.||+|.+..++..||+|.++.........+.+|+.+++.++||||+++++++.+...        
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            467778899999999999999998899999999876655555678899999999999999999986543221        


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          140 -----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       140 -----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                       ..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++....... ....
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~  164 (267)
T cd06645          89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRK  164 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cccc
Confidence                             2236789999999999999   899999999999999999999999999987554322 1223


Q ss_pred             eeecCCcccCchhhc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          203 VLAGTMGYLAPECVT---TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       203 ~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ...|+..|+|||.+.   ...++.++|+|||||++|||++|+.||..........      ... ....   ..+.... 
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~------~~~-~~~~---~~~~~~~-  233 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMT-KSNF---QPPKLKD-  233 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH------hhh-ccCC---CCCcccc-
Confidence            446889999999874   4558899999999999999999999986543221110      000 0000   0000000 


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                       ....+..+.+++.+||+.+|++||++++|+++.|
T Consensus       234 -~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         234 -KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             -cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence             0112345788999999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.9e-36  Score=276.66  Aligned_cols=230  Identities=25%  Similarity=0.367  Sum_probs=176.9

Q ss_pred             hhCccccCcccccCceEEEEEEECC----CCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD----QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR---  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  138 (387)
                      .++|...+.||+|+||.||+|.+..    .+..|++|.+... .....+.+.+|+.+++.++||||+++++++.+..   
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999999875    3578999988654 3344677889999999999999999998754311   


Q ss_pred             -------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccc
Q 043148          139 -------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF  187 (387)
Q Consensus       139 -------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  187 (387)
                                                     ...+..++.+++.||+|||+   ++++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence                                           11125688999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcc
Q 043148          188 GLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGK  265 (387)
Q Consensus       188 g~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  265 (387)
                      |+++.+...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+   ...+    ...
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY----LKD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH----HHc
Confidence            999765332111 1112235678999999988889999999999999999998 999997543221   1111    111


Q ss_pred             CchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          266 GQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      +         ........++..+.+++.+||+.||++|||+.++++.|..
T Consensus       235 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  275 (280)
T cd05043         235 G---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD  275 (280)
T ss_pred             C---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            1         0011112234568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.3e-36  Score=273.30  Aligned_cols=226  Identities=27%  Similarity=0.453  Sum_probs=174.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh---------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR---------  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------  138 (387)
                      ++|.....||+|+||.||++.+..+ ..+|+|.+.... ...+.+.+|+++++.++|||++++++++....         
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCC
Confidence            5577888999999999999998664 569999876533 33567889999999999999999988654321         


Q ss_pred             -----------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          139 -----------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       139 -----------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                       ...+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++...........
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence                             01135788999999999999   9999999999999999999999999999976543322111


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |..||......+.   ..+.    ..+         .....
T Consensus       161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~----~~~---------~~~~~  224 (260)
T cd05069         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQV----ERG---------YRMPC  224 (260)
T ss_pred             CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcC---------CCCCC
Confidence            22335678999999988889999999999999999999 8999976443221   1111    111         01112


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      +...+..+.+++.+||+.||.+||++++|++.|+
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  258 (260)
T cd05069         225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE  258 (260)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence            2334566889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.5e-36  Score=277.72  Aligned_cols=244  Identities=22%  Similarity=0.269  Sum_probs=178.4

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      ++.+|...+.||+|+||.||+|....++..||+|.+.... ......+.+|+++++.++|+||+++++++.+...     
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999998889999999986543 2233467889999999999999999987654321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          ..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++....... 
T Consensus        83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  158 (291)
T cd07870          83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-  158 (291)
T ss_pred             ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence                                1235688999999999999   8999999999999999999999999999875433211 


Q ss_pred             eeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc-----------
Q 043148          200 QTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ-----------  267 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------  267 (387)
                      ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......  .......+.......           
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhhcc
Confidence            12233468899999998754 4788999999999999999999999755432  111111221111000           


Q ss_pred             --hhhhhcccCCcccc-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          268 --LLEAADGRLSKEFD-----ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       268 --~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                        ..............     ......+.+++.+|++.||.+|||+.|++.|.|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence              00000000000000     0113457789999999999999999999998774

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.6e-36  Score=279.49  Aligned_cols=234  Identities=28%  Similarity=0.417  Sum_probs=178.4

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCC-CCCccceehhhcchhh-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-------  139 (387)
                      +|...+.||+|+||.||++.+..++..+|+|.+.... ......+.+|+.++.++. |+||+++++++.....       
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            3445678999999999999999999999999986543 344567889999999996 9999999986543211       


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            ..+..++.+++.||+|||+.  .+++||||||+||+++.++.+||+|||+++......
T Consensus        85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence                                  12357889999999999972  489999999999999999999999999987554321


Q ss_pred             CceeeeeecCCcccCchhhccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          198 GSQTTVLAGTMGYLAPECVTTG---KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                        ......+++.|+|||.+.+.   .++.++||||||+++|||++|+.||.....     ..+....... +     ..+
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~-----~~~  229 (288)
T cd06616         163 --AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-G-----DPP  229 (288)
T ss_pred             --ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-C-----CCC
Confidence              11233578899999998866   689999999999999999999999975431     1111111110 0     011


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .+........+..+.+++.+||+.||.+|||+++|+++.++..
T Consensus       230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence            1222222335667899999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3e-36  Score=276.85  Aligned_cols=232  Identities=27%  Similarity=0.411  Sum_probs=175.3

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHH-HhcCCCCCccceehhhcchhh------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRI-ISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      ++|...+.||+|+||.||++++..+|..||+|++.... .....++..|+.. ++.++||||+++++++.....      
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999999999999999987542 2334556667665 566789999999887644221      


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhccc-ceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQ-CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~-~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                            ..+..++.|++.||.|||+   + +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence                                  1235789999999999998   6 8999999999999999999999999998765432


Q ss_pred             CCceeeeeecCCcccCchhhcc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          197 LGSQTTVLAGTMGYLAPECVTT----GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                      .  ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||.......  ..   ...... +     .
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~---~~~~~~-~-----~  224 (283)
T cd06617         158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQ---LKQVVE-E-----P  224 (283)
T ss_pred             c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HH---HHHHHh-c-----C
Confidence            1  1122457888999998864    446889999999999999999999996533211  00   111000 0     0


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .+..   .....+..+.+++.+||+.+|.+||++++++++.|+...
T Consensus       225 ~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         225 SPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            0111   111245568899999999999999999999999987764

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.2e-36  Score=280.82  Aligned_cols=227  Identities=25%  Similarity=0.397  Sum_probs=172.4

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCe--EEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNT--EIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~---  139 (387)
                      .++|...+.||+|+||.||+|.+..++.  .+++|.+... .......+.+|++++.++ +||||+++++++.+...   
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            3567888999999999999999877665  4577777543 334456788999999999 89999999987644221   


Q ss_pred             --------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc
Q 043148          140 --------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN  181 (387)
Q Consensus       140 --------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~  181 (387)
                                                            ..+..++.|++.||+|||+   ++++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence                                                  1235688999999999999   99999999999999999999


Q ss_pred             EEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 043148          182 AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVW  260 (387)
Q Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~  260 (387)
                      +||+|||++......  .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+..   .   
T Consensus       163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~---  234 (303)
T cd05088         163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---E---  234 (303)
T ss_pred             EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH---H---
Confidence            999999998643211  11112234567999999988889999999999999999998 99999754432111   1   


Q ss_pred             HHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                       ....         ......+...+..+.+++.+||+.+|++||+++++++++.
T Consensus       235 -~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~  278 (303)
T cd05088         235 -KLPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  278 (303)
T ss_pred             -HHhc---------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence             0100         0011111223445788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-36  Score=276.84  Aligned_cols=233  Identities=24%  Similarity=0.371  Sum_probs=179.1

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      ++|+..+.||+|+||.||++.+..++..||+|.+... .......+.+|++++.+++||||+++++++....        
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            3577788999999999999999988999999988654 3344567899999999999999999998654321        


Q ss_pred             --------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          139 --------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       139 --------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                          ...+..++.+++.||.|||+.  .+++|+||||+||+++.++.+||+|||++......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence                                123467889999999999962  58999999999999999999999999998755332  


Q ss_pred             ceeeeeecCCcccCchhhccC------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          199 SQTTVLAGTMGYLAPECVTTG------KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                       ......++..|+|||.+.+.      .++.++|+|||||++|||++|+.||............            ..+.
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~------------~~~~  223 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL------------SAIV  223 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH------------HHHh
Confidence             12233577899999988543      3588999999999999999999999754322111110            0111


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .. .....+......+.+++.+||+.+|.+||++++++++.|+...
T Consensus       224 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         224 DG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             hc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence            11 1122333456668899999999999999999999999886543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.8e-36  Score=274.86  Aligned_cols=230  Identities=20%  Similarity=0.339  Sum_probs=183.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------  140 (387)
                      ..|+..+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+++++.++||||+++++++.+....      
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34667788999999999999998889999999987543 34567889999999999999999999977653321      


Q ss_pred             ------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          141 ------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       141 ------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                        .+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~  159 (277)
T cd06640          84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRN  159 (277)
T ss_pred             CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cccc
Confidence                              125688999999999999   999999999999999999999999999997654322 1222


Q ss_pred             eeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          203 VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       203 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      ...++..|+|||.+.+..++.++|+||||+++|||++|..||..........                ............
T Consensus       160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----------------~~~~~~~~~~~~  223 (277)
T cd06640         160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF----------------LIPKNNPPTLTG  223 (277)
T ss_pred             cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh----------------hhhcCCCCCCch
Confidence            3457888999999988889999999999999999999999997544221110                001111223344


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          283 RQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ..+..+.+++.+||+.+|.+||++.+++++.++..
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06640         224 EFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK  258 (277)
T ss_pred             hhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence            56677889999999999999999999999988654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.1e-36  Score=279.77  Aligned_cols=230  Identities=27%  Similarity=0.457  Sum_probs=174.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCe----EEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNT----EIAVKRVSRGSK-QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      ++|...+.||+|+||.||+|.+..++.    .+|+|.+..... ....++.+|+.++..++||||++++++|.....   
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v   86 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV   86 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence            556778899999999999999876665    578998865432 334578899999999999999999997754211   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+++......
T Consensus        87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE  163 (303)
T ss_pred             ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCcc
Confidence                                  1236788999999999999   999999999999999999999999999998654322


Q ss_pred             Cc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          198 GS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       198 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||........   .    .....+..       
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~----~~~~~~~~-------  229 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---P----DLLEKGER-------  229 (303)
T ss_pred             cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHCCCC-------
Confidence            11 1112334678999999998889999999999999999997 9999975432111   1    11111110       


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                        ...+......+.+++..||..+|.+||+++++++.+...
T Consensus       230 --~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         230 --LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              011112334578899999999999999999999998743

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-36  Score=272.66  Aligned_cols=223  Identities=30%  Similarity=0.482  Sum_probs=172.4

Q ss_pred             CcccccCceEEEEEEECCCC---eEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCCccceehhhcchh-----------
Q 043148           74 GKLGEGGFGGVYRGLLSDQN---TEIAVKRVSRGSK-QGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-----------  138 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----------  138 (387)
                      ++||+|+||.||+|.+...+   ..+|+|.+..... ...+++.+|+++++.++||||+++++++....           
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG   80 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence            46999999999999876554   7899999876543 34667899999999999999999998764321           


Q ss_pred             -------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce--eee
Q 043148          139 -------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ--TTV  203 (387)
Q Consensus       139 -------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~  203 (387)
                                   ...+..++.|++.||+|||+   .+++|+||||+|||++.++.+||+|||+++.........  ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence                         11236899999999999999   999999999999999999999999999998664432211  111


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..||......+   ...++.    ...         ....+.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~----~~~---------~~~~~~  221 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE----SGE---------RLPRPE  221 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH----cCC---------cCCCCC
Confidence            223467999999998889999999999999999998 999997654321   111111    111         011222


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          283 RQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ..+..+.+++.+||..+|.+||++.++++.|..
T Consensus       222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            334568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.2e-36  Score=279.97  Aligned_cols=228  Identities=21%  Similarity=0.303  Sum_probs=178.4

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------------
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------------  139 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------------  139 (387)
                      ...||+|+||.||++....++..||+|.+........+.+.+|+.++..++||||+++++++.....             
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            4479999999999999988899999999876555556778899999999999999999987654321             


Q ss_pred             -----------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCC
Q 043148          140 -----------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM  208 (387)
Q Consensus       140 -----------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~  208 (387)
                                 ..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++....... .......++.
T Consensus       106 ~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~  181 (297)
T cd06659         106 TDIVSQTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTP  181 (297)
T ss_pred             HHHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceecCc
Confidence                       1236789999999999999   999999999999999999999999999987554322 1223356889


Q ss_pred             cccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHH
Q 043148          209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECL  288 (387)
Q Consensus       209 ~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (387)
                      .|+|||.+.+..++.++||||||+++|||++|+.||......+...   ..    .....     .  ...........+
T Consensus       182 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~~----~~~~~-----~--~~~~~~~~~~~l  247 (297)
T cd06659         182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RL----RDSPP-----P--KLKNAHKISPVL  247 (297)
T ss_pred             cccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH----hccCC-----C--CccccCCCCHHH
Confidence            9999999998889999999999999999999999997543222111   10    00000     0  001111234457


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          289 MIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       289 ~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .+++..||+.+|.+||++++++++.++...
T Consensus       248 ~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         248 RDFLERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence            889999999999999999999999886643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-36  Score=272.87  Aligned_cols=231  Identities=21%  Similarity=0.331  Sum_probs=181.1

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      ++|...+.||.|+||.||+|....++..+++|.+........+.+.+|+++++.++||||+++++++.+...        
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            578888999999999999999988889999999987655567889999999999999999999987644321        


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++....... ...
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~  158 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKR  158 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh-hcc
Confidence                              1225689999999999999   999999999999999999999999999987654321 122


Q ss_pred             eeeecCCcccCchhhccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          202 TVLAGTMGYLAPECVTTG---KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ....++..|+|||.+...   .++.++||||||+++|||++|+.||...........       ......    .+ ...
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-------~~~~~~----~~-~~~  226 (262)
T cd06613         159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-------ISKSNF----PP-PKL  226 (262)
T ss_pred             ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhccC----CC-ccc
Confidence            234578889999998776   788999999999999999999999976442221110       000000    00 011


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ......+..+.+++.+||+.+|.+|||+.+|+.+.|
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            122345567899999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.6e-36  Score=280.09  Aligned_cols=244  Identities=23%  Similarity=0.321  Sum_probs=180.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--QGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      .++|+..+.||+|+||.||+|.+..+|..||+|.+.....  .....+.+|+.++.+++|+||+++++++.+..      
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4678899999999999999999998999999999865422  22345678999999999999999988764321      


Q ss_pred             ---------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          139 ---------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       139 ---------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                           ...+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence                                 11125689999999999999   999999999999999999999999999998665432


Q ss_pred             CceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc--h------
Q 043148          198 GSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ--L------  268 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~------  268 (387)
                      . ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.   .......  .      
T Consensus       163 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  238 (309)
T cd07845         163 K-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII---QLLGTPNESIWPGFSD  238 (309)
T ss_pred             C-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCChhhchhhhc
Confidence            1 1222345778999999875 457899999999999999999999998655433222111   1111000  0      


Q ss_pred             ------hhhhcccCC--ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          269 ------LEAADGRLS--KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       269 ------~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                            .........  ..........+.+++.+|++.||++|||++++++|.|+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~  295 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE  295 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                  000000000  0000113556788999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.8e-36  Score=277.23  Aligned_cols=235  Identities=23%  Similarity=0.359  Sum_probs=184.8

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .++|...+.||+|+||.||++....++..||+|.+........+.+.+|+.+++.++|||+++++++|.....       
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            3678888999999999999999888889999999876555556788999999999999999999987654321       


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          140 -----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       140 -----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                       ..+..++.+++.||.|||+   ++++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~  173 (293)
T cd06647          98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS  173 (293)
T ss_pred             CCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccc
Confidence                             1235688999999999999   9999999999999999999999999998875543221 222


Q ss_pred             eeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          203 VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       203 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      ...+++.|++||.+....++.++||||||+++|++++|+.||............      .        ..+........
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~--------~~~~~~~~~~~  239 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------A--------TNGTPELQNPE  239 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------h--------cCCCCCCCCcc
Confidence            345788899999998888999999999999999999999999765432211100      0        00001111122


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 043148          283 RQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPL  319 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  319 (387)
                      .....+.+++..||+.+|.+||++++++.|.|+....
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            3455688899999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1e-35  Score=270.66  Aligned_cols=231  Identities=26%  Similarity=0.387  Sum_probs=180.1

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      ++|...+.||+|+||.||+|....+|+.||+|.++..   .....+.+.+|++++++++|+||+++++++.+...     
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            5788899999999999999999988999999988642   23346788999999999999999999987544211     


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                              ..+..++.+++.||.|||+   .+++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence                                    1235788999999999999   9999999999999999999999999999876543


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      ... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+    ....+.        
T Consensus       159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~--------  224 (267)
T cd08224         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK----KIEKCD--------  224 (267)
T ss_pred             CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHh----hhhcCC--------
Confidence            221 123345788999999998888999999999999999999999998654321 111111    111110        


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ............+.+++.+||..+|.+||++.+|++.+..
T Consensus       225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~  264 (267)
T cd08224         225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE  264 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence            1111112455678899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.1e-36  Score=278.22  Aligned_cols=241  Identities=20%  Similarity=0.247  Sum_probs=181.1

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      +|...+.||+|+||.||+|.+..+|..||+|.+....  ......+.+|+.+++.++||||+++++++.+...       
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778889999999999999998889999999987653  3345688999999999999999999987654321       


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++...........
T Consensus        81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence                              1236789999999999999   9999999999999999999999999999986654332223


Q ss_pred             eeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCch------------
Q 043148          202 TVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL------------  268 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------  268 (387)
                      ....++..|+|||.+.+. .++.++||||+|+++|||++|..||........   ..+..........            
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCcchh
Confidence            345688899999988654 468999999999999999999888865443221   1112111111000            


Q ss_pred             hhhhcccC----CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          269 LEAADGRL----SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       269 ~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .....+..    ......+....+.+++.+|++.||.+||+++++++|.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence            00000000    001112234678899999999999999999999999886

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.6e-36  Score=271.58  Aligned_cols=227  Identities=23%  Similarity=0.350  Sum_probs=179.0

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      +|...+.||+|++|.||++....+++.+|+|.+...  .....+.+.+|++++++++|+|++++++.+.....       
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            477889999999999999999988999999998653  23445678899999999999999999876542210       


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           ..+..++.+++.||.|||+   ++++||||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence                                 1125788999999999999   999999999999999999999999999987654322 


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......+++.|+|||.+.+..++.++||||||+++++|++|+.||........      ..... .+.         ..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~-~~~---------~~  220 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRII-EGK---------LP  220 (257)
T ss_pred             CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHH-hcC---------CC
Confidence            122334578899999999988899999999999999999999999975432111      11111 111         11


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ..+......+.+++.+||+.||.+||++.+++++.|+
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            2233455668899999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.5e-36  Score=282.01  Aligned_cols=231  Identities=24%  Similarity=0.371  Sum_probs=173.4

Q ss_pred             hhCccccCcccccCceEEEEEEEC-----CCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLS-----DQNTEIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  139 (387)
                      .++|...+.||+|+||.||+|.+.     .+++.||||++.... ......+.+|+.++.++ +||||++++++|.....
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            357888999999999999999842     357889999997543 33356788999999999 68999999986643211


Q ss_pred             --------------------------------------------------------------------------------
Q 043148          140 --------------------------------------------------------------------------------  139 (387)
Q Consensus       140 --------------------------------------------------------------------------------  139 (387)
                                                                                                      
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence                                                                                            


Q ss_pred             -------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-ceeeeee
Q 043148          140 -------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLA  205 (387)
Q Consensus       140 -------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~  205 (387)
                                   ..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||++........ .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                         0124578899999999999   9999999999999999999999999999876532211 1112233


Q ss_pred             cCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       206 g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||........  .    ......+..         ...+...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~----~~~~~~~~~---------~~~~~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F----CRRLKEGTR---------MRAPDYT  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--H----HHHHhccCC---------CCCCCCC
Confidence            5677999999988889999999999999999997 9999875432211  1    111111110         0111112


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          285 MECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ...+.+++..||+.||.+|||+.+|+++|..
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~  338 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  338 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            3457899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.3e-36  Score=304.67  Aligned_cols=235  Identities=29%  Similarity=0.435  Sum_probs=177.1

Q ss_pred             HHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH
Q 043148           62 ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL  140 (387)
Q Consensus        62 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  140 (387)
                      ...+-..+|+....||+||||.||+++.+-+|+.||||++... +........+|+++|++|+|||+|+++..+-+....
T Consensus       473 ~~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~  552 (1351)
T KOG1035|consen  473 QFSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE  552 (1351)
T ss_pred             chhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence            3456778899999999999999999999999999999998654 334456678999999999999999988644221000


Q ss_pred             --------------------------------------------------------------------------------
Q 043148          141 --------------------------------------------------------------------------------  140 (387)
Q Consensus       141 --------------------------------------------------------------------------------  140 (387)
                                                                                                      
T Consensus       553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~  632 (1351)
T KOG1035|consen  553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN  632 (1351)
T ss_pred             cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------------------------------------HHHHHHHHHHHHHHH
Q 043148          141 -----------------------------------------------------------------ILHKIALGLASAVLY  155 (387)
Q Consensus       141 -----------------------------------------------------------------~l~~i~~~i~~~l~~  155 (387)
                                                                                       .+++++.+|++||.|
T Consensus       633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence                                                                             005789999999999


Q ss_pred             hhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc----C-------------CCCceeeeeecCCcccCchhhcc
Q 043148          156 LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD----H-------------ELGSQTTVLAGTMGYLAPECVTT  218 (387)
Q Consensus       156 LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~----~-------------~~~~~~~~~~g~~~y~aPE~~~~  218 (387)
                      +|+   +|||||||||.|||+|++..+||+|||++....    .             ......+..+||.-|+|||++.+
T Consensus       713 IH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            999   999999999999999999999999999997621    0             01113456789999999999975


Q ss_pred             C---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHh
Q 043148          219 G---KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWC  295 (387)
Q Consensus       219 ~---~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  295 (387)
                      .   .|+.|+|+||+||+++||+.   ||...-+.  ...    ...+..+.+...      ..+.......-.+++.|+
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--a~i----L~~LR~g~iP~~------~~f~~~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER--ASI----LTNLRKGSIPEP------ADFFDPEHPEEASLIRWL  854 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHH--HHH----HHhcccCCCCCC------cccccccchHHHHHHHHH
Confidence            4   49999999999999999974   56532211  111    111222222211      122333444456899999


Q ss_pred             cCCCCCCCCCHHHHHHHhc
Q 043148          296 CHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       296 l~~dp~~RPs~~evl~~l~  314 (387)
                      ++.||.+|||+.|+++.=+
T Consensus       855 l~hdP~kRPtA~eLL~s~l  873 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLNSEL  873 (1351)
T ss_pred             hcCCCccCCCHHHHhhccC
Confidence            9999999999999998754

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.5e-36  Score=277.39  Aligned_cols=238  Identities=24%  Similarity=0.367  Sum_probs=183.6

Q ss_pred             cCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcc
Q 043148           58 FTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHE  136 (387)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  136 (387)
                      .++.++....+.|+..+.||+|+||.||+|.+..++..+|+|.+.... ....++..|+.++..+ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            466677777889999999999999999999999889999999986543 3346788899999998 79999999887642


Q ss_pred             h------h---------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEE
Q 043148          137 Q------R---------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAK  183 (387)
Q Consensus       137 ~------~---------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  183 (387)
                      .      .                           ...+..++.|++.||.|||+   .+++|+||+|+||+++.++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence            1      0                           11125678899999999999   9999999999999999999999


Q ss_pred             EccccccccccCCCCceeeeeecCCcccCchhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 043148          184 LGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT-----TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW  258 (387)
Q Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~  258 (387)
                      |+|||++........ ......+++.|+|||.+.     ...++.++||||||+++|||++|+.||...........   
T Consensus       162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~---  237 (282)
T cd06636         162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL---  237 (282)
T ss_pred             EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh---
Confidence            999999875533211 223345788999999875     34578899999999999999999999975432211110   


Q ss_pred             HHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          259 VWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                                  ..............+..+.+++..||+.||.+||++.|++++.|+
T Consensus       238 ------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         238 ------------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ------------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                        000001111112345568899999999999999999999998774

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.4e-36  Score=278.63  Aligned_cols=230  Identities=27%  Similarity=0.415  Sum_probs=175.9

Q ss_pred             hhCccccCcccccCceEEEEEEE-----CCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  139 (387)
                      .++|...+.||+|+||.||++.+     ...+..||||.++... ....+.+.+|+++++++ +||||+++++++.....
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            46788899999999999999975     2345689999987543 33456789999999999 79999999987654321


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccc
Q 043148          140 ---------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL  192 (387)
Q Consensus       140 ---------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~  192 (387)
                                                 ..+..++.+++.||.|||+   ++++|+||||+|||++.++.++|+|||+++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence                                       1225688999999999999   9999999999999999999999999999975


Q ss_pred             ccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          193 VDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       193 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+..      ......+    
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~------~~~~~~~----  260 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF------YKLIKEG----  260 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH------HHHHHcC----
Confidence            5432211 1112345678999999998889999999999999999998 99998754432111      1111111    


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                           .....+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       261 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~  299 (302)
T cd05055         261 -----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG  299 (302)
T ss_pred             -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence                 111112223456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.9e-36  Score=271.94  Aligned_cols=229  Identities=23%  Similarity=0.343  Sum_probs=177.0

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-----hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-----KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      .+|...+.||+|+||.||+|.+..++..||||.+....     ....+.+.+|+++++.++||||+++++++.+...   
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999999999999999875321     2234678889999999999999999987654210   


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                              .....++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||+++....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence                                    1125689999999999999   9999999999999999999999999999875532


Q ss_pred             CCC--ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          196 ELG--SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       196 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ...  .......++..|+|||.+.+..++.++||||||+++|||++|+.||.........      ....         .
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~---------~  223 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIA---------T  223 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH------HHHh---------c
Confidence            111  1122345788999999998888999999999999999999999999754322110      1110         0


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .......+......+.+++..|+. +|++||++++++++.|.
T Consensus       224 ~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~  264 (265)
T cd06652         224 QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV  264 (265)
T ss_pred             CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence            111122344455667788888985 99999999999998774

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3e-36  Score=272.61  Aligned_cols=224  Identities=22%  Similarity=0.317  Sum_probs=176.3

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      +|...+.||+|+||.||++.+..++..+|+|.+... .....+.+.+|+.+++.++|+||+++++.+.+...        
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            467788999999999999999999999999998643 34456778899999999999999999887654321        


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.+++.||.|||+   ++++|+||||+||+++.++.++|+|||++....... ..
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence                               1235789999999999999   999999999999999999999999999987654321 12


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      .....+++.|+|||++.+..++.++|+||||+++|+|++|..||........   .   .. ...+..         ...
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~---~~-~~~~~~---------~~~  220 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---I---LK-VCQGSY---------KPL  220 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---H---HH-HhcCCC---------CCC
Confidence            2234688899999999988899999999999999999999999975432111   1   11 111111         112


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINV  312 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~  312 (387)
                      +......+.+++.+||+.||.+||++.+++..
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            22344557889999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.5e-36  Score=277.18  Aligned_cols=235  Identities=24%  Similarity=0.371  Sum_probs=174.4

Q ss_pred             hCccccCcccccCceEEEEEEECC----------------CCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccce
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSD----------------QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHL  130 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l  130 (387)
                      ++|+..+.||+|+||.||++...+                ++..+|+|.+... ......++.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            568889999999999999986432                3457999998754 33446789999999999999999999


Q ss_pred             ehhhcchhh------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCccee
Q 043148          131 IGWCHEQRQ------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNV  174 (387)
Q Consensus       131 ~~~~~~~~~------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Ni  174 (387)
                      ++++.....                                    ..+..++.|++.||+|||+   .+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence            987643211                                    1246788999999999999   9999999999999


Q ss_pred             EeCCCCcEEEccccccccccCCCCce-eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh--CCCCCCCCCCcc
Q 043148          175 VLDSNFNAKLGDFGLARLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC--GRKPVEPRQEPS  251 (387)
Q Consensus       175 ll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t--g~~p~~~~~~~~  251 (387)
                      |++.++.++|+|||+++.+....... .....+++.|++||....+.++.++||||||+++|||++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            99999999999999987653321111 112234678999999888889999999999999999998  778886544322


Q ss_pred             hhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          252 KVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ....   .......... .     .....+..++..+.+++.+||+.||.+||++.+|++.|.
T Consensus       242 ~~~~---~~~~~~~~~~-~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 VIEN---TGEFFRDQGR-Q-----VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHH---HHHHHhhccc-c-----ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            2111   1111111000 0     000111223456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6e-36  Score=276.65  Aligned_cols=233  Identities=18%  Similarity=0.246  Sum_probs=168.4

Q ss_pred             hhCccccCcccccCceEEEEEEECCC---CeEEEEEEecCCChhh-----------HHHHHHHHHHHhcCCCCCccceeh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQ---NTEIAVKRVSRGSKQG-----------KKEYISEVRIISRLRHRNLVHLIG  132 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~  132 (387)
                      .++|.+.+.||+|+||.||+|.+.++   +..+|+|.........           ......+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36788999999999999999998876   5667777643322111           011223445566778999999887


Q ss_pred             hhcchh----------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEE
Q 043148          133 WCHEQR----------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKL  184 (387)
Q Consensus       133 ~~~~~~----------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl  184 (387)
                      ++....                            ...+..++.|++.||.|||+   ++++||||||+|||++.++.++|
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             eeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEEE
Confidence            532211                            12235789999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCC------ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh-hHHH
Q 043148          185 GDFGLARLVDHELG------SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKV-RLVE  257 (387)
Q Consensus       185 ~Dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~-~~~~  257 (387)
                      +|||+++.+.....      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            99999986543211      1122346899999999999999999999999999999999999999876432211 1110


Q ss_pred             -HHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 043148          258 -WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL  313 (387)
Q Consensus       258 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  313 (387)
                       ........+.        .   .....+..+.+++..|++.+|.+||+++++++.+
T Consensus       248 ~~~~~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        248 CDFIKRLHEGK--------I---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHHhhhhh--------h---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence             0011111110        0   0112345688999999999999999999999875

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.4e-36  Score=274.61  Aligned_cols=237  Identities=27%  Similarity=0.360  Sum_probs=182.5

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      ++|+..+.||+|+||.||++....++..||+|.+.... ....+.+.+|++++..++||||+++++++.....       
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56777889999999999999998889999999886543 3446788999999999999999999987755322       


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.+++.+|.|||+.  .+++||||+|+||+++.++.++|+|||++......   ..
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---~~  159 (284)
T cd06620          85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IA  159 (284)
T ss_pred             CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---cc
Confidence                              12367889999999999972  58999999999999999999999999998654322   11


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh-----hHHHHHHHHhccCchhhhhcccC
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKV-----RLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                      ....++..|+|||.+.+..++.++|+|||||++|+|++|+.||.........     ....+........      .+.+
T Consensus       160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~  233 (284)
T cd06620         160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPRL  233 (284)
T ss_pred             CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCCC
Confidence            2346889999999998888999999999999999999999999865432111     1111111111000      0111


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                         .....+..+.+++.+||+.||.+|||+.|+++++++...
T Consensus       234 ---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         234 ---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             ---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence               111244568899999999999999999999999887654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4e-36  Score=274.10  Aligned_cols=228  Identities=28%  Similarity=0.479  Sum_probs=174.9

Q ss_pred             hCccccCcccccCceEEEEEEECCCCe---EEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNT---EIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      .+|+..+.||+|+||.||+|.+..++.   .||||.+... ......+|..|+.+++.++||||+++++++.+....   
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457788899999999999999876554   6999998754 344567899999999999999999999876543221   


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                             .+..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence                                   136788999999999999   999999999999999999999999999987654322


Q ss_pred             Ccee--eee--ecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          198 GSQT--TVL--AGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       198 ~~~~--~~~--~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                      ....  ...  ..+..|+|||.+.+..++.++||||||+++||+++ |..||......+   ...++.    ..      
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~----~~------  227 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIE----QD------  227 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHH----cC------
Confidence            1111  111  12357999999998899999999999999999886 999997544221   111111    10      


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                         .....+...+..+.+++..||+.+|.+||++++|+..|+
T Consensus       228 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  266 (269)
T cd05065         228 ---YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD  266 (269)
T ss_pred             ---CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence               001112233456788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-36  Score=272.12  Aligned_cols=227  Identities=29%  Similarity=0.486  Sum_probs=176.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .++|.+.+.||+|+||.||+|.+.+ +..+|||.+.... ...+++.+|+.+++.++|+||+++++++.+...       
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            4678889999999999999999865 6789999987533 345789999999999999999999987654221       


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          ..+..++.+++.||.|||+   ++++|+||+|+||+++.++.+||+|||++.........
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence                                1125788999999999999   89999999999999999999999999998766432211


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......+..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ......    ..         ...
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~----~~---------~~~  223 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVE----RG---------YRM  223 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cC---------CCC
Confidence            1122234568999999998889999999999999999998 999997543221   111111    00         011


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ..+...+..+.+++.+|++.+|.+||+++++++.|+
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~  259 (261)
T cd05034         224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE  259 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence            112223556889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.1e-36  Score=282.00  Aligned_cols=247  Identities=18%  Similarity=0.257  Sum_probs=182.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      .++|...+.||+|+||.||+|+...++..||||.+...  .......+.+|+.+++.++|+||+++++++....      
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788999999999999999999999999999998653  2333556788999999999999999988764321      


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ...+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.....
T Consensus        84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence                                   11236789999999999999   9999999999999999999999999999976543


Q ss_pred             CCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------HHhccC
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW--------DLYGKG  266 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~  266 (387)
                      .. .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||................        ......
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         161 KG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             Cc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            21 12233457889999998765 458899999999999999999999997654222111111000        000000


Q ss_pred             chhhhhc---ccCC---ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          267 QLLEAAD---GRLS---KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       267 ~~~~~~~---~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ...+...   ....   .......+..+.+++.+||+.||.+|||+++++++.|+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence            0000000   0000   0111234566889999999999999999999999998764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.1e-36  Score=271.87  Aligned_cols=227  Identities=23%  Similarity=0.354  Sum_probs=179.6

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      +|+..+.||+|+||.+|++....+++.||+|.+...  .....+++.+|+.+++.++||||+++++++.+...       
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            477889999999999999999988999999998643  33445688999999999999999999987654321       


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          ..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence                                1235788999999999999   9999999999999999999999999999976543211 


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||......+.      ..... .+.         ...
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~~---------~~~  220 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKII-RGS---------YPP  220 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHh-cCC---------CCC
Confidence            12234578889999999888899999999999999999999999975432211      11111 110         111


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .+......+.+++.+||+.+|.+||++.+|+++.|+
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            223345568899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-36  Score=277.07  Aligned_cols=240  Identities=24%  Similarity=0.339  Sum_probs=179.9

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcch--hhH-----
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ--RQL-----  140 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~-----  140 (387)
                      |...+.||+|+||.||+|....++..+|+|.+....  ......+.+|+++++.++|||++++++++.+.  ...     
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            556788999999999999999889999999997653  33456788999999999999999999987655  111     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          .+..++.+++.||+|||+   .+++|+||+|+||++++++.+||+|||++..........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence                                126789999999999999   899999999999999999999999999998665433222


Q ss_pred             eeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc------hhh---
Q 043148          201 TTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ------LLE---  270 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~---  270 (387)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............   ........      ...   
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI---FELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCchhhccccccchh
Confidence            233456788999998765 45789999999999999999999999765543222211   11110000      000   


Q ss_pred             --hh------cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          271 --AA------DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       271 --~~------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                        ..      ...+...+...++..+.+++..||+.+|.+||++++++++.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence              00      0000001111125678899999999999999999999998774

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.5e-36  Score=278.35  Aligned_cols=244  Identities=26%  Similarity=0.327  Sum_probs=181.7

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchh----
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----  138 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  138 (387)
                      ...++|+..+.||+|+||.||+|.+..++..||+|.++...  ......+.+|+++++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678899999999999999999999889999999986542  233456788999999999999999988765432    


Q ss_pred             -------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccc
Q 043148          139 -------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF  187 (387)
Q Consensus       139 -------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  187 (387)
                                                     ...+..++.|++.||+|||+   .+|+|+||+|+||++++++.+||+||
T Consensus        84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCcc
Confidence                                           11236789999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC
Q 043148          188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG  266 (387)
Q Consensus       188 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  266 (387)
                      |++...............++..|+|||.+.+. .++.++||||||+++|||++|+.||...........   +.......
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~---~~~~~~~~  237 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL---ISRLCGSP  237 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCC
Confidence            99986644322222233457789999988653 478999999999999999999999975443222211   11111110


Q ss_pred             ch---hhhh--------c------ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          267 QL---LEAA--------D------GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       267 ~~---~~~~--------~------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ..   ..+.        +      ..... .....+..+.+++..||+.||.+||++.+++++.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             Chhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            00   0000        0      00000 011235568899999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.5e-36  Score=278.00  Aligned_cols=244  Identities=24%  Similarity=0.306  Sum_probs=180.0

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCCccceehhhcch--h-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--QGKKEYISEVRIISRLRHRNLVHLIGWCHEQ--R-----  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~-----  138 (387)
                      ++|...+.||+|+||.||+|.+..+++.+++|.++....  .....+.+|+.++.+++||||+++++++...  .     
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            568888999999999999999998899999999865432  2234567899999999999999999876543  1     


Q ss_pred             --------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          139 --------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       139 --------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                          ...+..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||++....... 
T Consensus        85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  160 (293)
T cd07843          85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-  160 (293)
T ss_pred             ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence                                11126799999999999999   999999999999999999999999999998665432 


Q ss_pred             ceeeeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH--------HHHHhcc----
Q 043148          199 SQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW--------VWDLYGK----  265 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~----  265 (387)
                      .......+++.|+|||.+.+.. ++.++|+||||+++|||++|..||...........+..        .|..+..    
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            1222345688899999887544 68999999999999999999999986543322111100        0100000    


Q ss_pred             --CchhhhhcccCCccccHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          266 --GQLLEAADGRLSKEFDER-QMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       266 --~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                        ..........+...++.. ....+.+++..||+.||++|||+.|++++.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence              000000011111122222 35668899999999999999999999998774

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-36  Score=278.29  Aligned_cols=243  Identities=21%  Similarity=0.287  Sum_probs=176.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      .++|...+.||+|+||.||+|..+.+++.||+|.+..... .....+.+|+++++.++||||+++++++.+...      
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            3678889999999999999999988899999999865432 223557789999999999999999987654321      


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+++....... .
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~  159 (291)
T cd07844          84 YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T  159 (291)
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence                               1236778899999999999   9999999999999999999999999999875432211 1


Q ss_pred             eeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc---hhhh-----
Q 043148          201 TTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ---LLEA-----  271 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-----  271 (387)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......  ......+.......   ....     
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhccc
Confidence            122346788999998875 458899999999999999999999997554211  11111111111100   0000     


Q ss_pred             -hc--------ccCCcccc-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          272 -AD--------GRLSKEFD-ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       272 -~~--------~~~~~~~~-~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                       ..        ..+..... ......+.+++.+||+.+|.+|||+.+++++.||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence             00        00000000 0012557789999999999999999999998875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.2e-36  Score=281.63  Aligned_cols=255  Identities=20%  Similarity=0.278  Sum_probs=187.9

Q ss_pred             ccCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhh
Q 043148           57 RFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWC  134 (387)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~  134 (387)
                      +....++....++|...+.||+|+||.||+|....++..||+|++....  ....+.+.+|++++.+++||||+++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            3445667778899999999999999999999998889999999986542  23346688899999999999999998866


Q ss_pred             cchh-----------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEc
Q 043148          135 HEQR-----------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLG  185 (387)
Q Consensus       135 ~~~~-----------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~  185 (387)
                      ....                             ...+..++.|++.||.|||+   ++++||||||+||+++.++.+||+
T Consensus        86 ~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             eecccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEe
Confidence            4211                             11235689999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH------
Q 043148          186 DFGLARLVDHELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW------  258 (387)
Q Consensus       186 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~------  258 (387)
                      |||+++....    ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..      
T Consensus       163 dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (345)
T cd07877         163 DFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  238 (345)
T ss_pred             cccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999875432    2223457889999998866 4688999999999999999999999975443222111100      


Q ss_pred             --HHHHhccCch---hhhhcccCCccc---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          259 --VWDLYGKGQL---LEAADGRLSKEF---DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       259 --~~~~~~~~~~---~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                        ....+.....   ...........+   .......+.+++.+|++.||.+||++.+++++.|+..-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence              0000000000   000000000000   01124457899999999999999999999999998753

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=272.41  Aligned_cols=244  Identities=25%  Similarity=0.345  Sum_probs=177.9

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhc--CCCCCccceehhhcchh---
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISR--LRHRNLVHLIGWCHEQR---  138 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---  138 (387)
                      +...+.....+.||+|.||.||+|.++  |..||||++..   .+...+.+|.++.+.  |+|+||+.|++.-...+   
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc--CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            445567778899999999999999995  67899999953   446678889888875  49999999987432211   


Q ss_pred             -------------------------hHHHHHHHHHHHHHHHHhhhhc-----ccceeeccCCcceeEeCCCCcEEEcccc
Q 043148          139 -------------------------QLILHKIALGLASAVLYLHEEW-----EQCIVHRDIKSSNVVLDSNFNAKLGDFG  188 (387)
Q Consensus       139 -------------------------~~~l~~i~~~i~~~l~~LH~~~-----~~~iiH~dlk~~Nill~~~~~~kl~Dfg  188 (387)
                                               ..-+.+++..+|.||++||.+-     ++.|.|||||+.|||+.+++.+.|+|+|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence                                     1123789999999999999753     6789999999999999999999999999


Q ss_pred             ccccccCCC---CceeeeeecCCcccCchhhccCC------CCCccchHHHHHHHHHHHhC----------CCCCCCCCC
Q 043148          189 LARLVDHEL---GSQTTVLAGTMGYLAPECVTTGK------ASKESDVYSFGVVALEVACG----------RKPVEPRQE  249 (387)
Q Consensus       189 ~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dvws~Gvil~el~tg----------~~p~~~~~~  249 (387)
                      +|-......   .......+||.+|||||++...-      --..+||||||+++||+..+          +.||.+..+
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            996544321   22344568999999999986432      12468999999999999754          257765443


Q ss_pred             cchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          250 PSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .+..  .+.+.+.+-..++...++.++   ...+.+..+.+++..||..+|..|-|+-.+-+.+....
T Consensus       442 ~DPs--~eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  442 SDPS--FEEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCCC--HHHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            3211  111222222222222222222   34567788999999999999999999998888776433

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.9e-36  Score=271.64  Aligned_cols=215  Identities=26%  Similarity=0.420  Sum_probs=162.6

Q ss_pred             CcccccCceEEEEEEECCC------------CeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-
Q 043148           74 GKLGEGGFGGVYRGLLSDQ------------NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-  140 (387)
                      +.||+|+||.||+|.+...            ...|++|.+..........+.+|+.++..++||||+++++++...... 
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            3689999999999986422            335899988665555566788999999999999999999976543211 


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc-------EEEcccc
Q 043148          141 -------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN-------AKLGDFG  188 (387)
Q Consensus       141 -------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~-------~kl~Dfg  188 (387)
                                               .+..++.|++.||+|||+   ++++||||||+|||++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence                                     125789999999999999   99999999999999987664       8999999


Q ss_pred             ccccccCCCCceeeeeecCCcccCchhhc-cCCCCCccchHHHHHHHHHHH-hCCCCCCCCCCcchhhHHHHHHHHhccC
Q 043148          189 LARLVDHELGSQTTVLAGTMGYLAPECVT-TGKASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKG  266 (387)
Q Consensus       189 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gvil~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~  266 (387)
                      ++......     ....++..|+|||++. +..++.++||||||+++|||+ +|..||......+...       .. ..
T Consensus       158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~-~~  224 (262)
T cd05077         158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------FY-EG  224 (262)
T ss_pred             CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------HH-hc
Confidence            98654321     2235778899999887 466899999999999999997 5888876543221110       00 00


Q ss_pred             chhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ..      ...    ......+.+++.+||+.||.+||++.+|++.++
T Consensus       225 ~~------~~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         225 QC------MLV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             Cc------cCC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            00      001    112345788999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.6e-36  Score=277.71  Aligned_cols=239  Identities=21%  Similarity=0.338  Sum_probs=181.6

Q ss_pred             cCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcc
Q 043148           58 FTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHE  136 (387)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  136 (387)
                      +.++.+..+.++|+..+.||+|+||.||++....++..+|+|.+.... .....+.+|+.++..+ +||||+++++++..
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            445566778899999999999999999999999889999999876432 2346678899999999 69999999987631


Q ss_pred             h-----h-----------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcE
Q 043148          137 Q-----R-----------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA  182 (387)
Q Consensus       137 ~-----~-----------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  182 (387)
                      .     .                             ...+..++.|++.||.|||+   .+++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence            1     0                             01124588999999999999   999999999999999999999


Q ss_pred             EEccccccccccCCCCceeeeeecCCcccCchhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 043148          183 KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT-----GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVE  257 (387)
Q Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~  257 (387)
                      ||+|||+++...... .......|++.|+|||.+..     ..++.++|||||||++|||++|+.||.........    
T Consensus       164 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~----  238 (286)
T cd06638         164 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL----  238 (286)
T ss_pred             EEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH----
Confidence            999999987654322 12233468899999998753     44788999999999999999999999754322111    


Q ss_pred             HHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          258 WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                        .. .....     .+..  ..+......+.+++.+||+.||.+|||+.|+++++++
T Consensus       239 --~~-~~~~~-----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         239 --FK-IPRNP-----PPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             --hh-ccccC-----CCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence              00 00000     0000  0111223458889999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-35  Score=270.55  Aligned_cols=232  Identities=25%  Similarity=0.440  Sum_probs=181.1

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC------hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS------KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      +|+..+.||+|+||.||++....++..+|+|.+....      ....+.+.+|+++++.++|+||+++++++.+...   
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4677889999999999999998889999999986532      1235678899999999999999999998765432   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC-cEEEccccccccccCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF-NAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~  196 (387)
                                            ..+..++.|++.||.|||+   ++++|+||+|+||+++.++ .+||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence                                  1236788999999999999   9999999999999998776 5999999998766443


Q ss_pred             CC---ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          197 LG---SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       197 ~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ..   .......++..|+|||.+.+..++.++||||+|+++|+|++|..||............   ..         ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~---------~~~  225 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FK---------IAS  225 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HH---------Hhc
Confidence            11   1122345788999999998888999999999999999999999999754332211111   11         001


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .......+......+.+++.+|++.+|.+||++.+++++.++
T Consensus       226 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~  267 (268)
T cd06630         226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF  267 (268)
T ss_pred             cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence            111233444566778899999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.2e-36  Score=271.78  Aligned_cols=225  Identities=27%  Similarity=0.477  Sum_probs=172.9

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      .+|...+.||+|+||.||++.+.. +..+|+|.+.... ....++.+|+++++.++|||++++++++.....        
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            457778899999999999998864 6789999886542 334678999999999999999999987643221        


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.+++.+|+|||+   .+++|+||||+||+++.++.+||+|||+++..........
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence                              1236788899999999999   8999999999999999999999999999875543222112


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      ....++.+|+|||.+.+..++.++||||||+++|||++ |+.||.......   ..+    ....+.  ....       
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~--~~~~-------  222 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVE----TINAGF--RLYK-------  222 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH----HHhCCC--CCCC-------
Confidence            22234578999999998889999999999999999998 999997544221   111    111110  0011       


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINVL  313 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  313 (387)
                      +...+..+.+++.+||+.+|++||++.+++++|
T Consensus       223 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            111345688999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9.9e-36  Score=270.27  Aligned_cols=222  Identities=29%  Similarity=0.437  Sum_probs=165.8

Q ss_pred             CcccccCceEEEEEEECC---CCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----------
Q 043148           74 GKLGEGGFGGVYRGLLSD---QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----------  139 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----------  139 (387)
                      +.||+|+||.||+|.+.+   ....+|+|.+... .....+.+.+|+.+++.++||||+++++++...+.          
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998643   3467999998543 33456788899999999999999999997642211          


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC---c
Q 043148          140 -----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG---S  199 (387)
Q Consensus       140 -----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~---~  199 (387)
                                       ..+..++.+++.||.|||+   .+++||||||+|||++.++.+||+|||+++.......   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence                             1125678899999999999   9999999999999999999999999999875433211   1


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACG-RKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ......++..|+|||.+.+..++.++||||||+++|||++| ..||......   ......   . .+.         ..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~---~-~~~---------~~  221 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYL---L-QGR---------RL  221 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---h-cCC---------CC
Confidence            11123456789999999888899999999999999999995 5566543221   111111   1 110         01


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ..+...+..+.+++..||+.+|++||++.+|++.++
T Consensus       222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~  257 (262)
T cd05058         222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE  257 (262)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            111223456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.9e-36  Score=272.68  Aligned_cols=229  Identities=27%  Similarity=0.418  Sum_probs=176.3

Q ss_pred             hCccccCcccccCceEEEEEEECCC---CeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQ---NTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      ++|...+.||+|+||.||+|.+.+.   ...|+||...... ....+.+.+|+.+++.++||||+++++++.+...    
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~   85 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM   85 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence            4577788999999999999987543   3469999886654 4556789999999999999999999987654321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           ..+..++.+++.||.|||+   .+++||||||+||+++.++.+||+|||+++.......
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence                                 1225688999999999999   9999999999999999999999999999876544321


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      .......+++.|+|||.+....++.++||||||+++||+++ |..||......+..   .+.    ..+.         .
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~----~~~~---------~  226 (270)
T cd05056         163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRI----ENGE---------R  226 (270)
T ss_pred             eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH----HcCC---------c
Confidence            11222234568999999988889999999999999999986 99999765432211   111    1110         0


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ...+...+..+.+++.+|+..+|.+|||+.+++..|..
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~  264 (270)
T cd05056         227 LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD  264 (270)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            01122344568889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.7e-36  Score=281.37  Aligned_cols=249  Identities=17%  Similarity=0.277  Sum_probs=184.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      .++|...+.||+|+||.||+|....++..||+|++....  ....+.+.+|+.++..++||||+++++++....      
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            378888999999999999999999999999999987542  234567788999999999999999888764211      


Q ss_pred             ----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          139 ----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       139 ----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                            ...+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......
T Consensus        84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence                                  11236789999999999999   99999999999999999999999999998765432


Q ss_pred             CCc---eeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhc
Q 043148          197 LGS---QTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV--------WDLYG  264 (387)
Q Consensus       197 ~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~  264 (387)
                      ...   ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...........+...        .....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            211   1123467889999998865 45899999999999999999999999765433221111100        00000


Q ss_pred             cCchhhhh---cccCC---ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          265 KGQLLEAA---DGRLS---KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       265 ~~~~~~~~---~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .....+..   .....   .......+..+.+++..||+.+|.+||++.+++.++|+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~  300 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY  300 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence            00011100   00000   01112345678999999999999999999999999998643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.5e-36  Score=275.49  Aligned_cols=229  Identities=25%  Similarity=0.399  Sum_probs=176.2

Q ss_pred             hhCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  140 (387)
                      .++|...+.||+|+||.||++.+..     ++..+|+|.+.... .....++.+|+.++++++||||++++++|.+....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            4678889999999999999998743     56889999987543 34456799999999999999999999876543211


Q ss_pred             -----------------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcce
Q 043148          141 -----------------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSN  173 (387)
Q Consensus       141 -----------------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~N  173 (387)
                                                                     .+..++.+++.||.|||+   ++++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence                                                           124689999999999999   999999999999


Q ss_pred             eEeCCCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcc
Q 043148          174 VVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPS  251 (387)
Q Consensus       174 ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~  251 (387)
                      |+++.++.++|+|||++........ ........+..|+|||.+.+..++.++||||||+++|||++ |..||.+....+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875433211 11112234667999999998899999999999999999997 888886543221


Q ss_pred             hhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          252 KVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                         ..    .....+...         ..+...+..+.+++.+||+.||.+|||+.|+++.|+
T Consensus       241 ---~~----~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 ---VI----YYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             ---HH----HHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence               11    111111110         112234456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.7e-36  Score=304.70  Aligned_cols=230  Identities=21%  Similarity=0.307  Sum_probs=174.9

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++....   ....+++.+|+++++.++||||+++++++.+.+..    
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57889999999999999999999899999999986532   23356799999999999999999999876543210    


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccc
Q 043148          141 --------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG  188 (387)
Q Consensus       141 --------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  188 (387)
                                                      .+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence                                            124678899999999999   999999999999999999999999999


Q ss_pred             ccccccCCCC-----------------ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 043148          189 LARLVDHELG-----------------SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPS  251 (387)
Q Consensus       189 ~~~~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~  251 (387)
                      +++.......                 .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9976521110                 00112468999999999999999999999999999999999999997633221


Q ss_pred             hhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHhc
Q 043148          252 KVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPS-IRQVINVLN  314 (387)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~evl~~l~  314 (387)
                      ...     ..     ..   ..+. ........+..+.+++.+|++.||++||+ ++++++.|.
T Consensus       239 i~~-----~~-----~i---~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le  288 (932)
T PRK13184        239 ISY-----RD-----VI---LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE  288 (932)
T ss_pred             hhh-----hh-----hc---cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            100     00     00   0000 00001233455788999999999999965 666666553

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.5e-36  Score=276.39  Aligned_cols=239  Identities=23%  Similarity=0.355  Sum_probs=183.7

Q ss_pred             cCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcc
Q 043148           58 FTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHE  136 (387)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  136 (387)
                      +++.++..++++|...+.||+|+||.||++....+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            455667777899999999999999999999999889999999986532 2346677899999999 89999999987643


Q ss_pred             hh----------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcE
Q 043148          137 QR----------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA  182 (387)
Q Consensus       137 ~~----------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  182 (387)
                      .+                                  ...+..++.|++.||.|||+   .+++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence            21                                  01125688999999999999   999999999999999999999


Q ss_pred             EEccccccccccCCCCceeeeeecCCcccCchhhccC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 043148          183 KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG-----KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVE  257 (387)
Q Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~  257 (387)
                      ||+|||++........ ......++..|+|||.+...     .++.++|||||||++|||++|+.||.........    
T Consensus       168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~----  242 (291)
T cd06639         168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL----  242 (291)
T ss_pred             EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH----
Confidence            9999999876543221 12234578899999987643     3688999999999999999999999764432111    


Q ss_pred             HHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          258 WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                        .... .....     .+  ..+......+.+++.+||+.+|.+||++.|+++|.|+
T Consensus       243 --~~~~-~~~~~-----~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  290 (291)
T cd06639         243 --FKIP-RNPPP-----TL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI  290 (291)
T ss_pred             --HHHh-cCCCC-----CC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence              1110 01000     00  1122334568899999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.5e-36  Score=279.19  Aligned_cols=247  Identities=22%  Similarity=0.281  Sum_probs=178.8

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchh-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-----  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  138 (387)
                      ..++|...+.||+|+||.||+|....++..||||.+....  ......+.+|++++++++||||++++++|....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3467899999999999999999999899999999986432  222345678999999999999999998654321     


Q ss_pred             ----------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccc
Q 043148          139 ----------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA  190 (387)
Q Consensus       139 ----------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~  190 (387)
                                                  ...+..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||++
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence                                        11236789999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCc---eeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC
Q 043148          191 RLVDHELGS---QTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG  266 (387)
Q Consensus       191 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  266 (387)
                      .........   ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+..+.......
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            765432211   11233567889999988664 47889999999999999999999997655433222222211100000


Q ss_pred             -----chhhhhcc-cCCccc---------cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          267 -----QLLEAADG-RLSKEF---------DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       267 -----~~~~~~~~-~~~~~~---------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                           ......+. ......         .......+.+++.+||+.||.+|||++|+++|.|+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                 00000000 000000         00112346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=7.5e-36  Score=272.04  Aligned_cols=228  Identities=26%  Similarity=0.460  Sum_probs=175.1

Q ss_pred             hCccccCcccccCceEEEEEEECCC---CeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQ---NTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      ++|+..+.||+|+||.||+|.+..+   +..+|+|.+.... ....+.+.+|+.++..++||||+++++++.+....   
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            5788889999999999999987543   3479999986542 34456889999999999999999999876543322   


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                             .+..++.|++.||.|||+   ++++||||||+|||++.++.++|+|||++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence                                   126788999999999999   999999999999999999999999999998664432


Q ss_pred             Ccee--eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          198 GSQT--TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       198 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      ....  ....++..|+|||.+.+..++.++|+||||+++||+++ |..||......+.   ...+    .++.       
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~~~-------  226 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAI----EEGY-------  226 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHH----hCCC-------
Confidence            1111  11223467999999998889999999999999999886 9999976543221   1111    1110       


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                        ....+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus       227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  264 (267)
T cd05066         227 --RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD  264 (267)
T ss_pred             --cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence              01111223456789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.4e-36  Score=271.18  Aligned_cols=233  Identities=21%  Similarity=0.334  Sum_probs=180.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      ++|+..+.||.|+||.||+|....++..+++|++.... ....+.+.+|+++++.++|+||+++++.+....        
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999998889999999986542 335678899999999999999999988654321        


Q ss_pred             --------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          139 --------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       139 --------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                          ...+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence                                12346788999999999999   9999999999999999999999999999876544322


Q ss_pred             c---eeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          199 S---QTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       199 ~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      .   ......++..|+|||.+... .++.++|+||||+++|||++|+.||.........      ......      ..+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~~~~~~------~~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL------MLTLQN------DPP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH------HHHhcC------CCC
Confidence            1   12334578899999998877 6899999999999999999999999755432111      111111      011


Q ss_pred             cCCccc-cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          275 RLSKEF-DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       275 ~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .+.... ....+..+.+++..||+.||.+||++.++++|.|+
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            111111 12345668899999999999999999999999774

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.1e-35  Score=269.88  Aligned_cols=229  Identities=26%  Similarity=0.403  Sum_probs=179.7

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      +|+..+.||.|+||.||++....++..+|+|.+...  .....+.+..|+++++.++||||+++++++....        
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477788999999999999999988999999998653  3444567889999999999999999988653211        


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhc--ccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEW--EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~--~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                                             ...+..++.+++.||.|||...  ..+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence                                   0123568899999999999211  289999999999999999999999999999866


Q ss_pred             cCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          194 DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       194 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ..... ......+++.|+|||.+....++.++|+||||+++|+|++|+.||.......   ...    ....+       
T Consensus       161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~----~~~~~-------  225 (265)
T cd08217         161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LAS----KIKEG-------  225 (265)
T ss_pred             cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHH----HHhcC-------
Confidence            54321 1233468899999999998889999999999999999999999997654211   111    11111       


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                        .....+...+..+.+++.+|++.+|.+||++.+|+++.+
T Consensus       226 --~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~  264 (265)
T cd08217         226 --KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL  264 (265)
T ss_pred             --CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCC
Confidence              112233445567889999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.9e-36  Score=275.03  Aligned_cols=231  Identities=24%  Similarity=0.414  Sum_probs=175.5

Q ss_pred             HhhCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  139 (387)
                      ..++|.+.+.||+|+||.||+|..++     .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45788999999999999999997642     35579999886543 2334568899999999999999999987643321


Q ss_pred             H-----------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEE
Q 043148          140 L-----------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKL  184 (387)
Q Consensus       140 ~-----------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl  184 (387)
                      .                                   .+..++.|++.||.|||+   ++++||||||+||+++.++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence            1                                   234588899999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 043148          185 GDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDL  262 (387)
Q Consensus       185 ~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~  262 (387)
                      +|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+   ...    .
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~----~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK----F  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----H
Confidence            999998754332111 1112234678999999998889999999999999999998 788987543221   111    1


Q ss_pred             hccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          263 YGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ...+..         ...+...+..+.+++.+||+.||++|||+.++++.+..
T Consensus       234 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  277 (288)
T cd05061         234 VMDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD  277 (288)
T ss_pred             HHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            111110         11122334568999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=9.4e-36  Score=269.49  Aligned_cols=226  Identities=23%  Similarity=0.355  Sum_probs=180.1

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      +|+..+.||+|+||.||.++...++..+++|.+...  .....+++.+|++++++++|+||+++++++.+...       
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            578889999999999999999999999999998654  34556778999999999999999999987654322       


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          ..+..++.+++.+|.|||+   .+++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence                                1235688999999999999   8999999999999999999999999999876544321 


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......+++.|+|||.+.+..++.++||||||+++|||++|..||......+..      .... .+.        . ..
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~~-~~~--------~-~~  220 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV------VKIV-QGN--------Y-TP  220 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHH-cCC--------C-CC
Confidence            223345789999999998888899999999999999999999999754322111      1111 111        1 11


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .....+..+.+++.+||+.+|.+||++.+++++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence            12334556889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-36  Score=270.25  Aligned_cols=222  Identities=29%  Similarity=0.424  Sum_probs=175.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      .++|...+.||+|+||.||+|...  |+.||+|.+..... ..+++.+|+.++..++|+||+++++++.+..        
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            356778889999999999999874  78899999976544 5678999999999999999999998765321        


Q ss_pred             -------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          139 -------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       139 -------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                         ...+..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||.++....... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence                               11236789999999999999   9999999999999999999999999999986533211 


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                         ....+..|+|||.+....++.++||||||+++|||++ |..||......+   ..    .....+         ...
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~---------~~~  218 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PHVEKG---------YRM  218 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHhcC---------CCC
Confidence               2234567999999988889999999999999999997 999987543221   11    111111         111


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ..+...+..+.+++.+||..+|.+||++.++++.|.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  254 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA  254 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence            122234566889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-35  Score=273.67  Aligned_cols=232  Identities=23%  Similarity=0.314  Sum_probs=180.5

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----------  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----------  139 (387)
                      |...+.||+|++|.||++....++..+++|.+........+.+.+|+.++..++||||+++++++.....          
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            4445689999999999999988899999999876555556778999999999999999999987543221          


Q ss_pred             --------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeee
Q 043148          140 --------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA  205 (387)
Q Consensus       140 --------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  205 (387)
                                    ..+..++.+++.||+|||+   ++++||||+|+||+++.++.++|+|||++........ ......
T Consensus       101 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~  176 (285)
T cd06648         101 GALTDIVTHTRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLV  176 (285)
T ss_pred             CCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccccc
Confidence                          1235789999999999999   9999999999999999999999999998875443221 222345


Q ss_pred             cCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHH
Q 043148          206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM  285 (387)
Q Consensus       206 g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (387)
                      |++.|+|||.+.+..++.++||||||+++|||++|+.||.........   ....    ...     .+..  .......
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~---~~~~----~~~-----~~~~--~~~~~~~  242 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM---KRIR----DNL-----PPKL--KNLHKVS  242 (285)
T ss_pred             CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH---HHHH----hcC-----CCCC--cccccCC
Confidence            788999999998888999999999999999999999999754322111   1111    000     0001  0111244


Q ss_pred             HHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 043148          286 ECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPL  319 (387)
Q Consensus       286 ~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  319 (387)
                      ..+.+++.+||+.+|++||++.+++++.++....
T Consensus       243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence            5689999999999999999999999998876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.5e-36  Score=281.47  Aligned_cols=230  Identities=27%  Similarity=0.393  Sum_probs=174.2

Q ss_pred             hCccccCcccccCceEEEEEEECC-------CCeEEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchh
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSD-------QNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQR  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  138 (387)
                      .+|.+.+.||+|+||.||++++..       .+..||+|.+... .....+++.+|++++.++ +||||++++++|.+..
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            468889999999999999998643       2246899988653 234467899999999999 7999999998765432


Q ss_pred             hH-----------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC
Q 043148          139 QL-----------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD  177 (387)
Q Consensus       139 ~~-----------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~  177 (387)
                      ..                                         .+..++.|++.||.|||+   ++++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence            11                                         113478899999999999   9999999999999999


Q ss_pred             CCCcEEEccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 043148          178 SNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRL  255 (387)
Q Consensus       178 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~  255 (387)
                      .++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.   
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---  245 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---  245 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---
Confidence            9999999999999765432111 1112234567999999998889999999999999999998 8888865432211   


Q ss_pred             HHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          256 VEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                          ......+         .....+...+..+.+++.+||+.+|.+||++.|+++.|...
T Consensus       246 ----~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         246 ----FKLLKEG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             ----HHHHHcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence                1111111         11112223345688999999999999999999999999744

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8.1e-36  Score=271.39  Aligned_cols=229  Identities=28%  Similarity=0.451  Sum_probs=175.7

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC------hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS------KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      +|...+.||+|+||.||+|... ++..+|+|.+....      ......+.+|+++++.++|+||++++++|.+...   
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            4677889999999999999875 58899999886432      1223568899999999999999999998755322   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC-
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE-  196 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-  196 (387)
                                            ..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++...... 
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence                                  1235688999999999999   89999999999999999999999999998754321 


Q ss_pred             ----CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          197 ----LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       197 ----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                          .........++..|+|||.+.+..++.++||||||+++|+|++|+.||............      ....      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~~------  224 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI------GAHR------  224 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh------hhcc------
Confidence                111122345788999999999888999999999999999999999999754322111000      0000      


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                        ......+......+.+++.+||+.+|.+||++.+++++.|+
T Consensus       225 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         225 --GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             --CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence              01112223345667899999999999999999999998764

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.3e-35  Score=269.51  Aligned_cols=230  Identities=30%  Similarity=0.463  Sum_probs=177.9

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      +|...+.||+|+||.||+|....++..|++|.+.....  ...+.+.+|+++++.++|+||+++++++.+...       
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            47778899999999999999988899999999876543  356788999999999999999999987643321       


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce-
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ-  200 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  200 (387)
                                        .....++.+++.||.|||+   .+++|+||+|+||++++++.+||+|||++.......... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence                              1235689999999999999   999999999999999999999999999987654432211 


Q ss_pred             --eeeeecCCcccCchhhccCC---CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          201 --TTVLAGTMGYLAPECVTTGK---ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       201 --~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                        .....++..|+|||.+.+..   ++.++||||||+++||+++|+.||.........     ..... .+     ..+.
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~-----~~~~~-~~-----~~~~  226 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI-----MFHVG-AG-----HKPP  226 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH-----HHHHh-cC-----CCCC
Confidence              11245788999999988766   889999999999999999999999754321110     01000 00     0011


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      +..  .......+.+++.+||+.+|.+||++.+++.+.|
T Consensus       227 ~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~  263 (264)
T cd06626         227 IPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF  263 (264)
T ss_pred             CCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence            111  1122555778999999999999999999998876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.1e-36  Score=272.10  Aligned_cols=233  Identities=24%  Similarity=0.400  Sum_probs=175.5

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh----------hhHHHHHHHHHHHhcCCCCCccceehhhcchh
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK----------QGKKEYISEVRIISRLRHRNLVHLIGWCHEQR  138 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  138 (387)
                      +|...+.||+|+||.||+|....++..+|+|.+.....          ...+.+..|+.++..++|||++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            46677899999999999999988899999998854211          11246778999999999999999998765432


Q ss_pred             hH-------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          139 QL-------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       139 ~~-------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                      ..                         .+..++.|++.||.|||+   ++++||||+|+||+++.++.++|+|||++...
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            11                         235688999999999999   89999999999999999999999999998754


Q ss_pred             cCCCC-ceeeeeecCCcccCchhhccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          194 DHELG-SQTTVLAGTMGYLAPECVTTGK--ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       194 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      ..... .......++..|+|||.+....  ++.++|+||||+++||+++|..||.......      ......... .  
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~-~--  229 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------AMFKLGNKR-S--  229 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------HHHHhhccc-c--
Confidence            43211 1122345788999999987654  7899999999999999999999996433211      111111110 0  


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                        ............+..+.+++.+||+.+|.+||++++|+++.|+
T Consensus       230 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         230 --APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             --CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence              0111112222345678889999999999999999999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.1e-35  Score=275.39  Aligned_cols=243  Identities=21%  Similarity=0.280  Sum_probs=180.0

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCChh-----hHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ-----GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      +|...+.||+|+||.||+|....+++.||||.+......     ....+..|++++..++|+||+++++++.+...    
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            467788999999999999999888999999999765322     34567789999999999999999987765321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           ..+..++.|+++||.|||+   ++++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence                                 1236789999999999999   9999999999999999999999999999976644321


Q ss_pred             ceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC---------ch
Q 043148          199 SQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG---------QL  268 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~  268 (387)
                       ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||......+...   .........         ..
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG---KIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH---HHHHHcCCCchhhhhhcccc
Confidence             1222345778999998865 457899999999999999999988877544322211   111111000         00


Q ss_pred             hhhhcccCC-----ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          269 LEAADGRLS-----KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       269 ~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .........     ..........+.+++.+||+.||++|||+.|++++.|+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~  288 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND  288 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence            000000000     01112335678899999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.3e-36  Score=280.28  Aligned_cols=240  Identities=18%  Similarity=0.222  Sum_probs=171.6

Q ss_pred             cCccccc--CceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---------
Q 043148           73 AGKLGEG--GFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---------  139 (387)
Q Consensus        73 ~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---------  139 (387)
                      .++||+|  +|++||++....+|..||+|++....  ......+.+|+++++.++||||++++++|.....         
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            5679999  78999999999999999999986542  3334567789999999999999999987644321         


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-c-
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-S-  199 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~-  199 (387)
                                        ..+..++.|++.||.|||+   ++++||||||+|||++.++.++++||+.......... . 
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence                              2236789999999999999   9999999999999999999999999986543221100 0 


Q ss_pred             ----eeeeeecCCcccCchhhcc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh----ccC---
Q 043148          200 ----QTTVLAGTMGYLAPECVTT--GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLY----GKG---  266 (387)
Q Consensus       200 ----~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~---  266 (387)
                          ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.........  ........    ...   
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCccccccccchh
Confidence                0112345678999999876  45899999999999999999999999754322110  00000000    000   


Q ss_pred             ---------------chhh---------hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          267 ---------------QLLE---------AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       267 ---------------~~~~---------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                                     ....         .................+.+++.+||+.||.+|||++|+++++|+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence                           0000         00000001112234556889999999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.4e-36  Score=281.05  Aligned_cols=249  Identities=20%  Similarity=0.263  Sum_probs=181.8

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh---
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~---  139 (387)
                      ..++|...+.||+|+||.||+|.+..++..+|+|.+...  .......+.+|+.++.++ +||||++++++|.....   
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            457788899999999999999999888999999988542  233455677899999999 99999999998753221   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            .....++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        85 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          85 YLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             EEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence                                  1124689999999999999   999999999999999999999999999997654322


Q ss_pred             C----ceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------HHhc
Q 043148          198 G----SQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW--------DLYG  264 (387)
Q Consensus       198 ~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~  264 (387)
                      .    .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+.........        ....
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence            1    12233467889999998765 457899999999999999999999997654332211111000        0000


Q ss_pred             cCchhhhhc----cc--CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          265 KGQLLEAAD----GR--LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       265 ~~~~~~~~~----~~--~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .......++    ..  .........+..+.+++.+||+.||.+|||+.+++++.++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~  300 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ  300 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence            000000000    00  000111124566889999999999999999999999987543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8.8e-36  Score=270.96  Aligned_cols=232  Identities=27%  Similarity=0.416  Sum_probs=180.5

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchh---------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR---------  138 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------  138 (387)
                      +|+..+.||+|+||.||++.+..+++.+|+|.+.... ....+++.+|+++++.++||||+++++++....         
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5677889999999999999999889999999987653 345677899999999999999999987654321         


Q ss_pred             -----------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          139 -----------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       139 -----------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                       ...+..++.+++.||.|||+  ..+++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--  157 (265)
T cd06605          82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--  157 (265)
T ss_pred             CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence                             12235789999999999997  378999999999999999999999999998755332111  


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD  281 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (387)
                       ...++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...+......         ... ....+
T Consensus       158 -~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~---------~~~-~~~~~  225 (265)
T cd06605         158 -TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIV---------NEP-PPRLP  225 (265)
T ss_pred             -cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHh---------cCC-CCCCC
Confidence             15678899999999988999999999999999999999999975432111 1111111111         110 11111


Q ss_pred             H-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          282 E-RQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       282 ~-~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      . .....+.+++..||..||.+|||+.+++.+.|+.
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~  261 (265)
T cd06605         226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK  261 (265)
T ss_pred             hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence            1 1556688999999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=267.71  Aligned_cols=221  Identities=29%  Similarity=0.464  Sum_probs=171.0

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCCccceehhhcchhh-------------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ-GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------------  139 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------------  139 (387)
                      +.||+|+||.||++.+.. ++.||+|.+...... ....+.+|+++++.++|+||+++++++.+...             
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            369999999999999987 899999998765333 56789999999999999999999887654321             


Q ss_pred             -------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee-eeee
Q 043148          140 -------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT-TVLA  205 (387)
Q Consensus       140 -------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~  205 (387)
                                   ..+..++.+++.+|.|||+   ++++||||+|+||+++.++.+||+|||++........... ....
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence                         1225688899999999999   9999999999999999999999999999875542211111 1122


Q ss_pred             cCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       206 g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .+..|+|||.+.+..++.++|+||||+++|||++ |..||...........       ...         ......+...
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-------~~~---------~~~~~~~~~~  220 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-------IES---------GYRMPAPQLC  220 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-------Hhc---------CCCCCCCccC
Confidence            3567999999988889999999999999999999 8888876543211111       100         0011122334


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          285 MECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      +..+.+++.+||+.+|.+||++.|+++.|.
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            556889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.7e-36  Score=276.57  Aligned_cols=230  Identities=27%  Similarity=0.411  Sum_probs=174.9

Q ss_pred             hhCccccCcccccCceEEEEEEEC-------CCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcch
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLS-------DQNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ  137 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  137 (387)
                      .++|.+.+.||+|+||.||+++..       .++..||+|.+... ......++.+|+.++..+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467788899999999999999752       23457999998654 234467889999999999 899999999876443


Q ss_pred             hhH-----------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe
Q 043148          138 RQL-----------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL  176 (387)
Q Consensus       138 ~~~-----------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill  176 (387)
                      ...                                         .+..++.|++.||.|||+   ++++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence            211                                         124578899999999999   999999999999999


Q ss_pred             CCCCcEEEccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 043148          177 DSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVR  254 (387)
Q Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~  254 (387)
                      +.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+   
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---  247 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  247 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence            99999999999999866432211 1222345678999999988889999999999999999998 788886543211   


Q ss_pred             HHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          255 LVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                          .......+.         ....+...+..+.+++.+||+.+|.+||++.|+++.|..
T Consensus       248 ----~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~  295 (304)
T cd05101         248 ----LFKLLKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR  295 (304)
T ss_pred             ----HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence                111111111         111122345668889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.7e-36  Score=269.70  Aligned_cols=226  Identities=27%  Similarity=0.430  Sum_probs=177.3

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-----hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-----KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      +|...+.||+|+||.||+|....++..|++|.+....     ....+.+.+|+.+++.++|+||+++++++.+....   
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4667788999999999999998789999999986543     23456788999999999999999999887553221   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.+++.||.|||+   .+++|+||+|+||+++.++.+||+|||++....... 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-  156 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence                                  225688999999999999   999999999999999999999999999987654322 


Q ss_pred             ceeeeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                       ......++..|++||.+.... ++.++|+||||+++|+|++|+.||........      .........         .
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~---------~  220 (258)
T cd06632         157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA------VFKIGRSKE---------L  220 (258)
T ss_pred             -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH------HHHHHhccc---------C
Confidence             223445788999999987766 89999999999999999999999976542111      111100000         1


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ...+......+.+++.+||+.+|.+||++.+++.+.+
T Consensus       221 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  257 (258)
T cd06632         221 PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF  257 (258)
T ss_pred             CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence            1122334566788999999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-37  Score=289.38  Aligned_cols=230  Identities=22%  Similarity=0.352  Sum_probs=183.3

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI-------  141 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-------  141 (387)
                      .|.++..||.|+||.||+|..++++..-|.|.+...+.....+|+-|++||...+||+||+|++.|...+.++       
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            3556778999999999999999888888899998888888999999999999999999999998654433221       


Q ss_pred             -------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          142 -------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       142 -------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                         +..++.+++.||.|||+   +.|||||||+.|||++.+|.++|+|||.+....... ....
T Consensus       113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qkRD  188 (1187)
T KOG0579|consen  113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QKRD  188 (1187)
T ss_pred             CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHH-hhhc
Confidence                               36799999999999999   999999999999999999999999999986433221 2234


Q ss_pred             eeecCCcccCchhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          203 VLAGTMGYLAPECVT-----TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       203 ~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      .+.|||.|||||+..     ..+|+.++||||||++|.||..+.+|............+            ...-.|.+ 
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi------------aKSePPTL-  255 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI------------AKSEPPTL-  255 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH------------hhcCCCcc-
Confidence            567999999999864     568999999999999999999999997654432111100            00011111 


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                       --+......+.+++..||..||..||++.++++|+|+.
T Consensus       256 -lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  256 -LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             -cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence             12334556688899999999999999999999999865

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.1e-36  Score=286.98  Aligned_cols=232  Identities=24%  Similarity=0.391  Sum_probs=175.7

Q ss_pred             HhhCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCC-CCCccceehhhcchh
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGS-KQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQR  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  138 (387)
                      ..++|...+.||+|+||.||+|++.+     .+..||||++.... ....+.+.+|+++|..+. ||||++++++|....
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            34567778899999999999998643     35689999997543 333457889999999997 999999998765432


Q ss_pred             hH------------------------------------------------------------------------------
Q 043148          139 QL------------------------------------------------------------------------------  140 (387)
Q Consensus       139 ~~------------------------------------------------------------------------------  140 (387)
                      ..                                                                              
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            11                                                                              


Q ss_pred             ---------------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeE
Q 043148          141 ---------------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVV  175 (387)
Q Consensus       141 ---------------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nil  175 (387)
                                                                   .+..++.|++.||.|||+   ++++||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEE
Confidence                                                         023477899999999999   99999999999999


Q ss_pred             eCCCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchh
Q 043148          176 LDSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKV  253 (387)
Q Consensus       176 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~  253 (387)
                      ++.++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |..||......+. 
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-  350 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-  350 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence            99999999999999976432211 11122346788999999998889999999999999999998 8899865432211 


Q ss_pred             hHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          254 RLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                           .......+         .....+......+.+++..||+.+|.+||++++|++.|..
T Consensus       351 -----~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         351 -----FYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             -----HHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                 11111111         1111222345668899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.7e-35  Score=268.65  Aligned_cols=227  Identities=24%  Similarity=0.447  Sum_probs=175.0

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      .++|...+.||+|+||.||++.+.. +..+|+|.+... ....+.+.+|+++++.++|+||+++.+++.+..        
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeC
Confidence            3678889999999999999998754 567999988654 334567899999999999999999988754311        


Q ss_pred             ------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          139 ------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       139 ------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                        ...+..++.+++.||.|||+   .+++|+||+|+||+++.++.+||+|||.+..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  159 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence                              01125688999999999998   999999999999999999999999999987654322111


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      .....++..|+|||.+....++.++|+||||+++|++++ |+.||........   ..+    ...+         ....
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~----~~~~---------~~~~  223 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRA----LERG---------YRMP  223 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHH----HhCC---------CCCC
Confidence            222335677999999988889999999999999999998 9999976443221   111    1111         1111


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .....+..+.+++.+||+.+|++||++.++++.|+
T Consensus       224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~  258 (260)
T cd05073         224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD  258 (260)
T ss_pred             CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence            12234456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.3e-35  Score=268.78  Aligned_cols=220  Identities=29%  Similarity=0.428  Sum_probs=171.4

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh---------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR---------  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------  138 (387)
                      ++|...+.||+|+||.||++...  +..+|+|.+....  ..+.+.+|+.+++.++|+|++++++++....         
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            46788899999999999999874  6789999986432  3467899999999999999999998643211         


Q ss_pred             -------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          139 -------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       139 -------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                         ...+..++.+++.||+|||+   ++++||||||+||+++.++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence                               01235788999999999999   999999999999999999999999999987543321  


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                        ....++..|+|||++.+..++.++||||||+++|||++ |+.||......+   ....    ...         ....
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~----~~~---------~~~~  218 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEK---------GYKM  218 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----Hhc---------CCCC
Confidence              12234567999999988889999999999999999997 999986543211   1111    111         1111


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ......+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  254 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE  254 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence            222334566889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=272.54  Aligned_cols=239  Identities=21%  Similarity=0.296  Sum_probs=180.4

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      |...+.||+|++|.||++....++..+++|.+.....  .....+.+|+++++.++|+||+++++++.....        
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            4567789999999999999988899999999876532  345678899999999999999999987754321        


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          140 -----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       140 -----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                       .....++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~  156 (283)
T cd05118          81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYT  156 (283)
T ss_pred             CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cccc
Confidence                             1225789999999999999   999999999999999999999999999987665432 1222


Q ss_pred             eeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc------hhh-----
Q 043148          203 VLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ------LLE-----  270 (387)
Q Consensus       203 ~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~-----  270 (387)
                      ...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....   .........      ..+     
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhhhhhh
Confidence            34577889999998876 689999999999999999999999976553322111   111111000      000     


Q ss_pred             ---hhcc--cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          271 ---AADG--RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       271 ---~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                         ....  .............+.+++..||+.||.+||++++++.+.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence               0000  00011223456778999999999999999999999999874

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.3e-36  Score=277.43  Aligned_cols=230  Identities=27%  Similarity=0.400  Sum_probs=174.7

Q ss_pred             hhCccccCcccccCceEEEEEEECC-------CCeEEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcch
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD-------QNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ  137 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  137 (387)
                      .++|.+.+.||+|+||.||++...+       +...+|+|.+... ......++..|++++..+ +||||++++++|.+.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3678899999999999999998643       2356999998754 234456788999999999 799999999865432


Q ss_pred             hh-----------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe
Q 043148          138 RQ-----------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL  176 (387)
Q Consensus       138 ~~-----------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill  176 (387)
                      ..                                         ..+..++.|++.||+|||+   ++++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence            11                                         1235689999999999998   999999999999999


Q ss_pred             CCCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 043148          177 DSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVR  254 (387)
Q Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~  254 (387)
                      +.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.  
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~--  251 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--  251 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--
Confidence            9999999999999875543211 11112224568999999998889999999999999999998 8888865332111  


Q ss_pred             HHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          255 LVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                           .......         .....+......+.+++..||+.+|.+||++.++++.|..
T Consensus       252 -----~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~  298 (307)
T cd05098         252 -----FKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  298 (307)
T ss_pred             -----HHHHHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence                 1111111         1112233345678889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-36  Score=274.06  Aligned_cols=239  Identities=23%  Similarity=0.298  Sum_probs=175.9

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      |+..+.||.|++|.||+|.+..+|..||+|++....  ......+.+|+++++.++|||++++++++.+...        
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            556788999999999999998889999999986543  2234578899999999999999999988654322        


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.|++.||.|||+   ++++||||+|+||+++.++.++|+|||++........ ..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~  156 (283)
T cd07835          81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TY  156 (283)
T ss_pred             CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-cc
Confidence                              1236789999999999999   8999999999999999999999999999976543221 11


Q ss_pred             eeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC---------chhhh
Q 043148          202 TVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG---------QLLEA  271 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~  271 (387)
                      ....++..|+|||++.+. .++.++||||||+++|+|++|+.||..........  . +.......         .+.+.
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF--R-IFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHHhCCCChHHhhhhhhchhh
Confidence            223467889999987664 47899999999999999999999997654321111  1 00000000         00000


Q ss_pred             ---hc---ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          272 ---AD---GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       272 ---~~---~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                         ..   ..............+.+++.+||+.||.+|||++|++++.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence               00   000011112234568899999999999999999999998774

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3e-35  Score=274.97  Aligned_cols=229  Identities=24%  Similarity=0.398  Sum_probs=178.0

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      |...+.||+|+||.||++++..++..+|+|.+....   ......+.+|+++++.++|||++++++++.+...       
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            666788999999999999998889999999986532   2334578899999999999999999997654321       


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.+++.||.|||+   ++++||||+|+||+++.++.+||+|||++......     
T Consensus       107 ~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----  178 (317)
T cd06635         107 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----  178 (317)
T ss_pred             CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----
Confidence                              1225688999999999999   99999999999999999999999999998654322     


Q ss_pred             eeeecCCcccCchhhc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          202 TVLAGTMGYLAPECVT---TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ....+++.|+|||.+.   ...++.++||||||+++|||++|+.||..........      ...         ......
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------~~~---------~~~~~~  243 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIA---------QNESPT  243 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH------HHH---------hccCCC
Confidence            2345788999999874   4568899999999999999999999987543221111      000         000111


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPS  321 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  321 (387)
                      .........+.+++.+||+.+|.+||++.++++++++....+.
T Consensus       244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  286 (317)
T cd06635         244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE  286 (317)
T ss_pred             CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence            1122344568899999999999999999999999987665443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.6e-36  Score=275.20  Aligned_cols=241  Identities=19%  Similarity=0.222  Sum_probs=176.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCC-CCCccceehhhcchhh-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  139 (387)
                      ++|+..+.||+|+||.||+|.+..++..||+|.+....  ......+.+|+.++..++ ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888899999999999999999899999999886542  223467888999999995 6999999886543211     


Q ss_pred             -----------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC-CCcEEEccccc
Q 043148          140 -----------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS-NFNAKLGDFGL  189 (387)
Q Consensus       140 -----------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfg~  189 (387)
                                                   ..+..++.||+.||.|||+   ++++||||+|+||+++. ++.+||+|||+
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence                                         1236689999999999999   99999999999999998 88999999999


Q ss_pred             cccccCCCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCch
Q 043148          190 ARLVDHELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL  268 (387)
Q Consensus       190 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (387)
                      +........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..........   .+.........
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~~~  233 (295)
T cd07837         158 GRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL---HIFKLLGTPTE  233 (295)
T ss_pred             ceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHhCCCCh
Confidence            875543211 1122346788999998865 457899999999999999999999997654322111   11111100000


Q ss_pred             h---hhh-------ccc----CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          269 L---EAA-------DGR----LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       269 ~---~~~-------~~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .   ...       -+.    ......+.....+.+++.+||+.||.+||+++|++.+.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~  294 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF  294 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence            0   000       000    0001112245668899999999999999999999999886

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=269.82  Aligned_cols=220  Identities=26%  Similarity=0.425  Sum_probs=167.2

Q ss_pred             CcccccCceEEEEEEECCCCe--EEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchh-----------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNT--EIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQR-----------  138 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----------  138 (387)
                      +.||+|+||.||+|.+.+++.  .+++|.+... .....+.+.+|++++.++ +||||++++++|....           
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            369999999999999987665  4688888653 344556889999999999 7999999988664321           


Q ss_pred             ------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccc
Q 043148          139 ------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG  188 (387)
Q Consensus       139 ------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  188 (387)
                                                    ...+..++.+++.||+|||+   ++++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence                                          11236788999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCc
Q 043148          189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQ  267 (387)
Q Consensus       189 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (387)
                      ++......  ........+..|+|||++....++.++||||||+++|||++ |..||......+..   .    ....+ 
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~----~~~~~-  227 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---E----KLPQG-  227 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH---H----HHhCC-
Confidence            98632211  11112233567999999988889999999999999999997 99999654322111   1    11010 


Q ss_pred             hhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          268 LLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                              .....+......+.+++.+||+.||.+|||+.++++.|.
T Consensus       228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  266 (270)
T cd05047         228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  266 (270)
T ss_pred             --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence                    111112223455789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-35  Score=272.54  Aligned_cols=243  Identities=21%  Similarity=0.306  Sum_probs=179.5

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-------  140 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-------  140 (387)
                      +|+..+.||.|++|.||+|++..++..||||.+..... .....+.+|+++++.++||||+++++++.+.+..       
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            57788999999999999999998899999999876532 2346678899999999999999999987654221       


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          ....++.|++.||.|||+   ++++||||+|+||++++++.++|+|||++........ .
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  156 (284)
T cd07836          81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T  156 (284)
T ss_pred             CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence                                125789999999999999   8999999999999999999999999999975543211 1


Q ss_pred             eeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhcc-Cchhh
Q 043148          201 TTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV--------WDLYGK-GQLLE  270 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~-~~~~~  270 (387)
                      .....++..|++||.+.+. .++.++||||||+++|+|++|+.||......+........        ++.+.. .....
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP  236 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence            2234568889999988654 4789999999999999999999999866543322211100        000000 00000


Q ss_pred             hhccc---CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          271 AADGR---LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       271 ~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .....   ......+..+..+.+++.+|++.||.+||++.+++++.|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            00000   0011112335567899999999999999999999998774

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.8e-35  Score=266.23  Aligned_cols=224  Identities=31%  Similarity=0.519  Sum_probs=174.3

Q ss_pred             cccCcccccCceEEEEEEECCCC----eEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           71 AEAGKLGEGGFGGVYRGLLSDQN----TEIAVKRVSRGSKQ-GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        71 ~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      .+.+.||.|+||.||++.+...+    ..||+|.+...... ..+.+..|++++..++|+||+++++++.+...      
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            45678999999999999998766    88999999765433 56789999999999999999999987654221      


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           ..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence                                 1235788999999999999   9999999999999999999999999999976654322


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      .......+++.|+|||.+....++.++||||||+++++|++ |+.||.......   ....    .....         .
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~----~~~~~---------~  222 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEY----LKKGY---------R  222 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhcCC---------C
Confidence            11112336789999999988889999999999999999998 788887533221   1111    11111         1


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL  313 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  313 (387)
                      ...+...+..+.+++.+|+..||.+|||+.|+++.|
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            111222456688899999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=9e-36  Score=277.30  Aligned_cols=246  Identities=24%  Similarity=0.301  Sum_probs=178.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--QGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      .++|...+.||+|+||.||+|.+..++..+|+|.+.....  .....+.+|+++++.++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            5789999999999999999999998899999999865422  22346778999999999999999988753321      


Q ss_pred             ---------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          139 ---------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       139 ---------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                                                 ...+..++.|+++||.|||+   ++++|+||||+||++++++.+||+|||+++
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccch
Confidence                                       11236789999999999999   999999999999999999999999999997


Q ss_pred             cccCCCCc----------eeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 043148          192 LVDHELGS----------QTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW  260 (387)
Q Consensus       192 ~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~  260 (387)
                      ........          ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            65432111          11223567889999987654 58899999999999999999999997655432222111110


Q ss_pred             HHhccC------chhh----hhcccCCccc---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          261 DLYGKG------QLLE----AADGRLSKEF---DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       261 ~~~~~~------~~~~----~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ......      .+..    ..........   .......+.+++.+||+.||.+|||+.|++.+.|+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            000000      0000    0000000000   01123557899999999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.9e-35  Score=275.89  Aligned_cols=231  Identities=27%  Similarity=0.422  Sum_probs=174.1

Q ss_pred             hhCccccCcccccCceEEEEEEEC-------CCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcch
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLS-------DQNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ  137 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  137 (387)
                      .++|...+.||+|+||.||++...       .....+|+|.+... ......++..|++++..+ +||||++++++|.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            356788899999999999999753       23457999998754 234456788999999999 699999999876543


Q ss_pred             hhH-----------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe
Q 043148          138 RQL-----------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL  176 (387)
Q Consensus       138 ~~~-----------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill  176 (387)
                      ...                                         .+..++.|++.||.|||+   ++++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence            211                                         124578899999999998   999999999999999


Q ss_pred             CCCCcEEEccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 043148          177 DSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVR  254 (387)
Q Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~  254 (387)
                      +.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.  
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--  245 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL--  245 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            99999999999999765432111 1112234467999999998889999999999999999999 8899865432211  


Q ss_pred             HHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          255 LVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                           ......+.         ....+..++..+.+++.+||+.||.+||++.++++.|+..
T Consensus       246 -----~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         246 -----FKLLREGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             -----HHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence                 11111111         1112223345678899999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.1e-35  Score=267.06  Aligned_cols=225  Identities=22%  Similarity=0.354  Sum_probs=176.5

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      +|...+.||+|+||.||++....++..+|+|.+...  .....+.+.+|+++++.++|||++++++.+....        
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477888999999999999999889999999998654  2344678889999999999999999987654321        


Q ss_pred             -------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC-cEEEccccccccccCCCC
Q 043148          139 -------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF-NAKLGDFGLARLVDHELG  198 (387)
Q Consensus       139 -------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~  198 (387)
                                         ...+..++.+++.+|.|||+   ++++|+||+|+||+++.++ .+||+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence                               12236788999999999999   9999999999999998654 68999999998664432 


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                       ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........   .....    ...         ..
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~----~~~---------~~  219 (256)
T cd08220         157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIM----SGT---------FA  219 (256)
T ss_pred             -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHHH----hcC---------CC
Confidence             22234578899999999988889999999999999999999999976543221   11110    000         11


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ..+......+.+++.+||+.+|.+|||++|++++.+
T Consensus       220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~  255 (256)
T cd08220         220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPI  255 (256)
T ss_pred             CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCC
Confidence            122234556889999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.3e-35  Score=273.81  Aligned_cols=225  Identities=28%  Similarity=0.349  Sum_probs=179.9

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ++|...+.||+|+||.||++.+..+++.+|+|.+....   ....+.+.+|++++++++||||+++++++.+....    
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888899999999999999999889999999986532   23456788999999999999999999876543211    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           .+..++.|++.||.|||+   ++++|+||+|+||+++.++.+||+|||++......   
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---  154 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---  154 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence                                 225688999999999999   99999999999999999999999999999765443   


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                       .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......   ..    .....+.          ..
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~----------~~  216 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IY----EKILEGK----------VR  216 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHhcCC----------cc
Confidence             223457889999999988888999999999999999999999997544211   11    1110110          11


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFE  316 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~  316 (387)
                      .+......+.+++.+||+.||.+||     +++|++++.|+.
T Consensus       217 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  258 (290)
T cd05580         217 FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA  258 (290)
T ss_pred             CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccc
Confidence            2222345678899999999999999     899999998864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=270.96  Aligned_cols=231  Identities=24%  Similarity=0.370  Sum_probs=178.9

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh----
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~----  139 (387)
                      ..+++|...+.||+|+||.||+|....+++.+++|.+..... ..+++.+|+.+++++ +|+||+++++++.+...    
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            356889999999999999999999988899999999876543 356789999999999 79999999988743221    


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccc
Q 043148          140 -------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG  188 (387)
Q Consensus       140 -------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  188 (387)
                                                     ..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence                                           1124688999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCceeeeeecCCcccCchhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 043148          189 LARLVDHELGSQTTVLAGTMGYLAPECVTT-----GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLY  263 (387)
Q Consensus       189 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  263 (387)
                      ++....... .......++..|+|||.+..     ..++.++||||||+++|+|++|+.||.........      ....
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~  231 (275)
T cd06608         159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL------FKIP  231 (275)
T ss_pred             cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH------HHhh
Confidence            987554322 12233457889999998753     34678999999999999999999999754322111      0100


Q ss_pred             ccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                       ...     .+.  ...+......+.+++.+||..||++|||+.+++++.|
T Consensus       232 -~~~-----~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~  274 (275)
T cd06608         232 -RNP-----PPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF  274 (275)
T ss_pred             -ccC-----CCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence             000     001  1112234567889999999999999999999999876

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-35  Score=279.20  Aligned_cols=243  Identities=21%  Similarity=0.289  Sum_probs=184.5

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchh-----h--
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-----Q--  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~--  139 (387)
                      +|.+.+.||+|+||.||+|+...++..+|||.+....  ....+.+.+|+.+++.++||||+++++++....     .  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5778889999999999999998889999999987653  445678899999999999999999999876543     1  


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            ..+..++.+++.||.|||+   ++++||||||.|||++.++.++|+|||++.......
T Consensus        81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence                                  0125689999999999999   999999999999999999999999999998665432


Q ss_pred             C--ceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc---------
Q 043148          198 G--SQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGK---------  265 (387)
Q Consensus       198 ~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------  265 (387)
                      .  .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+   ......         
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~  234 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI---VEVLGTPSEEDLKFI  234 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH---HHhcCCCChhHhhhc
Confidence            1  122334578899999999887 7899999999999999999999999766543221111   111100         


Q ss_pred             --Cchhhhhc---ccCC---ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          266 --GQLLEAAD---GRLS---KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       266 --~~~~~~~~---~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                        ........   ....   .......+..+.+++..||+.+|.+||++++++++.|+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  294 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ  294 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence              00000000   0000   0011224566889999999999999999999999998864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-35  Score=271.68  Aligned_cols=214  Identities=26%  Similarity=0.404  Sum_probs=161.2

Q ss_pred             cccccCceEEEEEEECCC------------------------CeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccce
Q 043148           75 KLGEGGFGGVYRGLLSDQ------------------------NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHL  130 (387)
Q Consensus        75 ~lg~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  130 (387)
                      .||+|+||.||+|.+..+                        ...|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999985321                        24589998866544455678899999999999999999


Q ss_pred             ehhhcchhhH--------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC----
Q 043148          131 IGWCHEQRQL--------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF----  180 (387)
Q Consensus       131 ~~~~~~~~~~--------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----  180 (387)
                      +++|.+....                          ....++.|++.||+|||+   ++++||||||+|||++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcccC
Confidence            9987654321                          125789999999999999   9999999999999997654    


Q ss_pred             ---cEEEccccccccccCCCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHH-hCCCCCCCCCCcchhhH
Q 043148          181 ---NAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRL  255 (387)
Q Consensus       181 ---~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~-tg~~p~~~~~~~~~~~~  255 (387)
                         .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+....
T Consensus       159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  233 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF  233 (274)
T ss_pred             ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence               3799999987543221     12346788999998875 55899999999999999985 69999876543221110


Q ss_pred             HHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          256 VEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                             ...       ......    .....+.+++.+||+.+|.+|||+.+|++.|.
T Consensus       234 -------~~~-------~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         234 -------YEK-------KHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -------HHh-------ccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                   000       001111    11235788999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-35  Score=266.18  Aligned_cols=222  Identities=31%  Similarity=0.519  Sum_probs=175.6

Q ss_pred             CcccccCceEEEEEEECCC---CeEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCCccceehhhcchh-----------
Q 043148           74 GKLGEGGFGGVYRGLLSDQ---NTEIAVKRVSRGSKQ-GKKEYISEVRIISRLRHRNLVHLIGWCHEQR-----------  138 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----------  138 (387)
                      +.||+|+||.||+|.....   +..+++|.+...... ..+.+.+|++.+..++|+||+++++++.+..           
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4699999999999999865   889999999765433 3678999999999999999999988765421           


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ...+..++.+++.||.|||+   ++++|+||+|+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence                                   12336899999999999999   9999999999999999999999999999986654


Q ss_pred             CCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          196 ELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       196 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ... .......++..|+|||.+....++.++||||||+++|||++ |..||.......   ..    .....+       
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~-------  223 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VL----EYLRKG-------  223 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHHcC-------
Confidence            321 11223456789999999988889999999999999999999 699998663221   11    111111       


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                        .....+...+..+.+++.+||+.||.+|||+.|++++|+
T Consensus       224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 --YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              111223334567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-34  Score=267.45  Aligned_cols=238  Identities=28%  Similarity=0.377  Sum_probs=182.1

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      ++|...+.||.|++|.||++.+..++..+|+|.+..... .....+.+|+++++.++||||++++++|.+...       
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            367888899999999999999988899999999875433 345778999999999999999999987643210       


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                              ..+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence                                    1124689999999999999   9999999999999999999999999999865433


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCc--chhhHHHHHHHHhccCchhhhhc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEP--SKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ..   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......  .......+..    ......+ .
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~-~  229 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMPNPEL-K  229 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----cCCchhh-c
Confidence            21   12335678899999999889999999999999999999999999865321  1111111111    1011111 0


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ...  .........+.+++.+||+.+|.+|||+.|++++.|+...
T Consensus       230 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         230 DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            000  0011235668899999999999999999999999997543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-35  Score=272.42  Aligned_cols=236  Identities=24%  Similarity=0.351  Sum_probs=177.1

Q ss_pred             hCccccCcccccCceEEEEEEECC----CCeEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCCccceehhhcchh--h-
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSD----QNTEIAVKRVSRGSKQ-GKKEYISEVRIISRLRHRNLVHLIGWCHEQR--Q-  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~-  139 (387)
                      ++|...+.||+|+||.||++.+..    ++..+|||.+...... ..+.+.+|+++++.++||||+++++++....  . 
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            456667899999999999999753    3788999999765443 4678999999999999999999988765411  1 


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          140 -------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       140 -------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                                               ..+..++.+++.||.|||+   ++++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence                                     1125688999999999999   999999999999999999999999999998665


Q ss_pred             CCCCce--eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh--------hHHHHHHHHhc
Q 043148          195 HELGSQ--TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKV--------RLVEWVWDLYG  264 (387)
Q Consensus       195 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~--------~~~~~~~~~~~  264 (387)
                      ......  .....++..|++||.+....++.++||||||+++|||++|+.|+.........        .......    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  236 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL----  236 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH----
Confidence            321111  11223456799999998888999999999999999999999998653321100        0011111    


Q ss_pred             cCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          265 KGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                           +.+........+..++..+.+++.+||+.+|.+|||+.||+++|..
T Consensus       237 -----~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         237 -----ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             -----HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence                 1111111112223344668899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.5e-35  Score=266.80  Aligned_cols=223  Identities=28%  Similarity=0.403  Sum_probs=171.6

Q ss_pred             CcccccCceEEEEEEECC-CC--eEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCCccceehhhcch------------
Q 043148           74 GKLGEGGFGGVYRGLLSD-QN--TEIAVKRVSRGSK-QGKKEYISEVRIISRLRHRNLVHLIGWCHEQ------------  137 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------------  137 (387)
                      +.||+|+||.||+|.+.. ++  ..||||.+..... ...+.+.+|+.++++++||||+++++++.+.            
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG   80 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence            368999999999999855 23  3699999977655 5677899999999999999999998865430            


Q ss_pred             --------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc--ee
Q 043148          138 --------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS--QT  201 (387)
Q Consensus       138 --------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~  201 (387)
                                    ....+..++.|++.||.|||+   ++++|+||+|+||+++.++.+||+|||+++........  ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence                          112236688999999999999   99999999999999999999999999999866442211  11


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.   ......   ..         .....
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~---~~---------~~~~~  222 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDK---EG---------ERLER  222 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh---cC---------CcCCC
Confidence            12346778999999998899999999999999999998 9999965432221   111110   00         00111


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      +...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            2233456889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.5e-35  Score=268.55  Aligned_cols=228  Identities=25%  Similarity=0.301  Sum_probs=180.6

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      +|...+.||.|+||.||++.+..++..+|+|.+....   ....+.+.+|++++++++||||+++++++.+...      
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778889999999999999998889999999996542   2346788999999999999999999887654321      


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.++++||.|||+   ++++|+||+|+||++++++.++|+|||++.......  .
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~  155 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L  155 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence                               1236789999999999999   999999999999999999999999999987654321  2


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      .....++..|+|||.+....++.++|+||||+++|+|++|+.||.........    +.......          .....
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~----------~~~~~  221 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QIRAKQET----------ADVLY  221 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH----HHHHHhcc----------ccccC
Confidence            23345788999999998888999999999999999999999999865532111    11111100          11122


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHhcc
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSI--RQVINVLNF  315 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~--~evl~~l~~  315 (387)
                      +...+..+.+++.+||+.||.+||++  +|++++.|+
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         222 PATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             cccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            23344678899999999999999999  998887664

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.1e-35  Score=274.79  Aligned_cols=242  Identities=21%  Similarity=0.310  Sum_probs=178.5

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchh-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-------  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  138 (387)
                      ++|+..+.||+|++|.||+|.+..+++.||+|.+....  ......+.+|+++++.++||||+++++++.+..       
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            56888999999999999999999889999999986542  233467889999999999999999999875432       


Q ss_pred             -------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC-CCcEEEccccccccccCCCC
Q 043148          139 -------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS-NFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       139 -------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                         ...+..++.|++.||.|||+   ++++|+||+|+||+++. ++.+||+|||++....... 
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-  157 (294)
T PLN00009         82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-  157 (294)
T ss_pred             cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence                               12235688999999999999   99999999999999985 5679999999997554321 


Q ss_pred             ceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc---------h
Q 043148          199 SQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ---------L  268 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~  268 (387)
                      .......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||......+....   .........         +
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK---IFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChhhccccccc
Confidence            112233567899999988764 578999999999999999999999976543322111   111111000         0


Q ss_pred             hhhh--cccCC----ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          269 LEAA--DGRLS----KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       269 ~~~~--~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ....  .+...    ..........+.+++.+|++.+|++||++.+++++.|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~  288 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK  288 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence            0000  00000    011122345578899999999999999999999998865

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.3e-35  Score=268.05  Aligned_cols=226  Identities=24%  Similarity=0.389  Sum_probs=162.7

Q ss_pred             CcccccCceEEEEEEECC--CCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----------
Q 043148           74 GKLGEGGFGGVYRGLLSD--QNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----------  139 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----------  139 (387)
                      +.||+|+||.||+|....  ....+++|.+.... ......+.+|+++++.++||||++++++|.+...           
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543  34578999876443 3345678899999999999999999987654321           


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-c
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-S  199 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  199 (387)
                                         ..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence                               1235788999999999999   9999999999999999999999999999865432211 1


Q ss_pred             eeeeeecCCcccCchhhcc-------CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          200 QTTVLAGTMGYLAPECVTT-------GKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                      ......+++.|+|||++..       ..++.++||||||+++|||++ |..||......+..      ....... ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~~~~-~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL------KQVVREQ-DIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH------HHHhhcc-CccC
Confidence            1122345678999998753       356889999999999999999 78888754332211      1111111 1111


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ..+    ..+......+..++..|| .||.+|||+++|++.|.
T Consensus       231 ~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111    122234455667888898 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.5e-35  Score=268.73  Aligned_cols=222  Identities=30%  Similarity=0.494  Sum_probs=169.5

Q ss_pred             CcccccCceEEEEEEECCCC------eEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           74 GKLGEGGFGGVYRGLLSDQN------TEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      +.||+|+||.||+|.+.+..      ..+|+|.+.... ......+.+|+++++.++||||++++++|.....       
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36999999999999986433      679999886543 3446788999999999999999999997654321       


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC-----cEEEccccc
Q 043148          140 -------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF-----NAKLGDFGL  189 (387)
Q Consensus       140 -------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-----~~kl~Dfg~  189 (387)
                                               ..+..++.+++.||.|||+   .+++|+||+|+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence                                     1124588999999999998   9999999999999999887     899999999


Q ss_pred             cccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCc
Q 043148          190 ARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQ  267 (387)
Q Consensus       190 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (387)
                      +........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   ....+    ..+ 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~-  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV----TAG-  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH----hcC-
Confidence            875433211 11112235678999999998899999999999999999998 999997543221   11111    010 


Q ss_pred             hhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          268 LLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                              .....+...+..+.+++.+||+.+|.+||++++|++.|.
T Consensus       230 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         230 --------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             --------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                    111222334567889999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.8e-36  Score=270.97  Aligned_cols=215  Identities=24%  Similarity=0.415  Sum_probs=163.1

Q ss_pred             CcccccCceEEEEEEECCCCe-------EEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNT-------EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------  140 (387)
                      +.||+|+||.||+|.....+.       .+++|.+........+.+.+|+.+++.++|||++++++++......      
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998865443       3888888665555567889999999999999999999887543221      


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc--------EEEcccccccc
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN--------AKLGDFGLARL  192 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~--------~kl~Dfg~~~~  192 (387)
                                          ....++.|++.||.|||+   ++++||||||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence                                125689999999999999   99999999999999987765        69999998864


Q ss_pred             ccCCCCceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCC-CCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          193 VDHELGSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGR-KPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       193 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      ...     .....+++.|+|||++.+. .++.++||||||+++|||++|. .|+..........       ....     
T Consensus       158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------~~~~-----  220 (258)
T cd05078         158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------FYED-----  220 (258)
T ss_pred             cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------HHHc-----
Confidence            432     1224578889999999864 5799999999999999999985 5554332211110       0000     


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                            ....+......+.+++..||+.||++|||++++++.|+
T Consensus       221 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  01112222345789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-35  Score=271.94  Aligned_cols=235  Identities=24%  Similarity=0.327  Sum_probs=174.2

Q ss_pred             hCccccCcccccCceEEEEEEE----CCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchh--h-
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLL----SDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--Q-  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~-  139 (387)
                      +.|...+.||+|+||.||++.+    ..++..||+|.+.... ......+.+|+++++.++||||+++++++.+..  . 
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467788999999999999985    3457889999987543 344567899999999999999999988765431  0 


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          140 -------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       140 -------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                                               .....++.+++.||.|||+   ++++||||||+||+++.++.++|+|||+++...
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccc
Confidence                                     1125788999999999999   999999999999999999999999999998654


Q ss_pred             CCCCc--eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcc--------hhhHHHHHHHHhc
Q 043148          195 HELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPS--------KVRLVEWVWDLYG  264 (387)
Q Consensus       195 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~~  264 (387)
                      .....  ......++..|+|||.+.+..++.++||||||+++|||++++.|........        .............
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE  240 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence            33211  1123446678999999988889999999999999999999877653221100        0000000011111


Q ss_pred             cCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          265 KGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .+         .....+...+..+.+++.+||+.||.+||++.++++.++
T Consensus       241 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  281 (284)
T cd05079         241 EG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE  281 (284)
T ss_pred             cC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence            11         111112234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-35  Score=269.51  Aligned_cols=230  Identities=27%  Similarity=0.434  Sum_probs=175.9

Q ss_pred             hCccccCcccccCceEEEEEEECCCCe----EEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchh----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNT----EIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  138 (387)
                      .+|...+.||+|+||.||+|.+..++.    .+|+|.+.... ......+.+|+.+++.++||||++++++|....    
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v   86 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI   86 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence            567788899999999999999876554    58999886653 344578899999999999999999998764311    


Q ss_pred             ---------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          139 ---------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       139 ---------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                           ...+..++.|++.||+|||+   ++++||||||+||+++.++.+||+|||+++......
T Consensus        87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence                                 12336789999999999999   999999999999999999999999999998664322


Q ss_pred             Cce-eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          198 GSQ-TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       198 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      ... .....++..|+|||.+....++.++|+||||+++||+++ |+.||......+.   .    .....+.        
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~----~~~~~~~--------  228 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI---P----DLLEKGE--------  228 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH---H----HHHhCCC--------
Confidence            111 111223567999999988889999999999999999998 9999976542211   1    1111110        


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                       ....+......+.+++..||..||..||++.++++.+...
T Consensus       229 -~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         229 -RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             0111112334578899999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.6e-35  Score=266.97  Aligned_cols=227  Identities=26%  Similarity=0.419  Sum_probs=172.6

Q ss_pred             ccccCcccccCceEEEEEEECC---CCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSD---QNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      |.+.+.||+|+||.||+|.+..   ++..||||.+...  .....+++.+|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            4567789999999999998643   4688999998654  3345667899999999999999999998543210      


Q ss_pred             -------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccc
Q 043148          139 -------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF  187 (387)
Q Consensus       139 -------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  187 (387)
                                                     ...+..++.|++.||+|||+   ++++||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence                                           01136789999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhcc
Q 043148          188 GLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGK  265 (387)
Q Consensus       188 g~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  265 (387)
                      |+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||......+   ...+..    .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~----~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI----K  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH----c
Confidence            998865432111 1122335678999999988889999999999999999999 888887543221   111111    1


Q ss_pred             CchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          266 GQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ...       +  ..+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       231 ~~~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         231 GNR-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             CCc-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            100       0  1112234568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3e-35  Score=269.54  Aligned_cols=229  Identities=22%  Similarity=0.358  Sum_probs=179.2

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-------  140 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-------  140 (387)
                      -|...+.||.|+||.||+|.+..++..+|+|.+.... ......+.+|++++..++||||+++++++.+....       
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3566788999999999999998889999999986543 33456788999999999999999999876543321       


Q ss_pred             -----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          141 -----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       141 -----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                       .+..++.+++.++.|||+   .+++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        85 ~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~  160 (277)
T cd06641          85 GGGSALDLLEPGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNT  160 (277)
T ss_pred             CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhcc
Confidence                             126789999999999999   999999999999999999999999999987554321 11223


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||.......   ...   . ....         ........
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~---~-~~~~---------~~~~~~~~  224 (277)
T cd06641         161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLF---L-IPKN---------NPPTLEGN  224 (277)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHH---H-HhcC---------CCCCCCcc
Confidence            457888999999988888999999999999999999999997543211   111   0 0010         11122233


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .+..+.+++.+||+.+|.+||++.+++++.++..
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~  258 (277)
T cd06641         225 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR  258 (277)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence            4566888999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4e-35  Score=268.26  Aligned_cols=229  Identities=25%  Similarity=0.368  Sum_probs=174.7

Q ss_pred             hCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCCccceehhhcchhh--
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGSKQ-GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  139 (387)
                      ++|...+.||+|+||.||+|+.+.     +...+++|.+...... ..+.+.+|++++++++|+||+++++++.+...  
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            567888899999999999999753     3467999988654433 45789999999999999999999987754211  


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccc
Q 043148          140 --------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF  187 (387)
Q Consensus       140 --------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  187 (387)
                                                      .....++.|++.||.|||+   .+++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence                                            1125688999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccC
Q 043148          188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKG  266 (387)
Q Consensus       188 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  266 (387)
                      |++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...    ....+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~----~~~~~  234 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN----RLQAG  234 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH----HHHcC
Confidence            9986443222222223345678999999988888999999999999999998 888986543221   111    11111


Q ss_pred             chhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ..        ....+...+..+.+++.+||+.+|.+||++.|++..|+
T Consensus       235 ~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 KL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             Cc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            11        11112233456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2e-35  Score=271.08  Aligned_cols=237  Identities=22%  Similarity=0.265  Sum_probs=175.3

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCC-CCCccceehhhcch--hh------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQ--RQ------  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~------  139 (387)
                      |...+.||+|+||.||+|....++..+|+|.+.... ........+|+.++.++. |+|++++++++.+.  ..      
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456788999999999999999889999999987542 222334567899999885 99999999987654  21      


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.|++.||.|||+   .+++||||+|+||+++. +.+||+|||++........  
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~--  154 (282)
T cd07831          81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP--  154 (282)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence                               1236789999999999999   99999999999999999 9999999999976543221  


Q ss_pred             eeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC-----------ch
Q 043148          201 TTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG-----------QL  268 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~  268 (387)
                      .....++..|+|||.+.. ..++.++|||||||++|||++|..||...+..+.   ..+........           ..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhccccc
Confidence            123457889999997654 4578899999999999999999999976553322   11111111110           00


Q ss_pred             hhhhccc-CC---ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          269 LEAADGR-LS---KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       269 ~~~~~~~-~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .....+. ..   .......+..+.+++.+||+.+|.+||++++++++.|+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            0000000 00   01112346779999999999999999999999999874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.8e-35  Score=266.03  Aligned_cols=226  Identities=26%  Similarity=0.409  Sum_probs=163.8

Q ss_pred             CcccccCceEEEEEEECC--CCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----------
Q 043148           74 GKLGEGGFGGVYRGLLSD--QNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----------  140 (387)
                      +.||+|+||.||+|.+..  ++..+|+|.++... ......+.+|+.+++.++||||+++++++.+....          
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            369999999999998653  34679999886543 33445788999999999999999999876543211          


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc-
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS-  199 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  199 (387)
                                          .+..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||++......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence                                224678899999999999   99999999999999999999999999998654322111 


Q ss_pred             eeeeeecCCcccCchhhccC-------CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          200 QTTVLAGTMGYLAPECVTTG-------KASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                      ......++..|+|||++...       .++.++||||||+++|||++ |+.||......+..   ...   . .......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~---~-~~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYT---V-REQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHH---h-hcccCCC
Confidence            11223467789999988642       35789999999999999996 99999754432211   110   0 0111111


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ..+.+.    ......+.+++..|| .+|.+|||++||+..|.
T Consensus       231 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            112111    122344677888998 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.2e-35  Score=267.02  Aligned_cols=227  Identities=24%  Similarity=0.373  Sum_probs=177.2

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      +|...+.||+|+||.||+|....+|..+|+|.+...  .....+.+.+|+++++.++|+||+++++.+.+..        
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            477788999999999999999999999999998653  2234567889999999999999999998765432        


Q ss_pred             -------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC-cEEEccccccccccCCCC
Q 043148          139 -------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF-NAKLGDFGLARLVDHELG  198 (387)
Q Consensus       139 -------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~  198 (387)
                                         ...+..++.+++.||.|||+   .+++|+||+|+||++++++ .+||+|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-  156 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence                               12236788999999999999   9999999999999999886 46999999987654322 


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......|++.|+|||.+.+..++.++|+||||+++|||++|+.||.......      ....... ...         .
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~---------~  220 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQ-GYF---------A  220 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc-ccC---------C
Confidence            12223457889999999988889999999999999999999999996543211      1111111 110         1


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .........+.+++.+||+.+|.+|||+.+++++.|+
T Consensus       221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            1122334568889999999999999999999999774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.5e-35  Score=267.08  Aligned_cols=227  Identities=28%  Similarity=0.397  Sum_probs=173.7

Q ss_pred             CccccCcccccCceEEEEEEECC-CCeEEEEEEecCC----------ChhhHHHHHHHHHHHhc-CCCCCccceehhhcc
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSD-QNTEIAVKRVSRG----------SKQGKKEYISEVRIISR-LRHRNLVHLIGWCHE  136 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  136 (387)
                      +|...+.||+|+||.||+|.+.. .+..+|+|.+...          ......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            46778899999999999999977 6788999987532          22334567789988865 799999999987654


Q ss_pred             hhh-----------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccc
Q 043148          137 QRQ-----------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF  187 (387)
Q Consensus       137 ~~~-----------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  187 (387)
                      ...                             ..+..++.|++.||.|||+.  .+++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence            321                             12356888999999999952  68999999999999999999999999


Q ss_pred             cccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc
Q 043148          188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ  267 (387)
Q Consensus       188 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (387)
                      |++.......  ......++..|++||.+.+..++.++||||||+++|||++|+.||.........   .   . .....
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~---~---~-~~~~~  229 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA---T---K-IVEAV  229 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH---H---H-Hhhcc
Confidence            9997654432  233456788999999999888999999999999999999999999654322111   1   1 00111


Q ss_pred             hhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          268 LLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                              ............+.+++.+||+.||.+||++.|+..++.
T Consensus       230 --------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 --------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --------CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                    111111123456888999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-35  Score=268.39  Aligned_cols=230  Identities=25%  Similarity=0.394  Sum_probs=178.5

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCC---CCCccceehhhcchhh-----
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLR---HRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~-----  139 (387)
                      .|+..+.||+|+||.||+|.+..++..+|+|.+... ......++.+|+.+++.++   |||++++++++.+...     
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            466778999999999999999888999999998654 3344567889999999986   9999999987654321     


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus        82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06917          82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-K  157 (277)
T ss_pred             ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-c
Confidence                               1236788999999999999   9999999999999999999999999999976654322 2


Q ss_pred             eeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          201 TTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      .....|+..|+|||.+.++ .++.++|+||||+++|+|++|+.||..........       .....     ..+.+.. 
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~-----~~~~~~~-  224 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKS-----KPPRLED-  224 (277)
T ss_pred             cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccC-----CCCCCCc-
Confidence            2334688899999988754 47899999999999999999999997543221110       00000     0111111 


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                        ......+.+++.+||+.||.+||++.+++.+.|+..
T Consensus       225 --~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~  260 (277)
T cd06917         225 --NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA  260 (277)
T ss_pred             --ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence              113456888999999999999999999999988754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.9e-35  Score=266.09  Aligned_cols=220  Identities=28%  Similarity=0.436  Sum_probs=171.4

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      ++|...+.||+|+||.||++..  +++.+|+|.+....  ....+.+|+.++..++|||++++++++.....        
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCC
Confidence            5578889999999999999975  57789999986532  34678999999999999999999987543211        


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......    
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence                              1225688999999999998   999999999999999999999999999987543211    


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      .....+..|+|||.+.+..++.++|+||||+++|||++ |+.||......+.       ......+         .....
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~---------~~~~~  218 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------KECVEKG---------YRMEP  218 (254)
T ss_pred             CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhCC---------CCCCC
Confidence            11233567999999988889999999999999999997 9999975442211       1111111         11111


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ....+..+.+++.+||+.+|..||+++++++.+.
T Consensus       219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            2334566889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.8e-35  Score=271.58  Aligned_cols=234  Identities=25%  Similarity=0.405  Sum_probs=175.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-----  139 (387)
                      .++|...+.||+|+||.||+|.+..++..||||.+.... ......+..|+.++.+. .||||++++++|.+...     
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            356778899999999999999998889999999997543 23445677788777666 49999999998754321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          .....++.+++.||.|||+.  .+++||||+|+||++++++.+||+|||++.......  
T Consensus        94 e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~--  169 (296)
T cd06618          94 ELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK--  169 (296)
T ss_pred             eccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC--
Confidence                                12257999999999999972  589999999999999999999999999987654321  


Q ss_pred             eeeeeecCCcccCchhhccCC----CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          200 QTTVLAGTMGYLAPECVTTGK----ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~----~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      ......++..|+|||.+.+..    ++.++||||||+++|||++|+.||......  ....   ....... .     +.
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~---~~~~~~~-~-----~~  238 (296)
T cd06618         170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVL---TKILQEE-P-----PS  238 (296)
T ss_pred             cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHH---HHHhcCC-C-----CC
Confidence            112234678899999987553    788999999999999999999999653221  1111   1111110 0     00


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ..  ........+.+++.+||+.||.+||++++++++.|+..
T Consensus       239 ~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         239 LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence            00  01123456889999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.4e-35  Score=276.10  Aligned_cols=247  Identities=20%  Similarity=0.252  Sum_probs=180.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      ..+|...+.||.|+||.||+|....++..||+|.+........+.+.+|+++++.++||||+++++++....        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            367889999999999999999999999999999987666566678899999999999999999887543321        


Q ss_pred             -----------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC-CCCcEEEcccc
Q 043148          139 -----------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD-SNFNAKLGDFG  188 (387)
Q Consensus       139 -----------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kl~Dfg  188 (387)
                                                   ...+..++.|++.||.|||+   .+++||||||+||+++ .++.+||+|||
T Consensus        84 ~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          84 SLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             cccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECCcc
Confidence                                         11236789999999999999   9999999999999998 45678999999


Q ss_pred             ccccccCCCCc--eeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH-----
Q 043148          189 LARLVDHELGS--QTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW-----  260 (387)
Q Consensus       189 ~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~-----  260 (387)
                      ++.........  ......++..|+|||.+.. ..++.++|||||||++|||++|+.||................     
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            99765332111  1122356888999998754 557899999999999999999999997654322211110000     


Q ss_pred             ---HHhccCchhhhhc-ccCC-----ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          261 ---DLYGKGQLLEAAD-GRLS-----KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       261 ---~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                         ..... ....... ....     ..........+.+++.+||+.||.+|||+.+++++.|+..
T Consensus       241 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         241 EDRNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HHhhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence               00000 0000000 0000     0111123456789999999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.4e-35  Score=261.75  Aligned_cols=227  Identities=26%  Similarity=0.409  Sum_probs=179.9

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh----------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----------  138 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----------  138 (387)
                      +|...+.||+|++|.||++.+..++..+++|++........+.+.+|++.++.++|+|++++++++....          
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4677889999999999999998889999999997765556788999999999999999999998764322          


Q ss_pred             ----------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          139 ----------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       139 ----------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                      ...+..++.+++.+|.|||+   .+++||||+|+||+++.++.++|+|||.+........  ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~  155 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN  155 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence                            11235689999999999999   9999999999999999999999999999876654321  23


Q ss_pred             eeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          203 VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       203 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      ...++..|++||.+....++.++||||||+++|+|++|+.||...........   ..    ......     .  ....
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~----~~~~~~-----~--~~~~  221 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---IA----TNGPPG-----L--RNPE  221 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HH----hcCCCC-----c--Cccc
Confidence            45678899999999888899999999999999999999999975532211110   00    000000     0  0011


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          283 RQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .....+.+++..||+.||++|||+.+++++.|
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            12456889999999999999999999998864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.7e-35  Score=264.61  Aligned_cols=214  Identities=28%  Similarity=0.471  Sum_probs=164.0

Q ss_pred             CcccccCceEEEEEEECCCC----------eEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-----
Q 043148           74 GKLGEGGFGGVYRGLLSDQN----------TEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-----  138 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  138 (387)
                      +.||+|+||.||+|.+..++          ..+++|.+...... ...+.+|+.+++.++||||+++++++....     
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence            36999999999999998766          45888877654333 678899999999999999999999764210     


Q ss_pred             --------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC-------cEEEccccccc
Q 043148          139 --------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF-------NAKLGDFGLAR  191 (387)
Q Consensus       139 --------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-------~~kl~Dfg~~~  191 (387)
                                          ......++.|++.||.|||+   ++++||||||+|||++.++       .+||+|||++.
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence                                11235688999999999999   9999999999999999888       79999999987


Q ss_pred             cccCCCCceeeeeecCCcccCchhhccC--CCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCch
Q 043148          192 LVDHELGSQTTVLAGTMGYLAPECVTTG--KASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQL  268 (387)
Q Consensus       192 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (387)
                      ....     .....++..|+|||.+...  .++.++||||||+++|||++ |..||..........       .+.... 
T Consensus       157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-------~~~~~~-  223 (259)
T cd05037         157 TVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------FYQDQH-  223 (259)
T ss_pred             cccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------HHhcCC-
Confidence            5433     1223466789999998876  78999999999999999999 577776553221111       000000 


Q ss_pred             hhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          269 LEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                            ....    .....+.+++.+||..+|.+|||+.++++.|.
T Consensus       224 ------~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         224 ------RLPM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ------CCCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  0000    01156889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.9e-35  Score=264.43  Aligned_cols=223  Identities=26%  Similarity=0.333  Sum_probs=176.6

Q ss_pred             ccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------------
Q 043148           76 LGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------------  140 (387)
Q Consensus        76 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------------  140 (387)
                      ||.|+||.||++++..++..+|+|.+....   ....+.+.+|+++++.++||||+++++++.+....            
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999998889999999986542   23456789999999999999999999876544322            


Q ss_pred             -------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecC
Q 043148          141 -------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT  207 (387)
Q Consensus       141 -------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~  207 (387)
                                   .+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++.......  ......++
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~  155 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT  155 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence                         125688899999999999   999999999999999999999999999998664432  22234578


Q ss_pred             CcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHH
Q 043148          208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMEC  287 (387)
Q Consensus       208 ~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (387)
                      ..|++||.+....++.++|+||||+++|+|++|..||....... ....   ..         ..........+......
T Consensus       156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~---------~~~~~~~~~~~~~~~~~  222 (262)
T cd05572         156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIY---ND---------ILKGNGKLEFPNYIDKA  222 (262)
T ss_pred             cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHH---HH---------HhccCCCCCCCcccCHH
Confidence            89999999988889999999999999999999999997655311 1111   11         11111112233333567


Q ss_pred             HHHHHHHhcCCCCCCCCC-----HHHHHHHhccC
Q 043148          288 LMIVGLWCCHPDFTNRPS-----IRQVINVLNFE  316 (387)
Q Consensus       288 l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~  316 (387)
                      +.+++..||+.+|.+||+     ++|++++.|+.
T Consensus       223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  256 (262)
T cd05572         223 AKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN  256 (262)
T ss_pred             HHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence            899999999999999999     99999999875

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8.7e-35  Score=264.06  Aligned_cols=233  Identities=24%  Similarity=0.386  Sum_probs=185.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      ++|+..+.||+|++|.||++....++..|+||++..... .....+.+|++.+..++|+||+++++++.....       
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            367888999999999999999998899999999876544 456789999999999999999999987654322       


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        .....++.|++.||.|||+.  .+++|+||+|+||+++.++.++|+|||++......... .
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~  157 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-C  157 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-c
Confidence                              12367899999999999973  78999999999999999999999999999866443221 2


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD  281 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (387)
                      ....++..|+|||.+....++.++|+||||+++|+|++|+.||.............++.    .         ......+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~---------~~~~~~~  224 (264)
T cd06623         158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----D---------GPPPSLP  224 (264)
T ss_pred             cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----c---------CCCCCCC
Confidence            23457889999999998889999999999999999999999997665322222222111    1         0111122


Q ss_pred             HH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          282 ER-QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       282 ~~-~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .. .+..+.+++..||+.+|.+||++.+++++.|++
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~  260 (264)
T cd06623         225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIK  260 (264)
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHH
Confidence            22 556788999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.6e-35  Score=269.41  Aligned_cols=228  Identities=23%  Similarity=0.299  Sum_probs=178.4

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------------  139 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------------  139 (387)
                      ..||+|+||.||++....++..||||.+..........+.+|+.+++.++|+||+++++++.....              
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            469999999999999998999999999866555566779999999999999999999987654321              


Q ss_pred             ----------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCc
Q 043148          140 ----------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG  209 (387)
Q Consensus       140 ----------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~  209 (387)
                                ..+..++.|++.+|+|||+   .+++|+||+|+||++++++.++|+|||++........ ......+++.
T Consensus       106 ~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~  181 (292)
T cd06657         106 DIVTHTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGTPY  181 (292)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccCcc
Confidence                      1236789999999999999   8999999999999999999999999999875543221 2233457889


Q ss_pred             ccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHH
Q 043148          210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM  289 (387)
Q Consensus       210 y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  289 (387)
                      |+|||.+.+..++.++|+||||+++|||++|..||.........   ......         ....+.  ........+.
T Consensus       182 y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~~~~~~---------~~~~~~--~~~~~~~~l~  247 (292)
T cd06657         182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRDN---------LPPKLK--NLHKVSPSLK  247 (292)
T ss_pred             ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhh---------CCcccC--CcccCCHHHH
Confidence            99999998888899999999999999999999999754322111   111100         001110  1112344577


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 043148          290 IVGLWCCHPDFTNRPSIRQVINVLNFEAPL  319 (387)
Q Consensus       290 ~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  319 (387)
                      +++.+||+.||.+||++.+++++.|+....
T Consensus       248 ~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         248 GFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             HHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence            899999999999999999999998877654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6e-35  Score=275.00  Aligned_cols=245  Identities=21%  Similarity=0.280  Sum_probs=178.9

Q ss_pred             hCccc-cCcccccCceEEEEEEECCCCeEEEEEEecCCChhh--------------HHHHHHHHHHHhcCCCCCccceeh
Q 043148           68 NNFAE-AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQG--------------KKEYISEVRIISRLRHRNLVHLIG  132 (387)
Q Consensus        68 ~~~~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  132 (387)
                      ++|.. .+.||+|+||.||+|.+..+++.||||.+.......              ...+.+|++++..++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45553 467999999999999998889999999986542221              125778999999999999999998


Q ss_pred             hhcchhhH------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccc
Q 043148          133 WCHEQRQL------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG  188 (387)
Q Consensus       133 ~~~~~~~~------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  188 (387)
                      ++......                        ....++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||
T Consensus        88 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         88 VYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             EEecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCcc
Confidence            86543321                        125689999999999999   999999999999999999999999999


Q ss_pred             ccccccCCC-------------CceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 043148          189 LARLVDHEL-------------GSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR  254 (387)
Q Consensus       189 ~~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~  254 (387)
                      ++.......             ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......+.. 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~-  243 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL-  243 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-
Confidence            987654110             1111223467789999998764 4689999999999999999999999866543222 


Q ss_pred             HHHHHHHHhccCchh---hh--------hcccCCc---cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          255 LVEWVWDLYGKGQLL---EA--------ADGRLSK---EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       255 ~~~~~~~~~~~~~~~---~~--------~~~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                        ..+..........   ..        .......   .........+.+++..||+.+|.+||+++|++.+.|+...
T Consensus       244 --~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        244 --GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             --HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence              2222211111000   00        0000000   0111234568899999999999999999999999998754

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=264.20  Aligned_cols=228  Identities=24%  Similarity=0.365  Sum_probs=177.9

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC-----ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-----SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  138 (387)
                      .+|...+.||+|+||.||+|.+..++..||+|.+...     .......+.+|++++++++|+||+++++++.+..    
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688899999999999999999988999999987532     2234567889999999999999999998764321    


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ......++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||+++....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence                                   11225688999999999999   9999999999999999999999999999976543


Q ss_pred             CC--CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          196 EL--GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       196 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ..  ........++..|+|||.+.+..++.++|+||||+++|||++|+.||.........      ..         ...
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~---------~~~  223 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI------FK---------IAT  223 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH------HH---------HHc
Confidence            21  11122345788999999998888899999999999999999999999754322111      11         111


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .......+......+.+++..||+ +|..||+..+++.|++
T Consensus       224 ~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~  263 (264)
T cd06653         224 QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF  263 (264)
T ss_pred             CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence            111223445556678899999999 5799999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.2e-35  Score=275.92  Aligned_cols=249  Identities=21%  Similarity=0.270  Sum_probs=184.0

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-h
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-Q  139 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~  139 (387)
                      +...+++|...+.||.|+||.||++....++..||+|.+...  .....+.+..|++++..++||||+++++++.... .
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            345678899999999999999999999989999999988643  2334567889999999999999999999774321 1


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                             ..+..++.|+++||.|||+   ++++||||+|+||+++.++.++|+|||++......
T Consensus        85 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          85 IYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             EEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence                                   1125688999999999999   99999999999999999999999999998754332


Q ss_pred             CCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH--------HHHHhccCc
Q 043148          197 LGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW--------VWDLYGKGQ  267 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~  267 (387)
                          .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..............        .........
T Consensus       162 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd07856         162 ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN  237 (328)
T ss_pred             ----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence                123356788999998766 5689999999999999999999999976543211111000        000000011


Q ss_pred             hhhhhc-ccCCcccc-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          268 LLEAAD-GRLSKEFD-----ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       268 ~~~~~~-~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ..+... .......+     ......+.+++.+||+.+|.+||++.+++.+.|+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~  294 (328)
T cd07856         238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY  294 (328)
T ss_pred             hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence            111100 00000111     1234668899999999999999999999999987654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=9.7e-35  Score=270.40  Aligned_cols=228  Identities=24%  Similarity=0.396  Sum_probs=176.5

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      +.|...+.||+|+||.||+|+...++..+|+|.+...   ......++.+|+++++.++|+|++++++++.....     
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            3466677899999999999999888999999998643   23345678899999999999999999887544321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          ..+..++.+++.||.|||+   .+++||||+|+||+++.++.++|+|||++......   
T Consensus        95 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             EccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence                                1225678899999999999   99999999999999999999999999998755432   


Q ss_pred             eeeeeecCCcccCchhhc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          200 QTTVLAGTMGYLAPECVT---TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                        ....+++.|+|||.+.   ...++.++||||||+++|||++|+.||.........      .... ..        ..
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~-~~--------~~  231 (308)
T cd06634         169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIA-QN--------ES  231 (308)
T ss_pred             --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------HHHh-hc--------CC
Confidence              2345788999999874   356788999999999999999999998654322111      0000 00        00


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ...........+.+++.+||+.+|.+||++.+++++.|+...
T Consensus       232 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            111122345568889999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.3e-35  Score=270.81  Aligned_cols=232  Identities=21%  Similarity=0.248  Sum_probs=176.1

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ++|...+.||+|+||.||++....+++.|++|.+....   ....+.+.+|++++..++||||+++++.+......    
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888899999999999999999999999999986543   23356788999999999999999999876544321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-  198 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-  198 (387)
                                           .+..++.+++.||.|||+   ++++||||||+||+++.++.+||+|||+++....... 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence                                 125678899999999999   9999999999999999999999999999864211100 


Q ss_pred             -------------ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 043148          199 -------------SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGK  265 (387)
Q Consensus       199 -------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  265 (387)
                                   .......++..|+|||.+....++.++|+||||+++|||++|..||.+....+   ..   .... .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~---~~~~-~  230 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LF---GQVI-S  230 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHH-h
Confidence                         00112346788999999988889999999999999999999999997543221   11   1100 0


Q ss_pred             CchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHhccC
Q 043148          266 GQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPS---IRQVINVLNFE  316 (387)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs---~~evl~~l~~~  316 (387)
                      +.   ...+.    .....+..+.+++.+||+.||.+||+   +.+++++.|+.
T Consensus       231 ~~---~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~  277 (305)
T cd05609         231 DD---IEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL  277 (305)
T ss_pred             cc---cCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcccc
Confidence            00   00000    11124455789999999999999998   67888887763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=266.55  Aligned_cols=238  Identities=25%  Similarity=0.350  Sum_probs=175.9

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHhcC---CCCCccceehhhcchhh-----
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--QGKKEYISEVRIISRL---RHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  139 (387)
                      |++.+.||+|+||.||+|.+..++..+|+|.+.....  .....+.+|+.++.++   +|||++++++++.+...     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5567889999999999999988899999999964322  2234566788777665   69999999988754332     


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          140 --------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       140 --------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                                                ..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence                                      1125689999999999999   99999999999999999999999999998766


Q ss_pred             cCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCch-----
Q 043148          194 DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL-----  268 (387)
Q Consensus       194 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  268 (387)
                      ....  ......++..|+|||.+.+..++.++|+||||+++|||++|+.||......+..   ..+.+.......     
T Consensus       158 ~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         158 SFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL---DKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             cCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH---HHHHHHcCCCChHhcCC
Confidence            4331  122334688899999999888999999999999999999999998765433221   111111110000     


Q ss_pred             -----hhhhcccCC---ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          269 -----LEAADGRLS---KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       269 -----~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                           .........   ..........+.+++.+||+.||.+||++.+++++.|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                 000000001   11123345678899999999999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-36  Score=278.49  Aligned_cols=232  Identities=25%  Similarity=0.369  Sum_probs=180.4

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecC--CChhhHHHHHHHHHHHhcCC-CCCccceehhhcchhh----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSR--GSKQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----  139 (387)
                      .+.|+..+.||+||-+.||++...+ .+.+|+|++..  .+.+...-|.+|+..|.+|+ |.+||++++|-..+..    
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            4568888999999999999998765 56778877643  35666788999999999995 9999999998543322    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           .+++.+..|++.++.++|.   .||||.||||.|+|+- .|.+||+|||+|..+..+..
T Consensus       439 mE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  439 MECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             eecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence                                 2446788999999999999   9999999999999885 46899999999987765432


Q ss_pred             -ceeeeeecCCcccCchhhccCC-----------CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC
Q 043148          199 -SQTTVLAGTMGYLAPECVTTGK-----------ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG  266 (387)
Q Consensus       199 -~~~~~~~g~~~y~aPE~~~~~~-----------~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  266 (387)
                       -....++||+.||+||.+....           .+.++||||+|||||+|+.|+.||.....     .+         .
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~---------a  580 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QI---------A  580 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HH---------H
Confidence             2345678999999999885432           46789999999999999999999964321     11         1


Q ss_pred             chhhhhcccCCccccHHH-HHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          267 QLLEAADGRLSKEFDERQ-MECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ++..+.++....+++..- ...+++++..||+.||++||+..++|+|.+...
T Consensus       581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            244455554433443221 122899999999999999999999999987543

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.6e-34  Score=261.16  Aligned_cols=224  Identities=25%  Similarity=0.349  Sum_probs=179.3

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      +|+..+.||+|+||.||++....++..+++|.+...  .......+.+|+++++.++|+||+++++++.+...       
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477888999999999999999888999999998654  23445678899999999999999999887654211       


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            ..+..++.+++.||.|||+   .+++|+||+|.||+++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence                                  1235788899999999999   99999999999999999999999999999766543 


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                        ......++..|++||.+.+..++.++|+||||+++|||++|+.||........   ..    ....         ...
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~----~~~~---------~~~  218 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RY----KVQR---------GKY  218 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHhc---------CCC
Confidence              12234578899999999988899999999999999999999999976542211   11    1111         111


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ...+......+.+++.+|++.+|.+||++.++++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~  255 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPA  255 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence            2233355667899999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.6e-34  Score=261.03  Aligned_cols=230  Identities=28%  Similarity=0.437  Sum_probs=183.2

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCCccceehhhcch--hhH----
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--QGKKEYISEVRIISRLRHRNLVHLIGWCHEQ--RQL----  140 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~----  140 (387)
                      +|...+.||+|++|.||+|....++..|++|.+.....  ...+.+.+|++++++++||||+++++++.+.  ...    
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            46777899999999999999998899999999866542  4567889999999999999999999877654  211    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           .+..++.+++.+|.|||+   .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence                                 125789999999999999   99999999999999999999999999998866543221


Q ss_pred             -eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 -QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 -~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                       ......++..|++||.+....++.++||||||+++++|++|..||......     ....+..         .......
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~---------~~~~~~~  223 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKI---------GSSGEPP  223 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhc---------cccCCCc
Confidence             123345788999999998888999999999999999999999999765511     1111111         1111122


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ..+......+.+++.+|++.||.+||++.+++++.|+
T Consensus       224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            2333446778999999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.5e-34  Score=271.56  Aligned_cols=238  Identities=19%  Similarity=0.270  Sum_probs=171.3

Q ss_pred             ccccc--CceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----------
Q 043148           75 KLGEG--GFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----------  139 (387)
Q Consensus        75 ~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----------  139 (387)
                      .||+|  +||+||++.+..+|+.||+|++...  .....+.+.+|+.+++.++||||++++++|.....           
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            56766  9999999999989999999998653  23345678899999999999999999988754321           


Q ss_pred             ----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce---
Q 043148          140 ----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ---  200 (387)
Q Consensus       140 ----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~---  200 (387)
                                      ..+..++.|++.||.|||+   ++++||||||+|||++.++.++++||+.+..........   
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence                            1124689999999999998   999999999999999999999999998653322111100   


Q ss_pred             ---eeeeecCCcccCchhhccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH--------------
Q 043148          201 ---TTVLAGTMGYLAPECVTTG--KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWD--------------  261 (387)
Q Consensus       201 ---~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~--------------  261 (387)
                         .....++..|+|||++.+.  .++.++||||||+++|||++|+.||.........  ......              
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccchh
Confidence               0112345679999998764  4789999999999999999999999765432111  000000              


Q ss_pred             --H-------hc----cC-----chhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          262 --L-------YG----KG-----QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       262 --~-------~~----~~-----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                        .       ..    +.     .........+...........+.+++.+||+.||.+|||+.|++++.|+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence              0       00    00     000111111222223446677899999999999999999999999998643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-34  Score=266.27  Aligned_cols=233  Identities=23%  Similarity=0.344  Sum_probs=181.8

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      .++.|...+.||+|+||.||+|.+..++..+++|.+..... ....+.+|++++..++|+|++++++++.....      
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            45667778899999999999999988889999999976544 56778899999999999999999987643211      


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          ..+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence                                1235689999999999999   9999999999999999999999999999865443221 


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......++..|++||.+.+..++.++|+||||+++|+|++|+.||..........      .. ......       ...
T Consensus       172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~------~~-~~~~~~-------~~~  237 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF------LI-TTKGIP-------PLK  237 (286)
T ss_pred             hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-HhcCCC-------CCc
Confidence            1223346788999999988889999999999999999999999997543221110      00 000000       001


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ........+.+++.+||+.+|.+||++.+++++.++..
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            11224456889999999999999999999999988765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-35  Score=236.16  Aligned_cols=245  Identities=21%  Similarity=0.296  Sum_probs=186.0

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      +|...++||+|.||+||+|+..+++..||+|+++..+  +.-....++|+-+++.++|.|||+++++...+.        
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4555678999999999999999999999999987653  334677899999999999999999987544322        


Q ss_pred             -----h------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          139 -----Q------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       139 -----~------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                           .            ...+.++.|+++||.++|+   ..+.||||||.|.||+.||++|++|||+++.++.... ..
T Consensus        83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr-cy  158 (292)
T KOG0662|consen   83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CY  158 (292)
T ss_pred             hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-ee
Confidence                 1            1237889999999999999   9999999999999999999999999999998776432 33


Q ss_pred             eeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCc---hhhhhcccC
Q 043148          202 TVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQ---LLEAADGRL  276 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  276 (387)
                      ...+-|..|.+|.++.+.+ |+...|+||-||++.|+.. |++.|.+.+..++...+-|......+..   +..+.|-..
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            4456789999999998876 8999999999999999987 7777777766665555554433322221   222222222


Q ss_pred             Ccccc---------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          277 SKEFD---------ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       277 ~~~~~---------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .+.++         +.....=.+++...+.-+|.+|.++++.+++..|.-
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d  288 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD  288 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence            22221         111222356777788889999999999999987653

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2e-34  Score=268.88  Aligned_cols=225  Identities=24%  Similarity=0.386  Sum_probs=174.8

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------  140 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------  140 (387)
                      |...+.||+|+||.||+|+...++..|++|.+....   ......+.+|+++++.++|||++++++++.+....      
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999998889999999986532   23345788999999999999999999876553221      


Q ss_pred             -------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          141 -------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       141 -------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                         .+..++.|++.+|.|||+   ++++|+||+|+||+++.++.+||+|||++.....     .
T Consensus       103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~  174 (313)
T cd06633         103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----A  174 (313)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----C
Confidence                               225688999999999999   9999999999999999999999999999864322     1


Q ss_pred             eeeecCCcccCchhhc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          202 TVLAGTMGYLAPECVT---TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ....++..|+|||.+.   ...++.++||||||+++|||++|..||..........      ..... .        ...
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~~-~--------~~~  239 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQN-D--------SPT  239 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHhc-C--------CCC
Confidence            2345788999999874   4568889999999999999999999987654322111      10000 0        111


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .........+.+++.+||+.+|.+||++.+++.+.++..
T Consensus       240 ~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~  278 (313)
T cd06633         240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR  278 (313)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence            111223345788999999999999999999999998765

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.3e-35  Score=276.23  Aligned_cols=247  Identities=19%  Similarity=0.280  Sum_probs=183.2

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      ...++|...+.||+|+||.||+|++..++..||||.+...  .....+.+.+|+.+++.++||||+++++++.....   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            3467899999999999999999999988999999998653  23344667889999999999999999887654321   


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          140 --------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       140 --------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                                                ..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++...
T Consensus        92 ~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (343)
T cd07851          92 FQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT  168 (343)
T ss_pred             cccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence                                      1236789999999999999   99999999999999999999999999999765


Q ss_pred             cCCCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhc
Q 043148          194 DHELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV--------WDLYG  264 (387)
Q Consensus       194 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~  264 (387)
                      ...    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...        .....
T Consensus       169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             ccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            432    223457888999998865 35789999999999999999999999765432211111000        00000


Q ss_pred             cCchhhhhc---ccCCccc---cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          265 KGQLLEAAD---GRLSKEF---DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       265 ~~~~~~~~~---~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .......+.   ......+   ....+..+.+++.+||+.||.+|||+.+|+++.|+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence            000000000   0000011   11235678899999999999999999999999998754

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.2e-35  Score=257.11  Aligned_cols=249  Identities=21%  Similarity=0.337  Sum_probs=181.8

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCe----EEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCCccceehhhcchh--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNT----EIAVKRVSRGSK--QGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  138 (387)
                      ...|+....||+|.||.||+|...+++.    .+|+|.++...+  .--....+|+.+++.++|||++.+..++.+.+  
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3568888999999999999997655433    689999976532  22356789999999999999999988775521  


Q ss_pred             ----------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC----CcEEEcc
Q 043148          139 ----------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN----FNAKLGD  186 (387)
Q Consensus       139 ----------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~----~~~kl~D  186 (387)
                                                  ...+..|+.||+.|+.|||+   +-|+||||||.|||+..+    |.+||+|
T Consensus       103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence                                        11236899999999999999   899999999999999877    8999999


Q ss_pred             ccccccccCCCCc--eeeeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCC------cchhhHHH
Q 043148          187 FGLARLVDHELGS--QTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQE------PSKVRLVE  257 (387)
Q Consensus       187 fg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~------~~~~~~~~  257 (387)
                      ||+++.+......  .....+-|..|.|||.+.+.. |+.+.|||+.|||+.||++-++.|.+...      +-..+.+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999988764322  234456789999999988765 99999999999999999999888865432      12223333


Q ss_pred             HHHHHhccCchhhhhc---------------ccCCccc------c--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          258 WVWDLYGKGQLLEAAD---------------GRLSKEF------D--ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       258 ~~~~~~~~~~~~~~~~---------------~~~~~~~------~--~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .+.+..+.....+..+               .......      .  ..-.....+|+.++|..||.+|.|+++.+++..
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            3333322211111000               0000000      0  001122578899999999999999999999988


Q ss_pred             cCCC
Q 043148          315 FEAP  318 (387)
Q Consensus       315 ~~~~  318 (387)
                      |...
T Consensus       340 F~~d  343 (438)
T KOG0666|consen  340 FTED  343 (438)
T ss_pred             cccC
Confidence            7543

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.1e-34  Score=264.35  Aligned_cols=223  Identities=22%  Similarity=0.308  Sum_probs=166.7

Q ss_pred             cccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHH---hcCCCCCccceehhhcchhh---------
Q 043148           75 KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRII---SRLRHRNLVHLIGWCHEQRQ---------  139 (387)
Q Consensus        75 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~---------  139 (387)
                      .||+|+||.||++....+++.+|+|.+....   ......+.+|..++   ...+||||+.+++++...+.         
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999889999999986532   12223344554443   34479999998876543221         


Q ss_pred             ----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          140 ----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       140 ----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                      ..+..++.|++.||.|||+   ++++||||||+|||+++++.++|+|||++......   ....
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~  154 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHA  154 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---CccC
Confidence                            1236789999999999999   99999999999999999999999999998754332   1123


Q ss_pred             eecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          204 LAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      ..|+..|+|||.+.. ..++.++||||||+++|||++|..||.......... .   ....          .......+.
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~---~~~~----------~~~~~~~~~  220 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-I---DRMT----------LTVNVELPD  220 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-H---HHHh----------hcCCcCCcc
Confidence            458899999998864 558899999999999999999999997654322111 1   1100          011122333


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          283 RQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      ..+..+.+++..||+.||.+||     +++++++|+++..
T Consensus       221 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         221 SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence            4556788999999999999999     6999999998765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=263.18  Aligned_cols=227  Identities=23%  Similarity=0.372  Sum_probs=185.7

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH--------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI--------  141 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~--------  141 (387)
                      |.+..+||+|+||.||++.++++|..+|||.+..  ..+.++...|+.+|++.+.|++|+++|.+.....++        
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            5678899999999999999999999999999854  456789999999999999999999998654433222        


Q ss_pred             ------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          142 ------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       142 ------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                        +..++...++||+|||.   ..-||||||+.|||++-+|.+||+|||.+..+.... .....
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNT  188 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNT  188 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCc
Confidence                              24678889999999999   778999999999999999999999999997665432 23345


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      ..||+.|||||++..-.|+.++||||||++..||..|++||.+..+...+.++              ...+......++.
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI--------------PT~PPPTF~KPE~  254 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI--------------PTKPPPTFKKPEE  254 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec--------------cCCCCCCCCChHh
Confidence            67999999999999999999999999999999999999999765432111100              0112222334567


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .+..+.+++..||-.+|++|-|+.++++|.+..
T Consensus       255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fik  287 (502)
T KOG0574|consen  255 WSSEFNDFIRSCLIKKPEERKTALRLCEHTFIK  287 (502)
T ss_pred             hhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhc
Confidence            788899999999999999999999999998644

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2e-34  Score=260.31  Aligned_cols=227  Identities=26%  Similarity=0.403  Sum_probs=179.6

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      +|...+.||.|+||.||++.+..++..+++|.+....  ....+.+.+|+++++.++|||++++++.+....        
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999998889999999987543  355678899999999999999999887543321        


Q ss_pred             ---------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          139 ---------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       139 ---------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                           ...+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence                                 11236789999999999999   899999999999999999999999999997654432


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                       .......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||.......   ..   .... ...         .
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~---~~~~-~~~---------~  220 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LA---LKIL-KGQ---------Y  220 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HH---HHHh-cCC---------C
Confidence             12233467889999999988889999999999999999999999997544221   11   1111 111         1


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ...+......+.+++.+||..+|.+||++.+++++.++
T Consensus       221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            11222344568899999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.2e-34  Score=260.74  Aligned_cols=226  Identities=23%  Similarity=0.354  Sum_probs=161.2

Q ss_pred             CcccccCceEEEEEEECCC--CeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----------
Q 043148           74 GKLGEGGFGGVYRGLLSDQ--NTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----------  139 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----------  139 (387)
                      +.||+|+||.||+|....+  ...+++|.+.... ....+.+.+|+.++..++||||++++++|.+...           
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999975432  2356777765443 3456789999999999999999999987654321           


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC-Cce
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL-GSQ  200 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~  200 (387)
                                        ..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++....... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence                              1235678899999999999   999999999999999999999999999975422111 111


Q ss_pred             eeeeecCCcccCchhhcc-------CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          201 TTVLAGTMGYLAPECVTT-------GKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~-------~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..||......+.   ..   ... .+......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~---~~~-~~~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV---LN---HVI-KDQQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHH-hhcccccC
Confidence            223457889999998753       235789999999999999997 5678765433211   11   111 11112222


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ++.+...    ....+.+++..|| .+|.+||++++|++.|.
T Consensus       231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2222222    3345677888899 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-34  Score=272.18  Aligned_cols=248  Identities=19%  Similarity=0.271  Sum_probs=182.6

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchh---
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR---  138 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  138 (387)
                      ....++|...+.||+|+||.||++....++..||||.+....  ......+.+|+++++.++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            345678999999999999999999999889999999986432  233456889999999999999999988764322   


Q ss_pred             --------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccc
Q 043148          139 --------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL  192 (387)
Q Consensus       139 --------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~  192 (387)
                                                ...+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++..
T Consensus        91 ~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          91 RFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             ccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence                                      11235789999999999999   9999999999999999999999999999975


Q ss_pred             ccCCCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHH--------HHHHHh
Q 043148          193 VDHELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVE--------WVWDLY  263 (387)
Q Consensus       193 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~--------~~~~~~  263 (387)
                      ....    .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.............        .....+
T Consensus       168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         168 TDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            5432    123356889999998876 458899999999999999999999997654321111000        000000


Q ss_pred             ccCchhhhhc--ccCC----ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          264 GKGQLLEAAD--GRLS----KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       264 ~~~~~~~~~~--~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ..........  +...    ..........+.+++.+|++.||.+|||+.+++.+.|+..-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            0000000000  0000    01112234457899999999999999999999999987653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.6e-34  Score=264.80  Aligned_cols=223  Identities=25%  Similarity=0.323  Sum_probs=172.4

Q ss_pred             ccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------------
Q 043148           76 LGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------------  139 (387)
Q Consensus        76 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------------  139 (387)
                      ||+|+||+||++....+|+.+|+|.+....   ......+..|+++++.++||||+++++++.....             
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999998889999999986532   2234567789999999999999999876644221             


Q ss_pred             --------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeee
Q 043148          140 --------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA  205 (387)
Q Consensus       140 --------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  205 (387)
                                    ..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......  .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence                          1125678899999999999   99999999999999999999999999998765432  1222345


Q ss_pred             cCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHH
Q 043148          206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM  285 (387)
Q Consensus       206 g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (387)
                      ++..|+|||.+.+..++.++||||||+++|+|++|+.||............   ....    .      ......+....
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~----~------~~~~~~~~~~~  222 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KRRT----L------EMAVEYPDKFS  222 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hhcc----c------cccccCCccCC
Confidence            778999999998888999999999999999999999999765432111111   0000    0      00112223345


Q ss_pred             HHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccC
Q 043148          286 ECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFE  316 (387)
Q Consensus       286 ~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~  316 (387)
                      ..+.+++.+||+.||.+||     ++.++++|.|+.
T Consensus       223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~  258 (277)
T cd05577         223 PEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK  258 (277)
T ss_pred             HHHHHHHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence            6688999999999999999     888899998874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=263.70  Aligned_cols=242  Identities=23%  Similarity=0.306  Sum_probs=178.4

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  139 (387)
                      |+..+.||+|+||.||+|....++..+|+|.+....  ....+.+..|+.+++.++|+||+++++++.+...        
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455678999999999999999889999999997653  3335678899999999999999999987655321        


Q ss_pred             -----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          140 -----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       140 -----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                       ..+..++.+++.||.|||+   ++++||||+|+||+++.++.++|+|||++........ ...
T Consensus        81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (282)
T cd07829          81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT  156 (282)
T ss_pred             CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence                             1236788999999999999   9999999999999999999999999999876544321 222


Q ss_pred             eeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH--------HHHHhccCchhhhhc
Q 043148          203 VLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW--------VWDLYGKGQLLEAAD  273 (387)
Q Consensus       203 ~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~  273 (387)
                      ...++..|+|||.+.+. .++.++||||||+++|||++|+.||......+.......        .+.....-......-
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            33457789999998766 789999999999999999999999976543222111100        000000000000000


Q ss_pred             ccC----CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          274 GRL----SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       274 ~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      +..    ...........+.+++..||+.||.+||++++++.+.|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            000    001111225568999999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-35  Score=276.27  Aligned_cols=230  Identities=25%  Similarity=0.308  Sum_probs=188.4

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI  141 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  141 (387)
                      ..-...|.+.+.||+|.|+.|.+|++..++..||||.+.+..  ....+.+.+|+++|..|+|||||+++.+......++
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            344577889999999999999999999999999999997753  344566899999999999999999999876544332


Q ss_pred             -------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          142 -------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       142 -------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                               ...++.|+.++++|||+   +.|+|||||++||||+++.++||+|||++..+.. 
T Consensus       132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-  207 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-  207 (596)
T ss_pred             EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc-
Confidence                                     25789999999999999   9999999999999999999999999999998764 


Q ss_pred             CCceeeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                       .......+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-.+...               ..+...
T Consensus       208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------------rvl~gk  271 (596)
T KOG0586|consen  208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------------RVLRGK  271 (596)
T ss_pred             -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------------hheeee
Confidence             345566789999999999998886 689999999999999999999998655322111               011111


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      +  ..+......+.+++++.+-.+|.+|++++++.++-|.
T Consensus       272 ~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~  309 (596)
T KOG0586|consen  272 Y--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR  309 (596)
T ss_pred             e--cccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence            1  1223344557788999999999999999999998774

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-34  Score=259.05  Aligned_cols=226  Identities=26%  Similarity=0.415  Sum_probs=179.7

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      +|...+.||+|++|.||++....++..+++|.+.....  ...+.+.+|++++.+++|||++++++++.+...       
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            46778899999999999999988899999999976643  456789999999999999999999887654321       


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.+++.+|.|||+   .+++||||+|+||+++.++.++|+|||++......... .
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~  156 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-D  156 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-c
Confidence                              1236789999999999999   99999999999999999999999999999866543221 2


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD  281 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (387)
                      ....++..|+|||.+.+..++.++|||++|+++|+|++|+.||........      .+.....          .....+
T Consensus       157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~----------~~~~~~  220 (254)
T cd06627         157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA------LFRIVQD----------DHPPLP  220 (254)
T ss_pred             cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHhcc----------CCCCCC
Confidence            234578899999999888889999999999999999999999975432111      1111100          011222


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          282 ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       282 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ......+.+++.+||+.+|++||++.+++.+.+
T Consensus       221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~  253 (254)
T cd06627         221 EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPW  253 (254)
T ss_pred             CCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCC
Confidence            334566889999999999999999999998765

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.7e-34  Score=271.54  Aligned_cols=242  Identities=19%  Similarity=0.268  Sum_probs=175.8

Q ss_pred             CccccCcccccCceEEEEEEECCC--CeEEEEEEecCC--ChhhHHHHHHHHHHHhcC-CCCCccceehhhcch------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQ--NTEIAVKRVSRG--SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ------  137 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  137 (387)
                      +|...+.||+|+||.||++....+  +..||+|.+...  .....+.+.+|++++.++ +||||+++++.+...      
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            477788999999999999999887  889999998653  222356788999999999 599999998753211      


Q ss_pred             ----------------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          138 ----------------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       138 ----------------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                            ....+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~  157 (332)
T cd07857          81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSE  157 (332)
T ss_pred             EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence                                  011226789999999999999   9999999999999999999999999999976543


Q ss_pred             CCC---ceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc-------
Q 043148          196 ELG---SQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYG-------  264 (387)
Q Consensus       196 ~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------  264 (387)
                      ...   .......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.........   .......+       
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~  234 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQL---NQILQVLGTPDEETL  234 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHH---HHHHHHhCCCCHHHH
Confidence            211   11223468899999998765 46899999999999999999999999765432211   11111000       


Q ss_pred             ----cCchh---hhhcccCC---ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          265 ----KGQLL---EAADGRLS---KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       265 ----~~~~~---~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                          .....   ........   ..........+.+++.+|++.||.+|||+.+++.+.|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~  296 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA  296 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence                00000   00000000   001111245688999999999999999999999998864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2e-34  Score=264.00  Aligned_cols=228  Identities=24%  Similarity=0.349  Sum_probs=180.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCC-CCCccceehhhcchhhH---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~---  140 (387)
                      ++|...+.||+|+||.||++....++..||+|++...   .....+.+.+|++++.+++ ||||+++++++.+....   
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4688889999999999999999988999999998653   2233567889999999998 99999999987553211   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence                                  236789999999999999   9999999999999999999999999999876543221


Q ss_pred             -------------------ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 043148          199 -------------------SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV  259 (387)
Q Consensus       199 -------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~  259 (387)
                                         .......++..|+|||.+....++.++||||||++++++++|+.||.......   .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~  234 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TFQKI  234 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HHHHH
Confidence                               12223456789999999988889999999999999999999999998654211   11111


Q ss_pred             HHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHhcc
Q 043148          260 WDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSI----RQVINVLNF  315 (387)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~----~evl~~l~~  315 (387)
                      .            .  .....+...+..+.+++..||+.+|.+||++    +++++|.|+
T Consensus       235 ~------------~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         235 L------------K--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             H------------h--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            0            0  1112223335668899999999999999999    999998774

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=269.01  Aligned_cols=249  Identities=23%  Similarity=0.297  Sum_probs=191.4

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI---  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~---  141 (387)
                      +.|..-++||+||||.||-++.+.+|+.+|.|.+.+..   .....-.++|-.+|++++.+.||.+--.++..+.++   
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            55778889999999999999999999999999986542   233455778999999999999999866665544333   


Q ss_pred             ------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          142 ------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       142 ------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                              ..-++.+|+.||++||.   ..||.|||||+|||+|+.|+++|+|.|+|..+... 
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g-  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG-  340 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCC-
Confidence                                    25688999999999999   99999999999999999999999999999876553 


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                       ......+||.+|||||++....|+...|.||+||++|||+.|+.||...........+   ....          ..-.
T Consensus       341 -~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv---drr~----------~~~~  406 (591)
T KOG0986|consen  341 -KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV---DRRT----------LEDP  406 (591)
T ss_pred             -CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH---HHHH----------hcch
Confidence             3344458999999999999999999999999999999999999999754432211111   0100          0113


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC-CCCCCCCCCCCccccCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA-PLPSLPSKLPVPMYYAP  334 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~-~~~~~~~~~~~~~~~~p  334 (387)
                      .++++..++.+.++....|+.||.+|.     .+++|-+|+.|.. ++..+-..+-.|++.++
T Consensus       407 ~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPd  469 (591)
T KOG0986|consen  407 EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPD  469 (591)
T ss_pred             hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCC
Confidence            455666677788888889999999997     5668999987643 44443333333333333

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-34  Score=261.32  Aligned_cols=241  Identities=20%  Similarity=0.229  Sum_probs=175.0

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHhcCC-CCCccceehhhcchhh--------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-QGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQ--------  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~--------  139 (387)
                      |...+.||+|+||.||+|....+++.|+||.+..... .......+|+..+.+++ ||||+++++++.+...        
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5567889999999999999988899999999865432 23334567999999998 9999999988755321        


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.|++.+|.|||+   ++++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~~  155 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PY  155 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--Cc
Confidence                              1236788999999999999   999999999999999999999999999997654321  12


Q ss_pred             eeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH----------HHHHhccCchhh
Q 043148          202 TVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW----------VWDLYGKGQLLE  270 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~----------~~~~~~~~~~~~  270 (387)
                      ....++..|+|||.+.. ..++.++|+||||+++|||++|+.||......+.......          ............
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            23457888999998754 4578999999999999999999999976544322211110          000000000000


Q ss_pred             hhcccCC---ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          271 AADGRLS---KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       271 ~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .......   ..........+.+++.+||+.||.+|||++|++.+.|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0000000   01111124668899999999999999999999998764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.5e-34  Score=260.94  Aligned_cols=223  Identities=22%  Similarity=0.308  Sum_probs=172.4

Q ss_pred             ccccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------------
Q 043148           76 LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------------  139 (387)
Q Consensus        76 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------------  139 (387)
                      ||.|+||.||++.+..++..+++|.+.....   ...+.+.+|++++..++||||+++++.+.....             
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999998899999999865433   445678899999999999999999876644321             


Q ss_pred             ------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-------ce
Q 043148          140 ------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-------SQ  200 (387)
Q Consensus       140 ------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-------~~  200 (387)
                                  ..+..++.|++.||+|||+   ++++|+||+|+||+++.++.++|+|||++........       ..
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence                        1235789999999999999   9999999999999999999999999999875433211       12


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      .....++..|++||......++.++||||||+++|||++|..||.........   .   . ...+.        .....
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---~---~-~~~~~--------~~~~~  222 (265)
T cd05579         158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF---Q---N-ILNGK--------IEWPE  222 (265)
T ss_pred             ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---H---H-HhcCC--------cCCCc
Confidence            23345778899999998888999999999999999999999999755422111   1   1 10110        00000


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHhccC
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSI---RQVINVLNFE  316 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~---~evl~~l~~~  316 (387)
                      ....+..+.+++..||+.+|.+|||+   .+++++.|+.
T Consensus       223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~  261 (265)
T cd05579         223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK  261 (265)
T ss_pred             cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence            11125668899999999999999999   8888888764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-35  Score=276.22  Aligned_cols=221  Identities=26%  Similarity=0.298  Sum_probs=182.1

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhHHH--
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQLIL--  142 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l--  142 (387)
                      +++.|.....+|.|+|+.|-.+.+..+++..+||++.+.    ..+-.+|+.++... +||||+++.+.+.+..+.++  
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            367788888899999999999999999999999999665    23344677776665 79999999998877544322  


Q ss_pred             ----------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEe-CCCCcEEEccccccccccCCCCc
Q 043148          143 ----------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL-DSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       143 ----------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill-~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                            ..|+.+|+.++.|||+   +|++||||||+|||+ +..++++|+|||.++.....   
T Consensus       396 e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---  469 (612)
T ss_pred             hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence                                  4599999999999999   999999999999999 68999999999999866543   


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                       ....+-|..|.|||++....|++++|+||||++||+|++|+.||.......  .    +...+            ..+.
T Consensus       470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--e----i~~~i------------~~~~  530 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--E----IHTRI------------QMPK  530 (612)
T ss_pred             -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--H----HHHhh------------cCCc
Confidence             333456889999999998999999999999999999999999998655431  1    11111            1233


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      +....+....+|+.+||+.||.+||+|.++..|.|+
T Consensus       531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            446677788999999999999999999999999998

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=273.01  Aligned_cols=224  Identities=24%  Similarity=0.324  Sum_probs=182.9

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH---------
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI---------  141 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~---------  141 (387)
                      .+.||+|.||+||-|.++.+|+.||||++.+.  ......++.+|+.||++++||.||.+.--|+..+..+         
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            46899999999999999999999999999765  2344578999999999999999999988776643321         


Q ss_pred             -----H------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC---CcEEEccccccccccCCCCcee
Q 043148          142 -----L------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN---FNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       142 -----l------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                           +            .-+..||+.||.|||.   ++|+|+||||+|||+...   -.+||+|||++++++...  ..
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FR  723 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FR  723 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh--hh
Confidence                 1            4577899999999999   999999999999999754   368999999999987643  33


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD  281 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (387)
                      ...+||+.|+|||++..+.|...-|+||.||++|--++|..||+...+..+  .++.+.          +   ..+.+..
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQNAa----------F---MyPp~PW  788 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQNAA----------F---MYPPNPW  788 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--Hhhccc----------c---ccCCCch
Confidence            456799999999999999999999999999999999999999986554321  111111          1   1233445


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          282 ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       282 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .+.....++++...|+..-.+|.|.+.-+.|.|..
T Consensus       789 ~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq  823 (888)
T KOG4236|consen  789 SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ  823 (888)
T ss_pred             hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence            56667788999999999999999999999998854

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-34  Score=284.58  Aligned_cols=231  Identities=28%  Similarity=0.411  Sum_probs=181.0

Q ss_pred             hhCccccCcccccCceEEEEEEECC-------CCeEEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcch
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD-------QNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ  137 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  137 (387)
                      .++....+.||+|.||.|++|....       ....||||.++.. ...+.+.+..|+++|..+ +|+||+.++|+|.+.
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            3444556689999999999997532       1467999998765 345678899999999999 599999999987652


Q ss_pred             h-----------------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe
Q 043148          138 R-----------------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL  176 (387)
Q Consensus       138 ~-----------------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill  176 (387)
                      .                                         ..-+..++.|||.|++||++   .+++||||.++|||+
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLI  451 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEe
Confidence            1                                         11246899999999999999   999999999999999


Q ss_pred             CCCCcEEEccccccccccCCCCceeeeee--cCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchh
Q 043148          177 DSNFNAKLGDFGLARLVDHELGSQTTVLA--GTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKV  253 (387)
Q Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~  253 (387)
                      .++..+||+|||+++..............  -+..|||||.+....|+.++|||||||+||||++ |..||.+...... 
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~-  530 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE-  530 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH-
Confidence            99999999999999865543333222222  3557999999999999999999999999999999 9999976332211 


Q ss_pred             hHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          254 RLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                       +.    +.+         ......+.+..+...+.++++.||+.+|++||++.++++.+..
T Consensus       531 -l~----~~l---------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  531 -LL----EFL---------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             -HH----HHH---------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence             11    122         2222334556667778899999999999999999999988864

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-35  Score=293.80  Aligned_cols=234  Identities=27%  Similarity=0.384  Sum_probs=184.6

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      .+-++.....||.|.||.||-|...++|...|+|-+....  ....+...+|+.++..++|||+|+++|+-.+.+.    
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            3455666789999999999999999999999999876542  2334567789999999999999999985433322    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC-
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL-  197 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-  197 (387)
                                           .+...+..|++.|+.|||+   .|||||||||.||||+.+|.+|++|||.|..+..+. 
T Consensus      1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence                                 2336788999999999999   999999999999999999999999999998775542 


Q ss_pred             --CceeeeeecCCcccCchhhccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          198 --GSQTTVLAGTMGYLAPECVTTG---KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       198 --~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                        ........||+.|||||++.+.   ....+.||||+||++.||+||+.||...+..       |+.       +..+ 
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aI-------My~V- 1454 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAI-------MYHV- 1454 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHH-------HhHH-
Confidence              1223356799999999999754   3577899999999999999999999866543       111       0111 


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ...-.+.++...+..-.+++..|++.||++|+++.|++++-+...
T Consensus      1455 ~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1455 AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            111234455667777889999999999999999999999876443

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.8e-33  Score=258.01  Aligned_cols=223  Identities=22%  Similarity=0.303  Sum_probs=166.4

Q ss_pred             cccccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHH---HHhcCCCCCccceehhhcchhh---------
Q 043148           75 KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK---QGKKEYISEVR---IISRLRHRNLVHLIGWCHEQRQ---------  139 (387)
Q Consensus        75 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~---------  139 (387)
                      .||+|+||.||++....+++.||+|.+.....   .....+..|..   .+....||||+.+++++.+...         
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999988899999999865421   11223344443   4445689999998876654221         


Q ss_pred             ----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          140 ----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       140 ----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                      ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.......   ...
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~  154 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHA  154 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcC
Confidence                            1236789999999999999   999999999999999999999999999987553321   123


Q ss_pred             eecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          204 LAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      ..|+..|+|||.+.++ .++.++||||||+++|||++|+.||...........    ....      ..    .....+.
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~------~~----~~~~~~~  220 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT------LT----MAVELPD  220 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHh------hc----cCCCCCC
Confidence            4688999999998754 589999999999999999999999976533221110    0000      00    0112222


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          283 RQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      ..+..+.+++.+|+..+|.+||     ++.+++++.|+..
T Consensus       221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~  260 (278)
T cd05606         221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS  260 (278)
T ss_pred             cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence            3356688899999999999999     9999999998755

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=257.44  Aligned_cols=235  Identities=25%  Similarity=0.317  Sum_probs=182.7

Q ss_pred             HHHHHHhhCccccCcccccCceEEEEEEECCCC-----eEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhh
Q 043148           61 RELSRATNNFAEAGKLGEGGFGGVYRGLLSDQN-----TEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC  134 (387)
Q Consensus        61 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  134 (387)
                      .++.....++.....+-+|.||.||.|.+++..     +.|-+|.++.. +.-....++.|.-.+..+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            345555567777888999999999999876543     34666766543 344466788999999999999999999877


Q ss_pred             cchhh----------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC
Q 043148          135 HEQRQ----------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF  180 (387)
Q Consensus       135 ~~~~~----------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~  180 (387)
                      .+...                                  .-+..++.|++.|++|||.   .++||.||.++|++||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhe
Confidence            55321                                  1125789999999999999   9999999999999999999


Q ss_pred             cEEEccccccccccCCC-CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 043148          181 NAKLGDFGLARLVDHEL-GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEW  258 (387)
Q Consensus       181 ~~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~  258 (387)
                      .+||+|=.+++.+-+.. .......-.+..||+||.+....|+.++|||||||+||||+| |+.||...++.+....+  
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl--  511 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL--  511 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH--
Confidence            99999999998653322 222223345778999999999999999999999999999998 99999876654432211  


Q ss_pred             HHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          259 VWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                           .+         ...-.-+.+++++|..++.-||+.+|++||+++|++.-|.
T Consensus       512 -----kd---------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  512 -----KD---------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS  553 (563)
T ss_pred             -----hc---------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence                 11         2223345567788999999999999999999999998774

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=252.16  Aligned_cols=229  Identities=27%  Similarity=0.365  Sum_probs=173.2

Q ss_pred             ccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhHH--------
Q 043148           72 EAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQLI--------  141 (387)
Q Consensus        72 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~--------  141 (387)
                      .+..||.|+||+|++-.++..|+..|||+++... ..+.++++.|.+...+- +.||||+++|.+..+..-+        
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~  147 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI  147 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence            3568999999999999999999999999997654 46678899999876554 7999999999765543211        


Q ss_pred             ---------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          142 ---------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       142 ---------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                           +-.|..-...||.||..+  ..|||||+||+|||+|..|.+||||||++..+...  ..
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iA  223 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IA  223 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH--HH
Confidence                                 123444568999999985  78999999999999999999999999998755432  22


Q ss_pred             eeeeecCCcccCchhhcc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          201 TTVLAGTMGYLAPECVTT--GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .+..+|-..|||||.+..  ..|+-++||||||++|||+.||..||...+..     .+.+.... .+..     +.+..
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~Vv-~gdp-----p~l~~  292 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQVV-IGDP-----PILLF  292 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHHHH-cCCC-----CeecC
Confidence            334567788999998864  34899999999999999999999999876531     11111111 1111     11111


Q ss_pred             c-ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          279 E-FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       279 ~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      . ..-+....+.+++.-|+..|...||...++..+...
T Consensus       293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fy  330 (361)
T KOG1006|consen  293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFY  330 (361)
T ss_pred             cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchh
Confidence            1 112355668899999999999999999999988753

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=253.20  Aligned_cols=229  Identities=26%  Similarity=0.347  Sum_probs=181.0

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHHH-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-  142 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l-  142 (387)
                      .++|..++.||+|.||.|-+++-+.+++.+|+|++++.-   ......-+.|-++|+.-+||.+..+--.|...+.+++ 
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            467888999999999999999999999999999998753   3344556789999999999998776544443332211 


Q ss_pred             ------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          143 ------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       143 ------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                              +-+-..|+.||.|||+   ++|+.||||.+|.|+|.+|++||+|||+++.- ...+
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I~~g  322 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEE-IKYG  322 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhc-cccc
Confidence                                    3466789999999999   99999999999999999999999999999743 2345


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ......+|||.|+|||++....|+.++|.|.+||++|||++|+.||...+......++-             ..+    .
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-------------~ed----~  385 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-------------MED----L  385 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-------------hhh----c
Confidence            66778999999999999999999999999999999999999999998765432221110             001    1


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFE  316 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~  316 (387)
                      .++.........|+...|..||++|.     .+.||.++.+|.
T Consensus       386 kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~  428 (516)
T KOG0690|consen  386 KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFA  428 (516)
T ss_pred             cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhc
Confidence            23334445567778888999999996     578888887653

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=256.02  Aligned_cols=222  Identities=23%  Similarity=0.247  Sum_probs=166.9

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHH-hcCCCCCccceehhhcchhh----------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK---QGKKEYISEVRII-SRLRHRNLVHLIGWCHEQRQ----------  139 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~----------  139 (387)
                      +.||+|+||.||+|....+++.||+|.+.....   .....+..|..++ ...+|+|++++++++.+...          
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            469999999999999988899999999865432   2223344555544 45589999999987754321          


Q ss_pred             ---------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeee
Q 043148          140 ---------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       140 ---------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                     ..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++.....     ....
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~  153 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF  153 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence                           1236789999999999999   9999999999999999999999999999875432     1233


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .+++.|++||.+.+..++.++||||||+++|||++|..||........       +........      ..........
T Consensus       154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~------~~~~~~~~~~  220 (260)
T cd05611         154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-------FDNILSRRI------NWPEEVKEFC  220 (260)
T ss_pred             CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhccc------CCCCcccccC
Confidence            578899999999888899999999999999999999999975443211       111111100      0111122234


Q ss_pred             HHHHHHHHHHhcCCCCCCCCC---HHHHHHHhccC
Q 043148          285 MECLMIVGLWCCHPDFTNRPS---IRQVINVLNFE  316 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs---~~evl~~l~~~  316 (387)
                      +..+.+++.+||+.+|.+||+   ++|++.+.|+.
T Consensus       221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~  255 (260)
T cd05611         221 SPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK  255 (260)
T ss_pred             CHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhh
Confidence            566889999999999999995   47888888764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-35  Score=249.91  Aligned_cols=247  Identities=23%  Similarity=0.338  Sum_probs=183.3

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .|.-..+||+|.||.||+|+.+++|+.||+|++...+  ..-....++|+++|..|+|+|++.+++.|.....       
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            3445668999999999999999999999998764322  2224567899999999999999999998854211       


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          140 --------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       140 --------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                                                ..+.+++.++..||.|+|.   ..|+|||+|+.|+||+.++.+||+|||+++.+
T Consensus        98 t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~f  174 (376)
T KOG0669|consen   98 TFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAF  174 (376)
T ss_pred             eeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence                                      1136889999999999999   99999999999999999999999999999866


Q ss_pred             cCCC---CceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HH
Q 043148          194 DHEL---GSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV--------WD  261 (387)
Q Consensus       194 ~~~~---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~--------~~  261 (387)
                      ....   ....+..+-|+.|.+||.+.+. .|+++.|||..||++.||++|.+-+.+..+..+...+...        |.
T Consensus       175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP  254 (376)
T KOG0669|consen  175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP  254 (376)
T ss_pred             ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence            4432   1223344568999999998765 5999999999999999999999999887766655554432        11


Q ss_pred             HhccCchhhhhccc-CCcc-c--cHHH------HHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          262 LYGKGQLLEAADGR-LSKE-F--DERQ------MECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       262 ~~~~~~~~~~~~~~-~~~~-~--~~~~------~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ....-.+.+.+.-. +... +  -++.      ....++|+..++..||.+|+++++++.|.+|...
T Consensus       255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence            11111111111000 1100 0  0111      1245688899999999999999999999987654

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.8e-33  Score=255.13  Aligned_cols=226  Identities=24%  Similarity=0.343  Sum_probs=172.4

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-----hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-----KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      +|.+.+.||+|+||.||++.+...+..+++|.++...     .....++..|+.++..++||||+++++++.+....   
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4777889999999999999988776667777765421     22344677899999999999999999876543211   


Q ss_pred             --------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          141 --------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       141 --------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                                                .+..++.|++.||.|||+   ++++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence                                      125678999999999999   99999999999999975 569999999987654


Q ss_pred             CCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          195 HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      .... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.......   .   ..... .         
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~---~~~~~-~---------  219 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---V---VLRIV-E---------  219 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---H---HHHHH-c---------
Confidence            3221 2223457889999999988888999999999999999999999996433111   1   11110 0         


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ......+...+..+.+++.+||+.+|.+||++.+++++.|+
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            11122334556678899999999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.6e-33  Score=260.40  Aligned_cols=233  Identities=21%  Similarity=0.273  Sum_probs=165.8

Q ss_pred             CceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------------------
Q 043148           80 GFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------------------  139 (387)
Q Consensus        80 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------------------  139 (387)
                      ++|.||.++...++..||||++...  .....+.+.+|+++++.++|+||+++++++.+...                  
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            3445555555557899999998754  34456789999999999999999999887654321                  


Q ss_pred             ---------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC------ceeeee
Q 043148          140 ---------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG------SQTTVL  204 (387)
Q Consensus       140 ---------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~  204 (387)
                               ..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||.+........      ......
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~  168 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS  168 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence                     2236788999999999999   9999999999999999999999999998864432111      111233


Q ss_pred             ecCCcccCchhhcc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH----hccCc-------hhh-
Q 043148          205 AGTMGYLAPECVTT--GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDL----YGKGQ-------LLE-  270 (387)
Q Consensus       205 ~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~-------~~~-  270 (387)
                      .++..|+|||.+..  ..++.++||||||+++|||++|+.||........  ..+.....    .....       ... 
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
T cd08216         169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDSMSQS  246 (314)
T ss_pred             cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCCcCcc
Confidence            46778999999875  3588999999999999999999999986442211  11111000    00000       000 


Q ss_pred             ---hhcc----cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          271 ---AADG----RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       271 ---~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                         ..++    .............+.+++.+||+.||.+|||++++++++++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~  300 (314)
T cd08216         247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ  300 (314)
T ss_pred             cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence               0000    0111222344567889999999999999999999999998753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-34  Score=262.67  Aligned_cols=230  Identities=25%  Similarity=0.352  Sum_probs=191.1

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHHH--
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL--  142 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l--  142 (387)
                      .+++....||-|+||.|-++........+|+|++++.   +....+....|-++|...+.|.||+++-.|.+....|+  
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            4445567899999999999998776666899988764   34455678899999999999999999999999887765  


Q ss_pred             -----------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          143 -----------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       143 -----------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                             +-++.-+.+|++|||+   ++||.|||||+|+++|.+|-+||.|||+++.+..  +.
T Consensus       500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--g~  574 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--GR  574 (732)
T ss_pred             HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc--CC
Confidence                                   3456678999999999   9999999999999999999999999999998866  46


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      .+.+++||+.|.|||++.....+.++|.||||+++|||++|.+||.+.++....+++-.-.+               .-+
T Consensus       575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid---------------~i~  639 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID---------------KIE  639 (732)
T ss_pred             ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh---------------hhh
Confidence            77889999999999999999999999999999999999999999998876544433311111               123


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  317 (387)
                      ++........+++++.+..+|.+|..     ..+|-+|-||..
T Consensus       640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            44555666788899999999999985     789999998753

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2e-33  Score=259.18  Aligned_cols=233  Identities=22%  Similarity=0.278  Sum_probs=174.8

Q ss_pred             CccccCcccccCceEEEEEEEC---CCCeEEEEEEecCCC----hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh-
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLS---DQNTEIAVKRVSRGS----KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ-  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-  139 (387)
                      +|+..+.||+|+||.||++...   .+|..||+|++....    ....+.+.+|++++..+ +|+||+++++++..... 
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4677889999999999999874   368899999986532    22346778899999999 59999999876544321 


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                              ..+..++.|++.||.|||+   .+++||||+|+|||++.++.+||+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence                                    1225677799999999999   9999999999999999999999999999976544


Q ss_pred             CCCceeeeeecCCcccCchhhccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTG--KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ..........++..|+|||.+...  .++.++||||||+++|+|++|..||..........  .........        
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~--------  227 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA--EISRRILKS--------  227 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH--HHHHHhhcc--------
Confidence            322223345678899999998753  46789999999999999999999996433221111  111110000        


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                         ....+......+.+++.+||+.||.+||     +.++++.+.++..
T Consensus       228 ---~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  273 (290)
T cd05613         228 ---EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK  273 (290)
T ss_pred             ---CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence               0112233445678899999999999997     8999999988654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.4e-33  Score=254.64  Aligned_cols=231  Identities=20%  Similarity=0.235  Sum_probs=172.9

Q ss_pred             HHHHHHHhhCccccCcc--cccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcc
Q 043148           60 YRELSRATNNFAEAGKL--GEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHE  136 (387)
Q Consensus        60 ~~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  136 (387)
                      ..+.....++|.+.+.+  |+|+||.||++..+.++..+|+|.+.......     .|+.....+ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence            34555566777777776  99999999999999999999999986532111     122222222 79999999987644


Q ss_pred             hhh-------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC-cEEEcccccc
Q 043148          137 QRQ-------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF-NAKLGDFGLA  190 (387)
Q Consensus       137 ~~~-------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfg~~  190 (387)
                      ...                         ..+..++.|+++||.|||+   .+++||||||+||+++.++ .++|+|||++
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            321                         1236789999999999999   9999999999999999998 9999999998


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      ......     ....++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+....        
T Consensus       158 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--------  223 (267)
T PHA03390        158 KIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--------  223 (267)
T ss_pred             eecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh--------
Confidence            765432     12357889999999998889999999999999999999999998543321 1111111110        


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHhccC
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPS-IRQVINVLNFE  316 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~evl~~l~~~  316 (387)
                        ..  ...........+.+++.+||+.+|.+||+ ++++++|.|+.
T Consensus       224 --~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        224 --QK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             --cc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence              00  11122245566889999999999999996 69999998864

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.3e-33  Score=257.47  Aligned_cols=232  Identities=24%  Similarity=0.275  Sum_probs=170.1

Q ss_pred             CccccCcccccCceEEEEEEEC---CCCeEEEEEEecCCC----hhhHHHHHHHHHHHhcC-CCCCccceehhhcchh--
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLS---DQNTEIAVKRVSRGS----KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQR--  138 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--  138 (387)
                      +|...+.||+|+||.||+++..   .++..||||.+....    ....+.+.+|++++.++ +||||+++++.+....  
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4677889999999999999863   356889999986532    22345688999999999 5999999877543321  


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ...+..++.|++++|.|||+   .+++||||+|+||+++.++.++|+|||+++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence                                   11235678899999999999   9999999999999999999999999999876544


Q ss_pred             CCCceeeeeecCCcccCchhhccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGK--ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ..........++..|++||.+.+..  .+.++||||||+++|||++|..||.........  ..........        
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~--------  227 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILKS--------  227 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHcc--------
Confidence            3222223345788999999987655  788999999999999999999999643321111  1111111100        


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHhccC
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQ---VINVLNFE  316 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~e---vl~~l~~~  316 (387)
                         ....+......+.+++.+||+.||++|||+.+   +++++++.
T Consensus       228 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~  270 (288)
T cd05583         228 ---KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ  270 (288)
T ss_pred             ---CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccc
Confidence               01122223455788999999999999999654   46666554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-33  Score=249.83  Aligned_cols=219  Identities=28%  Similarity=0.325  Sum_probs=172.7

Q ss_pred             ccccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------------
Q 043148           76 LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------------  139 (387)
Q Consensus        76 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------------  139 (387)
                      ||+|+||.||++....++..+|+|.+.....   .....+..|+++++.++||||+++++.+.....             
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6999999999999988899999999876432   245678899999999999999999887654321             


Q ss_pred             ------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecC
Q 043148          140 ------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT  207 (387)
Q Consensus       140 ------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~  207 (387)
                                  ..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~  156 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT  156 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence                        2236788999999999999   999999999999999999999999999987654321 122344578


Q ss_pred             CcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHH
Q 043148          208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMEC  287 (387)
Q Consensus       208 ~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (387)
                      ..|++||...+...+.++|+||||+++|++++|..||.......   ....+   . .        .  ....+......
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~---~-~--------~--~~~~~~~~~~~  219 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKI---L-K--------D--PLRFPEFLSPE  219 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH---h-c--------C--CCCCCCCCCHH
Confidence            89999999988888999999999999999999999996544311   11111   0 0        0  11222223566


Q ss_pred             HHHHHHHhcCCCCCCCCCH---HHHHHHhcc
Q 043148          288 LMIVGLWCCHPDFTNRPSI---RQVINVLNF  315 (387)
Q Consensus       288 l~~l~~~cl~~dp~~RPs~---~evl~~l~~  315 (387)
                      +.+++.+||..||.+||++   ++++++.||
T Consensus       220 l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         220 ARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            8899999999999999999   899888764

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=268.82  Aligned_cols=178  Identities=35%  Similarity=0.522  Sum_probs=151.1

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh----------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----------  138 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----------  138 (387)
                      +...+.||+|+||.||+|+.+.+|+.||||.++.. .....+...+|+++|++|+|+|||++++.-++..          
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            33456899999999999999999999999999775 3455778899999999999999999887544322          


Q ss_pred             ------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC--CCC--cEEEcccccc
Q 043148          139 ------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD--SNF--NAKLGDFGLA  190 (387)
Q Consensus       139 ------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~--~~~--~~kl~Dfg~~  190 (387)
                                              +..++.++..+..||.|||+   ++|+||||||.||++-  ++|  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence                                    12247889999999999998   9999999999999984  334  3699999999


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcch
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSK  252 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~  252 (387)
                      +....+  ......+||..|++||.+.. +.|+..+|.|||||++||++||..||.....+..
T Consensus       172 rel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~  232 (732)
T KOG4250|consen  172 RELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN  232 (732)
T ss_pred             ccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc
Confidence            987664  46677899999999999985 7899999999999999999999999988766543

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-34  Score=283.66  Aligned_cols=239  Identities=25%  Similarity=0.272  Sum_probs=190.7

Q ss_pred             HHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcc
Q 043148           60 YRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHE  136 (387)
Q Consensus        60 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  136 (387)
                      ..+++-..++|.+.+.||+|+||.|.+++.+.+++.||+|++++.   .......|..|-.+|..-+.+-|+++.-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            446666778999999999999999999999999999999999773   34456778999999998889999988887777


Q ss_pred             hhhHHH-------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          137 QRQLIL-------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       137 ~~~~~l-------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      .+++|+                         +-+...|.-||.-||+   .|+|||||||+|||||..|++||+|||.+-
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHH
Confidence            766553                         3456778888888998   999999999999999999999999999998


Q ss_pred             cccCCCCceeeeeecCCcccCchhhc----c-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC
Q 043148          192 LVDHELGSQTTVLAGTMGYLAPECVT----T-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG  266 (387)
Q Consensus       192 ~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  266 (387)
                      .+..+..-.....+|||.|.+||++.    + +.|+..+|.||+||++|||+.|..||....--+...            
T Consensus       224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~------------  291 (1317)
T KOG0612|consen  224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG------------  291 (1317)
T ss_pred             hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH------------
Confidence            88877667778889999999999986    3 569999999999999999999999997543222211            


Q ss_pred             chhhhhcccCCcccc--HHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHhccCC
Q 043148          267 QLLEAADGRLSKEFD--ERQMECLMIVGLWCCHPDFTNRPS---IRQVINVLNFEA  317 (387)
Q Consensus       267 ~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dp~~RPs---~~evl~~l~~~~  317 (387)
                         .+++..-...+|  ..+++...+||...+. +|..|..   ++++-.|++|..
T Consensus       292 ---KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  292 ---KIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             ---HHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence               112111111122  3356667777777555 6678877   999999998764

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=245.56  Aligned_cols=239  Identities=23%  Similarity=0.307  Sum_probs=183.6

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhHHH---------
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQLIL---------  142 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l---------  142 (387)
                      .+.||+|+|+.|--+....+|..+|||++.+.....+.+..+|++++..- .|+||+.+++||+++...++         
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            45799999999999999999999999999888777889999999999988 59999999999998765543         


Q ss_pred             ----------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc---EEEccccccccccCCC------
Q 043148          143 ----------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN---AKLGDFGLARLVDHEL------  197 (387)
Q Consensus       143 ----------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kl~Dfg~~~~~~~~~------  197 (387)
                                      ..+..+|+.||.|||.   +||.||||||+|||......   +||+||.+..-+....      
T Consensus       163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  163 LLSHIQKRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence                            4688999999999999   99999999999999976554   7999998865332211      


Q ss_pred             CceeeeeecCCcccCchhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh-------hHH-HHHHHHhc
Q 043148          198 GSQTTVLAGTMGYLAPECVT-----TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKV-------RLV-EWVWDLYG  264 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~-------~~~-~~~~~~~~  264 (387)
                      .......+|+-.|||||+..     ...|+.++|.||||||||-|++|..||.+.-..+..       ... +...+.+.
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ  319 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ  319 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence            11223456888999999864     235899999999999999999999999876543321       111 11222222


Q ss_pred             cCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 043148          265 KGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLP  320 (387)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  320 (387)
                      ++.. +     .+..-....+....+++...+..|+.+|-++.++++|+|.....+
T Consensus       320 EGkY-e-----FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  320 EGKY-E-----FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             ccCC-c-----CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            2221 1     111222345666788889999999999999999999999765433

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-34  Score=255.14  Aligned_cols=244  Identities=20%  Similarity=0.312  Sum_probs=187.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCC--C----CccceehhhcchhhH
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRH--R----NLVHLIGWCHEQRQL  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~~~  140 (387)
                      +.+|.+...+|+|.||.|-...+..++..||||+++..... .+..+-|+++|+++.+  |    .+|.+.+||...+..
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            78899999999999999999999998999999999766544 4556789999999932  2    367777776544332


Q ss_pred             --------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC----------------
Q 043148          141 --------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS----------------  178 (387)
Q Consensus       141 --------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~----------------  178 (387)
                                                .++.++.|+++++++||+   .+++|.||||+|||+-+                
T Consensus       167 CivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~  243 (415)
T KOG0671|consen  167 CIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI  243 (415)
T ss_pred             EEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCcccee
Confidence                                      237899999999999999   99999999999999831                


Q ss_pred             ----CCcEEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 043148          179 ----NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR  254 (387)
Q Consensus       179 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~  254 (387)
                          +..+||+|||.++.....    ....+.|..|.|||++.+-.++..+||||+||||+|+++|...|...++.+...
T Consensus       244 r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa  319 (415)
T KOG0671|consen  244 RPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA  319 (415)
T ss_pred             ccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence                345899999999865543    245678999999999999999999999999999999999999999887666554


Q ss_pred             HHHHHHH--------------HhccCc-----------hhhhhcccCC----ccccHHHHHHHHHHHHHhcCCCCCCCCC
Q 043148          255 LVEWVWD--------------LYGKGQ-----------LLEAADGRLS----KEFDERQMECLMIVGLWCCHPDFTNRPS  305 (387)
Q Consensus       255 ~~~~~~~--------------~~~~~~-----------~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs  305 (387)
                      +.+.+..              ....+.           .....+....    ....+.+...|.+|+..+|..||.+|+|
T Consensus       320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT  399 (415)
T KOG0671|consen  320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT  399 (415)
T ss_pred             HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence            4433211              000110           0111111110    1122345666999999999999999999


Q ss_pred             HHHHHHHhccCCC
Q 043148          306 IRQVINVLNFEAP  318 (387)
Q Consensus       306 ~~evl~~l~~~~~  318 (387)
                      +.|+++|++|...
T Consensus       400 l~EAL~HpFF~~~  412 (415)
T KOG0671|consen  400 LREALSHPFFARL  412 (415)
T ss_pred             HHHHhcCHHhhcC
Confidence            9999999998754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=1.8e-31  Score=265.40  Aligned_cols=244  Identities=18%  Similarity=0.205  Sum_probs=153.9

Q ss_pred             HhhCccccCcccccCceEEEEEEECCC----CeEEEEEEecCCChhhHHHHHHHHH----------HHhcC-------CC
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQ----NTEIAVKRVSRGSKQGKKEYISEVR----------IISRL-------RH  124 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~----------~l~~l-------~h  124 (387)
                      ..++|...+.||+|+||.||+|++..+    +..||||++......  +.+..|..          .+..+       ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNERVRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHHHHHhhchhhHHHHHHhhhcccccccC
Confidence            467899999999999999999999888    899999988643221  11111100          00000       01


Q ss_pred             CCccceehhhcch--------------------------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcc
Q 043148          125 RNLVHLIGWCHEQ--------------------------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS  172 (387)
Q Consensus       125 ~niv~l~~~~~~~--------------------------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~  172 (387)
                      ..+.-+++|+...                                ....+..++.|++.||.|||+   ++|+||||||+
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~  284 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQ  284 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHH
Confidence            1111112221110                                011245789999999999999   99999999999


Q ss_pred             eeEeCC-CCcEEEccccccccccCCCCceeeeeecCCcccCchhhccC----------------------CCCCccchHH
Q 043148          173 NVVLDS-NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG----------------------KASKESDVYS  229 (387)
Q Consensus       173 Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~Dvws  229 (387)
                      |||++. ++.+||+|||+++..............+++.|+|||.+...                      .++.++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            999986 57999999999986544333333456789999999965322                      2345679999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC--chhhhhcccCCcc------ccHHHHHHHHHHHHHhcCCCCC
Q 043148          230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG--QLLEAADGRLSKE------FDERQMECLMIVGLWCCHPDFT  301 (387)
Q Consensus       230 ~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dp~  301 (387)
                      |||+||||+++..++....    ......+ ......  .......+....+      ..+.......+|+.+||+.||.
T Consensus       365 lGviL~el~~~~~~~~~~~----~~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSNL----IQFNRQL-KRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             HHHHHHHHHhCcCCCchHH----HHHHHHH-HhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            9999999998776643211    0000000 000000  0000111110000      0011122355899999999999


Q ss_pred             CCCCHHHHHHHhccCCCC
Q 043148          302 NRPSIRQVINVLNFEAPL  319 (387)
Q Consensus       302 ~RPs~~evl~~l~~~~~~  319 (387)
                      +|||+.|+++|+|+....
T Consensus       440 kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        440 QRISAKAALAHPYFDREG  457 (566)
T ss_pred             cCCCHHHHhCCcCcCCCC
Confidence            999999999999986643

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=3.6e-32  Score=276.75  Aligned_cols=122  Identities=28%  Similarity=0.394  Sum_probs=104.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++....   ......+..|+.++..++||||+++++++.....    
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            367889999999999999999999889999999986542   2334678899999999999999999876543221    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                                           ..++.++.||+.||.|||.   ++|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence                                 1236789999999999999   899999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=236.27  Aligned_cols=243  Identities=21%  Similarity=0.262  Sum_probs=182.6

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----H-
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----I-  141 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----~-  141 (387)
                      .+..+-||.|+||.||...+..+|+.||+|++...  +-...+.+.+|+++|..++|.|++..++...-....     + 
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34467899999999999999999999999998654  334567889999999999999999887754332111     1 


Q ss_pred             -----------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          142 -----------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       142 -----------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                             +.-++.||++||.|||+   .+|.||||||.|.|++.|..+||+|||+++.......
T Consensus       135 ~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  135 LTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence                                   14578999999999999   9999999999999999999999999999998776655


Q ss_pred             ceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------HHhccCchh
Q 043148          199 SQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW--------DLYGKGQLL  269 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~  269 (387)
                      ...+..+-|..|.|||++.+. .|+.+.||||.||++.||+.++..|......++..++....        ..--++.-.
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence            566666778899999999875 49999999999999999999999998777665554442211        111111111


Q ss_pred             hhhcccCC-cc--------ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          270 EAADGRLS-KE--------FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       270 ~~~~~~~~-~~--------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .++..... +.        -+...-.....+.+.++..||..|.+..+.+.++..
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            11111111 00        011122234566778899999999999999998864

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=237.27  Aligned_cols=233  Identities=23%  Similarity=0.257  Sum_probs=181.7

Q ss_pred             HhhCcccc-CcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcchh-----
Q 043148           66 ATNNFAEA-GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQR-----  138 (387)
Q Consensus        66 ~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  138 (387)
                      .+++|.+. ++||-|--|.|-.+..+.++..+|+|++..     .....+|+++.... .|||||.+++++.+.-     
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            46777765 579999999999999999999999999854     34556888887666 6999999999886531     


Q ss_pred             -----------hHH---------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC---CCcEEEccccc
Q 043148          139 -----------QLI---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGL  189 (387)
Q Consensus       139 -----------~~~---------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Dfg~  189 (387)
                                 +++               ...|..||+.|+.|||+   .+|.||||||+|+|...   |-.+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccc
Confidence                       111               14799999999999999   99999999999999964   55789999999


Q ss_pred             cccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh
Q 043148          190 ARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL  269 (387)
Q Consensus       190 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (387)
                      ++.....  ......+-|+.|.|||++...+|+..+|+||+||++|-|++|..||.........   --+...+..+.  
T Consensus       211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---pgMk~rI~~gq--  283 (400)
T KOG0604|consen  211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKRRIRTGQ--  283 (400)
T ss_pred             ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC---hhHHhHhhccC--
Confidence            9865542  3344567799999999999999999999999999999999999999865542111   00111111110  


Q ss_pred             hhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                          -....+.....++...++++..|..+|.+|.|+++++.|.|...
T Consensus       284 ----y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~  327 (400)
T KOG0604|consen  284 ----YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ  327 (400)
T ss_pred             ----ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence                11223344567888999999999999999999999999999653

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=6.4e-32  Score=226.29  Aligned_cols=244  Identities=18%  Similarity=0.264  Sum_probs=182.7

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCCccceehhhcchhh-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  139 (387)
                      ..++|++.+++|+|.|+.||.|....++..++||++++..   .+...+|+++|..|. ||||+++++...+...     
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            3477889999999999999999988889999999997543   567889999999996 9999999998765421     


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC-CcEEEccccccccccCCCCc
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN-FNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                         .-++....+++.||.|+|+   +||+|||+||.|++||.. ..++|+|+|++.++...  .
T Consensus       113 iFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~--~  187 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--K  187 (338)
T ss_pred             HhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCC--c
Confidence                               1136788999999999999   999999999999999954 57999999999988764  3


Q ss_pred             eeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCC-cchhhHHHHH------HHHhc------c
Q 043148          200 QTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQE-PSKVRLVEWV------WDLYG------K  265 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~-~~~~~~~~~~------~~~~~------~  265 (387)
                      .....+.+..|.-||.+... .|+..-|+|||||++..|+..+.||-...+ .++.-.+..+      ...+.      +
T Consensus       188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld  267 (338)
T KOG0668|consen  188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD  267 (338)
T ss_pred             eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence            34455667788999988754 589999999999999999999999865433 3322111111      11111      1


Q ss_pred             CchhhhhcccCC--------ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          266 GQLLEAADGRLS--------KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       266 ~~~~~~~~~~~~--------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .....++.....        .+...-...+.++++.+.|..|.++|||+.|.+.|+.|..
T Consensus       268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence            111221111110        1111113356788999999999999999999999998754

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=8.7e-32  Score=241.02  Aligned_cols=204  Identities=21%  Similarity=0.174  Sum_probs=156.8

Q ss_pred             cCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------------------
Q 043148           79 GGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------------------  139 (387)
Q Consensus        79 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------------------  139 (387)
                      |.||.||++++..+++.+|+|.+....     .+..|...+....||||+++++++.+...                   
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999999999999999996643     23345555556679999999987654321                   


Q ss_pred             ------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCcccCc
Q 043148          140 ------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAP  213 (387)
Q Consensus       140 ------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aP  213 (387)
                            ..+..++.|++.||.|||+   ++++||||||+||+++.++.++++|||.+......    .....++..|+||
T Consensus        79 ~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aP  151 (237)
T cd05576          79 FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAP  151 (237)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCC
Confidence                  1126788999999999999   99999999999999999999999999987655432    1223456779999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHH
Q 043148          214 ECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL  293 (387)
Q Consensus       214 E~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  293 (387)
                      |.+.+..++.++||||+|+++|||++|+.|+........            .     .    .....+......+.+++.
T Consensus       152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~-----~----~~~~~~~~~~~~~~~li~  210 (237)
T cd05576         152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------T-----H----TTLNIPEWVSEEARSLLQ  210 (237)
T ss_pred             cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------c-----c----cccCCcccCCHHHHHHHH
Confidence            999888889999999999999999999988753221100            0     0    001122234456888999


Q ss_pred             HhcCCCCCCCCCH-----HHHHHHhcc
Q 043148          294 WCCHPDFTNRPSI-----RQVINVLNF  315 (387)
Q Consensus       294 ~cl~~dp~~RPs~-----~evl~~l~~  315 (387)
                      +|++.||.+||++     +++++|.|+
T Consensus       211 ~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         211 QLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HHccCCHHHhcCCCccchHHHHcCCCC
Confidence            9999999999986     888887764

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=6.6e-31  Score=234.68  Aligned_cols=216  Identities=27%  Similarity=0.352  Sum_probs=169.6

Q ss_pred             CceEEEEEEECCCCeEEEEEEecCCChhh-HHHHHHHHHHHhcCCCCCccceehhhcchh--------------------
Q 043148           80 GFGGVYRGLLSDQNTEIAVKRVSRGSKQG-KKEYISEVRIISRLRHRNLVHLIGWCHEQR--------------------  138 (387)
Q Consensus        80 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------------------  138 (387)
                      +||.||+|....++..+++|++....... .+.+.+|++.+++++|+|++++++++....                    
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999998889999999997665444 688999999999999999999998765421                    


Q ss_pred             -----hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCcccCc
Q 043148          139 -----QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAP  213 (387)
Q Consensus       139 -----~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aP  213 (387)
                           ...+..++.+++.++.|||.   .+++|+||+|+||+++.++.++|+|||.+.......  ......++..|++|
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p  155 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP  155 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence                 12236789999999999999   899999999999999999999999999998665432  23344578899999


Q ss_pred             hhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccH-HHHHHHHHHH
Q 043148          214 ECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE-RQMECLMIVG  292 (387)
Q Consensus       214 E~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~  292 (387)
                      |.+....++.++|||+||+++++|++|..||.......  ...+    ......        ....... .....+.+++
T Consensus       156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~----~~~~~~--------~~~~~~~~~~~~~~~~~i  221 (244)
T smart00220      156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFK----KIGKPK--------PPFPPPEWKISPEAKDLI  221 (244)
T ss_pred             HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHH----HHhccC--------CCCccccccCCHHHHHHH
Confidence            99988888999999999999999999999997632221  1111    111110        0000000 0445688999


Q ss_pred             HHhcCCCCCCCCCHHHHHHHhc
Q 043148          293 LWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       293 ~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .+|+..+|.+||++.+++++.+
T Consensus       222 ~~~l~~~p~~Rp~~~~~~~~~~  243 (244)
T smart00220      222 RKLLVKDPEKRLTAEEALQHPF  243 (244)
T ss_pred             HHHccCCchhccCHHHHhhCCC
Confidence            9999999999999999999765

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-32  Score=247.94  Aligned_cols=237  Identities=27%  Similarity=0.390  Sum_probs=178.4

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChh-h------HHHHHHHHHHHhcCCCCCccceehhhcchh-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ-G------KKEYISEVRIISRLRHRNLVHLIGWCHEQR-  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  138 (387)
                      .++|-.++.||+|||+.||+|.+....+.||||+-.....+ +      .+...+|.+|.+.|+||.||++++|+.-+. 
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            35677788999999999999999888999999986543211 1      245678999999999999999998764321 


Q ss_pred             --------------hHHH-----------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC---CCCcEEEcccccc
Q 043148          139 --------------QLIL-----------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD---SNFNAKLGDFGLA  190 (387)
Q Consensus       139 --------------~~~l-----------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~---~~~~~kl~Dfg~~  190 (387)
                                    .+++           +.|.+||+.||.||.+ .+.+|||-||||.|||+-   .-|.+||+|||++
T Consensus       542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence                          1222           6799999999999997 458999999999999995   3578999999999


Q ss_pred             ccccCCCCc------eeeeeecCCcccCchhhccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 043148          191 RLVDHELGS------QTTVLAGTMGYLAPECVTTG----KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW  260 (387)
Q Consensus       191 ~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~----~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~  260 (387)
                      +++..+...      ......||.+|++||++.-+    +.+.++||||.|||+|.++.|+.||.......++  ++   
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--Lq---  695 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--LQ---  695 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--Hh---
Confidence            988764332      23456899999999987533    4688999999999999999999999865433221  11   


Q ss_pred             HHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                          ...+.....  ......+.+......++.+||++.-++|....++..+..+
T Consensus       696 ----eNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl  744 (775)
T KOG1151|consen  696 ----ENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL  744 (775)
T ss_pred             ----hhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence                112221111  1111223345557789999999999999999888877654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=241.42  Aligned_cols=228  Identities=23%  Similarity=0.305  Sum_probs=178.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhHHH
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQLIL  142 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  142 (387)
                      ..+|..+..||+|+||.|.+|..+++...+|||++++.   ...+.+--+.|-++|... +-|.++++..+|...+.+++
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            35788888999999999999999999999999999875   233344456788888766 57788888777766544432


Q ss_pred             -------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          143 -------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       143 -------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                               .-++..||-||-+||+   ++||.||||.+|||+|.+|++||+|||+++.-- -.
T Consensus       428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~~  503 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-FD  503 (683)
T ss_pred             EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccc-cC
Confidence                                     3578889999999999   999999999999999999999999999997422 22


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      +......+||+.|+|||++...+|+..+|.|||||+||||+.|+.||++.++.+...               .+++.  .
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~---------------aI~eh--n  566 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---------------AIMEH--N  566 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------HHHHc--c
Confidence            345667899999999999999999999999999999999999999999877543221               12222  1


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhcc
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNF  315 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~  315 (387)
                      ..++...+.+...+....+...|.+|..     -++|-.|..+
T Consensus       567 vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FF  609 (683)
T KOG0696|consen  567 VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFF  609 (683)
T ss_pred             CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcch
Confidence            2345555666777778888999999953     2356566543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2e-30  Score=252.13  Aligned_cols=240  Identities=19%  Similarity=0.272  Sum_probs=161.4

Q ss_pred             HhhCccccCcccccCceEEEEEEEC----------------CCCeEEEEEEecCCChhhHHHH--------------HHH
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLS----------------DQNTEIAVKRVSRGSKQGKKEY--------------ISE  115 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E  115 (387)
                      ..++|.+.++||+|+||.||+|.+.                ..++.||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3678999999999999999999752                2356799999865443333333              346


Q ss_pred             HHHHhcCCCCCc-----cceehhhcch-----------------------------------------------------
Q 043148          116 VRIISRLRHRNL-----VHLIGWCHEQ-----------------------------------------------------  137 (387)
Q Consensus       116 ~~~l~~l~h~ni-----v~l~~~~~~~-----------------------------------------------------  137 (387)
                      +.++.+++|.++     ++++++|...                                                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            667777766554     5566655321                                                     


Q ss_pred             ----hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCcccCc
Q 043148          138 ----RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAP  213 (387)
Q Consensus       138 ----~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aP  213 (387)
                          ....+..++.|++.+|.|||+   ++++||||||+|||++.++.+||+|||++...............+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence                001235688999999999999   8999999999999999999999999999975543222222223357899999


Q ss_pred             hhhccCC--------------------C--CCccchHHHHHHHHHHHhCCC-CCCCCCCcch-h---hHHHHHHHHhccC
Q 043148          214 ECVTTGK--------------------A--SKESDVYSFGVVALEVACGRK-PVEPRQEPSK-V---RLVEWVWDLYGKG  266 (387)
Q Consensus       214 E~~~~~~--------------------~--~~~~Dvws~Gvil~el~tg~~-p~~~~~~~~~-~---~~~~~~~~~~~~~  266 (387)
                      |.+....                    |  ..+.||||+||++++|++|.. |+........ .   ......|..+.. 
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~-  458 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG-  458 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc-
Confidence            9875332                    1  234799999999999999875 6653211100 0   000001111111 


Q ss_pred             chhhhhcccCCccccHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHHHhccC
Q 043148          267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDF---TNRPSIRQVINVLNFE  316 (387)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp---~~RPs~~evl~~l~~~  316 (387)
                             ........+.......+++.+++..+|   .+|+|++|+++|.|+.
T Consensus       459 -------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        459 -------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             -------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence                   111111223345667888899998765   6899999999999974

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=220.45  Aligned_cols=184  Identities=29%  Similarity=0.458  Sum_probs=149.2

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHh-cCCCCCccceehhhcchh--
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIIS-RLRHRNLVHLIGWCHEQR--  138 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~--  138 (387)
                      +....+++.....||+|++|.|-+-++..+|...|+|++... ..+..++.++|+++.. ....|.+|+|+|...+..  
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            334445555577899999999999999999999999999654 4566778889998854 558999999999654332  


Q ss_pred             --------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccc
Q 043148          139 --------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL  192 (387)
Q Consensus       139 --------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~  192 (387)
                                                +.++-+|+..+.+||.|||+  +..++|||+||+||||+.+|.+|+||||++..
T Consensus       121 wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  121 WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGY  198 (282)
T ss_pred             EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEccccccee
Confidence                                      22346899999999999999  48899999999999999999999999999976


Q ss_pred             ccCCCCceeeeeecCCcccCchhhcc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCc
Q 043148          193 VDHELGSQTTVLAGTMGYLAPECVTT----GKASKESDVYSFGVVALEVACGRKPVEPRQEP  250 (387)
Q Consensus       193 ~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~  250 (387)
                      +....  ..+...|-..|||||.+..    ..|+-++||||||+++.||.+++.||.....+
T Consensus       199 L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  199 LVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             ehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence            64421  2233456778999998863    36899999999999999999999999876543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-32  Score=263.16  Aligned_cols=223  Identities=27%  Similarity=0.370  Sum_probs=166.8

Q ss_pred             ccccCcccccCceE-EEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH-------
Q 043148           70 FAEAGKLGEGGFGG-VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL-------  140 (387)
Q Consensus        70 ~~~~~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~-------  140 (387)
                      |...+.+|.|+-|+ ||+|.+  .|+.||||++-..   ...-..+|+..|+.- +|||||++++.-.+.+..       
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            34456789999886 899999  5789999998432   234567899999888 699999998753332211       


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC---C--CcEEEcccccccccc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---N--FNAKLGDFGLARLVD  194 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~--~~~kl~Dfg~~~~~~  194 (387)
                                           ..+.+..|+++||++||+   .+|+||||||.||||+.   +  ..++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence                                 126788999999999999   99999999999999975   3  468999999999876


Q ss_pred             CCCCc--eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          195 HELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       195 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                      .....  ......||-+|+|||.+....-+.++||||+||++|+.++ |..||...-..+. +.+.      +...+.. 
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl~------~~~~L~~-  734 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NILT------GNYTLVH-  734 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhhc------Cccceee-
Confidence            65332  2345679999999999998888889999999999999988 5899976432211 0000      0000000 


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                          +.. . .++  ...+||..+++.+|..||++.+|+.|+.|-
T Consensus       735 ----L~~-~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  735 ----LEP-L-PDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             ----ecc-C-chH--HHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence                111 1 111  577899999999999999999999998653

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-29  Score=221.44  Aligned_cols=244  Identities=21%  Similarity=0.243  Sum_probs=184.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      ..+|...+.+|.|.. .|-.+.+.-.++.||+|.+...  .....++..+|..++..++|+||++++.++.-.+      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356777788999988 7777777778899999988554  3445677889999999999999999999875322      


Q ss_pred             ----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          139 ----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       139 ----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                            +..+..++.|++.|++|||+   .+|+||||||+||++..+..+||.|||+++.....
T Consensus        95 e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen   95 EVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD  171 (369)
T ss_pred             hHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc
Confidence                                  22236899999999999999   99999999999999999999999999999865443


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH---------HH-----
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW---------DL-----  262 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~---------~~-----  262 (387)
                        -..+..+.+..|.|||++.+..|.+.+||||.||++.||++|+..|.+.+..++...+....         ++     
T Consensus       172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence              24455677889999999998889999999999999999999999998766544433221110         00     


Q ss_pred             --------hccCchhhhhcccC-C--ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          263 --------YGKGQLLEAADGRL-S--KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       263 --------~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                              +......+.+...+ .  .+.+......+.+++.++|-.||++|.+++++++|+.+.
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                    00001111111100 0  111222344577899999999999999999999998664

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.5e-30  Score=224.46  Aligned_cols=234  Identities=21%  Similarity=0.303  Sum_probs=177.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhHHH
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQLIL  142 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  142 (387)
                      .++|..+..||+|+|..|-+++++.+.+.+|+|++++.   ..++.+=.+.|-.++... +||.+|.+..+|..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            47788999999999999999999999999999999764   334445566788888766 79999999988876654432


Q ss_pred             -------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          143 -------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       143 -------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                               +-+...|.-||.|||+   +|||.||||.+|+|+|..|++||+|||+++.-- ..
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l-~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-GP  404 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCC-CC
Confidence                                     3456678999999999   999999999999999999999999999997432 33


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCC--CCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPR--QEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      +......+||+.|.|||++.+..|+..+|.|++||+++||+.|+.||.-.  ++++ .+.-++....+-+..+       
T Consensus       405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d-~ntedylfqvilekqi-------  476 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD-MNTEDYLFQVILEKQI-------  476 (593)
T ss_pred             CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc-cchhHHHHHHHhhhcc-------
Confidence            45677889999999999999999999999999999999999999999742  2222 1222233332222111       


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCC------CHHHHHHHhcc
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRP------SIRQVINVLNF  315 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP------s~~evl~~l~~  315 (387)
                         ..+...+-....++..-+..||++|.      .+.++-.|.+|
T Consensus       477 ---riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ff  519 (593)
T KOG0695|consen  477 ---RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFF  519 (593)
T ss_pred             ---cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhh
Confidence               11222222344566667799999985      35667666554

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2e-30  Score=242.51  Aligned_cols=172  Identities=30%  Similarity=0.486  Sum_probs=150.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--------hhHHHHHHHHHHHhcCC---CCCccceehhhcc
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--------QGKKEYISEVRIISRLR---HRNLVHLIGWCHE  136 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  136 (387)
                      .+|...+.+|.|+||.|+++.++.+...|+||.+.+...        ...-..-.|+.||..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            457888999999999999999999999999999976521        11122446999999997   9999999999998


Q ss_pred             hhhHHH--------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccc
Q 043148          137 QRQLIL--------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA  190 (387)
Q Consensus       137 ~~~~~l--------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~  190 (387)
                      ++..++                          ..|+.|++-|+++||+   .+|+|||||-+|+.++.+|-+||+|||.+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccch
Confidence            876554                          5799999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVE  245 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~  245 (387)
                      .....   .....++||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus       718 a~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  718 AYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            76654   34567899999999999999887 678899999999999999999985

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3e-29  Score=244.84  Aligned_cols=238  Identities=23%  Similarity=0.347  Sum_probs=189.7

Q ss_pred             CHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcch
Q 043148           59 TYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ  137 (387)
Q Consensus        59 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  137 (387)
                      .++.+...+.-|++.+.||.|.+|.||+++...+++..|+|++.... ...++...|.++++.+ .|||++.++|++...
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            34445555677888999999999999999999999999999986643 3356677899999988 699999999976321


Q ss_pred             --------------------------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEc
Q 043148          138 --------------------------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLG  185 (387)
Q Consensus       138 --------------------------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~  185 (387)
                                                      ++..+..|+..++.||.+||.   ..++|||+|-.|||++.++.+||+
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEe
Confidence                                            223457899999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCceeeeeecCCcccCchhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 043148          186 DFGLARLVDHELGSQTTVLAGTMGYLAPECVTT-----GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW  260 (387)
Q Consensus       186 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~  260 (387)
                      |||++..+....+. ..+..||+.|||||++..     ..|+..+|+||||++..||.-|.+|+-++.......      
T Consensus       166 DFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF------  238 (953)
T KOG0587|consen  166 DFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF------  238 (953)
T ss_pred             eeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc------
Confidence            99999877665443 345679999999999853     357889999999999999999999987655321110      


Q ss_pred             HHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                              .-...|...-..+....+.+.+++..||..|-.+||++.++++|.+.
T Consensus       239 --------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi  285 (953)
T KOG0587|consen  239 --------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI  285 (953)
T ss_pred             --------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence                    00112222233456778889999999999999999999999998864

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=6.3e-30  Score=236.48  Aligned_cols=264  Identities=22%  Similarity=0.250  Sum_probs=194.7

Q ss_pred             hhhhhhccCCCCCccCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC
Q 043148           44 ALEDEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR  123 (387)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  123 (387)
                      .+.+.+....+..++.+-|+.  -.+|.+....|+|-|++|.+|.+...|..||||++... ....+.=+.|+++|++|+
T Consensus       410 ~L~DNWdDaEGYYrv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~  486 (752)
T KOG0670|consen  410 GLQDNWDDAEGYYRVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLN  486 (752)
T ss_pred             ccccCcccccceEEEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhh
Confidence            344445555555555555554  47899999999999999999999988999999999764 334556678999999984


Q ss_pred             ------CCCccceehhhcchhhHHH---------------------------HHHHHHHHHHHHHhhhhcccceeeccCC
Q 043148          124 ------HRNLVHLIGWCHEQRQLIL---------------------------HKIALGLASAVLYLHEEWEQCIVHRDIK  170 (387)
Q Consensus       124 ------h~niv~l~~~~~~~~~~~l---------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk  170 (387)
                            --|+++|+-.|...++++|                           ..++.|+.-||..|..   .+|+|.|||
T Consensus       487 ~AD~Edk~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIK  563 (752)
T KOG0670|consen  487 DADPEDKFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIK  563 (752)
T ss_pred             ccCchhhhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccC
Confidence                  2377888777665554432                           5789999999999998   999999999


Q ss_pred             cceeEeCCCC-cEEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 043148          171 SSNVVLDSNF-NAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE  249 (387)
Q Consensus       171 ~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~  249 (387)
                      |.|||+++.. .+||||||.|.....+.   .+.+.-+..|.|||++.+.+|+...|+||.||+||||.||+..|.+..+
T Consensus       564 PDNiLVNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN  640 (752)
T KOG0670|consen  564 PDNILVNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN  640 (752)
T ss_pred             ccceEeccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence            9999999765 57999999997665432   2223335579999999999999999999999999999999999998877


Q ss_pred             cchhhHHHHHH-----HHhccCch---------------------------hhhhcc------cC-----CccccHHHHH
Q 043148          250 PSKVRLVEWVW-----DLYGKGQL---------------------------LEAADG------RL-----SKEFDERQME  286 (387)
Q Consensus       250 ~~~~~~~~~~~-----~~~~~~~~---------------------------~~~~~~------~~-----~~~~~~~~~~  286 (387)
                      .....+...+.     .++..+.+                           ...+.|      .+     .+.-......
T Consensus       641 N~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~  720 (752)
T KOG0670|consen  641 NQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQ  720 (752)
T ss_pred             HHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHH
Confidence            65554332221     01111100                           000001      00     1122234566


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          287 CLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       287 ~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .+.+|+..|+..||.+|.|..++|+|+++.
T Consensus       721 ~~rdLLdkml~LdP~KRit~nqAL~HpFi~  750 (752)
T KOG0670|consen  721 QLRDLLDKMLILDPEKRITVNQALKHPFIT  750 (752)
T ss_pred             HHHHHHHHHhccChhhcCCHHHHhcCCccc
Confidence            788999999999999999999999998764

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.1e-29  Score=236.65  Aligned_cols=242  Identities=23%  Similarity=0.338  Sum_probs=177.0

Q ss_pred             cCHHHHHHHh---hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhh---HHHHHHHHHHHhcCCCCCcccee
Q 043148           58 FTYRELSRAT---NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQG---KKEYISEVRIISRLRHRNLVHLI  131 (387)
Q Consensus        58 ~~~~~~~~~~---~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~  131 (387)
                      -.|.-|+++.   .-|..++.||-|+||+|.+++-.++...+|+|.+++.+.-.   ......|..||...+++-||+|+
T Consensus       616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy  695 (1034)
T KOG0608|consen  616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY  695 (1034)
T ss_pred             hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence            3455555554   34777889999999999999998898899999998765332   34466899999999999999999


Q ss_pred             hhhcchhhHHH-------------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcc
Q 043148          132 GWCHEQRQLIL-------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD  186 (387)
Q Consensus       132 ~~~~~~~~~~l-------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  186 (387)
                      -.|.+.+.+|+                         +-+...+..|+++.|.   .|+|||||||+|||||.+|++||+|
T Consensus       696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTD  772 (1034)
T KOG0608|consen  696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTD  772 (1034)
T ss_pred             EEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeee
Confidence            88877654432                         3456778999999998   9999999999999999999999999


Q ss_pred             cccccccc---CCC-------Cc-------------------------------eeeeeecCCcccCchhhccCCCCCcc
Q 043148          187 FGLARLVD---HEL-------GS-------------------------------QTTVLAGTMGYLAPECVTTGKASKES  225 (387)
Q Consensus       187 fg~~~~~~---~~~-------~~-------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~  225 (387)
                      |||+.-+.   ...       .+                               .....+||+.|+|||++....|+..+
T Consensus       773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c  852 (1034)
T KOG0608|consen  773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC  852 (1034)
T ss_pred             ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence            99985321   100       00                               01134699999999999999999999


Q ss_pred             chHHHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCC
Q 043148          226 DVYSFGVVALEVACGRKPVEPRQEPSKV-RLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRP  304 (387)
Q Consensus       226 Dvws~Gvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP  304 (387)
                      |.||.|||||||+.|+.||-.....+.. ..+.|-.          .++-.....+..++...   +...|+..|  .|.
T Consensus       853 dwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~----------~l~~~~~~~ls~e~~~l---i~kLc~sad--~RL  917 (1034)
T KOG0608|consen  853 DWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN----------FLHIPYQGNLSKEALDL---IQKLCCSAD--SRL  917 (1034)
T ss_pred             hhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh----------ccccccccccCHHHHHH---HHHHhcChh--hhh
Confidence            9999999999999999999876655432 2233221          11212223333433332   334466554  443


Q ss_pred             ---CHHHHHHHhccCC
Q 043148          305 ---SIRQVINVLNFEA  317 (387)
Q Consensus       305 ---s~~evl~~l~~~~  317 (387)
                         -.++|-.|.||..
T Consensus       918 Gkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  918 GKNGADQVKAHPFFKG  933 (1034)
T ss_pred             cccchhhhhcCccccc
Confidence               4667888888754

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-27  Score=220.47  Aligned_cols=242  Identities=24%  Similarity=0.324  Sum_probs=172.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-----C---CCccceehhhcchhh
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-----H---RNLVHLIGWCHEQRQ  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~~~  139 (387)
                      .+|.+.++||-|.|++||++.+..+.+.||+|+.+..... .+..+.||++|++++     |   ..||+|+++|.....
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            7888999999999999999999999999999998654322 456778999999883     2   378999998754210


Q ss_pred             ------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC----------
Q 043148          140 ------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN----------  179 (387)
Q Consensus       140 ------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~----------  179 (387)
                                                    .++..|+.||+.||.|||.+  .+|||.||||+|||+..+          
T Consensus       157 NG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~e~~~~~~~~~  234 (590)
T KOG1290|consen  157 NGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCSTEIDPAKDARE  234 (590)
T ss_pred             CCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeeccccchhhhhhh
Confidence                                          12378999999999999995  789999999999999211          


Q ss_pred             --------------------------------------------------------------------------------
Q 043148          180 --------------------------------------------------------------------------------  179 (387)
Q Consensus       180 --------------------------------------------------------------------------------  179 (387)
                                                                                                      
T Consensus       235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~  314 (590)
T KOG1290|consen  235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES  314 (590)
T ss_pred             hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence                                                                                            


Q ss_pred             ----------------------------------------------------------------------------CcEE
Q 043148          180 ----------------------------------------------------------------------------FNAK  183 (387)
Q Consensus       180 ----------------------------------------------------------------------------~~~k  183 (387)
                                                                                                  ..+|
T Consensus       315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK  394 (590)
T KOG1290|consen  315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK  394 (590)
T ss_pred             chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence                                                                                        0012


Q ss_pred             EccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcc---hhhHHHHHH
Q 043148          184 LGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPS---KVRLVEWVW  260 (387)
Q Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~---~~~~~~~~~  260 (387)
                      |+|||-|.....    ..+.-..|..|.|||++.+..|++.+||||++|++|||+||...|+......   +.+.+..+.
T Consensus       395 IaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~  470 (590)
T KOG1290|consen  395 IADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIM  470 (590)
T ss_pred             Eeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHH
Confidence            222222222111    0111235667999999999999999999999999999999999997654321   122222222


Q ss_pred             HHhc--------cCc-hhhhhccc--------C-----------CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043148          261 DLYG--------KGQ-LLEAADGR--------L-----------SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINV  312 (387)
Q Consensus       261 ~~~~--------~~~-~~~~~~~~--------~-----------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~  312 (387)
                      ++++        .++ ..++++.+        +           .-.++.+....+.+++.-+|+.+|.+|||+.+.++|
T Consensus       471 ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h  550 (590)
T KOG1290|consen  471 ELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH  550 (590)
T ss_pred             HHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence            2211        111 11111110        0           124567788889999999999999999999999999


Q ss_pred             hccC
Q 043148          313 LNFE  316 (387)
Q Consensus       313 l~~~  316 (387)
                      +|..
T Consensus       551 PwLn  554 (590)
T KOG1290|consen  551 PWLN  554 (590)
T ss_pred             cccc
Confidence            9965

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=1.4e-26  Score=201.71  Aligned_cols=186  Identities=33%  Similarity=0.539  Sum_probs=155.9

Q ss_pred             ccccCceEEEEEEECCCCeEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCCccceehhhcchh----------------
Q 043148           76 LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ-GKKEYISEVRIISRLRHRNLVHLIGWCHEQR----------------  138 (387)
Q Consensus        76 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----------------  138 (387)
                      ||+|.+|.||++....++..+++|.+...... ..+.+.+|++.++.++|++++++++++....                
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999877899999999765432 3578999999999999999999988765411                


Q ss_pred             ----------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC-CCcEEEccccccccccCCCCceeeeeecC
Q 043148          139 ----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS-NFNAKLGDFGLARLVDHELGSQTTVLAGT  207 (387)
Q Consensus       139 ----------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~  207 (387)
                                ......++.++++++.+||+   .+++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~  156 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT  156 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence                      11235788999999999999   89999999999999999 89999999999976644321 12234467


Q ss_pred             CcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHH
Q 043148          208 MGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME  286 (387)
Q Consensus       208 ~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (387)
                      ..|++||..... .++.+.|+|++|+++++|                                                .
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~  188 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------P  188 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------H
Confidence            789999998877 788999999999999999                                                3


Q ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 043148          287 CLMIVGLWCCHPDFTNRPSIRQVINVL  313 (387)
Q Consensus       287 ~l~~l~~~cl~~dp~~RPs~~evl~~l  313 (387)
                      .+.+++..|++.+|.+||++.++++++
T Consensus       189 ~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         189 ELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            477889999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-27  Score=205.16  Aligned_cols=237  Identities=24%  Similarity=0.373  Sum_probs=168.7

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcch-------
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ-------  137 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-------  137 (387)
                      ..+.|.+.+.||+|.||.+-+++++.+.+.+++|.+... ....++|.+|...--.| .|.||+.-+++..+.       
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            346688899999999999999999999999999998664 33468899999887667 599999877643221       


Q ss_pred             ------------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC--CCCcEEEccccccccccCCC
Q 043148          138 ------------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD--SNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       138 ------------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                        .+..-..++.|+++|+.|+|+   ++++|||||.+||||-  +..++||+|||+.+..+...
T Consensus       101 qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV  177 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV  177 (378)
T ss_pred             eccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence                              122337899999999999999   9999999999999993  34589999999997654321


Q ss_pred             CceeeeeecCCcccCchhhcc---C--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          198 GSQTTVLAGTMGYLAPECVTT---G--KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~---~--~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                      .    ...-+..|.+||....   .  ...+.+|+|.||+++|.++||+.||..... .+...  |-|..+..+...   
T Consensus       178 ~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y--~~~~~w~~rk~~---  247 (378)
T KOG1345|consen  178 K----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPY--WEWEQWLKRKNP---  247 (378)
T ss_pred             h----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchH--HHHHHHhcccCc---
Confidence            1    1123456899997643   2  347789999999999999999999984332 22222  233333333222   


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHHhccCCCC
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNR---PSIRQVINVLNFEAPL  319 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Ps~~evl~~l~~~~~~  319 (387)
                        +++..+ ....+.+.++-.+-+..+|++|   .+.......+|.+..+
T Consensus       248 --~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i  294 (378)
T KOG1345|consen  248 --ALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI  294 (378)
T ss_pred             --cCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence              121111 1233445666777889999999   5566555666765543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=4.1e-27  Score=213.65  Aligned_cols=249  Identities=25%  Similarity=0.335  Sum_probs=177.8

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEECC---CCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcchh
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLSD---QNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQR  138 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  138 (387)
                      +....+.|...++||+|.|++||++.+..   ..+.||+|.+...+  ......+|+++|..+ .+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            44556778899999999999999999877   67899999986543  345688999999999 5999999988776554


Q ss_pred             hH----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC-CCcEEEccccccccccC
Q 043148          139 QL----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS-NFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 ~~----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~  195 (387)
                      ..                      .+..++..+..||.++|.   +|||||||||.|+|.+. .+.-.|.|||++.....
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~  185 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG  185 (418)
T ss_pred             eeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHh
Confidence            32                      236788999999999999   99999999999999984 45679999999872110


Q ss_pred             C---------------C--C--------------------------ceeeeeecCCcccCchhhccCC-CCCccchHHHH
Q 043148          196 E---------------L--G--------------------------SQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFG  231 (387)
Q Consensus       196 ~---------------~--~--------------------------~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~G  231 (387)
                      .               .  +                          ...-...||++|.|||++...+ .+.+.||||.|
T Consensus       186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G  265 (418)
T KOG1167|consen  186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence            0               0  0                          0011236999999999987654 68999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCcch--hhHHH-----HHH---HHhcc------Cc---hhhh-----------hcc-----cC
Q 043148          232 VVALEVACGRKPVEPRQEPSK--VRLVE-----WVW---DLYGK------GQ---LLEA-----------ADG-----RL  276 (387)
Q Consensus       232 vil~el~tg~~p~~~~~~~~~--~~~~~-----~~~---~~~~~------~~---~~~~-----------~~~-----~~  276 (387)
                      ||++.+++++.||-...+.-.  ..+..     .+.   ...+.      ..   +.+.           ..+     ..
T Consensus       266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~  345 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE  345 (418)
T ss_pred             ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence            999999999999864432211  11000     000   00000      00   0000           000     00


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .....+..+..+++++.+|+..||.+|.|+++.|+|.++.
T Consensus       346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence            0111122344688999999999999999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1.2e-25  Score=198.61  Aligned_cols=174  Identities=33%  Similarity=0.536  Sum_probs=145.7

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCCccceehhhcch-----------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ-GKKEYISEVRIISRLRHRNLVHLIGWCHEQ-----------  137 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----------  137 (387)
                      |...+.||+|++|.||++....++..+++|.+...... ..+.+.+|++.+..++|+|++++++++...           
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            45567899999999999999888899999999776544 678899999999999999999998865432           


Q ss_pred             ---------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          138 ---------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       138 ---------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                     ....+..++.+++.++.+||+   .+++|+||+|.||+++.++.++|+|||.+............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence                           112246788999999999999   89999999999999999999999999999876543211223


Q ss_pred             eeecCCcccCchhh-ccCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 043148          203 VLAGTMGYLAPECV-TTGKASKESDVYSFGVVALEVACGRKPVEP  246 (387)
Q Consensus       203 ~~~g~~~y~aPE~~-~~~~~~~~~Dvws~Gvil~el~tg~~p~~~  246 (387)
                      ...++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            44577889999998 666778899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=3.4e-27  Score=224.28  Aligned_cols=233  Identities=21%  Similarity=0.306  Sum_probs=179.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcch---------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ---------  137 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  137 (387)
                      .++|....++|.|.||.||+++++.++...|+|+++.....+.+-.+.|+-+++.-+|||||.++|-+...         
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            46788889999999999999999999999999999887777777788999999999999999988744322         


Q ss_pred             ----------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          138 ----------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       138 ----------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                      .+..+..+++..++||.|||+   ++=+|||||-.|||+++.|.+|++|||.+..+..... ..
T Consensus        94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-Kr  169 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-KR  169 (829)
T ss_pred             cCCCcccceeeecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhh-hh
Confidence                            123346788999999999999   9999999999999999999999999999876654332 23


Q ss_pred             eeeecCCcccCchhhc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          202 TVLAGTMGYLAPECVT---TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ..+.||+.|||||+..   .+.|...+|||+.|+...|+---+.|..........       .+...    ..+++.- .
T Consensus       170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-------~LmTk----S~~qpp~-l  237 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-------FLMTK----SGFQPPT-L  237 (829)
T ss_pred             hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH-------HHhhc----cCCCCCc-c
Confidence            3467999999999864   567999999999999999997777765432221111       01000    0111110 1


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      +-.....+.+.++++.|+-.+|++||+++.+++|...
T Consensus       238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fv  274 (829)
T KOG0576|consen  238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFV  274 (829)
T ss_pred             cCCccchHHHHHHHHHHhcCCCccCCChhhheeceee
Confidence            1122345568889999999999999999998887653

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=4.1e-26  Score=237.61  Aligned_cols=174  Identities=18%  Similarity=0.224  Sum_probs=118.3

Q ss_pred             CCCCccceehhhcch------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC------------
Q 043148          123 RHRNLVHLIGWCHEQ------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS------------  178 (387)
Q Consensus       123 ~h~niv~l~~~~~~~------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~------------  178 (387)
                      .|.+++.+++++...            ....+..++.||++||.|||+   ++|+||||||+||||+.            
T Consensus        51 ~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvHrDlKP~NiLl~~~~~~k~~d~~~~  127 (793)
T PLN00181         51 DDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVVHNVRPSCFVMSSFNHVSFIESASC  127 (793)
T ss_pred             ccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeeeccCCchhEEEcccCcEEEeecccc
Confidence            455666666654322            122346799999999999999   99999999999999954            


Q ss_pred             -------CCcEEEccccccccccCCC---------------CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHH
Q 043148          179 -------NFNAKLGDFGLARLVDHEL---------------GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE  236 (387)
Q Consensus       179 -------~~~~kl~Dfg~~~~~~~~~---------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~e  236 (387)
                             ++.+|++|||+++......               ........||+.|||||++.+..|+.++|||||||+|||
T Consensus       128 ~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~E  207 (793)
T PLN00181        128 SDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFE  207 (793)
T ss_pred             CcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHH
Confidence                   4456666777665321100               000112357888999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          237 VACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       237 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      |++|..|+.....     .......        ....+..     .........++.+||+.||.+||++.|++++.|+.
T Consensus       208 Ll~~~~~~~~~~~-----~~~~~~~--------~~~~~~~-----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~  269 (793)
T PLN00181        208 LFCPVSSREEKSR-----TMSSLRH--------RVLPPQI-----LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFIN  269 (793)
T ss_pred             HhhCCCchhhHHH-----HHHHHHH--------hhcChhh-----hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhh
Confidence            9998887643211     0000000        0011100     01122345778899999999999999999999875


Q ss_pred             C
Q 043148          317 A  317 (387)
Q Consensus       317 ~  317 (387)
                      .
T Consensus       270 ~  270 (793)
T PLN00181        270 E  270 (793)
T ss_pred             h
Confidence            4

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=2.9e-25  Score=189.39  Aligned_cols=153  Identities=20%  Similarity=0.170  Sum_probs=113.8

Q ss_pred             hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCcccCchhhc
Q 043148          138 RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT  217 (387)
Q Consensus       138 ~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  217 (387)
                      ....+..++.|++.||.|||+   ++      ||+|||++.++.+|+  ||++.......      ..|++.|+|||++.
T Consensus        15 ~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g~~~y~aPE~~~   77 (176)
T smart00750       15 NEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------SRVDPYFMAPEVIQ   77 (176)
T ss_pred             CHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc------CCCcccccChHHhc
Confidence            345678899999999999998   55      999999999999999  99987654421      25789999999999


Q ss_pred             cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHH--HHHHHHHHh
Q 043148          218 TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME--CLMIVGLWC  295 (387)
Q Consensus       218 ~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~l~~~c  295 (387)
                      +..++.++|||||||++|||++|+.||........  ............      .+. ..........  .+.+++..|
T Consensus        78 ~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~------~~~-~~~~~~~~~~~~~~~~~i~~c  148 (176)
T smart00750       78 GQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMPAD------DPR-DRSNLESVSAARSFADFMRVC  148 (176)
T ss_pred             CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhccC------Ccc-ccccHHHHHhhhhHHHHHHHH
Confidence            99999999999999999999999999965432211  111111100000      000 0011222333  589999999


Q ss_pred             cCCCCCCCCCHHHHHHHhccC
Q 043148          296 CHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       296 l~~dp~~RPs~~evl~~l~~~  316 (387)
                      |+.||.+||++.|++++++..
T Consensus       149 l~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      149 ASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HhcccccccCHHHHHHHHHHH
Confidence            999999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=3.7e-22  Score=186.66  Aligned_cols=153  Identities=22%  Similarity=0.273  Sum_probs=116.4

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEECC-CCeEEEEEEecCC-----ChhhHHHHHHHHHHHhcCCCCCccc-eeh---
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLSD-QNTEIAVKRVSRG-----SKQGKKEYISEVRIISRLRHRNLVH-LIG---  132 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~---  132 (387)
                      ......+|...+.||+|+||+||+|++.. +++.+|||++...     .....+.+.+|+++|+.++|+|++. +++   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~   92 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGK   92 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCC
Confidence            34456789999999999999999998875 6778899986532     1223567899999999999999985 333   


Q ss_pred             ------hhcchhhHH-----HHHHHHHHHHHHHHhhhhcccceeeccC-CcceeEeCCCCcEEEccccccccccCCCC--
Q 043148          133 ------WCHEQRQLI-----LHKIALGLASAVLYLHEEWEQCIVHRDI-KSSNVVLDSNFNAKLGDFGLARLVDHELG--  198 (387)
Q Consensus       133 ------~~~~~~~~~-----l~~i~~~i~~~l~~LH~~~~~~iiH~dl-k~~Nill~~~~~~kl~Dfg~~~~~~~~~~--  198 (387)
                            |+....-..     ...++.+++++|.|||+   ++|+|||| ||+|||++.++.+||+|||+++.+.....  
T Consensus        93 ~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~  169 (365)
T PRK09188         93 DGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALY  169 (365)
T ss_pred             cEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchh
Confidence                  222111001     14678899999999999   99999999 99999999999999999999986644211  


Q ss_pred             -----ceeeeeecCCcccCchhhcc
Q 043148          199 -----SQTTVLAGTMGYLAPECVTT  218 (387)
Q Consensus       199 -----~~~~~~~g~~~y~aPE~~~~  218 (387)
                           .......+++.|+|||.+..
T Consensus       170 ~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        170 RIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             hhhhhhhhhhhhccCccCCcccCCh
Confidence                 11124457788999998864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=8.1e-22  Score=184.28  Aligned_cols=231  Identities=23%  Similarity=0.287  Sum_probs=166.4

Q ss_pred             CccccCcccccCceEEEEEEECCCC-eEEEEEEecCCChhhHHHHHHHHHHHhcCCC----CCccceehhhc-chhh---
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQN-TEIAVKRVSRGSKQGKKEYISEVRIISRLRH----RNLVHLIGWCH-EQRQ---  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~~-~~~~---  139 (387)
                      +|.+.+.||+|+||.||++....++ ..+|+|............+..|..++..+.+    +++..+++... ....   
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999987764 6789998766543333377789998888863    46777766552 2211   


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC-----CcEEEccccccc
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN-----FNAKLGDFGLAR  191 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-----~~~kl~Dfg~~~  191 (387)
                                             .....++.|++.+|.+||+   .|++||||||.|+++...     ..+.|.|||+++
T Consensus        99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence                                   1126899999999999999   999999999999999865     358999999998


Q ss_pred             --cccCCCC------ce-eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 043148          192 --LVDHELG------SQ-TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDL  262 (387)
Q Consensus       192 --~~~~~~~------~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  262 (387)
                        .+....+      .. .....||..|+++....+...+.+.|+||++.++.|++.|..||................. 
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~-  254 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR-  254 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh-
Confidence              3222211      11 2345699999999999999999999999999999999999999976554332211111100 


Q ss_pred             hccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          263 YGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                        .    .....     .....+..+.++...+-..+...+|....+...+.
T Consensus       255 --~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~  295 (322)
T KOG1164|consen  255 --K----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLK  295 (322)
T ss_pred             --h----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHH
Confidence              0    00000     11222334555555566689999999999988764

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=7.5e-23  Score=176.08  Aligned_cols=217  Identities=19%  Similarity=0.315  Sum_probs=164.9

Q ss_pred             ccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHHH-------
Q 043148           72 EAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-------  142 (387)
Q Consensus        72 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l-------  142 (387)
                      ...+|.+...|..|+|++.  |..+++|++...  ......+|..|.-.|+-+.||||..++|.|.......+       
T Consensus       194 l~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            3457888999999999995  456777776433  33345689999999999999999999999987654332       


Q ss_pred             --------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEc--cccccccccCCCCce
Q 043148          143 --------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLG--DFGLARLVDHELGSQ  200 (387)
Q Consensus       143 --------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~--Dfg~~~~~~~~~~~~  200 (387)
                                          .+++.++|+|++|||+. ++-|..-.|.+..+++|++.+++|.  |--++-        +
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf--------q  342 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------Q  342 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--------e
Confidence                                68999999999999984 3445556799999999999988774  322221        1


Q ss_pred             eeeeecCCcccCchhhccCCC---CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          201 TTVLAGTMGYLAPECVTTGKA---SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~---~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      .....-.+.||+||.++..+-   -.++|+|||.+++|||.|+..||.+..+.+..-               ++.-..+.
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialeglr  407 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGLR  407 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhcccc
Confidence            111223678999999987653   467999999999999999999998766543221               12223455


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ...++..+..+.+++.-|+..||.+||.++.|+-.|+
T Consensus       408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpile  444 (448)
T KOG0195|consen  408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILE  444 (448)
T ss_pred             ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence            6667777788899999999999999999999987775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=6.9e-22  Score=196.58  Aligned_cols=235  Identities=23%  Similarity=0.217  Sum_probs=167.0

Q ss_pred             ccCcccccCceEEEEEEECCCCeEEEEEEec----CC-Chhh-HHHHHHHHHHHhcCCCCCccceehhhcch--------
Q 043148           72 EAGKLGEGGFGGVYRGLLSDQNTEIAVKRVS----RG-SKQG-KKEYISEVRIISRLRHRNLVHLIGWCHEQ--------  137 (387)
Q Consensus        72 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~----~~-~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  137 (387)
                      ....+|.|++|.|+...........+.|.+.    .. .... ...+..|+.+-..++|||++..+..+.+.        
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4568999999988888776656656666543    11 1111 11255677778889999987655433221        


Q ss_pred             ----hhH------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC---
Q 043148          138 ----RQL------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG---  198 (387)
Q Consensus       138 ----~~~------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~---  198 (387)
                          +..            -...++.|++.|+.|+|+   .||.|||+|++|+++..+|.+||+|||.+..+.....   
T Consensus       402 ~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  402 YCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             cccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence                110            014688999999999999   9999999999999999999999999999986655433   


Q ss_pred             ceeeeeecCCcccCchhhccCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASK-ESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      ......+|+-.|+|||++.+..|.+ ..||||.|+++..|.+|+.||......++..     .........   -...-.
T Consensus       479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~---~~~~~~  550 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQR---NIFEGP  550 (601)
T ss_pred             hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccccc---ccccCh
Confidence            2345667899999999999998864 6899999999999999999998655443321     000000000   000001


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .......+.....++.++++.||.+|-|+++|++..|+..
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~  590 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS  590 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence            1222344555678899999999999999999999999754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=9.4e-21  Score=170.08  Aligned_cols=208  Identities=17%  Similarity=0.206  Sum_probs=134.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCC---C-------Cccceeh--
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRH---R-------NLVHLIG--  132 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~-------niv~l~~--  132 (387)
                      ..+.....||.|+++.||.+++.++|+.+|||.+....   ....+++.+|.-....+.+   |       .++--++  
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            34455778999999999999999999999999985432   2345666666655544322   1       1110000  


Q ss_pred             ----------------------hh---c----chh-----------------hHHHHHHHHHHHHHHHHhhhhcccceee
Q 043148          133 ----------------------WC---H----EQR-----------------QLILHKIALGLASAVLYLHEEWEQCIVH  166 (387)
Q Consensus       133 ----------------------~~---~----~~~-----------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH  166 (387)
                                            ++   .    +-.                 ...-..+..|+++.+++||+   .|++|
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH  168 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH  168 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence                                  00   0    000                 00114566899999999999   99999


Q ss_pred             ccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCcccCchhhccC--------CCCCccchHHHHHHHHHHH
Q 043148          167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG--------KASKESDVYSFGVVALEVA  238 (387)
Q Consensus       167 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~~Dvws~Gvil~el~  238 (387)
                      +||+|+|++++.+|.++|+||+.....+..    ......+..|.+||.....        .++.+.|.|++|+++|.|+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999887654331    1112345779999976432        4788999999999999999


Q ss_pred             hCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCC
Q 043148          239 CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNR  303 (387)
Q Consensus       239 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R  303 (387)
                      +|..||...........                   .. .... +.++.+..|+...|+.||.+|
T Consensus       245 C~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999986543221110                   11 1223 677788999999999999987

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=4.9e-22  Score=185.99  Aligned_cols=145  Identities=28%  Similarity=0.393  Sum_probs=106.4

Q ss_pred             HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC-----CceeeeeecCCcccCchhhc
Q 043148          143 HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL-----GSQTTVLAGTMGYLAPECVT  217 (387)
Q Consensus       143 ~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~  217 (387)
                      ..++.|++.|+.|      ++.+|+|+||.||+...+..+||.|||+........     ....+...||..||+||.+.
T Consensus       362 ~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~  435 (516)
T KOG1033|consen  362 LDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIR  435 (516)
T ss_pred             HHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHh
Confidence            3577888888888      689999999999999999999999999987655433     33456678999999999999


Q ss_pred             cCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhc
Q 043148          218 TGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCC  296 (387)
Q Consensus       218 ~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  296 (387)
                      +..|+.++||||||++|+|++. =..+++..                  +.+.++-+..+++.+..+.+. -..|+.+++
T Consensus       436 g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------------------~t~~d~r~g~ip~~~~~d~p~-e~~ll~~ll  496 (516)
T KOG1033|consen  436 GQQYSEKVDIYALGLILAELLIQFSTQFERI------------------ATLTDIRDGIIPPEFLQDYPE-EYTLLQQLL  496 (516)
T ss_pred             hhhhhhhcchhhHHHHHHHHHHHhccHHHHH------------------HhhhhhhcCCCChHHhhcCcH-HHHHHHHhc
Confidence            9999999999999999999986 22222211                  112223333333333333332 235788999


Q ss_pred             CCCCCCCCCHHHHHHH
Q 043148          297 HPDFTNRPSIRQVINV  312 (387)
Q Consensus       297 ~~dp~~RPs~~evl~~  312 (387)
                      ...|.+||++.++.-+
T Consensus       497 s~~p~~RP~~~~~~~~  512 (516)
T KOG1033|consen  497 SPSPEERPSAIEVALH  512 (516)
T ss_pred             CCCcccCchHHHHhhh
Confidence            9999999966555443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=1.1e-19  Score=160.74  Aligned_cols=180  Identities=23%  Similarity=0.319  Sum_probs=143.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCCccceehhhcchhhHH----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQLI----  141 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~----  141 (387)
                      .-+|.+.++||+|.||+.|.|...-++..||||.-..  .....++..|.+..+.|. .+.|..++-|-.++..-+    
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            3468899999999999999999888899999997543  333467778888888774 677766554443332211    


Q ss_pred             ---------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC-----cEEEccccccccccC
Q 043148          142 ---------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF-----NAKLGDFGLARLVDH  195 (387)
Q Consensus       142 ---------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-----~~kl~Dfg~~~~~~~  195 (387)
                                           +..++.|++.-++|+|+   +.+|.|||||+|+||...+     .+.++|||+++.+..
T Consensus       105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence                                 25789999999999999   9999999999999997543     478999999987765


Q ss_pred             CCC------ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 043148          196 ELG------SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPS  251 (387)
Q Consensus       196 ~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~  251 (387)
                      ...      .......||-+||+-....+..-+...|+-|+|-+++..+.|..||.+.....
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t  243 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT  243 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence            422      22344569999999998889999999999999999999999999998865443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.83  E-value=4.7e-20  Score=184.66  Aligned_cols=223  Identities=20%  Similarity=0.202  Sum_probs=155.1

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHH---HHHHHHHhcCCCCCccceehhhcchhhHHH--
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEY---ISEVRIISRLRHRNLVHLIGWCHEQRQLIL--  142 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~l--  142 (387)
                      ++...+.||++.|=+|.+|++++ |. |+||++-+.. .-....|   +.|++ ...++|||.+++--+....+..++  
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            55667789999999999999876 55 9999986653 3334444   44555 556699999998777655544333  


Q ss_pred             ----------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccc--ccCCCC
Q 043148          143 ----------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL--VDHELG  198 (387)
Q Consensus       143 ----------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~--~~~~~~  198 (387)
                                            ..|+.|++.||.-+|.   .+|+|||||.+||||+.-.-+.|+||..-+.  +..+..
T Consensus       101 qyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  101 QYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence                                  5689999999999999   9999999999999999999999999987642  222222


Q ss_pred             ceeeee----ecCCcccCchhhccC----------C-CCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 043148          199 SQTTVL----AGTMGYLAPECVTTG----------K-ASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDL  262 (387)
Q Consensus       199 ~~~~~~----~g~~~y~aPE~~~~~----------~-~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~  262 (387)
                      ....-+    ..-..|+|||.+...          . .+++-||||+||++.||++ |++||.-.+      +..+-.  
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aYr~--  249 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAYRS--  249 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhHhc--
Confidence            222222    222369999976431          2 5678899999999999988 788885211      111000  


Q ss_pred             hccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 043148          263 YGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL  313 (387)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  313 (387)
                      .+.......+.        .-+...+.+++..|++.||.+|-++++.++.-
T Consensus       250 ~~~~~~e~~Le--------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  250 GNADDPEQLLE--------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             cCccCHHHHHH--------hCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence            00000011110        00112467889999999999999999999874

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.83  E-value=1.5e-19  Score=167.98  Aligned_cols=232  Identities=28%  Similarity=0.391  Sum_probs=169.3

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCChh---hHHHHHHHHHHHhcCCCC-Cccceehhhcchh-------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ---GKKEYISEVRIISRLRHR-NLVHLIGWCHEQR-------  138 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~-------  138 (387)
                      |...+.||.|+||.||++.+.   ..+++|.+......   ....+.+|+.++..+.|+ +|+++.+++....       
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            556778999999999999986   67999998765332   477899999999999988 7999887663321       


Q ss_pred             ---------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC-cEEEccccccccccCC
Q 043148          139 ---------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF-NAKLGDFGLARLVDHE  196 (387)
Q Consensus       139 ---------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~  196 (387)
                                           ......+..+++.++.|+|+   .+++|||+||+||+++..+ .++++|||.+......
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence                                 11225788999999999999   8999999999999999998 7999999999755443


Q ss_pred             CCc-----eeeeeecCCcccCchhhcc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCc-chhhHHHHHHHHhccCc
Q 043148          197 LGS-----QTTVLAGTMGYLAPECVTT---GKASKESDVYSFGVVALEVACGRKPVEPRQEP-SKVRLVEWVWDLYGKGQ  267 (387)
Q Consensus       197 ~~~-----~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~  267 (387)
                      ...     ......++..|++||.+.+   ..+....|+|++|++++++++|..||...... ........+......  
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence            221     2356679999999999987   57889999999999999999999997655431 011111111111100  


Q ss_pred             hhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043148          268 LLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINV  312 (387)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~  312 (387)
                         .................+.+++..|+..+|..|.+..+....
T Consensus       234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence               000000011002223457788899999999999999987765

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=1.3e-19  Score=153.78  Aligned_cols=228  Identities=21%  Similarity=0.267  Sum_probs=161.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCC-CCccceehhhcchhh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRH-RNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~------  139 (387)
                      ...|...++||+|+||.+|.|....+|..||||.-+..  ....++..|.++...|+| ..|..+..|..+...      
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            46789999999999999999999999999999986443  233567788888888864 344444444333221      


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC---cEEEccccccccccCCC
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF---NAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kl~Dfg~~~~~~~~~  197 (387)
                                         ...+-++-|++.-++|+|.   ++++||||||+|+|..-+.   .+.++|||+++.+....
T Consensus        92 LLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen   92 LLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             ccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence                               1225678899999999999   9999999999999997544   57899999998764432


Q ss_pred             ------CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          198 ------GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       198 ------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                            ........||.+|.+-....+...+...|+-|+|.+|..+-.|..||.+..........+.+.+.-....+ +.
T Consensus       169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i-e~  247 (341)
T KOG1163|consen  169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI-EV  247 (341)
T ss_pred             ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH-HH
Confidence                  22234456899999887777777788999999999999999999999987766554444433332211111 11


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQ  308 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~e  308 (387)
                      +        ....+.++...+..|-..--.+-|...-
T Consensus       248 L--------C~G~P~EF~myl~Y~R~L~F~E~Pdy~y  276 (341)
T KOG1163|consen  248 L--------CKGFPAEFAMYLNYCRGLGFEEKPDYMY  276 (341)
T ss_pred             H--------hCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence            1        1122333455566677777777776543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.78  E-value=1.5e-19  Score=157.70  Aligned_cols=154  Identities=13%  Similarity=0.094  Sum_probs=116.1

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHH---------HHHHHHHHHhcCCCCCccceehhhcc
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKK---------EYISEVRIISRLRHRNLVHLIGWCHE  136 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~h~niv~l~~~~~~  136 (387)
                      ..++|...+.||.|+||.||+...  ++..+|||.+.........         .+.+|++.+.++.|++|....+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            357899999999999999999655  3668999999754322222         26789999999999999888776442


Q ss_pred             hhh--------H----------HH-------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          137 QRQ--------L----------IL-------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       137 ~~~--------~----------~l-------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      ...        .          -+       .....+++.+|..+|.   .+++|||++|+||+++.++ ++|+|||...
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~liDfg~~~  182 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LRIIDLSGKR  182 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EEEEECCCcc
Confidence            210        0          01       3456799999999999   9999999999999999988 9999999886


Q ss_pred             cccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHH
Q 043148          192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVA  238 (387)
Q Consensus       192 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~  238 (387)
                      ........             ..++....|..++|+|+||+++.-+.
T Consensus       183 ~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        183 CTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            44321111             11344455778999999999987653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.78  E-value=1.1e-19  Score=181.89  Aligned_cols=209  Identities=23%  Similarity=0.254  Sum_probs=145.4

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHHHHHHH
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIA  146 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l~~i~  146 (387)
                      ..+|+.++.|..|+||.||..+++.+.+.+|+|+= +..     .+++-  ++.....|.+|   |-|...-.. +-..-
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~-----lilRn--ilt~a~npfvv---gDc~tllk~-~g~lP  149 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQN-----LILRN--ILTFAGNPFVV---GDCATLLKN-IGPLP  149 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccc-ccc-----hhhhc--cccccCCccee---chhhhhccc-CCCCc
Confidence            36788899999999999999999988899999542 211     11111  55555667665   323211000 00112


Q ss_pred             HHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC--------------CceeeeeecCCcccC
Q 043148          147 LGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL--------------GSQTTVLAGTMGYLA  212 (387)
Q Consensus       147 ~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--------------~~~~~~~~g~~~y~a  212 (387)
                      .+++.+++|||+   .+|+|||+||+|.+|..-|++|++|||+.+......              .-.....+||+.|.|
T Consensus       150 vdmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyia  226 (1205)
T KOG0606|consen  150 VDMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIA  226 (1205)
T ss_pred             chhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccC
Confidence            234789999999   999999999999999999999999999986432110              001234589999999


Q ss_pred             chhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHH
Q 043148          213 PECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVG  292 (387)
Q Consensus       213 PE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  292 (387)
                      ||++....|+..+|+|++|+++||.+-|+.||.+....+....+-  .    +        .....+-.+....+..+++
T Consensus       227 PeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi--s----d--------~i~wpE~dea~p~Ea~dli  292 (1205)
T KOG0606|consen  227 PEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI--S----D--------DIEWPEEDEALPPEAQDLI  292 (1205)
T ss_pred             hhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh--h----h--------hccccccCcCCCHHHHHHH
Confidence            999999999999999999999999999999998876554322110  0    0        0001111233344466778


Q ss_pred             HHhcCCCCCCCC
Q 043148          293 LWCCHPDFTNRP  304 (387)
Q Consensus       293 ~~cl~~dp~~RP  304 (387)
                      ...|+.+|..|-
T Consensus       293 ~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  293 EQLLRQNPLCRL  304 (1205)
T ss_pred             HHHHHhChHhhc
Confidence            888899999994

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.77  E-value=1.6e-19  Score=172.37  Aligned_cols=209  Identities=25%  Similarity=0.247  Sum_probs=153.9

Q ss_pred             cccccCceEEEEEEE---CCCCeEEEEEEecCCChh--hHHHHHHHHHHHhcCC-CCCccceehhhcchhhHHH------
Q 043148           75 KLGEGGFGGVYRGLL---SDQNTEIAVKRVSRGSKQ--GKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQLIL------  142 (387)
Q Consensus        75 ~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l------  142 (387)
                      .+|+|.||.|++.+-   .+.|..+|+|.+.+....  .......|..++...+ ||.+|++.-.+......++      
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999988642   334677999988765321  2225667888999997 9999999877766544332      


Q ss_pred             -------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          143 -------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       143 -------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                         ......++-+++++|.   .+++|||+|++||+++.+|.+++.|||+++..-...     .
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----~  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----I  152 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh-----h
Confidence                               3456678889999999   999999999999999999999999999998653321     1


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      .+||..|||||++.  .....+|.||||++++||++|..||..    +....               +..  .....+.+
T Consensus       153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~---------------Il~--~~~~~p~~  209 (612)
T KOG0603|consen  153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKR---------------ILK--AELEMPRE  209 (612)
T ss_pred             cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHH---------------Hhh--hccCCchh
Confidence            27899999999988  567899999999999999999999976    11111               110  12234455


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHhc
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSI-----RQVINVLN  314 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~-----~evl~~l~  314 (387)
                      ....+.+++......+|..|--.     .|+.++..
T Consensus       210 l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f  245 (612)
T KOG0603|consen  210 LSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEF  245 (612)
T ss_pred             hhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccch
Confidence            55556667777778888888643     45555543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=9e-19  Score=158.42  Aligned_cols=153  Identities=26%  Similarity=0.297  Sum_probs=104.8

Q ss_pred             HHHHHHHHHHHHHhhhhcccceeeccCCcceeEe--CCCC--cEEEccccccccccC-----CCCceeeeeecCCcccCc
Q 043148          143 HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL--DSNF--NAKLGDFGLARLVDH-----ELGSQTTVLAGTMGYLAP  213 (387)
Q Consensus       143 ~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill--~~~~--~~kl~Dfg~~~~~~~-----~~~~~~~~~~g~~~y~aP  213 (387)
                      .-++.|+++|+.|||.   +++.|||||++|||+  |.++  .+.|+|||.+-....     +..+......|.-.-|||
T Consensus       344 ~~~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAP  420 (598)
T KOG4158|consen  344 RVILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAP  420 (598)
T ss_pred             HHHHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecch
Confidence            4588999999999999   999999999999998  4444  467899998753222     111122223456678999


Q ss_pred             hhhccCC------CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHH
Q 043148          214 ECVTTGK------ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMEC  287 (387)
Q Consensus       214 E~~~~~~------~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (387)
                      |+....+      .-.++|.|+.|.+.||+++...||....... .+.-.     +.+     .-    .+..+..++..
T Consensus       421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~-----Yqe-----~q----LPalp~~vpp~  485 (598)
T KOG4158|consen  421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRT-----YQE-----SQ----LPALPSRVPPV  485 (598)
T ss_pred             hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhh-----hhh-----hh----CCCCcccCChH
Confidence            9886432      1358999999999999999999998633211 10000     111     11    12233445555


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHHh
Q 043148          288 LMIVGLWCCHPDFTNRPSIRQVINVL  313 (387)
Q Consensus       288 l~~l~~~cl~~dp~~RPs~~evl~~l  313 (387)
                      +.+++...++.||.+|++..-..+.|
T Consensus       486 ~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  486 ARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHHHHhcCCccccCCccHHHhHH
Confidence            77888889999999999876555443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=1.2e-17  Score=142.88  Aligned_cols=171  Identities=13%  Similarity=0.013  Sum_probs=122.7

Q ss_pred             ccCcccccCceEEEEEEECCCCeEEEEEEecCCChhh----HHHHHHHHHHHhcCC-CCCccceehhhcc--------hh
Q 043148           72 EAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQG----KKEYISEVRIISRLR-HRNLVHLIGWCHE--------QR  138 (387)
Q Consensus        72 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~--------~~  138 (387)
                      +...|++|+||+||.+..  .+.+++.+.+.......    ...+.+|+++|++|. |+++++++++...        +.
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~   83 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGA   83 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCc
Confidence            456899999999997765  57788888776554321    235789999999995 5778888764210        11


Q ss_pred             hHH------HHHHHHHHHHHHHHhhhhcccceeeccC-CcceeEeCCCCcEEEccccccccccCCCCc----e-------
Q 043148          139 QLI------LHKIALGLASAVLYLHEEWEQCIVHRDI-KSSNVVLDSNFNAKLGDFGLARLVDHELGS----Q-------  200 (387)
Q Consensus       139 ~~~------l~~i~~~i~~~l~~LH~~~~~~iiH~dl-k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~----~-------  200 (387)
                      .+.      -..++.+++.+|.++|+   .||+|||| ||+|||++.++.++|+|||++.........    .       
T Consensus        84 ~L~~~~~~~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~l  160 (218)
T PRK12274         84 AMYQRPPRGDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHL  160 (218)
T ss_pred             cHHhhhhhhhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHH
Confidence            110      13577899999999999   99999999 799999999999999999999854432210    0       


Q ss_pred             -eeeeecCCcccCchhhccC-CCC-CccchHHHHHHHHHHHhCCCCCCCC
Q 043148          201 -TTVLAGTMGYLAPECVTTG-KAS-KESDVYSFGVVALEVACGRKPVEPR  247 (387)
Q Consensus       201 -~~~~~g~~~y~aPE~~~~~-~~~-~~~Dvws~Gvil~el~tg~~p~~~~  247 (387)
                       ......++.|+.|+-..-. ..+ ...+.++-|.-+|.++|++.+.-..
T Consensus       161 lk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        161 LKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence             0112246677788744322 222 5668889999999999999886543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.73  E-value=3e-18  Score=163.49  Aligned_cols=187  Identities=23%  Similarity=0.334  Sum_probs=130.4

Q ss_pred             HhcCCCCCccceehhhcchhh--------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcc
Q 043148          119 ISRLRHRNLVHLIGWCHEQRQ--------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSS  172 (387)
Q Consensus       119 l~~l~h~niv~l~~~~~~~~~--------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~  172 (387)
                      |+.+.|.|+.+|+|.+.++..                          .+...+..+++.||.|||+.  ....|+.|++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence            456789999999987765432                          23367889999999999982  33399999999


Q ss_pred             eeEeCCCCcEEEccccccccccCC-CCceeeeeecCCcccCchhhccCC-------CCCccchHHHHHHHHHHHhCCCCC
Q 043148          173 NVVLDSNFNAKLGDFGLARLVDHE-LGSQTTVLAGTMGYLAPECVTTGK-------ASKESDVYSFGVVALEVACGRKPV  244 (387)
Q Consensus       173 Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~Dvws~Gvil~el~tg~~p~  244 (387)
                      |+++|....+||+|||+....... .........-..-|.|||.+....       .+.++||||||++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999998765321 111111222345699999987631       467799999999999999999999


Q ss_pred             CCCCCcch-hhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          245 EPRQEPSK-VRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       245 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ........ ...+.++..     .-.....|.+...  .+....+..++..||..+|..||++++|-..+.
T Consensus       159 ~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~  222 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLL  222 (484)
T ss_pred             ccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence            86443322 222322222     0011111111111  134446889999999999999999999987765

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.73  E-value=3.5e-18  Score=147.05  Aligned_cols=117  Identities=16%  Similarity=0.170  Sum_probs=86.8

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCCChh--h-------HH-----------------HHHHHHHHHhcCCCCC
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ--G-------KK-----------------EYISEVRIISRLRHRN  126 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~E~~~l~~l~h~n  126 (387)
                      .+.||+|+||.||+|.+. +|+.||||+++.....  .       ..                 ....|++.+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            457999999999999987 7999999999754211  1       11                 2234899999886655


Q ss_pred             ccc-----------eehhhcchh------------hHHHHHHHHHHHHHHHHh-hhhcccceeeccCCcceeEeCCCCcE
Q 043148          127 LVH-----------LIGWCHEQR------------QLILHKIALGLASAVLYL-HEEWEQCIVHRDIKSSNVVLDSNFNA  182 (387)
Q Consensus       127 iv~-----------l~~~~~~~~------------~~~l~~i~~~i~~~l~~L-H~~~~~~iiH~dlk~~Nill~~~~~~  182 (387)
                      +..           +++++....            ...+..++.|++.+|.|+ |+   .+|+||||||+|||++ ++.+
T Consensus        81 v~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          81 IPCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CCcE
Confidence            422           233343211            123467899999999999 57   8999999999999998 4789


Q ss_pred             EEcccccccccc
Q 043148          183 KLGDFGLARLVD  194 (387)
Q Consensus       183 kl~Dfg~~~~~~  194 (387)
                      +|+|||++....
T Consensus       157 ~LiDFG~a~~~~  168 (190)
T cd05147         157 YIIDVSQSVEHD  168 (190)
T ss_pred             EEEEccccccCC
Confidence            999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.70  E-value=3.2e-17  Score=141.41  Aligned_cols=119  Identities=18%  Similarity=0.203  Sum_probs=91.3

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCCChh---------------------h-----HHHHHHHHHHHhcCCCCC
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ---------------------G-----KKEYISEVRIISRLRHRN  126 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~n  126 (387)
                      ...||+|+||.||+|.+. +|+.||||+++.....                     .     ...+..|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            457999999999999987 7999999998764211                     0     112357889999998887


Q ss_pred             ccc-----------eehhhcchh------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEE
Q 043148          127 LVH-----------LIGWCHEQR------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAK  183 (387)
Q Consensus       127 iv~-----------l~~~~~~~~------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  183 (387)
                      +..           +++++....            ......++.+++.++.+||+.  .+|+||||||+|||++ ++.++
T Consensus        81 i~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CCCEE
Confidence            632           344443221            112367899999999999973  7999999999999999 88999


Q ss_pred             EccccccccccC
Q 043148          184 LGDFGLARLVDH  195 (387)
Q Consensus       184 l~Dfg~~~~~~~  195 (387)
                      |+|||++.....
T Consensus       158 liDFG~a~~~~~  169 (190)
T cd05145         158 IIDVSQAVELDH  169 (190)
T ss_pred             EEEcccceecCC
Confidence            999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.68  E-value=1.1e-16  Score=139.17  Aligned_cols=114  Identities=18%  Similarity=0.219  Sum_probs=87.3

Q ss_pred             cccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-----CCCCccceehhhcchh---hH--
Q 043148           71 AEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-----RHRNLVHLIGWCHEQR---QL--  140 (387)
Q Consensus        71 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~--  140 (387)
                      ...+.||+|+||.||.  +..++.. +||++........+.+.+|++++..+     .||||++++|++.+..   ..  
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            4466899999999996  5555555 69988765455567899999999999     5799999998775542   10  


Q ss_pred             ---------------HH--------HHHHHHHHHHH-HHhhhhcccceeeccCCcceeEeCC----CCcEEEcccccc
Q 043148          141 ---------------IL--------HKIALGLASAV-LYLHEEWEQCIVHRDIKSSNVVLDS----NFNAKLGDFGLA  190 (387)
Q Consensus       141 ---------------~l--------~~i~~~i~~~l-~~LH~~~~~~iiH~dlk~~Nill~~----~~~~kl~Dfg~~  190 (387)
                                     ++        ..++.+++.++ +|||+   ++|+||||||+|||++.    ++.++|+||+.+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence                           01        12466777777 99999   99999999999999974    347999995443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=9e-16  Score=156.53  Aligned_cols=176  Identities=19%  Similarity=0.236  Sum_probs=129.4

Q ss_pred             HHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC---CCCcc---------
Q 043148           61 RELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR---HRNLV---------  128 (387)
Q Consensus        61 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv---------  128 (387)
                      .++..-.+.|.+.+.||+|+||+||+|...+ |+.||+|+-+..+...   |.--.+++.+|+   -+-|+         
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence            4555566788899999999999999999887 9999999987765332   111122222222   01111         


Q ss_pred             -------------ceehhhcc---hhhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC-------CCCcEEEc
Q 043148          129 -------------HLIGWCHE---QRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD-------SNFNAKLG  185 (387)
Q Consensus       129 -------------~l~~~~~~---~~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-------~~~~~kl~  185 (387)
                                   .|++++..   -.+.+...+..+++..+++||.   .+|||+||||+|+||.       .+..++|+
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEE
Confidence                         11222221   1233457889999999999999   9999999999999994       24468999


Q ss_pred             cccccccccCC-CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCC
Q 043148          186 DFGLARLVDHE-LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP  243 (387)
Q Consensus       186 Dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p  243 (387)
                      |||.+..+.-- .+.......+|-.+-.+|...++.++.+.|-|.|+.+++-|+.|+.-
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99998755432 23345566788899999999999999999999999999999998753

>smart00090 RIO RIO-like kinase

Probab=99.61  E-value=1.2e-15  Score=135.70  Aligned_cols=122  Identities=19%  Similarity=0.187  Sum_probs=91.1

Q ss_pred             CccccCcccccCceEEEEEE-ECCCCeEEEEEEecCCChh------------------------hHHHHHHHHHHHhcCC
Q 043148           69 NFAEAGKLGEGGFGGVYRGL-LSDQNTEIAVKRVSRGSKQ------------------------GKKEYISEVRIISRLR  123 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  123 (387)
                      .|.+.+.||+|+||.||+|. ...+|+.||||++......                        ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998 6567999999998653210                        1123568999999886


Q ss_pred             CCC--ccceeh---------hhcch------------hhHHHHHHHHHHHHHHHHhhhhcccc-eeeccCCcceeEeCCC
Q 043148          124 HRN--LVHLIG---------WCHEQ------------RQLILHKIALGLASAVLYLHEEWEQC-IVHRDIKSSNVVLDSN  179 (387)
Q Consensus       124 h~n--iv~l~~---------~~~~~------------~~~~l~~i~~~i~~~l~~LH~~~~~~-iiH~dlk~~Nill~~~  179 (387)
                      +..  +.++++         ++...            .......++.+++.++.+||+   .+ ++||||||+||+++ +
T Consensus       109 ~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIli~-~  184 (237)
T smart00090      109 EAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNILVH-D  184 (237)
T ss_pred             hcCCCCCeeeEecCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEEEE-C
Confidence            532  222222         11110            011235789999999999999   88 99999999999999 8


Q ss_pred             CcEEEcccccccccc
Q 043148          180 FNAKLGDFGLARLVD  194 (387)
Q Consensus       180 ~~~kl~Dfg~~~~~~  194 (387)
                      +.++|+|||.+....
T Consensus       185 ~~i~LiDFg~a~~~~  199 (237)
T smart00090      185 GKVVIIDVSQSVELD  199 (237)
T ss_pred             CCEEEEEChhhhccC
Confidence            899999999987543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.60  E-value=5.9e-15  Score=128.23  Aligned_cols=129  Identities=16%  Similarity=0.162  Sum_probs=94.3

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh----------------------hhHHHHHHHHHHHh
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK----------------------QGKKEYISEVRIIS  120 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~  120 (387)
                      +......|...+.||+|+||.||++... +|+.||||++.....                      .....+..|..++.
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            3333334777889999999999999875 589999998754320                      01123567888888


Q ss_pred             cCCCCC--ccceeh---------hhcchhh------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEE
Q 043148          121 RLRHRN--LVHLIG---------WCHEQRQ------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAK  183 (387)
Q Consensus       121 ~l~h~n--iv~l~~---------~~~~~~~------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  183 (387)
                      .+.|++  +...++         ++....-      .....++.+++.++.++|+   .+++||||+|.||++++++.++
T Consensus        89 ~l~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          89 ALYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             HHHHcCCCCCceeecCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCCCcEE
Confidence            887763  333322         2221110      1234688999999999999   9999999999999999999999


Q ss_pred             EccccccccccC
Q 043148          184 LGDFGLARLVDH  195 (387)
Q Consensus       184 l~Dfg~~~~~~~  195 (387)
                      |+|||++.....
T Consensus       166 liDfg~~~~~~~  177 (198)
T cd05144         166 IIDWPQMVSTDH  177 (198)
T ss_pred             EEECCccccCCC
Confidence            999999965543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.55  E-value=1.6e-14  Score=144.12  Aligned_cols=121  Identities=19%  Similarity=0.298  Sum_probs=90.3

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEec-CC-C------hhhHHHHHHHHHHHhcCCCCCccceehhhcch
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVS-RG-S------KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ  137 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~-~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  137 (387)
                      ....|...+.||+|+||.||+|.+...  .+++|+.. +. .      ....+.+.+|++++..++|++++....++.+.
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            344556678999999999999998553  34444322 11 1      11235688999999999999987754443321


Q ss_pred             hhH--------------H---HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccc
Q 043148          138 RQL--------------I---LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL  192 (387)
Q Consensus       138 ~~~--------------~---l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~  192 (387)
                      ...              +   ...++.+++.+|.|||+   .+++||||||+|||+ .++.++|+|||+++.
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            111              1   25688999999999999   999999999999999 678999999999974

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.54  E-value=1.7e-14  Score=126.57  Aligned_cols=113  Identities=23%  Similarity=0.269  Sum_probs=87.4

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCCh--------hhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--------QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      +.||+|++|.||+|.+  .|..+++|.......        .....+.+|++++..+.|+++.....++.+...      
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            4799999999999988  467899997653321        113467889999999998887654433221111      


Q ss_pred             ---------H------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccc
Q 043148          140 ---------L------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL  192 (387)
Q Consensus       140 ---------~------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~  192 (387)
                               .      ....++.+++.+|.+||+   .+++|+|++|.|||++ ++.++|+|||.+..
T Consensus        80 ~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGMEELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence                     0      124888999999999999   9999999999999999 78999999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=1.1e-15  Score=152.35  Aligned_cols=235  Identities=24%  Similarity=0.290  Sum_probs=168.9

Q ss_pred             hCccccCcccccCceEEEEEEECC-CCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCC-CCCccceehhhcchhhHHH-
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSD-QNTEIAVKRVSRGS--KQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQLIL-  142 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l-  142 (387)
                      ..|...+.||+|+|+.|-...... ....+|+|.+....  .........|..+-..+. |+|++++++...+.+..++ 
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            446667779999999998877633 34457777665543  222333445777777776 9999999987655443332 


Q ss_pred             --------------------------HHHHHHHHHHHHHhh-hhcccceeeccCCcceeEeCCCC-cEEEcccccccccc
Q 043148          143 --------------------------HKIALGLASAVLYLH-EEWEQCIVHRDIKSSNVVLDSNF-NAKLGDFGLARLVD  194 (387)
Q Consensus       143 --------------------------~~i~~~i~~~l~~LH-~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~  194 (387)
                                                ...+.|+..++.|+| .   .++.|+|+||+|.+++..+ .++++|||++..+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence                                      568899999999999 6   9999999999999999999 99999999998766


Q ss_pred             C--CCCceeeeeec-CCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          195 H--ELGSQTTVLAG-TMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       195 ~--~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      .  ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... ...|...     .   
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~-----~---  247 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSN-----K---  247 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccc-----c---
Confidence            5  22333445567 9999999998875 4578899999999999999999999765543311 1111100     0   


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                         ................++..+++..+|..|.+.+++-...|...
T Consensus       248 ---~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  248 ---GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ---cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence               00011122233444667788888899999999999988777554

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.52  E-value=3e-14  Score=123.80  Aligned_cols=112  Identities=22%  Similarity=0.304  Sum_probs=84.0

Q ss_pred             cccccCceEEEEEEECCCCeEEEEEEecCCCh--------hhHHHHHHHHHHHhcCCCCCccc--eehhhcc--------
Q 043148           75 KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--------QGKKEYISEVRIISRLRHRNLVH--LIGWCHE--------  136 (387)
Q Consensus        75 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~--l~~~~~~--------  136 (387)
                      .||+|+||.||+|.+  ++..+++|.......        .....+.+|++++..++|+++..  ++....+        
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            389999999999996  467899998643211        12356778999999998776433  2222111        


Q ss_pred             ---hh--hHHHH---HHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccc
Q 043148          137 ---QR--QLILH---KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL  192 (387)
Q Consensus       137 ---~~--~~~l~---~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~  192 (387)
                         ..  .....   .++.+++.+|.+||+   .+++|+|++|.||+++ ++.+++.|||++..
T Consensus        79 ~~g~~l~~~~~~~~~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGNDELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence               10  11111   689999999999999   9999999999999999 88999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.47  E-value=2.7e-13  Score=116.62  Aligned_cols=119  Identities=24%  Similarity=0.302  Sum_probs=82.2

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCCChh--hHHHH----------------------HHHHHHHhcCCCCC--
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ--GKKEY----------------------ISEVRIISRLRHRN--  126 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~h~n--  126 (387)
                      .+.||+|+||.||+|.+. +++.||||++......  ....+                      ..|.+.+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999986 6889999998653211  11111                      24555555553322  


Q ss_pred             ccc---------eehhhcch----------hh-HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcc
Q 043148          127 LVH---------LIGWCHEQ----------RQ-LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD  186 (387)
Q Consensus       127 iv~---------l~~~~~~~----------~~-~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  186 (387)
                      +.+         +++++...          .. .....++.+++.++.++|..  .+++|+||||+||+++ ++.++|+|
T Consensus        81 ~~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~~~~liD  157 (187)
T cd05119          81 VPKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DGKVYIID  157 (187)
T ss_pred             CCceEecCCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CCcEEEEE
Confidence            221         12222220          00 23467889999999999973  7899999999999999 89999999


Q ss_pred             ccccccccC
Q 043148          187 FGLARLVDH  195 (387)
Q Consensus       187 fg~~~~~~~  195 (387)
                      ||.+.....
T Consensus       158 fg~a~~~~~  166 (187)
T cd05119         158 VPQAVEIDH  166 (187)
T ss_pred             CcccccccC
Confidence            999975443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.43  E-value=4.4e-13  Score=110.47  Aligned_cols=116  Identities=20%  Similarity=0.141  Sum_probs=93.0

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCC--CCccceehhhcchh------------
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRH--RNLVHLIGWCHEQR------------  138 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~------------  138 (387)
                      .+.||+|.++.||++...+  ..+++|.......  ...+..|+..+..++|  .++++++++.....            
T Consensus         3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             ceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4679999999999999844  6899999865433  5678899999999976  47777766554311            


Q ss_pred             ------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccc
Q 043148          139 ------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL  192 (387)
Q Consensus       139 ------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~  192 (387)
                            ......++.+++.+|++||.....+++|+|++|+||++++++.+++.|||.+..
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence                  123367889999999999985556899999999999999999999999998863

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.41  E-value=6.5e-13  Score=118.48  Aligned_cols=115  Identities=21%  Similarity=0.296  Sum_probs=86.3

Q ss_pred             cCccc-ccCceEEEEEEECCCCeEEEEEEecCCC-------------hhhHHHHHHHHHHHhcCCCCCc--cceehhhcc
Q 043148           73 AGKLG-EGGFGGVYRGLLSDQNTEIAVKRVSRGS-------------KQGKKEYISEVRIISRLRHRNL--VHLIGWCHE  136 (387)
Q Consensus        73 ~~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~  136 (387)
                      ...|| .||.|+||.+...  +..++||++....             ......+.+|++++..|+|++|  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            34687 8999999998874  6789999885421             1234567889999999998775  444433111


Q ss_pred             ----------------h-hhH--HH------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          137 ----------------Q-RQL--IL------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       137 ----------------~-~~~--~l------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                                      + ..+  ++      ...+.+++.+|.+||+   .||+||||||.|||++.++.++|+|||.+.
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LIDfg~~~  190 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLIDFDRGE  190 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence                            0 111  11      2457789999999999   999999999999999999999999999886


Q ss_pred             c
Q 043148          192 L  192 (387)
Q Consensus       192 ~  192 (387)
                      .
T Consensus       191 ~  191 (239)
T PRK01723        191 L  191 (239)
T ss_pred             c
Confidence            4

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=7e-13  Score=127.09  Aligned_cols=226  Identities=26%  Similarity=0.292  Sum_probs=159.7

Q ss_pred             hCccccCcccc--cCceEEEEEEE--CCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCC-CCCccceehhhcchhhH
Q 043148           68 NNFAEAGKLGE--GGFGGVYRGLL--SDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQL  140 (387)
Q Consensus        68 ~~~~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  140 (387)
                      +.|...+.+|.  |.+|.||.+..  ..++..+|+|.-+..  .......-.+|+.....++ |+|.++....+.+.+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            44566778999  99999999998  788899999984332  2233445557777777774 99999976655544333


Q ss_pred             H-------------------------HHHHHHHHHH----HHHHhhhhcccceeeccCCcceeEeCCC-CcEEEcccccc
Q 043148          141 I-------------------------LHKIALGLAS----AVLYLHEEWEQCIVHRDIKSSNVVLDSN-FNAKLGDFGLA  190 (387)
Q Consensus       141 ~-------------------------l~~i~~~i~~----~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfg~~  190 (387)
                      +                         +...+.+..+    ||.++|+   .+++|-|+||.||++..+ ...+++|||+.
T Consensus       194 fiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  194 FIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCccee
Confidence            2                         3567777777    9999999   999999999999999999 88999999999


Q ss_pred             ccccCCCCce----eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC
Q 043148          191 RLVDHELGSQ----TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG  266 (387)
Q Consensus       191 ~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  266 (387)
                      ..++...-..    .....+...|++||... +-++...|+|++|.+..+..++..+........        |......
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~~~r~~  341 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WSQLRQG  341 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC--------ccccccc
Confidence            8776543111    11125778899999765 556889999999999999988776654331110        0000000


Q ss_pred             chhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 043148          267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL  313 (387)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  313 (387)
                      .        +..++.......+...+..+++.+|..|++.+.+..+-
T Consensus       342 ~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~  380 (524)
T KOG0601|consen  342 Y--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALN  380 (524)
T ss_pred             c--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccc
Confidence            0        11222222233445577888999999999998887654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=4.7e-12  Score=112.70  Aligned_cols=175  Identities=22%  Similarity=0.294  Sum_probs=116.8

Q ss_pred             HHhcCCCCCccceehhhcchhh----------------------------------HHHHHHHHHHHHHHHHhhhhcccc
Q 043148          118 IISRLRHRNLVHLIGWCHEQRQ----------------------------------LILHKIALGLASAVLYLHEEWEQC  163 (387)
Q Consensus       118 ~l~~l~h~niv~l~~~~~~~~~----------------------------------~~l~~i~~~i~~~l~~LH~~~~~~  163 (387)
                      -|-.+-|.|||++..|+.+..+                                  ..+.+++.||..||.|||+ |.++
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence            3445579999999998866432                                  1126899999999999998 6789


Q ss_pred             eeeccCCcceeEeCCCCcEEEcccccccc---ccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhC
Q 043148          164 IVHRDIKSSNVVLDSNFNAKLGDFGLARL---VDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACG  240 (387)
Q Consensus       164 iiH~dlk~~Nill~~~~~~kl~Dfg~~~~---~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg  240 (387)
                      |+|+++..+.|++..++-+|++--.-...   .............+-++|.+||.-.....+.++|||+||+..+||..+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            99999999999999999998854221110   000111223344567899999987777778899999999999999877


Q ss_pred             CCCC-CCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHh
Q 043148          241 RKPV-EPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL  313 (387)
Q Consensus       241 ~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  313 (387)
                      ..-- +....-.....+..+        +.- ....+           -..++..|++.+|..||+|++++.|+
T Consensus       279 Eiq~tnseS~~~~ee~ia~~--------i~~-len~l-----------qr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIANV--------IIG-LENGL-----------QRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             eeccCCCcceeehhhhhhhh--------eee-ccCcc-----------ccCcCcccccCCCCCCcchhhhhcCc
Confidence            6532 211111100000000        000 00001           12356789999999999999999875

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.19  E-value=7.4e-11  Score=114.56  Aligned_cols=150  Identities=17%  Similarity=0.215  Sum_probs=110.8

Q ss_pred             EEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--------------------HHHHH
Q 043148           86 RGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--------------------ILHKI  145 (387)
Q Consensus        86 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--------------------~l~~i  145 (387)
                      .|..+.++.+|.|+..+...........+-++.|+.++||||+++++.+......                    ++...
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~l~~~~v~~G  109 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKELGKEEVCLG  109 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHHhHHHHHHHH
Confidence            4666777889999988776554445667889999999999999999977665532                    23567


Q ss_pred             HHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCcc
Q 043148          146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES  225 (387)
Q Consensus       146 ~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~  225 (387)
                      +.||+.||.|||+.  .+++|++|.-..|++++.|+.||++|.++........ .......-..|..|+.+....  -..
T Consensus       110 l~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~  184 (690)
T KOG1243|consen  110 LFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSI  184 (690)
T ss_pred             HHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cch
Confidence            89999999999973  7899999999999999999999999988754332111 011111112355665443222  346


Q ss_pred             chHHHHHHHHHHHhC
Q 043148          226 DVYSFGVVALEVACG  240 (387)
Q Consensus       226 Dvws~Gvil~el~tg  240 (387)
                      |.|-||++++|++.|
T Consensus       185 D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  185 DSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhHHHHHHHHhCc
Confidence            999999999999998

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.09  E-value=4.5e-10  Score=108.88  Aligned_cols=118  Identities=19%  Similarity=0.249  Sum_probs=77.0

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCChhhH----------------------------------------HHHH
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGK----------------------------------------KEYI  113 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  113 (387)
                      +.||.|++|.||+|++++ |+.||||+.++......                                        -+|.
T Consensus       123 ~plasaSigQVh~A~l~~-G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVD-GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEecC-CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            579999999999999875 89999999866421100                                        0244


Q ss_pred             HHHHHHhcC----C-CCCcc--ce-----------ehhhcchh--hH--------HHHHHHHHHHH-HHHHhhhhcccce
Q 043148          114 SEVRIISRL----R-HRNLV--HL-----------IGWCHEQR--QL--------ILHKIALGLAS-AVLYLHEEWEQCI  164 (387)
Q Consensus       114 ~E~~~l~~l----~-h~niv--~l-----------~~~~~~~~--~~--------~l~~i~~~i~~-~l~~LH~~~~~~i  164 (387)
                      +|++.+.++    + ++++.  ++           ++|+....  ..        ....++..++. .+..+|.   .|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~---~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLR---DGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHh---CCc
Confidence            455554444    2 23321  11           12221110  00        01245555555 4567777   999


Q ss_pred             eeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       165 iH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                      +|+|++|.||+++.++.++++|||++..+..
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999976543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.04  E-value=3.4e-10  Score=95.56  Aligned_cols=115  Identities=18%  Similarity=0.092  Sum_probs=81.3

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCcc-ceehhhcchhh------------
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-HLIGWCHEQRQ------------  139 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~------------  139 (387)
                      .+.|+.|.++.||++...  +..+++|....... ....+..|++++..+.+.+++ +++.+..+...            
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELL   79 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccc
Confidence            346899999999999874  67899998755422 233567899999888654443 34433321111            


Q ss_pred             ---HHHHHHHHHHHHHHHHhhhhc--ccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          140 ---LILHKIALGLASAVLYLHEEW--EQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       140 ---~~l~~i~~~i~~~l~~LH~~~--~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                         ......+.+++.+|+.||...  ..+++|+|++|.||+++ ++.++++||+.+.
T Consensus        80 ~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          80 TEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence               011356789999999999821  12359999999999999 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.01  E-value=3e-10  Score=109.17  Aligned_cols=228  Identities=21%  Similarity=0.226  Sum_probs=149.5

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEEC-CCCeEEEEEEecCCChhhHH--HHHHHHHHHhcC-CCCCccceehhhcchh
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLS-DQNTEIAVKRVSRGSKQGKK--EYISEVRIISRL-RHRNLVHLIGWCHEQR  138 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~l~~~~~~~~  138 (387)
                      ......+|..+..||.|.|+.||..... .++..+++|.+.+.......  .-+.|+-+...+ .|.++++....+...+
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            4445677888899999999999998765 67889999988665332222  223455555555 4777777554333322


Q ss_pred             hHH-------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC-CcEEEcccccccc
Q 043148          139 QLI-------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN-FNAKLGDFGLARL  192 (387)
Q Consensus       139 ~~~-------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfg~~~~  192 (387)
                      ..+                         .+.+..+++.++.++|+   +.++|+|+||+||++..+ +..++.|||.+..
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccc
Confidence            211                         25778889999999998   999999999999999886 7789999998864


Q ss_pred             ccCCCCceeeeeecCCccc--CchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          193 VDHELGSQTTVLAGTMGYL--APECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       193 ~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      +...    .......-++.  +++......+..+.|+++||.-+.|.+++..--.......                  .
T Consensus       417 ~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~------------------~  474 (524)
T KOG0601|consen  417 LAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL------------------T  474 (524)
T ss_pred             ccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce------------------e
Confidence            2221    11112222334  4555556778999999999999999998775432211100                  0


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      +....+ ...+. ....+..+.......++..||.+.++..+..+..
T Consensus       475 i~~~~~-p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  475 IRSGDT-PNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             eecccc-cCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            000000 01111 1133455666677899999999999888776543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.01  E-value=6.1e-10  Score=109.44  Aligned_cols=36  Identities=22%  Similarity=0.289  Sum_probs=31.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG  104 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~  104 (387)
                      ..|+. +.||+|++|.||+|+++++|+.||||+.++.
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~  155 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPD  155 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcc
Confidence            45665 6899999999999999888999999999754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.90  E-value=1.1e-09  Score=111.12  Aligned_cols=232  Identities=19%  Similarity=0.161  Sum_probs=149.3

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCCccceehh--hcchhhH
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQL  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~--~~~~~~~  140 (387)
                      ..+.+.+.+-+-+|.++.++.+.-...|...++|.......   .+.+....+-.++-..+||-++...--  |.....+
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            44566667788899999999987766665555555433221   112223333334433455666644333  2211111


Q ss_pred             H-----------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC-
Q 043148          141 I-----------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE-  196 (387)
Q Consensus       141 ~-----------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~-  196 (387)
                      .                       .+.....+...++|||+   ..+.|+|++|.|+++..++..+++|||.......- 
T Consensus       882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccccc
Confidence            1                       13345567889999998   77999999999999999999999999843221100 


Q ss_pred             ----C---------------------C----ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 043148          197 ----L---------------------G----SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPR  247 (387)
Q Consensus       197 ----~---------------------~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~  247 (387)
                          .                     .    .......+|+.|.+||...+......+|+|++|++++|.++|..||+..
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                0                     0    1122356899999999999999999999999999999999999999876


Q ss_pred             CCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHhc
Q 043148          248 QEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIR---QVINVLN  314 (387)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~---evl~~l~  314 (387)
                      .......       .+....+       -....+........+++...+..+|.+|-.+.   ++-.+..
T Consensus      1039 tpq~~f~-------ni~~~~~-------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~ 1094 (1205)
T KOG0606|consen 1039 TPQQIFE-------NILNRDI-------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPF 1094 (1205)
T ss_pred             chhhhhh-------ccccCCC-------CCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCc
Confidence            5432211       1101000       11223334455566777788899999998776   5555543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.81  E-value=1.3e-09  Score=106.44  Aligned_cols=155  Identities=20%  Similarity=0.284  Sum_probs=104.7

Q ss_pred             HHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce--------eeeeecCCcccCchhhcc
Q 043148          147 LGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ--------TTVLAGTMGYLAPECVTT  218 (387)
Q Consensus       147 ~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~  218 (387)
                      .+++.|+.|+|.  ..++||++|.|++|.++.++..||+.|+++..........        .........|.|||++..
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345589999998  4889999999999999999999999999876443311110        111224567999999999


Q ss_pred             CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcC
Q 043148          219 GKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCH  297 (387)
Q Consensus       219 ~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  297 (387)
                      ...+.++|+||+|+++|-+.. |+.-+............         ....+.-    ......+.+.++.+=+.+.+.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~---------~~~~~~~----~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS---------RNLLNAG----AFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh---------hcccccc----cccccccCcHHHHHHHHHHhc
Confidence            888999999999999999985 55544433322111100         0000010    111223344455666677889


Q ss_pred             CCCCCCCCHHHHHHHhccC
Q 043148          298 PDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       298 ~dp~~RPs~~evl~~l~~~  316 (387)
                      .++.-||++.++.....+.
T Consensus       251 ~~~~~rp~~~~l~~~~ff~  269 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLSIPFFS  269 (700)
T ss_pred             CCcccCcchhhhhcccccC
Confidence            9999999998888776654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.75  E-value=1.8e-07  Score=88.84  Aligned_cols=142  Identities=15%  Similarity=0.256  Sum_probs=110.9

Q ss_pred             ceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcch-----------------------
Q 043148           81 FGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ-----------------------  137 (387)
Q Consensus        81 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----------------------  137 (387)
                      -.+.|++...-+|..|++|++.............-++..+++.|+|+|+|.+++...                       
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            356899999999999999999655444444455678889999999999998876421                       


Q ss_pred             ----------------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          138 ----------------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       138 ----------------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                            .+.+++.++.|+..||.++|+   .|+..+-|.+.+|+++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence                                  123458899999999999999   9999999999999999999999998887765544


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCC
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP  243 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p  243 (387)
                      +..               |-+..   -.+-|.-.||.+++.|.||..-
T Consensus       446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            321               11111   2366889999999999999654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.74  E-value=9e-08  Score=82.01  Aligned_cols=118  Identities=16%  Similarity=0.128  Sum_probs=80.2

Q ss_pred             CcccccCceEEEEEEECC------CCeEEEEEEecCCC------------h---------hh-HHHHH----HHHHHHhc
Q 043148           74 GKLGEGGFGGVYRGLLSD------QNTEIAVKRVSRGS------------K---------QG-KKEYI----SEVRIISR  121 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~------------~---------~~-~~~~~----~E~~~l~~  121 (387)
                      ..||.|--+.||.|...+      .+..+|||+.+...            .         .+ .+.+.    +|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            478999999999998653      25789999986421            0         01 22233    78888887


Q ss_pred             CCC--CCccceeh---------hhcch------------hhHHHHHHHHHHHHHHHHh-hhhcccceeeccCCcceeEeC
Q 043148          122 LRH--RNLVHLIG---------WCHEQ------------RQLILHKIALGLASAVLYL-HEEWEQCIVHRDIKSSNVVLD  177 (387)
Q Consensus       122 l~h--~niv~l~~---------~~~~~------------~~~~l~~i~~~i~~~l~~L-H~~~~~~iiH~dlk~~Nill~  177 (387)
                      +..  -++...++         +..+.            ....+..+..+++.+|..| |.   .+++|+||++.||+++
T Consensus        83 l~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~~NIL~~  159 (197)
T cd05146          83 MQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSEYNMLWH  159 (197)
T ss_pred             HHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEE
Confidence            742  22222222         22211            0112356678999999998 77   8999999999999997


Q ss_pred             CCCcEEEccccccccccC
Q 043148          178 SNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       178 ~~~~~kl~Dfg~~~~~~~  195 (387)
                       ++.+.|+|||.+.....
T Consensus       160 -~~~v~iIDF~qav~~~h  176 (197)
T cd05146         160 -DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             -CCcEEEEECCCceeCCC
Confidence             46899999998865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.49  E-value=6.8e-07  Score=83.06  Aligned_cols=106  Identities=22%  Similarity=0.260  Sum_probs=85.1

Q ss_pred             hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCcccCchhhc
Q 043148          138 RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT  217 (387)
Q Consensus       138 ~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  217 (387)
                      ...++.+.+..++.+.+-||+   .|.+-+|++++|+|+.+++.+.|.|-..-...  ..+......+|...|.+||.-.
T Consensus       115 ~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~--~ng~~~~cpVg~~eftPPElQ~  189 (637)
T COG4248         115 AWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN--ANGTLHLCPVGVSEFTPPELQT  189 (637)
T ss_pred             ccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec--cCCceEecccCccccCCHHHhc
Confidence            345678999999999999999   99999999999999999999999875433322  2234455667889999999754


Q ss_pred             -----cCCCCCccchHHHHHHHHHHHhC-CCCCCCCC
Q 043148          218 -----TGKASKESDVYSFGVVALEVACG-RKPVEPRQ  248 (387)
Q Consensus       218 -----~~~~~~~~Dvws~Gvil~el~tg-~~p~~~~~  248 (387)
                           +..-+...|-|.|||++++++.| +.||.+..
T Consensus       190 ~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         190 LPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             cccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence                 33457789999999999999875 99998643

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.47  E-value=6.1e-07  Score=74.47  Aligned_cols=116  Identities=24%  Similarity=0.336  Sum_probs=80.4

Q ss_pred             ccCcccccCceEEEEEEECCCCeEEEEEEecCC--------ChhhHHHHHHHHHHHhcCC-----CCCccc--------e
Q 043148           72 EAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--------SKQGKKEYISEVRIISRLR-----HRNLVH--------L  130 (387)
Q Consensus        72 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~-----h~niv~--------l  130 (387)
                      ....|-+|+-+.|+++.+  .|+...||.-...        ..-.+++..+|++.|.++.     -|-+..        +
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            456788999999999998  4677777753221        1123466778999888764     333322        1


Q ss_pred             ehhhcc---h------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc---EEEcccccccc
Q 043148          131 IGWCHE---Q------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN---AKLGDFGLARL  192 (387)
Q Consensus       131 ~~~~~~---~------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kl~Dfg~~~~  192 (387)
                      ++|+..   .            ....+..++..|.+.+.-||.   .+|+|+||..+||++..++.   +.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            111111   0            111235788999999999999   99999999999999976653   57999999864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.47  E-value=7.3e-07  Score=74.28  Aligned_cols=112  Identities=21%  Similarity=0.226  Sum_probs=77.2

Q ss_pred             cccccCceEEEEEEECCCCeEEEEEEecCCC--------hhhHHHHHHHHHHHhcCCC--CCccceehhhcchhh-----
Q 043148           75 KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--------KQGKKEYISEVRIISRLRH--RNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        75 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~-----  139 (387)
                      .+++|+-+.+|.+.+.  |..+++|.-.+..        .-......+|++++.+++-  -+...++++..+...     
T Consensus         3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            5789999999999774  4456776532221        1123456689999987742  233333333322211     


Q ss_pred             --------HHH---HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccc
Q 043148          140 --------LIL---HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL  192 (387)
Q Consensus       140 --------~~l---~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~  192 (387)
                              .+.   ..++..+...+.-||.   .+|+|+||.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEARPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhcchHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence                    111   2578888999999999   9999999999999998765 99999999863

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.44  E-value=8.4e-07  Score=78.05  Aligned_cols=117  Identities=19%  Similarity=0.245  Sum_probs=84.6

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHhcCCC--CCccceehhhcchh---h--------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-QGKKEYISEVRIISRLRH--RNLVHLIGWCHEQR---Q--------  139 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~--------  139 (387)
                      +.|+.|..+.||++...+ |..+++|....... .....+..|.++++.+.+  .++.+++.++.+..   .        
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            468999999999998854 67899998755322 235678899999999865  33455555544321   0        


Q ss_pred             ----------------HHHHHHHHHHHHHHHHhhhhc-------------------------------------------
Q 043148          140 ----------------LILHKIALGLASAVLYLHEEW-------------------------------------------  160 (387)
Q Consensus       140 ----------------~~l~~i~~~i~~~l~~LH~~~-------------------------------------------  160 (387)
                                      .....++.+++++|.+||+..                                           
T Consensus        83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (223)
T cd05154          83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR  162 (223)
T ss_pred             CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence                            012356788888888888521                                           


Q ss_pred             ----------ccceeeccCCcceeEeCC--CCcEEEccccccc
Q 043148          161 ----------EQCIVHRDIKSSNVVLDS--NFNAKLGDFGLAR  191 (387)
Q Consensus       161 ----------~~~iiH~dlk~~Nill~~--~~~~kl~Dfg~~~  191 (387)
                                ...++|+|+.+.||+++.  ++.+.|+||+.+.
T Consensus       163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                      245799999999999998  6678999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.22  E-value=1.6e-05  Score=67.91  Aligned_cols=107  Identities=23%  Similarity=0.293  Sum_probs=67.2

Q ss_pred             EEEEEEECCCCeEEEEEEecCCC--------------h------------hhHHHHHHHHHHHhcCCCC--Ccccee---
Q 043148           83 GVYRGLLSDQNTEIAVKRVSRGS--------------K------------QGKKEYISEVRIISRLRHR--NLVHLI---  131 (387)
Q Consensus        83 ~Vy~~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~---  131 (387)
                      .||.|...+ |..+|||..+...              .            .......+|.+.|.++..-  ++.+.+   
T Consensus         1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            389998865 7899999986421              0            0123456799999998654  333333   


Q ss_pred             ------hhhcchh------------hHHHHHHHHHHHHHHHH-hhhhcccceeeccCCcceeEeCCCCcEEEcccccccc
Q 043148          132 ------GWCHEQR------------QLILHKIALGLASAVLY-LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL  192 (387)
Q Consensus       132 ------~~~~~~~------------~~~l~~i~~~i~~~l~~-LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~  192 (387)
                            ++...+.            ......++.+++..+.. +|.   .||+|+||.+.||+++++ .+.|+|||.+..
T Consensus        80 ~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen   80 RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred             CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEecCccee
Confidence                  2333100            11235677777775555 466   999999999999999988 999999998864


Q ss_pred             cc
Q 043148          193 VD  194 (387)
Q Consensus       193 ~~  194 (387)
                      ..
T Consensus       156 ~~  157 (188)
T PF01163_consen  156 SS  157 (188)
T ss_dssp             TT
T ss_pred             cC
Confidence            43

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.18  E-value=1.6e-05  Score=70.40  Aligned_cols=115  Identities=24%  Similarity=0.282  Sum_probs=78.1

Q ss_pred             cccCcccccCceEEEEEEECCCCeEEEEEEecCCCh----------------------hhHHHHHHHHHHHhcCCCC--C
Q 043148           71 AEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK----------------------QGKKEYISEVRIISRLRHR--N  126 (387)
Q Consensus        71 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--n  126 (387)
                      .+.+.||-|--+.||.|...+ |.++|||.-+....                      -.+....+|.+.|.+|...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            456789999999999999875 88999997643210                      1123456899999888533  3


Q ss_pred             ccceehhh--------------------cchhhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcc
Q 043148          127 LVHLIGWC--------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD  186 (387)
Q Consensus       127 iv~l~~~~--------------------~~~~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  186 (387)
                      +.+-+++-                    .++...++..++..+..+    -.   .|++|+|+.+-||+++++|.+.++|
T Consensus       173 VP~P~~~nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~----~~---~GiVHGDlSefNIlV~~dg~~~vID  245 (304)
T COG0478         173 VPKPIAWNRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKA----YR---RGIVHGDLSEFNILVTEDGDIVVID  245 (304)
T ss_pred             CCCccccccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHH----HH---cCccccCCchheEEEecCCCEEEEe
Confidence            43333321                    111222334444444333    34   8999999999999999999999999


Q ss_pred             ccccccc
Q 043148          187 FGLARLV  193 (387)
Q Consensus       187 fg~~~~~  193 (387)
                      |--+...
T Consensus       246 wPQ~v~~  252 (304)
T COG0478         246 WPQAVPI  252 (304)
T ss_pred             CcccccC
Confidence            9766543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=97.97  E-value=3.7e-05  Score=69.56  Aligned_cols=111  Identities=18%  Similarity=0.053  Sum_probs=72.4

Q ss_pred             ccccCceEEEEEEECCCCeEEEEEEecCCChh-----------hHHHHHHHHHHHhcCC-----CCCccceeh-------
Q 043148           76 LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ-----------GKKEYISEVRIISRLR-----HRNLVHLIG-------  132 (387)
Q Consensus        76 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~-----h~niv~l~~-------  132 (387)
                      +-......|++..+  +|+.+.||+.......           ....+.+|.+.+..+.     -|.+|.+..       
T Consensus        30 v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         30 FRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            33333344667766  4788999987543311           1114678888887763     343332211       


Q ss_pred             ---h-----hc---chh------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC-------CCcE
Q 043148          133 ---W-----CH---EQR------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS-------NFNA  182 (387)
Q Consensus       133 ---~-----~~---~~~------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-------~~~~  182 (387)
                         +     ..   .-.            ......++.+++..+.-||.   .||+|+||+++|||++.       +..+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceE
Confidence               0     00   000            01224678889999999999   99999999999999975       4678


Q ss_pred             EEccccccc
Q 043148          183 KLGDFGLAR  191 (387)
Q Consensus       183 kl~Dfg~~~  191 (387)
                      .++||+.++
T Consensus       185 ~LIDl~r~~  193 (268)
T PRK15123        185 SVIDLHRAQ  193 (268)
T ss_pred             EEEECCccc
Confidence            999999885

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.90  E-value=2.5e-06  Score=83.25  Aligned_cols=158  Identities=19%  Similarity=0.188  Sum_probs=112.2

Q ss_pred             ccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCC-ccceehhhcchhhH----------
Q 043148           72 EAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRN-LVHLIGWCHEQRQL----------  140 (387)
Q Consensus        72 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~----------  140 (387)
                      ..+.+++|++++++|.+...+ +....+.+...     ....-++++|.+++||| .++.++-+..+...          
T Consensus       246 ~fh~fvK~altknpKkRptae-klL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAE-KLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG  319 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChh-hheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence            345588999999999887553 33346655432     34456899999999999 55555443332221          


Q ss_pred             -----------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          141 -----------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       141 -----------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                       .+..++..-.+++++||+   -.=+|+|    ||+..+ +..+..||+....+....  ....
T Consensus       320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t  389 (829)
T KOG0576|consen  320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT  389 (829)
T ss_pred             ccccccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence                             124556666788999998   4457888    766655 688999999887665432  3345


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCC
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE  245 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~  245 (387)
                      ..+++.|+|||+.....+..+.|+|++|+--.++.-|-.|-.
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            568999999999999999999999999987667766666643

>PRK09902 hypothetical protein; Provisional

Probab=97.83  E-value=9.8e-05  Score=63.70  Aligned_cols=110  Identities=17%  Similarity=0.210  Sum_probs=78.8

Q ss_pred             ccccCceEEEEEEECCCCeEEEEEEecCC---C---hhhHHHHHHHHHHHhcCCCCC--ccceehhhcc-----------
Q 043148           76 LGEGGFGGVYRGLLSDQNTEIAVKRVSRG---S---KQGKKEYISEVRIISRLRHRN--LVHLIGWCHE-----------  136 (387)
Q Consensus        76 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----------  136 (387)
                      -|+||-+.|++-.+.  |..+=+|+-...   +   .-....|.+|...+..|..-+  +.+.+ ++..           
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            567899999998774  446888876522   1   235678999999998885322  22222 2210           


Q ss_pred             -----h--hhH--H-------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc--EEEccccccc
Q 043148          137 -----Q--RQL--I-------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN--AKLGDFGLAR  191 (387)
Q Consensus       137 -----~--~~~--~-------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~--~kl~Dfg~~~  191 (387)
                           .  ..+  +             -..+..+++..++-||+   .++.|+|+.+.||+++.++.  ++++||.-++
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence                 0  000  1             14788999999999999   99999999999999986666  8999998765

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.76  E-value=7.6e-05  Score=73.38  Aligned_cols=34  Identities=26%  Similarity=0.385  Sum_probs=31.1

Q ss_pred             cceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       162 ~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                      .|++|.|..|.||+++.++++.+.|||+...+..
T Consensus       284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            7899999999999999999999999999876554

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.73  E-value=0.00022  Score=62.59  Aligned_cols=134  Identities=19%  Similarity=0.185  Sum_probs=82.7

Q ss_pred             cCHHHHHHHhhCccccCc---ccccCceEEEEEEECCCCeEEEEEEecCCChh-------------------hHHH----
Q 043148           58 FTYRELSRATNNFAEAGK---LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ-------------------GKKE----  111 (387)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------------------~~~~----  111 (387)
                      .|++.+....++..+...   |++|.-..||+|... ++..+|||++......                   +.++    
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            456666666666655544   556777789999864 4789999999653211                   1111    


Q ss_pred             -HHHHHHHHhcCC--C---------CCccceehhhcchh------------hHHHHHHHHHHHHHHHHhhhhcccceeec
Q 043148          112 -YISEVRIISRLR--H---------RNLVHLIGWCHEQR------------QLILHKIALGLASAVLYLHEEWEQCIVHR  167 (387)
Q Consensus       112 -~~~E~~~l~~l~--h---------~niv~l~~~~~~~~------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~  167 (387)
                       ...|..-|.++.  +         .+-|-++++..+..            ......+..++++.+.-|-.  ..+++|+
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHg  191 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHG  191 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccc
Confidence             124555555542  1         12222233322210            00234556666666666654  2789999


Q ss_pred             cCCcceeEeCCCCcEEEccccccccccC
Q 043148          168 DIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       168 dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                      ||..-|||+. ++.+.|+|||-+....+
T Consensus       192 DLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         192 DLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             cchhhheEEE-CCeEEEEECccccccCC
Confidence            9999999999 88999999998865543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.55  E-value=9.9e-05  Score=64.34  Aligned_cols=48  Identities=27%  Similarity=0.369  Sum_probs=43.4

Q ss_pred             HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC---cEEEcccccccc
Q 043148          142 LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF---NAKLGDFGLARL  192 (387)
Q Consensus       142 l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kl~Dfg~~~~  192 (387)
                      ...++.+++..+.-||.   .|++|+|+++.|||++.+.   .+.++||+.++.
T Consensus       120 ~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  120 RRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            36788999999999999   9999999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.44  E-value=0.00088  Score=70.21  Aligned_cols=176  Identities=19%  Similarity=0.156  Sum_probs=115.3

Q ss_pred             HHHHHHHHHhcCCCCCccceehhhcchhhH-----------------------------HHHHHHHHHHHHHHHhhhhcc
Q 043148          111 EYISEVRIISRLRHRNLVHLIGWCHEQRQL-----------------------------ILHKIALGLASAVLYLHEEWE  161 (387)
Q Consensus       111 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----------------------------~l~~i~~~i~~~l~~LH~~~~  161 (387)
                      ....|.+.+.++.|+|++.+++|-.+....                             .++.+..++.+||.|+|+   
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~---  304 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS---  304 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH---
Confidence            344577778888999999988875432110                             125677889999999999   


Q ss_pred             cceeeccCCcc---eeEeCCCCcEEEc--cccccccccCCCCceeeeeecCCcccCchhhccCCCCC--ccchHHHHHHH
Q 043148          162 QCIVHRDIKSS---NVVLDSNFNAKLG--DFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK--ESDVYSFGVVA  234 (387)
Q Consensus       162 ~~iiH~dlk~~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~Dvws~Gvil  234 (387)
                      ....|.-|..+   +-..+..+...++  ||+............  ....+..|-++|......+..  ..|+|.+|..+
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            55556555555   4455666677776  888887665432222  223345677888776665544  47999999999


Q ss_pred             HHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          235 LEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       235 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ..+..|..+-......                  ..+++.    ...    ..+......|+..++++|++..+++.+..
T Consensus       383 ~~~~~~~~i~~~~~~~------------------~~~l~~----~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f  436 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAVP------------------VSLLDV----LST----SELLDALPKCLDEDSEERLSALELLTHPF  436 (1351)
T ss_pred             hhhhhcCcccccccch------------------hhhhcc----ccc----hhhhhhhhhhcchhhhhccchhhhhhchh
Confidence            9998876653211110                  011110    000    03556778899999999999999999876


Q ss_pred             cCC
Q 043148          315 FEA  317 (387)
Q Consensus       315 ~~~  317 (387)
                      ...
T Consensus       437 ~~~  439 (1351)
T KOG1035|consen  437 LRF  439 (1351)
T ss_pred             ccc
Confidence            443

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.43  E-value=0.0011  Score=55.16  Aligned_cols=113  Identities=21%  Similarity=0.239  Sum_probs=73.5

Q ss_pred             ccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccc-eehhhcc--------hhhHH-
Q 043148           72 EAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVH-LIGWCHE--------QRQLI-  141 (387)
Q Consensus        72 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~--------~~~~~-  141 (387)
                      ..+.|++|.+|.||+|.+.  |..+|+|.-+.  +..+..+..|+++|..+.--++.+ ++.|-.+        +..+. 
T Consensus        26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~  101 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGK  101 (201)
T ss_pred             hhhhhhcccccEEEEeecc--CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhh
Confidence            4568999999999999995  56899997654  334678889999999887555532 3322211        11111 


Q ss_pred             --H---HHHHHHHHHHHHHhhhhcccceeeccCC-cceeEeCCCCcEEEccccccc
Q 043148          142 --L---HKIALGLASAVLYLHEEWEQCIVHRDIK-SSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       142 --l---~~i~~~i~~~l~~LH~~~~~~iiH~dlk-~~Nill~~~~~~kl~Dfg~~~  191 (387)
                        .   .+-...+++.---|-.   .||-|+.|. |...+|-.++.+.|+||..|+
T Consensus       102 ~~~~~~rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112         102 LEIGGDRKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hhhcccHHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchh
Confidence              0   2233444554333333   899999997 444444445599999999886

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.32  E-value=0.0007  Score=59.88  Aligned_cols=111  Identities=21%  Similarity=0.185  Sum_probs=67.6

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-----CCCccce----------ehhhcchh
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-----HRNLVHL----------IGWCHEQR  138 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l----------~~~~~~~~  138 (387)
                      ..||+|..+.||+.    .+..+++|......  ......+|.+++..+.     .|.++.+          ++++....
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            46899999999983    14467888876532  3345678888887764     3333322          12221110


Q ss_pred             ---------hHHHHHHHHHHHHHHHHhhhh----------------------------------------cccceeeccC
Q 043148          139 ---------QLILHKIALGLASAVLYLHEE----------------------------------------WEQCIVHRDI  169 (387)
Q Consensus       139 ---------~~~l~~i~~~i~~~l~~LH~~----------------------------------------~~~~iiH~dl  169 (387)
                               ..-...++..+++.+.-||+.                                        ....++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence                     000112334444444444431                                        1234689999


Q ss_pred             CcceeEeCCCCcEEEccccccc
Q 043148          170 KSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       170 k~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      .|.||++++++ +.++||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999999874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.26  E-value=0.0019  Score=55.33  Aligned_cols=113  Identities=25%  Similarity=0.282  Sum_probs=81.0

Q ss_pred             hCccccCcccccCc-eEEEEEEECCCCeEEEEEEecCC---C--------h----------hhHHHHHHHHHHHhcCC--
Q 043148           68 NNFAEAGKLGEGGF-GGVYRGLLSDQNTEIAVKRVSRG---S--------K----------QGKKEYISEVRIISRLR--  123 (387)
Q Consensus        68 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~---~--------~----------~~~~~~~~E~~~l~~l~--  123 (387)
                      .+++..+.||.|.- |.||+++.  +|..+|+|.+..-   .        .          .-...|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            77888999999999 99999998  5779999994321   0        0          11235778888887774  


Q ss_pred             -CCCc--cceehhhcchh--hHH-H---------------------------HHHHHHHHHHHHHhhhhcccceeeccCC
Q 043148          124 -HRNL--VHLIGWCHEQR--QLI-L---------------------------HKIALGLASAVLYLHEEWEQCIVHRDIK  170 (387)
Q Consensus       124 -h~ni--v~l~~~~~~~~--~~~-l---------------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk  170 (387)
                       +.++  |+++||..-..  +.. +                           ..-+.+|.+-|..+|.   .+|+-+|++
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~k---~gI~~~Dv~  191 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILHK---LGIVPRDVK  191 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHHH---CCeeeccCc
Confidence             5566  99999874321  111 0                           2345566777777777   999999999


Q ss_pred             cceeEeCCCCcEEEcccccc
Q 043148          171 SSNVVLDSNFNAKLGDFGLA  190 (387)
Q Consensus       171 ~~Nill~~~~~~kl~Dfg~~  190 (387)
                      +.|..     .-||+|||.+
T Consensus       192 ~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  192 PRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ccccc-----CCEEEecccC
Confidence            99975     4489999864

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.19  E-value=0.0027  Score=55.16  Aligned_cols=119  Identities=14%  Similarity=0.152  Sum_probs=71.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHH---------HHHHHHhcCCC---CCccc-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI---------SEVRIISRLRH---RNLVH-----  129 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~---------~E~~~l~~l~h---~niv~-----  129 (387)
                      ..+|...+.+-......|.+-..  +|..+.+|..+.......+.|.         +++..+..++.   ..+..     
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            46677777777777666766655  5788999988664332222222         33333333321   11111     


Q ss_pred             -------------eehhhcchhh---H-HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          130 -------------LIGWCHEQRQ---L-ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       130 -------------l~~~~~~~~~---~-~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                                   +++|.+...-   . +-..++..+.+++.-||.   .|+.|+|..|.|++++.++ +++.||+..+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence                         1112211110   0 012355678888999999   9999999999999998654 9999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=96.98  E-value=0.0021  Score=56.63  Aligned_cols=46  Identities=20%  Similarity=0.187  Sum_probs=35.9

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR  123 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  123 (387)
                      +.|+.|..+.||+....+  ..+++|.....  .....+..|..++..+.
T Consensus         3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~   48 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLA   48 (239)
T ss_dssp             EEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHH
T ss_pred             ccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHH
Confidence            468899999999999865  48999987543  45567778888888774

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=96.97  E-value=0.0033  Score=54.18  Aligned_cols=109  Identities=22%  Similarity=0.353  Sum_probs=72.4

Q ss_pred             ccCcccccCceEEEEEEECCCCeEEEEEEecCCC----------------hhhHHHHHHHHHHHhcCC------CCCccc
Q 043148           72 EAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS----------------KQGKKEYISEVRIISRLR------HRNLVH  129 (387)
Q Consensus        72 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~  129 (387)
                      ....||+|+.=.||.=  .+ +....||++....                ....++..+|+.....+.      +.+|.+
T Consensus         5 ~~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3557999999999863  33 5568899886654                223466677777666655      788999


Q ss_pred             eehhhcchhhH--------------------HH------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC---
Q 043148          130 LIGWCHEQRQL--------------------IL------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF---  180 (387)
Q Consensus       130 l~~~~~~~~~~--------------------~l------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---  180 (387)
                      ++|+.++....                    ++      ..+...+-.-..||-+   ..|+.+||+|.||++..+.   
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~---~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLD---HHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHH---cCCeecCCCcccEEEEecCCCc
Confidence            99987553211                    11      2233334444566666   8899999999999996432   


Q ss_pred             -cEEEcc
Q 043148          181 -NAKLGD  186 (387)
Q Consensus       181 -~~kl~D  186 (387)
                       .+.|+|
T Consensus       159 ~~lvlID  165 (199)
T PF10707_consen  159 FRLVLID  165 (199)
T ss_pred             eEEEEEe
Confidence             466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.94  E-value=0.0043  Score=61.18  Aligned_cols=40  Identities=23%  Similarity=0.392  Sum_probs=32.1

Q ss_pred             hhhhcccceeeccCCcceeEeCC----CCcEEEccccccccccC
Q 043148          156 LHEEWEQCIVHRDIKSSNVVLDS----NFNAKLGDFGLARLVDH  195 (387)
Q Consensus       156 LH~~~~~~iiH~dlk~~Nill~~----~~~~kl~Dfg~~~~~~~  195 (387)
                      ++.....|++|+|-.|.||+++.    ++.+.+.|||+......
T Consensus       314 ~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  314 LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            33334478999999999999984    67899999999876554

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.90  E-value=0.016  Score=55.39  Aligned_cols=61  Identities=13%  Similarity=0.121  Sum_probs=40.9

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCC-----C--hhhHHHHHHHHHHHhcCC---CCCccceehh
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-----S--KQGKKEYISEVRIISRLR---HRNLVHLIGW  133 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~  133 (387)
                      .+.||.|.+..||+....++++.+.||.-...     .  .-..+.+..|.+.|..+.   ..++.+++.+
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~  101 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY  101 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence            35799999999999998754468999985321     1  123556777888887752   2345555544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=96.79  E-value=0.0046  Score=55.28  Aligned_cols=30  Identities=20%  Similarity=0.259  Sum_probs=26.5

Q ss_pred             cceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       162 ~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      ..++|+|+.|.|||++++....|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            448999999999999998778899999774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.53  E-value=0.0065  Score=52.00  Aligned_cols=79  Identities=20%  Similarity=0.129  Sum_probs=63.9

Q ss_pred             HHHHHHhcCCC-CCccceehhhcch------h------------------hHHHHHHHHHHHHHHHHhhhhcccceeecc
Q 043148          114 SEVRIISRLRH-RNLVHLIGWCHEQ------R------------------QLILHKIALGLASAVLYLHEEWEQCIVHRD  168 (387)
Q Consensus       114 ~E~~~l~~l~h-~niv~l~~~~~~~------~------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~d  168 (387)
                      .|.-+|+.+.+ +++.+++|+|.+-      .                  .....+++.++++.+.+|++.....+.-+|
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcD   87 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCD   87 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEee
Confidence            57888888865 6999999988531      1                  112268999999999999986656688999


Q ss_pred             CCcceeEeCCCCcEEEcccccccc
Q 043148          169 IKSSNVVLDSNFNAKLGDFGLARL  192 (387)
Q Consensus       169 lk~~Nill~~~~~~kl~Dfg~~~~  192 (387)
                      ++++|+-+++++++|+.|......
T Consensus        88 v~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   88 VSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cchHHeEEeCCCcEEEEechhcch
Confidence            999999999999999999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=96.48  E-value=0.014  Score=51.97  Aligned_cols=30  Identities=20%  Similarity=0.317  Sum_probs=25.5

Q ss_pred             cceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       162 ~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      ..++|+|+.+.||+++.+...-|.||+.+.
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            348999999999999877666799999875

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.33  E-value=0.011  Score=53.17  Aligned_cols=29  Identities=28%  Similarity=0.322  Sum_probs=25.5

Q ss_pred             cceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       162 ~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      ..++|+|+.|.||++++++ +.|.||..+.
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            3589999999999999877 7899999875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.22  E-value=0.014  Score=51.70  Aligned_cols=30  Identities=23%  Similarity=0.397  Sum_probs=26.7

Q ss_pred             cceeeccCCcceeEeCC-CCcEEEccccccc
Q 043148          162 QCIVHRDIKSSNVVLDS-NFNAKLGDFGLAR  191 (387)
Q Consensus       162 ~~iiH~dlk~~Nill~~-~~~~kl~Dfg~~~  191 (387)
                      ..++|+|+.+.|||+++ ++.+.++||..+.
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            56899999999999998 5789999998774

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PLN02876 acyl-CoA dehydrogenase

Probab=96.21  E-value=0.023  Score=60.12  Aligned_cols=63  Identities=13%  Similarity=0.273  Sum_probs=42.9

Q ss_pred             cCcccccCceEEEEEEECCCC--eEEEEEEecCCC-hhhHHHHHHHHHHHhcCC-CCCc--cceehhhc
Q 043148           73 AGKLGEGGFGGVYRGLLSDQN--TEIAVKRVSRGS-KQGKKEYISEVRIISRLR-HRNL--VHLIGWCH  135 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~  135 (387)
                      .+.++.|.+..+|+......+  ..+++|+..... ......+.+|+++|+.+. |.++  .+++.+|.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~  111 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCT  111 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEec
Confidence            456889999999998775432  467777764432 223457889999999985 6654  55555543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.20  E-value=0.019  Score=52.92  Aligned_cols=30  Identities=27%  Similarity=0.381  Sum_probs=26.8

Q ss_pred             cceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       162 ~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      .+++|+|+.|.||++++++.+.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            569999999999999998778899998774

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.12  E-value=0.063  Score=49.80  Aligned_cols=31  Identities=26%  Similarity=0.374  Sum_probs=27.6

Q ss_pred             ccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       161 ~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      ..+++|+|+.+.||+++.++...|.||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            4789999999999999998877899999774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.00  E-value=0.02  Score=52.55  Aligned_cols=128  Identities=14%  Similarity=0.163  Sum_probs=78.0

Q ss_pred             HHHHHHHhhC---ccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh-----h-----------------hHHHHHH
Q 043148           60 YRELSRATNN---FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-----Q-----------------GKKEYIS  114 (387)
Q Consensus        60 ~~~~~~~~~~---~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~-----------------~~~~~~~  114 (387)
                      |--|+...++   +.+.+.||-|.-+-||.+-+.+ |++.++|.-+....     .                 ++-...+
T Consensus        81 yLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~k  159 (465)
T KOG2268|consen   81 YLALKTLSNRGSVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATK  159 (465)
T ss_pred             HHHHHHHHhcchhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHH
Confidence            3444444443   5678899999999999999865 88899886543210     0                 0122346


Q ss_pred             HHHHHhcCC-CC-Cccceehhhcc------------hh---hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC
Q 043148          115 EVRIISRLR-HR-NLVHLIGWCHE------------QR---QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD  177 (387)
Q Consensus       115 E~~~l~~l~-h~-niv~l~~~~~~------------~~---~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~  177 (387)
                      |...|+.|. |- -+.+.++++..            -+   ..-...+...+...+.-|..   .|+||+|..--||+++
T Consensus       160 EfafmkaL~e~gfpVPkpiD~~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~---~GlIHgDFNEFNimv~  236 (465)
T KOG2268|consen  160 EFAFMKALYERGFPVPKPIDHNRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLAN---HGLIHGDFNEFNIMVK  236 (465)
T ss_pred             HHHHHHHHHHcCCCCCCcccccceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHH---cCceecccchheeEEe
Confidence            777777663 21 11222222111            00   00012333334444455555   8999999999999999


Q ss_pred             CCCcEEEccccccc
Q 043148          178 SNFNAKLGDFGLAR  191 (387)
Q Consensus       178 ~~~~~kl~Dfg~~~  191 (387)
                      +++.++++||--..
T Consensus       237 dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMV  250 (465)
T ss_pred             cCCCEEEeechHhh
Confidence            99999999996543

>PRK05231 homoserine kinase; Provisional

Probab=95.92  E-value=0.075  Score=49.53  Aligned_cols=31  Identities=23%  Similarity=0.352  Sum_probs=26.6

Q ss_pred             ccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       161 ~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      ..+++|+|+.+.||+++.+...-|.||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            4689999999999999976666899999874

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.83  E-value=0.028  Score=48.75  Aligned_cols=128  Identities=17%  Similarity=0.201  Sum_probs=76.2

Q ss_pred             EEEEEecCCChh-hHHHHHHHHHHHhcCCC------CC---ccceehhhcchhhHHHHHHHHHHHHHHHHhhhhccccee
Q 043148           96 IAVKRVSRGSKQ-GKKEYISEVRIISRLRH------RN---LVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIV  165 (387)
Q Consensus        96 vavK~~~~~~~~-~~~~~~~E~~~l~~l~h------~n---iv~l~~~~~~~~~~~l~~i~~~i~~~l~~LH~~~~~~ii  165 (387)
                      ..+|++....-. ...-|..+.++++++.-      .|   .=-+++.|........-.+..+ ++.|.-.|+++ .+.+
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~ArmhGilrL~NDn~~~yGvIlE~Cy~~~i~~~N~i~ag-i~~L~~fH~~~-~~~l  165 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMHGILRLKNDNNYKYGVILERCYKIKINFSNFITAG-IKDLMDFHSEN-QHCL  165 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhhheeEeecCCCceeEEEEeeccCcccchhHHHHHh-HHHHHHhhccC-CCee
Confidence            344444332222 34556778888877631      11   1113445555544444444443 46778888643 7899


Q ss_pred             eccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCC
Q 043148          166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGR  241 (387)
Q Consensus       166 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~  241 (387)
                      |+|..|+||+-|..|.+||.|-+..-.       .      +..|.-   ......+.++.+-+|=.-++++....
T Consensus       166 HGD~np~NiM~D~~G~lKlVDP~~Ll~-------~------~V~~vN---~~Y~~lT~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  166 HGDCNPDNIMCDKFGYLKLVDPVCLLE-------N------QVNMVN---IEYESLTQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             cCCCChhheeecCCCCEEecChhhhhh-------h------eeeEEe---eeccccChHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999764321       0      011211   11233467777777777777776543

The function of this family is unknown.

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=95.39  E-value=0.0051  Score=37.34  Aligned_cols=29  Identities=28%  Similarity=0.727  Sum_probs=18.8

Q ss_pred             ceEEehHHHHHHHHHHHHHHHHHHHHhhh
Q 043148            5 TGLIVGLLVGIGALACGLGVIWFMYWRKR   33 (387)
Q Consensus         5 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~   33 (387)
                      .++.+|+++.++++++++++++|++|||+
T Consensus        11 vaIa~~VvVPV~vI~~vl~~~l~~~~rR~   39 (40)
T PF08693_consen   11 VAIAVGVVVPVGVIIIVLGAFLFFWYRRK   39 (40)
T ss_pred             EEEEEEEEechHHHHHHHHHHhheEEecc
Confidence            45557777777777777766666555543

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.08  E-value=0.79  Score=43.84  Aligned_cols=61  Identities=15%  Similarity=0.206  Sum_probs=39.3

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCC-----C-hhhHHHHHHHHHHHhcCC--CC-Cccceehh
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-----S-KQGKKEYISEVRIISRLR--HR-NLVHLIGW  133 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~--h~-niv~l~~~  133 (387)
                      .+.||-|.-..||++.+...+..|+||.-...     + .-..++..-|.+.|+.+.  -| .+.+++.+
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~  103 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF  103 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE
Confidence            45789999999999998543567999975321     1 223456666777777652  23 44455554

>PLN02236 choline kinase

Probab=94.97  E-value=0.083  Score=49.89  Aligned_cols=30  Identities=20%  Similarity=0.367  Sum_probs=26.1

Q ss_pred             cceeeccCCcceeEeCC-CCcEEEccccccc
Q 043148          162 QCIVHRDIKSSNVVLDS-NFNAKLGDFGLAR  191 (387)
Q Consensus       162 ~~iiH~dlk~~Nill~~-~~~~kl~Dfg~~~  191 (387)
                      ..++|+|+++.|||+++ ++.+.++||..+.
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            46899999999999986 4689999998874

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=94.76  E-value=0.26  Score=46.48  Aligned_cols=59  Identities=14%  Similarity=0.111  Sum_probs=37.0

Q ss_pred             cccccCceEEEEEEECCCCeEEEEEEecCC------C-hhhHHHHHHHHHHHhcCC--CC-Cccceehh
Q 043148           75 KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG------S-KQGKKEYISEVRIISRLR--HR-NLVHLIGW  133 (387)
Q Consensus        75 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~--h~-niv~l~~~  133 (387)
                      .||-|....||++...++++.|+||.-...      + .-...+...|.+.|....  -| .+.+++.|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~   70 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF   70 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE
Confidence            589999999999998654468999975321      1 223445556777776552  23 34445443

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK10593 hypothetical protein; Provisional

Probab=93.97  E-value=0.57  Score=43.22  Aligned_cols=58  Identities=10%  Similarity=-0.003  Sum_probs=38.1

Q ss_pred             ccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCC---CCccceehh
Q 043148           72 EAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRH---RNLVHLIGW  133 (387)
Q Consensus        72 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~  133 (387)
                      ..+.||.|..+.||+....+ + .+.+|..+.  ......+..|.+.|+.|.-   -.+.+++++
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~   78 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGV   78 (297)
T ss_pred             eeeecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEE
Confidence            35679999999999987543 3 466776432  1134578889998887742   245555543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=93.93  E-value=0.012  Score=63.88  Aligned_cols=81  Identities=20%  Similarity=0.130  Sum_probs=67.1

Q ss_pred             ceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCC
Q 043148          163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRK  242 (387)
Q Consensus       163 ~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~  242 (387)
                      --+|++||+-|.+|..+..+|++++|+.+...+. ....+...+++.|+.|+....-.++.++|+|..|+-+|+..-|..
T Consensus      1360 T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~ 1438 (2724)
T KOG1826|consen 1360 TNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNA 1438 (2724)
T ss_pred             cchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccH
Confidence            3689999999999999999999999999843332 223344567788999999888889999999999999999988877


Q ss_pred             CC
Q 043148          243 PV  244 (387)
Q Consensus       243 p~  244 (387)
                      +|
T Consensus      1439 ~f 1440 (2724)
T KOG1826|consen 1439 YF 1440 (2724)
T ss_pred             HH
Confidence            76

>PHA03111 Ser/Thr kinase; Provisional

Probab=93.74  E-value=0.071  Score=49.06  Aligned_cols=36  Identities=19%  Similarity=0.249  Sum_probs=25.9

Q ss_pred             HHHHHHHHHHHHHHh-hhhcccceeeccCCcceeEeC
Q 043148          142 LHKIALGLASAVLYL-HEEWEQCIVHRDIKSSNVVLD  177 (387)
Q Consensus       142 l~~i~~~i~~~l~~L-H~~~~~~iiH~dlk~~Nill~  177 (387)
                      ++-++.||+-..-.+ .-.+....+|-||||+|||+-
T Consensus       281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF  317 (444)
T PHA03111        281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF  317 (444)
T ss_pred             HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence            366788887655344 223346799999999999994

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=93.45  E-value=0.1  Score=47.75  Aligned_cols=45  Identities=20%  Similarity=0.228  Sum_probs=31.5

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL  122 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l  122 (387)
                      .+.++.|....+|+..  .++..+-||.-.   ......|..|.+-|+.|
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L   66 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKAL   66 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHH
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHH
Confidence            4568889999999877  457789999875   33345677888888777

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=93.37  E-value=0.14  Score=47.25  Aligned_cols=31  Identities=26%  Similarity=0.333  Sum_probs=27.6

Q ss_pred             ccceeeccCCcceeEeCCC----CcEEEccccccc
Q 043148          161 EQCIVHRDIKSSNVVLDSN----FNAKLGDFGLAR  191 (387)
Q Consensus       161 ~~~iiH~dlk~~Nill~~~----~~~kl~Dfg~~~  191 (387)
                      ...++|+|+.+.||+++++    +.+.++||..+.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            4679999999999999985    889999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []

Probab=93.14  E-value=0.079  Score=31.64  Aligned_cols=7  Identities=43%  Similarity=0.952  Sum_probs=2.5

Q ss_pred             ehHHHHH
Q 043148            9 VGLLVGI   15 (387)
Q Consensus         9 ~~~~~~~   15 (387)
                      +|+++|+
T Consensus        10 v~V~vg~   16 (38)
T PF02439_consen   10 VAVVVGM   16 (38)
T ss_pred             HHHHHHH
Confidence            3333333

This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=93.05  E-value=0.082  Score=41.31  Aligned_cols=30  Identities=27%  Similarity=0.376  Sum_probs=14.0

Q ss_pred             eEEehHHHHHHHHHHHH-HHHHHHHHhhhcC
Q 043148            6 GLIVGLLVGIGALACGL-GVIWFMYWRKRVG   35 (387)
Q Consensus         6 ~~i~~~~~~~~~~~~~~-~~~~~~~~~~~~~   35 (387)
                      +.|++|++|+++.++++ ++++|+++|++++
T Consensus        64 ~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk   94 (122)
T PF01102_consen   64 PAIIGIIFGVMAGVIGIILLISYCIRRLRKK   94 (122)
T ss_dssp             TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred             cceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence            34566666655544443 3344444444443

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=92.86  E-value=0.53  Score=44.17  Aligned_cols=29  Identities=24%  Similarity=0.356  Sum_probs=25.1

Q ss_pred             ceeeccCCcceeEeCC-CCcEEEccccccc
Q 043148          163 CIVHRDIKSSNVVLDS-NFNAKLGDFGLAR  191 (387)
Q Consensus       163 ~iiH~dlk~~Nill~~-~~~~kl~Dfg~~~  191 (387)
                      -++|+|+.+.|||+++ ++.++++||..+.
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            3699999999999974 5789999999874

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=92.72  E-value=0.12  Score=47.82  Aligned_cols=52  Identities=21%  Similarity=0.335  Sum_probs=33.4

Q ss_pred             HHHHHHHHHHHHHhhh-hcccceeeccCCcceeEeCCC------------------CcEEEcccccccccc
Q 043148          143 HKIALGLASAVLYLHE-EWEQCIVHRDIKSSNVVLDSN------------------FNAKLGDFGLARLVD  194 (387)
Q Consensus       143 ~~i~~~i~~~l~~LH~-~~~~~iiH~dlk~~Nill~~~------------------~~~kl~Dfg~~~~~~  194 (387)
                      +-++.|+|-..--+-+ .+....+|-||||+|||+-+.                  -.++|.||.+++..+
T Consensus       278 kfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~  348 (434)
T PF05445_consen  278 KFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN  348 (434)
T ss_pred             HHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence            5677777543321322 234679999999999999322                  236777888776543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=92.60  E-value=0.053  Score=52.79  Aligned_cols=81  Identities=20%  Similarity=0.180  Sum_probs=46.4

Q ss_pred             CccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC-chhhhhcccCCccccHHHHHHHHHHHHHhcCCCCC
Q 043148          223 KESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG-QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFT  301 (387)
Q Consensus       223 ~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~  301 (387)
                      +|+|||++|.++.|+..|...+......+...   .+....... ........   ..+..++....+++...|+-..|.
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~---~i~k~~~~d~~~~~~a~e---~~~~~~~d~~~~~~~~~c~~~~~~  183 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAELTESEYLE---ILLKYYTDDQELLSTAME---HLIQLLADKKRLPLLKKCLWLEPI  183 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHH---HHHHhccCchhHHHHHHH---HHHHHhhhHhHHHHhccCCccccc
Confidence            59999999999999998887654333222211   111111111 11000000   023344556677888899999999


Q ss_pred             CCCCHHHH
Q 043148          302 NRPSIRQV  309 (387)
Q Consensus       302 ~RPs~~ev  309 (387)
                      .||...+.
T Consensus       184 ir~l~~~~  191 (725)
T KOG1093|consen  184 IRPLPMEL  191 (725)
T ss_pred             cccchhHH
Confidence            88855443

>PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region

Probab=92.12  E-value=0.038  Score=44.45  Aligned_cols=15  Identities=27%  Similarity=0.782  Sum_probs=9.8

Q ss_pred             eEEehHHHHHHHHHH
Q 043148            6 GLIVGLLVGIGALAC   20 (387)
Q Consensus         6 ~~i~~~~~~~~~~~~   20 (387)
                      .+|||+++|+++.++
T Consensus        49 nIVIGvVVGVGg~il   63 (154)
T PF04478_consen   49 NIVIGVVVGVGGPIL   63 (154)
T ss_pred             cEEEEEEecccHHHH
Confidence            577888887655433

The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway [].

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=91.68  E-value=0.28  Score=42.66  Aligned_cols=30  Identities=27%  Similarity=0.463  Sum_probs=21.8

Q ss_pred             cceeeccCCcceeEe-CCCCcEEEccccccc
Q 043148          162 QCIVHRDIKSSNVVL-DSNFNAKLGDFGLAR  191 (387)
Q Consensus       162 ~~iiH~dlk~~Nill-~~~~~~kl~Dfg~~~  191 (387)
                      ..++|+||.+.|||+ +.++.++++||..+.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            568999999999999 889999999999874

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK10271 thiK thiamine kinase; Provisional

Probab=91.64  E-value=0.13  Score=43.66  Aligned_cols=29  Identities=24%  Similarity=0.307  Sum_probs=25.6

Q ss_pred             cceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       162 ~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      ...+|+|+.|.|+++++++ ++++||+.+.
T Consensus        77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eeeecCCCCCccEEEECCC-EEEEeCCccc
Confidence            4569999999999998877 8999999885

>PLN02756 S-methyl-5-thioribose kinase

Probab=91.59  E-value=0.66  Score=44.57  Aligned_cols=61  Identities=13%  Similarity=0.146  Sum_probs=38.7

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCC----Ch---hhHHHHHHHHHHHhcCC---CCCccceehhhc
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG----SK---QGKKEYISEVRIISRLR---HRNLVHLIGWCH  135 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  135 (387)
                      .+.||-|....||+....  +..++||+-...    +.   -...+-..|.+.|..+.   ..++.+++.+|.
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de  107 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR  107 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC
Confidence            457899999999998763  456999986421    11   12344445566666553   246666777665

>KOG4258 consensus Insulin/growth factor receptor (contains protein kinase domain) [Signal transduction mechanisms]

Probab=91.47  E-value=0.054  Score=55.04  Aligned_cols=31  Identities=29%  Similarity=0.512  Sum_probs=24.0

Q ss_pred             cCHHHHHHHhhCccccCcccccCceEEEEEEE
Q 043148           58 FTYRELSRATNNFAEAGKLGEGGFGGVYRGLL   89 (387)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~   89 (387)
                      +-.+|++...+ ....+.||+|+||.||.|.-
T Consensus       985 yv~deWe~~r~-it~~relg~gsfg~Vy~g~~ 1015 (1025)
T KOG4258|consen  985 YVPDEWEVSRE-ITLGRELGQGSFGMVYEGNA 1015 (1025)
T ss_pred             CChhHHHHHHH-HhhhhhhccCccceEEEecC
Confidence            44566666555 67788999999999999964

>PF12877 DUF3827: Domain of unknown function (DUF3827); InterPro: IPR024606 The function of the proteins in this entry is not currently known, but one of the human proteins (Q9HCM3 from SWISSPROT) has been implicated in pilocytic astrocytomas [, , ]

Probab=91.28  E-value=0.25  Score=49.00  Aligned_cols=33  Identities=21%  Similarity=0.296  Sum_probs=26.1

Q ss_pred             CCcceEEehHHHHHHHHHHHHHHHHHHHHhhhc
Q 043148            2 KNKTGLIVGLLVGIGALACGLGVIWFMYWRKRV   34 (387)
Q Consensus         2 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~   34 (387)
                      .+..|||+|+++.+++++++++++.|+++|+.+
T Consensus       266 ~~NlWII~gVlvPv~vV~~Iiiil~~~LCRk~K  298 (684)
T PF12877_consen  266 PNNLWIIAGVLVPVLVVLLIIIILYWKLCRKNK  298 (684)
T ss_pred             CCCeEEEehHhHHHHHHHHHHHHHHHHHhcccc
Confidence            467899999999888888887777777766554

In the majority of cases of pilocytic astrocytomas a tandem duplication produces an in-frame fusion of the gene encoding this protein and the BRAF oncogene. The resulting fusion protein has constitutive BRAF kinase activity and is capable of transforming cells.

>PRK06148 hypothetical protein; Provisional

Probab=90.91  E-value=0.59  Score=50.73  Aligned_cols=31  Identities=29%  Similarity=0.437  Sum_probs=26.3

Q ss_pred             ccceeeccCCcceeEeCCCC--cEE-Eccccccc
Q 043148          161 EQCIVHRDIKSSNVVLDSNF--NAK-LGDFGLAR  191 (387)
Q Consensus       161 ~~~iiH~dlk~~Nill~~~~--~~k-l~Dfg~~~  191 (387)
                      ..++||+|+.+.|||++.+.  .+. |+|||-+.
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            46799999999999999875  555 99999774

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=90.71  E-value=0.6  Score=43.65  Aligned_cols=28  Identities=32%  Similarity=0.551  Sum_probs=25.3

Q ss_pred             eeeccCCcceeEeCCCCc-EEEccccccc
Q 043148          164 IVHRDIKSSNVVLDSNFN-AKLGDFGLAR  191 (387)
Q Consensus       164 iiH~dlk~~Nill~~~~~-~kl~Dfg~~~  191 (387)
                      +||+|+.|.||+++.+.. ..+.||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999999885 8899999764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=90.71  E-value=0.45  Score=44.01  Aligned_cols=29  Identities=21%  Similarity=0.328  Sum_probs=25.5

Q ss_pred             cceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       162 ~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      .+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            68999999999999988 678899998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	387
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-37
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-35
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-30
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-29
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-26
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-26
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-25
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-16
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-07
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-06
3soa_A	444	Full-Length Human Camkii Length = 444		2e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-05
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-05
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-05
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-05
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-04
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 96/306 (31%), Positives = 161/306 (52%), Gaps = 34/306 (11%)
Query: 41  IDIALEDEFEKGTGP-KRFTYRELSRATNNXXXXXXXXXXXXXXVYRGLLSDQNTEIAVK 99
            D+  E++ E   G  KRF+ REL  A++N              VY+G L+D  T +AVK
Sbjct: 10  FDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVK 68
Query: 100 RVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHEQRQLIL---------------- 142
           R+     QG + ++ +EV +IS   HRNL+ L G+C    + +L                
Sbjct: 69  RLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 128
Query: 143 -------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL 189
                         +IALG A  + YLH+  +  I+HRD+K++N++LD  F A +GDFGL
Sbjct: 129 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 188
Query: 190 ARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQ- 248
           A+L+D++       + GT+G++APE ++TGK+S+++DV+ +GV+ LE+  G++  +  + 
Sbjct: 189 AKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 248
Query: 249 -EPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIR 307
                V L++WV  L  + +L    D  L   + + ++E L+ V L C       RP + 
Sbjct: 249 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 308
Query: 308 QVINVL 313
           +V+ +L
Sbjct: 309 EVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 95/306 (31%), Positives = 160/306 (52%), Gaps = 34/306 (11%)
Query: 41  IDIALEDEFEKGTGP-KRFTYRELSRATNNXXXXXXXXXXXXXXVYRGLLSDQNTEIAVK 99
            D+  E++ E   G  KRF+ REL  A++N              VY+G L+D    +AVK
Sbjct: 2   FDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXL-VAVK 60
Query: 100 RVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHEQRQLIL---------------- 142
           R+     QG + ++ +EV +IS   HRNL+ L G+C    + +L                
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 143 -------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL 189
                         +IALG A  + YLH+  +  I+HRD+K++N++LD  F A +GDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 190 ARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQ- 248
           A+L+D++       + G +G++APE ++TGK+S+++DV+ +GV+ LE+  G++  +  + 
Sbjct: 181 AKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 249 -EPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIR 307
                V L++WV  L  + +L    D  L   + + ++E L+ V L C       RP + 
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 308 QVINVL 313
           +V+ +L
Sbjct: 301 EVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 93/302 (30%), Positives = 143/302 (47%), Gaps = 36/302 (11%)
Query: 40  AIDIALEDEFEKGTGPKRFTYRELSRATNNXXXXXXXXXXXXXXVYRGLLSDQNTEIAVK 99
           +I+ AL   +       R    +L  ATNN              VY+G+L D   ++A+K
Sbjct: 11  SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALK 69
Query: 100 RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL----------------- 142
           R +  S QG +E+ +E+  +S  RH +LV LIG+C E+ ++IL                 
Sbjct: 70  RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
Query: 143 ------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
                        +I +G A  + YLH    + I+HRD+KS N++LD NF  K+ DFG++
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGIS 186
Query: 191 RLVDHELGSQ--TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQ 248
           +    ELG      V+ GT+GY+ PE    G+ +++SDVYSFGVV  EV C R  +    
Sbjct: 187 K-KGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 249 EPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQ 308
               V L EW  + +  GQL +  D  L+ +     +       + C      +RPS+  
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 309 VI 310
           V+
Sbjct: 306 VL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 142/301 (47%), Gaps = 34/301 (11%)
Query: 40  AIDIALEDEFEKGTGPKRFTYRELSRATNNXXXXXXXXXXXXXXVYRGLLSDQNTEIAVK 99
           +I+ AL   +       R    +L  ATNN              VY+G+L D   ++A+K
Sbjct: 11  SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALK 69
Query: 100 RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL----------------- 142
           R +  S QG +E+ +E+  +S  RH +LV LIG+C E+ ++IL                 
Sbjct: 70  RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
Query: 143 ------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
                        +I +G A  + YLH    + I+HRD+KS N++LD NF  K+ DFG++
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGIS 186
Query: 191 RL-VDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
           +   + +      V+ GT+GY+ PE    G+ +++SDVYSFGVV  EV C R  +     
Sbjct: 187 KKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 250 PSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQV 309
              V L EW  + +  GQL +  D  L+ +     +       + C      +RPS+  V
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
Query: 310 I 310
           +
Sbjct: 307 L 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 145/297 (48%), Gaps = 51/297 (17%)
Query: 58  FTYRELSRATNNXXXXXXXXXXXXX------XVYRGLLSDQNTEIAVKR----VSRGSKQ 107
           F++ EL   TNN                    VY+G ++  NT +AVK+    V   +++
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 72
Query: 108 GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL------------------------- 142
            K+++  E++++++ +H NLV L+G+  +   L L                         
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 143 H---KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS 199
           H   KIA G A+ + +LHE      +HRDIKS+N++LD  F AK+ DFGLAR    E  +
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA--SEKFA 187
Query: 200 QTTV---LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
           QT +   + GT  Y+APE +  G+ + +SD+YSFGVV LE+  G   V+  +EP ++ L 
Sbjct: 188 QTVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLD 245
Query: 257 EWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
                   +  + +  D +++ + D   +E +  V   C H     RP I++V  +L
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 145/297 (48%), Gaps = 51/297 (17%)
Query: 58  FTYRELSRATNNXXXXXXXXXXXXX------XVYRGLLSDQNTEIAVKR----VSRGSKQ 107
           F++ EL   TNN                    VY+G ++  NT +AVK+    V   +++
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 72
Query: 108 GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL------------------------- 142
            K+++  E++++++ +H NLV L+G+  +   L L                         
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 143 H---KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS 199
           H   KIA G A+ + +LHE      +HRDIKS+N++LD  F AK+ DFGLAR    E  +
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA--SEKFA 187
Query: 200 QTTV---LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
           QT +   + GT  Y+APE +  G+ + +SD+YSFGVV LE+  G   V+  +EP ++ L 
Sbjct: 188 QTVMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLD 245
Query: 257 EWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
                   +  + +  D +++ + D   +E +  V   C H     RP I++V  +L
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 144/297 (48%), Gaps = 51/297 (17%)
Query: 58  FTYRELSRATNNXXXXXXXXXXXXX------XVYRGLLSDQNTEIAVKR----VSRGSKQ 107
           F++ EL   TNN                    VY+G ++  NT +AVK+    V   +++
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 66
Query: 108 GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL------------------------- 142
            K+++  E++++++ +H NLV L+G+  +   L L                         
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 143 H---KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS 199
           H   KIA G A+ + +LHE      +HRDIKS+N++LD  F AK+ DFGLAR    E  +
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA--SEKFA 181
Query: 200 QTTV---LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
           Q  +   + GT  Y+APE +  G+ + +SD+YSFGVV LE+  G   V+  +EP ++ L 
Sbjct: 182 QXVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLD 239
Query: 257 EWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
                   +  + +  D +++ + D   +E +  V   C H     RP I++V  +L
Sbjct: 240 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 139/295 (47%), Gaps = 47/295 (15%)
Query: 58  FTYRELSRATNNXXXXXXXXXXXXX------XVYRGLLSDQNTEIAVKR----VSRGSKQ 107
           F++ EL   TNN                    VY+G ++  NT +AVK+    V   +++
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 63
Query: 108 GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL------------------------- 142
            K+++  E+++ ++ +H NLV L+G+  +   L L                         
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 143 H---KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELG 198
           H   KIA G A+ + +LHE      +HRDIKS+N++LD  F AK+ DFGLAR  +     
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW 258
              + + GT  Y APE +  G+ + +SD+YSFGVV LE+  G   V+  +EP ++ L   
Sbjct: 181 VXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIK 238
Query: 259 VWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
                 +  + +  D + + + D   +E    V   C H     RP I++V  +L
Sbjct: 239 EEIEDEEKTIEDYIDKKXN-DADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 114/253 (45%), Gaps = 53/253 (20%)
Query: 94  TEIAVKRVSRGSKQGKK--EYISEVRIISRLRHRNLVHLIGWCHEQRQL----------- 140
           +++AVK +       ++  E++ EV I+ RLRH N+V  +G   +   L           
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 141 ---ILHK--------------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAK 183
              +LHK              +A  +A  + YLH      IVHR++KS N+++D  +  K
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVK 179
Query: 184 LGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           + DFGL+RL      S  +  AGT  ++APE +    ++++SDVYSFGV+  E+A  ++P
Sbjct: 180 VCDFGLSRLKASTFLSSKSA-AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
Query: 244 VEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME---CLMIVGLWCCHPDF 300
                           W      Q++ A   +  +    R +      +I G W   P  
Sbjct: 239 ----------------WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEP-- 280
Query: 301 TNRPSIRQVINVL 313
             RPS   ++++L
Sbjct: 281 WKRPSFATIMDLL 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 55/254 (21%)
Query: 94  TEIAVKRVSRGSKQGKK--EYISEVRIISRLRHRNLVHLIGWCHEQRQL----------- 140
           +++AVK +       ++  E++ EV I+ RLRH N+V  +G   +   L           
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 141 ---ILHK--------------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAK 183
              +LHK              +A  +A  + YLH      IVHRD+KS N+++D  +  K
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVK 179
Query: 184 LGDFGLARL-VDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRK 242
           + DFGL+RL     L S+    AGT  ++APE +    ++++SDVYSFGV+  E+A  ++
Sbjct: 180 VCDFGLSRLKASXFLXSKXA--AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 243 PVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME---CLMIVGLWCCHPD 299
           P                W      Q++ A   +  +    R +      +I G W   P 
Sbjct: 238 P----------------WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEP- 280
Query: 300 FTNRPSIRQVINVL 313
              RPS   ++++L
Sbjct: 281 -WKRPSFATIMDLL 293

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 118/256 (46%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 27  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 85
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 86  TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 142
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 143 GENHLVKVADFGLSRLMT---GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 199
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  +PS+      V++L  K   +E  +G   K ++       ++   
Sbjct: 200 LWEIATYGMSPYPGIDPSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 246
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 247 WQWNP--SDRPSFAEI 260

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 118/256 (46%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 27  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 85
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 86  IEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 142
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 143 GENHLVKVADFGLSRLMT---GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 199
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  +PS+      V++L  K   +E  +G   K ++       ++   
Sbjct: 200 LWEIATYGMSPYPGIDPSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 246
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 247 WQWNP--SDRPSFAEI 260

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 118/256 (46%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 27  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 85
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 86  TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 142
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 143 GENHLVKVADFGLSRLMT---GDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 199
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  +PS+      V++L  K   +E  +G   K ++       ++   
Sbjct: 200 LWEIATYGMSPYPGIDPSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 246
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 247 WQWNP--SDRPSFAEI 260

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 112/241 (46%), Gaps = 50/241 (20%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG--------- 132
           VY+G     + ++AVK   V+  + Q  + + +EV ++ + RH N++  +G         
Sbjct: 28  VYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAI 84
Query: 133 ---WCH---------------EQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNV 174
              WC                E ++LI   IA   A  + YLH    + I+HRD+KS+N+
Sbjct: 85  VTQWCEGSSLYHHLHASETKFEMKKLI--DIARQTARGMDYLHA---KSIIHRDLKSNNI 139
Query: 175 VLDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECV---TTGKASKESDVYSF 230
            L  +   K+GDFGLA +     GS Q   L+G++ ++APE +    +   S +SDVY+F
Sbjct: 140 FLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF 199
Query: 231 GVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL---LEAADGRLSKEFDERQMEC 287
           G+V  E+  G+ P       S +   + + ++ G+G L   L        K       EC
Sbjct: 200 GIVLYELMTGQLPY------SNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 253
Query: 288 L 288
           L
Sbjct: 254 L 254

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 117/257 (45%), Gaps = 57/257 (22%)
Query: 92  QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC---------------- 134
           ++  +A+K +  G +++ +++++SE  I+ +  H N++ L G                  
Sbjct: 76  RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENG 135
Query: 135 --------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKL 184
                   H+ +  I+  + +  G+ + + YL +      VHRD+ + NV++DSN   K+
Sbjct: 136 SLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKV 192
Query: 185 GDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV-ACGR 241
            DFGL+R+++ +  +  T   G +   + APE +     S  SDV+SFGVV  EV A G 
Sbjct: 193 SDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252
Query: 242 KPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMEC---LMIVGLWCCH 297
           +P                W++  +  +    +G RL        M C   L  + L C H
Sbjct: 253 RP---------------YWNMTNRDVISSVEEGYRLPAP-----MGCPHALHQLMLDCWH 292
Query: 298 PDFTNRPSIRQVINVLN 314
            D   RP   Q+++VL+
Sbjct: 293 KDRAQRPRFSQIVSVLD 309

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 117/257 (45%), Gaps = 57/257 (22%)
Query: 92  QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC---------------- 134
           ++  +A+K +  G +++ +++++SE  I+ +  H N++ L G                  
Sbjct: 76  RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENG 135
Query: 135 --------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKL 184
                   H+ +  I+  + +  G+ + + YL +      VHRD+ + NV++DSN   K+
Sbjct: 136 SLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKV 192
Query: 185 GDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV-ACGR 241
            DFGL+R+++ +  +  T   G +   + APE +     S  SDV+SFGVV  EV A G 
Sbjct: 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252
Query: 242 KPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMEC---LMIVGLWCCH 297
           +P                W++  +  +    +G RL        M C   L  + L C H
Sbjct: 253 RP---------------YWNMTNRDVISSVEEGYRLPAP-----MGCPHALHQLMLDCWH 292
Query: 298 PDFTNRPSIRQVINVLN 314
            D   RP   Q+++VL+
Sbjct: 293 KDRAQRPRFSQIVSVLD 309

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 111/241 (46%), Gaps = 50/241 (20%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG--------- 132
           VY+G     + ++AVK   V+  + Q  + + +EV ++ + RH N++  +G         
Sbjct: 40  VYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAI 96
Query: 133 ---WCH---------------EQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNV 174
              WC                E ++LI   IA   A  + YLH    + I+HRD+KS+N+
Sbjct: 97  VTQWCEGSSLYHHLHASETKFEMKKLI--DIARQTARGMDYLHA---KSIIHRDLKSNNI 151
Query: 175 VLDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECV---TTGKASKESDVYSF 230
            L  +   K+GDFGLA       GS Q   L+G++ ++APE +    +   S +SDVY+F
Sbjct: 152 FLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF 211
Query: 231 GVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL---LEAADGRLSKEFDERQMEC 287
           G+V  E+  G+ P       S +   + + ++ G+G L   L        K       EC
Sbjct: 212 GIVLYELMTGQLPY------SNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265
Query: 288 L 288
           L
Sbjct: 266 L 266

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL 121
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L SN   K+ DFG +    H   S+ T L GT+ 
Sbjct: 122 ANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRTTLCGTLD 175
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G  P E
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 111/241 (46%), Gaps = 50/241 (20%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG--------- 132
           VY+G     + ++AVK   V+  + Q  + + +EV ++ + RH N++  +G         
Sbjct: 40  VYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAI 96
Query: 133 ---WCH---------------EQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNV 174
              WC                E ++LI   IA   A  + YLH    + I+HRD+KS+N+
Sbjct: 97  VTQWCEGSSLYHHLHASETKFEMKKLI--DIARQTARGMDYLHA---KSIIHRDLKSNNI 151
Query: 175 VLDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECV---TTGKASKESDVYSF 230
            L  +   K+GDFGLA       GS Q   L+G++ ++APE +    +   S +SDVY+F
Sbjct: 152 FLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF 211
Query: 231 GVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL---LEAADGRLSKEFDERQMEC 287
           G+V  E+  G+ P       S +   + + ++ G+G L   L        K       EC
Sbjct: 212 GIVLYELMTGQLPY------SNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265
Query: 288 L 288
           L
Sbjct: 266 L 266

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 30  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 88
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 89  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 145
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 146 GENHLVKVADFGLSRLMT---GDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 202
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 203 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 249
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 250 WQWNP--SDRPSFAEI 263

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 30  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 88
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 89  IEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 145
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 146 GENHLVKVADFGLSRLMT---GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 202
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 203 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 249
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 250 WQWNP--SDRPSFAEI 263

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 31  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 89
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 90  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 146
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 147 GENHLVKVADFGLSRLMT---GDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 203
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 204 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 250
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 251 WQWNP--SDRPSFAEI 264

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 29  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 88  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 144
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 145 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 202 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 248
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 249 WQWNP--SDRPSFAEI 262

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 34  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 93  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 149
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 150 GENHLVKVADFGLSRLMT---GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 206
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 207 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 253
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 254 WQWNP--SDRPSFAEI 267

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 29  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 88  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 144
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 145 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 202 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 248
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 249 WQWNP--SDRPSFAEI 262

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 42  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 100
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 101 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 157
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 158 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 214
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 215 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 261
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 262 WQWNP--SDRPSFAEI 275

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 34  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 93  IEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 149
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 150 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 206
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 207 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 253
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 254 WQWNP--SDRPSFAEI 267

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 34  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 93  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 149
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 150 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 206
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 207 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 253
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 254 WQWNP--SDRPSFAEI 267

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 28/200 (14%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI- 141
           VYR  +  +  ++A+K + +G+ K   +E + E +I+ +L +  +V LIG C  +  ++ 
Sbjct: 30  VYR--MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 87
Query: 142 --------LHKIALG------LASAVLYLHEEW-------EQCIVHRDIKSSNVVLDSNF 180
                   LHK  +G      +++    LH+         E+  VHRD+ + NV+L +  
Sbjct: 88  MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH 147
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAG--TMGYLAPECVTTGKASKESDVYSFGVVALE-V 237
            AK+ DFGL++ +  +    T   AG   + + APEC+   K S  SDV+S+GV   E +
Sbjct: 148 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 207
Query: 238 ACGRKPVEPRQEPSKVRLVE 257
           + G+KP +  + P  +  +E
Sbjct: 208 SYGQKPYKKMKGPEVMAFIE 227

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 31  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 89
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 90  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 146
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 147 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 203
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 204 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 250
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 251 WQWNP--SDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 31  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 89
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 90  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 146
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 147 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 203
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 204 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 250
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 251 WQWNP--SDRPSFAEI 264

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 75/156 (48%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L+GT+ 
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLD 172
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 143
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 144 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLD 197
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 33  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 92  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 148
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 149 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 205
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 206 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 252
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 253 WQWNP--SDRPSFAEI 266

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 29  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 88  TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 144
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 145 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 202 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 248
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 249 WQWNP--SDRPSFAEI 262

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 95/191 (49%), Gaps = 37/191 (19%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG--------- 132
           VY+G     + ++AVK   V+  + Q  + + +EV ++ + RH N++  +G         
Sbjct: 24  VYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAI 80
Query: 133 ---WC-----HEQRQLI--------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
              WC     +    +I        L  IA   A  + YLH    + I+HRD+KS+N+ L
Sbjct: 81  VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFL 137
Query: 177 DSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTT---GKASKESDVYSFGV 232
             +   K+GDFGLA +     GS Q   L+G++ ++APE +        S +SDVY+FG+
Sbjct: 138 HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGI 197
Query: 233 VALEVACGRKP 243
           V  E+  G+ P
Sbjct: 198 VLYELMTGQLP 208

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 134
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 135 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLD 188
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 189 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 29  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 88  IEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 144
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 145 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 202 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 248
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 249 WQWNP--SDRPSFAEI 262

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 29  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 88  IEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 144
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 145 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 202 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 248
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 249 WQWNP--SDRPSFAEI 262

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 34  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 93  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 149
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 150 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 206
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 207 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 253
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 254 WQWNP--SDRPSFAEI 267

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 95/191 (49%), Gaps = 37/191 (19%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG--------- 132
           VY+G     + ++AVK   V+  + Q  + + +EV ++ + RH N++  +G         
Sbjct: 24  VYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAI 80
Query: 133 ---WC-----HEQRQLI--------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
              WC     +    +I        L  IA   A  + YLH    + I+HRD+KS+N+ L
Sbjct: 81  VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFL 137
Query: 177 DSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTT---GKASKESDVYSFGV 232
             +   K+GDFGLA +     GS Q   L+G++ ++APE +        S +SDVY+FG+
Sbjct: 138 HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGI 197
Query: 233 VALEVACGRKP 243
           V  E+  G+ P
Sbjct: 198 VLYELMTGQLP 208

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 39/192 (20%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG--------- 132
           VY+G     + ++AVK   V+  + Q  + + +EV ++ + RH N++  +G         
Sbjct: 26  VYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAI 82
Query: 133 ---WCHEQRQLILH--------------KIALGLASAVLYLHEEWEQCIVHRDIKSSNVV 175
              WC E   L  H               IA   A  + YLH    + I+HRD+KS+N+ 
Sbjct: 83  VTQWC-EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 138
Query: 176 LDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECV---TTGKASKESDVYSFG 231
           L  +   K+GDFGLA +     GS Q   L+G++ ++APE +        S +SDVY+FG
Sbjct: 139 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 198
Query: 232 VVALEVACGRKP 243
           +V  E+  G+ P
Sbjct: 199 IVLYELMTGQLP 210

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 29  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 88  TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 144
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 145 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 202 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 248
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 249 WQWNP--SDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 34  VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 92
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 93  TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 149
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 150 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 206
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 207 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 253
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 254 WQWNP--SDRPSFAEI 267

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 39/192 (20%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG--------- 132
           VY+G     + ++AVK   V+  + Q  + + +EV ++ + RH N++  +G         
Sbjct: 29  VYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAI 85
Query: 133 ---WCHEQRQLILH--------------KIALGLASAVLYLHEEWEQCIVHRDIKSSNVV 175
              WC E   L  H               IA   A  + YLH    + I+HRD+KS+N+ 
Sbjct: 86  VTQWC-EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 141
Query: 176 LDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECV---TTGKASKESDVYSFG 231
           L  +   K+GDFGLA +     GS Q   L+G++ ++APE +        S +SDVY+FG
Sbjct: 142 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 201
Query: 232 VVALEVACGRKP 243
           +V  E+  G+ P
Sbjct: 202 IVLYELMTGQLP 213

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 39/192 (20%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG--------- 132
           VY+G     + ++AVK   V+  + Q  + + +EV ++ + RH N++  +G         
Sbjct: 29  VYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAI 85
Query: 133 ---WCHEQRQLILH--------------KIALGLASAVLYLHEEWEQCIVHRDIKSSNVV 175
              WC E   L  H               IA   A  + YLH    + I+HRD+KS+N+ 
Sbjct: 86  VTQWC-EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 141
Query: 176 LDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECV---TTGKASKESDVYSFG 231
           L  +   K+GDFGLA +     GS Q   L+G++ ++APE +        S +SDVY+FG
Sbjct: 142 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 201
Query: 232 VVALEVACGRKP 243
           +V  E+  G+ P
Sbjct: 202 IVLYELMTGQLP 213

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLD 174
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLD 171
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 57  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 116
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 117 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLD 170
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 171 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 118/258 (45%), Gaps = 51/258 (19%)
Query: 88  LLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           L S +   +A+K +  G +++ +++++ E  I+ +  H N++ L G              
Sbjct: 68  LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 127
Query: 135 ------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                       H+ +  ++  + +  G+AS + YL +      VHRD+ + N++++SN 
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNL 184
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV- 237
             K+ DFGLAR+++ +  +  T   G +   + +PE +   K +  SDV+S+G+V  EV 
Sbjct: 185 VCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMECLMIVGLWCC 296
           + G +P                W++  +  +    +G RL    D      L  + L C 
Sbjct: 245 SYGERP---------------YWEMSNQDVIKAVDEGYRLPPPMD--CPAALYQLMLDCW 287
Query: 297 HPDFTNRPSIRQVINVLN 314
             D  NRP   Q++++L+
Sbjct: 288 QKDRNNRPKFEQIVSILD 305

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 39/192 (20%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG--------- 132
           VY+G     + ++AVK   V+  + Q  + + +EV ++ + RH N++  +G         
Sbjct: 51  VYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAI 107
Query: 133 ---WCHEQRQLILH--------------KIALGLASAVLYLHEEWEQCIVHRDIKSSNVV 175
              WC E   L  H               IA   A  + YLH    + I+HRD+KS+N+ 
Sbjct: 108 VTQWC-EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 163
Query: 176 LDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECV---TTGKASKESDVYSFG 231
           L  +   K+GDFGLA +     GS Q   L+G++ ++APE +        S +SDVY+FG
Sbjct: 164 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 223
Query: 232 VVALEVACGRKP 243
           +V  E+  G+ P
Sbjct: 224 IVLYELMTGQLP 235

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLD 174
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLD 176
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 121
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 122 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLD 175
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 55  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 114
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 115 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLD 168
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 169 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLD 176
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 177 YLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 39/192 (20%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG--------- 132
           VY+G     + ++AVK   V+  + Q  + + +EV ++ + RH N++  +G         
Sbjct: 52  VYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAI 108
Query: 133 ---WCHEQRQLILH--------------KIALGLASAVLYLHEEWEQCIVHRDIKSSNVV 175
              WC E   L  H               IA   A  + YLH    + I+HRD+KS+N+ 
Sbjct: 109 VTQWC-EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 164
Query: 176 LDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECV---TTGKASKESDVYSFG 231
           L  +   K+GDFGLA +     GS Q   L+G++ ++APE +        S +SDVY+FG
Sbjct: 165 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 224
Query: 232 VVALEVACGRKP 243
           +V  E+  G+ P
Sbjct: 225 IVLYELMTGQLP 236

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 114/256 (44%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 48  VYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIV 106
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HRD+ + N ++
Sbjct: 107 TEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLV 163
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +     S +SDV++FGV+
Sbjct: 164 GENHVVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVL 220
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V+DL  KG  +E  +G   K ++       ++   
Sbjct: 221 LWEIATYGMSPYPGIDLSQ------VYDLLEKGYRMEQPEGCPPKVYE-------LMRAC 267
Query: 294 WCCHPDFTNRPSIRQV 309
           W   P   +RPS  + 
Sbjct: 268 WKWSP--ADRPSFAET 281

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTXLCGTLD 171
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 118/258 (45%), Gaps = 51/258 (19%)
Query: 88  LLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           L S +   +A+K +  G +++ +++++ E  I+ +  H N++ L G              
Sbjct: 68  LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 127
Query: 135 ------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                       H+ +  ++  + +  G+AS + YL +      VHRD+ + N++++SN 
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGFVHRDLAARNILINSNL 184
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV- 237
             K+ DFGL+R+++ +  +  T   G +   + +PE +   K +  SDV+S+G+V  EV 
Sbjct: 185 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMECLMIVGLWCC 296
           + G +P                W++  +  +    +G RL    D      L  + L C 
Sbjct: 245 SYGERP---------------YWEMSNQDVIKAVDEGYRLPPPMD--CPAALYQLMLDCW 287
Query: 297 HPDFTNRPSIRQVINVLN 314
             D  NRP   Q++++L+
Sbjct: 288 QKDRNNRPKFEQIVSILD 305

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 118/258 (45%), Gaps = 51/258 (19%)
Query: 88  LLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           L S +   +A+K +  G +++ +++++ E  I+ +  H N++ L G              
Sbjct: 66  LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 125
Query: 135 ------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                       H+ +  ++  + +  G+AS + YL +      VHRD+ + N++++SN 
Sbjct: 126 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNL 182
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV- 237
             K+ DFGL+R+++ +  +  T   G +   + +PE +   K +  SDV+S+G+V  EV 
Sbjct: 183 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 242
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMECLMIVGLWCC 296
           + G +P                W++  +  +    +G RL    D      L  + L C 
Sbjct: 243 SYGERP---------------YWEMSNQDVIKAVDEGYRLPPPMD--CPAALYQLMLDCW 285
Query: 297 HPDFTNRPSIRQVINVLN 314
             D  NRP   Q++++L+
Sbjct: 286 QKDRNNRPKFEQIVSILD 303

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 118/258 (45%), Gaps = 51/258 (19%)
Query: 88  LLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           L S +   +A+K +  G +++ +++++ E  I+ +  H N++ L G              
Sbjct: 68  LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 127
Query: 135 ------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                       H+ +  ++  + +  G+AS + YL +      VHRD+ + N++++SN 
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNL 184
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV- 237
             K+ DFGL+R+++ +  +  T   G +   + +PE +   K +  SDV+S+G+V  EV 
Sbjct: 185 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMECLMIVGLWCC 296
           + G +P                W++  +  +    +G RL    D      L  + L C 
Sbjct: 245 SYGERP---------------YWEMSNQDVIKAVDEGYRLPPPMD--CPAALYQLMLDCW 287
Query: 297 HPDFTNRPSIRQVINVLN 314
             D  NRP   Q++++L+
Sbjct: 288 QKDRNNRPKFEQIVSILD 305

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 118/258 (45%), Gaps = 51/258 (19%)
Query: 88  LLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           L S +   +A+K +  G +++ +++++ E  I+ +  H N++ L G              
Sbjct: 68  LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 127
Query: 135 ------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                       H+ +  ++  + +  G+AS + YL +      VHRD+ + N++++SN 
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNL 184
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV- 237
             K+ DFGL+R+++ +  +  T   G +   + +PE +   K +  SDV+S+G+V  EV 
Sbjct: 185 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMECLMIVGLWCC 296
           + G +P                W++  +  +    +G RL    D      L  + L C 
Sbjct: 245 SYGERP---------------YWEMSNQDVIKAVDEGYRLPPPMD--CPAALYQLMLDCW 287
Query: 297 HPDFTNRPSIRQVINVLN 314
             D  NRP   Q++++L+
Sbjct: 288 QKDRNNRPKFEQIVSILD 305

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 118/258 (45%), Gaps = 51/258 (19%)
Query: 88  LLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           L S +   +A+K +  G +++ +++++ E  I+ +  H N++ L G              
Sbjct: 68  LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 127
Query: 135 ------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                       H+ +  ++  + +  G+AS + YL +      VHRD+ + N++++SN 
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNL 184
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV- 237
             K+ DFGL+R+++ +  +  T   G +   + +PE +   K +  SDV+S+G+V  EV 
Sbjct: 185 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMECLMIVGLWCC 296
           + G +P                W++  +  +    +G RL    D      L  + L C 
Sbjct: 245 SYGERP---------------YWEMSNQDVIKAVDEGYRLPPPMD--CPAALYQLMLDCW 287
Query: 297 HPDFTNRPSIRQVINVLN 314
             D  NRP   Q++++L+
Sbjct: 288 QKDRNNRPKFEQIVSILD 305

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTELCGTLD 171
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 118/258 (45%), Gaps = 51/258 (19%)
Query: 88  LLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           L S +   +A+K +  G +++ +++++ E  I+ +  H N++ L G              
Sbjct: 68  LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEX 127
Query: 135 ------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                       H+ +  ++  + +  G+AS + YL +      VHRD+ + N++++SN 
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNL 184
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV- 237
             K+ DFGL+R+++ +  +  T   G +   + +PE +   K +  SDV+S+G+V  EV 
Sbjct: 185 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMECLMIVGLWCC 296
           + G +P                W++  +  +    +G RL    D      L  + L C 
Sbjct: 245 SYGERP---------------YWEMSNQDVIKAVDEGYRLPPPMD--CPAALYQLMLDCW 287
Query: 297 HPDFTNRPSIRQVINVLN 314
             D  NRP   Q++++L+
Sbjct: 288 QKDRNNRPKFEQIVSILD 305

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 73/156 (46%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL 121
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L SN   K+ DFG +    H   S+   L GT+ 
Sbjct: 122 ANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRDTLCGTLD 175
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G  P E
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 117/251 (46%), Gaps = 53/251 (21%)
Query: 96  IAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC-------------------- 134
           +A+K +  G + + +++++SE  I+ +  H N++HL G                      
Sbjct: 60  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 119
Query: 135 ----HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
               ++ R  ++  + +  G+ S + YL +      VHRD+ + N++++SN   K+ DFG
Sbjct: 120 FLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFG 176
Query: 189 LARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVE 245
           ++R+++ +  +  T   G +   + APE +   K +  SDV+S+G+V  EV + G +P  
Sbjct: 177 MSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-- 234
Query: 246 PRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFD-ERQMECLMIVGLWCCHPDFTNR 303
                         WD+  +  +    +G RL    D    +  LM   L C   + ++R
Sbjct: 235 -------------YWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLM---LDCWQKERSDR 278
Query: 304 PSIRQVINVLN 314
           P   Q++N+L+
Sbjct: 279 PKFGQIVNMLD 289

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 118/258 (45%), Gaps = 51/258 (19%)
Query: 88  LLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           L S +   +A+K +  G +++ +++++ E  I+ +  H N++ L G              
Sbjct: 68  LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEX 127
Query: 135 ------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                       H+ +  ++  + +  G+AS + YL +      VHRD+ + N++++SN 
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGAVHRDLAARNILINSNL 184
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV- 237
             K+ DFGL+R+++ +  +  T   G +   + +PE +   K +  SDV+S+G+V  EV 
Sbjct: 185 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMECLMIVGLWCC 296
           + G +P                W++  +  +    +G RL    D      L  + L C 
Sbjct: 245 SYGERP---------------YWEMSNQDVIKAVDEGYRLPPPMD--CPAALYQLMLDCW 287
Query: 297 HPDFTNRPSIRQVINVLN 314
             D  NRP   Q++++L+
Sbjct: 288 QKDRNNRPKFEQIVSILD 305

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 31/196 (15%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ----------------- 137
           ++A+K +  GS   + ++I E  ++ +L H  LV L G C EQ                 
Sbjct: 53  KVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 111
Query: 138 -----RQLILHKIALGLA----SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
                R L   +  LG+       + YL E    C++HRD+ + N ++  N   K+ DFG
Sbjct: 112 YLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFG 168
Query: 189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPR 247
           + R V  +  + +T     + + +PE  +  + S +SDV+SFGV+  EV   G+ P E R
Sbjct: 169 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 228
Query: 248 QEPSKVRLVEWVWDLY 263
                V  +   + LY
Sbjct: 229 SNSEVVEDISTGFRLY 244

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLD 172
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 118/258 (45%), Gaps = 51/258 (19%)
Query: 88  LLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           L S +   +A+K +  G +++ +++++ E  I+ +  H N++ L G              
Sbjct: 68  LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 127
Query: 135 ------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                       H+ +  ++  + +  G+AS + YL +      VHRD+ + N++++SN 
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNL 184
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV- 237
             K+ DFGL+R+++ +  +  T   G +   + +PE +   K +  SDV+S+G+V  EV 
Sbjct: 185 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMECLMIVGLWCC 296
           + G +P                W++  +  +    +G RL    D      L  + L C 
Sbjct: 245 SYGERP---------------YWEMSNQDVIKAVDEGYRLPPPMD--CPAALYQLMLDCW 287
Query: 297 HPDFTNRPSIRQVINVLN 314
             D  NRP   Q++++L+
Sbjct: 288 QKDRNNRPKFEQIVSILD 305

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 39/192 (20%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG--------- 132
           VY+G     + ++AVK   V+  + Q  + + +EV ++ + RH N++  +G         
Sbjct: 24  VYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAI 80
Query: 133 ---WCHEQRQLILH--------------KIALGLASAVLYLHEEWEQCIVHRDIKSSNVV 175
              WC E   L  H               IA   A  + YLH    + I+HRD+KS+N+ 
Sbjct: 81  VTQWC-EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 136
Query: 176 LDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECV---TTGKASKESDVYSFG 231
           L  +   K+GDFGLA       GS Q   L+G++ ++APE +        S +SDVY+FG
Sbjct: 137 LHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196
Query: 232 VVALEVACGRKP 243
           +V  E+  G+ P
Sbjct: 197 IVLYELMTGQLP 208

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 118/258 (45%), Gaps = 51/258 (19%)
Query: 88  LLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           L S +   +A+K +  G +++ +++++ E  I+ +  H N++ L G              
Sbjct: 39  LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 98
Query: 135 ------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                       H+ +  ++  + +  G+AS + YL +      VHRD+ + N++++SN 
Sbjct: 99  MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNL 155
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV- 237
             K+ DFGL+R+++ +  +  T   G +   + +PE +   K +  SDV+S+G+V  EV 
Sbjct: 156 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 215
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMECLMIVGLWCC 296
           + G +P                W++  +  +    +G RL    D      L  + L C 
Sbjct: 216 SYGERP---------------YWEMSNQDVIKAVDEGYRLPPPMD--CPAALYQLMLDCW 258
Query: 297 HPDFTNRPSIRQVINVLN 314
             D  NRP   Q++++L+
Sbjct: 259 QKDRNNRPKFEQIVSILD 276

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLD 171
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLD 176
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 118/258 (45%), Gaps = 51/258 (19%)
Query: 88  LLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           L S +   +A+K +  G +++ +++++ E  I+ +  H N++ L G              
Sbjct: 39  LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEX 98
Query: 135 ------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                       H+ +  ++  + +  G+AS + YL +      VHRD+ + N++++SN 
Sbjct: 99  MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNL 155
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV- 237
             K+ DFGL+R+++ +  +  T   G +   + +PE +   K +  SDV+S+G+V  EV 
Sbjct: 156 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 215
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMECLMIVGLWCC 296
           + G +P                W++  +  +    +G RL    D      L  + L C 
Sbjct: 216 SYGERP---------------YWEMSNQDVIKAVDEGYRLPPPMD--CPAALYQLMLDCW 258
Query: 297 HPDFTNRPSIRQVINVLN 314
             D  NRP   Q++++L+
Sbjct: 259 QKDRNNRPKFEQIVSILD 276

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 118/258 (45%), Gaps = 51/258 (19%)
Query: 88  LLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           L S +   +A+K +  G +++ +++++ E  I+ +  H N++ L G              
Sbjct: 56  LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 115
Query: 135 ------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                       H+ +  ++  + +  G+AS + YL +      VHRD+ + N++++SN 
Sbjct: 116 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNL 172
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV- 237
             K+ DFGL+R+++ +  +  T   G +   + +PE +   K +  SDV+S+G+V  EV 
Sbjct: 173 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 232
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMECLMIVGLWCC 296
           + G +P                W++  +  +    +G RL    D      L  + L C 
Sbjct: 233 SYGERP---------------YWEMSNQDVIKAVDEGYRLPPPMD--CPAALYQLMLDCW 275
Query: 297 HPDFTNRPSIRQVINVLN 314
             D  NRP   Q++++L+
Sbjct: 276 QKDRNNRPKFEQIVSILD 293

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 39/192 (20%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG--------- 132
           VY+G     + ++AVK   V+  + Q  + + +EV ++ + RH N++  +G         
Sbjct: 44  VYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAI 100
Query: 133 ---WCHEQRQLILH--------------KIALGLASAVLYLHEEWEQCIVHRDIKSSNVV 175
              WC E   L  H               IA   A  + YLH    + I+HRD+KS+N+ 
Sbjct: 101 VTQWC-EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 156
Query: 176 LDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECV---TTGKASKESDVYSFG 231
           L  +   K+GDFGLA       GS Q   L+G++ ++APE +        S +SDVY+FG
Sbjct: 157 LHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 216
Query: 232 VVALEVACGRKP 243
           +V  E+  G+ P
Sbjct: 217 IVLYELMTGQLP 228

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLD 171
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 117/258 (45%), Gaps = 51/258 (19%)
Query: 88  LLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           L S +   +A+K +  G +++ +++++ E  I+ +  H N++ L G              
Sbjct: 68  LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 127
Query: 135 ------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                       H+ +  ++  + +  G+AS + YL +      VHRD+ + N++++SN 
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNL 184
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV- 237
             K+ DFGL R+++ +  +  T   G +   + +PE +   K +  SDV+S+G+V  EV 
Sbjct: 185 VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMECLMIVGLWCC 296
           + G +P                W++  +  +    +G RL    D      L  + L C 
Sbjct: 245 SYGERP---------------YWEMSNQDVIKAVDEGYRLPPPMD--CPAALYQLMLDCW 287
Query: 297 HPDFTNRPSIRQVINVLN 314
             D  NRP   Q++++L+
Sbjct: 288 QKDRNNRPKFEQIVSILD 305

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+   L GT+ 
Sbjct: 118 ANALSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLD 171
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 31/196 (15%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ----------------- 137
           ++A+K +  G+   ++++I E  ++ +L H  LV L G C EQ                 
Sbjct: 31  KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89
Query: 138 -----RQLILHKIALGLA----SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
                R L   +  LG+       + YL E    C++HRD+ + N ++  N   K+ DFG
Sbjct: 90  YLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFG 146
Query: 189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPR 247
           + R V  +  + +T     + + +PE  +  + S +SDV+SFGV+  EV   G+ P E R
Sbjct: 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206
Query: 248 QEPSKVRLVEWVWDLY 263
                V  +   + LY
Sbjct: 207 SNSEVVEDISTGFRLY 222

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 117/254 (46%), Gaps = 57/254 (22%)
Query: 96  IAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------------- 141
           +A+K +  G +++ +++++SE  I+ +  H N++HL G   +   ++             
Sbjct: 64  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 123
Query: 142 -------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
                        L  +  G+A+ + YL +      VHRD+ + N++++SN   K+ DFG
Sbjct: 124 FLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFG 180
Query: 189 LARLVDHELG--SQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV-ACGRKP 243
           L+R ++ +    + T+ L G +   + APE +   K +  SDV+S+G+V  EV + G +P
Sbjct: 181 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240
Query: 244 VEPRQEPSKVRLVEWVWDLYGKGQLLEA--ADGRLSKEFD-ERQMECLMIVGLWCCHPDF 300
                           WD+  +  ++ A   D RL    D    +  LM   L C   D 
Sbjct: 241 ---------------YWDMTNQ-DVINAIEQDYRLPPPMDCPSALHQLM---LDCWQKDR 281
Query: 301 TNRPSIRQVINVLN 314
            +RP   Q++N L+
Sbjct: 282 NHRPKFGQIVNTLD 295

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 36/181 (19%)
Query: 95  EIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG------------WCHEQRQL 140
           ++AVK   V+  + Q  + + +EV ++ + RH N++  +G            WC E   L
Sbjct: 60  DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWC-EGSSL 118
Query: 141 ILH--------------KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
             H               IA   A  + YLH    + I+HRD+KS+N+ L  +   K+GD
Sbjct: 119 YHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGD 175
Query: 187 FGLARLVDHELGS-QTTVLAGTMGYLAPECV---TTGKASKESDVYSFGVVALEVACGRK 242
           FGLA       GS Q   L+G++ ++APE +        S +SDVY+FG+V  E+  G+ 
Sbjct: 176 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 235
Query: 243 P 243
           P
Sbjct: 236 P 236

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 31/196 (15%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ----------------- 137
           ++A+K +  G+   ++++I E  ++ +L H  LV L G C EQ                 
Sbjct: 36  KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 94
Query: 138 -----RQLILHKIALGLA----SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
                R L   +  LG+       + YL E    C++HRD+ + N ++  N   K+ DFG
Sbjct: 95  YLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFG 151
Query: 189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPR 247
           + R V  +  + +T     + + +PE  +  + S +SDV+SFGV+  EV   G+ P E R
Sbjct: 152 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211
Query: 248 QEPSKVRLVEWVWDLY 263
                V  +   + LY
Sbjct: 212 SNSEVVEDISTGFRLY 227

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 117/251 (46%), Gaps = 53/251 (21%)
Query: 96  IAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC-------------------- 134
           +A+K +  G + + +++++SE  I+ +  H N++HL G                      
Sbjct: 45  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 104
Query: 135 ----HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
               ++ R  ++  + +  G+ S + YL +      VHRD+ + N++++SN   K+ DFG
Sbjct: 105 FLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFG 161
Query: 189 LARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVE 245
           ++R+++ +  +  T   G +   + APE +   K +  SDV+S+G+V  EV + G +P  
Sbjct: 162 MSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-- 219
Query: 246 PRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFD-ERQMECLMIVGLWCCHPDFTNR 303
                         WD+  +  +    +G RL    D    +  LM   L C   + ++R
Sbjct: 220 -------------YWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLM---LDCWQKERSDR 263
Query: 304 PSIRQVINVLN 314
           P   Q++N+L+
Sbjct: 264 PKFGQIVNMLD 274

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 119
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ +FG +    H   S+ T L GT+ 
Sbjct: 120 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLD 173
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 31/196 (15%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ----------------- 137
           ++A+K +  G+   ++++I E  ++ +L H  LV L G C EQ                 
Sbjct: 33  KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 91
Query: 138 -----RQLILHKIALGLA----SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
                R L   +  LG+       + YL E    C++HRD+ + N ++  N   K+ DFG
Sbjct: 92  YLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFG 148
Query: 189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPR 247
           + R V  +  + +T     + + +PE  +  + S +SDV+SFGV+  EV   G+ P E R
Sbjct: 149 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 208
Query: 248 QEPSKVRLVEWVWDLY 263
                V  +   + LY
Sbjct: 209 SNSEVVEDISTGFRLY 224

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 31/196 (15%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ----------------- 137
           ++A+K +  G+   ++++I E  ++ +L H  LV L G C EQ                 
Sbjct: 34  KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD 92
Query: 138 -----RQLILHKIALGLA----SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
                R L   +  LG+       + YL E    C++HRD+ + N ++  N   K+ DFG
Sbjct: 93  YLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFG 149
Query: 189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPR 247
           + R V  +  + +T     + + +PE  +  + S +SDV+SFGV+  EV   G+ P E R
Sbjct: 150 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209
Query: 248 QEPSKVRLVEWVWDLY 263
                V  +   + LY
Sbjct: 210 SNSEVVEDISTGFRLY 225

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ +FG +    H   S+ T L GT+ 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLD 174
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 117/251 (46%), Gaps = 53/251 (21%)
Query: 96  IAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC-------------------- 134
           +A+K +  G + + +++++SE  I+ +  H N++HL G                      
Sbjct: 39  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 98
Query: 135 ----HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
               ++ R  ++  + +  G+ S + YL +      VHRD+ + N++++SN   K+ DFG
Sbjct: 99  FLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFG 155
Query: 189 LARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVE 245
           ++R+++ +  +  T   G +   + APE +   K +  SDV+S+G+V  EV + G +P  
Sbjct: 156 MSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-- 213
Query: 246 PRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFD-ERQMECLMIVGLWCCHPDFTNR 303
                         WD+  +  +    +G RL    D    +  LM   L C   + ++R
Sbjct: 214 -------------YWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLM---LDCWQKERSDR 257
Query: 304 PSIRQVINVLN 314
           P   Q++N+L+
Sbjct: 258 PKFGQIVNMLD 268

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 118/259 (45%), Gaps = 53/259 (20%)
Query: 88  LLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           L   ++  +A+K +  G +++ +++++ E  I+ +  H N+VHL G              
Sbjct: 66  LPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEF 125
Query: 135 ------------HEQRQLILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                       H+ +  ++  + +  G+A+ + YL    +   VHRD+ + N++++SN 
Sbjct: 126 MENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLA---DMGYVHRDLAARNILVNSNL 182
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV- 237
             K+ DFGL+R+++ +  +  T   G +   + APE +   K +  SDV+S+G+V  EV 
Sbjct: 183 VCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 242
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFD-ERQMECLMIVGLWC 295
           + G +P                WD+  +  +    +G RL    D    +  LM   L C
Sbjct: 243 SYGERP---------------YWDMSNQDVIKAIEEGYRLPAPMDCPAGLHQLM---LDC 284
Query: 296 CHPDFTNRPSIRQVINVLN 314
              +   RP   Q++ +L+
Sbjct: 285 WQKERAERPKFEQIVGILD 303

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+   L GT+ 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLD 171
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 28/200 (14%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI- 141
           VYR  +  +  ++A+K + +G+ K   +E + E +I+ +L +  +V LIG C  +  ++ 
Sbjct: 356 VYR--MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV 413
Query: 142 --------LHKIALG------LASAVLYLHEEW-------EQCIVHRDIKSSNVVLDSNF 180
                   LHK  +G      +++    LH+         E+  VHR++ + NV+L +  
Sbjct: 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH 473
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAG--TMGYLAPECVTTGKASKESDVYSFGVVALE-V 237
            AK+ DFGL++ +  +    T   AG   + + APEC+   K S  SDV+S+GV   E +
Sbjct: 474 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533
Query: 238 ACGRKPVEPRQEPSKVRLVE 257
           + G+KP +  + P  +  +E
Sbjct: 534 SYGQKPYKKMKGPEVMAFIE 553

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+   L GT+ 
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDTLCGTLD 172
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+   L GT+ 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLD 174
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 89/177 (50%), Gaps = 27/177 (15%)
Query: 93  NTEIAVKRV---SRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--QLILHKI-- 145
           N ++A+K +    R  ++  K +  EV   S+L H+N+V +I    E     L++  I  
Sbjct: 36  NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95
Query: 146 -----------ALGLASAVLYLHE-------EWEQCIVHRDIKSSNVVLDSNFNAKLGDF 187
                       L + +A+ + ++         +  IVHRDIK  N+++DSN   K+ DF
Sbjct: 96  PTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDF 155
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE-SDVYSFGVVALEVACGRKP 243
           G+A+ +     +QT  + GT+ Y +PE    G+A+ E +D+YS G+V  E+  G  P
Sbjct: 156 GIAKALSETSLTQTNHVLGTVQYFSPEQ-AKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+   L GT+ 
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLD 171
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL     G                       L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+ T L GT+ 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLD 176
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 119
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+   L GT+ 
Sbjct: 120 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLD 173
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+   L GT+ 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCGTLD 174
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 65/107 (60%), Gaps = 7/107 (6%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL K+++ +   + YL E+ +  I+HRD+K SN++++S    KL DFG++ +L+D    S
Sbjct: 115 ILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 168
Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
                 GT  Y+APE +     S +SD++S G+  +E+A GR P+ P
Sbjct: 169 MANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 143
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+   L GT+ 
Sbjct: 144 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTLD 197
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 236 VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HR++ + N ++
Sbjct: 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLV 351
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 352 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 408
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 409 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 455
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 456 WQWNP--SDRPSFAEI 469

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 28/184 (15%)
Query: 89  LSDQNT-EIAVKRVSRGS---KQGKKEYIS-EVRIISRLRHRNLVHLIGW---------- 133
           +SD +T E+   ++   S   K  ++E +S E+ I   L H+++V   G+          
Sbjct: 60  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119
Query: 134 ---CHEQRQLILHK--IALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLDSNFN 181
              C  +  L LHK   AL    A  YL +    C       ++HRD+K  N+ L+ +  
Sbjct: 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE 179
Query: 182 AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGR 241
            K+GDFGLA  V+++ G +  VL GT  Y+APE ++    S E DV+S G +   +  G+
Sbjct: 180 VKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
Query: 242 KPVE 245
            P E
Sbjct: 239 PPFE 242

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 80/153 (52%), Gaps = 10/153 (6%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL K+++ +   + YL E+ +  I+HRD+K SN++++S    KL DFG++ +L+D    S
Sbjct: 105 ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 158
Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV 259
                 GT  Y++PE +     S +SD++S G+  +E+A GR P+ P       R    +
Sbjct: 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAI 218
Query: 260 WDLYG---KGQLLEAADGRLSKEFDERQMECLM 289
           ++L          +   G  S EF +   +CL+
Sbjct: 219 FELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 251

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 28/184 (15%)
Query: 89  LSDQNT-EIAVKRVSRGS---KQGKKEYIS-EVRIISRLRHRNLVHLIGW---------- 133
           +SD +T E+   ++   S   K  ++E +S E+ I   L H+++V   G+          
Sbjct: 58  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 117
Query: 134 ---CHEQRQLILHK--IALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLDSNFN 181
              C  +  L LHK   AL    A  YL +    C       ++HRD+K  N+ L+ +  
Sbjct: 118 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE 177
Query: 182 AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGR 241
            K+GDFGLA  V+++ G +  VL GT  Y+APE ++    S E DV+S G +   +  G+
Sbjct: 178 VKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 236
Query: 242 KPVE 245
            P E
Sbjct: 237 PPFE 240

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 117/256 (45%), Gaps = 52/256 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--------- 134
           VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C         
Sbjct: 275 VYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 333
Query: 135 ------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                              E   ++L  +A  ++SA+ YL +   +  +HR++ + N ++
Sbjct: 334 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLV 390
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVV 233
             N   K+ DFGL+RL+    G   T  AG    + + APE +   K S +SDV++FGV+
Sbjct: 391 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 447
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+A       P  + S+      V++L  K   +E  +G   K ++       ++   
Sbjct: 448 LWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYE-------LMRAC 494
Query: 294 WCCHPDFTNRPSIRQV 309
           W  +P  ++RPS  ++
Sbjct: 495 WQWNP--SDRPSFAEI 508

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 28/184 (15%)
Query: 89  LSDQNT-EIAVKRVSRGS---KQGKKEYIS-EVRIISRLRHRNLVHLIGW---------- 133
           +SD +T E+   ++   S   K  ++E +S E+ I   L H+++V   G+          
Sbjct: 34  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93
Query: 134 ---CHEQRQLILHK--IALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLDSNFN 181
              C  +  L LHK   AL    A  YL +    C       ++HRD+K  N+ L+ +  
Sbjct: 94  LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE 153
Query: 182 AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGR 241
            K+GDFGLA  V+++ G +  VL GT  Y+APE ++    S E DV+S G +   +  G+
Sbjct: 154 VKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
Query: 242 KPVE 245
            P E
Sbjct: 213 PPFE 216

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL    LG                       L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+   L GT+ 
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTLD 174
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 109/257 (42%), Gaps = 56/257 (21%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVR----IISRLRHRNLVHLIGWCHEQRQL---------- 140
           E+AVK       +   + I  VR    + + L+H N++ L G C ++  L          
Sbjct: 32  EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG 91
Query: 141 --------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD--------S 178
                         IL   A+ +A  + YLH+E    I+HRD+KSSN+++         S
Sbjct: 92  PLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151
Query: 179 NFNAKLGDFGLARLVDHELGSQTTV-LAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           N   K+ DFGLAR    E    T +  AG   ++APE +     SK SDV+S+GV+  E+
Sbjct: 152 NKILKITDFGLAR----EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWEL 207
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCH 297
             G  P          R ++ +   YG       A  +L+        E    +   C +
Sbjct: 208 LTGEVP---------FRGIDGLAVAYG------VAMNKLALPIPSTCPEPFAKLMEDCWN 252
Query: 298 PDFTNRPSIRQVINVLN 314
           PD  +RPS   +++ L 
Sbjct: 253 PDPHSRPSFTNILDQLT 269

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 65/107 (60%), Gaps = 7/107 (6%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL K+++ +   + YL E+ +  I+HRD+K SN++++S    KL DFG++ +L+D    S
Sbjct: 132 ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 185
Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
                 GT  Y++PE +     S +SD++S G+  +E+A GR P+ P
Sbjct: 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 65/107 (60%), Gaps = 7/107 (6%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL K+++ +   + YL E+ +  I+HRD+K SN++++S    KL DFG++ +L+D    S
Sbjct: 167 ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 220
Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
                 GT  Y++PE +     S +SD++S G+  +E+A GR P+ P
Sbjct: 221 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 65/107 (60%), Gaps = 7/107 (6%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL K+++ +   + YL E+ +  I+HRD+K SN++++S    KL DFG++ +L+D    S
Sbjct: 105 ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 158
Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
                 GT  Y++PE +     S +SD++S G+  +E+A GR P+ P
Sbjct: 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 65/107 (60%), Gaps = 7/107 (6%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL K+++ +   + YL E+ +  I+HRD+K SN++++S    KL DFG++ +L+D    S
Sbjct: 105 ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 158
Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
                 GT  Y++PE +     S +SD++S G+  +E+A GR P+ P
Sbjct: 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 65/107 (60%), Gaps = 7/107 (6%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL K+++ +   + YL E+ +  I+HRD+K SN++++S    KL DFG++ +L+D    S
Sbjct: 105 ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 158
Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
                 GT  Y++PE +     S +SD++S G+  +E+A GR P+ P
Sbjct: 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 65/107 (60%), Gaps = 7/107 (6%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL K+++ +   + YL E+ +  I+HRD+K SN++++S    KL DFG++ +L+D    S
Sbjct: 105 ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 158
Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
                 GT  Y++PE +     S +SD++S G+  +E+A GR P+ P
Sbjct: 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           +T++AVK + +GS      +++E  ++ +L+H+ LV L     ++   I           
Sbjct: 43  HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 101
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A  + ++ E   +  +HRD++++N+++    + K+ D
Sbjct: 102 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIAD 158
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLARL++    +        + + APE +  G  + +SDV+SFG++  E+   GR P  
Sbjct: 159 FGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 218
Query: 246 PRQEPSKVRLVE 257
               P  ++ +E
Sbjct: 219 GMTNPEVIQNLE 230

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 113/247 (45%), Gaps = 47/247 (19%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL------------ 142
           ++A+K++   S+  +K +I E+R +SR+ H N+V L G C     L++            
Sbjct: 34  DVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVL 91
Query: 143 ------------HKIA--LGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA-KLGDF 187
                       H ++  L  +  V YLH    + ++HRD+K  N++L +     K+ DF
Sbjct: 92  HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 151
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPR 247
           G A     ++ +  T   G+  ++APE       S++ DV+S+G++  EV   RKP +  
Sbjct: 152 GTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 207
Query: 248 QEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIR 307
             P+  R+   +W ++            L K    + +E LM     C   D + RPS+ 
Sbjct: 208 GGPA-FRI---MWAVHN------GTRPPLIKNLP-KPIESLMTR---CWSKDPSQRPSME 253
Query: 308 QVINVLN 314
           +++ ++ 
Sbjct: 254 EIVKIMT 260

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 90/182 (49%), Gaps = 34/182 (18%)
Query: 92  QNTEI-AVKRVSRGSKQGKKEY---ISEVRIISRLRHRNLVHLIG-WCHEQRQLILHKIA 146
           +N+E+ A+K++S   KQ  +++   I EVR + +LRH N +   G +  E    ++ +  
Sbjct: 77  RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136
Query: 147 LGLASAVLYLHEEWEQ---------------------CIVHRDIKSSNVVLDSNFNAKLG 185
           LG AS +L +H++  Q                      ++HRD+K+ N++L      KLG
Sbjct: 137 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLG 196
Query: 186 DFGLARLVDHELGSQTTVLAGTMGYLAPECVTT---GKASKESDVYSFGVVALEVACGRK 242
           DFG A ++     +      GT  ++APE +     G+   + DV+S G+  +E+A  + 
Sbjct: 197 DFGSASIM-----APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251
Query: 243 PV 244
           P+
Sbjct: 252 PL 253

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           +T++AVK + +GS      +++E  ++ +L+H+ LV L     ++   I           
Sbjct: 46  HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 104
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A  + ++ E   +  +HRD++++N+++    + K+ D
Sbjct: 105 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIAD 161
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLARL++    +        + + APE +  G  + +SDV+SFG++  E+   GR P  
Sbjct: 162 FGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 221
Query: 246 PRQEPSKVRLVE 257
               P  ++ +E
Sbjct: 222 GMTNPEVIQNLE 233

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 113/247 (45%), Gaps = 47/247 (19%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL------------ 142
           ++A+K++   S+  +K +I E+R +SR+ H N+V L G C     L++            
Sbjct: 33  DVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVL 90
Query: 143 ------------HKIA--LGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA-KLGDF 187
                       H ++  L  +  V YLH    + ++HRD+K  N++L +     K+ DF
Sbjct: 91  HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPR 247
           G A     ++ +  T   G+  ++APE       S++ DV+S+G++  EV   RKP +  
Sbjct: 151 GTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206
Query: 248 QEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIR 307
             P+  R+   +W ++            L K    + +E LM     C   D + RPS+ 
Sbjct: 207 GGPA-FRI---MWAVHN------GTRPPLIKNLP-KPIESLMTR---CWSKDPSQRPSME 252
Query: 308 QVINVLN 314
           +++ ++ 
Sbjct: 253 EIVKIMT 259

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           +T++AVK + +GS      +++E  ++ +L+H+ LV L     ++   I           
Sbjct: 45  HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 103
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A  + ++ E   +  +HRD++++N+++    + K+ D
Sbjct: 104 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIAD 160
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLARL++    +        + + APE +  G  + +SDV+SFG++  E+   GR P  
Sbjct: 161 FGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 220
Query: 246 PRQEPSKVRLVE 257
               P  ++ +E
Sbjct: 221 GMTNPEVIQNLE 232

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           +T++AVK + +GS      +++E  ++ +L+H+ LV L     ++   I           
Sbjct: 39  HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 97
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A  + ++ E   +  +HRD++++N+++    + K+ D
Sbjct: 98  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIAD 154
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLARL++    +        + + APE +  G  + +SDV+SFG++  E+   GR P  
Sbjct: 155 FGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 214
Query: 246 PRQEPSKVRLVE 257
               P  ++ +E
Sbjct: 215 GMTNPEVIQNLE 226

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           +T++AVK + +GS      +++E  ++ +L+H+ LV L     ++   I           
Sbjct: 38  HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 96
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A  + ++ E   +  +HRD++++N+++    + K+ D
Sbjct: 97  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIAD 153
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLARL++    +        + + APE +  G  + +SDV+SFG++  E+   GR P  
Sbjct: 154 FGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 213
Query: 246 PRQEPSKVRLVE 257
               P  ++ +E
Sbjct: 214 GMTNPEVIQNLE 225

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           +T++AVK + +GS      +++E  ++ +L+H+ LV L     ++   I           
Sbjct: 37  HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 95
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A  + ++ E   +  +HRD++++N+++    + K+ D
Sbjct: 96  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIAD 152
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLARL++    +        + + APE +  G  + +SDV+SFG++  E+   GR P  
Sbjct: 153 FGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212
Query: 246 PRQEPSKVRLVE 257
               P  ++ +E
Sbjct: 213 GMTNPEVIQNLE 224

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           +T++AVK + +GS      +++E  ++ +L+H+ LV L     ++   I           
Sbjct: 37  HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 95
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A  + ++ E   +  +HRD++++N+++    + K+ D
Sbjct: 96  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIAD 152
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLARL++    +        + + APE +  G  + +SDV+SFG++  E+   GR P  
Sbjct: 153 FGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212
Query: 246 PRQEPSKVRLVE 257
               P  ++ +E
Sbjct: 213 GMTNPEVIQNLE 224

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 86/180 (47%), Gaps = 34/180 (18%)
Query: 95  EIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG------------WC------ 134
           ++AVK  +V   + +  + + +EV ++ + RH N++  +G            WC      
Sbjct: 60  DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLY 119
Query: 135 ---HEQ----RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF 187
              H Q    +   L  IA   A  + YLH    + I+HRD+KS+N+ L      K+GDF
Sbjct: 120 KHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDF 176
Query: 188 GLARLVDHELGSQTT-VLAGTMGYLAPECV---TTGKASKESDVYSFGVVALEVACGRKP 243
           GLA +     GSQ      G++ ++APE +        S +SDVYS+G+V  E+  G  P
Sbjct: 177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 89/184 (48%), Gaps = 28/184 (15%)
Query: 89  LSDQNT-EIAVKRVSRGS---KQGKKEYIS-EVRIISRLRHRNLVHLIGW---------- 133
           +SD +T E+   ++   S   K  ++E +S E+ I   L H+++V   G+          
Sbjct: 36  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 95
Query: 134 ---CHEQRQLILHK--IALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLDSNFN 181
              C  +  L LHK   AL    A  YL +    C       ++HRD+K  N+ L+ +  
Sbjct: 96  LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE 155
Query: 182 AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGR 241
            K+GDFGLA  V+++ G +   L GT  Y+APE ++    S E DV+S G +   +  G+
Sbjct: 156 VKIGDFGLATKVEYD-GERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 214
Query: 242 KPVE 245
            P E
Sbjct: 215 PPFE 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 89/184 (48%), Gaps = 28/184 (15%)
Query: 89  LSDQNT-EIAVKRVSRGS---KQGKKEYIS-EVRIISRLRHRNLVHLIGW---------- 133
           +SD +T E+   ++   S   K  ++E +S E+ I   L H+++V   G+          
Sbjct: 36  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 95
Query: 134 ---CHEQRQLILHK--IALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLDSNFN 181
              C  +  L LHK   AL    A  YL +    C       ++HRD+K  N+ L+ +  
Sbjct: 96  LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE 155
Query: 182 AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGR 241
            K+GDFGLA  V+++ G +   L GT  Y+APE ++    S E DV+S G +   +  G+
Sbjct: 156 VKIGDFGLATKVEYD-GERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 214
Query: 242 KPVE 245
            P E
Sbjct: 215 PPFE 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 89/184 (48%), Gaps = 28/184 (15%)
Query: 89  LSDQNT-EIAVKRVSRGS---KQGKKEYIS-EVRIISRLRHRNLVHLIGW---------- 133
           +SD +T E+   ++   S   K  ++E +S E+ I   L H+++V   G+          
Sbjct: 40  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 99
Query: 134 ---CHEQRQLILHK--IALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLDSNFN 181
              C  +  L LHK   AL    A  YL +    C       ++HRD+K  N+ L+ +  
Sbjct: 100 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE 159
Query: 182 AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGR 241
            K+GDFGLA  V+++ G +   L GT  Y+APE ++    S E DV+S G +   +  G+
Sbjct: 160 VKIGDFGLATKVEYD-GERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 218
Query: 242 KPVE 245
            P E
Sbjct: 219 PPFE 222

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 90/182 (49%), Gaps = 34/182 (18%)
Query: 92  QNTEI-AVKRVSRGSKQGKKEY---ISEVRIISRLRHRNLVHLIG-WCHEQRQLILHKIA 146
           +N+E+ A+K++S   KQ  +++   I EVR + +LRH N +   G +  E    ++ +  
Sbjct: 38  RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 97
Query: 147 LGLASAVLYLHEEWEQ---------------------CIVHRDIKSSNVVLDSNFNAKLG 185
           LG AS +L +H++  Q                      ++HRD+K+ N++L      KLG
Sbjct: 98  LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLG 157
Query: 186 DFGLARLVDHELGSQTTVLAGTMGYLAPECVTT---GKASKESDVYSFGVVALEVACGRK 242
           DFG A ++     +      GT  ++APE +     G+   + DV+S G+  +E+A  + 
Sbjct: 158 DFGSASIM-----APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
Query: 243 PV 244
           P+
Sbjct: 213 PL 214

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 72/156 (46%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           EV I S LRH N++ L G+ H+  +  LIL     G                       L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A+A+ Y H    + ++HRDIK  N++L S    K+ DFG +    H   S+   L GT+ 
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLXGTLD 176
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++S GV+  E   G+ P E
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 33/179 (18%)
Query: 95  EIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL---------- 142
           E+AVK + +   +    ++   EVRI+  L H N+V L      ++ L L          
Sbjct: 34  EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV 93
Query: 143 --HKIALG-------------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF 187
             + +A G             + SAV Y H+++   IVHRD+K+ N++LD++ N K+ DF
Sbjct: 94  FDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADF 150
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS-KESDVYSFGVVALEVACGRKPVE 245
           G +   +   G++     G+  Y APE     K    E DV+S GV+   +  G  P +
Sbjct: 151 GFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 33/179 (18%)
Query: 95  EIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL---------- 142
           E+AVK + +   +    ++   EVRI+  L H N+V L      ++ L L          
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV 100
Query: 143 --HKIALG-------------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF 187
             + +A G             + SAV Y H+++   IVHRD+K+ N++LD++ N K+ DF
Sbjct: 101 FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADF 157
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVE 245
           G +   +   G++     G+  Y APE     K    E DV+S GV+   +  G  P +
Sbjct: 158 GFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           +T++AVK + +GS      +++E  ++ +L+H+ LV L     ++   I           
Sbjct: 37  HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 95
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A  + ++ E   +  +HRD++++N+++    + K+ D
Sbjct: 96  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIAD 152
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLARL++    +        + + APE +  G  + +SDV+SFG++  E+   GR P  
Sbjct: 153 FGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212
Query: 246 PRQEPSKVRLVE 257
               P  ++ +E
Sbjct: 213 GMTNPEVIQNLE 224

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 33/179 (18%)
Query: 95  EIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL---------- 142
           E+AVK + +   +    ++   EVRI+  L H N+V L      ++ L L          
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV 100
Query: 143 --HKIALG-------------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF 187
             + +A G             + SAV Y H+++   IVHRD+K+ N++LD++ N K+ DF
Sbjct: 101 FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADF 157
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVE 245
           G +   +   G++     G+  Y APE     K    E DV+S GV+   +  G  P +
Sbjct: 158 GFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 92/187 (49%), Gaps = 36/187 (19%)
Query: 88  LLSDQNTE--IAVKRVSRGSKQGKKEYI-SEVRIISRLRHRNLVHLI------GWCHEQR 138
           L  D+ T+  +A+K +++ + +GK+  + +E+ ++ +++H N+V L       G  +   
Sbjct: 36  LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 139 QLI-------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVV---L 176
           QL+                     ++   +  AV YLH+     IVHRD+K  N++   L
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSL 152
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
           D +    + DFGL+++ D   GS  +   GT GY+APE +     SK  D +S GV+A  
Sbjct: 153 DEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 210
Query: 237 VACGRKP 243
           + CG  P
Sbjct: 211 LLCGYPP 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 92/187 (49%), Gaps = 36/187 (19%)
Query: 88  LLSDQNTE--IAVKRVSRGSKQGKKEYI-SEVRIISRLRHRNLVHLI------GWCHEQR 138
           L  D+ T+  +A+K +++ + +GK+  + +E+ ++ +++H N+V L       G  +   
Sbjct: 36  LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 139 QLI-------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVV---L 176
           QL+                     ++   +  AV YLH+     IVHRD+K  N++   L
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSL 152
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
           D +    + DFGL+++ D   GS  +   GT GY+APE +     SK  D +S GV+A  
Sbjct: 153 DEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 210
Query: 237 VACGRKP 243
           + CG  P
Sbjct: 211 LLCGYPP 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 92/187 (49%), Gaps = 36/187 (19%)
Query: 88  LLSDQNTE--IAVKRVSRGSKQGKKEYI-SEVRIISRLRHRNLVHLI------GWCHEQR 138
           L  D+ T+  +A+K +++ + +GK+  + +E+ ++ +++H N+V L       G  +   
Sbjct: 36  LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 139 QLI-------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVV---L 176
           QL+                     ++   +  AV YLH+     IVHRD+K  N++   L
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSL 152
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
           D +    + DFGL+++ D   GS  +   GT GY+APE +     SK  D +S GV+A  
Sbjct: 153 DEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 210
Query: 237 VACGRKP 243
           + CG  P
Sbjct: 211 LLCGYPP 217

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 92/187 (49%), Gaps = 36/187 (19%)
Query: 88  LLSDQNTE--IAVKRVSRGSKQGKKEYI-SEVRIISRLRHRNLVHLI------GWCHEQR 138
           L  D+ T+  +A+K +++ + +GK+  + +E+ ++ +++H N+V L       G  +   
Sbjct: 36  LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 139 QLI-------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVV---L 176
           QL+                     ++   +  AV YLH+     IVHRD+K  N++   L
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSL 152
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
           D +    + DFGL+++ D   GS  +   GT GY+APE +     SK  D +S GV+A  
Sbjct: 153 DEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 210
Query: 237 VACGRKP 243
           + CG  P
Sbjct: 211 LLCGYPP 217

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           +T++AVK + +GS      +++E  ++ +L+H+ LV L     ++   I           
Sbjct: 37  HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 95
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A  + ++ E   +  +HRD++++N+++    + K+ D
Sbjct: 96  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIAD 152
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLARL++    +        + + APE +  G  + +SDV+SFG++  E+   GR P  
Sbjct: 153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212
Query: 246 PRQEPSKVRLVE 257
               P  ++ +E
Sbjct: 213 GMTNPEVIQNLE 224

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           +T++AVK + +GS      +++E  ++ +L+H+ LV L     ++   I           
Sbjct: 42  HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 100
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A  + ++ E   +  +HRD++++N+++    + K+ D
Sbjct: 101 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIAD 157
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLARL++    +        + + APE +  G  + +SDV+SFG++  E+   GR P  
Sbjct: 158 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 217
Query: 246 PRQEPSKVRLVE 257
               P  ++ +E
Sbjct: 218 GMTNPEVIQNLE 229

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           +T++AVK + +GS      +++E  ++ +L+H+ LV L     ++   I           
Sbjct: 43  HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 101
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A  + ++ E   +  +HRD++++N+++    + K+ D
Sbjct: 102 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIAD 158
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLARL++    +        + + APE +  G  + +SDV+SFG++  E+   GR P  
Sbjct: 159 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 218
Query: 246 PRQEPSKVRLVE 257
               P  ++ +E
Sbjct: 219 GMTNPEVIQNLE 230

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/250 (22%), Positives = 114/250 (45%), Gaps = 51/250 (20%)
Query: 96  IAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------------- 141
           +A+K +  G +++ +++++ E  I+ +  H N++HL G   + + ++             
Sbjct: 53  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDT 112
Query: 142 -------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
                        L  +  G+++ + YL +      VHRD+ + N++++SN   K+ DFG
Sbjct: 113 FLKKNDGQFTVIQLVGMLRGISAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFG 169
Query: 189 LARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           L+R+++ +  +  T   G +   + APE +   K +  SDV+S+G+V  EV   G +P  
Sbjct: 170 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP-- 227
Query: 246 PRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFDERQMECLMIVGLWCCHPDFTNRP 304
                         W++  +  +    +G RL    D      L  + L C   +  +RP
Sbjct: 228 -------------YWEMTNQDVIKAVEEGYRLPSPMD--CPAALYQLMLDCWQKERNSRP 272
Query: 305 SIRQVINVLN 314
              +++N+L+
Sbjct: 273 KFDEIVNMLD 282

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 116/254 (45%), Gaps = 57/254 (22%)
Query: 96  IAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------------- 141
           +A+K +  G +++ +++++SE  I+ +  H N++HL G   +   ++             
Sbjct: 38  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 97
Query: 142 -------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
                        L  +  G+A+ + YL +      VHR + + N++++SN   K+ DFG
Sbjct: 98  FLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRALAARNILVNSNLVCKVSDFG 154
Query: 189 LARLVDHELG--SQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV-ACGRKP 243
           L+R ++ +    + T+ L G +   + APE +   K +  SDV+S+G+V  EV + G +P
Sbjct: 155 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 214
Query: 244 VEPRQEPSKVRLVEWVWDLYGKGQLLEA--ADGRLSKEFD-ERQMECLMIVGLWCCHPDF 300
                           WD+  +  ++ A   D RL    D    +  LM   L C   D 
Sbjct: 215 ---------------YWDMTNQ-DVINAIEQDYRLPPPMDCPSALHQLM---LDCWQKDR 255
Query: 301 TNRPSIRQVINVLN 314
            +RP   Q++N L+
Sbjct: 256 NHRPKFGQIVNTLD 269

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           +T++AVK + +GS      +++E  ++ +L+H+ LV L     ++   I           
Sbjct: 47  HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 105
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A  + ++ E   +  +HRD++++N+++    + K+ D
Sbjct: 106 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIAD 162
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLARL++    +        + + APE +  G  + +SDV+SFG++  E+   GR P  
Sbjct: 163 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 222
Query: 246 PRQEPSKVRLVE 257
               P  ++ +E
Sbjct: 223 GMTNPEVIQNLE 234

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 32  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIXIVTEYMSKGSLL 90
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 91  DFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 147
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 148 FGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 43/200 (21%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-------EVRIISRLRHRNLVHLIGWCHE 136
           V++G L    + +A+K +  G  +G+ E I        EV I+S L H N+V L G  H 
Sbjct: 35  VHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94
Query: 137 QRQLILH------------------------KIALGLASAVLYLHEEWEQCIVHRDIKSS 172
             ++++                         ++ L +A  + Y+  +    IVHRD++S 
Sbjct: 95  PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSP 153
Query: 173 NVVLDS-----NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS--KES 225
           N+ L S        AK+ DFGL++   H +      L G   ++APE +   + S  +++
Sbjct: 154 NIFLQSLDENAPVCAKVADFGLSQQSVHSVSG----LLGNFQWMAPETIGAEEESYTEKA 209
Query: 226 DVYSFGVVALEVACGRKPVE 245
           D YSF ++   +  G  P +
Sbjct: 210 DTYSFAMILYTILTGEGPFD 229

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 33/179 (18%)
Query: 95  EIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL---------- 142
           E+AVK + +   +    ++   EVRI+  L H N+V L      ++ L L          
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV 100
Query: 143 --HKIALG-------------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF 187
             + +A G             + SAV Y H+++   IVHRD+K+ N++LD++ N K+ DF
Sbjct: 101 FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADF 157
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVE 245
           G +   +   G++     G   Y APE     K    E DV+S GV+   +  G  P +
Sbjct: 158 GFSN--EFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           +T++AVK + +GS      +++E  ++ +L+H+ LV L     ++   I           
Sbjct: 32  HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 90
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A  + ++ E   +  +HRD++++N+++    + K+ D
Sbjct: 91  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIAD 147
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLARL++    +        + + APE +  G  + +SDV+SFG++  E+   GR P  
Sbjct: 148 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 207
Query: 246 PRQEPSKVRLVE 257
               P  ++ +E
Sbjct: 208 GMTNPEVIQNLE 219

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 33/179 (18%)
Query: 95  EIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL---------- 142
           E+AVK + +   +    ++   EVRI+  L H N+V L      ++ L L          
Sbjct: 42  EVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEV 101
Query: 143 --HKIALG-------------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF 187
             + +A G             + SAV Y H+++   IVHRD+K+ N++LD + N K+ DF
Sbjct: 102 FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADF 158
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVE 245
           G +   +  +G++     G+  Y APE     K    E DV+S GV+   +  G  P +
Sbjct: 159 GFSN--EFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 118/267 (44%), Gaps = 57/267 (21%)
Query: 84  VYRGLL----SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+G+L      +   +A+K +  G +++ + +++ E  I+ +  H N++ L G   + +
Sbjct: 60  VYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119
Query: 139 QL------------------------ILHKIAL--GLASAVLYLHEEWEQCIVHRDIKSS 172
            +                        +L  + +  G+A+ + YL        VHRD+ + 
Sbjct: 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAAR 176
Query: 173 NVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSF 230
           N++++SN   K+ DFGL+R+++ +  +  T   G +   + APE ++  K +  SDV+SF
Sbjct: 177 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF 236
Query: 231 GVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG-RLSKEFD-ERQMEC 287
           G+V  EV   G +P                W+L     +    DG RL    D    +  
Sbjct: 237 GIVMWEVMTYGERP---------------YWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 281
Query: 288 LMIVGLWCCHPDFTNRPSIRQVINVLN 314
           LM   + C   +   RP    ++++L+
Sbjct: 282 LM---MQCWQQERARRPKFADIVSILD 305

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 31/196 (15%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ----------------- 137
           ++A+K +  G+   ++++I E  ++ +L H  LV L G C EQ                 
Sbjct: 33  KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 91
Query: 138 -----RQLILHKIALGLA----SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
                R L   +  LG+       + YL E     ++HRD+ + N ++  N   K+ DFG
Sbjct: 92  YLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ASVIHRDLAARNCLVGENQVIKVSDFG 148
Query: 189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPR 247
           + R V  +  + +T     + + +PE  +  + S +SDV+SFGV+  EV   G+ P E R
Sbjct: 149 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 208
Query: 248 QEPSKVRLVEWVWDLY 263
                V  +   + LY
Sbjct: 209 SNSEVVEDISTGFRLY 224

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 50/214 (23%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGS--KQGKKEYI-SEVRIISRLRHRNLVHLIGW------- 133
           VYR        E+A+K + + +  K G  + + +EV+I  +L+H +++ L  +       
Sbjct: 27  VYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86
Query: 134 ------CH------------------EQRQLILHKIALGLASAVLYLHEEWEQCIVHRDI 169
                 CH                  E R   +H+I  G+    LYLH      I+HRD+
Sbjct: 87  YLVLEMCHNGEMNRYLKNRVKPFSENEARHF-MHQIITGM----LYLHSHG---ILHRDL 138
Query: 170 KSSNVVLDSNFNAKLGDFGLARLVD--HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
             SN++L  N N K+ DFGLA  +   HE   +   L GT  Y++PE  T      ESDV
Sbjct: 139 TLSNLLLTRNMNIKIADFGLATQLKMPHE---KHYTLCGTPNYISPEIATRSAHGLESDV 195
Query: 228 YSFGVVALEVACGRKPVEP---RQEPSKVRLVEW 258
           +S G +   +  GR P +    +   +KV L ++
Sbjct: 196 WSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVIEYMSKGSLL 100
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 101 DFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 157
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 158 FGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           NT++A+K +  G+    + ++ E +I+ +L+H  LV L     E+   I           
Sbjct: 33  NTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAVVSEEPIYIVTEYMNKGSLL 91
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A+ + Y+        +HRD++S+N+++ +    K+ D
Sbjct: 92  DFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGNGLICKIAD 148
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE-VACGRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E V  GR P
Sbjct: 149 FGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 31  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLL 89
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 90  DFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 146
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 147 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 33  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLL 91
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 92  DFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 148
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 149 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 34/168 (20%)
Query: 109 KKEYISEVRIISRLRHRNLVH----LIGWCHEQRQLILHKIALGLASAVL--------YL 156
           K+  +SEV ++  L+H N+V     +I   +    +++     G  ++V+        YL
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 157 HEEW------------EQC---------IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH 195
            EE+            ++C         ++HRD+K +NV LD   N KLGDFGLAR+++H
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           +     T   GT  Y++PE +     +++SD++S G +  E+     P
Sbjct: 169 DTSFAKT-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 35  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLL 93
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 94  DFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 150
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 151 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 83/179 (46%), Gaps = 33/179 (18%)
Query: 95  EIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL---------- 142
           E+AV+ + +   +    ++   EVRI+  L H N+V L      ++ L L          
Sbjct: 41  EVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV 100
Query: 143 --HKIALG-------------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF 187
             + +A G             + SAV Y H+++   IVHRD+K+ N++LD++ N K+ DF
Sbjct: 101 FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADF 157
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVE 245
           G +   +   G++     G+  Y APE     K    E DV+S GV+   +  G  P +
Sbjct: 158 GFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 57/254 (22%)
Query: 96  IAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------------- 141
           +A+K +  G +++ ++E++SE  I+ +  H N++ L G       ++             
Sbjct: 47  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 106
Query: 142 -------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
                        L  +  G+AS + YL E      VHRD+ + N++++SN   K+ DFG
Sbjct: 107 FLRLNDGQFTVIQLVGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFG 163
Query: 189 LARLVDHELG--SQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV-ACGRKP 243
           L+R ++      ++T+ L G +   + APE +   K +  SD +S+G+V  EV + G +P
Sbjct: 164 LSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223
Query: 244 VEPRQEPSKVRLVEWVWDLYGKGQLLEA--ADGRLSKEFD-ERQMECLMIVGLWCCHPDF 300
                           WD+  +  ++ A   D RL    D    +  LM   L C   D 
Sbjct: 224 ---------------YWDMSNQ-DVINAIEQDYRLPPPPDCPTSLHQLM---LDCWQKDR 264
Query: 301 TNRPSIRQVINVLN 314
             RP   QV++ L+
Sbjct: 265 NARPRFPQVVSALD 278

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 29/188 (15%)
Query: 84  VYRGLLSDQNTE---IAVKRVSRGSKQGKKE-YISEVRIISRLRHRNLVHLIGWCHEQRQ 139
           VY G+ ++   E   +AVK   +      KE ++SE  I+  L H ++V LIG   E+  
Sbjct: 24  VYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT 83
Query: 140 LIL---------------HKIALGLASAVLY--------LHEEWEQCIVHRDIKSSNVVL 176
            I+               +K +L + + VLY         + E   C VHRDI   N+++
Sbjct: 84  WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC-VHRDIAVRNILV 142
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
            S    KLGDFGL+R ++ E   + +V    + +++PE +   + +  SDV+ F V   E
Sbjct: 143 ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWE 202
Query: 237 V-ACGRKP 243
           + + G++P
Sbjct: 203 ILSFGKQP 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVIEYMSKGSLL 100
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 101 DFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 157
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 158 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLL 100
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 101 DFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 157
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 158 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 34/168 (20%)
Query: 109 KKEYISEVRIISRLRHRNLVH----LIGWCHEQRQLILHKIALGLASAVL--------YL 156
           K+  +SEV ++  L+H N+V     +I   +    +++     G  ++V+        YL
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 157 HEEW------------EQC---------IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH 195
            EE+            ++C         ++HRD+K +NV LD   N KLGDFGLAR+++H
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           +  S      GT  Y++PE +     +++SD++S G +  E+     P
Sbjct: 169 D-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVMEYMSKGCLL 100
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 101 DFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 157
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 158 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 64/105 (60%), Gaps = 7/105 (6%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL K+++ +   + YL E+ +  I+HRD+K SN++++S    KL DFG++ +L+D    S
Sbjct: 124 ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 177
Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPV 244
                 GT  Y++PE +     S +SD++S G+  +E+A GR P+
Sbjct: 178 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGCLL 100
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 101 DFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 157
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 158 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 7/92 (7%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL 211
           A+ YLH    + I++RD+K  N++LD N + K+ DFG A+ V       T  L GT  Y+
Sbjct: 118 ALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGTPDYI 170
Query: 212 APECVTTGKASKESDVYSFGVVALEVACGRKP 243
           APE V+T   +K  D +SFG++  E+  G  P
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 208 TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLL 266
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 267 DFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 323
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 324 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 29/188 (15%)
Query: 84  VYRGLLSDQNTE---IAVKRVSRGSKQGKKE-YISEVRIISRLRHRNLVHLIGWCHEQRQ 139
           VY G+ ++   E   +AVK   +      KE ++SE  I+  L H ++V LIG   E+  
Sbjct: 28  VYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT 87
Query: 140 LIL---------------HKIALGLASAVLY--------LHEEWEQCIVHRDIKSSNVVL 176
            I+               +K +L + + VLY         + E   C VHRDI   N+++
Sbjct: 88  WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC-VHRDIAVRNILV 146
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
            S    KLGDFGL+R ++ E   + +V    + +++PE +   + +  SDV+ F V   E
Sbjct: 147 ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWE 206
Query: 237 V-ACGRKP 243
           + + G++P
Sbjct: 207 ILSFGKQP 214

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 62/115 (53%), Gaps = 5/115 (4%)
Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL 204
           + L +   V+ L     Q I+HRD+K  N++LD + +  + DF +A ++  E  +Q T +
Sbjct: 117 VKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTM 174
Query: 205 AGTMGYLAPECVTTGKASKES---DVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
           AGT  Y+APE  ++ K +  S   D +S GV A E+  GR+P   R   S   +V
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVCEYMSKGSLL 100
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 101 DFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 157
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 158 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 14/135 (10%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIK 170
           EY+  V +      R++VH  G    +R + +      +A A   L+   +  I+HRD+K
Sbjct: 96  EYVDGVTL------RDIVHTEGPMTPKRAIEV------IADACQALNFSHQNGIIHRDVK 143
Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVY 228
            +N+++ +    K+ DFG+AR +     S  QT  + GT  YL+PE          SDVY
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 203
Query: 229 SFGVVALEVACGRKP 243
           S G V  EV  G  P
Sbjct: 204 SLGCVLYEVLTGEPP 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 14/135 (10%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIK 170
           EY+  V +      R++VH  G    +R + +      +A A   L+   +  I+HRD+K
Sbjct: 96  EYVDGVTL------RDIVHTEGPMTPKRAIEV------IADACQALNFSHQNGIIHRDVK 143
Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVY 228
            +N+++ +    K+ DFG+AR +     S  QT  + GT  YL+PE          SDVY
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 203
Query: 229 SFGVVALEVACGRKP 243
           S G V  EV  G  P
Sbjct: 204 SLGCVLYEVLTGEPP 218

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 208 TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLL 266
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 267 DFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 323
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 324 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 29/188 (15%)
Query: 84  VYRGLLSDQNTE---IAVKRVSRGSKQGKKE-YISEVRIISRLRHRNLVHLIGWCHEQRQ 139
           VY G+ ++   E   +AVK   +      KE ++SE  I+  L H ++V LIG   E+  
Sbjct: 40  VYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT 99
Query: 140 LIL---------------HKIALGLASAVLY--------LHEEWEQCIVHRDIKSSNVVL 176
            I+               +K +L + + VLY         + E   C VHRDI   N+++
Sbjct: 100 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC-VHRDIAVRNILV 158
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
            S    KLGDFGL+R ++ E   + +V    + +++PE +   + +  SDV+ F V   E
Sbjct: 159 ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWE 218
Query: 237 V-ACGRKP 243
           + + G++P
Sbjct: 219 ILSFGKQP 226

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 208 TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVGEYMSKGSLL 266
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 267 DFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 323
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 324 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 14/135 (10%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIK 170
           EY+  V +      R++VH  G    +R + +      +A A   L+   +  I+HRD+K
Sbjct: 96  EYVDGVTL------RDIVHTEGPMTPKRAIEV------IADACQALNFSHQNGIIHRDVK 143
Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVY 228
            +N+++ +    K+ DFG+AR +     S  QT  + GT  YL+PE          SDVY
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 203
Query: 229 SFGVVALEVACGRKP 243
           S G V  EV  G  P
Sbjct: 204 SLGCVLYEVLTGEPP 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 14/135 (10%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIK 170
           EY+  V +      R++VH  G    +R + +      +A A   L+   +  I+HRD+K
Sbjct: 96  EYVDGVTL------RDIVHTEGPMTPKRAIEV------IADACQALNFSHQNGIIHRDVK 143
Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVY 228
            +N+++ +    K+ DFG+AR +     S  QT  + GT  YL+PE          SDVY
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 203
Query: 229 SFGVVALEVACGRKP 243
           S G V  EV  G  P
Sbjct: 204 SLGCVLYEVLTGEPP 218

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 71/131 (54%), Gaps = 20/131 (15%)
Query: 128 VHLIGWCHEQ---------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS 178
           + L+G C E+          + IL K+ + +  A+ YL E+    ++HRD+K SN++LD 
Sbjct: 103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDE 160
Query: 179 NFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPECVTTGKASK-----ESDVYSFGV 232
               KL DFG++ RLVD +   ++   AG   Y+APE +     +K      +DV+S G+
Sbjct: 161 RGQIKLCDFGISGRLVDDKAKDRS---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGI 217
Query: 233 VALEVACGRKP 243
             +E+A G+ P
Sbjct: 218 SLVELATGQFP 228

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 14/135 (10%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIK 170
           EY+  V +      R++VH  G    +R + +      +A A   L+   +  I+HRD+K
Sbjct: 96  EYVDGVTL------RDIVHTEGPMTPKRAIEV------IADACQALNFSHQNGIIHRDVK 143
Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVY 228
            +N+++ +    K+ DFG+AR +     S  QT  + GT  YL+PE          SDVY
Sbjct: 144 PANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVY 203
Query: 229 SFGVVALEVACGRKP 243
           S G V  EV  G  P
Sbjct: 204 SLGCVLYEVLTGEPP 218

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 57/254 (22%)
Query: 96  IAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------------- 141
           +A+K +  G +++ ++E++SE  I+ +  H N++ L G       ++             
Sbjct: 45  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 104
Query: 142 -------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
                        L  +  G+AS + YL E      VHRD+ + N++++SN   K+ DFG
Sbjct: 105 FLRLNDGQFTVIQLVGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFG 161
Query: 189 LARLVDHELG--SQTTVLAGTMG--YLAPECVTTGKASKESDVYSFGVVALEV-ACGRKP 243
           L+R ++      + T+ L G +   + APE +   K +  SD +S+G+V  EV + G +P
Sbjct: 162 LSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221
Query: 244 VEPRQEPSKVRLVEWVWDLYGKGQLLEA--ADGRLSKEFD-ERQMECLMIVGLWCCHPDF 300
                           WD+  +  ++ A   D RL    D    +  LM   L C   D 
Sbjct: 222 ---------------YWDMSNQ-DVINAIEQDYRLPPPPDCPTSLHQLM---LDCWQKDR 262
Query: 301 TNRPSIRQVINVLN 314
             RP   QV++ L+
Sbjct: 263 NARPRFPQVVSALD 276

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 14/135 (10%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIK 170
           EY+  V +      R++VH  G    +R + +      +A A   L+   +  I+HRD+K
Sbjct: 113 EYVDGVTL------RDIVHTEGPMTPKRAIEV------IADACQALNFSHQNGIIHRDVK 160
Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVY 228
            +N+++ +    K+ DFG+AR +     S  QT  + GT  YL+PE          SDVY
Sbjct: 161 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 220
Query: 229 SFGVVALEVACGRKP 243
           S G V  EV  G  P
Sbjct: 221 SLGCVLYEVLTGEPP 235

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 39  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLL 97
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  ++  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 98  DFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 154
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 155 FGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ ++RH  LV L     E+   I           
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAVVSEEPIYIVTEYMSKGSLL 100
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 101 DFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 157
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 158 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 83/179 (46%), Gaps = 33/179 (18%)
Query: 95  EIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL---------- 142
           E+AV+ + +   +    ++   EVRI+  L H N+V L      ++ L L          
Sbjct: 41  EVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV 100
Query: 143 --HKIALG-------------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF 187
             + +A G             + SAV Y H+++   IVHRD+K+ N++LD++ N K+ DF
Sbjct: 101 FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADF 157
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVE 245
           G +   +   G++     G+  Y APE     K    E DV+S GV+   +  G  P +
Sbjct: 158 GFSN--EFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/108 (39%), Positives = 62/108 (57%), Gaps = 10/108 (9%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL KI L    A+ +L E  +  I+HRDIK SN++LD + N KL DFG++ +LVD    +
Sbjct: 126 ILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT 183
Query: 200 QTTVLAGTMGYLAPECVTTGKASK----ESDVYSFGVVALEVACGRKP 243
           +    AG   Y+APE +    + +     SDV+S G+   E+A GR P
Sbjct: 184 RD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 8/105 (7%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SAV Y H      +VHRD+K  NV+LD++ NAK+ DFGL+ ++    G       G+ 
Sbjct: 120 ILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSCGSP 174
Query: 209 GYLAPECVTTGK--ASKESDVYSFGVVALEVACGRKPVEPRQEPS 251
            Y APE V +G+  A  E D++S GV+   + CG  P +    P+
Sbjct: 175 NYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 81/178 (45%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 42  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLL 100
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD+ ++N+++  N   K+ D
Sbjct: 101 DFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLAAANILVGENLVCKVAD 157
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 158 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 39  TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLL 97
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  ++  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 98  DFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 154
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 155 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 291 TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLL 349
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 350 DFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 406
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGLARL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 407 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 35/198 (17%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--QLI 141
           VY G        IA+K +     +  +    E+ +   L+H+N+V  +G   E    ++ 
Sbjct: 24  VYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 83
Query: 142 LHKIALGLASAVL--------------------------YLHEEWEQCIVHRDIKSSNVV 175
           + ++  G  SA+L                          YLH+     IVHRDIK  NV+
Sbjct: 84  MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVL 140
Query: 176 LDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK--ASKESDVYSFGV 232
           +++     K+ DFG ++ +   +   T    GT+ Y+APE +  G     K +D++S G 
Sbjct: 141 INTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGC 199
Query: 233 VALEVACGRKPVEPRQEP 250
             +E+A G+ P     EP
Sbjct: 200 TIIEMATGKPPFYELGEP 217

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 35/198 (17%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--QLI 141
           VY G        IA+K +     +  +    E+ +   L+H+N+V  +G   E    ++ 
Sbjct: 38  VYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97
Query: 142 LHKIALGLASAVL--------------------------YLHEEWEQCIVHRDIKSSNVV 175
           + ++  G  SA+L                          YLH+     IVHRDIK  NV+
Sbjct: 98  MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVL 154
Query: 176 LDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA--SKESDVYSFGV 232
           +++     K+ DFG ++ +   +   T    GT+ Y+APE +  G     K +D++S G 
Sbjct: 155 INTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGC 213
Query: 233 VALEVACGRKPVEPRQEP 250
             +E+A G+ P     EP
Sbjct: 214 TIIEMATGKPPFYELGEP 231

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 11/172 (6%)
Query: 86  RGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKI 145
           R +L+D N    VK       +GK   I +      L  R L   + +  E  +  L ++
Sbjct: 81  RDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAEL 139
Query: 146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR-LVDHELGSQTTVL 204
           ALGL     +LH      I++RD+K  N++LD   + KL DFGL++  +DHE   +    
Sbjct: 140 ALGLD----HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHE--KKAYSF 190
Query: 205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
            GT+ Y+APE V     S  +D +S+GV+  E+  G  P + +     + L+
Sbjct: 191 CGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 43/200 (21%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-------EVRIISRLRHRNLVHLIGWCHE 136
           V++G L    + +A+K +  G  +G+ E I        EV I+S L H N+V L G  H 
Sbjct: 35  VHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94
Query: 137 QRQLILH------------------------KIALGLASAVLYLHEEWEQCIVHRDIKSS 172
             ++++                         ++ L +A  + Y+  +    IVHRD++S 
Sbjct: 95  PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSP 153
Query: 173 NVVLDS-----NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS--KES 225
           N+ L S        AK+ DFG ++   H +      L G   ++APE +   + S  +++
Sbjct: 154 NIFLQSLDENAPVCAKVADFGTSQQSVHSVSG----LLGNFQWMAPETIGAEEESYTEKA 209
Query: 226 DVYSFGVVALEVACGRKPVE 245
           D YSF ++   +  G  P +
Sbjct: 210 DTYSFAMILYTILTGEGPFD 229

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 62/108 (57%), Gaps = 10/108 (9%)
Query: 137 QRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDH 195
           Q   IL +I  GL     YLH E +   +HRDIK++NV+L  +   KL DFG+A +L D 
Sbjct: 105 QIATILREILKGLD----YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           ++   T V  GT  ++APE +       ++D++S G+ A+E+A G  P
Sbjct: 158 QIKRNTFV--GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 64/106 (60%), Gaps = 5/106 (4%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ 200
           IL K+++ +   + YL E+ +  I+HRD+K SN++++S    KL DFG++  +  E+ ++
Sbjct: 108 ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE 165
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
                GT  Y++PE +     S +SD++S G+  +E+A GR P  P
Sbjct: 166 ---FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPP 208

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 91/192 (47%), Gaps = 31/192 (16%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
           +T++AVK + +GS      +++E  ++ +L+H+ LV L     ++   I           
Sbjct: 33  HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLV 91
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +A  + ++ E   +  +HR+++++N+++    + K+ D
Sbjct: 92  DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRNLRAANILVSDTLSCKIAD 148
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLARL++    +        + + APE +  G  + +SDV+SFG++  E+   GR P  
Sbjct: 149 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 208
Query: 246 PRQEPSKVRLVE 257
               P  ++ +E
Sbjct: 209 GMTNPEVIQNLE 220

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 25/175 (14%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVL 154
           ++A+K +  GS   + E+I E +++  L H  LV L G C +QR + +    +     + 
Sbjct: 50  DVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 108
Query: 155 YLHEE---------WEQC--------------IVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           YL E           E C               +HRD+ + N +++     K+ DFGL+R
Sbjct: 109 YLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
Query: 192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVE 245
            V  +  + +      + +  PE +   K S +SD+++FGV+  E+ + G+ P E
Sbjct: 169 YVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 35  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 94
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HRD+ + N+++++ 
Sbjct: 95  IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 154
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 155 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 214

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 29  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 88
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HRD+ + N+++++ 
Sbjct: 89  IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 148
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 149 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 208

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 31  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HRD+ + N+++++ 
Sbjct: 91  IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 150
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 151 NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 33/179 (18%)
Query: 95  EIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL---------- 142
           E+AVK + +   +    ++   EVRI   L H N+V L      ++ L L          
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEV 100
Query: 143 --HKIALG-------------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF 187
             + +A G             + SAV Y H+++   IVHRD+K+ N++LD++ N K+ DF
Sbjct: 101 FDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADF 157
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVE 245
           G +   +   G++     G   Y APE     K    E DV+S GV+   +  G  P +
Sbjct: 158 GFSN--EFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----HLIG---WCHEQ-------RQ 139
           ++AVK++    +Q ++   +EV I+    H N+V     +L+G   W   +         
Sbjct: 72  QVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTD 131
Query: 140 LILHK---------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           ++ H          + L +  A+ YLH    Q ++HRDIKS +++L S+   KL DFG  
Sbjct: 132 IVTHTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFC 188
Query: 191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPV---EPR 247
             V  E+  +   L GT  ++APE ++      E D++S G++ +E+  G  P     P 
Sbjct: 189 AQVSKEVPKRKX-LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 247
Query: 248 QEPSKVR--LVEWVWDLYGKGQLLEA-ADGRLSKEFDER 283
           Q   ++R  L   V DL+    +L    D  L +E  +R
Sbjct: 248 QAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQR 286

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 25/175 (14%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVL 154
           ++A+K +  GS   + E+I E +++  L H  LV L G C +QR + +    +     + 
Sbjct: 35  DVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 93
Query: 155 YLHEE---------WEQC--------------IVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           YL E           E C               +HRD+ + N +++     K+ DFGL+R
Sbjct: 94  YLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 153
Query: 192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVE 245
            V  +  + +      + +  PE +   K S +SD+++FGV+  E+ + G+ P E
Sbjct: 154 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 30  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 89
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HRD+ + N+++++ 
Sbjct: 90  IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 149
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 150 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 209

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 62  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HRD+ + N+++++ 
Sbjct: 122 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 181
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 182 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 43/200 (21%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-------EVRIISRLRHRNLVHLIGWCHE 136
           V++G L    + +A+K +  G  +G+ E I        EV I+S L H N+V L G  H 
Sbjct: 35  VHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94
Query: 137 QRQLILH------------------------KIALGLASAVLYLHEEWEQCIVHRDIKSS 172
             ++++                         ++ L +A  + Y+  +    IVHRD++S 
Sbjct: 95  PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSP 153
Query: 173 NVVLDS-----NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS--KES 225
           N+ L S        AK+ DF L++   H +      L G   ++APE +   + S  +++
Sbjct: 154 NIFLQSLDENAPVCAKVADFSLSQQSVHSVSG----LLGNFQWMAPETIGAEEESYTEKA 209
Query: 226 DVYSFGVVALEVACGRKPVE 245
           D YSF ++   +  G  P +
Sbjct: 210 DTYSFAMILYTILTGEGPFD 229

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/108 (37%), Positives = 62/108 (57%), Gaps = 10/108 (9%)
Query: 137 QRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDH 195
           Q   IL +I  GL     YLH E +   +HRDIK++NV+L  +   KL DFG+A +L D 
Sbjct: 125 QIATILREILKGLD----YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 177
Query: 196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           ++   T V  GT  ++APE +       ++D++S G+ A+E+A G  P
Sbjct: 178 QIKRNTFV--GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 36  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 95
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HRD+ + N+++++ 
Sbjct: 96  IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 155
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 156 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 31  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HRD+ + N+++++ 
Sbjct: 91  IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 150
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 151 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 25/175 (14%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVL 154
           ++A+K +  GS   + E+I E +++  L H  LV L G C +QR + +    +     + 
Sbjct: 34  DVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 92
Query: 155 YLHEE---------WEQC--------------IVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           YL E           E C               +HRD+ + N +++     K+ DFGL+R
Sbjct: 93  YLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 152
Query: 192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVE 245
            V  +  + +      + +  PE +   K S +SD+++FGV+  E+ + G+ P E
Sbjct: 153 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 55/90 (61%), Gaps = 6/90 (6%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAP 213
           YLH E +   +HRDIK++NV+L    + KL DFG+A +L D ++   T V  GT  ++AP
Sbjct: 135 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAP 189
Query: 214 ECVTTGKASKESDVYSFGVVALEVACGRKP 243
           E +       ++D++S G+ A+E+A G  P
Sbjct: 190 EVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 37  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 96
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HRD+ + N+++++ 
Sbjct: 97  IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 156
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 157 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 216

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 25/175 (14%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVL 154
           ++A+K +  GS   + E+I E +++  L H  LV L G C +QR + +    +     + 
Sbjct: 30  DVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 88
Query: 155 YLHEE---------WEQC--------------IVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           YL E           E C               +HRD+ + N +++     K+ DFGL+R
Sbjct: 89  YLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 148
Query: 192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVE 245
            V  +  + +      + +  PE +   K S +SD+++FGV+  E+ + G+ P E
Sbjct: 149 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 25/175 (14%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVL 154
           ++A+K +  GS   + E+I E +++  L H  LV L G C +QR + +    +     + 
Sbjct: 50  DVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 108
Query: 155 YLHEE---------WEQC--------------IVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           YL E           E C               +HRD+ + N +++     K+ DFGL+R
Sbjct: 109 YLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
Query: 192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVE 245
            V  +  + +      + +  PE +   K S +SD+++FGV+  E+ + G+ P E
Sbjct: 169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 91/191 (47%), Gaps = 25/191 (13%)
Query: 91  DQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC-HEQRQLILHKIALGL 149
           +++T++AVK +  GS    + +++E  ++  L+H  LV L      E   +I   +A G 
Sbjct: 37  NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGS 95
Query: 150 ASAVLYLHEEWEQCI----------------------VHRDIKSSNVVLDSNFNAKLGDF 187
               L   E  +Q +                      +HRD++++N+++ ++   K+ DF
Sbjct: 96  LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADF 155
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEP 246
           GLAR+++    +        + + APE +  G  + +SDV+SFG++ +E+   GR P   
Sbjct: 156 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 215
Query: 247 RQEPSKVRLVE 257
              P  +R +E
Sbjct: 216 MSNPEVIRALE 226

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 34  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 93
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HRD+ + N+++++ 
Sbjct: 94  IMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 153
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 154 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 82/180 (45%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 34  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 93
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H E    I                     +HRD+ + N+++++ 
Sbjct: 94  IMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 153
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 154 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 31  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HRD+ + N+++++ 
Sbjct: 91  IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 150
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 151 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 38  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 97
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HRD+ + N+++++ 
Sbjct: 98  IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 157
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 158 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 34  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 93
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HRD+ + N+++++ 
Sbjct: 94  IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 153
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 154 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSN---FNAKLGDFGLARLVDHELGSQTTVLA 205
           ++SA+ YLHE     I+HRD+K  N+VL         K+ D G A+ +D   G   T   
Sbjct: 131 ISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFV 185
Query: 206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW 258
           GT+ YLAPE +   K +   D +SFG +A E   G +P  P  +P     V+W
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQW 233

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 25/175 (14%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVL 154
           ++A+K +  GS   + E+I E +++  L H  LV L G C +QR + +    +     + 
Sbjct: 41  DVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 99
Query: 155 YLHEE---------WEQC--------------IVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           YL E           E C               +HRD+ + N +++     K+ DFGL+R
Sbjct: 100 YLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 159
Query: 192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVE 245
            V  +  + +      + +  PE +   K S +SD+++FGV+  E+ + G+ P E
Sbjct: 160 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 214

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSN---FNAKLGDFGLARLVDHELGSQTTVLA 205
           ++SA+ YLHE     I+HRD+K  N+VL         K+ D G A+ +D   G   T   
Sbjct: 130 ISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFV 184
Query: 206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW 258
           GT+ YLAPE +   K +   D +SFG +A E   G +P  P  +P     V+W
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQW 232

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 60/106 (56%), Gaps = 10/106 (9%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV-DHELGSQTTVLAGT 207
           + SAV Y H      +VHRD+K  NV+LD++ NAK+ DFGL+ ++ D E    +    G+
Sbjct: 120 ILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGS 173
Query: 208 MGYLAPECVTTGK--ASKESDVYSFGVVALEVACGRKPVEPRQEPS 251
             Y APE V +G+  A  E D++S GV+   + CG  P +    P+
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 49  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 108
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HRD+ + N+++++ 
Sbjct: 109 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 168
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 169 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 25/175 (14%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVL 154
           ++A+K +  GS   + E+I E +++  L H  LV L G C +QR + +    +     + 
Sbjct: 35  DVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 93
Query: 155 YLHEE---------WEQC--------------IVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           YL E           E C               +HRD+ + N +++     K+ DFGL+R
Sbjct: 94  YLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 153
Query: 192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVE 245
            V  +  + +      + +  PE +   K S +SD+++FGV+  E+ + G+ P E
Sbjct: 154 YVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 91/191 (47%), Gaps = 25/191 (13%)
Query: 91  DQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGW-CHEQRQLILHKIALGL 149
           +++T++AVK +  GS    + +++E  ++  L+H  LV L      E   +I   +A G 
Sbjct: 210 NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGS 268
Query: 150 ASAVLYLHEEWEQCI----------------------VHRDIKSSNVVLDSNFNAKLGDF 187
               L   E  +Q +                      +HRD++++N+++ ++   K+ DF
Sbjct: 269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADF 328
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEP 246
           GLAR+++    +        + + APE +  G  + +SDV+SFG++ +E+   GR P   
Sbjct: 329 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388
Query: 247 RQEPSKVRLVE 257
              P  +R +E
Sbjct: 389 MSNPEVIRALE 399

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 49  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 108
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HRD+ + N+++++ 
Sbjct: 109 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 168
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 169 NRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL 211
            V YLH      ++HRD+K  N+ L+ + + K+GDFGLA  ++ + G +   L GT  Y+
Sbjct: 154 GVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKTLCGTPNYI 209
Query: 212 APECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           APE +     S E D++S G +   +  G+ P E
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 27/189 (14%)
Query: 84  VYRGL-LSDQNTEIAVK-RVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ 139
           V++G+ +S +N  +AV  +  +   S   +++++ E   + +  H ++V LIG   E   
Sbjct: 26  VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 85
Query: 140 LIL---------------HKIALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLD 177
            I+                K +L LAS +LY ++             VHRDI + NV++ 
Sbjct: 86  WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 145
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           SN   KLGDFGL+R ++     + +     + ++APE +   + +  SDV+ FGV   E+
Sbjct: 146 SNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 205
Query: 238 AC-GRKPVE 245
              G KP +
Sbjct: 206 LMHGVKPFQ 214

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 81/178 (45%), Gaps = 31/178 (17%)
Query: 93  NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----------- 141
            T +A+K +  G+    + ++ E +++ +LRH  LV L     E+   I           
Sbjct: 209 TTRVAIKTLKPGN-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLL 267
Query: 142 ---------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                          L  +A  +AS + Y+        VHRD++++N+++  N   K+ D
Sbjct: 268 DFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD 324
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
           FGL RL++    +        + + APE    G+ + +SDV+SFG++  E+   GR P
Sbjct: 325 FGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 84/186 (45%), Gaps = 31/186 (16%)
Query: 86  RGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL--- 142
           R +L+ +   I +   ++ +    ++   EVRI+  L H N+V L      ++ L L   
Sbjct: 32  RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 91
Query: 143 ---------HKIALG-------------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                    + +A G             + SAV Y H++    IVHRD+K+ N++LD++ 
Sbjct: 92  YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADM 148
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVAC 239
           N K+ DFG +   +  +G +     G+  Y APE     K    E DV+S GV+   +  
Sbjct: 149 NIKIADFGFSN--EFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 206
Query: 240 GRKPVE 245
           G  P +
Sbjct: 207 GSLPFD 212

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL 211
            V YLH      ++HRD+K  N+ L+ + + K+GDFGLA  ++ + G +   L GT  Y+
Sbjct: 154 GVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKXLCGTPNYI 209
Query: 212 APECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           APE +     S E D++S G +   +  G+ P E
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 34/168 (20%)
Query: 109 KKEYISEVRIISRLRHRNLVH----LIGWCHEQRQLILHKIALGLASAVL--------YL 156
           K+  +SEV ++  L+H N+V     +I   +    +++     G  ++V+        YL
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 157 HEEW------------EQC---------IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH 195
            EE+            ++C         ++HRD+K +NV LD   N KLGDFGLAR+++H
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           +         GT  Y++PE +     +++SD++S G +  E+     P
Sbjct: 169 D-EDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 31/186 (16%)
Query: 86  RGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL--- 142
           R +L+ +   I +   ++ +    ++   EVRI+  L H N+V L      ++ L L   
Sbjct: 35  RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94
Query: 143 ---------HKIALG-------------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                    + +A G             + SAV Y H++    IVHRD+K+ N++LD++ 
Sbjct: 95  YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADM 151
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVAC 239
           N K+ DFG +   +  +G +     G   Y APE     K    E DV+S GV+   +  
Sbjct: 152 NIKIADFGFSN--EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
Query: 240 GRKPVE 245
           G  P +
Sbjct: 210 GSLPFD 215

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 8/105 (7%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + S V Y H      +VHRD+K  NV+LD++ NAK+ DFGL+ ++    G       G+ 
Sbjct: 125 ILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRXSCGSP 179
Query: 209 GYLAPECVTTGK--ASKESDVYSFGVVALEVACGRKPVEPRQEPS 251
            Y APE V +G+  A  E D++S GV+   + CG  P +    P+
Sbjct: 180 NYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 112/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 47  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 106
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + +L     +  VHRD+ + 
Sbjct: 107 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAAR 163
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR ++D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 164 NCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 223
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 224 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 268
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 269 EVMLKCWHPKAEMRPSFSELVS 290

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 61/108 (56%), Gaps = 10/108 (9%)
Query: 137 QRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDH 195
           Q   IL +I  GL     YLH E +   +HRDIK++NV+L  +   KL DFG+A +L D 
Sbjct: 105 QIATILREILKGLD----YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           ++  +     GT  ++APE +       ++D++S G+ A+E+A G  P
Sbjct: 158 QI--KRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL 211
            V YLH      ++HRD+K  N+ L+ + + K+GDFGLA  ++ + G +   L GT  Y+
Sbjct: 138 GVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKDLCGTPNYI 193
Query: 212 APECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           APE +     S E D++S G +   +  G+ P E
Sbjct: 194 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 61/108 (56%), Gaps = 10/108 (9%)
Query: 137 QRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDH 195
           Q   IL +I  GL     YLH E +   +HRDIK++NV+L  +   KL DFG+A +L D 
Sbjct: 120 QIATILREILKGLD----YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172
Query: 196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           ++  +     GT  ++APE +       ++D++S G+ A+E+A G  P
Sbjct: 173 QI--KRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 60/104 (57%), Gaps = 10/104 (9%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL +I  GL     YLH E +   +HRDIK++NV+L    + KL DFG+A +L D ++  
Sbjct: 121 ILREILKGLD----YLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 171
Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           +     GT  ++APE +       ++D++S G+ A+E+A G  P
Sbjct: 172 KRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 59/118 (50%), Gaps = 11/118 (9%)
Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL 204
           I   L  AV +LH      IVHRD+K  N++LD N   +L DFG +     E G +   L
Sbjct: 205 IMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFS--CHLEPGEKLREL 259
Query: 205 AGTMGYLAPECV------TTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
            GT GYLAPE +      T     KE D+++ GV+   +  G  P   R++   +R++
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 70/133 (52%), Gaps = 6/133 (4%)
Query: 118 IISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD 177
           ++  L   +L++ I  CH   +  L +     A  +L L     + IV+RD+K  N++LD
Sbjct: 96  VMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 152
Query: 178 SNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
            + + K+ DFG+ +  ++ LG ++T    GT  Y+APE +   K +   D +SFGV+  E
Sbjct: 153 KDGHIKIADFGMCK--ENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210
Query: 237 VACGRKPVEPRQE 249
           +  G+ P   + E
Sbjct: 211 MLIGQSPFHGQDE 223

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL 211
            V YLH      ++HRD+K  N+ L+ + + K+GDFGLA  ++ + G +   L GT  Y+
Sbjct: 154 GVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKDLCGTPNYI 209
Query: 212 APECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           APE +     S E D++S G +   +  G+ P E
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 45  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 104
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + YL     +  VHRD+ + 
Sbjct: 105 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAAR 161
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 162 NCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 221
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 222 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 266
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 267 EVMLKCWHPKAEMRPSFSELVS 288

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 57/96 (59%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 141 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   ASK SD+++ G +  ++  G  P
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 38  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 97
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + YL     +  VHRD+ + 
Sbjct: 98  SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAAR 154
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 155 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 214
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 215 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 259
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 260 EVMLKCWHPKAEMRPSFSELVS 281

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 37/195 (18%)
Query: 84  VYRGLLSDQ----NTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWC---- 134
           VY+G+   +       +A+K ++  +  +   E++ E  I++ + H +LV L+G C    
Sbjct: 31  VYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT 90
Query: 135 -----------------HEQRQLILHKIALG----LASAVLYLHEEWEQCIVHRDIKSSN 173
                            HE +  I  ++ L     +A  ++YL E   + +VHRD+ + N
Sbjct: 91  IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARN 147
Query: 174 VVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFG 231
           V++ S  + K+ DFGLARL++ +   +     G M   ++A EC+   K + +SDV+S+G
Sbjct: 148 VLVKSPNHVKITDFGLARLLEGD-EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYG 206
Query: 232 VVALEVAC-GRKPVE 245
           V   E+   G KP +
Sbjct: 207 VTIWELMTFGGKPYD 221

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 44  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 103
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + YL     +  VHRD+ + 
Sbjct: 104 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAAR 160
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 161 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 220
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 221 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 265
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 266 EVMLKCWHPKAEMRPSFSELVS 287

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 27/189 (14%)
Query: 84  VYRGL-LSDQNTEIAVK-RVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ 139
           V++G+ +S +N  +AV  +  +   S   +++++ E   + +  H ++V LIG   E   
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 465
Query: 140 LIL---------------HKIALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLD 177
            I+                K +L LAS +LY ++             VHRDI + NV++ 
Sbjct: 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 525
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           SN   KLGDFGL+R ++     + +     + ++APE +   + +  SDV+ FGV   E+
Sbjct: 526 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 585
Query: 238 AC-GRKPVE 245
              G KP +
Sbjct: 586 LMHGVKPFQ 594

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 41  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + YL     +  VHRD+ + 
Sbjct: 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAAR 157
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 158 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 217
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 218 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 262
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 263 EVMLKCWHPKAEMRPSFSELVS 284

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 27/189 (14%)
Query: 84  VYRGL-LSDQNTEIAVK-RVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ 139
           V++G+ +S +N  +AV  +  +   S   +++++ E   + +  H ++V LIG   E   
Sbjct: 26  VHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 85
Query: 140 LIL---------------HKIALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLD 177
            I+                K +L LAS +LY ++             VHRDI + NV++ 
Sbjct: 86  WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 145
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           SN   KLGDFGL+R ++     + +     + ++APE +   + +  SDV+ FGV   E+
Sbjct: 146 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 205
Query: 238 AC-GRKPVE 245
              G KP +
Sbjct: 206 LMHGVKPFQ 214

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 27/189 (14%)
Query: 84  VYRGL-LSDQNTEIAVK-RVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ 139
           V++G+ +S +N  +AV  +  +   S   +++++ E   + +  H ++V LIG   E   
Sbjct: 54  VHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 113
Query: 140 LIL---------------HKIALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLD 177
            I+                K +L LAS +LY ++             VHRDI + NV++ 
Sbjct: 114 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 173
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           SN   KLGDFGL+R ++     + +     + ++APE +   + +  SDV+ FGV   E+
Sbjct: 174 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 233
Query: 238 AC-GRKPVE 245
              G KP +
Sbjct: 234 LMHGVKPFQ 242

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 43  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 102
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + YL     +  VHRD+ + 
Sbjct: 103 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAAR 159
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 160 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 219
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 220 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 264
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVS 286

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQL 140
           Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V   G C+       +L
Sbjct: 32  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 91
Query: 141 ILHKIALGLASAVLYLHEEWEQCI---------------------VHRDIKSSNVVLDSN 179
           I+  +  G     L  H+E    I                     +HR++ + N+++++ 
Sbjct: 92  IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENE 151
Query: 180 FNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              K+GDFGL +++  D E           + + APE +T  K S  SDV+SFGVV  E+
Sbjct: 152 NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 211

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 47  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 106
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + +L     +  VHRD+ + 
Sbjct: 107 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAAR 163
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 164 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 223
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 224 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 268
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 269 EVMLKCWHPKAEMRPSFSELVS 290

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 86/189 (45%), Gaps = 32/189 (16%)
Query: 84  VYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-I 141
           V+ G L   NT +AVK          K +++ E RI+ +  H N+V LIG C +++ + I
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189
Query: 142 LHKIALG-------------------------LASAVLYLHEEWEQCIVHRDIKSSNVVL 176
           + ++  G                          A+ + YL     +C +HRD+ + N ++
Sbjct: 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLV 246
Query: 177 DSNFNAKLGDFGLARL-VDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVAL 235
                 K+ DFG++R   D    +   +    + + APE +  G+ S ESDV+SFG++  
Sbjct: 247 TEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306
Query: 236 EV-ACGRKP 243
           E  + G  P
Sbjct: 307 ETFSLGASP 315

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 44  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 103
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + +L     +  VHRD+ + 
Sbjct: 104 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAAR 160
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 161 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 220
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 221 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 265
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 266 EVMLKCWHPKAEMRPSFSELVS 287

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 86/189 (45%), Gaps = 32/189 (16%)
Query: 84  VYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-I 141
           V+ G L   NT +AVK          K +++ E RI+ +  H N+V LIG C +++ + I
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189
Query: 142 LHKIALG-------------------------LASAVLYLHEEWEQCIVHRDIKSSNVVL 176
           + ++  G                          A+ + YL     +C +HRD+ + N ++
Sbjct: 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLV 246
Query: 177 DSNFNAKLGDFGLARL-VDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVAL 235
                 K+ DFG++R   D    +   +    + + APE +  G+ S ESDV+SFG++  
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306
Query: 236 EV-ACGRKP 243
           E  + G  P
Sbjct: 307 ETFSLGASP 315

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 46  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 105
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + YL     +  VHRD+ + 
Sbjct: 106 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAAR 162
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 163 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 222
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 223 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 267
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 268 EVMLKCWHPKAEMRPSFSELVS 289

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 27/189 (14%)
Query: 84  VYRGL-LSDQNTEIAVK-RVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ 139
           V++G+ +S +N  +AV  +  +   S   +++++ E   + +  H ++V LIG   E   
Sbjct: 26  VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 85
Query: 140 LIL---------------HKIALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLD 177
            I+                K +L LAS +LY ++             VHRDI + NV++ 
Sbjct: 86  WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 145
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           SN   KLGDFGL+R ++     + +     + ++APE +   + +  SDV+ FGV   E+
Sbjct: 146 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 205
Query: 238 AC-GRKPVE 245
              G KP +
Sbjct: 206 LMHGVKPFQ 214

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 46  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 105
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + +L     +  VHRD+ + 
Sbjct: 106 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAAR 162
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 163 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 222
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 223 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 267
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 268 EVMLKCWHPKAEMRPSFSELVS 289

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 51  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 110
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + +L     +  VHRD+ + 
Sbjct: 111 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAAR 167
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 168 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 227
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 228 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 272
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 273 EVMLKCWHPKAEMRPSFSELVS 294

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 46  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 105
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + +L     +  VHRD+ + 
Sbjct: 106 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAAR 162
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 163 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 222
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 223 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 267
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 268 EVMLKCWHPKAEMRPSFSELVS 289

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 46  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 105
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + YL     +  VHRD+ + 
Sbjct: 106 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAAR 162
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 163 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 222
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 223 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 267
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 268 EVMLKCWHPKAEMRPSFSELVS 289

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 45  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 104
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + YL     +  VHRD+ + 
Sbjct: 105 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAAR 161
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 162 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 221
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 222 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 266
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 267 EVMLKCWHPKAEMRPSFSELVS 288

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 27/189 (14%)
Query: 84  VYRGL-LSDQNTEIAVK-RVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ 139
           V++G+ +S +N  +AV  +  +   S   +++++ E   + +  H ++V LIG   E   
Sbjct: 23  VHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 82
Query: 140 LIL---------------HKIALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLD 177
            I+                K +L LAS +LY ++             VHRDI + NV++ 
Sbjct: 83  WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 142
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           SN   KLGDFGL+R ++     + +     + ++APE +   + +  SDV+ FGV   E+
Sbjct: 143 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 202
Query: 238 AC-GRKPVE 245
              G KP +
Sbjct: 203 LMHGVKPFQ 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 27/189 (14%)
Query: 84  VYRGL-LSDQNTEIAVK-RVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ 139
           V++G+ +S +N  +AV  +  +   S   +++++ E   + +  H ++V LIG   E   
Sbjct: 28  VHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 87
Query: 140 LIL---------------HKIALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLD 177
            I+                K +L LAS +LY ++             VHRDI + NV++ 
Sbjct: 88  WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 147
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           SN   KLGDFGL+R ++     + +     + ++APE +   + +  SDV+ FGV   E+
Sbjct: 148 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 207
Query: 238 AC-GRKPVE 245
              G KP +
Sbjct: 208 LMHGVKPFQ 216

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 61/109 (55%), Gaps = 6/109 (5%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR-LVDHELGSQTTVLAGT 207
           LA A+ +LH      I++RD+K  N++LD   + KL DFGL++  +DHE   +     GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGT 189
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
           + Y+APE V     ++ +D +SFGV+  E+  G  P + +     + ++
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 105 VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + +L     +  VHRD+ + 
Sbjct: 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAAR 221
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 222 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 281
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 282 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 326
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 327 EVMLKCWHPKAEMRPSFSELVS 348

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 64  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 123
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + YL     +  VHRD+ + 
Sbjct: 124 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAAR 180
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 181 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 240
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 241 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 285
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 286 EVMLKCWHPKAEMRPSFSELVS 307

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 70/133 (52%), Gaps = 6/133 (4%)
Query: 118 IISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD 177
           ++  L   +L++ I  CH   +  L +     A  +L L     + IV+RD+K  N++LD
Sbjct: 97  VMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 153
Query: 178 SNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
            + + K+ DFG+ +  ++ LG ++T    GT  Y+APE +   K +   D +SFGV+  E
Sbjct: 154 KDGHIKIADFGMCK--ENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 211
Query: 237 VACGRKPVEPRQE 249
           +  G+ P   + E
Sbjct: 212 MLIGQSPFHGQDE 224

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 27/189 (14%)
Query: 84  VYRGL-LSDQNTEIAVK-RVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ 139
           V++G+ +S +N  +AV  +  +   S   +++++ E   + +  H ++V LIG   E   
Sbjct: 31  VHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 90
Query: 140 LIL---------------HKIALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLD 177
            I+                K +L LAS +LY ++             VHRDI + NV++ 
Sbjct: 91  WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 150
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           SN   KLGDFGL+R ++     + +     + ++APE +   + +  SDV+ FGV   E+
Sbjct: 151 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 210
Query: 238 AC-GRKPVE 245
              G KP +
Sbjct: 211 LMHGVKPFQ 219

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 111/262 (42%), Gaps = 52/262 (19%)
Query: 84  VYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLVHLIGWC----- 134
           VY G L D +      AVK ++R +  G+  ++++E  I+    H N++ L+G C     
Sbjct: 65  VYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 124
Query: 135 ----------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                                 H      L    L +A  + YL     +  VHRD+ + 
Sbjct: 125 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAAR 181
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD  F  K+ DFGLAR + D E  S    T     + ++A E + T K + +SDV+S
Sbjct: 182 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 241
Query: 230 FGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLM 289
           FGV+  E+     P  P      +     V+ L G+ +LL+           E   + L 
Sbjct: 242 FGVLLWELMTRGAPPYPDVNTFDIT----VYLLQGR-RLLQP----------EYCPDPLY 286
Query: 290 IVGLWCCHPDFTNRPSIRQVIN 311
            V L C HP    RPS  ++++
Sbjct: 287 EVMLKCWHPKAEMRPSFSELVS 308

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 61/109 (55%), Gaps = 6/109 (5%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR-LVDHELGSQTTVLAGT 207
           LA A+ +LH      I++RD+K  N++LD   + KL DFGL++  +DHE   +     GT
Sbjct: 136 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGT 190
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
           + Y+APE V     ++ +D +SFGV+  E+  G  P + +     + ++
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 239

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 27/189 (14%)
Query: 84  VYRGL-LSDQNTEIAVK-RVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ 139
           V++G+ +S +N  +AV  +  +   S   +++++ E   + +  H ++V LIG   E   
Sbjct: 29  VHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 88
Query: 140 LIL---------------HKIALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLD 177
            I+                K +L LAS +LY ++             VHRDI + NV++ 
Sbjct: 89  WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 148
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           SN   KLGDFGL+R ++     + +     + ++APE +   + +  SDV+ FGV   E+
Sbjct: 149 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 208
Query: 238 AC-GRKPVE 245
              G KP +
Sbjct: 209 LMHGVKPFQ 217

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 3/95 (3%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SA+ YLH E  + +V+RD+K  N++LD + + K+ DFGL +    + G+      GT 
Sbjct: 260 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFCGTP 316
Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 317 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 95/193 (49%), Gaps = 37/193 (19%)
Query: 84  VYRGLLSDQN----TEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWC---- 134
           VY+G+   +       +A+K ++  +  +   E++ E  I++ + H +LV L+G C    
Sbjct: 54  VYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT 113
Query: 135 -----------------HEQRQLILHKIALG----LASAVLYLHEEWEQCIVHRDIKSSN 173
                            HE +  I  ++ L     +A  ++YL E   + +VHRD+ + N
Sbjct: 114 IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARN 170
Query: 174 VVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG--YLAPECVTTGKASKESDVYSFG 231
           V++ S  + K+ DFGLARL++ +   +     G M   ++A EC+   K + +SDV+S+G
Sbjct: 171 VLVKSPNHVKITDFGLARLLEGD-EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYG 229
Query: 232 VVALEVAC-GRKP 243
           V   E+   G KP
Sbjct: 230 VTIWELMTFGGKP 242

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 3/95 (3%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SA+ YLH E  + +V+RD+K  N++LD + + K+ DFGL +    + G+      GT 
Sbjct: 257 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFCGTP 313
Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 33/163 (20%)
Query: 109 KKEYISEVRIISRLRHRNLVHL--IGWCHEQRQLILHKIALG------------------ 148
           KK   +E+ ++ RL H N++ L  I     +  L+L  +  G                  
Sbjct: 92  KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA 151
Query: 149 -----LASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
                +  AV YLHE     IVHRD+K  N++  +   +   K+ DFGL+++V+H++  +
Sbjct: 152 DAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           T  + GT GY APE +       E D++S G++   + CG +P
Sbjct: 209 T--VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 108/252 (42%), Gaps = 55/252 (21%)
Query: 88  LLSD-QNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----- 141
           +L D +  ++AVK +   +    + +++E  ++++LRH NLV L+G   E++  +     
Sbjct: 210 MLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267
Query: 142 -----------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS 178
                                  L K +L +  A+ YL        VHRD+ + NV++  
Sbjct: 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSE 324
Query: 179 NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV- 237
           +  AK+ DFGL +    E  S        + + APE +   K S +SDV+SFG++  E+ 
Sbjct: 325 DNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 380
Query: 238 ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCH 297
           + GR P         V  VE       KG  ++A DG     +D  +          C H
Sbjct: 381 SFGRVPYPRIPLKDVVPRVE-------KGYKMDAPDGCPPAVYDVMKN---------CWH 424
Query: 298 PDFTNRPSIRQV 309
            D   RP+  Q+
Sbjct: 425 LDAATRPTFLQL 436

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 61/109 (55%), Gaps = 6/109 (5%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR-LVDHELGSQTTVLAGT 207
           LA A+ +LH      I++RD+K  N++LD   + KL DFGL++  +DHE   +     GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGT 189
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
           + Y+APE V     ++ +D +SFGV+  E+  G  P + +     + ++
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 119 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 118 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 26/168 (15%)
Query: 96  IAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----QLILHKIALG-- 148
           +AVK +  G   Q +  +  E+ I+  L H ++V   G C +Q     QL++  + LG  
Sbjct: 40  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL 99
Query: 149 ----------LASAVLYLHEEWE-------QCIVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
                     LA  +L+  +  E       Q  +HR + + NV+LD++   K+GDFGLA+
Sbjct: 100 RDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAK 159
Query: 192 LVD--HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            V   HE           + + APEC+   K    SDV+SFGV   E+
Sbjct: 160 AVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 117 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 116 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 26/168 (15%)
Query: 96  IAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----QLILHKIALG-- 148
           +AVK +  G   Q +  +  E+ I+  L H ++V   G C +Q     QL++  + LG  
Sbjct: 41  VAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL 100
Query: 149 ----------LASAVLYLHEEWE-------QCIVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
                     LA  +L+  +  E       Q  +HR + + NV+LD++   K+GDFGLA+
Sbjct: 101 RDYLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAK 160
Query: 192 LVD--HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            V   HE           + + APEC+   K    SDV+SFGV   E+
Sbjct: 161 AVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYEL 208

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/104 (38%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SAV Y H      IVHRD+K  N++LD + N K+ DFGL+ ++    G+      G+ 
Sbjct: 112 IISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSP 166
Query: 209 GYLAPECVTTGK--ASKESDVYSFGVVALEVACGRKPVEPRQEP 250
            Y APE V +GK  A  E DV+S GV+   + C R P +    P
Sbjct: 167 NYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 209

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 89/186 (47%), Gaps = 32/186 (17%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----HLIG---W-- 133
           VY  +      E+A+++++   +  K+  I+E+ ++   ++ N+V     +L+G   W  
Sbjct: 36  VYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95
Query: 134 ----------------CHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD 177
                           C ++ Q+    +      A+ +LH      ++HRDIKS N++L 
Sbjct: 96  MEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEFLHSNQ---VIHRDIKSDNILLG 150
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            + + KL DFG    +  E   ++T + GT  ++APE VT      + D++S G++A+E+
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
Query: 238 ACGRKP 243
             G  P
Sbjct: 210 IEGEPP 215

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/104 (38%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SAV Y H      IVHRD+K  N++LD + N K+ DFGL+ ++    G+      G+ 
Sbjct: 122 IISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSP 176
Query: 209 GYLAPECVTTGK--ASKESDVYSFGVVALEVACGRKPVEPRQEP 250
            Y APE V +GK  A  E DV+S GV+   + C R P +    P
Sbjct: 177 NYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 219

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/104 (38%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SAV Y H      IVHRD+K  N++LD + N K+ DFGL+ ++    G+      G+ 
Sbjct: 121 IISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSP 175
Query: 209 GYLAPECVTTGK--ASKESDVYSFGVVALEVACGRKPVEPRQEP 250
            Y APE V +GK  A  E DV+S GV+   + C R P +    P
Sbjct: 176 NYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 218

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/104 (38%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SAV Y H      IVHRD+K  N++LD + N K+ DFGL+ ++    G+      G+ 
Sbjct: 116 IISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSP 170
Query: 209 GYLAPECVTTGK--ASKESDVYSFGVVALEVACGRKPVEPRQEP 250
            Y APE V +GK  A  E DV+S GV+   + C R P +    P
Sbjct: 171 NYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 213

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 138 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 123 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 54/232 (23%)
Query: 109 KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-------------------------- 142
           K E ++E  ++ +L +  +V +IG C  +  +++                          
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE 115
Query: 143 --HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELG 198
             H++++G+     YL E      VHRD+ + NV+L +   AK+ DFGL++ +  D    
Sbjct: 116 LVHQVSMGMK----YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 168
Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVE 257
              T     + + APEC+   K S +SDV+SFGV+  E  + G+KP    +      ++E
Sbjct: 169 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228
Query: 258 WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQV 309
                  KG+ +    G        R+M  LM +   C   D  NRP    V
Sbjct: 229 -------KGERMGCPAGC------PREMYDLMNL---CWTYDVENRPGFAAV 264

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 141 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 85/192 (44%), Gaps = 51/192 (26%)
Query: 96  IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI-------------- 141
           +AVK +   S   +K++  E  +++ L+H ++V   G C E   LI              
Sbjct: 46  VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 105
Query: 142 -------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                                    LH IA  +A+ ++YL     Q  VHRD+ + N ++
Sbjct: 106 LRAHGPDAVLMAEGNPPTELTQSQMLH-IAQQIAAGMVYLAS---QHFVHRDLATRNCLV 161
Query: 177 DSNFNAKLGDFGLARLV----DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGV 232
             N   K+GDFG++R V     + +G  T +    + ++ PE +   K + ESDV+S GV
Sbjct: 162 GENLLVKIGDFGMSRDVYSTDYYRVGGHTML---PIRWMPPESIMYRKFTTESDVWSLGV 218
Query: 233 VALEV-ACGRKP 243
           V  E+   G++P
Sbjct: 219 VLWEIFTYGKQP 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 54/232 (23%)
Query: 109 KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-------------------------- 142
           K E ++E  ++ +L +  +V +IG C  +  +++                          
Sbjct: 52  KDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE 111
Query: 143 --HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELG 198
             H++++G+     YL E      VHRD+ + NV+L +   AK+ DFGL++ +  D    
Sbjct: 112 LVHQVSMGMK----YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164
Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVE 257
              T     + + APEC+   K S +SDV+SFGV+  E  + G+KP    +      ++E
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224
Query: 258 WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQV 309
                  KG+ +    G        R+M  LM +   C   D  NRP    V
Sbjct: 225 -------KGERMGCPAGC------PREMYDLMNL---CWTYDVENRPGFAAV 260

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 141 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 54/232 (23%)
Query: 109 KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-------------------------- 142
           K E ++E  ++ +L +  +V +IG C  +  +++                          
Sbjct: 50  KDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE 109
Query: 143 --HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELG 198
             H++++G+     YL E      VHRD+ + NV+L +   AK+ DFGL++ +  D    
Sbjct: 110 LVHQVSMGMK----YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 162
Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVE 257
              T     + + APEC+   K S +SDV+SFGV+  E  + G+KP    +      ++E
Sbjct: 163 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 222
Query: 258 WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQV 309
                  KG+ +    G        R+M  LM +   C   D  NRP    V
Sbjct: 223 -------KGERMGCPAGC------PREMYDLMNL---CWTYDVENRPGFAAV 258

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 138 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 141 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 34/177 (19%)
Query: 96  IAVKRVSRGSKQGKKEYI-SEVRIISRLRHRNLVHL--IGWCHEQRQLILHKIALG---- 148
            AVK + + + +GK+  I +E+ ++ +++H N+V L  I        L++  ++ G    
Sbjct: 50  FAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFD 109
Query: 149 -------------------LASAVLYLHEEWEQCIVHRDIKSSNVVL---DSNFNAKLGD 186
                              +  AV YLH      IVHRD+K  N++    D      + D
Sbjct: 110 RIVEKGFYTEKDASTLIRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISD 166
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGL+++     G   +   GT GY+APE +     SK  D +S GV+A  + CG  P
Sbjct: 167 FGLSKMEGK--GDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 89/186 (47%), Gaps = 32/186 (17%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----HLIG---W-- 133
           VY  +      E+A+++++   +  K+  I+E+ ++   ++ N+V     +L+G   W  
Sbjct: 37  VYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 96
Query: 134 ----------------CHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD 177
                           C ++ Q+    +      A+ +LH      ++HRDIKS N++L 
Sbjct: 97  MEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEFLHSNQ---VIHRDIKSDNILLG 151
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            + + KL DFG    +  E  S+ + + GT  ++APE VT      + D++S G++A+E+
Sbjct: 152 MDGSVKLTDFGFCAQITPE-QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 210
Query: 238 ACGRKP 243
             G  P
Sbjct: 211 IEGEPP 216

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 141 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 146 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 54/232 (23%)
Query: 109 KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-------------------------- 142
           K E ++E  ++ +L +  +V +IG C  +  +++                          
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE 131
Query: 143 --HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELG 198
             H++++G+     YL E      VHRD+ + NV+L +   AK+ DFGL++ +  D    
Sbjct: 132 LVHQVSMGMK----YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVE 257
              T     + + APEC+   K S +SDV+SFGV+  E  + G+KP    +      ++E
Sbjct: 185 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244
Query: 258 WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQV 309
                  KG+ +    G        R+M  LM +   C   D  NRP    V
Sbjct: 245 -------KGERMGCPAGC------PREMYDLMNL---CWTYDVENRPGFAAV 280

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 54/232 (23%)
Query: 109 KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-------------------------- 142
           K E ++E  ++ +L +  +V +IG C  +  +++                          
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE 131
Query: 143 --HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELG 198
             H++++G+     YL E      VHRD+ + NV+L +   AK+ DFGL++ +  D    
Sbjct: 132 LVHQVSMGMK----YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVE 257
              T     + + APEC+   K S +SDV+SFGV+  E  + G+KP    +      ++E
Sbjct: 185 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244
Query: 258 WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQV 309
                  KG+ +    G        R+M  LM +   C   D  NRP    V
Sbjct: 245 -------KGERMGCPAGC------PREMYDLMNL---CWTYDVENRPGFAAV 280

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 142 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 89/186 (47%), Gaps = 32/186 (17%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----HLIG---W-- 133
           VY  +      E+A+++++   +  K+  I+E+ ++   ++ N+V     +L+G   W  
Sbjct: 36  VYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95
Query: 134 ----------------CHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD 177
                           C ++ Q+    +      A+ +LH      ++HRDIKS N++L 
Sbjct: 96  MEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEFLHSNQ---VIHRDIKSDNILLG 150
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            + + KL DFG    +  E  S+ + + GT  ++APE VT      + D++S G++A+E+
Sbjct: 151 MDGSVKLTDFGFCAQITPE-QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
Query: 238 ACGRKP 243
             G  P
Sbjct: 210 IEGEPP 215

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 54/232 (23%)
Query: 109 KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-------------------------- 142
           K E ++E  ++ +L +  +V +IG C  +  +++                          
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE 115
Query: 143 --HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELG 198
             H++++G+     YL E      VHRD+ + NV+L +   AK+ DFGL++ +  D    
Sbjct: 116 LVHQVSMGMK----YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY 168
Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVE 257
              T     + + APEC+   K S +SDV+SFGV+  E  + G+KP    +      ++E
Sbjct: 169 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228
Query: 258 WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQV 309
                  KG+ +    G        R+M  LM +   C   D  NRP    V
Sbjct: 229 -------KGERMGCPAGC------PREMYDLMNL---CWTYDVENRPGFAAV 264

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 54/232 (23%)
Query: 109 KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-------------------------- 142
           K E ++E  ++ +L +  +V +IG C  +  +++                          
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE 121
Query: 143 --HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELG 198
             H++++G+     YL E      VHRD+ + NV+L +   AK+ DFGL++ +  D    
Sbjct: 122 LVHQVSMGMK----YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174
Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVE 257
              T     + + APEC+   K S +SDV+SFGV+  E  + G+KP    +      ++E
Sbjct: 175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
Query: 258 WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQV 309
                  KG+ +    G        R+M  LM +   C   D  NRP    V
Sbjct: 235 -------KGERMGCPAGC------PREMYDLMNL---CWTYDVENRPGFAAV 270

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 87/194 (44%), Gaps = 43/194 (22%)
Query: 96  IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--------------I 141
           + +K + R  ++ ++ ++ EV+++  L H N++  IG  ++ ++L              I
Sbjct: 38  MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGI 97
Query: 142 LHKI------------ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL 189
           +  +            A  +AS + YLH      I+HRD+ S N ++  N N  + DFGL
Sbjct: 98  IKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGL 154
Query: 190 ARLVDHELGS-------------QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
           ARL+  E                +   + G   ++APE +      ++ DV+SFG+V  E
Sbjct: 155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE 214
Query: 237 VACGRKPVEPRQEP 250
           +  GR   +P   P
Sbjct: 215 II-GRVNADPDYLP 227

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 3/95 (3%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SA+ YLH E  + +V+RD+K  N++LD + + K+ DFGL +    + G+      GT 
Sbjct: 117 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKXFCGTP 173
Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 174 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 144 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 3/95 (3%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SA+ YLH E  + +V+RD+K  N++LD + + K+ DFGL +    + G+      GT 
Sbjct: 119 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKXFCGTP 175
Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 176 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 3/95 (3%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SA+ YLH E  + +V+RD+K  N++LD + + K+ DFGL +    + G+      GT 
Sbjct: 118 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKXFCGTP 174
Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 141 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 54/232 (23%)
Query: 109 KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-------------------------- 142
           K E ++E  ++ +L +  +V +IG C  +  +++                          
Sbjct: 70  KDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE 129
Query: 143 --HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELG 198
             H++++G+     YL E      VHRD+ + NV+L +   AK+ DFGL++ +  D    
Sbjct: 130 LVHQVSMGMK----YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 182
Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVE 257
              T     + + APEC+   K S +SDV+SFGV+  E  + G+KP    +      ++E
Sbjct: 183 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 242
Query: 258 WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQV 309
                  KG+ +    G        R+M  LM +   C   D  NRP    V
Sbjct: 243 -------KGERMGCPAGC------PREMYDLMNL---CWTYDVENRPGFAAV 278

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 56/96 (58%), Gaps = 4/96 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + SA+ YLH    + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT
Sbjct: 142 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             Y++PE +T   A K SD+++ G +  ++  G  P
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 28/172 (16%)
Query: 96  IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----HLIG---WCHEQ-------RQL 140
           +AVK++    +Q ++   +EV I+   +H N+V     +L+G   W   +         +
Sbjct: 57  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 116
Query: 141 ILHK---------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           + H          + L +  A+  LH    Q ++HRDIKS +++L  +   KL DFG   
Sbjct: 117 VTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCA 173
Query: 192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            V  E+  +   L GT  ++APE ++      E D++S G++ +E+  G  P
Sbjct: 174 QVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 28/172 (16%)
Query: 96  IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----HLIG---WCHEQ-------RQL 140
           +AVK++    +Q ++   +EV I+   +H N+V     +L+G   W   +         +
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 107
Query: 141 ILHK---------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           + H          + L +  A+  LH    Q ++HRDIKS +++L  +   KL DFG   
Sbjct: 108 VTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCA 164
Query: 192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            V  E+  +   L GT  ++APE ++      E D++S G++ +E+  G  P
Sbjct: 165 QVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 28/172 (16%)
Query: 96  IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----HLIG---WCHEQ-------RQL 140
           +AVK++    +Q ++   +EV I+   +H N+V     +L+G   W   +         +
Sbjct: 59  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 118
Query: 141 ILHK---------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           + H          + L +  A+  LH    Q ++HRDIKS +++L  +   KL DFG   
Sbjct: 119 VTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCA 175
Query: 192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            V  E+  +   L GT  ++APE ++      E D++S G++ +E+  G  P
Sbjct: 176 QVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 107/254 (42%), Gaps = 60/254 (23%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI--- 141
           YRG       ++AVK +   +    + +++E  ++++LRH NLV L+G   E++  +   
Sbjct: 27  YRG------NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78
Query: 142 -------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                                    L K +L +  A+ YL        VHRD+ + NV++
Sbjct: 79  TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLV 135
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
             +  AK+ DFGL +    E  S        + + APE +   K S +SDV+SFG++  E
Sbjct: 136 SEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 191
Query: 237 V-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWC 295
           + + GR P         V  VE       KG  ++A DG     ++  +          C
Sbjct: 192 IYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPDGCPPAVYEVMKN---------C 235
Query: 296 CHPDFTNRPSIRQV 309
            H D   RPS  Q+
Sbjct: 236 WHLDAAMRPSFLQL 249

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 28/172 (16%)
Query: 96  IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----HLIG---WCHEQ-------RQL 140
           +AVK++    +Q ++   +EV I+   +H N+V     +L+G   W   +         +
Sbjct: 179 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 238
Query: 141 ILHK---------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           + H          + L +  A+  LH    Q ++HRDIKS +++L  +   KL DFG   
Sbjct: 239 VTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCA 295
Query: 192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            V  E+  +   L GT  ++APE ++      E D++S G++ +E+  G  P
Sbjct: 296 QVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 28/172 (16%)
Query: 96  IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----HLIG---WCHEQ-------RQL 140
           +AVK++    +Q ++   +EV I+   +H N+V     +L+G   W   +         +
Sbjct: 52  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 111
Query: 141 ILHK---------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           + H          + L +  A+  LH    Q ++HRDIKS +++L  +   KL DFG   
Sbjct: 112 VTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCA 168
Query: 192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            V  E+  +   L GT  ++APE ++      E D++S G++ +E+  G  P
Sbjct: 169 QVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQTTVLAG 206
           + SA+ YLH    + +V+RDIK  N++LD + + K+ DFGL +  + D   G+      G
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKXFCG 167
Query: 207 TMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           T  YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 28/172 (16%)
Query: 96  IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----HLIG---WCHEQ-------RQL 140
           +AVK++    +Q ++   +EV I+   +H N+V     +L+G   W   +         +
Sbjct: 102 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 161
Query: 141 ILH---------KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           + H          + L +  A+  LH    Q ++HRDIKS +++L  +   KL DFG   
Sbjct: 162 VTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCA 218
Query: 192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            V  E+  +   L GT  ++APE ++      E D++S G++ +E+  G  P
Sbjct: 219 QVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 89/186 (47%), Gaps = 32/186 (17%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----HLIG---W-- 133
           VY  +      E+A+++++   +  K+  I+E+ ++   ++ N+V     +L+G   W  
Sbjct: 36  VYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95
Query: 134 ----------------CHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD 177
                           C ++ Q+    +      A+ +LH      ++HRDIKS N++L 
Sbjct: 96  MEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEFLHSNQ---VIHRDIKSDNILLG 150
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            + + KL DFG    +  E  S+ + + GT  ++APE VT      + D++S G++A+E+
Sbjct: 151 MDGSVKLTDFGFCAQITPE-QSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
Query: 238 ACGRKP 243
             G  P
Sbjct: 210 IEGEPP 215

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQTTVLAG 206
           + SA+ YLH    + +V+RDIK  N++LD + + K+ DFGL +  + D   G+      G
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKTFCG 167
Query: 207 TMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           T  YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQTTVLAG 206
           + SA+ YLH    + +V+RDIK  N++LD + + K+ DFGL +  + D   G+      G
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKTFCG 167
Query: 207 TMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           T  YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQTTVLAG 206
           + SA+ YLH    + +V+RDIK  N++LD + + K+ DFGL +  + D   G+      G
Sbjct: 119 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKXFCG 172
Query: 207 TMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           T  YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQTTVLAG 206
           + SA+ YLH    + +V+RDIK  N++LD + + K+ DFGL +  + D   G+      G
Sbjct: 117 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKTFCG 170
Query: 207 TMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           T  YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 171 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 91/191 (47%), Gaps = 35/191 (18%)
Query: 91  DQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGW-CHEQRQLILHKIALGL 149
           +++T++AVK +  GS    + +++E  ++  L+H  LV L      E   +I   +A G 
Sbjct: 204 NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGS 262
Query: 150 ASAVLYLHEEWEQCI----------------------VHRDIKSSNVVLDSNFNAKLGDF 187
               L   E  +Q +                      +HRD++++N+++ ++   K+ DF
Sbjct: 263 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADF 322
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEP 246
           GLAR     +G++  +      + APE +  G  + +SDV+SFG++ +E+   GR P   
Sbjct: 323 GLAR-----VGAKFPI-----KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 372
Query: 247 RQEPSKVRLVE 257
              P  +R +E
Sbjct: 373 MSNPEVIRALE 383

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 26/168 (15%)
Query: 96  IAVKRV-SRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE----QRQLILHKIALG-- 148
           +AVK + +    Q +  +  E+ I+  L H +++   G C +      QL++  + LG  
Sbjct: 63  VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 149 ----------LASAVLYLHEEWE-------QCIVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
                     LA  +L+  +  E       Q  +HRD+ + NV+LD++   K+GDFGLA+
Sbjct: 123 RDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182
Query: 192 LVD--HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            V   HE           + + APEC+   K    SDV+SFGV   E+
Sbjct: 183 AVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 107/254 (42%), Gaps = 60/254 (23%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI--- 141
           YRG       ++AVK +   +    + +++E  ++++LRH NLV L+G   E++  +   
Sbjct: 42  YRG------NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93
Query: 142 -------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                                    L K +L +  A+ YL        VHRD+ + NV++
Sbjct: 94  TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLV 150
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
             +  AK+ DFGL +    E  S        + + APE +   K S +SDV+SFG++  E
Sbjct: 151 SEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 206
Query: 237 V-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWC 295
           + + GR P         V  VE       KG  ++A DG     ++  +          C
Sbjct: 207 IYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPDGCPPAVYEVMKN---------C 250
Query: 296 CHPDFTNRPSIRQV 309
            H D   RPS  Q+
Sbjct: 251 WHLDAAMRPSFLQL 264

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 59/119 (49%), Gaps = 11/119 (9%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
           KI   L   +  LH+     IVHRD+K  N++LD + N KL DFG +  +D   G +   
Sbjct: 115 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLRE 169
Query: 204 LAGTMGYLAPECVTTGKAS------KESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
           + GT  YLAPE +            KE D++S GV+   +  G  P   R++   +R++
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 228

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK--A 221
           IVHRD+K  N++LD N N K+ DFGL+ ++    G+      G+  Y APE V  GK  A
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPE-VINGKLYA 185
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQEPS 251
             E DV+S G+V   +  GR P +    P+
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 59/119 (49%), Gaps = 11/119 (9%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
           KI   L   +  LH+     IVHRD+K  N++LD + N KL DFG +  +D   G +   
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLRS 182
Query: 204 LAGTMGYLAPECVTTGKAS------KESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
           + GT  YLAPE +            KE D++S GV+   +  G  P   R++   +R++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 54/195 (27%)
Query: 96  IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI-------------- 141
           +AVK +   +   +K++  E  +++ L+H ++V   G C +   LI              
Sbjct: 48  VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 107
Query: 142 ----------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSN 173
                                       LH IA  +AS ++YL     Q  VHRD+ + N
Sbjct: 108 LRAHGPDAMILVDGQPRQAKGELGLSQMLH-IASQIASGMVYLAS---QHFVHRDLATRN 163
Query: 174 VVLDSNFNAKLGDFGLARLV----DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYS 229
            ++ +N   K+GDFG++R V     + +G  T +    + ++ PE +   K + ESDV+S
Sbjct: 164 CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML---PIRWMPPESIMYRKFTTESDVWS 220
Query: 230 FGVVALEV-ACGRKP 243
           FGV+  E+   G++P
Sbjct: 221 FGVILWEIFTYGKQP 235

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQTTVLAG 206
           + SA+ YLH    + +V+RDIK  N++LD + + K+ DFGL +  + D   G+      G
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKXFCG 167
Query: 207 TMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           T  YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 68/125 (54%), Gaps = 14/125 (11%)
Query: 119 ISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS 178
           I RLR++ L        ++   IL     GL     YLH   +   +HRDIK+ N++L++
Sbjct: 114 IIRLRNKTL------TEDEIATILQSTLKGLE----YLHFMRK---IHRDIKAGNILLNT 160
Query: 179 NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVA 238
             +AKL DFG+A  +   +  +  V+ GT  ++APE +     +  +D++S G+ A+E+A
Sbjct: 161 EGHAKLADFGVAGQLTDXMAKRNXVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMA 219
Query: 239 CGRKP 243
            G+ P
Sbjct: 220 EGKPP 224

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQTTVLAG 206
           + SA+ YLH    + +V+RDIK  N++LD + + K+ DFGL +  + D   G+      G
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKXFCG 167
Query: 207 TMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           T  YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 89/186 (47%), Gaps = 32/186 (17%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----HLIG---W-- 133
           VY  +      E+A+++++   +  K+  I+E+ ++   ++ N+V     +L+G   W  
Sbjct: 37  VYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 96
Query: 134 ----------------CHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD 177
                           C ++ Q+    +      A+ +LH      ++HR+IKS N++L 
Sbjct: 97  MEYLAGGSLTDVVTETCMDEGQI--AAVCRECLQALEFLHSNQ---VIHRNIKSDNILLG 151
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            + + KL DFG    +  E   ++T + GT  ++APE VT      + D++S G++A+E+
Sbjct: 152 MDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 210
Query: 238 ACGRKP 243
             G  P
Sbjct: 211 IEGEPP 216

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 96  IAVKRV-SRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ----RQLILHKIALG-- 148
           +AVK + +    Q +  +  E+ I+  L H +++   G C +Q     QL++  + LG  
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 149 ----------LASAVLYLHEEWE-------QCIVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
                     LA  +L+  +  E       Q  +HR++ + NV+LD++   K+GDFGLA+
Sbjct: 106 RDYLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165
Query: 192 LVD--HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            V   HE           + + APEC+   K    SDV+SFGV   E+
Sbjct: 166 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 59/119 (49%), Gaps = 11/119 (9%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
           KI   L   +  LH+     IVHRD+K  N++LD + N KL DFG +  +D   G +   
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLRE 182
Query: 204 LAGTMGYLAPECVTTGKAS------KESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
           + GT  YLAPE +            KE D++S GV+   +  G  P   R++   +R++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 52/202 (25%)
Query: 88  LLSDQNTE-IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----- 141
           LL +Q+   +AVK +   S+  ++++  E  +++ L+H+++V   G C E R L+     
Sbjct: 42  LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 101
Query: 142 -----------------------------------LHKIALGLASAVLYLHEEWEQCIVH 166
                                              L  +A  +A+ ++YL        VH
Sbjct: 102 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVH 158
Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLV----DHELGSQTTVLAGTMGYLAPECVTTGKAS 222
           RD+ + N ++      K+GDFG++R +     + +G +T +    + ++ PE +   K +
Sbjct: 159 RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML---PIRWMPPESILYRKFT 215
Query: 223 KESDVYSFGVVALEV-ACGRKP 243
            ESDV+SFGVV  E+   G++P
Sbjct: 216 TESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 52/202 (25%)
Query: 88  LLSDQNTE-IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----- 141
           LL +Q+   +AVK +   S+  ++++  E  +++ L+H+++V   G C E R L+     
Sbjct: 36  LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 95
Query: 142 -----------------------------------LHKIALGLASAVLYLHEEWEQCIVH 166
                                              L  +A  +A+ ++YL        VH
Sbjct: 96  MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVH 152
Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLV----DHELGSQTTVLAGTMGYLAPECVTTGKAS 222
           RD+ + N ++      K+GDFG++R +     + +G +T +    + ++ PE +   K +
Sbjct: 153 RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML---PIRWMPPESILYRKFT 209
Query: 223 KESDVYSFGVVALEV-ACGRKP 243
            ESDV+SFGVV  E+   G++P
Sbjct: 210 TESDVWSFGVVLWEIFTYGKQP 231

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 90/189 (47%), Gaps = 27/189 (14%)
Query: 84  VYRGL-LSDQNTEIAVK-RVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ 139
           V++G+ +S +N  +AV  +  +   S   +++++ E   + +  H ++V LIG   E   
Sbjct: 26  VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 85
Query: 140 LIL---------------HKIALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLD 177
            I+                K +L LAS +LY ++             VHRDI + NV++ 
Sbjct: 86  WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 145
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           +    KLGDFGL+R ++     + +     + ++APE +   + +  SDV+ FGV   E+
Sbjct: 146 ATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 205
Query: 238 AC-GRKPVE 245
              G KP +
Sbjct: 206 LMHGVKPFQ 214

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 96  IAVKRV-SRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ----RQLILHKIALG-- 148
           +AVK + +    Q +  +  E+ I+  L H +++   G C +Q     QL++  + LG  
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 149 ----------LASAVLYLHEEWE-------QCIVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
                     LA  +L+  +  E       Q  +HR++ + NV+LD++   K+GDFGLA+
Sbjct: 106 RDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165
Query: 192 LVD--HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            V   HE           + + APEC+   K    SDV+SFGV   E+
Sbjct: 166 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 63/110 (57%), Gaps = 10/110 (9%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGS 199
           IL KIA+ +  A+ +LH +    ++HRD+K SNV++++    K+ DFG++  LVD     
Sbjct: 154 ILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD---SV 208
Query: 200 QTTVLAGTMGYLAPECVTTGKASK----ESDVYSFGVVALEVACGRKPVE 245
             T+ AG   Y+APE +      K    +SD++S G+  +E+A  R P +
Sbjct: 209 AKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 258

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 38/166 (22%)
Query: 109 KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-------------------------- 142
           K E ++E  ++ +L +  +V +IG C  +  +++                          
Sbjct: 414 KDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE 473
Query: 143 --HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELG 198
             H++++G+     YL E      VHRD+ + NV+L +   AK+ DFGL++ +  D    
Sbjct: 474 LVHQVSMGMK----YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526
Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKP 243
              T     + + APEC+   K S +SDV+SFGV+  E  + G+KP
Sbjct: 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 38/166 (22%)
Query: 109 KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-------------------------- 142
           K E ++E  ++ +L +  +V +IG C  +  +++                          
Sbjct: 415 KDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE 474
Query: 143 --HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELG 198
             H++++G+     YL E      VHRD+ + NV+L +   AK+ DFGL++ +  D    
Sbjct: 475 LVHQVSMGMK----YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 527
Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKP 243
              T     + + APEC+   K S +SDV+SFGV+  E  + G+KP
Sbjct: 528 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 8/106 (7%)
Query: 146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQTTV 203
           A  + SA+++LH+   + I++RD+K  NV+LD   + KL DFG+ +  + +   G  T  
Sbjct: 130 AAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN---GVTTAT 183
Query: 204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
             GT  Y+APE +         D ++ GV+  E+ CG  P E   E
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 84/173 (48%), Gaps = 28/173 (16%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLV-----HLIG---WCH----------- 135
           ++AVK +    +Q ++   +EV I+   +H N+V     +L+G   W             
Sbjct: 72  QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD 131
Query: 136 --EQRQLILHKIAL---GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
              Q +L   +IA     +  A+ YLH    Q ++HRDIKS +++L  +   KL DFG  
Sbjct: 132 IVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFC 188
Query: 191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             +  ++  +   L GT  ++APE ++    + E D++S G++ +E+  G  P
Sbjct: 189 AQISKDVPKRKX-LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 52/202 (25%)
Query: 88  LLSDQNTE-IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----- 141
           LL +Q+   +AVK +   S+  ++++  E  +++ L+H+++V   G C E R L+     
Sbjct: 65  LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124
Query: 142 -----------------------------------LHKIALGLASAVLYLHEEWEQCIVH 166
                                              L  +A  +A+ ++YL        VH
Sbjct: 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVH 181
Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLV----DHELGSQTTVLAGTMGYLAPECVTTGKAS 222
           RD+ + N ++      K+GDFG++R +     + +G +T +    + ++ PE +   K +
Sbjct: 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML---PIRWMPPESILYRKFT 238
Query: 223 KESDVYSFGVVALEV-ACGRKP 243
            ESDV+SFGVV  E+   G++P
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQP 260

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 51/86 (59%), Gaps = 6/86 (6%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           ++HRDIK  NV+L  N   KL DFG++  +D  +G + T + GT  ++APE +   +   
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPD 208
Query: 224 -----ESDVYSFGVVALEVACGRKPV 244
                +SD++S G+ A+E+A G  P+
Sbjct: 209 ATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 90/189 (47%), Gaps = 27/189 (14%)
Query: 84  VYRGL-LSDQNTEIAVK-RVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ 139
           V++G+ +S +N  +AV  +  +   S   +++++ E   + +  H ++V LIG   E   
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV 465
Query: 140 LIL---------------HKIALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLD 177
            I+                K +L LAS +LY ++             VHRDI + NV++ 
Sbjct: 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 525
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           +    KLGDFGL+R ++     + +     + ++APE +   + +  SDV+ FGV   E+
Sbjct: 526 ATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 585
Query: 238 AC-GRKPVE 245
              G KP +
Sbjct: 586 LMHGVKPFQ 594

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 84  VYRGLLSDQNTEIAVKRV---SRGSKQGKKEYISEVRIISRLRHRNLV------------ 128
           VYR         +A+K+V        + + + I E+ ++ +L H N++            
Sbjct: 48  VYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107
Query: 129 -------------HLIGWCHEQRQLILH----KIALGLASAVLYLHEEWEQCIVHRDIKS 171
                         +I    +Q++LI      K  + L SA+ ++H      ++HRDIK 
Sbjct: 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKP 164
Query: 172 SNVVLDSNFNAKLGDFGLARLVDHELGSQTTV---LAGTMGYLAPECVTTGKASKESDVY 228
           +NV + +    KLGD GL R       S+TT    L GT  Y++PE +     + +SD++
Sbjct: 165 ANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 220
Query: 229 SFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECL 288
           S G +  E+A  + P    +            +LY   + +E  D       D    E  
Sbjct: 221 SLGCLLYEMAALQSPFYGDK-----------MNLYSLCKKIEQCDYPPLPS-DHYSEELR 268
Query: 289 MIVGLWCCHPDFTNRPSIRQVINV 312
            +V + C +PD   RP +  V +V
Sbjct: 269 QLVNM-CINPDPEKRPDVTYVYDV 291

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 27/180 (15%)
Query: 92  QNTEIAVKRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL------- 142
           Q   +A+KR+   ++        I E+ ++  L H N+V LI   H +R L L       
Sbjct: 44  QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK 103
Query: 143 --------HKIALGLASAVLYLHEEW-------EQCIVHRDIKSSNVVLDSNFNAKLGDF 187
                   +K  L  +   +YL++         +  I+HRD+K  N++++S+   KL DF
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADF 163
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVT-TGKASKESDVYSFGVVALEVACGRKPVEP 246
           GLAR     + S T  +  T+ Y AP+ +  + K S   D++S G +  E+  G KP+ P
Sbjct: 164 GLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFP 221

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 27/180 (15%)
Query: 92  QNTEIAVKRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL------- 142
           Q   +A+KR+   ++        I E+ ++  L H N+V LI   H +R L L       
Sbjct: 44  QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK 103
Query: 143 --------HKIALGLASAVLYLHEEW-------EQCIVHRDIKSSNVVLDSNFNAKLGDF 187
                   +K  L  +   +YL++         +  I+HRD+K  N++++S+   KL DF
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADF 163
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVT-TGKASKESDVYSFGVVALEVACGRKPVEP 246
           GLAR     + S T  +  T+ Y AP+ +  + K S   D++S G +  E+  G KP+ P
Sbjct: 164 GLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFP 221

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 106/254 (41%), Gaps = 60/254 (23%)
Query: 85  YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI--- 141
           YRG       ++AVK +   +    + +++E  ++++LRH NLV L+G   E++  +   
Sbjct: 33  YRG------NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 84
Query: 142 -------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                                    L K +L +  A+ YL        VHRD+ + NV++
Sbjct: 85  TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLV 141
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
             +  AK+ DFGL +    E  S        + + APE +     S +SDV+SFG++  E
Sbjct: 142 SEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWE 197
Query: 237 V-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWC 295
           + + GR P         V  VE       KG  ++A DG     ++  +          C
Sbjct: 198 IYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPDGCPPAVYEVMKN---------C 241
Query: 296 CHPDFTNRPSIRQV 309
            H D   RPS  Q+
Sbjct: 242 WHLDAAMRPSFLQL 255

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 31/192 (16%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEY-ISEVRIISRLRHRNLVHLIGWCHEQRQLIL 142
           VY+GL       +A+K V   S++G     I E+ ++  L+H N+V L    H + +L L
Sbjct: 21  VYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80
Query: 143 -------------HKIALGLASAVLYL----HEEW----------EQCIVHRDIKSSNVV 175
                            +G     L L    + +W          E  I+HRD+K  N++
Sbjct: 81  VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLL 140
Query: 176 LDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVA 234
           ++     KLGDFGLAR     + + ++ +  T+ Y AP+ +   +    S D++S G + 
Sbjct: 141 INKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCIL 199
Query: 235 LEVACGRKPVEP 246
            E+  G KP+ P
Sbjct: 200 AEMITG-KPLFP 210

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 44/187 (23%)
Query: 96  IAVKRVSRGSKQGK-KEYISEVRIISRLRHRNLV---------------------HLIG- 132
           +A+K++S    Q   +  + E++I+ R RH N++                     HL+G 
Sbjct: 71  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGA 130
Query: 133 ----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA 182
                       ++     L++I  GL     Y+H      ++HRD+K SN++L++  + 
Sbjct: 131 DLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHRDLKPSNLLLNTTXDL 183
Query: 183 KLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVAC 239
           K+ DFGLAR+   DH+     T    T  Y APE +   K  +K  D++S G +  E+  
Sbjct: 184 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243
Query: 240 GRKPVEP 246
            R P+ P
Sbjct: 244 NR-PIFP 249

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 151 SAVLYLHEEWEQCIVHRDIKSSNVVL---DSNFNAKLGDFGLARLVDHELGSQTTVLAGT 207
           SAV YLHE     IVHRD+K  N++    + N    + DFGL+++   E     +   GT
Sbjct: 117 SAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGT 170
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            GY+APE +     SK  D +S GV+   + CG  P
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 96  EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 148
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 149 DLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 209 IDIWSVGCILAEMLSNR-PIFP 229

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 1/134 (0%)
Query: 112 YISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKS 171
           + +E R+   + + N   L+     QR+L         A   L L+   E+ I++RD+K 
Sbjct: 122 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 181
Query: 172 SNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFG 231
            NV+LDS  + KL D+G+ +      G  T+   GT  Y+APE +         D ++ G
Sbjct: 182 DNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG 240
Query: 232 VVALEVACGRKPVE 245
           V+  E+  GR P +
Sbjct: 241 VLMFEMMAGRSPFD 254

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 58/112 (51%), Gaps = 15/112 (13%)
Query: 137 QRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE 196
           +R + LH I L +A AV +LH +    ++HRD+K SN+    +   K+GDFGL   +D +
Sbjct: 116 ERSVCLH-IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171
Query: 197 LGSQTTVL-----------AGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              QT +             GT  Y++PE +     S + D++S G++  E+
Sbjct: 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 43/200 (21%)
Query: 86  RGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL--- 142
           +G  SD N  I         ++  +E  +E+ ++  L H N++ L     +++   L   
Sbjct: 76  KGRYSDDNKNI---------EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTE 126
Query: 143 --------------HK--------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVL---D 177
                         HK        I   + S + YLH+     IVHRDIK  N++L   +
Sbjct: 127 FYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKN 183
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           S  N K+ DFGL+     +   +  +  GT  Y+APE V   K +++ DV+S GV+   +
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKLRDRL--GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYIL 240
Query: 238 ACGRKPVEPRQEPSKVRLVE 257
            CG  P   + +   ++ VE
Sbjct: 241 LCGYPPFGGQNDQDIIKKVE 260

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 1/134 (0%)
Query: 112 YISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKS 171
           + +E R+   + + N   L+     QR+L         A   L L+   E+ I++RD+K 
Sbjct: 79  FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 138
Query: 172 SNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFG 231
            NV+LDS  + KL D+G+ +      G  T+   GT  Y+APE +         D ++ G
Sbjct: 139 DNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALG 197
Query: 232 VVALEVACGRKPVE 245
           V+  E+  GR P +
Sbjct: 198 VLMFEMMAGRSPFD 211

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 1/134 (0%)
Query: 112 YISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKS 171
           + +E R+   + + N   L+     QR+L         A   L L+   E+ I++RD+K 
Sbjct: 90  FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 149
Query: 172 SNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFG 231
            NV+LDS  + KL D+G+ +      G  T+   GT  Y+APE +         D ++ G
Sbjct: 150 DNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALG 208
Query: 232 VVALEVACGRKPVE 245
           V+  E+  GR P +
Sbjct: 209 VLMFEMMAGRSPFD 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/146 (33%), Positives = 72/146 (49%), Gaps = 15/146 (10%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIK 170
           E  +EV II  L   +L  +I         I + I   L  AV  LH      ++HRD+K
Sbjct: 84  ENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL-RAVKVLHG---SNVIHRDLK 139
Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELG---------SQTTVLAGTMGYLAPEC-VTTGK 220
            SN++++SN + K+ DFGLAR++D             S  T    T  Y APE  +T+ K
Sbjct: 140 PSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAK 199
Query: 221 ASKESDVYSFGVVALEVACGRKPVEP 246
            S+  DV+S G +  E+   R+P+ P
Sbjct: 200 YSRAMDVWSCGCILAELFL-RRPIFP 224

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 1/134 (0%)
Query: 112 YISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKS 171
           + +E R+   + + N   L+     QR+L         A   L L+   E+ I++RD+K 
Sbjct: 75  FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 134
Query: 172 SNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFG 231
            NV+LDS  + KL D+G+ +      G  T+   GT  Y+APE +         D ++ G
Sbjct: 135 DNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALG 193
Query: 232 VVALEVACGRKPVE 245
           V+  E+  GR P +
Sbjct: 194 VLMFEMMAGRSPFD 207

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 100 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 152
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 153 DLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 212
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 213 IDIWSVGCILAEMLSNR-PIFP 233

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 96  EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 148
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 149 DLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 209 IDIWSVGCILAEMLSNR-PIFP 229

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/146 (33%), Positives = 72/146 (49%), Gaps = 15/146 (10%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIK 170
           E  +EV II  L   +L  +I         I + I   L  AV  LH      ++HRD+K
Sbjct: 84  ENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL-RAVKVLHG---SNVIHRDLK 139
Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELG---------SQTTVLAGTMGYLAPEC-VTTGK 220
            SN++++SN + K+ DFGLAR++D             S  T    T  Y APE  +T+ K
Sbjct: 140 PSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAK 199
Query: 221 ASKESDVYSFGVVALEVACGRKPVEP 246
            S+  DV+S G +  E+   R+P+ P
Sbjct: 200 YSRAMDVWSCGCILAELFL-RRPIFP 224

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 100 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 152
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 153 DLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 212
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 213 IDIWSVGCILAEMLSNR-PIFP 233

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 96  EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 148
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 149 DLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 209 IDIWSVGCILAEMLSNR-PIFP 229

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 60/107 (56%), Gaps = 10/107 (9%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL-GSQTT 202
           +I++GL     +LH+   + I++RD+K  NV+LDS  + K+ DFG+ +  +H + G  T 
Sbjct: 128 EISIGL----FFLHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTR 178
Query: 203 VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
              GT  Y+APE +      K  D +++GV+  E+  G+ P +   E
Sbjct: 179 EFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 225

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/146 (33%), Positives = 75/146 (51%), Gaps = 15/146 (10%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIK 170
           E  +EV II  L   +L  +I         I + I   L  AV  LH      ++HRD+K
Sbjct: 84  ENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL-RAVKVLHG---SNVIHRDLK 139
Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHE-------LGSQTTVL--AGTMGYLAPEC-VTTGK 220
            SN++++SN + K+ DFGLAR++D          G Q+ ++    T  Y APE  +T+ K
Sbjct: 140 PSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAK 199
Query: 221 ASKESDVYSFGVVALEVACGRKPVEP 246
            S+  DV+S G +  E+   R+P+ P
Sbjct: 200 YSRAMDVWSCGCILAELFL-RRPIFP 224

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 98  EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 150
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 151 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 210
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 211 IDIWSVGCILAEMLSNR-PIFP 231

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 31/178 (17%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVL 154
           ++AVK +  GS   + E+  E + + +L H  LV   G C ++  + +    +     + 
Sbjct: 34  DVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN 92
Query: 155 YLHEE---------WEQC--------------IVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
           YL             E C               +HRD+ + N ++D +   K+ DFG+ R
Sbjct: 93  YLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152
Query: 192 LVDHELGSQTTVLAGT---MGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVE 245
            V   L  Q     GT   + + APE     K S +SDV++FG++  EV + G+ P +
Sbjct: 153 YV---LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 94  EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 146
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 147 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 206
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 207 IDIWSVGCILAEMLSNR-PIFP 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 94  EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 146
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 147 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 206
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 207 IDIWSVGCILAEMLSNR-PIFP 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 96  EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 148
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 149 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 209 IDIWSVGCILAEMLSNR-PIFP 229

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 25/161 (15%)
Query: 101 VSRGSKQGKKEYISEVRIISRLRHRNLVH-------------LIGWC---------HEQR 138
           +SR S + ++E   EV +++ ++H N+V              ++ +C         + Q+
Sbjct: 59  ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK 118
Query: 139 QLILH--KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE 196
            ++    +I        L L    ++ I+HRDIKS N+ L  +   +LGDFG+AR+++  
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178
Query: 197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           +      + GT  YL+PE       + +SD+++ G V  E+
Sbjct: 179 VELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 61/107 (57%), Gaps = 8/107 (7%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ 200
           IL KIA+ +  A+ +LH +    ++HRD+K SNV++++    K+ DFG++  +  ++   
Sbjct: 110 ILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD 167
Query: 201 TTVLAGTMGYLAPECVTTGKASK----ESDVYSFGVVALEVACGRKP 243
             + AG   Y+APE +      K    +SD++S G+  +E+A  R P
Sbjct: 168 --IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 100 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 152
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 212
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 213 IDIWSVGCILAEMLSNR-PIFP 233

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 101 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 153
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 154 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 213
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 214 IDIWSVGCILAEMLSNR-PIFP 234

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 102 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 154
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 155 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 214
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 215 IDIWSVGCILAEMLSNR-PIFP 235

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 93  EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 145
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 146 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 205
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 206 IDIWSVGCILAEMLSNR-PIFP 226

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 100 EQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 152
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 212
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 213 IDIWSVGCILAEMLSNR-PIFP 233

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 100 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 152
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 212
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 213 IDIWSVGCILAEMLSNR-PIFP 233

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 98  EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 150
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 151 DLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 210
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 211 IDIWSVGCILAEMLSNR-PIFP 231

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 98  EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 150
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 151 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 210
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 211 IDIWSVGCILAEMLSNR-PIFP 231

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 104 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 156
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 157 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 216
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 217 IDIWSVGCILAEMLSNR-PIFP 237

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 96  EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 148
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 149 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 209 IDIWSVGCILAEMLSNR-PIFP 229

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 12/108 (11%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQT 201
           +IA+GL     +L     + I++RD+K  NV+LDS  + K+ DFG+ +  + D   G  T
Sbjct: 129 EIAIGL----FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD---GVTT 178
Query: 202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
               GT  Y+APE +      K  D ++FGV+  E+  G+ P E   E
Sbjct: 179 KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 37/194 (19%)
Query: 84  VYRGLLSDQ---NTEIAVKRVSRGSKQGKKE-YISEVRIISRLRHRNLVHLIG------- 132
           VY G   DQ     + A+K +SR ++  + E ++ E  ++  L H N++ LIG       
Sbjct: 37  VYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96
Query: 133 --------WCH----------EQRQLILHKIALGL--ASAVLYLHEEWEQCIVHRDIKSS 172
                    CH          ++   +   I+ GL  A  + YL E   Q  VHRD+ + 
Sbjct: 97  LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAAR 153
Query: 173 NVVLDSNFNAKLGDFGLAR-LVDHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYS 229
           N +LD +F  K+ DFGLAR ++D E  S  Q       + + A E + T + + +SDV+S
Sbjct: 154 NCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWS 213
Query: 230 FGVVALEVACGRKP 243
           FGV+  E+     P
Sbjct: 214 FGVLLWELLTRGAP 227

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 121/270 (44%), Gaps = 61/270 (22%)
Query: 91  DQNTEIAVKRVSRGSKQGKKE-YISEVRIISRL-RHRNLVHLIGWC-HEQRQLILHKI-- 145
           D   ++AVK +   +   +KE  +SE++I+S L +H N+V+L+G C H    L++ +   
Sbjct: 74  DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 146 -------------------ALGLASA------VLYLHEEWEQCI--------VHRDIKSS 172
                              A  +A++      +L+   +  Q +        +HRD+ + 
Sbjct: 134 YGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAAR 193
Query: 173 NVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECVTTGKASKESDVY 228
           NV+L +   AK+GDFGLAR +   +     ++ G     + ++APE +     + +SDV+
Sbjct: 194 NVLLTNGHVAKIGDFGLARDI---MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 229 SFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMEC 287
           S+G++  E+ + G  P       SK    + V D Y   Q            F  + +  
Sbjct: 251 SYGILLWEIFSLGLNPYPGILVNSK--FYKLVKDGYQMAQ----------PAFAPKNIYS 298
Query: 288 LMIVGLWCCHPDFTNRPSIRQVINVLNFEA 317
           +M    W   P  T+RP+ +Q+ + L  +A
Sbjct: 299 IM-QACWALEP--THRPTFQQICSFLQEQA 325

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 121/270 (44%), Gaps = 61/270 (22%)
Query: 91  DQNTEIAVKRVSRGSKQGKKE-YISEVRIISRL-RHRNLVHLIGWC-HEQRQLILHKI-- 145
           D   ++AVK +   +   +KE  +SE++I+S L +H N+V+L+G C H    L++ +   
Sbjct: 74  DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 146 -------------------ALGLASA------VLYLHEEWEQCI--------VHRDIKSS 172
                              A  +A++      +L+   +  Q +        +HRD+ + 
Sbjct: 134 YGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAAR 193
Query: 173 NVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECVTTGKASKESDVY 228
           NV+L +   AK+GDFGLAR +   +     ++ G     + ++APE +     + +SDV+
Sbjct: 194 NVLLTNGHVAKIGDFGLARDI---MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 229 SFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMEC 287
           S+G++  E+ + G  P       SK    + V D Y   Q            F  + +  
Sbjct: 251 SYGILLWEIFSLGLNPYPGILVNSK--FYKLVKDGYQMAQ----------PAFAPKNIYS 298
Query: 288 LMIVGLWCCHPDFTNRPSIRQVINVLNFEA 317
           +M    W   P  T+RP+ +Q+ + L  +A
Sbjct: 299 IM-QACWALEP--THRPTFQQICSFLQEQA 325

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 34/175 (19%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL-------------G 198
           A+ Y+H    Q I+HRD+K  N+ +D + N K+GDFGLA+ V   L              
Sbjct: 128 ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 199 SQTTVLAGTMGYLAPECVT-TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVE 257
              T   GT  Y+A E +  TG  +++ D+YS G++  E+     P     E  +V ++ 
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME--RVNIL- 238
Query: 258 WVWDLYGKGQLLEAADGRLSKEFDERQMEC-LMIVGLWCCHPDFTNRPSIRQVIN 311
                    + L +       +FD+ +M+    I+ L   H D   RP  R ++N
Sbjct: 239 ---------KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDH-DPNKRPGARTLLN 283

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 34/175 (19%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL-------------G 198
           A+ Y+H    Q I+HRD+K  N+ +D + N K+GDFGLA+ V   L              
Sbjct: 128 ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 199 SQTTVLAGTMGYLAPECVT-TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVE 257
              T   GT  Y+A E +  TG  +++ D+YS G++  E+     P     E  +V ++ 
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME--RVNIL- 238
Query: 258 WVWDLYGKGQLLEAADGRLSKEFDERQMEC-LMIVGLWCCHPDFTNRPSIRQVIN 311
                    + L +       +FD+ +M+    I+ L   H D   RP  R ++N
Sbjct: 239 ---------KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDH-DPNKRPGARTLLN 283

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 2/134 (1%)
Query: 112 YISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKS 171
           + +E ++   L + N   L     ++ +   H++ + +   VL L    +  I++RDIK 
Sbjct: 128 FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 187
Query: 172 SNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA--SKESDVYS 229
            N++LDSN +  L DFGL++    +   +     GT+ Y+AP+ V  G +   K  D +S
Sbjct: 188 ENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWS 247
Query: 230 FGVVALEVACGRKP 243
            GV+  E+  G  P
Sbjct: 248 LGVLMYELLTGASP 261

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 116 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 168
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+     T    T  Y APE +   K  +K 
Sbjct: 169 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 228
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 229 IDIWSVGCILAEMLSNR-PIFP 249

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 11/139 (7%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 146
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR        +  V+  T  Y APE +      
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV--TRYYRAPEVILGMGYK 203
Query: 223 KESDVYSFGVVALEVACGR 241
           +  D++S G +  E+ C +
Sbjct: 204 ENVDIWSVGCIMGEMVCHK 222

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 6/102 (5%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + S + +LH+   + I++RD+K  NV+LD + N ++ D GLA  V+ + G ++T   AGT
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGT 352
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
            G++APE +   +     D ++ GV   E+   R P   R E
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 6/102 (5%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + S + +LH+   + I++RD+K  NV+LD + N ++ D GLA  V+ + G ++T   AGT
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGT 352
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
            G++APE +   +     D ++ GV   E+   R P   R E
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 6/102 (5%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + S + +LH+   + I++RD+K  NV+LD + N ++ D GLA  V+ + G ++T   AGT
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGT 352
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
            G++APE +   +     D ++ GV   E+   R P   R E
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 42/197 (21%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLR---HRNLVHLIGWCHEQR 138
           VY+         +A+K  RV  G +      + EV ++ RL    H N+V L+  C   R
Sbjct: 20  VYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 79
Query: 139 QLILHKIAL-------------------GLASAVL------------YLHEEWEQCIVHR 167
                K+ L                   GL +  +            +LH     CIVHR
Sbjct: 80  TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHR 136
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           D+K  N+++ S    KL DFGLAR+  +++     V+  T+ Y APE +     +   D+
Sbjct: 137 DLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV--TLWYRAPEVLLQSTYATPVDM 194
Query: 228 YSFGVVALEVACGRKPV 244
           +S G +  E+   RKP+
Sbjct: 195 WSVGCIFAEM-FRRKPL 210

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/84 (38%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT-----G 219
           VHRDIK  NV+LD N + +L DFG    ++ +   Q++V  GT  Y++PE +       G
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 220 KASKESDVYSFGVVALEVACGRKP 243
           K   E D +S GV   E+  G  P
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/84 (38%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT-----G 219
           VHRDIK  NV+LD N + +L DFG    ++ +   Q++V  GT  Y++PE +       G
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 220 KASKESDVYSFGVVALEVACGRKP 243
           K   E D +S GV   E+  G  P
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 6/102 (5%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGT 207
           + S + +LH+   + I++RD+K  NV+LD + N ++ D GLA  V+ + G ++T   AGT
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGT 352
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
            G++APE +   +     D ++ GV   E+   R P   R E
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/88 (39%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL 211
           A+ +LH    Q +VH D+K +N+ L      KLGDFGL  LV+        V  G   Y+
Sbjct: 169 ALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYM 223
Query: 212 APECVTTGKASKESDVYSFGVVALEVAC 239
           APE +  G     +DV+S G+  LEVAC
Sbjct: 224 APELL-QGSYGTAADVFSLGLTILEVAC 250

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 12/108 (11%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR--LVDHELGSQT 201
           +IA+GL     +L     + I++RD+K  NV+LDS  + K+ DFG+ +  + D   G  T
Sbjct: 450 EIAIGL----FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD---GVTT 499
Query: 202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
               GT  Y+APE +      K  D ++FGV+  E+  G+ P E   E
Sbjct: 500 KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 84/185 (45%), Gaps = 32/185 (17%)
Query: 91  DQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC--HEQRQLILHKIALG 148
           + +T++AVK +  G+    + ++ E  ++  L+H  LV L       E   +I   +A G
Sbjct: 35  NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKG 93
Query: 149 -------------------------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAK 183
                                    +A  + Y+     +  +HRD++++NV++  +   K
Sbjct: 94  SLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCK 150
Query: 184 LGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRK 242
           + DFGLAR+++    +        + + APE +  G  + +SDV+SFG++  E+   G+ 
Sbjct: 151 IADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKI 210
Query: 243 PVEPR 247
           P   R
Sbjct: 211 PYPGR 215

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 42/197 (21%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLR---HRNLVHLIGWCHEQR 138
           VY+         +A+K  RV  G +      + EV ++ RL    H N+V L+  C   R
Sbjct: 20  VYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 79
Query: 139 QLILHKIAL-------------------GLASAVL------------YLHEEWEQCIVHR 167
                K+ L                   GL +  +            +LH     CIVHR
Sbjct: 80  TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHR 136
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           D+K  N+++ S    KL DFGLAR+  +++     V+  T+ Y APE +     +   D+
Sbjct: 137 DLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV--TLWYRAPEVLLQSTYATPVDM 194
Query: 228 YSFGVVALEVACGRKPV 244
           +S G +  E+   RKP+
Sbjct: 195 WSVGCIFAEM-FRRKPL 210

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 70/140 (50%), Gaps = 13/140 (9%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 146
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR        +  V+  T  Y APE V  G   
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV--TRYYRAPE-VILGMGY 202
Query: 223 KES-DVYSFGVVALEVACGR 241
           KE+ D++S G +  E+ C +
Sbjct: 203 KENVDLWSVGCIMGEMVCHK 222

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++ +G+     +LH     
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIK----HLHS---A 145
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 203
Query: 223 KESDVYSFGVVALEVACG 240
           +  D++S GV+  E+  G
Sbjct: 204 ENVDIWSVGVIMGEMIKG 221

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 27/175 (15%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
           ++A  +A  + YL+    +  VHRD+ + N ++  +F  K+GDFG+ R    ++      
Sbjct: 134 QMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXX 186
Query: 204 LAGTMG-----YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW 258
             G  G     ++APE +  G  +  SD++SFGVV  E+    +  +P Q  S  +++++
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKF 244
Query: 259 VWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           V D    G  L+  D    +  D  +M C      W  +P+   RP+  +++N+L
Sbjct: 245 VMD----GGYLDQPDNCPERVTDLMRM-C------WQFNPNM--RPTFLEIVNLL 286

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 118/269 (43%), Gaps = 63/269 (23%)
Query: 91  DQNTEIAVKRVSRGSKQGKKE-YISEVRIISRL-RHRNLVHLIGWC-------------- 134
           D   ++AVK +   +   +KE  +SE++I+S L +H N+V+L+G C              
Sbjct: 74  DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 135 ------------------HEQRQLILHKI---ALGLASAVLYLHEEWEQCIVHRDIKSSN 173
                              + R L L  +   +  +A  + +L  +   CI HRD+ + N
Sbjct: 134 YGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASK--NCI-HRDVAARN 190
Query: 174 VVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECVTTGKASKESDVYS 229
           V+L +   AK+GDFGLAR +   +     ++ G     + ++APE +     + +SDV+S
Sbjct: 191 VLLTNGHVAKIGDFGLARDI---MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 247
Query: 230 FGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECL 288
           +G++  E+ + G  P       SK    + V D Y   Q            F  + +  +
Sbjct: 248 YGILLWEIFSLGLNPYPGILVNSK--FYKLVKDGYQMAQ----------PAFAPKNIYSI 295
Query: 289 MIVGLWCCHPDFTNRPSIRQVINVLNFEA 317
           M    W   P  T+RP+ +Q+ + L  +A
Sbjct: 296 M-QACWALEP--THRPTFQQICSFLQEQA 321

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           +LH     CIVHRD+K  N+++ S    KL DFGLAR+  +++     V+  T+ Y APE
Sbjct: 135 FLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWYRAPE 189
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKPV 244
            +     +   D++S G +  E+   RKP+
Sbjct: 190 VLLQSTYATPVDMWSVGCIFAEM-FRRKPL 218

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 116/272 (42%), Gaps = 63/272 (23%)
Query: 91  DQNTEIAVKRVSRGSKQGKKE-YISEVRIISRL-RHRNLVHLIGWC-HEQRQLIL----- 142
           D   ++AVK +   +   +KE  +SE++I+S L +H N+V+L+G C H    L++     
Sbjct: 74  DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 133
Query: 143 ---------HKIALGLASAVLYLHEEWEQC-----------------------IVHRDIK 170
                     K   GL  +    H   EQ                         +HRD+ 
Sbjct: 134 YGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVA 193
Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECVTTGKASKESD 226
           + NV+L +   AK+GDFGLAR +   +     ++ G     + ++APE +     + +SD
Sbjct: 194 ARNVLLTNGHVAKIGDFGLARDI---MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSD 250
Query: 227 VYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM 285
           V+S+G++  E+ + G  P       SK    + V D Y   Q            F  + +
Sbjct: 251 VWSYGILLWEIFSLGLNPYPGILVNSK--FYKLVKDGYQMAQ----------PAFAPKNI 298
Query: 286 ECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA 317
             +M    W   P  T+RP+ +Q+ + L  +A
Sbjct: 299 YSIM-QACWALEP--THRPTFQQICSFLQEQA 327

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++ +G+     +LH     
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIK----HLHS---A 145
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 203
Query: 223 KESDVYSFGVVALEVACG 240
           +  D++S GV+  E+  G
Sbjct: 204 ENVDIWSVGVIMGEMIKG 221

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 60/110 (54%), Gaps = 10/110 (9%)
Query: 133 WCHEQRQLILHKI-ALGL----ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF 187
           W  ++R   L K+ AL L       V Y+H    + ++HRD+K SN+ L      K+GDF
Sbjct: 124 WIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           GL   + ++   + T   GT+ Y++PE +++    KE D+Y+ G++  E+
Sbjct: 181 GLVTSLKND--GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 52/103 (50%), Gaps = 4/103 (3%)
Query: 146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA 205
           A  +ASA+ YLH      IV+RD+K  N++LDS  +  L DFGL +  + E  S T+   
Sbjct: 145 AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFC 200
Query: 206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQ 248
           GT  YLAPE +      +  D +  G V  E+  G  P   R 
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 42/197 (21%)
Query: 84  VYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLR---HRNLVHLIGWCHEQR 138
           VY+         +A+K  RV  G +      + EV ++ RL    H N+V L+  C   R
Sbjct: 20  VYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 79
Query: 139 QLILHKIAL-------------------GLASAVL------------YLHEEWEQCIVHR 167
                K+ L                   GL +  +            +LH     CIVHR
Sbjct: 80  TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHR 136
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           D+K  N+++ S    KL DFGLAR+  +++     V+  T+ Y APE +     +   D+
Sbjct: 137 DLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV--TLWYRAPEVLLQSTYATPVDM 194
Query: 228 YSFGVVALEVACGRKPV 244
           +S G +  E+   RKP+
Sbjct: 195 WSVGCIFAEM-FRRKPL 210

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           E+ I S LRH N++ +  + H++++  L+L     G                       L
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL 124
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A A+ Y HE   + ++HRDIK  N+++      K+ DFG +    H    +   + GT+ 
Sbjct: 125 ADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLD 178
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++  GV+  E   G  P +
Sbjct: 179 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 65/270 (24%)
Query: 91  DQNTEIAVKRVSRGSKQGKKE-YISEVRIISRL-RHRNLVHLIGWC-------------- 134
           D   ++AVK +   +   +KE  +SE++I+S L +H N+V+L+G C              
Sbjct: 66  DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 125
Query: 135 ------------------HEQRQL----ILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                              + R L    +LH  +  +A  + +L  +   CI HRD+ + 
Sbjct: 126 YGDLLNFLRRKAEADLDKEDGRPLELRDLLH-FSSQVAQGMAFLASK--NCI-HRDVAAR 181
Query: 173 NVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECVTTGKASKESDVY 228
           NV+L +   AK+GDFGLAR +   +     ++ G     + ++APE +     + +SDV+
Sbjct: 182 NVLLTNGHVAKIGDFGLARDI---MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 238
Query: 229 SFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMEC 287
           S+G++  E+ + G  P       SK    + V D Y   Q            F  + +  
Sbjct: 239 SYGILLWEIFSLGLNPYPGILVNSK--FYKLVKDGYQMAQ----------PAFAPKNIYS 286
Query: 288 LMIVGLWCCHPDFTNRPSIRQVINVLNFEA 317
           +M    W   P  T+RP+ +Q+ + L  +A
Sbjct: 287 IM-QACWALEP--THRPTFQQICSFLQEQA 313

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           E+ I S LRH N++ +  + H++++  L+L     G                       L
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL 123
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A A+ Y HE   + ++HRDIK  N+++      K+ DFG +    H    +   + GT+ 
Sbjct: 124 ADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLD 177
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +      ++ D++  GV+  E   G  P +
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 121/270 (44%), Gaps = 54/270 (20%)
Query: 84  VYRGLLSDQ-NTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHE-QRQL 140
           V +G++ D+  T +A+K V+  +   ++ E+++E  ++      ++V L+G   + Q  L
Sbjct: 39  VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 98
Query: 141 ILHKIAL--GLASAVLYLHEEWEQC-----------------------------IVHRDI 169
           ++ ++     L S +  L  E E                                VHRD+
Sbjct: 99  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 158
Query: 170 KSSNVVLDSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
            + N ++  +F  K+GDFG+ R +   D+       +L   + +++PE +  G  +  SD
Sbjct: 159 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--VRWMSPESLKDGVFTTYSD 216
Query: 227 VYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME 286
           V+SFGVV  E+A   +  +P Q  S  +++ +V +    G LL+  D      F+  +M 
Sbjct: 217 VWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVME----GGLLDKPDNCPDMLFELMRM- 269
Query: 287 CLMIVGLWCCHPDFTNRPSIRQVINVLNFE 316
           C      W  +P    RPS  ++I+ +  E
Sbjct: 270 C------WQYNPKM--RPSFLEIISSIKEE 291

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 99  IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 151
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 152 TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 99  IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 151
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 152 TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKXQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 XELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 100 IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 152
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 153 TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 15/107 (14%)
Query: 142 LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT 201
           LH I + +A AV +LH    + ++HRD+K SN+    +   K+GDFGL   +D +   QT
Sbjct: 167 LH-IFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 202 TVLA-----------GTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            +             GT  Y++PE +     S + D++S G++  E+
Sbjct: 223 VLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 121/270 (44%), Gaps = 54/270 (20%)
Query: 84  VYRGLLSDQ-NTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHE-QRQL 140
           V +G++ D+  T +A+K V+  +   ++ E+++E  ++      ++V L+G   + Q  L
Sbjct: 67  VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 126
Query: 141 ILHKIAL--GLASAVLYLHEEWEQC-----------------------------IVHRDI 169
           ++ ++     L S +  L  E E                                VHRD+
Sbjct: 127 VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 186
Query: 170 KSSNVVLDSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
            + N ++  +F  K+GDFG+ R +   D+       +L   + +++PE +  G  +  SD
Sbjct: 187 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--VRWMSPESLKDGVFTTYSD 244
Query: 227 VYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME 286
           V+SFGVV  E+A   +  +P Q  S  +++ +V +    G LL+  D      F+  +M 
Sbjct: 245 VWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVME----GGLLDKPDNCPDMLFELMRM- 297
Query: 287 CLMIVGLWCCHPDFTNRPSIRQVINVLNFE 316
           C      W  +P    RPS  ++I+ +  E
Sbjct: 298 C------WQYNPKM--RPSFLEIISSIKEE 319

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 121/270 (44%), Gaps = 54/270 (20%)
Query: 84  VYRGLLSDQ-NTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHE-QRQL 140
           V +G++ D+  T +A+K V+  +   ++ E+++E  ++      ++V L+G   + Q  L
Sbjct: 45  VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104
Query: 141 ILHKIAL--GLASAVLYLHEEWEQC-----------------------------IVHRDI 169
           ++ ++     L S +  L  E E                                VHRD+
Sbjct: 105 VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 164
Query: 170 KSSNVVLDSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
            + N ++  +F  K+GDFG+ R +   D+       +L   + +++PE +  G  +  SD
Sbjct: 165 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--VRWMSPESLKDGVFTTYSD 222
Query: 227 VYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME 286
           V+SFGVV  E+A   +  +P Q  S  +++ +V +    G LL+  D      F+  +M 
Sbjct: 223 VWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVME----GGLLDKPDNCPDMLFELMRM- 275
Query: 287 CLMIVGLWCCHPDFTNRPSIRQVINVLNFE 316
           C      W  +P    RPS  ++I+ +  E
Sbjct: 276 C------WQYNPKM--RPSFLEIISSIKEE 297

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 69/140 (49%), Gaps = 13/140 (9%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 87  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 140
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE V  G   
Sbjct: 141 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPE-VILGMGY 196
Query: 223 KES-DVYSFGVVALEVACGR 241
           KE+ D++S G +  E+ C +
Sbjct: 197 KENVDLWSVGCIMGEMVCHK 216

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 27/175 (15%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
           ++A  +A  + YL+    +  VHRD+ + N ++  +F  K+GDFG+ R    ++      
Sbjct: 131 QMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXX 183
Query: 204 LAGTMG-----YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW 258
             G  G     ++APE +  G  +  SD++SFGVV  E+    +  +P Q  S  +++++
Sbjct: 184 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKF 241
Query: 259 VWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           V D    G  L+  D    +  D  +M C      W  +P    RP+  +++N+L
Sbjct: 242 VMD----GGYLDQPDNCPERVTDLMRM-C------WQFNPKM--RPTFLEIVNLL 283

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 121/270 (44%), Gaps = 54/270 (20%)
Query: 84  VYRGLLSDQ-NTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHE-QRQL 140
           V +G++ D+  T +A+K V+  +   ++ E+++E  ++      ++V L+G   + Q  L
Sbjct: 36  VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 95
Query: 141 ILHKIAL--GLASAVLYLHEEWEQC-----------------------------IVHRDI 169
           ++ ++     L S +  L  E E                                VHRD+
Sbjct: 96  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 155
Query: 170 KSSNVVLDSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
            + N ++  +F  K+GDFG+ R +   D+       +L   + +++PE +  G  +  SD
Sbjct: 156 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--VRWMSPESLKDGVFTTYSD 213
Query: 227 VYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME 286
           V+SFGVV  E+A   +  +P Q  S  +++ +V +    G LL+  D      F+  +M 
Sbjct: 214 VWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVME----GGLLDKPDNCPDMLFELMRM- 266
Query: 287 CLMIVGLWCCHPDFTNRPSIRQVINVLNFE 316
           C      W  +P    RPS  ++I+ +  E
Sbjct: 267 C------WQYNPKM--RPSFLEIISSIKEE 288

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 99  IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 151
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 100 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 152
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+          T  Y APE +   K  +K 
Sbjct: 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKS 212
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 213 IDIWSVGCILAEMLSNR-PIFP 233

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 14/142 (9%)
Query: 111 EYISEVRIISRLRHRNLVHLIGWCHEQRQLI---LHKIALGLASAVLYLHEEWEQCIVHR 167
           E + +V I+  L   +L  L+   H     I   L++I  GL     Y+H      ++HR
Sbjct: 101 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS---ANVLHR 153
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA-SKE 224
           D+K SN++L++  + K+ DFGLAR+   DH+          T  Y APE +   K  +K 
Sbjct: 154 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKS 213
Query: 225 SDVYSFGVVALEVACGRKPVEP 246
            D++S G +  E+   R P+ P
Sbjct: 214 IDIWSVGCILAEMLSNR-PIFP 234

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 121/270 (44%), Gaps = 54/270 (20%)
Query: 84  VYRGLLSDQ-NTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHE-QRQL 140
           V +G++ D+  T +A+K V+  +   ++ E+++E  ++      ++V L+G   + Q  L
Sbjct: 38  VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 97
Query: 141 ILHKIAL--GLASAVLYLHEEWEQC-----------------------------IVHRDI 169
           ++ ++     L S +  L  E E                                VHRD+
Sbjct: 98  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 157
Query: 170 KSSNVVLDSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
            + N ++  +F  K+GDFG+ R +   D+       +L   + +++PE +  G  +  SD
Sbjct: 158 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--VRWMSPESLKDGVFTTYSD 215
Query: 227 VYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME 286
           V+SFGVV  E+A   +  +P Q  S  +++ +V +    G LL+  D      F+  +M 
Sbjct: 216 VWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVME----GGLLDKPDNCPDMLFELMRM- 268
Query: 287 CLMIVGLWCCHPDFTNRPSIRQVINVLNFE 316
           C      W  +P    RPS  ++I+ +  E
Sbjct: 269 C------WQYNPKM--RPSFLEIISSIKEE 290

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 87/173 (50%), Gaps = 23/173 (13%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV---DHELGSQ 200
           ++A  +A  + YL+    +  VHRD+ + N ++  +F  K+GDFG+ R +   D+     
Sbjct: 134 QMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 190
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW 260
             +L   + ++APE +  G  +  SD++SFGVV  E+    +  +P Q  S  +++++V 
Sbjct: 191 KGLLP--VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVM 246
Query: 261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           D    G  L+  D    +  D  +M C      W  +P    RP+  +++N+L
Sbjct: 247 D----GGYLDQPDNCPERVTDLMRM-C------WQFNPKM--RPTFLEIVNLL 286

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 86/172 (50%), Gaps = 21/172 (12%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
           ++A  +A  + YL+    +  VHRD+ + N ++  +F  K+GDFG+ R + +E       
Sbjct: 134 QMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETAYYRKG 189
Query: 204 LAGTMG--YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWD 261
             G +   ++APE +  G  +  SD++SFGVV  E+    +  +P Q  S  +++++V D
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVMD 247
Query: 262 LYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
               G  L+  D    +  D  +M C      W  +P    RP+  +++N+L
Sbjct: 248 ----GGYLDQPDNCPERVTDLMRM-C------WQFNPKM--RPTFLEIVNLL 286

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 98  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 151
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 152 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 208
Query: 223 KESDVYSFGVVALEVACGR 241
           +  D++S G +  E+ C +
Sbjct: 209 ENVDLWSVGCIMGEMVCHK 227

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 99  IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 151
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 152 TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 27/175 (15%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
           ++A  +A  + YL+    +  VHRD+ + N ++  +F  K+GDFG+ R    ++      
Sbjct: 134 QMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXX 186
Query: 204 LAGTMG-----YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW 258
             G  G     ++APE +  G  +  SD++SFGVV  E+    +  +P Q  S  +++++
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKF 244
Query: 259 VWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           V D    G  L+  D    +  D  +M C      W  +P    RP+  +++N+L
Sbjct: 245 VMD----GGYLDQPDNCPERVTDLMRM-C------WQFNPKM--RPTFLEIVNLL 286

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 55  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 113
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 114 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 166
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 167 XELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222
Query: 239 CGR 241
            GR
Sbjct: 223 TGR 225

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 98  IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 150
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 121/270 (44%), Gaps = 54/270 (20%)
Query: 84  VYRGLLSDQ-NTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHE-QRQL 140
           V +G++ D+  T +A+K V+  +   ++ E+++E  ++      ++V L+G   + Q  L
Sbjct: 32  VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 91
Query: 141 ILHKIAL--GLASAVLYLHEEWEQC-----------------------------IVHRDI 169
           ++ ++     L S +  L  E E                                VHRD+
Sbjct: 92  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 151
Query: 170 KSSNVVLDSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
            + N ++  +F  K+GDFG+ R +   D+       +L   + +++PE +  G  +  SD
Sbjct: 152 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--VRWMSPESLKDGVFTTYSD 209
Query: 227 VYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME 286
           V+SFGVV  E+A   +  +P Q  S  +++ +V +    G LL+  D      F+  +M 
Sbjct: 210 VWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVME----GGLLDKPDNCPDMLFELMRM- 262
Query: 287 CLMIVGLWCCHPDFTNRPSIRQVINVLNFE 316
           C      W  +P    RPS  ++I+ +  E
Sbjct: 263 C------WQYNPKM--RPSFLEIISSIKEE 284

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 87/173 (50%), Gaps = 23/173 (13%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV---DHELGSQ 200
           ++A  +A  + YL+    +  VHRD+ + N ++  +F  K+GDFG+ R +   D+     
Sbjct: 133 QMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW 260
             +L   + ++APE +  G  +  SD++SFGVV  E+    +  +P Q  S  +++++V 
Sbjct: 190 KGLLP--VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVM 245
Query: 261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           D    G  L+  D    +  D  +M C      W  +P    RP+  +++N+L
Sbjct: 246 D----GGYLDQPDNCPERVTDLMRM-C------WQFNPKM--RPTFLEIVNLL 285

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/272 (23%), Positives = 119/272 (43%), Gaps = 58/272 (21%)
Query: 84  VYRGLLSDQ-NTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHE-QRQL 140
           V +G++ D+  T +A+K V+  +   ++ E+++E  ++      ++V L+G   + Q  L
Sbjct: 39  VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 98
Query: 141 ILHKIAL--GLASAVLYLHEEWEQC-----------------------------IVHRDI 169
           ++ ++     L S +  L  E E                                VHRD+
Sbjct: 99  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 158
Query: 170 KSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG-----YLAPECVTTGKASKE 224
            + N ++  +F  K+GDFG+ R    ++        G  G     +++PE +  G  +  
Sbjct: 159 AARNCMVAEDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTY 214
Query: 225 SDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ 284
           SDV+SFGVV  E+A   +  +P Q  S  +++ +V +    G LL+  D      F+  +
Sbjct: 215 SDVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVME----GGLLDKPDNCPDMLFELMR 268
Query: 285 MECLMIVGLWCCHPDFTNRPSIRQVINVLNFE 316
           M C      W  +P    RPS  ++I+ +  E
Sbjct: 269 M-C------WQYNPKM--RPSFLEIISSIKEE 291

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 121/270 (44%), Gaps = 54/270 (20%)
Query: 84  VYRGLLSDQ-NTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHE-QRQL 140
           V +G++ D+  T +A+K V+  +   ++ E+++E  ++      ++V L+G   + Q  L
Sbjct: 38  VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 97
Query: 141 ILHKIAL--GLASAVLYLHEEWEQC-----------------------------IVHRDI 169
           ++ ++     L S +  L  E E                                VHRD+
Sbjct: 98  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 157
Query: 170 KSSNVVLDSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
            + N ++  +F  K+GDFG+ R +   D+       +L   + +++PE +  G  +  SD
Sbjct: 158 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--VRWMSPESLKDGVFTTYSD 215
Query: 227 VYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME 286
           V+SFGVV  E+A   +  +P Q  S  +++ +V +    G LL+  D      F+  +M 
Sbjct: 216 VWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVME----GGLLDKPDNCPDMLFELMRM- 268
Query: 287 CLMIVGLWCCHPDFTNRPSIRQVINVLNFE 316
           C      W  +P    RPS  ++I+ +  E
Sbjct: 269 C------WQYNPKM--RPSFLEIISSIKEE 290

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 55  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 113
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 114 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 166
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 167 XELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222
Query: 239 CGR 241
            GR
Sbjct: 223 TGR 225

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 99  IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 151
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 100 IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 152
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 99  IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 151
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 152 TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 99  IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 151
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 100 IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 152
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 99  IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 151
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 99  IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 151
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 44/191 (23%)
Query: 92  QNTEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRNL-----------------VHLIGW 133
           + T +A+K++S    Q   +  + E++I+ R RH N+                 V+++  
Sbjct: 67  RKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQD 126
Query: 134 CHE--------QRQL-------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS 178
             E         +QL        L++I  GL     Y+H      ++HRD+K SN+++++
Sbjct: 127 LMETDLYKLLKSQQLSNDHICYFLYQILRGLK----YIHS---ANVLHRDLKPSNLLINT 179
Query: 179 NFNAKLGDFGLARLVD--HELGSQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVAL 235
             + K+ DFGLAR+ D  H+     T    T  Y APE +   K  +K  D++S G +  
Sbjct: 180 TCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 239
Query: 236 EVACGRKPVEP 246
           E+   R P+ P
Sbjct: 240 EMLSNR-PIFP 249

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 100 IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 152
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 99  IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 151
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 99  IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 151
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 100 IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 152
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 100 IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 152
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 99  IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 151
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 61  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 119
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 120 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 172
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 173 XELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 228
Query: 239 CGR 241
            GR
Sbjct: 229 TGR 231

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 100 IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 152
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 122/273 (44%), Gaps = 60/273 (21%)
Query: 84  VYRGLLSDQ-NTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHE-QRQL 140
           V +G++ D+  T +A+K V+  +   ++ E+++E  ++      ++V L+G   + Q  L
Sbjct: 35  VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 94
Query: 141 ILH----------------------------------KIALGLASAVLYLHEEWEQCIVH 166
           ++                                   ++A  +A  + YL+       VH
Sbjct: 95  VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVH 151
Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           RD+ + N ++  +F  K+GDFG+ R +   D+       +L   + +++PE +  G  + 
Sbjct: 152 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--VRWMSPESLKDGVFTT 209
Query: 224 ESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER 283
            SDV+SFGVV  E+A   +  +P Q  S  +++ +V +    G LL+  D      F+  
Sbjct: 210 YSDVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVME----GGLLDKPDNCPDMLFELM 263
Query: 284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE 316
           +M C      W  +P    RPS  ++I+ +  E
Sbjct: 264 RM-C------WQYNPKM--RPSFLEIISSIKEE 287

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 9/115 (7%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           IG      Q   H++  G    V+YLH      I HRDIK  N++LD   N K+ DFGLA
Sbjct: 100 IGMPEPDAQRFFHQLMAG----VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLA 152
Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKP 243
            +  +    +    + GT+ Y+APE +   +   E  DV+S G+V   +  G  P
Sbjct: 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 122/273 (44%), Gaps = 60/273 (21%)
Query: 84  VYRGLLSDQ-NTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHE-QRQL 140
           V +G++ D+  T +A+K V+  +   ++ E+++E  ++      ++V L+G   + Q  L
Sbjct: 45  VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104
Query: 141 ILH----------------------------------KIALGLASAVLYLHEEWEQCIVH 166
           ++                                   ++A  +A  + YL+       VH
Sbjct: 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVH 161
Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           RD+ + N ++  +F  K+GDFG+ R +   D+       +L   + +++PE +  G  + 
Sbjct: 162 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--VRWMSPESLKDGVFTT 219
Query: 224 ESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER 283
            SDV+SFGVV  E+A   +  +P Q  S  +++ +V +    G LL+  D      F+  
Sbjct: 220 YSDVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVME----GGLLDKPDNCPDMLFELM 273
Query: 284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE 316
           +M C      W  +P    RPS  ++I+ +  E
Sbjct: 274 RM-C------WQYNPKM--RPSFLEIISSIKEE 297

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 18/111 (16%)
Query: 144 KIALGLASAVLYLHEE-----WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG 198
           K+AL  AS + +LH E      +  I HRD+KS N+++  N    + D GLA  V H+  
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSA 200
Query: 199 SQTTVLA-----GTMGYLAPECVTTG------KASKESDVYSFGVVALEVA 238
           + T  +A     GT  Y+APE +         ++ K +D+Y+ G+V  E+A
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 60/109 (55%), Gaps = 8/109 (7%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ 200
           IL KIA+ +  A+ +LH +    ++HRD+K SNV++++    K  DFG++  +  ++   
Sbjct: 137 ILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKD 194
Query: 201 TTVLAGTMGYLAPECVTTGKASK----ESDVYSFGVVALEVACGRKPVE 245
             + AG   Y APE +      K    +SD++S G+  +E+A  R P +
Sbjct: 195 --IDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYD 241

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+         T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDFGLARHTDDEMAG----FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+         T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDFGLARHTDDEMAG----FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 18/111 (16%)
Query: 144 KIALGLASAVLYLHEEW-----EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG 198
           K+AL  AS + +LH E      +  I HRD+KS N+++  N    + D GLA  V H+  
Sbjct: 104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSA 161
Query: 199 SQTTVLA-----GTMGYLAPECVTTG------KASKESDVYSFGVVALEVA 238
           + T  +A     GT  Y+APE +         ++ K +D+Y+ G+V  E+A
Sbjct: 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 18/111 (16%)
Query: 144 KIALGLASAVLYLHEEW-----EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG 198
           K+AL  AS + +LH E      +  I HRD+KS N+++  N    + D GLA  V H+  
Sbjct: 105 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSA 162
Query: 199 SQTTVLA-----GTMGYLAPECVTTG------KASKESDVYSFGVVALEVA 238
           + T  +A     GT  Y+APE +         ++ K +D+Y+ G+V  E+A
Sbjct: 163 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 52  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 110
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 111 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 163
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 164 SELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219
Query: 239 CGR 241
            GR
Sbjct: 220 TGR 222

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 2/94 (2%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           IV+RD+K  N++LD + + ++ D GLA  V    G       GT+GY+APE V   + + 
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRVGTVGYMAPEVVKNERYTF 364
Query: 224 ESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVE 257
             D ++ G +  E+  G+ P + R++  K   VE
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 49/89 (55%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     K+ DFGLA+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 2/94 (2%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           IV+RD+K  N++LD + + ++ D GLA  V    G       GT+GY+APE V   + + 
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRVGTVGYMAPEVVKNERYTF 364
Query: 224 ESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVE 257
             D ++ G +  E+  G+ P + R++  K   VE
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKXQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 56  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 114
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 115 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 167
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 168 SELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 239 CGR 241
            GR
Sbjct: 224 TGR 226

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 88/173 (50%), Gaps = 23/173 (13%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV---DHELGSQ 200
           ++A  +A  + YL+    +  VHR++ + N ++  +F  K+GDFG+ R +   D+     
Sbjct: 134 QMAAEIADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 190
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW 260
             +L   + ++APE +  G  +  SD++SFGVV  E+    +  +P Q  S  +++++V 
Sbjct: 191 KGLLP--VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVM 246
Query: 261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           D    G  L+  D    +  D  +M C      W  +P+   RP+  +++N+L
Sbjct: 247 D----GGYLDQPDNCPERVTDLMRM-C------WQFNPNM--RPTFLEIVNLL 286

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 18/111 (16%)
Query: 144 KIALGLASAVLYLHEE-----WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG 198
           K+AL  AS + +LH E      +  I HRD+KS N+++  N    + D GLA  V H+  
Sbjct: 110 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSA 167
Query: 199 SQTTVLA-----GTMGYLAPECVTTG------KASKESDVYSFGVVALEVA 238
           + T  +A     GT  Y+APE +         ++ K +D+Y+ G+V  E+A
Sbjct: 168 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 55  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 113
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 114 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 166
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 167 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222
Query: 239 CGR 241
            GR
Sbjct: 223 TGR 225

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 18/111 (16%)
Query: 144 KIALGLASAVLYLHEE-----WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG 198
           K+AL  AS + +LH E      +  I HRD+KS N+++  N    + D GLA  V H+  
Sbjct: 107 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSA 164
Query: 199 SQTTVLA-----GTMGYLAPECVTTG------KASKESDVYSFGVVALEVA 238
           + T  +A     GT  Y+APE +         ++ K +D+Y+ G+V  E+A
Sbjct: 165 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 49  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 107
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 108 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 160
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 161 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 216
Query: 239 CGR 241
            GR
Sbjct: 217 TGR 219

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 88/173 (50%), Gaps = 23/173 (13%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV---DHELGSQ 200
           ++A  +A  + YL+    +  VHR++ + N ++  +F  K+GDFG+ R +   D+     
Sbjct: 135 QMAAEIADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW 260
             +L   + ++APE +  G  +  SD++SFGVV  E+    +  +P Q  S  +++++V 
Sbjct: 192 KGLLP--VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVM 247
Query: 261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           D    G  L+  D    +  D  +M C      W  +P+   RP+  +++N+L
Sbjct: 248 D----GGYLDQPDNCPERVTDLMRM-C------WQFNPNM--RPTFLEIVNLL 287

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 57  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 115
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 116 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 168
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 169 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 239 CGR 241
            GR
Sbjct: 225 TGR 227

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 46  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 105 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 157
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+         T  Y APE +       ++ D++S G +  E+ 
Sbjct: 158 CELKILDFGLARHTDDEMAG----FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213
Query: 239 CGR 241
            GR
Sbjct: 214 TGR 216

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 52  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 110
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 111 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 163
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 164 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219
Query: 239 CGR 241
            GR
Sbjct: 220 TGR 222

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 18/111 (16%)
Query: 144 KIALGLASAVLYLHEE-----WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG 198
           K+AL  AS + +LH E      +  I HRD+KS N+++  N    + D GLA  V H+  
Sbjct: 130 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSA 187
Query: 199 SQTTVLA-----GTMGYLAPECVTTG------KASKESDVYSFGVVALEVA 238
           + T  +A     GT  Y+APE +         ++ K +D+Y+ G+V  E+A
Sbjct: 188 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 56  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 114
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 115 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 167
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 168 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 239 CGR 241
            GR
Sbjct: 224 TGR 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 60  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 118
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 119 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 171
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 172 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 227
Query: 239 CGR 241
            GR
Sbjct: 228 TGR 230

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 46  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 105 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 157
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 158 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213
Query: 239 CGR 241
            GR
Sbjct: 214 TGR 216

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 55  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 113
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 114 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 166
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 167 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222
Query: 239 CGR 241
            GR
Sbjct: 223 TGR 225

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 82/184 (44%), Gaps = 49/184 (26%)
Query: 95  EIAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------H 129
           +IAVK++SR  +     K+ Y  E+R++  ++H N++                      H
Sbjct: 78  KIAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTH 136
Query: 130 LIG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS 178
           L+G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ 
Sbjct: 137 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNE 189
Query: 179 NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEV 237
           +   K+ DFGLAR  D E+    T    T  Y APE +      +   D++S G +  E+
Sbjct: 190 DCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAEL 245
Query: 238 ACGR 241
             GR
Sbjct: 246 LTGR 249

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 61  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 119
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 120 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 172
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 173 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 228
Query: 239 CGR 241
            GR
Sbjct: 229 TGR 231

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 52  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 110
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 111 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 163
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 164 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219
Query: 239 CGR 241
            GR
Sbjct: 220 TGR 222

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 47  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 105
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 106 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 158
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 159 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 214
Query: 239 CGR 241
            GR
Sbjct: 215 TGR 217

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDFGLARHTDDEM----TGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 52  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 110
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 111 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 163
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 164 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219
Query: 239 CGR 241
            GR
Sbjct: 220 TGR 222

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 47  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 105
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 106 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 158
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 159 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 214
Query: 239 CGR 241
            GR
Sbjct: 215 TGR 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 62  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 120
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 121 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 173
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 174 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229
Query: 239 CGR 241
            GR
Sbjct: 230 TGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 62  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 120
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 121 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 173
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 174 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229
Query: 239 CGR 241
            GR
Sbjct: 230 TGR 232

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     K+ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 163 LIYRDLKPENLLIDQQGYIKVADFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 219 AVDWWALGVLIYEMAAGYPP 238

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 48  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 106
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 107 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 159
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 160 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 215
Query: 239 CGR 241
            GR
Sbjct: 216 TGR 218

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     K+ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 56  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 114
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 115 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 167
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 168 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 239 CGR 241
            GR
Sbjct: 224 TGR 226

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     K+ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     K+ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 70  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 128
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 129 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 181
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 182 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 237
Query: 239 CGR 241
            GR
Sbjct: 238 TGR 240

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 73  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 131
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 132 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 184
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 185 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 240
Query: 239 CGR 241
            GR
Sbjct: 241 TGR 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 69  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 127
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 128 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 180
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 181 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 236
Query: 239 CGR 241
            GR
Sbjct: 237 TGR 239

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 87/190 (45%), Gaps = 34/190 (17%)
Query: 96  IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--------------- 140
           I + R +  S     + + EV ++  L H N++ L  +  ++R                 
Sbjct: 67  IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDE 126
Query: 141 ILHKIALG----------LASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDF 187
           I+H++             + S V YLH+     IVHRD+K  N++L+S   +   K+ DF
Sbjct: 127 IIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPR 247
           GL+ + +++   +  +  GT  Y+APE V   K  ++ DV+S GV+   +  G  P   +
Sbjct: 184 GLSAVFENQKKMKERL--GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQ 240
Query: 248 QEPSKVRLVE 257
            +   +R VE
Sbjct: 241 TDQEILRKVE 250

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/182 (20%), Positives = 83/182 (45%), Gaps = 26/182 (14%)
Query: 91  DQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLA 150
           + +T++AVK +  G+    + ++ E  ++  L+H  LV L     ++  + +    +   
Sbjct: 34  NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKG 92
Query: 151 SAVLYLHEEW------------------------EQCIVHRDIKSSNVVLDSNFNAKLGD 186
           S + +L  +                          +  +HRD++++NV++  +   K+ D
Sbjct: 93  SLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIAD 152
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVE 245
           FGLAR+++    +        + + APE +  G  + +S+V+SFG++  E+   G+ P  
Sbjct: 153 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYP 212
Query: 246 PR 247
            R
Sbjct: 213 GR 214

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  LAGT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLAGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 34/188 (18%)
Query: 98  VKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----------------QLI 141
           +K+ S  +       + EV ++ +L H N++ L  +  ++R                ++I
Sbjct: 54  IKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII 113
Query: 142 LHK---------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN---AKLGDFGL 189
           L +         I   + S   YLH+     IVHRD+K  N++L+S       K+ DFGL
Sbjct: 114 LRQKFSEVDAAVIMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGL 170
Query: 190 ARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
           +     E+G +     GT  Y+APE V   K  ++ DV+S GV+   + CG  P   + +
Sbjct: 171 S--AHFEVGGKMKERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTD 227
Query: 250 PSKVRLVE 257
              ++ VE
Sbjct: 228 QEILKRVE 235

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 46  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 105 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 157
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 158 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213
Query: 239 CGR 241
            GR
Sbjct: 214 TGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 56  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 114
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 115 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 167
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 168 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 239 CGR 241
            GR
Sbjct: 224 TGR 226

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 69  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 127
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 128 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 180
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 181 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 236
Query: 239 CGR 241
            GR
Sbjct: 237 TGR 239

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 46  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 105 MGADLNNIVKCAKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 157
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 158 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213
Query: 239 CGR 241
            GR
Sbjct: 214 TGR 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 70  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 128
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 129 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 181
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 182 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 237
Query: 239 CGR 241
            GR
Sbjct: 238 TGR 240

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 17/99 (17%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL-------------G 198
           A+ Y+H    Q I+HR++K  N+ +D + N K+GDFGLA+ V   L              
Sbjct: 128 ALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 199 SQTTVLAGTMGYLAPECVT-TGKASKESDVYSFGVVALE 236
              T   GT  Y+A E +  TG  +++ D YS G++  E
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 54/95 (56%), Gaps = 4/95 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           ++ A+ +LH+   + I++RD+K  N++L+   + KL DFGL +   H+ G+ T    GT+
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-GTVTHTFCGTI 185
Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            Y+APE +     ++  D +S G +  ++  G  P
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 34/188 (18%)
Query: 98  VKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----------------QLI 141
           +K+ S  +       + EV ++ +L H N++ L  +  ++R                ++I
Sbjct: 37  IKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII 96
Query: 142 LHK---------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN---AKLGDFGL 189
           L +         I   + S   YLH+     IVHRD+K  N++L+S       K+ DFGL
Sbjct: 97  LRQKFSEVDAAVIMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGL 153
Query: 190 ARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
           +     E+G +     GT  Y+APE V   K  ++ DV+S GV+   + CG  P   + +
Sbjct: 154 S--AHFEVGGKMKERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTD 210
Query: 250 PSKVRLVE 257
              ++ VE
Sbjct: 211 QEILKRVE 218

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 5/100 (5%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           LA  V+ +    +   VHRDIK  N+++D N + +L DFG    +  +   Q++V  GT 
Sbjct: 181 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240
Query: 209 GYLAPECVTT-----GKASKESDVYSFGVVALEVACGRKP 243
            Y++PE +       G+   E D +S GV   E+  G  P
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 66/138 (47%), Gaps = 11/138 (7%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++ +G+     +LH     
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIK----HLHS---A 145
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 203
Query: 223 KESDVYSFGVVALEVACG 240
           +  D++S G +  E+  G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 58/263 (22%)
Query: 94  TEIAVKRV-SRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ-------------- 137
           T++AVK + S  +++   + ISE+ ++  + +H+N+++L+G C +               
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 138 -RQLILHKIALGLASAVLYLHEEWEQC-----------------------IVHRDIKSSN 173
            R+ +  +   GL  +    H   EQ                         +HRD+ + N
Sbjct: 121 LREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 180
Query: 174 VVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGV 232
           V++  +   K+ DFGLAR + H +   +TT     + ++APE +     + +SDV+SFGV
Sbjct: 181 VLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 240
Query: 233 VALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIV 291
           +  E+   G  P            VE ++ L  +G        R+ K  +      +M+ 
Sbjct: 241 LLWEIFTLGGSPYPGVP-------VEELFKLLKEGH-------RMDKPSNCTNELYMMMR 286
Query: 292 GLWCCHPDFTNRPSIRQVINVLN 314
             W   P  + RP+ +Q++  L+
Sbjct: 287 DCWHAVP--SQRPTFKQLVEDLD 307

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 80/188 (42%), Gaps = 44/188 (23%)
Query: 93  NTEIAVKRVSRGSKQG-KKEYISEVRIISRLRHRNLVHLIG------------WC----H 135
           N  +AVK      KQ  + EY  EV  +  ++H N++  IG            W     H
Sbjct: 47  NEYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104
Query: 136 EQRQLI------------LHKIALGLASAVLYLHEE-------WEQCIVHRDIKSSNVVL 176
           E+  L             L  IA  +A  + YLHE+        +  I HRDIKS NV+L
Sbjct: 105 EKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164
Query: 177 DSNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPECVTTG-----KASKESDVYSF 230
            +N  A + DFGLA +    +    T    GT  Y+APE +         A    D+Y+ 
Sbjct: 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
Query: 231 GVVALEVA 238
           G+V  E+A
Sbjct: 225 GLVLWELA 232

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 54/95 (56%), Gaps = 4/95 (4%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           ++ A+ +LH+   + I++RD+K  N++L+   + KL DFGL +   H+ G+ T    GT+
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-GTVTHXFCGTI 185
Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            Y+APE +     ++  D +S G +  ++  G  P
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     K+ DFG A+ V      +T  L GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----GRTWXLCGTPEYLAPE 209
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     K+ DFG A+ V      +T  L GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----GRTWXLCGTPEYLAPE 209
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     K+ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     K+ DFG A+ V      +T  L GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----GRTWXLCGTPEYLAPE 209
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     K+ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     K+ DFG A+ V      +T  L GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----GRTWXLCGTPEYLAPE 209
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 86/191 (45%), Gaps = 35/191 (18%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--I 141
           VY+    + +   A K +   S++  ++Y+ E+ I++   H N+V L+   + +  L  +
Sbjct: 53  VYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 112
Query: 142 LHKIALGLASAVL------------------------YLHEEWEQCIVHRDIKSSNVVLD 177
           +   A G   AV+                        YLH+     I+HRD+K+ N++  
Sbjct: 113 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFT 169
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK-----ESDVYSFGV 232
            + + KL DFG++      +  + + + GT  ++APE V    +       ++DV+S G+
Sbjct: 170 LDGDIKLADFGVSAKNTRXIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 228
Query: 233 VALEVACGRKP 243
             +E+A    P
Sbjct: 229 TLIEMAEIEPP 239

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 46/80 (57%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFGLA+ V      +T  L GT  YLAPE + +   +K
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGLAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 73  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 131
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 132 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 184
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+         T  Y APE +       ++ D++S G +  E+ 
Sbjct: 185 CELKILDFGLARHTDDEMXG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 240
Query: 239 CGR 241
            GR
Sbjct: 241 TGR 243

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 86/191 (45%), Gaps = 35/191 (18%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--I 141
           VY+    + +   A K +   S++  ++Y+ E+ I++   H N+V L+   + +  L  +
Sbjct: 53  VYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 112
Query: 142 LHKIALGLASAVL------------------------YLHEEWEQCIVHRDIKSSNVVLD 177
           +   A G   AV+                        YLH+     I+HRD+K+ N++  
Sbjct: 113 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFT 169
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK-----ESDVYSFGV 232
            + + KL DFG++      +  + + + GT  ++APE V    +       ++DV+S G+
Sbjct: 170 LDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 228
Query: 233 VALEVACGRKP 243
             +E+A    P
Sbjct: 229 TLIEMAEIEPP 239

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 39/201 (19%)
Query: 95  EIAVKRVSRGSKQGK--KEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL---------- 142
           E AVK +++ S + K     + EV ++ +L H N++ L     +     +          
Sbjct: 49  EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 143 ---------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKL 184
                           +I   + S + Y+H+     IVHRD+K  N++L+S   + + K+
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKI 165
Query: 185 GDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPV 244
            DFGL+         +  +  GT  Y+APE V  G   ++ DV+S GV+   +  G  P 
Sbjct: 166 IDFGLSTCFQQNTKMKDRI--GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPF 222
Query: 245 EPRQEPSKVRLVE---WVWDL 262
             + E   ++ VE   + +DL
Sbjct: 223 YGKNEYDILKRVETGKYAFDL 243

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 58/263 (22%)
Query: 94  TEIAVKRV-SRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ-------------- 137
           T++AVK + S  +++   + ISE+ ++  + +H+N+++L+G C +               
Sbjct: 102 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161
Query: 138 -RQLILHKIALGLASAVLYLHEEWEQC-----------------------IVHRDIKSSN 173
            R+ +  +   GL  +    H   EQ                         +HRD+ + N
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221
Query: 174 VVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGV 232
           V++  +   K+ DFGLAR + H +   +TT     + ++APE +     + +SDV+SFGV
Sbjct: 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 281
Query: 233 VALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIV 291
           +  E+   G  P            VE ++ L  +G        R+ K  +      +M+ 
Sbjct: 282 LLWEIFTLGGSPYPGVP-------VEELFKLLKEGH-------RMDKPSNCTNELYMMMR 327
Query: 292 GLWCCHPDFTNRPSIRQVINVLN 314
             W   P  + RP+ +Q++  L+
Sbjct: 328 DCWHAVP--SQRPTFKQLVEDLD 348

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 65/138 (47%), Gaps = 11/138 (7%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 146
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV--TRYYRAPEVILGMGYK 203
Query: 223 KESDVYSFGVVALEVACG 240
           +  D++S G +  E+  G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 39/201 (19%)
Query: 95  EIAVKRVSRGSKQGK--KEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL---------- 142
           E AVK +++ S + K     + EV ++ +L H N++ L     +     +          
Sbjct: 49  EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 143 ---------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKL 184
                           +I   + S + Y+H+     IVHRD+K  N++L+S   + + K+
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKI 165
Query: 185 GDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPV 244
            DFGL+         +  +  GT  Y+APE V  G   ++ DV+S GV+   +  G  P 
Sbjct: 166 IDFGLSTCFQQNTKMKDRI--GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPF 222
Query: 245 EPRQEPSKVRLVE---WVWDL 262
             + E   ++ VE   + +DL
Sbjct: 223 YGKNEYDILKRVETGKYAFDL 243

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ D+GLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDYGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 70  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 128
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 129 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 181
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+         T  Y APE +       ++ D++S G +  E+ 
Sbjct: 182 CELKILDFGLARHTDDEMXGXV----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 237
Query: 239 CGR 241
            GR
Sbjct: 238 TGR 240

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 39/201 (19%)
Query: 95  EIAVKRVSRGSKQGK--KEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL---------- 142
           E AVK +++ S + K     + EV ++ +L H N++ L     +     +          
Sbjct: 49  EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 143 ---------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKL 184
                           +I   + S + Y+H+     IVHRD+K  N++L+S   + + K+
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKI 165
Query: 185 GDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPV 244
            DFGL+         +  +  GT  Y+APE V  G   ++ DV+S GV+   +  G  P 
Sbjct: 166 IDFGLSTCFQQNTKMKDRI--GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPF 222
Query: 245 EPRQEPSKVRLVE---WVWDL 262
             + E   ++ VE   + +DL
Sbjct: 223 YGKNEYDILKRVETGKYAFDL 243

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++S+  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 62  VAVKKLSKPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 120
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 121 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 173
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 174 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229
Query: 239 CGR 241
            GR
Sbjct: 230 TGR 232

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 58/263 (22%)
Query: 94  TEIAVKRV-SRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ-------------- 137
           T++AVK + S  +++   + ISE+ ++  + +H+N+++L+G C +               
Sbjct: 50  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 109
Query: 138 -RQLILHKIALGLASAVLYLHEEWEQC-----------------------IVHRDIKSSN 173
            R+ +  +   GL  +    H   EQ                         +HRD+ + N
Sbjct: 110 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 169
Query: 174 VVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGV 232
           V++  +   K+ DFGLAR + H +   +TT     + ++APE +     + +SDV+SFGV
Sbjct: 170 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 229
Query: 233 VALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIV 291
           +  E+   G  P            VE ++ L  +G        R+ K  +      +M+ 
Sbjct: 230 LLWEIFTLGGSPYPGVP-------VEELFKLLKEGH-------RMDKPSNCTNELYMMMR 275
Query: 292 GLWCCHPDFTNRPSIRQVINVLN 314
             W   P  + RP+ +Q++  L+
Sbjct: 276 DCWHAVP--SQRPTFKQLVEDLD 296

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 65/138 (47%), Gaps = 11/138 (7%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 146
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 203
Query: 223 KESDVYSFGVVALEVACG 240
           +  D++S G +  E+  G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 65/138 (47%), Gaps = 11/138 (7%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 94  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 147
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 148 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 204
Query: 223 KESDVYSFGVVALEVACG 240
           +  D++S G +  E+  G
Sbjct: 205 ENVDIWSVGCIMGEMIKG 222

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 33/184 (17%)
Query: 91  DQNTEIAVKRV--SRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--------- 139
           D    +A+K+   S   K  KK  + E++++ +LRH NLV+L+  C ++++         
Sbjct: 48  DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD 107
Query: 140 ----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAK 183
                            ++ K    + + + + H      I+HRDIK  N+++  +   K
Sbjct: 108 HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVK 164
Query: 184 LGDFGLARLVDHELGSQTTVLAGTMGYLAPE-CVTTGKASKESDVYSFGVVALEVACGRK 242
           L DFG AR +    G        T  Y APE  V   K  K  DV++ G +  E+  G +
Sbjct: 165 LCDFGFARTLAAP-GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-E 222
Query: 243 PVEP 246
           P+ P
Sbjct: 223 PLFP 226

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 58/263 (22%)
Query: 94  TEIAVKRV-SRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ-------------- 137
           T++AVK + S  +++   + ISE+ ++  + +H+N+++L+G C +               
Sbjct: 54  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 113
Query: 138 -RQLILHKIALGLASAVLYLHEEWEQC-----------------------IVHRDIKSSN 173
            R+ +  +   GL  +    H   EQ                         +HRD+ + N
Sbjct: 114 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 173
Query: 174 VVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGV 232
           V++  +   K+ DFGLAR + H +   +TT     + ++APE +     + +SDV+SFGV
Sbjct: 174 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 233
Query: 233 VALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIV 291
           +  E+   G  P            VE ++ L  +G        R+ K  +      +M+ 
Sbjct: 234 LLWEIFTLGGSPYPGVP-------VEELFKLLKEGH-------RMDKPSNCTNELYMMMR 279
Query: 292 GLWCCHPDFTNRPSIRQVINVLN 314
             W   P  + RP+ +Q++  L+
Sbjct: 280 DCWHAVP--SQRPTFKQLVEDLD 300

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 65/138 (47%), Gaps = 11/138 (7%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 146
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 203
Query: 223 KESDVYSFGVVALEVACG 240
           +  D++S G +  E+  G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 65/153 (42%), Gaps = 33/153 (21%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQR----QLILH------------------------KIA 146
           E+ I+  L H N+V   G C E      +LI+                         K A
Sbjct: 73  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132
Query: 147 LGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVL 204
           + +   + YL        VHRD+ + NV+++S    K+GDFGL + +  D E  +     
Sbjct: 133 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDR 189
Query: 205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              + + APEC+   K    SDV+SFGV   E+
Sbjct: 190 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 58/263 (22%)
Query: 94  TEIAVKRV-SRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ-------------- 137
           T++AVK + S  +++   + ISE+ ++  + +H+N+++L+G C +               
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 138 -RQLILHKIALGLASAVLYLHEEWEQC-----------------------IVHRDIKSSN 173
            R+ +  +   GL  +    H   EQ                         +HRD+ + N
Sbjct: 121 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 180
Query: 174 VVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGV 232
           V++  +   K+ DFGLAR + H +   +TT     + ++APE +     + +SDV+SFGV
Sbjct: 181 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 240
Query: 233 VALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIV 291
           +  E+   G  P            VE ++ L  +G        R+ K  +      +M+ 
Sbjct: 241 LLWEIFTLGGSPYPGVP-------VEELFKLLKEGH-------RMDKPSNCTNELYMMMR 286
Query: 292 GLWCCHPDFTNRPSIRQVINVLN 314
             W   P  + RP+ +Q++  L+
Sbjct: 287 DCWHAVP--SQRPTFKQLVEDLD 307

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 58/263 (22%)
Query: 94  TEIAVKRV-SRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ-------------- 137
           T++AVK + S  +++   + ISE+ ++  + +H+N+++L+G C +               
Sbjct: 53  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 112
Query: 138 -RQLILHKIALGLASAVLYLHEEWEQC-----------------------IVHRDIKSSN 173
            R+ +  +   GL  +    H   EQ                         +HRD+ + N
Sbjct: 113 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 172
Query: 174 VVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGV 232
           V++  +   K+ DFGLAR + H +   +TT     + ++APE +     + +SDV+SFGV
Sbjct: 173 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 232
Query: 233 VALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIV 291
           +  E+   G  P            VE ++ L  +G        R+ K  +      +M+ 
Sbjct: 233 LLWEIFTLGGSPYPGVP-------VEELFKLLKEGH-------RMDKPSNCTNELYMMMR 278
Query: 292 GLWCCHPDFTNRPSIRQVINVLN 314
             W   P  + RP+ +Q++  L+
Sbjct: 279 DCWHAVP--SQRPTFKQLVEDLD 299

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 65/138 (47%), Gaps = 11/138 (7%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIK----HLHS---A 145
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 203
Query: 223 KESDVYSFGVVALEVACG 240
           +  D++S G +  E+  G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 148 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEYLAPEIILSKGYNK 203
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 204 AVDWWALGVLIYEMAAGYPP 223

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 65/138 (47%), Gaps = 11/138 (7%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIK----HLHS---A 145
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 203
Query: 223 KESDVYSFGVVALEVACG 240
           +  D++S G +  E+  G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKSQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGL R  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 SELKILDFGLCRHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 85/191 (44%), Gaps = 35/191 (18%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--I 141
           VY+    + +   A K +   S++  ++Y+ E+ I++   H N+V L+   + +  L  +
Sbjct: 53  VYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 112
Query: 142 LHKIALGLASAVL------------------------YLHEEWEQCIVHRDIKSSNVVLD 177
           +   A G   AV+                        YLH+     I+HRD+K+ N++  
Sbjct: 113 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFT 169
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK-----ESDVYSFGV 232
            + + KL DFG++      +  +   + GT  ++APE V    +       ++DV+S G+
Sbjct: 170 LDGDIKLADFGVSAKNTRXIQRRDXFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 228
Query: 233 VALEVACGRKP 243
             +E+A    P
Sbjct: 229 TLIEMAEIEPP 239

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 83/189 (43%), Gaps = 46/189 (24%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-----EVRIISRLRHRNLVHLI-GWCHEQ 137
           VY+    + N  +A+K++  G +   K+ I+     E++++  L H N++ L+  + H+ 
Sbjct: 26  VYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85
Query: 138 R------------QLILHKIALGLASAVL------------YLHEEWEQCIVHRDIKSSN 173
                        ++I+   +L L  + +            YLH+ W   I+HRD+K +N
Sbjct: 86  NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNN 142
Query: 174 VVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG---TMGYLAPECVTTGKASKESDVYSF 230
           ++LD N   KL DFGLA+      GS          T  Y APE +   +      +Y  
Sbjct: 143 LLLDENGVLKLADFGLAK----SFGSPNRAYXHQVVTRWYRAPELLFGAR------MYGV 192
Query: 231 GVVALEVAC 239
           GV    V C
Sbjct: 193 GVDMWAVGC 201

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 118/272 (43%), Gaps = 58/272 (21%)
Query: 84  VYRGLLSDQ-NTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHE-QRQL 140
           V +G++ D+  T +A+K V+  +   ++ E+++E  ++      ++V L+G   + Q  L
Sbjct: 30  VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 89
Query: 141 ILHKIAL--GLASAVLYLHEEWEQC-----------------------------IVHRDI 169
           ++ ++     L S +  L  E E                                VHRD+
Sbjct: 90  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 149
Query: 170 KSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG-----YLAPECVTTGKASKE 224
            + N ++  +F  K+GDFG+ R    ++        G  G     +++PE +  G  +  
Sbjct: 150 AARNCMVAEDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTY 205
Query: 225 SDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ 284
           SDV+SFGVV  E+A   +  +P Q  S  +++ +V +    G LL+  D       +  +
Sbjct: 206 SDVWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVME----GGLLDKPDNCPDMLLELMR 259
Query: 285 MECLMIVGLWCCHPDFTNRPSIRQVINVLNFE 316
           M C      W  +P    RPS  ++I+ +  E
Sbjct: 260 M-C------WQYNPKM--RPSFLEIISSIKEE 282

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 114/263 (43%), Gaps = 58/263 (22%)
Query: 94  TEIAVKRV-SRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ-------------- 137
           T++AVK + S  +++   + ISE+ ++  + +H+N+++L+G C +               
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 138 -RQLILHKIALGLASAVLYLHEEWEQC-----------------------IVHRDIKSSN 173
            R+ +  +   GL  +    H   EQ                         +HRD+ + N
Sbjct: 121 LREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 180
Query: 174 VVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGV 232
           V++  +   K+ DFGLAR + H +   +TT     + ++APE +     + +SDV+SFGV
Sbjct: 181 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 240
Query: 233 VALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIV 291
           +  E+   G  P            VE ++ L  +G        R+ K  +      +M+ 
Sbjct: 241 LLWEIFTLGGSPYPGVP-------VEELFKLLKEGH-------RMDKPSNCTNELYMMMR 286
Query: 292 GLWCCHPDFTNRPSIRQVINVLN 314
             W   P  + RP+ +Q++  L+
Sbjct: 287 DCWHAVP--SQRPTFKQLVEDLD 307

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 10/102 (9%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKPV---EPRQEPSKV 253
            + +   +K  D ++ GV+  E+A G  P    EP Q   K+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKI 250

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 65/153 (42%), Gaps = 33/153 (21%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQR----QLILH------------------------KIA 146
           E+ I+  L H N+V   G C E      +LI+                         K A
Sbjct: 61  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 120
Query: 147 LGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVL 204
           + +   + YL        VHRD+ + NV+++S    K+GDFGL + +  D E  +     
Sbjct: 121 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDR 177
Query: 205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              + + APEC+   K    SDV+SFGV   E+
Sbjct: 178 DSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 210

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEYLAPE 209
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 65/138 (47%), Gaps = 11/138 (7%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIK----HLHS---A 145
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 203
Query: 223 KESDVYSFGVVALEVACG 240
           +  D++S G +  E+  G
Sbjct: 204 ENVDIWSVGCIMGEMIKG 221

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 113/263 (42%), Gaps = 58/263 (22%)
Query: 94  TEIAVKRV-SRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ-------------- 137
           T++AVK + S  +++   + ISE+ ++  + +H+N+++L+G C +               
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 138 -RQLILHKIALGLASAVLYLHEEWEQC-----------------------IVHRDIKSSN 173
            R+ +  +   GL       H   EQ                         +HRD+ + N
Sbjct: 121 LREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 180
Query: 174 VVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGV 232
           V++  +   K+ DFGLAR + H +   +TT     + ++APE +     + +SDV+SFGV
Sbjct: 181 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 240
Query: 233 VALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIV 291
           +  E+   G  P            VE ++ L  +G        R+ K  +      +M+ 
Sbjct: 241 LLWEIFTLGGSPYPGVP-------VEELFKLLKEGH-------RMDKPSNCTNELYMMMR 286
Query: 292 GLWCCHPDFTNRPSIRQVINVLN 314
             W   P  + RP+ +Q++  L+
Sbjct: 287 DCWHAVP--SQRPTFKQLVEDLD 307

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 157 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 212
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 213 AVDWWALGVLIYEMAAGYPP 232

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLXGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 201
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 81/197 (41%), Gaps = 44/197 (22%)
Query: 84  VYRGLLSDQNTEIAVKRVSR----------GSKQGKKEYISEVRIISRLRHRNLVHLIGW 133
           V+  +  ++N E+ VK + +            K GK     E+ I+SR+ H N++ ++  
Sbjct: 40  VWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK--VTLEIAILSRVEHANIIKVLDI 97
Query: 134 CHEQR--QLILHKIALGL------------------------ASAVLYLHEEWEQCIVHR 167
              Q   QL++ K   GL                         SAV YL     + I+HR
Sbjct: 98  FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHR 154
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKESD 226
           DIK  N+V+  +F  KL DFG A  +  E G       GT+ Y APE +        E +
Sbjct: 155 DIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELE 212
Query: 227 VYSFGVVALEVACGRKP 243
           ++S GV    +     P
Sbjct: 213 MWSLGVTLYTLVFEENP 229

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 201
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 120/279 (43%), Gaps = 70/279 (25%)
Query: 91  DQNTEIAVKRVSRGSKQGKKE-YISEVRIISRL-RHRNLVHLIGWC-HEQRQLILHKIA- 146
           D   ++AVK +   +   +KE  +SE++I+S L +H N+V+L+G C H    L++ +   
Sbjct: 59  DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC 118
Query: 147 ---------------LGLASA--------------------VLYLHEEWEQCI------- 164
                          LG + A                    +L+   +  Q +       
Sbjct: 119 YGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN 178
Query: 165 -VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECVTTG 219
            +HRD+ + NV+L +   AK+GDFGLAR +   +     ++ G     + ++APE +   
Sbjct: 179 CIHRDVAARNVLLTNGHVAKIGDFGLARDI---MNDSNYIVKGNARLPVKWMAPESIFDC 235
Query: 220 KASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK 278
             + +SDV+S+G++  E+ + G  P       SK    + V D Y   Q           
Sbjct: 236 VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FYKLVKDGYQMAQ----------P 283
Query: 279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA 317
            F  + +  +M    W   P  T+RP+ +Q+ + L  +A
Sbjct: 284 AFAPKNIYSIM-QACWALEP--THRPTFQQICSFLQEQA 319

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 209
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 65/138 (47%), Gaps = 11/138 (7%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 91  TPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK----HLHS---A 143
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 144 GIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVV--TRYYRAPEVILGMGYK 201
Query: 223 KESDVYSFGVVALEVACG 240
           +  D++S G +  E+  G
Sbjct: 202 ENVDIWSVGCIMGELVKG 219

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 209
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 219 AVDWWALGVLIYEMAAGYPP 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 219 AVDWWALGVLIYEMAAGYPP 238

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 65/138 (47%), Gaps = 11/138 (7%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V I+  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 95  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 148
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 149 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV--TRYYRAPEVILGMGYK 205
Query: 223 KESDVYSFGVVALEVACG 240
           +  D++S G +  E+  G
Sbjct: 206 ENVDIWSVGCIMGEMIKG 223

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 219 AVDWWALGVLIYEMAAGYPP 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 4/98 (4%)
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A  VL L       ++HRD+K  N++LD + + KL DFG    +D           GT  
Sbjct: 181 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPD 240
Query: 210 YLAPECVTT----GKASKESDVYSFGVVALEVACGRKP 243
           Y++PE + +    G   +E D +S GV   E+  G  P
Sbjct: 241 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 46/75 (61%), Gaps = 2/75 (2%)
Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG--TMGYLAPECVTTGKAS 222
           VHRD+ + N++++S  + K+ DFGLA+L+  +         G   + + APE ++    S
Sbjct: 133 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFS 192
Query: 223 KESDVYSFGVVALEV 237
           ++SDV+SFGVV  E+
Sbjct: 193 RQSDVWSFGVVLYEL 207

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 143 YLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 195
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 196 IILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 119/270 (44%), Gaps = 54/270 (20%)
Query: 84  VYRGLLSDQ-NTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHE-QRQL 140
           V +G++ D+  T +A+K V+  +   ++ E+++E  ++      ++V L+G   + Q  L
Sbjct: 32  VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 91
Query: 141 ILHKIAL--GLASAVLYLHEEWEQC-----------------------------IVHRDI 169
           ++ ++     L S +  L  E E                                VHRD+
Sbjct: 92  VIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 151
Query: 170 KSSNVVLDSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
            + N  +  +F  K+GDFG+ R +   D+       +L   + +++PE +  G  +  SD
Sbjct: 152 AARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--VRWMSPESLKDGVFTTYSD 209
Query: 227 VYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME 286
           V+SFGVV  E+A   +  +P Q  S  +++ +V +    G LL+  D       +  +M 
Sbjct: 210 VWSFGVVLWEIATLAE--QPYQGLSNEQVLRFVME----GGLLDKPDNCPDMLLELMRM- 262
Query: 287 CLMIVGLWCCHPDFTNRPSIRQVINVLNFE 316
           C      W  +P    RPS  ++I+ +  E
Sbjct: 263 C------WQYNPKM--RPSFLEIISSIKEE 284

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 209
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 229
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 113/263 (42%), Gaps = 58/263 (22%)
Query: 94  TEIAVKRV-SRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ-------------- 137
           T++AVK + S  +++   + ISE+ ++  + +H+N+++L+G C +               
Sbjct: 46  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 105
Query: 138 -RQLILHKIALGLASAVLYLHEEWEQC-----------------------IVHRDIKSSN 173
            R+ +  +   GL       H   EQ                         +HRD+ + N
Sbjct: 106 LREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165
Query: 174 VVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGV 232
           V++  +   K+ DFGLAR + H +   +TT     + ++APE +     + +SDV+SFGV
Sbjct: 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225
Query: 233 VALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIV 291
           +  E+   G  P            VE ++ L  +G        R+ K  +      +M+ 
Sbjct: 226 LLWEIFTLGGSPYPGVP-------VEELFKLLKEGH-------RMDKPSNCTNELYMMMR 271
Query: 292 GLWCCHPDFTNRPSIRQVINVLN 314
             W   P  + RP+ +Q++  L+
Sbjct: 272 DCWHAVP--SQRPTFKQLVEDLD 292

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 4/80 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE + +   +K
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 224 ESDVYSFGVVALEVACGRKP 243
             D ++ GV+  E+A G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 111 EYISEVRIISRLRHRNLVHLI---GWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHR 167
           E  SEV +++ L   +L +++       E  Q +++++  GL     Y+H      I+HR
Sbjct: 103 EDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLK----YIHS---AGIIHR 155
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-D 226
           D+K SNV ++ +   ++ DFGLAR  D E+    T    T  Y APE +       ++ D
Sbjct: 156 DLKPSNVAVNEDSELRILDFGLARQADEEM----TGYVATRWYRAPEIMLNWMHYNQTVD 211
Query: 227 VYSFGVVALEVACGR 241
           ++S G +  E+  G+
Sbjct: 212 IWSVGCIMAELLQGK 226

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 229
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 31/160 (19%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQLIL-------------------------HKIAL 147
           I E+ I+  L+H N+V L    H +++L+L                             L
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 148 GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT 207
            L + + Y H+   + ++HRD+K  N++++     K+ DFGLAR     +   T  +  T
Sbjct: 108 QLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-T 163
Query: 208 MGYLAPECVT-TGKASKESDVYSFGVVALEVACGRKPVEP 246
           + Y AP+ +  + K S   D++S G +  E+  G  P+ P
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFP 202

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 111 EYISEVRIISRLRHRNLVHLI---GWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHR 167
           E  SEV +++ L   +L +++       E  Q +++++  GL     Y+H      I+HR
Sbjct: 103 EDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLK----YIHS---AGIIHR 155
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-D 226
           D+K SNV ++ +   ++ DFGLAR  D E+    T    T  Y APE +       ++ D
Sbjct: 156 DLKPSNVAVNEDSELRILDFGLARQADEEM----TGYVATRWYRAPEIMLNWMHYNQTVD 211
Query: 227 VYSFGVVALEVACGR 241
           ++S G +  E+  G+
Sbjct: 212 IWSVGCIMAELLQGK 226

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 111 EYISEVRIISRLRHRNLVHLI---GWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHR 167
           E  SEV +++ L   +L +++       E  Q +++++  GL     Y+H      I+HR
Sbjct: 95  EDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLK----YIHS---AGIIHR 147
Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-D 226
           D+K SNV ++ +   ++ DFGLAR  D E+    T    T  Y APE +       ++ D
Sbjct: 148 DLKPSNVAVNEDCELRILDFGLARQADEEM----TGYVATRWYRAPEIMLNWMHYNQTVD 203
Query: 227 VYSFGVVALEVACGR 241
           ++S G +  E+  G+
Sbjct: 204 IWSVGCIMAELLQGK 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/121 (28%), Positives = 64/121 (52%), Gaps = 13/121 (10%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV----DHE 196
           IL ++  GL     YLH+  +   +HRD+K+ N++L  + + ++ DFG++  +    D  
Sbjct: 126 ILREVLEGLE----YLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178
Query: 197 LGSQTTVLAGTMGYLAPECVTTGKASK-ESDVYSFGVVALEVACGRKPVEPRQEPSKVRL 255
                    GT  ++APE +   +    ++D++SFG+ A+E+A G  P   +  P KV +
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH-KYPPMKVLM 237
Query: 256 V 256
           +
Sbjct: 238 L 238

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/121 (28%), Positives = 64/121 (52%), Gaps = 13/121 (10%)
Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV----DHE 196
           IL ++  GL     YLH+  +   +HRD+K+ N++L  + + ++ DFG++  +    D  
Sbjct: 121 ILREVLEGLE----YLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 173
Query: 197 LGSQTTVLAGTMGYLAPECVTTGKASK-ESDVYSFGVVALEVACGRKPVEPRQEPSKVRL 255
                    GT  ++APE +   +    ++D++SFG+ A+E+A G  P   +  P KV +
Sbjct: 174 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH-KYPPMKVLM 232
Query: 256 V 256
           +
Sbjct: 233 L 233

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR SR S++G  ++E   EV I+ ++ H N++ L    +E R    LIL  ++ G     
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD-VYENRTDVVLILELVSGGELFDF 105
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             +   V YLH    + I H D+K  N+ +LD N    + KL D
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +  E G +   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 163 FGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA---KLGDFGLARLVDHELGSQTTVLAGTM 208
           AVL+ H+     +VHRD+K  N++L S       KL DFGLA  V+ E  +     AGT 
Sbjct: 133 AVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTP 188
Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           GYL+PE +      K  D+++ GV+   +  G  P
Sbjct: 189 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V       T  L GT  YLAPE
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GATWTLCGTPEYLAPE 229
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 88  LLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKI 145
           LL   N +  +  ++  + Q   E   +V ++  L   NL  +I     HE+   +L+++
Sbjct: 76  LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 135
Query: 146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA 205
             G+     +LH      I+HRD+K SN+V+ S+   K+ DFGLAR           V+ 
Sbjct: 136 LCGIK----HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV- 187
Query: 206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACG 240
            T  Y APE +     +   D++S G +  E+  G
Sbjct: 188 -TRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR SR S++G  ++E   EV I+ ++ H N++ L    +E R    LIL  ++ G     
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD-VYENRTDVVLILELVSGGELFDF 105
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             +   V YLH    + I H D+K  N+ +LD N    + KL D
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +  E G +   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 163 FGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 86  TPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIK----HLHSA--- 138
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 139 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 196
Query: 223 KESDVYSFGVVALEVA 238
           +  D++S G +  E+ 
Sbjct: 197 ENVDIWSVGCIMGEMV 212

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 31/160 (19%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQLIL-------------------------HKIAL 147
           I E+ I+  L+H N+V L    H +++L+L                             L
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 148 GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT 207
            L + + Y H+   + ++HRD+K  N++++     K+ DFGLAR     +   T  +  T
Sbjct: 108 QLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-T 163
Query: 208 MGYLAPECVT-TGKASKESDVYSFGVVALEVACGRKPVEP 246
           + Y AP+ +  + K S   D++S G +  E+  G  P+ P
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFP 202

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 57  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 115
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 116 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 168
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR        + T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 169 CELKILDFGLAR----HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 239 CGR 241
            GR
Sbjct: 225 TGR 227

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR SR S++G  ++E   EV I+ ++ H N++ L    +E R    LIL  ++ G     
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD-VYENRTDVVLILELVSGGELFDF 105
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             +   V YLH    + I H D+K  N+ +LD N    + KL D
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +  E G +   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 163 FGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 31/160 (19%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQLIL-------------------------HKIAL 147
           I E+ I+  L+H N+V L    H +++L+L                             L
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 148 GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT 207
            L + + Y H+   + ++HRD+K  N++++     K+ DFGLAR     +   T  +  T
Sbjct: 108 QLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-T 163
Query: 208 MGYLAPECVT-TGKASKESDVYSFGVVALEVACGRKPVEP 246
           + Y AP+ +  + K S   D++S G +  E+  G  P+ P
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-APLFP 202

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+  FGLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILGFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +VHRD+K  N+++ S+   KL DFGLAR+   ++   + V+  T+ Y APE +     + 
Sbjct: 141 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLLQSSYAT 198
Query: 224 ESDVYSFGVVALEVACGRKPV 244
             D++S G +  E+   RKP+
Sbjct: 199 PVDLWSVGCIFAEM-FRRKPL 218

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/115 (36%), Positives = 59/115 (51%), Gaps = 12/115 (10%)
Query: 137 QRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN--FNAKLGDFGLA---- 190
           QR+ ++  I   + SA+ YLH    Q I HRDIK  N +  +N  F  KL DFGL+    
Sbjct: 165 QREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFY 221
Query: 191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKAS--KESDVYSFGVVALEVACGRKP 243
           +L + E    TT  AGT  ++APE + T   S   + D +S GV+   +  G  P
Sbjct: 222 KLNNGEYYGMTTK-AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIK----HLHSA--- 145
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 203
Query: 223 KESDVYSFGVVALEVA 238
           +  D++S G +  E+ 
Sbjct: 204 ENVDIWSVGCIMGEMV 219

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 52/110 (47%), Gaps = 14/110 (12%)
Query: 142 LHKIALGLASAVLYLHEEWEQC--------IVHRDIKSSNVVLDSNFNAKLGDFGLA-RL 192
           L  +A  ++  + YLHE+   C        I HRD KS NV+L S+  A L DFGLA R 
Sbjct: 114 LCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRF 173
Query: 193 VDHELGSQTTVLAGTMGYLAPECVTTG-----KASKESDVYSFGVVALEV 237
              +    T    GT  Y+APE +         A    D+Y+ G+V  E+
Sbjct: 174 EPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 223

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 59/110 (53%), Gaps = 10/110 (9%)
Query: 133 WCHEQRQLILHKI-ALGL----ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF 187
           W  ++R   L K+ AL L       V Y+H    + +++RD+K SN+ L      K+GDF
Sbjct: 110 WIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDF 166
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
           GL   + ++   +     GT+ Y++PE +++    KE D+Y+ G++  E+
Sbjct: 167 GLVTSLKND--GKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIK----HLHSA--- 145
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 203
Query: 223 KESDVYSFGVVALEVA 238
           +  D++S G +  E+ 
Sbjct: 204 ENVDIWSVGCIMGEMV 219

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +VHRD+K  N+++ S+   KL DFGLAR+   ++   + V+  T+ Y APE +     + 
Sbjct: 141 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLLQSSYAT 198
Query: 224 ESDVYSFGVVALEVACGRKPV 244
             D++S G +  E+   RKP+
Sbjct: 199 PVDLWSVGCIFAEM-FRRKPL 218

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 115/264 (43%), Gaps = 64/264 (24%)
Query: 96  IAVKRV-SRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL--ILHKIALG--- 148
           +AVK +    +++   + +SE+ ++  + +H+N++HL+G C +   L  I+   + G   
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLR 129
Query: 149 ------------------------------------LASAVLYLHEEWEQCIVHRDIKSS 172
                                               LA  + YL  +  +CI HRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--KCI-HRDLAAR 186
Query: 173 NVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFG 231
           NV++  N   K+ DFGLAR +++ +   +TT     + ++APE +     + +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 232 VVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMI 290
           V+  E+   G  P            VE ++ L  +G        R+ K  +      +M+
Sbjct: 247 VLMWEIFTLGGSPYPGIP-------VEELFKLLKEGH-------RMDKPANCTNELYMMM 292
Query: 291 VGLWCCHPDFTNRPSIRQVINVLN 314
              W   P  + RP+ +Q++  L+
Sbjct: 293 RDCWHAVP--SQRPTFKQLVEDLD 314

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 57  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 115
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 116 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 168
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR        + T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 169 CELKILDFGLAR----HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 239 CGR 241
            GR
Sbjct: 225 TGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 57  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 115
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 116 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 168
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DFGLAR        + T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 169 CELKILDFGLAR----HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 239 CGR 241
            GR
Sbjct: 225 TGR 227

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 4/98 (4%)
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A  VL L        +HRD+K  N++LD + + KL DFG    ++ E   +     GT  
Sbjct: 175 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 210 YLAPECVTT----GKASKESDVYSFGVVALEVACGRKP 243
           Y++PE + +    G   +E D +S GV   E+  G  P
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 4/98 (4%)
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A  VL L        +HRD+K  N++LD + + KL DFG    ++ E   +     GT  
Sbjct: 180 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 210 YLAPECVTT----GKASKESDVYSFGVVALEVACGRKP 243
           Y++PE + +    G   +E D +S GV   E+  G  P
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 4/98 (4%)
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A  VL L        +HRD+K  N++LD + + KL DFG    ++ E   +     GT  
Sbjct: 180 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 210 YLAPECVTT----GKASKESDVYSFGVVALEVACGRKP 243
           Y++PE + +    G   +E D +S GV   E+  G  P
Sbjct: 240 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 31/156 (19%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQ--LILHKIALG-----------------------L 149
           E+ I + L H N++ L  + +++R+  LIL     G                       L
Sbjct: 73  EIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEEL 132
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A A++Y H    + ++HRDIK  N++L      K+ DFG +    H    +   + GT+ 
Sbjct: 133 ADALMYCHG---KKVIHRDIKPENLLLGLKGELKIADFGWSV---HAPSLRRKTMCGTLD 186
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
           YL PE +     +++ D++  GV+  E+  G  P E
Sbjct: 187 YLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ DF LAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDFYLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 46/236 (19%)
Query: 103 RGSKQGKKEYISEVRIISRLRHRNLVHLIGWCH-EQRQLILHKIALG------------- 148
           +  +Q  +     +  I  L H ++V L+G C     QL+   + LG             
Sbjct: 71  KSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGAL 130
Query: 149 -----------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL 197
                      +A  + YL E     +VHR++ + NV+L S    ++ DFG+A L+  + 
Sbjct: 131 GPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 187
Query: 198 GSQTTVLAGT-MGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRL 255
                  A T + ++A E +  GK + +SDV+S+GV   E+   G +P       + +RL
Sbjct: 188 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY------AGLRL 241
Query: 256 VEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
            E V DL  KG+ L A     + +     ++C MI        D   RP+ +++ N
Sbjct: 242 AE-VPDLLEKGERL-AQPQICTIDVYMVMVKCWMI--------DENIRPTFKELAN 287

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 47/81 (58%), Gaps = 3/81 (3%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           +VHRD+K  N+++ S+   KL DFGLAR+   ++   + V+  T+ Y APE +     + 
Sbjct: 141 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLLQSSYAT 198
Query: 224 ESDVYSFGVVALEVACGRKPV 244
             D++S G +  E+   RKP+
Sbjct: 199 PVDLWSVGCIFAEM-FRRKPL 218

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 46/236 (19%)
Query: 103 RGSKQGKKEYISEVRIISRLRHRNLVHLIGWCH-EQRQLILHKIALG------------- 148
           +  +Q  +     +  I  L H ++V L+G C     QL+   + LG             
Sbjct: 53  KSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGAL 112
Query: 149 -----------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL 197
                      +A  + YL E     +VHR++ + NV+L S    ++ DFG+A L+  + 
Sbjct: 113 GPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
Query: 198 GSQTTVLAGT-MGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRL 255
                  A T + ++A E +  GK + +SDV+S+GV   E+   G +P       + +RL
Sbjct: 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY------AGLRL 223
Query: 256 VEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
            E V DL  KG+ L A     + +     ++C MI        D   RP+ +++ N
Sbjct: 224 AE-VPDLLEKGERL-AQPQICTIDVYMVMVKCWMI--------DENIRPTFKELAN 269

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 37/194 (19%)
Query: 95  EIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL--------- 142
           E AVK +S+     K  K+  + EV+++ +L H N++ L  +  ++    L         
Sbjct: 59  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 118
Query: 143 ----------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAK 183
                            +I   + S + Y+H+     IVHRD+K  N++L+S   + N +
Sbjct: 119 LFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIR 175
Query: 184 LGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           + DFGL+     E   +     GT  Y+APE V  G   ++ DV+S GV+   +  G  P
Sbjct: 176 IIDFGLS--THFEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 232
Query: 244 VEPRQEPSKVRLVE 257
                E   ++ VE
Sbjct: 233 FNGANEYDILKKVE 246

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 67/136 (49%), Gaps = 13/136 (9%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 131 TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 184
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE V  G   
Sbjct: 185 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPE-VILGMGY 240
Query: 223 KES-DVYSFGVVALEV 237
           KE+ D++S G +  E+
Sbjct: 241 KENVDIWSVGCIMGEM 256

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR SR S++G  ++E   EV I+ ++ H N++ L    +E R    LIL  ++ G     
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD-VYENRTDVVLILELVSGGELFDF 105
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             +   V YLH    + I H D+K  N+ +LD N    + KL D
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +  E G +   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 163 FGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ D GLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDAGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 86  TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 139
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 140 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 196
Query: 223 KESDVYSFGVVALEVA 238
           +  D++S G +  E+ 
Sbjct: 197 ENVDIWSVGCIMGEMV 212

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 146
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 203
Query: 223 KESDVYSFGVVALEVA 238
           +  D++S G +  E+ 
Sbjct: 204 ENVDIWSVGCIMGEMV 219

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR ++ S++G  +++   EV I+  ++H N++ L    +E +    LIL  +A G     
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDF 104
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             + + V YLH      I H D+K  N+ +LD N      K+ D
Sbjct: 105 LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +D   G++   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 162 FGLAHKID--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 67/137 (48%), Gaps = 13/137 (9%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 131 TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 184
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE V  G   
Sbjct: 185 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPE-VILGMGY 240
Query: 223 KES-DVYSFGVVALEVA 238
           KE+ D++S G +  E+ 
Sbjct: 241 KENVDIWSVGCIMGEMV 257

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 11/153 (7%)
Query: 88  LLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKI 145
           L+   N +  +  ++  + Q   E   +V ++  L   NL  +I     HE+   +L+++
Sbjct: 76  LMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA 205
             G+     +LH      I+HRD+K SN+V+ S+   K+ DFGLAR           V+ 
Sbjct: 136 LCGIK----HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV- 187
Query: 206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVA 238
            T  Y APE +      +  D++S G +  E+ 
Sbjct: 188 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 146
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 203
Query: 223 KESDVYSFGVVALEVA 238
           +  D++S G +  E+ 
Sbjct: 204 ENVDIWSVGCIMGEMV 219

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR SR S++G  ++E   EV I+ ++ H N++ L    +E R    LIL  ++ G     
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD-VYENRTDVVLILELVSGGELFDF 105
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             +   V YLH    + I H D+K  N+ +LD N    + KL D
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +  E G +   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 163 FGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR ++ S++G  +++   EV I+  ++H N++ L    +E +    LIL  +A G     
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDF 104
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             + + V YLH      I H D+K  N+ +LD N      K+ D
Sbjct: 105 LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +D   G++   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 162 FGLAHKID--FGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 11/153 (7%)
Query: 88  LLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKI 145
           L+   N +  +  ++  + Q   E   +V ++  L   NL  +I     HE+   +L+++
Sbjct: 76  LMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA 205
             G+     +LH      I+HRD+K SN+V+ S+   K+ DFGLAR           V+ 
Sbjct: 136 LCGIK----HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV- 187
Query: 206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVA 238
            T  Y APE +      +  D++S G +  E+ 
Sbjct: 188 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 87  TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 140
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 141 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 197
Query: 223 KESDVYSFGVVALEVA 238
           +  D++S G +  E+ 
Sbjct: 198 ENVDIWSVGCIMGEMV 213

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 94  TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 147
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 148 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 204
Query: 223 KESDVYSFGVVALEVA 238
           +  D++S G +  E+ 
Sbjct: 205 ENVDIWSVGCIMGEMV 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 92  TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 145
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 146 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 202
Query: 223 KESDVYSFGVVALEVA 238
           +  D++S G +  E+ 
Sbjct: 203 ENVDIWSVGCIMGEMV 218

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  ++A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 46/75 (61%), Gaps = 2/75 (2%)
Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG--TMGYLAPECVTTGKAS 222
           VHRD+ + N++++S  + K+ DFGLA+L+  +         G   + + APE ++    S
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 208
Query: 223 KESDVYSFGVVALEV 237
           ++SDV+SFGVV  E+
Sbjct: 209 RQSDVWSFGVVLYEL 223

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 46/75 (61%), Gaps = 2/75 (2%)
Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG--TMGYLAPECVTTGKAS 222
           VHRD+ + N++++S  + K+ DFGLA+L+  +         G   + + APE ++    S
Sbjct: 136 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 195
Query: 223 KESDVYSFGVVALEV 237
           ++SDV+SFGVV  E+
Sbjct: 196 RQSDVWSFGVVLYEL 210

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 94  TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 147
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 148 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 204
Query: 223 KESDVYSFGVVALEVA 238
           +  D++S G +  E+ 
Sbjct: 205 ENVDIWSVGCIMGEMV 220

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 11/136 (8%)
Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGW--CHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           + Q   E   +V ++  L   NL  +I     HE+   +L+++  G+     +LH     
Sbjct: 87  TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSAG-- 140
Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I+HRD+K SN+V+ S+   K+ DFGLAR           V+  T  Y APE +      
Sbjct: 141 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYK 197
Query: 223 KESDVYSFGVVALEVA 238
           +  D++S G +  E+ 
Sbjct: 198 ENVDIWSVGCIMGEMV 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR ++ S++G  +++   EV I+  ++H N++ L    +E +    LIL  +A G     
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDF 103
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             + + V YLH      I H D+K  N+ +LD N      K+ D
Sbjct: 104 LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 160
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +D   G++   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 161 FGLAHKID--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGT 207
           LA  + YL  +  +CI HRD+ + NV++  N   K+ DFGLAR +++ +   +TT     
Sbjct: 166 LARGMEYLASQ--KCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKG 266
           + ++APE +     + +SDV+SFGV+  E+   G  P            VE ++ L  +G
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------VEELFKLLKEG 275
Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   R+ K  +      +M+   W   P  + RP+ +Q++  L+
Sbjct: 276 H-------RMDKPANCTNELYMMMRDCWHAVP--SQRPTFKQLVEDLD 314

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR ++ S++G  +++   EV I+  ++H N++ L    +E +    LIL  +A G     
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDF 104
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             + + V YLH      I H D+K  N+ +LD N      K+ D
Sbjct: 105 LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +D   G++   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 162 FGLAHKID--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR ++ S++G  +++   EV I+  ++H N++ L    +E +    LIL  +A G     
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDF 103
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             + + V YLH      I H D+K  N+ +LD N      K+ D
Sbjct: 104 LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 160
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +D   G++   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 161 FGLAHKID--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR ++ S++G  +++   EV I+  ++H N++ L    +E +    LIL  +A G     
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDF 104
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             + + V YLH      I H D+K  N+ +LD N      K+ D
Sbjct: 105 LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +D   G++   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 162 FGLAHKID--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR ++ S++G  +++   EV I+  ++H N++ L    +E +    LIL  +A G     
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDF 104
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             + + V YLH      I H D+K  N+ +LD N      K+ D
Sbjct: 105 LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +D   G++   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 162 FGLAHKID--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 46/75 (61%), Gaps = 2/75 (2%)
Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG--TMGYLAPECVTTGKAS 222
           VHRD+ + N++++S  + K+ DFGLA+L+  +         G   + + APE ++    S
Sbjct: 137 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 196
Query: 223 KESDVYSFGVVALEV 237
           ++SDV+SFGVV  E+
Sbjct: 197 RQSDVWSFGVVLYEL 211

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR ++ S++G  +++   EV I+  ++H N++ L    +E +    LIL  +A G     
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDF 104
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             + + V YLH      I H D+K  N+ +LD N      K+ D
Sbjct: 105 LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +D   G++   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 162 FGLAHKID--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR ++ S++G  +++   EV I+  ++H N++ L    +E +    LIL  +A G     
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDF 104
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             + + V YLH      I H D+K  N+ +LD N      K+ D
Sbjct: 105 LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +D   G++   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 162 FGLAHKID--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 37/194 (19%)
Query: 95  EIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLV------------HLIGWCHEQRQ 139
           E AVK +S+     K  K+  + EV+++ +L H N++            +L+G  +   +
Sbjct: 53  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 112
Query: 140 LI-------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAK 183
           L                +I   + S + Y+H+     IVHRD+K  N++L+S   + N +
Sbjct: 113 LFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIR 169
Query: 184 LGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           + DFGL+     E   +     GT  Y+APE V  G   ++ DV+S GV+   +  G  P
Sbjct: 170 IIDFGLS--THFEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
Query: 244 VEPRQEPSKVRLVE 257
                E   ++ VE
Sbjct: 227 FNGANEYDILKKVE 240

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGT 207
           LA  + YL  +  +CI HRD+ + NV++  N   K+ DFGLAR +++ +   +TT     
Sbjct: 166 LARGMEYLASQ--KCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKG 266
           + ++APE +     + +SDV+SFGV+  E+   G  P            VE ++ L  +G
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------VEELFKLLKEG 275
Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   R+ K  +      +M+   W   P  + RP+ +Q++  L+
Sbjct: 276 H-------RMDKPANCTNELYMMMRDCWHAVP--SQRPTFKQLVEDLD 314

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR ++ S++G  +++   EV I+  ++H N++ L    +E +    LIL  +A G     
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDF 104
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             + + V YLH      I H D+K  N+ +LD N      K+ D
Sbjct: 105 LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +D   G++   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 162 FGLAHKID--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 14/109 (12%)
Query: 144 KIALGLASAVLYLHEEW-----EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL---VDH 195
           +I L +AS + +LH E      +  I HRD+KS N+++  N    + D GLA +     +
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 196 ELGSQTTVLAGTMGYLAPEC------VTTGKASKESDVYSFGVVALEVA 238
           +L        GT  Y+APE       V    + K  D+++FG+V  EVA
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ D GLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDRGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 81/187 (43%), Gaps = 26/187 (13%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKK-EYISEVRIISRLRHRNLVHLIGWCHEQRQLIL 142
           VY+G     +  +A+K +    ++G     I EV ++  L+H N+V L    H ++ L L
Sbjct: 18  VYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 77
Query: 143 ----------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF 180
                                 H + L L   +  L     Q ++HRD+K  N++++   
Sbjct: 78  VFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG 137
Query: 181 NAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT-TGKASKESDVYSFGVVALEVAC 239
             KL DFGLAR       +    +  T+ Y  P+ +  +   S + D++  G +  E+A 
Sbjct: 138 ELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196
Query: 240 GRKPVEP 246
           GR P+ P
Sbjct: 197 GR-PLFP 202

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 14/109 (12%)
Query: 144 KIALGLASAVLYLHEEW-----EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL---VDH 195
           +I L +AS + +LH E      +  I HRD+KS N+++  N    + D GLA +     +
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 196 ELGSQTTVLAGTMGYLAPEC------VTTGKASKESDVYSFGVVALEVA 238
           +L        GT  Y+APE       V    + K  D+++FG+V  EVA
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR SR S++G  ++E   EV I+ ++ H N++ L    +E R    LIL  ++ G     
Sbjct: 47  KRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD-VYENRTDVVLILELVSGGELFDF 105
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             +   V YLH    + I H D+K  N+ +LD N    + KL D
Sbjct: 106 LAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +  E G +   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 163 FGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR ++ S++G  +++   EV I+  ++H N++ L    +E +    LIL  +A G     
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDF 104
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             + + V YLH      I H D+K  N+ +LD N      K+ D
Sbjct: 105 LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +D   G++   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 162 FGLAHKID--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 49/183 (26%)
Query: 96  IAVKRVSRGSK---QGKKEYISEVRIISRLRHRNLV----------------------HL 130
           +AVK++SR  +     K+ Y  E+R++  ++H N++                      HL
Sbjct: 50  VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 108
Query: 131 IG-----------WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN 179
           +G              +  Q ++++I  GL     Y+H      I+HRD+K SN+ ++ +
Sbjct: 109 MGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS---ADIIHRDLKPSNLAVNED 161
Query: 180 FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVA 238
              K+ D GLAR  D E+    T    T  Y APE +       ++ D++S G +  E+ 
Sbjct: 162 CELKILDGGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 239 CGR 241
            GR
Sbjct: 218 TGR 220

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR ++ S++G  +++   EV I+  ++H N++ L    +E +    LIL  +A G     
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDF 104
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             + + V YLH      I H D+K  N+ +LD N      K+ D
Sbjct: 105 LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +D   G++   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 162 FGLAHKID--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 57  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 116
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ 
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 175
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 176 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGT 207
           LA  + YL  +  +CI HRD+ + NV++  N   K+ DFGLAR +++ +   +TT     
Sbjct: 166 LARGMEYLASQ--KCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKG 266
           + ++APE +     + +SDV+SFGV+  E+   G  P            VE ++ L  +G
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------VEELFKLLKEG 275
Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   R+ K  +      +M+   W   P  + RP+ +Q++  L+
Sbjct: 276 H-------RMDKPANCTNELYMMMRDCWHAVP--SQRPTFKQLVEDLD 314

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ 
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 169 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 37/194 (19%)
Query: 95  EIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLV------------HLIGWCHEQRQ 139
           E AVK +S+     K  K+  + EV+++ +L H N++            +L+G  +   +
Sbjct: 77  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 136
Query: 140 LI-------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAK 183
           L                +I   + S + Y+H+     IVHRD+K  N++L+S   + N +
Sbjct: 137 LFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIR 193
Query: 184 LGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           + DFGL+     E   +     GT  Y+APE V  G   ++ DV+S GV+   +  G  P
Sbjct: 194 IIDFGLS--THFEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 250
Query: 244 VEPRQEPSKVRLVE 257
                E   ++ VE
Sbjct: 251 FNGANEYDILKKVE 264

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGT 207
           LA  + YL  +  +CI HRD+ + NV++  N   K+ DFGLAR +++ +   +TT     
Sbjct: 166 LARGMEYLASQ--KCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKG 266
           + ++APE +     + +SDV+SFGV+  E+   G  P            VE ++ L  +G
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------VEELFKLLKEG 275
Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   R+ K  +      +M+   W   P  + RP+ +Q++  L+
Sbjct: 276 H-------RMDKPANCTNELYMMMRDCWHAVP--SQRPTFKQLVEDLD 314

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGT 207
           LA  + YL  +  +CI HRD+ + NV++  N   K+ DFGLAR +++ +   +TT     
Sbjct: 166 LARGMEYLASQ--KCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKG 266
           + ++APE +     + +SDV+SFGV+  E+   G  P            VE ++ L  +G
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------VEELFKLLKEG 275
Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   R+ K  +      +M+   W   P  + RP+ +Q++  L+
Sbjct: 276 H-------RMDKPANCTNELYMMMRDCWHAVP--SQRPTFKQLVEDLD 314

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGT 207
           LA  + YL  +  +CI HRD+ + NV++  N   K+ DFGLAR +++ +   +TT     
Sbjct: 166 LARGMEYLASQ--KCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKG 266
           + ++APE +     + +SDV+SFGV+  E+   G  P            VE ++ L  +G
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------VEELFKLLKEG 275
Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   R+ K  +      +M+   W   P  + RP+ +Q++  L+
Sbjct: 276 H-------RMDKPANCTNELYMMMRDCWHAVP--SQRPTFKQLVEDLD 314

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 61/122 (50%), Gaps = 22/122 (18%)
Query: 137 QRQLILHKIALGLASA----VLYLHEEW-----EQCIVHRDIKSSNVVLDSNFNAKLGDF 187
           QRQ +   +AL LA +    + +LH E      +  I HRD KS NV++ SN    + D 
Sbjct: 98  QRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADL 157
Query: 188 GLARLVDHELGSQTTVLA-----GTMGYLAPECVTTG------KASKESDVYSFGVVALE 236
           GLA  V H  GS    +      GT  Y+APE +         ++ K +D+++FG+V  E
Sbjct: 158 GLA--VMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWE 215
Query: 237 VA 238
           +A
Sbjct: 216 IA 217

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 37/194 (19%)
Query: 95  EIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLV------------HLIGWCHEQRQ 139
           E AVK +S+     K  K+  + EV+++ +L H N++            +L+G  +   +
Sbjct: 76  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 135
Query: 140 LI-------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAK 183
           L                +I   + S + Y+H+     IVHRD+K  N++L+S   + N +
Sbjct: 136 LFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIR 192
Query: 184 LGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           + DFGL+     E   +     GT  Y+APE V  G   ++ DV+S GV+   +  G  P
Sbjct: 193 IIDFGLS--THFEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 249
Query: 244 VEPRQEPSKVRLVE 257
                E   ++ VE
Sbjct: 250 FNGANEYDILKKVE 263

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGT 207
           LA  + YL  +  +CI HRD+ + NV++  N   K+ DFGLAR +++ +   +TT     
Sbjct: 153 LARGMEYLASQ--KCI-HRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 209
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKG 266
           + ++APE +     + +SDV+SFGV+  E+   G  P            VE ++ L  +G
Sbjct: 210 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------VEELFKLLKEG 262
Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   R+ K  +      +M+   W   P  + RP+ +Q++  L+
Sbjct: 263 H-------RMDKPANCTNELYMMMRDCWHAVP--SQRPTFKQLVEDLD 301

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 14/109 (12%)
Query: 144 KIALGLASAVLYLHEEW-----EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL---VDH 195
           +I L +AS + +LH E      +  I HRD+KS N+++  N    + D GLA +     +
Sbjct: 138 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 197
Query: 196 ELGSQTTVLAGTMGYLAPEC------VTTGKASKESDVYSFGVVALEVA 238
           +L        GT  Y+APE       V    + K  D+++FG+V  EVA
Sbjct: 198 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA---KLGDFGLARLVDHELGSQTTVLAGTM 208
           AVL+ H+     +VHR++K  N++L S       KL DFGLA  V+ E  +     AGT 
Sbjct: 122 AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTP 177
Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           GYL+PE +      K  D+++ GV+   +  G  P
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
           +I   +  A+ YLH      I HRD+K  N++  S   N   KL DFG A+       + 
Sbjct: 125 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NS 179
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            T    T  Y+APE +   K  K  D++S GV+   + CG  P
Sbjct: 180 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 222

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 82/189 (43%), Gaps = 41/189 (21%)
Query: 87  GLLSDQNT-EIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVHLIG------------ 132
           G+ +D +  ++AVK +    S+Q + +++ E  IIS+L H+N+V  IG            
Sbjct: 68  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILL 127
Query: 133 ----------WCHEQR----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                     +  E R           L L  +A  +A    YL E      +HRDI + 
Sbjct: 128 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 184
Query: 173 NVVLDSNFN---AKLGDFGLAR-LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           N +L        AK+GDFG+AR +       +       + ++ PE    G  + ++D +
Sbjct: 185 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244
Query: 229 SFGVVALEV 237
           SFGV+  E+
Sbjct: 245 SFGVLLWEI 253

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGT 207
           LA  + YL  +  +CI HRD+ + NV++  N   K+ DFGLAR +++ +   +TT     
Sbjct: 155 LARGMEYLASQ--KCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 211
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKG 266
           + ++APE +     + +SDV+SFGV+  E+   G  P            VE ++ L  +G
Sbjct: 212 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------VEELFKLLKEG 264
Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   R+ K  +      +M+   W   P  + RP+ +Q++  L+
Sbjct: 265 H-------RMDKPANCTNELYMMMRDCWHAVP--SQRPTFKQLVEDLD 303

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 39/197 (19%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLV--HLIGWCHEQRQLILHKIALG------ 148
           KR    S++G  ++E   EV I+  +RH N++  H I        LIL  ++ G      
Sbjct: 47  KRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL 106
Query: 149 -----------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGDF 187
                            +   V YLH    + I H D+K  N+ +LD N      KL DF
Sbjct: 107 AEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF 163
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPV--E 245
           G+A  +  E G++   + GT  ++APE V       E+D++S GV+   +  G  P   E
Sbjct: 164 GIAHKI--EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 221
Query: 246 PRQEP-SKVRLVEWVWD 261
            +QE  + +  V + +D
Sbjct: 222 TKQETLTNISAVNYDFD 238

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
           +I   +  A+ YLH      I HRD+K  N++  S   N   KL DFG A+       + 
Sbjct: 126 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NS 180
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            T    T  Y+APE +   K  K  D++S GV+   + CG  P
Sbjct: 181 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 223

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
           +I   +  A+ YLH      I HRD+K  N++  S   N   KL DFG A+       + 
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NS 175
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            T    T  Y+APE +   K  K  D++S GV+   + CG  P
Sbjct: 176 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 65/154 (42%), Gaps = 27/154 (17%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQ--RQLILHKIALG-----LASAVLYLHEEWEQCI--- 164
           E RI  +L+H N+V L     E+    L+   +  G     + +   Y   +   CI   
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 114
Query: 165 ------------VHRDIKSSNVVLDSNFNA---KLGDFGLARLVDHELGSQTTVLAGTMG 209
                       VHR++K  N++L S       KL DFGLA  V+          AGT G
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPG 172
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           YL+PE +     SK  D+++ GV+   +  G  P
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---LILHKIALG----- 148
           KR ++ S++G  +++   EV I+  ++H N++ L    +E +    LIL  +A G     
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITL-HEVYENKTDVILILELVAGGELFDF 104
Query: 149 ------------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGD 186
                             + + V YLH      I H D+K  N+ +LD N      K+ D
Sbjct: 105 LAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           FGLA  +D   G++   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 162 FGLAHKID--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNF---NAKLGDFGLARLVDHELGSQTTVLAGTM 208
            V YLH+     IVH D+K  N++L S +   + K+ DFG++R + H    +   + GT 
Sbjct: 143 GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--ACELREIMGTP 197
Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            YLAPE +     +  +D+++ G++A  +     P
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
           +I   +  A+ YLH      I HRD+K  N++  S   N   KL DFG A+       + 
Sbjct: 127 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NS 181
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            T    T  Y+APE +   K  K  D++S GV+   + CG  P
Sbjct: 182 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 224

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 82/189 (43%), Gaps = 41/189 (21%)
Query: 87  GLLSDQNT-EIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVHLIG------------ 132
           G+ +D +  ++AVK +    S+Q + +++ E  IIS+L H+N+V  IG            
Sbjct: 54  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILL 113
Query: 133 ----------WCHEQR----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                     +  E R           L L  +A  +A    YL E      +HRDI + 
Sbjct: 114 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 170
Query: 173 NVVLDSNFN---AKLGDFGLAR-LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           N +L        AK+GDFG+AR +       +       + ++ PE    G  + ++D +
Sbjct: 171 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 230
Query: 229 SFGVVALEV 237
           SFGV+  E+
Sbjct: 231 SFGVLLWEI 239

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGT 207
           LA  + YL  +  +CI HRD+ + NV++  N   K+ DFGLAR +++ +   +TT     
Sbjct: 158 LARGMEYLASQ--KCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 214
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKG 266
           + ++APE +     + +SDV+SFGV+  E+   G  P            VE ++ L  +G
Sbjct: 215 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------VEELFKLLKEG 267
Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   R+ K  +      +M+   W   P  + RP+ +Q++  L+
Sbjct: 268 H-------RMDKPANCTNELYMMMRDCWHAVP--SQRPTFKQLVEDLD 306

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 39/197 (19%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLV--HLIGWCHEQRQLILHKIALG------ 148
           KR    S++G  ++E   EV I+  +RH N++  H I        LIL  ++ G      
Sbjct: 61  KRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL 120
Query: 149 -----------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGDF 187
                            +   V YLH    + I H D+K  N+ +LD N      KL DF
Sbjct: 121 AEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF 177
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPV--E 245
           G+A  +  E G++   + GT  ++APE V       E+D++S GV+   +  G  P   E
Sbjct: 178 GIAHKI--EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 235
Query: 246 PRQEP-SKVRLVEWVWD 261
            +QE  + +  V + +D
Sbjct: 236 TKQETLTNISAVNYDFD 252

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGT 207
           LA  + YL  +  +CI HRD+ + NV++  N   K+ DFGLAR +++ +   +TT     
Sbjct: 212 LARGMEYLASQ--KCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 268
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKG 266
           + ++APE +     + +SDV+SFGV+  E+   G  P            VE ++ L  +G
Sbjct: 269 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------VEELFKLLKEG 321
Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   R+ K  +      +M+   W   P  + RP+ +Q++  L+
Sbjct: 322 H-------RMDKPANCTNELYMMMRDCWHAVP--SQRPTFKQLVEDLD 360

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 21/168 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGT 207
           LA  + YL  +  +CI HRD+ + NV++  N   K+ DFGLAR +++ +    TT     
Sbjct: 166 LARGMEYLASQ--KCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLP 222
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKG 266
           + ++APE +     + +SDV+SFGV+  E+   G  P            VE ++ L  +G
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------VEELFKLLKEG 275
Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   R+ K  +      +M+   W   P  + RP+ +Q++  L+
Sbjct: 276 H-------RMDKPANCTNELYMMMRDCWHAVP--SQRPTFKQLVEDLD 314

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ 
Sbjct: 110 FQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 113
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ 
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 172
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
           +I   +  A+ YLH      I HRD+K  N++  S   N   KL DFG A+       + 
Sbjct: 120 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NS 174
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            T    T  Y+APE +   K  K  D++S GV+   + CG  P
Sbjct: 175 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 217

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA---KLGDFGLARLVDHELGSQTT--VLAG 206
           AVL+ H+     +VHRD+K  N++L S       KL DFGLA  V    G Q      AG
Sbjct: 115 AVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ---GDQQAWFGFAG 168
Query: 207 TMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           T GYL+PE +      K  D+++ GV+   +  G  P
Sbjct: 169 TPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
           +I   +  A+ YLH      I HRD+K  N++  S   N   KL DFG A+       + 
Sbjct: 165 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NS 219
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            T    T  Y+APE +   K  K  D++S GV+   + CG  P
Sbjct: 220 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
           +I   +  A+ YLH      I HRD+K  N++  S   N   KL DFG A+       + 
Sbjct: 119 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NS 173
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            T    T  Y+APE +   K  K  D++S GV+   + CG  P
Sbjct: 174 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 57  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 116
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ 
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 175
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 176 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
           +I   +  A+ YLH      I HRD+K  N++  S   N   KL DFG A+       + 
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NS 175
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            T    T  Y+APE +   K  K  D++S GV+   + CG  P
Sbjct: 176 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 65/154 (42%), Gaps = 27/154 (17%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQ--RQLILHKIALG-----LASAVLYLHEEWEQCI--- 164
           E RI  +L+H N+V L     E+    L+   +  G     + +   Y   +   CI   
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 137
Query: 165 ------------VHRDIKSSNVVLDSNFNA---KLGDFGLARLVDHELGSQTTVLAGTMG 209
                       VHR++K  N++L S       KL DFGLA  V+          AGT G
Sbjct: 138 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPG 195
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           YL+PE +     SK  D+++ GV+   +  G  P
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 39/197 (19%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLV--HLIGWCHEQRQLILHKIALG------ 148
           KR    S++G  ++E   EV I+  +RH N++  H I        LIL  ++ G      
Sbjct: 40  KRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL 99
Query: 149 -----------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGDF 187
                            +   V YLH    + I H D+K  N+ +LD N      KL DF
Sbjct: 100 AEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPV--E 245
           G+A  +  E G++   + GT  ++APE V       E+D++S GV+   +  G  P   E
Sbjct: 157 GIAHKI--EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214
Query: 246 PRQEP-SKVRLVEWVWD 261
            +QE  + +  V + +D
Sbjct: 215 TKQETLTNISAVNYDFD 231

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT  YLAP 
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPA 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 65/154 (42%), Gaps = 27/154 (17%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQ--RQLILHKIALG-----LASAVLYLHEEWEQCI--- 164
           E RI  +L+H N+V L     E+    L+   +  G     + +   Y   +   CI   
Sbjct: 54  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 113
Query: 165 ------------VHRDIKSSNVVLDSNFNA---KLGDFGLARLVDHELGSQTTVLAGTMG 209
                       VHR++K  N++L S       KL DFGLA  V+          AGT G
Sbjct: 114 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPG 171
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           YL+PE +     SK  D+++ GV+   +  G  P
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ 
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ 
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 167
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
           +I   +  A+ YLH      I HRD+K  N++  S   N   KL DFG A+       + 
Sbjct: 171 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NS 225
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            T    T  Y+APE +   K  K  D++S GV+   + CG  P
Sbjct: 226 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 268

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ 
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ 
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 167
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 13/101 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA---KLGDFGLARLVDHELGSQTTVLA 205
           +  A+ Y H+     I+HRD+K  NV+L S  N+   KLGDFG+A     +LG    V  
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPENVLLASKENSAPVKLGDFGVAI----QLGESGLVAG 191
Query: 206 GTMG---YLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           G +G   ++APE V      K  DV+  GV+   +  G  P
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ 
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 167
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 65/154 (42%), Gaps = 27/154 (17%)
Query: 115 EVRIISRLRHRNLVHLIGWCHEQ--RQLILHKIALG-----LASAVLYLHEEWEQCI--- 164
           E RI  +L+H N+V L     E+    L+   +  G     + +   Y   +   CI   
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 114
Query: 165 ------------VHRDIKSSNVVLDSNFNA---KLGDFGLARLVDHELGSQTTVLAGTMG 209
                       VHR++K  N++L S       KL DFGLA  V+          AGT G
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPG 172
Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           YL+PE +     SK  D+++ GV+   +  G  P
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ 
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 169
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ 
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 168
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 48/103 (46%), Gaps = 8/103 (7%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
           +I   +  A+ YLH      I HRD+K  N++  S   N   KL DFG A+       + 
Sbjct: 135 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NS 189
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            T    T  Y+APE +   K  K  D++S GV+   + CG  P
Sbjct: 190 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 232

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 61/199 (30%)
Query: 95  EIAVKRVSR-GSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ--------------- 137
           + A+KR+    SK   +++  E+ ++ +L  H N+++L+G C  +               
Sbjct: 44  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 103
Query: 138 ---------------------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIK 170
                                       Q +LH  A  +A  + YL ++     +HRD+ 
Sbjct: 104 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLH-FAADVARGMDYLSQKQ---FIHRDLA 159
Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG-----YLAPECVTTGKASKES 225
           + N+++  N+ AK+ DFGL+R        Q   +  TMG     ++A E +     +  S
Sbjct: 160 ARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 212
Query: 226 DVYSFGVVALE-VACGRKP 243
           DV+S+GV+  E V+ G  P
Sbjct: 213 DVWSYGVLLWEIVSLGGTP 231

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 88/191 (46%), Gaps = 35/191 (18%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG-WCHEQRQLIL 142
           VY+    +     A K +   S++  ++YI E+ I++   H  +V L+G + H+ +  I+
Sbjct: 35  VYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94
Query: 143 HKIALG-------------------------LASAVLYLHEEWEQCIVHRDIKSSNVVLD 177
            +   G                         +  A+ +LH    + I+HRD+K+ NV++ 
Sbjct: 95  IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMT 151
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT--TGKASK---ESDVYSFGV 232
              + +L DFG++      L  + + + GT  ++APE V   T K +    ++D++S G+
Sbjct: 152 LEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLGI 210
Query: 233 VALEVACGRKP 243
             +E+A    P
Sbjct: 211 TLIEMAQIEPP 221

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 88/191 (46%), Gaps = 35/191 (18%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG-WCHEQRQLIL 142
           VY+    +     A K +   S++  ++YI E+ I++   H  +V L+G + H+ +  I+
Sbjct: 27  VYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 86
Query: 143 HKIALG-------------------------LASAVLYLHEEWEQCIVHRDIKSSNVVLD 177
            +   G                         +  A+ +LH    + I+HRD+K+ NV++ 
Sbjct: 87  IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMT 143
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT--TGKASK---ESDVYSFGV 232
              + +L DFG++      L  + + + GT  ++APE V   T K +    ++D++S G+
Sbjct: 144 LEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLGI 202
Query: 233 VALEVACGRKP 243
             +E+A    P
Sbjct: 203 TLIEMAQIEPP 213

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 61/199 (30%)
Query: 95  EIAVKRVSR-GSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ--------------- 137
           + A+KR+    SK   +++  E+ ++ +L  H N+++L+G C  +               
Sbjct: 54  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 113
Query: 138 ---------------------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIK 170
                                       Q +LH  A  +A  + YL ++     +HRD+ 
Sbjct: 114 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLH-FAADVARGMDYLSQKQ---FIHRDLA 169
Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG-----YLAPECVTTGKASKES 225
           + N+++  N+ AK+ DFGL+R        Q   +  TMG     ++A E +     +  S
Sbjct: 170 ARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 222
Query: 226 DVYSFGVVALE-VACGRKP 243
           DV+S+GV+  E V+ G  P
Sbjct: 223 DVWSYGVLLWEIVSLGGTP 241

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 48/85 (56%), Gaps = 8/85 (9%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECVTTG 219
           +VH+D+ + NV++    N K+ D GL R V     +    L G     + ++APE +  G
Sbjct: 166 VVHKDLATRNVLVYDKLNVKISDLGLFREV---YAADYYKLLGNSLLPIRWMAPEAIMYG 222
Query: 220 KASKESDVYSFGVVALEV-ACGRKP 243
           K S +SD++S+GVV  EV + G +P
Sbjct: 223 KFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTVLAGT 207
           LA  + YL  +  +CI HRD+ + NV++  N   ++ DFGLAR +++ +   +TT     
Sbjct: 166 LARGMEYLASQ--KCI-HRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLP 222
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKG 266
           + ++APE +     + +SDV+SFGV+  E+   G  P            VE ++ L  +G
Sbjct: 223 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------VEELFKLLKEG 275
Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   R+ K  +      +M+   W   P  + RP+ +Q++  L+
Sbjct: 276 H-------RMDKPANCTNELYMMMRDCWHAVP--SQRPTFKQLVEDLD 314

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           AV YLHE     I+HRD+K  NV+L S   +   K+ DFG ++++     S    L GT 
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 180
Query: 209 GYLAPEC-VTTGKA--SKESDVYSFGVVALEVACGRKP 243
            YLAPE  V+ G A  ++  D +S GV+      G  P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           AV YLHE     I+HRD+K  NV+L S   +   K+ DFG ++++     S    L GT 
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 180
Query: 209 GYLAPEC-VTTGKA--SKESDVYSFGVVALEVACGRKP 243
            YLAPE  V+ G A  ++  D +S GV+      G  P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           AV YLHE     I+HRD+K  NV+L S   +   K+ DFG ++++     S    L GT 
Sbjct: 125 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 179
Query: 209 GYLAPEC-VTTGKA--SKESDVYSFGVVALEVACGRKP 243
            YLAPE  V+ G A  ++  D +S GV+      G  P
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 164 IVHRDIKSSNVVLDSNFNA---KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK 220
           IVHRD+K  N++L S       KL DFGLA  V  E  +     AGT GYL+PE +    
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG-FAGTPGYLSPEVLRKDP 209
Query: 221 ASKESDVYSFGVVALEVACGRKP 243
             K  D+++ GV+   +  G  P
Sbjct: 210 YGKPVDIWACGVILYILLVGYPP 232

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           AV YLHE     I+HRD+K  NV+L S   +   K+ DFG ++++     S    L GT 
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 180
Query: 209 GYLAPEC-VTTGKA--SKESDVYSFGVVALEVACGRKP 243
            YLAPE  V+ G A  ++  D +S GV+      G  P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           AV YLHE     I+HRD+K  NV+L S   +   K+ DFG ++++     S    L GT 
Sbjct: 265 AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 319
Query: 209 GYLAPEC-VTTGKA--SKESDVYSFGVVALEVACGRKP 243
            YLAPE  V+ G A  ++  D +S GV+      G  P
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 44/78 (56%), Gaps = 7/78 (8%)
Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECVTTG 219
           +VH+D+ + NV++    N K+ D GL R V     +    L G     + ++APE +  G
Sbjct: 149 VVHKDLATRNVLVYDKLNVKISDLGLFREV---YAADYYKLLGNSLLPIRWMAPEAIMYG 205
Query: 220 KASKESDVYSFGVVALEV 237
           K S +SD++S+GVV  EV
Sbjct: 206 KFSIDSDIWSYGVVLWEV 223

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 11/98 (11%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           AV YLHE     I+HRD+K  NV+L S   +   K+ DFG ++++     S    L GT 
Sbjct: 251 AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 305
Query: 209 GYLAPEC---VTTGKASKESDVYSFGVVALEVACGRKP 243
            YLAPE    V T   ++  D +S GV+      G  P
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 47/103 (45%), Gaps = 8/103 (7%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
           +I   +  A+ YLH      I HRD+K  N++  S   N   KL DFG A+       + 
Sbjct: 165 EIXKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NS 219
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            T    T  Y+APE +   K  K  D +S GV+   + CG  P
Sbjct: 220 LTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPP 262

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 36/176 (20%)
Query: 99  KRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL--HKIALG------ 148
           KR ++ S++G  +++   EV I+  ++H N++ L      +  +IL    +A G      
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL 105
Query: 149 -----------------LASAVLYLHEEWEQCIVHRDIKSSNV-VLDSNF---NAKLGDF 187
                            + + V YLH      I H D+K  N+ +LD N      K+ DF
Sbjct: 106 AEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162
Query: 188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           GLA  +D   G++   + GT  ++APE V       E+D++S GV+   +  G  P
Sbjct: 163 GLAHKID--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 50/105 (47%), Gaps = 12/105 (11%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
           +I   +  A+ YLH      I HRD+K  N++  S   N   KL DFG A+    E  S 
Sbjct: 119 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 171
Query: 201 TTVLAG--TMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            ++     T  Y+APE +   K  K  D++S GV+   + CG  P
Sbjct: 172 NSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           AV YLHE     I+HRD+K  NV+L S   +   K+ DFG ++++     S    L GT 
Sbjct: 132 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 186
Query: 209 GYLAPEC-VTTGKA--SKESDVYSFGVVALEVACGRKP 243
            YLAPE  V+ G A  ++  D +S GV+      G  P
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 48/276 (17%)
Query: 84  VYRGLLSDQNTEIAVKRV--SRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL- 140
           V++    D    +A+K+   S      KK  + E+R++ +L+H NLV+L+     +R+L 
Sbjct: 19  VFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH 78
Query: 141 ---------ILHK---------------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                    +LH+               I      AV + H+    CI HRD+K  N+++
Sbjct: 79  LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH--NCI-HRDVKPENILI 135
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE-CVTTGKASKESDVYSFGVVAL 235
             +   KL DFG ARL+          +A T  Y +PE  V   +     DV++ G V  
Sbjct: 136 TKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYGPPVDVWAIGCVFA 194
Query: 236 EVACGRKPVEP-RQEPSKVRLV-EWVWDLYGKGQLLEAADGRLS--KEFDERQMECLMI- 290
           E+  G  P+ P + +  ++ L+ + + DL  + Q + + +   S  K  D   ME L + 
Sbjct: 195 ELLSG-VPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELK 253
Query: 291 --------VGLW--CCHPDFTNRPSIRQVINVLNFE 316
                   +GL   C H D T R +  Q+++   FE
Sbjct: 254 FPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 41/189 (21%)
Query: 87  GLLSDQNT-EIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVHLIG------------ 132
           G+ +D +  ++AVK +    S+Q + +++ E  IIS+  H+N+V  IG            
Sbjct: 68  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILM 127
Query: 133 ----------WCHEQR----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                     +  E R           L L  +A  +A    YL E      +HRDI + 
Sbjct: 128 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 184
Query: 173 NVVLDSNFN---AKLGDFGLAR-LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           N +L        AK+GDFG+AR +       +       + ++ PE    G  + ++D +
Sbjct: 185 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244
Query: 229 SFGVVALEV 237
           SFGV+  E+
Sbjct: 245 SFGVLLWEI 253

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 41/189 (21%)
Query: 87  GLLSDQNT-EIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVHLIG------------ 132
           G+ +D +  ++AVK +    S+Q + +++ E  IIS+  H+N+V  IG            
Sbjct: 53  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILM 112
Query: 133 ----------WCHEQR----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                     +  E R           L L  +A  +A    YL E      +HRDI + 
Sbjct: 113 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 169
Query: 173 NVVLDSNFN---AKLGDFGLAR-LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           N +L        AK+GDFG+AR +       +       + ++ PE    G  + ++D +
Sbjct: 170 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229
Query: 229 SFGVVALEV 237
           SFGV+  E+
Sbjct: 230 SFGVLLWEI 238

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQLIL-----HK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L L     H+             I L L  + L
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYL 108
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ 
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLW 167
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 41/189 (21%)
Query: 87  GLLSDQNT-EIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVHLIG------------ 132
           G+ +D +  ++AVK +    S+Q + +++ E  IIS+  H+N+V  IG            
Sbjct: 53  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 112
Query: 133 ----------WCHEQR----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                     +  E R           L L  +A  +A    YL E      +HRDI + 
Sbjct: 113 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 169
Query: 173 NVVLDSNFN---AKLGDFGLAR-LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           N +L        AK+GDFG+AR +       +       + ++ PE    G  + ++D +
Sbjct: 170 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229
Query: 229 SFGVVALEV 237
           SFGV+  E+
Sbjct: 230 SFGVLLWEI 238

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 42/84 (50%)
Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
            HRD+K  N+++ ++  A L DFG+A     E  +Q     GT+ Y APE  +   A+  
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 225 SDVYSFGVVALEVACGRKPVEPRQ 248
           +D+Y+   V  E   G  P +  Q
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQ 239

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 51/109 (46%), Gaps = 8/109 (7%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA--KLGDFGLARLVDHELGSQTTVLAG 206
           L S V Y H      + HRD+K  N +LD +     K+ DFG ++     L SQ     G
Sbjct: 124 LISGVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA--SVLHSQPKSAVG 178
Query: 207 TMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR 254
           T  Y+APE +   +   K +DV+S GV    +  G  P E  +EP   R
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 227

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 41/189 (21%)
Query: 87  GLLSDQNT-EIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVHLIG------------ 132
           G+ +D +  ++AVK +    S+Q + +++ E  IIS+  H+N+V  IG            
Sbjct: 45  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 104
Query: 133 ----------WCHEQR----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                     +  E R           L L  +A  +A    YL E      +HRDI + 
Sbjct: 105 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 161
Query: 173 NVVLDSNFN---AKLGDFGLAR-LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           N +L        AK+GDFG+AR +       +       + ++ PE    G  + ++D +
Sbjct: 162 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 221
Query: 229 SFGVVALEV 237
           SFGV+  E+
Sbjct: 222 SFGVLLWEI 230

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 41/189 (21%)
Query: 87  GLLSDQNT-EIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVHLIG------------ 132
           G+ +D +  ++AVK +    S+Q + +++ E  IIS+  H+N+V  IG            
Sbjct: 70  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 129
Query: 133 ----------WCHEQR----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                     +  E R           L L  +A  +A    YL E      +HRDI + 
Sbjct: 130 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 186
Query: 173 NVVLDSNFN---AKLGDFGLAR-LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           N +L        AK+GDFG+AR +       +       + ++ PE    G  + ++D +
Sbjct: 187 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 246
Query: 229 SFGVVALEV 237
           SFGV+  E+
Sbjct: 247 SFGVLLWEI 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 41/189 (21%)
Query: 87  GLLSDQNT-EIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVHLIG------------ 132
           G+ +D +  ++AVK +    S+Q + +++ E  IIS+  H+N+V  IG            
Sbjct: 54  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 113
Query: 133 ----------WCHEQR----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                     +  E R           L L  +A  +A    YL E      +HRDI + 
Sbjct: 114 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 170
Query: 173 NVVLDSNFN---AKLGDFGLAR-LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           N +L        AK+GDFG+AR +       +       + ++ PE    G  + ++D +
Sbjct: 171 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 230
Query: 229 SFGVVALEV 237
           SFGV+  E+
Sbjct: 231 SFGVLLWEI 239

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A  +L L     + +V+RD+K +N++LD + + ++ D GLA   D     +     GT G
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFS-KKKPHASVGTHG 355
Query: 210 YLAPECVTTGKASKES-DVYSFGVVALEVACGRKPVEPRQEPSK 252
           Y+APE +  G A   S D +S G +  ++  G  P   RQ  +K
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTK 397

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 38/187 (20%)
Query: 90  SDQNTEIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           S +   +AVK +        +   ++I EV  +  L HRNL+ L G              
Sbjct: 43  SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELA 102
Query: 135 -----------HEQRQLI--LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN 181
                      H+   L+  L + A+ +A  + YL     +  +HRD+ + N++L +   
Sbjct: 103 PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDL 159
Query: 182 AKLGDFGLARLV----DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            K+GDFGL R +    DH +  +   +     + APE + T   S  SD + FGV   E+
Sbjct: 160 VKIGDFGLMRALPQNDDHXVMQEHRKVP--FAWCAPESLKTRTFSHASDTWMFGVTLWEM 217
Query: 238 -ACGRKP 243
              G++P
Sbjct: 218 FTYGQEP 224

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A  +L L     + +V+RD+K +N++LD + + ++ D GLA   D     +     GT G
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFS-KKKPHASVGTHG 355
Query: 210 YLAPECVTTGKASKES-DVYSFGVVALEVACGRKPVEPRQEPSK 252
           Y+APE +  G A   S D +S G +  ++  G  P   RQ  +K
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTK 397

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A  +L L     + +V+RD+K +N++LD + + ++ D GLA   D     +     GT G
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFS-KKKPHASVGTHG 355
Query: 210 YLAPECVTTGKASKES-DVYSFGVVALEVACGRKPVEPRQEPSK 252
           Y+APE +  G A   S D +S G +  ++  G  P   RQ  +K
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTK 397

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 38/187 (20%)
Query: 90  SDQNTEIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           S +   +AVK +        +   ++I EV  +  L HRNL+ L G              
Sbjct: 33  SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELA 92
Query: 135 -----------HEQRQLI--LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN 181
                      H+   L+  L + A+ +A  + YL     +  +HRD+ + N++L +   
Sbjct: 93  PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDL 149
Query: 182 AKLGDFGLARLV----DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            K+GDFGL R +    DH +  +   +     + APE + T   S  SD + FGV   E+
Sbjct: 150 VKIGDFGLMRALPQNDDHXVMQEHRKVP--FAWCAPESLKTRTFSHASDTWMFGVTLWEM 207
Query: 238 -ACGRKP 243
              G++P
Sbjct: 208 FTYGQEP 214

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 41/189 (21%)
Query: 87  GLLSDQNT-EIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVHLIG------------ 132
           G+ +D +  ++AVK +    S+Q + +++ E  IIS+  H+N+V  IG            
Sbjct: 80  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 139
Query: 133 ----------WCHEQR----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                     +  E R           L L  +A  +A    YL E      +HRDI + 
Sbjct: 140 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 196
Query: 173 NVVLDSNFN---AKLGDFGLAR-LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           N +L        AK+GDFG+AR +       +       + ++ PE    G  + ++D +
Sbjct: 197 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 256
Query: 229 SFGVVALEV 237
           SFGV+  E+
Sbjct: 257 SFGVLLWEI 265

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 41/189 (21%)
Query: 87  GLLSDQNT-EIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVHLIG------------ 132
           G+ +D +  ++AVK +    S+Q + +++ E  IIS+  H+N+V  IG            
Sbjct: 60  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 119
Query: 133 ----------WCHEQR----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                     +  E R           L L  +A  +A    YL E      +HRDI + 
Sbjct: 120 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 176
Query: 173 NVVLDSNFN---AKLGDFGLAR-LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           N +L        AK+GDFG+AR +       +       + ++ PE    G  + ++D +
Sbjct: 177 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 236
Query: 229 SFGVVALEV 237
           SFGV+  E+
Sbjct: 237 SFGVLLWEI 245

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 43/190 (22%)
Query: 87  GLLSDQNT-EIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVHLIG------------ 132
           G+ +D +  ++AVK +    S+Q + +++ E  IIS+  H+N+V  IG            
Sbjct: 94  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 153
Query: 133 ----------WCHEQR----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                     +  E R           L L  +A  +A    YL E      +HRDI + 
Sbjct: 154 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 210
Query: 173 NVVLDSNFN---AKLGDFGLARLVDHELG--SQTTVLAGTMGYLAPECVTTGKASKESDV 227
           N +L        AK+GDFG+AR + +  G   +       + ++ PE    G  + ++D 
Sbjct: 211 NCLLTCPGPGRVAKIGDFGMARDI-YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 269
Query: 228 YSFGVVALEV 237
           +SFGV+  E+
Sbjct: 270 WSFGVLLWEI 279

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           A  +L L     + +V+RD+K +N++LD + + ++ D GLA   D     +     GT G
Sbjct: 298 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFS-KKKPHASVGTHG 354
Query: 210 YLAPECVTTGKASKES-DVYSFGVVALEVACGRKPVEPRQEPSK 252
           Y+APE +  G A   S D +S G +  ++  G  P   RQ  +K
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTK 396

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           YLH      +++RD+K  N+++D     ++ DFG A+ V      +T  L GT   LAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEALAPE 208
Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKP 243
            + +   +K  D ++ GV+  E+A G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 43/190 (22%)
Query: 87  GLLSDQNT-EIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVHLIG------------ 132
           G+ +D +  ++AVK +    S+Q + +++ E  IIS+  H+N+V  IG            
Sbjct: 71  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 130
Query: 133 ----------WCHEQR----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                     +  E R           L L  +A  +A    YL E      +HRDI + 
Sbjct: 131 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 187
Query: 173 NVVLDSNFN---AKLGDFGLARLVDHELG--SQTTVLAGTMGYLAPECVTTGKASKESDV 227
           N +L        AK+GDFG+AR + +  G   +       + ++ PE    G  + ++D 
Sbjct: 188 NCLLTCPGPGRVAKIGDFGMARDI-YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 246
Query: 228 YSFGVVALEV 237
           +SFGV+  E+
Sbjct: 247 WSFGVLLWEI 256

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 63/123 (51%), Gaps = 27/123 (21%)
Query: 130 LIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL 189
           L+ WC +        IA G++    YL +     +VHRD+ + NV++ S  + K+ DFGL
Sbjct: 121 LLNWCMQ--------IAKGMS----YLEDVR---LVHRDLAARNVLVKSPNHVKITDFGL 165
Query: 190 ARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRK 242
           ARL+D      H  G +  +      ++A E +   + + +SDV+S+GV   E+   G K
Sbjct: 166 ARLLDIDETEYHADGGKVPI-----KWMALESILRRRFTHQSDVWSYGVTVWELMTFGAK 220
Query: 243 PVE 245
           P +
Sbjct: 221 PYD 223

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 37/194 (19%)
Query: 95  EIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNL------------VHLIGWCHEQRQ 139
           E AVK +S+     K  K+  + EV+++ +L H N+             +L+G  +   +
Sbjct: 53  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGE 112
Query: 140 LI-------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAK 183
           L                +I   + S + Y H+     IVHRD+K  N++L+S   + N +
Sbjct: 113 LFDEIISRKRFSEVDAARIIRQVLSGITYXHK---NKIVHRDLKPENLLLESKSKDANIR 169
Query: 184 LGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           + DFGL+     E   +     GT  Y+APE V  G   ++ DV+S GV+   +  G  P
Sbjct: 170 IIDFGLS--THFEASKKXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
Query: 244 VEPRQEPSKVRLVE 257
                E   ++ VE
Sbjct: 227 FNGANEYDILKKVE 240

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 32  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 91
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI+  +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 92  VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 148
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 149 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 203
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 204 WSYGVTVWELMTFGSKPYDGIPASEISSI 232

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 41/189 (21%)
Query: 87  GLLSDQNT-EIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIG------------ 132
           G+ +D +  ++AVK +    S+Q + +++ E  IIS+  H+N+V  IG            
Sbjct: 68  GMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 127
Query: 133 ----------WCHEQR----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                     +  E R           L L  +A  +A    YL E      +HRDI + 
Sbjct: 128 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 184
Query: 173 NVVLDSNFN---AKLGDFGLAR-LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           N +L        AK+GDFG+AR +       +       + ++ PE    G  + ++D +
Sbjct: 185 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244
Query: 229 SFGVVALEV 237
           SFGV+  E+
Sbjct: 245 SFGVLLWEI 253

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 43/85 (50%), Gaps = 8/85 (9%)
Query: 164 IVHRDIKSSNVVLDSNFNA---KLGDFGLARLVDHELGSQTT--VLAGTMGYLAPECVTT 218
           IVHRD+K  N++L S       KL DFGLA  V    G Q      AGT GYL+PE +  
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ---GDQQAWFGFAGTPGYLSPEVLRK 180
Query: 219 GKASKESDVYSFGVVALEVACGRKP 243
               K  D+++ GV+   +  G  P
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 32  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 91
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI+  +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 92  VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 148
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 149 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 203
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 204 WSYGVTVWELMTFGSKPYDGIPASEISSI 232

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 38/187 (20%)
Query: 90  SDQNTEIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           S +   +AVK +        +   ++I EV  +  L HRNL+ L G              
Sbjct: 33  SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELA 92
Query: 135 -----------HEQRQLI--LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN 181
                      H+   L+  L + A+ +A  + YL     +  +HRD+ + N++L +   
Sbjct: 93  PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDL 149
Query: 182 AKLGDFGLARLV----DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            K+GDFGL R +    DH +  +   +     + APE + T   S  SD + FGV   E+
Sbjct: 150 VKIGDFGLMRALPQNDDHYVMQEHRKVP--FAWCAPESLKTRTFSHASDTWMFGVTLWEM 207
Query: 238 -ACGRKP 243
              G++P
Sbjct: 208 FTYGQEP 214

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 31  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI+  +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 91  VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 147
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 202
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSI 231

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 33  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 92
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI+  +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 93  VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 149
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 150 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 204
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 205 WSYGVTVWELMTFGSKPYDGIPASEISSI 233

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 34  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 93
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI+  +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 94  VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 150
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 151 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 205
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 206 WSYGVTVWELMTFGSKPYDGIPASEISSI 234

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 35  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 94
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI+  +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 95  VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 151
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 152 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 206
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 207 WSYGVTVWELMTFGSKPYDGIPASEISSI 235

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 38/187 (20%)
Query: 90  SDQNTEIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           S +   +AVK +        +   ++I EV  +  L HRNL+ L G              
Sbjct: 37  SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELA 96
Query: 135 -----------HEQRQLI--LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN 181
                      H+   L+  L + A+ +A  + YL     +  +HRD+ + N++L +   
Sbjct: 97  PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDL 153
Query: 182 AKLGDFGLARLV----DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            K+GDFGL R +    DH +  +   +     + APE + T   S  SD + FGV   E+
Sbjct: 154 VKIGDFGLMRALPQNDDHYVMQEHRKVP--FAWCAPESLKTRTFSHASDTWMFGVTLWEM 211
Query: 238 -ACGRKP 243
              G++P
Sbjct: 212 FTYGQEP 218

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 38  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 97
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI+  +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 98  VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 154
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 155 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 209
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 210 WSYGVTVWELMTFGSKPYDGIPASEISSI 238

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 38/187 (20%)
Query: 90  SDQNTEIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           S +   +AVK +        +   ++I EV  +  L HRNL+ L G              
Sbjct: 33  SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELA 92
Query: 135 -----------HEQRQLI--LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN 181
                      H+   L+  L + A+ +A  + YL     +  +HRD+ + N++L +   
Sbjct: 93  PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDL 149
Query: 182 AKLGDFGLARLV----DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            K+GDFGL R +    DH +  +   +     + APE + T   S  SD + FGV   E+
Sbjct: 150 VKIGDFGLMRALPQNDDHYVMQEHRKVP--FAWCAPESLKTRTFSHASDTWMFGVTLWEM 207
Query: 238 -ACGRKP 243
              G++P
Sbjct: 208 FTYGQEP 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 38/187 (20%)
Query: 90  SDQNTEIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           S +   +AVK +        +   ++I EV  +  L HRNL+ L G              
Sbjct: 43  SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELA 102
Query: 135 -----------HEQRQLI--LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN 181
                      H+   L+  L + A+ +A  + YL     +  +HRD+ + N++L +   
Sbjct: 103 PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDL 159
Query: 182 AKLGDFGLARLV----DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            K+GDFGL R +    DH +  +   +     + APE + T   S  SD + FGV   E+
Sbjct: 160 VKIGDFGLMRALPQNDDHYVMQEHRKVP--FAWCAPESLKTRTFSHASDTWMFGVTLWEM 217
Query: 238 -ACGRKP 243
              G++P
Sbjct: 218 FTYGQEP 224

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 38/187 (20%)
Query: 90  SDQNTEIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLVHLIGWC------------ 134
           S +   +AVK +        +   ++I EV  +  L HRNL+ L G              
Sbjct: 37  SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELA 96
Query: 135 -----------HEQRQLI--LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN 181
                      H+   L+  L + A+ +A  + YL     +  +HRD+ + N++L +   
Sbjct: 97  PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDL 153
Query: 182 AKLGDFGLARLV----DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
            K+GDFGL R +    DH +  +   +     + APE + T   S  SD + FGV   E+
Sbjct: 154 VKIGDFGLMRALPQNDDHYVMQEHRKVP--FAWCAPESLKTRTFSHASDTWMFGVTLWEM 211
Query: 238 -ACGRKP 243
              G++P
Sbjct: 212 FTYGQEP 218

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 43/85 (50%), Gaps = 8/85 (9%)
Query: 164 IVHRDIKSSNVVLDSNFNA---KLGDFGLARLVDHELGSQTT--VLAGTMGYLAPECVTT 218
           IVHRD+K  N++L S       KL DFGLA  V    G Q      AGT GYL+PE +  
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ---GDQQAWFGFAGTPGYLSPEVLRK 180
Query: 219 GKASKESDVYSFGVVALEVACGRKP 243
               K  D+++ GV+   +  G  P
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/218 (20%), Positives = 92/218 (42%), Gaps = 52/218 (23%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLI------------ 131
           V+  + +D +  +A+K++     Q  K  + E++II RL H N+V +             
Sbjct: 27  VFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86
Query: 132 -----------------------------GWCHEQRQLILHKIALGLASAVLYLHEEWEQ 162
                                            E  +L ++++  GL     Y+H     
Sbjct: 87  DVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLK----YIHS---A 139
Query: 163 CIVHRDIKSSNVVLDS-NFNAKLGDFGLARLVDHELGSQTTVLAG--TMGYLAPE-CVTT 218
            ++HRD+K +N+ +++ +   K+GDFGLAR++D     +  +  G  T  Y +P   ++ 
Sbjct: 140 NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP 199
Query: 219 GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
              +K  D+++ G +  E+  G+       E  +++L+
Sbjct: 200 NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 113
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 172
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 170
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 112
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 171
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 170
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 168
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 167
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 112
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 171
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYL 112
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 171
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 170
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 167
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 169
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 51/109 (46%), Gaps = 8/109 (7%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLG--DFGLARLVDHELGSQTTVLAG 206
           L S V Y H      + HRD+K  N +LD +   +L   DFG ++     L SQ     G
Sbjct: 124 LISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVG 178
Query: 207 TMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR 254
           T  Y+APE +   +   K +DV+S GV    +  G  P E  +EP   R
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 227

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 168
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 80/184 (43%), Gaps = 47/184 (25%)
Query: 94  TEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIG------------------- 132
            ++A+K++ R   S+   K    E+R++  +RH N++ L+                    
Sbjct: 51  AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 110
Query: 133 ---------WCHEQR-----QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS 178
                      HE+      Q +++++  GL     Y+H      I+HRD+K  N+ ++ 
Sbjct: 111 FMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR----YIHA---AGIIHRDLKPGNLAVNE 163
Query: 179 NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEV 237
           +   K+ DFGLAR  D E+         T  Y APE +    + ++  D++S G +  E+
Sbjct: 164 DCELKILDFGLARQADSEMXGXVV----TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219
Query: 238 ACGR 241
             G+
Sbjct: 220 ITGK 223

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 168
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 50/100 (50%), Gaps = 7/100 (7%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVL---DSNFNAKLGDFGLARLVDHELGSQTTVLA 205
           L SAV ++H+     +VHRD+K  N++    + N   K+ DFG ARL   +     T   
Sbjct: 115 LVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-C 170
Query: 206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE 245
            T+ Y APE +      +  D++S GV+   +  G+ P +
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 61/199 (30%)
Query: 95  EIAVKRVSR-GSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ--------------- 137
           + A+KR+    SK   +++  E+ ++ +L  H N+++L+G C  +               
Sbjct: 51  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 110
Query: 138 ---------------------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIK 170
                                       Q +LH  A  +A  + YL ++     +HR++ 
Sbjct: 111 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLH-FAADVARGMDYLSQKQ---FIHRNLA 166
Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG-----YLAPECVTTGKASKES 225
           + N+++  N+ AK+ DFGL+R        Q   +  TMG     ++A E +     +  S
Sbjct: 167 ARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 219
Query: 226 DVYSFGVVALE-VACGRKP 243
           DV+S+GV+  E V+ G  P
Sbjct: 220 DVWSYGVLLWEIVSLGGTP 238

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 168
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 51/109 (46%), Gaps = 8/109 (7%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLG--DFGLARLVDHELGSQTTVLAG 206
           L S V Y H      + HRD+K  N +LD +   +L   DFG ++     L SQ     G
Sbjct: 123 LISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVG 177
Query: 207 TMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR 254
           T  Y+APE +   +   K +DV+S GV    +  G  P E  +EP   R
Sbjct: 178 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 226

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 169
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 169
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL-----ILHK-------------IALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L      LH+             I L L  + L
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYL 109
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 168
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 51/109 (46%), Gaps = 8/109 (7%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLG--DFGLARLVDHELGSQTTVLAG 206
           L S V Y H      I HRD+K  N +LD +   +L   DFG ++     L SQ     G
Sbjct: 125 LLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVG 179
Query: 207 TMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR 254
           T  Y+APE +   +   K +DV+S GV    +  G  P E  +EP   R
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR 228

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 56  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 115
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 116 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 172
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 173 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 227
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 228 WSYGVTVWELMTFGSKPYDGIPASEISSI 256

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 47/192 (24%)
Query: 87  GLLSDQNT-EIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVHLIG------------ 132
           G+ +D +  ++AVK +    S+Q + +++ E  IIS+  H+N+V  IG            
Sbjct: 54  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 113
Query: 133 ----------WCHEQR----------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSS 172
                     +  E R           L L  +A  +A    YL E      +HRDI + 
Sbjct: 114 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAAR 170
Query: 173 NVVLDSNFN---AKLGDFGLA----RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES 225
           N +L        AK+GDFG+A    R   +  G    +    + ++ PE    G  + ++
Sbjct: 171 NCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML---PVKWMPPEAFMEGIFTSKT 227
Query: 226 DVYSFGVVALEV 237
           D +SFGV+  E+
Sbjct: 228 DTWSFGVLLWEI 239

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 25  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 84
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 85  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 141
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 142 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 196
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 197 WSYGVTVWELMTFGSKPYDGIPASEISSI 225

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/112 (28%), Positives = 58/112 (51%), Gaps = 12/112 (10%)
Query: 131 IGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
           + +  E+ Q +++++  GL     Y+H      +VHRD+K  N+ ++ +   K+ DFGLA
Sbjct: 121 LKFSEEKIQYLVYQMLKGLK----YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGR 241
           R  D E+    T    T  Y APE + +     ++ D++S G +  E+  G+
Sbjct: 174 RHADAEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 13/101 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           L   + YLH    Q I+HRDIK SN+++  + + K+ DFG    V +E      +L+ T+
Sbjct: 146 LIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFG----VSNEFKGSDALLSNTV 198
Query: 209 G---YLAPECVTTGK---ASKESDVYSFGVVALEVACGRKP 243
           G   ++APE ++  +   + K  DV++ GV       G+ P
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 31  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 91  VQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 147
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 202
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSI 231

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 64/127 (50%), Gaps = 14/127 (11%)
Query: 118 IISRLRHRNLVHLIG--WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVV 175
           ++      +L  ++G  +  E+ Q +++++  GL     Y+H      +VHRD+K  N+ 
Sbjct: 124 LVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLK----YIHSA---GVVHRDLKPGNLA 176
Query: 176 LDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVA 234
           ++ +   K+ DFGLAR  D E+    T    T  Y APE + +     ++ D++S G + 
Sbjct: 177 VNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 232
Query: 235 LEVACGR 241
            E+  G+
Sbjct: 233 AEMLTGK 239

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 28  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 87
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 88  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLED---RRLVHRDLAARN 144
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 145 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 199
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 200 WSYGVTVWELMTFGSKPYDGIPASEISSI 228

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 34  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 93
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 94  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 150
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 151 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 205
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 206 WSYGVTVWELMTFGSKPYDGIPASEISSI 234

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 114/278 (41%), Gaps = 72/278 (25%)
Query: 87  GLL-SDQNTEIAVKRVSRGSKQGKKE-YISEVRIISRL-RHRNLVHLIGWC--------- 134
           GL+ SD    +AVK +   +   ++E  +SE++++S L  H N+V+L+G C         
Sbjct: 69  GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 128
Query: 135 --------------HEQRQLILHKIALGL--------------------ASAVLYLHEEW 160
                          ++   I  K +  +                    A  + +L  + 
Sbjct: 129 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK- 187
Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECV 216
             CI HRD+ + N++L      K+ DFGLAR + ++      V+ G     + ++APE +
Sbjct: 188 -NCI-HRDLAARNILLTHGRITKICDFGLARHIKND---SNYVVKGNARLPVKWMAPESI 242
Query: 217 TTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR 275
                + ESDV+S+G+   E+ + G  P       SK              ++++     
Sbjct: 243 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY------------KMIKEGFRM 290
Query: 276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           LS E    +M  +M     C   D   RP+ +Q++ ++
Sbjct: 291 LSPEHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLI 325

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 31  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 91  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 147
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 202
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSI 231

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 41  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 100
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 101 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 157
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 158 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 212
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 213 WSYGVTVWELMTFGSKPYDGIPASEISSI 241

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 29/175 (16%)
Query: 95  EIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL------------ 142
           ++A K +     + K+E  +E+ ++++L H NL+ L      +  ++L            
Sbjct: 116 KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175
Query: 143 ----HKIALGLASAVLYLHEEWEQC-------IVHRDIKSSNVVLDSNFNAK---LGDFG 188
                   L     +L++ +  E         I+H D+K  N+ L  N +AK   + DFG
Sbjct: 176 RIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENI-LCVNRDAKQIKIIDFG 234
Query: 189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           LAR   ++   +  V  GT  +LAPE V     S  +D++S GV+A  +  G  P
Sbjct: 235 LARR--YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 76/179 (42%), Gaps = 32/179 (17%)
Query: 96  IAVKRV--SRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------------- 140
           +A+KRV      +      + E+ ++  L+H+N+V L    H  ++L             
Sbjct: 30  VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK 89
Query: 141 ------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
                       I+      L   + + H    + ++HRD+K  N++++ N   KL DFG
Sbjct: 90  YFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLADFG 146
Query: 189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKPVEP 246
           LAR     +   +  +  T+ Y  P+ +   K    S D++S G +  E+A   +P+ P
Sbjct: 147 LARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFP 204

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 34  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 93
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 94  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 150
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 151 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 205
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 206 WSYGVTVWELMTFGSKPYDGIPASEISSI 234

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 13/107 (12%)
Query: 134 CHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV 193
           C EQ   I  ++A G+A    YL E   +  VHRD+ + N ++  N   K+ DFGL+R +
Sbjct: 173 CAEQ-LCIARQVAAGMA----YLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 194 ---DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              D+        +   + ++ PE +   + + ESDV+++GVV  E+
Sbjct: 225 YSADYYKADGNDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 31  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 91  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 147
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 202
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSI 231

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 37  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 96
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 97  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 153
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 154 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 208
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 209 WSYGVTVWELMTFGSKPYDGIPASEISSI 237

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 34  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 93
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 94  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 150
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 151 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 205
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 206 WSYGVTVWELMTFGSKPYDGIPASEISSI 234

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 33  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 92
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 93  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 149
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 150 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 204
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 205 WSYGVTVWELMTFGSKPYDGIPASEISSI 233

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 38  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 97
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 98  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 154
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 155 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 209
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 210 WSYGVTVWELMTFGSKPYDGIPASEISSI 238

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 38  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 97
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 98  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 154
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 155 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 209
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 210 WSYGVTVWELMTFGSKPYDGIPASEISSI 238

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 31  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 91  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 147
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 202
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSI 231

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 114/278 (41%), Gaps = 72/278 (25%)
Query: 87  GLL-SDQNTEIAVKRVSRGSKQGKKE-YISEVRIISRL-RHRNLVHLIGWC--------- 134
           GL+ SD    +AVK +   +   ++E  +SE++++S L  H N+V+L+G C         
Sbjct: 64  GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 123
Query: 135 --------------HEQRQLILHKIALGL--------------------ASAVLYLHEEW 160
                          ++   I  K +  +                    A  + +L  + 
Sbjct: 124 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK- 182
Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECV 216
             CI HRD+ + N++L      K+ DFGLAR + ++      V+ G     + ++APE +
Sbjct: 183 -NCI-HRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGNARLPVKWMAPESI 237
Query: 217 TTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR 275
                + ESDV+S+G+   E+ + G  P       SK              ++++     
Sbjct: 238 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY------------KMIKEGFRM 285
Query: 276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           LS E    +M  +M     C   D   RP+ +Q++ ++
Sbjct: 286 LSPEHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLI 320

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 61/130 (46%), Gaps = 26/130 (20%)
Query: 128 VHLIGWCHEQRQLILHKIALGLASAVLYLHEE------WEQCIVHRDIKSSNVVLDSNFN 181
           +H   W    R  + H +  GLA    YLH E      ++  I HRD+ S NV++ ++  
Sbjct: 105 LHTSDWVSSCR--LAHSVTRGLA----YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158
Query: 182 AKLGDFGLA-RLVDHEL---GSQTTVL---AGTMGYLAPECVTTG-------KASKESDV 227
             + DFGL+ RL  + L   G +        GT+ Y+APE +           A K+ D+
Sbjct: 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDM 218
Query: 228 YSFGVVALEV 237
           Y+ G++  E+
Sbjct: 219 YALGLIYWEI 228

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 114/278 (41%), Gaps = 72/278 (25%)
Query: 87  GLL-SDQNTEIAVKRVSRGSKQGKKE-YISEVRIISRL-RHRNLVHLIGWC--------- 134
           GL+ SD    +AVK +   +   ++E  +SE++++S L  H N+V+L+G C         
Sbjct: 69  GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 128
Query: 135 --------------HEQRQLILHKIALGL--------------------ASAVLYLHEEW 160
                          ++   I  K +  +                    A  + +L  + 
Sbjct: 129 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK- 187
Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECV 216
             CI HRD+ + N++L      K+ DFGLAR + ++      V+ G     + ++APE +
Sbjct: 188 -NCI-HRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGNARLPVKWMAPESI 242
Query: 217 TTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR 275
                + ESDV+S+G+   E+ + G  P       SK              ++++     
Sbjct: 243 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY------------KMIKEGFRM 290
Query: 276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           LS E    +M  +M     C   D   RP+ +Q++ ++
Sbjct: 291 LSPEHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLI 325

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL------------------ILHKIALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L                   L  I L L  + L
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL 112
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 171
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL------------------ILHKIALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L                   L  I L L  + L
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL 111
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 170
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL------------------ILHKIALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L                   L  I L L  + L
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL 110
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 169
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL------------------ILHKIALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L                   L  I L L  + L
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL 112
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 171
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 25/153 (16%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQL------------------ILHKIALGLASAVL 154
           I E+ ++  L H N+V L+   H + +L                   L  I L L  + L
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYL 112
Query: 155 Y-LHEEWEQC----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
           + L +    C    ++HRD+K  N+++++    KL DFGLAR     + +    +  T+ 
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLW 171
Query: 210 YLAPECVTTGK-ASKESDVYSFGVVALEVACGR 241
           Y APE +   K  S   D++S G +  E+   R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 9/103 (8%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
           +I   + +A+ +LH      I HRD+K  N++  S   +   KL DFG A+        Q
Sbjct: 113 EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQ 168
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           T     T  Y+APE +   K  K  D++S GV+   + CG  P
Sbjct: 169 TPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 209

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 9/103 (8%)
Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQ 200
           +I   + +A+ +LH      I HRD+K  N++  S   +   KL DFG A+        Q
Sbjct: 132 EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQ 187
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           T     T  Y+APE +   K  K  D++S GV+   + CG  P
Sbjct: 188 TPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 114/278 (41%), Gaps = 72/278 (25%)
Query: 87  GLL-SDQNTEIAVKRVSRGSKQGKKE-YISEVRIISRL-RHRNLVHLIGWC--------- 134
           GL+ SD    +AVK +   +   ++E  +SE++++S L  H N+V+L+G C         
Sbjct: 62  GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 121
Query: 135 --------------HEQRQLILHKIALGL--------------------ASAVLYLHEEW 160
                          ++   I  K +  +                    A  + +L  + 
Sbjct: 122 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK- 180
Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECV 216
             CI HRD+ + N++L      K+ DFGLAR + ++      V+ G     + ++APE +
Sbjct: 181 -NCI-HRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGNARLPVKWMAPESI 235
Query: 217 TTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR 275
                + ESDV+S+G+   E+ + G  P       SK              ++++     
Sbjct: 236 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY------------KMIKEGFRM 283
Query: 276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           LS E    +M  +M     C   D   RP+ +Q++ ++
Sbjct: 284 LSPEHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLI 318

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 114/278 (41%), Gaps = 72/278 (25%)
Query: 87  GLL-SDQNTEIAVKRVSRGSKQGKKE-YISEVRIISRL-RHRNLVHLIGWC--------- 134
           GL+ SD    +AVK +   +   ++E  +SE++++S L  H N+V+L+G C         
Sbjct: 46  GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 105
Query: 135 --------------HEQRQLILHKIALGL--------------------ASAVLYLHEEW 160
                          ++   I  K +  +                    A  + +L  + 
Sbjct: 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK- 164
Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPECV 216
             CI HRD+ + N++L      K+ DFGLAR + ++      V+ G     + ++APE +
Sbjct: 165 -NCI-HRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGNARLPVKWMAPESI 219
Query: 217 TTGKASKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR 275
                + ESDV+S+G+   E+ + G  P       SK              ++++     
Sbjct: 220 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY------------KMIKEGFRM 267
Query: 276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           LS E    +M  +M     C   D   RP+ +Q++ ++
Sbjct: 268 LSPEHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLI 302

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 24/172 (13%)
Query: 119 ISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNV-VLD 177
           + R +   +  L  WC   RQ++           + +LH      I+HRD+K  N+ +  
Sbjct: 120 LKRFKVXKIKVLRSWC---RQIL---------KGLQFLHTRTPP-IIHRDLKCDNIFITG 166
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEV 237
              + K+GD GLA L   +  S    + GT  + APE     K  +  DVY+FG   LE 
Sbjct: 167 PTGSVKIGDLGLATL---KRASFAKAVIGTPEFXAPEXYEE-KYDESVDVYAFGXCXLEX 222
Query: 238 ACGRKPVEPRQEPSKV--RLVEWV----WDLYGKGQLLEAADGRLSKEFDER 283
           A    P    Q  +++  R+   V    +D     ++ E  +G + +  DER
Sbjct: 223 ATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 274

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 14/109 (12%)
Query: 144 KIALGLASAVLYLHEEW-----EQCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVD--H 195
           K+A    S + +LH E      +  I HRD+KS N+++  N    + D GLA + +   +
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 196 ELGSQTTVLAGTMGYLAPECVTTG------KASKESDVYSFGVVALEVA 238
           E+        GT  Y+ PE +         ++   +D+YSFG++  EVA
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 52/205 (25%)
Query: 85  YRGLLSDQNTE--IAVKRVSRGSKQ--GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL 140
           Y  L  D+NTE  +A+K+V+R  +     K  + E+ I++RL+   ++ L         L
Sbjct: 41  YVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100
Query: 141 ILHK--IALGLASAVL--------YLHEEW----------------EQCIVHRDIKSSNV 174
              +  I L +A + L        +L EE                 E  I+HRD+K +N 
Sbjct: 101 KFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANC 160
Query: 175 VLDSNFNAKLGDFGLARLVDHE---------------------LGSQTTVLAGTMGYLAP 213
           +L+ + + K+ DFGLAR ++ E                     L  Q T    T  Y AP
Sbjct: 161 LLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP 220
Query: 214 ECVTTGKA-SKESDVYSFGVVALEV 237
           E +   +  +K  D++S G +  E+
Sbjct: 221 ELILLQENYTKSIDIWSTGCIFAEL 245

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 35  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 94
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI+  +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 95  VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 151
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFG A+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 152 VLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 206
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 207 WSYGVTVWELMTFGSKPYDGIPASEISSI 235

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 33  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 92
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI+  +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 93  VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 149
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFG A+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 150 VLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 204
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 205 WSYGVTVWELMTFGSKPYDGIPASEISSI 233

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 7/102 (6%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           LA  V+ +        VHRDIK  N++LD   + +L DFG    +  +   ++ V  GT 
Sbjct: 168 LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227
Query: 209 GYLAPECVTT-------GKASKESDVYSFGVVALEVACGRKP 243
            YL+PE +         G    E D ++ GV A E+  G+ P
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 60/128 (46%), Gaps = 27/128 (21%)
Query: 142 LHK--IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL------- 192
           +HK  +   L   + YLH      ++HRD+K SN++L++  + K+ DFGL+R        
Sbjct: 109 VHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 193 ---VDHELGSQT----------TVLAGTMGYLAPECVT-TGKASKESDVYSFGVVALEVA 238
              +   +   T          T    T  Y APE +  + K +K  D++S G +  E+ 
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 239 CGRKPVEP 246
           CG KP+ P
Sbjct: 226 CG-KPIFP 232

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 33  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 92
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI+  +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 93  VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 149
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFG A+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 150 VLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 204
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 205 WSYGVTVWELMTFGSKPYDGIPASEISSI 233

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 11/92 (11%)
Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR-LVDHEL-GSQTT 202
           I   + ++  Y+H E   C  HRD+K SN+++D N   KL DFG +  +VD ++ GS+  
Sbjct: 156 IIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR-- 211
Query: 203 VLAGTMGYLAPECVTTGKASK--ESDVYSFGV 232
              GT  ++ PE  +   +    + D++S G+
Sbjct: 212 ---GTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 46/107 (42%), Gaps = 4/107 (3%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           L S V Y H      + HRD+K  N +LD +   +L            L SQ     GT 
Sbjct: 124 LISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTP 180
Query: 209 GYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR 254
            Y+APE +   +   K +DV+S GV    +  G  P E  +EP   R
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 227

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 46/80 (57%), Gaps = 8/80 (10%)
Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV----DHELGSQTTVLAGTMGYLAPECVT 217
           +CI HRD+ + N++L  N   K+ DFGLAR +    D+     T +    + ++APE + 
Sbjct: 219 KCI-HRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL---PLKWMAPESIF 274
Query: 218 TGKASKESDVYSFGVVALEV 237
               S +SDV+S+GV+  E+
Sbjct: 275 DKIYSTKSDVWSYGVLLWEI 294

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFN-AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           +VHRDIK  N+++D     AKL DFG   L+  E     T   GT  Y  PE ++  +  
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYH 216
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
           +  + V+S G++  ++ CG  P E  QE
Sbjct: 217 ALPATVWSLGILLYDMVCGDIPFERDQE 244

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 90/209 (43%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEIAVKRV-----SRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++ +           S +  KE + E  +++ + + ++  L+G C    
Sbjct: 65  VYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 124
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 125 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 181
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFGLA+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 182 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 236
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 237 WSYGVTVWELMTFGSKPYDGIPASEISSI 265

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 14/127 (11%)
Query: 133 WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVV-LDSNFNA---KLGDFG 188
           +   +   +LH I       V YLH    Q +VHRD+K SN++ +D + N    ++ DFG
Sbjct: 118 FSEREASFVLHTIG----KTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFG 170
Query: 189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE--P 246
            A+ +  E G   T    T  ++APE +      +  D++S G++   +  G  P    P
Sbjct: 171 FAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGP 229
Query: 247 RQEPSKV 253
              P ++
Sbjct: 230 SDTPEEI 236

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 46/107 (42%), Gaps = 4/107 (3%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           L S V Y H      + HRD+K  N +LD +   +L            L SQ     GT 
Sbjct: 124 LISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTP 180
Query: 209 GYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR 254
            Y+APE +   +   K +DV+S GV    +  G  P E  +EP   R
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 227

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/179 (22%), Positives = 76/179 (42%), Gaps = 32/179 (17%)
Query: 96  IAVKRV--SRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------------- 140
           +A+KRV      +      + E+ ++  L+H+N+V L    H  ++L             
Sbjct: 30  VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK 89
Query: 141 ------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG 188
                       I+      L   + + H    + ++HRD+K  N++++ N   KL +FG
Sbjct: 90  YFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFG 146
Query: 189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSFGVVALEVACGRKPVEP 246
           LAR     +   +  +  T+ Y  P+ +   K    S D++S G +  E+A   +P+ P
Sbjct: 147 LARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 14/127 (11%)
Query: 133 WCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVV-LDSNFNA---KLGDFG 188
           +   +   +LH I       V YLH    Q +VHRD+K SN++ +D + N    ++ DFG
Sbjct: 118 FSEREASFVLHTIG----KTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFG 170
Query: 189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE--P 246
            A+ +  E G   T    T  ++APE +      +  D++S G++   +  G  P    P
Sbjct: 171 FAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGP 229
Query: 247 RQEPSKV 253
              P ++
Sbjct: 230 SDTPEEI 236

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 159 EWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT----MGYLAPE 214
           E++ C VHRD+ + NV++      K+ DFGLAR +   +     V+ G     + ++APE
Sbjct: 189 EFKSC-VHRDLAARNVLVTHGKVVKICDFGLARDI---MSDSNYVVRGNARLPVKWMAPE 244
Query: 215 CVTTGKASKESDVYSFGVVALEV-ACGRKP 243
            +  G  + +SDV+S+G++  E+ + G  P
Sbjct: 245 SLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 31  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 91  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 147
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFG A+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 148 VLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 202
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSI 231

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 33  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 92
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 93  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 149
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFG A+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 150 VLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 204
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 205 WSYGVTVWELMTFGSKPYDGIPASEISSI 233

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 47/209 (22%)
Query: 84  VYRGLLSDQNTEI----AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR 138
           VY+GL   +  ++    A+K +    S +  KE + E  +++ + + ++  L+G C    
Sbjct: 38  VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 97
Query: 139 -QLILHKIALG------------------------LASAVLYLHEEWEQCIVHRDIKSSN 173
            QLI   +  G                        +A  + YL +   + +VHRD+ + N
Sbjct: 98  VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 154
Query: 174 VVLDSNFNAKLGDFGLARLVD------HELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           V++ +  + K+ DFG A+L+       H  G +  +      ++A E +     + +SDV
Sbjct: 155 VLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-----KWMALESILHRIYTHQSDV 209
Query: 228 YSFGVVALEVAC-GRKPVE--PRQEPSKV 253
           +S+GV   E+   G KP +  P  E S +
Sbjct: 210 WSYGVTVWELMTFGSKPYDGIPASEISSI 238

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVL-DSNFNA--KLGDFGLARLVDHELGSQTTVLA 205
           + +A+ Y H    Q +VH+D+K  N++  D++ ++  K+ DFGLA L   +    +T  A
Sbjct: 133 MMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAA 187
Query: 206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           GT  Y+APE V     + + D++S GVV   +  G  P
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 54/115 (46%), Gaps = 10/115 (8%)
Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVV-LDSNFNA---KLGDFGLARLVDHELGSQ 200
           +   +   V YLH    Q +VHRD+K SN++ +D + N    ++ DFG A+ +  E G  
Sbjct: 121 VLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE--PRQEPSKV 253
            T    T  ++APE +         D++S GV+   +  G  P    P   P ++
Sbjct: 178 MTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 20/147 (13%)
Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG--TMGYLAPECVTT 218
           E  +VHRD+ + N+++      K+ DFGL+R V +E  S      G   + ++A E +  
Sbjct: 168 EMSLVHRDLAARNILVAEGRKMKISDFGLSRDV-YEEDSXVKRSQGRIPVKWMAIESLFD 226
Query: 219 GKASKESDVYSFGVVALE-VACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS 277
              + +SDV+SFGV+  E V  G  P  P   P      E +++L   G  +E  D   S
Sbjct: 227 HIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIPP------ERLFNLLKTGHRMERPDN-CS 278
Query: 278 KEFDERQMECLMIVGLWCCHPDFTNRP 304
           +E     ++C      W   PD   RP
Sbjct: 279 EEMYRLMLQC------WKQEPD--KRP 297

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 13/101 (12%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA---KLGDFGLARLVDHELGSQTTVLA 205
           +  A+ Y H+     I+HRD+K   V+L S  N+   KLG FG+A     +LG    V  
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI----QLGESGLVAG 191
Query: 206 GTMG---YLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           G +G   ++APE V      K  DV+  GV+   +  G  P
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+     +  T   GT  Y  PE +   +  
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHDEE 215

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 76/187 (40%), Gaps = 44/187 (23%)
Query: 95  EIAVK---RVSRGSKQGKKEYI-------SEVRIISRLRHRNLVHLIGWCHEQRQL---- 140
           +IAV+   R+ R +K+  K ++        E+ I+  L H N++ L     +   +    
Sbjct: 26  KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85
Query: 141 -----------ILHK----------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVL--- 176
                      ++HK          I   + SAV Y H+     + HRD+K  N +    
Sbjct: 86  ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTD 142
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
             +   KL DFGLA     + G       GT  Y++P+ V  G    E D +S GV+   
Sbjct: 143 SPDSPLKLIDFGLA--ARFKPGKMMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYV 199
Query: 237 VACGRKP 243
           + CG  P
Sbjct: 200 LLCGYPP 206

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 76/187 (40%), Gaps = 44/187 (23%)
Query: 95  EIAVK---RVSRGSKQGKKEYI-------SEVRIISRLRHRNLVHLIGWCHEQRQL---- 140
           +IAV+   R+ R +K+  K ++        E+ I+  L H N++ L     +   +    
Sbjct: 43  KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 102
Query: 141 -----------ILHK----------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVL--- 176
                      ++HK          I   + SAV Y H+     + HRD+K  N +    
Sbjct: 103 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTD 159
Query: 177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
             +   KL DFGLA     + G       GT  Y++P+ V  G    E D +S GV+   
Sbjct: 160 SPDSPLKLIDFGLA--ARFKPGKMMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYV 216
Query: 237 VACGRKP 243
           + CG  P
Sbjct: 217 LLCGYPP 223

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 83/188 (44%), Gaps = 50/188 (26%)
Query: 96  IAVKRVSRGSKQGK-KEYISEVRIISRL-RHRNLVHLIGWC------------------- 134
           +AVK +  G+   + +  +SE++I+  +  H N+V+L+G C                   
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 135 -----HEQRQLILHKIA--------LGLASAVLYLHE--------EWEQCIVHRDIKSSN 173
                 ++ + + +K+A        L L   + Y  +           +CI HRD+ + N
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARN 178
Query: 174 VVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVTTGKASKESDVYS 229
           ++L      K+ DFGLAR +  +      V  G     + ++APE +     + +SDV+S
Sbjct: 179 ILLSEKNVVKICDFGLARDIXKD---PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235
Query: 230 FGVVALEV 237
           FGV+  E+
Sbjct: 236 FGVLLWEI 243

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 48/98 (48%), Gaps = 13/98 (13%)
Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA---KLGDFGLARLVDHELGSQTTVLAGTM 208
           A+ Y H+     I+HRD+K   V+L S  N+   KLG FG+A     +LG    V  G +
Sbjct: 144 ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI----QLGESGLVAGGRV 196
Query: 209 G---YLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           G   ++APE V      K  DV+  GV+   +  G  P
Sbjct: 197 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 234

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+     +  T   GT  Y  PE +   +  
Sbjct: 134 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 190
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 191 GRSAAVWSLGILLYDMVCGDIPFEHDEE 218

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+     +  T   GT  Y  PE +   +  
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHDEE 215

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 83/188 (44%), Gaps = 50/188 (26%)
Query: 96  IAVKRVSRGSKQGK-KEYISEVRIISRL-RHRNLVHLIGWC------------------- 134
           +AVK +  G+   + +  +SE++I+  +  H N+V+L+G C                   
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 110
Query: 135 -----HEQRQLILHKIA--------LGLASAVLYLHE--------EWEQCIVHRDIKSSN 173
                 ++ + + +K+A        L L   + Y  +           +CI HRD+ + N
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARN 169
Query: 174 VVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVTTGKASKESDVYS 229
           ++L      K+ DFGLAR +  +      V  G     + ++APE +     + +SDV+S
Sbjct: 170 ILLSEKNVVKICDFGLARDIXKD---PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 226
Query: 230 FGVVALEV 237
           FGV+  E+
Sbjct: 227 FGVLLWEI 234

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 83/188 (44%), Gaps = 50/188 (26%)
Query: 96  IAVKRVSRGSKQGK-KEYISEVRIISRL-RHRNLVHLIGWC------------------- 134
           +AVK +  G+   + +  +SE++I+  +  H N+V+L+G C                   
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 135 -----HEQRQLILHKIA--------LGLASAVLYLHE--------EWEQCIVHRDIKSSN 173
                 ++ + + +K+A        L L   + Y  +           +CI HRD+ + N
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARN 169
Query: 174 VVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVTTGKASKESDVYS 229
           ++L      K+ DFGLAR +  +      V  G     + ++APE +     + +SDV+S
Sbjct: 170 ILLSEKNVVKICDFGLARDIXKD---PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 226
Query: 230 FGVVALEV 237
           FGV+  E+
Sbjct: 227 FGVLLWEI 234

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 191
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 192 GRSAAVWSLGILLYDMVCGDIPFEHDEE 219

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 187
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHDEE 215

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 82/196 (41%), Gaps = 40/196 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCH---EQRQL 140
           VY+  L D    +A+K+V     QGK     E++I+ +L H N+V L  + +   E++  
Sbjct: 36  VYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91
Query: 141 ILHKIALGLASAV---------------------LYLHEEWEQC-------IVHRDIKSS 172
           +   + L    A                      LY+++ +          I HRDIK  
Sbjct: 92  VYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 151
Query: 173 NVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSF 230
           N++LD +    KL DFG A+ +    G        +  Y APE +        S DV+S 
Sbjct: 152 NLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSA 209
Query: 231 GVVALEVACGRKPVEP 246
           G V  E+  G +P+ P
Sbjct: 210 GCVLAELLLG-QPIFP 224

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+     +  T   GT  Y  PE +   +  
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEHDEE 262

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 191
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 192 GRSAAVWSLGILLYDMVCGDIPFEHDEE 219

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 192
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEHDEE 220

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 192
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEHDEE 220

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 158 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 214
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 215 GRSAAVWSLGILLYDMVCGDIPFEHDEE 242

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 192
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEHDEE 220

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 10/115 (8%)
Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVV-LDSNFNA---KLGDFGLARLVDHELGSQ 200
           +   +   V YLH    Q +VHRD+K SN++ +D + N    ++ DFG A+ +  E G  
Sbjct: 121 VLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVE--PRQEPSKV 253
            T    T  ++APE +         D++S GV+      G  P    P   P ++
Sbjct: 178 XTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEI 231

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 207
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEHDEE 235

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 206
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 207 GRSAAVWSLGILLYDMVCGDIPFEHDEE 234

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 18/142 (12%)
Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG--TMGYLAPECVTT 218
           E  +VHRD+ + N+++      K+ DFGL+R V +E  S      G   + ++A E +  
Sbjct: 168 EMKLVHRDLAARNILVAEGRKMKISDFGLSRDV-YEEDSXVKRSQGRIPVKWMAIESLFD 226
Query: 219 GKASKESDVYSFGVVALE-VACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS 277
              + +SDV+SFGV+  E V  G  P  P   P      E +++L   G  +E  D   S
Sbjct: 227 HIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIPP------ERLFNLLKTGHRMERPDN-CS 278
Query: 278 KEFDERQMECLMIVGLWCCHPD 299
           +E     ++C      W   PD
Sbjct: 279 EEMYRLMLQC------WKQEPD 294

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 234
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEHDEE 262

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 207
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEHDEE 235

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 206
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 207 GRSAAVWSLGILLYDMVCGDIPFEHDEE 234

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 219
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDEE 247

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 219
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDEE 247

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 234
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEHDEE 262

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 220
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDEE 248

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 82/188 (43%), Gaps = 50/188 (26%)
Query: 96  IAVKRVSRGSKQGK-KEYISEVRIISRL-RHRNLVHLIGWC------------------- 134
           +AVK +  G+   + +  +SE++I+  +  H N+V+L+G C                   
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 135 -----HEQRQLILHKIA--------LGLASAVLYLHE--------EWEQCIVHRDIKSSN 173
                 ++ + + +K+A        L L   + Y  +           +CI HRD+ + N
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARN 178
Query: 174 VVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVTTGKASKESDVYS 229
           ++L      K+ DFGLAR +         V  G     + ++APE +     + +SDV+S
Sbjct: 179 ILLSEKNVVKICDFGLARDI---YKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235
Query: 230 FGVVALEV 237
           FGV+  E+
Sbjct: 236 FGVLLWEI 243

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 219
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDEE 247

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 220
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDEE 248

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 219
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDEE 247

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 207
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEHDEE 235

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 220
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDEE 248

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 226
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPFEHDEE 254

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 220
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDEE 248

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 164 IVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-A 221
           ++HRDIK  N+++D N    KL DFG   L+   +    T   GT  Y  PE +   +  
Sbjct: 183 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYH 239
Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQE 249
            + + V+S G++  ++ CG  P E  +E
Sbjct: 240 GRSAAVWSLGILLYDMVCGDIPFEHDEE 267

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 20/147 (13%)
Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG--TMGYLAPECVTT 218
           E  +VHRD+ + N+++      K+ DFGL+R V +E  S      G   + ++A E +  
Sbjct: 168 EMKLVHRDLAARNILVAEGRKMKISDFGLSRDV-YEEDSYVKRSQGRIPVKWMAIESLFD 226
Query: 219 GKASKESDVYSFGVVALE-VACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS 277
              + +SDV+SFGV+  E V  G  P  P   P      E +++L   G  +E  D   S
Sbjct: 227 HIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIPP------ERLFNLLKTGHRMERPDN-CS 278
Query: 278 KEFDERQMECLMIVGLWCCHPDFTNRP 304
           +E     ++C      W   PD   RP
Sbjct: 279 EEMYRLMLQC------WKQEPD--KRP 297

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 8/84 (9%)
Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVTTGK 220
           +HRD+ + N++L      K+ DFGLAR +  +      V  G     + ++APE +    
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIXKD---PDXVRKGDARLPLKWMAPETIFDRV 226
Query: 221 ASKESDVYSFGVVALEV-ACGRKP 243
            + +SDV+SFGV+  E+ + G  P
Sbjct: 227 YTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 82/196 (41%), Gaps = 40/196 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---- 139
           VY+  L D    +A+K+V     QGK     E++I+ +L H N+V L  + +   +    
Sbjct: 36  VYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91
Query: 140 ----LILH----------------KIALGLASAVLYLHEEWEQC-------IVHRDIKSS 172
               L+L                 K  L +    LY+++ +          I HRDIK  
Sbjct: 92  VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 151
Query: 173 NVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSF 230
           N++LD +    KL DFG A+ +    G        +  Y APE +        S DV+S 
Sbjct: 152 NLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSA 209
Query: 231 GVVALEVACGRKPVEP 246
           G V  E+  G +P+ P
Sbjct: 210 GCVLAELLLG-QPIFP 224

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 82/196 (41%), Gaps = 40/196 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---- 139
           VY+  L D    +A+K+V     QGK     E++I+ +L H N+V L  + +   +    
Sbjct: 36  VYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91
Query: 140 ----LILH----------------KIALGLASAVLYLHEEWEQC-------IVHRDIKSS 172
               L+L                 K  L +    LY+++ +          I HRDIK  
Sbjct: 92  VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 151
Query: 173 NVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSF 230
           N++LD +    KL DFG A+ +    G        +  Y APE +        S DV+S 
Sbjct: 152 NLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSA 209
Query: 231 GVVALEVACGRKPVEP 246
           G V  E+  G +P+ P
Sbjct: 210 GCVLAELLLG-QPIFP 224

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 42/77 (54%), Gaps = 7/77 (9%)
Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVTTGK 220
           +HRD+ + N++L      K+ DFGLAR +  +      V  G     + ++APE +    
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIXKD---PDXVRKGDARLPLKWMAPETIFDRV 226
Query: 221 ASKESDVYSFGVVALEV 237
            + +SDV+SFGV+  E+
Sbjct: 227 YTIQSDVWSFGVLLWEI 243

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/172 (22%), Positives = 71/172 (41%), Gaps = 38/172 (22%)
Query: 107 QGKKEYISEVRIISRLRHRNLVHLIG--WCHEQRQLIL---------------------- 142
            G+     E++++ RLRH+N++ L+   +  E++++ +                      
Sbjct: 48  NGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP 107
Query: 143 ----HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG 198
               H     L   + YLH    Q IVH+DIK  N++L +    K+   G+A  + H   
Sbjct: 108 VCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL-HPFA 163
Query: 199 SQTTVLA--GTMGYLAPECVTTGK---ASKESDVYSFGVVALEVACGRKPVE 245
           +  T     G+  +  PE +  G    +  + D++S GV    +  G  P E
Sbjct: 164 ADDTCRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 82/188 (43%), Gaps = 50/188 (26%)
Query: 96  IAVKRVSRGSKQGK-KEYISEVRIISRL-RHRNLVHLIGWC------------------- 134
           +AVK +  G+   + +  +SE++I+  +  H N+V+L+G C                   
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 135 -----HEQRQLILHKIA--------LGLASAVLYLHE--------EWEQCIVHRDIKSSN 173
                 ++ + + +K+A        L L   + Y  +           +CI HRD+ + N
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARN 178
Query: 174 VVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVTTGKASKESDVYS 229
           ++L      K+ DFGLAR +         V  G     + ++APE +     + +SDV+S
Sbjct: 179 ILLSEKNVVKICDFGLARDI---YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235
Query: 230 FGVVALEV 237
           FGV+  E+
Sbjct: 236 FGVLLWEI 243

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 83/188 (44%), Gaps = 50/188 (26%)
Query: 96  IAVKRVSRGSKQGK-KEYISEVRIISRL-RHRNLVHLIGWC------------------- 134
           +AVK +  G+   + +  +SE++I+  +  H N+V+L+G C                   
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 135 -----HEQRQLILHKIA--------LGLASAVLYLHE--------EWEQCIVHRDIKSSN 173
                 ++ + + +K+A        L L   + Y  +           +CI HRD+ + N
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARN 169
Query: 174 VVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVTTGKASKESDVYS 229
           ++L      K+ DFGLAR +  +      V  G     + ++APE +     + +SDV+S
Sbjct: 170 ILLSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 226
Query: 230 FGVVALEV 237
           FGV+  E+
Sbjct: 227 FGVLLWEI 234

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 83/188 (44%), Gaps = 50/188 (26%)
Query: 96  IAVKRVSRGSKQGK-KEYISEVRIISRL-RHRNLVHLIGWC------------------- 134
           +AVK +  G+   + +  +SE++I+  +  H N+V+L+G C                   
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 135 -----HEQRQLILHKIA--------LGLASAVLYLHE--------EWEQCIVHRDIKSSN 173
                 ++ + + +K+A        L L   + Y  +           +CI HRD+ + N
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARN 169
Query: 174 VVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVTTGKASKESDVYS 229
           ++L      K+ DFGLAR +  +      V  G     + ++APE +     + +SDV+S
Sbjct: 170 ILLSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 226
Query: 230 FGVVALEV 237
           FGV+  E+
Sbjct: 227 FGVLLWEI 234

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 83/188 (44%), Gaps = 50/188 (26%)
Query: 96  IAVKRVSRGSKQGK-KEYISEVRIISRL-RHRNLVHLIGWC------------------- 134
           +AVK +  G+   + +  +SE++I+  +  H N+V+L+G C                   
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156
Query: 135 -----HEQRQLILHKIA--------LGLASAVLYLHE--------EWEQCIVHRDIKSSN 173
                 ++ + + +K+A        L L   + Y  +           +CI HRD+ + N
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARN 215
Query: 174 VVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVTTGKASKESDVYS 229
           ++L      K+ DFGLAR +  +      V  G     + ++APE +     + +SDV+S
Sbjct: 216 ILLSEKNVVKICDFGLARDIYKD---PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 272
Query: 230 FGVVALEV 237
           FGV+  E+
Sbjct: 273 FGVLLWEI 280

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 72/181 (39%), Gaps = 41/181 (22%)
Query: 96  IAVKRVSRGSKQGK-----------KEYISEVRIISRLRHRNL-------VH-------- 129
           +A+KRV      G+           K  + E+R+++   H N+       VH        
Sbjct: 49  VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK 108
Query: 130 -----------LIGWCHEQRQLI-LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD 177
                      L    H+QR +I    I   +   +L LH   E  +VHRD+   N++L 
Sbjct: 109 LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA 168
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALE 236
            N +  + DF LAR  +    +  T       Y APE V   K  +K  D++S G V  E
Sbjct: 169 DNNDITICDFNLAR--EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAE 226
Query: 237 V 237
           +
Sbjct: 227 M 227

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 72/181 (39%), Gaps = 41/181 (22%)
Query: 96  IAVKRVSRGSKQGK-----------KEYISEVRIISRLRHRNL-------VH-------- 129
           +A+KRV      G+           K  + E+R+++   H N+       VH        
Sbjct: 49  VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK 108
Query: 130 -----------LIGWCHEQRQLI-LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD 177
                      L    H+QR +I    I   +   +L LH   E  +VHRD+   N++L 
Sbjct: 109 LYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA 168
Query: 178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALE 236
            N +  + DF LAR  +    +  T       Y APE V   K  +K  D++S G V  E
Sbjct: 169 DNNDITICDFNLAR--EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAE 226
Query: 237 V 237
           +
Sbjct: 227 M 227

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 11/111 (9%)
Query: 136 EQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR-LVD 194
           E  +  L+++  GL     Y+H      ++HRD+K SN++++ N   K+GDFG+AR L  
Sbjct: 159 EHVRYFLYQLLRGLK----YMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCT 211
Query: 195 HELGSQ--TTVLAGTMGYLAPEC-VTTGKASKESDVYSFGVVALEVACGRK 242
                Q   T    T  Y APE  ++  + ++  D++S G +  E+   R+
Sbjct: 212 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 8/84 (9%)
Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVTTGK 220
           +HRD+ + N++L      K+ DFGLAR +         V  G     + ++APE +    
Sbjct: 166 IHRDLAARNILLSEKNVVKIXDFGLARDI---YKDPDYVRKGDARLPLKWMAPETIFDRV 222
Query: 221 ASKESDVYSFGVVALEV-ACGRKP 243
            + +SDV+SFGV+  E+ + G  P
Sbjct: 223 YTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 57/260 (21%), Positives = 100/260 (38%), Gaps = 60/260 (23%)
Query: 95  EIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL---------- 142
           E+A++   + R ++   K +  EV    + RH N+V  +G C     L +          
Sbjct: 57  EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116
Query: 143 ----------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD 186
                            +IA  +   + YLH    + I+H+D+KS NV  D N    + D
Sbjct: 117 YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITD 172
Query: 187 FGL----ARLVDHELGSQTTVLAGTMGYLAPECVTTGKA---------SKESDVYSFGVV 233
           FGL      L       +  +  G + +LAPE +              SK SDV++ G +
Sbjct: 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232
Query: 234 ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL 293
             E+         R+ P K +  E +    G G     +   + KE  +        + L
Sbjct: 233 WYELHA-------REWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISD--------ILL 277
Query: 294 WCCHPDFTNRPSIRQVINVL 313
           +C   +   RP+  +++++L
Sbjct: 278 FCWAFEQEERPTFTKLMDML 297

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 11/111 (9%)
Query: 136 EQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR-LVD 194
           E  +  L+++  GL     Y+H      ++HRD+K SN++++ N   K+GDFG+AR L  
Sbjct: 158 EHVRYFLYQLLRGLK----YMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210
Query: 195 HELGSQ--TTVLAGTMGYLAPEC-VTTGKASKESDVYSFGVVALEVACGRK 242
                Q   T    T  Y APE  ++  + ++  D++S G +  E+   R+
Sbjct: 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 71/173 (41%), Gaps = 27/173 (15%)
Query: 96  IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-----------HK 144
            A K V    +  K+    E++ +S LRH  LV+L     +  ++++            K
Sbjct: 79  FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 138
Query: 145 IA-----LGLASAVLYLHE-------EWEQCIVHRDIKSSNVVLDSNFNA--KLGDFGLA 190
           +A     +    AV Y+ +         E   VH D+K  N++  +  +   KL DFGL 
Sbjct: 139 VADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 198
Query: 191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             +D +      V  GT  + APE          +D++S GV++  +  G  P
Sbjct: 199 AHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 60/141 (42%), Gaps = 41/141 (29%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQ----------LIL----HKIALGLASAVL---- 154
           + E++I+  L+H N+V+LI  C  +            L+     H +A GL S VL    
Sbjct: 65  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFT 123
Query: 155 ----------------YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG 198
                           Y+H      I+HRD+K++NV++  +   KL DFGLAR       
Sbjct: 124 LSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 199 SQTTVLAG---TMGYLAPECV 216
           SQ         T+ Y  PE +
Sbjct: 181 SQPNRYXNRVVTLWYRPPELL 201

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 82/195 (42%), Gaps = 37/195 (18%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQG--KKEYISEVRIISRLRHRNLVHLIGWCHEQRQL- 140
           VY+ + +  N  +A+KR+    ++       I EV ++  L+HRN++ L    H   +L 
Sbjct: 50  VYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109
Query: 141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD 177
                                  ++      L + V + H    +C+ HRD+K  N++L 
Sbjct: 110 LIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS--RRCL-HRDLKPQNLLLS 166
Query: 178 SNFNA-----KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFG 231
            +  +     K+GDFGLAR     +  Q T    T+ Y  PE +   +  S   D++S  
Sbjct: 167 VSDASETPVLKIGDFGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIA 225
Query: 232 VVALEVACGRKPVEP 246
            +  E+   + P+ P
Sbjct: 226 CIWAEMLM-KTPLFP 239

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 40/196 (20%)
Query: 84  VYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCH---EQRQL 140
           VY+  L D    +A+K+V     Q K+    E++I+ +L H N+V L  + +   E++ +
Sbjct: 36  VYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDV 91
Query: 141 I------------LHKIA---------LGLASAVLYLHEEWEQC-------IVHRDIKSS 172
           +            ++++A         L +    LY+++ +          I HRDIK  
Sbjct: 92  VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 151
Query: 173 NVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES-DVYSF 230
           N++LD +    KL DFG A+ +    G        +  Y APE +        S DV+S 
Sbjct: 152 NLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSA 209
Query: 231 GVVALEVACGRKPVEP 246
           G V  E+  G +P+ P
Sbjct: 210 GCVLAELLLG-QPIFP 224

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 71/173 (41%), Gaps = 27/173 (15%)
Query: 96  IAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL-----------HK 144
            A K V    +  K+    E++ +S LRH  LV+L     +  ++++            K
Sbjct: 185 FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK 244
Query: 145 IA-----LGLASAVLYLHE-------EWEQCIVHRDIKSSNVVLDSNFNA--KLGDFGLA 190
           +A     +    AV Y+ +         E   VH D+K  N++  +  +   KL DFGL 
Sbjct: 245 VADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304
Query: 191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             +D +      V  GT  + APE          +D++S GV++  +  G  P
Sbjct: 305 AHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 29/156 (18%)
Query: 114 SEVRIISRLRHRNLVHLIGWCHEQRQLIL-----------HKIA-----LGLASAVLYLH 157
           +E+ I+++L H  L++L     ++ +++L            +IA     +  A  + Y+ 
Sbjct: 97  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156
Query: 158 EE-------WEQCIVHRDIKSSNVVLDSN--FNAKLGDFGLA-RLVDHELGSQTTVLAGT 207
           +         E  IVH DIK  N++ ++    + K+ DFGLA +L   E+   TT    T
Sbjct: 157 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---AT 213
Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
             + APE V        +D+++ GV+   +  G  P
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 60/141 (42%), Gaps = 41/141 (29%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQ----------LIL----HKIALGLASAVL---- 154
           + E++I+  L+H N+V+LI  C  +            L+     H +A GL S VL    
Sbjct: 64  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFT 122
Query: 155 ----------------YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG 198
                           Y+H      I+HRD+K++NV++  +   KL DFGLAR       
Sbjct: 123 LSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 199 SQTTVLAG---TMGYLAPECV 216
           SQ         T+ Y  PE +
Sbjct: 180 SQPNRYXNRVVTLWYRPPELL 200

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 82/182 (45%), Gaps = 36/182 (19%)
Query: 93  NTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE-------QRQLILH 143
           + ++AVK  ++   S++  +E++SE   +    H N++ L+G C E       +  +IL 
Sbjct: 62  SLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121
Query: 144 KIALG-LASAVLY-----------------------LHEEW--EQCIVHRDIKSSNVVLD 177
            +  G L + +LY                       L  E+   +  +HRD+ + N +L 
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR 181
Query: 178 SNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALE 236
            +    + DFGL+ ++   +   Q  +    + ++A E +     + +SDV++FGV   E
Sbjct: 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWE 241
Query: 237 VA 238
           +A
Sbjct: 242 IA 243

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 8/80 (10%)
Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVT 217
           +CI HRD+ + N++L      K+ DFGLAR +         V  G     + ++APE + 
Sbjct: 218 KCI-HRDLAARNILLSEKNVVKICDFGLARDI---YKDPDYVRKGDARLPLKWMAPETIF 273
Query: 218 TGKASKESDVYSFGVVALEV 237
               + +SDV+SFGV+  E+
Sbjct: 274 DRVYTIQSDVWSFGVLLWEI 293

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 8/84 (9%)
Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVTTGK 220
           +HRD+ + N++L      K+ DFGLAR +         V  G     + ++APE +    
Sbjct: 166 IHRDLAARNILLSEKNVVKICDFGLARDI---YKDPDYVRKGDARLPLKWMAPETIFDRV 222
Query: 221 ASKESDVYSFGVVALEV-ACGRKP 243
            + +SDV+SFGV+  E+ + G  P
Sbjct: 223 YTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 60/141 (42%), Gaps = 41/141 (29%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQ----------LIL----HKIALGLASAVL---- 154
           + E++I+  L+H N+V+LI  C  +            L+     H +A GL S VL    
Sbjct: 65  LREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLA-GLLSNVLVKFT 123
Query: 155 ----------------YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG 198
                           Y+H      I+HRD+K++NV++  +   KL DFGLAR       
Sbjct: 124 LSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 199 SQTTVLAG---TMGYLAPECV 216
           SQ         T+ Y  PE +
Sbjct: 181 SQPNRYXNRVVTLWYRPPELL 201

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 60/141 (42%), Gaps = 41/141 (29%)
Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQRQ----------LIL----HKIALGLASAVL---- 154
           + E++I+  L+H N+V+LI  C  +            L+     H +A GL S VL    
Sbjct: 65  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFT 123
Query: 155 ----------------YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG 198
                           Y+H      I+HRD+K++NV++  +   KL DFGLAR       
Sbjct: 124 LSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 199 SQTTVLAG---TMGYLAPECV 216
           SQ         T+ Y  PE +
Sbjct: 181 SQPNRYXNRVVTLWYRPPELL 201

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 28/108 (25%), Positives = 49/108 (45%), Gaps = 10/108 (9%)
Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVL----DSNFNAKLGDFGLARLVDHELGSQTTV- 203
           +   + YLH  W   ++HRD+K +N+++          K+ D G ARL +  L     + 
Sbjct: 137 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 204 -LAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQE 249
            +  T  Y APE +   +  +K  D+++ G +  E+         RQE
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/77 (32%), Positives = 41/77 (53%), Gaps = 7/77 (9%)
Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVTTGK 220
           +HRD+ + N++L      K+ DFGLAR +         V  G     + ++APE +    
Sbjct: 172 IHRDLAARNILLSEKNVVKICDFGLARDI---YKDPDYVRKGDARLPLKWMAPETIFDRV 228
Query: 221 ASKESDVYSFGVVALEV 237
            + +SDV+SFGV+  E+
Sbjct: 229 YTIQSDVWSFGVLLWEI 245

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 8/80 (10%)
Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG----TMGYLAPECVT 217
           +CI HRD+ + N++L      K+ DFGLAR +         V  G     + ++APE + 
Sbjct: 213 KCI-HRDLAARNILLSEKNVVKICDFGLARDI---YKDPDYVRKGDARLPLKWMAPETIF 268
Query: 218 TGKASKESDVYSFGVVALEV 237
               + +SDV+SFGV+  E+
Sbjct: 269 DRVYTIQSDVWSFGVLLWEI 288

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 55/251 (21%), Positives = 97/251 (38%), Gaps = 50/251 (19%)
Query: 94  TEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILHKIALGLASAV 153
           TE+ +K + +  +   + +     ++S+L H++LV   G C    + IL +  +   S  
Sbjct: 41  TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLD 100
Query: 154 LYLHEE-------W----------------EQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
            YL +        W                E  ++H ++ + N++L    + K G+    
Sbjct: 101 TYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160
Query: 191 RLVDHELGSQTTVLAGT-----MGYLAPECVTTGK-ASKESDVYSFGVVALEVAC-GRKP 243
           +L D   G   TVL        + ++ PEC+   K  +  +D +SFG    E+   G KP
Sbjct: 161 KLSDP--GISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
Query: 244 VEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNR 303
           +       K++  E       + QL       L+           +I       PD  +R
Sbjct: 219 LSALDSQRKLQFYE------DRHQLPAPKAAELAN----------LINNCMDYEPD--HR 260
Query: 304 PSIRQVINVLN 314
           PS R +I  LN
Sbjct: 261 PSFRAIIRDLN 271

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	387
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-118
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-110
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-110
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-60
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-50
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-50
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-49
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-48
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-46
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-46
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-45
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-44
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-44
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-41
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-40
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-40
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-34
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-31
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-31
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-31
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-31
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-30
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-30
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-30
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-29
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-29
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-29
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-29
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-29
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-29
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-29
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-29
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-29
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-29
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-28
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-28
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-28
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-28
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-28
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-28
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-28
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-28
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-27
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-27
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-27
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-26
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-25
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-08
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-24
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-24
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-23
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-23
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-23
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-22
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-22
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-22
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-21
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-21
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-21
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-20
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-19
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-15
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-15
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-04
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-05
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-07
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  344 bits (886), Expect = e-118
 Identities = 105/305 (34%), Positives = 171/305 (56%), Gaps = 34/305 (11%)

Query: 42  DIALEDEFEKGTG-PKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKR 100
           D+  E++ E   G  KRF+ REL  A++NF+    LG GGFG VY+G L+D  T +AVKR
Sbjct: 3   DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKR 61

Query: 101 VSRGSKQG-KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL----------------- 142
           +     QG + ++ +EV +IS   HRNL+ L G+C    + +L                 
Sbjct: 62  LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121

Query: 143 ------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
                        +IALG A  + YLH+  +  I+HRD+K++N++LD  F A +GDFGLA
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181

Query: 191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEP 250
           +L+D++    TT + GT+G++APE ++TGK+S+++DV+ +GV+ LE+  G++  +  +  
Sbjct: 182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241

Query: 251 --SKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQ 308
               V L++WV  L  + +L    D  L   + + ++E L+ V L C       RP + +
Sbjct: 242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301

Query: 309 VINVL 313
           V+ +L
Sbjct: 302 VVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  324 bits (834), Expect = e-110
 Identities = 99/310 (31%), Positives = 152/310 (49%), Gaps = 34/310 (10%)

Query: 40  AIDIALEDEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVK 99
           +I+ AL   +       R    +L  ATNNF     +G G FG VY+G+L D   ++A+K
Sbjct: 11  SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALK 69

Query: 100 RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL------------H---- 143
           R +  S QG +E+ +E+  +S  RH +LV LIG+C E+ ++IL            H    
Sbjct: 70  RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129

Query: 144 -------------KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA 190
                        +I +G A  + YLH      I+HRD+KS N++LD NF  K+ DFG++
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186

Query: 191 RLVDHELGSQ-TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
           +       +  +TV+ GT+GY+ PE    G+ +++SDVYSFGVV  EV C R  +     
Sbjct: 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

Query: 250 PSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQV 309
              V L EW  + +  GQL +  D  L+ +     +       + C      +RPS+  V
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

Query: 310 INVLNFEAPL 319
           +  L +   L
Sbjct: 307 LWKLEYALRL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  323 bits (831), Expect = e-110
 Identities = 92/312 (29%), Positives = 157/312 (50%), Gaps = 49/312 (15%)

Query: 46  EDEFEKGTGPKRFTYRELSRATNNFAE------AGKLGEGGFGGVYRGLLSDQNTEIAVK 99
           +      T    F++ EL   TNNF E        K+GEGGFG VY+G +++    +AVK
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--TVAVK 60

Query: 100 RVS----RGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL------------- 142
           +++      +++ K+++  E++++++ +H NLV L+G+  +   L L             
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 143 ---------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF 187
                           KIA G A+ + +LHE      +HRDIKS+N++LD  F AK+ DF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDF 177

Query: 188 GLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
           GLAR  +    +  T+ + GT  Y+APE +  G+ + +SD+YSFGVV LE+  G   V+ 
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 247 RQEPSKVRLVEWVWDLYG-KGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPS 305
            +EP    L++   ++   +  + +  D +++ + D   +E +  V   C H     RP 
Sbjct: 237 HREPQL--LLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPD 293

Query: 306 IRQVINVLNFEA 317
           I++V  +L    
Sbjct: 294 IKKVQQLLQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  196 bits (500), Expect = 4e-60
 Identities = 67/304 (22%), Positives = 103/304 (33%), Gaps = 50/304 (16%)

Query: 58  FTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVR 117
                L   +           G FG V++  L   N  +AVK      KQ   +   EV 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSW-QNEYEVY 70

Query: 118 IISRLRHRNLVHLIGWC------HEQRQLI------------LH----------KIALGL 149
            +  ++H N++  IG             LI            L            IA  +
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETM 130

Query: 150 ASAVLYLHEE-------WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS-QT 201
           A  + YLHE+        +  I HRDIKS NV+L +N  A + DFGLA   +    +  T
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190

Query: 202 TVLAGTMGYLAPE-----CVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
               GT  Y+APE           A    D+Y+ G+V  E+A      +   +   +   
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250

Query: 257 EWVWDLYGKGQLLEAADGR-----LSKEFDERQMECLMIVGLWCC-HPDFTNRPSIRQVI 310
           E +        + E    +     L   + +     ++   +  C   D   R S   V 
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310

Query: 311 NVLN 314
             + 
Sbjct: 311 ERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  170 bits (434), Expect = 1e-50
 Identities = 74/273 (27%), Positives = 125/273 (45%), Gaps = 55/273 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIG 132
           K+G G FG V+R       +++AVK +       +   E++ EV I+ RLRH N+V  +G
Sbjct: 44  KIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 133 WCHEQRQL--------------ILH--------------KIALGLASAVLYLHEEWEQCI 164
              +   L              +LH               +A  +A  + YLH      I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
           VHR++KS N+++D  +  K+ DFGL+RL      S  +  AGT  ++APE +    ++++
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA-AGTPEWMAPEVLRDEPSNEK 219

Query: 225 SDVYSFGVVALEVACGRKP---VEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD 281
           SDVYSFGV+  E+A  ++P   + P Q          V  +  K + LE     + +  +
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQ---------VVAAVGFKCKRLE-----IPRNLN 265

Query: 282 ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
             Q+  ++     C   +   RPS   ++++L 
Sbjct: 266 P-QVAAII---EGCWTNEPWKRPSFATIMDLLR 294

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  170 bits (433), Expect = 2e-50
 Identities = 70/289 (24%), Positives = 122/289 (42%), Gaps = 50/289 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
            +G G FG V +     +  ++A+K++   S+  +K +I E+R +SR+ H N+V L G C
Sbjct: 15  VVGRGAFGVVCKAKW--RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 135 HEQRQLI------------LH--------------KIALGLASAVLYLHEEWEQCIVHRD 168
                L+            LH                 L  +  V YLH    + ++HRD
Sbjct: 71  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 169 IKSSNVVLDSNFN-AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           +K  N++L +     K+ DFG A  +   + +      G+  ++APE       S++ DV
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK----GSAAWMAPEVFEGSNYSEKCDV 186

Query: 228 YSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMEC 287
           +S+G++  EV   RKP +    P+    + W       G         L K   +  +E 
Sbjct: 187 FSWGIILWEVITRRKPFDEIGGPAFR--IMWA---VHNGTRPP-----LIKNLPK-PIES 235

Query: 288 LMIVGLWCCHPDFTNRPSIRQVINVL-NFEAPLPSLPSKLPVPMYYAPP 335
           LM     C   D + RPS+ +++ ++ +     P     L  P  ++ P
Sbjct: 236 LM---TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLP 281

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  166 bits (422), Expect = 5e-49
 Identities = 61/281 (21%), Positives = 118/281 (41%), Gaps = 62/281 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGK-------KEYISEVRIISRLRHRNL 127
           ++G+GGFG V++G L    + +A+K +  G  +G+       +E+  EV I+S L H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85

Query: 128 VHLIGWCHEQRQLI------------LH------------KIALGLASAVLYLHEEWEQC 163
           V L G  H   +++            L             ++ L +A  + Y+       
Sbjct: 86  VKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPP 144

Query: 164 IVHRDIKSSNVVLDS-----NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT 218
           IVHRD++S N+ L S        AK+ DFGL++   H +        G   ++APE +  
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL----GNFQWMAPETIGA 200

Query: 219 GKA--SKESDVYSFGVVALEVACGRKP---VEPRQEPSKVRLVEWVWDLYGKGQLLEAAD 273
            +   ++++D YSF ++   +  G  P       +       ++++  +  +G       
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-------IKFINMIREEGLRPT--- 250

Query: 274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
             + ++   R +  ++     C   D   RP    ++  L+
Sbjct: 251 --IPEDCPPR-LRNVI---ELCWSGDPKKRPHFSYIVKELS 285

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  165 bits (418), Expect = 6e-48
 Identities = 59/336 (17%), Positives = 112/336 (33%), Gaps = 66/336 (19%)

Query: 58  FTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVR 117
               E S   +N      +G G +G VY+G L      +AVK  S  ++Q    +I+E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ---NFINEKN 57

Query: 118 I--ISRLRHRNLVHLIGWC-------HEQRQLILH----------------------KIA 146
           I  +  + H N+   I            +  L++                       ++A
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLA 117

Query: 147 LGLASAVLYLHEEWEQ------CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH----- 195
             +   + YLH E  +       I HRD+ S NV++ ++    + DFGL+  +       
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177

Query: 196 --ELGSQTTVLAGTMGYLAPE-------CVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
             E  +      GT+ Y+APE             A K+ D+Y+ G++  E+      + P
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

Query: 247 RQEPSKVRLV--EWVWDLYGKGQLLEAADGR-----LSKEFDERQMECLMIVGL--WCCH 297
            +   + ++     V +      +              + + E  +    +      C  
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297

Query: 298 PDFTNRPSIRQVINVLN-FEAPLPSLPSKLPVPMYY 332
            D   R + +     +           S  P   ++
Sbjct: 298 QDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHH 333

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  160 bits (407), Expect = 1e-46
 Identities = 64/300 (21%), Positives = 112/300 (37%), Gaps = 70/300 (23%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
            LG+G FG   +    +    + +K + R  ++ ++ ++ EV+++  L H N++  IG  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 135 HEQRQL--------------ILH------------KIALGLASAVLYLHEEWEQCIVHRD 168
           ++ ++L              I+               A  +AS + YLH      I+HRD
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRD 133

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHE-------------LGSQTTVLAGTMGYLAPEC 215
           + S N ++  N N  + DFGLARL+  E                +   + G   ++APE 
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193

Query: 216 VTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR 275
           +      ++ DV+SFG+V  E+       +P   P  +     V                
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNA-DPDYLPRTMDFGLNVRGFL-----------D 241

Query: 276 LSKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVP 329
                      C      +    + CC  D   RPS  ++ + L  E     L   LP+ 
Sbjct: 242 R-----YCPPNCPPSFFPIT---VRCCDLDPEKRPSFVKLEHWL--ETLRMHLAGHLPLG 291

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  158 bits (401), Expect = 4e-46
 Identities = 72/279 (25%), Positives = 112/279 (40%), Gaps = 62/279 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG----SKQGKKEYISEVRIISRLRHRNLVHL 130
            +G GGFG VYR        E+AVK           Q  +    E ++ + L+H N++ L
Sbjct: 14  IIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 131 IGWCHEQRQL--------------ILH----------KIALGLASAVLYLHEEWEQCIVH 166
            G C ++  L              +L             A+ +A  + YLH+E    I+H
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 167 RDIKSSNVVLD--------SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT 218
           RD+KSSN+++         SN   K+ DFGLAR       +     AG   ++APE +  
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR---TTKMSAAGAYAWMAPEVIRA 188

Query: 219 GKASKESDVYSFGVVALEVACGRKP---VEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR 275
              SK SDV+S+GV+  E+  G  P   ++              + +      L      
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---------VAYGVAMNKLALP----- 234

Query: 276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
           +     E     LM     C +PD  +RPS   +++ L 
Sbjct: 235 IPSTCPE-PFAKLM---EDCWNPDPHSRPSFTNILDQLT 269

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  155 bits (394), Expect = 1e-44
 Identities = 63/302 (20%), Positives = 114/302 (37%), Gaps = 72/302 (23%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIG 132
            +G+G FG VY G     + E+A++ +     ++   K +  EV    + RH N+V  +G
Sbjct: 40  LIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 133 WCHEQRQL--------------ILH------------KIALGLASAVLYLHEEWEQCIVH 166
            C     L              ++             +IA  +   + YLH    + I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS----QTTVLAGTMGYLAPECVTTGKA- 221
           +D+KS NV  D N    + DFGL  +           +  +  G + +LAPE +      
Sbjct: 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 222 --------SKESDVYSFGVVALEVACGRKP---VEPRQEPSKVRLVEWVWDLYGKGQLLE 270
                   SK SDV++ G +  E+     P           ++          G G    
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM----------GTGMKPN 262

Query: 271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPM 330
            +   + KE  +     ++   L+C   +   RP+  +++++L     LP    +L  P 
Sbjct: 263 LSQIGMGKEISD-----IL---LFCWAFEQEERPTFTKLMDMLE---KLPKRNRRLSHPG 311

Query: 331 YY 332
           ++
Sbjct: 312 HF 313

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  152 bits (386), Expect = 7e-44
 Identities = 51/278 (18%), Positives = 96/278 (34%), Gaps = 66/278 (23%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIG 132
           KL E   G +++G    Q  +I VK +     S +  +++  E   +    H N++ ++G
Sbjct: 17  KLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 133 WC------------------------HEQRQLILH-----KIALGLASAVLYLHEEWEQC 163
            C                        HE    ++      K AL +A  + +LH   E  
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPL 133

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-- 221
           I    + S +V++D +  A++    +          Q+        ++APE     K   
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPE-ALQKKPED 186

Query: 222 --SKESDVYSFGVVALEVACGRKP---VEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL 276
              + +D++SF V+  E+     P   +   +   KV L         +G         +
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL---------EGLRPT-----I 232

Query: 277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   +  LM     C + D   RP    ++ +L 
Sbjct: 233 PPGISP-HVSKLM---KICMNEDPAKRPKFDMIVPILE 266

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  152 bits (387), Expect = 8e-44
 Identities = 71/277 (25%), Positives = 123/277 (44%), Gaps = 62/277 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIG 132
           ++G G FG VY+G     + ++AVK ++    + Q  + + +EV ++ + RH N++  +G
Sbjct: 31  RIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 133 WCHEQRQLI-------------LHK------------IALGLASAVLYLHEEWEQCIVHR 167
           +    +  I             LH             IA   A  + YLH    + I+HR
Sbjct: 88  YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHR 144

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT-TVLAGTMGYLAPECV---TTGKASK 223
           D+KS+N+ L  +   K+GDFGLA       GS     L+G++ ++APE +    +   S 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204

Query: 224 ESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD-GRLSKEFDE 282
           +SDVY+FG+V  E+  G+ P                 ++  + Q++E    G LS +  +
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYS---------------NINNRDQIIEMVGRGSLSPDLSK 249

Query: 283 RQMEC------LMIVGLWCCHPDFTNRPSIRQVINVL 313
            +  C      LM     C       RPS  +++  +
Sbjct: 250 VRSNCPKRMKRLM---AECLKKKRDERPSFPRILAEI 283

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  144 bits (365), Expect = 3e-40
 Identities = 63/290 (21%), Positives = 112/290 (38%), Gaps = 56/290 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRI--ISRLRHRNLVHLIG 132
            +G+G FG V+RG    +  E+AVK  S    + ++ +  E  I     LRH N++  I 
Sbjct: 49  SIGKGRFGEVWRGKW--RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103

Query: 133 WCHEQRQL------------------ILH----------KIALGLASAVLYLHEEWEQC- 163
             ++                       L+          K+AL  AS + +LH E     
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 164 ----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL---AGTMGYLAPE-- 214
               I HRD+KS N+++  N    + D GLA   D    +         GT  Y+APE  
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223

Query: 215 ----CVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE 270
                +   ++ K +D+Y+ G+V  E+A  R  +    E  ++   + V       ++ +
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282

Query: 271 A-ADGRLSKEFDERQMECLMIVGLW-----CCHPDFTNRPSIRQVINVLN 314
              + +L      R   C  +  +      C + +   R +  ++   L+
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  142 bits (361), Expect = 6e-40
 Identities = 60/223 (26%), Positives = 89/223 (39%), Gaps = 52/223 (23%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRI--ISRLRHRNLVHLIG 132
            +G+G +G V+RG    Q   +AVK  S    + +K +  E  +     LRH N++  I 
Sbjct: 15  CVGKGRYGEVWRGSW--QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 133 WC----HEQRQL--------------ILH----------KIALGLASAVLYLHEEWEQC- 163
                 H   QL               L           +I L +AS + +LH E     
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129

Query: 164 ----IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH---ELGSQTTVLAGTMGYLAPE-- 214
               I HRD+KS N+++  N    + D GLA +      +L        GT  Y+APE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189

Query: 215 ----CVTTGKASKESDVYSFGVVALEVACGRKP---VEPRQEP 250
                V    + K  D+++FG+V  EVA        VE  + P
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  139 bits (353), Expect = 2e-38
 Identities = 65/293 (22%), Positives = 105/293 (35%), Gaps = 62/293 (21%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRI--ISRLRHRNLVHLIG 132
           ++G+G +G V+ G    +  ++AVK         +  +  E  I     +RH N++  I 
Sbjct: 44  QIGKGRYGEVWMGKW--RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 133 WCHE----QRQL--------------ILH----------KIALGLASAVLYLHEE----- 159
              +      QL               L           K+A    S + +LH E     
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL---AGTMGYLAPE-- 214
            +  I HRD+KS N+++  N    + D GLA     +            GT  Y+ PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218

Query: 215 ----CVTTGKASKESDVYSFGVVALEVACGRKP---VEPRQEPSKVRL-----VEWVWDL 262
                    ++   +D+YSFG++  EVA        VE  Q P    +      E + ++
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278

Query: 263 YG-KGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
              K       +   S E   RQM  LM     C   +  +R +  +V   L 
Sbjct: 279 VCIKKLRPSFPNRWSSDECL-RQMGKLMT---ECWAHNPASRLTALRVKKTLA 327

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  128 bits (324), Expect = 8e-35
 Identities = 55/272 (20%), Positives = 107/272 (39%), Gaps = 52/272 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIG 132
            +G G +G   +         +  K +  G  ++  K+  +SEV ++  L+H N+V    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 133 WCHEQRQLILH-------------------------------KIALGLASAVLYLHE--E 159
              ++    L+                               ++   L  A+   H   +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
               ++HRD+K +NV LD   N KLGDFGLAR+++H+  S      GT  Y++PE +   
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKTFVGTPYYMSPEQMNRM 191

Query: 220 KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE 279
             +++SD++S G +  E+     P     +      +        +G+       R+   
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------EGKF-----RRIPYR 239

Query: 280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
           + +   E   I+     +    +RPS+ +++ 
Sbjct: 240 YSD---ELNEIIT-RMLNLKDYHRPSVEEILE 267

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  128 bits (325), Expect = 1e-34
 Identities = 61/279 (21%), Positives = 95/279 (34%), Gaps = 52/279 (18%)

Query: 61  RELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRI 118
           R  S    +F    +LG G +G V++    +     AVKR        + +   ++EV  
Sbjct: 50  RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGS 109

Query: 119 ISRL-RHRNLVHLIG---------------------WCHEQRQLI----LHKIALGLASA 152
             ++ +H   V L                        C      +    +         A
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLA 169

Query: 153 VLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLA 212
           + +LH    Q +VH D+K +N+ L      KLGDFGL   +      +     G   Y+A
Sbjct: 170 LAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMA 224

Query: 213 PECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA 272
           PE +  G     +DV+S G+  LEVAC  +   P             W    +G L    
Sbjct: 225 PE-LLQGSYGTAADVFSLGLTILEVACNMEL--PHGGEG--------WQQLRQGYLPPEF 273

Query: 273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
              LS E     +  L         PD   R +   ++ 
Sbjct: 274 TAGLSSELRSVLVMML--------EPDPKLRATAEALLA 304

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  129 bits (325), Expect = 1e-34
 Identities = 58/297 (19%), Positives = 97/297 (32%), Gaps = 66/297 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLGEGGF  V            A+KR+    +Q ++E   E  +     H N++ L+ +C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 135 HEQRQ-----LIL----------------------------HKIALGLASAVLYLHEEWE 161
             +R       +L                              + LG+   +  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA--------GTMGYLAP 213
           +   HRD+K +N++L       L D G        +      L          T+ Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 214 ECVTT---GKASKESDVYSFGVVALEVACGRKPVEPRQEP--SKVRLVEWVWDLYGKGQL 268
           E  +        + +DV+S G V   +  G  P +   +   S    V        + QL
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV--------QNQL 264

Query: 269 LEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF-EAPLPSLPS 324
                 R S    +      ++        D   RP I  +++ L   + P P   +
Sbjct: 265 SIPQSPRHSSALWQ------LL--NSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHT 313

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  128 bits (324), Expect = 2e-34
 Identities = 62/279 (22%), Positives = 111/279 (39%), Gaps = 53/279 (18%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRV---SRGSKQGKKEYISEVRIISRLRH 124
            NF    K+G G F  VYR         +A+K+V        + + + I E+ ++ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 125 RNLVHLIGWCHEQRQLI----------LH-------------------KIALGLASAVLY 155
            N++       E  +L           L                    K  + L SA+ +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 156 LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPEC 215
           +H    + ++HRDIK +NV + +    KLGD GL R    +  +  +++ GT  Y++PE 
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207

Query: 216 VTTGKASKESDVYSFGVVALEVACGRKP--VEPRQEPSKVRLVEWVWDLYGKGQLLEAAD 273
           +     + +SD++S G +  E+A  + P   +     S  + +E       +        
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-------QCDYPPLPS 260

Query: 274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINV 312
              S+E  +    C+        +PD   RP +  V +V
Sbjct: 261 DHYSEELRQLVNMCI--------NPDPEKRPDVTYVYDV 291

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  128 bits (323), Expect = 5e-34
 Identities = 53/266 (19%), Positives = 102/266 (38%), Gaps = 49/266 (18%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIG 132
           K+GEG FG       ++   +  +K ++    S + ++E   EV +++ ++H N+V    
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 133 WCHEQRQLI----------LH-----------------KIALGLASAVLYLHEEWEQCIV 165
              E   L           L                     + +  A+ ++H+   + I+
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKIL 147

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES 225
           HRDIKS N+ L  +   +LGDFG+AR+++  +        GT  YL+PE       + +S
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC-IGTPYYLSPEICENKPYNNKS 206

Query: 226 DVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM 285
           D+++ G V  E+   +   E     + V  +         G          S +      
Sbjct: 207 DIWALGCVLYELCTLKHAFEAGSMKNLVLKII-------SGS-FPPVSLHYSYDLRSLVS 258

Query: 286 ECLMIVGLWCCHPDFTNRPSIRQVIN 311
           +            +  +RPS+  ++ 
Sbjct: 259 QLF--------KRNPRDRPSVNSILE 276

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  127 bits (321), Expect = 2e-33
 Identities = 67/279 (24%), Positives = 102/279 (36%), Gaps = 68/279 (24%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGW 133
           ++G G FG V+ G L   NT +AVK          K +++ E RI+ +  H N+V LIG 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 134 CHEQRQL--------------------------ILHKIALGLASAVLYLHEEWEQCIVHR 167
           C +++ +                           L ++    A+ + YL     +C +HR
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHR 237

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGY----LAPECVTTGKASK 223
           D+ + N ++      K+ DFG++R              G         APE +  G+ S 
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEA---DGVYAASGGLRQVPVKWTAPEALNYGRYSS 294

Query: 224 ESDVYSFGVVALEVA-CGRKPVEPRQEPSKV-RLVEWVWDLYGKGQLLEAADGRLSKEFD 281
           ESDV+SFG++  E    G  P  P     +    VE                GRL     
Sbjct: 295 ESDVWSFGILLWETFSLGASPY-PNLSNQQTREFVE--------------KGGRL----- 334

Query: 282 ERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
                C      LM     C   +   RPS   +   L 
Sbjct: 335 PCPELCPDAVFRLM---EQCWAYEPGQRPSFSTIYQELQ 370

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  123 bits (312), Expect = 6e-33
 Identities = 53/291 (18%), Positives = 107/291 (36%), Gaps = 73/291 (25%)

Query: 64  SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR 123
            R   +F E   +G GGFG V++           +KRV   +++ ++E    V+ +++L 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLD 62

Query: 124 HRNLVHLIG--------------------------------------WCHEQRQLILH-- 143
           H N+VH  G                                      W  ++R   L   
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 144 ---KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ 200
              ++   +   V Y+H    + +++RD+K SN+ L      K+GDFGL   + ++    
Sbjct: 123 LALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179

Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW 260
            +   GT+ Y++PE +++    KE D+Y+ G++  E+           +          +
Sbjct: 180 RSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---------FF 228

Query: 261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
                G +         K+         ++           +RP+  +++ 
Sbjct: 229 TDLRDGII----SDIFDKKEKT------LL--QKLLSKKPEDRPNTSEILR 267

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  122 bits (309), Expect = 2e-32
 Identities = 60/300 (20%), Positives = 107/300 (35%), Gaps = 75/300 (25%)

Query: 65  RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVS-RGSKQGKKEYISEVRIISRLR 123
           R   +F     LG GGFG V+       +   A+KR+     +  +++ + EV+ +++L 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 124 HRNLVHLIGWCHEQRQLILH---------------------------------------- 143
           H  +V       E+                                              
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
            I L +A AV +LH    + ++HRD+K SN+    +   K+GDFGL   +D +   QT +
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 204 LA-----------GTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPS 251
                        GT  Y++PE    G + S + D++S G++  E+     P   + E  
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV 234

Query: 252 KVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
           +               L +  + +    F ++     ++V      P    RP    +I 
Sbjct: 235 RT--------------LTDVRNLKFPPLFTQKYPCEYVMV-QDMLSPSPMERPEAINIIE 279

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  122 bits (309), Expect = 4e-32
 Identities = 61/311 (19%), Positives = 105/311 (33%), Gaps = 70/311 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRNLVHLIGW 133
            L EGGF  VY         E A+KR+    ++  +  I EV  + +L  H N+V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 134 CHEQRQ---------LIL--------------------------HKIALGLASAVLYLHE 158
               ++         L+L                           KI      AV ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 159 EWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA-----------GT 207
           + +  I+HRD+K  N++L +    KL DFG A  + H      +               T
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 208 MGYLAPECVTTGK---ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYG 264
             Y  PE +         ++ D+++ G +   +   + P E   + +K+R+V        
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE---DGAKLRIV-------- 262

Query: 265 KGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPS 324
            G+            F       L+         +   R SI +V++ L   A   ++  
Sbjct: 263 NGKYSIPPHDTQYTVF-----HSLIR---AMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314

Query: 325 KLPVPMYYAPP 335
           K P+       
Sbjct: 315 KSPITELLEQN 325

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  120 bits (303), Expect = 2e-31
 Identities = 63/303 (20%), Positives = 106/303 (34%), Gaps = 76/303 (25%)

Query: 64  SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR 123
            R  ++F E   LG+G FG V +   +  +   A+K++   +++     +SEV +++ L 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLN 60

Query: 124 HRNLVHLIG-WCHEQRQLILHKIALG---------------------------------- 148
           H+ +V     W   +  +                                          
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 149 ----LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL------- 197
               +  A+ Y+H    Q I+HRD+K  N+ +D + N K+GDFGLA+ V   L       
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 198 ------GSQTTVLAGTMGYLAPECVTTGKAS--KESDVYSFGVVALEVACGRKPVEPRQE 249
                     T   GT  Y+A E V  G     ++ D+YS G++  E+         R  
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN 236

Query: 250 P-SKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQ 308
              K+R            +     D    K   +      +I        D   RP  R 
Sbjct: 237 ILKKLRS--------VSIEFPPDFDDNKMKVEKK------II--RLLIDHDPNKRPGART 280

Query: 309 VIN 311
           ++N
Sbjct: 281 LLN 283

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  120 bits (303), Expect = 2e-31
 Identities = 66/306 (21%), Positives = 118/306 (38%), Gaps = 75/306 (24%)

Query: 52  GTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQN----TEIAVKRVSRG-SK 106
           G  P +   R L        +   LG G FG VY+GL   +       +A+K +    S 
Sbjct: 1   GEAPNQALLRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 58

Query: 107 QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------------------------- 141
           +  KE + E  +++ + + ++  L+G C      +                         
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY 118

Query: 142 LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT 201
           L    + +A  + YL    ++ +VHRD+ + NV++ +  + K+ DFGLA+L+  E   + 
Sbjct: 119 LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE--EKE 173

Query: 202 TVLAGTM---GYLAPECVTTGKASKESDVYSFGVVALEVA-CGRKP---VEPRQEPSKVR 254
               G      ++A E +     + +SDV+S+GV   E+   G KP   +   +  S + 
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

Query: 255 LVEWVWDLYGKGQLLEAADGRLSKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQ 308
                     KG+       RL      +   C      +M     C   D  +RP  R+
Sbjct: 234 ----------KGE-------RL-----PQPPICTIDVYMIM---RKCWMIDADSRPKFRE 268

Query: 309 VINVLN 314
           +I   +
Sbjct: 269 LIIEFS 274

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  119 bits (300), Expect = 4e-31
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 40/203 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEI--AVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHL 130
           +LG G FG V +G    +      AVK  +        K E ++E  ++ +L +  +V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 131 IGWCHEQRQLI------------------------LHKIALGLASAVLYLHEEWEQCIVH 166
           IG C  +  ++                        + ++   ++  + YL E  E   VH
Sbjct: 84  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-E--ESNFVH 140

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-----APECVTTGKA 221
           RD+ + NV+L +   AK+ DFGL++ +  +   +    A T G       APEC+   K 
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRAD---ENYYKAQTHGKWPVKWYAPECINYYKF 197

Query: 222 SKESDVYSFGVVALEVA-CGRKP 243
           S +SDV+SFGV+  E    G+KP
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKP 220

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  118 bits (298), Expect = 5e-31
 Identities = 68/279 (24%), Positives = 113/279 (40%), Gaps = 67/279 (24%)

Query: 75  KLGEGGFGGVYRGLLSDQN---TEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHL 130
            LGEG FG VY G+ ++       +AVK   +  +   K++++SE  I+  L H ++V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 131 IGWCHEQRQLI-------------------------LHKIALGLASAVLYLHEEWEQCIV 165
           IG   E+   I                         L   +L +  A+ YL        V
Sbjct: 79  IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCV 135

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM---GYLAPECVTTGKAS 222
           HRDI   N+++ S    KLGDFGL+R ++          + T     +++PE +   + +
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIE---DEDYYKASVTRLPIKWMSPESINFRRFT 192

Query: 223 KESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD 281
             SDV+ F V   E+   G++P    +    + ++E       KG        RL     
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-------KG-------DRL----- 233

Query: 282 ERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
            +   C      LM     C   D ++RP   +++  L+
Sbjct: 234 PKPDLCPPVLYTLM---TRCWDYDPSDRPRFTELVCSLS 269

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  118 bits (297), Expect = 7e-31
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 40/203 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEI--AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLI 131
           +LG G FG V +G+   +  +I  A+K + +G  K   +E + E +I+ +L +  +V LI
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 132 GWCHEQRQLI-------------------------LHKIALGLASAVLYLHEEWEQCIVH 166
           G C  +  ++                         + ++   ++  + YL E   +  VH
Sbjct: 77  GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 133

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-----APECVTTGKA 221
           RD+ + NV+L +   AK+ DFGL++ +  +    +   A + G       APEC+   K 
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPECINFRKF 190

Query: 222 SKESDVYSFGVVALEVA-CGRKP 243
           S  SDV+S+GV   E    G+KP
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  118 bits (298), Expect = 9e-31
 Identities = 44/209 (21%), Positives = 81/209 (38%), Gaps = 45/209 (21%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNL--VHL 130
           ++G GG   V++ L +++    A+K V+      Q    Y +E+  +++L+  +   + L
Sbjct: 35  QIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 131 IGWCHEQRQL-------------ILHK-----------IALGLASAVLYLHEEWEQCIVH 166
             +    + +              L K               +  AV  +H+     IVH
Sbjct: 94  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVH 150

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLV-DHELGSQTTVLAGTMGYLAPECVT-------- 217
            D+K +N ++      KL DFG+A  +             GT+ Y+ PE +         
Sbjct: 151 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209

Query: 218 ---TGKASKESDVYSFGVVALEVACGRKP 243
                K S +SDV+S G +   +  G+ P
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  118 bits (297), Expect = 1e-30
 Identities = 66/302 (21%), Positives = 110/302 (36%), Gaps = 66/302 (21%)

Query: 52  GTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLL---SDQNTEIAVKRVSRG---S 105
           G GP +     +     +     KLG+G FG V RG     S +   +AVK +       
Sbjct: 4   GEGPLQSLTCLIGE--KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ 61

Query: 106 KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------------------------ 141
            +   ++I EV  +  L HRNL+ L G        +                        
Sbjct: 62  PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLG 121

Query: 142 -LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ 200
            L + A+ +A  + YL     +  +HRD+ + N++L +    K+GDFGL R +       
Sbjct: 122 TLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 178

Query: 201 TTVLAGTMGY--LAPECVTTGKASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVE 257
                  + +   APE + T   S  SD + FGV   E+   G++P       S++    
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNGSQIL--- 234

Query: 258 WVWDLYGKGQLLEAADGRLSKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVIN 311
                      ++    RL      R  +C      +M   + C      +RP+   + +
Sbjct: 235 ---------HKIDKEGERL-----PRPEDCPQDIYNVM---VQCWAHKPEDRPTFVALRD 277

Query: 312 VL 313
            L
Sbjct: 278 FL 279

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  117 bits (296), Expect = 1e-30
 Identities = 59/270 (21%), Positives = 103/270 (38%), Gaps = 59/270 (21%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVS--RGSKQGKKEYISEVRIISRLRHRNLVHLIG 132
           ++G G F  VY+GL ++   E+A   +   + +K  ++ +  E  ++  L+H N+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 133 ----WCHEQRQLIL-----------------------------HKIALGLASAVLYLHEE 159
                   ++ ++L                              +I  GL     +LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ----FLHTR 148

Query: 160 WEQCIVHRDIKSSNVVLDS-NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT 218
               I+HRD+K  N+ +     + K+GD GLA L      S    + GT  ++APE +  
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPE-MYE 203

Query: 219 GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK 278
            K  +  DVY+FG+  LE+A    P    Q  ++      ++     G    + D     
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPASFDKVAIP 257

Query: 279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQ 308
           E  E    C+          +   R SI+ 
Sbjct: 258 EVKEIIEGCI--------RQNKDERYSIKD 279

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  118 bits (298), Expect = 1e-30
 Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 35/202 (17%)

Query: 72  EAGK-LGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYI-SEVRIISRLRHRNL 127
             G+ LG+GGF   +    +D     A K V +    K  ++E +  E+ I   L H+++
Sbjct: 44  VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 103

Query: 128 VHLIGWCHEQRQLIL-----------HKIA--------------LGLASAVLYLHEEWEQ 162
           V   G+  +   + +                               +     YLH     
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---N 160

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA- 221
            ++HRD+K  N+ L+ +   K+GDFGLA  V+++ G +  VL GT  Y+APE V + K  
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPE-VLSKKGH 218

Query: 222 SKESDVYSFGVVALEVACGRKP 243
           S E DV+S G +   +  G+ P
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPP 240

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  116 bits (293), Expect = 3e-30
 Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 35/202 (17%)

Query: 72  EAGK-LGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYI-SEVRIISRLRHRNL 127
             G+ LG+GGF   +    +D     A K V +    K  ++E +  E+ I   L H+++
Sbjct: 18  VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 77

Query: 128 VHLIGWCHEQRQLIL-----------HKIA--------------LGLASAVLYLHEEWEQ 162
           V   G+  +   + +                               +     YLH     
Sbjct: 78  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---N 134

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA- 221
            ++HRD+K  N+ L+ +   K+GDFGLA  V+++ G +  VL GT  Y+APE V + K  
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPE-VLSKKGH 192

Query: 222 SKESDVYSFGVVALEVACGRKP 243
           S E DV+S G +   +  G+ P
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPP 214

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  117 bits (294), Expect = 4e-30
 Identities = 66/327 (20%), Positives = 118/327 (36%), Gaps = 77/327 (23%)

Query: 54  GPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQN----TEIAVKRVSRGS-KQG 108
           G  +   R          +   LG G FG V++G+   +       + +K +   S +Q 
Sbjct: 1   GAMKVLARIFKE--TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS 58

Query: 109 KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI-------------------------LH 143
            +     +  I  L H ++V L+G C      +                         L 
Sbjct: 59  FQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLL 118

Query: 144 KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV 203
              + +A  + YL E     +VHR++ + NV+L S    ++ DFG+A L+  +   +  +
Sbjct: 119 NWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD--DKQLL 173

Query: 204 LAGTM---GYLAPECVTTGKASKESDVYSFGVVALEVA-CGRKP---VEPRQEPSKVRLV 256
            +       ++A E +  GK + +SDV+S+GV   E+   G +P   +   + P  +   
Sbjct: 174 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-- 231

Query: 257 EWVWDLYGKGQLLEAADGRLSKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVI 310
                   KG+       RL      +   C      +M   + C   D   RP+ +++ 
Sbjct: 232 --------KGE-------RL-----AQPQICTIDVYMVM---VKCWMIDENIRPTFKELA 268

Query: 311 NVLN--FEAPLPSLPSKLPVPMYYAPP 335
           N        P   L  K       AP 
Sbjct: 269 NEFTRMARDPPRYLVIKRESGPGIAPG 295

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  117 bits (294), Expect = 4e-30
 Identities = 64/288 (22%), Positives = 109/288 (37%), Gaps = 66/288 (22%)

Query: 75  KLGEGGFGGVYRGLL----SDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHL 130
           +LG+G FG V          +    +AVK++       ++++  E++I+  L    +V  
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89

Query: 131 IGWCHEQR----QLI------------------------LHKIALGLASAVLYLHEEWEQ 162
            G  +       +L+                        L   +  +   + YL     +
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SR 146

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-----APECVT 217
             VHRD+ + N++++S  + K+ DFGLA+L+  +            G       APE ++
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV---VREPGQSPIFWYAPESLS 203

Query: 218 TGKASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEW----VWDLYGKGQLLEAA 272
               S++SDV+SFGVV  E+     K   P  E  ++   E     +  L    +LLE  
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL---ELLE-E 259

Query: 273 DGRLSKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
             RL          C      LM     C  P   +RPS   +   L+
Sbjct: 260 GQRL-----PAPPACPAEVHELM---KLCWAPSPQDRPSFSALGPQLD 299

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  115 bits (291), Expect = 4e-30
 Identities = 67/285 (23%), Positives = 109/285 (38%), Gaps = 69/285 (24%)

Query: 75  KLGEGGFGGVYRGLL---SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHL 130
            +GEG FG V++G+     +    +A+K      S   +++++ E   + +  H ++V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 131 IGWCHEQRQLI-------------------------LHKIALGLASAVLYLHEEWEQCIV 165
           IG   E    I                         L   A  L++A+ YL     +  V
Sbjct: 82  IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFV 138

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM---GYLAPECVTTGKAS 222
           HRDI + NV++ SN   KLGDFGL+R ++          +       ++APE +   + +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFRRFT 195

Query: 223 KESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD 281
             SDV+ FGV   E+   G KP +  +    +  +E        G        RL     
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NG-------ERL----- 236

Query: 282 ERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN--FEAP 318
                C      LM     C   D + RP   ++   L+   E  
Sbjct: 237 PMPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLSTILEEE 278

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  117 bits (296), Expect = 6e-30
 Identities = 43/209 (20%), Positives = 81/209 (38%), Gaps = 45/209 (21%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNL--VHL 130
           ++G GG   V++ L +++    A+K V+      Q    Y +E+  +++L+  +   + L
Sbjct: 63  QIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 131 IGWCHEQRQL-------------ILHK-----------IALGLASAVLYLHEEWEQCIVH 166
             +    + +              L K               +  AV  +H+     IVH
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVH 178

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLV-DHELGSQTTVLAGTMGYLAPECV--------- 216
            D+K +N ++      KL DFG+A  +             G + Y+ PE +         
Sbjct: 179 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237

Query: 217 --TTGKASKESDVYSFGVVALEVACGRKP 243
             +  K S +SDV+S G +   +  G+ P
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  114 bits (288), Expect = 1e-29
 Identities = 65/283 (22%), Positives = 110/283 (38%), Gaps = 68/283 (24%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           ++G G FG V+ G   ++  ++A+K +  G+   ++++I E  ++ +L H  LV L G C
Sbjct: 15  EIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 135 --------------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRD 168
                                            L  + L +   + YL E    C++HRD
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRD 129

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM---GYLAPECVTTGKASKES 225
           + + N ++  N   K+ DFG+ R V      Q T   GT     + +PE  +  + S +S
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186

Query: 226 DVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ 284
           DV+SFGV+  EV   G+ P E R     V  +                  RL      + 
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS--------------TGFRL-----YKP 227

Query: 285 MEC------LMIVGLWCCHPDFTNRPSIRQVINVLN--FEAPL 319
                    +M     C      +RP+  +++  L    E+ L
Sbjct: 228 RLASTHVYQIM---NHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  115 bits (291), Expect = 1e-29
 Identities = 78/337 (23%), Positives = 135/337 (40%), Gaps = 81/337 (24%)

Query: 28  MYWRKRVGGHKEAIDIALEDEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRG 87
           +Y++ ++   +   +      +E+     R   RE+  +  +  +   +G G  G V  G
Sbjct: 14  LYFQGKLPEPQFYAEP---HTYEEPGRAGRSFTREIEASRIHIEK--IIGSGDSGEVCYG 68

Query: 88  LL---SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----- 138
            L     ++  +A+K +  G +++ +++++SE  I+ +  H N++ L G     R     
Sbjct: 69  RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128

Query: 139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVV 175
                                  QL+   +  G+ + + YL +      VHRD+ + NV+
Sbjct: 129 TEYMENGSLDTFLRTHDGQFTIMQLV--GMLRGVGAGMRYLSD---LGYVHRDLAARNVL 183

Query: 176 LDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-----APECVTTGKASKESDVYSF 230
           +DSN   K+ DFGL+R+++ +          T G +     APE +     S  SDV+SF
Sbjct: 184 VDSNLVCKVSDFGLSRVLEDD---PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSF 240

Query: 231 GVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMEC-- 287
           GVV  EV   G +P         +  VE                 RL        M C  
Sbjct: 241 GVVMWEVLAYGERPYWNMTNRDVISSVE--------------EGYRL-----PAPMGCPH 281

Query: 288 ----LMIVGLWCCHPDFTNRPSIRQVINVLN--FEAP 318
               LM   L C H D   RP   Q+++VL+    +P
Sbjct: 282 ALHQLM---LDCWHKDRAQRPRFSQIVSVLDALIRSP 315

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  115 bits (291), Expect = 1e-29
 Identities = 44/209 (21%), Positives = 82/209 (39%), Gaps = 45/209 (21%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNL--VHL 130
           ++G GG   V++ L +++    A+K V+      Q    Y +E+  +++L+  +   + L
Sbjct: 16  QIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 131 IGWCHEQRQL-------------ILHK-----------IALGLASAVLYLHEEWEQCIVH 166
             +    + +              L K               +  AV  +H+     IVH
Sbjct: 75  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVH 131

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLV-DHELGSQTTVLAGTMGYLAPECV--------- 216
            D+K +N ++      KL DFG+A  +             GT+ Y+ PE +         
Sbjct: 132 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190

Query: 217 --TTGKASKESDVYSFGVVALEVACGRKP 243
             +  K S +SDV+S G +   +  G+ P
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  115 bits (290), Expect = 1e-29
 Identities = 71/297 (23%), Positives = 108/297 (36%), Gaps = 63/297 (21%)

Query: 75  KLGEGGFGGVYRGLL----SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVH 129
            LGEG FG V               +AVK +      Q +  +  E+ I+  L H +++ 
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 130 LIGWCHEQR----QLI----------------------LHKIALGLASAVLYLHEEWEQC 163
             G C +      QL+                      L   A  +   + YLH    Q 
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQH 154

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-----APECVTT 218
            +HRD+ + NV+LD++   K+GDFGLA+ V               G       APEC+  
Sbjct: 155 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR---VREDGDSPVFWYAPECLKE 211

Query: 219 GKASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD--GR 275
            K    SDV+SFGV   E+         P  +  ++  +     +    +L E  +   R
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-GQMTVL-RLTELLERGER 269

Query: 276 LSKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN--FEAPLPSLPS 324
           L      R  +C      LM     C   + + RP+   +I +L    E      PS
Sbjct: 270 L-----PRPDKCPAEVYHLM---KNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  115 bits (289), Expect = 2e-29
 Identities = 61/283 (21%), Positives = 113/283 (39%), Gaps = 73/283 (25%)

Query: 75  KLGEGGFGGVYRGLLSDQ----NTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVH 129
            LG G FG VY+GL   +       +A+K +   +  +  KE + E  +++ + + ++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 130 LIGWCHEQRQLI-------------------------LHKIALGLASAVLYLHEEWEQCI 164
           L+G C      +                         L    + +A  + YL    ++ +
Sbjct: 82  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRL 138

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM---GYLAPECVTTGKA 221
           VHRD+ + NV++ +  + K+ DFGLA+L+  E   +     G      ++A E +     
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE--EKEYHAEGGKVPIKWMALESILHRIY 196

Query: 222 SKESDVYSFGVVALEVA-CGRKP---VEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS 277
           + +SDV+S+GV   E+   G KP   +   +  S +           KG+       RL 
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------KGE-------RL- 238

Query: 278 KEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
                +   C      +M   + C   D  +RP  R++I   +
Sbjct: 239 ----PQPPICTIDVYMIM---VKCWMIDADSRPKFRELIIEFS 274

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  118 bits (297), Expect = 3e-29
 Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 43/214 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI-SEVRIISRLRHRNLVHLI-- 131
           +LG GGFG V R +  D   ++A+K+  +      +E    E++I+ +L H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 132 ----GWCHEQRQLIL----------------HKIALGL------------ASAVLYLHEE 159
                        +L                 +   GL            +SA+ YLHE 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139

Query: 160 WEQCIVHRDIKSSNVVLDSNFNA---KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV 216
               I+HRD+K  N+VL         K+ D G A+ +D   G   T   GT+ YLAPE +
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQYLAPELL 195

Query: 217 TTGKASKESDVYSFGVVALEVACGRKPVEPRQEP 250
              K +   D +SFG +A E   G +P  P  +P
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  116 bits (293), Expect = 3e-29
 Identities = 65/276 (23%), Positives = 113/276 (40%), Gaps = 50/276 (18%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLG+G FG V+ G  +   T +A+K +  G+    + ++ E +++ +LRH  LV L    
Sbjct: 191 KLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 135 HEQRQLI--------------------------LHKIALGLASAVLYLHEEWEQCIVHRD 168
            E+   I                          L  +A  +AS + Y+        VHRD
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 305

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           ++++N+++  N   K+ DFGLARL++    +        + + APE    G+ + +SDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365

Query: 229 SFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMEC 287
           SFG++  E+   GR P         +  VE       +G  +        +   +     
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRMPCPPE-CPESLHD----- 412

Query: 288 LMIVGLWCCHPDFTNRPSIRQVINVLN--FEAPLPS 321
           LM     C   +   RP+   +   L   F +  P 
Sbjct: 413 LM---CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  113 bits (286), Expect = 3e-29
 Identities = 70/299 (23%), Positives = 109/299 (36%), Gaps = 76/299 (25%)

Query: 62  ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQ---NTEIAVKRVSRG-SKQGKKEYISEVR 117
            +            +G+G FG VY G   DQ     + A+K +SR    Q  + ++ E  
Sbjct: 15  LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74

Query: 118 IISRLRHRNLVHLIGWCHEQRQLI---------------------------LHKIALGLA 150
           ++  L H N++ LIG       L                            L    L +A
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVA 134

Query: 151 SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGY 210
             + YL E   Q  VHRD+ + N +LD +F  K+ DFGLAR +        +V       
Sbjct: 135 RGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR--EYYSVQQHRHAR 189

Query: 211 L-----APECVTTGKASKESDVYSFGVVALEVA-CGRKP---VEPRQEPSKVRLVEWVWD 261
           L     A E + T + + +SDV+SFGV+  E+   G  P   ++P            +  
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----------LTH 239

Query: 262 LYGKGQLLEAADGRLSKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
              +G        RL      +   C      +M     C   D   RP+ R ++  + 
Sbjct: 240 FLAQG-------RRL-----PQPEYCPDSLYQVM---QQCWEADPAVRPTFRVLVGEVE 283

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  114 bits (287), Expect = 3e-29
 Identities = 64/288 (22%), Positives = 116/288 (40%), Gaps = 65/288 (22%)

Query: 75  KLGEGGFG----GVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHL 130
           +LG+G FG      Y  L  +    +AVK++   +++  +++  E+ I+  L+H N+V  
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107

Query: 131 IGWC--------------------------HEQR----QLILHKIALGLASAVLYLHEEW 160
            G C                          H++R    +L+       +   + YL    
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ--YTSQICKGMEYLG--- 162

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-----APEC 215
            +  +HRD+ + N+++++    K+GDFGL +++  +   +        G       APE 
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEYYKVKEPGESPIFWYAPES 219

Query: 216 VTTGKASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA-AD 273
           +T  K S  SDV+SFGVV  E+     K   P  E  ++   +    +     L+E   +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF-HLIELLKN 278

Query: 274 G-RLSKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
             RL      R   C      +M     C + +   RPS R +   ++
Sbjct: 279 NGRL-----PRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVD 318

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  113 bits (286), Expect = 4e-29
 Identities = 65/314 (20%), Positives = 103/314 (32%), Gaps = 72/314 (22%)

Query: 53  TGPKRFTY---RELSRATNNFAEAGKLGEGGFGGVYRGLLS----DQNTEIAVKRVSRG- 104
           +  K  T        +          LGEG FG V          +   ++AVK +    
Sbjct: 5   SEKKPATEVDPTHFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES 62

Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ--------------------------- 137
                 +   E+ I+  L H N+V   G C E                            
Sbjct: 63  GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK 122

Query: 138 ---RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD 194
              +Q +    A+ +   + YL     +  VHRD+ + NV+++S    K+GDFGL + ++
Sbjct: 123 INLKQQLK--YAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177

Query: 195 HELGSQTTVLAGTMGYL-----APECVTTGKASKESDVYSFGVVALEVA-CGRKPVEPRQ 248
            +   +                APEC+   K    SDV+SFGV   E+         P  
Sbjct: 178 TD---KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA 234

Query: 249 EPSKVRLVEWVWDLYGKGQLLEA-ADG-RLSKEFDERQMEC------LMIVGLWCCHPDF 300
              K  +      +    +L+    +G RL          C      LM     C     
Sbjct: 235 LFLK-MIGPTHGQMTVT-RLVNTLKEGKRL-----PCPPNCPDEVYQLM---RKCWEFQP 284

Query: 301 TNRPSIRQVINVLN 314
           +NR S + +I    
Sbjct: 285 SNRTSFQNLIEGFE 298

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  113 bits (285), Expect = 4e-29
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 33/198 (16%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS----EVRIISRLRHRNLVHL 130
           KLG GG   VY    +  N ++A+K       + K+E +     EV   S+L H+N+V +
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 131 IGWCHEQ---------------RQLILHK----------IALGLASAVLYLHEEWEQCIV 165
           I    E                 + I                 +   + + H+     IV
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD---MRIV 133

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES 225
           HRDIK  N+++DSN   K+ DFG+A+ +     +QT  + GT+ Y +PE        + +
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT 193

Query: 226 DVYSFGVVALEVACGRKP 243
           D+YS G+V  E+  G  P
Sbjct: 194 DIYSIGIVLYEMLVGEPP 211

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  113 bits (285), Expect = 4e-29
 Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 65/288 (22%)

Query: 75  KLGEGGFGGVYRGLL----SDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHL 130
           +LG+G FG V          +    +AVK++   +++  +++  E+ I+  L+H N+V  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76

Query: 131 IGWC--------------------------HEQR----QLILHKIALGLASAVLYLHEEW 160
            G C                          H++R    +L+       +   + YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ--YTSQICKGMEYLG--- 131

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-----APEC 215
            +  +HRD+ + N+++++    K+GDFGL +++  +   +        G       APE 
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEFFKVKEPGESPIFWYAPES 188

Query: 216 VTTGKASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA-AD 273
           +T  K S  SDV+SFGVV  E+     K   P  E  ++   +    +     L+E   +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF-HLIELLKN 247

Query: 274 G-RLSKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
             RL      R   C      +M     C + +   RPS R +   ++
Sbjct: 248 NGRL-----PRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRVD 287

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  117 bits (295), Expect = 4e-29
 Identities = 67/280 (23%), Positives = 118/280 (42%), Gaps = 68/280 (24%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEI--AVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLI 131
           +LG G FG V +G+   +  +I  A+K + +G  K   +E + E +I+ +L +  +V LI
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 132 GWCHEQRQLI-------------------------LHKIALGLASAVLYLHEEWEQCIVH 166
           G C  +  ++                         + ++   ++  + YL E   +  VH
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 459

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-----APECVTTGKA 221
           R++ + NV+L +   AK+ DFGL++ +  +    +   A + G       APEC+   K 
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPECINFRKF 516

Query: 222 SKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF 280
           S  SDV+S+GV   E    G+KP +  + P  +  +E       +G+       R+    
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGK-------RM---- 558

Query: 281 DERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
            E   EC      LM     C    + +RP    V   + 
Sbjct: 559 -ECPPECPPELYALM---SDCWIYKWEDRPDFLTVEQRMR 594

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  118 bits (296), Expect = 5e-29
 Identities = 69/281 (24%), Positives = 109/281 (38%), Gaps = 71/281 (25%)

Query: 75  KLGEGGFGGVYRGLL---SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHL 130
            +GEG FG V++G+     +    +A+K      S   +++++ E   + +  H ++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 131 IGWCHEQRQLI-------------------------LHKIALGLASAVLYLHEEWEQCIV 165
           IG   E    I                         L   A  L++A+ YL     +  V
Sbjct: 457 IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFV 513

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-----APECVTTGK 220
           HRDI + NV++ SN   KLGDFGL+R ++       T    + G L     APE +   +
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWMAPESINFRR 568

Query: 221 ASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE 279
            +  SDV+ FGV   E+   G KP +  +    +  +E        G        RL   
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NG-------ERL--- 611

Query: 280 FDERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
                  C      LM     C   D + RP   ++   L+
Sbjct: 612 --PMPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLS 647

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  115 bits (289), Expect = 5e-29
 Identities = 69/286 (24%), Positives = 108/286 (37%), Gaps = 76/286 (26%)

Query: 75  KLGEGGFGGVYRGLLSDQN---TEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHL 130
            +G G FG VY G L D +      AVK ++R        ++++E  I+    H N++ L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 131 IGWCHEQRQLI---------------------------LHKIALGLASAVLYLHEEWEQC 163
           +G C                                  L    L +A  + +L     + 
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KK 212

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-----APECVTT 218
            VHRD+ + N +LD  F  K+ DFGLAR +  +     +V   T   L     A E + T
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK--EFDSVHNKTGAKLPVKWMALESLQT 270

Query: 219 GKASKESDVYSFGVVALEVAC-GRKP---VEPRQEPSKVRLVEWVWDLYGKGQLLEAADG 274
            K + +SDV+SFGV+  E+   G  P   V              +     +G        
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----------ITVYLLQG-------R 313

Query: 275 RLSKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
           RL      +   C      +M   L C HP    RPS  ++++ ++
Sbjct: 314 RL-----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 351

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  116 bits (292), Expect = 6e-29
 Identities = 64/267 (23%), Positives = 116/267 (43%), Gaps = 48/267 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLG G +G VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 135 HEQRQL---------------------------ILHKIALGLASAVLYLHEEWEQCIVHR 167
             +                              +L  +A  ++SA+ YL +   +  +HR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHR 342

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDV 227
           ++ + N ++  N   K+ DFGL+RL+  +  +        + + APE +   K S +SDV
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402

Query: 228 YSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME 286
           ++FGV+  E+A  G  P           L+E       K   +E  +G   ++  E    
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDYRMERPEG-CPEKVYE---- 450

Query: 287 CLMIVGLWCCHPDFTNRPSIRQVINVL 313
            LM     C   + ++RPS  ++    
Sbjct: 451 -LM---RACWQWNPSDRPSFAEIHQAF 473

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  114 bits (288), Expect = 7e-29
 Identities = 66/284 (23%), Positives = 118/284 (41%), Gaps = 74/284 (26%)

Query: 75  KLGEGGFGGVYRGLL---SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHL 130
            +G G FG V  G L   S +   +A+K +  G +++ +++++ E  I+ +  H N++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 131 IGWCHEQR----------------------------QLILHKIALGLASAVLYLHEEWEQ 162
            G   + +                            QL+   +  G+AS + YL +    
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV--GMLRGIASGMKYLSD---M 166

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-----APECVT 217
             VHRD+ + N++++SN   K+ DFGL R+++ +            G +     +PE + 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD---PEAAYTTRGGKIPIRWTSPEAIA 223

Query: 218 TGKASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL 276
             K +  SDV+S+G+V  EV   G +P         ++ V+                 RL
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------------EGYRL 269

Query: 277 SKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   M+C      LM   L C   D  NRP   Q++++L+
Sbjct: 270 -----PPPMDCPAALYQLM---LDCWQKDRNNRPKFEQIVSILD 305

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  112 bits (283), Expect = 8e-29
 Identities = 70/286 (24%), Positives = 108/286 (37%), Gaps = 76/286 (26%)

Query: 75  KLGEGGFGGVYRGLLSDQN---TEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHL 130
            +G G FG VY G L D +      AVK ++R        ++++E  I+    H N++ L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 131 IGWCHEQRQLI---------------------------LHKIALGLASAVLYLHEEWEQC 163
           +G C                                  L    L +A  + YL     + 
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KK 148

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-----APECVTT 218
            VHRD+ + N +LD  F  K+ DFGLAR +  +     +V   T   L     A E + T
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK--EYYSVHNKTGAKLPVKWMALESLQT 206

Query: 219 GKASKESDVYSFGVVALEVAC-GRKP---VEPRQEPSKVRLVEWVWDLYGKGQLLEAADG 274
            K + +SDV+SFGV+  E+   G  P   V              +     +G        
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----------ITVYLLQG-------R 249

Query: 275 RLSKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
           RL      +   C      +M   L C HP    RPS  ++++ ++
Sbjct: 250 RL-----LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 287

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  116 bits (291), Expect = 1e-28
 Identities = 65/276 (23%), Positives = 113/276 (40%), Gaps = 50/276 (18%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLG+G FG V+ G  +   T +A+K +  G+    + ++ E +++ +LRH  LV L    
Sbjct: 274 KLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 135 HEQRQLI--------------------------LHKIALGLASAVLYLHEEWEQCIVHRD 168
            E+   I                          L  +A  +AS + Y+        VHRD
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 388

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVY 228
           ++++N+++  N   K+ DFGLARL++    +        + + APE    G+ + +SDV+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448

Query: 229 SFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMEC 287
           SFG++  E+   GR P         +  VE       +G  +        +   +     
Sbjct: 449 SFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRMPCPPE-CPESLHD----- 495

Query: 288 LMIVGLWCCHPDFTNRPSIRQVINVLN--FEAPLPS 321
           LM     C   +   RP+   +   L   F +  P 
Sbjct: 496 LM---CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  111 bits (281), Expect = 1e-28
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 36/203 (17%)

Query: 72  EAGK-LGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYI-SEVRIISRLRHRNL 127
           + G  LG+G F GVYR        E+A+K + + +  K G  + + +EV+I  +L+H ++
Sbjct: 14  KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI 73

Query: 128 VHLIGWCHEQRQLIL--------------------------HKIALGLASAVLYLHEEWE 161
           + L  +  +   + L                                + + +LYLH    
Sbjct: 74  LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS--- 130

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA 221
             I+HRD+  SN++L  N N K+ DFGLA  +        T L GT  Y++PE + T  A
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE-IATRSA 188

Query: 222 -SKESDVYSFGVVALEVACGRKP 243
              ESDV+S G +   +  GR P
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPP 211

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  111 bits (280), Expect = 1e-28
 Identities = 65/291 (22%), Positives = 105/291 (36%), Gaps = 68/291 (23%)

Query: 60  YRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRII 119
           + EL R      +  +LG G FG V  G    Q  ++AVK +  GS   + E+  E + +
Sbjct: 2   HMELKREEITLLK--ELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMS-EDEFFQEAQTM 57

Query: 120 SRLRHRNLVHLIGWC--------------------------HEQRQLILHKIALGLASAV 153
            +L H  LV   G C                                 L ++   +   +
Sbjct: 58  MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM---GY 210
            +L        +HRD+ + N ++D +   K+ DFG+ R V  +   Q     GT     +
Sbjct: 118 AFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGTKFPVKW 171

Query: 211 LAPECVTTGKASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL 269
            APE     K S +SDV++FG++  EV   G+ P +       V  V             
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS------------ 219

Query: 270 EAADGRLSKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
                RL      R          +M     C H     RP+ +Q+++ + 
Sbjct: 220 --QGHRL-----YRPHLASDTIYQIM---YSCWHELPEKRPTFQQLLSSIE 260

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  112 bits (282), Expect = 1e-28
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 43/203 (21%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCH 135
           LG+G +G VY G        IA+K +     +  +    E+ +   L+H+N+V  +G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 136 EQRQL--------------------------------ILHKIALGLASAVLYLHEEWEQC 163
           E   +                                   +I  GL     YLH+     
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLK----YLHD---NQ 142

Query: 164 IVHRDIKSSNVVLDS-NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-- 220
           IVHRDIK  NV++++ +   K+ DFG ++ +   +   T    GT+ Y+APE +  G   
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGPRG 201

Query: 221 ASKESDVYSFGVVALEVACGRKP 243
             K +D++S G   +E+A G+ P
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPP 224

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  112 bits (283), Expect = 2e-28
 Identities = 67/292 (22%), Positives = 122/292 (41%), Gaps = 79/292 (27%)

Query: 75  KLGEGGFGGVYRGLL----SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVH 129
            +G G FG VY+G+L      +   +A+K +  G +++ + +++ E  I+ +  H N++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 130 LIGWCHEQR----------------------------QLILHKIALGLASAVLYLHEEWE 161
           L G   + +                            QL+   +  G+A+ + YL     
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLV--GMLRGIAAGMKYLAN--- 165

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG------TMGYLAPEC 215
              VHRD+ + N++++SN   K+ DFGL+R+++ +  +  T   G      T    APE 
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEA 221

Query: 216 VTTGKASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG 274
           ++  K +  SDV+SFG+V  EV   G +P         ++ +         G        
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-------DG-------F 267

Query: 275 RLSKEFDERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN--FEAP 318
           RL        M+C      LM   + C   +   RP    ++++L+    AP
Sbjct: 268 RL-----PTPMDCPSAIYQLM---MQCWQQERARRPKFADIVSILDKLIRAP 311

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  111 bits (280), Expect = 2e-28
 Identities = 61/276 (22%), Positives = 104/276 (37%), Gaps = 66/276 (23%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           +LG G FG V  G    Q  ++A+K +  GS   + E+I E +++  L H  LV L G C
Sbjct: 31  ELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 135 --------------------------HEQRQLILHKIALGLASAVLYLHEEWEQCIVHRD 168
                                     H  +   L ++   +  A+ YL     +  +HRD
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 145

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM---GYLAPECVTTGKASKES 225
           + + N +++     K+ DFGL+R V      + T   G+     +  PE +   K S +S
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202

Query: 226 DVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ 284
           D+++FGV+  E+   G+ P E          +                  RL      R 
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA--------------QGLRL-----YRP 243

Query: 285 MEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
                    +M     C H     RP+ + +++ + 
Sbjct: 244 HLASEKVYTIM---YSCWHEKADERPTFKILLSNIL 276

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  110 bits (277), Expect = 5e-28
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 35/201 (17%)

Query: 72  EAGK-LGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYI-SEVRIISRLRHRNL 127
           E G+ LG+G FG VY          +A+K + +    K G +  +  EV I S LRH N+
Sbjct: 12  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71

Query: 128 VHLIGWCHEQRQLIL-------------------------HKIALGLASAVLYLHEEWEQ 162
           + L G+ H+  ++ L                               LA+A+ Y H    +
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---K 128

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            ++HRDIK  N++L S    K+ DFG +         +T  L GT+ YL PE +      
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTD-LCGTLDYLPPEMIEGRMHD 185

Query: 223 KESDVYSFGVVALEVACGRKP 243
           ++ D++S GV+  E   G+ P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  109 bits (276), Expect = 7e-28
 Identities = 65/279 (23%), Positives = 119/279 (42%), Gaps = 72/279 (25%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           +LG G FG V+ G  +  +T++AVK + +GS      +++E  ++ +L+H+ LV L    
Sbjct: 20  RLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 135 HEQRQLI--------------------------LHKIALGLASAVLYLHEEWEQCIVHRD 168
            ++   I                          L  +A  +A  + ++ E   +  +HRD
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT------MGYLAPECVTTGKAS 222
           ++++N+++    + K+ DFGLARL++    ++ T   G           APE +  G  +
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWT---APEAINYGTFT 188

Query: 223 KESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD 281
            +SDV+SFG++  E+   GR P      P  ++ +E       +G        R+     
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RG-------YRM----- 229

Query: 282 ERQMEC------LMIVGLWCCHPDFTNRPSIRQVINVLN 314
            R   C      LM     C      +RP+   + +VL 
Sbjct: 230 VRPDNCPEELYQLM---RLCWKERPEDRPTFDYLRSVLE 265

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  110 bits (276), Expect = 7e-28
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 42/202 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLG G +G VY G+    +  +AVK +   + +  +E++ E  ++  ++H NLV L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 135 ------------------------HEQRQL---ILHKIALGLASAVLYLHEEWEQCIVHR 167
                                     ++++   +L  +A  ++SA+ YL +   +  +HR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHR 135

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-----APECVTTGKAS 222
           D+ + N ++  N   K+ DFGL+RL+  +     T  A           APE +   K S
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPIKWTAPESLAYNKFS 190

Query: 223 KESDVYSFGVVALEVA-CGRKP 243
            +SDV++FGV+  E+A  G  P
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP 212

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  110 bits (276), Expect = 8e-28
 Identities = 60/304 (19%), Positives = 100/304 (32%), Gaps = 87/304 (28%)

Query: 64  SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISR 121
           SR T  F E  K+G G FG V++ +        A+KR  +       ++  + EV   + 
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 122 L-RHRNLVHLIG-WCHEQR--------------------------------QLILHKIAL 147
           L +H ++V     W  +                                  + +L ++  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 148 GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN-------------------FNAKLGDFG 188
           GL     Y+H      +VH DIK SN+ +                         K+GD G
Sbjct: 127 GLR----YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPR 247
               +     S   V  G   +LA E +        ++D+++  +  +  A       PR
Sbjct: 180 HVTRI-----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL--PR 232

Query: 248 QEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIR 307
                       W    +G+ L      LS+EF E      ++      HPD   RPS  
Sbjct: 233 NGDQ--------WHEIRQGR-LPRIPQVLSQEFTE------LL--KVMIHPDPERRPSAM 275

Query: 308 QVIN 311
            ++ 
Sbjct: 276 ALVK 279

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  109 bits (275), Expect = 9e-28
 Identities = 58/302 (19%), Positives = 110/302 (36%), Gaps = 79/302 (26%)

Query: 60  YRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQN-------TEIAVKRVSRGSKQGKKEY 112
           + ++      F E   LG+G F  +++G+  +         TE+ +K + +  +   + +
Sbjct: 2   FHKIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF 59

Query: 113 ISEVRIISRLRHRNLVHLIGWCHEQR--------------------------QLILHKIA 146
                ++S+L H++LV   G C                               L   ++A
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119

Query: 147 LGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN--------AKLGDFGLARLVDHELG 198
             LA+A+ +L    E  ++H ++ + N++L    +         KL D G++  V  +  
Sbjct: 120 KQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176

Query: 199 SQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVA-CGRKPVEPRQEPSKVRLV 256
            Q  +      ++ PEC+   K  +  +D +SFG    E+   G KP+       K++  
Sbjct: 177 LQERI-----PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231

Query: 257 EWVWDLYGKGQLLEAADGRLSKEFDERQMEC----LMIVGLWCCHPDFTNRPSIRQVINV 312
           E           L A                    L+     C   +  +RPS R +I  
Sbjct: 232 E-------DRHQLPAPKA------------AELANLI---NNCMDYEPDHRPSFRAIIRD 269

Query: 313 LN 314
           LN
Sbjct: 270 LN 271

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  112 bits (281), Expect = 2e-27
 Identities = 49/199 (24%), Positives = 95/199 (47%), Gaps = 38/199 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLG G FG V+    +   T++AVK +  GS    + +++E  ++  L+H  LV L    
Sbjct: 195 KLGAGQFGEVWMATYNKH-TKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 135 HEQRQLI--------------------------LHKIALGLASAVLYLHEEWEQCIVHRD 168
            ++   I                          L   +  +A  + ++ +   +  +HRD
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 309

Query: 169 IKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG---YLAPECVTTGKASKES 225
           ++++N+++ ++   K+ DFGLAR+++    ++ T   G      + APE +  G  + +S
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366

Query: 226 DVYSFGVVALEVA-CGRKP 243
           DV+SFG++ +E+   GR P
Sbjct: 367 DVWSFGILLMEIVTYGRIP 385

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  109 bits (273), Expect = 3e-27
 Identities = 53/221 (23%), Positives = 76/221 (34%), Gaps = 48/221 (21%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI-SEVRIISRLRHRNLVHLIG- 132
            LG+G    V+RG         A+K  +  S     +    E  ++ +L H+N+V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 133 -WCHEQRQLIL----------------HKIALGL------------ASAVLYLHEEWEQC 163
                 R  +L                   A GL               + +L E     
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132

Query: 164 IVHRDIKSSNVVL----DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
           IVHR+IK  N++     D     KL DFG AR ++     Q   L GT  YL P+     
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLYGTEEYLHPDMYERA 190

Query: 220 KA--------SKESDVYSFGVVALEVACGRKPVEPRQEPSK 252
                         D++S GV     A G  P  P + P +
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  107 bits (270), Expect = 5e-27
 Identities = 49/201 (24%), Positives = 87/201 (43%), Gaps = 35/201 (17%)

Query: 72  EAGK-LGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYI-SEVRIISRLRHRNL 127
           + G+ LG+G FG VY          +A+K + +    K+G +  +  E+ I S LRH N+
Sbjct: 17  DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 76

Query: 128 VHLIGWCHEQRQLIL-------------------------HKIALGLASAVLYLHEEWEQ 162
           + +  + H+++++ L                               LA A+ Y HE   +
Sbjct: 77  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE---R 133

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            ++HRDIK  N+++      K+ DFG +         +   + GT+ YL PE +      
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRTMCGTLDYLPPEMIEGKTHD 190

Query: 223 KESDVYSFGVVALEVACGRKP 243
           ++ D++  GV+  E   G  P
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPP 211

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  108 bits (272), Expect = 5e-27
 Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 60/234 (25%)

Query: 61  RELSRATNNFAEAGKLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRGSKQGKKEYISE 115
             + R         +LGEG FG V+               +AVK +   S+  ++++  E
Sbjct: 36  HHIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQRE 93

Query: 116 VRIISRLRHRNLVHLIGWCHEQRQLI---------------------------------- 141
             +++ L+H+++V   G C E R L+                                  
Sbjct: 94  AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153

Query: 142 ------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH 195
                 L  +A  +A+ ++YL        VHRD+ + N ++      K+GDFG++R +  
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY- 209

Query: 196 ELGSQTTVLAGTMGYL-----APECVTTGKASKESDVYSFGVVALEVA-CGRKP 243
              S      G    L      PE +   K + ESDV+SFGVV  E+   G++P
Sbjct: 210 ---STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  108 bits (271), Expect = 6e-27
 Identities = 60/310 (19%), Positives = 105/310 (33%), Gaps = 79/310 (25%)

Query: 75  KLGEGGFGGVYRGLLSDQN---TEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVH 129
            LG+G FG V    L  ++    ++AVK +     +    +E++ E   +    H ++  
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 130 LIGWC---------------------------------HEQRQLI----LHKIALGLASA 152
           L+G                                    E    +    L +  + +A  
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 153 VLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL- 211
           + YL     +  +HRD+ + N +L  +    + DFGL+R +     S      G    L 
Sbjct: 150 MEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY----SGDYYRQGCASKLP 202

Query: 212 ----APECVTTGKASKESDVYSFGVVALEVA-CGRKP---VEPRQEPSKVRLVEWVWDLY 263
               A E +     +  SDV++FGV   E+   G+ P   +E  +          +++  
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----------IYNYL 252

Query: 264 GKGQLLEAADGRLSK-EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSL 322
             G        RL +      ++  LM     C   D   RPS   +   L       S+
Sbjct: 253 IGG-------NRLKQPPECMEEVYDLM---YQCWSADPKQRPSFTCLRMELENILGHLSV 302

Query: 323 PSKLPVPMYY 332
            S    P+Y 
Sbjct: 303 LSTSQDPLYI 312

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  108 bits (271), Expect = 7e-27
 Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 54/216 (25%)

Query: 75  KLGEGGFGGVYRGLLSDQN---TEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVH 129
            LGEG FG V  G L  ++    ++AVK +     S++  +E++SE   +    H N++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 130 LIGWCHEQRQLI------------------------------------LHKIALGLASAV 153
           L+G C E                                         L K  + +A  +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-- 211
            YL     +  +HRD+ + N +L  +    + DFGL++ +     S      G +  +  
Sbjct: 161 EYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY----SGDYYRQGRIAKMPV 213

Query: 212 ---APECVTTGKASKESDVYSFGVVALEVA-CGRKP 243
              A E +     + +SDV++FGV   E+A  G  P
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  107 bits (270), Expect = 1e-26
 Identities = 47/203 (23%), Positives = 78/203 (38%), Gaps = 46/203 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           ++G G FG V+R        + AVK+V     +     + E+   + L    +V L G  
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAV 119

Query: 135 HEQRQL-----------------------------ILHKIALGLASAVLYLHEEWEQCIV 165
            E   +                              L +   GL     YLH    + I+
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE----YLHT---RRIL 172

Query: 166 HRDIKSSNVVLDSN-FNAKLGDFGLARLVDHELGSQTTV----LAGTMGYLAPECVTTGK 220
           H D+K+ NV+L S+   A L DFG A  +  +   ++ +    + GT  ++APE V    
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232

Query: 221 ASKESDVYSFGVVALEVACGRKP 243
              + D++S   + L +  G  P
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHP 255

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  108 bits (271), Expect = 2e-26
 Identities = 53/223 (23%), Positives = 77/223 (34%), Gaps = 48/223 (21%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI-SEVRIISRLRHRNLVHLIGW 133
            LG+G    V+RG         A+K  +  S     +    E  ++ +L H+N+V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 134 --CHEQRQLIL----------------HKIALGL------------ASAVLYLHEEWEQC 163
                 R  +L                   A GL               + +L E     
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132

Query: 164 IVHRDIKSSNVVL----DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
           IVHR+IK  N++     D     KL DFG AR ++     Q   L GT  YL P+     
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLYGTEEYLHPDMYERA 190

Query: 220 KA--------SKESDVYSFGVVALEVACGRKPVEPRQEPSKVR 254
                         D++S GV     A G  P  P + P + +
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  106 bits (266), Expect = 3e-26
 Identities = 51/206 (24%), Positives = 79/206 (38%), Gaps = 43/206 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQ--NTEIAVKRVSRGSKQGKKEYIS----EVRIISRLRHRNLV 128
            LG GG   V+     D   + ++AVK V R        +      E +  + L H  +V
Sbjct: 19  ILGFGGMSEVHLAR--DLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 129 HL--IGWCHEQ-----------------RQLILHK----------IALGLASAVLYLHEE 159
            +   G                      R ++  +          +      A+ + H+ 
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ- 134

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS--QTTVLAGTMGYLAPECVT 217
               I+HRD+K +N+++ +    K+ DFG+AR +     S  QT  + GT  YL+PE   
Sbjct: 135 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 218 TGKASKESDVYSFGVVALEVACGRKP 243
                  SDVYS G V  EV  G  P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP 218

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  106 bits (266), Expect = 4e-26
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 54/216 (25%)

Query: 75  KLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLV 128
           +LG+G FG VY G+          T +A+K V+   S + + E+++E  ++      ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 129 HLIGWC-HEQRQLI----------------------------------LHKIALGLASAV 153
            L+G     Q  L+                                  + ++A  +A  +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-- 211
            YL+       VHRD+ + N ++  +F  K+GDFG+ R +            G  G L  
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYRKGGKGLLPV 204

Query: 212 ---APECVTTGKASKESDVYSFGVVALEVA-CGRKP 243
              +PE +  G  +  SDV+SFGVV  E+A    +P
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  105 bits (265), Expect = 5e-26
 Identities = 70/309 (22%), Positives = 113/309 (36%), Gaps = 73/309 (23%)

Query: 75  KLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLV 128
            LG G FG VY G +S         ++AVK +    S+Q + +++ E  IIS+  H+N+V
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 129 HLIGWC----------------------------HEQRQLI----LHKIALGLASAVLYL 156
             IG                                Q   +    L  +A  +A    YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 157 HEEWEQCIVHRDIKSSNVVLD---SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-- 211
            E      +HRDI + N +L        AK+GDFG+AR +     S      G    L  
Sbjct: 157 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRASYYRK--GGCAMLPV 209

Query: 212 ---APECVTTGKASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKV-RLVEWVWDLYGKG 266
               PE    G  + ++D +SFGV+  E+   G  P  P +   +V   V         G
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVLEFVT-------SG 261

Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKL 326
             ++         +       +M     C      +RP+   ++  + +    P + +  
Sbjct: 262 GRMDPPKNCPGPVYR------IM---TQCWQHQPEDRPNFAIILERIEYCTQDPDVIN-T 311

Query: 327 PVPMYYAPP 335
            +P+ Y P 
Sbjct: 312 ALPIEYGPL 320

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  105 bits (263), Expect = 7e-26
 Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 59/221 (26%)

Query: 75  KLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVH 129
           +LGEG FG V+     +         +AVK +   +   +K++  E  +++ L+H ++V 
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81

Query: 130 LIGWCHEQRQLI-----------------------------------------LHKIALG 148
             G C +   LI                                         +  IA  
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +AS ++YL     Q  VHRD+ + N ++ +N   K+GDFG++R V     S      G  
Sbjct: 142 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY----STDYYRVGGH 194

Query: 209 GYL-----APECVTTGKASKESDVYSFGVVALEVA-CGRKP 243
             L      PE +   K + ESDV+SFGV+  E+   G++P
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  104 bits (261), Expect = 8e-26
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 50/203 (24%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
            +G+G FG V  G    +  ++AVK +   +    + +++E  ++++LRH NLV L+G  
Sbjct: 28  TIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 135 HEQRQLI----------------------------LHKIALGLASAVLYLHEEWEQCIVH 166
            E++  +                            L K +L +  A+ YL        VH
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 140

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-----APECVTTGKA 221
           RD+ + NV++  +  AK+ DFGL +                 G L     APE +   K 
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASS---------TQDTGKLPVKWTAPEALREKKF 191

Query: 222 SKESDVYSFGVVALEVA-CGRKP 243
           S +SDV+SFG++  E+   GR P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP 214

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  105 bits (263), Expect = 8e-26
 Identities = 46/199 (23%), Positives = 78/199 (39%), Gaps = 33/199 (16%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS----EVRIISRLRHRNLV- 128
             +G GG G VY    + +   +A+K +   +      + +    E R   RL+  ++V 
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 129 -HLIGWCHEQ-------------RQLILHK----------IALGLASAVLYLHEEWEQCI 164
            H  G    Q               ++  +          I   + SA+   H       
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA---AGA 155

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
            HRD+K  N+++ ++  A L DFG+A     E  +Q     GT+ Y+APE  +   A+  
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215

Query: 225 SDVYSFGVVALEVACGRKP 243
           +D+Y+   V  E   G  P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  107 bits (268), Expect = 9e-26
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 40/198 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
            +G+G FG V  G    +  ++AVK +   +    + +++E  ++++LRH NLV L+G  
Sbjct: 200 TIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 135 HEQRQLI----------------------------LHKIALGLASAVLYLHEEWEQCIVH 166
            E++  +                            L K +L +  A+ YL        VH
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 312

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
           RD+ + NV++  +  AK+ DFGL +  +      T  L   + + APE +   K S +SD
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSD 368

Query: 227 VYSFGVVALEVA-CGRKP 243
           V+SFG++  E+   GR P
Sbjct: 369 VWSFGILLWEIYSFGRVP 386

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  105 bits (263), Expect = 2e-25
 Identities = 70/309 (22%), Positives = 111/309 (35%), Gaps = 73/309 (23%)

Query: 75  KLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLV 128
            LG G FG VY G +S         ++AVK +    S+Q + +++ E  IIS+  H+N+V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 129 HLIGWC----------------------------HEQRQLI----LHKIALGLASAVLYL 156
             IG                                Q   +    L  +A  +A    YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 157 HEEWEQCIVHRDIKSSNVVLD---SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL-- 211
            E      +HRDI + N +L        AK+GDFG+AR  D           G    L  
Sbjct: 198 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRK--GGCAMLPV 250

Query: 212 ---APECVTTGKASKESDVYSFGVVALEVA-CGRKPVEPRQEPSKV-RLVEWVWDLYGKG 266
               PE    G  + ++D +SFGV+  E+   G  P  P +   +V   V         G
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVLEFVT-------SG 302

Query: 267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKL 326
             ++         +       +M     C      +RP+   ++  + +    P +    
Sbjct: 303 GRMDPPKNCPGPVYR------IM---TQCWQHQPEDRPNFAIILERIEYCTQDPDVI-NT 352

Query: 327 PVPMYYAPP 335
            +P+ Y P 
Sbjct: 353 ALPIEYGPL 361

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  104 bits (262), Expect = 2e-25
 Identities = 54/251 (21%), Positives = 100/251 (39%), Gaps = 33/251 (13%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRN 126
           ++F +  +LG G  G V++         +A K +    K     + I E++++       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 127 LVHLIG--------W-CHE-------------QRQL---ILHKIALGLASAVLYLHEEWE 161
           +V   G          C E               ++   IL K+++ +   + YL E+ +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPECVTTGK 220
             I+HRD+K SN++++S    KL DFG++ +L+D    S      GT  Y++PE +    
Sbjct: 153 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTH 206

Query: 221 ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF 280
            S +SD++S G+  +E+A GR P+ P        +     +                   
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266

Query: 281 DERQMECLMIV 291
                   M +
Sbjct: 267 FGMDSRPPMAI 277

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  103 bits (260), Expect = 2e-25
 Identities = 52/212 (24%), Positives = 82/212 (38%), Gaps = 38/212 (17%)

Query: 64  SRATNNFAEA----GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRII 119
           S  T N  +       LG G F  V+           A+K + +          +E+ ++
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60

Query: 120 SRLRHRNLVHLIGWCHEQRQL---------------ILHK----------IALGLASAVL 154
            +++H N+V L                         IL +          +   + SAV 
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVK 120

Query: 155 YLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYL 211
           YLHE     IVHRD+K  N++  +   N    + DFGL+++         +   GT GY+
Sbjct: 121 YLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTACGTPGYV 174

Query: 212 APECVTTGKASKESDVYSFGVVALEVACGRKP 243
           APE +     SK  D +S GV+   + CG  P
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  103 bits (259), Expect = 2e-25
 Identities = 47/202 (23%), Positives = 90/202 (44%), Gaps = 36/202 (17%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVH 129
           +    K+G+G  G VY  +      E+A+++++   +  K+  I+E+ ++   ++ N+V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 130 LIG--------W-----CH---------------EQRQLILHKIALGLASAVLYLHEEWE 161
            +         W                       Q   +  +    L     +LH    
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE----FLHS--- 134

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA 221
             ++HRDIKS N++L  + + KL DFG    +  E   ++T+  GT  ++APE VT    
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAY 193

Query: 222 SKESDVYSFGVVALEVACGRKP 243
             + D++S G++A+E+  G  P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  103 bits (259), Expect = 3e-25
 Identities = 49/202 (24%), Positives = 86/202 (42%), Gaps = 36/202 (17%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVH 129
                K+GEG  G V          ++AVK +    +Q ++   +EV I+   +H N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 130 LIG--------W-----CH---------------EQRQLILHKIALGLASAVLYLHEEWE 161
           +          W                      EQ   +   +   LA    YLH    
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALA----YLHA--- 159

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA 221
           Q ++HRDIKS +++L  +   KL DFG    +  ++  + ++  GT  ++APE ++    
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPYWMAPEVISRSLY 218

Query: 222 SKESDVYSFGVVALEVACGRKP 243
           + E D++S G++ +E+  G  P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPP 240

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  102 bits (257), Expect = 4e-25
 Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 62/237 (26%)

Query: 60  YRELSRATNNFAEAGKLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRG-SKQGKKEYI 113
            +E+S +   F E  +LGE  FG VY+G L      +Q   +A+K +        ++E+ 
Sbjct: 3   LKEISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60

Query: 114 SEVRIISRLRHRNLVHLIGWC-HEQRQLI------------------------------- 141
            E  + +RL+H N+V L+G    +Q   +                               
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120

Query: 142 ---------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL 192
                       +   +A+ + YL       +VH+D+ + NV++    N K+ D GL R 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFRE 177

Query: 193 VDHELGSQTTVLAGTMGYL-----APECVTTGKASKESDVYSFGVVALEVA-CGRKP 243
           V     +           L     APE +  GK S +SD++S+GVV  EV   G +P
Sbjct: 178 VY----AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  104 bits (261), Expect = 4e-25
 Identities = 38/367 (10%), Positives = 81/367 (22%), Gaps = 91/367 (24%)

Query: 38  KEAIDIALEDEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIA 97
           + A D  +         P R    EL            LG+            +      
Sbjct: 49  QSAADSLVSTSLWNTGQPFRVE-SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE 107

Query: 98  VKRVSRGSKQGKKE-------------------------YISEVRIISRLRHRNLVHLI- 131
           V       +                              ++  +     ++      +I 
Sbjct: 108 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 167

Query: 132 GWCHEQRQLILH-----------------------------------KIALGLASAVLYL 156
               E+   +L                                    ++ L +   +  L
Sbjct: 168 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV 216
           H      +VH  ++  ++VLD      L  F           S            A   +
Sbjct: 228 HH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERML 284

Query: 217 T-----TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA 271
                     +   D ++ G+    + C   P     + + +   EW++           
Sbjct: 285 PFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT---DDAALGGSEWIFR---------- 331

Query: 272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPMY 331
           +   + +          ++ G         +R    Q +    +E     L + LP+   
Sbjct: 332 SCKNIPQPVRA------LLEGF--LRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQT 383

Query: 332 YAPPINI 338
              P   
Sbjct: 384 DGEPTRE 390

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  102 bits (256), Expect = 7e-25
 Identities = 39/183 (21%), Positives = 73/183 (39%), Gaps = 38/183 (20%)

Query: 141 ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ 200
           I  +IA  +     +LH    + ++HRD+K SN+    +   K+GDFGL   +D +   Q
Sbjct: 169 IFIQIAEAVE----FLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221

Query: 201 TTVLA-----------GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
           T +             GT  Y++PE +     S + D++S G++  E+         + E
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQME 278

Query: 250 PSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER-QMECLMIVGLWCCHPDFTNRPSIRQ 308
             ++              + +  + +    F ++   E +M+       P  T RP    
Sbjct: 279 RVRI--------------ITDVRNLKFPLLFTQKYPQEHMMV--QDMLSPSPTERPEATD 322

Query: 309 VIN 311
           +I 
Sbjct: 323 IIE 325

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 21/135 (15%), Positives = 40/135 (29%), Gaps = 1/135 (0%)

Query: 64  SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI-SEVRIISRL 122
           SR   +F     +G GGFG V+       +   A+KR+   +++  +E +  EV+ +++L
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61

Query: 123 RHRNLVHLIGWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA 182
            H  +V       E       +    +                          +D     
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121

Query: 183 KLGDFGLARLVDHEL 197
                         L
Sbjct: 122 NTVGQLQPSSPKVYL 136

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  104 bits (262), Expect = 8e-25
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 38/222 (17%)

Query: 53  TGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY 112
             P  F   +    +  +    KLG G +G V        + E A+K + + +       
Sbjct: 22  ATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRK-TSVSTSSN 80

Query: 113 ---ISEVRIISRLRHRNLVHLIGWCHEQRQL---------------ILHK---------- 144
              + EV ++  L H N++ L  +  ++R                 I+H+          
Sbjct: 81  SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV 140

Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQT 201
           I   + S V YLH+     IVHRD+K  N++L+S   +   K+ DFGL+ + ++    + 
Sbjct: 141 IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKM 195

Query: 202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
               GT  Y+APE V   K  ++ DV+S GV+   +  G  P
Sbjct: 196 KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  104 bits (260), Expect = 1e-24
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 37/200 (18%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY---ISEVRIISRLRHRNLVHLI 131
            LG+G FG V          E AVK +S+   + K +    + EV+++ +L H N++ L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92

Query: 132 GWCHEQRQL---------------ILHK----------IALGLASAVLYLHEEWEQCIVH 166
            +  ++                  I+ +          I   + S + Y+H+     IVH
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVH 149

Query: 167 RDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           RD+K  N++L+S   + N ++ DFGL+   +     +     GT  Y+APE V  G   +
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYYIAPE-VLHGTYDE 206

Query: 224 ESDVYSFGVVALEVACGRKP 243
           + DV+S GV+   +  G  P
Sbjct: 207 KCDVWSTGVILYILLSGCPP 226

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  103 bits (258), Expect = 2e-24
 Identities = 42/205 (20%), Positives = 75/205 (36%), Gaps = 43/205 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGW 133
            LG G  G +    + D N ++AVKR+     +       EV+++     H N++     
Sbjct: 31  VLGHGAEGTIVYRGMFD-NRDVAVKRIL---PECFSFADREVQLLRESDEHPNVIRYFCT 86

Query: 134 CHEQR--------------QLILHK-----------IALGLASAVLYLHEEWEQCIVHRD 168
             +++              + +  K           +     S + +LH      IVHRD
Sbjct: 87  EKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRD 143

Query: 169 IKSSNVVL-----DSNFNAKLGDFGLARLVDHELGSQTTV--LAGTMGYLAPE---CVTT 218
           +K  N+++          A + DFGL + +     S +    + GT G++APE       
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK 203

Query: 219 GKASKESDVYSFGVVALEVACGRKP 243
              +   D++S G V   V      
Sbjct: 204 ENPTYTVDIFSAGCVFYYVISEGSH 228

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 99.6 bits (249), Expect = 4e-24
 Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 39/202 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI-SEVRIISRLRHRNLVHLIGW 133
           KLG G FG V+         E  +K +++   Q   E I +E+ ++  L H N++ +   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 134 CHEQRQL---------------ILHKIALG--------------LASAVLYLHEEWEQCI 164
             +   +               I+   A G              + +A+ Y H    Q +
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHV 145

Query: 165 VHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA 221
           VH+D+K  N++      +   K+ DFGLA L        +T  AGT  Y+APE V     
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAAGTALYMAPE-VFKRDV 202

Query: 222 SKESDVYSFGVVALEVACGRKP 243
           + + D++S GVV   +  G  P
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLP 224

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  102 bits (256), Expect = 5e-24
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 47/210 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSR-------------GSKQGKKEYISEVRIISR 121
           KLG G +G V      + ++E A+K + +               ++  +E  +E+ ++  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102

Query: 122 LRHRNLVHLIGWCHEQRQL---------------ILHK----------IALGLASAVLYL 156
           L H N++ L     +++                 I+++          I   + S + YL
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYL 162

Query: 157 HEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAP 213
           H+     IVHRDIK  N++L++     N K+ DFGL+         +     GT  Y+AP
Sbjct: 163 HK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKLRDRLGTAYYIAP 217

Query: 214 ECVTTGKASKESDVYSFGVVALEVACGRKP 243
           E V   K +++ DV+S GV+   + CG  P
Sbjct: 218 E-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 99.2 bits (248), Expect = 6e-24
 Identities = 47/197 (23%), Positives = 76/197 (38%), Gaps = 34/197 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
            +G G +G V   +        A K++ +   +    +  E+ I+  L H N++ L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 135 HEQRQL---------------ILHK----------IALGLASAVLYLHEEWEQCIVHRDI 169
            +   +               ++HK          I   + SAV Y H+     + HRD+
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDL 132

Query: 170 KSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
           K  N +  +   +   KL DFGLA       G       GT  Y++P+ V  G    E D
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGTPYYVSPQ-VLEGLYGPECD 189

Query: 227 VYSFGVVALEVACGRKP 243
            +S GV+   + CG  P
Sbjct: 190 EWSAGVMMYVLLCGYPP 206

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 99.2 bits (248), Expect = 6e-24
 Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 36/199 (18%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI--SEVRIISRLRHRNLVHLIG 132
            LG+G FG V +        E AVK +++ S + K       EV ++ +L H N++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 133 WCHEQRQL---------------ILHK----------IALGLASAVLYLHEEWEQCIVHR 167
              +                   I+ +          I   + S + Y+H+     IVHR
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHR 145

Query: 168 DIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
           D+K  N++L+S   + + K+ DFGL+        ++     GT  Y+APE V  G   ++
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAPE-VLRGTYDEK 202

Query: 225 SDVYSFGVVALEVACGRKP 243
            DV+S GV+   +  G  P
Sbjct: 203 CDVWSAGVILYILLSGTPP 221

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 99.3 bits (248), Expect = 6e-24
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 37/198 (18%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-EVRIISRLRHRNLVHLIG- 132
           K+G+G FG V++G+ +     +A+K +     + + E I  E+ ++S+     +    G 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88

Query: 133 -------W-----CH---------------EQRQLILHKIALGLASAVLYLHEEWEQCIV 165
                  W                       Q   IL +I  GL     YLH    +  +
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLD----YLHS---EKKI 141

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES 225
           HRDIK++NV+L  +   KL DFG+A  +      + T   GT  ++APE +       ++
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSAYDSKA 200

Query: 226 DVYSFGVVALEVACGRKP 243
           D++S G+ A+E+A G  P
Sbjct: 201 DIWSLGITAIELARGEPP 218

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  100 bits (252), Expect = 6e-24
 Identities = 47/235 (20%), Positives = 92/235 (39%), Gaps = 38/235 (16%)

Query: 32  KRVGGHKEAIDIALEDEFEKGTGPKRFTYRELSRATNNFAE----AGKLGEGGFGGVYRG 87
            +V G  +   I   D+F +    K +  + +     +  +      +LG G FG V+R 
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKK-YVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRC 70

Query: 88  LLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL----- 142
           +          K ++      K    +E+ I+++L H  L++L     ++ +++L     
Sbjct: 71  VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130

Query: 143 ------HKI-----------ALGLA----SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN 181
                  +I            +         + ++HE     IVH DIK  N++ ++   
Sbjct: 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKA 187

Query: 182 A--KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVA 234
           +  K+ DFGLA  ++        V   T  + APE V        +D+++ GV+ 
Sbjct: 188 SSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 99.3 bits (248), Expect = 7e-24
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 45/210 (21%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVH 129
           +   G+LG+G FG VY+    +     A K +   S++  ++YI E+ I++   H  +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 130 LIG--------W-----CH-----------------EQRQLILHKIALGLASAVLYLHEE 159
           L+G        W     C                   Q Q++  ++   L     +LH  
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN----FLHS- 135

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
             + I+HRD+K+ NV++    + +L DFG++      L  + + + GT  ++APE V   
Sbjct: 136 --KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPE-VVMC 191

Query: 220 KASKES------DVYSFGVVALEVACGRKP 243
           +  K++      D++S G+  +E+A    P
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  101 bits (253), Expect = 1e-23
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 38/200 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY---ISEVRIISRLRHRNLVHLI 131
            LG+G FG V +        E AVK +++ +    K+    + EV ++ +L H N++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINK-ASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 132 GWCHEQRQL---------------ILHK----------IALGLASAVLYLHEEWEQCIVH 166
               +                   I+ +          I   + S + Y+H+     IVH
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVH 144

Query: 167 RDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           RD+K  N++L+S   + + K+ DFGL+        ++     GT  Y+APE V  G   +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAPE-VLRGTYDE 201

Query: 224 ESDVYSFGVVALEVACGRKP 243
           + DV+S GV+   +  G  P
Sbjct: 202 KCDVWSAGVILYILLSGTPP 221

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 35/197 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           +LG G    VYR          A+K + +     KK   +E+ ++ RL H N++ L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 135 HEQRQL---------------ILHK----------IALGLASAVLYLHEEWEQCIVHRDI 169
               ++               I+ K              +  AV YLHE     IVHRD+
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDL 174

Query: 170 KSSNVVL---DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
           K  N++      +   K+ DFGL+++V+H        + GT GY APE +       E D
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPEILRGCAYGPEVD 232

Query: 227 VYSFGVVALEVACGRKP 243
           ++S G++   + CG +P
Sbjct: 233 MWSVGIITYILLCGFEP 249

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  101 bits (252), Expect = 2e-23
 Identities = 37/202 (18%), Positives = 78/202 (38%), Gaps = 44/202 (21%)

Query: 74  GKLGEGGFGGVYRGL---LSDQNTEIAVKRV-SRGSKQGKKEYISEVRIISRLRHRNLV- 128
           G +  GG G +Y  L   ++ +   + +K +   G  + +   ++E + ++ + H ++V 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGR--PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143

Query: 129 ------------HLIGWC------------HEQRQLILHK---IALGLASAVLYLHEEWE 161
                         +G+              + ++L + +     L +  A+ YLH    
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS--- 200

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA 221
             +V+ D+K  N++L      KL D G    ++         L GT G+ APE +     
Sbjct: 201 IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPE-IVRTGP 253

Query: 222 SKESDVYSFGVVALEVACGRKP 243
           +  +D+Y+ G     +      
Sbjct: 254 TVATDIYTVGRTLAALTLDLPT 275

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 99.0 bits (246), Expect = 3e-23
 Identities = 26/187 (13%), Positives = 49/187 (26%), Gaps = 17/187 (9%)

Query: 143 HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT 202
           H +   L      L     + +VH      N+ +  +    LGD         ++G++  
Sbjct: 197 HILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGP 249

Query: 203 VLAGTMGYLAPECVTTGKA--SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW 260
             +  + Y   E +    A  +   + +  G+    V C   P        K        
Sbjct: 250 ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSL 309

Query: 261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLP 320
            + G   L   +   L            +I            R    + +    F     
Sbjct: 310 RVPGTDSLAFGSCTPLPDFVKT------LIGRFLNFDRR--RRLLPLEAMETPEFLQLQN 361

Query: 321 SLPSKLP 327
            + S L 
Sbjct: 362 EISSSLS 368

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 99.0 bits (247), Expect = 3e-23
 Identities = 48/214 (22%), Positives = 86/214 (40%), Gaps = 39/214 (18%)

Query: 55  PKRFTYRELSRATNNFAE------AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQG 108
           P  F +R ++                 LG G FG V++   +    ++A K +     + 
Sbjct: 70  PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129

Query: 109 KKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL------------HKIALG-------- 148
           K+E  +E+ ++++L H NL+ L      +  ++L              I           
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189

Query: 149 ------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA--KLGDFGLARLVDHELGSQ 200
                 +   + ++H+     I+H D+K  N++  +      K+ DFGLAR        +
Sbjct: 190 ILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--REK 244

Query: 201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVA 234
             V  GT  +LAPE V     S  +D++S GV+A
Sbjct: 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 97.7 bits (244), Expect = 4e-23
 Identities = 72/343 (20%), Positives = 124/343 (36%), Gaps = 99/343 (28%)

Query: 55  PKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLS--DQNTEIAVKRVSRG-SKQGKKE 111
           P    Y  L      F +   +GEG FG V +  +       + A+KR+    SK   ++
Sbjct: 14  PDPTIYPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 71

Query: 112 YISEVRIISRL-RHRNLVHLIGWC-HEQRQLI---------------------------- 141
           +  E+ ++ +L  H N+++L+G C H     +                            
Sbjct: 72  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131

Query: 142 ------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL 189
                       L   A  +A  + YL +   +  +HRD+ + N+++  N+ AK+ DFGL
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 188

Query: 190 ARLVDHELGSQTTVLAGTMGYL-----APECVTTGKASKESDVYSFGVVALEVA-CGRKP 243
           +R  +         +  TMG L     A E +     +  SDV+S+GV+  E+   G  P
Sbjct: 189 SRGQE-------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

Query: 244 ---VEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMEC------LMIVGLW 294
              +   +          +++   +G  L            E+ + C      LM     
Sbjct: 242 YCGMTCAE----------LYEKLPQGYRL------------EKPLNCDDEVYDLM---RQ 276

Query: 295 CCHPDFTNRPSIRQVINVLN--FEAPLPSLPSKLPVPMYYAPP 335
           C       RPS  Q++  LN   E     + + L     YA  
Sbjct: 277 CWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGI 319

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 97.9 bits (244), Expect = 4e-23
 Identities = 39/222 (17%), Positives = 80/222 (36%), Gaps = 61/222 (27%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-----------------EVR 117
            L +G F  +   L    N   A+K+  +   + K+++                   E++
Sbjct: 38  TLNQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 118 IISRLRHRNLVHLIGWCHEQRQLIL---------------------------------HK 144
           II+ +++   +   G      ++ +                                   
Sbjct: 96  IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155

Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL 204
           I   + ++  Y+H E  + I HRD+K SN+++D N   KL DFG +  +      +    
Sbjct: 156 IIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKIKGS 210

Query: 205 AGTMGYLAPECVTTGKAS---KESDVYSFGVVALEVACGRKP 243
            GT  ++ PE   + ++S    + D++S G+    +     P
Sbjct: 211 RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 97.4 bits (243), Expect = 4e-23
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 38/209 (18%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSR-GSKQGKKEYISEVRIISRL-RHR 125
           N+    G++G G  G V++         IAVK++ R G+K+  K  + ++ ++ +     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 126 NLVHLIG--------W-CHE-------------QRQL---ILHKIALGLASAVLYLHEEW 160
            +V   G        +   E             Q  +   IL K+ + +  A+ YL E+ 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK- 143

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGL-ARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
              ++HRD+K SN++LD     KL DFG+  RLVD    ++    AG   Y+APE +   
Sbjct: 144 -HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD--KAKDR-SAGCAAYMAPERIDPP 199

Query: 220 KASKE-----SDVYSFGVVALEVACGRKP 243
             +K      +DV+S G+  +E+A G+ P
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFP 228

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 97.4 bits (243), Expect = 6e-23
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 41/212 (19%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSR-GSKQGKKEYISEVRIISRL-RHR 125
            +  + G++G G +G V + +       +AVKR+     ++ +K+ + ++ ++ R     
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 126 NLVHLIG--------W-CHE-----------------QRQL---ILHKIALGLASAVLYL 156
            +V   G        W C E                    +   IL KI L    A+ +L
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL-ARLVDHELGSQTTVLAGTMGYLAPEC 215
            E  +  I+HRDIK SN++LD + N KL DFG+  +LVD  +        G   Y+APE 
Sbjct: 142 KENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDA--GCRPYMAPER 196

Query: 216 VTTGKASKE----SDVYSFGVVALEVACGRKP 243
           +    + +     SDV+S G+   E+A GR P
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 97.1 bits (242), Expect = 7e-23
 Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 52/212 (24%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIG- 132
            +G G +G VY+G         A+K +   +   ++E   E+ ++ +   HRN+    G 
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGA 89

Query: 133 -------------W-----CH------------------EQRQLILHKIALGLASAVLYL 156
                        W     C                   E    I  +I  GL+    +L
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS----HL 145

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV 216
           H+     ++HRDIK  NV+L  N   KL DFG++  +D  +G + T   GT  ++APE +
Sbjct: 146 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEVI 201

Query: 217 TTGKASKES-----DVYSFGVVALEVACGRKP 243
              +    +     D++S G+ A+E+A G  P
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 96.2 bits (240), Expect = 9e-23
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 40/221 (18%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSR-GSKQGKKEYISEVRIISRL-RHR 125
           ++     +LG G +G V +         +AVKR+    + Q +K  + ++ I  R     
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 126 NLVHLIG--------W-CHE----------------QRQL---ILHKIALGLASAVLYLH 157
             V   G        W C E                 + +   IL KIA+ +  A+ +LH
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126

Query: 158 EEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL-ARLVDHELGSQTTVLAGTMGYLAPECV 216
            +    ++HRD+K SNV++++    K+ DFG+   LVD    ++    AG   Y+APE +
Sbjct: 127 SKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD--VAKDID-AGCKPYMAPERI 181

Query: 217 TTGKASKE----SDVYSFGVVALEVACGRKPVEPRQEPSKV 253
                 K     SD++S G+  +E+A  R P +    P + 
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ 222

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 49/230 (21%), Positives = 85/230 (36%), Gaps = 68/230 (29%)

Query: 75  KLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLV 128
            +GEG FG V++            T +AVK +    S   + ++  E  +++   + N+V
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 129 HLIGWCHEQRQLI----------------------------------------------- 141
            L+G C   + +                                                
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 142 --LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS 199
                IA  +A+ + YL E   +  VHRD+ + N ++  N   K+ DFGL+R +     S
Sbjct: 174 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIY----S 226

Query: 200 QTTVLAGTMGYL-----APECVTTGKASKESDVYSFGVVALEVA-CGRKP 243
                A     +      PE +   + + ESDV+++GVV  E+   G +P
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 44/205 (21%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS---------EVRIISRLRHRN 126
           LG G FG V+  +  ++N E+ VK + +  K  +  +I          E+ I+SR+ H N
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKK-EKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90

Query: 127 LVHLIGWCHEQR--QLILHKIALG------------------------LASAVLYLHEEW 160
           ++ ++     Q   QL++ K   G                        L SAV YL    
Sbjct: 91  IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL-- 148

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK 220
            + I+HRDIK  N+V+  +F  KL DFG A  +  E G       GT+ Y APE V  G 
Sbjct: 149 -KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFCGTIEYCAPE-VLMGN 204

Query: 221 --ASKESDVYSFGVVALEVACGRKP 243
                E +++S GV    +     P
Sbjct: 205 PYRGPELEMWSLGVTLYTLVFEENP 229

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 40/207 (19%)

Query: 67  TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRN 126
              F    KLGEG +G VY+ +  +    +A+K+V    +   +E I E+ I+ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85

Query: 127 LVHLIG--------W-----CH-----------------EQRQLILHKIALGLASAVLYL 156
           +V   G        W     C                  ++   IL     GL     YL
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE----YL 141

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV 216
           H       +HRDIK+ N++L++  +AKL DFG+A  +   +  + TV+ GT  ++APE +
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVI 197

Query: 217 TTGKASKESDVYSFGVVALEVACGRKP 243
                +  +D++S G+ A+E+A G+ P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 94.9 bits (237), Expect = 2e-22
 Identities = 52/191 (27%), Positives = 79/191 (41%), Gaps = 39/191 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY---ISEVRIISRLRHRNLVHLI 131
           +LG+G F  V R +      E A K ++   K   +++     E RI  +L+H N+V L 
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 132 GWCHEQRQL---------------ILHK----------IALGLASAVLYLHEEWEQCIVH 166
               E+                  I+ +              +  ++ Y H      IVH
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVH 128

Query: 167 RDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-S 222
           R++K  N++L S       KL DFGLA  V+          AGT GYL+PE V      S
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPE-VLKKDPYS 185

Query: 223 KESDVYSFGVV 233
           K  D+++ GV+
Sbjct: 186 KPVDIWACGVI 196

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 48/217 (22%), Positives = 85/217 (39%), Gaps = 42/217 (19%)

Query: 61  RELSRATNNFAEA----GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEV 116
           ++L R +  F +       +G G +    R +    N E AVK + +  +   +E    +
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----I 66

Query: 117 RIISRL-RHRNLVHLIGWCHEQRQL---------------ILHK----------IALGLA 150
            I+ R  +H N++ L     + + +               IL +          +   + 
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126

Query: 151 SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA----KLGDFGLARLVDHELGSQTTVLAG 206
             V YLH    Q +VHRD+K SN++           ++ DFG A+ +  E G   T    
Sbjct: 127 KTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-CY 182

Query: 207 TMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           T  ++APE +         D++S GV+   +  G  P
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 52/190 (27%), Positives = 76/190 (40%), Gaps = 36/190 (18%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG 132
           +LG+G F  V R +      E A       + S +  ++   E RI   L+H N+V L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 133 WCHEQRQLIL-------------------------HKIALGLASAVLYLHEEWEQCIVHR 167
              E+    L                               +  AVL+ H+     +VHR
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHR 134

Query: 168 DIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-SK 223
           ++K  N++L S       KL DFGLA  V+ E        AGT GYL+PE V       K
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPE-VLRKDPYGK 192

Query: 224 ESDVYSFGVV 233
             D+++ GV+
Sbjct: 193 PVDLWACGVI 202

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 95.6 bits (238), Expect = 3e-22
 Identities = 50/200 (25%), Positives = 79/200 (39%), Gaps = 47/200 (23%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI--------SEVRIISRLR-HR 125
            +G G    V R +      E AVK +   +++   E +         E  I+ ++  H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 126 NLVHLIGWCHEQRQL---------------ILHK----------IALGLASAVLYLHEEW 160
           +++ LI        +               +  K          I   L  AV +LH   
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA-- 218

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK 220
              IVHRD+K  N++LD N   +L DFG +  ++   G +   L GT GYLAPE +    
Sbjct: 219 -NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLRELCGTPGYLAPE-ILKCS 274

Query: 221 A-------SKESDVYSFGVV 233
                    KE D+++ GV+
Sbjct: 275 MDETHPGYGKEVDLWACGVI 294

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 94.8 bits (236), Expect = 5e-22
 Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 47/204 (23%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGK---KEYISEVRIISRLRHRNLVHLI 131
           ++G G FG VY       +  +A+K++S   KQ     ++ I EVR + +LRH N +   
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120

Query: 132 G--------W-----CH----------------EQRQLILHKIALGLASAVLYLHEEWEQ 162
           G        W     C                  +   + H    GLA    YLH     
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA----YLHS---H 173

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            ++HRD+K+ N++L      KLGDFG        +    +   GT  ++APE +      
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANSF-VGTPYWMAPEVILAMDEG 228

Query: 223 ---KESDVYSFGVVALEVACGRKP 243
               + DV+S G+  +E+A  + P
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPP 252

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 96.8 bits (241), Expect = 5e-22
 Identities = 48/238 (20%), Positives = 90/238 (37%), Gaps = 37/238 (15%)

Query: 38  KEAIDIALEDEFEKGTGPKRFTYRELSRATNNFAE----AGKLGEGGFGGVYRGLLSDQN 93
           +    ++   +       K++  + +    ++  +      +LG G FG V+R       
Sbjct: 123 RGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATG 182

Query: 94  TEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLIL----------- 142
              A K V    +  K+    E++ +S LRH  LV+L     +  ++++           
Sbjct: 183 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242

Query: 143 HKIALG---------------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA--KLG 185
            K+A                 +   + ++HE      VH D+K  N++  +  +   KL 
Sbjct: 243 EKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLI 299

Query: 186 DFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
           DFGL   +D        V  GT  + APE          +D++S GV++  +  G  P
Sbjct: 300 DFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 49/236 (20%), Positives = 86/236 (36%), Gaps = 52/236 (22%)

Query: 55  PKRFTYREL-----SRATNNFAE----AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS 105
            K F + +L     S       +    +  LG G  G V          ++A++ +S+  
Sbjct: 113 NKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRK 172

Query: 106 KQGKKEYIS--------EVRIISRLRHRNLVHLIGWCHEQR--------------QLILH 143
                   +        E+ I+ +L H  ++ +  +   +                 ++ 
Sbjct: 173 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG 232

Query: 144 K----------IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLA 190
                          +  AV YLHE     I+HRD+K  NV+L S   +   K+ DFG +
Sbjct: 233 NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289

Query: 191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKA---SKESDVYSFGVVALEVACGRKP 243
           +++     S    L GT  YLAPE + +      ++  D +S GV+      G  P
Sbjct: 290 KILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 93.5 bits (233), Expect = 8e-22
 Identities = 62/284 (21%), Positives = 106/284 (37%), Gaps = 77/284 (27%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-EVRIISRLRHRNLVHLIG- 132
            +G G    V     + +  ++A+KR++    Q   + +  E++ +S+  H N+V     
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 133 -------W----------------------CHEQRQL-------ILHKIALGLASAVLYL 156
                  W                       H+   L       IL ++  GL     YL
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE----YL 137

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG----LARLVDHELGSQTTVLAGTMGYLA 212
           H+      +HRD+K+ N++L  + + ++ DFG    LA   D           GT  ++A
Sbjct: 138 HK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194

Query: 213 PECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKV----------RLVEWVWD 261
           PE +   +    ++D++SFG+ A+E+A G  P   +  P KV           L   V D
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYH-KYPPMKVLMLTLQNDPPSLETGVQD 253

Query: 262 LYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPS 305
                   +    +  K F +      MI    C   D   RP+
Sbjct: 254 --------KEMLKKYGKSFRK------MIS--LCLQKDPEKRPT 281

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 94.3 bits (235), Expect = 9e-22
 Identities = 52/191 (27%), Positives = 79/191 (41%), Gaps = 39/191 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY---ISEVRIISRLRHRNLVHLI 131
           +LG+G F  V R +      E A K ++   K   +++     E RI  +L+H N+V L 
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 132 GWCHEQRQL---------------ILHK----------IALGLASAVLYLHEEWEQCIVH 166
               E+                  I+ +              +  ++ Y H      IVH
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVH 151

Query: 167 RDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-S 222
           R++K  N++L S       KL DFGLA  V+          AGT GYL+PE V      S
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPE-VLKKDPYS 208

Query: 223 KESDVYSFGVV 233
           K  D+++ GV+
Sbjct: 209 KPVDIWACGVI 219

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 93.9 bits (234), Expect = 9e-22
 Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 59/221 (26%)

Query: 75  KLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNL 127
            LG G FG V           D   ++AVK +        K+  +SE++I+S L +H N+
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 128 VHLIGWC-HEQRQLI--------------------------------------LHKIALG 148
           V+L+G C H    L+                                      L   +  
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +A  + +L     +  +HRD+ + NV+L +   AK+GDFGLAR + ++    +  +    
Sbjct: 173 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SNYIVKGN 225

Query: 209 GYL-----APECVTTGKASKESDVYSFGVVALEVA-CGRKP 243
             L     APE +     + +SDV+S+G++  E+   G  P
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 93.5 bits (233), Expect = 9e-22
 Identities = 56/225 (24%), Positives = 86/225 (38%), Gaps = 50/225 (22%)

Query: 64  SRATNNFAEA----GKLGEGGFGGVYRGLLSDQNTEIAVKRVSR---------GSKQGKK 110
           S +T+ F E       LG G    V R +      E AVK +             ++ ++
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 111 EYISEVRIISRL-RHRNLVHLIGWCHEQRQL---------------ILHK---------- 144
             + EV I+ ++  H N++ L                         +  K          
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128

Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL 204
           I   L   +  LH+     IVHRD+K  N++LD + N KL DFG +  +D   G +   +
Sbjct: 129 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREV 183

Query: 205 AGTMGYLAPECVTTGKA------SKESDVYSFGVVALEVACGRKP 243
            GT  YLAPE +            KE D++S GV+   +  G  P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 63/300 (21%), Positives = 114/300 (38%), Gaps = 87/300 (29%)

Query: 75  KLGEGGFGGVYRGLL-------SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHR 125
            LGEG FG V              +   +AVK +    +++   + +SE+ ++  + +H+
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 126 NLVHLIGWC-HEQRQLI----------------------------------------LHK 144
           N+++L+G C  +    +                                        L  
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL 204
               LA  + YL     Q  +HRD+ + NV++  N   K+ DFGLAR +++         
Sbjct: 208 CTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID----YYK 260

Query: 205 AGTMGYL-----APECVTTGKASKESDVYSFGVVALEVAC-GRKP---VEPRQEPSKVRL 255
             T G L     APE +     + +SDV+SFGV+  E+   G  P   +   +       
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------- 313

Query: 256 VEWVWDLYGKGQLLEAADGRLSK-EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
              ++ L  +G        R+ K      ++  +M     C H   + RP+ +Q++  L+
Sbjct: 314 ---LFKLLKEG-------HRMDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLD 360

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 52/198 (26%), Positives = 79/198 (39%), Gaps = 36/198 (18%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRNLVHLIGW 133
            LGEG F    + +    N   AVK +S   K+ +     E+  +     H N+V L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEV 74

Query: 134 CHEQRQL---------------ILHK----------IALGLASAVLYLHEEWEQCIVHRD 168
            H+Q                  I  K          I   L SAV ++H+     +VHRD
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRD 131

Query: 169 IKSSNVVL---DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES 225
           +K  N++    + N   K+ DFG ARL   +     T    T+ Y APE +      +  
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPELLNQNGYDESC 190

Query: 226 DVYSFGVVALEVACGRKP 243
           D++S GV+   +  G+ P
Sbjct: 191 DLWSLGVILYTMLSGQVP 208

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 62/214 (28%)

Query: 75  KLGEGGFGGVYRGLL-------SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHR 125
            LGEG FG V              +   +AVK +    +++   + +SE+ ++  + +H+
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101

Query: 126 NLVHLIGWC-HEQRQLI----------------------------------------LHK 144
           N+++L+G C  +    +                                        L  
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161

Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL 204
               LA  + YL     Q  +HRD+ + NV++  N   K+ DFGLAR + + +       
Sbjct: 162 CTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYK--- 214

Query: 205 AGTMGYL-----APECVTTGKASKESDVYSFGVV 233
             T G L     APE +     + +SDV+SFGV+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 61/299 (20%), Positives = 107/299 (35%), Gaps = 85/299 (28%)

Query: 75  KLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNL 127
            LG G FG V                +AVK +  G +    +  +SE++I+  +  H N+
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 128 VHLIGWCHEQRQ---LI---------------------------------------LHKI 145
           V+L+G C +      +I                                       L   
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153

Query: 146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA 205
           +  +A  + +L     +  +HRD+ + N++L      K+ DFGLAR +          + 
Sbjct: 154 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIY----KDPDYVR 206

Query: 206 GTMGYL-----APECVTTGKASKESDVYSFGVVALEVA-CGRKP---VEPRQEPSKVRLV 256
                L     APE +     + +SDV+SFGV+  E+   G  P   V+  +E       
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------- 259

Query: 257 EWVWDLYGKGQLLEAADGRLSK-EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                   +G        R+   ++   +M   M   L C H + + RP+  +++  L 
Sbjct: 260 --FCRRLKEG-------TRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLG 306

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 93.8 bits (233), Expect = 2e-21
 Identities = 38/212 (17%), Positives = 67/212 (31%), Gaps = 50/212 (23%)

Query: 75  KLGEG--GFGGVYRGLLSDQNTEIAVKRVS--RGSKQGKKEYISEVRIISRLRHRNLVHL 130
            +G+G      V           + V+R++    S +       E+ +     H N+V  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91

Query: 131 IG--------W----------------CHEQRQL-------ILHKIALGLASAVLYLHEE 159
                     W                 H    +       IL  +   L     Y+H  
Sbjct: 92  RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD----YIHH- 146

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL------AGTMGYLAP 213
                VHR +K+S++++  +    L        +      Q  V          + +L+P
Sbjct: 147 --MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

Query: 214 ECVTTGKA--SKESDVYSFGVVALEVACGRKP 243
           E +         +SD+YS G+ A E+A G  P
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 94.1 bits (234), Expect = 3e-21
 Identities = 49/227 (21%), Positives = 82/227 (36%), Gaps = 68/227 (29%)

Query: 75  KLGEGGFGGV-YRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIG 132
            LG G  G V ++G    +   +AVKR+             E+++++    H N++    
Sbjct: 22  ILGYGSSGTVVFQGSFQGR--PVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRYY- 75

Query: 133 WCHEQRQ----------------LILHK-----------------IALGLASAVLYLHEE 159
            C E                   L+  K                 +   +AS V +LH  
Sbjct: 76  -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133

Query: 160 WEQCIVHRDIKSSNVVLDS-------------NFNAKLGDFGLARLVDHELGSQTTVL-- 204
               I+HRD+K  N+++ +             N    + DFGL + +D    S  T L  
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191

Query: 205 -AGTMGYLAPE-------CVTTGKASKESDVYSFGVVALEVACGRKP 243
            +GT G+ APE         T  + ++  D++S G V   +    K 
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 91.9 bits (229), Expect = 4e-21
 Identities = 50/225 (22%), Positives = 84/225 (37%), Gaps = 63/225 (28%)

Query: 75  KLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNL 127
            LG G FG V          SD    +AVK +        ++  +SE++++S L  H N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 128 VHLIGWC-HEQRQLI------------------------------------------LHK 144
           V+L+G C      L+                                          L  
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL 204
            +  +A  + +L     +  +HRD+ + N++L      K+ DFGLAR + ++       +
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS----NYV 202

Query: 205 AGTMGYL-----APECVTTGKASKESDVYSFGVVALEVA-CGRKP 243
                 L     APE +     + ESDV+S+G+   E+   G  P
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 92.8 bits (230), Expect = 4e-21
 Identities = 33/278 (11%), Positives = 67/278 (24%), Gaps = 81/278 (29%)

Query: 38  KEAIDIALEDEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIA 97
           + A D  +         P R    EL            LG+            +      
Sbjct: 44  QSAADSLVSTSLWNTGQPFRVE-SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE 102

Query: 98  VK------RVSRGSKQGKKEYISEVRIISRLR----------------------HRNLVH 129
           V       R    + +  KE +  +R++  ++                       + ++ 
Sbjct: 103 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 162

Query: 130 LIGWCHEQRQLILH---------------------------------KIALGLASAVLYL 156
           +     +   L                                    ++ L +   +  L
Sbjct: 163 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV 216
           H      +VH  ++  ++VLD      L  F               V + + G+  PE  
Sbjct: 223 HH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVSRGFEPPELE 274

Query: 217 TT-----------GKASKESDVYSFGVVALEVACGRKP 243
                           +   D ++ G+V   + C   P
Sbjct: 275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 91.1 bits (227), Expect = 5e-21
 Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 40/195 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS------EVRIISRLRHRNLV 128
           +LG G F  V +        E A K + +      +  +S      EV I+  +RH N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 129 HLIGWCHEQRQLIL-----------HKI----------ALGL----ASAVLYLHEEWEQC 163
            L      +  ++L             +          A          V YLH    + 
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS---KR 128

Query: 164 IVHRDIKSSNVVLDS----NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
           I H D+K  N++L      N   KL DFG+A  ++   G++   + GT  ++APE V   
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFKNIFGTPEFVAPEIVNYE 186

Query: 220 KASKESDVYSFGVVA 234
               E+D++S GV+ 
Sbjct: 187 PLGLEADMWSIGVIT 201

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 92.4 bits (230), Expect = 5e-21
 Identities = 50/198 (25%), Positives = 77/198 (38%), Gaps = 45/198 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS------EVRIISRLRHRNLV 128
            +G+G F  V R +  +   + AVK V   +K      +S      E  I   L+H ++V
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDV-AKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 129 HLIGWCHEQRQL---------------ILHKIALG--------------LASAVLYLHEE 159
            L+        L               I+ +   G              +  A+ Y H+ 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD- 148

Query: 160 WEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV 216
               I+HRD+K   V+L S   +   KLG FG+A  +  E G       GT  ++APE V
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPE-V 204

Query: 217 TTGKA-SKESDVYSFGVV 233
              +   K  DV+  GV+
Sbjct: 205 VKREPYGKPVDVWGCGVI 222

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 91.5 bits (228), Expect = 5e-21
 Identities = 43/189 (22%), Positives = 73/189 (38%), Gaps = 36/189 (19%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
            LG G FG V+R + +        K V       +     E+ I++  RHRN++HL    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 135 HEQRQLIL-----------HKI-----------ALGLA----SAVLYLHEEWEQCIVHRD 168
               +L++            +I            +        A+ +LH      I H D
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFD 127

Query: 169 IKSSNVVLDSNFNA--KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKES 225
           I+  N++  +  ++  K+ +FG AR +    G    +L     Y APE V      S  +
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPE-VHQHDVVSTAT 184

Query: 226 DVYSFGVVA 234
           D++S G + 
Sbjct: 185 DMWSLGTLV 193

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 91.6 bits (228), Expect = 5e-21
 Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 48/214 (22%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-------EVRIISRLR----H 124
           LG+GGFG V+ G       ++A+K + R ++      +S       EV ++ ++     H
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 125 RNLVHLIGWCHEQRQLIL------------HKIALG--------------LASAVLYLHE 158
             ++ L+ W   Q   +L              I                 + +A+ + H 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157

Query: 159 EWEQCIVHRDIKSSNVVLDS-NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT 217
              + +VHRDIK  N+++D     AKL DFG   L+        T   GT  Y  PE   
Sbjct: 158 ---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFDGTRVYSPPE-WI 210

Query: 218 TGK--ASKESDVYSFGVVALEVACGRKPVEPRQE 249
           +     +  + V+S G++  ++ CG  P E  QE
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPFERDQE 244

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 91.2 bits (227), Expect = 5e-21
 Identities = 47/205 (22%), Positives = 83/205 (40%), Gaps = 42/205 (20%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS----EVRIISRLRHRNLVHLI 131
           LGEG +G V   L S+     AVK + +   +      +    E++++ RLRH+N++ L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 132 G-WCHEQRQLI--------------LHKIALG-------------LASAVLYLHEEWEQC 163
               +E++Q +              L  +                L   + YLH    Q 
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QG 129

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS---QTTVLAGTMGYLAPECVTTGK 220
           IVH+DIK  N++L +    K+   G+A  +         +T+   G+  +  PE      
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS--QGSPAFQPPEIANGLD 187

Query: 221 --ASKESDVYSFGVVALEVACGRKP 243
             +  + D++S GV    +  G  P
Sbjct: 188 TFSGFKVDIWSAGVTLYNITTGLYP 212

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 91.2 bits (227), Expect = 7e-21
 Identities = 48/206 (23%), Positives = 78/206 (37%), Gaps = 46/206 (22%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-------EVRIISRLRHR--N 126
           LG GGFG VY G+    N  +A+K V +  +      +        EV ++ ++      
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 127 LVHLIGWCHEQRQLIL------------HKIALG--------------LASAVLYLHEEW 160
           ++ L+ W       +L              I                 +  AV + H   
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 167

Query: 161 EQCIVHRDIKSSNVVLDSN-FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
              ++HRDIK  N+++D N    KL DFG   L+     +  T   GT  Y  PE     
Sbjct: 168 -CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPE-WIRY 222

Query: 220 K--ASKESDVYSFGVVALEVACGRKP 243
                + + V+S G++  ++ CG  P
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIP 248

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 90.3 bits (225), Expect = 7e-21
 Identities = 55/222 (24%), Positives = 85/222 (38%), Gaps = 56/222 (25%)

Query: 72  EAGK-LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-EVRIISRLRHRNLVH 129
           +  + LGEG +G V   +       +AVK V         E I  E+ I   L H N+V 
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 130 LI----------------------------GWCHEQ------RQLILHKIALGLASAVLY 155
                                             E        QL+         + V+Y
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVVY 120

Query: 156 LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA---GTMGYLA 212
           LH      I HRDIK  N++LD   N K+ DFGLA +  +   ++  +L    GT+ Y+A
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY--NNRERLLNKMCGTLPYVA 175

Query: 213 PECVTTGK--ASKESDVYSFGVVALEVACGRKPVEPRQEPSK 252
           PE +   +   ++  DV+S G+V   +  G  P +   +  +
Sbjct: 176 PE-LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 91.6 bits (227), Expect = 8e-21
 Identities = 38/245 (15%), Positives = 67/245 (27%), Gaps = 58/245 (23%)

Query: 50  EKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNT-----EIAVKRVSRG 104
            +   P      E    +        LGEG F  VY     D N      +  +K     
Sbjct: 47  WQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-- 104

Query: 105 SKQGKKEYISEVRIISRLR---HRNLVHLIGWCHEQRQLIL------------------- 142
                 E+    +++ RL+       +        Q   +L                   
Sbjct: 105 -PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKN 163

Query: 143 -----------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL-----------DSNF 180
                         A+ +   +  +H+     I+H DIK  N +L           D + 
Sbjct: 164 TPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220

Query: 181 NAKLGDFGLAR-LVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVA 238
              L D G +  +     G+  T    T G+   E + + K  + + D +        + 
Sbjct: 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCML 279

Query: 239 CGRKP 243
            G   
Sbjct: 280 FGTYM 284

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 44/195 (22%), Positives = 75/195 (38%), Gaps = 40/195 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI------SEVRIISRLRHRNLV 128
           +LG G F  V +        E A K + +   +  +  +       EV I+ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 129 HLIGWCHEQRQLIL-------------------------HKIALGLASAVLYLHEEWEQC 163
            L      +  ++L                               +   V YLH    + 
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KK 135

Query: 164 IVHRDIKSSNVVLDS----NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
           I H D+K  N++L        + KL DFGLA  ++   G +   + GT  ++APE V   
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVAPEIVNYE 193

Query: 220 KASKESDVYSFGVVA 234
               E+D++S GV+ 
Sbjct: 194 PLGLEADMWSIGVIT 208

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 55/213 (25%), Positives = 82/213 (38%), Gaps = 56/213 (26%)

Query: 72  EAGK-LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-EVRIISRLRHRNLVH 129
           +  + LGEG +G V   +       +AVK V         E I  E+ I   L H N+V 
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 130 LI----------------------------GWCHEQ------RQLILHKIALGLASAVLY 155
                                             E        QL+         + V+Y
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------AGVVY 120

Query: 156 LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA---GTMGYLA 212
           LH      I HRDIK  N++LD   N K+ DFGLA +  +   ++  +L    GT+ Y+A
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY--NNRERLLNKMCGTLPYVA 175

Query: 213 PECVTTGK--ASKESDVYSFGVVALEVACGRKP 243
           PE +   +   ++  DV+S G+V   +  G  P
Sbjct: 176 PE-LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 55/206 (26%), Positives = 83/206 (40%), Gaps = 53/206 (25%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYIS-EVRIISRLRHRNLVHLI-- 131
           +G+G F  V          E+A+K + +        + +  EVRI+  L H N+V L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 132 --------------------------GWCHEQ------RQLILHKIALGLASAVLYLHEE 159
                                     G   E+      RQ++         SAV Y H+ 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV---------SAVQYCHQ- 132

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
             + IVHRD+K+ N++LD++ N K+ DFG +       G +     G   Y APE +  G
Sbjct: 133 --KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFCGAPPYAAPE-LFQG 187

Query: 220 K--ASKESDVYSFGVVALEVACGRKP 243
           K     E DV+S GV+   +  G  P
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLP 213

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 63/225 (28%)

Query: 75  KLGEGGFGGVYRGLL-------SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHR 125
            LGEG FG V             ++ T++AVK +    +++   + ISE+ ++  + +H+
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 126 NLVHLIGWC-HEQRQLI----------------------------------------LHK 144
           N+++L+G C  +    +                                        L  
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195

Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL 204
            A  +A  + YL     +  +HRD+ + NV++  +   K+ DFGLAR + H         
Sbjct: 196 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----YYK 248

Query: 205 AGTMGYL-----APECVTTGKASKESDVYSFGVVALEVA-CGRKP 243
             T G L     APE +     + +SDV+SFGV+  E+   G  P
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 44/195 (22%), Positives = 75/195 (38%), Gaps = 40/195 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI------SEVRIISRLRHRNLV 128
           +LG G F  V +        E A K + +   +  +  +       EV I+ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 129 HLIGWCHEQRQLIL-------------------------HKIALGLASAVLYLHEEWEQC 163
            L      +  ++L                               +   V YLH    + 
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KK 135

Query: 164 IVHRDIKSSNVVLDS----NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
           I H D+K  N++L        + KL DFGLA  ++   G +   + GT  ++APE V   
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVAPEIVNYE 193

Query: 220 KASKESDVYSFGVVA 234
               E+D++S GV+ 
Sbjct: 194 PLGLEADMWSIGVIT 208

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 47/209 (22%), Positives = 76/209 (36%), Gaps = 47/209 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS--------EVRIISRLRHRN 126
            LG G  G V          ++A+K +S+          +        E+ I+ +L H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 127 LVHLIGWCHEQRQLIL-------------------------HKIALGLASAVLYLHEEWE 161
           ++ +  +  +     +                               +  AV YLHE   
Sbjct: 77  IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--- 132

Query: 162 QCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT 218
             I+HRD+K  NV+L S   +   K+ DFG ++++     S    L GT  YLAPE V  
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLAPE-VLV 189

Query: 219 GKA----SKESDVYSFGVVALEVACGRKP 243
                  ++  D +S GV+      G  P
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 88.8 bits (221), Expect = 5e-20
 Identities = 46/219 (21%), Positives = 81/219 (36%), Gaps = 67/219 (30%)

Query: 75  KLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLV 128
            LGEG FG V +            T +AVK +    S    ++ +SE  ++ ++ H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 129 HLIGWC---------------------------------------------HEQRQLILH 143
            L G C                                             H   + +  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 144 K----IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS 199
                 A  ++  + YL    E  +VHRD+ + N+++      K+ DFGL+R V  E   
Sbjct: 150 GDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED-- 204

Query: 200 QTTVLAGTMGYL-----APECVTTGKASKESDVYSFGVV 233
             + +  + G +     A E +     + +SDV+SFGV+
Sbjct: 205 --SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 88.5 bits (220), Expect = 6e-20
 Identities = 45/196 (22%), Positives = 77/196 (39%), Gaps = 42/196 (21%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRV------SRGSKQGKKEYISEVRIISRLRHRNLV 128
           +LG G F  V +        + A K +      S      +++   EV I+  ++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 129 HLIGWCHEQRQLIL-----------HKI----------ALGLA----SAVLYLHEEWEQC 163
            L      +  +IL             +          A        + V YLH      
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQ 134

Query: 164 IVHRDIKSSNVVLDS----NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
           I H D+K  N++L          K+ DFGLA  +D   G++   + GT  ++APE +   
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFVAPE-IVNY 191

Query: 220 KA-SKESDVYSFGVVA 234
           +    E+D++S GV+ 
Sbjct: 192 EPLGLEADMWSIGVIT 207

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 89.3 bits (222), Expect = 7e-20
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 8/112 (7%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           L  A+ YL     Q I+HRD+K  N++LD + +  + DF +A ++     +Q T +AGT 
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITTMAGTK 178

Query: 209 GYLAPECVTTGKA---SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVE 257
            Y+APE  ++ K    S   D +S GV A E+  GR+P   R   S   +V 
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 32/197 (16%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYI-SEVRIISRLRHRNLVHLIG 132
           LGEG F  V        + E A+K + +    K+ K  Y+  E  ++SRL H   V L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 133 WCHEQRQL--ILHKIALG-----------------------LASAVLYLHEEWEQCIVHR 167
              +  +L   L     G                       + SA+ YLH    + I+HR
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHR 154

Query: 168 DIKSSNVVLDSNFNAKLGDFGLA-RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
           D+K  N++L+ + + ++ DFG A  L      ++     GT  Y++PE +T   A K SD
Sbjct: 155 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSD 214

Query: 227 VYSFGVVALEVACGRKP 243
           +++ G +  ++  G  P
Sbjct: 215 LWALGCIIYQLVAGLPP 231

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 47/204 (23%), Positives = 71/204 (34%), Gaps = 45/204 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGW 133
            LG G  G V +        + A+K +    K  +     EV +  R  +  ++V ++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDV 123

Query: 134 CHEQRQL-------------------ILHK------------IALGLASAVLYLHEEWEQ 162
                                     I  +            I   +  A+ YLH     
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 180

Query: 163 CIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
            I HRD+K  N++  S   N   KL DFG A+         T     T  Y+APE +   
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEVLGPE 238

Query: 220 KASKESDVYSFGVVALEVACGRKP 243
           K  K  D++S GV+   + CG  P
Sbjct: 239 KYDKSCDMWSLGVIMYILLCGYPP 262

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 44/198 (22%), Positives = 75/198 (37%), Gaps = 43/198 (21%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRNLVHLIGWC 134
           LGEG    V   +    + E AVK + +     +     EV ++ + + HRN++ LI + 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 135 HEQRQL---------------ILHK----------IALGLASAVLYLHEEWEQCIVHRDI 169
            E+ +                I  +          +   +ASA+ +LH    + I HRD+
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRDL 137

Query: 170 KSSNVVL---DSNFNAKLGDFGLARLVDHELGSQTTV------LAGTMGYLAPECVTTGK 220
           K  N++    +     K+ DF L   +                  G+  Y+APE V    
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197

Query: 221 AS-----KESDVYSFGVV 233
                  K  D++S GV+
Sbjct: 198 EEASIYDKRCDLWSLGVI 215

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 45/221 (20%), Positives = 85/221 (38%), Gaps = 39/221 (17%)

Query: 48  EFEKGTGPKRFTYRELSRATNNFAEAGK-LGEGGFGGVYRGLLSDQNTEIAVK--RVSRG 104
                 G +   ++ +    N +    K LG G F  V + +      E A K  +  R 
Sbjct: 8   SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67

Query: 105 SKQGKKEYISEVRIISRLRHR-NLVHLIGWCHEQRQLIL-----------HKI------- 145
            +  + E + E+ ++   +    +++L        ++IL                     
Sbjct: 68  GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM 127

Query: 146 -----ALGLA----SAVLYLHEEWEQCIVHRDIKSSNVVL---DSNFNAKLGDFGLARLV 193
                 + L       V YLH+     IVH D+K  N++L       + K+ DFG++R +
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184

Query: 194 DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVA 234
            H    +   + GT  YLAPE +     +  +D+++ G++A
Sbjct: 185 GH--ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 43/204 (21%), Positives = 70/204 (34%), Gaps = 46/204 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGW 133
            LG G  G V          + A+K +    K  +     EV    +     ++V ++  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILDV 90

Query: 134 CHEQRQL-------------------ILHK------------IALGLASAVLYLHEEWEQ 162
                                     I  +            I   + +A+ +LH     
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---H 147

Query: 163 CIVHRDIKSSNVVL---DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
            I HRD+K  N++    + +   KL DFG A+       +  T    T  Y+APE +   
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTP-CYTPYYVAPEVLGPE 204

Query: 220 KASKESDVYSFGVVALEVACGRKP 243
           K  K  D++S GV+   + CG  P
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPP 228

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 33/160 (20%)

Query: 62  ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-----EV 116
           ++      + +   LGEG F  VY+    + N  +A+K++  G +   K+ I+     E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 117 RIISRLRHRNLVHLIGWCHEQRQLIL---------------HKIALG----------LAS 151
           +++  L H N++ L+     +  + L               + + L              
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR 191
            + YLH+ W   I+HRD+K +N++LD N   KL DFGLA+
Sbjct: 124 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 86.2 bits (214), Expect = 5e-19
 Identities = 57/305 (18%), Positives = 106/305 (34%), Gaps = 91/305 (29%)

Query: 75  KLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNL 127
            LG G FG V          +  + ++AVK +        ++  +SE++++++L  H N+
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 128 VHLIGWCHEQRQLIL--------------------------------------------- 142
           V+L+G C     + L                                             
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 143 ---HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS 199
                 A  +A  + +L     +  VHRD+ + NV++      K+ DFGLAR +  +   
Sbjct: 172 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS-- 226

Query: 200 QTTVLAGTMGYL-----APECVTTGKASKESDVYSFGVVALEVA-CGRKP---VEPRQEP 250
               +      L     APE +  G  + +SDV+S+G++  E+   G  P   +      
Sbjct: 227 --NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN- 283

Query: 251 SKVRLVEWVWDLYGKGQLLEAADGRLSK-EFDERQMECLMIVGLWCCHPDFTNRPSIRQV 309
                    + L   G        ++ +  +   ++  +M     C   D   RPS   +
Sbjct: 284 --------FYKLIQNG-------FKMDQPFYATEEIYIIM---QSCWAFDSRKRPSFPNL 325

Query: 310 INVLN 314
            + L 
Sbjct: 326 TSFLG 330

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 56/213 (26%), Positives = 78/213 (36%), Gaps = 59/213 (27%)

Query: 72  EAGK-LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS-EVRIISRLRHRNLVH 129
           +  K +G G FG             +AVK + RG      E +  E+     LRH N+V 
Sbjct: 23  DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVR 80

Query: 130 LI----------------------------GWCHEQ------RQLILHKIALGLASAVLY 155
                                         G   E       +QL+         S V Y
Sbjct: 81  FKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL---------SGVSY 131

Query: 156 LHEEWEQCIVHRDIKSSNVVLDSNF--NAKLGDFGLARL-VDHELGSQTTVLAGTMGYLA 212
            H      I HRD+K  N +LD +     K+ DFG ++  V H    ++TV  GT  Y+A
Sbjct: 132 CHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV--GTPAYIA 185

Query: 213 PECVTTGK--ASKESDVYSFGVVALEVACGRKP 243
           PE V   +    K +DV+S GV    +  G  P
Sbjct: 186 PE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 82.3 bits (204), Expect = 4e-18
 Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 54/207 (26%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYIS-EVRIISRLRHRNLVHLI- 131
           LG G FG V  G       ++AVK ++R           I  E++ +   RH +++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 132 ---------------------------GWCHEQ------RQLILHKIALGLASAVLYLHE 158
                                      G   E       +Q++         SAV Y H 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL---------SAVDYCHR 129

Query: 159 EWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT 218
                +VHRD+K  NV+LD++ NAK+ DFGL+ ++      +T+   G+  Y APE V +
Sbjct: 130 ---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VIS 183

Query: 219 GK--ASKESDVYSFGVVALEVACGRKP 243
           G+  A  E D++S GV+   + CG  P
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLP 210

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 58/206 (28%), Positives = 84/206 (40%), Gaps = 53/206 (25%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYIS-EVRIISRLRHRNLVHLI- 131
           LGEG FG V          ++A+K +SR    K      +  E+  +  LRH +++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 132 --------------------------GWCHEQ------RQLILHKIALGLASAVLYLHEE 159
                                         E       +Q+I          A+ Y H  
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQII---------CAIEYCHR- 126

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
               IVHRD+K  N++LD N N K+ DFGL+ ++      +T+   G+  Y APE V  G
Sbjct: 127 --HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VING 181

Query: 220 K--ASKESDVYSFGVVALEVACGRKP 243
           K  A  E DV+S G+V   +  GR P
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLP 207

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 81.9 bits (203), Expect = 8e-18
 Identities = 49/232 (21%), Positives = 83/232 (35%), Gaps = 77/232 (33%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSR-------------------------GSKQGKK 110
           +G+G +G V      + NT  A+K +S+                            +G  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 111 EYIS-EVRIISRLRHRNLVHLI-----------------------------GWCHEQ--- 137
           E +  E+ I+ +L H N+V L+                                 E    
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140

Query: 138 ---RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD 194
              + LI           + YLH    Q I+HRDIK SN+++  + + K+ DFG++    
Sbjct: 141 FYFQDLI---------KGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 195 HELGSQTTVLAGTMGYLAPECVTTGKAS---KESDVYSFGVVALEVACGRKP 243
                 +    GT  ++APE ++  +     K  DV++ GV       G+ P
Sbjct: 189 GSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 54/207 (26%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYIS-EVRIISRLRHRNLVHLI- 131
           LG G FG V  G       ++AVK ++R           I  E++ +   RH +++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 132 ---------------------------GWCHEQ------RQLILHKIALGLASAVLYLHE 158
                                      G   E+      +Q++         S V Y H 
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL---------SGVDYCHR 134

Query: 159 EWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT 218
                +VHRD+K  NV+LD++ NAK+ DFGL+ ++      +T+   G+  Y APE V +
Sbjct: 135 ---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPE-VIS 188

Query: 219 GK--ASKESDVYSFGVVALEVACGRKP 243
           G+  A  E D++S GV+   + CG  P
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLP 215

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 46/207 (22%), Positives = 86/207 (41%), Gaps = 38/207 (18%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKE-----YISEVRIISRL 122
             + +  K+GEG +G V++    + +  +A+KRV         E      + E+ ++  L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKEL 58

Query: 123 RHRNLVHLIGWCHEQRQLIL---------------HKIALGLA----------SAVLYLH 157
           +H+N+V L    H  ++L L                   L               + + H
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 158 EEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT 217
                 ++HRD+K  N++++ N   KL +FGLAR     +   +  +  T+ Y  P+ + 
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174

Query: 218 TGKA-SKESDVYSFGVVALEVACGRKP 243
             K  S   D++S G +  E+A   +P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP 201

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 42/174 (24%), Positives = 72/174 (41%), Gaps = 32/174 (18%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGK-KEYISEVRIISRLRHRN 126
             + +  KLGEG +  VY+G     +  +A+K +    ++G     I EV ++  L+H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 127 LVHLIGWCHEQRQLIL---------------HKIALG----------LASAVLYLHEEWE 161
           +V L    H ++ L L                   +           L   + Y H +  
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK- 120

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT-VLAGTMGYLAPE 214
             ++HRD+K  N++++     KL DFGLAR       +    V+  T+ Y  P+
Sbjct: 121 --VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPD 170

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 80.3 bits (199), Expect = 4e-17
 Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 40/182 (21%)

Query: 64  SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEI-AVKRVSRGSKQGKKE-----YISEVR 117
                 + +  K+GEG +G VY+    D    I A+KR+   ++    E      I E+ 
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAK--DSQGRIVALKRIRLDAE---DEGIPSTAIREIS 71

Query: 118 IISRLRHRNLVHLIGWCHEQRQLIL---------------HKIALGLA----------SA 152
           ++  L H N+V LI   H +R L L               +K  L  +            
Sbjct: 72  LLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRG 131

Query: 153 VLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLA 212
           V + H+     I+HRD+K  N++++S+   KL DFGLAR     + S T  +  T+ Y A
Sbjct: 132 VAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRA 187

Query: 213 PE 214
           P+
Sbjct: 188 PD 189

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 80.3 bits (199), Expect = 4e-17
 Identities = 43/178 (24%), Positives = 76/178 (42%), Gaps = 31/178 (17%)

Query: 64  SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQG-KKEYISEVRIISR 121
            ++   +   G +GEG +G V +    D    +A+K+       +  KK  + E++++ +
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80

Query: 122 LRHRNLVHLIGWCHEQRQLIL---------------HKIALG----------LASAVLYL 156
           LRH NLV+L+  C ++++  L                   L           + + + + 
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           H      I+HRDIK  N+++  +   KL DFG AR +          +A T  Y APE
Sbjct: 141 HSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE 194

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 79.1 bits (196), Expect = 8e-17
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 31/174 (17%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQG-KKEYISEVRIISRLRHR 125
             + + GK+GEG +G V++    D    +A+K+          KK  + E+R++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 126 NLVHLIGWCHEQRQLIL---------------HKIALG----------LASAVLYLHEEW 160
           NLV+L+     +R+L L               ++  +              AV + H+  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
               +HRD+K  N+++  +   KL DFG ARL+          +A T  Y +PE
Sbjct: 123 ---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE 172

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 78.3 bits (194), Expect = 2e-16
 Identities = 42/178 (23%), Positives = 75/178 (42%), Gaps = 40/178 (22%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEI-AVKRVSRGSKQGKKE-----YISEVRIISR 121
             +    K+GEG +G VY+    +   E  A+K++    +    E      I E+ I+  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKE---DEGIPSTTIREISILKE 56

Query: 122 LRHRNLVHLIGWCHEQRQLIL---------------HKIALGLA----------SAVLYL 156
           L+H N+V L    H +++L+L                +  L             + + Y 
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           H+     ++HRD+K  N++++     K+ DFGLAR     +   T  +  T+ Y AP+
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 50/190 (26%), Positives = 76/190 (40%), Gaps = 44/190 (23%)

Query: 64  SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEY-ISEVRIISR 121
           S AT+ +    ++G G +G VY+         +A+K V   +   G     IS VR ++ 
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 122 LR------HRNLVHLIGWCHEQRQLILHKIAL---------------------------- 147
           LR      H N+V L+  C   R     K+ L                            
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD 124

Query: 148 ---GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVL 204
                   + +LH      IVHRD+K  N+++ S    KL DFGLAR+  +++     V+
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV 181

Query: 205 AGTMGYLAPE 214
             T+ Y APE
Sbjct: 182 --TLWYRAPE 189

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 78.0 bits (193), Expect = 3e-16
 Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 43/184 (23%)

Query: 66  ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKE-----YISEVRIIS 120
           +++ F +  KLG G +  VY+GL       +A+K V    K   +E      I E+ ++ 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMK 58

Query: 121 RLRHRNLVHLIGWCHEQRQLIL---------------HKIALG---------------LA 150
            L+H N+V L    H + +L L                 +                  L 
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 151 SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGY 210
             + + HE     I+HRD+K  N++++     KLGDFGLAR     + + ++ +  T+ Y
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWY 174

Query: 211 LAPE 214
            AP+
Sbjct: 175 RAPD 178

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 77.6 bits (192), Expect = 3e-16
 Identities = 44/178 (24%), Positives = 76/178 (42%), Gaps = 38/178 (21%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKE-----YISEVRIISRL 122
            NF +  K+GEG +G VY+         +A+K++   ++    E      I E+ ++  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKEL 59

Query: 123 RHRNLVHLIGWCHEQRQL-------------ILHKIALG-------------LASAVLYL 156
            H N+V L+   H + +L              +   AL              L   + + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE 214
           H      ++HRD+K  N+++++    KL DFGLAR     + + T  +  T+ Y APE
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 43/198 (21%)

Query: 53  TGPKRFTYREL--SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKK 110
            GP   +      + + + +    KLGEG +G VY+ + +  N  +A+KR+    +   +
Sbjct: 17  QGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---E 73

Query: 111 E-----YISEVRIISRLRHRNLVHLIGWCHEQRQLIL--------------HKIALG--- 148
           E      I EV ++  L+HRN++ L    H   +L L                  +    
Sbjct: 74  EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRV 133

Query: 149 -------LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA-----KLGDFGLARLVDHE 196
                  L + V + H       +HRD+K  N++L  +  +     K+GDFGLAR     
Sbjct: 134 IKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190

Query: 197 LGSQTTVLAGTMGYLAPE 214
           +   T  +  T+ Y  PE
Sbjct: 191 IRQFTHEII-TLWYRPPE 207

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 44/191 (23%), Positives = 77/191 (40%), Gaps = 47/191 (24%)

Query: 65  RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKE-----YISEVRII 119
              + + +  K+G+G FG V++        ++A+K+V   ++   KE      + E++I+
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE---KEGFPITALREIKIL 70

Query: 120 SRLRHRNLVHLIGWCHEQRQLILHK---------------------------------IA 146
             L+H N+V+LI  C  +                                        + 
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130

Query: 147 LGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG 206
             L + + Y+H      I+HRD+K++NV++  +   KL DFGLAR       SQ      
Sbjct: 131 QMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 207 ---TMGYLAPE 214
              T+ Y  PE
Sbjct: 188 RVVTLWYRPPE 198

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 56/241 (23%), Positives = 91/241 (37%), Gaps = 54/241 (22%)

Query: 38  KEAIDIALEDEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIA 97
           KE +  A ED  +K   P + T +      + F     LG G FG V      +     A
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQ-----LDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70

Query: 98  VKRVSRGSKQGKKEYI----------SEVRIISRLRHRNLVHLIGWCHEQRQL------- 140
           +K +        K+ +          +E RI+  +    LV L     +   L       
Sbjct: 71  MKIL-------DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123

Query: 141 -------ILHKI-----------ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA 182
                   L +I           A  +     YLH      +++RD+K  N+++D     
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYI 180

Query: 183 KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRK 242
           ++ DFG A+     +  +T  L GT   LAPE + +   +K  D ++ GV+  E+A G  
Sbjct: 181 QVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

Query: 243 P 243
           P
Sbjct: 237 P 237

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 44/204 (21%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY---ISEVRIISRLRHRNLV---- 128
           LG GGFG V+   +       A K++++   + +K Y   + E +I++++  R +V    
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252

Query: 129 ----------------------HLIGWCHEQRQLILHK-------IALGLASAVLYLHEE 159
                                 H+     +       +       I  GL     +LH+ 
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE----HLHQ- 307

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
             + I++RD+K  NV+LD + N ++ D GLA  +     ++T   AGT G++APE +   
Sbjct: 308 --RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGYAGTPGFMAPELLLGE 364

Query: 220 KASKESDVYSFGVVALEVACGRKP 243
           +     D ++ GV   E+   R P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 77.5 bits (191), Expect = 7e-16
 Identities = 30/100 (30%), Positives = 49/100 (49%), Gaps = 8/100 (8%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +  A+  +H+      VHRDIK  N+++D N + +L DFG    +  +   Q++V  GT 
Sbjct: 184 MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240

Query: 209 GYLAPECVTTGKAS-----KESDVYSFGVVALEVACGRKP 243
            Y++PE +   +        E D +S GV   E+  G  P
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 78.0 bits (192), Expect = 9e-16
 Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 7/96 (7%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +   + ++H    + +V+RD+K +N++LD + + ++ D GLA         +     GT 
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTH 354

Query: 209 GYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKP 243
           GY+APE +  G A    +D +S G +  ++  G  P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 48/199 (24%), Positives = 87/199 (43%), Gaps = 37/199 (18%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY---ISEVRIISRLRHRNLVHLIG 132
           LG+GGFG V    +       A K++ +   + +K     ++E +I+ ++  R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250

Query: 133 WCHEQRQ---LILHKIALG-------------------------LASAVLYLHEEWEQCI 164
           + +E +    L+L  +  G                         +   +  LH    + I
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERI 307

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
           V+RD+K  N++LD + + ++ D GLA  V    G       GT+GY+APE V   + +  
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 365

Query: 225 SDVYSFGVVALEVACGRKP 243
            D ++ G +  E+  G+ P
Sbjct: 366 PDWWALGCLLYEMIAGQSP 384

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 7/99 (7%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +  A+  +H       +HRD+K  N++LD + + KL DFG    ++ E   +     GT 
Sbjct: 177 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233

Query: 209 GYLAPECVTT----GKASKESDVYSFGVVALEVACGRKP 243
            Y++PE + +    G   +E D +S GV   E+  G  P
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 48/192 (25%), Positives = 76/192 (39%), Gaps = 50/192 (26%)

Query: 64  SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEI-AVKRVSRGSKQGKKEY---ISEVRII 119
            RA   +    ++GEG +G V++           A+KRV    +    E    +S +R +
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREV 62

Query: 120 SRLR------HRNLVHLIGWCHEQRQLILHKIAL-------------------------- 147
           + LR      H N+V L   C   R     K+ L                          
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122

Query: 148 -----GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT 202
                 L   + +LH      +VHRD+K  N+++ S+   KL DFGLAR+   ++   + 
Sbjct: 123 KDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179

Query: 203 VLAGTMGYLAPE 214
           V+  T+ Y APE
Sbjct: 180 VV--TLWYRAPE 189

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 41/191 (21%), Positives = 68/191 (35%), Gaps = 58/191 (30%)

Query: 72  EAGKLGEGGFGGVYRGLLSDQNT--EIAVKRVSRGSKQGKKEYIS-----EVRIISRLRH 124
           E  K+G G +G VY+    D     + A+K++       +   IS     E+ ++  L+H
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-------EGTGISMSACREIALLRELKH 77

Query: 125 RNLVHLI-----------------------GWCHEQRQLILHKIALGLA----------- 150
            N++ L                              R    +K  + L            
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 151 -SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA----KLGDFGLARLVDHELGSQTTVLA 205
              + YLH  W   ++HRD+K +N+++          K+ D G ARL +  L     +  
Sbjct: 138 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 206 G--TMGYLAPE 214
              T  Y APE
Sbjct: 195 VVVTFWYRAPE 205

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 46/207 (22%), Positives = 88/207 (42%), Gaps = 47/207 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSR--GSKQGKKEYISEVRIISRLRHRNLVHLI- 131
            +G G +G V   +      ++A+K++SR   S+   K    E+ ++  ++H N++ L+ 
Sbjct: 31  HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 90

Query: 132 -------------------------------GWCHEQRQLILHKIALGLASAVLYLHEEW 160
                                           +  E+ Q +++++  GL     Y+H   
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLK----YIHS-- 144

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE-CVTTG 219
              +VHRD+K  N+ ++ +   K+ DFGLAR  D E+    T    T  Y APE  ++  
Sbjct: 145 -AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILSWM 199

Query: 220 KASKESDVYSFGVVALEVACGRKPVEP 246
             ++  D++S G +  E+    K +  
Sbjct: 200 HYNQTVDIWSVGCIMAEML-TGKTLFK 225

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 74.5 bits (183), Expect = 5e-15
 Identities = 34/102 (33%), Positives = 50/102 (49%), Gaps = 10/102 (9%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA--KLGDFGLARLVDHELGSQTTVL-- 204
           + SA+ YLH    Q I HRDIK  N +  +N +   KL DFGL++        +   +  
Sbjct: 177 IFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233

Query: 205 -AGTMGYLAPECVTTGKAS--KESDVYSFGVVALEVACGRKP 243
            AGT  ++APE + T   S   + D +S GV+   +  G  P
Sbjct: 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 41.7 bits (98), Expect = 2e-04
 Identities = 14/73 (19%), Positives = 35/73 (47%), Gaps = 5/73 (6%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVK-----RVSRGSKQGKKEYISEVRIISRLRHRNLVH 129
            +G+G +G V   + +      A+K     ++ + + +  +   +EVR++ +L H N+  
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 130 LIGWCHEQRQLIL 142
           L     +++ + L
Sbjct: 93  LYEVYEDEQYICL 105

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 75.1 bits (185), Expect = 5e-15
 Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 10/102 (9%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +  A+  +H       VHRDIK  N++LD   + +L DFG    +  +   ++ V  GT 
Sbjct: 171 IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227

Query: 209 GYLAPE-------CVTTGKASKESDVYSFGVVALEVACGRKP 243
            YL+PE          TG    E D ++ GV A E+  G+ P
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 46/214 (21%), Positives = 83/214 (38%), Gaps = 44/214 (20%)

Query: 67  TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSR--GSKQGKKEYISEVRIISRLRH 124
              +     +G G  G V     +     +A+K++SR   ++   K    E+ ++  + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 125 RNLVHLI--------------------------------GWCHEQRQLILHKIALGLASA 152
           +N++ L+                                   HE+   +L+++  G+   
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK-- 141

Query: 153 VLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLA 212
             +LH      I+HRD+K SN+V+ S+   K+ DFGLAR          T    T  Y A
Sbjct: 142 --HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRA 194

Query: 213 PECVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
           PE +      +  D++S G +  E+      + P
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMI-KGGVLFP 227

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 53/251 (21%), Positives = 95/251 (37%), Gaps = 48/251 (19%)

Query: 34  VGGHKEAIDIALEDEFEKGTGPKRFTYRELSRAT----NNFAEAGKLGEGGFGGVYRGLL 89
                +   IA      K     +F   E+  +T      +     +G G  G V     
Sbjct: 24  FDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYD 83

Query: 90  SDQNTEIAVKRVSR--GSKQGKKEYISEVRIISRLRHRNLVHLI---------------- 131
           +  +  +A+K++SR   ++   K    E+ ++  + H+N++ L+                
Sbjct: 84  AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143

Query: 132 ----------------GWCHEQRQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVV 175
                              HE+   +L+++  G+     +LH      I+HRD+K SN+V
Sbjct: 144 LVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK----HLHS---AGIIHRDLKPSNIV 196

Query: 176 LDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVAL 235
           + S+   K+ DFGLAR          T    T  Y APE +      +  D++S G +  
Sbjct: 197 VKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254

Query: 236 EVACGRKPVEP 246
           E+    K + P
Sbjct: 255 EMV-RHKILFP 264

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 53/207 (25%), Positives = 81/207 (39%), Gaps = 53/207 (25%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLI--- 131
            +G G FG VY+  L D    +A+K+V     Q K+    E++I+ +L H N+V L    
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFF 116

Query: 132 -----------------------------GWCHEQR------QLILHKIALGLASAVLYL 156
                                            +Q       +L ++++   LA    Y+
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA----YI 172

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHELGSQTTVLAGTMGYLAPE- 214
           H      I HRDIK  N++LD +    KL DFG A+ +    G        +  Y APE 
Sbjct: 173 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRAPEL 227

Query: 215 CVTTGKASKESDVYSFGVVALEVACGR 241
                  +   DV+S G V  E+  G+
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 33/97 (34%), Positives = 53/97 (54%), Gaps = 5/97 (5%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +  A+ +LH+     I++RDIK  N++LDSN +  L DFGL++    +   +     GT+
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224

Query: 209 GYLAPECVTTGKA--SKESDVYSFGVVALEVACGRKP 243
            Y+AP+ V  G +   K  D +S GV+  E+  G  P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 49/203 (24%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI----------SEVRIISRLRHR 125
           LG G FG V+           A+K +       KKE +           E  ++S + H 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLMLSIVTHP 66

Query: 126 NLVHLIGWCHEQRQL--ILHKIALG-----------------------LASAVLYLHEEW 160
            ++ + G   + +Q+  I+  I  G                       +  A+ YLH   
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-- 124

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK 220
            + I++RD+K  N++LD N + K+ DFG A+     +   T  L GT  Y+APE V+T  
Sbjct: 125 -KDIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYTLCGTPDYIAPEVVSTKP 179

Query: 221 ASKESDVYSFGVVALEVACGRKP 243
            +K  D +SFG++  E+  G  P
Sbjct: 180 YNKSIDWWSFGILIYEMLAGYTP 202

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 46/207 (22%), Positives = 87/207 (42%), Gaps = 48/207 (23%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSR--GSKQGKKEYISEVRIISRLRHRNLVHLI-- 131
           +G G +G V   +      ++A+K++ R   S+   K    E+R++  +RH N++ L+  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92

Query: 132 -------------------------------GWCHEQRQLILHKIALGLASAVLYLHEEW 160
                                              ++ Q +++++  GL     Y+H   
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR----YIHA-- 146

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE-CVTTG 219
              I+HRD+K  N+ ++ +   K+ DFGLAR  D E+    T    T  Y APE  +   
Sbjct: 147 -AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVVTRWYRAPEVILNWM 201

Query: 220 KASKESDVYSFGVVALEVACGRKPVEP 246
           + ++  D++S G +  E+    K +  
Sbjct: 202 RYTQTVDIWSVGCIMAEMI-TGKTLFK 227

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 72.1 bits (177), Expect = 5e-14
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 3/95 (3%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SA+ YLH E  + +V+RD+K  N++LD + + K+ DFGL +    + G+      GT 
Sbjct: 257 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTP 313

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 38/156 (24%), Positives = 64/156 (41%), Gaps = 51/156 (32%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
            +G G FG V++  L + + E+A+K+V     Q K+    E++I+  ++H N+V L  + 
Sbjct: 47  VIGNGSFGVVFQAKLVESD-EVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFF 101

Query: 135 HEQR--------------------------------------QLILHKIALGLASAVLYL 156
           +                                         +L ++++   LA    Y+
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA----YI 157

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNA-KLGDFGLAR 191
           H      I HRDIK  N++LD      KL DFG A+
Sbjct: 158 HS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 36/95 (37%), Positives = 50/95 (52%), Gaps = 4/95 (4%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +ASA+ YLH      IV+RD+K  N++LDS  +  L DFGL +  + E  S T+   GT 
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTP 203

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            YLAPE +      +  D +  G V  E+  G  P
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 40/219 (18%), Positives = 75/219 (34%), Gaps = 49/219 (22%)

Query: 64  SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR 123
            +  + F      G+G FG V  G        +A+K+V     + +   +  ++ ++ L 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLH 77

Query: 124 HRNLVHLI---------------------------------GWCHEQR------QLILHK 144
           H N+V L                                   +  +        ++ L +
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137

Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD-SNFNAKLGDFGLARLVDHELGSQTTV 203
           +   +      LH      + HRDIK  NV+++ ++   KL DFG A+ +          
Sbjct: 138 LIRSIG----CLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP--SEPNVA 190

Query: 204 LAGTMGYLAPE-CVTTGKASKESDVYSFGVVALEVACGR 241
              +  Y APE        +   D++S G +  E+  G 
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 4/95 (4%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SA+ YLH    + +V+RDIK  N++LD + + K+ DFGL +      G+      GT 
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTP 169

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            YLAPE +      +  D +  GVV  E+ CGR P
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 48/207 (23%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSR--GSKQGKKEYISEVRIISRLRHRNLVHLI-- 131
           +G G +G V     +     +AVK++SR   S    K    E+R++  ++H N++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96

Query: 132 -------------------------------GWCHEQRQLILHKIALGLASAVLYLHEEW 160
                                              +  Q ++++I  GL     Y+H   
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK----YIHS-- 150

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE-CVTTG 219
              I+HRD+K SN+ ++ +   K+ DFGLAR    E+    T    T  Y APE  +   
Sbjct: 151 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM----TGYVATRWYRAPEIMLNWM 205

Query: 220 KASKESDVYSFGVVALEVACGRKPVEP 246
             ++  D++S G +  E+    + + P
Sbjct: 206 HYNQTVDIWSVGCIMAELL-TGRTLFP 231

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 4/95 (4%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           LA A+ +LH      I++RD+K  N++LD   + KL DFGL++    +   +     GT+
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTV 190

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            Y+APE V     ++ +D +SFGV+  E+  G  P
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 46/208 (22%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ--GKKEYISEVRIISRLRHRNLVHLI-- 131
           +GEG +G V     +     +A+K++S    Q   ++    E++I+ R RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 93

Query: 132 ------------------------------GWCHEQRQLILHKIALGLASAVLYLHEEWE 161
                                            ++     L++I  GL     Y+H    
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK----YIHS--- 146

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT--TVLAGTMGYLAPE-CVTT 218
             ++HRD+K SN++L++  + K+ DFGLAR+ D +       T    T  Y APE  + +
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206

Query: 219 GKASKESDVYSFGVVALEVACGRKPVEP 246
              +K  D++S G +  E+    +P+ P
Sbjct: 207 KGYTKSIDIWSVGCILAEML-SNRPIFP 233

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 43/199 (21%), Positives = 77/199 (38%), Gaps = 35/199 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRNLVHLIGW 133
           KLG G +  V+  +    N ++ VK +    K   K+   E++I+  LR   N++ L   
Sbjct: 43  KLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADI 99

Query: 134 CHEQRQ----LI--------LHKI--ALG----------LASAVLYLHEEWEQCIVHRDI 169
             +       L+          ++   L           +  A+ Y H      I+HRD+
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS---MGIMHRDV 156

Query: 170 KSSNVVLDS-NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE-CVTTGKASKESDV 227
           K  NV++D  +   +L D+GLA       G +  V   +  +  PE  V         D+
Sbjct: 157 KPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPELLVDYQMYDYSLDM 214

Query: 228 YSFGVVALEVACGRKPVEP 246
           +S G +   +   ++P   
Sbjct: 215 WSLGCMLASMIFRKEPFFH 233

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 4/95 (4%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           ++ A+ YLHE   + I++RD+K  NV+LDS  + KL D+G+ +      G  T+   GT 
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTP 174

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            Y+APE +         D ++ GV+  E+  GR P
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 68.7 bits (169), Expect = 4e-13
 Identities = 28/95 (29%), Positives = 52/95 (54%), Gaps = 4/95 (4%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           ++ A+ +LH+   + I++RD+K  N++L+   + KL DFGL +      G+ T    GT+
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTI 185

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            Y+APE +     ++  D +S G +  ++  G  P
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 43/204 (21%), Positives = 64/204 (31%), Gaps = 66/204 (32%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGW 133
            LG G  G V +        + A+K +    K  +     EV +  R  +  ++V ++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDV 79

Query: 134 CHEQRQL-------------------ILHK------------IALGLASAVLYLHEEWEQ 162
                                     I  +            I   +  A+ YLH     
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 136

Query: 163 CIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
            I HRD+K  N++  S   N   KL DFG                       A E  T  
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFG----------------------FAKE-TTGE 173

Query: 220 KASKESDVYSFGVVALEVACGRKP 243
           K  K  D++S GV+   + CG  P
Sbjct: 174 KYDKSCDMWSLGVIMYILLCGYPP 197

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 4/95 (4%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +A  + +L     + I++RD+K  NV+LDS  + K+ DFG+ +  +   G  T    GT 
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTP 506

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            Y+APE +      K  D ++FGV+  E+  G+ P
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 67.8 bits (166), Expect = 5e-13
 Identities = 23/211 (10%), Positives = 52/211 (24%), Gaps = 61/211 (28%)

Query: 74  GKLGEGGFGGVYRGLLSDQNT--EIAVKRV---SRGSKQGKKEYISEVRIISRLRHRNLV 128
              G       ++ L  D     ++A+  V           +E +S    +SR+    + 
Sbjct: 37  IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 129 HLIGWCHEQ---------------RQLILH--------KIALGLASAVLYLHEEWEQCIV 165
            ++   H +               +++           +    LA+A    H      + 
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG---VA 151

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES 225
                 S V +  + +  L                          +         A+ + 
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYP---------------------ATMPD-------ANPQD 183

Query: 226 DVYSFGVVALEVACGRKPVEPRQEPSKVRLV 256
           D+   G     +   R P+      S +   
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLAPA 214

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 4/95 (4%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           ++ A+ YLHE   + I++RD+K  NV+LDS  + KL D+G+ +      G  T+   GT 
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTP 217

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            Y+APE +         D ++ GV+  E+  GR P
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 68.0 bits (167), Expect = 7e-13
 Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 4/95 (4%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +   + +LH    + IV+RD+K  N++LD + + K+ DFG+ +  +    ++T    GT 
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTP 182

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            Y+APE +   K +   D +SFGV+  E+  G+ P
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.0 bits (167), Expect = 8e-13
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 4/95 (4%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           +A  + +L     + I++RD+K  NV+LDS  + K+ DFG+ +  +   G  T    GT 
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTP 185

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            Y+APE +      K  D ++FGV+  E+  G+ P
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 67.7 bits (166), Expect = 9e-13
 Identities = 48/218 (22%), Positives = 78/218 (35%), Gaps = 57/218 (26%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI-----------SEVRIISRLR 123
            +  G +G V  G+   +   +A+KRV      G+   I            E+R+++   
Sbjct: 29  FISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 124 HRNLVHLI----------------------------------GWCHEQRQLILHKIALGL 149
           H N++ L                                       +  Q  ++ I LGL
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147

Query: 150 ASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMG 209
                 LHE     +VHRD+   N++L  N +  + DF LAR    +  +  T       
Sbjct: 148 H----VLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHRW 198

Query: 210 YLAPE-CVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
           Y APE  +     +K  D++S G V  E+   RK +  
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFR 235

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 4/95 (4%)

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
           + SA+++LH+   + I++RD+K  NV+LD   + KL DFG+ +      G  T    GT 
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTATFCGTP 188

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            Y+APE +         D ++ GV+  E+ CG  P
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 55/218 (25%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLI--- 131
            LG GG G V+  + +D +  +A+K++     Q  K  + E++II RL H N+V +    
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77

Query: 132 --------------------------------------GWCHEQRQLILHKIALGLASAV 153
                                                     E  +L ++++  GL    
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLK--- 134

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDS-NFNAKLGDFGLARLVDHELGSQTTVLAG---TMG 209
            Y+H      ++HRD+K +N+ +++ +   K+GDFGLAR++D    S    L+    T  
Sbjct: 135 -YIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH-YSHKGHLSEGLVTKW 189

Query: 210 YLAPE-CVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
           Y +P   ++    +K  D+++ G +  E+    K +  
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKTLFA 226

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 48/235 (20%), Positives = 85/235 (36%), Gaps = 64/235 (27%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSR--GSKQGKKEYISEVRIISRLRHRNLVHL-- 130
            +G G +G VY     +    +A+K+V+R        K  + E+ I++RL+   ++ L  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92

Query: 131 -------------------------------IGWCHEQRQLILHKIALGLASAVLYLHEE 159
                                          I    E  + IL+ + LG      ++HE 
Sbjct: 93  LIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGEN----FIHE- 147

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG------------- 206
               I+HRD+K +N +L+ + + K+ DFGLAR ++ E  +                    
Sbjct: 148 --SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205

Query: 207 --------TMGYLAPE-CVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSK 252
                   T  Y APE  +     +K  D++S G +  E+    +          
Sbjct: 206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 29/108 (26%), Positives = 49/108 (45%), Gaps = 13/108 (12%)

Query: 142 LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT 201
           L   +  +A  + +L     +  +HRD+ + N++L      K+ DFGLAR +  +     
Sbjct: 195 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---- 247

Query: 202 TVLAGTMGYL-----APECVTTGKASKESDVYSFGVVALEVAC-GRKP 243
             +      L     APE +     + +SDV+SFGV+  E+   G  P
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 19/75 (25%), Positives = 35/75 (46%), Gaps = 7/75 (9%)

Query: 75  KLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRGSKQG-KKEYISEVRIISRL-RHRNL 127
            LG G FG V          +     +AVK +  G+     +  +SE++I+  +  H N+
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 128 VHLIGWCHEQRQLIL 142
           V+L+G C +    ++
Sbjct: 89  VNLLGACTKPGGPLM 103

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 33/185 (17%), Positives = 69/185 (37%), Gaps = 42/185 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSR--GSKQGKKEYISEVRIISRLRHRNLVHLIG 132
            +G G +G V       +   +A+K++ R        K  + E+ I++RL H ++V ++ 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119

Query: 133 WCH---------------------------------EQRQLILHKIALGLASAVLYLHEE 159
                                                  + +L+ + +G+     Y+H  
Sbjct: 120 IVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVK----YVHS- 174

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
               I+HRD+K +N +++ + + K+ DFGLAR VD+     + +                
Sbjct: 175 --AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232

Query: 220 KASKE 224
             + +
Sbjct: 233 TKNLK 237

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 51/215 (23%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSR-GSKQGKKEYISEVRIISRLRHRNLVHLI-- 131
            LGEG +G V           +A+K++            + E++I+   +H N++ +   
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77

Query: 132 ------------------------------GWCHEQRQLILHKIALGLASAVLYLHEEWE 161
                                             +  Q  +++    +      LH    
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVK----VLHG--- 130

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAG---------TMGYLA 212
             ++HRD+K SN++++SN + K+ DFGLAR++D      +              T  Y A
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190

Query: 213 PE-CVTTGKASKESDVYSFGVVALEVACGRKPVEP 246
           PE  +T+ K S+  DV+S G +  E+   R+P+ P
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFP 224

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 43/217 (19%), Positives = 78/217 (35%), Gaps = 58/217 (26%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR---------- 123
            KLG G F  V+       NT +A+K + RG K   +    E++++ R+           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 124 -HRNLVHLIGW-----------C----------------HEQRQL---ILHKIALGLASA 152
              +++ L+                              +E R +    + +I+  L   
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 143

Query: 153 VLYLHEEWEQCIVHRDIKSSNVVLD------SNFNAKLGDFGLARLVDHELGS--QTTVL 204
           + Y+H      I+H DIK  NV+++      +    K+ D G A   D    +  QT   
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE- 200

Query: 205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGR 241
                Y +PE +        +D++S   +  E+  G 
Sbjct: 201 -----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 33/177 (18%), Positives = 68/177 (38%), Gaps = 39/177 (22%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSR--GSKQGKKEYISEVRIISRLR-HRNLVHLI 131
           KLG+G +G V++ +       +AVK++     +    +    E+ I++ L  H N+V+L+
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75

Query: 132 GWC-----------------------------HEQRQLILHKIALGLASAVLYLHEEWEQ 162
                                              +Q +++++   +     YLH     
Sbjct: 76  NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIK----YLHS---G 128

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
            ++HRD+K SN++L++  + K+ DFGL+R   +       +                
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 32/148 (21%), Positives = 55/148 (37%), Gaps = 38/148 (25%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRH---------- 124
           K+G G FG +Y G       E+A+K     +K  +     E +I   ++           
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWC 73

Query: 125 ---------------RNLVHLIGWCHEQRQLILH---KIALGLASAVLYLHEEWEQCIVH 166
                           +L  L  +C   R+  L     +A  + S + Y+H    +  +H
Sbjct: 74  GAEGDYNVMVMELLGPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIH 128

Query: 167 RDIKSSNVVLDSNFNAK---LGDFGLAR 191
           RD+K  N ++          + DFGLA+
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 42/205 (20%), Positives = 78/205 (38%), Gaps = 48/205 (23%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVK---RVSRGSKQGKKEYISEVRIISRLRHR----- 125
             +G+G FG V +      +  +A+K      R  +Q  +E    +RI+  LR +     
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNT 158

Query: 126 -NLVHLIGW-CHEQ-------------RQLI------------LHKIALGLASAVLYLHE 158
            N++H++                     +LI            + K A  +   +  LH+
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218

Query: 159 EWEQCIVHRDIKSSNVVLDSNFNA--KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV 216
                I+H D+K  N++L     +  K+ DFG +      +    T +  +  Y APE +
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTYIQ-SRFYRAPEVI 271

Query: 217 TTGKASKESDVYSFGVVALEVACGR 241
              +     D++S G +  E+  G 
Sbjct: 272 LGARYGMPIDMWSLGCILAELLTGY 296

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 37/148 (25%), Positives = 60/148 (40%), Gaps = 38/148 (25%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRH---------- 124
           K+G G FG +Y G     N E+A+K  +  +K  +  Y  E +I   L+           
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWF 71

Query: 125 ---------------RNLVHLIGWCHEQRQLILH---KIALGLASAVLYLHEEWEQCIVH 166
                           +L  L  +C   R+L L     +A  + + V ++H    +  +H
Sbjct: 72  GVEGDYNVLVMDLLGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVH---SKSFLH 126

Query: 167 RDIKSSNVVLDSNFNAK---LGDFGLAR 191
           RDIK  N ++     A    + DFGLA+
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 31/150 (20%), Positives = 55/150 (36%), Gaps = 40/150 (26%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRH---------- 124
           ++GEG FG ++ G     N ++A+K   R S     +   E R    L            
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 125 ---------------RNLVHLIGWCHEQRQLILH---KIALGLASAVLYLHEEWEQCIVH 166
                           +L  L+  C   R+  +      A  + + V  +H   E+ +V+
Sbjct: 75  GQEGLHNVLVIDLLGPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIH---EKSLVY 129

Query: 167 RDIKSSNVVLDSNFNAK-----LGDFGLAR 191
           RDIK  N ++    +       + DFG+ +
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 35/157 (22%), Positives = 55/157 (35%), Gaps = 40/157 (25%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRH--- 124
            NF    K+G G FG +  G     N  +A+K     S+  +     E R   +L     
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66

Query: 125 ----------------------RNLVHLIGWCHEQRQLILH---KIALGLASAVLYLHEE 159
                                  +L  L   C   R   L     IA+ L S + Y+H +
Sbjct: 67  IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAK-----LGDFGLAR 191
               +++RD+K  N ++    N       + DF LA+
Sbjct: 125 ---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 39/205 (19%), Positives = 74/205 (36%), Gaps = 46/205 (22%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVK---RVSRGSKQGKKEYISEVRIISRLRHR----- 125
             +G+G FG V +     +   +A+K          Q + E    VR++  +        
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELMNKHDTEMK 115

Query: 126 -NLVHLIGW-CHEQ-------------RQLI------------LHKIALGLASAVLYLHE 158
             +VHL                       L+              K A  + +A+L+L  
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175

Query: 159 EWEQCIVHRDIKSSNVVLDSNFNA--KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV 216
             E  I+H D+K  N++L +   +  K+ DFG +  +   +      +  +  Y +PE +
Sbjct: 176 P-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQ-SRFYRSPEVL 230

Query: 217 TTGKASKESDVYSFGVVALEVACGR 241
                    D++S G + +E+  G 
Sbjct: 231 LGMPYDLAIDMWSLGCILVEMHTGE 255

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 27/110 (24%), Positives = 49/110 (44%), Gaps = 12/110 (10%)

Query: 139 QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA-KLGDFGLARLVDHEL 197
            + ++++   +     ++H      I HRDIK  N++++S  N  KL DFG A+ +    
Sbjct: 144 SIYIYQLFRAVG----FIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP-- 194

Query: 198 GSQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEP 246
              +     +  Y APE +      +   D++S G V  E+    KP+  
Sbjct: 195 SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL-ILGKPLFS 243

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 16/57 (28%), Positives = 25/57 (43%), Gaps = 4/57 (7%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLI 131
            LG G FG V      +     A+K+V     Q  +    E+ I+  L H N++ L+
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVNIIKLV 66

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 21/165 (12%), Positives = 50/165 (30%), Gaps = 52/165 (31%)

Query: 75  KLGEGGFGGVYRG--------LLSDQNTEIAVKRVSRGSK----------QGKKEYISEV 116
                  G +Y              Q  + ++K  ++  +            K   +++ 
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 117 RIISRLRH-------------------------RNLVHLIGWCHEQR---QLILHKIALG 148
           + +                              R+L   +    +     + +L ++A  
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVL-QVACR 167

Query: 149 LASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAK--LGDFGLAR 191
           L  A+ +LHE      VH ++ + N+ +D    ++  L  +G A 
Sbjct: 168 LLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 49.4 bits (118), Expect = 8e-07
 Identities = 30/166 (18%), Positives = 57/166 (34%), Gaps = 54/166 (32%)

Query: 75  KLGEGGFGGVYRGLLSDQ-----NTEIAVKRVSRGSKQ-----------GKKEYISEVRI 118
            +G+GGFG +Y   ++       +    VK     +              K E I +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 119 ISRLRH----------------------------RNLVHLIGWCHEQRQLILH---KIAL 147
             +L++                             +L  +       ++       +++L
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA--KRFSRKTVLQLSL 159

Query: 148 GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAK--LGDFGLAR 191
            +   + Y+HE      VH DIK+SN++L+     +  L D+GLA 
Sbjct: 160 RILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 43/261 (16%), Positives = 75/261 (28%), Gaps = 94/261 (36%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRN------- 126
            KLG G F  V+          +A+K V + ++   +  + E+R++  +R+ +       
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 127 --------------------LVH---------LIGWCHEQR--QLILHKIALGLASAVLY 155
                               +V           I   + Q      + KI   +   + Y
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161

Query: 156 LHEEWEQCIVHRDIKSSNVVL--------------------------------------- 176
           LH +    I+H DIK  N++L                                       
Sbjct: 162 LHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219

Query: 177 ----------DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
                           K+ D G A  V             T  Y + E +     +  +D
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPAD 275

Query: 227 VYSFGVVALEVACGRKPVEPR 247
           ++S   +A E+A G    EP 
Sbjct: 276 IWSTACMAFELATGDYLFEPH 296

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 44.1 bits (103), Expect = 4e-05
 Identities = 21/102 (20%), Positives = 36/102 (35%), Gaps = 22/102 (21%)

Query: 53  TGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK------ 106
            GP  F++      T       K+GEG FG V++      +T +A+K ++          
Sbjct: 8   KGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGS 62

Query: 107 --QGKKEYISEVRIISRL---------RHRNLVHLIGWCHEQ 137
             +  +E + E+ I   L         R    + L      Q
Sbjct: 63  HQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQ 104

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 43.6 bits (103), Expect = 7e-05
 Identities = 30/162 (18%), Positives = 60/162 (37%), Gaps = 49/162 (30%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ--------------GKKEYISEVRIIS 120
           K+G GGFG +Y    +++  + A   V    ++               KK+ I +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 121 RLRH----------------------------RNLVHLIGWCHE-QRQLILHKIALGLAS 151
           +L +                             +L  + G     ++  +L ++ + +  
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL-QLGIRMLD 162

Query: 152 AVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAK--LGDFGLAR 191
            + Y+HE      VH DIK++N++L      +  L D+GL+ 
Sbjct: 163 VLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 44/222 (19%), Positives = 80/222 (36%), Gaps = 66/222 (29%)

Query: 74  GKLGEGGFGGVYRGL-LSDQNTEIAVK---RVSRGSKQGKKEYISEVRIISRLRHR---- 125
           G LGEG FG V   L  +   +++A+K    V +  +  +     E+ ++ +++ +    
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL----EINVLKKIKEKDKEN 80

Query: 126 --NLVHLIGW-------C----------------HEQRQLILH---KIALGLASAVLYLH 157
               V +  W       C                +  +   L     +A  L  A+ +LH
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140

Query: 158 EEWEQCIVHRDIKSSNVVLDSNFNA-------------------KLGDFGLARLVDHELG 198
           E     + H D+K  N++  ++                      ++ DFG A        
Sbjct: 141 EN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH- 196

Query: 199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACG 240
             TT++A T  Y  PE +     ++  DV+S G +  E   G
Sbjct: 197 --TTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 45/226 (19%), Positives = 75/226 (33%), Gaps = 70/226 (30%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVK---RVSRGSKQGKKEYISEVRIISRLRHR----- 125
            K+G+G FG V      D     AVK    + + ++  K     E  I+ ++++      
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDDINNN 96

Query: 126 NLVHLIGW-------C----------------HEQRQL---ILHKIALGLASAVLYLHEE 159
           N+V   G        C                +         +    + +  A+ YL + 
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156

Query: 160 WEQCIVHRDIKSSNVVLDSNFNA-------------------------KLGDFGLARLVD 194
               + H D+K  N++LD  +                           KL DFG A    
Sbjct: 157 ---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213

Query: 195 HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACG 240
                  +++  T  Y APE +        SD++SFG V  E+  G
Sbjct: 214 DYH---GSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 40.6 bits (94), Expect = 8e-04
 Identities = 48/370 (12%), Positives = 102/370 (27%), Gaps = 119/370 (32%)

Query: 25  IWFMYW---RKRVGGHKEAIDIALEDEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGF 81
              ++W    K+    ++ ++  L   ++    P +   R+ S  T  + E         
Sbjct: 64  TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIE--------- 114

Query: 82  GGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRI-ISRLRHRNLVHLIG-------- 132
               R  L + N   A   VSR       +   ++R  +  LR    V + G        
Sbjct: 115 ---QRDRLYNDNQVFAKYNVSR------LQPYLKLRQALLELRPAKNVLIDGVLGSGKTW 165

Query: 133 --------------------W-----CH------EQRQLILHKIALGLASAV-------- 153
                               W     C+      E  Q +L++I     S          
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL 225

Query: 154 -----------LYLHEEWEQC-IVHRDIKSSNVVLDSNFNAKL----GDFGLARLVDHEL 197
                      L   + +E C +V  +++++      N + K+        +   +    
Sbjct: 226 RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAAT 285

Query: 198 GSQTTVLAGTMGYLAPECVTTGKASKE--SDVYSFGVVAL-EVACGRKPV-------EPR 247
            +  ++   +M     E        K             L        P          R
Sbjct: 286 TTHISLDHHSMTLTPDE-------VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIR 338

Query: 248 QEPSKVRLVEW-VWDLYGKGQLLEAADGRLS--KEFDERQM-ECLMIVGLWCCHPDFTNR 303
              +      W  W      +L    +  L+  +  + R+M + L +       P   + 
Sbjct: 339 DGLAT-----WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF------PPSAHI 387

Query: 304 PSIRQVINVL 313
           P+   +++++
Sbjct: 388 PT--ILLSLI 395

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	387
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.72
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.52
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.9
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.7
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.37
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.25
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.67
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.59
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.58
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.53
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.2
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.17
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.06
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	96.74
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	96.54
3ats_A	357	Putative uncharacterized protein; hypothetical pro	96.43
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.07
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.95
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	95.75
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.7
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	95.47
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.36
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.34
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.16
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	94.75
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	93.75
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	92.67
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	92.64
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	91.7
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	90.09
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.44
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	88.26
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	86.45
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	84.19
2l9u_A	40	Receptor tyrosine-protein kinase ERBB-3; transmenb	81.36
2l34_A	33	TYRO protein tyrosine kinase-binding protein; immu	80.9

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-53  Score=396.96  Aligned_cols=233  Identities=23%  Similarity=0.312  Sum_probs=192.3

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~------  141 (387)
                      +.|+..++||+|+||+||+|+++.+|+.||||++........+.+.+|+++|+.++|||||++++++.+.+..+      
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999999999999999997665556677899999999999999999999887654332      


Q ss_pred             ------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          142 ------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       142 ------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                        +..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++.+.... .....
T Consensus       154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~  229 (346)
T 4fih_A          154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS  229 (346)
T ss_dssp             TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCC
T ss_pred             CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccccc
Confidence                              26799999999999999   999999999999999999999999999998765432 23345


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      .+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+..   ..+..    .     ..+.  ......
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~i~~----~-----~~~~--~~~~~~  295 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRD----N-----LPPR--LKNLHK  295 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHH----S-----SCCC--CSCGGG
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHHc----C-----CCCC--CCcccc
Confidence            68999999999999999999999999999999999999999765432211   11111    0     1111  112233


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .+..+.+|+.+||+.||.+|||++|+++|.|+...
T Consensus       296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence            45668899999999999999999999999998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.9e-54  Score=402.34  Aligned_cols=233  Identities=22%  Similarity=0.349  Sum_probs=184.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      .++|...+.||+|+||+||+|++..+|+.||||++...  .....+.+.+|+++|++++|||||++++++.+....    
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            36899999999999999999999999999999999754  344567899999999999999999999987664322    


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                             .+..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++......
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence                                   235789999999999999   999999999999999999999999999998664321


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||......+.   ..   ... .+..         
T Consensus       180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~---~i~-~~~~---------  242 (350)
T 4b9d_A          180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL---VL---KII-SGSF---------  242 (350)
T ss_dssp             -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH---HHH-HTCC---------
T ss_pred             -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HH---HHH-cCCC---------
Confidence             122345799999999999999999999999999999999999999976543221   11   111 1111         


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPL  319 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  319 (387)
                      ...+...+..+.+|+.+||+.||.+|||++|+++|.|+....
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            112233455688999999999999999999999999986544

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2e-53  Score=396.01  Aligned_cols=231  Identities=26%  Similarity=0.411  Sum_probs=180.9

Q ss_pred             hCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      ++|...++||+|+||.||+|++..     ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+....  
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            567778899999999999999753     5789999999887777788999999999999999999999998764321  


Q ss_pred             --------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcE
Q 043148          141 --------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA  182 (387)
Q Consensus       141 --------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  182 (387)
                                                            .+..++.||+.||.|||+   ++|+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence                                                  125799999999999999   999999999999999999999


Q ss_pred             EEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 043148          183 KLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVW  260 (387)
Q Consensus       183 kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~  260 (387)
                      ||+|||+++....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||......+.   ...  
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~--  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---IDC--  272 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HHH--
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HHH--
Confidence            9999999986644322 22334578999999999999999999999999999999999 8999986543221   111  


Q ss_pred             HHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                        +..+.         ....+..++..+.+|+.+||+.||.+||||+||+++|+...
T Consensus       273 --i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          273 --ITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             --HHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --HHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence              11111         11223345566889999999999999999999999997543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-53  Score=391.27  Aligned_cols=229  Identities=27%  Similarity=0.420  Sum_probs=184.9

Q ss_pred             hCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      ++|...+.||+|+||+||+|++..     ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..  
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            567788999999999999998753     5788999999887777788999999999999999999999998664321  


Q ss_pred             ------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEE
Q 043148          141 ------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKL  184 (387)
Q Consensus       141 ------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl  184 (387)
                                                          .+..++.||+.||.|||+   ++|+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence                                                125789999999999999   99999999999999999999999


Q ss_pred             ccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 043148          185 GDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDL  262 (387)
Q Consensus       185 ~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~  262 (387)
                      +|||+++........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||......+   ...    .
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~----~  242 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE----C  242 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH----H
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----H
Confidence            999999866443222 2233568999999999999999999999999999999998 899998654322   111    1


Q ss_pred             hccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          263 YGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      +..+.         ....+..++..+.+|+.+||+.||.+|||++||++.|+.
T Consensus       243 i~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~  286 (299)
T 4asz_A          243 ITQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN  286 (299)
T ss_dssp             HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            11111         112233455678899999999999999999999988863

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.9e-53  Score=389.36  Aligned_cols=231  Identities=26%  Similarity=0.382  Sum_probs=183.5

Q ss_pred             hCccccCcccccCceEEEEEEEC-----CCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLS-----DQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-  140 (387)
                      .+++..++||+|+||+||+|++.     .+++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+.... 
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34556779999999999999974     356889999997543 34467899999999999999999999998654321 


Q ss_pred             ----------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC
Q 043148          141 ----------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF  180 (387)
Q Consensus       141 ----------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~  180 (387)
                                                              .+..++.|||.||.|||+   ++|+||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence                                                    125689999999999999   9999999999999999999


Q ss_pred             cEEEccccccccccCCC-CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 043148          181 NAKLGDFGLARLVDHEL-GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEW  258 (387)
Q Consensus       181 ~~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~  258 (387)
                      .+||+|||+++...... ........||+.|||||++.++.|+.++|||||||+||||+| |+.||.+....+   ... 
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~-  258 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVE-  258 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHH-
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHH-
Confidence            99999999998664432 222344578999999999999999999999999999999998 899998655322   111 


Q ss_pred             HHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          259 VWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                         .+..+.         ....+..++..+.+|+.+||+.||.+||||.||+++|+...
T Consensus       259 ---~i~~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          259 ---MIRNRQ---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             ---HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ---HHHcCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence               111111         11233445667889999999999999999999999997543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-52  Score=385.13  Aligned_cols=233  Identities=27%  Similarity=0.457  Sum_probs=178.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      .+++...++||+|+||+||+|++.+   .||||+++..  +....+.|.+|+++|++++|||||+++|+|.++..     
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEE
Confidence            3567778899999999999999754   5999998654  34556789999999999999999999998865321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC-C
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL-G  198 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~  198 (387)
                                          .....++.|||.||.|||+   ++|+||||||+||||++++.+||+|||+++...... .
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence                                1126799999999999999   999999999999999999999999999998665432 2


Q ss_pred             ceeeeeecCCcccCchhhcc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          199 SQTTVLAGTMGYLAPECVTT---GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      ......+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+.......      ......+.    ..+.
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~~~----~~p~  258 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGRGY----ASPD  258 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHTTC----CCCC
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcCC----CCCC
Confidence            23445679999999999864   45899999999999999999999999865533211      11111111    1111


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      + ...+..++..+.+++.+||+.||.+||||.||+++|+..
T Consensus       259 ~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          259 L-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             S-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             c-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            1 122334556788999999999999999999999998753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1e-52  Score=380.48  Aligned_cols=231  Identities=26%  Similarity=0.390  Sum_probs=175.9

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI---  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~---  141 (387)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.+..   ....+.+.+|+++|+.++|||||++++++.+....+   
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999999999999999997542   233567999999999999999999999876654322   


Q ss_pred             ---------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          142 ---------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       142 ---------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                           ...++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....  ..
T Consensus        93 Ey~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~  167 (275)
T 3hyh_A           93 EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NF  167 (275)
T ss_dssp             ECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCC--Cc
Confidence                                 26899999999999999   99999999999999999999999999999865442  23


Q ss_pred             eeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          201 TTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ....+||+.|||||++.+..| +.++||||+||++|||++|+.||.+.....   ...    .+..+.          ..
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~----~i~~~~----------~~  230 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFK----NISNGV----------YT  230 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHTC----------CC
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHH----HHHcCC----------CC
Confidence            345679999999999998876 689999999999999999999997643221   111    111111          11


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLP  320 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  320 (387)
                      ++...+..+.+++.+||+.||.+|||++|+++|.|+....|
T Consensus       231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p  271 (275)
T 3hyh_A          231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLP  271 (275)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCC
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccCCC
Confidence            22234456789999999999999999999999999976554

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-52  Score=379.58  Aligned_cols=226  Identities=25%  Similarity=0.429  Sum_probs=179.1

Q ss_pred             cccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcch----h------
Q 043148           71 AEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ----R------  138 (387)
Q Consensus        71 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~------  138 (387)
                      ...++||+|+||+||+|.+..++..||||.+...  .....+.|.+|+++|++++|||||+++++|.+.    .      
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            5566899999999999999999999999998643  345567899999999999999999999987531    1      


Q ss_pred             -------------------hHHHHHHHHHHHHHHHHhhhhcccc--eeeccCCcceeEeC-CCCcEEEccccccccccCC
Q 043148          139 -------------------QLILHKIALGLASAVLYLHEEWEQC--IVHRDIKSSNVVLD-SNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       139 -------------------~~~l~~i~~~i~~~l~~LH~~~~~~--iiH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~  196 (387)
                                         ...+..++.||+.||.|||+   ++  |+||||||+||||+ .++.+||+|||+++.... 
T Consensus       109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence                               11126789999999999998   76  99999999999998 489999999999985443 


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                        ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+......      +...+..+.        .
T Consensus       185 --~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~------~~~~i~~~~--------~  247 (290)
T 3fpq_A          185 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGV--------K  247 (290)
T ss_dssp             --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTC--------C
T ss_pred             --CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH------HHHHHHcCC--------C
Confidence              23445689999999998865 699999999999999999999999976443221      111111111        1


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ....+...+..+.+|+.+||+.||.+|||++|+++|+|+..
T Consensus       248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            11222223345788999999999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3e-52  Score=397.44  Aligned_cols=233  Identities=23%  Similarity=0.315  Sum_probs=192.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~------  141 (387)
                      +.|+..++||+|+||.||+|+++.+|+.||||++........+.+.+|+++|+.++|||||+++++|.+.+..+      
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999999999999999998766666778999999999999999999999887654332      


Q ss_pred             ------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          142 ------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       142 ------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                        +..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++.+.... .....
T Consensus       231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~  306 (423)
T 4fie_A          231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS  306 (423)
T ss_dssp             TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCBCC
T ss_pred             CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccccc
Confidence                              26799999999999999   999999999999999999999999999998765432 23345


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      .+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+..   ..+.    ..     ..+.+  .....
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~i~----~~-----~~~~~--~~~~~  372 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIR----DN-----LPPRL--KNLHK  372 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH----HS-----CCCCC--SCTTS
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHH----cC-----CCCCC--ccccc
Confidence            68999999999999999999999999999999999999999765432211   1111    11     01111  11223


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .+..+.+|+.+||+.||.+|||++|+++|.|+...
T Consensus       373 ~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          373 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence            45568899999999999999999999999998753

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.4e-52  Score=383.20  Aligned_cols=231  Identities=25%  Similarity=0.339  Sum_probs=188.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI--  141 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~--  141 (387)
                      .++|+..+.||+|+||+||+|++..+|+.||||++.+.   .....+.+.+|+++|+.++|||||++++++.+....+  
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36799999999999999999999999999999999653   2234577999999999999999999999887654332  


Q ss_pred             -----------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC-
Q 043148          142 -----------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL-  197 (387)
Q Consensus       142 -----------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-  197 (387)
                                             ...++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.... 
T Consensus       111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence                                   26799999999999999   999999999999999999999999999998765432 


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      .......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..+.   ...+.    .+.          
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~----~~~----------  250 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI---FAKII----KLE----------  250 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HTC----------
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----cCC----------
Confidence            2334567899999999999999999999999999999999999999976543221   11111    111          


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHhccCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQ------VINVLNFEA  317 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~e------vl~~l~~~~  317 (387)
                      ..++...+..+.+|+.+||+.||.+|||++|      |++|+||..
T Consensus       251 ~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~  296 (311)
T 4aw0_A          251 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES  296 (311)
T ss_dssp             CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence            1122334456889999999999999999987      577888753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.6e-51  Score=379.04  Aligned_cols=226  Identities=21%  Similarity=0.186  Sum_probs=180.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI-----  141 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-----  141 (387)
                      .+.|...++||+|+||.||+|+++.+|+.||||+++....     ..+|+.+|+.++|||||++++++.+....+     
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            3567888899999999999999999999999999975422     247999999999999999999887654332     


Q ss_pred             --------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC-cEEEccccccccccCCCCc-
Q 043148          142 --------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF-NAKLGDFGLARLVDHELGS-  199 (387)
Q Consensus       142 --------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~-  199 (387)
                                          ...++.||+.||.|||+   ++|+||||||+||||+.++ .+||+|||+++........ 
T Consensus       132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence                                26799999999999999   9999999999999999987 6999999999876543211 


Q ss_pred             ---eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          200 ---QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       200 ---~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                         .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+.      ....        .
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~~--------~  274 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SEPP--------P  274 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HSCC--------G
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cCCC--------C
Confidence               1223579999999999999999999999999999999999999998765443322111      0100        0


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ....+..++..+.+++.+||+.||.+|||+.|++++|.
T Consensus       275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~  312 (336)
T 4g3f_A          275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG  312 (336)
T ss_dssp             GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence            11233345566889999999999999999999999885

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.6e-50  Score=379.44  Aligned_cols=236  Identities=23%  Similarity=0.365  Sum_probs=187.5

Q ss_pred             HHHHHHhhCccccCcccccCceEEEEEEECCC-----CeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCC-CCccceehh
Q 043148           61 RELSRATNNFAEAGKLGEGGFGGVYRGLLSDQ-----NTEIAVKRVSRGS-KQGKKEYISEVRIISRLRH-RNLVHLIGW  133 (387)
Q Consensus        61 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~  133 (387)
                      .+++...++|+..+.||+|+||.||+|.+...     ++.||||++.... ....+.|.+|+++|.+++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            34444567899999999999999999997653     3689999997653 3456789999999999965 999999998


Q ss_pred             hcchhh-H-----------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCc
Q 043148          134 CHEQRQ-L-----------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKS  171 (387)
Q Consensus       134 ~~~~~~-~-----------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~  171 (387)
                      |.+... .                                         .+..++.|||.||.|||+   ++||||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCc
Confidence            854321 1                                         124688999999999999   9999999999


Q ss_pred             ceeEeCCCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCC
Q 043148          172 SNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQE  249 (387)
Q Consensus       172 ~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~  249 (387)
                      +|||+++++.+||+|||+++....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+...
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654332 23345678999999999999999999999999999999998 9999987553


Q ss_pred             cchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          250 PSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .+..      ...+..+         .....+..++..+.+++..||+.||.+|||+.||+++|.
T Consensus       294 ~~~~------~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~  343 (353)
T 4ase_A          294 DEEF------CRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  343 (353)
T ss_dssp             SHHH------HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHH------HHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence            3211      1111111         112233344566889999999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.5e-51  Score=376.29  Aligned_cols=229  Identities=23%  Similarity=0.302  Sum_probs=178.4

Q ss_pred             hCccccCcccccCceEEEEEEEC---CCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH-
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLS---DQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI-  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-  141 (387)
                      ++|++.+.||+|+||+||+|+..   .+++.||||++.+..  ......+.+|+++|++++|||||++++++.+....+ 
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            67999999999999999999873   457899999997542  233457889999999999999999999887654332 


Q ss_pred             ------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          142 ------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       142 ------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                              +..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence                                    26799999999999999   999999999999999999999999999998654322


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+..   ..+.    ...          
T Consensus       181 -~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---~~i~----~~~----------  242 (304)
T 3ubd_A          181 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM---TMIL----KAK----------  242 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HCC----------
T ss_pred             -ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH---HHHH----cCC----------
Confidence             2334567999999999999999999999999999999999999999865432211   1111    111          


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFEA  317 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  317 (387)
                      ..++...+..+.+|+.+||+.||.+|||     ++|+++|.|+..
T Consensus       243 ~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          243 LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            1122334556889999999999999998     689999999853

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.5e-50  Score=367.53  Aligned_cols=230  Identities=25%  Similarity=0.421  Sum_probs=172.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      .++|+..+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+.      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            457899999999999999999999999999999997543 3446789999999999999999999987643221      


Q ss_pred             ----------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEc
Q 043148          140 ----------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLG  185 (387)
Q Consensus       140 ----------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~  185 (387)
                                                        ..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence                                              1135789999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCc-----------eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 043148          186 DFGLARLVDHELGS-----------QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR  254 (387)
Q Consensus       186 Dfg~~~~~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~  254 (387)
                      |||+++........           .....+||+.|||||++.+..|+.++|||||||++|||++   ||....  +   
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~---  232 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--E---  232 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--H---
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--H---
Confidence            99999876543211           1234579999999999999999999999999999999996   775321  1   


Q ss_pred             HHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          255 LVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .......         +...... .........+.+++.+||+.||.+|||+.|+++|.|+..
T Consensus       233 ~~~~~~~---------~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~  285 (299)
T 4g31_A          233 RVRTLTD---------VRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED  285 (299)
T ss_dssp             HHHHHHH---------HHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred             HHHHHHH---------HhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence            1111111         1111111 122334455678999999999999999999999998753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.9e-49  Score=363.51  Aligned_cols=241  Identities=24%  Similarity=0.302  Sum_probs=173.0

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----H---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----L---  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~---  140 (387)
                      ++|...+.||+|+||+||+|++  +|+.||||++..... ....+..|+..+.+++|||||+++|+|.+...    .   
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            5677888999999999999998  478999999964321 12223345566678899999999999865421    1   


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhh-----cccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEE-----WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~-----~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                                           ....++.|++.||+|||+.     +.++|+||||||+||||+.++.+||+|||+++...
T Consensus        80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence                                 1257999999999999973     13499999999999999999999999999998765


Q ss_pred             CCCCc---eeeeeecCCcccCchhhccC------CCCCccchHHHHHHHHHHHhCCCCCCCCCCcch--------hhHHH
Q 043148          195 HELGS---QTTVLAGTMGYLAPECVTTG------KASKESDVYSFGVVALEVACGRKPVEPRQEPSK--------VRLVE  257 (387)
Q Consensus       195 ~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~--------~~~~~  257 (387)
                      .....   .....+||+.|||||++.+.      .|+.++|||||||++|||+||+.||........        .....
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~  239 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence            43222   22345799999999999764      367899999999999999999887653322110        00111


Q ss_pred             HHHHHhccCchhhhhcccCCccc-cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          258 WVWDLYGKGQLLEAADGRLSKEF-DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .........    ..++.+.... ..+.+..+.+|+.+||+.||.+||||.||++.|+.
T Consensus       240 ~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          240 EMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             HHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            111111111    1122222222 23566778999999999999999999999999863

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=371.74  Aligned_cols=245  Identities=18%  Similarity=0.244  Sum_probs=187.3

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcch------h-
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ------R-  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~-  138 (387)
                      ++|.+.+.||+|+||+||+|++..+|+.||||++...  .....+.+.+|+++|+.++|||||++++++...      . 
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999999999999999999754  234467789999999999999999999875421      1 


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ...+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus       134 ~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~  210 (398)
T 4b99_A          134 VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT  210 (398)
T ss_dssp             EEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence                                   11237899999999999999   9999999999999999999999999999986643


Q ss_pred             CC---CceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc----
Q 043148          196 EL---GSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ----  267 (387)
Q Consensus       196 ~~---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  267 (387)
                      ..   .......+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+....+....+   ........    
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~g~p~~~~~  287 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVLGTPSPAVI  287 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCCCCGGGT
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhcCCCChHHh
Confidence            21   2233456899999999998875 4699999999999999999999999876544333222   11111110    


Q ss_pred             -------hhhh---hcccCCc---cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          268 -------LLEA---ADGRLSK---EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       268 -------~~~~---~~~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                             ....   +.+....   .........+.+|+.+||+.||.+|||++|+++|.|+...
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence                   0000   0000000   0111234567899999999999999999999999998753

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.2e-46  Score=375.65  Aligned_cols=233  Identities=23%  Similarity=0.261  Sum_probs=192.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------  140 (387)
                      .++|.+.+.||+|+||.||+|+++.+|+.||||.+........+.+.+|+++|+.++|||||++++++.+....      
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            46899999999999999999999999999999999887777778899999999999999999999987654322      


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC--CcEEEccccccccccCCCC
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN--FNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~--~~~kl~Dfg~~~~~~~~~~  198 (387)
                                          .+..++.||+.||.|||+   ++|+||||||+|||++.+  +.+||+|||+++.+...  
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--  310 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--  310 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence                                236789999999999999   999999999999999854  89999999999877543  


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+....+       ...      +.....
T Consensus       311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i-------~~~------~~~~~~  377 (573)
T 3uto_A          311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-------KSC------DWNMDD  377 (573)
T ss_dssp             SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-------HTT------CCCCCS
T ss_pred             CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------HhC------CCCCCc
Confidence            3445668999999999999999999999999999999999999999865533221111       111      111122


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ......+..+.+|+.+||+.||.+|||+.|+++|.|+..
T Consensus       378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~  416 (573)
T 3uto_A          378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP  416 (573)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence            222334566889999999999999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-46  Score=355.08  Aligned_cols=247  Identities=23%  Similarity=0.271  Sum_probs=181.2

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEEC---CCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcchh
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLS---DQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQR  138 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  138 (387)
                      +....++|++.+.||+|+||+||+|+++   .+++.||||.+....  ...++.+|+++|..+ +|||||++++++.+..
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            3345688999999999999999999874   457899999986543  345788999999998 6999999998876654


Q ss_pred             hHH----------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC-CcEEEccccccccccC
Q 043148          139 QLI----------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN-FNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 ~~~----------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~  195 (387)
                      ..+                      +..++.|++.||+|||+   ++|+||||||+|||++.+ +.+||+|||+|+....
T Consensus        94 ~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            322                      37899999999999999   999999999999999877 7999999999975543


Q ss_pred             CCC---------------------------ceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 043148          196 ELG---------------------------SQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPR  247 (387)
Q Consensus       196 ~~~---------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~  247 (387)
                      ...                           ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            211                           112345799999999999876 4899999999999999999999999654


Q ss_pred             CCcchhhHHHHHHHHhcc----------------------Cchhhhh---------cccC---------CccccHHHHHH
Q 043148          248 QEPSKVRLVEWVWDLYGK----------------------GQLLEAA---------DGRL---------SKEFDERQMEC  287 (387)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~----------------------~~~~~~~---------~~~~---------~~~~~~~~~~~  287 (387)
                      .+..  .....+....+.                      .......         .+..         ..+.....+..
T Consensus       251 ~~~~--~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          251 SDDL--TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             SSHH--HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCHH--HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            4321  111111111000                      0000000         0000         00111223456


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          288 LMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       288 l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      +.+|+.+||+.||.+|||++|+++|+|+.
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~  357 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALLHPFFK  357 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence            78999999999999999999999999985

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-45  Score=343.49  Aligned_cols=257  Identities=35%  Similarity=0.598  Sum_probs=217.0

Q ss_pred             CccCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhc
Q 043148           56 KRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCH  135 (387)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  135 (387)
                      .++++.++...+++|...+.||+|+||.||+|++. ++..||||.+........+.+.+|+++++.++||||+++++++.
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            34555667778899999999999999999999975 58899999998776677788999999999999999999999875


Q ss_pred             chhh-----------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcc
Q 043148          136 EQRQ-----------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD  186 (387)
Q Consensus       136 ~~~~-----------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  186 (387)
                      +...                             ..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEee
Confidence            5322                             2236899999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCC-CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 043148          187 FGLARLVDHEL-GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGK  265 (387)
Q Consensus       187 fg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  265 (387)
                      ||+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+......|.......
T Consensus       183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T 2qkw_B          183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN  262 (321)
T ss_dssp             CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred             cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence            99997654322 12233456899999999999889999999999999999999999999877666666667776666666


Q ss_pred             CchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          266 GQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      +.+....++.+........+..+.+++.+||+.||.+|||+.|++++|+..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            667777777777777888999999999999999999999999999999744

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-45  Score=366.70  Aligned_cols=231  Identities=22%  Similarity=0.307  Sum_probs=182.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHH---HHHHHHhcCCCCCccceehhhcchhhH
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYI---SEVRIISRLRHRNLVHLIGWCHEQRQL  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~  140 (387)
                      .++|.+.+.||+|+||.||+|+.+.+|+.||||++.+..   ........   .++.++..++|||||++++++.+....
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            367999999999999999999999999999999996531   11222333   446777888999999999988765433


Q ss_pred             H-------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          141 I-------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       141 ~-------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                      +                         ...++.||+.||.|||+   ++|+||||||+||||+.+|.+||+|||+++....
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            2                         26789999999999999   9999999999999999999999999999987654


Q ss_pred             CCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      .   .....+||+.|||||++.. ..|+.++|||||||++|||++|+.||.+....+...+......            .
T Consensus       345 ~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~------------~  409 (689)
T 3v5w_A          345 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------------M  409 (689)
T ss_dssp             C---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH------------C
T ss_pred             C---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC------------C
Confidence            3   2345689999999999975 5799999999999999999999999976443332211111110            0


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccCC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFEA  317 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  317 (387)
                        ...++...+..+.+|+.+||+.||.+|++     ++||++|.||..
T Consensus       410 --~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          410 --AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             --CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence              11223334566889999999999999998     799999999853

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.6e-45  Score=342.67  Aligned_cols=265  Identities=37%  Similarity=0.658  Sum_probs=217.6

Q ss_pred             CCCCccCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCCcccee
Q 043148           53 TGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-QGKKEYISEVRIISRLRHRNLVHLI  131 (387)
Q Consensus        53 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~  131 (387)
                      ...+.+++.++....++|...+.||+|+||.||+|++. +++.||||++..... .....+.+|++++..++||||++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   93 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR   93 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence            34567899999999999999999999999999999865 488999999976532 2334789999999999999999999


Q ss_pred             hhhcchhh-----------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcE
Q 043148          132 GWCHEQRQ-----------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA  182 (387)
Q Consensus       132 ~~~~~~~~-----------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  182 (387)
                      ++|.+...                             ..+..++.|++.||.|||+.+..+++||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            98755321                             1236799999999999999222299999999999999999999


Q ss_pred             EEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCC--CcchhhHHHHHH
Q 043148          183 KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQ--EPSKVRLVEWVW  260 (387)
Q Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~--~~~~~~~~~~~~  260 (387)
                      ||+|||++...............||+.|+|||++.+..++.++||||||+++|||++|+.||....  .........|..
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            999999998776544444555669999999999998889999999999999999999999996321  112233455555


Q ss_pred             HHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ............+..+........+..+.+++.+||+.||.+|||+.||+++|+....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            5555666677777777778888999999999999999999999999999999986543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.2e-44  Score=331.13  Aligned_cols=234  Identities=22%  Similarity=0.351  Sum_probs=190.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------  140 (387)
                      .++|...+.||+|+||.||+|.+..+++.||||.+........+.+.+|+.+++.++||||+++++++.+....      
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999999999999999999766556677899999999999999999999987654321      


Q ss_pred             ------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          141 ------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       141 ------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                        .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++........ ...
T Consensus        99 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  174 (297)
T 3fxz_A           99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS  174 (297)
T ss_dssp             CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred             CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccC
Confidence                              236899999999999999   9999999999999999999999999999986654322 233


Q ss_pred             eeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          203 VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       203 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||..........      ......        ......+.
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~~~~~~--------~~~~~~~~  240 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNG--------TPELQNPE  240 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHC--------SCCCSCGG
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCC--------CCCCCCcc
Confidence            4578999999999999999999999999999999999999997654322111      100000        01111223


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          283 RQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ..+..+.+++.+||+.||.+|||++|+++|.|+...
T Consensus       241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            345568899999999999999999999999998654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.1e-43  Score=328.12  Aligned_cols=244  Identities=22%  Similarity=0.299  Sum_probs=196.1

Q ss_pred             CccCHHHHHHHhhC----------ccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCC
Q 043148           56 KRFTYRELSRATNN----------FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHR  125 (387)
Q Consensus        56 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  125 (387)
                      ..++++++..+++.          |...+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45788898888865          66777899999999999999988999999999877666678899999999999999


Q ss_pred             Cccceehhhcchhh------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc
Q 043148          126 NLVHLIGWCHEQRQ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN  181 (387)
Q Consensus       126 niv~l~~~~~~~~~------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~  181 (387)
                      ||+++++++.....                        ..+..++.|++.||.|||+   .+++||||||+|||++.++.
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~  179 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGR  179 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCc
Confidence            99999998765432                        2236899999999999999   99999999999999999999


Q ss_pred             EEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 043148          182 AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWD  261 (387)
Q Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~  261 (387)
                      +||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......   ....+..
T Consensus       180 ~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~~~~~~  255 (321)
T 2c30_A          180 VKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLRD  255 (321)
T ss_dssp             EEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHH
T ss_pred             EEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhc
Confidence            99999999986654322 2234578999999999999999999999999999999999999997644221   1111111


Q ss_pred             HhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          262 LYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                          .     ..+.+  ......+..+.+++.+||+.||.+|||+.|+++++|+..
T Consensus       256 ----~-----~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  300 (321)
T 2c30_A          256 ----S-----PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ  300 (321)
T ss_dssp             ----S-----SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred             ----C-----CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence                0     01111  111223455888999999999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-43  Score=331.02  Aligned_cols=230  Identities=24%  Similarity=0.320  Sum_probs=186.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      .++|...+.||+|+||.||+|++..+|+.||||++...  .....+.+.+|+++++.++||||+++++++.+....    
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            57899999999999999999999999999999998654  344567789999999999999999999987654321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++......  .
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--G  168 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--C
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--C
Confidence                                 236789999999999999   99999999999999999999999999999866443  2


Q ss_pred             eeeeeecCCcccCchhhccCCCC-CccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKAS-KESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~-~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ......||+.|+|||++.+..+. .++||||||+++|||++|+.||.+.......   .    ....+.          .
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~----~i~~~~----------~  231 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR---E----RVLRGK----------Y  231 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHCC----------C
T ss_pred             ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH---H----HHHhCC----------C
Confidence            23445799999999999988765 7999999999999999999999765422211   1    111110          1


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ..+...+..+.+++.+||+.||.+|||++|+++|.|+...
T Consensus       232 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  271 (328)
T 3fe3_A          232 RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG  271 (328)
T ss_dssp             CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred             CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence            1122234557889999999999999999999999998654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.5e-43  Score=344.41  Aligned_cols=243  Identities=21%  Similarity=0.243  Sum_probs=185.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+++|+.++||||+++++++.....     
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            57899999999999999999999999999999999754  34456788999999999999999999998743321     


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                             ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  217 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  217 (464)
T ss_dssp             EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred             eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence                                   1236799999999999999   99999999999999999999999999999866442


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC----------
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG----------  266 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  266 (387)
                        .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+   ....+..          
T Consensus       218 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i---~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          218 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV---IEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             --CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCSCCHHHHTTSCH
T ss_pred             --cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCCHHHHHHcch
Confidence              2334567899999999999999999999999999999999999999876543322211   1111100          


Q ss_pred             ---------------chhhhhcccC---CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          267 ---------------QLLEAADGRL---SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       267 ---------------~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                                     .........+   ...........+.+|+.+||+.||.+|||++|+++|+|+..
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence                           0000000000   01112233667899999999999999999999999999863

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.5e-43  Score=329.00  Aligned_cols=236  Identities=24%  Similarity=0.313  Sum_probs=184.8

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      .++|...+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+...      
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            4789999999999999999999998999999999865432 334678899999999999999999998765432      


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC-Cc
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL-GS  199 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  199 (387)
                                         ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++....... ..
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence                               2347899999999999999   999999999999999999999999999998654322 11


Q ss_pred             eeeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ...    ....         ....
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~----~~~~---------~~~~  228 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD----WKEK---------KTYL  228 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHH----HHTT---------CTTS
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHH----Hhcc---------cccC
Confidence            2234578999999999987775 78999999999999999999999865543211 111    0000         0011


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPL  319 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  319 (387)
                      .........+.+++.+||+.||.+|||+.|++++.|+....
T Consensus       229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            11122345578899999999999999999999999987654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.7e-43  Score=322.35  Aligned_cols=244  Identities=21%  Similarity=0.322  Sum_probs=187.1

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      ++|...+.||+|+||+||+|.+..+++.||||++....  ......+.+|+++++.++||||+++++++.+....     
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999999999999999997543  33457888999999999999999999987654321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  157 (292)
T 3o0g_A           82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RC  157 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SC
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-cc
Confidence                                236799999999999999   999999999999999999999999999998665332 22


Q ss_pred             eeeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh------hhhc
Q 043148          201 TTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL------EAAD  273 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~  273 (387)
                      .....+|+.|+|||++.+.. ++.++||||||+++|||++|..||.......  .....+..........      ...+
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhccccc
Confidence            33456899999999998766 8999999999999999999888865433221  2222222222111100      0000


Q ss_pred             ---------ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          274 ---------GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       274 ---------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                               ..............+.+++.+||+.||.+|||++|+++|.|+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  288 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence                     00001112234556789999999999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.8e-43  Score=323.96  Aligned_cols=245  Identities=24%  Similarity=0.311  Sum_probs=185.5

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      ..++|...+.||+|+||.||+|++.. ++.||+|++....  ......+.+|+++++.++||||+++++++.+....   
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            35789999999999999999999865 8999999986542  23356788999999999999999999987654321   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        98 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  173 (311)
T 3niz_A           98 FEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-  173 (311)
T ss_dssp             EECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred             EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence                                  236789999999999999   999999999999999999999999999998765332 


Q ss_pred             ceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh-------
Q 043148          199 SQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE-------  270 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  270 (387)
                      .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+   ...........       
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI---FSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH---HHHHCCCCTTTSGGGTTS
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHHCCCChHHhhhhhcc
Confidence            22334568999999999876 56899999999999999999999999876655433222   22211111000       


Q ss_pred             ---------hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          271 ---------AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       271 ---------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                               .................+.+++.+||+.||.+|||++|+++|.|+..-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence                     000000001112234567899999999999999999999999998753

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.7e-43  Score=325.83  Aligned_cols=232  Identities=24%  Similarity=0.374  Sum_probs=185.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------  140 (387)
                      .++|...+.||+|+||.||+|.+..++..||+|.+........+.+.+|++++..++||||+++++++.+....      
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            46788899999999999999999999999999999877777788999999999999999999999987654321      


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          .+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence                                236789999999999999   999999999999999999999999999998664432111


Q ss_pred             -------------eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc
Q 043148          201 -------------TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ  267 (387)
Q Consensus       201 -------------~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (387)
                                   .....||+.|+|||++.+..++.++||||||+++|||++|..|+............          .
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~----------~  235 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----------N  235 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------C
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------h
Confidence                         11456899999999999999999999999999999999999998764432211000          0


Q ss_pred             hhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          268 LLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .....+...    +..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus       236 ~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~  279 (310)
T 3s95_A          236 VRGFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET  279 (310)
T ss_dssp             HHHHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hhccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            011111111    12233457889999999999999999999998864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1e-42  Score=329.30  Aligned_cols=233  Identities=21%  Similarity=0.261  Sum_probs=187.3

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChh------hHHHHHHHHHHHhcCCCCCccceehhhcchhh
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ------GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  139 (387)
                      ..++|...+.||+|+||.||+++...+|..||+|.+......      ..+.+.+|+.+|..++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            357799999999999999999999999999999999765321      35789999999999999999999998765432


Q ss_pred             H-------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC----cEEEcccccc
Q 043148          140 L-------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF----NAKLGDFGLA  190 (387)
Q Consensus       140 ~-------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kl~Dfg~~  190 (387)
                      .                         .+..++.||+.||.|||+   ++|+||||||+|||++.++    .+||+|||++
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            1                         236899999999999999   9999999999999998877    7999999999


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      ......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+..   .    .+....   
T Consensus       167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~---~----~i~~~~---  234 (361)
T 2yab_A          167 HEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---A----NITAVS---  234 (361)
T ss_dssp             EECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---H----HHHTTC---
T ss_pred             eEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----HHHhcC---
Confidence            876543  2233456999999999999999999999999999999999999999765432211   1    111110   


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                         ...........+..+.+++.+||+.||.+|||+.|+++|+|+.
T Consensus       235 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  277 (361)
T 2yab_A          235 ---YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (361)
T ss_dssp             ---CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred             ---CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence               0111112223455688999999999999999999999999976

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=327.73  Aligned_cols=227  Identities=26%  Similarity=0.364  Sum_probs=177.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~---  140 (387)
                      .++|...+.||+|+||+||+|++..+++.||||++...  .......+..|+..+..+ +||||++++++|.+....   
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            36799999999999999999999988999999998654  233445566666666555 899999999988654322   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++......  
T Consensus       136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--  210 (311)
T 3p1a_A          136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--  210 (311)
T ss_dssp             EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccC--
Confidence                                  236799999999999999   89999999999999999999999999999766443  


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......||+.|+|||++.+ .++.++||||||+++|||++|..|+.....          +.....        .....
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~--------~~~~~  271 (311)
T 3p1a_A          211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQ--------GYLPP  271 (311)
T ss_dssp             ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTT--------TCCCH
T ss_pred             CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhc--------cCCCc
Confidence            22334568999999998876 789999999999999999999776643210          111111        11122


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ......+..+.+++.+||+.||.+|||++|+++++|+..
T Consensus       272 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            223334566889999999999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4e-43  Score=328.94  Aligned_cols=233  Identities=24%  Similarity=0.335  Sum_probs=187.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++....   ......+.+|+++++.++||||+++++++.+....   
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            468999999999999999999999999999999986431   22245788999999999999999999987654321   


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           ....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++......  .
T Consensus        88 ~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~  162 (336)
T 3h4j_B           88 IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--N  162 (336)
T ss_dssp             ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--B
T ss_pred             EECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--c
Confidence                                 236799999999999999   99999999999999999999999999999866443  2


Q ss_pred             eeeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..........               .+..  ...
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---------------~i~~--~~~  225 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---------------KVNS--CVY  225 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------------CCCS--SCC
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------------HHHc--CCC
Confidence            2334569999999999988776 789999999999999999999997654332111               0000  011


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPS  321 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  321 (387)
                      ..+...+..+.+++.+||+.||.+|||++|+++++|+....+.
T Consensus       226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  268 (336)
T 3h4j_B          226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPD  268 (336)
T ss_dssp             CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCCG
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCcc
Confidence            2223345568899999999999999999999999998765543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-42  Score=325.90  Aligned_cols=230  Identities=26%  Similarity=0.324  Sum_probs=185.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      .++|...+.||+|+||.||+++...+|+.||||++.+.   .......+.+|++++..++||||+++++++.+....   
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            46789999999999999999999999999999999653   223456788999999999999999999887653321   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... .
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-G  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-T
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-C
Confidence                                  236788999999999999   99999999999999999999999999999754322 2


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......||+.|+|||++.+..++.++||||||+++|||++|+.||........   ..    .+....          .
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~----~i~~~~----------~  222 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FE----LILMEE----------I  222 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHCC----------C
T ss_pred             CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH---HH----HHHcCC----------C
Confidence            233456799999999999999999999999999999999999999976442211   11    110110          1


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      .++...+..+.+++.+||+.||.+||     +++|+++|.|+..
T Consensus       223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            12223445688999999999999999     9999999999753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=324.08  Aligned_cols=234  Identities=20%  Similarity=0.238  Sum_probs=188.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .++|...+.||+|+||.||++.+..++..+|+|.+... ......+.+|+.++..++||||+++++++.+...       
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            47899999999999999999999999999999998754 3445678899999999999999999998765322       


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC--CCcEEEccccccccccCCCC
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS--NFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                         ..+..++.|++.||.|||+   ++|+||||||+|||++.  ++.+||+|||++......  
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--  157 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--
Confidence                               1236899999999999999   99999999999999997  789999999999876543  


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......||+.|+|||++.+..++.++||||||+++|||++|..||........   ...+.    ...      .....
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~----~~~------~~~~~  224 (321)
T 1tki_A          158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IENIM----NAE------YTFDE  224 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHH----HTC------CCCCH
T ss_pred             CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHHH----cCC------CCCCh
Confidence            334456799999999999988899999999999999999999999976543221   11111    000      00111


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPL  319 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  319 (387)
                      ......+..+.+++.+||+.||.+|||+.|+++|+|+....
T Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            11123355688999999999999999999999999987543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8.6e-43  Score=337.26  Aligned_cols=244  Identities=19%  Similarity=0.211  Sum_probs=190.1

Q ss_pred             CHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhc
Q 043148           59 TYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCH  135 (387)
Q Consensus        59 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  135 (387)
                      .+.++....++|...+.||+|+||.||+|++..+++.||||++.+..   ......+.+|..++..++||||++++++|.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34566667789999999999999999999999999999999996532   122334889999999999999999999876


Q ss_pred             chhhH--------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccc
Q 043148          136 EQRQL--------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL  189 (387)
Q Consensus       136 ~~~~~--------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~  189 (387)
                      +....                          .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            54322                          235789999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCceeeeeecCCcccCchhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc
Q 043148          190 ARLVDHELGSQTTVLAGTMGYLAPECVT-----TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYG  264 (387)
Q Consensus       190 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  264 (387)
                      ++.............+||+.|+|||++.     ...|+.++|||||||++|||++|+.||......+....+   .... 
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i---~~~~-  297 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---MNHK-  297 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTHH-
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh---hhcc-
Confidence            9876554333444567999999999987     456899999999999999999999999865433222111   1000 


Q ss_pred             cCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhccCC
Q 043148          265 KGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTN--RPSIRQVINVLNFEA  317 (387)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~l~~~~  317 (387)
                          .....+..    ....+..+.+++.+||..+|++  ||+++|+++|.|+..
T Consensus       298 ----~~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          298 ----ERFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             ----HHCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             ----ccccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence                00000111    1123455788999999888888  999999999999853

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-42  Score=328.90  Aligned_cols=236  Identities=19%  Similarity=0.228  Sum_probs=190.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.+..........+.+|+++|..++||||+++++++.+...       
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            5789999999999999999999999999999999987766667789999999999999999999998755322       


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC--CCcEEEccccccccccCCCC
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS--NFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                         ..+..++.|++.||.|||+   ++|+||||||+|||++.  ++.+||+|||+++.....  
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~--  204 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--  204 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCC--
Confidence                               2247899999999999999   99999999999999974  577999999999876543  


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   ...+..    .      ......
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~i~~----~------~~~~~~  271 (387)
T 1kob_A          205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVKR----C------DWEFDE  271 (387)
T ss_dssp             SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHH----C------CCCCCS
T ss_pred             cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---HHHHHh----C------CCCCCc
Confidence            223445799999999999999999999999999999999999999986543221   111110    0      001111


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLP  320 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  320 (387)
                      ......+..+.+++.+||+.||.+|||+.|++++.|+.....
T Consensus       272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            112234556889999999999999999999999999876543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=322.94  Aligned_cols=233  Identities=21%  Similarity=0.262  Sum_probs=186.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh------hhHHHHHHHHHHHhcCCCCCccceehhhcchhh-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK------QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  139 (387)
                      .++|...+.||+|+||.||++.+..++..||+|.+.....      ...+.+.+|+.++..++||||+++++++.+... 
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4678899999999999999999999999999999875432      246789999999999999999999998765322 


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC----cEEEccccccc
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF----NAKLGDFGLAR  191 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kl~Dfg~~~  191 (387)
                                              ..+..++.|++.||.|||+   ++|+||||||+|||++.++    .+||+|||+++
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence                                    1236899999999999999   9999999999999999887    89999999998


Q ss_pred             cccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       192 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                      ......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+...   .+..          
T Consensus       167 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~~~~----------  231 (326)
T 2y0a_A          167 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---NVSA----------  231 (326)
T ss_dssp             ECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---HHHH----------
T ss_pred             ECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHHh----------
Confidence            765322  2334568999999999998999999999999999999999999997654322111   1100          


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .............+..+.+++.+||+.||.+|||+.|+++|.|+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence            0011111112233456889999999999999999999999999764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-42  Score=322.88  Aligned_cols=245  Identities=24%  Similarity=0.356  Sum_probs=173.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      .++|...+.||+|+||.||+|.+..+++.||||.+.... ....+.+.+|+++++.++||||+++++++.+...      
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467888999999999999999999899999999997553 3345778899999999999999999998765421      


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                              ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence                                    1235678899999999999   9999999999999999999999999999986643


Q ss_pred             CCCceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc---hhhh
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ---LLEA  271 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  271 (387)
                      .. .......+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+...   .+........   ....
T Consensus       161 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          161 PV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK---LIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             CC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCTTTCGGG
T ss_pred             Cc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCChhHhhhh
Confidence            32 122344689999999998764 68999999999999999999999998655433222   2222111100   0000


Q ss_pred             -----hcccC------------CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          272 -----ADGRL------------SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       272 -----~~~~~------------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                           ..+..            ...........+.+++.+||+.||.+|||+.|++++.|+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  300 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY  300 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence                 00000            000111234568899999999999999999999999998653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.4e-42  Score=320.32  Aligned_cols=234  Identities=29%  Similarity=0.423  Sum_probs=176.4

Q ss_pred             HHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh
Q 043148           62 ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        62 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  139 (387)
                      ++....++|.+.+.||+|+||.||+|++  ++..||||++....  ....+.+.+|++++++++||||+++++++.+...
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            3344567899999999999999999987  57899999987653  3445789999999999999999999998765432


Q ss_pred             H----------------------------HHHHHHHHHHHHHHHhhhhcccc--eeeccCCcceeEeCCCCcEEEccccc
Q 043148          140 L----------------------------ILHKIALGLASAVLYLHEEWEQC--IVHRDIKSSNVVLDSNFNAKLGDFGL  189 (387)
Q Consensus       140 ~----------------------------~l~~i~~~i~~~l~~LH~~~~~~--iiH~dlk~~Nill~~~~~~kl~Dfg~  189 (387)
                      .                            .+..++.|++.||.|||+   ++  |+||||||+|||++.++.+||+|||+
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            1                            125789999999999999   88  99999999999999999999999999


Q ss_pred             cccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh
Q 043148          190 ARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL  269 (387)
Q Consensus       190 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (387)
                      ++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+...   .+.         
T Consensus       186 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~---~~~---------  252 (309)
T 3p86_A          186 SRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA---AVG---------  252 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH---HHH---------
T ss_pred             Cccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH---------
Confidence            97544321 22334578999999999999999999999999999999999999997654322111   000         


Q ss_pred             hhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                         ........+...+..+.+++.+||+.||.+|||+.++++.|...
T Consensus       253 ---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          253 ---FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             ---HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               00111122333455688999999999999999999999988643

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.8e-42  Score=317.95  Aligned_cols=242  Identities=23%  Similarity=0.345  Sum_probs=181.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      ++|...+.||+|+||.||+|++ .+++.||+|.+.....  ...+.+.+|+++++.++||||+++++++.+...      
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            5788999999999999999998 5688999999865432  234778899999999999999999998765432      


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++....... ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  156 (288)
T 1ob3_A           81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK  156 (288)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-cc
Confidence                               1236789999999999999   999999999999999999999999999997654321 12


Q ss_pred             eeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh---h-----h
Q 043148          201 TTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL---E-----A  271 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~-----~  271 (387)
                      .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+..   ..+..........   .     .
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHHCCCChhhchhhhcccc
Confidence            2344689999999998764 5899999999999999999999999865433221   2222221111000   0     0


Q ss_pred             hcccC-------CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          272 ADGRL-------SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       272 ~~~~~-------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .++..       ........+..+.+++.+||+.||.+|||++|+++|.|+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            00000       01111234556789999999999999999999999999763

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=326.09  Aligned_cols=246  Identities=19%  Similarity=0.290  Sum_probs=167.8

Q ss_pred             hCccc-cCcccccCceEEEEEEEC--CCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcc--hh----
Q 043148           68 NNFAE-AGKLGEGGFGGVYRGLLS--DQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHE--QR----  138 (387)
Q Consensus        68 ~~~~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~----  138 (387)
                      +.|.. .++||+|+||.||+|++.  .++..||||++....  ....+.+|+++|+.++||||+++++++..  ..    
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            44655 457999999999999976  457899999996543  23578899999999999999999998733  11    


Q ss_pred             -----------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe----CCCCcEEEc
Q 043148          139 -----------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL----DSNFNAKLG  185 (387)
Q Consensus       139 -----------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~~kl~  185 (387)
                                                   ...+..++.||+.||.|||+   ++|+||||||+|||+    +.++.+||+
T Consensus        98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence                                         11236789999999999999   999999999999999    778999999


Q ss_pred             cccccccccCCCC--ceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcc------hhhHH
Q 043148          186 DFGLARLVDHELG--SQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPS------KVRLV  256 (387)
Q Consensus       186 Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~------~~~~~  256 (387)
                      |||+++.......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......      .....
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            9999987654221  223446789999999999874 58999999999999999999999997654321      11122


Q ss_pred             HHHHHHhccCchh---hh------------h-cccCCc-c-------ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043148          257 EWVWDLYGKGQLL---EA------------A-DGRLSK-E-------FDERQMECLMIVGLWCCHPDFTNRPSIRQVINV  312 (387)
Q Consensus       257 ~~~~~~~~~~~~~---~~------------~-~~~~~~-~-------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~  312 (387)
                      ..+....+.....   .+            . ...... .       ........+.+|+.+||+.||.+|||++|+++|
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            2222221111000   00            0 000000 0       000013457889999999999999999999999


Q ss_pred             hccCCC
Q 043148          313 LNFEAP  318 (387)
Q Consensus       313 l~~~~~  318 (387)
                      .|+...
T Consensus       335 p~f~~~  340 (405)
T 3rgf_A          335 PYFLED  340 (405)
T ss_dssp             GGGTSS
T ss_pred             hhhccC
Confidence            998754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=327.22  Aligned_cols=234  Identities=23%  Similarity=0.324  Sum_probs=178.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCC--CCccceehhhcchhhH--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRH--RNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~--  140 (387)
                      .++|.+.+.||+|+||.||++.+. +++.||||++...  .....+.+.+|+.++..++|  |||+++++++.+....  
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            456899999999999999999985 4889999998654  34455788999999999976  9999999987654321  


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||.|||+   ++|+||||||+|||++ ++.+||+|||+++.......
T Consensus        87 v~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           87 VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             EECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence                                  236789999999999999   9999999999999997 67899999999986654322


Q ss_pred             c-eeeeeecCCcccCchhhcc-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC
Q 043148          199 S-QTTVLAGTMGYLAPECVTT-----------GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG  266 (387)
Q Consensus       199 ~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  266 (387)
                      . ......||+.|+|||++.+           ..++.++||||||+++|||++|+.||......     ....       
T Consensus       163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~-------  230 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKL-------  230 (343)
T ss_dssp             -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHH-------
T ss_pred             cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHH-------
Confidence            1 2334579999999999865           67899999999999999999999999754321     1111       


Q ss_pred             chhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 043148          267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPL  319 (387)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  319 (387)
                        ....++.....++......+.+++.+||+.||.+|||+.|+++|+|+....
T Consensus       231 --~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          231 --HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             --HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             --HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence              112222222223333345678999999999999999999999999987543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=334.30  Aligned_cols=235  Identities=23%  Similarity=0.247  Sum_probs=185.5

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      ...++|...+.||+|+||.||++.+..+|+.+|+|.+....  ....+.+.+|+++++.++||||+++++++.+....  
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            45678999999999999999999999999999999997643  34466789999999999999999999987654321  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC---CCCcEEEcccccccccc
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD---SNFNAKLGDFGLARLVD  194 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~---~~~~~kl~Dfg~~~~~~  194 (387)
                                             .+..++.|++.||.|||+   ++|+||||||+|||++   .++.+||+|||++....
T Consensus        88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence                                   236799999999999999   9999999999999998   56789999999997665


Q ss_pred             CCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          195 HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      ... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........   ...    +..+..      
T Consensus       165 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~---~~~----i~~~~~------  230 (444)
T 3soa_A          165 GEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL---YQQ----IKAGAY------  230 (444)
T ss_dssp             TTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH----HHHTCC------
T ss_pred             CCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH---HHH----HHhCCC------
Confidence            432 222345799999999999999999999999999999999999999976542221   111    111110      


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ..........+..+.+++.+||+.||.+|||+.|+++|+|+.
T Consensus       231 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~  272 (444)
T 3soa_A          231 DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS  272 (444)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred             CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence            011111123345688999999999999999999999999874

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-42  Score=332.09  Aligned_cols=247  Identities=21%  Similarity=0.291  Sum_probs=178.5

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCC-CCCccceehhhcchhh--
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQ--  139 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~--  139 (387)
                      ...++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++..+. ||||+++++++.....  
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3468899999999999999999999999999999998653  3455677889999999997 9999999998754321  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                             .....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           86 VYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             EEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             EEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence                                   1125788999999999999   99999999999999999999999999999865321


Q ss_pred             C--------------------CceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 043148          197 L--------------------GSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRL  255 (387)
Q Consensus       197 ~--------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~  255 (387)
                      .                    .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  242 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER  242 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            0                    112234579999999999986 6789999999999999999999999987654332222


Q ss_pred             HHHHHHHhccCchhhhh---------------------cccCCcccc------------HHHHHHHHHHHHHhcCCCCCC
Q 043148          256 VEWVWDLYGKGQLLEAA---------------------DGRLSKEFD------------ERQMECLMIVGLWCCHPDFTN  302 (387)
Q Consensus       256 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~------------~~~~~~l~~l~~~cl~~dp~~  302 (387)
                      +   ...........+.                     .......++            ......+.+|+.+||+.||.+
T Consensus       243 i---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          243 I---IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             H---HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             H---HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence            1   1111111000000                     000000000            022456889999999999999


Q ss_pred             CCCHHHHHHHhccCC
Q 043148          303 RPSIRQVINVLNFEA  317 (387)
Q Consensus       303 RPs~~evl~~l~~~~  317 (387)
                      |||++|+++|+|+..
T Consensus       320 R~t~~e~l~Hp~~~~  334 (388)
T 3oz6_A          320 RISANDALKHPFVSI  334 (388)
T ss_dssp             SCCHHHHTTSTTTTT
T ss_pred             CCCHHHHhCCHHHHH
Confidence            999999999999753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=318.00  Aligned_cols=231  Identities=22%  Similarity=0.265  Sum_probs=178.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--------------------------hhHHHHHHHHHHHh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--------------------------QGKKEYISEVRIIS  120 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  120 (387)
                      .++|...+.||+|+||.||+|++..+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4789999999999999999999999999999999865421                          11356889999999


Q ss_pred             cCCCCCccceehhhcchh--------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCccee
Q 043148          121 RLRHRNLVHLIGWCHEQR--------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNV  174 (387)
Q Consensus       121 ~l~h~niv~l~~~~~~~~--------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Ni  174 (387)
                      .++||||+++++++.+..                          ...+..++.|++.||.|||+   ++|+||||||+||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNL  168 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHE
Confidence            999999999999876421                          12247899999999999999   9999999999999


Q ss_pred             EeCCCCcEEEccccccccccCCCCceeeeeecCCcccCchhhccCC---CCCccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 043148          175 VLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK---ASKESDVYSFGVVALEVACGRKPVEPRQEPS  251 (387)
Q Consensus       175 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~  251 (387)
                      |++.++.+||+|||+++...... .......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||.......
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            99999999999999998665432 2233457899999999987665   3788999999999999999999997543211


Q ss_pred             hhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          252 KVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                         ...    ......        .........+..+.+++.+||+.||.+|||+.|+++|.|+.
T Consensus       248 ---~~~----~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          248 ---LHS----KIKSQA--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             ---HHH----HHHHCC--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             ---HHH----HHhccc--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence               111    111110        00011122345588999999999999999999999998863

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.3e-42  Score=326.34  Aligned_cols=235  Identities=25%  Similarity=0.295  Sum_probs=186.6

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      ...++|...+.||+|+||.||+|.+..++..||+|++...  .....+.+.+|+++++.++||||+++++++.+....  
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3467899999999999999999999999999999999654  334567789999999999999999999987654321  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC---cEEEcccccccccc
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF---NAKLGDFGLARLVD  194 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kl~Dfg~~~~~~  194 (387)
                                             .+..++.|++.||.|||+   ++|+||||||+|||++.++   .+||+|||++....
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence                                   236789999999999999   9999999999999998654   59999999998665


Q ss_pred             CCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          195 HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ....+.    .+..      
T Consensus       183 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i~----~~~~------  247 (362)
T 2bdw_A          183 DS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIK----AGAY------  247 (362)
T ss_dssp             TC--CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTCC------
T ss_pred             CC--cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH----hCCC------
Confidence            32  22234579999999999999899999999999999999999999997644221   111111    1110      


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ..........+..+.+++.+||+.||.+|||+.|+++|.|+..
T Consensus       248 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          248 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            0111111234456889999999999999999999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.8e-43  Score=334.70  Aligned_cols=241  Identities=20%  Similarity=0.230  Sum_probs=189.2

Q ss_pred             HHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcch
Q 043148           61 RELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ  137 (387)
Q Consensus        61 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  137 (387)
                      .++....++|...+.||+|+||.||+|++..+++.||+|++.+..   ......+.+|+.++..++||||++++++|.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            345556789999999999999999999999999999999986521   12234578999999999999999999988664


Q ss_pred             hhH------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          138 RQL------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       138 ~~~------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                      ...                        ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~  218 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  218 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence            322                        236789999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCceeeeeecCCcccCchhhccCC----CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh
Q 043148          194 DHELGSQTTVLAGTMGYLAPECVTTGK----ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL  269 (387)
Q Consensus       194 ~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (387)
                      ...........+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...........+   ....     .
T Consensus       219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i---~~~~-----~  290 (410)
T 3v8s_A          219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI---MNHK-----N  290 (410)
T ss_dssp             CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTHH-----H
T ss_pred             ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH---Hhcc-----c
Confidence            554333344567999999999998655    789999999999999999999999865432221111   1000     0


Q ss_pred             hhhcccCCccccHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHhccCC
Q 043148          270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTN--RPSIRQVINVLNFEA  317 (387)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~l~~~~  317 (387)
                      .     +........+..+.+++.+||+.+|.+  ||+++||++|.|+..
T Consensus       291 ~-----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          291 S-----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             H-----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             c-----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence            0     000001123455788999999999998  999999999999865

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-41  Score=318.41  Aligned_cols=230  Identities=23%  Similarity=0.353  Sum_probs=180.4

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      ..++|...+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||++++++|.+...     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            4578999999999999999999999889999999997543 3456789999999999999999999987633210     


Q ss_pred             --------------------------------------------------------------------------------
Q 043148          140 --------------------------------------------------------------------------------  139 (387)
Q Consensus       140 --------------------------------------------------------------------------------  139 (387)
                                                                                                      
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                                                            


Q ss_pred             HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-----------ceeeeeecCC
Q 043148          140 LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-----------SQTTVLAGTM  208 (387)
Q Consensus       140 ~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~g~~  208 (387)
                      ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......           .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            1246789999999999999   9999999999999999999999999999987654321           1123346899


Q ss_pred             cccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHH
Q 043148          209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECL  288 (387)
Q Consensus       209 ~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  288 (387)
                      .|+|||.+.+..++.++||||||+++|||++|..|+..     .   .. .....        ... ............+
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~---~~-~~~~~--------~~~-~~~~~~~~~~~~~  302 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----R---VR-IITDV--------RNL-KFPLLFTQKYPQE  302 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----H---HH-HHHHH--------HTT-CCCHHHHHHCHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----H---HH-HHHHh--------hcc-CCCcccccCChhH
Confidence            99999999999999999999999999999998766421     0   00 01101        011 1122223445567


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          289 MIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       289 ~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .+++.+||+.||.+|||+.|++++.|+.
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~~~~f~  330 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIENAIFE  330 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHHSTTCC
T ss_pred             HHHHHHHccCCCCcCCCHHHHhhchhhh
Confidence            8899999999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.9e-41  Score=309.94  Aligned_cols=253  Identities=35%  Similarity=0.619  Sum_probs=200.4

Q ss_pred             CCCccCHHHHHHHhhCcccc------CcccccCceEEEEEEECCCCeEEEEEEecCC----ChhhHHHHHHHHHHHhcCC
Q 043148           54 GPKRFTYRELSRATNNFAEA------GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG----SKQGKKEYISEVRIISRLR  123 (387)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~  123 (387)
                      ....|++.++..++++|...      +.||+|+||.||+|.+  ++..||||.+...    .....+.+.+|+++++.++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            34678999999999999887      8899999999999987  4789999998653    2344678999999999999


Q ss_pred             CCCccceehhhcchhh----------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeE
Q 043148          124 HRNLVHLIGWCHEQRQ----------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVV  175 (387)
Q Consensus       124 h~niv~l~~~~~~~~~----------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nil  175 (387)
                      ||||+++++++.+...                            ..+..++.|++.||.|||+   ++++||||||+||+
T Consensus        89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil  165 (307)
T 2nru_A           89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL  165 (307)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred             CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence            9999999998754321                            1236789999999999999   99999999999999


Q ss_pred             eCCCCcEEEccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 043148          176 LDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR  254 (387)
Q Consensus       176 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~  254 (387)
                      ++.++.+||+|||++......... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||..........
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  244 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL  244 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence            999999999999999865543222 2233568999999998865 57899999999999999999999998765443322


Q ss_pred             HHHHHHHHh-ccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          255 LVEWVWDLY-GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       255 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .+.  .... ....+.+.+++.+ ...+...+..+.+++..||+.||.+|||+.+|+++|+.
T Consensus       245 ~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~  303 (307)
T 2nru_A          245 DIK--EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE  303 (307)
T ss_dssp             HHH--HHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HHH--HHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            211  1111 1222334444433 34566778889999999999999999999999999874

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=321.61  Aligned_cols=231  Identities=28%  Similarity=0.423  Sum_probs=181.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCC---eEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQN---TEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      .++|.+.+.||+|+||.||+|.+..++   ..||||.+... .....+.+.+|++++..++||||+++++++.+....  
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            356888899999999999999997544   45999999765 445567899999999999999999999988654322  


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          141 ------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       141 ------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                              .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence                                    236789999999999999   99999999999999999999999999999876543


Q ss_pred             CCc--eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          197 LGS--QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       197 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ...  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+...       ....        
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-------~~~~--------  269 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS-------SVEE--------  269 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-------HHHT--------
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH-------HHHc--------
Confidence            221  2223345778999999998899999999999999999999 999997654322111       1111        


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                       ......+..++..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       270 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          270 -GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             111122334456688999999999999999999999999743

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.9e-42  Score=326.20  Aligned_cols=231  Identities=26%  Similarity=0.366  Sum_probs=186.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      .++|...+.||+|+||.||++.+..+++.||+|.+....   ....+.+.+|+++|..++||||+++++++.+....   
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467899999999999999999999999999999986532   23456788999999999999999999987654322   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++......  
T Consensus        94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--  168 (384)
T ss_dssp             ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence                                  236789999999999999   99999999999999999999999999999866442  


Q ss_pred             ceeeeeecCCcccCchhhcc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          199 SQTTVLAGTMGYLAPECVTT---GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .......||+.|+|||++..   ..++.++|||||||++|||++|+.||.................              
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--------------  234 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--------------  234 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--------------
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--------------
Confidence            23445679999999999874   4589999999999999999999999986554332222221111              


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHhccC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPS-IRQVINVLNFE  316 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~evl~~l~~~  316 (387)
                      ....++...+..+.+++.+||+.||.+||+ ++++++|.|+.
T Consensus       235 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~  276 (384)
T 4fr4_A          235 TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN  276 (384)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGT
T ss_pred             cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhh
Confidence            011222334556889999999999999998 99999998875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-41  Score=331.41  Aligned_cols=248  Identities=21%  Similarity=0.260  Sum_probs=171.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      .++|.+.+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+++|..++||||+++++++....      
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            47899999999999999999999999999999998654  3445678999999999999999999999873221      


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ...+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++....
T Consensus       132 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             EEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             EEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence                                   11236899999999999999   9999999999999999999999999999987643


Q ss_pred             CCC--------------------------ceeeeeecCCcccCchhh-ccCCCCCccchHHHHHHHHHHHh---------
Q 043148          196 ELG--------------------------SQTTVLAGTMGYLAPECV-TTGKASKESDVYSFGVVALEVAC---------  239 (387)
Q Consensus       196 ~~~--------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dvws~Gvil~el~t---------  239 (387)
                      ...                          ......+||+.|+|||++ ....|+.++|||||||++|||++         
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~  288 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH  288 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence            211                          123345789999999986 45679999999999999999999         


Q ss_pred             --CCCCCCCCCCc-----------------chhhHHHHHHHHhccCchhhh--------------hcccC---CccccHH
Q 043148          240 --GRKPVEPRQEP-----------------SKVRLVEWVWDLYGKGQLLEA--------------ADGRL---SKEFDER  283 (387)
Q Consensus       240 --g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~--------------~~~~~---~~~~~~~  283 (387)
                        |+.+|.+....                 ........+....+......+              +....   .......
T Consensus       289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (458)
T 3rp9_A          289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA  368 (458)
T ss_dssp             GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred             ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence              56666543210                 001111112222211110000              00000   0011122


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ....+.+|+.+||+.||.+|||++|+++|.|+..
T Consensus       369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~  402 (458)
T 3rp9_A          369 SSADAIHLLKRMLVFNPNKRITINECLAHPFFKE  402 (458)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             CCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence            3566889999999999999999999999999865

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.4e-42  Score=324.47  Aligned_cols=231  Identities=24%  Similarity=0.403  Sum_probs=176.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeE----EEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTE----IAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  139 (387)
                      .++|...+.||+|+||.||+|++..++..    ||+|.+... .....+.+.+|+.++++++||||++++++|.+...  
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   93 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL   93 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence            36788999999999999999998776654    588887543 33456789999999999999999999998765321  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                             ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence                                   1236799999999999999   99999999999999999999999999999876543


Q ss_pred             CCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          197 LGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       197 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      ... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........+                ..
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~----------------~~  234 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----------------EK  234 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----------------HT
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH----------------Hc
Confidence            222 2233456889999999999999999999999999999999 99999865543221111                11


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ......+......+.+++.+||+.||.+||++.+++++|...
T Consensus       235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          235 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111122233445688999999999999999999999998643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=327.69  Aligned_cols=231  Identities=26%  Similarity=0.341  Sum_probs=181.6

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH-
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL-  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~-  140 (387)
                      ..++|...+.||+|+||.||+|++..+++.||||++.+.   .....+.+.+|.+++..+ +||||+++++++.+.... 
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            357899999999999999999999999999999999753   233456788999999988 799999999987654322 


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          141 ------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       141 ------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                              .+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence                                    126789999999999999   99999999999999999999999999999753322


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+..   ..+.    .+        . 
T Consensus       178 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---~~i~----~~--------~-  240 (353)
T 3txo_A          178 -GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF---EAIL----ND--------E-  240 (353)
T ss_dssp             ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HC--------C-
T ss_pred             -CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH---HHHH----cC--------C-
Confidence             22344567999999999999888999999999999999999999999765432211   1111    11        0 


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHhccCC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSI------RQVINVLNFEA  317 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~------~evl~~l~~~~  317 (387)
                       ..++......+.+++.+||+.||.+||++      +|+++|.|+..
T Consensus       241 -~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          241 -VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             -CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence             11222344557889999999999999998      99999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.5e-43  Score=321.03  Aligned_cols=237  Identities=22%  Similarity=0.361  Sum_probs=181.1

Q ss_pred             hhCccccCcccccCceEEEEEE----ECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGL----LSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      .++|+..+.||+|+||.||+|+    ...+++.||||++........+.+.+|++++..++||||++++++|.....   
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            4678899999999999999998    456789999999987777777889999999999999999999997744221   


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          140 -------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       140 -------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                                               ..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence                                     1236789999999999999   999999999999999999999999999998664


Q ss_pred             CCCC--ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCc---------chhhHHHHHHHHh
Q 043148          195 HELG--SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEP---------SKVRLVEWVWDLY  263 (387)
Q Consensus       195 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~---------~~~~~~~~~~~~~  263 (387)
                      ....  .......++..|+|||.+.+..++.++||||||+++|||++|..|+......         .........    
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  241 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL----  241 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH----
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH----
Confidence            4321  1122334667799999999999999999999999999999999998643210         000000011    


Q ss_pred             ccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                           .+..........+..++..+.+++.+||+.||.+|||+.|+++.|..
T Consensus       242 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~  288 (295)
T 3ugc_A          242 -----IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  288 (295)
T ss_dssp             -----HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             -----HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence                 11111111222334455678899999999999999999999998863

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-42  Score=331.19  Aligned_cols=231  Identities=26%  Similarity=0.433  Sum_probs=182.7

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ..++|...+.||+|+||.||+|.+..+++.||||.+.... ....+.+.+|+++|+.++||||++++++|.+....    
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3467888999999999999999999889999999987543 33456788999999999999999999987653221    


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++.......
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence                                  236789999999999999   9999999999999999999999999999976443211


Q ss_pred             ce-eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          199 SQ-TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       199 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                      .. .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.........       .....+         .
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~---------~  332 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-------EFVEKG---------G  332 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-------HHHHTT---------C
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC---------C
Confidence            11 112235678999999998899999999999999999998 99999765432211       111111         1


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ....+..++..+.+++..||+.||.+|||+++|++.|+.
T Consensus       333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            112223345568899999999999999999999998863

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.1e-42  Score=317.57  Aligned_cols=247  Identities=24%  Similarity=0.343  Sum_probs=182.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      .++|...+.||+|+||.||+|++..+++.||||++....  ....+.+.+|++++..++||||+++++++.+....    
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            368999999999999999999999999999999986543  33356788999999999999999999987654321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           .+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++....... .
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  157 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-D  157 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-c
Confidence                                 236789999999999999   999999999999999999999999999998665322 2


Q ss_pred             eeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------HHhccCchhh
Q 043148          200 QTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW--------DLYGKGQLLE  270 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~  270 (387)
                      ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.........        ..+.......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence            2234568999999999876 568999999999999999999999998765443322221110        0000000000


Q ss_pred             ---hhcccCCc---cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          271 ---AADGRLSK---EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       271 ---~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                         ..++....   ......+..+.+++.+||+.||.+|||++|+++|.|+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  290 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN  290 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence               00000000   001224455889999999999999999999999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-42  Score=329.40  Aligned_cols=253  Identities=23%  Similarity=0.242  Sum_probs=189.8

Q ss_pred             CccCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-----CCCccce
Q 043148           56 KRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-----HRNLVHL  130 (387)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l  130 (387)
                      ..+++.+.....++|.+.+.||+|+||.||+|++..+++.||||++... ......+..|++++..++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            3444555555678999999999999999999999999999999999643 344567788999999886     9999999


Q ss_pred             ehhhcchhh--------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC------
Q 043148          131 IGWCHEQRQ--------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS------  178 (387)
Q Consensus       131 ~~~~~~~~~--------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~------  178 (387)
                      ++++.....                          ..+..++.|++.||.|||+   ++|+||||||+|||++.      
T Consensus       102 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEE
T ss_pred             cceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccccc
Confidence            997754322                          1236789999999999999   99999999999999986      


Q ss_pred             -------------------CCcEEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh
Q 043148          179 -------------------NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC  239 (387)
Q Consensus       179 -------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t  239 (387)
                                         ++.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|||++
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence                               789999999999865432    234568999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcchhhHHHHHH--------HHhccCchhhhhcc-----cCC----------------ccccHHHHHHHHH
Q 043148          240 GRKPVEPRQEPSKVRLVEWVW--------DLYGKGQLLEAADG-----RLS----------------KEFDERQMECLMI  290 (387)
Q Consensus       240 g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~-----~~~----------------~~~~~~~~~~l~~  290 (387)
                      |+.||......+....+....        ............+.     ...                ..........+.+
T Consensus       255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  334 (360)
T 3llt_A          255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD  334 (360)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred             CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence            999998755433222221110        00000000000000     000                0011111256789


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          291 VGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       291 l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ++.+||+.||.+|||+.|+++|.|+.
T Consensus       335 li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          335 FLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHhcCChhhCCCHHHHhcCcccC
Confidence            99999999999999999999999863

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.6e-42  Score=325.28  Aligned_cols=237  Identities=26%  Similarity=0.267  Sum_probs=176.0

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .++|...+.||+|+||.||+++...+++.||||++.... ...+.+.+|+.+++.++||||+++++++.+...       
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            578999999999999999999999999999999997643 234678899999999999999999998755322       


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc--EEEccccccccccCCCCc
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN--AKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~--~kl~Dfg~~~~~~~~~~~  199 (387)
                                        ..+..++.|++.||.|||+   ++|+||||||+|||++.++.  +||+|||+++.....  .
T Consensus        98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~  172 (361)
T 3uc3_A           98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S  172 (361)
T ss_dssp             CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--C
Confidence                              1236799999999999999   99999999999999987775  999999999743322  2


Q ss_pred             eeeeeecCCcccCchhhccCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKE-SDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~-~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ......||+.|+|||++.+..+..+ +||||||+++|||++|+.||............  ....         .......
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~---------~~~~~~~  241 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRI---------LSVKYSI  241 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHH---------HTTCCCC
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHH---------hcCCCCC
Confidence            2334568999999999988887655 89999999999999999999875543322111  1111         1111111


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLP  320 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  320 (387)
                      ......+..+.+++.+||+.||.+|||+.|+++|.|+....+
T Consensus       242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  283 (361)
T 3uc3_A          242 PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP  283 (361)
T ss_dssp             CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred             CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence            111123455789999999999999999999999999866543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.3e-42  Score=314.51  Aligned_cols=235  Identities=26%  Similarity=0.350  Sum_probs=180.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      .++|...+.||+|+||.||+|++..++..||+|.+...   .....+.+.+|+.++..++||||+++++++.+....   
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            46799999999999999999999999999999998543   334457889999999999999999999987654321   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++........
T Consensus        90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence                                  236789999999999999   9999999999999999999999999999987654433


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........      ........ ..     ....
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~-~~-----~~~~  234 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS-VP-----NVTT  234 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC-CC-----CHHH
T ss_pred             cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc-CC-----Ccch
Confidence            334455789999999999999999999999999999999999999976543211      11111111 00     0011


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhccC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRP-SIRQVINVLNFE  316 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~l~~~  316 (387)
                      ......+..+.+++.+||+.||.+|| +++++.+.|...
T Consensus       235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            12223456688999999999999998 888888888643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.8e-42  Score=325.17  Aligned_cols=230  Identities=26%  Similarity=0.397  Sum_probs=181.8

Q ss_pred             hhCccccCcccccCceEEEEEEEC-------CCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccceehhhcch
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLS-------DQNTEIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ  137 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  137 (387)
                      .++|...+.||+|+||.||+|++.       .++..||||++.... ....+.+.+|++++..+ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467888999999999999999874       345679999997653 34567899999999999 899999999987543


Q ss_pred             hh-----------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe
Q 043148          138 RQ-----------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL  176 (387)
Q Consensus       138 ~~-----------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill  176 (387)
                      ..                                         ..+..++.|++.||.|||+   ++|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence            21                                         1124588999999999999   999999999999999


Q ss_pred             CCCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 043148          177 DSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVR  254 (387)
Q Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~  254 (387)
                      +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999986544221 12223456788999999999999999999999999999999 999998654332111


Q ss_pred             HHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          255 LVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                             ....+         .....+..++..+.+++.+||+.||.+|||+.|++++|+.
T Consensus       317 -------~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~  361 (370)
T 2psq_A          317 -------LLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  361 (370)
T ss_dssp             -------HHHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                   11111         1122233445568899999999999999999999999863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.8e-42  Score=327.92  Aligned_cols=250  Identities=18%  Similarity=0.206  Sum_probs=184.4

Q ss_pred             HhhCccccCccccc--CceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--
Q 043148           66 ATNNFAEAGKLGEG--GFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  139 (387)
                      ..++|.+.+.||+|  +||.||+|++..+++.||||++...  .....+.+.+|+++++.++||||+++++++.+...  
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            35789999999999  9999999999999999999999654  24445778899999999999999999998765432  


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          140 -------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       140 -------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                                               ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||.+....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence                                     1236799999999999999   999999999999999999999999999986442


Q ss_pred             CCCC------ceeeeeecCCcccCchhhcc--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHH-HHHHH-Hhc
Q 043148          195 HELG------SQTTVLAGTMGYLAPECVTT--GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV-EWVWD-LYG  264 (387)
Q Consensus       195 ~~~~------~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~-~~~~~-~~~  264 (387)
                      ....      .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.......... ..... ...
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            2110      11122368889999999987  57899999999999999999999999875543322100 00000 000


Q ss_pred             c------------------Cchhhhh---------cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          265 K------------------GQLLEAA---------DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       265 ~------------------~~~~~~~---------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .                  .......         ...............+.+|+.+||+.||.+|||+.|+++|.|+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence            0                  0000000         000001123334566889999999999999999999999999865


Q ss_pred             C
Q 043148          318 P  318 (387)
Q Consensus       318 ~  318 (387)
                      -
T Consensus       340 ~  340 (389)
T 3gni_B          340 I  340 (389)
T ss_dssp             C
T ss_pred             H
Confidence            3

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.8e-42  Score=324.15  Aligned_cols=229  Identities=24%  Similarity=0.381  Sum_probs=182.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      .+.|...+.||+|+||.||+|+...+++.||||++....   ....+.+.+|++++..++||||+++++++.+....   
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            356888999999999999999998899999999997543   23346789999999999999999999987654321   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++......  
T Consensus       133 ~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             EecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence                                  236789999999999999   99999999999999999999999999999765432  


Q ss_pred             ceeeeeecCCcccCchhhc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          199 SQTTVLAGTMGYLAPECVT---TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                         ....||+.|+|||++.   ...++.++||||||+++|||++|+.||........      ........      .+ 
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~------~~-  271 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE------SP-  271 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC------CC-
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcC------CC-
Confidence               2346899999999985   56789999999999999999999999976542211      11111111      01 


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                        .......+..+.+++.+||+.||.+|||++++++++|+...
T Consensus       272 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          272 --ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             --CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence              11112234557889999999999999999999999997654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.7e-42  Score=324.77  Aligned_cols=233  Identities=24%  Similarity=0.292  Sum_probs=183.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC-----ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-----SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  139 (387)
                      .++|...+.||+|+||.||+|.+..+++.||||++...     .....+.+.+|++++..++||||+++++++.+...  
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46799999999999999999999999999999998542     12246789999999999999999999997755321  


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc---EEEccccc
Q 043148          140 ---------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN---AKLGDFGL  189 (387)
Q Consensus       140 ---------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kl~Dfg~  189 (387)
                                                 ..+..++.|++.||.|||+   ++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence                                       1235689999999999999   99999999999999987655   99999999


Q ss_pred             cccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh
Q 043148          190 ARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL  269 (387)
Q Consensus       190 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (387)
                      +....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....    ....    ....+.. 
T Consensus       180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~----~i~~~~~-  249 (351)
T 3c0i_A          180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE----GIIKGKY-  249 (351)
T ss_dssp             CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH----HHHHTCC-
T ss_pred             eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH----HHHcCCC-
Confidence            98765432 223345689999999999999999999999999999999999999975321    1111    1111100 


Q ss_pred             hhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                           ..........+..+.+++.+||+.||.+|||+.|+++|.|+..
T Consensus       250 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          250 -----KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             -----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             -----CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence                 0011111223456889999999999999999999999998754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=323.09  Aligned_cols=244  Identities=21%  Similarity=0.281  Sum_probs=178.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ-GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      ++|...+.||+|+||.||+|++..+++.||||++...... ....+.+|+++++.++||||+++++++.+...       
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            5789999999999999999999989999999999654322 12245679999999999999999998765432       


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++....... ...
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~  157 (324)
T 3mtl_A           82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY  157 (324)
T ss_dssp             CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccc
Confidence                              1236789999999999999   999999999999999999999999999997554321 223


Q ss_pred             eeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc---hhhhh-----
Q 043148          202 TVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ---LLEAA-----  272 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----  272 (387)
                      ....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+..   ..+........   .....     
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhhcchhh
Confidence            34468999999999876 56899999999999999999999999876543322   22222211110   00000     


Q ss_pred             ----cccCC----ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          273 ----DGRLS----KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       273 ----~~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                          .+...    ..........+.+++.+||+.||.+|||++|+++|.|+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                00000    01112234567899999999999999999999999998654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.9e-42  Score=325.76  Aligned_cols=237  Identities=21%  Similarity=0.274  Sum_probs=184.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~--  140 (387)
                      .++|...+.||+|+||.||++++..+++.||||++.+..   ....+.+..|..++.++ +||||+++++++.+....  
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            478999999999999999999999999999999997542   23345678899999877 899999999987654322  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                             ....++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC-
Confidence                                   126789999999999999   99999999999999999999999999999753222 


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh--hHHHHHHHHhccCchhhhhccc
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKV--RLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+..  .............         
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---------  277 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------  277 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC---------
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc---------
Confidence            23344567999999999999999999999999999999999999999754322111  1111111111111         


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHhccCC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPS------IRQVINVLNFEA  317 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs------~~evl~~l~~~~  317 (387)
                       ...++...+..+.+++.+||+.||.+||+      ++|+++|.|+..
T Consensus       278 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          278 -QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             -ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence             11222334556889999999999999998      489999999853

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.1e-42  Score=324.51  Aligned_cols=227  Identities=22%  Similarity=0.240  Sum_probs=178.1

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------------
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------------  140 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------------  140 (387)
                      .+.||+|+||.||+|.+..+|..||+|++........+.+.+|++++..++||||+++++++.+....            
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56799999999999999999999999999887767778899999999999999999999987653221            


Q ss_pred             --------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe--CCCCcEEEccccccccccCCCCceeeee
Q 043148          141 --------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL--DSNFNAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 --------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                    ....++.|++.||.|||+   ++|+||||||+|||+  +.++.+||+|||+++......  .....
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~  248 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVN  248 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccc
Confidence                          125788999999999999   999999999999999  677899999999998765432  23344


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .||+.|+|||++.+..++.++||||||+++|||++|+.||......+..   ..+..   ..       ...........
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~i~~---~~-------~~~~~~~~~~~  315 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL---NNILA---CR-------WDLEDEEFQDI  315 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHH---TC-------CCSCSGGGTTS
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh---cc-------CCCChhhhccC
Confidence            6899999999999888999999999999999999999999765432211   11110   00       00111112234


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          285 MECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      +..+.+++.+||+.||.+|||+.|+++|.|+..
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence            556889999999999999999999999999753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-42  Score=317.76  Aligned_cols=227  Identities=26%  Similarity=0.335  Sum_probs=184.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      .++|...+.||+|+||.||+++...+|+.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+....   
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467899999999999999999999999999999996532   23356788999999999999999999987654321   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....   
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence                                  235789999999999999   9999999999999999999999999999986543   


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                       ......||+.|+|||++.+..++.++||||||+++|||++|+.||........   ..   ...         ...  .
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~---~i~---------~~~--~  220 (318)
T 1fot_A          159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YE---KIL---------NAE--L  220 (318)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH---HHH---------HCC--C
T ss_pred             -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH---HHH---------hCC--C
Confidence             22345789999999999999999999999999999999999999976442211   11   111         110  1


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      .++......+.+++.+||+.||.+||     +++++++|.|+..
T Consensus       221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            12223345688999999999999999     9999999999863

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=318.10  Aligned_cols=245  Identities=24%  Similarity=0.309  Sum_probs=182.3

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-----hhhHHHHHHHHHHHhcC---CCCCccceehhhcch
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-----KQGKKEYISEVRIISRL---RHRNLVHLIGWCHEQ  137 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~  137 (387)
                      ..++|...+.||+|+||.||+|++..+++.||||++....     ......+.+|+++++.+   +||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4678999999999999999999998899999999986432     12235667787777766   499999999987542


Q ss_pred             h-------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcc
Q 043148          138 R-------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD  186 (387)
Q Consensus       138 ~-------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  186 (387)
                      .                               ...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEee
Confidence            2                               11236799999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC
Q 043148          187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG  266 (387)
Q Consensus       187 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  266 (387)
                      ||+++.....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..   ..+.......
T Consensus       164 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~  238 (308)
T 3g33_A          164 FGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIGLP  238 (308)
T ss_dssp             CSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHHHHHHCCC
T ss_pred             CccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCC
Confidence            9999865432  2233456899999999999999999999999999999999999999865543322   2222221111


Q ss_pred             chhhh----------hccc---CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          267 QLLEA----------ADGR---LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       267 ~~~~~----------~~~~---~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .....          ..+.   ............+.+++.+||+.||.+|||+.|+++|.|+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            00000          0000   0001112345668899999999999999999999999997653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-41  Score=317.17  Aligned_cols=240  Identities=22%  Similarity=0.278  Sum_probs=185.9

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC-----ChhhHHHHHHHHHHHhcCCCCCccceehhhcch
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-----SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ  137 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  137 (387)
                      +....++|...+.||+|+||.||+|.+..++..||+|++...     .....+.+.+|+++++.++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            556678899999999999999999999999999999998643     334567899999999999999999999987543


Q ss_pred             h-----------------------------------------------------------------hHHHHHHHHHHHHH
Q 043148          138 R-----------------------------------------------------------------QLILHKIALGLASA  152 (387)
Q Consensus       138 ~-----------------------------------------------------------------~~~l~~i~~~i~~~  152 (387)
                      .                                                                 ...+..++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            2                                                                 12245789999999


Q ss_pred             HHHhhhhcccceeeccCCcceeEeCCCC--cEEEccccccccccCCCC---ceeeeeecCCcccCchhhcc--CCCCCcc
Q 043148          153 VLYLHEEWEQCIVHRDIKSSNVVLDSNF--NAKLGDFGLARLVDHELG---SQTTVLAGTMGYLAPECVTT--GKASKES  225 (387)
Q Consensus       153 l~~LH~~~~~~iiH~dlk~~Nill~~~~--~~kl~Dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~--~~~~~~~  225 (387)
                      |.|||+   ++|+||||||+|||++.++  .+||+|||+++.......   .......||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            999999   9999999999999998776  899999999986543211   12345568999999999875  6789999


Q ss_pred             chHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCC
Q 043148          226 DVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPS  305 (387)
Q Consensus       226 Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs  305 (387)
                      ||||||+++|||++|+.||......+..      ........       ..........+..+.+++.+||+.||.+||+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~------~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTI------SQVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHH------HHHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence            9999999999999999999765433211      11111110       0111111223456889999999999999999


Q ss_pred             HHHHHHHhccCCC
Q 043148          306 IRQVINVLNFEAP  318 (387)
Q Consensus       306 ~~evl~~l~~~~~  318 (387)
                      +.+++++.|+...
T Consensus       325 ~~~~l~hp~~~~~  337 (345)
T 3hko_A          325 AMRALQHPWISQF  337 (345)
T ss_dssp             HHHHHHSHHHHTT
T ss_pred             HHHHhcChhhccC
Confidence            9999999998654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.7e-42  Score=321.91  Aligned_cols=247  Identities=23%  Similarity=0.317  Sum_probs=178.1

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-  140 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-  140 (387)
                      ....++|...+.||+|+||.||+|++..+++.||||++.....  ...+.+.+|+++++.++||||+++++++.+.... 
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            4456889999999999999999999999999999999975532  2345678999999999999999999987654322 


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe-----CCCCcEEEcccccccc
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL-----DSNFNAKLGDFGLARL  192 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill-----~~~~~~kl~Dfg~~~~  192 (387)
                                             .+..++.|++.||.|||+   ++|+||||||+|||+     +.++.+||+|||+++.
T Consensus       110 lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          110 LIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence                                   236799999999999999   999999999999999     5556699999999986


Q ss_pred             ccCCCCceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc---h
Q 043148          193 VDHELGSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ---L  268 (387)
Q Consensus       193 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~  268 (387)
                      ..... .......+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+....   +........   .
T Consensus       187 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~  262 (329)
T 3gbz_A          187 FGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK---IFEVLGLPDDTTW  262 (329)
T ss_dssp             HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCTTTS
T ss_pred             cCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH---HHHHhCCCchhhh
Confidence            64332 223345679999999999875 489999999999999999999999976543322211   111111100   0


Q ss_pred             hhh-------------hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          269 LEA-------------ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       269 ~~~-------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ...             ....+...........+.+++.+||+.||.+|||++|+++|.|+..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  324 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH  324 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence            000             0000000111113456789999999999999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=320.53  Aligned_cols=248  Identities=21%  Similarity=0.278  Sum_probs=181.6

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChh-----hHHHHHHHHHHHhcCCCCCccceehhhcchh
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ-----GKKEYISEVRIISRLRHRNLVHLIGWCHEQR  138 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  138 (387)
                      ....++|...+.||+|+||.||+|.+..+|+.||||.+......     ..+.+.+|++++..++||||+++++++.+..
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            34567899999999999999999999988999999998653221     1346889999999999999999999876543


Q ss_pred             hH-------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          139 QL-------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       139 ~~-------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                      ..                         .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           86 NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             ceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            21                         236899999999999999   99999999999999999999999999999866


Q ss_pred             cCCCCceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          194 DHELGSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       194 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                      .... .......+|+.|+|||++.+. .++.++||||||+++|||++|..||......+.   ...+.............
T Consensus       163 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          163 GSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             TSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSS
T ss_pred             cCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChhhhh
Confidence            4332 223345689999999998764 489999999999999999999999976543322   22222221111100000


Q ss_pred             ------cc----cCC----ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          273 ------DG----RLS----KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       273 ------~~----~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                            +.    ...    .......+..+.+++.+||+.||.+|||+.|+++|.|+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence                  00    000    00112334668899999999999999999999999998654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7.8e-42  Score=319.16  Aligned_cols=232  Identities=22%  Similarity=0.252  Sum_probs=162.0

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCCccceehhhcchhhH------------
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQL------------  140 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~------------  140 (387)
                      +.||+|+||.||+|.+..+++.||||++..   .....+.+|+.++..+. ||||+++++++.+....            
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            689999999999999999999999999854   34567789999999997 99999999987654321            


Q ss_pred             -------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC---cEEEccccccccccCCCCceeeee
Q 043148          141 -------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF---NAKLGDFGLARLVDHELGSQTTVL  204 (387)
Q Consensus       141 -------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~  204 (387)
                                   .+..++.|++.||.|||+   ++|+||||||+|||++.++   .+||+|||+++...... ......
T Consensus        94 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~  169 (325)
T 3kn6_A           94 FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTP  169 (325)
T ss_dssp             HHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccccc
Confidence                         236799999999999999   9999999999999997665   89999999998654332 223345


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ  284 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (387)
                      .||+.|+|||++.+..++.++||||||+++|||++|+.||..................+..+..      ..........
T Consensus       170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~~~~~  243 (325)
T 3kn6_A          170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEAWKNV  243 (325)
T ss_dssp             --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHHHHTS
T ss_pred             CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCcccccCC
Confidence            6899999999999999999999999999999999999999865432211111112222211111      1112222334


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          285 MECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       285 ~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      +..+.+++.+||+.||.+|||++|+++|.|+...
T Consensus       244 s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             CHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             CHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            6678899999999999999999999999998653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2e-41  Score=310.50  Aligned_cols=228  Identities=29%  Similarity=0.473  Sum_probs=181.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhh-------HHHHHHHHHHHhcCCCCCccceehhhcchhh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQG-------KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  139 (387)
                      .++|...+.||+|+||.||+|++..+++.||||.+.......       .+.+.+|++++..++||||+++++++.+...
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR   97 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence            478899999999999999999999999999999986543221       1678999999999999999999998755321


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccc--eeeccCCcceeEeCCCCc-----EEEcccc
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQC--IVHRDIKSSNVVLDSNFN-----AKLGDFG  188 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~--iiH~dlk~~Nill~~~~~-----~kl~Dfg  188 (387)
                                              ..+..++.|++.||.|||+   .+  ++||||||+|||++.++.     +||+|||
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence                                    1236799999999999999   88  999999999999988776     9999999


Q ss_pred             ccccccCCCCceeeeeecCCcccCchhhc--cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC
Q 043148          189 LARLVDHELGSQTTVLAGTMGYLAPECVT--TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG  266 (387)
Q Consensus       189 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  266 (387)
                      +++....    ......||+.|+|||++.  ...++.++||||||+++|||++|+.||......... .....       
T Consensus       175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~-------  242 (287)
T 4f0f_A          175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FINMI-------  242 (287)
T ss_dssp             TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HHHHH-------
T ss_pred             ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HHHHH-------
Confidence            9974433    234456899999999984  455789999999999999999999999865543221 11111       


Q ss_pred             chhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                           .........+...+..+.+++.+||+.||.+|||++|+++.|+
T Consensus       243 -----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  285 (287)
T 4f0f_A          243 -----REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS  285 (287)
T ss_dssp             -----HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence                 1111222233344567889999999999999999999999886

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-41  Score=311.91  Aligned_cols=246  Identities=23%  Similarity=0.256  Sum_probs=189.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  138 (387)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+++++.++||||+++++++.+..       
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            367889999999999999999999999999999997543 334677889999999999999999998764422       


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe----CCCCcEEEccccccc
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL----DSNFNAKLGDFGLAR  191 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~~kl~Dfg~~~  191 (387)
                                             ...+..++.|++.||.|||+   ++|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence                                   11236799999999999999   999999999999999    888899999999998


Q ss_pred             cccCCCCceeeeeecCCcccCchhhc--------cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHH
Q 043148          192 LVDHELGSQTTVLAGTMGYLAPECVT--------TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKV-RLVEWVWDL  262 (387)
Q Consensus       192 ~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~  262 (387)
                      ......  ......||+.|+|||++.        +..++.++||||||+++|||++|+.||......... .....+...
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             ECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            765432  223456899999999986        467899999999999999999999999765543322 122111111


Q ss_pred             hccCchhhh---------h--cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          263 YGKGQLLEA---------A--DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       263 ~~~~~~~~~---------~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .........         .  ...............+.+++.+||+.||.+|||++|+++++.-..
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            111000000         0  011123455778888999999999999999999999999987443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.7e-42  Score=339.04  Aligned_cols=231  Identities=26%  Similarity=0.426  Sum_probs=186.7

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      ...+|...+.||+|+||.||+|.+..++..||||.+.... ...++|.+|+++|++++||||++++++|.+....     
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            3567888899999999999999999889999999997543 3467899999999999999999999988654221     


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence                                  236789999999999999   9999999999999999999999999999987654322


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      .......+++.|+|||++....++.++||||||+++|||++ |+.||...........                +.....
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~----------------~~~~~~  437 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----------------LEKDYR  437 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH----------------HHTTCC
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----------------HHcCCC
Confidence            22223345778999999998899999999999999999999 9999987654322111                111112


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ...+..++..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            223334556688999999999999999999999999743

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.8e-41  Score=321.19  Aligned_cols=246  Identities=20%  Similarity=0.214  Sum_probs=180.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            47899999999999999999999999999999999753  3445677889999999999999999999875432      


Q ss_pred             ----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          139 ----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       139 ----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                            ...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       104 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~  180 (371)
T 2xrw_A          104 DVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  180 (371)
T ss_dssp             EEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred             ceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence                                  11236789999999999999   99999999999999999999999999999865432


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH----------------HH
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW----------------VW  260 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~----------------~~  260 (387)
                        .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+....+....+..                ..
T Consensus       181 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  258 (371)
T 2xrw_A          181 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  258 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred             --cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence              123345789999999999999999999999999999999999999987543222111100                00


Q ss_pred             HHhcc------Cchhhhhccc---CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          261 DLYGK------GQLLEAADGR---LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       261 ~~~~~------~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .....      ..........   ............+.+|+.+||+.||.+|||++|+++|.|+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence            00000      0000000000   011122334677899999999999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.5e-41  Score=318.19  Aligned_cols=237  Identities=22%  Similarity=0.277  Sum_probs=185.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~--  140 (387)
                      .++|...+.||+|+||.||++++..+++.||||++.+.   .....+.+.+|..++..+ +||||+++++++.+....  
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            36788999999999999999999999999999999754   234456788999999988 899999999987653321  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                             .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC-
Confidence                                   236789999999999999   99999999999999999999999999999753322 


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh--hHHHHHHHHhccCchhhhhccc
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKV--RLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .............        .
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--------~  235 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------Q  235 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--------C
T ss_pred             CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--------C
Confidence            22334567999999999999999999999999999999999999999753322110  0111111111111        1


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHhccCC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSI------RQVINVLNFEA  317 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~------~evl~~l~~~~  317 (387)
                        ..++...+..+.+++.+||+.||.+||++      +|+++|.|+..
T Consensus       236 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          236 --IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             --CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence              11223345568899999999999999994      89999999853

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.4e-41  Score=328.39  Aligned_cols=238  Identities=23%  Similarity=0.277  Sum_probs=179.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh---------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR---------  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------  138 (387)
                      .+|...+.||+|+||.||+|++..+++.||||++....    ..+.+|+++|+.++||||++++++|....         
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999999899999999986542    22347999999999999999988763210         


Q ss_pred             -------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC-CcEEEcccccccc
Q 043148          139 -------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN-FNAKLGDFGLARL  192 (387)
Q Consensus       139 -------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfg~~~~  192 (387)
                                               ...+..++.||+.||.|||+   ++|+||||||+|||++.+ +.+||+|||+++.
T Consensus       130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence                                     01135789999999999999   999999999999999965 5789999999986


Q ss_pred             ccCCCCceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh--
Q 043148          193 VDHELGSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL--  269 (387)
Q Consensus       193 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  269 (387)
                      .....  ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+...   .+....+.....  
T Consensus       207 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~---~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          207 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV---EIIKVLGTPTREQI  281 (420)
T ss_dssp             CCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCSCCHHHH
T ss_pred             cccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHHHH
Confidence            54322  22345689999999998765 69999999999999999999999998755332221   111111111100  


Q ss_pred             --------hhhcccCC-----ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          270 --------EAADGRLS-----KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       270 --------~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                              +...+.+.     ..+....+..+.+|+.+||+.||.+|||+.|+++|.|+..
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~  342 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  342 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence                    00001110     0112233566889999999999999999999999999753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=323.02  Aligned_cols=226  Identities=25%  Similarity=0.360  Sum_probs=183.9

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--------hhHHHHHHHHHHHhcCCCCCccceehhhcc
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--------QGKKEYISEVRIISRLRHRNLVHLIGWCHE  136 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  136 (387)
                      ...++|...+.||+|+||.||+|++..+++.||||++.....        .....+.+|+++++.++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            346789999999999999999999999999999999976431        133467789999999999999999998755


Q ss_pred             hhh--------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccc
Q 043148          137 QRQ--------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLA  190 (387)
Q Consensus       137 ~~~--------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~  190 (387)
                      ...                          ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            322                          1236799999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL  269 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (387)
                      ......  .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......                   
T Consensus       178 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------------  236 (335)
T 3dls_A          178 AYLERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------------  236 (335)
T ss_dssp             EECCTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------------
T ss_pred             eECCCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------------
Confidence            876543  22334578999999999988776 88999999999999999999999642211                   


Q ss_pred             hhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                        .....  ..+...+..+.+++.+||+.||.+|||+++++++.|+..+
T Consensus       237 --~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          237 --VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             --TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             --Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence              00000  1111234558899999999999999999999999998653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-41  Score=319.15  Aligned_cols=231  Identities=25%  Similarity=0.372  Sum_probs=186.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      .++|...+.||+|+||.||++.+..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+....   
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            46799999999999999999999999999999998653   334567889999999999999999999987654321   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++....... 
T Consensus       120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence                                  236789999999999999   999999999999999999999999999998664332 


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......|++.|+|||++.+..++.++||||||+++|||++|+.||......+...      . ....      ...   
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~-~~~~------~~~---  259 (335)
T 2owb_A          196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------R-IKKN------EYS---  259 (335)
T ss_dssp             CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------H-HHHT------CCC---
T ss_pred             ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH------H-HhcC------CCC---
Confidence            22334568999999999999889999999999999999999999997644221110      0 0000      011   


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                       .+......+.+++.+||+.||.+|||++|++++.|+...
T Consensus       260 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          260 -IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             -CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence             112233457889999999999999999999999987653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1e-41  Score=311.28  Aligned_cols=230  Identities=27%  Similarity=0.404  Sum_probs=182.6

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      ..++|...+.||+|+||.||+|.+..++..||||++....   ......+.+|+.+++.++||||+++++++.+....  
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3578999999999999999999999999999999985532   22356788999999999999999999987654321  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                             .+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++...... 
T Consensus        87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence                                   236789999999999999   99999999999999999999999999998654332 


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                        ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+   .    .          ..
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~----~----------~~  223 (279)
T 3fdn_A          163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---S----R----------VE  223 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---H----H----------TC
T ss_pred             --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH---H----h----------CC
Confidence              223456899999999999999999999999999999999999999764422211111   0    0          01


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ...+...+..+.+++.+||+.||.+|||++|+++|.|+...
T Consensus       224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          224 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence            11222344567889999999999999999999999997643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.7e-41  Score=311.38  Aligned_cols=237  Identities=24%  Similarity=0.303  Sum_probs=184.9

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC----hhhHHHHHHHHHHHhcCCCCCccceehhhcch--hh
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS----KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ--RQ  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  139 (387)
                      ..++|.+.+.||+|+||.||++.+..++..||+|++....    ......+.+|+++++.++||||+++++++.+.  ..
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3578999999999999999999999999999999996532    23457899999999999999999999987321  11


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          140 --------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       140 --------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                                                ..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++...
T Consensus        83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence                                      1236789999999999999   99999999999999999999999999999866


Q ss_pred             cCCC-CceeeeeecCCcccCchhhccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          194 DHEL-GSQTTVLAGTMGYLAPECVTTGK--ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       194 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      .... ........|++.|+|||++.+..  ++.++||||||+++|||++|+.||........       ......+.   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~i~~~~---  229 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-------FENIGKGS---  229 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHCC---
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-------HHHHhcCC---
Confidence            4321 22333456899999999988654  37899999999999999999999976432211       11111111   


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCC
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSL  322 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~  322 (387)
                         .    ..+......+.+++.+||+.||.+|||++|++++.|+....+..
T Consensus       230 ---~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          230 ---Y----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             ---C----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             ---C----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence               0    11222345578899999999999999999999999987655443

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.3e-42  Score=333.67  Aligned_cols=233  Identities=24%  Similarity=0.420  Sum_probs=184.7

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      .....++|...+.||+|+||.||+|.+.. +..||||.+.... ...+.|.+|+++|+.++||||+++++++.+...   
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv  260 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYII  260 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEE
Confidence            34456778889999999999999999965 7889999997643 457889999999999999999999998753211   


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                             ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence                                   1235789999999999999   99999999999999999999999999999865432


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .........+++.|+|||++....++.++||||||+++|||++ |+.||......+..   ..+.    .+         
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~----~~---------  401 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALE----RG---------  401 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHH----HT---------
T ss_pred             ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH----cC---------
Confidence            1111223346778999999999999999999999999999999 99999865433211   1111    11         


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .....+..++..+.+++.+||+.||.+|||+++|++.|+..
T Consensus       402 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~  442 (454)
T 1qcf_A          402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  442 (454)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            11112233456688999999999999999999999999744

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.8e-41  Score=307.72  Aligned_cols=230  Identities=23%  Similarity=0.386  Sum_probs=182.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .++|...+.||+|+||.||+|.+.. +..||+|.+.... ...+++.+|++++..++||||+++++++.+...       
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            4678899999999999999998875 7789999997643 335779999999999999999999998755322       


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++..........
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  161 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS  161 (268)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence                               1236799999999999999   999999999999999999999999999998665543333


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..........      . ...+         ....
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~-~~~~---------~~~~  225 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------K-VSQG---------HRLY  225 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------H-HHTT---------CCCC
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH------H-HHcC---------CCCC
Confidence            333456778999999998889999999999999999999 999997654322111      1 0010         0111


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .+...+..+.+++.+||+.||.+|||+.+++++|+...
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            12223456889999999999999999999999998544

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-42  Score=329.39  Aligned_cols=249  Identities=20%  Similarity=0.208  Sum_probs=190.7

Q ss_pred             cCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhh
Q 043148           58 FTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWC  134 (387)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~  134 (387)
                      +++.++....++|...+.||+|+||.||+++.+.+|+.||||++.+..   ....+.+.+|.+++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            345556666789999999999999999999999999999999996532   22234588999999999999999999877


Q ss_pred             cchhhH--------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccc
Q 043148          135 HEQRQL--------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG  188 (387)
Q Consensus       135 ~~~~~~--------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  188 (387)
                      .+....                          ....++.+++.||.|||+   ++|+||||||+|||++.++.+||+|||
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeech
Confidence            654322                          125688999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCceeeeeecCCcccCchhhc-------cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 043148          189 LARLVDHELGSQTTVLAGTMGYLAPECVT-------TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWD  261 (387)
Q Consensus       189 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~  261 (387)
                      +++.............+||+.|+|||++.       ...|+.++|||||||++|||++|+.||......+....+   ..
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i---~~  284 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI---VH  284 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HT
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH---Hh
Confidence            99876554333334467999999999987       356899999999999999999999999765433221111   10


Q ss_pred             HhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHHhccCC-CCCCC
Q 043148          262 LYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNR---PSIRQVINVLNFEA-PLPSL  322 (387)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Ps~~evl~~l~~~~-~~~~~  322 (387)
                      ..     ....   . .......+..+.+++.+||. +|.+|   |+++|+++|.|+.. .+..+
T Consensus       285 ~~-----~~~~---~-p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          285 YK-----EHLS---L-PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             HH-----HHCC---C-C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             cc-----cCcC---C-CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            00     0000   0 11122345568899999999 99998   69999999999864 34433

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-42  Score=326.04  Aligned_cols=232  Identities=25%  Similarity=0.406  Sum_probs=180.7

Q ss_pred             hhCccccCcccccCceEEEEEEE-----CCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  140 (387)
                      .++|...+.||+|+||.||+|++     ..++..||||++... .......+.+|+.++..++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            36788899999999999999994     346778999999654 345566899999999999999999999987553211


Q ss_pred             --------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC---cEEEc
Q 043148          141 --------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF---NAKLG  185 (387)
Q Consensus       141 --------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kl~  185 (387)
                                                      .+..++.|++.||.|||+   ++|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence                                            135689999999999999   9999999999999999555   59999


Q ss_pred             cccccccccCC-CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHh
Q 043148          186 DFGLARLVDHE-LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLY  263 (387)
Q Consensus       186 Dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  263 (387)
                      |||+++..... .........+|+.|+|||++.+..++.++|||||||++|||++ |..||......+..   .    ..
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~---~----~i  299 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---E----FV  299 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---H----HH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HH
Confidence            99999754322 1122334457889999999999999999999999999999998 99999765432211   1    11


Q ss_pred             ccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ..+         .....+..++..+.+++.+||+.||.+|||+.+|+++|+...
T Consensus       300 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          300 TSG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HcC---------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            111         111122334456889999999999999999999999998654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.3e-42  Score=319.89  Aligned_cols=242  Identities=26%  Similarity=0.293  Sum_probs=180.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .++|...+.||+|+||.||+|++.  ++.||||++.... .....+..|+.++..++||||+++++++.+...       
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            477899999999999999999985  7899999996543 334556679999999999999999998765321       


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhh-------cccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEE-------WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~-------~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                                           ..+..++.|++.||.|||+.       +.++|+||||||+|||++.++.+||+|||+++
T Consensus       100 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~  179 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL  179 (322)
T ss_dssp             EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence                                 12367899999999999982       01299999999999999999999999999998


Q ss_pred             cccCCCCc-eeeeeecCCcccCchhhccC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH-------
Q 043148          192 LVDHELGS-QTTVLAGTMGYLAPECVTTG-----KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW-------  258 (387)
Q Consensus       192 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~-------  258 (387)
                      ........ ......||+.|+|||++.+.     .++.++||||||+++|||++|+.||..............       
T Consensus       180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  259 (322)
T 3soc_A          180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL  259 (322)
T ss_dssp             EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred             ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence            66543221 22335689999999999863     456788999999999999999999987554322211110       


Q ss_pred             --HHHHhccCchhhhhcccCCcc-ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          259 --VWDLYGKGQLLEAADGRLSKE-FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       259 --~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                        .........    ..+.+... .....+..+.+++.+||+.||.+|||+.||++.|+.
T Consensus       260 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          260 EDMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             HHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hhhhhhhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence              111111110    11111111 123456679999999999999999999999999863

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.2e-41  Score=320.79  Aligned_cols=227  Identities=25%  Similarity=0.287  Sum_probs=185.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      .++|...+.||+|+||.||++++..+|+.||||++....   ....+.+.+|++++..++||||+++++++.+....   
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            468999999999999999999999999999999986532   23456788999999999999999999877654321   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....  
T Consensus       120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence                                  236789999999999999   99999999999999999999999999999865432  


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                        .....||+.|+|||++.+..++.++||||||+++|||++|+.||........   ..    .+..+.          .
T Consensus       195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~----~i~~~~----------~  255 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YE----KIVSGK----------V  255 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHCC----------C
T ss_pred             --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH---HH----HHHcCC----------C
Confidence              2345789999999999999999999999999999999999999976542211   11    111111          1


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFEA  317 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  317 (387)
                      .++...+..+.+++.+||+.||.+||+     ++||++|.|+..
T Consensus       256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            122234456889999999999999998     999999999753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=8e-42  Score=311.56  Aligned_cols=234  Identities=20%  Similarity=0.252  Sum_probs=187.2

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      ..++|...+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++||||+++++++.+....     
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            457799999999999999999999999999999999776566678899999999999999999999987654321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe---CCCCcEEEccccccccccCCC
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL---DSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                          .+..++.|++.||.|||+   ++++||||||+|||+   +.++.+||+|||++.......
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence                                236799999999999999   999999999999999   888999999999998665432


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                        ......+|+.|+|||.+.+. ++.++||||||+++|||++|+.||......+..   ..+.    .+.      ....
T Consensus       164 --~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~----~~~------~~~~  227 (277)
T 3f3z_A          164 --MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM---LKIR----EGT------FTFP  227 (277)
T ss_dssp             --CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HCC------CCCC
T ss_pred             --chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH---HHHH----hCC------CCCC
Confidence              23345689999999988654 899999999999999999999999765432211   1110    110      0011


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .......+..+.+++.+||+.||.+|||+.+++++.|+...
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            11111234568899999999999999999999999987654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=320.35  Aligned_cols=235  Identities=23%  Similarity=0.299  Sum_probs=171.8

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      ...++|...+.||+|+||.||+|++..+++.||||++....  ..+.+.+|++++..++||||+++++++.+...     
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            34678999999999999999999999989999999997543  34678899999999999999999998765322     


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC---CCcEEEccccccccccCC
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~~  196 (387)
                                          ..+..++.|++.||.|||+   .+|+||||||+|||++.   ++.+||+|||+++.....
T Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          128 ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence                                1236899999999999999   99999999999999975   889999999999865432


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                        .......||+.|+|||++.+..++.++||||||+++|||++|+.||........  ..    ..+.....      ..
T Consensus       205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~----~~i~~~~~------~~  270 (349)
T 2w4o_A          205 --VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF----RRILNCEY------YF  270 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH----HHHHTTCC------CC
T ss_pred             --cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH----HHHHhCCC------cc
Confidence              222345689999999999999999999999999999999999999976543221  11    11111100      01


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ........+..+.+++.+||+.||.+|||+.|++++.|+...
T Consensus       271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            111122345568899999999999999999999999998654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.1e-42  Score=327.82  Aligned_cols=231  Identities=26%  Similarity=0.466  Sum_probs=171.1

Q ss_pred             hhCccccCcccccCceEEEEEEEC---CCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLS---DQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      .++|...+.||+|+||.||+|++.   .++..||||.+... .....++|.+|++++.+++||||++++++|.+....  
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357888999999999999999886   45678999999765 344567899999999999999999999987654321  


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          141 ------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       141 ------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                              .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence                                    236789999999999999   99999999999999999999999999999866543


Q ss_pred             CCc--eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          197 LGS--QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       197 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ...  ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.   ..    ....+       
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~~----~i~~~-------  266 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IK----AVDEG-------  266 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---HH----HHHTT-------
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcC-------
Confidence            211  1122345778999999999999999999999999999998 9999976543221   11    11111       


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                        .....+..++..+.+++.+||+.||.+||++.+|++.|+..
T Consensus       267 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          267 --YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             --EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence              11111223455688999999999999999999999998643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7e-42  Score=310.70  Aligned_cols=228  Identities=27%  Similarity=0.466  Sum_probs=181.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL------  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------  140 (387)
                      .++|...+.||+|+||.||+|.+.. +..||+|++.... ...+++.+|++++.+++||||+++++++.+....      
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            3678889999999999999999875 7889999997643 3357799999999999999999999987654321      


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          .+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++..........
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence                                236789999999999999   999999999999999999999999999998654432222


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..   .    ....+         ....
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~---~----~~~~~---------~~~~  227 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---E----DISTG---------FRLY  227 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H----HHHTT---------CCCC
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH---H----HHhcC---------ccCC
Confidence            233446778999999999999999999999999999999 99999765432211   1    11111         1111


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .+...+..+.+++..||+.||.+|||+.+++++|..
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  263 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence            222234568899999999999999999999999863

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-41  Score=321.79  Aligned_cols=242  Identities=20%  Similarity=0.293  Sum_probs=181.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      .++|...+.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+++++.++||||+++++++.....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            47799999999999999999999999999999998653  33446778999999999999999999988754321     


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                              ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence                                    1236789999999999999   9999999999999999999999999999986543


Q ss_pred             CCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc-------
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ-------  267 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  267 (387)
                      .    .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+   ........       
T Consensus       181 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          181 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI---MKVTGTPPAEFVQRL  253 (367)
T ss_dssp             S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCHHHHHTC
T ss_pred             c----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCCHHHHHHh
Confidence            2    234568999999999887 67999999999999999999999999876543322211   11111100       


Q ss_pred             ----hhhh---hcc---cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          268 ----LLEA---ADG---RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       268 ----~~~~---~~~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                          ....   +..   .-...........+.+++.+||+.||.+|||++|+++|.|+..-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                0000   000   00011122335568899999999999999999999999998653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.2e-41  Score=316.35  Aligned_cols=243  Identities=21%  Similarity=0.256  Sum_probs=179.3

Q ss_pred             hhCcccc-CcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH----
Q 043148           67 TNNFAEA-GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        67 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~----  140 (387)
                      .+.|.+. +.||+|+||.||+|.+..+++.||||++..........+.+|++++.++ +||||+++++++.+....    
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4567774 6899999999999999888999999999876666678899999999885 799999999987654321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc---EEEccccccccccCC
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN---AKLGDFGLARLVDHE  196 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kl~Dfg~~~~~~~~  196 (387)
                                           .+..++.|++.||.|||+   ++|+||||||+|||++.++.   +||+|||++......
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence                                 236789999999999999   99999999999999998776   999999998765422


Q ss_pred             CC------ceeeeeecCCcccCchhhcc-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhH--------HH
Q 043148          197 LG------SQTTVLAGTMGYLAPECVTT-----GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRL--------VE  257 (387)
Q Consensus       197 ~~------~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~--------~~  257 (387)
                      ..      .......||+.|+|||++..     ..++.++||||||+++|||++|+.||......+....        ..
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            11      11223458999999999875     4588999999999999999999999987543321100        00


Q ss_pred             HHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          258 WVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ........+..      ..........+..+.+++.+||+.||.+|||+.|+++|.|+...
T Consensus       248 ~~~~~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          248 MLFESIQEGKY------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             HHHHHHHHCCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             HHHHHHhccCc------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            11111111100      01111111234568899999999999999999999999998754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-41  Score=325.87  Aligned_cols=232  Identities=22%  Similarity=0.325  Sum_probs=178.0

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCC--CCCccceehhhcchhhH---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLR--HRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~---  140 (387)
                      ++|.+.+.||+|+||.||++.+.. ++.||||++...  .....+.+.+|+.+|..++  ||||+++++++......   
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            459999999999999999999876 889999998654  3445678999999999996  59999999877543221   


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           ....++.||+.||.|||+   ++|+||||||+|||++ ++.+||+|||+++........
T Consensus       135 ~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          135 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             EECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence                                 236789999999999999   9999999999999996 589999999999866543211


Q ss_pred             -eeeeeecCCcccCchhhcc-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc
Q 043148          200 -QTTVLAGTMGYLAPECVTT-----------GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ  267 (387)
Q Consensus       200 -~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (387)
                       ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......     .....       
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~-------  278 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLH-------  278 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHH-------
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHH-------
Confidence             2234579999999999865           36899999999999999999999999754321     11111       


Q ss_pred             hhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          268 LLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                        .+.++.....++......+.+++.+||+.||.+|||+.|+++++|+...
T Consensus       279 --~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          279 --AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             --HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             --HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence              1122222222222234568899999999999999999999999998654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.2e-41  Score=320.14  Aligned_cols=240  Identities=23%  Similarity=0.352  Sum_probs=187.9

Q ss_pred             cCHHHHHHHhhCccccCcccccCceEEEEEE-----ECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccce
Q 043148           58 FTYRELSRATNNFAEAGKLGEGGFGGVYRGL-----LSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHL  130 (387)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l  130 (387)
                      +...++....++|...+.||+|+||.||+|+     ...+++.||||++.... ....+.+.+|++++..+ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            3445556667899999999999999999998     45567899999997643 34457799999999999 79999999


Q ss_pred             ehhhcchhh-----------------------------------------------------------------------
Q 043148          131 IGWCHEQRQ-----------------------------------------------------------------------  139 (387)
Q Consensus       131 ~~~~~~~~~-----------------------------------------------------------------------  139 (387)
                      +++|.+...                                                                       
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            997654221                                                                       


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC-
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL-  197 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-  197 (387)
                                           ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... 
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                                 1134588999999999999   999999999999999999999999999998654332 


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                      ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||..........  .    ....+         .
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--~----~~~~~---------~  313 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--R----RLKEG---------T  313 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH--H----HHHHT---------C
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH--H----HHHcC---------C
Confidence            223344568899999999999999999999999999999998 999998655432211  1    11111         1


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ....+...+..+.+++..||+.||.+|||+.|++++|..
T Consensus       314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  352 (359)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            111222334568899999999999999999999999863

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.1e-41  Score=313.73  Aligned_cols=233  Identities=21%  Similarity=0.266  Sum_probs=186.0

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh------hhHHHHHHHHHHHhcCCCCCccceehhhcchhh
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK------QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  139 (387)
                      ..++|...+.||+|+||.||+|++..+|..||||.+.....      ...+.+.+|++++..++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            35678999999999999999999999999999999976432      136789999999999999999999998765321


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC----cEEEcccccc
Q 043148          140 -------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF----NAKLGDFGLA  190 (387)
Q Consensus       140 -------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kl~Dfg~~  190 (387)
                                               ..+..++.|++.||.|||+   ++++||||||+|||++.++    .+||+|||++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence                                     1236899999999999999   9999999999999999888    7999999999


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      .......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..   .   . ....    
T Consensus       167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~---~-i~~~----  233 (321)
T 2a2a_A          167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---A---N-ITSV----  233 (321)
T ss_dssp             EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---H---H-HHTT----
T ss_pred             eecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH---H---H-HHhc----
Confidence            8665432  223456899999999999999999999999999999999999999765432211   1   1 1010    


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                        ............+..+.+++.+||+.||.+|||+.|+++|.|+.
T Consensus       234 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~  277 (321)
T 2a2a_A          234 --SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (321)
T ss_dssp             --CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred             --ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence              00111111123345688999999999999999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5e-41  Score=318.59  Aligned_cols=248  Identities=19%  Similarity=0.255  Sum_probs=189.2

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      ..++|...+.||+|+||.||+|.+..++..||||++.... ....+.+.+|++++..++||||+++++++....      
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3568999999999999999999999999999999997543 344578899999999999999999998764321      


Q ss_pred             ----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          139 ----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       139 ----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                            ...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++......
T Consensus       105 ~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          105 VYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             EEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence                                  11236799999999999999   99999999999999999999999999999866543


Q ss_pred             CCc--eeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh---
Q 043148          197 LGS--QTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE---  270 (387)
Q Consensus       197 ~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  270 (387)
                      ...  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+.   ..........   
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~~  258 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQEDLNC  258 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---HHHCSCCHHHHHT
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---HHhCCCCHHHHHH
Confidence            211  1234578999999998764 458999999999999999999999998766544332221   1111110000   


Q ss_pred             --------h----hcccC--CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 043148          271 --------A----ADGRL--SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPL  319 (387)
Q Consensus       271 --------~----~~~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  319 (387)
                              .    ..+..  ...........+.+++.+||+.||.+|||+.|+++|.|+....
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence                    0    00000  0011122345688999999999999999999999999987653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.9e-42  Score=322.67  Aligned_cols=233  Identities=22%  Similarity=0.309  Sum_probs=185.1

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  139 (387)
                      ....++|...+.||+|+||.||+|+++.+++.||||++.+..   ......+..|.+++..+ +||||+++++++.+...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345688999999999999999999999999999999996532   23456778899999876 99999999998765432


Q ss_pred             H-------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          140 L-------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       140 ~-------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                      .                         ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            1                         125789999999999999   999999999999999999999999999997543


Q ss_pred             CCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          195 HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      .. ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+..   ..+    ...      . 
T Consensus       170 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~i----~~~------~-  234 (345)
T 1xjd_A          170 LG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF---HSI----RMD------N-  234 (345)
T ss_dssp             CT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHC------C-
T ss_pred             cC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH----HhC------C-
Confidence            22 12334567999999999999999999999999999999999999999765432211   111    011      0 


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHhccCC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIR-QVINVLNFEA  317 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~-evl~~l~~~~  317 (387)
                         ..++...+..+.+++.+||+.||.+||++. ++++|.|+..
T Consensus       235 ---~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          235 ---PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             ---CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence               112223445688999999999999999998 9999998754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.5e-41  Score=308.32  Aligned_cols=235  Identities=24%  Similarity=0.284  Sum_probs=185.9

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      ..++|...+.||+|+||.||+|.+..++..||+|++...  .....+.+.+|++++..++||||+++++++.+...    
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            357899999999999999999999999999999998653  34456778899999999999999999998765322    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc---EEEccccccccccC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN---AKLGDFGLARLVDH  195 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kl~Dfg~~~~~~~  195 (387)
                                           ..+..++.|++.||.|||+   ++++||||||+||+++.++.   +||+|||++.....
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence                                 1236789999999999999   99999999999999987655   99999999976654


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .  .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.........   ..+.    .+..      .
T Consensus       161 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~----~~~~------~  225 (284)
T 3kk8_A          161 S--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---AQIK----AGAY------D  225 (284)
T ss_dssp             S--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HTCC------C
T ss_pred             C--ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH---HHHH----hccc------c
Confidence            3  2223456899999999999999999999999999999999999999764432211   1111    1100      0


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .........+..+.+++.+||+.||.+|||+.|++++.|+...
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          226 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence            1111112234558899999999999999999999999987643

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1e-41  Score=330.13  Aligned_cols=244  Identities=20%  Similarity=0.270  Sum_probs=183.0

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC------CCCCccceehhhcchhh-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL------RHRNLVHLIGWCHEQRQ-  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~-  139 (387)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++... ......+.+|++++..+      +|+||+++++++..... 
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            46799999999999999999999999999999999653 34456777888888776      57799999987654321 


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc--EEEcccccccc
Q 043148          140 -------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN--AKLGDFGLARL  192 (387)
Q Consensus       140 -------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~--~kl~Dfg~~~~  192 (387)
                                               ..+..++.||+.||.|||+   ++|+||||||+|||++.++.  +||+|||++..
T Consensus       175 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          175 CMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence                                     1246799999999999999   89999999999999999987  99999999975


Q ss_pred             ccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC------
Q 043148          193 VDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG------  266 (387)
Q Consensus       193 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------  266 (387)
                      ....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.   ......      
T Consensus       252 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~---~~~~~p~~~~~~  324 (429)
T 3kvw_A          252 EHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI---ELLGMPSQKLLD  324 (429)
T ss_dssp             TTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HHHCCCCHHHHH
T ss_pred             cCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHcCCCCHHHHH
Confidence            4432    234568999999999999999999999999999999999999998765443322211   111100      


Q ss_pred             ---chhhhhcc--------------------------------cCCcc----ccHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 043148          267 ---QLLEAADG--------------------------------RLSKE----FDERQMECLMIVGLWCCHPDFTNRPSIR  307 (387)
Q Consensus       267 ---~~~~~~~~--------------------------------~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~  307 (387)
                         .....++.                                .....    ........+.+|+.+||+.||.+|||++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence               00000000                                00000    0011245588999999999999999999


Q ss_pred             HHHHHhccCCCCCC
Q 043148          308 QVINVLNFEAPLPS  321 (387)
Q Consensus       308 evl~~l~~~~~~~~  321 (387)
                      |+++|.|+....+.
T Consensus       405 e~L~Hpw~~~~~~~  418 (429)
T 3kvw_A          405 QALRHPWLRRRLPK  418 (429)
T ss_dssp             HHHTSTTTC-----
T ss_pred             HHhCChhhccCCCC
Confidence            99999998876544

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.5e-41  Score=319.81  Aligned_cols=242  Identities=21%  Similarity=0.292  Sum_probs=174.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      .++|...+.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+++++.++||||+++++++....      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            47899999999999999999999999999999998654  3445678889999999999999999999875321      


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ...+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       108 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             eEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence                                   12246799999999999999   9999999999999999999999999999986543


Q ss_pred             CCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc-------
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ-------  267 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  267 (387)
                          ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....   +....+...       
T Consensus       185 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~p~~~~~~~~  257 (367)
T 2fst_X          185 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAELLKKI  257 (367)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHHTTC
T ss_pred             ----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCHHHHHHh
Confidence                2334578999999999887 6789999999999999999999999987654332222   222111110       


Q ss_pred             ----hhhhhc---ccCCc---cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          268 ----LLEAAD---GRLSK---EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       268 ----~~~~~~---~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                          ......   .....   .........+.+|+.+||+.||.+|||+.|+++|.|+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence                000000   00000   0011224568899999999999999999999999998753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.9e-41  Score=309.92  Aligned_cols=231  Identities=26%  Similarity=0.391  Sum_probs=172.2

Q ss_pred             HhhCccccCcccccCceEEEEEEECCC---CeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh---
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQ---NTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR---  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  138 (387)
                      ..++|...+.||+|+||.||+|.+..+   +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+..   
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~l   92 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI   92 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEE
Confidence            357888999999999999999998653   457999998764 3445678999999999999999999999864421   


Q ss_pred             ----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          139 ----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       139 ----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                            ...+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence                                  11236789999999999999   99999999999999999999999999999876543


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....   +.    .+.        
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~---i~----~~~--------  234 (281)
T 1mp8_A          170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IE----NGE--------  234 (281)
T ss_dssp             ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---HH----TTC--------
T ss_pred             cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH---HH----cCC--------
Confidence            3333334456789999999998999999999999999999997 9999986554332111   10    110        


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                       ....+...+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus       235 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          235 -RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  273 (281)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             111223345668899999999999999999999999863

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.4e-41  Score=317.32  Aligned_cols=248  Identities=21%  Similarity=0.288  Sum_probs=185.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      .++|...+.||+|+||.||+|++..+|+.||||++....  ......+.+|+++++.++||||+++++++.+...     
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999999999999999999986543  2335678899999999999999999987755321     


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          140 ----------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       140 ----------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                                                  ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence                                        1236899999999999999   999999999999999999999999999998


Q ss_pred             cccCCC---CceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc
Q 043148          192 LVDHEL---GSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ  267 (387)
Q Consensus       192 ~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (387)
                      ......   ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+...........
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            664321   122334568999999999876 4589999999999999999999999987554332222211110000000


Q ss_pred             hhhhh-----cc-----cCCccccHH-----HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          268 LLEAA-----DG-----RLSKEFDER-----QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       268 ~~~~~-----~~-----~~~~~~~~~-----~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .....     +.     .........     ....+.+++.+||+.||.+|||++|+++|.|+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  317 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  317 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence            00000     00     000000111     1345789999999999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.8e-41  Score=309.80  Aligned_cols=231  Identities=25%  Similarity=0.370  Sum_probs=186.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      .++|...+.||+|+||.||++.+..+++.+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+...    
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            46788999999999999999999999999999998654   23456778899999999999999999998765432    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++....... 
T Consensus        94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc-
Confidence                                 1236789999999999999   999999999999999999999999999998664322 


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+..      .. .....          .
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~-~~~~~----------~  232 (294)
T 2rku_A          170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LR-IKKNE----------Y  232 (294)
T ss_dssp             CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HH-HHTTC----------C
T ss_pred             cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-Hhhcc----------C
Confidence            2233456899999999999888999999999999999999999999765422111      01 11110          0


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ..+......+.+++.+||+.||.+|||++|++++.|+...
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          233 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence            1122234557889999999999999999999999988643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.5e-42  Score=332.93  Aligned_cols=231  Identities=25%  Similarity=0.328  Sum_probs=175.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      .++|...+.||+|+||.||+|....+|+.||||++...   .......+.+|+++++.++||||++++++|.+....   
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999999999999999999653   233456778999999999999999999987654322   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||.|||+.  ++|+||||||+|||++.++.+||+|||+++..... .
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~  303 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-G  303 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-C
Confidence                                  1267899999999999962  78999999999999999999999999999754332 2


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........   ..+.    ..      .    .
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~i~----~~------~----~  366 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---ELIL----ME------E----I  366 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HC------C----C
T ss_pred             cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH---HHHH----hC------C----C
Confidence            2334467999999999999999999999999999999999999999765432211   1110    00      0    1


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      .++...+..+.+++.+||+.||.+||     +++|+++|.|+..
T Consensus       367 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          367 RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            12223345688999999999999999     9999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.3e-41  Score=319.07  Aligned_cols=230  Identities=23%  Similarity=0.296  Sum_probs=184.4

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH-
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL-  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~-  140 (387)
                      ..++|...+.||+|+||.||+|+...+++.||||++.+..   ....+.+..|.+++..+ +||||+++++++.+.... 
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3578999999999999999999999989999999996542   23456788999999988 899999999877653221 


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          141 ------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       141 ------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                              ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence                                    225789999999999999   99999999999999999999999999999753322


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                       .......+||+.|+|||++.+..++.++||||||+++|||++|+.||......+.   ...+.    .        .. 
T Consensus       175 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~i~----~--------~~-  237 (353)
T 2i0e_A          175 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQSIM----E--------HN-  237 (353)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----H--------CC-
T ss_pred             -CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH---HHHHH----h--------CC-
Confidence             2233456799999999999999999999999999999999999999976542211   11111    1        11 


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFE  316 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~  316 (387)
                       ..++...+..+.+++.+||+.||.+||     +++++++|.|+.
T Consensus       238 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~  281 (353)
T 2i0e_A          238 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  281 (353)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence             112233455688999999999999999     469999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.9e-41  Score=310.03  Aligned_cols=229  Identities=25%  Similarity=0.404  Sum_probs=178.9

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      ..++|...+.||+|+||.||++.+.. +..||||++.... ...+++.+|++++..++||||+++++++.+...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            35788899999999999999999874 7889999997643 335779999999999999999999998765332      


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A          100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence                                1236899999999999999   99999999999999999999999999999865443222


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..........       ....         ....
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~-------~~~~---------~~~~  240 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-------HIAQ---------GLRL  240 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-------HHHT---------TCCC
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH-------HHhc---------ccCC
Confidence            2223346778999999998899999999999999999998 999997654322111       1101         1111


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ..+...+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            1122234568899999999999999999999999863

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.9e-41  Score=315.57  Aligned_cols=230  Identities=20%  Similarity=0.278  Sum_probs=174.2

Q ss_pred             hhCccccCcccccCceEEEEEEEC---CCCeEEEEEEecCCC----hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLS---DQNTEIAVKRVSRGS----KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  139 (387)
                      .++|...+.||+|+||.||+++..   .+++.||+|++....    ......+.+|+++++.++||||+++++++.+...
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            467999999999999999999985   578999999997642    2345567899999999999999999988765432


Q ss_pred             H-------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          140 L-------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       140 ~-------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                      .                         .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            1                         235689999999999999   999999999999999999999999999987543


Q ss_pred             CCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          195 HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      ... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........   ...+..            .
T Consensus       173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~------------~  236 (327)
T 3a62_A          173 HDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---IDKILK------------C  236 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHH------------T
T ss_pred             cCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHh------------C
Confidence            221 122345689999999999998999999999999999999999999976543211   111110            0


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                        ....+......+.+++.+||+.||.+||     ++.|+++|.|+..
T Consensus       237 --~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          237 --KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             --CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence              0112223345688999999999999999     8999999999863

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.9e-41  Score=309.52  Aligned_cols=229  Identities=27%  Similarity=0.442  Sum_probs=187.9

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      ..++|...+.||+|+||.||+|.+..++..||+|.+... ....+.+.+|+++++.++||||+++++++.+...      
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            467889999999999999999999998999999999754 3446789999999999999999999998765322      


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           ..+..++.+++.||.|||+   ++++||||||+||+++.++.+||+|||++........
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence                                 1236788999999999999   9999999999999999999999999999987665444


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||............                .....
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~----------------~~~~~  230 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----------------EKDYR  230 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----------------HTTCC
T ss_pred             ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------------hccCC
Confidence            44445567889999999999999999999999999999999 99999765533221111                11111


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ...+...+..+.+++.+||+.||.+|||+.++++.|.
T Consensus       231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~  267 (288)
T 3kfa_A          231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE  267 (288)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence            2223334566889999999999999999999999885

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.9e-42  Score=319.53  Aligned_cols=247  Identities=23%  Similarity=0.370  Sum_probs=183.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      .++|...+.||+|+||.||+|++..+++.||||++....  ....+.+.+|++++..++||||+++++++.+...     
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            467899999999999999999999999999999986543  3345678899999999999999999998865432     


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          ..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++....... .
T Consensus       104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E  179 (331)
T ss_dssp             ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-c
Confidence                                1236799999999999999   999999999999999999999999999997654322 2


Q ss_pred             eeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhccCc-hh
Q 043148          200 QTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV--------WDLYGKGQ-LL  269 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~-~~  269 (387)
                      ......+++.|+|||++.+. .++.++||||||+++|||++|+.||......+........        ...+.... ..
T Consensus       180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence            23345689999999999875 6899999999999999999999999876543322111100        00000000 00


Q ss_pred             hhhcccCC-----ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          270 EAADGRLS-----KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       270 ~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ....+...     .......+..+.+++.+||+.||.+|||+.|+++|.|+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            00001111     1111234567899999999999999999999999998753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.1e-41  Score=315.38  Aligned_cols=240  Identities=19%  Similarity=0.274  Sum_probs=186.2

Q ss_pred             HHHHHHHhhCcccc-CcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcC-CCCCccceehhhc
Q 043148           60 YRELSRATNNFAEA-GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRL-RHRNLVHLIGWCH  135 (387)
Q Consensus        60 ~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  135 (387)
                      +.......++|... +.||+|+||.||+|.+..+++.||||++...  .......+.+|+.++..+ +||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            34445566778877 7899999999999999999999999998754  233467899999999999 4699999999875


Q ss_pred             chhh---------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC---CCcEEEc
Q 043148          136 EQRQ---------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLG  185 (387)
Q Consensus       136 ~~~~---------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~  185 (387)
                      +...                           ..+..++.|++.||.|||+   ++|+||||||+|||++.   ++.+||+
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEe
Confidence            4322                           2247899999999999999   99999999999999998   7899999


Q ss_pred             cccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 043148          186 DFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGK  265 (387)
Q Consensus       186 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  265 (387)
                      |||+++.....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+   ..    
T Consensus       177 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~----  247 (327)
T 3lm5_A          177 DFGMSRKIGHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI---SQ----  247 (327)
T ss_dssp             CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH----
T ss_pred             eCccccccCCc--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH---Hh----
Confidence            99999866443  2233456899999999999999999999999999999999999999765432211111   00    


Q ss_pred             CchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          266 GQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                            .............+..+.+++.+||+.||.+|||+++++++.|+..
T Consensus       248 ------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~  293 (327)
T 3lm5_A          248 ------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ  293 (327)
T ss_dssp             ------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred             ------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence                  0011111222234556889999999999999999999999999764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.3e-40  Score=319.97  Aligned_cols=248  Identities=21%  Similarity=0.264  Sum_probs=181.4

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      .++|...+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+++|+.++||||+++++++....      
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            57899999999999999999999999999999999754  3445678999999999999999999998875431      


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ...+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       105 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          105 LYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             EEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             EEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence                                   11236899999999999999   9999999999999999999999999999987644


Q ss_pred             CCC---------------------ceeeeeecCCcccCchhh-ccCCCCCccchHHHHHHHHHHHhCCCCCC--------
Q 043148          196 ELG---------------------SQTTVLAGTMGYLAPECV-TTGKASKESDVYSFGVVALEVACGRKPVE--------  245 (387)
Q Consensus       196 ~~~---------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dvws~Gvil~el~tg~~p~~--------  245 (387)
                      ...                     ......+||+.|+|||++ ....++.++|||||||++|||++|..||.        
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p  261 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP  261 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence            321                     123456789999999986 45669999999999999999998655443        


Q ss_pred             ---CCCCc--------------chhhHHHHHHHHhccCchhh-----------hh---cccCCc---cccHHHHHHHHHH
Q 043148          246 ---PRQEP--------------SKVRLVEWVWDLYGKGQLLE-----------AA---DGRLSK---EFDERQMECLMIV  291 (387)
Q Consensus       246 ---~~~~~--------------~~~~~~~~~~~~~~~~~~~~-----------~~---~~~~~~---~~~~~~~~~l~~l  291 (387)
                         +...-              ........+....+......           ..   ......   ......+..+.+|
T Consensus       262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  341 (432)
T 3n9x_A          262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL  341 (432)
T ss_dssp             SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence               21100              00111111222222111100           00   000000   0012245568899


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          292 GLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       292 ~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      +.+||+.||.+|||++|+++|+|+..
T Consensus       342 l~~mL~~dP~~R~ta~e~L~Hp~f~~  367 (432)
T 3n9x_A          342 LESMLKFNPNKRITIDQALDHPYLKD  367 (432)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred             HHHHhcCCcccCCCHHHHhcChhhhh
Confidence            99999999999999999999999865

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-41  Score=328.67  Aligned_cols=232  Identities=24%  Similarity=0.367  Sum_probs=186.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      .++|...+.||+|+||.||+|++..+|+.||||++....   ......+.+|+++++.++||||+++++++.+...    
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467899999999999999999999899999999996532   1235678899999999999999999998765332    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           .....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++......  
T Consensus        95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--  169 (476)
T 2y94_A           95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--  169 (476)
T ss_dssp             EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc--
Confidence                                 1236899999999999999   99999999999999999999999999999876542  


Q ss_pred             ceeeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.........   .    .+..+.        . 
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~---~----~i~~~~--------~-  233 (476)
T 2y94_A          170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF---K----KICDGI--------F-  233 (476)
T ss_dssp             CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH---H----HHHTTC--------C-
T ss_pred             ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH---H----HHhcCC--------c-
Confidence            22334579999999999988775 78999999999999999999999865432211   1    111111        0 


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLP  320 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  320 (387)
                       ..+......+.+++.+||+.||.+|||++|+++|.|+....+
T Consensus       234 -~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          234 -YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             -CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence             111223445788999999999999999999999999876543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.4e-41  Score=315.41  Aligned_cols=233  Identities=23%  Similarity=0.343  Sum_probs=168.9

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCe---EEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNT---EIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  139 (387)
                      ...++|...+.||+|+||.||+|.+..++.   .||||.+...  .....+.+.+|+++++.++||||+++++++.+...
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345789999999999999999999877664   7999998764  34556789999999999999999999987643221


Q ss_pred             -------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcE
Q 043148          140 -------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA  182 (387)
Q Consensus       140 -------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  182 (387)
                                                           ..+..++.|++.||.|||+   ++++||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCE
Confidence                                                 1235789999999999999   999999999999999999999


Q ss_pred             EEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 043148          183 KLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVW  260 (387)
Q Consensus       183 kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~  260 (387)
                      ||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.....    
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----  252 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL----  252 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH----
Confidence            9999999986544321 12223456788999999999999999999999999999999 99999876543322111    


Q ss_pred             HHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                        . .+         .....+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       253 --~-~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          253 --I-GG---------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             --H-TT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --h-cC---------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              0 10         01112233445688999999999999999988888877643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=316.41  Aligned_cols=232  Identities=24%  Similarity=0.396  Sum_probs=177.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeE----EEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTE----IAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  139 (387)
                      .++|...+.||+|+||.||+|.+..++..    ||+|.+... .....+.+.+|+.++..++||||++++++|.+...  
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   93 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL   93 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence            46789999999999999999999877765    477777543 34457889999999999999999999998755321  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                             ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence                                   1236799999999999999   99999999999999999999999999999866443


Q ss_pred             CC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          197 LG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       197 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      .. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........+                ..
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----------------~~  234 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----------------EK  234 (327)
T ss_dssp             ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----------------HT
T ss_pred             cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----------------Hc
Confidence            21 12233456788999999999999999999999999999999 99999866543321111                11


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ......+...+..+.+++.+||+.||.+|||+.|+++.|....
T Consensus       235 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          235 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1111222334456888999999999999999999999987543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-40  Score=319.28  Aligned_cols=242  Identities=21%  Similarity=0.229  Sum_probs=187.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC--------CCCccceehhhcc--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR--------HRNLVHLIGWCHE--  136 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~--  136 (387)
                      .++|.+.+.||+|+||.||+|++..+++.||||++... ....+.+.+|++++..++        |+||+++++++..  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            47899999999999999999999999999999999653 444677889999999885        7889999987651  


Q ss_pred             --hh--------------------------hHHHHHHHHHHHHHHHHhhhhccc-ceeeccCCcceeEeCCCC-------
Q 043148          137 --QR--------------------------QLILHKIALGLASAVLYLHEEWEQ-CIVHRDIKSSNVVLDSNF-------  180 (387)
Q Consensus       137 --~~--------------------------~~~l~~i~~~i~~~l~~LH~~~~~-~iiH~dlk~~Nill~~~~-------  180 (387)
                        ..                          ...+..++.||+.||.|||+   + +|+||||||+|||++.++       
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhh
Confidence              11                          12246899999999999999   7 999999999999999775       


Q ss_pred             ------------------------------------------cEEEccccccccccCCCCceeeeeecCCcccCchhhcc
Q 043148          181 ------------------------------------------NAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT  218 (387)
Q Consensus       181 ------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~  218 (387)
                                                                .+||+|||++......    .....||+.|+|||++.+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence                                                      7999999999866442    233468999999999999


Q ss_pred             CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh---hHHHHHHHHhccCchhh---------hhcc----------c-
Q 043148          219 GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKV---RLVEWVWDLYGKGQLLE---------AADG----------R-  275 (387)
Q Consensus       219 ~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~---------~~~~----------~-  275 (387)
                      ..++.++|||||||++|||++|+.||.........   .....+...........         ....          . 
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            99999999999999999999999999876543321   11222222211110000         0000          0 


Q ss_pred             --------CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          276 --------LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       276 --------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                              -....+......+.+|+.+||+.||.+|||+.|+++|.|+.
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                    00123566778899999999999999999999999999874

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.3e-41  Score=314.01  Aligned_cols=234  Identities=22%  Similarity=0.266  Sum_probs=176.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      .++|...+.||+|+||.||+|++..+++.||||++....   ......+.+|++++..++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            478999999999999999999999999999999997643   3335678899999999999999999987654321    


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          140 -------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       140 -------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                                               ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA  167 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence                                     1136789999999999999   999999999999999999999999999998654


Q ss_pred             CCCC--ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          195 HELG--SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       195 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                      ....  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........      ...........   
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~---  238 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP---  238 (311)
T ss_dssp             --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCC---
T ss_pred             ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCCC---
Confidence            4321  122345689999999999999999999999999999999999999976543211      11111111100   


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                          ........+..+.+++.+||+.||.+||+..+++.+.+..
T Consensus       239 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          239 ----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             ----HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ----cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence                0011122345688999999999999999988888877654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8.2e-41  Score=304.50  Aligned_cols=237  Identities=24%  Similarity=0.322  Sum_probs=187.0

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      ..++|...+.||+|+||.||+|.+..+++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+...     
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            4578999999999999999999999889999999986442 3446788999999999999999999998765322     


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-  198 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-  198 (387)
                                          ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++........ 
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence                                2347899999999999999   9999999999999999999999999999976543211 


Q ss_pred             ceeeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||......... ...+    . ...        ..
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~----~-~~~--------~~  227 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW----K-EKK--------TY  227 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHH----H-TTC--------TT
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHh----h-hcc--------cc
Confidence            12234568999999999987765 78999999999999999999999865543211 1110    0 100        00


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPL  319 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  319 (387)
                      .......+..+.+++.+||+.||.+|||++|++++.|+..+.
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence            011122345678899999999999999999999999987654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.6e-41  Score=325.41  Aligned_cols=236  Identities=21%  Similarity=0.314  Sum_probs=176.4

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--------hhhHHHHHHHHHHHhcCCCCCccceehhhcc
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--------KQGKKEYISEVRIISRLRHRNLVHLIGWCHE  136 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  136 (387)
                      ...++|...+.||+|+||.||+|.+..+++.||||++....        ......+.+|+++|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45689999999999999999999999999999999986531        1122357899999999999999999998654


Q ss_pred             hh------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC---cEEEccccc
Q 043148          137 QR------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF---NAKLGDFGL  189 (387)
Q Consensus       137 ~~------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kl~Dfg~  189 (387)
                      ..                        ...+..++.|++.||.|||+   ++|+||||||+|||++.++   .+||+|||+
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            32                        12236899999999999999   9999999999999997544   599999999


Q ss_pred             cccccCCCCceeeeeecCCcccCchhhcc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC
Q 043148          190 ARLVDHELGSQTTVLAGTMGYLAPECVTT---GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG  266 (387)
Q Consensus       190 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  266 (387)
                      ++.....  .......||+.|+|||++.+   ..++.++||||||+++|||++|+.||.........  ...    ...+
T Consensus       289 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~----i~~~  360 (419)
T 3i6u_A          289 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQ----ITSG  360 (419)
T ss_dssp             TTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHH----HHTT
T ss_pred             ceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHH----HhcC
Confidence            9876542  22344678999999999863   56888999999999999999999999765433221  110    1111


Q ss_pred             chhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ..      ..........+..+.+++.+||+.||.+|||++|+++|.|+..
T Consensus       361 ~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          361 KY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             CC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CC------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            00      0111111224566889999999999999999999999999753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-41  Score=307.58  Aligned_cols=231  Identities=23%  Similarity=0.318  Sum_probs=177.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      .++|...+.||+|+||.||++....++..+|+|.+.... ....+.+.+|+++++.++||||+++++++.+...      
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            467899999999999999999999999999999986543 3346789999999999999999999998754321      


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe---CCCCcEEEccccccccc
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL---DSNFNAKLGDFGLARLV  193 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kl~Dfg~~~~~  193 (387)
                                             ..+..++.|++.||.|||+   ++|+||||||+|||+   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence                                   1236799999999999999   999999999999999   55678999999999765


Q ss_pred             cCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          194 DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       194 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ...  .......|++.|+|||.+. ..++.++||||||+++|||++|+.||......+.....   .  ...        
T Consensus       178 ~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~---~--~~~--------  241 (285)
T 3is5_A          178 KSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA---T--YKE--------  241 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H--HCC--------
T ss_pred             CCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh---c--cCC--------
Confidence            442  2233456899999999886 56899999999999999999999999765422211100   0  000        


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      +..... .......+.+++.+||+.||.+|||+.|++++.|+..
T Consensus       242 ~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          242 PNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             cccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            000000 0112345778999999999999999999999998753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.3e-41  Score=314.74  Aligned_cols=233  Identities=19%  Similarity=0.211  Sum_probs=182.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~------  139 (387)
                      .++|...+.||+|+||.||+|++..+++.||||.+.....  .+.+.+|+++++.+ +||||+++++++.+...      
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            4679999999999999999999988999999999865432  34688999999999 99999999987655432      


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc-----EEEccccccccccC
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN-----AKLGDFGLARLVDH  195 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~-----~kl~Dfg~~~~~~~  195 (387)
                                         ..+..++.|++.||.|||+   .+|+||||||+|||++.++.     +||+|||+++....
T Consensus        86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           86 LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             eCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence                               1236799999999999999   99999999999999999887     99999999986544


Q ss_pred             CCCc------eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh
Q 043148          196 ELGS------QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL  269 (387)
Q Consensus       196 ~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (387)
                      ....      ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+......... 
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-  241 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI-  241 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH-
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH-
Confidence            3221      124567999999999999999999999999999999999999999876544433322222111100000 


Q ss_pred             hhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                              .......+ .+.+++..||+.||.+||++++|++.|.
T Consensus       242 --------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          242 --------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             --------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             --------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence                    00011123 6889999999999999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.1e-41  Score=324.69  Aligned_cols=221  Identities=13%  Similarity=0.114  Sum_probs=171.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHH---HHHhcCCCCCccceehhh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEV---RIISRLRHRNLVHLIGWC------  134 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~------  134 (387)
                      .++|...+.||+|+||.||+|++..+|+.||||++...   .....+.+.+|+   ++++.++|||||++++.+      
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999999888999999999743   344567899999   455566899999987322      


Q ss_pred             -cchh------------------------------------------------hHHHHHHHHHHHHHHHHhhhhccccee
Q 043148          135 -HEQR------------------------------------------------QLILHKIALGLASAVLYLHEEWEQCIV  165 (387)
Q Consensus       135 -~~~~------------------------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~ii  165 (387)
                       .+.+                                                ...+..++.|++.||.|||+   ++|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iv  228 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV  228 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence             1110                                                02234689999999999999   9999


Q ss_pred             eccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCcccCchhhccC-----------CCCCccchHHHHHHH
Q 043148          166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG-----------KASKESDVYSFGVVA  234 (387)
Q Consensus       166 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dvws~Gvil  234 (387)
                      ||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||++
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            999999999999999999999999985332    3344567 999999999887           899999999999999


Q ss_pred             HHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          235 LEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       235 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      |||++|+.||..........               .+.. . ..    ..+..+.+++.+||+.||.+|||+.|++++.|
T Consensus       304 ~elltg~~Pf~~~~~~~~~~---------------~~~~-~-~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  362 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSE---------------WIFR-S-CK----NIPQPVRALLEGFLRYPKEDRLLPLQAMETPE  362 (377)
T ss_dssp             HHHHHSSCCC------CCSG---------------GGGS-S-CC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred             HHHHHCCCCCcccccccchh---------------hhhh-h-cc----CCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence            99999999997644322111               1111 0 01    22355888999999999999999999999988


Q ss_pred             cC
Q 043148          315 FE  316 (387)
Q Consensus       315 ~~  316 (387)
                      +.
T Consensus       363 f~  364 (377)
T 3byv_A          363 YE  364 (377)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2e-40  Score=305.36  Aligned_cols=235  Identities=19%  Similarity=0.241  Sum_probs=185.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~------  139 (387)
                      .++|...+.||+|+||.||+|.+..+++.||||++....  ..+.+.+|++++..+ +|+|++++++++.+...      
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            467999999999999999999998899999999986543  335678899999999 79999999987654321      


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc-----EEEccccccccccC
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN-----AKLGDFGLARLVDH  195 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~-----~kl~Dfg~~~~~~~  195 (387)
                                         ..+..++.|++.||.|||+   ++|+||||||+|||++.++.     +||+|||+++....
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A           87 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             ecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence                               2236899999999999999   99999999999999987776     99999999987654


Q ss_pred             CCC------ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh
Q 043148          196 ELG------SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL  269 (387)
Q Consensus       196 ~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (387)
                      ...      .......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+..........
T Consensus       164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (298)
T 1csn_A          164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  243 (298)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence            322      12344568999999999999999999999999999999999999998765444333332222211111111


Q ss_pred             hhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                               ......+..+.+++..||+.||.+||++++|++.|..
T Consensus       244 ---------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~  280 (298)
T 1csn_A          244 ---------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  280 (298)
T ss_dssp             ---------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             ---------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence                     1112234568899999999999999999999998863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.4e-41  Score=309.23  Aligned_cols=232  Identities=22%  Similarity=0.329  Sum_probs=168.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhh-HHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQG-KKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      .++|...+.||+|+||.||+|++..+++.||||++.... ... .+.+.++...++.++||||+++++++.+....    
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            478999999999999999999999999999999997642 222 33344555568888999999999987553211    


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhhhhccc-ceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          141 ------------------------ILHKIALGLASAVLYLHEEWEQ-CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       141 ------------------------~l~~i~~~i~~~l~~LH~~~~~-~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                              .+..++.|++.||.|||+   + +++||||||+||+++.++.+||+|||++.....
T Consensus        86 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence                                    135799999999999999   7 999999999999999999999999999976544


Q ss_pred             CCCceeeeeecCCcccCchhh----ccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          196 ELGSQTTVLAGTMGYLAPECV----TTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                      ..  ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||........  .   .......      
T Consensus       163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~---~~~~~~~------  229 (290)
T 3fme_A          163 DV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ--Q---LKQVVEE------  229 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH--H---HHHHHHS------
T ss_pred             cc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH--H---HHHHhcc------
Confidence            32  22334689999999996    456789999999999999999999999975433211  1   1111111      


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                         ..........+..+.+++.+||+.||.+|||+.|+++|+|+..
T Consensus       230 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          230 ---PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             ---CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             ---CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence               1111111233456889999999999999999999999998753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1e-40  Score=325.10  Aligned_cols=222  Identities=29%  Similarity=0.434  Sum_probs=179.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      .++|...+.||+|+||.||+|.+.  ++.||||+++...  ..+.|.+|+++|++++||||+++++++.+..        
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            467888999999999999999984  6799999997643  4678999999999999999999999864432        


Q ss_pred             --------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          139 --------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       139 --------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                          ...+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++.....  
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence                                11236789999999999999   99999999999999999999999999999854322  


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                        .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+       ..+         ..
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------~~~---------~~  404 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKG---------YK  404 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-------HTT---------CC
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcC---------CC
Confidence              122356889999999999999999999999999999998 99999876544322111       111         11


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ...+..++..+.+++..||+.||.+|||+.++++.|+.
T Consensus       405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            22333455678899999999999999999999998863

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.3e-41  Score=306.81  Aligned_cols=229  Identities=23%  Similarity=0.348  Sum_probs=184.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      .++|...+.||+|+||.||+|.+..++..||||.+....   ....+.+.+|++++..++||||+++++++.+...    
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            467899999999999999999999999999999986432   2234678999999999999999999998765321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......  
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence                                 1236789999999999999   99999999999999999999999999998755432  


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                       ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+...      ... ..      +    .
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~-~~------~----~  229 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------RIV-NV------D----L  229 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHH-TT------C----C
T ss_pred             -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------HHh-cc------c----c
Confidence             2234568999999999999899999999999999999999999997654221110      110 10      1    1


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .++...+..+.+++.+||+.||.+|||++++++|.|+...
T Consensus       230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            1222334567899999999999999999999999997654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.4e-41  Score=317.34  Aligned_cols=232  Identities=25%  Similarity=0.391  Sum_probs=179.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeE----EEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTE----IAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  139 (387)
                      .++|...+.||+|+||.||+|.+..++..    ||+|.+.... ......+.+|+.++..++||||++++++|.+...  
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL   91 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEE
Confidence            35788899999999999999999877765    7888775432 3334567889999999999999999998754321  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                             ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence                                   1236889999999999999   99999999999999999999999999999876543


Q ss_pred             CCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          197 LGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       197 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      ... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...........+       ..+.       
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~-------  234 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-------EKGE-------  234 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH-------HTTC-------
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH-------HcCC-------
Confidence            222 2344567889999999999999999999999999999999 99999875543322111       1110       


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                        ....+...+..+.+++.+||+.||.+|||+.+++++|....
T Consensus       235 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          235 --RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             --BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             --CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              01111122334778999999999999999999999997543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=306.84  Aligned_cols=228  Identities=25%  Similarity=0.449  Sum_probs=173.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      .++|...+.||+|+||.||+|.+.  ++.||||.+...  ...+.+.+|++++++++||||+++++++.+..        
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~   82 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAE   82 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCT
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCC
Confidence            357888999999999999999984  688999998643  34678999999999999999999999765421        


Q ss_pred             ------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc-EEEccccccccccCCCCc
Q 043148          139 ------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN-AKLGDFGLARLVDHELGS  199 (387)
Q Consensus       139 ------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~-~kl~Dfg~~~~~~~~~~~  199 (387)
                                        ...+..++.|+++||.|||+.+.++|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence                              1123678899999999999855578999999999999998886 799999999755432   


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                       .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........  .  .+... .+         ....
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~--~~~~~-~~---------~~~~  224 (307)
T 2eva_A          160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--I--MWAVH-NG---------TRPP  224 (307)
T ss_dssp             ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--H--HHHHH-TT---------CCCC
T ss_pred             -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--H--HHHHh-cC---------CCCC
Confidence             22345899999999999999999999999999999999999999765433211  1  11111 11         0111


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .....+..+.+++.+||+.||.+|||+++++++|...
T Consensus       225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            2223345688899999999999999999999998643

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.2e-41  Score=328.07  Aligned_cols=231  Identities=26%  Similarity=0.424  Sum_probs=178.7

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      ...++|...+.||+|+||.||+|.+.. +..||||.+.... ...+.|.+|+++|++++||||+++++++.+..      
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e  258 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE  258 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEeh
Confidence            345678889999999999999999976 5779999997643 34678999999999999999999999875421      


Q ss_pred             --------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          139 --------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       139 --------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                          ...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence                                11236789999999999999   9999999999999999999999999999987654322


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..       .....+         ..
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~---------~~  399 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERG---------YR  399 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTT---------CC
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC---------CC
Confidence            22333456789999999999999999999999999999999 99999765432211       111111         11


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ...+..++..+.+++.+||+.||.+|||+++|++.|...
T Consensus       400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~  438 (452)
T 1fmk_A          400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  438 (452)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            122334556788999999999999999999999999743

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.5e-41  Score=317.51  Aligned_cols=241  Identities=21%  Similarity=0.308  Sum_probs=183.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      .++|...+.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+.+++.++||||+++++++.....     
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            57899999999999999999999999999999999764  33446788999999999999999999998765432     


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                             ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       121 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  197 (371)
T 4exu_A          121 DFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE  197 (371)
T ss_dssp             CCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred             eEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence                                   1236799999999999999   99999999999999999999999999999755432


Q ss_pred             CCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc--------
Q 043148          197 LGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ--------  267 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  267 (387)
                          .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....   +........        
T Consensus       198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ---ILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCHHHHTTCS
T ss_pred             ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCcHHHHHHhh
Confidence                234467999999999887 6789999999999999999999999986553322211   111111000        


Q ss_pred             ---hh---hhhcccCCc---cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          268 ---LL---EAADGRLSK---EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       268 ---~~---~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                         ..   .........   .........+.+++.+||+.||.+|||+.|+++|.|+..
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  329 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP  329 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence               00   000000000   111223566889999999999999999999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.7e-40  Score=304.89  Aligned_cols=229  Identities=24%  Similarity=0.419  Sum_probs=180.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcch----h---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ----R---  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~---  138 (387)
                      +.|...+.||+|+||.||+|.+..++..||+|.+...  .....+.+.+|+.+++.++||||+++++++...    .   
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            3467778899999999999999999999999998653  345567899999999999999999999876431    0   


Q ss_pred             ----------------------hHHHHHHHHHHHHHHHHhhhhcccc--eeeccCCcceeEeC-CCCcEEEccccccccc
Q 043148          139 ----------------------QLILHKIALGLASAVLYLHEEWEQC--IVHRDIKSSNVVLD-SNFNAKLGDFGLARLV  193 (387)
Q Consensus       139 ----------------------~~~l~~i~~~i~~~l~~LH~~~~~~--iiH~dlk~~Nill~-~~~~~kl~Dfg~~~~~  193 (387)
                                            ...+..++.+++.||.|||+   .+  ++||||||+|||++ .++.+||+|||++...
T Consensus       106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence                                  11236789999999999999   77  99999999999998 8899999999999754


Q ss_pred             cCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          194 DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       194 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ...   ......|++.|+|||++. ..++.++||||||+++|+|++|+.||.........      ......+.      
T Consensus       183 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~------  246 (290)
T 1t4h_A          183 RAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGV------  246 (290)
T ss_dssp             CTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTC------
T ss_pred             ccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH------HHHHhccC------
Confidence            432   233456899999999886 45899999999999999999999999765433211      11111111      


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                        .....+...+..+.+++..||+.||.+|||++|+++|.|+..
T Consensus       247 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          247 --KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             --CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             --CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence              111222223345889999999999999999999999999764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.9e-41  Score=317.35  Aligned_cols=234  Identities=26%  Similarity=0.374  Sum_probs=183.4

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECCCCe-----EEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccceehhhcc
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSDQNT-----EIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHLIGWCHE  136 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  136 (387)
                      ....++|...+.||+|+||.||+|.+..++.     .||+|.+.... ....+.+.+|++++..+ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3345789999999999999999999876554     79999997653 34567799999999999 89999999998754


Q ss_pred             hhh---------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC
Q 043148          137 QRQ---------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD  177 (387)
Q Consensus       137 ~~~---------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~  177 (387)
                      ...                                       ..+..++.|++.||.|||+   ++|+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEEC
Confidence            321                                       1235688999999999999   9999999999999999


Q ss_pred             CCCcEEEccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 043148          178 SNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRL  255 (387)
Q Consensus       178 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~  255 (387)
                      .++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......... 
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-  277 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY-  277 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH-
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH-
Confidence            9999999999999865443221 2233456889999999999999999999999999999998 999998655432211 


Q ss_pred             HHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          256 VEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                           .....         ......+...+..+.+++..||+.||.+|||+.+++++|+.
T Consensus       278 -----~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          278 -----KLVKD---------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             -----HHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----HHHhc---------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence                 11111         11111122234568889999999999999999999999863

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.2e-41  Score=307.53  Aligned_cols=230  Identities=28%  Similarity=0.450  Sum_probs=179.0

Q ss_pred             HhhCccccCcccccCceEEEEEEECC---CCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSD---QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  139 (387)
                      ..++|...+.||+|+||.||+|.+..   ++..||+|.+... .....+.+.+|+++++.++||||+++++++.+...  
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI   89 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence            35788999999999999999998654   3456999998765 34456789999999999999999999998754321  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                             ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence                                   1236788999999999999   99999999999999999999999999999866543


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.....   .    .+.        
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~---~----~~~--------  231 (281)
T 3cc6_A          167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---E----KGD--------  231 (281)
T ss_dssp             ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH---H----HTC--------
T ss_pred             cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH---h----cCC--------
Confidence            3323334456889999999998999999999999999999998 99999765443322111   1    000        


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                       ....+...+..+.+++.+||+.||.+|||+.|++++|.
T Consensus       232 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  269 (281)
T 3cc6_A          232 -RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS  269 (281)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence             01112223456889999999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-41  Score=322.16  Aligned_cols=242  Identities=19%  Similarity=0.229  Sum_probs=181.4

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      ....++|...+.||+|+||.||+|.+..+|+.||||++.....    ...+|+++|+.++||||+++++++.....    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            4456889999999999999999999999999999999865422    23479999999999999999988733110    


Q ss_pred             --------------------------------------------------------------HHHHHHHHHHHHHHHHhh
Q 043148          140 --------------------------------------------------------------LILHKIALGLASAVLYLH  157 (387)
Q Consensus       140 --------------------------------------------------------------~~l~~i~~~i~~~l~~LH  157 (387)
                                                                                    ..+..++.|++.||.|||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                                                          112578999999999999


Q ss_pred             hhcccceeeccCCcceeEeC-CCCcEEEccccccccccCCCCceeeeeecCCcccCchhhccCC-CCCccchHHHHHHHH
Q 043148          158 EEWEQCIVHRDIKSSNVVLD-SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVAL  235 (387)
Q Consensus       158 ~~~~~~iiH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~  235 (387)
                      +   ++|+||||||+|||++ .++.+||+|||+++......  ......+|+.|+|||++.+.. ++.++||||||+++|
T Consensus       159 ~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          159 S---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             T---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             H---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            9   9999999999999997 68899999999998664432  233456899999999988754 899999999999999


Q ss_pred             HHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhh---------------hcccCCccccHHHHHHHHHHHHHhcCCCC
Q 043148          236 EVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA---------------ADGRLSKEFDERQMECLMIVGLWCCHPDF  300 (387)
Q Consensus       236 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp  300 (387)
                      ||++|+.||.+....+...   .+....+......+               ....+...++...+..+.+++.+||+.||
T Consensus       234 ell~g~~pf~~~~~~~~~~---~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLV---RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHH---HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHhCCCCCCCCChHHHHH---HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            9999999998755433222   11111111111000               00011111223345668899999999999


Q ss_pred             CCCCCHHHHHHHhccCC
Q 043148          301 TNRPSIRQVINVLNFEA  317 (387)
Q Consensus       301 ~~RPs~~evl~~l~~~~  317 (387)
                      .+|||+.|+++|.|+..
T Consensus       311 ~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          311 DLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             GGSCCHHHHHTSGGGHH
T ss_pred             hhCCCHHHHhcCHHHHH
Confidence            99999999999999753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.6e-40  Score=302.78  Aligned_cols=234  Identities=25%  Similarity=0.375  Sum_probs=176.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhc--CCCCCccceehhhcchh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISR--LRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~------  138 (387)
                      .++|...+.||+|+||.||+|++  +++.||||++..   .....+..|.+++..  ++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            57899999999999999999998  588999999854   334566677777766  79999999998753321      


Q ss_pred             ----------------------hHHHHHHHHHHHHHHHHhh--------hhcccceeeccCCcceeEeCCCCcEEEcccc
Q 043148          139 ----------------------QLILHKIALGLASAVLYLH--------EEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG  188 (387)
Q Consensus       139 ----------------------~~~l~~i~~~i~~~l~~LH--------~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  188 (387)
                                            ...+..++.|++.||.|||        +   ++|+||||||+|||++.++.+||+|||
T Consensus        82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeCC
Confidence                                  1123689999999999999        6   999999999999999999999999999


Q ss_pred             ccccccCCCCce---eeeeecCCcccCchhhccC------CCCCccchHHHHHHHHHHHhC----------CCCCCCCCC
Q 043148          189 LARLVDHELGSQ---TTVLAGTMGYLAPECVTTG------KASKESDVYSFGVVALEVACG----------RKPVEPRQE  249 (387)
Q Consensus       189 ~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~Gvil~el~tg----------~~p~~~~~~  249 (387)
                      +++.........   .....||+.|+|||++.+.      .++.++||||||+++|||++|          +.||.....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            997655432221   2234689999999999876      445799999999999999999          888865433


Q ss_pred             cchhhHHHHHHHHhccCchhhhhcccCC-ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          250 PSKVRLVEWVWDLYGKGQLLEAADGRLS-KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .....  ..........    ...+... .......+..+.+++.+||+.||.+|||+.+|++.|.
T Consensus       239 ~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  298 (301)
T 3q4u_A          239 NDPSF--EDMRKVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT  298 (301)
T ss_dssp             SSCCH--HHHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             CCcch--hhhhHHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence            22111  1111111111    0111111 1234457788999999999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.5e-40  Score=310.81  Aligned_cols=241  Identities=19%  Similarity=0.262  Sum_probs=184.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCCccceehhhcchh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQR-------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-------  138 (387)
                      .++|...+.||+|+||.||+|++..+++.||||++...   ..+.+.+|++++..++ ||||+++++++.+..       
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            37789999999999999999999999999999999643   3567899999999997 999999999876521       


Q ss_pred             -----------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC-cEEEccccccccccCCCCce
Q 043148          139 -----------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF-NAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       139 -----------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                       ...+..++.|++.||.|||+   ++|+||||||+|||++.++ .+||+|||+++......  .
T Consensus       112 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~  186 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--E  186 (330)
T ss_dssp             EECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--C
T ss_pred             EeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--c
Confidence                             11236799999999999999   9999999999999999776 89999999998665432  2


Q ss_pred             eeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh-------
Q 043148          201 TTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA-------  272 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  272 (387)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........  ...............+..       
T Consensus       187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~  264 (330)
T 3nsz_A          187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDKYNIEL  264 (330)
T ss_dssp             CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHHHhcCCchhhhHHHHhcccc
Confidence            334568899999999887 6689999999999999999999999965443211  111111111110000000       


Q ss_pred             --------c--------ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          273 --------D--------GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       273 --------~--------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                              .        ...........+..+.+++.+||+.||.+|||++|+++|.|+..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  325 (330)
T 3nsz_A          265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  325 (330)
T ss_dssp             CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence                    0        00111112224566889999999999999999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7e-41  Score=331.98  Aligned_cols=233  Identities=26%  Similarity=0.364  Sum_probs=187.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      .++|...+.||+|+||.||+|++..+|+.||||++....   ......+.+|+++|..++||||+++++++.+....   
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            466888999999999999999999999999999996532   23356788999999999999999999877553221   


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          141 ------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       141 ------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                              ....++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence                                    236789999999999999   99999999999999999999999999999876543


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.   .....          .
T Consensus       340 --~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~---~~i~~----------~  404 (576)
T 2acx_A          340 --QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKE----------V  404 (576)
T ss_dssp             --CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH---HHHHH----------C
T ss_pred             --ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH---HHhhc----------c
Confidence              22334579999999999999889999999999999999999999998754332211111   11100          0


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      ...++...+..+.+++.+||+.||.+||     +++||++|.|+..
T Consensus       405 ~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          405 PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            1122233455688999999999999999     8999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.2e-41  Score=303.45  Aligned_cols=225  Identities=31%  Similarity=0.488  Sum_probs=170.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh----hhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK----QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      .++|...+.||+|+||.||+|.+.  +..||||++.....    ...+.+.+|+++++.++||||+++++++.+....  
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            367889999999999999999984  78999999865432    2356789999999999999999999987654322  


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccc---eeeccCCcceeEeCC--------CCcEEEccc
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQC---IVHRDIKSSNVVLDS--------NFNAKLGDF  187 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~---iiH~dlk~~Nill~~--------~~~~kl~Df  187 (387)
                                            .+..++.|++.||.|||+   ++   ++||||||+|||++.        ++.+||+||
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence                                  236899999999999999   77   999999999999986        778999999


Q ss_pred             cccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc
Q 043148          188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ  267 (387)
Q Consensus       188 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (387)
                      |++.......   .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.........      ..      
T Consensus       161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~------  225 (271)
T 3dtc_A          161 GLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------YG------  225 (271)
T ss_dssp             CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HH------
T ss_pred             Cccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------Hh------
Confidence            9997654422   22446899999999999999999999999999999999999999765432111      11      


Q ss_pred             hhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          268 LLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                         ..........+...+..+.+++.+||+.||.+|||+.|++++|.
T Consensus       226 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~  269 (271)
T 3dtc_A          226 ---VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT  269 (271)
T ss_dssp             ---HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence               11111122223344566889999999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=306.74  Aligned_cols=231  Identities=25%  Similarity=0.367  Sum_probs=163.4

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      .++|...+.||+|+||.||+|++..+++.||||.+....   ....+.+.+|++++..++||||+++++++.+...    
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            467899999999999999999998889999999986432   1224678999999999999999999998765322    


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence                                  1236799999999999999   999999999999999999999999999998654322


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      . ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..........               ......  
T Consensus       167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~~--  228 (278)
T 3cok_A          167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVVLAD--  228 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC--
T ss_pred             C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHhhcc--
Confidence            1 2234568999999999998889999999999999999999999997654322110               000000  


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ...+...+..+.+++.+||+.||.+|||+++++++.|+...
T Consensus       229 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          229 YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            01122334567899999999999999999999999987653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-40  Score=313.16  Aligned_cols=246  Identities=22%  Similarity=0.287  Sum_probs=184.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  138 (387)
                      .++|...+.||+|+||.||+|.+..+|+.||||.+.... ......+.+|+++++.++||||+++++++....       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            578999999999999999999999899999999996543 344567889999999999999999998765321       


Q ss_pred             ---------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          139 ---------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       139 ---------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                           ...+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++.......
T Consensus        90 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           90 YIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             EEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence                                 11236799999999999999   999999999999999999999999999998664321


Q ss_pred             Cc---------eeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc
Q 043148          198 GS---------QTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ  267 (387)
Q Consensus       198 ~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (387)
                      ..         ......||+.|+|||++.. ..++.++||||||+++|||++|+.||..........   .+........
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~  243 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFGIIGTPH  243 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCC
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhCCCc
Confidence            11         1223468999999998764 678999999999999999999999998655332211   1111111100


Q ss_pred             h------------hhhhcc--cC----CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          268 L------------LEAADG--RL----SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       268 ~------------~~~~~~--~~----~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .            .+....  ..    ........+..+.+++.+||+.||.+|||+.|+++|.|+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            0            000000  00    001112345568899999999999999999999999998754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.4e-41  Score=317.60  Aligned_cols=249  Identities=17%  Similarity=0.233  Sum_probs=178.4

Q ss_pred             HHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-
Q 043148           61 RELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-  139 (387)
Q Consensus        61 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  139 (387)
                      .+.....++|.+.+.||+|+||.||+|++..++..||||++.... .....+.+|++.+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            456677899999999999999999999999999999999986542 334566788888999999999999888743111 


Q ss_pred             ----------------------------------HHHHHHHHHHHHHHHHhh--hhcccceeeccCCcceeEeCC-CCcE
Q 043148          140 ----------------------------------LILHKIALGLASAVLYLH--EEWEQCIVHRDIKSSNVVLDS-NFNA  182 (387)
Q Consensus       140 ----------------------------------~~l~~i~~~i~~~l~~LH--~~~~~~iiH~dlk~~Nill~~-~~~~  182 (387)
                                                        ..+..++.|++.||.|||  +   ++|+||||||+|||++. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcE
Confidence                                              123578999999999999  7   99999999999999997 8999


Q ss_pred             EEccccccccccCCCCceeeeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 043148          183 KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWD  261 (387)
Q Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~  261 (387)
                      ||+|||+++......  ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...........+   ..
T Consensus       172 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~---~~  246 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI---VR  246 (360)
T ss_dssp             EECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH
T ss_pred             EEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH---HH
Confidence            999999998665432  223446899999999987654 899999999999999999999999875543322211   11


Q ss_pred             HhccCc------------hhhhhccc------CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          262 LYGKGQ------------LLEAADGR------LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       262 ~~~~~~------------~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ......            .....+..      .........+..+.+++.+||+.||.+|||+.|+++|.|+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence            111100            00000000      0011112245678999999999999999999999999998653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.5e-41  Score=306.82  Aligned_cols=234  Identities=23%  Similarity=0.370  Sum_probs=183.8

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      .++|...+.||+|+||.||++.+..+++.||+|.+...  .....+.+.+|+++++.++||||+++++++.+..      
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            46899999999999999999999999999999999754  3445678999999999999999999999763211      


Q ss_pred             -------------------------hHHHHHHHHHHHHHHHHhhhhcccc-----eeeccCCcceeEeCCCCcEEEcccc
Q 043148          139 -------------------------QLILHKIALGLASAVLYLHEEWEQC-----IVHRDIKSSNVVLDSNFNAKLGDFG  188 (387)
Q Consensus       139 -------------------------~~~l~~i~~~i~~~l~~LH~~~~~~-----iiH~dlk~~Nill~~~~~~kl~Dfg  188 (387)
                                               ...+..++.|++.||.|||+   .+     ++||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence                                     11236789999999999999   77     9999999999999999999999999


Q ss_pred             ccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCch
Q 043148          189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL  268 (387)
Q Consensus       189 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (387)
                      ++....... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+   ...    ....+..
T Consensus       162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~----~i~~~~~  233 (279)
T 2w5a_A          162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAG----KIREGKF  233 (279)
T ss_dssp             HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHTCC
T ss_pred             hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHH----HHhhccc
Confidence            997654321 11223468999999999999899999999999999999999999997654221   111    1111111


Q ss_pred             hhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 043148          269 LEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLP  320 (387)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  320 (387)
                               ...+...+..+.+++.+||+.||.+|||+.||++++++..+.+
T Consensus       234 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          234 ---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             ---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence                     1122234456889999999999999999999999999776543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.3e-40  Score=304.34  Aligned_cols=233  Identities=22%  Similarity=0.282  Sum_probs=182.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh------hhHHHHHHHHHHHhcCCCCCccceehhhcchhh-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK------QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  139 (387)
                      .++|...+.||+|+||.||++++..+++.||+|.+.....      ...+.+.+|+++++.++||||+++++++.+... 
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            3678899999999999999999998899999999865421      236789999999999999999999998765321 


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC----cEEEccccccc
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF----NAKLGDFGLAR  191 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kl~Dfg~~~  191 (387)
                                              ..+..++.|++.||.|||+   ++++||||||+||+++.++    .+||+|||++.
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence                                    1236899999999999999   9999999999999999877    89999999998


Q ss_pred             cccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       192 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                      .....  .......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+..   .    .....     
T Consensus       161 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~----~~~~~-----  226 (283)
T 3bhy_A          161 KIEAG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL---T----NISAV-----  226 (283)
T ss_dssp             ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H----HHHTT-----
T ss_pred             eccCC--CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH---H----HhHhc-----
Confidence            65442  1223446899999999999999999999999999999999999999765422111   1    01010     


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                       ............+..+.+++.+||+.||.+|||+.|++++.|+..
T Consensus       227 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          227 -NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             -CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             -ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence             011111112233456889999999999999999999999988653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.8e-41  Score=317.58  Aligned_cols=245  Identities=21%  Similarity=0.294  Sum_probs=184.8

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      .++|...+.||+|+||.||++.+..++..||+|++... .....+.+.+|++++..++||||+++++++.+....     
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            46789999999999999999999999999999999765 344567899999999999999999999987654321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhccc-ceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQ-CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~-~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          .+..++.+++.||.|||+   + +|+||||||+|||++.++.+||+|||++......   
T Consensus       112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  185 (360)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence                                236799999999999998   5 8999999999999999999999999999755332   


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------------------
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV--------------------  259 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~--------------------  259 (387)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+........                    
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            223456899999999999999999999999999999999999999765432211110000                    


Q ss_pred             ---HHHhccCch----hhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          260 ---WDLYGKGQL----LEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       260 ---~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                         .........    ................+..+.+++.+||+.||.+|||++|+++|.|+..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence               000000000    0001111111111223456889999999999999999999999999754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=312.02  Aligned_cols=241  Identities=20%  Similarity=0.298  Sum_probs=184.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      .++|...+.||+|+||.||+|.+..+|+.||||.+...  .....+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            46789999999999999999999999999999999654  33345778999999999999999999988755321     


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                             ..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++.....
T Consensus       103 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  179 (353)
T 3coi_A          103 DFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE  179 (353)
T ss_dssp             CCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred             eEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence                                   2246899999999999999   99999999999999999999999999999765432


Q ss_pred             CCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc--------
Q 043148          197 LGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ--------  267 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  267 (387)
                          .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+...   .+........        
T Consensus       180 ----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          180 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT---QILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH---HHHHHHCBCCHHHHTTCS
T ss_pred             ----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHHHHHHHh
Confidence                234568999999999887 678999999999999999999999998655332211   1111111000        


Q ss_pred             ---hh---hhhcccC---CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          268 ---LL---EAADGRL---SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       268 ---~~---~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                         ..   .......   ........+..+.+++.+||+.||.+|||+.|+++|.|+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  311 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP  311 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence               00   0000000   01112234567889999999999999999999999999864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.9e-41  Score=318.25  Aligned_cols=252  Identities=20%  Similarity=0.227  Sum_probs=184.6

Q ss_pred             CHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh-----------hhHHHHHHHHHHHhcCCCCCc
Q 043148           59 TYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-----------QGKKEYISEVRIISRLRHRNL  127 (387)
Q Consensus        59 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~ni  127 (387)
                      ...++....++|...+.||+|+||.||+|.+.. +..||||++.....           ...+.+.+|++++..++||||
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            356788889999999999999999999999866 89999999854321           123789999999999999999


Q ss_pred             cceehhhcchh------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC
Q 043148          128 VHLIGWCHEQR------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD  177 (387)
Q Consensus       128 v~l~~~~~~~~------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~  177 (387)
                      +++++++....                              ...+..++.|++.||.|||+   ++|+||||||+|||++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLA  168 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEC
T ss_pred             cceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEc
Confidence            99999873211                              12236799999999999999   9999999999999999


Q ss_pred             CCCcEEEccccccccccCCCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 043148          178 SNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV  256 (387)
Q Consensus       178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~  256 (387)
                      .++.+||+|||++......  .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+..   
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---  243 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL---  243 (362)
T ss_dssp             TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---
T ss_pred             CCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence            9999999999999754332  22334568899999999877 67899999999999999999999999865533222   


Q ss_pred             HHHHHHhccCchh-----------hhhcccC-------CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          257 EWVWDLYGKGQLL-----------EAADGRL-------SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       257 ~~~~~~~~~~~~~-----------~~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ..+..........           +......       ...........+.+++.+||+.||.+|||+.|+++|.|+..-
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence            1111111111111           0000000       011122234568899999999999999999999999998764


Q ss_pred             C
Q 043148          319 L  319 (387)
Q Consensus       319 ~  319 (387)
                      .
T Consensus       324 ~  324 (362)
T 3pg1_A          324 F  324 (362)
T ss_dssp             C
T ss_pred             c
Confidence            3

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3e-40  Score=313.36  Aligned_cols=238  Identities=24%  Similarity=0.335  Sum_probs=185.3

Q ss_pred             HHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--------hhHHHHHHHHHHHhcC-CCCCcccee
Q 043148           61 RELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--------QGKKEYISEVRIISRL-RHRNLVHLI  131 (387)
Q Consensus        61 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~  131 (387)
                      .......++|...+.||+|+||.||+|++..+|+.||||++.....        ...+.+.+|+.++..+ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            3455667889999999999999999999988899999999865431        1245678999999999 799999999


Q ss_pred             hhhcchhh-------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcc
Q 043148          132 GWCHEQRQ-------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD  186 (387)
Q Consensus       132 ~~~~~~~~-------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  186 (387)
                      +++.....                         ..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEe
Confidence            98755322                         1236799999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCCceeeeeecCCcccCchhhcc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 043148          187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTT------GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW  260 (387)
Q Consensus       187 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~  260 (387)
                      ||++......  .......||+.|+|||++.+      ..++.++||||||+++|||++|+.||.......   ....+.
T Consensus       244 fG~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~i~  318 (365)
T 2y7j_A          244 FGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---MLRMIM  318 (365)
T ss_dssp             CTTCEECCTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             cCcccccCCC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHH
Confidence            9999866543  22334578999999999863      357899999999999999999999997643221   111111


Q ss_pred             HHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                          .+..      ..........+..+.+++.+||+.||.+|||+.|++++.|+.
T Consensus       319 ----~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          319 ----EGQY------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             ----HTCC------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             ----hCCC------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence                1100      000000112345588999999999999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.7e-41  Score=308.66  Aligned_cols=234  Identities=24%  Similarity=0.343  Sum_probs=183.7

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      ..++|...+.||+|+||.||++++..+|+.||+|.+........+.+.+|++++..++||||+++++++.+...      
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            35678999999999999999999998899999999987655556778999999999999999999997754321      


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe---CCCCcEEEccccccccccCCC
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL---DSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                         ..+..++.|++.||.|||+   .+++||||||+||++   +.++.+||+|||++...... 
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence                               1236789999999999999   999999999999999   78899999999998754332 


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                        ......|++.|+|||++.+..++.++||||||+++|||++|+.||.......   ....+.    .+..      ...
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~----~~~~------~~~  227 (304)
T 2jam_A          163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFEKIK----EGYY------EFE  227 (304)
T ss_dssp             --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----HCCC------CCC
T ss_pred             --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH----cCCC------CCC
Confidence              2223468999999999999999999999999999999999999997654221   111111    1110      011


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .......+..+.+++.+||+.||.+|||+.|++++.|+...
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            11222344568899999999999999999999999998654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.3e-40  Score=327.67  Aligned_cols=234  Identities=22%  Similarity=0.299  Sum_probs=183.7

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      ..++|.+.+.||+|+||.||++.+..+++.||||++...  .......+.+|+++++.++||||+++++++.+....   
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            457899999999999999999999989999999998643  233467889999999999999999999987654321   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC---CCCcEEEccccccccccC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD---SNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~  195 (387)
                                            .+..++.|++.||.|||+   ++|+||||||+|||++   .++.+||+|||+++....
T Consensus       100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence                                  236799999999999999   9999999999999995   556799999999986644


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .  .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+..   ..+.    .+..      .
T Consensus       177 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~----~~~~------~  240 (486)
T 3mwu_A          177 N--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---KRVE----TGKY------A  240 (486)
T ss_dssp             C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HTCC------C
T ss_pred             C--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hCCC------C
Confidence            3  22334568999999999875 5899999999999999999999999765432211   1111    1110      0


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .........+..+.+++.+||+.||.+|||+.|+++|+|+...
T Consensus       241 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence            1111122345568899999999999999999999999998654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=305.64  Aligned_cols=231  Identities=25%  Similarity=0.416  Sum_probs=178.6

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----------
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----------  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----------  139 (387)
                      |.....||+|+||.||+|.+..++..||||.+........+.+.+|+.++..++||||+++++++.+...          
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  103 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG  103 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence            4445589999999999999999999999999987766667889999999999999999999998754321          


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC-CCcEEEccccccccccCCCCce
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS-NFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                        ..+..++.|++.||.|||+   ++++||||||+||+++. ++.+||+|||++....... ..
T Consensus       104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~  179 (295)
T 2clq_A          104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PC  179 (295)
T ss_dssp             EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred             CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Cc
Confidence                              2235688999999999999   99999999999999987 8999999999997654321 12


Q ss_pred             eeeeecCCcccCchhhccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          201 TTVLAGTMGYLAPECVTTGK--ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .....|++.|+|||++.+..  ++.++||||||+++|||++|+.||......... ...  ....           ....
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~--~~~~-----------~~~~  245 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFK--VGMF-----------KVHP  245 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHH--HHHH-----------CCCC
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHh--hccc-----------cccc
Confidence            23456899999999987643  889999999999999999999999754322111 000  0000           1111


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ..+...+..+.+++.+||+.||.+||++.+++++.|+...
T Consensus       246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            2233345568889999999999999999999999998654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.7e-41  Score=315.38  Aligned_cols=229  Identities=24%  Similarity=0.293  Sum_probs=165.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCCccceehhhcch--------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQ--------  137 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--------  137 (387)
                      ..+|...+.||+|+||.||+|++..+++.||||++........+.+.+|+.++.++. ||||+++++++...        
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457889999999999999999999899999999997777777788999999999996 99999998876210        


Q ss_pred             ---------------------------hhHHHHHHHHHHHHHHHHhhhhcccc--eeeccCCcceeEeCCCCcEEEcccc
Q 043148          138 ---------------------------RQLILHKIALGLASAVLYLHEEWEQC--IVHRDIKSSNVVLDSNFNAKLGDFG  188 (387)
Q Consensus       138 ---------------------------~~~~l~~i~~~i~~~l~~LH~~~~~~--iiH~dlk~~Nill~~~~~~kl~Dfg  188 (387)
                                                 ....+..++.|++.||.|||+   .+  |+||||||+|||++.++.+||+|||
T Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCc
Confidence                                       011236799999999999999   78  9999999999999999999999999


Q ss_pred             ccccccCCCCc-----------eeeeeecCCcccCchhh---ccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 043148          189 LARLVDHELGS-----------QTTVLAGTMGYLAPECV---TTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR  254 (387)
Q Consensus       189 ~~~~~~~~~~~-----------~~~~~~g~~~y~aPE~~---~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~  254 (387)
                      ++.........           ......+|+.|+|||++   .+..++.++||||||+++|||++|+.||......... 
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-  262 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV-  262 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh-
Confidence            99866543211           11134589999999998   5667899999999999999999999999754322110 


Q ss_pred             HHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          255 LVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                                        ...............+.+++.+||+.||.+|||+.|++++|+...
T Consensus       263 ------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          263 ------------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             ---------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                              000001111112233778999999999999999999999997543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2e-40  Score=326.91  Aligned_cols=233  Identities=26%  Similarity=0.353  Sum_probs=180.1

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      ..++|...+.||+|+||.||+|++..++..||||++....  ......+.+|+++++.++||||++++++|.+....   
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3567999999999999999999999999999999997643  33467889999999999999999999987654321   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC---CcEEEccccccccccC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN---FNAKLGDFGLARLVDH  195 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kl~Dfg~~~~~~~  195 (387)
                                            .+..++.|++.||.|||+   ++|+||||||+|||++.+   +.+||+|||++.....
T Consensus       115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence                                  126799999999999999   999999999999999764   4599999999987654


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .  .......||+.|+|||++. ..++.++|||||||++|+|++|+.||......+....   +.    .+..      .
T Consensus       192 ~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~----~~~~------~  255 (494)
T 3lij_A          192 Q--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK---VE----KGKY------T  255 (494)
T ss_dssp             T--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH----HTCC------C
T ss_pred             C--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH----hCCC------C
Confidence            3  2233456999999999886 5689999999999999999999999986543221111   11    1110      0


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .........+..+.+++.+||+.||.+|||+.|+++|+|+..
T Consensus       256 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          256 FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            111111234456889999999999999999999999998753

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=317.27  Aligned_cols=232  Identities=26%  Similarity=0.396  Sum_probs=183.0

Q ss_pred             HhhCccccCcccccCceEEEEEEECC-------CCeEEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcc
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSD-------QNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHE  136 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  136 (387)
                      ..++|...+.||+|+||.||+|++..       .+..||||++... .......+.+|++++..+ +||||++++++|.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            35788999999999999999999743       3467999999765 344567899999999999 99999999997754


Q ss_pred             hh-----------------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeE
Q 043148          137 QR-----------------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVV  175 (387)
Q Consensus       137 ~~-----------------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nil  175 (387)
                      ..                                         ...+..++.|++.||.|||+   ++|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence            32                                         12246789999999999999   99999999999999


Q ss_pred             eCCCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchh
Q 043148          176 LDSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKV  253 (387)
Q Consensus       176 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~  253 (387)
                      ++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+. 
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~-  302 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-  302 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            99999999999999986644321 22333456789999999999999999999999999999999 9999976542211 


Q ss_pred             hHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          254 RLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                            ......+         .....+...+..+.+++.+||+.||.+|||+.||+++|+..
T Consensus       303 ------~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          303 ------FKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             ------HHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------HHHHHcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  1111111         11112223445688999999999999999999999999743

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.7e-41  Score=305.75  Aligned_cols=228  Identities=25%  Similarity=0.465  Sum_probs=181.5

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-------
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-------  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  138 (387)
                      ..++|...+.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|++++..++||||+++++++.+..       
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEec
Confidence            35778899999999999999999864 7889999996543 34678999999999999999999999765421       


Q ss_pred             -------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          139 -------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       139 -------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                         ...+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence                               11236889999999999999   99999999999999999999999999999876543222


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.   ..    ....+         ...
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~----~~~~~---------~~~  229 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQ----NLERG---------YRM  229 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH----HHHTT---------CCC
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HH----HHhcc---------cCC
Confidence            2233456788999999998889999999999999999999 9999976543221   11    11111         111


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ..+...+..+.+++..||+.||.+|||+.++++.|+
T Consensus       230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  265 (279)
T 1qpc_A          230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (279)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            122334456889999999999999999999999886

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.2e-41  Score=316.23  Aligned_cols=246  Identities=22%  Similarity=0.277  Sum_probs=186.8

Q ss_pred             hhCccccCcccccCceEEEEEEE----CCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLL----SDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  138 (387)
                      .++|...+.||+|+||.||++++    ..++..||||++........+.+.+|+++++.++||||+++++++....    
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36788999999999999999994    5678999999998877777788999999999999999999988764211    


Q ss_pred             ------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          139 ------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       139 ------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                                              ...+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence                                    11236789999999999999   999999999999999999999999999998765


Q ss_pred             CCCCc--eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          195 HELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       195 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                      .....  ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......... ..............+..
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPALSRLLELL  257 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-cccccccccHHHHHHHh
Confidence            43221  1223457788999999999889999999999999999999999986432110000 00000000000111122


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ........+...+..+.+++.+||+.||.+|||+.|++++|+..
T Consensus       258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            22222333445566789999999999999999999999999744

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.9e-41  Score=315.81  Aligned_cols=233  Identities=22%  Similarity=0.335  Sum_probs=181.2

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~----  140 (387)
                      ..++|...+.||+|+||.||++.++.+++.||||++.....    ...+|++++.++ +||||+++++++.+....    
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            46789999999999999999999999999999999966432    245688888887 799999999987654321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC----CcEEEccccccccccC
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN----FNAKLGDFGLARLVDH  195 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~----~~~kl~Dfg~~~~~~~  195 (387)
                                           .+..++.|++.||.|||+   ++|+||||||+|||+..+    +.+||+|||++.....
T Consensus        96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence                                 236799999999999999   999999999999998433    3599999999986654


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      ... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.............    .+..+..      .
T Consensus       173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~i~~~~~------~  241 (342)
T 2qr7_A          173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----RIGSGKF------S  241 (342)
T ss_dssp             TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH----HHHHCCC------C
T ss_pred             CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH----HHccCCc------c
Confidence            322 2334578999999999988889999999999999999999999998643322222221    1111111      1


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .........+..+.+++.+||+.||.+|||+.++++|.|+.
T Consensus       242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence            11112233456688999999999999999999999999974

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.7e-41  Score=328.80  Aligned_cols=233  Identities=24%  Similarity=0.319  Sum_probs=185.8

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      ..++|...+.||+|+||.||+++...+++.||||++....   ......+.+|++++++++||||+++++++.+....  
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3567999999999999999999999999999999986542   34567899999999999999999999987654321  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe---CCCCcEEEcccccccccc
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL---DSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~  194 (387)
                                             .+..++.|++.||.|||+   ++|+||||||+|||+   +.++.+||+|||+++...
T Consensus       104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence                                   236799999999999999   999999999999999   567899999999998665


Q ss_pred             CCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          195 HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      ...  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+..   ..+.    .+..      
T Consensus       181 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~----~~~~------  244 (484)
T 3nyv_A          181 ASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL---KKVE----KGKY------  244 (484)
T ss_dssp             CCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HCCC------
T ss_pred             ccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHH----cCCC------
Confidence            432  2234568999999999876 6899999999999999999999999865432211   1111    1110      


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ..........+..+.+++.+||+.||.+|||+.|+++|+|+..
T Consensus       245 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          245 TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence            0111112234566889999999999999999999999999754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-40  Score=313.56  Aligned_cols=235  Identities=24%  Similarity=0.352  Sum_probs=183.8

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcch
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ  137 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  137 (387)
                      ....++|...+.||+|+||.||+|++..     ++..||||.+.... ....+.+.+|++++..++||||++++++|.+.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            3446889999999999999999999863     45899999997653 34467899999999999999999999987543


Q ss_pred             hh-------------------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeecc
Q 043148          138 RQ-------------------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRD  168 (387)
Q Consensus       138 ~~-------------------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~d  168 (387)
                      ..                                                 ..+..++.|++.||.|||+   ++|+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence            21                                                 1124589999999999999   9999999


Q ss_pred             CCcceeEeCCCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCC
Q 043148          169 IKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEP  246 (387)
Q Consensus       169 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~  246 (387)
                      |||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999976543221 22334567889999999999999999999999999999999 9999976


Q ss_pred             CCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          247 RQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ....+.   .    .....+..         ...+...+..+.+++.+||+.||.+|||+.+++++|....
T Consensus       280 ~~~~~~---~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          280 MAHEEV---I----YYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             SCHHHH---H----HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CChHHH---H----HHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            542211   1    11111111         1122334456889999999999999999999999997543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.7e-40  Score=308.12  Aligned_cols=231  Identities=25%  Similarity=0.365  Sum_probs=183.0

Q ss_pred             HhhCccccCcccccCceEEEEEEE-----CCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  138 (387)
                      ..++|...+.||+|+||.||+|.+     ..++..||||.+... .....+.+.+|+++++.++||||+++++++.+.. 
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            357888999999999999999987     345689999999764 3445678999999999999999999998764421 


Q ss_pred             ------------------------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCC
Q 043148          139 ------------------------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIK  170 (387)
Q Consensus       139 ------------------------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk  170 (387)
                                                                      ...+..++.|++.||.|||+   ++++|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence                                                            11235789999999999999   999999999


Q ss_pred             cceeEeCCCCcEEEccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 043148          171 SSNVVLDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQ  248 (387)
Q Consensus       171 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~  248 (387)
                      |+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999866443221 2233456788999999998889999999999999999999 999997655


Q ss_pred             CcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          249 EPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .......       ...+         .....+...+..+.+++.+||+.||.+|||+.+++++|..
T Consensus       258 ~~~~~~~-------~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          258 PERLFNL-------LKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             GGGHHHH-------HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHH-------hhcC---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            4322111       1111         1112223345568899999999999999999999999863

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.8e-40  Score=306.71  Aligned_cols=231  Identities=21%  Similarity=0.357  Sum_probs=186.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      .+.|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++..++||||+++++++.+...      
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            466889999999999999999999889999999996543 3456789999999999999999999998755322      


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                        ..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....... ...
T Consensus       101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  176 (303)
T 3a7i_A          101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR  176 (303)
T ss_dssp             CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCB
T ss_pred             eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc-ccc
Confidence                              2236899999999999999   999999999999999999999999999997665432 122


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD  281 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (387)
                      ....|++.|+|||.+.+..++.++||||||+++|||++|+.||........   ...+    ...     .    .....
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~----~~~-----~----~~~~~  240 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV---LFLI----PKN-----N----PPTLE  240 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH----HHS-----C----CCCCC
T ss_pred             CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH---HHHh----hcC-----C----CCCCc
Confidence            345689999999999999999999999999999999999999975432211   1111    011     0    11112


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          282 ERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       282 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ...+..+.+++..||+.||.+|||+.++++++|+..
T Consensus       241 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          241 GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence            223455889999999999999999999999998754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7.5e-41  Score=317.81  Aligned_cols=230  Identities=26%  Similarity=0.318  Sum_probs=174.4

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHH-HhcCCCCCccceehhhcchhhH--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRI-ISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      .++|...+.||+|+||.||+++++.++..||||++.+..   ......+..|..+ ++.++||||+++++++.+....  
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            478999999999999999999999999999999997542   2334556777777 5778999999999887654322  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                             ....++.+|+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence                                   125689999999999999   99999999999999999999999999999754322 


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   ...+   .         ...+ 
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~i---~---------~~~~-  256 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNI---L---------NKPL-  256 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH---HHHH---H---------HSCC-
T ss_pred             CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH---H---------hccc-
Confidence            2233456799999999999999999999999999999999999999976442211   1111   1         1101 


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHhccCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSI----RQVINVLNFEA  317 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~----~evl~~l~~~~  317 (387)
                       .++......+.+++.+||+.||.+||++    .++.+|.|+..
T Consensus       257 -~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          257 -QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             -CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence             1122234567889999999999999986    68999988753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-41  Score=317.93  Aligned_cols=235  Identities=23%  Similarity=0.283  Sum_probs=182.3

Q ss_pred             hhCccccCcccccCceEEEEEEEC---CCCeEEEEEEecCCC----hhhHHHHHHHHHHHhcC-CCCCccceehhhcchh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLS---DQNTEIAVKRVSRGS----KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQR  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  138 (387)
                      .++|...+.||+|+||.||+++..   .+++.||||++....    ....+.+.+|++++..+ +||||+++++++.+..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            478999999999999999999984   478999999986532    23345677899999999 6999999998775543


Q ss_pred             hH-------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          139 QL-------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       139 ~~-------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                      ..                         .+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            21                         235788999999999999   99999999999999999999999999999865


Q ss_pred             cCCCCceeeeeecCCcccCchhhccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          194 DHELGSQTTVLAGTMGYLAPECVTTG--KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       194 ~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                      ............||+.|+|||++.+.  .++.++||||||+++|||++|+.||...........+.  ......      
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~~~------  281 (355)
T 1vzo_A          210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKS------  281 (355)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHC------
T ss_pred             ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH--HHHhcc------
Confidence            44333333445789999999999863  47899999999999999999999997654332221111  111100      


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                           ....+...+..+.+++.+||+.||.+||     +++|+++++|+..
T Consensus       282 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          282 -----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             -----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence                 1122233445678899999999999999     9999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3e-40  Score=316.91  Aligned_cols=232  Identities=22%  Similarity=0.266  Sum_probs=173.5

Q ss_pred             hhCcccc-CcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHh-cCCCCCccceehhhcc----hh--
Q 043148           67 TNNFAEA-GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIIS-RLRHRNLVHLIGWCHE----QR--  138 (387)
Q Consensus        67 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~--  138 (387)
                      .++|... +.||+|+||.||++.+..+++.||||++..     ...+.+|++++. ..+||||+++++++..    ..  
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            4566665 689999999999999999999999999863     245678888874 4589999999987643    11  


Q ss_pred             -------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC---CCcEEEcccccc
Q 043148          139 -------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLA  190 (387)
Q Consensus       139 -------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Dfg~~  190 (387)
                                               ...+..++.|++.||.|||+   .+|+||||||+|||++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence                                     11236799999999999999   99999999999999998   789999999999


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhh-HHHHHHHHhccCchh
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR-LVEWVWDLYGKGQLL  269 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~  269 (387)
                      +.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ....+.    .+.. 
T Consensus       212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~-  284 (400)
T 1nxk_A          212 KETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY-  284 (400)
T ss_dssp             EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC-
T ss_pred             cccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc-
Confidence            865432  22345578999999999999999999999999999999999999998655432111 111111    0000 


Q ss_pred             hhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                           ..........+..+.+++.+||+.||.+|||+.|+++|.|+...
T Consensus       285 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          285 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             -----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -----cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                 01111112345568899999999999999999999999998653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.9e-40  Score=303.33  Aligned_cols=233  Identities=27%  Similarity=0.469  Sum_probs=171.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      .++|...+.||+|+||.||+|++..   .||||++...  .....+.+.+|+++++.++||||+++++++....      
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEE
Confidence            5678999999999999999998743   5999998654  3445678999999999999999999998764321      


Q ss_pred             -------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC-C
Q 043148          139 -------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL-G  198 (387)
Q Consensus       139 -------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~  198 (387)
                                         ...+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++....... .
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence                               11236899999999999999   999999999999999999999999999997654321 1


Q ss_pred             ceeeeeecCCcccCchhhc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          199 SQTTVLAGTMGYLAPECVT---TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .......||+.|+|||.+.   +..++.++||||||+++|||++|+.||......+..  .    .....+...    +.
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~----~~~~~~~~~----~~  246 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--I----EMVGRGSLS----PD  246 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH--H----HHHHHTSCC----CC
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH--H----HHhcccccC----cc
Confidence            2233456899999999986   566888999999999999999999999765543211  1    111111111    00


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                       .......++..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       247 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          247 -LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             -TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             -hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence             1112233456688999999999999999999999998743

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-40  Score=305.97  Aligned_cols=235  Identities=21%  Similarity=0.212  Sum_probs=174.0

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      ..++|...+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.++..++||||+++++++.+....  
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            4588999999999999999999999889999999987542   23357789999999999999999999987653321  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                             .+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence                                   236799999999999999   999999999999999999999999999997665433


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      ........+++.|+|||.+.+..++.++||||||+++|||++|+.||......       ...........       ..
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~-------~~  254 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP-------RP  254 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC-------CG
T ss_pred             cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC-------Cc
Confidence            33334556899999999999989999999999999999999999999754321       11111111100       01


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhccCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRP-SIRQVINVLNFEA  317 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~l~~~~  317 (387)
                      .......+..+.+++.+||+.||.+|| +++++++.|....
T Consensus       255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence            112223345588899999999999999 9999999987543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6e-41  Score=307.56  Aligned_cols=227  Identities=22%  Similarity=0.384  Sum_probs=177.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCC-------eEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQN-------TEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  139 (387)
                      .++|...+.||+|+||.||+|.+..++       ..||+|.+........+.+.+|++++..++||||+++++++.+...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            467888999999999999999987766       5799999977666777889999999999999999999998765432


Q ss_pred             H--------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc--------EEEc
Q 043148          140 L--------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN--------AKLG  185 (387)
Q Consensus       140 ~--------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~--------~kl~  185 (387)
                      .                          .+..++.|++.||.|||+   ++++||||||+|||++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeec
Confidence            1                          236789999999999999   99999999999999998887        9999


Q ss_pred             cccccccccCCCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc
Q 043148          186 DFGLARLVDHELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYG  264 (387)
Q Consensus       186 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  264 (387)
                      |||++.....     .....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+........  ...    ...
T Consensus       164 Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~~~----~~~  232 (289)
T 4fvq_A          164 DPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KLQ----FYE  232 (289)
T ss_dssp             CCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHH----HHH
T ss_pred             cCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--HHH----Hhh
Confidence            9999865432     123457899999999987 6789999999999999999996554433222111  111    000


Q ss_pred             cCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          265 KGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .       ......    ..+..+.+++.+||+.||.+|||+.+++++|....+
T Consensus       233 ~-------~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          233 D-------RHQLPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             T-------TCCCCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             c-------cCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            0       001111    113347889999999999999999999999985543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-40  Score=307.30  Aligned_cols=234  Identities=21%  Similarity=0.307  Sum_probs=180.2

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      ..++|.+.+.||+|+||.||+|.+..++..||+|.+........+.+.+|++++..++||||+++++++.+...      
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            45789999999999999999999998899999999987666677889999999999999999999998755321      


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          ..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++...... ..
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  172 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ  172 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence                                1236789999999999999   99999999999999999999999999987533211 01


Q ss_pred             eeeeeecCCcccCchhh-----ccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          200 QTTVLAGTMGYLAPECV-----TTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      ......|++.|+|||++     ....++.++||||||+++|||++|+.||.........      ........      +
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~------~  240 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKSDP------P  240 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSCC------C
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHhccCC------c
Confidence            12234689999999998     3667899999999999999999999999765432111      11111100      0


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                        ....+...+..+.+++.+||+.||.+|||+.++++|.|+..
T Consensus       241 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  281 (302)
T 2j7t_A          241 --TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS  281 (302)
T ss_dssp             --CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred             --ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence              01112233456889999999999999999999999998764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.1e-40  Score=319.62  Aligned_cols=238  Identities=21%  Similarity=0.283  Sum_probs=178.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      ..+|...+.||+|+||.||+|++..++. +|+|++.....    ...+|+++++.++||||+++++++.....       
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            3568899999999999999999987554 89988854322    22369999999999999999988733211       


Q ss_pred             ---------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC-CCCcEEEccccccc
Q 043148          140 ---------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD-SNFNAKLGDFGLAR  191 (387)
Q Consensus       140 ---------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kl~Dfg~~~  191 (387)
                                                 ..+..++.|++.||.|||+   ++|+||||||+|||++ .++.+||+|||+++
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence                                       1235789999999999999   9999999999999999 79999999999998


Q ss_pred             cccCCCCceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh-
Q 043148          192 LVDHELGSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL-  269 (387)
Q Consensus       192 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  269 (387)
                      ......  ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....   +....+..... 
T Consensus       191 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~p~~~~  265 (394)
T 4e7w_A          191 ILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE---IIKVLGTPSREQ  265 (394)
T ss_dssp             ECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCHHH
T ss_pred             cccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCHHH
Confidence            664432  22345689999999998765 589999999999999999999999987654332221   11111111000 


Q ss_pred             --------------hhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          270 --------------EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       270 --------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                                    ......+...+....+..+.+++.+||+.||.+|||+.|+++|.|+..
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE  327 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence                          000000001112224557899999999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.9e-40  Score=313.29  Aligned_cols=234  Identities=12%  Similarity=0.043  Sum_probs=166.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHH---HHhcCCCCCccceehhh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK---QGKKEYISEVR---IISRLRHRNLVHLIGWC------  134 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~------  134 (387)
                      ..+|...+.||+|+||.||+|++..+++.||||++.....   ...+.+.+|++   .|.. +||||++++..+      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            4558889999999999999999998999999999987542   34556778854   5555 799977743211      


Q ss_pred             -------------------------------cchhh------------HHH------HHHHHHHHHHHHHhhhhccccee
Q 043148          135 -------------------------------HEQRQ------------LIL------HKIALGLASAVLYLHEEWEQCIV  165 (387)
Q Consensus       135 -------------------------------~~~~~------------~~l------~~i~~~i~~~l~~LH~~~~~~ii  165 (387)
                                                     ...-.            ...      ..++.|++.||+|||+   ++|+
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~iv  216 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLV  216 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCc
Confidence                                           10000            011      3566999999999999   9999


Q ss_pred             eccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCcccCchhhcc--CCCCCccchHHHHHHHHHHHhCCCC
Q 043148          166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT--GKASKESDVYSFGVVALEVACGRKP  243 (387)
Q Consensus       166 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~el~tg~~p  243 (387)
                      ||||||+|||++.++.+||+|||+++....    ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.|
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999986543    2223456799999999987  6799999999999999999999999


Q ss_pred             CCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          244 VEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      |..........        +.....................+..+.+++.+||+.||.+|||+.++++|.|+.
T Consensus       293 f~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  357 (371)
T 3q60_A          293 FGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL  357 (371)
T ss_dssp             TTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred             CCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence            98664321110        000000011111111111123456688999999999999999999999999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-40  Score=301.57  Aligned_cols=228  Identities=27%  Similarity=0.458  Sum_probs=179.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .++|...+.||+|+||.||++.+.. +..||+|.+..... ..+.+.+|++++..++||||+++++++.+...       
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hhheeeeeEecCCCceeEEEEEecC-CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            3678889999999999999999874 78899999976433 35789999999999999999999998755321       


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++..........
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence                               1236789999999999999   999999999999999999999999999997654321112


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      .....+++.|+|||++.+..++.++||||||+++|||++ |+.||........   ..    ....+         ....
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~----~i~~~---------~~~~  225 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VE----DISTG---------FRLY  225 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH----HHHTT---------CCCC
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH---HH----HHhcC---------CcCC
Confidence            223346778999999998899999999999999999999 8999976542211   11    11111         0111


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .+...+..+.+++.+||+.||.+|||+.+++++|..
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (267)
T 3t9t_A          226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  261 (267)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            122234568899999999999999999999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=308.29  Aligned_cols=245  Identities=19%  Similarity=0.264  Sum_probs=179.8

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcch---------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ---------  137 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  137 (387)
                      .++|...+.||+|+||.||+|.+..+++.||||.+........+.+.+|+++++.++||||+++++++...         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            46789999999999999999999999999999999877777778899999999999999999998775321         


Q ss_pred             ----------------------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC-CCCcEEEcccc
Q 043148          138 ----------------------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD-SNFNAKLGDFG  188 (387)
Q Consensus       138 ----------------------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kl~Dfg  188 (387)
                                                  ....+..++.|++.||.|||+   ++++||||||+|||++ +++.+||+|||
T Consensus        90 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           90 SLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             -CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             cccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence                                        112246799999999999999   9999999999999997 56799999999


Q ss_pred             ccccccCCCC--ceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 043148          189 LARLVDHELG--SQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGK  265 (387)
Q Consensus       189 ~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  265 (387)
                      +++.......  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+   ......
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~---~~~~~~  243 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI---LESIPV  243 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHSCC
T ss_pred             cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCC
Confidence            9986643211  12233456889999998865 67899999999999999999999999866533221111   111000


Q ss_pred             C----------chhhhhc-----ccC-CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          266 G----------QLLEAAD-----GRL-SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       266 ~----------~~~~~~~-----~~~-~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .          .+.....     +.. ........+..+.+++.+||+.||.+|||++|+++|.|+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI  311 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence            0          0000000     000 00111234566889999999999999999999999999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3e-40  Score=326.53  Aligned_cols=233  Identities=22%  Similarity=0.293  Sum_probs=185.0

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      ++|...+.||+|+||.||++++..+|+.||||++.+..   ......+.+|++++..++||||+++++++.+...     
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67888899999999999999999999999999996532   2234678899999999999999999887654321     


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                              .....++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence                                    1235688999999999999   9999999999999999999999999999987654


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      ... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+   ....        ... 
T Consensus       342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~---~~~i--------~~~-  408 (543)
T 3c4z_A          342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL---KQRV--------LEQ-  408 (543)
T ss_dssp             TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH---HHHH--------HHC-
T ss_pred             CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH---HHHH--------hhc-
Confidence            321 223457999999999999999999999999999999999999999865432211111   1111        011 


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccCC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFEA  317 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  317 (387)
                       ...++...+..+.+++.+||+.||.+||+     +++|++|.|+..
T Consensus       409 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          409 -AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             -ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence             11222334556888999999999999996     489999998864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-40  Score=311.40  Aligned_cols=233  Identities=24%  Similarity=0.363  Sum_probs=182.4

Q ss_pred             HhhCccccCcccccCceEEEEEEE-----CCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchh
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQR  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  138 (387)
                      ..++|...+.||+|+||.||+|.+     ..++..||||.+... .....+.+.+|+.++.++ +||||+++++++.+..
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457899999999999999999997     345678999999754 234467899999999999 8999999999765421


Q ss_pred             h------------------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCC
Q 043148          139 Q------------------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIK  170 (387)
Q Consensus       139 ~------------------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk  170 (387)
                      .                                                ..+..++.|++.||.|||+   ++|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence            1                                                1235689999999999999   999999999


Q ss_pred             cceeEeCCCCcEEEccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 043148          171 SSNVVLDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQ  248 (387)
Q Consensus       171 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~  248 (387)
                      |+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999999999999866543222 2334567889999999999999999999999999999998 999998765


Q ss_pred             CcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          249 EPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ......      .....         ......+...+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus       280 ~~~~~~------~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  332 (344)
T 1rjb_A          280 VDANFY------KLIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  332 (344)
T ss_dssp             CSHHHH------HHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cHHHHH------HHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            432111      11111         111122233456688999999999999999999999999754

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=307.18  Aligned_cols=235  Identities=23%  Similarity=0.300  Sum_probs=180.0

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      .++|...+.||+|+||.||++....+++.||||++........+.+.+|+++++.++||||+++++++....        
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            467999999999999999999998899999999997776777888999999999999999999999875210        


Q ss_pred             -------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          139 -------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       139 -------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                                               ...+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence                                     11236799999999999999   99999999999999999999999999998754


Q ss_pred             cCCCCc--------eeeeeecCCcccCchhhccCC---CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 043148          194 DHELGS--------QTTVLAGTMGYLAPECVTTGK---ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDL  262 (387)
Q Consensus       194 ~~~~~~--------~~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  262 (387)
                      ......        ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||......... .       
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~-------  256 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-V-------  256 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-H-------
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-h-------
Confidence            321100        012234689999999987554   689999999999999999999999532110000 0       


Q ss_pred             hccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          263 YGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                            ................+..+.+++.+||+.||.+|||+.+++++|+...+
T Consensus       257 ------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          257 ------ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             ------HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             ------hHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                  00000011111122334568899999999999999999999999986543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.1e-40  Score=306.16  Aligned_cols=232  Identities=25%  Similarity=0.372  Sum_probs=183.5

Q ss_pred             HhhCccccCcccccCceEEEEEEE-----CCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccceehhhcchh
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQR  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  138 (387)
                      ..++|...+.||+|+||.||+|++     ..++..||||.+.... ....+.+.+|++++.++ +||||+++++++.+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346889999999999999999985     4567899999997653 34567899999999999 9999999999765421


Q ss_pred             -------------------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeE
Q 043148          139 -------------------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVV  175 (387)
Q Consensus       139 -------------------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nil  175 (387)
                                                                 ...+..++.|++.||.|||+   ++++||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence                                                       11235789999999999999   99999999999999


Q ss_pred             eCCCCcEEEccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchh
Q 043148          176 LDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKV  253 (387)
Q Consensus       176 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~  253 (387)
                      ++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            999999999999999866543322 2233457889999999999999999999999999999999 99999866543221


Q ss_pred             hHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          254 RLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .  .    ....         ......+...+..+.+++.+||+.||.+|||+.|++++|+.
T Consensus       258 ~--~----~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  304 (313)
T 1t46_A          258 Y--K----MIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (313)
T ss_dssp             H--H----HHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             H--H----Hhcc---------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            1  1    1100         11111222344568899999999999999999999999863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.6e-39  Score=308.95  Aligned_cols=243  Identities=21%  Similarity=0.258  Sum_probs=184.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-----------CCCccceehhhc
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-----------HRNLVHLIGWCH  135 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  135 (387)
                      .++|...+.||+|+||.||+|++..+++.||||++... ....+.+.+|++++.+++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            36799999999999999999999999999999999653 344677889999998886           899999998765


Q ss_pred             chh------------------------------hHHHHHHHHHHHHHHHHhhhhccc-ceeeccCCcceeEeC------C
Q 043148          136 EQR------------------------------QLILHKIALGLASAVLYLHEEWEQ-CIVHRDIKSSNVVLD------S  178 (387)
Q Consensus       136 ~~~------------------------------~~~l~~i~~~i~~~l~~LH~~~~~-~iiH~dlk~~Nill~------~  178 (387)
                      ...                              ...+..++.|++.||.|||+   + +|+||||||+|||++      .
T Consensus        97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTT
T ss_pred             ccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcC
Confidence            421                              11236799999999999999   7 999999999999994      4


Q ss_pred             CCcEEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcch---hhH
Q 043148          179 NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSK---VRL  255 (387)
Q Consensus       179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~---~~~  255 (387)
                      .+.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|||++|+.||........   ...
T Consensus       174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence            558999999999866432    2234689999999999999999999999999999999999999986543221   111


Q ss_pred             HHHHHHHhccCch------------------------------hhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCC
Q 043148          256 VEWVWDLYGKGQL------------------------------LEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPS  305 (387)
Q Consensus       256 ~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs  305 (387)
                      ...+.........                              ......  ...++......+.+++.+||+.||.+|||
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccCC
Confidence            1111111111000                              000000  11345677888999999999999999999


Q ss_pred             HHHHHHHhccCCCC
Q 043148          306 IRQVINVLNFEAPL  319 (387)
Q Consensus       306 ~~evl~~l~~~~~~  319 (387)
                      +.|+++|.|+....
T Consensus       328 ~~ell~hp~f~~~~  341 (373)
T 1q8y_A          328 AGGLVNHPWLKDTL  341 (373)
T ss_dssp             HHHHHTCGGGTTCT
T ss_pred             HHHHhhChhhhccc
Confidence            99999999987653

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.5e-40  Score=307.50  Aligned_cols=235  Identities=22%  Similarity=0.326  Sum_probs=179.7

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--------hhhHHHHHHHHHHHhcCCCCCccceehhhcch
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--------KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ  137 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  137 (387)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||.+....        ......+.+|++++..++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4578999999999999999999999999999999986532        12234588999999999999999999887543


Q ss_pred             h------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc---EEEcccccc
Q 043148          138 R------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN---AKLGDFGLA  190 (387)
Q Consensus       138 ~------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kl~Dfg~~  190 (387)
                      .                        ...+..++.|++.||.|||+   ++++||||||+|||++.++.   +||+|||++
T Consensus        88 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           88 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            2                        11236789999999999999   99999999999999987665   999999999


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhc---cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVT---TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ  267 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (387)
                      ......  .......||+.|+|||++.   ...++.++||||||+++|||++|+.||.........  ...+.    .+.
T Consensus       165 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~----~~~  236 (322)
T 2ycf_A          165 KILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQIT----SGK  236 (322)
T ss_dssp             EECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHH----HTC
T ss_pred             eecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHH----hCc
Confidence            866432  1223446899999999874   466899999999999999999999999765433221  11111    110


Q ss_pred             hhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          268 LLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .      ..........+..+.+++.+||+.||.+|||+.+++++.|+..
T Consensus       237 ~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          237 Y------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             C------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             c------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            0      0111111223556889999999999999999999999998753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.7e-40  Score=303.81  Aligned_cols=233  Identities=26%  Similarity=0.373  Sum_probs=171.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      .++|...+.||+|+||.||+|....++..||||.+...   .......+.+|++++..++||||+++++++.+...    
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46799999999999999999999888999999999753   34456788999999999999999999987754321    


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          140 -------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       140 -------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                                               ..+..++.+++.||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence                                     1235789999999999999   999999999999999999999999999987654


Q ss_pred             CCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          195 HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      ... .......+++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....    .......       
T Consensus       188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~----~~~~~~~-------  254 (310)
T 2wqm_A          188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLC----KKIEQCD-------  254 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHH----HHHHTTC-------
T ss_pred             CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHH----HHhhccc-------
Confidence            322 12234468999999999999999999999999999999999999997543221 1111    1111111       


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                       .........+..+.+++.+||+.||.+|||+.+|+++|...
T Consensus       255 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l  295 (310)
T 2wqm_A          255 -YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM  295 (310)
T ss_dssp             -SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             11111123345688999999999999999999999998743

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-40  Score=331.42  Aligned_cols=231  Identities=26%  Similarity=0.424  Sum_probs=182.9

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      ...++|...+.||+|+||.||+|.+.. +..||||++.... ...++|.+|+++|++++||||+++++++.+..      
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e  341 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE  341 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeee
Confidence            345678888999999999999999976 5779999997643 34678999999999999999999999875421      


Q ss_pred             --------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          139 --------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       139 --------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                          ...+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence                                11236789999999999999   9999999999999999999999999999986543211


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      .......++..|+|||++....++.++||||||+++|||++ |+.||......+..       ..+..+         ..
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~-------~~i~~~---------~~  482 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERG---------YR  482 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH-------HHHHTT---------CC
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC---------CC
Confidence            11222346778999999999999999999999999999999 99999765432211       111111         11


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ...+..++..+.+++.+||+.||.+|||+++|++.|+..
T Consensus       483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~  521 (535)
T 2h8h_A          483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  521 (535)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            122234456688999999999999999999999999743

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.4e-40  Score=301.48  Aligned_cols=232  Identities=25%  Similarity=0.394  Sum_probs=176.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      .++|...+.||+|+||.||+|.+..+++.||||.+....   ....+.+.+|+++++.++||||+++++++.+...    
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            467899999999999999999999889999999986532   2235678899999999999999999998754321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......  
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--  164 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--  164 (276)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC--
Confidence                                 1236799999999999999   99999999999999999999999999999765442  


Q ss_pred             ceeeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                      .......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.......   ...    ....+.          
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~----~~~~~~----------  227 (276)
T 2h6d_A          165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFK----KIRGGV----------  227 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCC----------
T ss_pred             cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHH----HhhcCc----------
Confidence            12234468899999999987765 689999999999999999999997543221   111    111110          


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLP  320 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  320 (387)
                      ...+......+.+++.+||+.||.+|||+.|++++.|+....+
T Consensus       228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  270 (276)
T 2h6d_A          228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP  270 (276)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence            0112223455788999999999999999999999999876543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.8e-40  Score=324.40  Aligned_cols=234  Identities=24%  Similarity=0.368  Sum_probs=182.9

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh-------------hhHHHHHHHHHHHhcCCCCCccceeh
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-------------QGKKEYISEVRIISRLRHRNLVHLIG  132 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  132 (387)
                      ..++|...+.||+|+||.||+|.+..++..||||++.....             ...+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            46889999999999999999999999999999999875421             33567899999999999999999999


Q ss_pred             hhcchhhH-------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC---cEEE
Q 043148          133 WCHEQRQL-------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF---NAKL  184 (387)
Q Consensus       133 ~~~~~~~~-------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kl  184 (387)
                      ++.+....                         .+..++.|++.||.|||+   ++|+||||||+|||++.++   .+||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEE
Confidence            87654321                         236799999999999999   9999999999999999776   6999


Q ss_pred             ccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhc
Q 043148          185 GDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYG  264 (387)
Q Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  264 (387)
                      +|||++.......  ......||+.|+|||++. ..++.++||||||+++|+|++|..||......+....       +.
T Consensus       191 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-------i~  260 (504)
T 3q5i_A          191 VDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK-------VE  260 (504)
T ss_dssp             CCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HH
T ss_pred             EECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HH
Confidence            9999998765432  233456999999999987 4689999999999999999999999986543221111       11


Q ss_pred             cCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          265 KGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      .+..      ..........+..+.+++.+||+.||.+|||++|+++|.|+...
T Consensus       261 ~~~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          261 KGKY------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             HCCC------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             cCCC------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence            1110      00011112234568899999999999999999999999997654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.2e-40  Score=301.27  Aligned_cols=226  Identities=21%  Similarity=0.316  Sum_probs=177.1

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh---
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~---  139 (387)
                      ..++|...+.||+|+||.||+|.+..+++.||||.+...  ......++.+|+..+..+ +||||+++++++.+...   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            457899999999999999999999988999999998764  344567888999999999 99999999998754321   


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC--------------
Q 043148          140 --------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN--------------  179 (387)
Q Consensus       140 --------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~--------------  179 (387)
                                                ..+..++.|++.||.|||+   ++|+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence                                      2236799999999999999   999999999999999844              


Q ss_pred             -----CcEEEccccccccccCCCCceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh
Q 043148          180 -----FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKV  253 (387)
Q Consensus       180 -----~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~  253 (387)
                           ..+||+|||++.......     ...||+.|+|||.+.+. .++.++||||||+++|||++|..|+.....    
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred             ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence                 479999999998665432     23489999999999866 567899999999999999999887643210    


Q ss_pred             hHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          254 RLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                        .    .....+..         ...+...+..+.+++.+||+.||.+|||+.|+++|.|+...
T Consensus       237 --~----~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 --W----HEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             --H----HHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             --H----HHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence              1    11111111         11222334568899999999999999999999999997643

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.8e-39  Score=317.71  Aligned_cols=234  Identities=21%  Similarity=0.280  Sum_probs=179.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhh-cchh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC-HEQR-------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~-------  138 (387)
                      .++|.+.+.||+|+||.||+|++..+++.||||++.....  ..++..|++++..++|++.+..+.++ .+..       
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            4789999999999999999999998999999998865432  24578999999999875544433322 2111       


Q ss_pred             ------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe---CCCCcEEEccccccccccCCC
Q 043148          139 ------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL---DSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       139 ------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                        ...+..++.||+.||.|||+   ++|+||||||+||||   +.++.+||+|||+++......
T Consensus        84 ~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence                              12346899999999999999   999999999999999   588999999999998765432


Q ss_pred             Cc------eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          198 GS------QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       198 ~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                      ..      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........+.. 
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-  239 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA-  239 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH-
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH-
Confidence            21      12356799999999999999999999999999999999999999987665444333332222111111111 


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                              ....++..+.+++..||+.||.+||++.+|++.|.
T Consensus       240 --------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~  274 (483)
T 3sv0_A          240 --------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR  274 (483)
T ss_dssp             --------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             --------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence                    11123456889999999999999999999998774

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-40  Score=301.01  Aligned_cols=229  Identities=30%  Similarity=0.390  Sum_probs=175.6

Q ss_pred             CccccCcccccCceEEEEEEECCCCe---EEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNT---EIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      .|...+.||+|+||.||+|.+..++.   .+|+|.+.... ....+.+.+|+++++.++||||+++++++.+....    
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            35556889999999999999755443   79999997643 34567899999999999999999999987543221    


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                             .+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence                                   236789999999999999   999999999999999999999999999997554321


Q ss_pred             ---CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          198 ---GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       198 ---~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                         ........+++.|+|||.+.+..++.++||||||+++|||++|..|+........  ......    ..        
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~----~~--------  244 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTHFLA----QG--------  244 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHHHHH----TT--------
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHHHhh----cC--------
Confidence               1122334578899999999999999999999999999999996665443332211  111111    11        


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                       .....+...+..+.+++.+||+.||.+|||+.++++.|..
T Consensus       245 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  284 (298)
T 3pls_A          245 -RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ  284 (298)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             1111222334568899999999999999999999998863

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.7e-40  Score=303.49  Aligned_cols=232  Identities=23%  Similarity=0.342  Sum_probs=180.0

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh------
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ------  139 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  139 (387)
                      ..++|...+.||+|+||.||+|.+..+|+.||||.+....  ..+.+.+|++++..++||||+++++++.+...      
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4578999999999999999999999889999999997543  35678999999999999999999997754321      


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                          ..+..++.+++.||.|||+   .+++|+||||+||+++.++.+||+|||++........ 
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  180 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-  180 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence                                1236789999999999999   9999999999999999999999999999976544321 


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.........      ...... .     .+  ...
T Consensus       181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~-~-----~~--~~~  246 (314)
T 3com_A          181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FMIPTN-P-----PP--TFR  246 (314)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHS-C-----CC--CCS
T ss_pred             ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcC-C-----Cc--ccC
Confidence            223446899999999999989999999999999999999999999754422111      110000 0     00  011


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .+...+..+.+++.+||+.||.+|||+.+++++.|+..
T Consensus       247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~  284 (314)
T 3com_A          247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS  284 (314)
T ss_dssp             SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred             CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence            12223456889999999999999999999999998764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.1e-39  Score=309.25  Aligned_cols=240  Identities=20%  Similarity=0.229  Sum_probs=178.8

Q ss_pred             HhhCccccCcccccCceEEEEEEECCC-----CeEEEEEEecCCChhh-----------HHHHHHHHHHHhcCCCCCccc
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQ-----NTEIAVKRVSRGSKQG-----------KKEYISEVRIISRLRHRNLVH  129 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~  129 (387)
                      ..++|.+.+.||+|+||.||+|.+..+     ++.||||++.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            346899999999999999999998764     5789999987654221           123445666778889999999


Q ss_pred             eehhhcchh-----------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC--C
Q 043148          130 LIGWCHEQR-----------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD--S  178 (387)
Q Consensus       130 l~~~~~~~~-----------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~--~  178 (387)
                      +++++....                             ...+..++.|++.||.|||+   ++|+||||||+|||++  .
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSC
T ss_pred             EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCC
Confidence            999875431                             11236899999999999999   9999999999999999  8


Q ss_pred             CCcEEEccccccccccCCCCc------eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcch
Q 043148          179 NFNAKLGDFGLARLVDHELGS------QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSK  252 (387)
Q Consensus       179 ~~~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~  252 (387)
                      ++.+||+|||+++.+......      ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            899999999999765432111      11334599999999999999999999999999999999999999985433221


Q ss_pred             hhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          253 VRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                        ......... ...+..+.++.+..   ...+..+.+++..||+.||.+||++.+|++.|.
T Consensus       270 --~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~  325 (364)
T 3op5_A          270 --YVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILL  325 (364)
T ss_dssp             --HHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             --HHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence              111111111 11233333332211   122456888999999999999999999999885

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.7e-40  Score=300.31  Aligned_cols=236  Identities=20%  Similarity=0.283  Sum_probs=179.5

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-------
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-------  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  138 (387)
                      ..++|...+.||+|+||.||+|++..+++.||||++.....  ...+.+|++++..++|+|++..++++....       
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            45789999999999999999999988999999998754332  245788999999999998887766553211       


Q ss_pred             -------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe---CCCCcEEEccccccccccCC
Q 043148          139 -------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL---DSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       139 -------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                         ...+..++.|++.||.|||+   ++|+||||||+|||+   +.++.+||+|||+++.....
T Consensus        85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             ECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence                               12236899999999999999   999999999999999   78899999999999876543


Q ss_pred             CC------ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          197 LG------SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       197 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      ..      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................  
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  239 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--  239 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh--
Confidence            22      1223457899999999999999999999999999999999999999876544333333222211101000  


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                             .......+..+.+++..||+.||.+|||++++++.|..
T Consensus       240 -------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (296)
T 4hgt_A          240 -------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             -------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             -------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence                   01111224568899999999999999999999998863

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-40  Score=307.43  Aligned_cols=229  Identities=25%  Similarity=0.477  Sum_probs=172.5

Q ss_pred             hCccccCcccccCceEEEEEEECCCC----eEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQN----TEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      ++|...+.||+|+||.||+|.+..++    ..||||.+... .......+.+|++++..++||||+++++++.+...   
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            56777889999999999999886543    46999999764 34456679999999999999999999998765321   


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                             ..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence                                   1236789999999999999   99999999999999999999999999999866543


Q ss_pred             CCc--eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          197 LGS--QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       197 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ...  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.   .    .....+       
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~----~~~~~~-------  266 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---M----KAINDG-------  266 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H----HHHHTT-------
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---H----HHHHCC-------
Confidence            211  1222345778999999999999999999999999999999 9999976543211   1    111111       


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                        .....+...+..+.+++.+||+.||.+||++.+++++|+.
T Consensus       267 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  306 (333)
T 1mqb_A          267 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  306 (333)
T ss_dssp             --CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence              0111122345568899999999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.5e-40  Score=309.65  Aligned_cols=239  Identities=24%  Similarity=0.414  Sum_probs=186.3

Q ss_pred             CHHHHHHHhhCccccCcccccCceEEEEEEEC-----CCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceeh
Q 043148           59 TYRELSRATNNFAEAGKLGEGGFGGVYRGLLS-----DQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIG  132 (387)
Q Consensus        59 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~  132 (387)
                      ..+++....++|...+.||+|+||.||+|.+.     .++..||||.+.... ......+.+|+++++.++||||+++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            33445556788999999999999999999876     346789999997543 344567899999999999999999999


Q ss_pred             hhcchhh-----------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC
Q 043148          133 WCHEQRQ-----------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD  177 (387)
Q Consensus       133 ~~~~~~~-----------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~  177 (387)
                      ++.+...                                   ..+..++.|++.||.|||+   ++|+||||||+|||++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEc
Confidence            8754321                                   1235688999999999999   9999999999999999


Q ss_pred             CCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 043148          178 SNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRL  255 (387)
Q Consensus       178 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~  255 (387)
                      .++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||........   
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---  249 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---  249 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH---
Confidence            999999999999976543221 11223456889999999999999999999999999999999 8999976542211   


Q ss_pred             HHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          256 VEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .    .....+..         ...+...+..+.+++.+||+.||.+|||+.|++++|...
T Consensus       250 ~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          250 L----RFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             H----HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             H----HHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence            1    11111111         112233455688999999999999999999999999754

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-40  Score=301.40  Aligned_cols=229  Identities=27%  Similarity=0.447  Sum_probs=180.4

Q ss_pred             hCccccC-cccccCceEEEEEEEC--CCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-----
Q 043148           68 NNFAEAG-KLGEGGFGGVYRGLLS--DQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-----  138 (387)
Q Consensus        68 ~~~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  138 (387)
                      ++|...+ .||+|+||.||+|.+.  .++..||||.+... .....+.+.+|++++..++||||+++++++....     
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~   88 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM   88 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence            4566665 8999999999999864  45788999999765 3445678999999999999999999999874321     


Q ss_pred             --------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          139 --------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       139 --------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                          ...+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  165 (287)
T ss_dssp             ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence                                11236899999999999999   9999999999999999999999999999987654322


Q ss_pred             ce--eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          199 SQ--TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       199 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      ..  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+...       ....+         
T Consensus       166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-------~i~~~---------  229 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-------FIEQG---------  229 (287)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-------HHHTT---------
T ss_pred             eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-------HHhcC---------
Confidence            11  222346789999999998889999999999999999998 999997655432111       11111         


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .....+...+..+.+++..||+.||.+||++.+++++|+.
T Consensus       230 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  269 (287)
T 1u59_A          230 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  269 (287)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1112233445668899999999999999999999999873

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.5e-39  Score=297.70  Aligned_cols=235  Identities=20%  Similarity=0.283  Sum_probs=182.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  138 (387)
                      .++|...+.||+|+||.||+|++..+++.||||++.....  .+.+.+|++++..++|++++..+.++....        
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            5789999999999999999999988999999999865432  346889999999999988877665542211        


Q ss_pred             ------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC---CCCcEEEccccccccccCCC
Q 043148          139 ------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD---SNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       139 ------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                        ...+..++.|++.||.|||+   ++++||||||+|||++   .++.+||+|||++.......
T Consensus        86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           86 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             ecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence                              12236899999999999999   9999999999999994   88899999999998765432


Q ss_pred             Cc------eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          198 GS------QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       198 ~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                      ..      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.........   
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---  239 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI---  239 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH---
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch---
Confidence            21      123457899999999999999999999999999999999999999875543332222222211100000   


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                            .......+..+.+++.+||+.||.+|||+.+|++.|..
T Consensus       240 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  277 (296)
T 3uzp_A          240 ------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             ------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             ------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence                  01112234568899999999999999999999998863

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4e-40  Score=305.84  Aligned_cols=240  Identities=23%  Similarity=0.364  Sum_probs=187.2

Q ss_pred             cCHHHHHHHhhCccccCcccccCceEEEEEEE-----CCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccce
Q 043148           58 FTYRELSRATNNFAEAGKLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHL  130 (387)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l  130 (387)
                      +...++....++|...+.||+|+||.||+|++     ..+++.||||++.... ....+.+.+|++++..+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34455555678999999999999999999985     3467899999997653 34456789999999999 79999999


Q ss_pred             ehhhcchhh------------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeecc
Q 043148          131 IGWCHEQRQ------------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRD  168 (387)
Q Consensus       131 ~~~~~~~~~------------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~d  168 (387)
                      ++++.+...                                          ..+..++.|++.||.|||+   ++++|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence            997654211                                          1235788999999999999   9999999


Q ss_pred             CCcceeEeCCCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCC
Q 043148          169 IKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEP  246 (387)
Q Consensus       169 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~  246 (387)
                      |||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999986544322 22334567889999999999999999999999999999998 9999976


Q ss_pred             CCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          247 RQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .......  ..    ....+.         ....+...+..+.+++.+||+.||.+|||+.|++++|..
T Consensus       254 ~~~~~~~--~~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  307 (316)
T 2xir_A          254 VKIDEEF--CR----RLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  307 (316)
T ss_dssp             CCCSHHH--HH----HHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cchhHHH--HH----HhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            5533211  11    111110         111122234568889999999999999999999999863

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.5e-40  Score=307.35  Aligned_cols=234  Identities=26%  Similarity=0.388  Sum_probs=160.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHH-HHhcCCCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVR-IISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      .++|...+.||+|+||.||+|.+..+++.||||++.... .....++..|+. +++.++||||+++++++.+...     
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            467888999999999999999999899999999997653 334456666666 7778899999999997654321     


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhccc-ceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQ-CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~-~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                                              ..+..++.+++.||.|||+   . +++||||||+|||++.++.+||+|||+++...
T Consensus       101 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             eecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence                                    1236789999999999999   7 99999999999999999999999999997654


Q ss_pred             CCCCceeeeeecCCcccCchhh----ccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          195 HELGSQTTVLAGTMGYLAPECV----TTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      ...  ......|++.|+|||++    .+..++.++||||||+++|||++|+.||.........         ..  ....
T Consensus       178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------~~--~~~~  244 (327)
T 3aln_A          178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------LT--QVVK  244 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C--CCCC
T ss_pred             ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------HH--HHhc
Confidence            321  22334689999999998    4566899999999999999999999999764321100         00  0000


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ...+.+...........+.+++.+||+.||.+|||+.++++++|+.
T Consensus       245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  290 (327)
T 3aln_A          245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL  290 (327)
T ss_dssp             SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence            0011111111223445688999999999999999999999998864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.1e-40  Score=331.36  Aligned_cols=221  Identities=27%  Similarity=0.457  Sum_probs=173.3

Q ss_pred             cccccCceEEEEEEEC--CCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchh-------------
Q 043148           75 KLGEGGFGGVYRGLLS--DQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-------------  138 (387)
Q Consensus        75 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------------  138 (387)
                      .||+|+||.||+|.+.  .++..||||+++... ....+++.+|+++|+.++|||||+++++|.+..             
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L  422 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL  422 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence            7999999999999875  346779999997653 345788999999999999999999999875422             


Q ss_pred             ------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc--eeeee
Q 043148          139 ------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS--QTTVL  204 (387)
Q Consensus       139 ------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~  204 (387)
                                  ...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++........  .....
T Consensus       423 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  499 (613)
T 2ozo_A          423 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG  499 (613)
T ss_dssp             HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------------
T ss_pred             HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCC
Confidence                        11236799999999999999   99999999999999999999999999999876433211  12233


Q ss_pred             ecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       205 ~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      .+++.|+|||++.+..++.++|||||||++|||++ |+.||......+...       .+..+         .....+..
T Consensus       500 ~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-------~i~~~---------~~~~~p~~  563 (613)
T 2ozo_A          500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-------FIEQG---------KRMECPPE  563 (613)
T ss_dssp             --CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH-------HHHTT---------CCCCCCTT
T ss_pred             CCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcC---------CCCCCCCc
Confidence            45689999999999999999999999999999998 999998765433211       11111         11223334


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ++..+.+++..||+.||.+||++.+|++.|.
T Consensus       564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  594 (613)
T 2ozo_A          564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR  594 (613)
T ss_dssp             CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            5567889999999999999999999998886

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.4e-39  Score=302.14  Aligned_cols=234  Identities=25%  Similarity=0.387  Sum_probs=174.7

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEECC---CCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcch
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLSD---QNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ  137 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  137 (387)
                      +....++|...+.||+|+||.||+|.+..   ++..||||.+...  .....+.+.+|+.++..++||||+++++++.+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            33456788899999999999999998765   4568999998654  344467799999999999999999999976542


Q ss_pred             hh------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc
Q 043148          138 RQ------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN  181 (387)
Q Consensus       138 ~~------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~  181 (387)
                      ..                                    ..+..++.|++.||.|||+   ++++||||||+|||++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCc
Confidence            21                                    1236789999999999999   99999999999999999999


Q ss_pred             EEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 043148          182 AKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWV  259 (387)
Q Consensus       182 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~  259 (387)
                      +||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||..........   ..
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~---~~  262 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD---YL  262 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---HH
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH---HH
Confidence            99999999976543221 12233456889999999999999999999999999999999 889997655432211   11


Q ss_pred             HHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          260 WDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .    .+         .....+...+..+.+++.+||+.||.+|||+.+++++|..
T Consensus       263 ~----~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  305 (313)
T 3brb_A          263 L----HG---------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK  305 (313)
T ss_dssp             H----TT---------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             H----cC---------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            0    11         1112223345568899999999999999999999999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.7e-39  Score=299.16  Aligned_cols=236  Identities=24%  Similarity=0.302  Sum_probs=184.9

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---------hhhHHHHHHHHHHHhcCC-CCCccceehhh
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---------KQGKKEYISEVRIISRLR-HRNLVHLIGWC  134 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  134 (387)
                      ...++|...+.||+|+||.||+|.+..+++.||||.+....         ....+.+.+|++++.++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            45688999999999999999999999999999999996543         123467889999999995 99999999987


Q ss_pred             cchhh-------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccc
Q 043148          135 HEQRQ-------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL  189 (387)
Q Consensus       135 ~~~~~-------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~  189 (387)
                      .+...                         ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccc
Confidence            55321                         1236799999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCceeeeeecCCcccCchhhc------cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 043148          190 ARLVDHELGSQTTVLAGTMGYLAPECVT------TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLY  263 (387)
Q Consensus       190 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  263 (387)
                      +......  .......+++.|+|||++.      ...++.++||||||+++|||++|+.||........   ...+.   
T Consensus       171 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~---  242 (298)
T 1phk_A          171 SCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---LRMIM---  242 (298)
T ss_dssp             CEECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH---
T ss_pred             hhhcCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH---HHHHh---
Confidence            9866543  2233456899999999885      45688999999999999999999999976442211   11111   


Q ss_pred             ccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                       .+..      ..........+..+.+++.+||+.||.+|||+.|++++.|+...
T Consensus       243 -~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          243 -SGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             -HTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             -cCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence             1100      01111112345568899999999999999999999999998654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.8e-40  Score=333.52  Aligned_cols=231  Identities=23%  Similarity=0.290  Sum_probs=186.6

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH-
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL-  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~-  140 (387)
                      ..++|...+.||+|+||.||+|++..+++.||||++.+.   .....+.+..|.+++..+ +||||+++++++.+.... 
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            357899999999999999999999999999999999753   223456788999999988 799999999887654322 


Q ss_pred             ------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          141 ------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       141 ------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                              ....++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++.....
T Consensus       419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence                                    125789999999999999   99999999999999999999999999999854322


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                       ........||+.|+|||++.+..|+.++||||||+++|||++|+.||......+..   .    .+..        .  
T Consensus       496 -~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~---~----~i~~--------~--  557 (674)
T 3pfq_A          496 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---Q----SIME--------H--  557 (674)
T ss_dssp             -TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHS--------S--
T ss_pred             -CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH---H----HHHh--------C--
Confidence             22344567999999999999999999999999999999999999999865432211   1    1111        1  


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHhccCC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSI-----RQVINVLNFEA  317 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~-----~evl~~l~~~~  317 (387)
                      ...++...+..+.+|+..||+.||.+||++     +||++|.||..
T Consensus       558 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          558 NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            112233445668899999999999999997     99999998864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-40  Score=311.98  Aligned_cols=228  Identities=29%  Similarity=0.401  Sum_probs=167.8

Q ss_pred             CccccCcccccCceEEEEEEECCC---CeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-h----
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQ---NTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-Q----  139 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~----  139 (387)
                      .|...+.||+|+||.||+|.+..+   +..||||.+... .....+++.+|+.++++++||||++++++|.+.. .    
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            356678899999999999987533   246899998654 3345678999999999999999999999864321 1    


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence                                  1236788999999999999   999999999999999999999999999998654322


Q ss_pred             Cc---eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          198 GS---QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       198 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ..   ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....   +.    .+.      
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~---~~----~~~------  313 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LL----QGR------  313 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH---HH----TTC------
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH---HH----cCC------
Confidence            11   1233456788999999999999999999999999999999 6777876544332111   10    110      


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                         ....+..++..+.+++.+||+.||.+|||+.|++++|..
T Consensus       314 ---~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~  352 (373)
T 3c1x_A          314 ---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  352 (373)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               111122344568899999999999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-39  Score=299.85  Aligned_cols=247  Identities=21%  Similarity=0.285  Sum_probs=178.1

Q ss_pred             cCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC--CCCCccceehhhc
Q 043148           58 FTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL--RHRNLVHLIGWCH  135 (387)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~  135 (387)
                      .....-....++|...+.||+|+||.||+|++.  ++.||||++...   ....+..|.+++..+  +||||+++++++.
T Consensus        27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~  101 (337)
T 3mdy_A           27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADI  101 (337)
T ss_dssp             SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             CCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence            334444455688999999999999999999984  789999998542   344556666666655  8999999998765


Q ss_pred             chh----h------------------------HHHHHHHHHHHHHHHHhhhhc-----ccceeeccCCcceeEeCCCCcE
Q 043148          136 EQR----Q------------------------LILHKIALGLASAVLYLHEEW-----EQCIVHRDIKSSNVVLDSNFNA  182 (387)
Q Consensus       136 ~~~----~------------------------~~l~~i~~~i~~~l~~LH~~~-----~~~iiH~dlk~~Nill~~~~~~  182 (387)
                      +..    .                        ..+..++.|++.||.|||+..     .++|+||||||+|||++.++.+
T Consensus       102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          102 KGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             ESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             cCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence            431    1                        123679999999999999810     1299999999999999999999


Q ss_pred             EEccccccccccCCCCce---eeeeecCCcccCchhhccCCCCCc------cchHHHHHHHHHHHhC----------CCC
Q 043148          183 KLGDFGLARLVDHELGSQ---TTVLAGTMGYLAPECVTTGKASKE------SDVYSFGVVALEVACG----------RKP  243 (387)
Q Consensus       183 kl~Dfg~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~------~Dvws~Gvil~el~tg----------~~p  243 (387)
                      ||+|||++..........   .....||+.|+|||++.+..+...      +||||||+++|||++|          +.|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999997654432211   123468999999999988776665      9999999999999999          666


Q ss_pred             CCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc-ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          244 VEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE-FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      |.........  ...........    ...+..... ....++..+.+++.+||+.||.+|||+.+|+++|+.
T Consensus       262 ~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          262 YHDLVPSDPS--YEDMREIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             TTTTSCSSCC--HHHHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HhhhcCCCCc--hhhhHHHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence            6543322211  11111111111    111112111 123677889999999999999999999999999974

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.1e-40  Score=300.95  Aligned_cols=229  Identities=27%  Similarity=0.397  Sum_probs=177.9

Q ss_pred             hhCccccC-cccccCceEEEEEEE--CCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchh---
Q 043148           67 TNNFAEAG-KLGEGGFGGVYRGLL--SDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR---  138 (387)
Q Consensus        67 ~~~~~~~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  138 (387)
                      .++|...+ .||+|+||.||+|.+  ..++..||||++....  ....+.+.+|++++..++||||+++++++....   
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l   94 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML   94 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEE
Confidence            46777777 899999999999954  5567899999997543  233678999999999999999999999874321   


Q ss_pred             ---------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          139 ---------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       139 ---------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                           ...+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++.......
T Consensus        95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  171 (291)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence                                 11236899999999999999   999999999999999999999999999998765433


Q ss_pred             Cce--eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          198 GSQ--TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       198 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      ...  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........       ......+.       
T Consensus       172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~-------  237 (291)
T 1xbb_A          172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGE-------  237 (291)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTC-------
T ss_pred             CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCC-------
Confidence            221  222345788999999998889999999999999999999 9999986543221       11111111       


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                        ....+...+..+.+++..||+.||.+||++.++++.|.
T Consensus       238 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  275 (291)
T 1xbb_A          238 --RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  275 (291)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence              11222334566889999999999999999999999886

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=312.44  Aligned_cols=242  Identities=24%  Similarity=0.284  Sum_probs=186.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  138 (387)
                      .++|.+.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+++++.++||||+++++++.+..       
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357889999999999999999999999999999997543 334577889999999999999999998765432       


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe----CCCCcEEEccccccc
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL----DSNFNAKLGDFGLAR  191 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~~kl~Dfg~~~  191 (387)
                                             ...+..++.|++.||.|||+   ++|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence                                   11236799999999999999   999999999999999    888889999999998


Q ss_pred             cccCCCCceeeeeecCCcccCchhhcc--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 043148          192 LVDHELGSQTTVLAGTMGYLAPECVTT--------GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLY  263 (387)
Q Consensus       192 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  263 (387)
                      .....  .......||+.|+|||++.+        ..++.++||||||+++|||++|+.||..........  +.+....
T Consensus       165 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~~~~  240 (396)
T 4eut_A          165 ELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKII  240 (396)
T ss_dssp             ECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHHHHH
T ss_pred             EccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHHHHh
Confidence            66443  22234568999999999865        457889999999999999999999997654432211  1111111


Q ss_pred             ccCch---hhh-----------hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          264 GKGQL---LEA-----------ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       264 ~~~~~---~~~-----------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .....   ...           .+..............+.+++..||+.||.+||+++|+++.+..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~  306 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence            11100   000           00111224457788889999999999999999999999988753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-40  Score=307.38  Aligned_cols=242  Identities=19%  Similarity=0.325  Sum_probs=162.9

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      ..++|...+.||+|+||.||+|.+..++..||||.+.... ....+++.+|+.++..++||||+++++++....      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            4578999999999999999999998889999999986543 334567889999999999999999998764321      


Q ss_pred             ---------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          139 ---------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       139 ---------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                                                 ...+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence                                       12236789999999999999   999999999999999999999999999987


Q ss_pred             cccCCC----CceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC
Q 043148          192 LVDHEL----GSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG  266 (387)
Q Consensus       192 ~~~~~~----~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  266 (387)
                      ......    ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..........      ..... 
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~-  242 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------LTLQN-  242 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHHTS-
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH------HHhcc-
Confidence            654321    111234568999999999876 568999999999999999999999998655332111      01101 


Q ss_pred             chhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          267 QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ..................+..+.+++.+||+.||.+|||+.+++++.|+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  293 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK  293 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence            000000000001111223345788999999999999999999999998764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7e-40  Score=307.06  Aligned_cols=230  Identities=26%  Similarity=0.396  Sum_probs=180.1

Q ss_pred             hhCccccCcccccCceEEEEEEEC-------CCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcch
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLS-------DQNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ  137 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  137 (387)
                      .++|...+.||+|+||.||+|.+.       .++..||||++... .....+.+.+|++++..+ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            578999999999999999999975       35678999999764 334567899999999999 899999999977543


Q ss_pred             hh-----------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe
Q 043148          138 RQ-----------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL  176 (387)
Q Consensus       138 ~~-----------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill  176 (387)
                      ..                                         ..+..++.|++.||.|||+   ++|+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence            21                                         1235789999999999999   999999999999999


Q ss_pred             CCCCcEEEccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 043148          177 DSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVR  254 (387)
Q Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~  254 (387)
                      +.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.  
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--  268 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--  268 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH--
Confidence            99999999999999866543221 2223456788999999998889999999999999999999 9999976542211  


Q ss_pred             HHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          255 LVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                       ..    ....+         .....+...+..+.+++.+||+.||.+|||+.|++++|..
T Consensus       269 -~~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  315 (334)
T 2pvf_A          269 -FK----LLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  315 (334)
T ss_dssp             -HH----HHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HH----HHhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             11    11111         0111222344568899999999999999999999999874

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.3e-39  Score=306.67  Aligned_cols=245  Identities=18%  Similarity=0.200  Sum_probs=183.4

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-CC-----Cccceehhhcchh
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HR-----NLVHLIGWCHEQR  138 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~  138 (387)
                      ...++|...+.||+|+||.||+|.+..+++.||||++... .....++..|++++..++ |+     +|+++++++....
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            3468999999999999999999999999999999999643 344567788999988885 55     4888877664322


Q ss_pred             --------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC--CCCcEEEcccccc
Q 043148          139 --------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD--SNFNAKLGDFGLA  190 (387)
Q Consensus       139 --------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~--~~~~~kl~Dfg~~  190 (387)
                                                ......++.|++.||.|||+ +..+|+||||||+|||++  .++.+||+|||++
T Consensus       130 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          130 HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             ceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence                                      12236899999999999994 127999999999999994  5788999999999


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccC----
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKG----  266 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----  266 (387)
                      +.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+   .......    
T Consensus       209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i---~~~~~~~~~~~  281 (382)
T 2vx3_A          209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI---VEVLGIPPAHI  281 (382)
T ss_dssp             EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCSCCHHH
T ss_pred             eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHHH
Confidence            866432    23456899999999999999999999999999999999999999876543322221   1111100    


Q ss_pred             -----chhhhhccc-----------------------------------------CCccccHHHHHHHHHHHHHhcCCCC
Q 043148          267 -----QLLEAADGR-----------------------------------------LSKEFDERQMECLMIVGLWCCHPDF  300 (387)
Q Consensus       267 -----~~~~~~~~~-----------------------------------------~~~~~~~~~~~~l~~l~~~cl~~dp  300 (387)
                           .....++.-                                         -...........+.+|+.+||+.||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence                 000000000                                         0001122344578999999999999


Q ss_pred             CCCCCHHHHHHHhccCCC
Q 043148          301 TNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       301 ~~RPs~~evl~~l~~~~~  318 (387)
                      .+|||++|+++|.|+...
T Consensus       362 ~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC-
T ss_pred             hhCCCHHHHhcCcccccC
Confidence            999999999999998653

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-39  Score=296.34  Aligned_cols=222  Identities=28%  Similarity=0.417  Sum_probs=171.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .++|...+.||+|+||.||++.+  +|+.||||.+....  ..+.+.+|++++..++||||+++++++.+...       
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            57889999999999999999988  47899999986543  45789999999999999999999997543211       


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           ..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......  
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence                                 1136789999999999999   99999999999999999999999999998754432  


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                        .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+...       ....         ...
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~-------~~~~---------~~~  232 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-------RVEK---------GYK  232 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH-------HHTT---------TCC
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHhc---------CCC
Confidence              223357889999999999999999999999999999998 999997654332111       1111         111


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ...+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  270 (278)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence            22233345668899999999999999999999998863

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.5e-40  Score=303.07  Aligned_cols=236  Identities=24%  Similarity=0.310  Sum_probs=179.0

Q ss_pred             hhCccccCcccccCceEEEEEE----ECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGL----LSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  139 (387)
                      .++|...+.||+|+||.||+|+    ...+++.||||++.... ....+.+.+|++++..++||||+++++++.+...  
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            3558889999999999999999    45678999999997543 3445789999999999999999999998765311  


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          140 --------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       140 --------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                                                ..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++...
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccc
Confidence                                      1126789999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCc--eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCc--------chhhHHHHHHHHh
Q 043148          194 DHELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEP--------SKVRLVEWVWDLY  263 (387)
Q Consensus       194 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~  263 (387)
                      ......  ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+......        .........    
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----  252 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL----  252 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH----
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH----
Confidence            543221  122345778899999999989999999999999999999999986432100        000000111    


Q ss_pred             ccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                           ............+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       253 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  298 (302)
T 4e5w_A          253 -----VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE  298 (302)
T ss_dssp             -----HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -----HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence                 1111111122233345567889999999999999999999999886

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.9e-40  Score=332.41  Aligned_cols=222  Identities=27%  Similarity=0.410  Sum_probs=173.3

Q ss_pred             CcccccCceEEEEEEE--CCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----------
Q 043148           74 GKLGEGGFGGVYRGLL--SDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----------  139 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----------  139 (387)
                      +.||+|+||.||+|.+  ..+++.||||+++...  ....+++.+|+++|..++|||||+++++|.+...          
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g  454 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG  454 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence            4799999999999965  4556889999997542  3346789999999999999999999998864321          


Q ss_pred             --------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC--ceeee
Q 043148          140 --------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG--SQTTV  203 (387)
Q Consensus       140 --------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~  203 (387)
                                    ..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......  .....
T Consensus       455 ~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          455 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred             CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence                          1236799999999999999   9999999999999999999999999999987654321  12233


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      ..+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+..       ..+..+         .....+.
T Consensus       532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~---------~~~~~p~  595 (635)
T 4fl3_A          532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKG---------ERMGCPA  595 (635)
T ss_dssp             ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTT---------CCCCCCT
T ss_pred             CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC---------CCCCCCC
Confidence            456789999999999999999999999999999998 99999865533211       111111         1122233


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          283 RQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .++..+.+++..||+.||.+||++.+|++.|.
T Consensus       596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  627 (635)
T 4fl3_A          596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR  627 (635)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            45567889999999999999999999999885

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1e-39  Score=296.17  Aligned_cols=223  Identities=18%  Similarity=0.273  Sum_probs=176.8

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcch--hh---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ--RQ---  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~---  139 (387)
                      .++|...+.||+|+||.||+|++.  +..||||++...  .....+.+.+|+.++..++||||+++++++.+.  ..   
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            467888999999999999999984  789999999764  344567899999999999999999999987654  11   


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccc--eeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQC--IVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~--iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                                              ..+..++.|++.||.|||+   ++  ++||||||+||+++.++.++|+|||+....
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence                                    1236899999999999998   78  999999999999999999999998887543


Q ss_pred             cCCCCceeeeeecCCcccCchhhccCCCCC---ccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          194 DHELGSQTTVLAGTMGYLAPECVTTGKASK---ESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       194 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      ..      ....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||.........      ...        
T Consensus       164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~--------  223 (271)
T 3kmu_A          164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKV--------  223 (271)
T ss_dssp             SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHH--------
T ss_pred             cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHH--------
Confidence            22      1235789999999998765544   799999999999999999999765432211      111        


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                       .........+...+..+.+++..||+.||.+|||++++++.|..
T Consensus       224 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~  267 (271)
T 3kmu_A          224 -ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK  267 (271)
T ss_dssp             -HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence             11111222233445568899999999999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-39  Score=304.37  Aligned_cols=245  Identities=23%  Similarity=0.328  Sum_probs=183.6

Q ss_pred             HHhhCccccCcccccCceEEEEEEEC-CCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcC---CCCCccceehhhc---
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLS-DQNTEIAVKRVSRGS--KQGKKEYISEVRIISRL---RHRNLVHLIGWCH---  135 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---  135 (387)
                      .+.++|...+.||+|+||.||+|++. .+++.||||++....  ......+.+|+.+++.+   +||||++++++|.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            35688999999999999999999985 678999999986432  22234566777777665   8999999998875   


Q ss_pred             --chh--------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccc
Q 043148          136 --EQR--------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDF  187 (387)
Q Consensus       136 --~~~--------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  187 (387)
                        ...                          ...+..++.|++.||.|||+   ++++||||||+||+++.++.+||+||
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence              111                          11236789999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc
Q 043148          188 GLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ  267 (387)
Q Consensus       188 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (387)
                      |+++.....  .......+++.|+|||++.+..++.++||||||+++|||++|+.||......+.   ...+........
T Consensus       165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~  239 (326)
T 1blx_A          165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG  239 (326)
T ss_dssp             CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred             cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCC
Confidence            999765432  123345689999999999999999999999999999999999999986553322   222222111110


Q ss_pred             hhhh----------hc---ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          268 LLEA----------AD---GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       268 ~~~~----------~~---~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ....          ..   ...........+..+.+++.+||+.||.+|||+.|+++|.|+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  302 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  302 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence            0000          00   00001122334566889999999999999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=305.08  Aligned_cols=241  Identities=19%  Similarity=0.243  Sum_probs=174.8

Q ss_pred             hhCccccCcccccCceEEEEEEECC---CCeEEEEEEecCCChh-----------hHHHHHHHHHHHhcCCCCCccceeh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD---QNTEIAVKRVSRGSKQ-----------GKKEYISEVRIISRLRHRNLVHLIG  132 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  132 (387)
                      .++|...+.||+|+||.||+|.+..   ++..+|||.+......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3678999999999999999999986   6789999998765321           1234668889999999999999999


Q ss_pred             hhcc----hh------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC--cE
Q 043148          133 WCHE----QR------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF--NA  182 (387)
Q Consensus       133 ~~~~----~~------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~--~~  182 (387)
                      ++.+    ..                        ...+..++.|++.||.|||+   ++|+||||||+|||++.++  .+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTSE
T ss_pred             ccccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCcE
Confidence            8755    11                        12347899999999999999   9999999999999999887  99


Q ss_pred             EEccccccccccCCCC------ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 043148          183 KLGDFGLARLVDHELG------SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV  256 (387)
Q Consensus       183 kl~Dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~  256 (387)
                      ||+|||+++.......      .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........  .
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~  270 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA--V  270 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH--H
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH--H
Confidence            9999999986643211      1123456899999999999999999999999999999999999999643222111  1


Q ss_pred             HHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          257 EWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .......... +.........   ....+..+.+++..||+.||.+||++++|++.|+..
T Consensus       271 ~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          271 QTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            1111111000 0000000000   012345688999999999999999999999999843

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.3e-39  Score=298.36  Aligned_cols=230  Identities=29%  Similarity=0.392  Sum_probs=174.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCC---CeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQ---NTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  138 (387)
                      ..+|...+.||+|+||.||+|.+..+   ...+|+|.+... .....+.+.+|+.++++++||||++++++|.+..    
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            35678889999999999999997543   346899998764 3445678999999999999999999999854321    


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ...+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccc
Confidence                                   11236788999999999999   9999999999999999999999999999986543


Q ss_pred             CCC---ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          196 ELG---SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       196 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                      ...   .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+....   ..    .+     
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~---~~----~~-----  248 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LL----QG-----  248 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH---HH----TT-----
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---Hh----cC-----
Confidence            221   12234457788999999999999999999999999999999 5556655443321111   00    00     


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                          .....+...+..+.+++.+||+.||.+|||+.|+++.|..
T Consensus       249 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  288 (298)
T 3f66_A          249 ----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  288 (298)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                0111122234568899999999999999999999999863

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=308.36  Aligned_cols=240  Identities=22%  Similarity=0.363  Sum_probs=179.6

Q ss_pred             cCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcc
Q 043148           58 FTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHE  136 (387)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  136 (387)
                      +.+.++....++|...+.||+|+||.||+|++..+++.||||++.... .....+.+|+.++..+ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            334445556789999999999999999999999889999999986543 3457889999999999 79999999988754


Q ss_pred             hh---------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEE
Q 043148          137 QR---------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAK  183 (387)
Q Consensus       137 ~~---------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  183 (387)
                      ..                                 ...+..++.|++.||.|||+   ++++||||||+|||++.++.+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEE
Confidence            10                                 11236789999999999999   9999999999999999999999


Q ss_pred             EccccccccccCCCCceeeeeecCCcccCchhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 043148          184 LGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT-----TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEW  258 (387)
Q Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~  258 (387)
                      |+|||++........ ......|++.|+|||++.     +..++.++||||||+++|||++|+.||.........     
T Consensus       170 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----  243 (326)
T 2x7f_A          170 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----  243 (326)
T ss_dssp             ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----
T ss_pred             EeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH-----
Confidence            999999976543221 223456899999999987     566899999999999999999999999754422111     


Q ss_pred             HHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          259 VWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                       .... ....     +   .......+..+.+++.+||+.||.+||++.+++++.|+..
T Consensus       244 -~~~~-~~~~-----~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~  292 (326)
T 2x7f_A          244 -FLIP-RNPA-----P---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD  292 (326)
T ss_dssp             -HHHH-HSCC-----C---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred             -HHhh-cCcc-----c---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence             1110 0000     0   1111223456888999999999999999999999998764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=309.36  Aligned_cols=237  Identities=22%  Similarity=0.360  Sum_probs=182.8

Q ss_pred             hhCccccCcccccCceEEEEEEE----CCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLL----SDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  138 (387)
                      .++|...+.||+|+||.||++++    ..+++.||||.+........+.+.+|+++++.++||||+++++++....    
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46688899999999999999984    5578999999998777777788999999999999999999998764322    


Q ss_pred             ------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          139 ------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       139 ------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                                              ...+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence                                    11236789999999999999   999999999999999999999999999998765


Q ss_pred             CCCCce--eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCc---------chhhHHHHHHHHh
Q 043148          195 HELGSQ--TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEP---------SKVRLVEWVWDLY  263 (387)
Q Consensus       195 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~---------~~~~~~~~~~~~~  263 (387)
                      ......  .....++..|+|||.+.+..++.++||||||+++|||++|..|+......         .........    
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  272 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL----  272 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH----
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH----
Confidence            432211  12334677899999999888999999999999999999999987632100         000000011    


Q ss_pred             ccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                           .+.+........+..++..+.+++.+||+.||.+|||+.||++.|+.
T Consensus       273 -----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          273 -----IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             -----HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             -----HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                 11111111112233445668899999999999999999999998863

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.6e-39  Score=304.35  Aligned_cols=243  Identities=22%  Similarity=0.291  Sum_probs=183.0

Q ss_pred             hhCccccCcccccCceEEEEEEE-CCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCC------Cccceehhhcchh-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLL-SDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHR------NLVHLIGWCHEQR-  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~-  138 (387)
                      .++|.+.+.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|++++..++|+      +++++++++.+.. 
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999998 557899999999653 34467788999999888665      4888888765432 


Q ss_pred             -------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC---------------
Q 043148          139 -------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---------------  178 (387)
Q Consensus       139 -------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---------------  178 (387)
                                               ...+..++.|++.||.|||+   ++|+||||||+|||++.               
T Consensus        92 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           92 ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence                                     12346899999999999999   99999999999999987               


Q ss_pred             ----CCcEEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 043148          179 ----NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR  254 (387)
Q Consensus       179 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~  254 (387)
                          ++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+...
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                678999999999764432    233468999999999999999999999999999999999999998765433222


Q ss_pred             HHHHHHH--------HhccCch------------------hhhhccc-CCccccHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 043148          255 LVEWVWD--------LYGKGQL------------------LEAADGR-LSKEFDERQMECLMIVGLWCCHPDFTNRPSIR  307 (387)
Q Consensus       255 ~~~~~~~--------~~~~~~~------------------~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~  307 (387)
                      .......        .......                  .....+. ............+.+++.+||+.||.+|||+.
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  324 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR  324 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence            2211110        0000000                  0000000 00011234567789999999999999999999


Q ss_pred             HHHHHhccCC
Q 043148          308 QVINVLNFEA  317 (387)
Q Consensus       308 evl~~l~~~~  317 (387)
                      |+++|.|+..
T Consensus       325 ell~hp~f~~  334 (339)
T 1z57_A          325 EALKHPFFDL  334 (339)
T ss_dssp             HHTTSGGGGG
T ss_pred             HHhcCHHHHH
Confidence            9999998753

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.3e-40  Score=305.95  Aligned_cols=232  Identities=26%  Similarity=0.414  Sum_probs=176.0

Q ss_pred             hhCccccCcccccCceEEEEEE-----ECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGL-----LSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  139 (387)
                      .++|...+.||+|+||.||+|+     ...++..||||.+... ......++.+|+.++..++||||+++++++.+... 
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            4788999999999999999998     4456788999999654 34556789999999999999999999998754321 


Q ss_pred             -------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC---CCcEEEc
Q 043148          140 -------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLG  185 (387)
Q Consensus       140 -------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~  185 (387)
                                                     ..+..++.|++.||.|||+   ++++||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence                                           1236789999999999999   99999999999999994   4569999


Q ss_pred             cccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHh
Q 043148          186 DFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLY  263 (387)
Q Consensus       186 Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  263 (387)
                      |||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........   ..    ..
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~----~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LE----FV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HH----HH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HH----HH
Confidence            9999875433221 12233457889999999999999999999999999999998 9999976542211   11    11


Q ss_pred             ccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ..+.         ....+...+..+.+++.+||+.||.+||++.+++++|+...
T Consensus       259 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          259 TSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            1111         11122234456889999999999999999999999998654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-38  Score=299.59  Aligned_cols=245  Identities=24%  Similarity=0.335  Sum_probs=184.1

Q ss_pred             ccCHHHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhc--CCCCCccceehhh
Q 043148           57 RFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISR--LRHRNLVHLIGWC  134 (387)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~  134 (387)
                      ..++.--....++|...+.||+|+||.||+|.+  +++.||||++..   .....+.+|.+++..  ++||||+++++++
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~  105 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD  105 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence            344444455678899999999999999999998  489999999854   345678889999887  7899999999887


Q ss_pred             cchh----h------------------------HHHHHHHHHHHHHHHHhh--------hhcccceeeccCCcceeEeCC
Q 043148          135 HEQR----Q------------------------LILHKIALGLASAVLYLH--------EEWEQCIVHRDIKSSNVVLDS  178 (387)
Q Consensus       135 ~~~~----~------------------------~~l~~i~~~i~~~l~~LH--------~~~~~~iiH~dlk~~Nill~~  178 (387)
                      .+..    .                        ..+..++.|++.||.|||        +   ++|+||||||+|||++.
T Consensus       106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKK  182 (342)
T ss_dssp             ECCCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECT
T ss_pred             cccCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECC
Confidence            6542    1                        112679999999999999        6   89999999999999999


Q ss_pred             CCcEEEccccccccccCCCCc---eeeeeecCCcccCchhhccCC------CCCccchHHHHHHHHHHHhC---------
Q 043148          179 NFNAKLGDFGLARLVDHELGS---QTTVLAGTMGYLAPECVTTGK------ASKESDVYSFGVVALEVACG---------  240 (387)
Q Consensus       179 ~~~~kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~------~~~~~Dvws~Gvil~el~tg---------  240 (387)
                      ++.+||+|||++.........   ......||+.|+|||++.+..      ++.++||||||+++|||++|         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            999999999999766543221   123446899999999988653      33689999999999999999         


Q ss_pred             -CCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc-ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          241 -RKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE-FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       241 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                       ..||.........  ...........    ...+.+... ........+.+++.+||+.||.+|||+.+|+++|..
T Consensus       263 ~~~p~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~  333 (342)
T 1b6c_B          263 YQLPYYDLVPSDPS--VEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  333 (342)
T ss_dssp             CCCTTTTTSCSSCC--HHHHHHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccCccccCcCccc--HHHHHHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence             7788654332211  11111111111    111122221 224667789999999999999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.1e-40  Score=307.40  Aligned_cols=242  Identities=24%  Similarity=0.331  Sum_probs=180.8

Q ss_pred             ccccCcccccCceEEEEEEE----CCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           70 FAEAGKLGEGGFGGVYRGLL----SDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      |...+.||+|+||.||++.+    ..+++.||||++.... ....+.+.+|+++++.++||||+++++++.+...     
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48889999999999988865    3468899999997653 3456789999999999999999999998865321     


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           ..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++........
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  189 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  189 (318)
T ss_dssp             EECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred             EEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence                                 1236799999999999999   9999999999999999999999999999987654322


Q ss_pred             c--eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          199 S--QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       199 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                      .  ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ....+.........+.+......
T Consensus       190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  268 (318)
T 3lxp_A          190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELLERGE  268 (318)
T ss_dssp             EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHHHTTC
T ss_pred             ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHHhccc
Confidence            1  12334578889999999998899999999999999999999999864321100 00000000000001122222222


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ....+..++..+.+++.+||+.||.+|||+.|+++.|+.
T Consensus       269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  307 (318)
T 3lxp_A          269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT  307 (318)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            233344456678999999999999999999999998863

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.2e-39  Score=298.61  Aligned_cols=233  Identities=26%  Similarity=0.407  Sum_probs=175.3

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-------
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-------  138 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  138 (387)
                      ..++|...+.||+|+||.||+|++..+++.||||.+.. .....+.+.+|+++++.++||||+++++++.+..       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            46789999999999999999999998899999999864 3445678899999999999999999988653210       


Q ss_pred             --------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcc
Q 043148          139 --------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGD  186 (387)
Q Consensus       139 --------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  186 (387)
                                                      ...+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence                                            11235789999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCC-------------CceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcch
Q 043148          187 FGLARLVDHEL-------------GSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSK  252 (387)
Q Consensus       187 fg~~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~  252 (387)
                      ||++.......             ........|++.|+|||++.+. .++.++||||||+++|||++   ||.....   
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~---  233 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME---  233 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH---
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh---
Confidence            99997654321             1122345689999999999864 68999999999999999998   5542111   


Q ss_pred             hhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          253 VRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                        .... ......      .........+...+..+.+++.+||+.||.+|||+.+++++.|+..
T Consensus       234 --~~~~-~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          234 --RVNI-LKKLRS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             --HHHH-HHHHHS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             --HHHH-HHhccc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence              1111 111111      1112223344445566889999999999999999999999999754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.6e-39  Score=301.73  Aligned_cols=238  Identities=23%  Similarity=0.313  Sum_probs=179.0

Q ss_pred             HHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCC--CCCccceehhhcch
Q 043148           62 ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLR--HRNLVHLIGWCHEQ  137 (387)
Q Consensus        62 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~  137 (387)
                      .+....++|...+.||+|+||.||++.+.. ++.||||.+...  .....+.+.+|++++..++  ||||+++++++.+.
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            334456789999999999999999999865 889999998654  3445678999999999997  59999999987553


Q ss_pred             hhH------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          138 RQL------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       138 ~~~------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                      ...                        .+..++.|++.||.|||+   ++++||||||+|||+++ +.+||+|||++...
T Consensus       101 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          101 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            321                        236789999999999999   99999999999999964 89999999999866


Q ss_pred             cCCCCc-eeeeeecCCcccCchhhcc-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 043148          194 DHELGS-QTTVLAGTMGYLAPECVTT-----------GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWD  261 (387)
Q Consensus       194 ~~~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~  261 (387)
                      ...... ......|++.|+|||.+.+           ..++.++||||||+++|||++|+.||.......     .....
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~  251 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHA  251 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHH
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHHHH
Confidence            443211 2234568999999999875           468889999999999999999999997543221     11111


Q ss_pred             HhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          262 LYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                               ..++.....++......+.+++.+||+.||.+|||+.|+++++|+...
T Consensus       252 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          252 ---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             ---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             ---------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence                     112212222222234568889999999999999999999999998654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-40  Score=304.25  Aligned_cols=232  Identities=25%  Similarity=0.400  Sum_probs=173.9

Q ss_pred             HHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh------hhHHHHHHHHHHHhcC----CCCCcccee
Q 043148           62 ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK------QGKKEYISEVRIISRL----RHRNLVHLI  131 (387)
Q Consensus        62 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~  131 (387)
                      +.....++|...+.||+|+||.||+|++..+++.||||++.....      .....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            344567889999999999999999999988899999999965432      1233456799999888    899999999


Q ss_pred             hhhcchhh--------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC-CCCcEEE
Q 043148          132 GWCHEQRQ--------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD-SNFNAKL  184 (387)
Q Consensus       132 ~~~~~~~~--------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kl  184 (387)
                      +++.+...                          ..+..++.|++.||.|||+   ++++||||||+||+++ .++.+||
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence            98754321                          1236799999999999999   8999999999999999 8899999


Q ss_pred             ccccccccccCCCCceeeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 043148          185 GDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLY  263 (387)
Q Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  263 (387)
                      +|||++......   ......|+..|+|||++.+..+ +.++||||||+++|||++|+.||.....         ..   
T Consensus       182 ~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~---  246 (312)
T 2iwi_A          182 IDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------IL---  246 (312)
T ss_dssp             CCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HH---
T ss_pred             EEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------Hh---
Confidence            999999866543   2234568999999999887765 4589999999999999999999964210         00   


Q ss_pred             ccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCC
Q 043148          264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSL  322 (387)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~  322 (387)
                               ..  ...++......+.+++.+||+.||.+|||++|++++.|+.......
T Consensus       247 ---------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~  294 (312)
T 2iwi_A          247 ---------EA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV  294 (312)
T ss_dssp             ---------HT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-----
T ss_pred             ---------hh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhcc
Confidence                     00  0111223345678899999999999999999999999987665443

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.1e-39  Score=304.74  Aligned_cols=228  Identities=25%  Similarity=0.409  Sum_probs=176.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEE--EEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEI--AVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~---  139 (387)
                      .++|...+.||+|+||.||+|++..++..+  |+|.+... .....+.+.+|++++.++ +||||+++++++.+...   
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            367888999999999999999998888765  99998754 334456789999999999 89999999987654321   


Q ss_pred             --------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc
Q 043148          140 --------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN  181 (387)
Q Consensus       140 --------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~  181 (387)
                                                            ..+..++.|++.||.|||+   ++|+||||||+|||++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence                                                  1235789999999999999   99999999999999999999


Q ss_pred             EEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 043148          182 AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVW  260 (387)
Q Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~  260 (387)
                      +||+|||+++.....  .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.       .
T Consensus       181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-------~  251 (327)
T 1fvr_A          181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------Y  251 (327)
T ss_dssp             EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------H
T ss_pred             EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-------H
Confidence            999999998743321  12233456889999999998889999999999999999998 9999976542211       1


Q ss_pred             HHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .....+         .....+...+..+.+++.+||+.||.+|||+++++++|..
T Consensus       252 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  297 (327)
T 1fvr_A          252 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  297 (327)
T ss_dssp             HHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            111111         1112222344568899999999999999999999999863

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-39  Score=298.36  Aligned_cols=223  Identities=23%  Similarity=0.366  Sum_probs=178.8

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcch--------
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ--------  137 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  137 (387)
                      ..++|...+.||+|+||.||+|.+..+++.||+|.+....    ..+.+|++++..++||||+++++++...        
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4577999999999999999999999889999999997643    3567899999999999999998865320        


Q ss_pred             -----------------------------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcE
Q 043148          138 -----------------------------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA  182 (387)
Q Consensus       138 -----------------------------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  182 (387)
                                                         ....+..++.|++.||.|||+   ++++||||||+|||++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence                                               011236789999999999999   999999999999999999999


Q ss_pred             EEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 043148          183 KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDL  262 (387)
Q Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  262 (387)
                      ||+|||++.......  ......+++.|+|||.+.+..++.++||||||+++|||++|..|+...        .. ....
T Consensus       162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~-~~~~  230 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SK-FFTD  230 (284)
T ss_dssp             EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HH-HHHH
T ss_pred             EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HH-HHHH
Confidence            999999998665432  223446899999999999999999999999999999999999886321        00 1111


Q ss_pred             hccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          263 YGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ..        ...+...    .+..+.+++.+||+.||.+|||+.|++++|+....
T Consensus       231 ~~--------~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          231 LR--------DGIISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             HH--------TTCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             hh--------ccccccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            11        1111122    23457789999999999999999999999986554

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.1e-39  Score=295.31  Aligned_cols=234  Identities=22%  Similarity=0.291  Sum_probs=182.1

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|++++++++||||+++++++.+...   
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            4567899999999999999999999988999999998654  23456789999999999999999999998754321   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC---CcEEEcccccccccc
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN---FNAKLGDFGLARLVD  194 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kl~Dfg~~~~~~  194 (387)
                                            ..+..++.|++.||.|||+   ++++||||||+||+++.+   +.+||+|||++....
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence                                  1236799999999999999   999999999999999764   469999999998654


Q ss_pred             CCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          195 HELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      ...  ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||......+.   ..    ....+...     
T Consensus       176 ~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~----~~~~~~~~-----  240 (287)
T 2wei_A          176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LK----RVETGKYA-----  240 (287)
T ss_dssp             CCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHCCCC-----
T ss_pred             CCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHcCCCC-----
Confidence            432  2223457889999998875 489999999999999999999999976542211   11    11111100     


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                       .........+..+.+++.+||+.||.+|||+.|++++.|+..
T Consensus       241 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          241 -FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             -CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             -CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence             001111223456889999999999999999999999988653

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.5e-39  Score=299.00  Aligned_cols=232  Identities=23%  Similarity=0.360  Sum_probs=163.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh-hh-HHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-QG-KKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      .++|...+.||+|+||.||+|.+..+++.||||.+..... .. .+.+.++..++..++||||+++++++.+...     
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            4678889999999999999999998899999999976532 22 3344455567888899999999998765432     


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhccc-ceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQ-CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~-~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                          ..+..++.+++.||.|||+   + +++||||||+|||++.++.+||+|||++....... 
T Consensus       104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (318)
T 2dyl_A          104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-  179 (318)
T ss_dssp             CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence                                1235799999999999998   5 99999999999999999999999999997654321 


Q ss_pred             ceeeeeecCCcccCchhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          199 SQTTVLAGTMGYLAPECVT-----TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                       ......+++.|+|||++.     ...++.++||||||+++|||++|+.||.......  ....   ......      .
T Consensus       180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~---~~~~~~------~  247 (318)
T 2dyl_A          180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVLT---KVLQEE------P  247 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHH---HHHHSC------C
T ss_pred             -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHHH---HHhccC------C
Confidence             223446899999999984     4568899999999999999999999997643221  1111   111110      0


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      +.+..  ....+..+.+++.+||+.||.+||++++++++.++.
T Consensus       248 ~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (318)
T 2dyl_A          248 PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK  288 (318)
T ss_dssp             CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence            00110  112344578899999999999999999999998864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-39  Score=298.81  Aligned_cols=233  Identities=25%  Similarity=0.344  Sum_probs=172.5

Q ss_pred             hhCccccCcccccCceEEEEEEECC-CC--eEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD-QN--TEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  138 (387)
                      .++|...+.||+|+||.||+|++.. ++  ..||||++...   .....+.+.+|++++..++||||+++++++.+..  
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK   96 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence            4678999999999999999998643 22  36999998654   2345678999999999999999999999875432  


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ...+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence                                   11236789999999999999   9999999999999999999999999999987654


Q ss_pred             CCCc--eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          196 ELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       196 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                      ....  ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.........      ......       
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~-------  240 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKE-------  240 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTS-------
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH------HHHHcc-------
Confidence            3221  1223456778999999998889999999999999999999 99999765432111      111111       


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                        ......+...+..+.+++.+||+.||.+|||+.+++++|....
T Consensus       241 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          241 --GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             --CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             --CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence              0111122334566889999999999999999999999997543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.6e-39  Score=303.31  Aligned_cols=240  Identities=20%  Similarity=0.289  Sum_probs=181.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCC-eEEEEEEecCCChhhHHHHHHHHHHHhcCCCCC------ccceehhhcchh-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQN-TEIAVKRVSRGSKQGKKEYISEVRIISRLRHRN------LVHLIGWCHEQR-  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~-  138 (387)
                      .++|...+.||+|+||.||+|.+..++ ..||||++... ....+.+.+|+++++.++|+|      ++.+++++.... 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            478999999999999999999997766 78999999653 344677889999999987665      777777554321 


Q ss_pred             -------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe-----------------
Q 043148          139 -------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL-----------------  176 (387)
Q Consensus       139 -------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill-----------------  176 (387)
                                               ...+..++.|++.||.|||+   ++|+||||||+|||+                 
T Consensus        97 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A           97 MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             EEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccccc
Confidence                                     12346799999999999999   999999999999999                 


Q ss_pred             --CCCCcEEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 043148          177 --DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR  254 (387)
Q Consensus       177 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~  254 (387)
                        +.++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+...
T Consensus       174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (355)
T 2eu9_A          174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV  249 (355)
T ss_dssp             EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence              56789999999999764432    233468999999999999999999999999999999999999998655433222


Q ss_pred             HHHHHHHHhccCch--------hhhh-c-------------------ccC--CccccHHHHHHHHHHHHHhcCCCCCCCC
Q 043148          255 LVEWVWDLYGKGQL--------LEAA-D-------------------GRL--SKEFDERQMECLMIVGLWCCHPDFTNRP  304 (387)
Q Consensus       255 ~~~~~~~~~~~~~~--------~~~~-~-------------------~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RP  304 (387)
                      ....   .......        .... .                   +.+  ...........+.+++.+||+.||.+||
T Consensus       250 ~~~~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          250 MMEK---ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHH---HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHH---HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            2211   1110000        0000 0                   000  0011223456788999999999999999


Q ss_pred             CHHHHHHHhccCC
Q 043148          305 SIRQVINVLNFEA  317 (387)
Q Consensus       305 s~~evl~~l~~~~  317 (387)
                      |+.|+++|.|+..
T Consensus       327 t~~e~l~hp~f~~  339 (355)
T 2eu9_A          327 TLAEALLHPFFAG  339 (355)
T ss_dssp             CHHHHTTSGGGGG
T ss_pred             CHHHHhcChhhcC
Confidence            9999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9.9e-39  Score=299.20  Aligned_cols=237  Identities=22%  Similarity=0.333  Sum_probs=169.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHH--HhcCCCCCccceehhhcc-----h--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRI--ISRLRHRNLVHLIGWCHE-----Q--  137 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~--  137 (387)
                      .++|...+.||+|+||.||+|++  +++.||||++...   ....+..|.++  +..++||||+++++++..     .  
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            47899999999999999999987  5789999998643   23445555555  445899999999863211     0  


Q ss_pred             ----------------------hhHHHHHHHHHHHHHHHHhhhhccc---------ceeeccCCcceeEeCCCCcEEEcc
Q 043148          138 ----------------------RQLILHKIALGLASAVLYLHEEWEQ---------CIVHRDIKSSNVVLDSNFNAKLGD  186 (387)
Q Consensus       138 ----------------------~~~~l~~i~~~i~~~l~~LH~~~~~---------~iiH~dlk~~Nill~~~~~~kl~D  186 (387)
                                            .......++.|++.||.|||+   .         +|+||||||+|||++.++.+||+|
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEee
Confidence                                  011236789999999999998   6         999999999999999999999999


Q ss_pred             ccccccccCCCC-------ceeeeeecCCcccCchhhcc-------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcch
Q 043148          187 FGLARLVDHELG-------SQTTVLAGTMGYLAPECVTT-------GKASKESDVYSFGVVALEVACGRKPVEPRQEPSK  252 (387)
Q Consensus       187 fg~~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~  252 (387)
                      ||+++.......       .......||+.|+|||++.+       ..++.++||||||+++|||++|..||........
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            999986643211       11223468999999999986       3466789999999999999999877654332211


Q ss_pred             h-hHH----------HHHHHHhccCchhhhhcccCCcc--ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          253 V-RLV----------EWVWDLYGKGQLLEAADGRLSKE--FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       253 ~-~~~----------~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      . ...          ............    .+.+...  .....+..+.+++.+||+.||.+|||+.|+++.|..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            1 000          000111111100    1111111  123466679999999999999999999999998863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.4e-40  Score=305.56  Aligned_cols=228  Identities=25%  Similarity=0.422  Sum_probs=179.7

Q ss_pred             HHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh------hhHHHHHHHHHHHhcCC--CCCccceehh
Q 043148           62 ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK------QGKKEYISEVRIISRLR--HRNLVHLIGW  133 (387)
Q Consensus        62 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~  133 (387)
                      +.....++|...+.||+|+||.||+|.+..+++.||||.+.....      ...+.+.+|+.++..++  ||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            344456889999999999999999999999999999999865421      12355778999999996  5999999998


Q ss_pred             hcchhh--------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC-CCCcEEEcc
Q 043148          134 CHEQRQ--------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD-SNFNAKLGD  186 (387)
Q Consensus       134 ~~~~~~--------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kl~D  186 (387)
                      +.+...                          ..+..++.|++.||.|||+   ++|+||||||+|||++ .++.+||+|
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            754321                          1236789999999999999   9999999999999999 789999999


Q ss_pred             ccccccccCCCCceeeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 043148          187 FGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGK  265 (387)
Q Consensus       187 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  265 (387)
                      ||+++.....   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....            ....
T Consensus       194 fg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~~~  258 (320)
T 3a99_A          194 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRG  258 (320)
T ss_dssp             CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHC
T ss_pred             Cccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hhcc
Confidence            9999866542   2233568999999999987765 6889999999999999999999964210            0000


Q ss_pred             CchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          266 GQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                       .          ...+...+..+.+++.+||+.||.+|||++|++++.|+...
T Consensus       259 -~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  300 (320)
T 3a99_A          259 -Q----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  300 (320)
T ss_dssp             -C----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             -c----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence             0          00111234557889999999999999999999999998653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=305.49  Aligned_cols=235  Identities=16%  Similarity=0.145  Sum_probs=174.2

Q ss_pred             hhCccccCcccccCceEEEEEEECC--------CCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCcccee-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD--------QNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLI-------  131 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~-------  131 (387)
                      .++|...+.||+|+||.||+|++..        .++.||||.+...     +.+.+|++++.+++||||++++       
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3679999999999999999999987        3789999998653     4678999999999999999843       


Q ss_pred             --------hhhcc-h--------------------------hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe
Q 043148          132 --------GWCHE-Q--------------------------RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL  176 (387)
Q Consensus       132 --------~~~~~-~--------------------------~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill  176 (387)
                              +++.. .                          ....+..++.|++.||.|||+   ++|+||||||+|||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFV  192 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEE
T ss_pred             ccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEE
Confidence                    33222 1                          112236899999999999999   999999999999999


Q ss_pred             CCCC--cEEEccccccccccCCCCc------eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 043148          177 DSNF--NAKLGDFGLARLVDHELGS------QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQ  248 (387)
Q Consensus       177 ~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~  248 (387)
                      +.++  .+||+|||+++........      ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  8999999999765432111      1123468999999999999999999999999999999999999998654


Q ss_pred             CcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          249 EPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .... ............  .....+...   .....+..+.+++.+||+.||.+|||+++|++.|..
T Consensus       273 ~~~~-~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  333 (352)
T 2jii_A          273 PNTE-DIMKQKQKFVDK--PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA  333 (352)
T ss_dssp             TCHH-HHHHHHHHHHHS--CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             cCHH-HHHHHHHhccCC--hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence            2211 111111111100  001111000   001224568899999999999999999999998864

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.6e-39  Score=324.10  Aligned_cols=231  Identities=26%  Similarity=0.393  Sum_probs=178.8

Q ss_pred             HHhhCccccCcccccCceEEEEEEECCC---CeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-
Q 043148           65 RATNNFAEAGKLGEGGFGGVYRGLLSDQ---NTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-  139 (387)
Q Consensus        65 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  139 (387)
                      ...++|...+.||+|+||.||+|.+..+   +..||||.+... .....+.+.+|+.++..++||||+++++++.+... 
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  466 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW  466 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceE
Confidence            3456788889999999999999998643   467999998754 34445789999999999999999999998754321 


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                              ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence                                    1225789999999999999   9999999999999999999999999999987654


Q ss_pred             CCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      ..........+++.|+|||++.+..++.++||||||+++|||++ |..||.+....+.   ...+.    .+.       
T Consensus       544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~i~----~~~-------  609 (656)
T 2j0j_A          544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIE----NGE-------  609 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHH----HTC-------
T ss_pred             CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHH----cCC-------
Confidence            43333334557789999999998999999999999999999997 9999976543221   11111    110       


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                        ....+..++..+.+++.+||+.||.+|||+.++++.|.
T Consensus       610 --~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~  647 (656)
T 2j0j_A          610 --RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  647 (656)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence              11122334566889999999999999999999999886

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.4e-38  Score=299.55  Aligned_cols=238  Identities=17%  Similarity=0.227  Sum_probs=181.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhh-----------------HHHHHHHHHHHhcCCCCCccc
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQG-----------------KKEYISEVRIISRLRHRNLVH  129 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~  129 (387)
                      .++|...+.||+|+||.||+|.+  +++.||||.+.......                 .+.+.+|++++..++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            47899999999999999999999  68999999986432111                 178999999999999999999


Q ss_pred             eehhhcchh---------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe
Q 043148          130 LIGWCHEQR---------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL  176 (387)
Q Consensus       130 l~~~~~~~~---------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill  176 (387)
                      +++++.+..                                 ...+..++.|++.||.|||+  .++++||||||+||++
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILM  185 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEE
Confidence            998764422                                 12346899999999999996  3799999999999999


Q ss_pred             CCCCcEEEccccccccccCCCCceeeeeecCCcccCchhhccC-CCCC-ccchHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 043148          177 DSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG-KASK-ESDVYSFGVVALEVACGRKPVEPRQEPSKVR  254 (387)
Q Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~  254 (387)
                      +.++.+||+|||++......   ......+++.|+|||.+.+. .++. ++||||||+++|||++|+.||........  
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE--  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH--
T ss_pred             cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--
Confidence            99999999999999865432   33445689999999999877 5666 99999999999999999999986554211  


Q ss_pred             HHHHHHHHhccCchhhhh---------cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          255 LVEWVWDLYGKGQLLEAA---------DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ..    .....+......         ............+..+.+++.+||+.||.+|||+.|+++|.|+..
T Consensus       261 ~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          261 LF----NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             HH----HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HH----HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence            11    111111110000         000000111334566889999999999999999999999999864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=8.5e-39  Score=308.18  Aligned_cols=221  Identities=14%  Similarity=0.082  Sum_probs=167.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCC-CCccceehh---------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRH-RNLVHLIGW---------  133 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~---------  133 (387)
                      .++|...+.||+|+||.||+|.+..+|+.||||++....   ....+.+.+|+.++..++| +|...+..+         
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345777889999999999999999999999999987432   2336789999999999987 332211111         


Q ss_pred             ------------hcc---------------------------------h---hhHHHHHHHHHHHHHHHHhhhhccccee
Q 043148          134 ------------CHE---------------------------------Q---RQLILHKIALGLASAVLYLHEEWEQCIV  165 (387)
Q Consensus       134 ------------~~~---------------------------------~---~~~~l~~i~~~i~~~l~~LH~~~~~~ii  165 (387)
                                  +..                                 .   .......++.|++.||.|||+   ++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ii  233 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV  233 (413)
T ss_dssp             EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence                        000                                 0   011336788999999999999   9999


Q ss_pred             eccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCcccCchhh----------ccCCCCCccchHHHHHHHH
Q 043148          166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV----------TTGKASKESDVYSFGVVAL  235 (387)
Q Consensus       166 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dvws~Gvil~  235 (387)
                      ||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||||++|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            9999999999999999999999998765432    344567 999999999          5556888999999999999


Q ss_pred             HHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          236 EVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       236 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ||++|+.||.........               ..++...  ..    .+..+.+++.+||+.||.+||++.+++++.|+
T Consensus       309 elltg~~Pf~~~~~~~~~---------------~~~~~~~--~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~  367 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGS---------------EWIFRSC--KN----IPQPVRALLEGFLRYPKEDRLLPLQAMETPEY  367 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCS---------------GGGGSSC--CC----CCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred             HHHHCCCCCCCcchhhhH---------------HHHHhhc--cc----CCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence            999999999765432211               1111110  11    23558899999999999999999999988775


Q ss_pred             C
Q 043148          316 E  316 (387)
Q Consensus       316 ~  316 (387)
                      .
T Consensus       368 ~  368 (413)
T 3dzo_A          368 E  368 (413)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.7e-38  Score=306.63  Aligned_cols=230  Identities=22%  Similarity=0.255  Sum_probs=169.9

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhHH-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQLI-----  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~-----  141 (387)
                      +.|...+.||+|+||+||.+.. .+|+.||||++...   ..+.+.+|++++.++ +||||+++++++.+....+     
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            3455567899999999987554 35899999998542   245678999999876 8999999998775533211     


Q ss_pred             --------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC-------------CcE
Q 043148          142 --------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN-------------FNA  182 (387)
Q Consensus       142 --------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-------------~~~  182 (387)
                                                +..++.|++.||.|||+   ++|+||||||+|||++.+             +.+
T Consensus        91 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           91 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             CCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence                                      13589999999999999   999999999999999654             489


Q ss_pred             EEccccccccccCCCCc---eeeeeecCCcccCchhhcc-------CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcc
Q 043148          183 KLGDFGLARLVDHELGS---QTTVLAGTMGYLAPECVTT-------GKASKESDVYSFGVVALEVAC-GRKPVEPRQEPS  251 (387)
Q Consensus       183 kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~  251 (387)
                      ||+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999876543221   1234579999999999975       568999999999999999999 999997543221


Q ss_pred             hhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          252 KVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                       .   .....   ...     .+..........+..+.+++.+||+.||.+|||+.++++|+|+.
T Consensus       248 -~---~i~~~---~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~  300 (434)
T 2rio_A          248 -S---NIIRG---IFS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW  300 (434)
T ss_dssp             -H---HHHHT---CCC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             -H---HHhcC---CCC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence             0   00000   000     01111222455677899999999999999999999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.5e-38  Score=298.22  Aligned_cols=234  Identities=21%  Similarity=0.211  Sum_probs=154.4

Q ss_pred             HhhCccccC-cccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcch----h--
Q 043148           66 ATNNFAEAG-KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ----R--  138 (387)
Q Consensus        66 ~~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--  138 (387)
                      ..++|.+.+ .||+|+||.||+|.+..+++.||||++...    .....+....+..++||||+++++++...    .  
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            457888855 699999999999999999999999998653    12222233345677999999999876541    0  


Q ss_pred             -------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC---CCcEEEcccccc
Q 043148          139 -------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLA  190 (387)
Q Consensus       139 -------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Dfg~~  190 (387)
                                               ...+..++.|++.||.|||+   ++++||||||+|||++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence                                     11236899999999999999   99999999999999986   455999999999


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      ......   ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||............   ......     
T Consensus       179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~-----  247 (336)
T 3fhr_A          179 KETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRL-----  247 (336)
T ss_dssp             EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             eecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhc-----
Confidence            765432   223456799999999998888999999999999999999999999765432211000   000000     


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                       .............+..+.+++.+||+.||.+|||+.|+++++|+...
T Consensus       248 -~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          248 -GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             -cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence             00011111112345568899999999999999999999999998654

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.6e-38  Score=302.92  Aligned_cols=229  Identities=23%  Similarity=0.278  Sum_probs=166.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhHH----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQLI----  141 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~----  141 (387)
                      ..+|...+.||+|+||+||.... .+++.||||++.....   ..+.+|+++|+.+ +||||+++++++.+....+    
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            35688889999999998654333 3588999999965432   2356899999999 7999999999876543221    


Q ss_pred             ---------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC-----CCcEEEccccccccccC
Q 043148          142 ---------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS-----NFNAKLGDFGLARLVDH  195 (387)
Q Consensus       142 ---------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-----~~~~kl~Dfg~~~~~~~  195 (387)
                                           ...++.|++.||.|||+   ++|+||||||+|||++.     ...+||+|||+++....
T Consensus        99 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A           99 LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence                                 25799999999999999   99999999999999953     34688999999986653


Q ss_pred             CCC--ceeeeeecCCcccCchhhc---cCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchh
Q 043148          196 ELG--SQTTVLAGTMGYLAPECVT---TGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLL  269 (387)
Q Consensus       196 ~~~--~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (387)
                      ...  .......||+.|+|||++.   ...++.++|||||||++|||++ |..||........       ......... 
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~~~~~~-  247 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILLGACSL-  247 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHTTCCCC-
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHhccCCc-
Confidence            321  2233457999999999997   4567889999999999999999 9999964332211       001111000 


Q ss_pred             hhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ..      ..........+.+++.+||+.||.+|||+.|+++|+|+.
T Consensus       248 ~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~  288 (432)
T 3p23_A          248 DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW  288 (432)
T ss_dssp             TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTC
T ss_pred             cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcccc
Confidence            00      011223455578899999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.5e-38  Score=296.13  Aligned_cols=224  Identities=16%  Similarity=0.165  Sum_probs=171.6

Q ss_pred             HHHhhCccccCcccccCceEEEEEE-----ECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC---CCCccceehhhc
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGL-----LSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR---HRNLVHLIGWCH  135 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  135 (387)
                      ....++|...+.||+|+||.||+|.     ...+++.||||++....   ..++..|++++..++   |+||+++++++.
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            3445778999999999999999994     56678999999997543   456778888888776   999999988764


Q ss_pred             chhh------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC-------
Q 043148          136 EQRQ------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS-------  178 (387)
Q Consensus       136 ~~~~------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-------  178 (387)
                      ....                              ..+..++.|++.||+|||+   ++|+||||||+|||++.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccc
Confidence            4221                              1236799999999999999   99999999999999998       


Q ss_pred             ----CCcEEEccccccccccCC-CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchh
Q 043148          179 ----NFNAKLGDFGLARLVDHE-LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKV  253 (387)
Q Consensus       179 ----~~~~kl~Dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~  253 (387)
                          ++.+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  294 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK  294 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence                899999999999765422 223344567999999999999999999999999999999999999998643321100


Q ss_pred             hHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHhc
Q 043148          254 RLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNR-PSIRQVINVLN  314 (387)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R-Ps~~evl~~l~  314 (387)
                                    +    ...+.. .+  ..+.+.+++..|++.+|.+| |+++++.+.+.
T Consensus       295 --------------~----~~~~~~-~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~  335 (365)
T 3e7e_A          295 --------------P----EGLFRR-LP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK  335 (365)
T ss_dssp             --------------E----CSCCTT-CS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred             --------------e----chhccc-cC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence                          0    000111 11  23456778899999999999 56777776654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.6e-38  Score=294.09  Aligned_cols=234  Identities=26%  Similarity=0.407  Sum_probs=173.6

Q ss_pred             HHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh
Q 043148           62 ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        62 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  139 (387)
                      +.....++|...+.||+|+||.||+|.+.+   .+|+|.+....  ....+.+.+|+.++..++||||+++++++.+...
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            334446789999999999999999999854   49999986542  2334567889999999999999999998765432


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccc
Q 043148          140 --------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV  193 (387)
Q Consensus       140 --------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~  193 (387)
                                                ..+..++.|++.||.|||+   ++++||||||+|||++ ++.+||+|||++...
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence                                      2237899999999999999   9999999999999998 679999999998754


Q ss_pred             cCCC----CceeeeeecCCcccCchhhcc---------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 043148          194 DHEL----GSQTTVLAGTMGYLAPECVTT---------GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW  260 (387)
Q Consensus       194 ~~~~----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~  260 (387)
                      ....    ........|++.|+|||++..         ..++.++||||||+++|||++|+.||.........      .
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~  253 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII------W  253 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH------H
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------H
Confidence            3211    112233458899999999874         35788999999999999999999999765432111      1


Q ss_pred             HHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          261 DLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      . ...+..     +...   ....+..+.+++..||+.||.+|||+.++++.|+...
T Consensus       254 ~-~~~~~~-----~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~  301 (319)
T 2y4i_B          254 Q-MGTGMK-----PNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP  301 (319)
T ss_dssp             H-HHTTCC-----CCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred             H-hccCCC-----CCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            1 111111     1110   1122344788999999999999999999999998543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.7e-37  Score=310.97  Aligned_cols=244  Identities=27%  Similarity=0.328  Sum_probs=178.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcc------hh-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHE------QR-  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~-  138 (387)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|++++..++||||+++++++..      .. 
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            47899999999999999999999888999999998764 44556789999999999999999999887643      11 


Q ss_pred             ---------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc---EEEcccc
Q 043148          139 ---------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN---AKLGDFG  188 (387)
Q Consensus       139 ---------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kl~Dfg  188 (387)
                                                 ...+..++.+++.||.|||+   .+|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence                                       11236799999999999999   99999999999999997765   9999999


Q ss_pred             ccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhH-H-HHHHHH-hcc
Q 043148          189 LARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRL-V-EWVWDL-YGK  265 (387)
Q Consensus       189 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~-~-~~~~~~-~~~  265 (387)
                      ++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........... . ...... ...
T Consensus       170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            998765432  23345789999999999999999999999999999999999999975432110000 0 000000 000


Q ss_pred             ----CchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          266 ----GQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       266 ----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                          +..................+..+.+++..||+.||.+|||+.+++++.|+
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F  301 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF  301 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTH
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHH
Confidence                00000000011223445567789999999999999999999988777664

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5e-36  Score=274.73  Aligned_cols=207  Identities=14%  Similarity=0.076  Sum_probs=162.4

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  140 (387)
                      .++|.+.+.||+|+||.||+|++..+++.||||++....   ....+.+.+|+.++..++||||+++++++.+....   
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999999889999999997653   33457899999999999999999999987654322   


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          ....++.|++.||.|||+   ++|+||||||+|||++.++.+||++++            
T Consensus       110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred             EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence                                136789999999999999   999999999999999999999998543            


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc--cCCc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG--RLSK  278 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  278 (387)
                               |++|       ++.++||||||+++|||++|+.||......+....            .......  ....
T Consensus       175 ---------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~~~~~~  226 (286)
T 3uqc_A          175 ---------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQPIEPA  226 (286)
T ss_dssp             ---------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSCBCCHH
T ss_pred             ---------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccCCCChh
Confidence                     3332       68899999999999999999999987654321100            0000000  0001


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ......+..+.+++.+||+.||.+| |+.|+++.|....
T Consensus       227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence            1222345568899999999999999 9999999997543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.6e-36  Score=305.52  Aligned_cols=213  Identities=19%  Similarity=0.297  Sum_probs=170.8

Q ss_pred             hhCccccCcccccCceEEEEEEECC-CCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD-QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      .++|.+.+.||+|+||.||+|.+.. +++.||||.+... .......+.+|++++.+++||||+++++++.+...     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4789999999999999999999975 6899999998654 33456678999999999999999999998865433     


Q ss_pred             H-----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 L-----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 ~-----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                      .                       .+..++.||+.||.|||+   ++|+||||||+|||++.+ .+||+|||+++.....
T Consensus       159 ~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred             eEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence            1                       126799999999999999   999999999999999986 8999999999866442


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                           ....||+.|+|||++.+.. +.++||||||+++|||++|..||........                       .
T Consensus       235 -----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------------------~  285 (681)
T 2pzi_A          235 -----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------------------P  285 (681)
T ss_dssp             -----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------------C
T ss_pred             -----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------------------c
Confidence                 3456899999999987654 8899999999999999999988764221100                       0


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINV  312 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~  312 (387)
                      ...........+.+++.+||+.||.+||+..+.+.+
T Consensus       286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  321 (681)
T 2pzi_A          286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA  321 (681)
T ss_dssp             TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHH
Confidence            011112234568899999999999999965554443

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.5e-35  Score=273.33  Aligned_cols=210  Identities=21%  Similarity=0.247  Sum_probs=158.8

Q ss_pred             hhCcccc-CcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHH-hcCCCCCccceehhhcc----hh--
Q 043148           67 TNNFAEA-GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRII-SRLRHRNLVHLIGWCHE----QR--  138 (387)
Q Consensus        67 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~--  138 (387)
                      .++|... +.||+|+||.||++.+..+++.||||++..     ...+.+|+.++ +.++||||+++++++..    ..  
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4667776 679999999999999999999999999854     34677888888 56699999999987654    11  


Q ss_pred             -------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC---CCcEEEcccccc
Q 043148          139 -------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLA  190 (387)
Q Consensus       139 -------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Dfg~~  190 (387)
                                               ...+..++.|++.||.|||+   ++++||||||+|||++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence                                     11236799999999999999   99999999999999998   789999999998


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      ....                       +..++.++||||||+++|||++|+.||.........           ......
T Consensus       168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~  213 (299)
T 3m2w_A          168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTR  213 (299)
T ss_dssp             EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred             cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHH
Confidence            6432                       234678999999999999999999999764432110           000000


Q ss_pred             hhc--ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          271 AAD--GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       271 ~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ...  ...........+..+.+++.+||+.||.+|||+.|+++|+|+...
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            000  011111112345668899999999999999999999999997653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.1e-36  Score=281.03  Aligned_cols=223  Identities=16%  Similarity=0.156  Sum_probs=166.5

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--------hhhHHHHHHHHHHHhcCC---------------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--------KQGKKEYISEVRIISRLR---------------  123 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------------  123 (387)
                      .++|...+.||+|+||.||+|++  +|+.||||++....        ....+.+.+|+.+++.++               
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46788899999999999999998  57999999997542        223478889999998886               


Q ss_pred             -----------CCCccceehhhcc-------------hh------------------------hHHHHHHHHHHHHHHHH
Q 043148          124 -----------HRNLVHLIGWCHE-------------QR------------------------QLILHKIALGLASAVLY  155 (387)
Q Consensus       124 -----------h~niv~l~~~~~~-------------~~------------------------~~~l~~i~~~i~~~l~~  155 (387)
                                 ||||+++++++.+             ..                        ...+..++.||+.||.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence                       5555555555543             11                        12347899999999999


Q ss_pred             hh-hhcccceeeccCCcceeEeCCCC--------------------cEEEccccccccccCCCCceeeeeecCCcccCch
Q 043148          156 LH-EEWEQCIVHRDIKSSNVVLDSNF--------------------NAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE  214 (387)
Q Consensus       156 LH-~~~~~~iiH~dlk~~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE  214 (387)
                      || +   ++|+||||||+|||++.++                    .+||+|||+++.....      ...||+.|+|||
T Consensus       177 lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE  247 (336)
T 2vuw_A          177 AEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDED  247 (336)
T ss_dssp             HHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSG
T ss_pred             HHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChh
Confidence            99 8   9999999999999999887                    8999999999866432      347999999999


Q ss_pred             hhccCCCCCccchHHHHHH-HHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHH
Q 043148          215 CVTTGKASKESDVYSFGVV-ALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL  293 (387)
Q Consensus       215 ~~~~~~~~~~~Dvws~Gvi-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  293 (387)
                      ++.+.. +.++||||++++ .+++++|..||...      .............   ...............+..+.+|+.
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~s~~~~dli~  317 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQ---MTFKTKCNTPAMKQIKRKIQEFHR  317 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHT---CCCSSCCCSHHHHHHHHHHHHHHH
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhh---hccCcccchhhhhhcCHHHHHHHH
Confidence            998766 889999998777 67788899988421      0000011110000   001111223345567888999999


Q ss_pred             HhcCCCCCCCCCHHHHH-HHhcc
Q 043148          294 WCCHPDFTNRPSIRQVI-NVLNF  315 (387)
Q Consensus       294 ~cl~~dp~~RPs~~evl-~~l~~  315 (387)
                      +||+.|     |++|++ +|.|+
T Consensus       318 ~~L~~d-----sa~e~l~~Hp~f  335 (336)
T 2vuw_A          318 TMLNFS-----SATDLLCQHSLF  335 (336)
T ss_dssp             HGGGSS-----SHHHHHHHCGGG
T ss_pred             HHhccC-----CHHHHHhcCCCc
Confidence            999976     999999 99986

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=1.3e-27  Score=238.26  Aligned_cols=164  Identities=18%  Similarity=0.094  Sum_probs=111.0

Q ss_pred             cccccCceEEEEEEECCCCeEEEEEEecCCC----------hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhHHH-
Q 043148           75 KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS----------KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQLIL-  142 (387)
Q Consensus        75 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l-  142 (387)
                      ..+.|++|.+..++..-.|..+++|.+....          ..+.++|.+|+++|+++ .|+||+++++++++....+| 
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            4566677666665555568889999996541          23456799999999999 79999999999988765543 


Q ss_pred             ---------------------HHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          143 ---------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       143 ---------------------~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                           ..|+.||+.||+|||+   +|||||||||+||||+.++.+||+|||+++...... ...
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~~~  396 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-SWP  396 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC----CCS
T ss_pred             EecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-ccc
Confidence                                 5799999999999999   999999999999999999999999999998665432 233


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCC
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP  243 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p  243 (387)
                      ...+||+.|||||++.+ .+..++|+|++|++++++.++..+
T Consensus       397 ~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            44679999999999875 467789999999998877655433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=1.6e-24  Score=214.87  Aligned_cols=168  Identities=15%  Similarity=0.149  Sum_probs=124.0

Q ss_pred             cccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--------hhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH-
Q 043148           71 AEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--------QGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI-  141 (387)
Q Consensus        71 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-  141 (387)
                      ...+.||+|+||.||+|..  .+..+++|.......        ...+.+.+|++++++++||||+++..++.+....+ 
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            4466899999999999955  467899998644321        12456899999999999999994433332222111 


Q ss_pred             ----------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce-----
Q 043148          142 ----------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ-----  200 (387)
Q Consensus       142 ----------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-----  200 (387)
                                      ...++.|+++||.|||+   ++|+||||||+|||++.  .+||+|||+++.........     
T Consensus       417 VmE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~  491 (540)
T 3en9_A          417 MMSYINGKLAKDVIEDNLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIV  491 (540)
T ss_dssp             EEECCCSEEHHHHSTTCTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHH
T ss_pred             EEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhh
Confidence                            24789999999999999   99999999999999999  99999999998765432111     


Q ss_pred             -eeeeecCCcccCchhhcc--CCCCCccchHHHHHHHHHHHhCCCCCC
Q 043148          201 -TTVLAGTMGYLAPECVTT--GKASKESDVYSFGVVALEVACGRKPVE  245 (387)
Q Consensus       201 -~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvil~el~tg~~p~~  245 (387)
                       .....||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       492 ~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          492 FKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             hhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence             134579999999999986  568888999999999998888877763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=6.3e-22  Score=180.36  Aligned_cols=144  Identities=18%  Similarity=0.099  Sum_probs=108.7

Q ss_pred             HHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh------------------hhHHHHHHHHHHHhcCCCC
Q 043148           64 SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK------------------QGKKEYISEVRIISRLRHR  125 (387)
Q Consensus        64 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~  125 (387)
                      ......|...+.||+|+||.||+|.+ .+|+.||||.++....                  .....+.+|+++|+.++| 
T Consensus        86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-  163 (282)
T 1zar_A           86 VRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-  163 (282)
T ss_dssp             HHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred             HhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence            33445566778999999999999999 7799999999964321                  135678999999999984 


Q ss_pred             Cccceehhhcchhh-----------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccc
Q 043148          126 NLVHLIGWCHEQRQ-----------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFG  188 (387)
Q Consensus       126 niv~l~~~~~~~~~-----------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  188 (387)
                        +++.+++.....                 .....++.|++.||.|||+   .+|+||||||+|||++ ++.+||+|||
T Consensus       164 --~~v~~~~~~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          164 --LAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             --SSSCCEEEEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             --CCcCeEEeccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence              444443322110                 1125799999999999999   9999999999999999 9999999999


Q ss_pred             ccccccCCCCceeeeeecCCcccCchhhcc----------CCCCCccchHH
Q 043148          189 LARLVDHELGSQTTVLAGTMGYLAPECVTT----------GKASKESDVYS  229 (387)
Q Consensus       189 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----------~~~~~~~Dvws  229 (387)
                      +++.              +..++|||++..          ..|+..+|+|.
T Consensus       238 ~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          238 QSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             TCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             CCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            9963              334788998753          34455556654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.72  E-value=5.5e-18  Score=152.32  Aligned_cols=119  Identities=20%  Similarity=0.161  Sum_probs=91.0

Q ss_pred             ccccCcccccCceEEEEEEECCCCeE--EEEEEecCCChh------------------------hHHHHHHHHHHHhcCC
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTE--IAVKRVSRGSKQ------------------------GKKEYISEVRIISRLR  123 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  123 (387)
                      |.+.+.||+|+||.||+|.+..+|+.  ||||+++.....                        ....+.+|++.|..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999998666888  999987543111                        1236788999999887


Q ss_pred             CCCc--cc---------eehhhcc-h------h-------hHHHHHHHHHHHHHHHHhh-hhcccceeeccCCcceeEeC
Q 043148          124 HRNL--VH---------LIGWCHE-Q------R-------QLILHKIALGLASAVLYLH-EEWEQCIVHRDIKSSNVVLD  177 (387)
Q Consensus       124 h~ni--v~---------l~~~~~~-~------~-------~~~l~~i~~~i~~~l~~LH-~~~~~~iiH~dlk~~Nill~  177 (387)
                      |+++  ..         +++++.. +      .       ......++.|++.+|.||| +   .+|+||||||+|||++
T Consensus       129 ~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~givHrDlkp~NILl~  205 (258)
T 1zth_A          129 EAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQE---AELVHADLSEYNIMYI  205 (258)
T ss_dssp             HTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHT---SCEECSSCSTTSEEES
T ss_pred             hCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEEc
Confidence            6643  22         2344421 0      0       1134688999999999999 8   9999999999999999


Q ss_pred             CCCcEEEccccccccc
Q 043148          178 SNFNAKLGDFGLARLV  193 (387)
Q Consensus       178 ~~~~~kl~Dfg~~~~~  193 (387)
                      .  .++|+|||++...
T Consensus       206 ~--~~~liDFG~a~~~  219 (258)
T 1zth_A          206 D--KVYFIDMGQAVTL  219 (258)
T ss_dssp             S--SEEECCCTTCEET
T ss_pred             C--cEEEEECcccccC
Confidence            8  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.52  E-value=3.9e-15  Score=139.62  Aligned_cols=121  Identities=12%  Similarity=0.155  Sum_probs=83.8

Q ss_pred             ccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh--------------hhHHH--------HHHHHHHHhcCCCCCc
Q 043148           70 FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK--------------QGKKE--------YISEVRIISRLRHRNL  127 (387)
Q Consensus        70 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~ni  127 (387)
                      |.+.+.||+|+||.||+|.... |+.||||+++....              .....        ...|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~-G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEK-GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTT-CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECCC-CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            8889999999999999999864 89999998754210              01111        1345666666543322


Q ss_pred             c--c---------eehhhcchh------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC----------
Q 043148          128 V--H---------LIGWCHEQR------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF----------  180 (387)
Q Consensus       128 v--~---------l~~~~~~~~------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----------  180 (387)
                      .  .         +++++....      ..-...++.|++.+|.|||.   .+||||||||.|||+++++          
T Consensus       176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd~~d~~~~~~  252 (397)
T 4gyi_A          176 PVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKDAEDPSSITL  252 (397)
T ss_dssp             SCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEECSSCTTSEEE
T ss_pred             CCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCCccccccccc
Confidence            1  1         122322110      01125788999999999999   9999999999999998876          


Q ss_pred             cEEEcccccccccc
Q 043148          181 NAKLGDFGLARLVD  194 (387)
Q Consensus       181 ~~kl~Dfg~~~~~~  194 (387)
                      .+.|+||+-+....
T Consensus       253 ~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          253 TPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEECCCTTCEETT
T ss_pred             ceEEEEeCCcccCC
Confidence            38999999775433

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.90  E-value=1.7e-09  Score=96.68  Aligned_cols=127  Identities=15%  Similarity=0.112  Sum_probs=93.7

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCCccceehhhcchhhHH
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQLI  141 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  141 (387)
                      +......|.....++.|+++.||+....  +..+++|+...........+.+|+++++.+. |.++.++++++.+....+
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            4455567887778888899999998753  6789999986432223446888999999884 666777777665432111


Q ss_pred             --------------------HHHHHHHHHHHHHHhhhhc-----------------------------------------
Q 043148          142 --------------------LHKIALGLASAVLYLHEEW-----------------------------------------  160 (387)
Q Consensus       142 --------------------l~~i~~~i~~~l~~LH~~~-----------------------------------------  160 (387)
                                          ...++.+++.+|..||+..                                         
T Consensus        87 lv~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             EEEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             EEEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence                                1367889999999999810                                         


Q ss_pred             ---------------ccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          161 ---------------EQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       161 ---------------~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                                     ...++|+|+++.||+++.+..+.|+||+.+.
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                           1558999999999999876666799999774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.70  E-value=6e-09  Score=92.74  Aligned_cols=120  Identities=17%  Similarity=0.070  Sum_probs=82.0

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCC--ccceehhhcchhhHH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRN--LVHLIGWCHEQRQLI----  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~----  141 (387)
                      .++......+.|..+.||+.... +|..+++|.....   ....+..|+.+++.+.+.+  +.+++++..+....+    
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            34444333345666999999753 4678999997553   2345778999998885434  344665543321100    


Q ss_pred             -------------HHHHHHHHHHHHHHhhhhc------------------------------------------------
Q 043148          142 -------------LHKIALGLASAVLYLHEEW------------------------------------------------  160 (387)
Q Consensus       142 -------------l~~i~~~i~~~l~~LH~~~------------------------------------------------  160 (387)
                                   ...++.+++..|..||+..                                                
T Consensus        96 ~i~G~~l~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (264)
T 1nd4_A           96 EVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  175 (264)
T ss_dssp             CCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             ecCCcccCcCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence                         1267888999999999732                                                


Q ss_pred             -------ccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          161 -------EQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       161 -------~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                             ...++|+|++|.||+++.++.+.|+||+.+.
T Consensus       176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                   1239999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.37  E-value=3.6e-07  Score=85.51  Aligned_cols=119  Identities=13%  Similarity=0.191  Sum_probs=83.3

Q ss_pred             ccCcccccCceEEEEEEECCCCeEEEEEEec--CCC-hhhHHHHHHHHHHHhcCC--CCCccceehhhcchh--------
Q 043148           72 EAGKLGEGGFGGVYRGLLSDQNTEIAVKRVS--RGS-KQGKKEYISEVRIISRLR--HRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        72 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~--------  138 (387)
                      ..+.|+.|.++.||+....  +..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+..        
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            3567899999999998864  4578888775  322 123457888999999886  445666766655431        


Q ss_pred             ------------------hHHHHHHHHHHHHHHHHhhhhc----------------------------------------
Q 043148          139 ------------------QLILHKIALGLASAVLYLHEEW----------------------------------------  160 (387)
Q Consensus       139 ------------------~~~l~~i~~~i~~~l~~LH~~~----------------------------------------  160 (387)
                                        ......++.+++..|..||...                                        
T Consensus       120 me~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (359)
T 3dxp_A          120 MEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS  199 (359)
T ss_dssp             EECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred             EEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence                              1112467889999999999721                                        


Q ss_pred             ---------------ccceeeccCCcceeEeCCCCc--EEEcccccccc
Q 043148          161 ---------------EQCIVHRDIKSSNVVLDSNFN--AKLGDFGLARL  192 (387)
Q Consensus       161 ---------------~~~iiH~dlk~~Nill~~~~~--~kl~Dfg~~~~  192 (387)
                                     ...++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                           257999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.25  E-value=1.7e-07  Score=85.66  Aligned_cols=160  Identities=20%  Similarity=0.208  Sum_probs=97.8

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCC--ccceehhhcchh-----------
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRN--LVHLIGWCHEQR-----------  138 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~-----------  138 (387)
                      .+.++.|....||+..     ..+++|+...  ......+.+|.++|+.+. +..  +.+++.+.....           
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568899999999853     3588998643  234567889999998773 322  222222211100           


Q ss_pred             -------h--------HHHHHHHHHHHHHHHHhhhhc-------------------------------------------
Q 043148          139 -------Q--------LILHKIALGLASAVLYLHEEW-------------------------------------------  160 (387)
Q Consensus       139 -------~--------~~l~~i~~~i~~~l~~LH~~~-------------------------------------------  160 (387)
                             .        .....++.+++..|..||+..                                           
T Consensus        98 i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  177 (304)
T 3sg8_A           98 IKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY  177 (304)
T ss_dssp             CCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred             cCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence                   0        012467788888888888510                                           


Q ss_pred             ------------ccceeeccCCcceeEeCC--CCcEEEccccccccccCCCCceeeeeecCCcc---cCchhhc----cC
Q 043148          161 ------------EQCIVHRDIKSSNVVLDS--NFNAKLGDFGLARLVDHELGSQTTVLAGTMGY---LAPECVT----TG  219 (387)
Q Consensus       161 ------------~~~iiH~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y---~aPE~~~----~~  219 (387)
                                  ...++|+|+++.||+++.  +..+.|+||+.+........-     .....+   ..|+...    ..
T Consensus       178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-----~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-----ISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-----HTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-----HHHHhhccccCHHHHHHHHHHc
Confidence                        135899999999999998  556789999988643221000     000011   1222211    00


Q ss_pred             -CC---------CCccchHHHHHHHHHHHhCCCCC
Q 043148          220 -KA---------SKESDVYSFGVVALEVACGRKPV  244 (387)
Q Consensus       220 -~~---------~~~~Dvws~Gvil~el~tg~~p~  244 (387)
                       ..         ....+.|+++.++|.+.+|..+|
T Consensus       253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             00         11257899999999999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.58  E-value=0.00011  Score=65.26  Aligned_cols=113  Identities=18%  Similarity=0.136  Sum_probs=75.9

Q ss_pred             ccccCce-EEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCCccceehhhcchhhHH------------
Q 043148           76 LGEGGFG-GVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQLI------------  141 (387)
Q Consensus        76 lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~------------  141 (387)
                      +..|..| .||+.....++..+.+|+-..   .....+.+|...|..+. +--+.++++++.+....+            
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            4445444 689988776677899998643   23567888999988774 323445555554332111            


Q ss_pred             ---------HHHHHHHHHHHHHHhhhhc----------------------------------------------------
Q 043148          142 ---------LHKIALGLASAVLYLHEEW----------------------------------------------------  160 (387)
Q Consensus       142 ---------l~~i~~~i~~~l~~LH~~~----------------------------------------------------  160 (387)
                               ...++.+++..|..||...                                                    
T Consensus       109 ~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  188 (272)
T 4gkh_A          109 QVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLP  188 (272)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCC
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhccc
Confidence                     1345666777777777521                                                    


Q ss_pred             ---ccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          161 ---EQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       161 ---~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                         ...++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       189 ~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          189 FSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence               1127999999999999987777899999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.53  E-value=8.3e-05  Score=70.31  Aligned_cols=50  Identities=14%  Similarity=0.193  Sum_probs=33.2

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCCCh-------hhHHHHHHHHHHHhcC
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK-------QGKKEYISEVRIISRL  122 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l  122 (387)
                      .+.||.|..+.||++....++..++||.......       .....+..|.+++..+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l   91 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQ   91 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHH
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHh
Confidence            4579999999999997655577899998653211       1234567788888766

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.20  E-value=0.0004  Score=62.44  Aligned_cols=54  Identities=20%  Similarity=0.171  Sum_probs=41.4

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR  123 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  123 (387)
                      .....+.+|.|..+.||+.+..+ |+.+.+|+-..........|..|...|+.|.
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~   69 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLG   69 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHT
T ss_pred             CeEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHH
Confidence            34556789999999999999864 8899999875544444456788999888773

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.06  E-value=0.001  Score=60.39  Aligned_cols=45  Identities=24%  Similarity=0.226  Sum_probs=33.2

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCC
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRH  124 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  124 (387)
                      .+.++.|....||+.     +..+++|+-.  .......+..|.++|..+.+
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~   68 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVG   68 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTT
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHh
Confidence            345788888899987     4568888752  23345678899999999864

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=96.74  E-value=0.0013  Score=40.21  Aligned_cols=31  Identities=19%  Similarity=0.055  Sum_probs=14.6

Q ss_pred             cceEEehHHH-HHHHHHHHHHHHHHHHHhhhc
Q 043148            4 KTGLIVGLLV-GIGALACGLGVIWFMYWRKRV   34 (387)
Q Consensus         4 ~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~   34 (387)
                      .++.|++-++ |++++++++++++|+++||++
T Consensus         9 ~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B            9 KIPSIATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             CSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             CcceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            3444544444 455555555444444444433

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=96.54  E-value=0.0018  Score=39.49  Aligned_cols=31  Identities=23%  Similarity=0.135  Sum_probs=14.0

Q ss_pred             cceEEehHHHH-HHHHHHHHHHHHHHHHhhhc
Q 043148            4 KTGLIVGLLVG-IGALACGLGVIWFMYWRKRV   34 (387)
Q Consensus         4 ~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~   34 (387)
                      .++.|++-+++ +++++++++.++|+++||++
T Consensus         8 ~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~   39 (44)
T 2l2t_A            8 RTPLIAAGVIGGLFILVIVGLTFAVYVRRKSI   39 (44)
T ss_dssp             SSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             CcceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence            34445444444 55555444444444444333

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=96.43  E-value=0.0044  Score=57.30  Aligned_cols=30  Identities=13%  Similarity=0.203  Sum_probs=25.8

Q ss_pred             cceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       162 ~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      ..++|+|+.+.|||++++..+.|+||+.+.
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            578999999999999965457899999875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.07  E-value=0.019  Score=52.12  Aligned_cols=61  Identities=11%  Similarity=0.093  Sum_probs=35.6

Q ss_pred             cCHHHHHHHhhCccc-----cCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC
Q 043148           58 FTYRELSRATNNFAE-----AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL  122 (387)
Q Consensus        58 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l  122 (387)
                      ++.+++......|..     .+.|+.|....+|+....+ | .+++|.....  .....+..|+.++..|
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~--~~~~~l~~e~~~l~~L   72 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHL   72 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC--CCHHHHHHHHHHHHHH
Confidence            556667666666654     2346678888999988743 3 6889988652  1223445566666555

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.95  E-value=0.011  Score=56.40  Aligned_cols=49  Identities=12%  Similarity=0.173  Sum_probs=34.0

Q ss_pred             cCcccccCceEEEEEEECC-------CCeEEEEEEecCCChhhHHHHHHHHHHHhcCC
Q 043148           73 AGKLGEGGFGGVYRGLLSD-------QNTEIAVKRVSRGSKQGKKEYISEVRIISRLR  123 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  123 (387)
                      .+.|+.|....+|+....+       ++..+.+|+.....  ....+..|..++..|.
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~  133 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLS  133 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHH
Confidence            4567888889999998753       24679999874321  1245667888888774

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=95.75  E-value=0.0072  Score=36.77  Aligned_cols=27  Identities=33%  Similarity=0.514  Sum_probs=13.6

Q ss_pred             eEEehHHHHHHHHHHHHHHHHHHHHhhh
Q 043148            6 GLIVGLLVGIGALACGLGVIWFMYWRKR   33 (387)
Q Consensus         6 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~   33 (387)
                      ..|++.++|++ +++++++.++++.|||
T Consensus        12 ~~Ia~~vVGvl-l~vi~~l~~~~~~RRR   38 (44)
T 2jwa_A           12 TSIISAVVGIL-LVVVLGVVFGILIKRR   38 (44)
T ss_dssp             HHHHHHHHHHH-HHHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHH-HHHHHHHHHHhheehh
Confidence            34677777744 4444444444444433

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.70  E-value=0.039  Score=52.89  Aligned_cols=50  Identities=8%  Similarity=-0.029  Sum_probs=30.6

Q ss_pred             CcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCC
Q 043148           74 GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRH  124 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  124 (387)
                      +.|+.|-...+|+....+.+..+++|+....... .-+...|..++..|..
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~  163 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYN  163 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTT
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHh
Confidence            4577788889999988554578999987442211 1112467777777753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=95.47  E-value=0.015  Score=52.70  Aligned_cols=45  Identities=18%  Similarity=0.135  Sum_probs=34.4

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL  122 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l  122 (387)
                      .+.|+.|....+|+...  ++..+++|+....   ....+..|...|+.|
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L   85 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALL   85 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHH
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHH
Confidence            45689999999999875  3567889987532   356788898888777

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.36  E-value=0.011  Score=53.22  Aligned_cols=28  Identities=18%  Similarity=0.185  Sum_probs=24.0

Q ss_pred             ceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          163 CIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       163 ~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      .++|+|+.+.||+ ..++.+.++||..+.
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence            3799999999999 556678999998875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.34  E-value=0.029  Score=52.36  Aligned_cols=30  Identities=30%  Similarity=0.387  Sum_probs=26.5

Q ss_pred             cceeeccCCcceeEeCCC----CcEEEccccccc
Q 043148          162 QCIVHRDIKSSNVVLDSN----FNAKLGDFGLAR  191 (387)
Q Consensus       162 ~~iiH~dlk~~Nill~~~----~~~kl~Dfg~~~  191 (387)
                      ..++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            468999999999999876    789999999875

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.16  E-value=0.017  Score=52.73  Aligned_cols=31  Identities=19%  Similarity=0.241  Sum_probs=28.0

Q ss_pred             ccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       161 ~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      ...++|+|+++.|||++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            4789999999999999988899999999774

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=94.75  E-value=0.011  Score=34.98  Aligned_cols=28  Identities=29%  Similarity=0.202  Sum_probs=17.1

Q ss_pred             ceEEehHHHHHHHHHHHHHHHHHHHHhh
Q 043148            5 TGLIVGLLVGIGALACGLGVIWFMYWRK   32 (387)
Q Consensus         5 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~   32 (387)
                      .+.|+|++++.++.+++++.+.|+++||
T Consensus        10 ~GaIAGiVvG~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A           10 GGEIVAVIFGLLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCceeeeehHHHHHHHHHHHHHHHHeec
Confidence            3456778887766555555555555554

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=93.75  E-value=0.065  Score=50.67  Aligned_cols=79  Identities=9%  Similarity=0.059  Sum_probs=45.7

Q ss_pred             ccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCcccCchhhccCC---CCCccchHHHHHHHHHH
Q 043148          161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK---ASKESDVYSFGVVALEV  237 (387)
Q Consensus       161 ~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~Gvil~el  237 (387)
                      ...++|+|+++.|||++.++ +++.||+.+........-......-...|.+|+......   .....++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            47899999999999999876 999999988643221100000000012355555443111   11123445677777777


Q ss_pred             HhC
Q 043148          238 ACG  240 (387)
Q Consensus       238 ~tg  240 (387)
                      +.+
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=92.67  E-value=0.42  Score=40.52  Aligned_cols=81  Identities=10%  Similarity=0.037  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeeeeecCCcccCchhhccCCC
Q 043148          142 LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA  221 (387)
Q Consensus       142 l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  221 (387)
                      .+.++.|.+.+|.-+-..  +.-..+=+.|..|++..+|.+.+.+ +.+.             .....+.|||... ...
T Consensus        51 aWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~~~~~~~pe~~~-~~~  113 (229)
T 2yle_A           51 AWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AGEPPPVAGKLGY-SQC  113 (229)
T ss_dssp             HHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C-------------------------CCSS-SSS
T ss_pred             HHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-------------ccccCCCChhhcc-ccc
Confidence            356677777766554110  1111333457899999999988764 1110             0112356788653 344


Q ss_pred             CCccchHHHHHHHHHHHh
Q 043148          222 SKESDVYSFGVVALEVAC  239 (387)
Q Consensus       222 ~~~~Dvws~Gvil~el~t  239 (387)
                      +.+.-|||+|+++|.-+-
T Consensus       114 te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A          114 METEVIESLGIIIYKALD  131 (229)
T ss_dssp             CHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHHHHhh
Confidence            678889999999998875

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=92.64  E-value=0.011  Score=56.82  Aligned_cols=59  Identities=5%  Similarity=0.092  Sum_probs=16.4

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEE------EEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhh
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAV------KRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWC  134 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  134 (387)
                      .+.||   ||.||+|.+.....+|||      |.....  .......+.+|..++..++|||+++.+++.
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            45666   999999999765578999      766542  223345788999999999999999987754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=91.70  E-value=0.18  Score=45.73  Aligned_cols=32  Identities=28%  Similarity=0.402  Sum_probs=27.8

Q ss_pred             ccceeeccCCcceeEeCCC----CcEEEcccccccc
Q 043148          161 EQCIVHRDIKSSNVVLDSN----FNAKLGDFGLARL  192 (387)
Q Consensus       161 ~~~iiH~dlk~~Nill~~~----~~~kl~Dfg~~~~  192 (387)
                      ...++|||+.+.|||++.+    +.+.|.||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3689999999999999875    6899999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=90.09  E-value=0.3  Score=44.11  Aligned_cols=29  Identities=21%  Similarity=0.287  Sum_probs=25.4

Q ss_pred             ccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       161 ~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      ...++|+|+++.|||++ + .+.|+||+.+.
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            36689999999999999 4 89999998775

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.44  E-value=0.41  Score=44.09  Aligned_cols=30  Identities=20%  Similarity=0.393  Sum_probs=25.1

Q ss_pred             ccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       161 ~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      ...++|+|+.+.|||++.+. +.|+||..+.
T Consensus       211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            36799999999999998665 8999998774

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=88.26  E-value=0.43  Score=43.53  Aligned_cols=32  Identities=22%  Similarity=0.337  Sum_probs=28.1

Q ss_pred             ccceeeccCCcceeEeCCCCcEEEcccccccc
Q 043148          161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARL  192 (387)
Q Consensus       161 ~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~  192 (387)
                      ...++|+|+.+.||+++.++.+.|.||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            36799999999999999888899999987753

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=86.45  E-value=0.19  Score=30.20  Aligned_cols=7  Identities=29%  Similarity=0.501  Sum_probs=2.8

Q ss_pred             HHHHHhh
Q 043148           26 WFMYWRK   32 (387)
Q Consensus        26 ~~~~~~~   32 (387)
                      +|+++||
T Consensus        33 ~~~~~rR   39 (41)
T 2k9y_A           33 GFFIHRR   39 (41)
T ss_dssp             HHSSSSS
T ss_pred             heeEeee
Confidence            3444443

>2l9u_A Receptor tyrosine-protein kinase ERBB-3; transmenbrane dimer, membrane protein, EGFR; NMR {Homo sapiens}

Probab=81.36  E-value=0.97  Score=25.39  Aligned_cols=22  Identities=14%  Similarity=0.339  Sum_probs=13.1

Q ss_pred             ehHHHHHHHHHHHHHHHHHHHH
Q 043148            9 VGLLVGIGALACGLGVIWFMYW   30 (387)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~   30 (387)
                      +.+++|+++++++++..|++++
T Consensus        10 lt~i~gl~vif~~lg~tflywr   31 (40)
T 2l9u_A           10 LTVIAGLVVIFMMLGGTFLYWR   31 (40)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCceeEEEc
Confidence            4566677777666665544433

>2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B

Probab=80.90  E-value=0.68  Score=26.24  Aligned_cols=27  Identities=22%  Similarity=0.418  Sum_probs=17.6

Q ss_pred             ceEEehHHHHHHHHHHHHHHHHHHHHh
Q 043148            5 TGLIVGLLVGIGALACGLGVIWFMYWR   31 (387)
Q Consensus         5 ~~~i~~~~~~~~~~~~~~~~~~~~~~~   31 (387)
                      .+.++|++++-.+..++++++.|++.|
T Consensus         6 ~gaIaGIVvgdi~~t~~i~~~vy~~~r   32 (33)
T 2l34_A            6 PGVLAGIVVGDLVLTVLIALAVYFLGR   32 (33)
T ss_dssp             THHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             cceEEeEeHHHHHHHHHHHHHHhheec
Confidence            345677888877776666666666543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	387
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-53
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-52
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-52
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-48
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-48
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-48
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-48
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-48
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-47
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-47
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-46
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-44
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-43
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-43
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-42
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-42
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-41
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-39
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-39
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-37
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-37
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-36
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-36
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-36
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-36
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-35
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-34
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-30
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-28
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-27
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-17

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 3e-55
 Identities = 71/280 (25%), Positives = 121/280 (43%), Gaps = 50/280 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVK--RVSRGSKQGKKEYISEVRIISRLRHRNLVHLIG 132
           ++G G FG VY+G       ++AVK   V+  + Q  + + +EV ++ + RH N++  +G
Sbjct: 15  RIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 133 WCHEQRQLI-------------------------LHKIALGLASAVLYLHEEWEQCIVHR 167
           +    +  I                         L  IA   A  + YLH    + I+HR
Sbjct: 72  YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHR 128

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTT---GKASK 223
           D+KS+N+ L  +   K+GDFGLA +     GS Q   L+G++ ++APE +        S 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188

Query: 224 ESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER 283
           +SDVY+FG+V  E+  G+ P         +   + +  + G+G L          +    
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLSPDLS-----KVRSN 237

Query: 284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLP 323
             + +  +   C       RP   Q++  +  E    SLP
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASI--ELLARSLP 275

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  180 bits (457), Expect = 1e-54
 Identities = 65/301 (21%), Positives = 125/301 (41%), Gaps = 63/301 (20%)

Query: 58  FTYRELSRATNNFAEAG---------KLGEGGFGGVYRGLL---SDQNTEIAVKRVSRG- 104
           FT+ + + A   FA+            +G G FG V  G L     +   +A+K +  G 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 105 SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLILH--------------------- 143
           +++ +++++SE  I+ +  H N++HL G   +   +++                      
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 144 -----KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG 198
                 +  G+A+ + YL +      VHRD+ + N++++SN   K+ DFGL+R ++ +  
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 199 SQTTVLA----GTMGYLAPECVTTGKASKESDVYSFGVVALE-VACGRKPVEPRQEPSKV 253
             T   A      + + APE +   K +  SDV+S+G+V  E ++ G +P          
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---------- 233

Query: 254 RLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
                 +       ++ A +              L  + L C   D  +RP   Q++N L
Sbjct: 234 ------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

Query: 314 N 314
           +
Sbjct: 288 D 288

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (456), Expect = 1e-54
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 46/286 (16%)

Query: 55  PKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS 114
           P    Y +      +     KLG G +G VY G+    +  +AVK +   + +  +E++ 
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 62

Query: 115 EVRIISRLRHRNLVHLIGWCHEQRQLILH---------------------------KIAL 147
           E  ++  ++H NLV L+G C  +    +                             +A 
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122

Query: 148 GLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGT 207
            ++SA+ YL +   +  +HRD+ + N ++  N   K+ DFGL+RL+  +  +        
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179

Query: 208 MGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ 267
           + + APE +   K S +SDV++FGV+  E+A       P  + S               Q
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------------Q 224

Query: 268 LLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           + E  +     E  E   E +  +   C   + ++RPS  ++    
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 5e-53
 Identities = 62/288 (21%), Positives = 112/288 (38%), Gaps = 50/288 (17%)

Query: 62  ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISR 121
           E+ R   +     KLG+G FG V+ G  +   T +A+K +        + ++ E +++ +
Sbjct: 13  EIPR--ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKP-GTMSPEAFLQEAQVMKK 68

Query: 122 LRHRNLVHLIGWCHEQRQLI--------------------------LHKIALGLASAVLY 155
           LRH  LV L     E+   I                          L  +A  +AS + Y
Sbjct: 69  LRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128

Query: 156 LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPEC 215
           +        VHRD++++N+++  N   K+ DFGLARL++    +        + + APE 
Sbjct: 129 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185

Query: 216 VTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR 275
              G+ + +SDV+SFG++  E+    +   P                    ++L+  +  
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---------------EVLDQVERG 230

Query: 276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN--FEAPLPS 321
                     E L  +   C   +   RP+   +   L   F +  P 
Sbjct: 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 6e-53
 Identities = 57/278 (20%), Positives = 116/278 (41%), Gaps = 48/278 (17%)

Query: 62  ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISR 121
           E+ R         +LG G FG V+ G  +  +T++AVK + +GS      +++E  ++ +
Sbjct: 9   EVPR--ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQ 64

Query: 122 LRHRNLVHLIGWCHEQRQLI--------------------------LHKIALGLASAVLY 155
           L+H+ LV L     ++   I                          L  +A  +A  + +
Sbjct: 65  LQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 156 LHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPEC 215
           + E   +  +HRD++++N+++    + K+ DFGLARL++    +        + + APE 
Sbjct: 125 IEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 216 VTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR 275
           +  G  + +SDV+SFG++  E+    +   P                    ++++  +  
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---------------EVIQNLERG 226

Query: 276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
                 +   E L  +   C      +RP+   + +VL
Sbjct: 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 1e-52
 Identities = 55/299 (18%), Positives = 110/299 (36%), Gaps = 58/299 (19%)

Query: 66  ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQG-KKEYISEVRIISRLRH 124
             ++F +  +LG G  G V++         +A K +    K   + + I E++++     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 125 RNLVHLIGWCHEQRQLIL-------------------------HKIALGLASAVLYLHEE 159
             +V   G  +   ++ +                          K+++ +   + YL E+
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
               I+HRD+K SN++++S    KL DFG++  +     S      GT  Y++PE +   
Sbjct: 124 --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGT 178

Query: 220 KASKESDVYSFGVVALEVACGRKP-----------------------VEPRQEPSKVRLV 256
             S +SD++S G+  +E+A GR P                         PR       L 
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238

Query: 257 EWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL----WCCHPDFTNRPSIRQVIN 311
            +  D      + E  D  +++   +       +        C   +   R  ++Q++ 
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 5e-52
 Identities = 56/272 (20%), Positives = 106/272 (38%), Gaps = 46/272 (16%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNL 127
           +      ++G G FG V+ G   +   ++A+K +       ++++I E  ++ +L H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKL 62

Query: 128 VHLIGWCHEQRQLIL--------------------------HKIALGLASAVLYLHEEWE 161
           V L G C EQ  + L                            + L +      +    E
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEE 119

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA 221
            C++HRD+ + N ++  N   K+ DFG+ R V  +  + +T     + + +PE  +  + 
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD 281
           S +SDV+SFGV+  EV    K   P +  S   +VE +   +                  
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKI--PYENRSNSEVVEDISTGF-------------RLYKP 224

Query: 282 ERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
                 +  +   C      +RP+  +++  L
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 6e-51
 Identities = 56/273 (20%), Positives = 109/273 (39%), Gaps = 48/273 (17%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNL 127
            +     +LG G FG V  G       ++A+K +  GS   + E+I E +++  L H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKL 61

Query: 128 VHLIGWCHEQRQLIL--------------------------HKIALGLASAVLYLHEEWE 161
           V L G C +QR + +                           ++   +  A+ YL     
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES--- 118

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA 221
           +  +HRD+ + N +++     K+ DFGL+R V  +  + +      + +  PE +   K 
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 222 SKESDVYSFGVVALEV-ACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF 280
           S +SD+++FGV+  E+ + G+ P                ++ +   +  E     L    
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMP----------------YERFTNSETAEHIAQGLRLYR 222

Query: 281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
                E +  +   C H     RP+ + +++ +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 5e-50
 Identities = 57/293 (19%), Positives = 117/293 (39%), Gaps = 51/293 (17%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTE----IAVKRVSRGSKQG-KKEYISEVRIISRL 122
           +       +G G FG VY+G+L   + +    +A+K +  G  +  + +++ E  I+ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 123 RHRNLVHLIGWCHEQRQLIL--------------------------HKIALGLASAVLYL 156
            H N++ L G   + + +++                            +  G+A+ + YL
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPE 214
                   VHRD+ + N++++SN   K+ DFGL+R++  D E    T+     + + APE
Sbjct: 127 AN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 215 CVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG 274
            ++  K +  SDV+SFG+V  EV    +                        ++++A + 
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------------EVMKAIND 228

Query: 275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLP 327
                        +  + + C   +   RP    ++++L+     P     L 
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (420), Expect = 6e-49
 Identities = 59/273 (21%), Positives = 105/273 (38%), Gaps = 54/273 (19%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGK---KEYISEVRIISRLRHRN 126
           F++  ++G G FG VY       +  +A+K++S   KQ     ++ I EVR + +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 127 LVHLIGWCHEQRQLIL-------------------------HKIALGLASAVLYLHEEWE 161
            +   G    +    L                           +  G    + YLH    
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS--- 133

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT--- 218
             ++HRD+K+ N++L      KLGDFG A ++            GT  ++APE +     
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVILAMDE 188

Query: 219 GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK 278
           G+   + DV+S G+  +E+A  + P+      S +  +        + +      G  S+
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQNESPALQSGHWSE 241

Query: 279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
            F        +     C      +RP+   ++ 
Sbjct: 242 YFRN-----FV---DSCLQKIPQDRPTSEVLLK 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 2e-48
 Identities = 59/279 (21%), Positives = 113/279 (40%), Gaps = 44/279 (15%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           K+G+G  G VY  +      E+A+++++   +  K+  I+E+ ++   ++ N+V+ +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 135 HEQRQLIL------------------------HKIALGLASAVLYLHEEWEQCIVHRDIK 170
               +L +                          +      A+ +LH      ++HRDIK
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIK 143

Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSF 230
           S N++L  + + KL DFG    +  E  S+ + + GT  ++APE VT      + D++S 
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202

Query: 231 GVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMI 290
           G++A+E+  G  P         + L+              A +G    +  E+       
Sbjct: 203 GIMAIEMIEGEPPYLNENPLRALYLI--------------ATNGTPELQNPEKLSAIFRD 248

Query: 291 VGLWCCHPDFTNRPSIRQVIN--VLNFEAPLPSLPSKLP 327
               C   D   R S ++++    L    PL SL   + 
Sbjct: 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-48
 Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 54/285 (18%)

Query: 64  SRATNNFAEAGKLGEGGFGGVYRGLLSDQN---TEIAVKRVSRGSKQGK-KEYISEVRII 119
           S    +F E   +G G FG VY G L D +      AVK ++R +  G+  ++++E  I+
Sbjct: 25  SSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82

Query: 120 SRLRHRNLVHLIGWCHEQRQLIL---------------------------HKIALGLASA 152
               H N++ L+G C       L                               L +A  
Sbjct: 83  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142

Query: 153 VLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV---DHELGSQTTVLAGTMG 209
              +     +  VHRD+ + N +LD  F  K+ DFGLAR +   + +     T     + 
Sbjct: 143 ---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199

Query: 210 YLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL 269
           ++A E + T K + +SDV+SFGV+  E+     P  P  + +   +  ++     +G+ L
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLL----QGRRL 253

Query: 270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
              +        E        V L C HP    RPS  ++++ ++
Sbjct: 254 LQPEY-CPDPLYE--------VMLKCWHPKAEMRPSFSELVSRIS 289

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 3e-48
 Identities = 62/282 (21%), Positives = 121/282 (42%), Gaps = 50/282 (17%)

Query: 75  KLGEGGFGGVYRGLL--SDQNTEIAVKRVSRGSKQG-KKEYISEVRIISRLRHRNLVHLI 131
           +LG G FG V +G+     +  ++A+K + +G+++   +E + E +I+ +L +  +V LI
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 132 GWCHEQRQLI-------------------------LHKIALGLASAVLYLHEEWEQCIVH 166
           G C  +  ++                         + ++   ++  + YL E   +  VH
Sbjct: 76  GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 132

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
           RD+ + NV+L +   AK+ DFGL++ +  D    +  +     + + APEC+   K S  
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192

Query: 225 SDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ 284
           SDV+S+GV   E     +   P ++     ++ ++     +G+ +E        E     
Sbjct: 193 SDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFI----EQGKRMECPPE-CPPELYA-- 243

Query: 285 MECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKL 326
                 +   C    + +RP    V   +   A   SL SK+
Sbjct: 244 ------LMSDCWIYKWEDRPDFLTVEQRM--RACYYSLASKV 277

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 5e-48
 Identities = 62/272 (22%), Positives = 104/272 (38%), Gaps = 51/272 (18%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRH 124
            +F     LG+G FG VY          +A+K + +        + +   EV I S LRH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 125 RNLVHLIGWCHEQRQLILH-------------------------KIALGLASAVLYLHEE 159
            N++ L G+ H+  ++ L                               LA+A+ Y H  
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS- 124

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTG 219
             + ++HRDIK  N++L S    K+ DFG +        S+ T L GT+ YL PE +   
Sbjct: 125 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 179

Query: 220 KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE 279
              ++ D++S GV+  E   G+ P E        + +  V             +      
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------EFTFPDF 226

Query: 280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
             E   + +          + + RP +R+V+ 
Sbjct: 227 VTEGARDLIS----RLLKHNPSQRPMLREVLE 254

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 6e-48
 Identities = 60/283 (21%), Positives = 112/283 (39%), Gaps = 53/283 (18%)

Query: 64  SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISR 121
           SRA  ++     +G G +G   +         +  K +  GS  +  K+  +SEV ++  
Sbjct: 1   SRA-EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59

Query: 122 LRHRNLVHLIGWCHEQRQLILH-------------------------------KIALGLA 150
           L+H N+V       ++    L+                               ++   L 
Sbjct: 60  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119

Query: 151 SAVLYLHE--EWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTM 208
            A+   H   +    ++HRD+K +NV LD   N KLGDFGLAR+++H+  S      GT 
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTP 178

Query: 209 GYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL 268
            Y++PE +     +++SD++S G +  E+     P     +      +        +G+ 
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------EGKF 231

Query: 269 LEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
                 R S E +E     ++       +    +RPS+ +++ 
Sbjct: 232 RRIPY-RYSDELNE-----II---TRMLNLKDYHRPSVEEILE 265

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 8e-48
 Identities = 56/287 (19%), Positives = 103/287 (35%), Gaps = 50/287 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
            +G+G FG V+RG       E+AVK  S   ++       E+     LRH N++  I   
Sbjct: 10  SIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREA-EIYQTVMLRHENILGFIAAD 66

Query: 135 HEQRQLILH----------------------------KIALGLASAVLYLHEEWEQC--- 163
           ++                                   K+AL  AS + +LH E       
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 164 --IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE---LGSQTTVLAGTMGYLAPECVTT 218
             I HRD+KS N+++  N    + D GLA   D     +        GT  Y+APE +  
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 219 ------GKASKESDVYSFGVVALEVACGRKPVEPRQEPS----KVRLVEWVWDLYGKGQL 268
                  ++ K +D+Y+ G+V  E+A         ++       +   +   +   K   
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246

Query: 269 LEAADGRLSKEFDERQ-MECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
            +     +   +   + +  +  +   C + +   R +  ++   L+
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 9e-48
 Identities = 57/269 (21%), Positives = 99/269 (36%), Gaps = 51/269 (18%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVS--RGSKQGKKEYISEVRIISRLRHRNLVHLIG 132
           ++G G F  VY+GL ++   E+A   +   + +K  ++ +  E  ++  L+H N+V    
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 133 WCHEQRQL-----------------------------ILHKIALGLASAVLYLHEEWEQC 163
                 +                              +L      +   + +LH      
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP- 134

Query: 164 IVHRDIKSSNVVLDS-NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
           I+HRD+K  N+ +     + K+GD GLA L      S    + GT  ++APE     K  
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE-EKYD 190

Query: 223 KESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE 282
           +  DVY+FG+  LE+A    P    Q          ++     G    + D     E  E
Sbjct: 191 ESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPASFDKVAIPEVKE 244

Query: 283 RQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
                   +   C   +   R SI+ ++N
Sbjct: 245 --------IIEGCIRQNKDERYSIKDLLN 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 3e-47
 Identities = 62/270 (22%), Positives = 107/270 (39%), Gaps = 48/270 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNT--EIAVKRVSRGSKQG--KKEYISEVRIISRLRHRNLVHL 130
           +LG G FG V +G    +     +AVK +   +     K E ++E  ++ +L +  +V +
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 131 IGWCHEQRQLI------------------------LHKIALGLASAVLYLHEEWEQCIVH 166
           IG C  +  ++                        + ++   ++  + YL E      VH
Sbjct: 74  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVH 130

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
           RD+ + NV+L +   AK+ DFGL++ +  D       T     + + APEC+   K S +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190

Query: 225 SDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQ 284
           SDV+SFGV+  E     +      +         V  +  KG+ +    G   +E  +  
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKG------SEVTAMLEKGERMGCPAG-CPREMYD-- 241

Query: 285 MECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
                 +   C   D  NRP    V   L 
Sbjct: 242 ------LMNLCWTYDVENRPGFAAVELRLR 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 6e-47
 Identities = 54/269 (20%), Positives = 106/269 (39%), Gaps = 49/269 (18%)

Query: 74  GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGW 133
           G+LG+G FG VY+    + +   A K +   S++  ++Y+ E+ I++   H N+V L+  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 134 CHEQRQLIL--------------------------HKIALGLASAVLYLHEEWEQCIVHR 167
            + +  L +                            +      A+ YLH   +  I+HR
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-----S 222
           D+K+ N++   + + KL DFG++      +  + +   GT  ++APE V    +      
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEVVMCETSKDRPYD 193

Query: 223 KESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE 282
            ++DV+S G+  +E+A    P         +  +        +   L     R S  F +
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI-----AKSEPPTLAQPS-RWSSNFKD 247

Query: 283 RQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
                 +     C   +   R +  Q++ 
Sbjct: 248 -----FL---KKCLEKNVDARWTTSQLLQ 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-46
 Identities = 57/299 (19%), Positives = 114/299 (38%), Gaps = 51/299 (17%)

Query: 70  FAEAGKLGEGGFGGVYRGLLSDQNTE----IAVKRVSRG-SKQGKKEYISEVRIISRLRH 124
           F +   LG G FG VY+GL   +  +    +A+K +    S +  KE + E  +++ + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 125 RNLVHLIGWCHEQRQLILH-------------------------KIALGLASAVLYLHEE 159
            ++  L+G C      ++                             + +A  + YL   
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL--- 127

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD-HELGSQTTVLAGTMGYLAPECVTT 218
            ++ +VHRD+ + NV++ +  + K+ DFGLA+L+   E           + ++A E +  
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187

Query: 219 GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK 278
              + +SDV+S+GV   E+                      +D     ++    +     
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKGERL 232

Query: 279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPS--LPSKLPVPMYYAPP 335
                    + ++ + C   D  +RP  R++I   +  A  P   L  +    M+   P
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSP 291

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  160 bits (405), Expect = 2e-46
 Identities = 57/286 (19%), Positives = 104/286 (36%), Gaps = 47/286 (16%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           +LG G FG V+R          A K V    +  K+    E++ +S LRH  LV+L    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 135 HEQRQLIL--------------------------HKIALGLASAVLYLHEEWEQCIVHRD 168
            +  ++++                           +    +   + ++H   E   VH D
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149

Query: 169 IKSSNVVLDSNFN--AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
           +K  N++  +  +   KL DFGL   +D +   + T   GT  + APE          +D
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTD 207

Query: 227 VYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME 286
           ++S GV++  +  G  P     +   +R V           + ++A   +S++  +    
Sbjct: 208 MWSVGVLSYILLSGLSPFGGENDDETLRNV-----KSCDWNMDDSAFSGISEDGKD---- 258

Query: 287 CLMIVGLWCCHPDFTNRPSIRQVINVLNF-EAPLPSLPSKLPVPMY 331
             +         D   R +I Q +          P   S++P   Y
Sbjct: 259 -FI---RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRY 300

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 4e-46
 Identities = 69/267 (25%), Positives = 111/267 (41%), Gaps = 54/267 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
            +G+G FG V  G    +  ++AVK +   +    + +++E  ++++LRH NLV L+G  
Sbjct: 14  TIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 135 HEQRQLI----------------------------LHKIALGLASAVLYLHEEWEQCIVH 166
            E++  +                            L K +L +  A+ YL        VH
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126

Query: 167 RDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
           RD+ + NV++  +  AK+ DFGL +    E  S        + + APE +   K S +SD
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 182

Query: 227 VYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME 286
           V+SFG++  E+    +   PR         + V     KG  ++A DG       E    
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVEKGYKMDAPDG-CPPAVYE---- 231

Query: 287 CLMIVGLWCCHPDFTNRPSIRQVINVL 313
               V   C H D   RPS  Q+   L
Sbjct: 232 ----VMKNCWHLDAAMRPSFLQLREQL 254

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 5e-45
 Identities = 59/272 (21%), Positives = 97/272 (35%), Gaps = 45/272 (16%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI-SEVRIISRLRHRN 126
            ++     LGEG +G V   +       +AVK V         E I  E+ I   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 127 LVHLIGWCHEQRQLIL-------------------------HKIALGLASAVLYLHEEWE 161
           +V   G   E     L                          +    L + V+YLH    
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 121

Query: 162 QCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD-HELGSQTTVLAGTMGYLAPECVTTGK 220
             I HRDIK  N++LD   N K+ DFGLA +   +        + GT+ Y+APE +   +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 221 -ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE 279
             ++  DV+S G+V   +  G +    +   S     +W      + +       ++   
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWK-----EKKTYLNPWKKIDSA 235

Query: 280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
                    ++  +   +P    R +I  +  
Sbjct: 236 PLA------LLHKILVENPS--ARITIPDIKK 259

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 2e-44
 Identities = 61/269 (22%), Positives = 104/269 (38%), Gaps = 47/269 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQN---TEIAVKRVSRGSKQGKKE-YISEVRIISRLRHRNLVHL 130
            +GEG FG V++G+          +A+K     +    +E ++ E   + +  H ++V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 131 IGWCHEQRQLIL-------------------------HKIALGLASAVLYLHEEWEQCIV 165
           IG   E    I+                            A  L++A+ YL     +  V
Sbjct: 74  IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFV 130

Query: 166 HRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKES 225
           HRDI + NV++ SN   KLGDFGL+R ++     + +     + ++APE +   + +  S
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 190

Query: 226 DVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQM 285
           DV+ FGV   E+        P Q      ++  +      G+ L                
Sbjct: 191 DVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIE----NGERLPMPPN-CPPTLYS--- 240

Query: 286 ECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
             LM     C   D + RP   ++   L+
Sbjct: 241 --LM---TKCWAYDPSRRPRFTELKAQLS 264

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-43
 Identities = 58/272 (21%), Positives = 100/272 (36%), Gaps = 50/272 (18%)

Query: 75  KLGEGGFGGVYRGLL---SDQNTEIAVKRVSR---GSKQGKKEYISEVRIISRLRHRNLV 128
           KLG+G FG V RG     S +   +AVK +        +   ++I EV  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 129 HLIGWCHEQRQLI-------------------------LHKIALGLASAVLYLHEEWEQC 163
            L G        +                         L + A+ +A  + YL     + 
Sbjct: 75  RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KR 131

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLAPECVTTGKA 221
            +HRD+ + N++L +    K+GDFGL R +  + +             + APE + T   
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191

Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD 281
           S  SD + FGV   E+    +   P    +  +++  +                      
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQILHKID------------KEGERLPRP 237

Query: 282 ERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
           E   + +  V + C      +RP+   + + L
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (379), Expect = 3e-43
 Identities = 62/310 (20%), Positives = 111/310 (35%), Gaps = 74/310 (23%)

Query: 60  YRELSRATNNFAEAGKLGEGGFGGVYRG-----LLSDQNTEIAVKRVSR-GSKQGKKEYI 113
              L    NN      +GEG FG V++      L  +  T +AVK +    S   + ++ 
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 114 SEVRIISRLRHRNLVHLIGWCHEQRQLIL------------------------------- 142
            E  +++   + N+V L+G C   + + L                               
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 143 ------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKL 184
                               IA  +A+ + YL E   +  VHRD+ + N ++  N   K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181

Query: 185 GDFGLARLV-DHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKP 243
            DFGL+R +   +        A  + ++ PE +   + + ESDV+++GVV  E+      
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 244 VEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNR 303
             P    +   ++ +V D    G +L   +     E           +   C      +R
Sbjct: 242 --PYYGMAHEEVIYYVRD----GNILACPEN-CPLELYN--------LMRLCWSKLPADR 286

Query: 304 PSIRQVINVL 313
           PS   +  +L
Sbjct: 287 PSFCSIHRIL 296

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 4e-43
 Identities = 66/314 (21%), Positives = 119/314 (37%), Gaps = 67/314 (21%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNT--EIAVKRVSR-GSKQGKKEYISEVRIISRL-R 123
           N+      +GEG FG V +  +       + A+KR+    SK   +++  E+ ++ +L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 124 HRNLVHLIGWCHEQRQLILH---------------------------------------- 143
           H N+++L+G C  +  L L                                         
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 144 -KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT 202
              A  +A  + YL    ++  +HRD+ + N+++  N+ AK+ DFGL+R    E+  + T
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 184

Query: 203 VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDL 262
           +    + ++A E +     +  SDV+S+GV+  E+        P    +   L E +   
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLP-- 240

Query: 263 YGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN--FEAPLP 320
             +G  LE        E  +        +   C       RPS  Q++  LN   E    
Sbjct: 241 --QGYRLEKPLN-CDDEVYD--------LMRQCWREKPYERPSFAQILVSLNRMLEERKT 289

Query: 321 SLPSKLPVPMYYAP 334
            + + L     YA 
Sbjct: 290 YVNTTLYEKFTYAG 303

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  150 bits (379), Expect = 1e-42
 Identities = 51/281 (18%), Positives = 101/281 (35%), Gaps = 46/281 (16%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           +LG G FG V+R +          K ++      K    +E+ I+++L H  L++L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 135 HEQRQLIL--------------------------HKIALGLASAVLYLHEEWEQCIVHRD 168
            ++ +++L                                    + ++H   E  IVH D
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152

Query: 169 IKSSNVVLDSNFNA--KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
           IK  N++ ++   +  K+ DFGLA  ++        V   T  + APE V        +D
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFYTD 210

Query: 227 VYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME 286
           +++ GV+   +  G  P     +   ++ V          +  E A   +S E  +    
Sbjct: 211 MWAIGVLGYVLLSGLSPFAGEDDLETLQNV-----KRCDWEFDEDAFSSVSPEAKD---- 261

Query: 287 CLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLP 327
             +         +   R ++   +     +    +L S++P
Sbjct: 262 -FI---KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 298

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 4e-42
 Identities = 51/290 (17%), Positives = 100/290 (34%), Gaps = 68/290 (23%)

Query: 75  KLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRGSKQG-KKEYISEVRIISRL-RHRNL 127
            LG G FG V          SD    +AVK +   +    ++  +SE++++S L  H N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 128 VHLIGWCHEQRQLIL-------------------------------------------HK 144
           V+L+G C      ++                                             
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS-QTTV 203
            +  +A  + +L     +  +HRD+ + N++L      K+ DFGLAR + ++        
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLY 263
               + ++APE +     + ESDV+S+G+   E+                        + 
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------PYPGMP 252

Query: 264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
              +  +           E     +  +   C   D   RP+ +Q++ ++
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-41
 Identities = 59/320 (18%), Positives = 108/320 (33%), Gaps = 80/320 (25%)

Query: 55  PKRFTYR---ELSRATNNFAEAGKLGEGGFGGVYRGLLSDQN-----TEIAVKRVSRGSK 106
            + + Y    E  R   N      LG G FG V        +      ++AVK +   + 
Sbjct: 23  FREYEYDLKWEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD 80

Query: 107 QG-KKEYISEVRIISRL-RHRNLVHLIGWCHEQRQLIL---------------------- 142
              ++  +SE++++++L  H N+V+L+G C     + L                      
Sbjct: 81  SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 140

Query: 143 --------------------------HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL 176
                                        A  +A  + +L     +  VHRD+ + NV++
Sbjct: 141 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLV 197

Query: 177 DSNFNAKLGDFGLARLVDHELGSQT-TVLAGTMGYLAPECVTTGKASKESDVYSFGVVAL 235
                 K+ DFGLAR +  +            + ++APE +  G  + +SDV+S+G++  
Sbjct: 198 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 257

Query: 236 E-VACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLW 294
           E  + G  P                  +       +        +      E + I+   
Sbjct: 258 EIFSLGVNPYP---------------GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQS 302

Query: 295 CCHPDFTNRPSIRQVINVLN 314
           C   D   RPS   + + L 
Sbjct: 303 CWAFDSRKRPSFPNLTSFLG 322

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 2e-40
 Identities = 56/300 (18%), Positives = 103/300 (34%), Gaps = 54/300 (18%)

Query: 65  RATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISR 121
           +   +F     LGEG F  V        + E A+K + +     +        E  ++SR
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 122 LRHRNLVHLIGWCHEQRQLIL----------------------HKIALGLASAVLYLHEE 159
           L H   V L     +  +L                               A  V  L   
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 160 WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE-LGSQTTVLAGTMGYLAPECVTT 218
             + I+HRD+K  N++L+ + + ++ DFG A+++  E   ++     GT  Y++PE +T 
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 219 GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK 278
             A K SD+++ G +  ++  G  P     E    + +     +  +    E    +   
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-----IKLEYDFPE----KFFP 235

Query: 279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINV-----------LNFEAPLPSLPSKLP 327
           +  +     L+         D T R    ++              + +E      P KL 
Sbjct: 236 KARD-----LV---EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 2e-40
 Identities = 58/296 (19%), Positives = 106/296 (35%), Gaps = 43/296 (14%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI-----SEVRIISRLRHRNLVH 129
            LGEG F  VY+    + N  +A+K++  G +   K+ I      E++++  L H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 130 LIGWCHEQRQLIL----------------------HKIALGLASAVLYLHEEWEQCIVHR 167
           L+     +  + L                        I   +   +  L    +  I+HR
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124

Query: 168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKESD 226
           D+K +N++LD N   KL DFGLA+       + T     T  Y APE +   +      D
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ-VVTRWYRAPELLFGARMYGVGVD 183

Query: 227 VYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV------------WDLYGKGQLLEAADG 274
           +++ G +  E+      +    +  ++  +                 L            
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243

Query: 275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF-EAPLPSLPSKLPVP 329
            L   F     + L ++       +   R +  Q + +  F   P P+   +LP P
Sbjct: 244 PLHHIFSAAGDDLLDLI-QGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 8e-40
 Identities = 54/328 (16%), Positives = 111/328 (33%), Gaps = 47/328 (14%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
            LG G FG V+R + +        K V       +     E+ I++  RHRN++HL    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 135 HEQRQLILH--------------------------KIALGLASAVLYLHEEWEQCIVHRD 168
               +L++                                +  A+ +LH      I H D
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFD 127

Query: 169 IKSSNVVLDSNFNA--KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESD 226
           I+  N++  +  ++  K+ +FG AR +    G    +L     Y APE       S  +D
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEVHQHDVVSTATD 185

Query: 227 VYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME 286
           ++S G +   +  G  P         +  +     +  +    E A   +S E  +    
Sbjct: 186 MWSLGTLVYVLLSGINPFLAETNQQIIENI-----MNAEYTFDEEAFKEISIEAMD---- 236

Query: 287 CLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLPSKLPVPMYYAPPINILKFTYTSS 346
             +         +  +R +  + +     +  +  + +K+   + +    + L     + 
Sbjct: 237 -FV---DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNM 292

Query: 347 GVTESDKFYGTQNSGSSGSTYSSLSSAA 374
            V+ +    G       G + + +  A+
Sbjct: 293 VVSAARISCGGAIRSQKGVSVAKVKVAS 320

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (354), Expect = 2e-39
 Identities = 49/201 (24%), Positives = 81/201 (40%), Gaps = 29/201 (14%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRH 124
            +F     LG G FG V+           A+K + +      +  +    E  ++S + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 125 RNLVHLIGWCHEQRQLI----------------------LHKIALGLASAVLYLHEEWEQ 162
             ++ + G   + +Q+                               A   L L     +
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            I++RD+K  N++LD N + K+ DFG A+ V       T  L GT  Y+APE V+T   +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 223 KESDVYSFGVVALEVACGRKP 243
           K  D +SFG++  E+  G  P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (352), Expect = 3e-39
 Identities = 57/295 (19%), Positives = 100/295 (33%), Gaps = 42/295 (14%)

Query: 69  NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRN 126
           NF +  K+GEG +G VY+         +A+K++     ++      I E+ ++  L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 127 LVHLIGWCHEQRQLILH-----------------------KIALGLASAVLYLHEEWEQC 163
           +V L+   H + +L L                         I   L   +  L       
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           ++HRD+K  N+++++    KL DFGLAR     + + T  +           +     S 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182

Query: 224 ESDVYSFGVVALEVACGRKP-------------VEPRQEPSKVRLVEWVWDLYGKGQLLE 270
             D++S G +  E+   R                     P +V           K    +
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242

Query: 271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVIN---VLNFEAPLPSL 322
            A    SK       +   ++     H D   R S +  +      +   P+P L
Sbjct: 243 WARQDFSKVVPPLDEDGRSLL-SQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 296

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 6e-39
 Identities = 61/294 (20%), Positives = 121/294 (41%), Gaps = 62/294 (21%)

Query: 62  ELSRATNNFAEAGKLGEGGFGGVYRGLL-----SDQNTEIAVKRVSRG-SKQGKKEYISE 115
           E++R       + +LG+G FG VY G+       +  T +A+K V+   S + + E+++E
Sbjct: 16  EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73

Query: 116 VRIISRLRHRNLVHLIGWCHEQRQLIL--------------------------------- 142
             ++      ++V L+G   + +  ++                                 
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 143 --HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV-DHELGS 199
              ++A  +A     +        VHRD+ + N ++  +F  K+GDFG+ R + + +   
Sbjct: 134 KMIQMAGEIADG---MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV 259
           +       + +++PE +  G  +  SDV+SFGVV  E+A   +   P Q  S  +++ +V
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFV 248

Query: 260 WDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVL 313
            +    G LL+  D        E        +   C   +   RPS  ++I+ +
Sbjct: 249 ME----GGLLDKPDN-CPDMLFE--------LMRMCWQYNPKMRPSFLEIISSI 289

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 52/278 (18%), Positives = 99/278 (35%), Gaps = 41/278 (14%)

Query: 60  YRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYI-SEVRI 118
           +++     + +     LG G F  V           +A+K +++ + +GK+  + +E+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 119 ISRLRHRNLVHLIGWCHEQRQLIL-------------------------HKIALGLASAV 153
           + +++H N+V L         L L                          ++   +  AV
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 120

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAP 213
            YLH+        +        LD +    + DFGL+++ D   GS  +   GT GY+AP
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAP 178

Query: 214 ECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD 273
           E +     SK  D +S GV+A  + CG  P     +      +     L  + +      
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-----LKAEYEFDSPYW 233

Query: 274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
             +S    +      +         D   R +  Q + 
Sbjct: 234 DDISDSAKD-----FI---RHLMEKDPEKRFTCEQALQ 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  137 bits (346), Expect = 9e-38
 Identities = 53/273 (19%), Positives = 97/273 (35%), Gaps = 52/273 (19%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLR- 123
           N+F+    +G GGFG VY    +D     A+K + +     KQG+   ++E  ++S +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 124 --HRNLVHLIGWCHEQRQLIL-------------------------HKIALGLASAVLYL 156
                +V +    H   +L                              A  +   + ++
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 157 HEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECV 216
           H    + +V+RD+K +N++LD + + ++ D GLA         +     GT GY+APE +
Sbjct: 124 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHASVGTHGYMAPEVL 177

Query: 217 TTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR 275
             G A    +D +S G +  ++  G  P    +   K  +      +  +          
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------LPDS 231

Query: 276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQ 308
            S E        L+         D   R     
Sbjct: 232 FSPELRS-----LL---EGLLQRDVNRRLGCLG 256

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  133 bits (335), Expect = 5e-37
 Identities = 61/284 (21%), Positives = 101/284 (35%), Gaps = 59/284 (20%)

Query: 69  NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---------KQGKKEYISEVRII 119
           N+     LG G    V R +      E AVK +             ++ ++  + EV I+
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 120 SRLR-HRNLVHLIGWCHEQRQLIL-------------------------HKIALGLASAV 153
            ++  H N++ L           L                          KI   L   +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAP 213
             LH+     IVHRD+K  N++LD + N KL DFG +  +D   G +   + GT  YLAP
Sbjct: 124 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLAP 178

Query: 214 ECVTTGKA------SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ 267
           E +            KE D++S GV+   +  G  P   R++   +R++     + G  Q
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-----MSGNYQ 233

Query: 268 LLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
                    S    +      ++       P    R +  + + 
Sbjct: 234 FGSPEWDDYSDTVKD------LVSRFLVVQPQ--KRYTAEEALA 269

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 7e-37
 Identities = 56/290 (19%), Positives = 105/290 (36%), Gaps = 67/290 (23%)

Query: 75  KLGEGGFGGVYRGLLSDQN-----TEIAVKRVSRGSKQG-KKEYISEVRIISR-LRHRNL 127
            LG G FG V        +       +AVK +  G+     +  +SE++I+     H N+
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 128 VHLIGWCHEQRQLIL------------------------------------------HKI 145
           V+L+G C +    ++                                             
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVL 204
           +  +A  + +L     +  +HRD+ + N++L      K+ DFGLAR +  +    +    
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 205 AGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYG 264
              + ++APE +     + +SDV+SFGV+  E+        P  +       E       
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-----DEEFCRRLK 251

Query: 265 KGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
           +G  + A D   + E  +          L C H + + RP+  +++  L 
Sbjct: 252 EGTRMRAPDY-TTPEMYQ--------TMLDCWHGEPSQRPTFSELVEHLG 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 9e-37
 Identities = 62/291 (21%), Positives = 118/291 (40%), Gaps = 69/291 (23%)

Query: 75  KLGEGGFGGVYRGLL-------SDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHR 125
            LGEG FG V             ++ T++AVK +    +++   + ISE+ ++  + +H+
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 126 NLVHLIGWCHEQRQLIL-----------------------------------------HK 144
           N+++L+G C +   L +                                           
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 145 IALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH-ELGSQTTV 203
            A  +A  + YL     +  +HRD+ + NV++  +   K+ DFGLAR + H +   +TT 
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLY 263
               + ++APE +     + +SDV+SFGV+  E+            P     VE ++ L 
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------PYPGVPVEELFKLL 250

Query: 264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
            +G  ++      + E           +   C H   + RP+ +Q++  L+
Sbjct: 251 KEGHRMDKPSN-CTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLD 292

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-36
 Identities = 62/296 (20%), Positives = 110/296 (37%), Gaps = 52/296 (17%)

Query: 63  LSRATNNFAEAGKLGEGGFGGVYRGL-LSDQNTEIAVKRVSR--GSKQGKKEYISEVRII 119
           L RA   +    ++GEG +G V++   L +    +A+KRV    G +      I EV ++
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 120 SRL---RHRNLVHLIGWCHEQRQLILHK-------------------------------I 145
             L    H N+V L   C   R     K                               +
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 146 ALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLA 205
              L   + +LH      +VHRD+K  N+++ S+   KL DFGLAR+   ++   + V  
Sbjct: 122 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-- 176

Query: 206 GTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV--------- 256
            T+ Y APE +     +   D++S G +  E+   +       +  ++  +         
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236

Query: 257 -EWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
            +W  D+    Q   +   +  ++F     E    + L C   +   R S    ++
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-36
 Identities = 49/269 (18%), Positives = 92/269 (34%), Gaps = 47/269 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS------EVRIISRLRHRNLV 128
           +LG G F  V +        + A K + +   +  +  +S      EV I+  ++H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 129 HLIGWCHEQRQLIL----------------------HKIALGLASAVLYLHEEWEQCIVH 166
            L      +  +IL                       +    L   +  ++      I H
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136

Query: 167 RDIKSSNVVLDSN----FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            D+K  N++L          K+ DFGLA  +D   G++   + GT  ++APE V      
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLG 194

Query: 223 KESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE 282
            E+D++S GV+   +  G  P     +   +  V          +  +      S    +
Sbjct: 195 LEADMWSIGVITYILLSGASPFLGDTKQETLANV-----SAVNYEFEDEYFSNTSALAKD 249

Query: 283 RQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
                 +         D   R +I+  + 
Sbjct: 250 -----FI---RRLLVKDPKKRMTIQDSLQ 270

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 3e-36
 Identities = 52/289 (17%), Positives = 103/289 (35%), Gaps = 45/289 (15%)

Query: 67  TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQG-KKEYISEVRIISRLRHR 125
              +     +GEG +G V     +     +A+K++S    Q   +  + E++I+ R RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 126 NLVHLIGWCHE-------------------------QRQLILHKIALGLASAVLYLHEEW 160
           N++ +                                + L    I   L   +  L    
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 161 EQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT--TVLAGTMGYLAPECVTT 218
              ++HRD+K SN++L++  + K+ DFGLAR+ D +       T    T  Y APE +  
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186

Query: 219 GKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR-- 275
            K  +K  D++S G +  E+   R     +    ++  +  +     +  L    + +  
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246

Query: 276 -------------LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
                         ++ F     + L ++       +   R  + Q + 
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLL-DKMLTFNPHKRIEVEQALA 294

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 3e-36
 Identities = 58/272 (21%), Positives = 99/272 (36%), Gaps = 50/272 (18%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEY---ISEVRIISR-LR 123
            +F     LG+G FG V+       N   A+K + +       +    + E R++S    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 124 HRNLVHLIGWCHEQRQLILH-------------------------KIALGLASAVLYLHE 158
           H  L H+      +  L                              A  +   + +L  
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL-- 119

Query: 159 EWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTT 218
              + IV+RD+K  N++LD + + K+ DFG+ +          T   GT  Y+APE +  
Sbjct: 120 -HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-CGTPDYIAPEILLG 177

Query: 219 GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK 278
            K +   D +SFGV+  E+  G+ P   + E      +      Y +          L K
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW---------LEK 228

Query: 279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVI 310
           E  +      ++V L+   P+   R  +R  I
Sbjct: 229 EAKD------LLVKLFVREPE--KRLGVRGDI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 9e-36
 Identities = 51/201 (25%), Positives = 78/201 (38%), Gaps = 26/201 (12%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRH 124
           N+F     LG+G FG V            A+K + +    +K      ++E R++   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 125 RNLVHLIGWCHEQRQLILH----------------------KIALGLASAVLYLHEEWEQ 162
             L  L        +L                         +     A  V  L     +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKAS 222
            +V+RDIK  N++LD + + K+ DFGL +    + G+      GT  YLAPE +      
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDNDYG 183

Query: 223 KESDVYSFGVVALEVACGRKP 243
           +  D +  GVV  E+ CGR P
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLP 204

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  130 bits (326), Expect = 1e-35
 Identities = 49/280 (17%), Positives = 99/280 (35%), Gaps = 37/280 (13%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRV--SRGSKQGKKEYISEVRIISRLRHR 125
             +    K+GEG +G VY+   +      A+K++   +  +      I E+ I+  L+H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 126 NLVHLIGWCHEQRQLIL----------------------HKIALGLASAVLYLHEEWEQC 163
           N+V L    H +++L+L                            L   +  +    ++ 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 164 IVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASK 223
           ++HRD+K  N++++     K+ DFGLAR     +   T  +           + + K S 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 224 ESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV--------WDLYGKGQLLEAADGR 275
             D++S G +  E+  G        E  ++  +  +        W    +    +     
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 276 LSKEFDERQMECLMIVGL----WCCHPDFTNRPSIRQVIN 311
                 E  ++ L   G+         D   R + +Q + 
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  129 bits (325), Expect = 2e-35
 Identities = 57/273 (20%), Positives = 93/273 (34%), Gaps = 44/273 (16%)

Query: 64  SRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGK---KEYISEVRIIS 120
           S  ++ +     LG GG   V+       + ++AVK +     +       +  E +  +
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 121 RLRHRNLVHLIGWC--------------------------HEQRQLILHKIALGLASAVL 154
            L H  +V +                              H +  +   +    +A A  
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122

Query: 155 YLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLV--DHELGSQTTVLAGTMGYLA 212
            L+   +  I+HRD+K +N+++ +    K+ DFG+AR +       +QT  + GT  YL+
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 213 PECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA 272
           PE          SDVYS G V  EV  G  P       S          +        A 
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-----VREDPIPPSAR 237

Query: 273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPS 305
              LS + D         V L     +  NR  
Sbjct: 238 HEGLSADLDA--------VVLKALAKNPENRYQ 262

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-35
 Identities = 46/274 (16%), Positives = 97/274 (35%), Gaps = 37/274 (13%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIG 132
           K+GEG +G V++    + +  +A+KRV      +      + E+ ++  L+H+N+V L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 133 WCHEQRQLIL----------------------HKIALGLASAVLYLHEEWEQCIVHRDIK 170
             H  ++L L                        +   L   +  L     + ++HRD+K
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK 128

Query: 171 SSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSF 230
             N++++ N   KL +FGLAR     +   +  +                 S   D++S 
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188

Query: 231 GVVALEVACGRKPVEPRQEPS----KVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQME 286
           G +  E+A   +P+ P  +      ++  +           + +  D +    +      
Sbjct: 189 GCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSL 248

Query: 287 CLMIVGL---------WCCHPDFTNRPSIRQVIN 311
             ++  L              +   R S  + + 
Sbjct: 249 VNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  129 bits (324), Expect = 2e-35
 Identities = 46/277 (16%), Positives = 95/277 (34%), Gaps = 51/277 (18%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           ++GEG FG ++ G     N ++A+K   R  +    +   E R    L     +  + + 
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 135 HEQRQLIL--------------------------HKIALGLASAVLYLHEEWEQCIVHRD 168
            ++    +                             A  + + V  +HE   + +V+RD
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRD 126

Query: 169 IKSSNVVLDSNFN-----AKLGDFGLARLVDHELGSQ------TTVLAGTMGYLAPECVT 217
           IK  N ++    +       + DFG+ +     +  Q         L+GT  Y++     
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 218 TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS 277
             + S+  D+ + G V +    G  P +  +  +  +  E + +      L E   G   
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG-FP 245

Query: 278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
           +EF +      M    +  +  F   P    +  + +
Sbjct: 246 EEFYK-----YM---HYARNLAFDATPDYDYLQGLFS 274

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (324), Expect = 3e-35
 Identities = 50/275 (18%), Positives = 90/275 (32%), Gaps = 49/275 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           K+G G FG +Y G       E+A+K     +K    +   E +I   ++    +  I WC
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 135 HEQRQLIL--------------------------HKIALGLASAVLYLHEEWEQCIVHRD 168
             +    +                            +A  + S + Y+H    +  +HRD
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRD 128

Query: 169 IKSSNVV---LDSNFNAKLGDFGLARLVDHELGSQ------TTVLAGTMGYLAPECVTTG 219
           +K  N +           + DFGLA+        Q         L GT  Y +       
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188

Query: 220 KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE 279
           + S+  D+ S G V +    G  P +  +  +K +  E + +      +     G    E
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG-YPSE 247

Query: 280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN 314
           F        +    +C    F ++P    +  +  
Sbjct: 248 FAT-----YL---NFCRSLRFDDKPDYSYLRQLFR 274

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 6e-34
 Identities = 64/329 (19%), Positives = 112/329 (34%), Gaps = 67/329 (20%)

Query: 52  GTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKE 111
           G GP R   +E+S     + +   +G G FG VY+  L D    +A+K+V +  +   + 
Sbjct: 11  GQGPDR--PQEVS-----YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR- 62

Query: 112 YISEVRIISRLRHRNLVHLIGWCHE--------------------QRQLILH-------- 143
              E++I+ +L H N+V L  + +                       ++  H        
Sbjct: 63  ---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119

Query: 144 ------KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN-FNAKLGDFGLARLVDHE 196
                      L  ++ Y+H      I HRDIK  N++LD +    KL DFG A+ +   
Sbjct: 120 PVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176

Query: 197 LGSQTTVLAGTMGYLAP-ECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRL 255
             + + +   +  Y AP         +   DV+S G V  E+  G+          ++  
Sbjct: 177 EPNVSYI--CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234

Query: 256 VEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL------------WCCHPDFTNR 303
           +  V     + Q+ E        +F + +      V                     T R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

Query: 304 PSIRQVIN---VLNFEAPLPSLPSKLPVP 329
            +  +            P   LP+    P
Sbjct: 295 LTPLEACAHSFFDELRDPNVKLPNGRDTP 323

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 1e-33
 Identities = 59/270 (21%), Positives = 101/270 (37%), Gaps = 59/270 (21%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKE------YISEVRIISRLR--HRN 126
            LG GGFG VY G+    N  +A+K V +       E         EV ++ ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 127 LVHLIGWCHEQRQLILH----------------------KIALGLASAVLY-LHEEWEQC 163
           ++ L+ W       +L                       ++A      VL  +       
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130

Query: 164 IVHRDIKSSNVVLDSN-FNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKA- 221
           ++HRDIK  N+++D N    KL DFG   L+     +  T   GT  Y  PE +   +  
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRYHRYH 187

Query: 222 SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFD 281
            + + V+S G++  ++ CG  P E  +E  + ++                   R+S E  
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF---------------FRQRVSSECQ 232

Query: 282 ERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
                 L+    WC     ++RP+  ++ N
Sbjct: 233 H-----LI---RWCLALRPSDRPTFEEIQN 254

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (313), Expect = 2e-33
 Identities = 62/311 (19%), Positives = 115/311 (36%), Gaps = 52/311 (16%)

Query: 63  LSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGK--KEYISEVRIIS 120
                + + +  K+G+G FG V++        ++A+K+V   +++       + E++I+ 
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64

Query: 121 RLRHRNLVHLIGWCHEQ------------------------------RQLILHKIALGLA 150
            L+H N+V+LI  C  +                               +  L +I   + 
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124

Query: 151 SAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS---QTTVLAGT 207
             +  L+      I+HRD+K++NV++  +   KL DFGLAR       S   + T    T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 208 MGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV------- 259
           + Y  PE +   +      D++  G +  E+      ++   E  ++ L+  +       
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 260 ----WDLYGKGQLLEAADGRLSKEFDERQMECLMIVGL----WCCHPDFTNRPSIRQVIN 311
                D Y   + LE   G+  K  D  +        L         D   R      +N
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

Query: 312 VLNF-EAPLPS 321
              F   P+PS
Sbjct: 305 HDFFWSDPMPS 315

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  120 bits (302), Expect = 1e-31
 Identities = 60/281 (21%), Positives = 103/281 (36%), Gaps = 49/281 (17%)

Query: 38  KEAIDIALEDEFEKGTGPKRFTYRELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIA 97
           KE +  A ED  +K   P + T +      + F     LG G FG V      +     A
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQ-----LDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70

Query: 98  VKRVSRGSKQGKKEY---ISEVRIISRLRHRNLVHLIGWCHEQRQLILH----------- 143
           +K + +      K+    ++E RI+  +    LV L     +   L +            
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130

Query: 144 --------------KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL 189
                           A  +     YLH      +++RD+K  N+++D     ++ DFG 
Sbjct: 131 HLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF 187

Query: 190 ARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQE 249
           A+ V      +T  L GT   LAPE + +   +K  D ++ GV+  E+A G     P   
Sbjct: 188 AKRVKG----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP---PFFA 240

Query: 250 PSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMI 290
              +++ E +    GK +         S +  +     L +
Sbjct: 241 DQPIQIYEKIV--SGKVRFPS----HFSSDLKDLLRNLLQV 275

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-30
 Identities = 52/305 (17%), Positives = 103/305 (33%), Gaps = 59/305 (19%)

Query: 58  FTYRELSRATNNFAEA----GKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKE 111
           F  +E+++              +G G +G V   +      ++A+K++ R   S+   K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 112 YISEVRIISRLRHRNLVHLIGWCHEQRQLILH---------------------------- 143
              E+R++  +RH N++ L+        L                               
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 144 -KIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT 202
             +   +   + Y+H      I+HRD+K  N+ ++ +   K+ DFGLAR  D    S+ T
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMT 176

Query: 203 VLAGTMGYLAPECV-TTGKASKESDVYSFGVVALEVACGRKP---------------VEP 246
               T  Y APE +    + ++  D++S G +  E+  G+                 V  
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236

Query: 247 RQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSI 306
                 V+ ++          L E      +          + ++       D   R + 
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL-EKMLVLDAEQRVTA 295

Query: 307 RQVIN 311
            + + 
Sbjct: 296 GEALA 300

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 7e-30
 Identities = 53/271 (19%), Positives = 88/271 (32%), Gaps = 54/271 (19%)

Query: 76  LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL-RHRNLVHLIGWC 134
           LG G  G V +        + A+K +         +   EV +  R  +  ++V ++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 74

Query: 135 HEQ-------------------RQLILHK------------IALGLASAVLYLHEEWEQC 163
                                    I  +            I   +  A+ YLH      
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---IN 131

Query: 164 IVHRDIKSSNVVLDSNFN---AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGK 220
           I HRD+K  N++  S       KL DFG A+       +  T    T  Y+APE +   K
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTPYYVAPEVLGPEK 189

Query: 221 ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF 280
             K  D++S GV+   + CG  P         +          G+ +        +S+E 
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248

Query: 281 DERQMECLMIVGLWCCHPDFTNRPSIRQVIN 311
                  L+         + T R +I + +N
Sbjct: 249 KM-----LI---RNLLKTEPTQRMTITEFMN 271

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 3e-28
 Identities = 58/335 (17%), Positives = 109/335 (32%), Gaps = 59/335 (17%)

Query: 58  FTYRELSRA----TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKE 111
           F  +EL++        +     +G G +G V     +     +AVK++SR   S    K 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 112 YISEVRIISRLRHRNLVHLIGWCHEQRQLI-----------------------------L 142
              E+R++  ++H N++ L+      R L                              +
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 123

Query: 143 HKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT 202
             +   +   + Y+H      I+HRD+K SN+ ++ +   K+ DFGLAR  D E    T 
Sbjct: 124 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTG 177

Query: 203 VLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV------ 256
            +A          +     ++  D++S G +  E+  GR          +++L+      
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237

Query: 257 --EWVWDLYGKG-------QLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIR 307
               +               L +      +  F       + ++       D   R +  
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL-EKMLVLDSDKRITAA 296

Query: 308 QVINVLNFEAPLPSLPSKLPVPMYYAPPINILKFT 342
           Q +    + A     P   PV   Y          
Sbjct: 297 QALA-HAYFAQYHD-PDDEPVADPYDQSFESRDLL 329

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-27
 Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 32/208 (15%)

Query: 68  NNFAEAGKLGEGGFGGVYRG---LLSDQNTEIAVKRVSRGS----KQGKKEYISEVRIIS 120
            NF     LG G +G V+        D     A+K + + +     +  +   +E +++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 121 RLRHR-NLVHLIGWCHEQRQLILH----------------------KIALGLASAVLYLH 157
            +R    LV L      + +L L                       ++ + +   VL L 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 158 EEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVT 217
              +  I++RDIK  N++LDSN +  L DFGL++    +   +     GT+ Y+AP+ V 
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203

Query: 218 TGKA--SKESDVYSFGVVALEVACGRKP 243
            G +   K  D +S GV+  E+  G  P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 6e-27
 Identities = 44/205 (21%), Positives = 80/205 (39%), Gaps = 35/205 (17%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIG 132
            +G G  G V     +  +  +A+K++SR   ++   K    E+ ++  + H+N++ L+ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 133 WCHEQRQL----------------------------ILHKIALGLASAVLYLHEEWEQCI 164
               Q+ L                             +  +   +   + +LH      I
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---I 140

Query: 165 VHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKE 224
           +HRD+K SN+V+ S+   K+ DFGLAR          T    T  Y APE +      + 
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKEN 198

Query: 225 SDVYSFGVVALEVACGRKPVEPRQE 249
            D++S G +  E+   +     R  
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPGRDY 223

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  105 bits (263), Expect = 3e-26
 Identities = 56/292 (19%), Positives = 105/292 (35%), Gaps = 56/292 (19%)

Query: 68  NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRN 126
           +++    KLG G +  V+  +    N ++ VK +       KK+   E++I+  LR   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPN 91

Query: 127 LVHLIGWCHEQ-----------------RQLI-------LHKIALGLASAVLYLHEEWEQ 162
           ++ L     +                  +QL        +      +  A+ Y H     
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SM 148

Query: 163 CIVHRDIKSSNVVLDS-NFNAKLGDFGLARLVDHELGSQTTVLAGTMGYLAPE-CVTTGK 220
            I+HRD+K  NV++D  +   +L D+GLA       G +  V   +  +  PE  V    
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPELLVDYQM 206

Query: 221 ASKESDVYSFGVVALEVACGRKP-------VEPRQEPSKVRLVEWVWDLYGKGQLLEAAD 273
                D++S G +   +   ++P        +     +KV   E ++D   K  +     
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 274 -----GRLSKEFDERQMECLMIVGL---------WCCHPDFTNRPSIRQVIN 311
                GR S++  ER +       +              D  +R + R+ + 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (249), Expect = 3e-24
 Identities = 43/228 (18%), Positives = 75/228 (32%), Gaps = 46/228 (20%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWC 134
           KLG G F  V+       NT +A+K V RG K   +    E++++ R+   +        
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 135 HEQRQLILH-----------------------------------------KIALGLASAV 153
                 +L                                          +I+  L   +
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 154 LYLHEEWEQCIVHRDIKSSNVVLDSN-FNAKLGDFGLARLVDH-ELGSQTTVLAGTMGYL 211
            Y+H      I+H DIK  NV+++       L    +A L +        T    T  Y 
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 212 APECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV 259
           +PE +        +D++S   +  E+  G    EP +  S  +  + +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 76.7 bits (188), Expect = 4e-17
 Identities = 29/154 (18%), Positives = 43/154 (27%), Gaps = 37/154 (24%)

Query: 75  KLGEGGFGGVYRGLLSDQNTEIAVK--RVSRGSKQ--------GKKEYISEVRIISRLRH 124
            +GEG    V+         E  VK  +V   S +        G   +       +R   
Sbjct: 7   LMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 125 RNLVHLIG----------------------WCHEQRQLILHKIALGLASAVLYLHEEWEQ 162
           R L  L G                        +  R     ++   +   V   +     
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG-- 123

Query: 163 CIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE 196
            IVH D+   N VL S     + DF  +  V  E
Sbjct: 124 -IVHGDLSQYN-VLVSEEGIWIIDFPQSVEVGEE 155

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	387
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.9
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.94
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.92
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.7
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.16
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.05

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=378.77  Aligned_cols=232  Identities=22%  Similarity=0.355  Sum_probs=191.4

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~------  141 (387)
                      ++|...+.||+|+||+||+|++..+|+.||||++........+.+.+|+++|+.++|||||++++++.+.+..+      
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999999999999999997665566788999999999999999999999887654322      


Q ss_pred             ------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceeee
Q 043148          142 ------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTTV  203 (387)
Q Consensus       142 ------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  203 (387)
                                        +..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus       100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~  175 (293)
T d1yhwa1         100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRST  175 (293)
T ss_dssp             TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCC
T ss_pred             CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccccc
Confidence                              36899999999999999   999999999999999999999999999998765432 23345


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDER  283 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (387)
                      ..||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....+..   .   ......        ......+..
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~---~~~~~~--------~~~~~~~~~  241 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL---Y---LIATNG--------TPELQNPEK  241 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H---HHHHHC--------SCCCSSGGG
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH---H---HHHhCC--------CCCCCCccc
Confidence            57999999999999999999999999999999999999999765432211   1   111110        011122233


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          284 QMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       284 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .+..+.+++.+||+.||.+|||++|+++|.|+..
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            4566889999999999999999999999999853

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=376.04  Aligned_cols=237  Identities=24%  Similarity=0.310  Sum_probs=187.4

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----  141 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----  141 (387)
                      .++|+..+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+....+    
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            467999999999999999999999999999999997653 234567899999999999999999999887654332    


Q ss_pred             ---------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-c
Q 043148          142 ---------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-S  199 (387)
Q Consensus       142 ---------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  199 (387)
                                           ...++.|++.||.|||+   ++|+||||||+|||+++++.+||+|||+++....... .
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence                                 36899999999999999   9999999999999999999999999999987654322 2


Q ss_pred             eeeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .....+||+.|||||++.+..+ +.++|||||||++|||++|+.||...........     ... .        .....
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-----~~~-~--------~~~~~  226 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-----DWK-E--------KKTYL  226 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-----HHH-T--------TCTTS
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-----HHh-c--------CCCCC
Confidence            2345679999999999988775 6789999999999999999999976543321110     000 1        00111


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLP  320 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  320 (387)
                      ......+..+.+|+.+||+.||.+|||++|+++|.|+..+.+
T Consensus       227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~  268 (271)
T d1nvra_         227 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  268 (271)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence            111233456788999999999999999999999999876543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-52  Score=371.85  Aligned_cols=227  Identities=27%  Similarity=0.405  Sum_probs=187.1

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI---  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~---  141 (387)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++.+..   ....+.+.+|+++++.++|||||++++++.+....+   
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57899999999999999999999999999999986432   234567899999999999999999999887654322   


Q ss_pred             ----------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          142 ----------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       142 ----------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                            +..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....   
T Consensus        86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred             eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence                                  26799999999999999   99999999999999999999999999999765442   


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                      ......||+.|||||++.+..|+.++|||||||++|||++|+.||......+..       ......          ...
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~----------~~~  222 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------KRISRV----------EFT  222 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTT----------CCC
T ss_pred             cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH-------HHHHcC----------CCC
Confidence            234557999999999999999999999999999999999999999764422211       111111          111


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ++...++.+.+++.+||+.||.+|||++|+++|+|+..
T Consensus       223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            22334566889999999999999999999999998753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-52  Score=379.18  Aligned_cols=231  Identities=26%  Similarity=0.436  Sum_probs=188.8

Q ss_pred             HhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           66 ATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        66 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      ..++|...+.||+|+||+||+|++..+++.||||+++.. ....++|.+|+++|++++|||||+++|+|.+....     
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            356788899999999999999999999999999998654 34467899999999999999999999988664322     


Q ss_pred             ----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          141 ----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       141 ----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                            .+..++.|++.||.|||+   ++|+||||||+||||++++.+||+|||+++.......
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence                                  236789999999999999   9999999999999999999999999999987765544


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......|++.|+|||++.+..|+.++|||||||++|||++|..|+........  .    ...         +......
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~----~~~---------i~~~~~~  235 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V----YEL---------LEKDYRM  235 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H----HHH---------HHTTCCC
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--H----HHH---------HhcCCCC
Confidence            444455689999999999999999999999999999999997777654332211  1    111         1112222


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      ..+...+..+.+|+..||+.||.+|||++||++.|+.
T Consensus       236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~  272 (287)
T d1opja_         236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  272 (287)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            3334455678999999999999999999999998863

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-51  Score=372.41  Aligned_cols=232  Identities=22%  Similarity=0.334  Sum_probs=188.3

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~------  141 (387)
                      +.|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+++|++++|||||++++++.+.+..+      
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888999999999999999999999999999998777777788999999999999999999999886643321      


Q ss_pred             --------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          142 --------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       142 --------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                          +..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~  167 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR  167 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccc
Confidence                                36899999999999999   999999999999999999999999999997553321 122


Q ss_pred             eeeecCCcccCchhhc-----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          202 TVLAGTMGYLAPECVT-----TGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                      ....||+.|+|||++.     ...|+.++|||||||++|||++|+.||.+....+....   +.    .+..     +  
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~---i~----~~~~-----~--  233 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK---IA----KSEP-----P--  233 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH---HH----HSCC-----C--
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH---HH----cCCC-----C--
Confidence            3457999999999984     45689999999999999999999999987654332111   11    0100     0  


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ....+...+..+.+|+.+||+.||.+|||++|+++|.|+..
T Consensus       234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            11122334566889999999999999999999999998754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=369.38  Aligned_cols=231  Identities=23%  Similarity=0.374  Sum_probs=174.4

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh--h---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR--Q---  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~---  139 (387)
                      .++|++.+.||+|+||+||+|+++.+|+.||||.+...  .....+.+.+|+++|++++|||||++++++.+..  .   
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            36799999999999999999999999999999998765  3445677899999999999999999999774321  1   


Q ss_pred             --------------------------HHHHHHHHHHHHHHHHhhhhc--ccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          140 --------------------------LILHKIALGLASAVLYLHEEW--EQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       140 --------------------------~~l~~i~~~i~~~l~~LH~~~--~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                                                ..+..++.|++.||.|||+..  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence                                      123679999999999999821  1249999999999999999999999999998


Q ss_pred             cccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       192 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                      ...... .......||+.|||||++.+..|+.++|||||||++|||++|+.||......+   ...    .+..+..   
T Consensus       163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~----~i~~~~~---  231 (269)
T d2java1         163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAG----KIREGKF---  231 (269)
T ss_dssp             HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH----HHHHTCC---
T ss_pred             ecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHH----HHHcCCC---
Confidence            765432 22345679999999999999999999999999999999999999997654322   111    1111111   


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                            ...+...+..+.+++.+||+.||.+|||++|+++|+|
T Consensus       232 ------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~  268 (269)
T d2java1         232 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  268 (269)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence                  1122234456889999999999999999999999987

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.3e-51  Score=373.77  Aligned_cols=229  Identities=26%  Similarity=0.439  Sum_probs=171.4

Q ss_pred             hCccccCcccccCceEEEEEEECCCCe---EEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH--
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNT---EIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI--  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~--  141 (387)
                      ++|+..+.||+|+||+||+|++..++.   .||||.+... .....+.|.+|+++|++++|||||+++|+|.+....+  
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            345567889999999999999876554   6899988654 4455678999999999999999999999886543221  


Q ss_pred             ------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          142 ------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       142 ------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                              +..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence                                    26799999999999999   999999999999999999999999999998765432


Q ss_pred             Cc----eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          198 GS----QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       198 ~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                      ..    ......||+.|||||.+.+..++.++|||||||++|||+| |+.||.+....+.   ...    +..       
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~~~----i~~-------  248 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---INA----IEQ-------  248 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH----HHT-------
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH---HHH----HHc-------
Confidence            21    1223457899999999999999999999999999999998 8999976543321   111    111       


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                        ......+..++..+.+++.+||+.||.+|||+.||++.|+.
T Consensus       249 --~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         249 --DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence              11122333456678899999999999999999999999863

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=362.50  Aligned_cols=226  Identities=26%  Similarity=0.436  Sum_probs=186.8

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~------  141 (387)
                      ++|+..+.||+|+||+||+|+++ +++.||||.++.... ..++|.+|++++++++||||++++|+|.+....+      
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            67888999999999999999986 588999999976533 4678999999999999999999999987643321      


Q ss_pred             --------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          142 --------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       142 --------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                          +..++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+++..........
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  158 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  158 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence                                26899999999999999   9999999999999999999999999999987665544444


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      ....+|+.|+|||++.+..++.++||||||+++|||+| |+.||......+...       .+..+         .....
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~-------~i~~~---------~~~~~  222 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-------HIAQG---------LRLYR  222 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-------HHHTT---------CCCCC
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH-------HHHhC---------CCCCC
Confidence            45678999999999999999999999999999999998 899998665332211       11111         11122


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      +...+..+.+++.+||+.||.+|||+++|+++|.
T Consensus       223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence            3334566889999999999999999999999984

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-51  Score=367.54  Aligned_cols=227  Identities=26%  Similarity=0.458  Sum_probs=171.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~------  141 (387)
                      ++|+..+.||+|+||.||+|++.+ +..||||+++.. ....++|.+|++++++++|||||+++|+|.+....+      
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            578889999999999999999875 778999999764 344678999999999999999999999886543221      


Q ss_pred             --------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCcee
Q 043148          142 --------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       142 --------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                          ...++.|++.||.|||+   ++|+||||||+|||+++++.+||+|||+++..........
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  159 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  159 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence                                26799999999999999   9999999999999999999999999999987655444444


Q ss_pred             eeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          202 TVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACG-RKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      ....||+.|+|||++.+..|+.++|||||||++|||+|+ +.||......   .....+..    +         .....
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~~----~---------~~~~~  223 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIST----G---------FRLYK  223 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHHH----T---------CCCCC
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHHh----c---------CCCCC
Confidence            456789999999999999999999999999999999995 5555433221   11111111    1         11122


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      +..++..+.+++.+||+.||.+|||++||+++|+.
T Consensus       224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            23344568899999999999999999999999863

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=366.39  Aligned_cols=233  Identities=27%  Similarity=0.487  Sum_probs=178.4

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      .++|...+.||+|+||+||+|++.+   .||||+++..  .....+.|.+|+++|.+++|||||++++++.+...     
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEe
Confidence            4678889999999999999998743   5999998654  34557889999999999999999999998755321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC-
Q 043148          140 --------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG-  198 (387)
Q Consensus       140 --------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-  198 (387)
                                          ..+..++.||++||+|||+   ++|+||||||+||||+.++.+||+|||+++....... 
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence                                1236899999999999999   9999999999999999999999999999986654322 


Q ss_pred             ceeeeeecCCcccCchhhcc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          199 SQTTVLAGTMGYLAPECVTT---GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .......||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+........      .....+..    .+.
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~------~~~~~~~~----~p~  230 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------FMVGRGYL----SPD  230 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHHTSC----CCC
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH------HHHhcCCC----CCc
Confidence            23345678999999999864   358999999999999999999999998655432211      11111110    000


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                       ....+..++..+.+++.+||+.||.+|||++||+++|+..
T Consensus       231 -~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         231 -LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             -GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             1122334456688999999999999999999999999754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=366.60  Aligned_cols=228  Identities=24%  Similarity=0.438  Sum_probs=182.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .++|+..+.||+|+||.||+|++++ +..||||+++... ...+.|.+|+++|.+++|||||+++|+|.+...       
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeC
Confidence            4678889999999999999999864 7899999997543 446789999999999999999999998765321       


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.||++||.|||+   ++|+||||||+||||++++.+||+|||+++.........
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~  166 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence                               1236899999999999999   999999999999999999999999999998776543333


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      .....||+.|+|||++.+..++.++|||||||++|||+||..|+.......  ....    .+..+         .....
T Consensus       167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~----~i~~~---------~~~~~  231 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQ----NLERG---------YRMVR  231 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH----HHHTT---------CCCCC
T ss_pred             ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHhc---------CCCCC
Confidence            445578999999999999999999999999999999999666554332221  1111    11111         11122


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      +...+..+.+++.+||+.||.+||||+||++.|+
T Consensus       232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~  265 (272)
T d1qpca_         232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (272)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence            3334556889999999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-50  Score=362.53  Aligned_cols=225  Identities=25%  Similarity=0.428  Sum_probs=178.4

Q ss_pred             cccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcch----h------
Q 043148           71 AEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQ----R------  138 (387)
Q Consensus        71 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~------  138 (387)
                      +..++||+|+||+||+|++..++..||+|.+...  .....+.+.+|+++|++++|||||++++++.+.    .      
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            4556899999999999999999999999998654  344567899999999999999999999987531    1      


Q ss_pred             -------------------hHHHHHHHHHHHHHHHHhhhhcccc--eeeccCCcceeEeC-CCCcEEEccccccccccCC
Q 043148          139 -------------------QLILHKIALGLASAVLYLHEEWEQC--IVHRDIKSSNVVLD-SNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       139 -------------------~~~l~~i~~~i~~~l~~LH~~~~~~--iiH~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~  196 (387)
                                         ...+..++.||+.||+|||+   ++  |+||||||+|||++ +++.+||+|||+++.....
T Consensus        92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence                               01126789999999999998   77  99999999999996 5889999999999864432


Q ss_pred             CCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          197 LGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       197 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                         ......||+.|||||++.+ .|+.++|||||||++|||++|+.||.........      ...+..+.        .
T Consensus       169 ---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~------~~~i~~~~--------~  230 (270)
T d1t4ha_         169 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGV--------K  230 (270)
T ss_dssp             ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTC--------C
T ss_pred             ---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH------HHHHHcCC--------C
Confidence               3345679999999998875 5999999999999999999999999765433211      11111111        1


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ...++...+..+.+++.+||+.||++|||++|+++|.|+.
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            1122223344578999999999999999999999999873

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=366.47  Aligned_cols=231  Identities=23%  Similarity=0.429  Sum_probs=175.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCC----eEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQN----TEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-  140 (387)
                      .++|+..+.||+|+||.||+|.++.++    ..||||++... ......+|.+|+++|++++|||||+++|+|.+.... 
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            356888899999999999999987654    47999999654 344566799999999999999999999988664322 


Q ss_pred             -------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          141 -------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       141 -------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                               .+..++.|++.||.|||+   ++|+||||||+||||+.++.+||+|||+++....
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence                                     126899999999999999   9999999999999999999999999999987654


Q ss_pred             CCCc--eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          196 ELGS--QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       196 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|..|+.......  ...    ..+.         
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~----~~i~---------  227 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVM----KAIN---------  227 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH----HHHH---------
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHH----HHHh---------
Confidence            3221  2233468999999999999999999999999999999999766654433221  111    1111         


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .......+..++..+.+++.+||+.||.+||||.||++.|+.
T Consensus       228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence            112223334455678899999999999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-50  Score=372.30  Aligned_cols=228  Identities=24%  Similarity=0.388  Sum_probs=184.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI---  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~---  141 (387)
                      +.|+..+.||+|+||+||+|++..+++.||||++....   ....+.+.+|+++|++++|||||++++++.+....+   
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45888999999999999999999999999999997653   234567899999999999999999999886654322   


Q ss_pred             ----------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          142 ----------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       142 ----------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                            +..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....   
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence                                  26899999999999999   99999999999999999999999999999865432   


Q ss_pred             eeeeeecCCcccCchhhcc---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          200 QTTVLAGTMGYLAPECVTT---GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                        ....||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+....+..      ..... ..        .
T Consensus       169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~------~~i~~-~~--------~  231 (309)
T d1u5ra_         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-NE--------S  231 (309)
T ss_dssp             --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH-SC--------C
T ss_pred             --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHh-CC--------C
Confidence              34579999999999864   45899999999999999999999999765432111      11111 11        1


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                      ....+...++.+.+|+.+||+.||.+|||++|+++|.|+...
T Consensus       232 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            111122334568899999999999999999999999987653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=374.22  Aligned_cols=245  Identities=21%  Similarity=0.292  Sum_probs=185.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----  141 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----  141 (387)
                      .++|+..+.||+|+||+||+|++..+|+.||+|+++.. .....+.+.+|+++|+.++|||||+++++|.+....+    
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            57899999999999999999999999999999999765 3444678999999999999999999999887654322    


Q ss_pred             ---------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          142 ---------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       142 ---------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                           +..++.|++.||.|||+.  ++|+||||||+|||++.++.+||+|||+|+.....   .
T Consensus        85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~  159 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M  159 (322)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---T
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---c
Confidence                                 367999999999999971  48999999999999999999999999999865432   2


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHH-HHHHHHh----------------
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLV-EWVWDLY----------------  263 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~-~~~~~~~----------------  263 (387)
                      ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.......... .......                
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            23467999999999999999999999999999999999999999865433211000 0000000                


Q ss_pred             ------ccCchhhh----hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          264 ------GKGQLLEA----ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       264 ------~~~~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                            ......+.    .............+..+.+++.+||+.||.+|||++|+++|.|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~  302 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  302 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence                  00000000    000000001111245688899999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-49  Score=371.08  Aligned_cols=233  Identities=22%  Similarity=0.257  Sum_probs=191.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI-----  141 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-----  141 (387)
                      .++|.+.+.||+|+||.||+|++..+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..+     
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999999999999999998877777788999999999999999999999887654322     


Q ss_pred             ---------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC--CCCcEEEccccccccccCCCC
Q 043148          142 ---------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD--SNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       142 ---------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           +..++.||+.||.|||+   ++|+||||||+|||++  .++.+||+|||+++.....  
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--  179 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--  179 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence                                 36899999999999999   9999999999999995  4678999999999876543  


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+..   ..+.    ..      ......
T Consensus       180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---~~i~----~~------~~~~~~  246 (350)
T d1koaa2         180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL---RNVK----SC------DWNMDD  246 (350)
T ss_dssp             SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HT------CCCSCC
T ss_pred             cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHH----hC------CCCCCc
Confidence            3344567999999999999999999999999999999999999999765432211   1111    00      011112


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ......++.+.+|+.+||+.||.+|||++|+++|.|+..
T Consensus       247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~  285 (350)
T d1koaa2         247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP  285 (350)
T ss_dssp             GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            222334556889999999999999999999999999764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.1e-49  Score=372.41  Aligned_cols=239  Identities=19%  Similarity=0.248  Sum_probs=195.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI-----  141 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-----  141 (387)
                      .++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+++|++++|||||++++++.+....+     
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            467999999999999999999999999999999998776667788899999999999999999999886643322     


Q ss_pred             ---------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC--CCCcEEEccccccccccCCCC
Q 043148          142 ---------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD--SNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       142 ---------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           +..++.||+.||.|||+   ++|+||||||+||||+  .++.+||+|||+++.....  
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--  182 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--  182 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence                                 36899999999999999   9999999999999998  6789999999999877653  


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....+..   ..+.    ..      +.....
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~~i~----~~------~~~~~~  249 (352)
T d1koba_         183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVK----RC------DWEFDE  249 (352)
T ss_dssp             SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHH----HC------CCCCCS
T ss_pred             CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hC------CCCCCc
Confidence            3345567999999999999999999999999999999999999999765433211   1111    10      111122


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPSLP  323 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~~  323 (387)
                      ......+..+.+|+.+||+.||.+|||++|+++|.|+......++
T Consensus       250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~~  294 (352)
T d1koba_         250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT  294 (352)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTCC
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcchhc
Confidence            222334556889999999999999999999999999876544433

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-50  Score=365.10  Aligned_cols=229  Identities=25%  Similarity=0.331  Sum_probs=181.8

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI---  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~---  141 (387)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+..   ....+.+.+|+++|++++||||+++++++.+.+..+   
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            67999999999999999999999999999999986532   234567899999999999999999999886654322   


Q ss_pred             ----------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC-C
Q 043148          142 ----------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL-G  198 (387)
Q Consensus       142 ----------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~  198 (387)
                                            +..++.|++.||.|||+   ++|+||||||+|||+++++.+||+|||+++...... .
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence                                  26799999999999999   999999999999999999999999999998765432 2


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......||+.|+|||++.+..|+.++|||||||++|||++|+.||......+..       ..+....          .
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------~~i~~~~----------~  227 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-------QKIIKLE----------Y  227 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHTTC----------C
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH-------HHHHcCC----------C
Confidence            2334567999999999999999999999999999999999999999865422211       1111111          1


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHH------HHHhccC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQV------INVLNFE  316 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ev------l~~l~~~  316 (387)
                      .++...+..+.+|+.+||+.||.+|||++|+      ++|.|+.
T Consensus       228 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~  271 (288)
T d1uu3a_         228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE  271 (288)
T ss_dssp             CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred             CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccC
Confidence            1223345568899999999999999999985      5566653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=368.25  Aligned_cols=229  Identities=24%  Similarity=0.403  Sum_probs=179.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCe----EEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH--
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNT----EIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL--  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  140 (387)
                      .+|+..+.||+|+||+||+|.+..+|+    .||+|.+... +....++|.+|++++++++|||||+++|+|.+....  
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v   88 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   88 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence            468999999999999999999987765    5899988654 344577899999999999999999999998764321  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          141 -----------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       141 -----------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                             .+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence                                   236799999999999999   999999999999999999999999999998765433


Q ss_pred             Cc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          198 GS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       198 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .. ......||+.|+|||++.++.|+.++|||||||++|||+| |+.||......+....+   .    .         .
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i---~----~---------~  229 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---E----K---------G  229 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH---H----H---------T
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH---H----c---------C
Confidence            22 2334568999999999999999999999999999999998 88898765543321111   1    1         1


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .....+..++..+.+++.+||+.||.+|||+.||+++|+.
T Consensus       230 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence            1122233445668899999999999999999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-49  Score=364.97  Aligned_cols=233  Identities=23%  Similarity=0.332  Sum_probs=171.8

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----  141 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----  141 (387)
                      .+.|+..+.||+|+||+||+|+++.+|+.||||++.... ......+.+|+++|+.++|||||++++++.+....+    
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            466999999999999999999999999999999997653 233466889999999999999999999876654322    


Q ss_pred             ---------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC---CCCcEEEccccccccccCCC
Q 043148          142 ---------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD---SNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       142 ---------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~---~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                           +..++.||+.||.|||+   ++|+||||||+|||+.   +++.+||+|||+++..... 
T Consensus        88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-  163 (307)
T d1a06a_          88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-  163 (307)
T ss_dssp             CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence                                 26899999999999999   9999999999999994   5789999999999865442 


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLS  277 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (387)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+..   .    .+....      ....
T Consensus       164 -~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~----~i~~~~------~~~~  229 (307)
T d1a06a_         164 -SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF---E----QILKAE------YEFD  229 (307)
T ss_dssp             ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---H----HHHTTC------CCCC
T ss_pred             -CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH---H----HHhccC------CCCC
Confidence             2334567999999999999999999999999999999999999999764432211   1    111111      1111


Q ss_pred             ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          278 KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       278 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .......+..+.+++.+||+.||.+|||++|+++|+|+..
T Consensus       230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            1222334566889999999999999999999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=360.73  Aligned_cols=228  Identities=27%  Similarity=0.455  Sum_probs=181.5

Q ss_pred             hCccccC-cccccCceEEEEEEECC--CCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           68 NNFAEAG-KLGEGGFGGVYRGLLSD--QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        68 ~~~~~~~-~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      ++|...+ +||+|+||.||+|.++.  ++..||||+++.. .....++|.+|+++|++++|||||+++|+|.++..    
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm   87 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM   87 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence            4566666 49999999999998753  4568999999765 34556789999999999999999999998865321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          140 ---------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       140 ---------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence                                 1236899999999999999   9999999999999999999999999999987654322


Q ss_pred             c--eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhccc
Q 043148          199 S--QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGR  275 (387)
Q Consensus       199 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (387)
                      .  ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+..       ..+..+.        
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-------~~i~~~~--------  229 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGK--------  229 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-------HHHHTTC--------
T ss_pred             ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC--------
Confidence            2  1233468899999999999999999999999999999998 99999876543221       1111111        


Q ss_pred             CCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          276 LSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       276 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                       ....+..++..+.+|+.+||+.||.+||||.+|++.|.
T Consensus       230 -~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~  267 (285)
T d1u59a_         230 -RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  267 (285)
T ss_dssp             -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence             12233445567889999999999999999999988775

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-49  Score=358.79  Aligned_cols=233  Identities=21%  Similarity=0.276  Sum_probs=188.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC------hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS------KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  140 (387)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+..      ....+.+.+|+++|++++|||||++++++.+....
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467999999999999999999999999999999986542      22367899999999999999999999988765432


Q ss_pred             H-------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC----cEEEccccccc
Q 043148          141 I-------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF----NAKLGDFGLAR  191 (387)
Q Consensus       141 ~-------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kl~Dfg~~~  191 (387)
                      +                         +..++.|++.||.|||+   ++|+||||||+|||++.++    .+||+|||++.
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhh
Confidence            2                         26799999999999999   9999999999999998876    49999999998


Q ss_pred             cccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhh
Q 043148          192 LVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEA  271 (387)
Q Consensus       192 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (387)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+...       .+...     
T Consensus       166 ~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~-------~i~~~-----  231 (293)
T d1jksa_         166 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-------NVSAV-----  231 (293)
T ss_dssp             ECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHTT-----
T ss_pred             hcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH-------HHHhc-----
Confidence            76543  23344578999999999999999999999999999999999999998654322111       11111     


Q ss_pred             hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          272 ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       272 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                       ............+..+.+|+.+||+.||.+|||++|+++|.|+..
T Consensus       232 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         232 -NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             -CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             -CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence             011112222334556889999999999999999999999999863

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-49  Score=359.96  Aligned_cols=238  Identities=21%  Similarity=0.284  Sum_probs=180.1

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCCChh-----hHHHHHHHHHHHhcCCCCCccceehhhcchhhHH------
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQ-----GKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI------  141 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~------  141 (387)
                      ++.||+|+||+||+|++..+|+.||||+++.....     ..+.+.+|+++|++++|||||++++++.+....+      
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            46799999999999999999999999998654322     1346889999999999999999999887654432      


Q ss_pred             -------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCceee
Q 043148          142 -------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQTT  202 (387)
Q Consensus       142 -------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  202 (387)
                                         +..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~  158 (299)
T d1ua2a_          83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT  158 (299)
T ss_dssp             SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred             cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc-ccc
Confidence                               26899999999999999   9999999999999999999999999999986654322 223


Q ss_pred             eeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc--------
Q 043148          203 VLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD--------  273 (387)
Q Consensus       203 ~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  273 (387)
                      ...||+.|+|||++... .|+.++|||||||++|||++|+.||......+...   .+.............+        
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~---~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT---RIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH---HHHHhcCCCChhhccchhccchhh
Confidence            45789999999998754 58999999999999999999999997655433222   2222211110000000        


Q ss_pred             --ccCC----ccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          274 --GRLS----KEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       274 --~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                        ....    ........+.+.+|+.+||+.||++|||++|+++|.|+..
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence              0000    0011123456889999999999999999999999999853

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-49  Score=357.04  Aligned_cols=222  Identities=27%  Similarity=0.393  Sum_probs=174.3

Q ss_pred             CcccccCceEEEEEEECC--CCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----------
Q 043148           74 GKLGEGGFGGVYRGLLSD--QNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----------  139 (387)
Q Consensus        74 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----------  139 (387)
                      ++||+|+||+||+|.+..  +++.||||+++..  +....++|.+|+++|++++|||||+++|+|.++..          
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g   92 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG   92 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence            469999999999998653  4578999999653  33446789999999999999999999999865421          


Q ss_pred             --------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce--eee
Q 043148          140 --------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ--TTV  203 (387)
Q Consensus       140 --------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~  203 (387)
                                    ..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.........  ...
T Consensus        93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred             cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence                          1236899999999999999   999999999999999999999999999998765433222  234


Q ss_pred             eecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccccH
Q 043148          204 LAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDE  282 (387)
Q Consensus       204 ~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (387)
                      ..||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+....+.       ...+..+         .....+.
T Consensus       170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~-------~~~i~~~---------~~~~~p~  233 (277)
T d1xbba_         170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKG---------ERMGCPA  233 (277)
T ss_dssp             -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTT---------CCCCCCT
T ss_pred             cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH-------HHHHHcC---------CCCCCCc
Confidence            568999999999999999999999999999999998 8999986543221       1111111         1122333


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          283 RQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       283 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .++..+.+|+.+||+.||.+|||+++|++.|.
T Consensus       234 ~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence            44567889999999999999999999987664

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=365.78  Aligned_cols=230  Identities=25%  Similarity=0.370  Sum_probs=182.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCC-----eEEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQN-----TEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  139 (387)
                      .++|+..+.||+|+||+||+|++...+     ..||||.+... .......+.+|+.+|.++ +|||||+++++|.+...
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            367889999999999999999986543     36999998654 344567899999999998 89999999998765432


Q ss_pred             H------------------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCc
Q 043148          140 L------------------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKS  171 (387)
Q Consensus       140 ~------------------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~  171 (387)
                      .                                                .+..++.|++.||+|||+   ++|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence            1                                                135689999999999999   9999999999


Q ss_pred             ceeEeCCCCcEEEccccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCC
Q 043148          172 SNVVLDSNFNAKLGDFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQE  249 (387)
Q Consensus       172 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~  249 (387)
                      +|||++.++.+||+|||+++........ ......||+.|||||++.+..|+.++|||||||++|||++ |+.||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999866543322 2334568999999999999999999999999999999998 8999986554


Q ss_pred             cchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          250 PSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      .....      ..         +........+...+..+.+|+.+||+.||.+|||++||+++|.
T Consensus       273 ~~~~~------~~---------~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DANFY------KL---------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHHHH------HH---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHH------HH---------HhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            32211      11         1111222333445567899999999999999999999999984

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.4e-49  Score=362.83  Aligned_cols=226  Identities=26%  Similarity=0.321  Sum_probs=186.0

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI---  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~---  141 (387)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+.   .....+.+.+|+.+|+.++|||||++++++.+....+   
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            6799999999999999999999999999999999653   2234578899999999999999999999886654322   


Q ss_pred             ----------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          142 ----------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       142 ----------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                            ...++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             eecCCccccccccccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence                                  25788999999999999   99999999999999999999999999999876542   


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                       .....||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+...      . +..+.          ..
T Consensus       158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~-i~~~~----------~~  219 (316)
T d1fota_         158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------K-ILNAE----------LR  219 (316)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------H-HHHCC----------CC
T ss_pred             -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH------H-HHcCC----------CC
Confidence             234679999999999999999999999999999999999999998654322111      1 10110          11


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      ++...+..+.+++.+||+.||.+||     |++++++|+|+..
T Consensus       220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence            2223345588899999999999996     9999999999754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=362.20  Aligned_cols=230  Identities=26%  Similarity=0.326  Sum_probs=188.6

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI--  141 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~--  141 (387)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++.+.   .....+.+.+|+++|+.++||||+++++++.+....+  
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            46799999999999999999999999999999999753   2234577899999999999999999999887654322  


Q ss_pred             -----------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          142 -----------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       142 -----------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                             +..++.|++.||.|||+   ++|+||||||+|||++++|.+||+|||+++..... .
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-G  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-T
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC-C
Confidence                                   36789999999999999   99999999999999999999999999999865432 2


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....+..   .    ....+.          .
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~---~----~i~~~~----------~  222 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---E----LILMEE----------I  222 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H----HHHHCC----------C
T ss_pred             cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH---H----HHhcCC----------C
Confidence            2344567999999999999999999999999999999999999999875532211   1    111111          1


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFEA  317 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  317 (387)
                      .++...+..+.+|+.+||+.||.+||+     ++|+++|.|+..
T Consensus       223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence            222334556789999999999999994     999999999754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=354.40  Aligned_cols=229  Identities=25%  Similarity=0.408  Sum_probs=176.8

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-------  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  139 (387)
                      .++|++.+.||+|+||.||+|++++ +..||||++... ....+.|.+|+.+|++++|||||+++|+|.+.+.       
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEec
Confidence            3678999999999999999999976 567999999654 3446789999999999999999999998865321       


Q ss_pred             -------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          140 -------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       140 -------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                         ..+..++.||+.||+|||+   ++|+||||||+|||||.++.+||+|||+++.........
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence                               1236899999999999999   999999999999999999999999999998765544344


Q ss_pred             eeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCccc
Q 043148          201 TTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEF  280 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (387)
                      .....||+.|+|||++....++.++||||||+++|||++|..|+.......  .....+    ..         ......
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~~i----~~---------~~~~~~  235 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQV----ER---------GYRMPC  235 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHH----HT---------TCCCCC
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHH----Hh---------cCCCCC
Confidence            445678999999999999999999999999999999999766665433221  111111    11         111223


Q ss_pred             cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          281 DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       281 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      +..+++.+.+++.+||+.||++|||+++|+++|+.
T Consensus       236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  270 (285)
T d1fmka3         236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  270 (285)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence            34455678899999999999999999999998863

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=353.44  Aligned_cols=229  Identities=26%  Similarity=0.404  Sum_probs=173.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCC---CeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh---
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQ---NTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ---  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  139 (387)
                      .++|+..+.||+|+||.||+|++..+   +..||||.+... .....+.|.+|+++|++++|||||+++|+|.+...   
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv   85 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII   85 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEE
Confidence            36788899999999999999998654   357999998654 34446789999999999999999999998865321   


Q ss_pred             ----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          140 ----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       140 ----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                            ..+..++.||+.||.|||+   ++++||||||+||+++.++.+||+|||+++......
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence                                  1236789999999999999   999999999999999999999999999998766544


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccC
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRL  276 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (387)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |..||......+...   .+    ..+.         
T Consensus       163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~---~i----~~~~---------  226 (273)
T d1mp8a_         163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RI----ENGE---------  226 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---HH----HTTC---------
T ss_pred             ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH---HH----HcCC---------
Confidence            444455678999999999999999999999999999999998 899998765443221   11    1111         


Q ss_pred             CccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          277 SKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       277 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ....+..++..+.+|+..||+.||.+|||++||+++|.
T Consensus       227 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~  264 (273)
T d1mp8a_         227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  264 (273)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            11223344567889999999999999999999999885

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-48  Score=364.36  Aligned_cols=226  Identities=25%  Similarity=0.302  Sum_probs=185.4

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  140 (387)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++.+.   .....+.+.+|+++|+.++|||||++++++.+....    
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            6799999999999999999999999999999998643   223356789999999999999999999987654321    


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           .+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....   
T Consensus       121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence                                 236799999999999999   99999999999999999999999999999876542   


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCcc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKE  279 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (387)
                       .....||+.|||||++.+..|+.++|||||||++|||++|+.||.+.....   ....+.    .+.          ..
T Consensus       195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~----~~~----------~~  256 (350)
T d1rdqe_         195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKIV----SGK----------VR  256 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HCC----------CC
T ss_pred             -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHHHHh----cCC----------CC
Confidence             234579999999999999999999999999999999999999997643221   111111    110          11


Q ss_pred             ccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          280 FDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       280 ~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      .+...+..+.+++.+||+.||.+|+     |++++++|.|+..
T Consensus       257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence            2223445688999999999999994     9999999999854

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-48  Score=357.89  Aligned_cols=236  Identities=19%  Similarity=0.249  Sum_probs=189.3

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI-----  141 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-----  141 (387)
                      .++|.+.+.||+|+||+||+|.+..+++.||||.++... .+...+.+|+++|+.++|||||++++++.+....+     
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            478999999999999999999999999999999997654 33567889999999999999999999876643322     


Q ss_pred             ---------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC--CcEEEccccccccccCCCC
Q 043148          142 ---------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN--FNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       142 ---------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~--~~~kl~Dfg~~~~~~~~~~  198 (387)
                                           +..++.||+.||.|||+   ++|+||||||+|||++.+  ..+||+|||+++.....  
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--  157 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence                                 36799999999999999   999999999999999854  48999999999876442  


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......+++.|+|||.+.+..|+.++|||||||++|||++|+.||......+....   +.    ...      .....
T Consensus       158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~---i~----~~~------~~~~~  224 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN---IM----NAE------YTFDE  224 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HH----HTC------CCCCH
T ss_pred             CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH---HH----hCC------CCCCh
Confidence            344556789999999999999999999999999999999999999986543221111   10    100      01111


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCCCCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAPLPS  321 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  321 (387)
                      ......+..+.+|+.+||+.||.+|||++|+++|.|+....+.
T Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~~  267 (321)
T d1tkia_         225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER  267 (321)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred             hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCccc
Confidence            1112235568899999999999999999999999998765433

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-48  Score=358.75  Aligned_cols=234  Identities=24%  Similarity=0.354  Sum_probs=183.5

Q ss_pred             HHHHhhCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcc
Q 043148           63 LSRATNNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHE  136 (387)
Q Consensus        63 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  136 (387)
                      ++-..++|+..+.||+|+||+||+|++++     +++.||||++.... ....++|.+|+++|++++||||++++++|.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            33345789999999999999999999753     46789999997643 3446789999999999999999999998764


Q ss_pred             hhhH-------------------------------------------------HHHHHHHHHHHHHHHhhhhcccceeec
Q 043148          137 QRQL-------------------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHR  167 (387)
Q Consensus       137 ~~~~-------------------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~  167 (387)
                      ....                                                 ....++.|++.||+|||+   ++++||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEee
Confidence            3210                                                 136789999999999999   999999


Q ss_pred             cCCcceeEeCCCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCC-CCCC
Q 043148          168 DIKSSNVVLDSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGR-KPVE  245 (387)
Q Consensus       168 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~-~p~~  245 (387)
                      ||||+|||+|.++.+||+|||+++....... .......+++.|+|||.+.+..|+.++|||||||++|||++|. .||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            9999999999999999999999986544322 2233456889999999999999999999999999999999986 5676


Q ss_pred             CCCCcchhhHHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          246 PRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .....+..   .    .+..+..         ...+..++..+.+|+.+||+.||.+||||.||+++|+.
T Consensus       245 ~~~~~e~~---~----~v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~  298 (301)
T d1lufa_         245 GMAHEEVI---Y----YVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR  298 (301)
T ss_dssp             TSCHHHHH---H----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCHHHHH---H----HHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            54433211   1    1112211         12233344568899999999999999999999999874

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=352.16  Aligned_cols=243  Identities=23%  Similarity=0.317  Sum_probs=185.5

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhHH----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQLI----  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----  141 (387)
                      ++|+..+.||+|+||+||+|++..+|+.||||++....  ....+.+.+|+++|++++|||||++++++.+....+    
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999999999999999996543  233678999999999999999999999887654322    


Q ss_pred             ----------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          142 ----------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       142 ----------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                            +..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence                                  36899999999999999   999999999999999999999999999998665432 2


Q ss_pred             eeeeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc---hhh---hh
Q 043148          200 QTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ---LLE---AA  272 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~---~~  272 (387)
                      ......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+...   .+........   ...   ..
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF---RIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGGST
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH---HHHHhcCCCchhhcccccccc
Confidence            333457899999999887665 5889999999999999999999998654332211   1111111100   000   00


Q ss_pred             c------ccCCc---cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          273 D------GRLSK---EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       273 ~------~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      +      .....   ......+..+.+|+.+||+.||++|||++|+++|.|+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~  288 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD  288 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence            0      00000   011123456788999999999999999999999999864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-48  Score=350.48  Aligned_cols=229  Identities=25%  Similarity=0.353  Sum_probs=172.9

Q ss_pred             hCccccCcccccCceEEEEEEECCC---CeEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh--
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQ---NTEIAVKRVSRG---SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ--  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  139 (387)
                      ++|+..+.||+|+||.||+|++...   ...||||++...   .....++|.+|+++|++++|||||+++|+|.+...  
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l   87 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM   87 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence            6788999999999999999986432   347999998654   23445789999999999999999999998865421  


Q ss_pred             -----------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCC
Q 043148          140 -----------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHE  196 (387)
Q Consensus       140 -----------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~  196 (387)
                                             ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence                                   1226899999999999999   99999999999999999999999999999876544


Q ss_pred             CCc--eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhc
Q 043148          197 LGS--QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAAD  273 (387)
Q Consensus       197 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (387)
                      ...  ......++..|+|||++.+..++.++||||||+++|||+| |+.||.+....+..   .++   ...        
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~---~~i---~~~--------  230 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---HKI---DKE--------  230 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHH---HTS--------
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH---HHH---HhC--------
Confidence            322  2233457889999999999999999999999999999998 89999865433211   111   111        


Q ss_pred             ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          274 GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       274 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                       ......+...+..+.+++.+||+.||++|||+.||++.|.
T Consensus       231 -~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~  270 (273)
T d1u46a_         231 -GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  270 (273)
T ss_dssp             -CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence             1112223344566889999999999999999999998875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3e-47  Score=357.71  Aligned_cols=231  Identities=22%  Similarity=0.312  Sum_probs=181.9

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHH---HHHHHHhcCCCCCccceehhhcchhhH
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYI---SEVRIISRLRHRNLVHLIGWCHEQRQL  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~  140 (387)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.+..   ......+.   .|+++++.++|||||++++++.+....
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            368999999999999999999999999999999986431   12223333   447778888999999999987664432


Q ss_pred             H-------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          141 I-------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       141 ~-------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                      +                         +..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            2                         36789999999999999   9999999999999999999999999999987654


Q ss_pred             CCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcc
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADG  274 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (387)
                      .   ......||+.|+|||++.. ..|+.++|||||||++|||++|+.||......+.....    .....         
T Consensus       160 ~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~---------  223 (364)
T d1omwa3         160 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLT---------  223 (364)
T ss_dssp             S---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSSS---------
T ss_pred             C---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hhccc---------
Confidence            3   2334579999999999875 56899999999999999999999999875543322111    11100         


Q ss_pred             cCCccccHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHhccCC
Q 043148          275 RLSKEFDERQMECLMIVGLWCCHPDFTNRPS-----IRQVINVLNFEA  317 (387)
Q Consensus       275 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  317 (387)
                       .....+...+..+.+|+.+||+.||.+|||     ++|+++|.|+..
T Consensus       224 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         224 -MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             -CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence             111222234556889999999999999999     799999999753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=341.44  Aligned_cols=220  Identities=30%  Similarity=0.438  Sum_probs=171.9

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-hH------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-QL------  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~------  140 (387)
                      ++|+..+.||+|+||.||+|+++  |..||||+++..  ...+.|.+|++++++++||||++++|+|.+.. ..      
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            56788889999999999999984  789999999653  34578999999999999999999999885422 11      


Q ss_pred             ---------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc
Q 043148          141 ---------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS  199 (387)
Q Consensus       141 ---------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  199 (387)
                                           .+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....   
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC---
Confidence                                 126799999999999999   99999999999999999999999999999865432   


Q ss_pred             eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                       .....+++.|+|||++.+..++.++||||||+++|||+| |+.||......+.   ..++    ..         ....
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~i----~~---------~~~~  219 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EK---------GYKM  219 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHH----TT---------TCCC
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHHH----Hc---------CCCC
Confidence             233467899999999999999999999999999999998 6888765543321   1111    11         1122


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      +.+...+..+.+++.+||+.||.+|||+.+|+++|+
T Consensus       220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~  255 (262)
T d1byga_         220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE  255 (262)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence            333444567889999999999999999999999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.4e-47  Score=342.94  Aligned_cols=233  Identities=24%  Similarity=0.314  Sum_probs=186.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh---------hhHHHHHHHHHHHhcCC-CCCccceehhhcc
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK---------QGKKEYISEVRIISRLR-HRNLVHLIGWCHE  136 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  136 (387)
                      .++|+..+.||+|+||+||+|++..+|+.||||++.....         ...+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            3689999999999999999999999999999999876421         12346889999999997 9999999998877


Q ss_pred             hhhHH-------------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          137 QRQLI-------------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       137 ~~~~~-------------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      .+..+                         ...++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhee
Confidence            54322                         26899999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCceeeeeecCCcccCchhhcc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhcc
Q 043148          192 LVDHELGSQTTVLAGTMGYLAPECVTT------GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGK  265 (387)
Q Consensus       192 ~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  265 (387)
                      ......  ......||+.|+|||.+.+      ..++.++||||+||++|||++|+.||.+.......       ..+..
T Consensus       159 ~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-------~~i~~  229 (277)
T d1phka_         159 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-------RMIMS  229 (277)
T ss_dssp             ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHH
T ss_pred             EccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-------HHHHh
Confidence            765532  3344679999999999853      34788999999999999999999999865432211       11111


Q ss_pred             CchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          266 GQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      +..      ..........++.+.+++.+||+.||.+|||++||++|.|+..
T Consensus       230 ~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         230 GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            110      1111222334566889999999999999999999999999864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.5e-47  Score=346.84  Aligned_cols=241  Identities=23%  Similarity=0.339  Sum_probs=182.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      ++|...+.||+|+||+||+|+++ +|+.||||++....  ....+.+.+|+.+|++++|||||++++++.+....     
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            58999999999999999999986 58999999996653  23367899999999999999999999988665432     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          .+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||.+....... ..
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~  156 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK  156 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc-cc
Confidence                                237899999999999999   999999999999999999999999999998765432 22


Q ss_pred             eeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCch------hhh--
Q 043148          201 TTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQL------LEA--  271 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~--  271 (387)
                      .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+....+....   +.........      ...  
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGGGSTT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHH---HHHhhCCCChhhccchhhhhh
Confidence            3344689999999998754 479999999999999999999999986553332221   1111111100      000  


Q ss_pred             -------hcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          272 -------ADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       272 -------~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                             ..+..........+..+.+++.+||+.||++|||++|+++|+|+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~  285 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                   000000112223445688999999999999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-46  Score=345.55  Aligned_cols=248  Identities=21%  Similarity=0.286  Sum_probs=182.7

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...  .....+++.+|+++|++++||||+++++++.....     
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999999999999999998554  33446778999999999999999999887643211     


Q ss_pred             ----------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          140 ----------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       140 ----------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                                                  ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceee
Confidence                                        1236899999999999999   999999999999999999999999999997


Q ss_pred             cccCCCC---ceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc
Q 043148          192 LVDHELG---SQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ  267 (387)
Q Consensus       192 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (387)
                      .......   .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.........+...........
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence            6653221   122335689999999998765 589999999999999999999999976543332222221110000000


Q ss_pred             --------hhhhhcccC--CccccH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          268 --------LLEAADGRL--SKEFDE-----RQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       268 --------~~~~~~~~~--~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                              .........  ......     .....+.+|+.+||+.||++|||++|+++|.|+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence                    000000000  000111     11334678999999999999999999999999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=352.14  Aligned_cols=229  Identities=23%  Similarity=0.317  Sum_probs=185.0

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHh-cCCCCCccceehhhcchhhHH--
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIIS-RLRHRNLVHLIGWCHEQRQLI--  141 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~--  141 (387)
                      ++|.+.+.||+|+||+||+|+++.+|+.||||++++..   ....+.+..|..++. .++|||||++++++.+....+  
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999999999999999996532   233556777877765 689999999999887654332  


Q ss_pred             -----------------------HHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          142 -----------------------LHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       142 -----------------------l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                             +..++.||+.||.|||+   ++|+||||||+|||+++++.+||+|||+++...... 
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence                                   36899999999999999   999999999999999999999999999998654432 


Q ss_pred             ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          199 SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       199 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                      .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....+...       ....+      .    .
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~-------~i~~~------~----~  220 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH-------SIRMD------N----P  220 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHC------C----C
T ss_pred             ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH-------HHHcC------C----C
Confidence            23344579999999999999999999999999999999999999998654322111       11111      1    1


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHhccCC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIR-QVINVLNFEA  317 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~-evl~~l~~~~  317 (387)
                      .++...+..+.+|+.+||+.||.+|||+. ++++|+|+..
T Consensus       221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            12233455688999999999999999995 8999998753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-47  Score=349.63  Aligned_cols=242  Identities=24%  Similarity=0.334  Sum_probs=182.0

Q ss_pred             hhCccccCcccccCceEEEEEEECCC-CeEEEEEEecCCC--hhhHHHHHHHHHHHhcC---CCCCccceehhhcchh--
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQ-NTEIAVKRVSRGS--KQGKKEYISEVRIISRL---RHRNLVHLIGWCHEQR--  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~--  138 (387)
                      .++|++.+.||+|+||+||+|++..+ ++.||||+++...  ......+.+|+++|+.|   +||||++++++|....  
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999998654 6789999986432  22234566777776655   8999999998774210  


Q ss_pred             -----------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccc
Q 043148          139 -----------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGL  189 (387)
Q Consensus       139 -----------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~  189 (387)
                                                   ...+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhh
Confidence                                         11236799999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh
Q 043148          190 ARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL  269 (387)
Q Consensus       190 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (387)
                      ++.....  .......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+....+   ..........
T Consensus       163 ~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~  237 (305)
T d1blxa_         163 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI---LDVIGLPGEE  237 (305)
T ss_dssp             CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCGG
T ss_pred             hhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhhCCCchh
Confidence            8765432  2334567999999999999999999999999999999999999999866543322221   1111110000


Q ss_pred             h----------hh---cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          270 E----------AA---DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       270 ~----------~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      .          ..   .......+.....+.+.+|+.+||+.||.+|||++|+++|+|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~  297 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ  297 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence            0          00   00001112223445678899999999999999999999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-48  Score=350.24  Aligned_cols=222  Identities=26%  Similarity=0.460  Sum_probs=178.0

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCCh------hhHHHHHHHHHHHhcCC--CCCccceehhhcchh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK------QGKKEYISEVRIISRLR--HRNLVHLIGWCHEQR  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  138 (387)
                      .++|.+.+.||+|+||+||+|++..+|+.||||++.....      ....++.+|+.+|++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            3679999999999999999999999999999999865321      12344678999999986  999999999876543


Q ss_pred             hH--------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCC-CcEEEccccccc
Q 043148          139 QL--------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSN-FNAKLGDFGLAR  191 (387)
Q Consensus       139 ~~--------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfg~~~  191 (387)
                      ..                          .+..++.|++.||.|||+   ++|+||||||+|||++.+ +.+||+|||+++
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccce
Confidence            21                          126799999999999999   999999999999999854 799999999998


Q ss_pred             cccCCCCceeeeeecCCcccCchhhccCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          192 LVDHELGSQTTVLAGTMGYLAPECVTTGKA-SKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       192 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      .....   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....         +.    ...   
T Consensus       160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------i~----~~~---  220 (273)
T d1xwsa_         160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------II----RGQ---  220 (273)
T ss_dssp             ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HH----HCC---
T ss_pred             ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---------Hh----hcc---
Confidence            65443   2334679999999999987765 6779999999999999999999964210         00    000   


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                             ..++...+..+.+++.+||+.||.+|||++|+++|.|+..
T Consensus       221 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  260 (273)
T d1xwsa_         221 -------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  260 (273)
T ss_dssp             -------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             -------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                   0111223456889999999999999999999999999864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=345.33  Aligned_cols=226  Identities=29%  Similarity=0.426  Sum_probs=175.1

Q ss_pred             cCcccccCceEEEEEEECCCC---eEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-h--------
Q 043148           73 AGKLGEGGFGGVYRGLLSDQN---TEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-Q--------  139 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~--------  139 (387)
                      .++||+|+||+||+|++..++   ..||||+++.. +....++|.+|+++|++++||||++++|+|.+.+ .        
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            457999999999999986643   36999999754 4556688999999999999999999999875432 1        


Q ss_pred             ------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCc--
Q 043148          140 ------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGS--  199 (387)
Q Consensus       140 ------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  199 (387)
                                        .....++.|++.||.|||+   ++|+||||||+||||++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence                              1126899999999999999   99999999999999999999999999999876543211  


Q ss_pred             -eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhhcccCCc
Q 043148          200 -QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAADGRLSK  278 (387)
Q Consensus       200 -~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (387)
                       ......||+.|+|||.+....++.++||||||+++|||++|+.||........  ...++.    .+.         ..
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i~----~g~---------~~  253 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLL----QGR---------RL  253 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----TTC---------CC
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHHH----cCC---------CC
Confidence             22234689999999999999999999999999999999998888765432211  111111    111         11


Q ss_pred             cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          279 EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       279 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ..+..++..+.+++.+||+.||++||||.||+++|+..
T Consensus       254 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            12233445688999999999999999999999998643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.1e-46  Score=339.93  Aligned_cols=232  Identities=23%  Similarity=0.269  Sum_probs=177.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCCccceehhhcchhh----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS---KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  139 (387)
                      .++|.+.+.||+|+||.||+|++..+|+.||||+++...   ......+.+|+++++.++|||||++++++.....    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999999999999999997643   3345678999999999999999999987754321    


Q ss_pred             -------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          140 -------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       140 -------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                                               ..+..++.||+.||.|||+   ++|+||||||+|||++.++..+|+|||.+....
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhc
Confidence                                     1126899999999999999   999999999999999999999999999987554


Q ss_pred             CCC--CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          195 HEL--GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       195 ~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                      ...  ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      ..........    
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~----  232 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPI----  232 (277)
T ss_dssp             ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCC----
T ss_pred             cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCC----
Confidence            322  2233456799999999999999999999999999999999999999976442211      1111111111    


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHhc
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRP-SIRQVINVLN  314 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~l~  314 (387)
                         .........+..+.+++.+||+.||.+|| |++++++.|.
T Consensus       233 ---~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         233 ---PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             ---CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ---CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence               11112223455688999999999999999 8999887764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-47  Score=345.96  Aligned_cols=230  Identities=23%  Similarity=0.358  Sum_probs=172.1

Q ss_pred             hhCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  139 (387)
                      .++|...+.||+|+||.||+|++..     +++.||||++... .....+.+.+|..++.++ +|+||+.+++++.+...
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            4679999999999999999999754     3478999999754 344566788888888877 68999999887643211


Q ss_pred             ------------------------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeC
Q 043148          140 ------------------------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLD  177 (387)
Q Consensus       140 ------------------------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~  177 (387)
                                                                ..+..++.||+.||.|||+   ++|+||||||+||||+
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence                                                      1135789999999999999   9999999999999999


Q ss_pred             CCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCcchhhH
Q 043148          178 SNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACG-RKPVEPRQEPSKVRL  255 (387)
Q Consensus       178 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg-~~p~~~~~~~~~~~~  255 (387)
                      +++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++| ..||.........  
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~--  246 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--  246 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence            999999999999986544322 223345789999999999999999999999999999999986 5577655433211  


Q ss_pred             HHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          256 VEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                          ......+         .....+...+..+.+++.+||+.||.+|||++||+++|+
T Consensus       247 ----~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~  292 (299)
T d1ywna1         247 ----CRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  292 (299)
T ss_dssp             ----HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----HHHHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence                1111111         112223334556889999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=345.27  Aligned_cols=231  Identities=24%  Similarity=0.407  Sum_probs=182.5

Q ss_pred             hhCccccCcccccCceEEEEEEECC-----CCeEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSD-----QNTEIAVKRVSRG-SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  140 (387)
                      .++|...+.||+|+||+||+|.+..     ++..||||+++.. .......|.+|++++++++|||||+++|+|......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            4678889999999999999998752     3578999999754 344456789999999999999999999987543221


Q ss_pred             -----------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEc
Q 043148          141 -----------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLG  185 (387)
Q Consensus       141 -----------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~  185 (387)
                                                         .+..++.|+++||.|||+   ++|+||||||+|||+++++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence                                               135689999999999999   999999999999999999999999


Q ss_pred             cccccccccCCCCc-eeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCC-CCCCCCCCcchhhHHHHHHHHh
Q 043148          186 DFGLARLVDHELGS-QTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGR-KPVEPRQEPSKVRLVEWVWDLY  263 (387)
Q Consensus       186 Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~~  263 (387)
                      |||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+||. .||......+..       ..+
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~-------~~i  248 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-------RFV  248 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH-------HHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH-------HHH
Confidence            99999866543221 223346899999999999999999999999999999999985 677654332211       111


Q ss_pred             ccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccC
Q 043148          264 GKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFE  316 (387)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  316 (387)
                      ..+.         ....+..++..+.+++.+||+.||.+|||+++|+++|...
T Consensus       249 ~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         249 MEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HhCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            1111         1122233456689999999999999999999999999754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=346.82  Aligned_cols=227  Identities=26%  Similarity=0.418  Sum_probs=176.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCe--EEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCCccceehhhcchhhH---
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNT--EIAVKRVSRG-SKQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQL---  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~---  140 (387)
                      ++|+..+.||+|+||+||+|+++.+|.  .||||.+... .....++|.+|+++|.++ +|||||+++|+|.+....   
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            677888999999999999999988776  4788887654 344567899999999999 799999999988664321   


Q ss_pred             --------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcE
Q 043148          141 --------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNA  182 (387)
Q Consensus       141 --------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  182 (387)
                                                            ....++.||+.||.|||+   ++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence                                                  135789999999999999   999999999999999999999


Q ss_pred             EEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCC-CCCCCCCcchhhHHHHHHH
Q 043148          183 KLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRK-PVEPRQEPSKVRLVEWVWD  261 (387)
Q Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~-p~~~~~~~~~~~~~~~~~~  261 (387)
                      ||+|||+++......  ......||..|+|||.+.+..++.++|||||||++|||++|.. ||......+   .    ..
T Consensus       167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~----~~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L----YE  237 (309)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H----HH
T ss_pred             EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---H----HH
Confidence            999999997554321  2234568999999999999999999999999999999999764 665443221   1    11


Q ss_pred             HhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          262 LYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                      .+..+         .....+...+..+.+|+.+||+.||++||||+||+++|+.
T Consensus       238 ~i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~  282 (309)
T d1fvra_         238 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  282 (309)
T ss_dssp             HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            11111         1122333445678899999999999999999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-46  Score=346.45  Aligned_cols=233  Identities=21%  Similarity=0.237  Sum_probs=180.3

Q ss_pred             hhCccccC-cccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhc-CCCCCccceehhhcch----h--
Q 043148           67 TNNFAEAG-KLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISR-LRHRNLVHLIGWCHEQ----R--  138 (387)
Q Consensus        67 ~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~----~--  138 (387)
                      .++|.+.+ .||+|+||.||+|++..+++.||||+++.     ...+.+|++++.+ .+|||||++++++.+.    .  
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46788765 59999999999999999999999999864     3567789998765 4899999999876431    1  


Q ss_pred             -------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC---CCcEEEcccccc
Q 043148          139 -------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLA  190 (387)
Q Consensus       139 -------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Dfg~~  190 (387)
                                               +..+..++.||+.||.|||+   ++|+||||||+|||++.   ++.+||+|||++
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence                                     11237899999999999999   99999999999999985   567999999999


Q ss_pred             ccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhh
Q 043148          191 RLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLE  270 (387)
Q Consensus       191 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (387)
                      +.....  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+..........   ......     
T Consensus       162 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~-----  231 (335)
T d2ozaa1         162 KETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRM-----  231 (335)
T ss_dssp             EECCCC--CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCS-----
T ss_pred             eeccCC--CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhc-----
Confidence            876543  2334567999999999999999999999999999999999999999765433221100   000000     


Q ss_pred             hhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          271 AADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       271 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                       .............+..+.+|+.+||+.||.+|||+.|+++|.|+...
T Consensus       232 -~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         232 -GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             -CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             -CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence             00111112223456678999999999999999999999999987543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-46  Score=341.86  Aligned_cols=231  Identities=24%  Similarity=0.366  Sum_probs=183.2

Q ss_pred             hhCccccCcccccCceEEEEEEEC-----CCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccceehhhcchhh
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLS-----DQNTEIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  139 (387)
                      .++|+..+.||+|+||.||+|++.     .+++.||||+++... ......|.+|+.++.++ +|||||+++|+|.+...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            468888999999999999999863     456789999997653 44566799999999999 69999999998865432


Q ss_pred             H-------------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe
Q 043148          140 L-------------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL  176 (387)
Q Consensus       140 ~-------------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill  176 (387)
                      .                                           .+..++.||+.||+|||+   ++++||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence            1                                           125789999999999999   999999999999999


Q ss_pred             CCCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 043148          177 DSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVR  254 (387)
Q Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~  254 (387)
                      +.++.+|++|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+| |..||......+...
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999987654332 23344678999999999999999999999999999999999 555555444322211


Q ss_pred             HHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          255 LVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                            .         ++........+...+..+.+|+.+||+.||.+|||++||+++|+.
T Consensus       259 ------~---------~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         259 ------K---------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             ------H---------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------H---------HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                  1         111112222333345668999999999999999999999999863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-46  Score=341.78  Aligned_cols=230  Identities=27%  Similarity=0.418  Sum_probs=177.8

Q ss_pred             hhCccccCcccccCceEEEEEEECCCC-------eEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCCccceehhhcch
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQN-------TEIAVKRVSRGS-KQGKKEYISEVRIISRL-RHRNLVHLIGWCHEQ  137 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  137 (387)
                      .++|...+.||+|+||.||+|+....+       ..||||+++... .....++.+|...+.++ +|||||+++++|.+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            367888999999999999999875543       479999997653 34567889999999888 899999999987653


Q ss_pred             hhH-----------------------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEe
Q 043148          138 RQL-----------------------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVL  176 (387)
Q Consensus       138 ~~~-----------------------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill  176 (387)
                      ...                                         .+..++.|++.||.|||+   ++|+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence            311                                         136899999999999999   999999999999999


Q ss_pred             CCCCcEEEccccccccccCCCC-ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 043148          177 DSNFNAKLGDFGLARLVDHELG-SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVAC-GRKPVEPRQEPSKVR  254 (387)
Q Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~t-g~~p~~~~~~~~~~~  254 (387)
                      +.++.+||+|||+++....... .......+++.|+|||.+.++.|+.++||||||+++|||++ |..||.......   
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence            9999999999999987654322 22344568899999999999999999999999999999998 788886544221   


Q ss_pred             HHHHHHHHhccCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhcc
Q 043148          255 LVEWVWDLYGKGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNF  315 (387)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  315 (387)
                          +...+..+         .....+...+..+.+|+.+||+.||.+|||+.||++.|+.
T Consensus       246 ----~~~~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         246 ----LFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             ----HHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----HHHHHHcC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                11111111         1222233345668999999999999999999999999863

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=344.09  Aligned_cols=244  Identities=20%  Similarity=0.296  Sum_probs=180.8

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchhh-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQ-----  139 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  139 (387)
                      .++|...+.||+|+||+||+|.+..+|+.||||+++..  .....+.+.+|+++|+.++|||||+++++|.....     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            47899999999999999999999999999999999754  33446788999999999999999999988754321     


Q ss_pred             ------------------------HHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          140 ------------------------LILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       140 ------------------------~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                              ..+..++.|++.||.|||+   ++|+||||||+|||++.++.+|++|||+++....
T Consensus        97 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          97 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceeccCC
Confidence                                    1236899999999999999   9999999999999999999999999999987654


Q ss_pred             CCCceeeeeecCCcccCchhhccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------HHhccC
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTG-KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVW--------DLYGKG  266 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~  266 (387)
                      .    .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..............        ......
T Consensus       174 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         174 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             c----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence            3    2345689999999998764 57899999999999999999999998765433222111110        000000


Q ss_pred             c---hhhhh---cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          267 Q---LLEAA---DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       267 ~---~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .   .....   ...............+.+|+.+||+.||.+|||++|+++|.|+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~  306 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  306 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence            0   00000   000001111223445788999999999999999999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=342.86  Aligned_cols=246  Identities=19%  Similarity=0.247  Sum_probs=183.4

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCCccceehhhcchh-------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS-KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  138 (387)
                      ..+|.+.+.||+|+||+||+|++..+|+.||||++.... ....+.+++|+++|++++||||+++++++....       
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457999999999999999999999999999999997543 344678899999999999999999988774421       


Q ss_pred             ---------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          139 ---------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       139 ---------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                           ...+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        87 ~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence                                 11237899999999999999   999999999999999999999999999998654432


Q ss_pred             C--ceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh-----
Q 043148          198 G--SQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL-----  269 (387)
Q Consensus       198 ~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  269 (387)
                      .  .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+........   .......     
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~  240 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI---LGSPSQEDLNCI  240 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH---HCSCCHHHHHTC
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh---ccCCChhhhhhh
Confidence            1  12345678999999999854 56789999999999999999999999765533322211111   0000000     


Q ss_pred             ------hh--hccc-CCc---cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCCC
Q 043148          270 ------EA--ADGR-LSK---EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEAP  318 (387)
Q Consensus       270 ------~~--~~~~-~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  318 (387)
                            ..  ..+. ...   .........+.+|+.+||+.||.+|||++|+++|.|+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                  00  0000 000   0111223457899999999999999999999999987643

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-45  Score=332.28  Aligned_cols=244  Identities=21%  Similarity=0.331  Sum_probs=187.0

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCCccceehhhcchhhH-----
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGS--KQGKKEYISEVRIISRLRHRNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  140 (387)
                      ++|+..+.||+|+||+||+|++..+++.||||+++...  .....++.+|+.+|+.++||||++++++|.+....     
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999999999999999986543  34467899999999999999999999988664322     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCCce
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELGSQ  200 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  200 (387)
                                          .+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||.++....... .
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~  157 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C  157 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-C
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc-c
Confidence                                236899999999999999   9999999999999999999999999999987654322 2


Q ss_pred             eeeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc------hhhhhc
Q 043148          201 TTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ------LLEAAD  273 (387)
Q Consensus       201 ~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  273 (387)
                      .....+++.|+|||++.... ++.++|||||||++|||++|+.||........  ....+........      .....+
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhhccc
Confidence            23345678899999987665 68999999999999999999999765443221  1222222111100      000000


Q ss_pred             ---------ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          274 ---------GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       274 ---------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                               ..............+.+|+.+||+.||++|||++|+++|.|+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence                     00011122233456788999999999999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-45  Score=340.98  Aligned_cols=240  Identities=23%  Similarity=0.262  Sum_probs=178.8

Q ss_pred             CccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh----------
Q 043148           69 NFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR----------  138 (387)
Q Consensus        69 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----------  138 (387)
                      +|...++||+|+||+||+|++..+|+.||||++.....    .+.+|+++|++++||||++++++|....          
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            57788899999999999999999999999999976432    2347999999999999999988763211          


Q ss_pred             ------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC-cEEEccccccccc
Q 043148          139 ------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF-NAKLGDFGLARLV  193 (387)
Q Consensus       139 ------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfg~~~~~  193 (387)
                                              ...+..++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence                                    01125789999999999999   9999999999999999775 8999999999876


Q ss_pred             cCCCCceeeeeecCCcccCchhhcc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhc
Q 043148          194 DHELGSQTTVLAGTMGYLAPECVTT-GKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV--------WDLYG  264 (387)
Q Consensus       194 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~  264 (387)
                      ....  ......|++.|+|||.+.+ ..|+.++||||+||++|||++|+.||......+....+...        +....
T Consensus       174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            5432  2334578999999998775 46899999999999999999999999866543322211110        00000


Q ss_pred             ----cCchhhhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          265 ----KGQLLEAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       265 ----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                          ....................+..+.+|+.+||+.||.+|||+.|+++|.|+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  308 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  308 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                00000000000001112233456889999999999999999999999998753

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=332.07  Aligned_cols=239  Identities=24%  Similarity=0.338  Sum_probs=173.8

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHH--HHHHHhcCCCCCccceehhhcchhh----H
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYIS--EVRIISRLRHRNLVHLIGWCHEQRQ----L  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~~----~  140 (387)
                      .++|...+.||+|+||.||+|++  +|+.||||++...   ..+.+..  |+..+..++|||||+++++|.+...    .
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            35677888999999999999997  5789999998543   2334444  4445567899999999999865421    0


Q ss_pred             --------------H----------HHHHHHHHHHHHHHhhhh-----cccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          141 --------------I----------LHKIALGLASAVLYLHEE-----WEQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       141 --------------~----------l~~i~~~i~~~l~~LH~~-----~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                                    +          ...++.+++.||.|||+.     +.++|+||||||+||||+.++.+||+|||+++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence                          1          157999999999999973     24799999999999999999999999999998


Q ss_pred             cccCCCCc---eeeeeecCCcccCchhhccCC------CCCccchHHHHHHHHHHHhCCCCCCCCCCcch--------hh
Q 043148          192 LVDHELGS---QTTVLAGTMGYLAPECVTTGK------ASKESDVYSFGVVALEVACGRKPVEPRQEPSK--------VR  254 (387)
Q Consensus       192 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~------~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~--------~~  254 (387)
                      ........   ......||+.|+|||++.+..      ++.++|||||||++|||+||..||........        ..
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            76543322   233467999999999987643      56789999999999999999988754322111        01


Q ss_pred             HHHHHHHHhccCchhhhhcccCCccc-cHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          255 LVEWVWDLYGKGQLLEAADGRLSKEF-DERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      ...........+.    .++.+.... ..+....+.+++.+||+.||.+|||+.||+++|.
T Consensus       237 ~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~  293 (303)
T d1vjya_         237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  293 (303)
T ss_dssp             CHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred             hHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence            1122222221111    122222222 3346677899999999999999999999999886

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-44  Score=334.83  Aligned_cols=245  Identities=20%  Similarity=0.217  Sum_probs=180.7

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh-------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR-------  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  138 (387)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...  +....+++.+|+.+|+.++|||||+++++|....       
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6799999999999999999999999999999999754  3444567899999999999999999999874321       


Q ss_pred             ---------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCC
Q 043148          139 ---------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHEL  197 (387)
Q Consensus       139 ---------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~  197 (387)
                                           ...+..++.|++.||.|||+   ++|+||||||+|||++.++.+|++|||+++..... 
T Consensus        97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~-  172 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-  172 (355)
T ss_dssp             EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhccccc-
Confidence                                 12247899999999999999   99999999999999999999999999998765543 


Q ss_pred             CceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH----------------HH
Q 043148          198 GSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWV----------------WD  261 (387)
Q Consensus       198 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~----------------~~  261 (387)
                       .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+...                ..
T Consensus       173 -~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  251 (355)
T d2b1pa1         173 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred             -cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence             2334556899999999999999999999999999999999999999865533222111100                00


Q ss_pred             HhccC------chhhhhcc---cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          262 LYGKG------QLLEAADG---RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       262 ~~~~~------~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      .....      ........   ..........+..+.+|+.+||+.||++|||++|+++|+|+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            00000      00111100   1111223446777899999999999999999999999999865

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=334.60  Aligned_cols=234  Identities=23%  Similarity=0.288  Sum_probs=184.4

Q ss_pred             hCccccCcccccCceEEEEEEE---CCCCeEEEEEEecCCC----hhhHHHHHHHHHHHhcCCC-CCccceehhhcchhh
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLL---SDQNTEIAVKRVSRGS----KQGKKEYISEVRIISRLRH-RNLVHLIGWCHEQRQ  139 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  139 (387)
                      ++|+..+.||+|+||+||+|+.   +.+|+.||||.+.+..    ....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999987   4468999999986532    2335678899999999976 899999988765432


Q ss_pred             H-------------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEcccccccccc
Q 043148          140 L-------------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVD  194 (387)
Q Consensus       140 ~-------------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~  194 (387)
                      .                         ....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            2                         236788999999999999   999999999999999999999999999998765


Q ss_pred             CCCCceeeeeecCCcccCchhhccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          195 HELGSQTTVLAGTMGYLAPECVTTG--KASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       195 ~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                      ...........|++.|++||.+.+.  .++.++|||||||+||||++|+.||......+....+....  .         
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~---------  249 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--L---------  249 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--H---------
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--c---------
Confidence            5444444556789999999998764  46889999999999999999999998765544332221110  0         


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHhccCC
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRP-----SIRQVINVLNFEA  317 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  317 (387)
                      ..  ....+...+..+.+++.+||+.||.+||     |++|+++|.|+..
T Consensus       250 ~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         250 KS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             cC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            00  1122334556788999999999999999     5899999999854

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1e-43  Score=330.08  Aligned_cols=242  Identities=19%  Similarity=0.256  Sum_probs=183.2

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCCccceehhhcchh--------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQR--------  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--------  138 (387)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++..   ..+++.+|+++|..++ ||||+++++++....        
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            6799999999999999999999999999999999653   3567889999999995 999999999875321        


Q ss_pred             ----------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCC-cEEEccccccccccCCCCcee
Q 043148          139 ----------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNF-NAKLGDFGLARLVDHELGSQT  201 (387)
Q Consensus       139 ----------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~  201 (387)
                                      ...+..++.||+.||.|||+   ++|+||||||+|||++.++ .+||+|||+++.....  ...
T Consensus       112 e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~--~~~  186 (328)
T d3bqca1         112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEY  186 (328)
T ss_dssp             ECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT--CCC
T ss_pred             eecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC--Ccc
Confidence                            12247899999999999999   9999999999999998655 6999999999876543  233


Q ss_pred             eeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchh-hHHHHH------HHHhc---cC---c
Q 043148          202 TVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKV-RLVEWV------WDLYG---KG---Q  267 (387)
Q Consensus       202 ~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~-~~~~~~------~~~~~---~~---~  267 (387)
                      ....+|+.|+|||.+.+.. ++.++||||+|+++|||++|+.||......... ..+...      .....   ..   .
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  266 (328)
T d3bqca1         187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR  266 (328)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred             cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence            4456899999999987654 799999999999999999999999765543211 111000      00000   00   0


Q ss_pred             hhhhhc--------ccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          268 LLEAAD--------GRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       268 ~~~~~~--------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                      ......        ..............+.+|+.+||+.||.+|||++|+++|+||..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            000000        00111111223456789999999999999999999999999863

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-44  Score=327.40  Aligned_cols=233  Identities=20%  Similarity=0.282  Sum_probs=174.6

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCccceehhhcchh---------
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR---------  138 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------  138 (387)
                      ++|++.+.||+|+||.||+|++..+|+.||||++.....  .+++..|+++++.++|+|++..++.+....         
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            579999999999999999999999999999999865432  345789999999998887776655443211         


Q ss_pred             -----------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC---CCcEEEccccccccccCCCC
Q 043148          139 -----------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS---NFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       139 -----------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~~~~  198 (387)
                                       ...+..++.|++.||+|||+   ++|+||||||+|||++.   +..+||+|||+++.......
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence                             11237899999999999999   99999999999999864   55799999999987654321


Q ss_pred             ------ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchhhhh
Q 043148          199 ------SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLLEAA  272 (387)
Q Consensus       199 ------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (387)
                            .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................     
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-----  236 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-----  236 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-----
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-----
Confidence                  123345799999999999999999999999999999999999999987654433222211111100000     


Q ss_pred             cccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          273 DGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       273 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                          ........+..+.+++..||+.||.+||+++++.+.|+
T Consensus       237 ----~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~  274 (299)
T d1ckia_         237 ----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  274 (299)
T ss_dssp             ----HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred             ----hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence                01112233456889999999999999999987766553

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-44  Score=333.76  Aligned_cols=241  Identities=22%  Similarity=0.310  Sum_probs=181.1

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCCccceehhhcchh------
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG--SKQGKKEYISEVRIISRLRHRNLVHLIGWCHEQR------  138 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  138 (387)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...  +....+.+.+|+++|+.++|||||++++++....      
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            57899999999999999999999999999999999754  3345567899999999999999999988764211      


Q ss_pred             -----------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccC
Q 043148          139 -----------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDH  195 (387)
Q Consensus       139 -----------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~  195 (387)
                                             ...+..++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||++.....
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccCc
Confidence                                   11237899999999999999   9999999999999999999999999999875543


Q ss_pred             CCCceeeeeecCCcccCchhhccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCc-------
Q 043148          196 ELGSQTTVLAGTMGYLAPECVTTGK-ASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQ-------  267 (387)
Q Consensus       196 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  267 (387)
                          ......|++.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+.......+.   .......       
T Consensus       174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~---~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGAELLKKI  246 (348)
T ss_dssp             ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCCCCHHHHTTC
T ss_pred             ----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCChHHhhhc
Confidence                233456889999999877654 6899999999999999999999998665333222211   1111000       


Q ss_pred             ----hhhhhc--ccCC-c---cccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhccCC
Q 043148          268 ----LLEAAD--GRLS-K---EFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLNFEA  317 (387)
Q Consensus       268 ----~~~~~~--~~~~-~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  317 (387)
                          ......  .... .   .........+.+|+.+||+.||.+|||++|+++|.|+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence                000000  0000 0   001123455789999999999999999999999999874

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-42  Score=316.52  Aligned_cols=234  Identities=19%  Similarity=0.242  Sum_probs=180.2

Q ss_pred             hhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCCC-CCccceehhhcchhhH-----
Q 043148           67 TNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLRH-RNLVHLIGWCHEQRQL-----  140 (387)
Q Consensus        67 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~-----  140 (387)
                      .++|.+.+.||+|+||+||+|++..+|+.||||++....  ....+.+|++.+..++| +|++.+++++.+....     
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            367999999999999999999999999999999986543  23457789999999965 8999888776543321     


Q ss_pred             --------------------HHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCC-----CCcEEEccccccccccC
Q 043148          141 --------------------ILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDS-----NFNAKLGDFGLARLVDH  195 (387)
Q Consensus       141 --------------------~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~-----~~~~kl~Dfg~~~~~~~  195 (387)
                                          ....++.|++.||.|||+   ++|+||||||+|||++.     ++.+||+|||+++....
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence                                126799999999999999   99999999999999974     56899999999987654


Q ss_pred             CCC------ceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhccCchh
Q 043148          196 ELG------SQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVRLVEWVWDLYGKGQLL  269 (387)
Q Consensus       196 ~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (387)
                      ...      .......||+.|||||.+.+..++.++||||||+++|||++|+.||..............+..........
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  238 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence            321      12334579999999999999999999999999999999999999998766544333222222211111111


Q ss_pred             hhhcccCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHhc
Q 043148          270 EAADGRLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQVINVLN  314 (387)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  314 (387)
                      +         .....++.+.+++..|++.+|.+||+++.+.+.+.
T Consensus       239 ~---------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~  274 (293)
T d1csna_         239 E---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  274 (293)
T ss_dssp             H---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             H---------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence            1         11123355888999999999999999988877654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-40  Score=313.69  Aligned_cols=244  Identities=20%  Similarity=0.230  Sum_probs=179.9

Q ss_pred             hCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-----------CCCccceehhhcc
Q 043148           68 NNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-----------HRNLVHLIGWCHE  136 (387)
Q Consensus        68 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  136 (387)
                      .+|.+.++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999999999999999997543 33567788999888775           5788888877643


Q ss_pred             hh------------------------------hHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCc-----
Q 043148          137 QR------------------------------QLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFN-----  181 (387)
Q Consensus       137 ~~------------------------------~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~-----  181 (387)
                      ..                              ...+..++.|++.||.|||+.  .+|+||||||+|||++.++.     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccc
Confidence            21                              123478999999999999973  78999999999999986653     


Q ss_pred             -EEEccccccccccCCCCceeeeeecCCcccCchhhccCCCCCccchHHHHHHHHHHHhCCCCCCCCCCcchhh---HHH
Q 043148          182 -AKLGDFGLARLVDHELGSQTTVLAGTMGYLAPECVTTGKASKESDVYSFGVVALEVACGRKPVEPRQEPSKVR---LVE  257 (387)
Q Consensus       182 -~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvil~el~tg~~p~~~~~~~~~~~---~~~  257 (387)
                       ++++|||.+......    .....||+.|+|||++....++.++||||+||+++||++|+.||..........   ...
T Consensus       170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence             899999999755432    234568999999999999999999999999999999999999997654321111   111


Q ss_pred             HHHHHhccC---------chhhhhc---------c----------cCCccccHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 043148          258 WVWDLYGKG---------QLLEAAD---------G----------RLSKEFDERQMECLMIVGLWCCHPDFTNRPSIRQV  309 (387)
Q Consensus       258 ~~~~~~~~~---------~~~~~~~---------~----------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ev  309 (387)
                      ......+..         ......+         .          .............+.+|+.+||..||.+|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            111111100         0000000         0          00123345677889999999999999999999999


Q ss_pred             HHHhccCCC
Q 043148          310 INVLNFEAP  318 (387)
Q Consensus       310 l~~l~~~~~  318 (387)
                      ++|.|+...
T Consensus       326 L~Hp~f~~~  334 (362)
T d1q8ya_         326 VNHPWLKDT  334 (362)
T ss_dssp             HTCGGGTTC
T ss_pred             hcCcccCCC
Confidence            999998743

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=3.1e-22  Score=169.74  Aligned_cols=149  Identities=19%  Similarity=0.152  Sum_probs=106.9

Q ss_pred             cccCcccccCceEEEEEEECCCCeEEEEEEecCCCh------------------hhHHHHHHHHHHHhcCCCCCccceeh
Q 043148           71 AEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSK------------------QGKKEYISEVRIISRLRHRNLVHLIG  132 (387)
Q Consensus        71 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~  132 (387)
                      .+.+.||+|+||.||+|.+. +|+.||||+++....                  ........|...+.++.|++++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            45678999999999999986 489999998753210                  11234456888999999999988765


Q ss_pred             hhcc---------h-----hhHHHHHHHHHHHHHHHHhhhhcccceeeccCCcceeEeCCCCcEEEccccccccccCCCC
Q 043148          133 WCHE---------Q-----RQLILHKIALGLASAVLYLHEEWEQCIVHRDIKSSNVVLDSNFNAKLGDFGLARLVDHELG  198 (387)
Q Consensus       133 ~~~~---------~-----~~~~l~~i~~~i~~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~  198 (387)
                      +...         .     .......++.|++.+|.|||+   ++|+||||||+|||++++ .++|+|||++.....+..
T Consensus        82 ~~~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~  157 (191)
T d1zara2          82 WEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGW  157 (191)
T ss_dssp             EETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTH
T ss_pred             ecCCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCc
Confidence            4211         1     112236789999999999999   999999999999999965 589999999976544321


Q ss_pred             ceeeeeecCCcccCc------hhhccCCCCCccchHHHHHHH
Q 043148          199 SQTTVLAGTMGYLAP------ECVTTGKASKESDVYSFGVVA  234 (387)
Q Consensus       199 ~~~~~~~g~~~y~aP------E~~~~~~~~~~~Dvws~Gvil  234 (387)
                      .         .|...      +. ..+.|+.++|+||..--+
T Consensus       158 ~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         158 R---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             H---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             H---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            1         11111      11 135678899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.90  E-value=8.8e-06  Score=70.08  Aligned_cols=129  Identities=16%  Similarity=0.121  Sum_probs=82.1

Q ss_pred             HHHHHHhhCccccCcccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCCccceehhhcchhh
Q 043148           61 RELSRATNNFAEAGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR-HRNLVHLIGWCHEQRQ  139 (387)
Q Consensus        61 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  139 (387)
                      .|+....+.|...+..+-++...||+...  ++..+.+|+...........+.+|...+..+. +--+.+++.++.+.+.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            35677777887766544444578998764  45678889886554444556677888877663 3223444444332211


Q ss_pred             HH--------------------HHHHHHHHHHHHHHhhhhc---------------------------------------
Q 043148          140 LI--------------------LHKIALGLASAVLYLHEEW---------------------------------------  160 (387)
Q Consensus       140 ~~--------------------l~~i~~~i~~~l~~LH~~~---------------------------------------  160 (387)
                      .+                    ...++.+++..+..||+..                                       
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred             eEEEEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence            00                    1345566666666666421                                       


Q ss_pred             -----------------ccceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          161 -----------------EQCIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       161 -----------------~~~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                                       ...++|+|+.|.|||+++++.+-|.||+.+.
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                             1237999999999999987777799999875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.94  E-value=0.00067  Score=59.59  Aligned_cols=62  Identities=11%  Similarity=0.110  Sum_probs=37.8

Q ss_pred             ccCHHHHHHHhhCccccCc-----ccccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcC
Q 043148           57 RFTYRELSRATNNFAEAGK-----LGEGGFGGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRL  122 (387)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l  122 (387)
                      .++.+|+.....+|...+.     |..|---+.|+....+ | .+++|++....  ..+++..|++++..|
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L   68 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHL   68 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhh
Confidence            3567888888888876543     3345556789988754 4 58999885432  233445566666655

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.92  E-value=0.0006  Score=62.02  Aligned_cols=50  Identities=12%  Similarity=0.163  Sum_probs=31.4

Q ss_pred             cCcccccCceEEEEEEECCCCeEEEEEEecCC----C---hhhHHHHHHHHHHHhcC
Q 043148           73 AGKLGEGGFGGVYRGLLSDQNTEIAVKRVSRG----S---KQGKKEYISEVRIISRL  122 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l  122 (387)
                      .+.||.|....||+.....+++.++||.-...    .   .....+...|.+.|..+
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~   87 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQ   87 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHH
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHh
Confidence            44789999999999988777888999975321    1   11233455677777655

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.70  E-value=0.0024  Score=53.73  Aligned_cols=29  Identities=17%  Similarity=0.221  Sum_probs=25.3

Q ss_pred             ceeeccCCcceeEeCCCCcEEEccccccc
Q 043148          163 CIVHRDIKSSNVVLDSNFNAKLGDFGLAR  191 (387)
Q Consensus       163 ~iiH~dlk~~Nill~~~~~~kl~Dfg~~~  191 (387)
                      .++|+|+.|.|||++++..+-|+||+.+.
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            37999999999999987767899998774

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.16  E-value=0.0031  Score=55.54  Aligned_cols=40  Identities=18%  Similarity=0.135  Sum_probs=29.4

Q ss_pred             eEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHhcCC
Q 043148           82 GGVYRGLLSDQNTEIAVKRVSRGSKQGKKEYISEVRIISRLR  123 (387)
Q Consensus        82 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  123 (387)
                      -.||+....+ |..+++|..+.. ....+++..|...+..|.
T Consensus        36 N~vy~v~~~d-g~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~   75 (325)
T d1zyla1          36 NRVYQFQDED-RRRFVVKFYRPE-RWTADQILEEHQFALQLV   75 (325)
T ss_dssp             SEEEEECCTT-CCCEEEEEECTT-TSCHHHHHHHHHHHHHHH
T ss_pred             ceeEEEEcCC-CCEEEEEEeCCC-CCCHHHHHHHHHHHHHHH
Confidence            3799998754 888999998654 234566778888887763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.05  E-value=0.056  Score=48.41  Aligned_cols=61  Identities=16%  Similarity=0.219  Sum_probs=37.7

Q ss_pred             cCcccccCceEEEEEEECCC-------CeEEEEEEecCCChhhHHHHHHHHHHHhcCCCCCc-cceehhhc
Q 043148           73 AGKLGEGGFGGVYRGLLSDQ-------NTEIAVKRVSRGSKQGKKEYISEVRIISRLRHRNL-VHLIGWCH  135 (387)
Q Consensus        73 ~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~  135 (387)
                      .+.|+.|--=.+|+....+.       +..|.+++....  .......+|..+++.+.-.++ .+++++|.
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~  115 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS  115 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence            35687788889999987542       345777766422  223445678888887742233 35666553